PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Christopher, MJ; Petti, AA; Rettig, MP; Miller, CA; Chendamarai, E; Duncavage, EJ; Klco, JM; Helton, NM; O'Laughlin, M; Fronick, CC; Fulton, RS; Wilson, RK; Wartman, LD; Welch, JS; Heath, SE; Baty, JD; Payton, JE; Graubert, TA; Link, DC; Walter, MJ; Westervelt, P; Ley, TJ; DiPersio, JF				Christopher, M. J.; Petti, A. A.; Rettig, M. P.; Miller, C. A.; Chendamarai, E.; Duncavage, E. J.; Klco, J. M.; Helton, N. M.; O'Laughlin, M.; Fronick, C. C.; Fulton, R. S.; Wilson, R. K.; Wartman, L. D.; Welch, J. S.; Heath, S. E.; Baty, J. D.; Payton, J. E.; Graubert, T. A.; Link, D. C.; Walter, M. J.; Westervelt, P.; Ley, T. J.; DiPersio, J. F.			Immune Escape of Relapsed AML Cells after Allogeneic Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; CLONAL EVOLUTION; MUTATIONAL LANDSCAPE; HOST-DISEASE; EXPRESSION; OUTCOMES; GRAFT; HLA; BLOCKADE; PATTERNS	BACKGROUND As consolidation therapy for acute myeloid leukemia (AML), allogeneic hematopoietic stem-cell transplantation provides a benefit in part by means of an immunemediated graft-versus-leukemia effect. We hypothesized that the immune-mediated selective pressure imposed by allogeneic transplantation may cause distinct patterns of tumor evolution in relapsed disease. METHODS We performed enhanced exome sequencing on paired samples obtained at initial presentation with AML and at relapse from 15 patients who had a relapse after hematopoietic stem-cell transplantation (with transplants from an HLA-matched sibling, HLA-matched unrelated donor, or HLA-mismatched unrelated donor) and from 20 patients who had a relapse after chemotherapy. We performed RNA sequencing and flow cytometry on a subgroup of these samples and on additional samples for validation. RESULTS On exome sequencing, the spectrum of gained and lost mutations observed with relapse after transplantation was similar to the spectrum observed with relapse after chemotherapy. Specifically, relapse after transplantation was not associated with the acquisition of previously unknown AML-specific mutations or structural variations in immune-related genes. In contrast, RNA sequencing of samples obtained at relapse after transplantation revealed dysregulation of pathways involved in adaptive and innate immunity, including down-regulation of major histocompatibility complex (MHC) class II genes (HLA-DPA1, HLA-DPB1, HLA-DQB1, and HLA-DRB1) to levels that were 3 to 12 times lower than the levels seen in paired samples obtained at presentation. Flow cytometry and immunohistochemical analysis confirmed decreased expression of MHC class II at relapse in 17 of 34 patients who had a relapse after transplantation. Evidence suggested that interferon-gamma treatment could rapidly reverse this phenotype in AML blasts in vitro. CONCLUSIONS AML relapse after transplantation was not associated with the acquisition of relapse- specific mutations in immune-related genes. However, it was associated with dysregulation of pathways that may influence immune function, including down-regulation of MHC class II genes, which are involved in antigen presentation. These epigenetic changes may be reversible with appropriate therapy.	[Christopher, M. J.; Petti, A. A.; Rettig, M. P.; Miller, C. A.; Chendamarai, E.; Helton, N. M.; Wartman, L. D.; Welch, J. S.; Heath, S. E.; Link, D. C.; Walter, M. J.; Westervelt, P.; Ley, T. J.; DiPersio, J. F.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO USA; [Petti, A. A.; Miller, C. A.; O'Laughlin, M.; Fronick, C. C.; Fulton, R. S.; Wartman, L. D.; Ley, T. J.] Washington Univ, McDonnell Genome Inst, St Louis, MO USA; [Duncavage, E. J.; Payton, J. E.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Baty, J. D.] Washington Univ, Div Biostat, St Louis, MO USA; [Klco, J. M.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wilson, R. K.] Nationwide Childrens Hosp, Inst Genom Med, Columbus, OH USA; [Graubert, T. A.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Massachusetts General Hospital	Ley, TJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave,Box 8007, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Miller, Christopher A./A-1060-2009	Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher A./0000-0003-4266-6700; Rettig, Michael/0000-0002-1091-0564	National Cancer Institute (NCI) K12 Program grant [CA167540]; NCI K08 Program [CA222630-01]; Specialized Program of Research Excellence Career Development Award [CA171963]; Leukemia and Lymphoma Society Scholar Award; NCI Outstanding Investigator Award [R35 CA197561]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NCI Research Specialist Awards [R50 CA211466, R50 CA211782]; Genomics of Acute Myeloid Leukemia Program Project grant [P01 CA101937]; Specialized Program of Research Excellence in Acute Myeloid Leukemia grant [P50 CA171963]; NATIONAL CANCER INSTITUTE [P01CA101937, R50CA211782, R35CA197561, P50CA171963, K08CA166229, K12CA167540, R50CA211466, K08CA222630, R35CA210084] Funding Source: NIH RePORTER	National Cancer Institute (NCI) K12 Program grant; NCI K08 Program; Specialized Program of Research Excellence Career Development Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NCI Outstanding Investigator Award; Barnes-Jewish Hospital Foundation; NCI Research Specialist Awards; Genomics of Acute Myeloid Leukemia Program Project grant; Specialized Program of Research Excellence in Acute Myeloid Leukemia grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a National Cancer Institute (NCI) K12 Program grant (CA167540, to Drs. Christopher and Petti), an NCI K08 Program grant (CA222630-01, to Dr. Christopher), a Specialized Program of Research Excellence Career Development Award (CA171963, to Dr. Christopher), NCI Research Specialist Awards (R50 CA211466, to Dr. Rettig; and R50 CA211782, to Dr. Miller), a Leukemia and Lymphoma Society Scholar Award (to Dr. Walter), a Genomics of Acute Myeloid Leukemia Program Project grant (P01 CA101937, to Drs. Ley and DiPersio), an NCI Outstanding Investigator Award (R35 CA197561, to Dr. Ley), a Barnes-Jewish Hospital Foundation grant (00335-0505-02, to Dr. Ley), and a Specialized Program of Research Excellence in Acute Myeloid Leukemia grant (P50 CA171963, to Drs. Link and DiPersio).	Albring JC, 2017, BONE MARROW TRANSPL, V52, P317, DOI 10.1038/bmt.2016.274; Bacher U, 2010, BIOL BLOOD MARROW TR, V16, P1649, DOI 10.1016/j.bbmt.2010.06.007; Della Porta MG, 2016, J CLIN ONCOL, V34, P3627, DOI 10.1200/JCO.2016.67.3616; Dermime S, 1997, BONE MARROW TRANSPL, V19, P989, DOI 10.1038/sj.bmt.1700778; Dickinson AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00496; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hamdi A, 2015, BONE MARROW TRANSPL, V50, P411, DOI 10.1038/bmt.2014.285; Hirsch P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12475; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Luskin MR, 2016, BIOL BLOOD MARROW TR, V22, P1961, DOI 10.1016/j.bbmt.2016.07.018; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Masuda K, 2007, CANCER SCI, V98, P102, DOI 10.1111/j.1349-7006.2006.00356.x; Mielcarek M, 2007, BIOL BLOOD MARROW TR, V13, P1160, DOI 10.1016/j.bbmt.2007.06.007; Pollyea DA, 2007, BONE MARROW TRANSPL, V40, P1027, DOI 10.1038/sj.bmt.1705852; Quek L, 2016, BLOOD ADV, V1, P193, DOI 10.1182/bloodadvances.2016000760; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Schmidt-Hieber M, 2010, CANCER GENET CYTOGEN, V198, P135, DOI 10.1016/j.cancergencyto.2010.01.005; Sood R, 2016, LEUKEMIA, V30, P501, DOI 10.1038/leu.2015.141; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Stolzel F, 2012, TRANSPLANTATION, V93, P744, DOI 10.1097/TP.0b013e3182481113; Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vollmer M, 2003, BRIT J HAEMATOL, V120, P1000, DOI 10.1046/j.1365-2141.2003.04212.x; Waterhouse M, 2011, BIOL BLOOD MARROW TR, V17, P1450, DOI 10.1016/j.bbmt.2011.07.012; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507; Wen HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051203; YUNIS JJ, 1989, BLOOD, V73, P931; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	33	190	193	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2018	379	24					2330	2341		10.1056/NEJMoa1808777	http://dx.doi.org/10.1056/NEJMoa1808777			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD9HM	30380364	Green Accepted, Bronze			2022-12-28	WOS:000452872600008
J	Righini, M; Robert-Ebadi, H; Elias, A; Sanchez, O; Le Moigne, E; Schmidt, J; Le Gall, C; Cornuz, J; Aujesky, D; Roy, PM; Chauleur, C; Rutschmann, OT; Poletti, PA; Le Gal, G				Righini, Marc; Robert-Ebadi, Helia; Elias, Antoine; Sanchez, Olivier; Le Moigne, Emmanuelle; Schmidt, Jeannot; Le Gall, Catherine; Cornuz, Jacques; Aujesky, Drahomir; Roy, Pierre-Marie; Chauleur, Celine; Rutschmann, Olivier T.; Poletti, Pierre-Alexandre; Le Gal, Gregoire		CT-PE-Pregnancy Grp	Diagnosis of Pulmonary Embolism During Pregnancy A Multicenter Prospective Management Outcome Study	ANNALS OF INTERNAL MEDICINE			English	Article							VENOUS THROMBOEMBOLISM DIAGNOSIS; CLINICAL-PREDICTION RULES; D-DIMER; ANGIOGRAPHY; CT; SOCIETY; ULTRASONOGRAPHY; THROMBOSIS	Background: Data on the optimal diagnostic management of pregnant women with suspected pulmonary embolism (PE) are limited, and guidelines provide inconsistent recommendations on use of diagnostic tests. Objective: To prospectively validate a diagnostic strategy in pregnant women with suspected PE. Design: Multicenter, multinational, prospective diagnostic management outcome study involving pretest clinical probability assessment, high-sensitivity D-dimer testing, bilateral lower limb compression ultrasonography (CUS), and computed tomography pulmonary angiography (CTPA). (ClinicalTrials.gov: NCT00740454) Setting: 11 centers in France and Switzerland between August 2008 and July 2016. Patients: Pregnant women with clinically suspected PE in emergency departments. Intervention: Pulmonary embolism was excluded in patients with a low or intermediate pretest clinical probability and a negative D-dimer result. All others underwent lower limb CUS and, if results were negative, CTPA. A ventilation-perfusion (V/Q) scan was done if CTPA results were inconclusive. Pulmonary embolism was excluded if results of the diagnostic work-up were negative, and untreated pregnant women had clinical follow-up at 3 months. Measurements: The primary outcome was the rate of adjudicated venous thromboembolic events during the 3-month follow-up. Results: 441 women were assessed for eligibility, and 395 were included in the study. Among these, PE was diagnosed in 28 (7.1%) (proximal deep venous thrombosis found on ultrasonography [n = 7], positive CTPA result [n = 19], and highprobability V/Q scan [n = 2]) and excluded in 367 (clinical probability and negative D-dimer result [n = 46], negative CTPA result [n = 290], normal or low-probability V/Q scan [n = 17], and other reason [n = 14]). Twenty-two women received extended anticoagulation during follow-up, mainly for previous venous thromboembolic disease. The rate of symptomatic venous thromboembolic events was 0.0% (95% CI, 0.0% to 1.0%) among untreated women after exclusion of PE on the basis of negative results on the diagnostic work-up. Limitation: There were several protocol deviations, reflecting the difficulty of performing studies in pregnant women with suspected PE. Conclusion: A diagnostic strategy based on assessment of clinical probability, D-dimer measurement, CUS, and CTPA can safely rule out PE in pregnant women.	[Righini, Marc; Robert-Ebadi, Helia] Geneva Univ Hosp, Dept Med Specialties, Div Angiol & Hemostasis, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Rutschmann, Olivier T.] Geneva Univ Hosp, Div Emergency Med, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Poletti, Pierre-Alexandre] Geneva Univ Hosp, Dept Radiol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Elias, Antoine] Ctr Hosp Toulon, Toulon, France; [Sanchez, Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Sanchez, Olivier] Hop Europeen Georges Pompidou, Serv Pneumol & Soins Intensif, 20 Rue Leblanc, F-75015 Paris, France; [Le Moigne, Emmanuelle] INSERM, UMR S 1140, Paris, France; [Le Moigne, Emmanuelle] F CRIN INNOVTE, St Etienne, France; [Le Moigne, Emmanuelle] Univ Brest, Dept Med Interne & Pneumol, Grp Etud Thrombose Bretagne Occidentale, EA3878, 2 Ave Foch, F-29609 Brest, France; [Schmidt, Jeannot] Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Le Gall, Catherine] Ctr Hosp Argenteuil, Argenteuil, France; [Cornuz, Jacques] CHU Vaudois, Dept Ambulatory Care & Community Med, Rue Bugnon 44, CH-1011 Lausanne, Switzerland; [Aujesky, Drahomir] Univ Bern, Univ Hosp Bern, Bern, Switzerland; [Roy, Pierre-Marie] Univ Hosp Angers, Dept Emergency Med, 4 Rue Larrey, F-49933 Angers, France; [Chauleur, Celine] Univ Lyon, INSERM, U1059, St Etienne, France; [Chauleur, Celine] Univ Hosp, St Etienne, France; [Le Gal, Gregoire] Univ Brest, Brest, France; [Le Gal, Gregoire] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Righini, Marc; Robert-Ebadi, Helia] Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland; [Elias, Antoine] Hop Sainte Musse, Vasc Med, 54 Rue Henri Sainte Claire, F-83056 Toulon, France; [Schmidt, Jeannot] CHU G Montpied, Ctr Hosp Univ, Pole Urgences, 58 Rue Montalembert, Clermont Ferrand, France; [Le Gall, Catherine] Ctr Hosp Gen, Emergency Dept, 69 Rue Colonel Prudhon, F-95100 Argenteuil, France; [Aujesky, Drahomir] Inselspital Bern, Bern Univ Hosp, Klin Allgemeine Innere Med, CH-3010 Bern, Switzerland; [Chauleur, Celine] St Etienne Univ Hosp, Serv Gyencol Obstet, Ave Albert Raimond, F-42270 St Etienne, France; [Le Gal, Gregoire] CHU Cavale Blanche, Brest Univ Hosp, Med Interne 1, F-29609 Brest, France	University of Geneva; University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Bretagne Occidentale; CHU Clermont Ferrand; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; Universite de Bretagne Occidentale; University of Ottawa; Ottawa Hospital Research Institute; University of Geneva; CHU Clermont Ferrand; University of Bern; University Hospital of Bern; CHU de St Etienne; CHU Brest	Righini, M (corresponding author), Geneva Univ Hosp, Dept Med Specialties, Div Angiol & Hemostasis, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.; Righini, M (corresponding author), Fac Med, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	Marc.Righini@hcuge.ch	Roy, Pierre-Marie/AAA-7737-2022; Righini, Marc/AAX-8731-2020; Robert-Ebadi, Helia/AAD-5021-2019	LE MOIGNE, Emmanuelle/0000-0001-5103-2406; Mousty, Eve/0000-0002-3648-0304	Swiss National Foundation for Scientific Research; International Society on Thrombosis and Haemostasis; Groupe d'Etude de la Thrombose de Bretagne Occidentale	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); International Society on Thrombosis and Haemostasis; Groupe d'Etude de la Thrombose de Bretagne Occidentale	Swiss National Foundation for Scientific Research, Groupe d'Etude de la Thrombose de Bretagne Occidentale, and International Society on Thrombosis and Haemostasis.	Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI [10.1097/AOG.0b013e3181a99def, 10.1097/AOG.0b013e3181aef106]; Campbell IA, 2003, THORAX, V58, P470; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chan WS, 2010, J THROMB HAEMOST, V8, P1004, DOI 10.1111/j.1538-7836.2010.03783.x; Chan WS, 2018, THROMB RES, V163, P221, DOI 10.1016/j.thromres.2017.09.003; Chan WS, 2014, J OBSTET GYNAECOL CA, V36, P527, DOI 10.1016/S1701-2163(15)30569-7; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P1040, DOI 10.1111/jth.13654; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Hunt BJ, 2018, BRIT J HAEMATOL, V180, P694, DOI 10.1111/bjh.15102; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2015, JAMA-J AM MED ASSOC, V313, P1668, DOI 10.1001/jama.2015.3703; Lee SY, 2017, TAIWAN J OBSTET GYNE, V56, P432, DOI 10.1016/j.tjog.2017.04.035; Leung AN, 2012, RADIOLOGY, V262, P635, DOI 10.1148/radiol.11114045; Linnemann B, 2016, VASA, V45, P103, DOI 10.1024/0301-1526/a000504; Liu SL, 2009, J OBSTET GYNAECOL CA, V31, P611, DOI 10.1016/S1701-2163(16)34240-2; Mclintock C, 2012, AUST NZ J OBSTET GYN, V52, P14, DOI 10.1111/j.1479-828X.2011.01361.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nijkeuter M, 2013, J THROMB HAEMOST, P11; Parker A, 2015, J THROMB HAEMOST, P13; Revel MP, 2011, RADIOLOGY, V258, P590, DOI 10.1148/radiol.10100986; Ridge CA, 2009, AM J ROENTGENOL, V193, P1223, DOI 10.2214/AJR.09.2360; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Righini M, 2015, THROMB HAEMOSTASIS, V113, P1184, DOI 10.1160/TH14-06-0530; Rodrigues JD, 2016, J THROMB HAEMOST, V14, P1765, DOI 10.1111/jth.13407; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Shahir K, 2010, AM J ROENTGENOL, V195, pW214, DOI 10.2214/AJR.09.3506; U-King-Im JM, 2008, EUR RADIOL, V18, P2709, DOI 10.1007/s00330-008-1100-0; Van der Pol LM, 2017, BLOOD REV, V31, P31, DOI 10.1016/j.blre.2016.09.003; van Mens TE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011053.pub2; Wan T, 2017, THROMB RES, V157, P23, DOI 10.1016/j.thromres.2017.06.025	35	92	94	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2018	169	11					766	+		10.7326/M18-1670	http://dx.doi.org/10.7326/M18-1670			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4WR	30357273				2022-12-28	WOS:000451806000006
J	Polovinkin, L; Hassaine, G; Perot, J; Neumann, E; Jensen, AA; Lefebvre, SN; Corringer, PJ; Neyton, J; Chipot, C; Dehez, F; Schoehn, G; Nury, H				Polovinkin, Lucie; Hassaine, Gherici; Perot, Jonathan; Neumann, Emmanuelle; Jensen, Anders A.; Lefebvre, Solene N.; Corringer, Pierre-Jean; Neyton, Jacques; Chipot, Christophe; Dehez, Francois; Schoehn, Guy; Nury, Hugues			Conformational transitions of the serotonin 5-HT3 receptor	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; MOLECULAR-DYNAMICS; ALLOSTERIC MODULATOR; AGONIST BINDING; 5-HYDROXYTRYPTAMINE; DESENSITIZATION; ACTIVATION; INTERFACE; MECHANISM	The serotonin 5-HT3 receptor is a pentameric ligand-gated ion channel (pLGIC). It belongs to a large family of receptors that function as allosteric signal transducers across the plasma membrane(1,2); upon binding of neurotransmitter molecules to extracellular sites, the receptors undergo complex conformational transitions that result in transient opening of a pore permeable to ions. 5-HT3 receptors are therapeutic targets for emesis and nausea, irritable bowel syndrome and depression(3). In spite of several reported pLGIC structures(4-8), no clear unifying view has emerged on the conformational transitions involved in channel gating. Here we report four cryo-electron microscopy structures of the full-length mouse 5-HT3 receptor in complex with the anti-emetic drug tropisetron, with serotonin, and with serotonin and a positive allosteric modulator, at resolutions ranging from 3.2 angstrom to 4.5 angstrom. The tropisetron-bound structure resembles those obtained with an inhibitory nanobody(5) or without ligand(9). The other structures include an 'open' state and two ligand-bound states. We present computational insights into the dynamics of the structures, their pore hydration and free-energy profiles, and characterize movements at the gate level and cation accessibility in the pore. Together, these data deepen our understanding of the gating mechanism of pLGICs and capture ligand binding in unprecedented detail.	[Polovinkin, Lucie; Perot, Jonathan; Neumann, Emmanuelle; Neyton, Jacques; Schoehn, Guy; Nury, Hugues] Univ Grenoble Alpes, IBS, CEA, CNRS, Grenoble, France; [Hassaine, Gherici] Theranyx, Marseille, France; [Jensen, Anders A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Lefebvre, Solene N.; Corringer, Pierre-Jean] Inst Pasteur, CNRS, UMR 3571, Channel Receptors Unit, Paris, France; [Chipot, Christophe; Dehez, Francois] Univ Lorraine, CNRS, LPCT, Nancy, France; [Chipot, Christophe; Dehez, Francois] CNRS, Lab Int Assoc, Vandoeuvre Les Nancy, France; [Chipot, Christophe; Dehez, Francois] Univ Illinois, Vandoeuvre Les Nancy, France; [Chipot, Christophe] Univ Illinois, Dept Phys, Urbana, IL USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Illinois System; University of Illinois Urbana-Champaign	Neyton, J; Nury, H (corresponding author), Univ Grenoble Alpes, IBS, CEA, CNRS, Grenoble, France.	jacques.neyton@ibs.fr; hugues.nury@ibs.fr	Polovinkin, Lucie/AAB-9056-2019; Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Lefebvre, Solene/0000-0002-1333-2042; Dehez, Francois/0000-0001-8076-6222; Nury, Hugues/0000-0002-3433-256X; Schoehn, Guy/0000-0002-1459-3201	Marie Curie CIG NeuroPenta; ERC Starting grant [637733]; FRISBI within the Grenoble PSB [ANR-10 INSB-05-02]; GRAL within the Grenoble PSB [ANR-10-LABX-49-01]; Rhone-Alpes Region; FRM; FEDER; GIS-IBISA	Marie Curie CIG NeuroPenta; ERC Starting grant(European Research Council (ERC)); FRISBI within the Grenoble PSB; GRAL within the Grenoble PSB; Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); FRM(Fondation pour la Recherche Medicale); FEDER(European Commission); GIS-IBISA	We acknowledge access to the C-CINA and ESRF Krios microscopes, and thank M. Chami, L. Kovacik, H. Stahlberg, G. Effantin, E. Kandiah and M. Hons for support. We thank L. Estrozi, M. Bacia, G. Effantin and A. Desfosses for advice on cryo-EM; the Vivaudou and Moreau laboratories for providing high-quality oocytes and help with electrophysiology; members of the Nury laboratory, M. Gielen and E. Pebay-Peyroula for discussions. The work was funded by the Marie Curie CIG NeuroPenta and ERC Starting grant 637733 (to H. N.). It used the platforms of the Grenoble Instruct-ERIC Center (ISBG: UMS 3518 CNRS-CEA-UGA-EMBL) with support from FRISBI (ANR-10 INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble PSB. The electron microscopy facility is supported by the Rhone-Alpes Region, the FRM, the FEDER and the GIS-IBISA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Comer J, 2014, J CHEM THEORY COMPUT, V10, P5276, DOI 10.1021/ct500874p; Comer J, 2015, J PHYS CHEM B, V119, P1129, DOI 10.1021/jp506633n; Corradi J, 2009, BIOPHYS J, V97, P1335, DOI 10.1016/j.bpj.2009.06.018; Cymes GD, 2012, NAT CHEM BIOL, V8, P975, DOI [10.1038/NCHEMBIO.1092, 10.1038/nchembio.1092]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Delbart F, 2018, J BIOL CHEM, V293, P2534, DOI 10.1074/jbc.M117.815316; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gasiorek A, 2016, BIOCHEM PHARMACOL, V110, P92, DOI 10.1016/j.bcp.2016.04.004; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gonzalez-Gutierrez G, 2017, J GEN PHYSIOL, V149, P1119, DOI 10.1085/jgp.201711803; Hassaine G, 2017, METHODS MOL BIOL, V1635, P139, DOI 10.1007/978-1-4939-7151-0_8; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Hu XQ, 2005, J PHYSIOL-LONDON, V568, P381, DOI 10.1113/jphysiol.2005.092866; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Menny A, 2017, ELIFE, V6, DOI 10.7554/eLife.23955; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Moreau CJ, 2015, METHOD ENZYMOL, V556, P425, DOI 10.1016/bs.mie.2014.12.017; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nemecz A, 2016, NEURON, V90, P452, DOI 10.1016/j.neuron.2016.03.032; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Ruepp MD, 2017, NEUROPHARMACOLOGY, V119, P48, DOI 10.1016/j.neuropharm.2017.01.023; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sparling BA, 2017, BIOORG MED CHEM LETT, V27, P3207, DOI 10.1016/j.bmcl.2017.04.073; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Steward LJ, 2000, MOL PHARMACOL, V57, P1249; Suryanarayanan A, 2005, BIOCHEMISTRY-US, V44, P9140, DOI 10.1021/bi050661e; Terwilliger TC, 2018, ACTA CRYSTALLOGR D, V74, P545, DOI 10.1107/S2059798318004655; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; Trick JL, 2016, STRUCTURE, V24, P2207, DOI 10.1016/j.str.2016.10.005; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Yan D, 1999, J BIOL CHEM, V274, P5537, DOI 10.1074/jbc.274.9.5537; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu FQ, 2012, BIOPHYS J, V103, P219, DOI 10.1016/j.bpj.2012.06.003	74	80	81	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					275	+		10.1038/s41586-018-0672-3	http://dx.doi.org/10.1038/s41586-018-0672-3			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401839	Green Accepted, Green Submitted			2022-12-28	WOS:000449943600049
J	Trost, BM; Huang, ZX; Murhade, GM				Trost, Barry M.; Huang, Zhongxing; Murhade, Ganesh M.			Catalytic palladium-oxyallyl cycloaddition	SCIENCE			English	Article							IRON CARBONYL; OXATRIMETHYLENEMETHANE PALLADIUM; STEREOSELECTIVE-SYNTHESIS; 1,3-DIENES; KETONES; REARRANGEMENT; COMPLEXES; CYCLOPROPANATION; HYDROCARBONS; INHIBITORS	Exploration of intermediates that enable chemoselective cycloaddition reactions and expeditious construction of fused-or bridged-ring systems is a continuous challenge for organic synthesis. As an intermediate of interest, the oxyallyl cation has been harnessed to synthesize architectures containing seven-membered rings via (4+3) cycloaddition. However, its potential to access five-membered skeletons is underdeveloped, largely due to the thermally forbidden (3+2) pathway. Here, the combination of a tailored precursor and a Pd(0) catalyst generates a Pd-oxyallyl intermediate that cyclizes with conjugated dienes to produce a diverse array of tetrahydrofuran skeletons. The cycloaddition overrides conventional (4+3) selectivity by proceeding through a stepwise pathway involving a Pd-allyl transfer and ring closure sequence. Subsequent treatment of the (3+2) adducts with a palladium catalyst converts the heterocycles to the carbocyclic cyclopentanones.	[Trost, Barry M.; Huang, Zhongxing; Murhade, Ganesh M.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Trost, BM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bmtrost@stanford.edu	Murhade, Ganesh/ABE-4024-2021; Murhade, Ganesh/ABG-7707-2021	Murhade, Ganesh/0000-0002-7042-789X; Murhade, Ganesh/0000-0002-7042-789X; Huang, Zhongxing/0000-0003-0196-3469	NSF [CHE-1360634]; NIH [GM033049]; Tamaki Foundation; SERB Indo-U.S.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033049] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tamaki Foundation; SERB Indo-U.S.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NSF (CHE-1360634) and the NIH (GM033049) for support of our programs. We are also grateful to the Tamaki Foundation for financial support. G.M.M. acknowledges the SERB Indo-U.S. Postdoctoral Fellowship for additional financial support.	Allen BDW, 2017, CHEM-EUR J, V23, P13830, DOI 10.1002/chem.201702486; Baran A, 2009, J ORG CHEM, V74, P88, DOI 10.1021/jo801344f; BOTICA I, 1971, AUST J CHEM, V24, P1467, DOI 10.1071/CH9711467; Brioche JCR, 2010, ORG LETT, V12, P4832, DOI 10.1021/ol102213s; BROUGHTON HB, 1986, J CHEM SOC CHEM COMM, P46, DOI 10.1039/c39860000046; CONTICELLO VP, 1992, J AM CHEM SOC, V114, P9708, DOI 10.1021/ja00050a088; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Fraser A. W., 2013, ENCY REAGENTS ORGANI, DOI [10.1002/0470842889X.RN01644, DOI 10.1002/0470842889X.RN01644]; FREEMAN PK, 1990, J ORG CHEM, V55, P3867, DOI 10.1021/jo00299a032; Fruhauf HW, 1997, CHEM REV, V97, P523, DOI 10.1021/cr941164z; HAYAKAWA Y, 1978, J AM CHEM SOC, V100, P1791, DOI 10.1021/ja00474a022; HOFFMANN HMR, 1984, ANGEW CHEM INT EDIT, V23, P1, DOI 10.1002/anie.198400013; HUGHES RP, 1972, J AM CHEM SOC, V94, P7723, DOI 10.1021/ja00777a600; Ikeda I, 1996, J ORG CHEM, V61, P4971, DOI 10.1021/jo951425k; Johnson R. A., 2004, ORG REACTIONS, V63, P117, DOI DOI 10.1002/EJOC.201800139; Kobayashi S., 2001, CYCLOADDITION REACTI; Koltun ES, 2000, J ORG CHEM, V65, P3530, DOI 10.1021/jo000215r; Kuga T, 2018, CHEM COMMUN, V54, P798, DOI 10.1039/c7cc08957k; Lautens M, 1996, CHEM REV, V96, P49, DOI 10.1021/cr950016l; Liu MT, 2018, ORG BIOMOL CHEM, V16, P2541, DOI [10.1039/c8ob00205c, 10.1039/C8OB00205C]; Lo BA, 2011, ORG LETT, V13, P864, DOI 10.1021/ol102897d; Madden KS, 2015, CHEM COMMUN, V51, P11409, DOI 10.1039/c5cc03273c; MALEK J, 1975, J ORGANOMET CHEM, V84, P139, DOI 10.1016/S0022-328X(00)90027-5; MANN J, 1986, TETRAHEDRON, V42, P4611, DOI 10.1016/S0040-4020(01)82046-9; Marcum JS, 2017, J AM CHEM SOC, V139, P15580, DOI 10.1021/jacs.7b08575; Masuya K, 1998, J AM CHEM SOC, V120, P1724, DOI 10.1021/ja972879x; Morii H, 2013, J BIOCHEM, V153, P257, DOI 10.1093/jb/mvs141; Nakamura E., 2003, ORG REACTIONS, V61, P1; Nasveschuk CG, 2008, ORG BIOMOL CHEM, V6, P240, DOI 10.1039/b714881j; NOYORI R, 1979, ACCOUNTS CHEM RES, V12, P61, DOI 10.1021/ar50134a003; NOYORI R, 1972, J AM CHEM SOC, V94, P7202, DOI 10.1021/ja00775a084; NOYORI R, 1983, ORG REACTIONS, V29, P163; OHE K, 1993, J ORG CHEM, V58, P1173, DOI 10.1021/jo00057a033; Ponder B. W., 1971, ORG PREP P INT, V3, P171, DOI 10.1080/00304947109356063; Radomkit S, 2011, TETRAHEDRON, V67, P3904, DOI 10.1016/j.tet.2011.03.059; REICH HJ, 1982, J AM CHEM SOC, V104, P7051, DOI 10.1021/ja00389a028; Romanski S, 2012, DALTON T, V41, P13862, DOI 10.1039/c2dt30662j; Suhrada CP, 1999, TETRAHEDRON, V55, P14547, DOI 10.1016/S0040-4020(99)00929-1; Surry DS, 2011, CHEM SCI, V2, P27, DOI 10.1039/c0sc00331j; TAKAHASH.Y, 1969, J ORGANOMET CHEM, V16, P177, DOI 10.1016/S0022-328X(00)81647-2; Tortajada A, 2018, J AM CHEM SOC, V140, P2050, DOI 10.1021/jacs.7b13220; TROST BM, 1990, TETRAHEDRON LETT, V31, P615, DOI 10.1016/S0040-4039(00)94582-9; TROST BM, 1989, J AM CHEM SOC, V111, P4430, DOI 10.1021/ja00194a043; TROST BM, 1986, ANGEW CHEM INT EDIT, V25, P1, DOI 10.1002/anie.198600013; TROST BM, 1981, J AM CHEM SOC, V103, P7550, DOI 10.1021/ja00415a024; Nguyen TT, 2018, ANGEW CHEM INT EDIT, V57, P1688, DOI 10.1002/anie.201711968; Wang SJ, 2013, J AGR FOOD CHEM, V61, P5122, DOI 10.1021/jf401612t; Wu J, 2015, SYNTHESIS-STUTTGART, V47, P22, DOI 10.1055/s-0034-1378918; Yasukawa N, 2018, GREEN CHEM, V20, P1213, DOI 10.1039/c7gc03819d	49	32	32	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		564	+		10.1126/science.aau4821	http://dx.doi.org/10.1126/science.aau4821			91	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385573				2022-12-28	WOS:000450460000041
J	Wall, S; Yang, S; Vidas, L; Chollet, M; Glownia, JM; Kozina, M; Katayama, T; Henighan, T; Jiang, M; Miller, TA; Reis, DA; Boatner, LA; Delaire, O; Trigo, M				Wall, Simon; Yang, Shan; Vidas, Luciana; Chollet, Matthieu; Glownia, James M.; Kozina, Michael; Katayama, Tetsuo; Henighan, Thomas; Jiang, Mason; Miller, Timothy A.; Reis, David A.; Boatner, Lynn A.; Delaire, Olivier; Trigo, Mariano			Ultrafast disordering of vanadium dimers in photoexcited VO2	SCIENCE			English	Article							STRUCTURAL PHASE-TRANSITIONS; METAL-INSULATOR TRANSITIONS; X-RAY-SCATTERING; LATTICE INSTABILITY; MOLECULAR-DYNAMICS; OPTICAL-PROPERTIES; VISUALIZATION; SOLIDS; DRIVEN; ORDER	Many ultrafast solid phase transitions are treated as chemical reactions that transform the structures between two different unit cells along a reaction coordinate, but this neglects the role of disorder. Although ultrafast diffraction provides insights into atomic dynamics during such transformations, diffraction alone probes an averaged unit cell and is less sensitive to randomness in the transition pathway. Using total scattering of femtosecond x-ray pulses, we show that atomic disordering in photoexcited vanadium dioxide (VO2) is central to the transition mechanism and that, after photoexcitation, the system explores a large volume of phase space on a time scale comparable to that of a single phonon oscillation. These results overturn the current understanding of an archetypal ultrafast phase transition and provide new microscopic insights into rapid evolution toward equilibrium in photoexcited matter.	[Wall, Simon; Vidas, Luciana; Miller, Timothy A.] Barcelona Inst Sci & Technol, Inst Ciencies Fotoniques ICFO, Barcelona 08860, Spain; [Yang, Shan; Delaire, Olivier] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Chollet, Matthieu; Glownia, James M.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Kozina, Michael; Henighan, Thomas; Jiang, Mason; Reis, David A.; Trigo, Mariano] SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA; [Katayama, Tetsuo] Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Hyogo 6795198, Japan; [Reis, David A.; Trigo, Mariano] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Reis, David A.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Boatner, Lynn A.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Delaire, Olivier] Duke Univ, Dept Phys, Durham, NC 27708 USA	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Duke University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Japan Synchrotron Radiation Research Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Duke University	Wall, S (corresponding author), Barcelona Inst Sci & Technol, Inst Ciencies Fotoniques ICFO, Barcelona 08860, Spain.; Delaire, O (corresponding author), Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA.; Trigo, M (corresponding author), SLAC Natl Accelerator Lab, Stanford PULSE Inst, Menlo Pk, CA 94025 USA.; Trigo, M (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.; Delaire, O (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	simon.wall@icfo.eu; olivier.delaire@duke.edu; mtrigo@slac.stanford.edu	Wall, Simon/E-3771-2012; Delaire, Olivier/AAZ-7838-2020; Miller, Timothy/C-9128-2011	Wall, Simon/0000-0002-6136-0224; Kozina, Michael/0000-0002-4747-345X; chollet, matthieu/0000-0002-9629-890X; Miller, Timothy/0000-0002-5585-7736; Delaire, Olivier/0000-0003-1230-2834	Spanish MINECO [SEV-2015-0522]; Ramon y Cajal programme [RYC-2013-14838]; Fondo Europeo de Desarrollo Regional [FIS2015-67898-P]; European Union's Horizon 2020 research and innovation programme Fundacio Privada Cellex [758461]; CERCA Programme - Generalitat de Catalunya; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under the Early Career Award [DE-SC0016166]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences through the Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231, DE-AC05-00OR22725]	Spanish MINECO(Spanish Government); Ramon y Cajal programme(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); European Union's Horizon 2020 research and innovation programme Fundacio Privada Cellex(Foundation CELLEX); CERCA Programme - Generalitat de Catalunya; U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under the Early Career Award(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences through the Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	Work at ICFO was supported by Spanish MINECO (Severo Ochoa grant SEV-2015-0522), Ramon y Cajal programme RYC-2013-14838, and Fondo Europeo de Desarrollo Regional FIS2015-67898-P (MINECO/FEDER), as well as by the European Union's Horizon 2020 research and innovation programme (grant agreement no. 758461) Fundacio Privada Cellex, and CERCA Programme - Generalitat de Catalunya. First-principles simulations and analysis (S.Y., O.D.) were supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, Materials Sciences and Engineering Division, under the Early Career Award no. DE-SC0016166. M.K., T.H., M.T., and D.A.R. were supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences through the Division of Materials Sciences and Engineering under contract no. DE-AC02-76SF00515. Use of the Linac Coherent Light Source (LCLS), and the Stanford Synchrotron Radiation Lightsource at SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. Additional x-ray measurements were performed at BL3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2016A8008). Ab initio calculations were performed using resources of the National Energy Research Scientific Computing Center, a U.S. DOE Office of Science User Facility supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. First principles simulations for this research used resources of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC05-00OR22725.	Aroyo MI, 2014, ACTA CRYSTALLOGR A, V70, P126, DOI 10.1107/S205327331303091X; Basov DN, 2017, NAT MATER, V16, P1077, DOI [10.1038/NMAT5017, 10.1038/nmat5017]; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Beaud P, 2014, NAT MATER, V13, P923, DOI [10.1038/nmat4046, 10.1038/NMAT4046]; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; BREWS JR, 1970, PHYS REV B, V1, P2557, DOI 10.1103/PhysRevB.1.2557; BRUCE AD, 1980, ADV PHYS, V29, P111, DOI 10.1080/00018738000101356; Budai JD, 2014, NATURE, V515, P535, DOI 10.1038/nature13865; Cavalleri A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161102; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chollet M, 2015, J SYNCHROTRON RADIAT, V22, P503, DOI 10.1107/S1600577515005135; COWLEY RA, 1980, ADV PHYS, V29, P1, DOI 10.1080/00018738000101346; Eyert V, 2002, ANN PHYS-BERLIN, V11, P650, DOI 10.1002/1521-3889(200210)11:9<650::AID-ANDP650>3.0.CO;2-K; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; GERVAIS F, 1985, PHYS REV B, V31, P4809, DOI 10.1103/PhysRevB.31.4809; GUPTA M, 1977, PHYS REV B, V16, P3338, DOI 10.1103/PhysRevB.16.3338; Hada M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.153401; Hellman O, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.104111; Hellmann S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2078; Ichikawa H, 2011, NAT MATER, V10, P101, DOI 10.1038/nmat2929; Katayama I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097401; Kolobov AV, 2011, NAT CHEM, V3, P311, DOI [10.1038/NCHEM.1007, 10.1038/nchem.1007]; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kubler C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116401; Liebsch A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.085109; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; LONGO JM, 1970, ACTA CHEM SCAND, V24, P420, DOI 10.3891/acta.chem.scand.24-0420; Mankowsky R, 2014, NATURE, V516, P71, DOI 10.1038/nature13875; MAREZIO M, 1972, PHYS REV B-SOLID ST, V5, P2541, DOI 10.1103/PhysRevB.5.2541; MCWHAN DB, 1974, PHYS REV B, V10, P490, DOI 10.1103/PhysRevB.10.490; Morrison VR, 2014, SCIENCE, V346, P445, DOI 10.1126/science.1253779; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rog T, 2003, J COMPUT CHEM, V24, P657, DOI 10.1002/jcc.10243; Lee S, 2017, SCIENCE, V355, P371, DOI 10.1126/science.aag0410; TERAUCHI H, 1978, PHYS REV B, V17, P2494, DOI 10.1103/PhysRevB.17.2494; Togo A, 2015, SCRIPTA MATER, V108, P1, DOI 10.1016/j.scriptamat.2015.07.021; Trigo M, 2013, NAT PHYS, V9, P790, DOI [10.1038/NPHYS2788, 10.1038/nphys2788]; VERLEUR HW, 1968, PHYS REV, V172, P788, DOI 10.1103/PhysRev.172.788; Waldecker L, 2015, NAT MATER, V14, P991, DOI [10.1038/NMAT4359, 10.1038/nmat4359]; Waseda Y., 2011, XRAY DIFFRACTION CRY; Yuan X, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035119	47	113	116	12	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		572	+		10.1126/science.aau3873	http://dx.doi.org/10.1126/science.aau3873			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385575	Green Submitted			2022-12-28	WOS:000450460000043
J	Economo, MN; Viswanathan, S; Tasic, B; Bas, E; Winnubst, J; Menon, V; Graybuck, LT; Nguyen, TN; Smith, KA; Yao, ZZ; Wang, LH; Gerfen, CR; Chandrashekar, J; Zeng, HK; Looger, LL; Svoboda, K				Economo, Michael N.; Viswanathan, Sarada; Tasic, Bosiljka; Bas, Erhan; Winnubst, Johan; Menon, Vilas; Graybuck, Lucas T.; Thuc Nghi Nguyen; Smith, Kimberly A.; Yao, Zizhen; Wang, Lihua; Gerfen, Charles R.; Chandrashekar, Jayaram; Zeng, Hongkui; Looger, Loren L.; Svoboda, Karel			Distinct descending motor cortex pathways and their roles in movement	NATURE			English	Article							RANGE CORTICOFUGAL AXONS; ANTICIPATORY ACTIVITY; CORTICAL ACTIVITY; NEURONS; CELL; RAT; ORGANIZATION; CIRCUITS; COLLATERALS; MECHANISMS	Activity in the motor cortex predicts movements, seconds before they are initiated. This preparatory activity has been observed across cortical layers, including in descending pyramidal tract neurons in layer 5. A key question is how preparatory activity is maintained without causing movement, and is ultimately converted to a motor command to trigger appropriate movements. Here, using single-cell transcriptional profiling and axonal reconstructions, we identify two types of pyramidal tract neuron. Both types project to several targets in the basal ganglia and brainstem. One type projects to thalamic regions that connect back to motor cortex; populations of these neurons produced early preparatory activity that persisted until the movement was initiated. The second type projects to motor centres in the medulla and mainly produced late preparatory activity and motor commands. These results indicate that two types of motor cortex output neurons have specialized roles in motor control.	[Economo, Michael N.; Viswanathan, Sarada; Bas, Erhan; Winnubst, Johan; Menon, Vilas; Wang, Lihua; Chandrashekar, Jayaram; Looger, Loren L.; Svoboda, Karel] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Tasic, Bosiljka; Graybuck, Lucas T.; Thuc Nghi Nguyen; Smith, Kimberly A.; Yao, Zizhen; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Gerfen, Charles R.] NIMH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Allen Institute for Brain Science; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Menon, Vilas/AAG-4109-2021	Menon, Vilas/0000-0002-4096-8601; Economo, Michael/0000-0001-9893-1505; Chandrashekar, jayaram/0000-0001-6412-0114; Nguyen, Thuc Nghi/0000-0002-6466-5883	Howard Hughes Medical Institute; Allen Institute for Brain Science; NIH Brain Initiative [U01MH105982]; Intramural Research Program of the NIMH [ZIA-MH002497-29]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002497, U01MH105982] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Allen Institute for Brain Science; NIH Brain Initiative; Intramural Research Program of the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Lemire and K. Aswath for single-cell sorting and bulk RNA-seq, S. Lindo for stereotaxic surgeries, D. Kao and T. Wang for help with RNA-seq analysis, D. Alcor for imaging assistance, and N. Li and H. Inagaki for help with electrophysiological recordings and for discussion. We thank M. Cembrowski, E. Bloss and F. Henry for discussion. H. Inagaki, M. Sherman, S. Romani, L. Luo, G. Shepherd and T. Wang provided comments on the manuscript. Imaging and reconstructions of neuronal morphology was performed by the Janelia MouseLight project (http://mouselight.janelia.org/).This work was funded by the Howard Hughes Medical Institute, the Allen Institute for Brain Science, the NIH Brain Initiative (U01MH105982 to H.Z.), and the Intramural Research Program of the NIMH (ZIA-MH002497-29 to C.R.G).	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CATSMANBERREVOETS CE, 1981, BRAIN RES, V218, P15, DOI 10.1016/0006-8993(81)90986-0; Chen TW, 2017, NEURON, V94, P866, DOI 10.1016/j.neuron.2017.05.005; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; DESCHENES M, 1994, BRAIN RES, V664, P215, DOI 10.1016/0006-8993(94)91974-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Druckmann S, 2012, CURR BIOL, V22, P2095, DOI 10.1016/j.cub.2012.08.058; Economon MN, 2016, ELIFE, V5, DOI 10.7554/eLife.10566; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; Jun J. J., 2017, PREPRINT; Kaufman MT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0085-16.2016; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kawaguchi Y, 2017, CEREB CORTEX, V27, P5755, DOI 10.1093/cercor/bhx252; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Kuypers H.G.J.M., 1981, COMPREHENSIVE PHYSL; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Leeden R., 2008, HDB MULTILEVEL ANAL, P401, DOI [10.1007/978-0-387-73186-5_11, DOI 10.1007/978-0-387-73186-5_11]; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Paletzki R., 2015, CURR PROTOC NEUROSCI, V73; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Stanek E, 2014, ELIFE, V3, DOI 10.7554/eLife.02511; STERIADE M, 1977, EXP NEUROL, V56, P334, DOI 10.1016/0014-4886(77)90352-1; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Svoboda K, 2018, CURR OPIN NEUROBIOL, V49, P33, DOI 10.1016/j.conb.2017.10.023; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; TOWE AL, 1964, EXP NEUROL, V10, P325, DOI 10.1016/0014-4886(64)90004-4; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Turner RS, 2000, J NEUROSCI, V20, P7096, DOI 10.1523/JNEUROSCI.20-18-07096.2000; von Economo CF, 1929, CYTOARCHITECTONICS H; Wang XH, 2017, CELL, V171, P440, DOI 10.1016/j.cell.2017.08.014; Yamawaki N, 2015, J NEUROSCI, V35, P2293, DOI 10.1523/JNEUROSCI.4023-14.2015	54	149	150	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					79	+		10.1038/s41586-018-0642-9	http://dx.doi.org/10.1038/s41586-018-0642-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382200	Green Submitted			2022-12-28	WOS:000448900900048
J	Iacobucci, G				Iacobucci, Gareth			Prisoners' health: government must do more, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health and Social Care Committee, 2018, PRIS HLTH 12 REP SES	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4607	10.1136/bmj.k4607	http://dx.doi.org/10.1136/bmj.k4607			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385432				2022-12-28	WOS:000449565500011
J	Simon, CS; Hadjantonakis, AK				Simon, Claire S.; Hadjantonakis, Anna-Katerina			Top to Tail: Anterior-Posterior Patterning Precedes Regional Nervous System Identity	CELL			English	Editorial Material							INDUCTION	In this issue, Metzis et al., demonstrate that in the development of the central nervous system, patterning along the anterior-posterior axis precedes acquisition of neural identity. This contrasts with the prevailing view that neural identity comes first, providing a new window on the origins of the brain and spinal cord.	[Simon, Claire S.; Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Hadjantonakis, AK (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	hadj@mskcc.org		Simon, Claire/0000-0001-9614-1403				Arkell RM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120030; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Metzis V, 2018, CELL, V175, P1105, DOI 10.1016/j.cell.2018.09.040; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Spemann H., 1924, ARCH MIKROSKOPISCHE, V100, P458; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002	10	1	1	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					905	907		10.1016/j.cell.2018.10.040	http://dx.doi.org/10.1016/j.cell.2018.10.040			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388450	Bronze			2022-12-28	WOS:000449100600006
J	Wroblewska, A; Dhainaut, M; Ben-Zvi, B; Rose, SA; Park, ES; Amir, ED; Bektesevic, A; Baccarini, A; Merad, M; Rahman, AH; Brown, BD				Wroblewska, Aleksandra; Dhainaut, Maxime; Ben-Zvi, Benjamin; Rose, Samuel A.; Park, Eun Sook; Amir, El-Ad David; Bektesevic, Anela; Baccarini, Alessia; Merad, Miriam; Rahman, Adeeb H.; Brown, Brian D.			Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens	CELL			English	Article							MASS CYTOMETRY; CANCER-IMMUNOTHERAPY; GENETIC SCREENS; GENOME; IMMUNE; LIBRARIES; VISUALIZATION; CIRCUITS; BLOCKADE; MELANOMA	CRISPR pools are being widely employed to identify gene functions. However, current technology, which utilizes DNA as barcodes, permits limited phenotyping and bulk-cell resolution. To enable novel screening capabilities, we developed a barcoding system operating at the protein level. We synthesized modules encoding triplet combinations of linear epitopes to generate >100 unique protein barcodes (Pro-Codes). Pro-Code-expressing vectors were introduced into cells and analyzed by CyTOF mass cytometry. Using just 14 antibodies, we detected 364 Pro-Code populations; establishing the largest set of protein-based reporters. By pairing each Pro-Code with a different CRISPR, we simultaneously analyzedmultiple phenotypic markers, including phospho-signaling, on dozens of knockouts. Pro-Code/CRISPR screens found two interferon-stimulated genes, the immunoproteasome component Psmb8 and a chaperone Rtp4, are important for antigen-dependent immune editing of cancer cells and identified Socs1 as a negative regulator of Pd-l1. The Pro-Code technology enables simultaneous high-dimensional proteinlevel phenotyping of 100s of genes with single-cell resolution.	[Wroblewska, Aleksandra; Dhainaut, Maxime; Rose, Samuel A.; Amir, El-Ad David; Merad, Miriam; Rahman, Adeeb H.; Brown, Brian D.] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Wroblewska, Aleksandra; Dhainaut, Maxime; Ben-Zvi, Benjamin; Rose, Samuel A.; Park, Eun Sook; Bektesevic, Anela; Baccarini, Alessia; Rahman, Adeeb H.; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Amir, El-Ad David; Merad, Miriam; Rahman, Adeeb H.; Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Amir, El-Ad David; Rahman, Adeeb H.] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Brown, Brian D.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Brown, Brian D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.	brian.brown@mssm.edu		Dhainaut, Maxime/0000-0003-3832-7095; Rose, Samuel/0000-0001-9701-0050; Wroblewska, Aleksandra/0000-0003-2059-6158	NIH [R01AI113221, R33CA182377, U19AI128949, S10OD023547]; Belgian American Educational Foundation; OCRFA Liz Tilberis Award; NATIONAL CANCER INSTITUTE [R33CA182377, R01CA154947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113221, U19AI128949, U24AI118644] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian American Educational Foundation; OCRFA Liz Tilberis Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Brody and L. Devi (Mount Sinai), J. Agudo (Harvard), and A. Telesnitsky (Michigan) for helpful discussions, A. Ventura (Sloan Kettering) and S. Elledge (Harvard) for helpful comments on the manuscript, and the Mount Sinai Human Immune Monitoring Center and Eduardo Farias for technical assistance. B.D.B. was supported by NIH (R01AI113221 and R33CA182377). M.M. was supported by NIH (U19AI128949). M.D. was supported by the Belgian American Educational Foundation. A. Baccarini was supported by the OCRFA Liz Tilberis Award. This work utilized a Helios mass cytometer supported by NIH (S10OD023547).	Adamson B., 2018, BIORXIV, V298349, DOI [10.1101/298349, DOI 10.1101/298349]; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/NMETH.1330, 10.1038/nmeth.1330]; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feldman D., 2018, LENTIVIRAL COPACKAGI, DOI [10.1101/262121, DOI 10.1101/262121]; Fread KI, 2017, BIOCOMPUT-PAC SYM, P588, DOI 10.1142/9789813207813_0054; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Hill AJ, 2018, NAT METHODS, V15, P271, DOI [10.1038/NMETH.4604, 10.1038/nmeth.4604]; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; King SR, 2008, J VIROL, V82, P2376, DOI 10.1128/JVI.02100-07; Kotecha N., 2010, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY1017S53; Lee M, 2019, CANCER RES TREAT, V51, P80, DOI 10.4143/crt.2017.500; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Minn AJ, 2016, CELL, V165, P272, DOI 10.1016/j.cell.2016.03.031; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/NMETH.2078, 10.1038/nmeth.2078]; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Sack LM, 2016, G3-GENES GENOM GENET, V6, P2781, DOI 10.1534/g3.116.030973; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schumacher TN, 2016, CURR OPIN IMMUNOL, V41, P98, DOI 10.1016/j.coi.2016.07.005; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	37	51	53	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1141	+		10.1016/j.cell.2018.09.022	http://dx.doi.org/10.1016/j.cell.2018.09.022			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30343902	Green Accepted, Bronze			2022-12-28	WOS:000449100600024
J	Kmietowicz, Z				Kmietowicz, Zosia			Health of 1.8 billion children is at serious risk from air pollution, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2018, WHOCEDPHE1801	1	2	2	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4580	10.1136/bmj.k4580	http://dx.doi.org/10.1136/bmj.k4580			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377202				2022-12-28	WOS:000449563200006
J	Hershkovitz, I; Duval, M; Grun, R; Mercier, N; Valladas, H; Ayalon, A; Bar-Matthews, M; Weber, GW; Quam, R; Zaidner, Y; Weinstein-Evron, M				Hershkovitz, Israel; Duval, Mathieu; Grun, Rainer; Mercier, Norbert; Valladas, Helene; Ayalon, Avner; Bar-Matthews, Miryam; Weber, Gerhard W.; Quam, Rolf; Zaidner, Yossi; Weinstein-Evron, Mina			Response to Comment on "The earliest modern humans outside Africa"	SCIENCE			English	Editorial Material							MISLIYA CAVE; MOUNT-CARMEL; ISRAEL; TOOTH	Our original claim, based on three independent numerical dating methods, of an age of similar to 185,000 years for the Misliya-1 modern human hemi-maxilla from Mount Carmel, Israel, is little affected by discounting uranium-series dating of adhering crusts. It confirms a much earlier out-of-Africa Homo sapiens expansion than previously suggested by the considerably younger (90,000 to 120,000 years) Skhul/Qafzeh hominins.	[Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Hershkovitz, Israel] Tel Aviv Univ, Dan David Ctr Human Evolut & Biohist Res, Steinhardt Museum Nat Hist, IL-6997801 Tel Aviv, Israel; [Hershkovitz, Israel] Tel Aviv Univ, Shmunis Family Anthropol Inst, Steinhardt Museum Nat Hist, IL-6997801 Tel Aviv, Israel; [Duval, Mathieu; Grun, Rainer] Griffith Univ, ARCHE, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Duval, Mathieu] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos 09002, Spain; [Grun, Rainer] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Mercier, Norbert] Univ Bordeaux Montaigne, Inst Rech Archeomateriaux, Ctr Rech Phys Appl Archeol CRP2A, CNRS,UMR 5060,Maison Archeol, F-33607 Pessac, France; [Valladas, Helene] UVSQ, CNRS, CEA, IPSL,LSCE,UMR, F-91198 Gif Sur Yvette, France; [Ayalon, Avner; Bar-Matthews, Miryam] Geol Survey Israel, IL-95501 Jerusalem, Israel; [Weber, Gerhard W.] Univ Vienna, Dept Anthropol, A-1090 Vienna, Austria; [Weber, Gerhard W.] Univ Vienna, Core Facil Microcomputed Tomog, A-1090 Vienna, Austria; [Quam, Rolf] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Zaidner, Yossi; Weinstein-Evron, Mina] Univ Haifa, Zinman Inst Archaeol, IL-3498838 Har Hakarmel, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Griffith University; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Australian National University; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Geological Survey Israel; University of Vienna; University of Vienna; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Haifa	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel.; Hershkovitz, I (corresponding author), Tel Aviv Univ, Dan David Ctr Human Evolut & Biohist Res, Steinhardt Museum Nat Hist, IL-6997801 Tel Aviv, Israel.; Hershkovitz, I (corresponding author), Tel Aviv Univ, Shmunis Family Anthropol Inst, Steinhardt Museum Nat Hist, IL-6997801 Tel Aviv, Israel.	anatom2@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020; Weber, Gerhard W/F-2583-2010; Duval, Mathieu/U-9446-2018	Hershkovitz, Israel/0000-0001-5841-6090; Weber, Gerhard W/0000-0002-8542-6259; Duval, Mathieu/0000-0003-3181-7753; Zaidner, Yossi/0000-0002-4247-4824; Quam, Rolf/0000-0002-1140-5615; Mercier, Norbert/0000-0002-6375-9108	Australian Research Council [FT150100215]	Australian Research Council(Australian Research Council)	M.D.'s research is currently funded by the Australian Research Council Future Fellowship grant FT150100215.	Duval M, 2018, QUAT GEOCHRONOL, V47, P120, DOI 10.1016/j.quageo.2018.05.001; Duval M, 2017, AM J PHYS ANTHROPOL, V163, P205, DOI 10.1002/ajpa.23180; Grun R, 2012, ARCHAEOL ANTHROP SCI, V4, P25, DOI 10.1007/s12520-011-0079-7; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Mercier N, 2007, J ARCHAEOL SCI, V34, P1064, DOI 10.1016/j.jas.2006.09.021; Mercier N, 2003, J HUM EVOL, V45, P401, DOI 10.1016/j.jhevol.2003.09.004; Sharp WD, 2018, SCIENCE, V362, DOI 10.1126/science.aat6598; Valladas H, 2013, J HUM EVOL, V65, P585, DOI 10.1016/j.jhevol.2013.07.005; Weinstein-Evron M., 2012, PALEOANTHROPOLOGY, V2012, P202, DOI [DOI 10.4207/PA.2012.ART75, 10.4207/PA.2012.ART75]; Yeshurun R, 2007, J HUM EVOL, V53, P656, DOI 10.1016/j.jhevol.2007.05.008; Zaidner Y., 2012, FARMING, V2012, P1	11	7	7	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413							eaat8964	10.1126/science.aat8964	http://dx.doi.org/10.1126/science.aat8964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361343	Green Published			2022-12-28	WOS:000450441900002
J	Woolston, C				Woolston, Chris			Paths less travelled	NATURE			English	Editorial Material																			0	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					611	614		10.1038/d41586-018-07111-8	http://dx.doi.org/10.1038/d41586-018-07111-8			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY1HQ	30356203	Bronze			2022-12-28	WOS:000448277800062
J	Slomski, A				Slomski, Anita			THC for Chronic Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1631	1631		10.1001/jama.2018.16202	http://dx.doi.org/10.1001/jama.2018.16202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357293				2022-12-28	WOS:000448069100031
J	Graham, C; Laffan, K; Pinto, S				Graham, Carol; Laffan, Kate; Pinto, Sergio			Well-being in metrics and policy	SCIENCE			English	Editorial Material							HAPPINESS; INCOME; PARADOX; PANEL		[Graham, Carol] Brookings Inst, Global Econ & Dev Program, Washington, DC 20036 USA; [Laffan, Kate] London Sch Econ, Psychol & Behav Sci Dept, London WC2 AZAE, England; [Pinto, Sergio] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA	Brookings Institution; University of London; London School Economics & Political Science; University System of Maryland; University of Maryland College Park	Graham, C (corresponding author), Brookings Inst, Global Econ & Dev Program, Washington, DC 20036 USA.	cgraham@brookings.edu; k.m.laffan@lse.ac.uk; stpinto@umd.edu		Pinto, Sergio/0000-0002-6910-0128				Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; CLARK AE, 1994, ECON J, V104, P648, DOI 10.2307/2234639; De Neve JE, 2012, P NATL ACAD SCI USA, V109, P19953, DOI 10.1073/pnas.1211437109; Di Tella R, 2010, J ECON BEHAV ORGAN, V76, P834, DOI 10.1016/j.jebo.2010.09.016; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Graham C, 2004, J ECON BEHAV ORGAN, V55, P319, DOI 10.1016/j.jebo.2003.09.002; Graham C., 2018, J POPUL ECON, V31, P1; Graham C, 2017, WORLD DEV, V96, P231, DOI 10.1016/j.worlddev.2017.03.009; Graham C, 2015, WORLD DEV, V68, P163, DOI 10.1016/j.worlddev.2014.11.018; Hall CC, 2014, PSYCHOL SCI, V25, P619, DOI 10.1177/0956797613510949; Haushofer J, 2014, SCIENCE, V344, P862, DOI 10.1126/science.1232491; Kasser T., 2017, PHIL T R SOC A, V375, P2095; Lalive R., 2010, J POLIT ECON, V92, P933; Lall J., 2018, GALLUP          0701; Monnat SM, 2017, J RURAL STUD, V55, P227, DOI 10.1016/j.jrurstud.2017.08.010; Stone A. A., 2013, SUBJECTIVE WELL BEIN	16	35	35	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					287	288		10.1126/science.aau5234	http://dx.doi.org/10.1126/science.aau5234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337395				2022-12-28	WOS:000447680100024
J	Mervis, J				Mervis, Jeffrey			Scientists who beat the odds seek victory in November	SCIENCE			English	News Item																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					271	273		10.1126/science.362.6412.271	http://dx.doi.org/10.1126/science.362.6412.271			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337387				2022-12-28	WOS:000447680100016
J	Sheetz, JB; Lemmon, MA				Sheetz, Joshua B.; Lemmon, Mark A.			Flipping ATP to AMPlify Kinase Functions	CELL			English	Editorial Material								Understanding protein kinase family members that lack key catalytic residues-or pseudokinases-is a major challenge in cell signaling. In this issue of Cell, Sreelatha et al. (2018) describe how one pseudokinase transfers adenosine monophosphate (AMP) rather than phosphate to protein substrates, revealing unexpected catalytic diversity for the kinase fold.	[Sheetz, Joshua B.; Lemmon, Mark A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Sheetz, Joshua B.; Lemmon, Mark A.] Yale Univ, Canc Biol Inst, West Haven, CT 06516 USA	Yale University; Yale University	Lemmon, MA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.; Lemmon, MA (corresponding author), Yale Univ, Canc Biol Inst, West Haven, CT 06516 USA.	mark.lemmon@yale.edu	Sheetz, Joshua/Z-1774-2019	Sheetz, Joshua/0000-0003-2052-1252; Lemmon, Mark/0000-0002-3379-5319	National Science Foundation Graduate Research Fellowship [DGE1122492]; National Institutes of Health [R35-GM122485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122485] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported in part by the National Science Foundation Graduate Research Fellowship (DGE1122492) to J.B.S. and the National Institutes of Health (R35-GM122485) to M.A.L.	Casey AK, 2018, CHEM REV, V118, P323, DOI 10.1021/acs.chemrev.7b00145; Chen Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003382; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murphy JM, 2017, CURR OPIN STRUC BIOL, V47, P95, DOI 10.1016/j.sbi.2017.07.004; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046	9	3	4	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					641	642		10.1016/j.cell.2018.10.011	http://dx.doi.org/10.1016/j.cell.2018.10.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340038	Green Accepted, Bronze			2022-12-28	WOS:000447780800008
J	Trusheim, MR; Cassidy, WM; Bach, PB				Trusheim, Mark R.; Cassidy, William M.; Bach, Peter B.			Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Trusheim, Mark R.] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Cassidy, William M.] US Senate, Washington, DC 20510 USA; [Cassidy, William M.] Louisiana State Univ, Hlth Sci Ctr, Baton Rouge, LA 70803 USA; [Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 485 Lexington Ave,2nd Floor, New York, NY 10017 USA	Massachusetts Institute of Technology (MIT); Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport; Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, 485 Lexington Ave,2nd Floor, New York, NY 10017 USA.	bachp@mskcc.org						[Anonymous], NAT STRAT EL HEP B C; [Anonymous], AM OV PHARM PAT PROB; Goldman D, WHAT HLTH CARE CAN L; Kodjak A., LOUISIANAS NEW APPRO; Louisiana Department of Health, REQ INF SUBSCR PAYM; National Governors Association, PUBL HLTH CRIS PHARM; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Sood N, 2018, ANN INTERN MED, V169, P118, DOI [10.7326/M18-0186, 10.7326/m18-0186]; Tribble SJ, WASHINGTON POST	9	45	45	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2018	320	19					1977	1978		10.1001/jama.2018.15782	http://dx.doi.org/10.1001/jama.2018.15782			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB0FC	30383176				2022-12-28	WOS:000450686800009
J	Brundin, P; Wyse, R				Brundin, Patrik; Wyse, Richard			Cancer enzyme affects Parkinson's disease New insights identify a possible target for slowing neurodegeneration	SCIENCE			English	Editorial Material							PARTHANATOS		[Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA; [Wyse, Richard] Cure Parkinsons Trust, 120 Baker St, London W1U 6TU, England	Van Andel Institute	Brundin, P (corresponding author), Van Andel Res Inst, Ctr Neurodegenerat Sci, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	patrik.brundin@vai.org						Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Athauda D, 2018, CNS DRUGS, V32, P747, DOI 10.1007/s40263-018-0548-y; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Brundin P, 2019, EUR J NEUROSCI, V49, P307, DOI 10.1111/ejn.14175; Brundin P, 2017, EXP NEUROL, V298, P225, DOI 10.1016/j.expneurol.2017.10.003; Brundin P, 2013, J PARKINSON DIS, V3, P231, DOI 10.3233/JPD-139000; Kam TI, 2018, SCIENCE, V362, P557, DOI 10.1126/science.aat8407; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Lehmann S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.72; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1111/ene.14108, 10.1038/nrdp.2017.13]; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5	14	6	6	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		521	522		10.1126/science.aav3986	http://dx.doi.org/10.1126/science.aav3986			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385560				2022-12-28	WOS:000450460000022
J	Helmi, A; Babusiaux, C; Koppelman, HH; Massari, D; Veljanoski, J; Brown, AGA				Helmi, Amina; Babusiaux, Carine; Koppelman, Helmer H.; Massari, Davide; Veljanoski, Jovan; Brown, Anthony G. A.			The merger that led to the formation of the Milky Way's inner stellar halo and thick disk	NATURE			English	Article							PHASE-SPACE STRUCTURE; MINOR MERGERS; DATA RELEASE; KINEMATICS; STARS; SIMULATIONS; GALAXY	The assembly of our Galaxy can be reconstructed using the motions and chemistry of individual stars(1,2). Chemo-dynamical studies of the stellar halo near the Sun have indicated the presence of multiple components(3), such as streams(4) and clumps(5), as well as correlations between the stars' chemical abundances and orbital parameters(6-8). Recently, analyses of two large stellar surveys(9,10) revealed the presence of a well populated elemental abundance sequence(7,11), two distinct sequences in the colour-magnitude diagram(12) and a prominent, slightly retrograde kinematic structure(13,14) in the halo near the Sun, which may trace an important accretion event experienced by the Galaxy(15). However, the link between these observations and their implications for Galactic history is not well understood. Here we report an analysis of the kinematics, chemistry, age and spatial distribution of stars that are mainly linked to two major Galactic components: the thick disk and the stellar halo. We demonstrate that the inner halo is dominated by debris from an object that at infall was slightly more massive than the Small Magellanic Cloud, and which we refer to as Gaia-Enceladus. The stars that originate in Gaia-Enceladus cover nearly the full sky, and their motions reveal the presence of streams and slightly retrograde and elongated trajectories. With an estimated mass ratio of four to one, the merger of the Milky Way with Gaia-Enceladus must have led to the dynamical heating of the precursor of the Galactic thick disk, thus contributing to the formation of this component approximately ten billion years ago. These findings are in line with the results of galaxy formation simulations, which predict that the inner stellar halo should be dominated by debris from only a few massive progenitors(2,16).	[Helmi, Amina; Koppelman, Helmer H.; Massari, Davide; Veljanoski, Jovan] Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands; [Babusiaux, Carine] Univ Grenoble Alpes, CNRS, IPAG, Grenoble, France; [Babusiaux, Carine] Univ PSL, CNRS, Observ Paris, GEPI, Meudon, France; [Brown, Anthony G. A.] Leiden Univ, Leiden Observ, Leiden, Netherlands	University of Groningen; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Leiden University; Leiden University - Excl LUMC	Helmi, A (corresponding author), Univ Groningen, Kapteyn Astron Inst, Groningen, Netherlands.	ahelmi@astro.rug.nl		Brown, Anthony/0000-0002-7419-9679; Koppelman, Helmer/0000-0003-1857-3766; Massari, Davide/0000-0001-8892-4301	Vici grant from the Netherlands Organisation for Scientific Research (NWO); Netherlands Research School for Astronomy (NOVA)	Vici grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Research School for Astronomy (NOVA)	We are grateful to A. Villalobos for permission to use his suite of simulations, and to M. Breddels for the software package Vaex (http://vaex.astro.rug.nl), which was used for part of our analyses. We thank H.-W. Rix, D. Hogg and A. Price-Whelan for comments. We have made use of data from the European Space Agency mission Gaia (http://www.cosmos.esa.int/gaia), processed by the Gaia Data Processing and Analysis Consortium (DPAC; see http://www.cosmos.esa.int/web/gaia/dpac/consortium).Funding for DPAC has been provided by national institutions, in particular the institutions participating in the Gaia Multilateral Agreement. We also used data from the APOGEE survey-a part of Sloan Digital Sky Survey IV, which is managed by the Astrophysical Research Consortium for the Participating Institutions of the Sloan Digital Sky Survey (SDSS) Collaboration (http://www.sdss.org).A.H., H.H.K., D. M. and J.V. acknowledge financial support from a Vici grant from the Netherlands Organisation for Scientific Research (NWO) and A.G.A.B. from the Netherlands Research School for Astronomy (NOVA).	Abolfathi B, 2018, ASTROPHYS J SUPPL S, V235, DOI 10.3847/1538-4365/aa9e8a; Arenou F, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833234; Babusiaux C., 2018, Astronomy & Astrophysics, V616, DOI 10.1051/0004-6361/201832843; Behroozi PS, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/57; Belokurov V, 2007, ASTROPHYS J, V657, pL89, DOI 10.1086/513144; Belokurov V, 2018, MON NOT R ASTRON SOC, V478, P611, DOI 10.1093/mnras/sty982; Bonaca A, 2017, ASTROPHYS J, V845, DOI 10.3847/1538-4357/aa7d0c; Brook CB, 2003, ASTROPHYS J, V585, pL125, DOI 10.1086/374306; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Brown AGA, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629512; Butkevich AG, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201730781; Carollo D, 2008, NATURE, V451, P216, DOI 10.1038/nature06542; Carollo D, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/87; Chiba M, 2000, ASTRON J, V119, P2843, DOI 10.1086/301409; Clementini G., 2018, GAIA DATA RELEASE; Conroy C, 2018, ASTROPHYS J LETT, V861, DOI 10.3847/2041-8213/aacdf1; Cooper AP, 2010, MON NOT R ASTRON SOC, V406, P744, DOI 10.1111/j.1365-2966.2010.16740.x; Deason AJ, 2018, ASTROPHYS J LETT, V862, DOI 10.3847/2041-8213/aad0ee; Fernandez-Alvar E, 2018, ASTROPHYS J, V852, DOI 10.3847/1538-4357/aa9ced; Freeman K, 2002, ANNU REV ASTRON ASTR, V40, P487, DOI 10.1146/annurev.astro.40.060401.093840; Perez AEG, 2016, ASTRON J, V151, DOI 10.3847/0004-6256/151/6/144; Hawkins K, 2014, MON NOT R ASTRON SOC, V445, P2575, DOI 10.1093/mnras/stu1910; Hayes CR, 2018, ASTROPHYS J, V852, DOI 10.3847/1538-4357/aa9cec; Haywood M, 2018, ASTROPHYS J, V863, DOI 10.3847/1538-4357/aad235; Helmi A, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832698; Helmi A, 1999, NATURE, V402, P53, DOI 10.1038/46980; Helmi A, 2003, MON NOT R ASTRON SOC, V339, P834, DOI 10.1046/j.1365-8711.2003.06227.x; Helmi A, 2008, ASTRON ASTROPHYS REV, V15, P145, DOI 10.1007/s00159-008-0009-6; Helmi A, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629990; Jean-Baptiste I, 2017, ASTRON ASTROPHYS, V604, DOI 10.1051/0004-6361/201629691; Katz D, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832865; Koppelman H, 2018, ASTROPHYS J LETT, V860, DOI 10.3847/2041-8213/aac882; Larsen JA, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/4/130; Majewski SR, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa784d; Marigo P, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/1/77; McMillan PJ, 2017, MON NOT R ASTRON SOC, V465, P76, DOI 10.1093/mnras/stw2759; Morrison HL, 2009, ASTROPHYS J, V694, P130, DOI 10.1088/0004-637X/694/1/130; MORRISON HL, 1990, ASTRON J, V100, P1191, DOI 10.1086/115587; Posti L, 2018, ASTRON ASTROPHYS, V615, DOI 10.1051/0004-6361/201732277; Prusti T, 2016, ASTRON ASTROPHYS, V595, DOI 10.1051/0004-6361/201629272; Robin AC, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118646; Schonrich R, 2010, MON NOT R ASTRON SOC, V403, P1829, DOI 10.1111/j.1365-2966.2010.16253.x; Schuster WJ, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118035; Van der Marel R. P., 2008, P IAU, V256, P81; VandenBerg DA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/134; Villalobos A, 2009, MON NOT R ASTRON SOC, V399, P166, DOI 10.1111/j.1365-2966.2009.15085.x; Villalobos A, 2008, MON NOT R ASTRON SOC, V391, P1806, DOI 10.1111/j.1365-2966.2008.13979.x	51	542	545	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					85	+		10.1038/s41586-018-0625-x	http://dx.doi.org/10.1038/s41586-018-0625-x			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382207	Green Submitted, Green Published			2022-12-28	WOS:000448900900049
J	Pennekamp, F; Pontarp, M; Tabi, A; Altermatt, F; Alther, R; Choffat, Y; Fronhofer, EA; Ganesanandamoorthy, P; Garnier, A; Griffiths, JI; Greene, S; Horgan, K; Massie, TM; Machler, E; Palamara, GM; Seymour, M; Petchey, OL				Pennekamp, Frank; Pontarp, Mikael; Tabi, Andrea; Altermatt, Florian; Alther, Roman; Choffat, Yves; Fronhofer, Emanuel A.; Ganesanandamoorthy, Pravin; Garnier, Aurelie; Griffiths, Jason I.; Greene, Suzanne; Horgan, Katherine; Massie, Thomas M.; Machler, Elvira; Palamara, Gian Marco; Seymour, Mathew; Petchey, Owen L.			Biodiversity increases and decreases ecosystem stability	NATURE			English	Article							ECOLOGICAL STABILITY; SPECIES RICHNESS; TEMPORAL VARIABILITY; ENVIRONMENTAL-CHANGE; MICROBIAL DIVERSITY; RESISTANCE; MULTIFUNCTIONALITY; PRODUCTIVITY; COMMUNITIES; RESILIENCE	Losses and gains in species diversity affect ecological stability(1-7) and the sustainability of ecosystem functions and services(8-13). Experiments and models have revealed positive, negative and no effects of diversity on individual components of stability, such as temporal variability, resistance and resilience(2,3,6,11,12,14). How these stability components covary remains poorly understood(15). Similarly, the effects of diversity on overall ecosystem stability(16), which is conceptually akin to ecosystem multifunctionality(17,18), remain unknown. Here we studied communities of aquatic ciliates to understand how temporal variability, resistance and overall ecosystem stability responded to diversity (that is, species richness) in a large experiment involving 690 micro-ecosystems sampled 19 times over 40 days, resulting in 12,939 samplings. Species richness increased temporal stability but decreased resistance to warming. Thus, two stability components covaried negatively along the diversity gradient. Previous biodiversity manipulation studies rarely reported such negative covariation despite general predictions of the negative effects of diversity on individual stability components(3). Integrating our findings with the ecosystem multifunctionality concept revealed hump- and U-shaped effects of diversity on overall ecosystem stability. That is, biodiversity can increase overall ecosystem stability when biodiversity is low, and decrease it when biodiversity is high, or the opposite with a U-shaped relationship. The effects of diversity on ecosystem multifunctionality would also be hump- or U-shaped if diversity had positive effects on some functions and negative effects on others. Linking the ecosystem multifunctionality concept and ecosystem stability can transform the perceived effects of diversity on ecological stability and may help to translate this science into policy-relevant information.	[Pennekamp, Frank; Pontarp, Mikael; Tabi, Andrea; Altermatt, Florian; Alther, Roman; Choffat, Yves; Fronhofer, Emanuel A.; Ganesanandamoorthy, Pravin; Garnier, Aurelie; Greene, Suzanne; Horgan, Katherine; Massie, Thomas M.; Machler, Elvira; Palamara, Gian Marco; Petchey, Owen L.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Pontarp, Mikael] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Altermatt, Florian; Alther, Roman; Fronhofer, Emanuel A.; Ganesanandamoorthy, Pravin; Machler, Elvira; Seymour, Mathew] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Griffiths, Jason I.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Fronhofer, Emanuel A.] Univ Montpellier, CNRS, ISEM, IRD,EPHE, Montpellier, France; [Greene, Suzanne] MIT, MIT Ctr Transportat & Logist, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Palamara, Gian Marco] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Syst Anal Integrated Assessment & Modelling, Dubendorf, Switzerland; [Seymour, Mathew] Bangor Univ, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales	University of Zurich; Umea University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Utah System of Higher Education; University of Utah; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Massachusetts Institute of Technology (MIT); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Bangor University	Pennekamp, F (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	frank.pennekamp@ieu.uzh.ch	Alther, Roman/H-8545-2019; Fronhofer, Emanuel A./AAY-3186-2021; Seymour, Mat/AAT-2716-2020; Fronhofer, Emanuel A./J-9784-2013; Garnier, Aurelie/AAJ-2073-2021; Pennekamp, Frank/ABD-3597-2020; Tabi, Andrea/M-7027-2019; Horgan, Katherine/A-9241-2019; Petchey, Owen/D-8851-2011; Palamara, Gian M./AAH-5274-2020	Alther, Roman/0000-0001-7582-3966; Fronhofer, Emanuel A./0000-0002-2219-784X; Fronhofer, Emanuel A./0000-0002-2219-784X; Pennekamp, Frank/0000-0003-0679-1045; Tabi, Andrea/0000-0002-5028-1117; Horgan, Katherine/0000-0002-3940-1747; Petchey, Owen/0000-0002-7724-1633; Palamara, Gian Marco/0000-0003-3517-9445; Altermatt, Florian/0000-0002-4831-6958; Greene, Suzanne/0000-0002-1234-4906; seymour, mathew/0000-0002-3654-4857; Garnier, Aurelie/0000-0002-3712-4301	University of Zurich Research Priority Programme on Global Change and Biodiversity; Swiss National Science Foundation [PP00P3_150698, 31003A_159498]; Institut des Sciences de l'Evolution, Montpellier [ISEM 2018-171]	University of Zurich Research Priority Programme on Global Change and Biodiversity; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institut des Sciences de l'Evolution, Montpellier	F. De Laender and B. Schmid provided feedback on previous drafts of the Letter; I. Donohue provided the list of publications from his 2016 review paper. The University of Zurich Research Priority Programme on Global Change and Biodiversity supported this research. In addition, funding came from the Swiss National Science Foundation (grant PP00P3_150698 to F.A. and 31003A_159498 to O.L.P.). This is publication ISEM 2018-171 of the Institut des Sciences de l'Evolution, Montpellier.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Antiqueira PAP, 2018, ECOL LETT, V21, P72, DOI 10.1111/ele.12873; Armsworth PR, 2003, P NATL ACAD SCI USA, V100, P7147, DOI 10.1073/pnas.0832226100; Arnoldi JF, 2016, J THEOR BIOL, V389, P47, DOI 10.1016/j.jtbi.2015.10.012; Baert JM, 2016, ECOLOGY, V97, P3433, DOI 10.1002/ecy.1601; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Byrnes JEK, 2014, METHODS ECOL EVOL, V5, P111, DOI 10.1111/2041-210X.12143; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Donohue I, 2016, ECOL LETT, V19, P1172, DOI 10.1111/ele.12648; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Duffy JE, 2003, ECOL LETT, V6, P637; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gamfeldt L, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0168; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Grilli J, 2017, NATURE, V548, P210, DOI 10.1038/nature23273; Gross K, 2014, AM NAT, V183, P1, DOI 10.1086/673915; Hallett LM, 2016, METHODS ECOL EVOL, V7, P1146, DOI 10.1111/2041-210X.12569; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Isbell F, 2015, NATURE, V526, P574, DOI 10.1038/nature15374; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; Legendre P., 2018, LMODEL2 MODEL 2 REGR; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Manning P, 2018, NAT ECOL EVOL, V2, P427, DOI 10.1038/s41559-017-0461-7; May R M, 1973, Monogr Popul Biol, V6, P1; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Pennekamp F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176682; Pennekamp F, 2015, ECOL EVOL, V5, P2584, DOI 10.1002/ece3.1529; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pinheiro J., 2018, NLME LINEAR NONLINEA; R Core Team, 2018, R LANG ENV STAT COMP; Schmid B, 2017, J PLANT ECOL, V10, P91, DOI 10.1093/jpe/rtw107; Slade EM, 2017, ECOLOGY, V98, P2626, DOI 10.1002/ecy.1954; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Vogel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036992; Wagg C, 2017, ECOLOGY, V98, P2952, DOI 10.1002/ecy.2003; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092; Zhang QG, 2006, OIKOS, V112, P218, DOI 10.1111/j.0030-1299.2006.14220.x; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	55	137	147	92	621	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					109	+		10.1038/s41586-018-0627-8	http://dx.doi.org/10.1038/s41586-018-0627-8			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30333623	Green Accepted, Green Submitted			2022-12-28	WOS:000448900900054
J	Sugita, Y; Matsunami, H; Kawaoka, Y; Noda, T; Wolf, M				Sugita, Yukihiko; Matsunami, Hideyuki; Kawaoka, Yoshihiro; Noda, Takeshi; Wolf, Matthias			Cryo-EM structure of the Ebola virus nucleoprotein-RNA complex at 3.6 angstrom resolution	NATURE			English	Article							CRYSTAL-STRUCTURE; UNASSEMBLED NUCLEOPROTEIN; HELICAL RECONSTRUCTION; PROTEIN STRUCTURES; VISUALIZATION; MECHANISM; REVEALS; DIFFERENTIATION; ARCHITECTURE; MICROSCOPY	Ebola virus causes haemorrhagic fever with a high fatality rate in humans and non-human primates. It belongs to the family Filoviridae in the order Mononegavirales, which are viruses that contain linear, non-segmented, negative-sense, single-stranded genomic RNA(1,2). The enveloped, filamentous virion contains the nucleocapsid, consisting of the helical nucleoprotein-RNA complex, VP24, VP30, VP35 and viral polymerase(1,3). The nucleoprotein-RNA complex acts as a scaffold for nucleocapsid formation and as a template for RNA replication and transcription by condensing RNA into the virion(4,5). RNA binding and nucleoprotein oligomerization are synergistic and do not readily occur independently(6). Although recent cryo-electron tomography studies have revealed the overall architecture of the nucleocapsid core(4,5), there has been no high-resolution reconstruction of the nucleocapsid. Here we report the structure of a recombinant Ebola virus nucleoprotein-RNA complex expressed in mammalian cells without chemical fixation, at near-atomic resolution using single-particle cryo-electron microscopy. Our structure reveals how the Ebola virus nucleocapsid core encapsidates its viral genome, its sequence-independent coordination with RNA by nucleoprotein, and the dynamic transition between the RNA-free and RNA-bound states. It provides direct structural evidence for the role of the N terminus of nucleoprotein in subunit oligomerization, and for the hydrophobic and electrostatic interactions that lead to the formation of the helical assembly. The structure is validated as representative of the native biological assembly of the nucleocapsid core by consistent dimensions and symmetry with the full virion(5). The atomic model provides a detailed mechanistic basis for understanding nucleocapsid assembly and highlights key structural features that may serve as targets for anti-viral drug development.	[Sugita, Yukihiko; Matsunami, Hideyuki; Wolf, Matthias] Okinawa Inst Sci & Technol Grad Univ, Mol Cryoelectron Microscopy Unit, Onna, Okinawa, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Special Pathogens, Int Res Ctr Infect Dis, Tokyo, Japan; [Noda, Takeshi] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Ultrastruct Virol, Kyoto, Japan; [Noda, Takeshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Sugita, Yukihiko] Osaka Univ, Inst Prot Res, Lab Adv Prot Characterizat, Res Ctr State Of The Art Funct Prot Anal, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST); Osaka University	Wolf, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Mol Cryoelectron Microscopy Unit, Onna, Okinawa, Japan.	matthias.wolf@oist.jp	Wolf, Matthias/G-7097-2015; Matsunami, Hideyuki/GOK-2037-2022; Matsunami, Hideyuki/E-6632-2010	Wolf, Matthias/0000-0001-8480-0918; Matsunami, Hideyuki/0000-0001-5814-3766; Matsunami, Hideyuki/0000-0001-5814-3766; Noda, Takeshi/0000-0002-0658-4663; Sugita, Yukihiko/0000-0001-6861-4840	MEXT [16H06429, 16K21723, 16H06434, 26892028]; Joint Research Project of Institute of Medical Science, University of Tokyo; Joint Research Program of Institute for Frontier Life and Medical Sciences, Kyoto University; JST [JPMJPR13L9]; AMED [17fk0108128h0001]; JSPS; Daiichi Sankyo Foundation of Life Science; J-PRIDE for Global Epidemic from AMED [JP17fm0208101j0001]; RPERID from AMED [JP17fk0108029h0002]; Okinawa Institute of Science and Technology Graduate University	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Joint Research Project of Institute of Medical Science, University of Tokyo; Joint Research Program of Institute for Frontier Life and Medical Sciences, Kyoto University; JST(Japan Science & Technology Agency (JST)); AMED(Japan Agency for Medical Research and Development (AMED)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiichi Sankyo Foundation of Life Science; J-PRIDE for Global Epidemic from AMED; RPERID from AMED; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	We thank Y. Takizawa, A. Maigne and M. Collins for helpful discussions and S. D. Aird for editing the manuscript. This work was supported by a Grant-in-Aid for Research Activity Start-up from MEXT (Grant no. 26892028) (to Y.S.), by Joint Research Project of Institute of Medical Science, University of Tokyo (to Y.S. and T.N.), by Joint Research Program of Institute for Frontier Life and Medical Sciences, Kyoto University (to Y.S.), by JST (Grant no. JPMJPR13L9), by AMED (Grant no. 17fk0108128h0001), from JSPS Core-to-Core Program A and from Daiichi Sankyo Foundation of Life Science (to T.N.), by J-PRIDE for Global Epidemic from AMED (JP17fm0208101j0001), by RPERID from AMED (JP17fk0108029h0002) and by a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (Grant no. 16H06429, 16K21723 and 16H06434) (to Y.K.). Y.S. and M.W. were supported by direct funding from Okinawa Institute of Science and Technology Graduate University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alayyoubi M, 2015, P NATL ACAD SCI USA, V112, pE1792, DOI 10.1073/pnas.1503941112; Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Ariza A, 2013, NUCLEIC ACIDS RES, V41, P5912, DOI 10.1093/nar/gkt268; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; BRASSEUR R, 1991, J BIOL CHEM, V266, P16120; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Dong SS, 2015, PROTEIN CELL, V6, P351, DOI 10.1007/s13238-015-0163-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Guryanov SG, 2016, J VIROL, V90, P2849, DOI 10.1128/JVI.02865-15; Gutsche I, 2015, SCIENCE, V348, P704, DOI 10.1126/science.aaa5137; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P19365, DOI 10.1073/pnas.1108515108; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Huang Y, 2002, MOL CELL, V10, P307, DOI 10.1016/S1097-2765(02)00588-9; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Lamb R. A, 2013, FIELDS VIROLOGY, P880; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leung DW, 2015, CELL REP, V11, P376, DOI 10.1016/j.celrep.2015.03.034; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Liu B., 2017, J VIROL, V91; Niu FF, 2013, P NATL ACAD SCI USA, V110, P9054, DOI 10.1073/pnas.1300035110; Noda T, 2011, J INFECT DIS, V204, pS878, DOI 10.1093/infdis/jir310; Noda T, 2010, J GEN VIROL, V91, P1478, DOI 10.1099/vir.0.019794-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Raymond DD, 2012, P NATL ACAD SCI USA, V109, P19208, DOI 10.1073/pnas.1213553109; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Su ZM, 2018, CELL, V172, P966, DOI 10.1016/j.cell.2018.02.009; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Wan W, 2017, NATURE, V551, P394, DOI 10.1038/nature24490; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Weik M, 2005, J VIROL, V79, P10660, DOI 10.1128/JVI.79.16.10660-10671.2005; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868; Yabukarski F, 2016, J MOL BIOL, V428, P2671, DOI 10.1016/j.jmb.2016.04.010; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	49	54	55	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					137	+		10.1038/s41586-018-0630-0	http://dx.doi.org/10.1038/s41586-018-0630-0			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30333622	Bronze			2022-12-28	WOS:000448900900060
J	Davies, JC; Moskowitz, SM; Brown, C; Horsley, A; Mall, MA; McKone, EF; Plant, BJ; Prais, D; Ramsey, BW; Taylor-Cousar, JL; Tullis, E; Uluer, A; McKee, CM; Robertson, S; Shilling, RA; Simard, C; Van Goor, F; Waltz, D; Xuan, F; Young, T; Rowe, SM				Davies, J. C.; Moskowitz, S. M.; Brown, C.; Horsley, A.; Mall, M. A.; McKone, E. F.; Plant, B. J.; Prais, D.; Ramsey, B. W.; Taylor-Cousar, J. L.; Tullis, E.; Uluer, A.; McKee, C. M.; Robertson, S.; Shilling, R. A.; Simard, C.; Van Goor, F.; Waltz, D.; Xuan, F.; Young, T.; Rowe, S. M.		VX16-659-101 Study Grp	VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TEZACAFTOR-IVACAFTOR; CFTR POTENTIATOR; G551D MUTATION; IN-VITRO	BACKGROUND The next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector VX-659, in triple combination with tezacaftor and ivacaftor (VX-659-tezacaftor-ivacaftor), was developed to restore the function of Phe508del CFTR protein in patients with cystic fibrosis. METHODS We evaluated the effects of VX-659-tezacaftor-ivacaftor on the processing, trafficking, and function of Phe508del CFTR protein using human bronchial epithelial cells. A range of oral VX-659-tezacaftor-ivacaftor doses in triple combination were then evaluated in randomized, controlled, double-blind, multicenter trials involving patients with cystic fibrosis who were heterozygous for the Phe508del CFTR mutation and a minimal-function CFTR mutation (Phe508del-MF genotypes) or homozygous for the Phe508del CFTR mutation (Phe508del-Phe508del genotype). The primary end points were safety and the absolute change from baseline in the percentage of predicted forced expiratory volume in 1 second (FEV1). RESULTS VX-659-tezacaftor-ivacaftor significantly improved the processing and trafficking of Phe508del CFTR protein as well as chloride transport in vitro. In patients, VX-659-tezacaftor-ivacaftor had an acceptable safety and side-effect profile. Most adverse events were mild or moderate. VX-659-tezacaftor-ivacaftor resulted in significant mean increases in the percentage of predicted FEV1 through day 29 (P<0.001) of up to 13.3 points in patients with Phe508del-MF genotypes; in patients with the Phe508del-Phe508del genotype already receiving tezacaftor-ivacaftor, adding VX-659 resulted in a further 9.7-point increase in the percentage of predicted FEV1. The sweat chloride concentrations and scores on the respiratory domain of the Cystic Fibrosis Questionnaire-Revised improved in both patient populations. CONCLUSIONS Robust in vitro activity of VX-659-tezacaftor-ivacaftor targeting Phe508del CFTR protein translated into improvements for patients with Phe508del-MF or Phe508del-Phe508del genotypes. VX-659 triple-combination regimens have the potential to treat the underlying cause of disease in approximately 90% of patients with cystic fibrosis. (Funded by Vertex Pharmaceuticals; VX16-659-101 and VX16-659-001 ClinicalTrials.gov numbers, NCT03224351 and NCT03029455.)	[Davies, J. C.] Imperial Coll London, London, England; [Davies, J. C.] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Horsley, A.] Manchester Adult Cyst Fibrosis Ctr, Manchester, Lancs, England; [Moskowitz, S. M.; McKee, C. M.; Robertson, S.; Shilling, R. A.; Simard, C.; Van Goor, F.; Waltz, D.; Xuan, F.; Young, T.] Vertex Pharmaceut, Boston, MA USA; [Uluer, A.] Boston Childrens Hosp, Boston, MA USA; [Uluer, A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Brown, C.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Mall, M. A.] Univ Med Berlin, Berlin, Germany; [Mall, M. A.] Berlin Inst Hlth, Berlin, Germany; [Mall, M. A.] German Ctr Lung Res, Giessen, Germany; [McKone, E. F.] St Vincents Univ Hosp, Dublin, Ireland; [McKone, E. F.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Plant, B. J.] Cork Univ Hosp, Cork, Ireland; [Plant, B. J.] Univ Coll Cork, Cork, Ireland; [Prais, D.] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Prais, D.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ramsey, B. W.] Seattle Childrens Hosp, Seattle, WA USA; [Taylor-Cousar, J. L.] Natl Jewish Hlth, Denver, CO USA; [Tullis, E.] St Michaels Hosp, Toronto, ON, Canada; [Rowe, S. M.] Univ Alabama Birmingham, Birmingham, AL USA	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Vertex Pharmaceuticals; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Indiana University System; Indiana University Bloomington; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University College Cork; University College Cork; Tel Aviv University; Sackler Faculty of Medicine; Seattle Children's Hospital; National Jewish Health; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Alabama System; University of Alabama Birmingham	Rowe, SM (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, MLCM 706,1918 Univ Blvd, Birmingham, AL 35294 USA.	smrowe@uab.edu	Prais, Dario/AAG-8297-2021; Mall, Marcus A./AAA-1498-2022	Prais, Dario/0000-0002-4165-0144; Mall, Marcus A./0000-0002-4057-2199; Davies, Jane/0000-0003-3506-1199; Horsley, Alex/0000-0003-1828-0058	Vertex Pharmaceuticals from the Cystic Fibrosis Foundation; National Institute for Health Research; National Institutes of Health [P30DK072482, R35HL135816, U54TR001368]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001356, UL1TR001417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507, P30DK072482] Funding Source: NIH RePORTER	Vertex Pharmaceuticals from the Cystic Fibrosis Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Vertex Pharmaceuticals, which received funding from the Cystic Fibrosis Foundation for the development of VX-659. The National Institute for Health Research provided support to the Respiratory Clinical Research Facility at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, and to the Manchester Clinical Research Facility at Wythenshawe Hospital, Manchester, United Kingdom. The National Institutes of Health provided grant support to the University of Alabama at Birmingham (P30DK072482, R35HL135816, and U54TR001368).	[Anonymous], 2016, VERTEX PROVIDES UPDA; [Anonymous], 2017, VERTEX REPORTS 3 QUA; [Anonymous], 2011, CLIN FUNCTIONAL TRAN; Cystic Fibrosis Trust, 2017, UK CYSTIC FIBROSIS R; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; De Boeck K, 2016, LANCET RESP MED, V4, P662, DOI 10.1016/S2213-2600(16)00023-0; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Flume P, 2018, J CYSTIC FIBROSIS S3, V17, pS64; Flume P, 2018, J CYST FIBROS S3, V17, pS29; Gentzsch M, 2018, CHEST, V154, P383, DOI 10.1016/j.chest.2018.04.036; Grootenhuis P, 2016, PEDIATR PULM, V51, P263; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ren CL, 2018, ANN AM THORAC SOC, V15, P271, DOI 10.1513/AnnalsATS.201707-539OT; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rowe SM, 2017, NEW ENGL J MED, V377, P2024, DOI 10.1056/NEJMoa1709847; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547	22	204	207	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1599	1611		10.1056/NEJMoa1807119	http://dx.doi.org/10.1056/NEJMoa1807119			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1GI	30334693	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000448273500005
J	Vatanen, T; Franzosa, EA; Schwager, R; Tripathi, S; Arthur, TD; Vehik, K; Lernmark, A; Hagopian, WA; Rewers, MJ; She, JX; Toppari, J; Ziegler, AG; Akolkar, B; Krischer, JP; Stewart, CJ; Ajami, NJ; Petrosino, JF; Gevers, D; Lahdesmaki, H; Vlamakis, H; Huttenhower, C; Xavier, RJ				Vatanen, Tommi; Franzosa, Eric A.; Schwager, Randall; Tripathi, Surya; Arthur, Timothy D.; Vehik, Kendra; Lernmark, Ake; Hagopian, William A.; Rewers, Marian J.; She, Jin-Xiong; Toppari, Jorma; Ziegler, Anette-G.; Akolkar, Beena; Krischer, Jeffrey P.; Stewart, Christopher J.; Ajami, Nadim J.; Petrosino, Joseph F.; Gevers, Dirk; Lahdesmaki, Harri; Vlamakis, Hera; Huttenhower, Curtis; Xavier, Ramnik J.			The human gut microbiome in early-onset type 1 diabetes from the TEDDY study	NATURE			English	Article							ENVIRONMENTAL DETERMINANTS; INTESTINAL MICROBIOTA; RISK-FACTORS; YOUNG TEDDY; CHILDREN; AUTOIMMUNITY; ASSOCIATION; CONTRIBUTES; DYNAMICS; SEQUENCE	Type 1 diabetes (T1D) is an autoimmune disease that targets pancreatic islet beta cells and incorporates genetic and environmental factors(1), including complex genetic elements(2), patient exposures(3) and the gut microbiome(4). Viral infections(5) and broader gut dysbioses(6) have been identified as potential causes or contributing factors; however, human studies have not yet identified microbial compositional or functional triggers that are predictive of islet autoimmunity or T1D. Here we analyse 10,913 metagenomes in stool samples from 783 mostly white, non-Hispanic children. The samples were collected monthly from three months of age until the clinical end point (islet autoimmunity or T1D) in the The Environmental Determinants of Diabetes in the Young (TEDDY) study, to characterize the natural history of the early gut microbiome in connection to islet autoimmunity, T1D diagnosis, and other common early life events such as antibiotic treatments and probiotics. The microbiomes of control children contained more genes that were related to fermentation and the biosynthesis of short-chain fatty acids, but these were not consistently associated with particular taxa across geographically diverse clinical centres, suggesting that microbial factors associated with T1D are taxonomically diffuse but functionally more coherent. When we investigated the broader establishment and development of the infant microbiome, both taxonomic and functional profiles were dynamic and highly individualized, and dominated in the first year of life by one of three largely exclusive Bifidobacterium species (B. bifidum, B. breve or B. longum) or by the phylum Proteobacteria. In particular, the strain-specific carriage of genes for the utilization of human milk oligosaccharide within a subset of B. longum was present specifically in breast-fed infants. These analyses of TEDDY gut metagenomes provide, to our knowledge, the largest and most detailed longitudinal functional profile of the developing gut microbiome in relation to islet autoimmunity, T1D and other early childhood events. Together with existing evidence from human cohorts(7,8) and a T1D mouse model(9), these data support the protective effects of short-chain fatty acids in early-onset human T1D.	[Vatanen, Tommi; Franzosa, Eric A.; Tripathi, Surya; Arthur, Timothy D.; Gevers, Dirk; Vlamakis, Hera; Huttenhower, Curtis; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Franzosa, Eric A.; Schwager, Randall; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vehik, Kendra; Krischer, Jeffrey P.] Univ S Florida, Hlth Informat Inst, Morsani Coll Med, Tampa, FL USA; [Lernmark, Ake] Lund Univ, Skane Univ Hosp SUS, Dept Clin Sci, CRC, Malmo, Sweden; [Hagopian, William A.] Pacific Northwest Res Inst, Seattle, WA USA; [Rewers, Marian J.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [She, Jin-Xiong] Augusta Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Toppari, Jorma] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku, Finland; [Ziegler, Anette-G.] Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany; [Ziegler, Anette-G.] Tech Univ Munich, Forschergrp Diabet, Klinikum Rechts Isar, Munich, Germany; [Ziegler, Anette-G.] Helmholtz Zentrum Munchen, Forschergrp Diabet eV, Munich, Germany; [Akolkar, Beena] NIDDK, Bethesda, MD USA; [Stewart, Christopher J.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Stewart, Christopher J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Lahdesmaki, Harri] Aalto Univ, Dept Comp Sci, Espoo, Finland; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Med Sch, Boston, MA 02115 USA; [Gevers, Dirk; Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA; [Huttenhower, Curtis] Janssen Human Microbiome Inst Janssen Res & Dev, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; State University System of Florida; University of South Florida; Lund University; Skane University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Augusta University; University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; Newcastle University - UK; Aalto University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Vatanen, T; Huttenhower, C; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Huttenhower, C (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA.	vatanen@broadinstitute.org; chuttenh@hsph.harvard.edu; xavier@molbio.mgh.harvard.edu	Lernmark, Åke/F-8140-2015; Gevers, Dirk/C-1451-2009; Petrosino, Joseph F./AAF-1621-2019; Stewart, Christopher/M-4615-2017; Vatanen, Tommi/J-5458-2018	Lernmark, Åke/0000-0003-1735-0499; Stewart, Christopher/0000-0002-6033-338X; Vatanen, Tommi/0000-0003-0949-1291; Kurppa, Kalle/0000-0003-4757-2164; Arthur, Timothy/0000-0002-3393-1691	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Centers for Disease Control and Prevention (CDC); JDRF [3-SRA-2016-141-Q-R, 2-SRA-2016-247-S-B, 2-SRA-2018-548-S-B]; NIH/NCATS Clinical and Translational Science Awards [UL1 TR000064, UL1 TR001082]; NIDDK [U54DE023798, R24DK110499]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063829, U01DK063865, UC4DK106955, UC4DK112243, UC4DK063863, U01DK063821, R24DK110499, U01DK063861, U01DK063790, P30DK048520, UC4DK063821, UC4DK063861, UC4DK100238, UC4DK063865, UC4DK063829, UC4DK063836, U01DK063863, UC4DK117483, U01DK063836, UC4DK095300] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); JDRF(Juvenile Diabetes Research Foundation); NIH/NCATS Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was performed on behalf of the TEDDY Study Group, which is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Centers for Disease Control and Prevention (CDC), and JDRF. This work supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082). C.H. was supported by funding from JDRF (3-SRA-2016-141-Q-R) and NIDDK (U54DE023798, R24DK110499). H.V. and R.J.X. were supported by funding from JDRF (2-SRA-2016-247-S-B, 2-SRA-2018-548-S-B).	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Costa FRC, 2016, J EXP MED, V213, P1223, DOI 10.1084/jem.20150744; Davis-Richardson AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00678; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Endesfelder D, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0163-4; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Hagopian WA, 2011, PEDIATR DIABETES, V12, P733, DOI 10.1111/j.1399-5448.2011.00774.x; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Huang K, 2014, NUCLEIC ACIDS RES, V42, pD617, DOI 10.1093/nar/gkt1078; Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Knip M, 2016, NAT REV ENDOCRINOL, V12, P154, DOI 10.1038/nrendo.2015.218; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Krischer J, 2007, PEDIATR DIABETES, V8, P286; Lachin JM, 2008, STAT MED, V27, P2509, DOI 10.1002/sim.3057; Lee HS, 2014, DIABETES-METAB RES, V30, P424, DOI 10.1002/dmrr.2510; Maffeis C, 2016, DIABETES-METAB RES, V32, P700, DOI 10.1002/dmrr.2790; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; O'Callaghan A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00925; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paun A, 2017, J IMMUNOL, V198, P590, DOI 10.4049/jimmunol.1601519; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; THURSTON B, 1994, APPL ENVIRON MICROB, V60, P1087, DOI 10.1128/AEM.60.4.1087-1092.1994; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Uusitalo U, 2016, JAMA PEDIATR, V170, P20, DOI 10.1001/jamapediatrics.2015.2757; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	52	348	357	8	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					589	+		10.1038/s41586-018-0620-2	http://dx.doi.org/10.1038/s41586-018-0620-2			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356183	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000448277800058
J	Watkins, DA; Yamey, G; Schaferhoff, M; Adeyi, O; Alleyne, G; Alwan, A; Berkley, S; Feachem, R; Frenk, J; Ghosh, G; Goldie, SJ; Guo, Y; Gupta, S; Knaul, F; Kruk, M; Nugent, R; Ogbuoji, O; Qi, JY; Reddy, S; Saxenian, H; Soucat, A; Jamison, DT; Summers, LH				Watkins, David A.; Yamey, Gavin; Schaferhoff, Marco; Adeyi, Olusoji; Alleyne, George; Alwan, Ala; Berkley, Seth; Feachem, Richard; Frenk, Julio; Ghosh, Gargee; Goldie, Sue J.; Guo, Yan; Gupta, Sanjeev; Knaul, Felicia; Kruk, Margaret; Nugent, Rachel; Ogbuoji, Osondu; Qi, Jinyuan; Reddy, Srinath; Saxenian, Helen; Soucat, Agnes; Jamison, Dean T.; Summers, Lawrence H.			Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health	LANCET			English	Review							DISEASE-CONTROL-PRIORITIES; DEVELOPMENT ASSISTANCE; UNDER-5 MORTALITY; KEY MESSAGES; COVERAGE; COUNTRY; TRENDS; RISK; MALARIA; INCOME		[Watkins, David A.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Yamey, Gavin; Ogbuoji, Osondu] Duke Univ, Ctr Policy Impact Global Hlth, Durham, NC USA; [Schaferhoff, Marco] Open Consultants, Berlin, Germany; [Adeyi, Olusoji] World Bank Grp, Hlth Nutr & Populat Global Practice, Washington, DC USA; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Alwan, Ala] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Berkley, Seth] Vaccine Alliance, Gavi, Geneva, Switzerland; [Feachem, Richard; Jamison, Dean T.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Frenk, Julio] Univ Miami, Off President, Miami, FL USA; [Ghosh, Gargee] Bill & Melinda Gates Fdn, Dev Policy & Finance, Seattle, WA USA; [Goldie, Sue J.; Kruk, Margaret] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Guo, Yan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing, Peoples R China; [Gupta, Sanjeev] Ctr Global Dev, Washington, DC USA; [Knaul, Felicia] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Nugent, Rachel] RTI Int, Seattle, WA USA; [Qi, Jinyuan] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Reddy, Srinath] Publ Hlth Fdn India, Delhi, India; [Saxenian, Helen] Results Dev, Washington, DC USA; [Soucat, Agnes] World Hlth Org, Dept Hlth Syst Finance & Governance, Geneva, Switzerland; [Summers, Lawrence H.] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA	University of Washington; University of Washington Seattle; Duke University; The World Bank; Pan American Health Organization; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Miami; Bill & Melinda Gates Foundation; Harvard University; Harvard T.H. Chan School of Public Health; Peking University; University of Miami; Research Triangle Institute; Princeton University; Public Health Foundation of India; World Health Organization; Harvard University	Watkins, DA (corresponding author), Univ Washington, Dept Med, Seattle, WA 98104 USA.	davidaw@uw.edu	Watkins, David/ABC-3783-2020	Watkins, David/0000-0001-6341-9595; Nugent, Rachel/0000-0001-6421-9077; Qi, Jinyuan/0000-0003-1942-392X; Knaul, Felicia/0000-0002-0512-4788; Reddy, K Srinath/0000-0003-3416-3548	Bill & Melinda Gates Foundation; Duke University	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Duke University	We would like to acknowledge the contribution of Sebastian Martinez, who assisted in the analysis of health financing data, and the contributions of Ipchita Bharali, Kaci Kennedy, Ally Perez, and Tiffany Wilk, who provided logistical support for meetings and assisted in the preparation of the manuscript. Financial support was provided by the Bill & Melinda Gates Foundation to The Duke University Center for Policy Impact in Global Health and to the Disease Control Priorities Network at the University of Washington Department of Global Health. Duke University provided financial support to host an author meeting. This Commission is dedicated to the memory of Adel Mahmoud, who was a commissioner for Global Health 2035.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ahuka-Mundeke S, 2018, LANCET, V392, P213, DOI 10.1016/S0140-6736(18)31387-4; Alvarez MM, 2016, SOC SCI MED, V159, P161, DOI 10.1016/j.socscimed.2016.05.006; Anand Geeta, 2017, NY TIMES; [Anonymous], 2018, LANCET, V391, P1, DOI 10.1016/S0140-6736(18)30003-5; [Anonymous], 2014, LANCET, V383, P187, DOI 10.1016/S0140-6736(14)60051-9; [Anonymous], 2012, LANCET, V379, P193, DOI 10.1016/S0140-6736(12)60081-6; [Anonymous], 2015, WORLD INNOVATION SUM; [Anonymous], 2018, WOM GIRLS HIV; [Anonymous], 2011, HLTH REF M CHALL AG; [Anonymous], 2018, US GOVT GLOB HLTH; [Anonymous], 2017, GULF NEWS; [Anonymous], GLOB MAL ACT PLAN; Atun R, 2017, LANCET GLOB HEALTH, V5, pE720, DOI [10.1016/S2214-109X(17)30198-5, 10.1016/s2214-109x(17)30198-5]; Bakx P, 2016, FISC STUD, V37, P593, DOI 10.1111/j.1475-5890.2016.12114; Balabanova D, 2011, GOOD HLTH LOW COST 2; Barroy H, 2018, HEALTH SYST REFORM, V4, P214, DOI 10.1080/23288604.2018.1441620; Baumgaertner Emily, 2018, NY TIMES; Bekker LG, 2018, LANCET, V392, P312, DOI [10.1016/S0140-6736(18)31070-5, 10.1016/s0140-6736(18)31070-5]; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Boyd CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041601; Boyle CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140092; Brownell KD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001254; Bundy DAP., 2017, DIS CONTROL PRIORITI, V8; Buse K, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0255-3; Carballo M, 2001, EMERG INFECT DIS, V7, P556; Chandy L., 2011, POVERTY NUMBERS CHAN; Chang AY, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010401; Chen I, 2018, LANCET, V391, P1556, DOI 10.1016/S0140-6736(18)30911-5; Clift C, 2013, CTR GLOBAL HLTH SECU; Clift C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2218; Coady D, 2017, WORLD DEV, V91, P11, DOI 10.1016/j.worlddev.2016.10.004; Croghan TW, 2006, MILBANK Q, V84, P333, DOI 10.1111/j.1468-0009.2006.00450.x; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Horst MMLL, 2010, REV PANAM SALUD PUBL, V27, P43, DOI 10.1590/S1020-49892010000100007; Fan VY, 2018, B WORLD HEALTH ORGAN, V96, P129, DOI 10.2471/BLT.17.199588; Fullman N, 2018, LANCET GLOB HEALTH, V6, pE122, DOI 10.1016/S2214-109X(17)30487-4; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gavi, 2018, REP PROGR POL COMM 2; Glassman A, 2016, HEALTH SYST REFORM, V2, P39, DOI 10.1080/23288604.2016.1124171; Global Polio Eradication Initiative, FIN RES REQ GPEI BUD; Gupta, 2018, MERELY COLLECTING MO; Harmon TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146387; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710; Holmes K, 2018, DIS CONTROL PRIORITI, V6; Hsiao AJ, 2015, J EPIDEMIOL GLOB HEA, V5, P41, DOI 10.1016/j.jegh.2014.10.001; Hug L, 2017, LEVELS TRENDS CHILD; Institute for Health Metrics and Evaluation (IHME), 2018, FIN GLOB HLTH 2017 F; International Monetary Fund, 2017, REG EC OUTL SUBS AFR; Jacobs Andrew, 2017, NY TIMES; Jamison DT, 2018, LANCET, V391, P1108, DOI 10.1016/S0140-6736(17)32906-9; Jamison DT, 2016, J HEALTH ECON, V48, P16, DOI 10.1016/j.jhealeco.2016.03.002; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kates J, 2018, DONOR GOVT FUNDING H; Ke C, 2018, LANCET GLOB HEALTH, V6, pE914, DOI 10.1016/s2214-109x(18)30242-0; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Kono DY, 2013, POLIT RES QUART, V66, P615, DOI 10.1177/1065912912456097; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kruk ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002360; Kuruvilla Shyama, 2014, Bull World Health Organ, V92, P533, DOI 10.2471/BLT.14.138131; Kuruvilla S, 2016, B WORLD HEALTH ORGAN, V94, P398, DOI 10.2471/BLT.16.170431; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Madhav N., 2017, DIS CONTROL PRIORITI, V9, P315, DOI [10.1596/978-1-4648-0527-1_ch17, DOI 10.1596/978-1-4648-0527-1]; McLean KA, 2016, VACCINE, V34, P5410, DOI 10.1016/j.vaccine.2016.08.019; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Menendez C, 2015, LANCET GLOB HEALTH, V3, pE130, DOI 10.1016/S2214-109X(15)70009-4; Miles T., 2018, WHO EXTREMELY CONCER; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moon S, 2017, HEALTH ECON POLICY L, V12, P195, DOI [10.1017/S1744133116000451, 10.1017/s1744133116000451]; Munshi V, 2016, HEALTH AFFAIR, V35, P1759, DOI 10.1377/hlthaff.2016.0552; Murphy F, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k595; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; Nishtar S, 2018, LANCET, V392, P245, DOI 10.1016/S0140-6736(18)31258-3; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; Nunes AR, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000068; O'Keefe L., 2018, VALUING MORTALITY RI; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Peabody J, 2018, DIS CONTROL PRIORITI, V9; Rabkin Miriam, 2012, AIDS, V26 Suppl 1, pS77; Reddy KS, 2018, JAMA-J AM MED ASSOC, V319, P2477, DOI 10.1001/jama.2018.5284; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; Rottingen J-A, 2016, 3 WHO CONSULTATION G; Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236; Schaferhoff M, 2015, LANCET, V386, P2436, DOI 10.1016/S0140-6736(15)61161-8; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Smit W, 2011, J URBAN HEALTH, V88, P875, DOI 10.1007/s11524-011-9605-2; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Sumner A., 2011, NEW BOTTOM BILLION W; TORJESEN I, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1597; United Nations Department of Economic and Social Affairs PD, 2017, WORLD POP PROSP 2017; United Nations High Commissioner for Refugees [UNHCR], 2018, FIG GLANC; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; Verguet Stephane, 2015, Lancet Glob Health, V3, pe288, DOI 10.1016/S2214-109X(14)70346-8; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang YP, 2016, LANCET, V387, P273, DOI 10.1016/S0140-6736(15)00554-1; Watkins DA, 2018, DIS CONTROL PRIORITI, V9; Weiser T, 2018, DIS CONTROL PRIORITI, V1; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, 2018, WHIT PAP FIN EST 13; WHO, 2018, GLOB HLTH EST 2019 D; WHO, 2017, GLOB INV TUB RES DEV; WHO, 2015, OR 2014 EB EP; WHO, 2018, 2 INT C PRIM HLTH CA; WHO, 2017, WHO BEG PIL PREQ BIO; WHO, 2018, HEALTH HUM WHO INV C; WHO, 2017, PROGR BUDG 2018 2019; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Bank, 2017, WORLD DEV IND 2017, DOI DOI 10.1596/26447; World Bank, 2014, WORLD DEV IND 2014; World Health Organization, 2017, HLTH SILK ROAD; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 1978, DECL ALM AT INT C PR; World Health Organization, 2018, TUB KEY FACTS; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; World Health Organization (WHO), 2018, 71 WORLD HLTH ASS GE; Xu K., 2018, NEW PERSPECTIVES GLO; Yamey G, MAXEY ROSENAU LAST P; Yamey G, 2018, HEALTH POLICY PLANN, V33, P429, DOI 10.1093/heapol/czx179; Yamey G, 2017, LANCET GLOB HEALTH, V5, pE742, DOI 10.1016/S2214-109X(17)30203-6; Yamey G, 2016, OXFORD REV ECON POL, V32, P122, DOI 10.1093/oxrep/grv024; Young Ruth, 2018, Gates Open Res, V2, P23, DOI 10.12688/gatesopenres.12817.3; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890	132	51	52	3	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1434	1460		10.1016/S0140-6736(18)32389-4	http://dx.doi.org/10.1016/S0140-6736(18)32389-4			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343859				2022-12-28	WOS:000447800900026
J	Clery, D				Clery, Daniel			Planet hunter nears its end	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					274	275		10.1126/science.362.6412.274	http://dx.doi.org/10.1126/science.362.6412.274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337389				2022-12-28	WOS:000447680100018
J	Gilbert, J; Lovibond, K; Mooney, A; Dudley, J				Gilbert, James; Lovibond, Kate; Mooney, Andrew; Dudley, Jan		Guideline Comm	Renal replacement therapy: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Gilbert, James; Lovibond, Kate] Royal Coll Physicians, Natl Guideline Ctr, London, England; [Mooney, Andrew] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Mooney, Andrew] Univ Leeds, Leeds, W Yorkshire, England; [Dudley, Jan] Bristol Royal Hosp Children, Bristol, Avon, England	Royal College of Physicians; University of Leeds; University of Leeds; Bristol Royal Hospital For Children	Gilbert, J (corresponding author), Royal Coll Physicians, Natl Guideline Ctr, London, England.	James.Gilbert@rcplondon.ac.uk	Shroff, Rukshana C/C-7347-2008; Shroff, Rukshana/AAG-5383-2019	Shroff, Rukshana C/0000-0001-8501-1072; Shroff, Rukshana/0000-0001-8501-1072	NICE	NICE	JG and KL are employees of the National Guideline Centre. The guideline discussed in this article was developed by the National Guideline Centre which received funding from NICE. No authors received specific funding to write this summary.	Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Kidney Research UK, 2018, DIAL DEC AID MAK RIG; National Institute for Health and Care Excellence, 2018, REN REPL THER CONS M; NHS, 2018, WAIT LIST KIDN TRANS; Renal Association, 2018, UK REN REG 20 ANN RE; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038	7	7	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4303	10.1136/bmj.k4303	http://dx.doi.org/10.1136/bmj.k4303			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341093				2022-12-28	WOS:000448271300002
J	van der Heijde, D; Wei, JCC; Dougados, M; Mease, P; Deodhar, A; Maksymowych, WP; Van den Bosch, F; Sieper, J; Tomita, T; Landewe, R; Zhao, FY; Krishnan, E; Adams, DH; Pangallo, B; Carlier, H				van der Heijde, Desiree; Wei, James Cheng-Chung; Dougados, Maxime; Mease, Philip; Deodhar, Atul; Maksymowych, Walter P.; Van den Bosch, Filip; Sieper, Joachim; Tomita, Tetsuya; Landewe, Robert; Zhao, Fangyi; Krishnan, Eswar; Adams, David H.; Pangallo, Beth; Carlier, Hilde		COAST-V Study Grp	Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial	LANCET			English	Article							SHORT-TERM IMPROVEMENT; SAFETY; EFFICACY; SECUKINUMAB; ETANERCEPT; PREVALENCE; PSORIASIS; CRITERIA; BURDEN; CELLS	Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are recommended for radiographic axial spondyloarthritis, otherwise known as ankylosing spondylitis, when conventional therapies are not effective. We report efficacy and safety data on ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17A (IL-17A), in patients with radiographic axial spondyloarthritis who have not previously been treated with bDMARDs. Methods In this phase 3, randomised, double-blind, placebo-controlled superiority study of ixekizumab, adult patients with inadequate response or intolerance to non-steroidal anti-inflammatory drugs, an established diagnosis of radiographic axial spondyloarthritis, radiographic sacroiliitis centrally defined by modified New York criteria, and at least one spondyloarthritis feature according to the Assessment of SpondyloArthritis international Society (ASAS) criteria, were recruited from 84 sites (12 countries) in Europe, Asia, and North America. By use of a computergenerated random sequence, patients were randomly assigned (1: 1: 1: 1) to 80 mg subcutaneous ixekizumab every two (Q2W) or four (Q4W) weeks, 40 mg adalimumab Q2W (active reference group), or placebo. The primary objective was to compare the proportion of patients achieving an ASAS40 response, a composite measure of clinical improvement in axial spondyloarthritis, at week 16 for both ixekizumab treatment groups versus the placebo group. The adalimumab reference group was included as an in-study active reference for comparison with placebo to provide additional context to interpretation of the ixekizumab study results. Findings Between June 20, 2016, and Aug 22, 2017, 341 patients were randomly assigned to either the placebo group (n=87), adalimumab group (n=90), ixekizumab Q2W (n=83), or ixekizumab Q4W (n=81). At week 16, compared with placebo (16 [18%] of 87), more patients achieved ASAS40 with ixekizumab Q2W (43 [52%] of 83; p<0.0001), ixekizumab Q4W (39 [48%] of 81; p<0.0001), and adalimumab (32 [36%] of 90; p=0.0053). One serious infection occurred in each of the ixekizumab Q2W (1%), ixekizumab Q4W (1%), and adalimumab (1%) groups; none were reported with placebo. One (1%) Candida infection occurred in the adalimumab group and one (1%) patient receiving ixekizumab Q2W was adjudicated as having probable Crohn's disease. No treatment-emergent opportunistic infections, malignancies, or deaths occurred. Interpretation Each dosing regimen of ixekizumab was superior to placebo for improving radiographic axial spondyloarthritis signs and symptoms in patients not previously treated with bDMARDs; the safety profile was consistent with previous indications of ixekizumab. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, POB 9600, NL-2300 RC Leiden, Netherlands; [Wei, James Cheng-Chung] China Med Univ, Grad Inst Integrated Med, Chung Shan Med Univ Hosp, Dept Internal Med,Chung Shan Med Univ,Inst Med, Taichung, Taiwan; [Dougados, Maxime] Hop Cochin, Dept Rheumatol, Paris, France; [Mease, Philip] Swedish Med Ctr, Seattle, WA USA; [Mease, Philip] Univ Washington, Seattle, WA 98195 USA; [Deodhar, Atul] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Maksymowych, Walter P.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Van den Bosch, Filip] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [Sieper, Joachim] Charite, Dept Rheumatol, Berlin, Germany; [Tomita, Tetsuya] Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, Suita, Osaka, Japan; [Landewe, Robert] Amsterdam Rheumatol & Clin Immunol Ctr, Amsterdam, Netherlands; [Landewe, Robert] Zuyderland Med Ctr, Heerlen, Netherlands; [Zhao, Fangyi; Krishnan, Eswar; Adams, David H.; Pangallo, Beth; Carlier, Hilde] Eli Lilly & Co, Indianapolis, IN 46285 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Swedish Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of Alberta; Ghent University; Ghent University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Osaka University; Eli Lilly	van der Heijde, D (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, POB 9600, NL-2300 RC Leiden, Netherlands.	mail@dvanderheijde.nl	van der Heijde, Désirée/I-6774-2019; Dougados, Maxime/P-5287-2016; Wei, James Cheng-Chung/AAL-8947-2020; LANDEWE, ROBERT B.M./ABD-7388-2021; krishnan, Eswar/AAY-1269-2020; Poddubnyy, Denis/V-1985-2019; Yakushin, Sergey/N-4165-2013; Moravcova, Radka/J-7155-2017	van der Heijde, Désirée/0000-0002-5781-158X; Wei, James Cheng-Chung/0000-0002-1235-0679; LANDEWE, ROBERT B.M./0000-0002-0577-6620; Poddubnyy, Denis/0000-0002-4537-6015; Yakushin, Sergey/0000-0001-7202-742X; Bessette, Louis/0000-0002-6834-2731; Maksymowych, Walter/0000-0002-1291-1755; Ramos-Remus, Cesar/0000-0002-4898-4219; Pacheco-Tena, Cesar/0000-0002-0793-8988; Blicharski, Tomasz/0000-0001-9747-8817; Nurmohamed, Michael/0000-0002-6274-1934; Moravcova, Radka/0000-0002-8855-4512	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Eli Lilly and Company.	Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Boonen A, 2006, J RHEUMATOL, V33, P4; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Brandt J, 2004, ANN RHEUM DIS, V63, P1438, DOI 10.1136/ard.2003.016717; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; Gao Xin, 2012, J Med Econ, V15, P1054, DOI 10.3111/13696998.2012.692341; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Inman RD, 2008, ARTHRITIS RHEUM-US, V58, P3402, DOI 10.1002/art.23969; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Landewe R, 2014, ANN RHEUM DIS, V73, P39, DOI 10.1136/annrheumdis-2013-204231; Mease PJ, 2017, ANN RHEUM DIS, V76, P79, DOI 10.1136/annrheumdis-2016-209709; Nash P, 2017, LANCET, V389, P2317, DOI 10.1016/S0140-6736(17)31429-0; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Paul C, 2018, BRIT J DERMATOL, V178, P1003, DOI 10.1111/bjd.16497; Pavelka K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1490-y; Reveille JD, 2012, ARTHRIT CARE RES, V64, P905, DOI 10.1002/acr.21621; Sepriano A, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000396; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2017, LANCET, V390, P73, DOI 10.1016/S0140-6736(16)31591-4; Strand V, 2013, ARTHRIT CARE RES, V65, P1299, DOI 10.1002/acr.21994; Strober B, 2017, J AM ACAD DERMATOL, V76, P432, DOI 10.1016/j.jaad.2016.09.026; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; Ward MM, 2016, ARTHRIT CARE RES, V68, P151, DOI 10.1002/acr.22708	29	185	188	2	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2018	392	10163					2441	2451		10.1016/S0140-6736(18)31946-9	http://dx.doi.org/10.1016/S0140-6736(18)31946-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD5RO	30360964	Green Submitted			2022-12-28	WOS:000452587800027
J	Perraki, A; DeFalco, TA; Derbyshire, P; Avila, J; Sere, D; Sklenar, J; Qi, XY; Stransfeld, L; Schwessinger, B; Kadota, Y; Macho, AP; Jiang, SS; Couto, D; Torii, KU; Menke, FLH; Zipfel, C				Perraki, Artemis; DeFalco, Thomas A.; Derbyshire, Paul; Avila, Julian; Sere, David; Sklenar, Jan; Qi, Xingyun; Stransfeld, Lena; Schwessinger, Benjamin; Kadota, Yasuhiro; Macho, Alberto P.; Jiang, Shushu; Couto, Daniel; Torii, Keiko U.; Menke, Frank L. H.; Zipfel, Cyril			Phosphocode-dependent functional dichotomy of a common co-receptor in plant signalling (vol 561, pg 248, 2018)	NATURE			English	Correction													Kadota, Yasuhiro/AGJ-3017-2022; Qi, Xingyun/AAW-7767-2020; TORII, KEIKO U./A-6041-2013; ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021; Kadota, Yasuhiro/AAC-4545-2019	Kadota, Yasuhiro/0000-0002-4782-1418; TORII, KEIKO U./0000-0002-6168-427X; ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Kadota, Yasuhiro/0000-0002-4782-1418; Avila, Julian/0000-0001-9388-3946; Macho, Alberto P/0000-0001-9935-8026; Couto, Daniel/0000-0003-0223-1497	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Perraki A, 2018, NATURE, V561, P248, DOI 10.1038/s41586-018-0471-x	1	0	0	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2018	563	7733								10.1038/s41586-018-0663-4	http://dx.doi.org/10.1038/s41586-018-0663-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC1YT	30333630	Bronze, Green Accepted			2022-12-28	WOS:000451599900009
J	Wilder, J; Choi, SS; Moylan, CA				Wilder, Julius; Choi, Steve S.; Moylan, Cynthia A.			Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIVER-DISEASE; UNITED-STATES		[Wilder, Julius; Choi, Steve S.; Moylan, Cynthia A.] Duke Univ Hlth Syst, Div Gastroenterol, Durham, NC USA; [Wilder, Julius] Duke Clin Res Inst, Durham, NC USA; [Choi, Steve S.; Moylan, Cynthia A.] Durham Vet Affairs Med Ctr, Durham, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Moylan, CA (corresponding author), Duke Univ, Sch Med, 905 S Lasalle St,GSRB1,DUMC 3256, Durham, NC 27710 USA.	cynthia.moylan@duke.edu	Choi, Steve/GZH-1598-2022	Moylan, Cynthia/0000-0001-8454-7086				Afdhal NH, 2015, CLIN GASTROENTEROL H, V13, P772, DOI 10.1016/j.cgh.2014.12.014; Centers for Medicare & Medicaid Services, 2018, PHYS FEE SCHED LOOK; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Wilder J, 2014, MED DEVICES-EVID RES, V7, P107, DOI 10.2147/MDER.S46943; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039	6	6	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2018	320	19					2031	2032		10.1001/jama.2018.13073	http://dx.doi.org/10.1001/jama.2018.13073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB0FC	30383175				2022-12-28	WOS:000450686800018
J	Gaudinier, A; Rodriguez-Medina, J; Zhang, LF; Olson, A; Liseron-Monfils, C; Bagman, AM; Foret, J; Abbitt, S; Tang, M; Li, BH; Runcie, DE; Kliebenstein, DJ; Shen, B; Frank, MJ; Ware, D; Brady, SM				Gaudinier, Allison; Rodriguez-Medina, Joel; Zhang, Lifang; Olson, Andrew; Liseron-Monfils, Christophe; Bagman, Anne-Maarit; Foret, Jessica; Abbitt, Shane; Tang, Michelle; Li, Baohua; Runcie, Daniel E.; Kliebenstein, Daniel J.; Shen, Bo; Frank, Mary J.; Ware, Doreen; Brady, Siobhan M.			Transcriptional regulation of nitrogen-associated metabolism and growth	NATURE			English	Article							ARABIDOPSIS-THALIANA ROOTS; NITRATE RESPONSE; EXPRESSION PATTERNS; SIGNALING PATHWAY; GENOMIC ANALYSIS; GENE FAMILY; TRANSPORTER; HORMONES; NETWORKS; SENSITIVITY	Nitrogen is an essential macronutrient for plant growth and basic metabolic processes. The application of nitrogen-containing fertilizer increases yield, which has been a substantial factor in the green revolution(1). Ecologically, however, excessive application of fertilizer has disastrous effects such as eutrophication(2). A better understanding of how plants regulate nitrogen metabolism is critical to increase plant yield and reduce fertilizer overuse. Here we present a transcriptional regulatory network and twenty-one transcription factors that regulate the architecture of root and shoot systems in response to changes in nitrogen availability. Genetic perturbation of a subset of these transcription factors revealed coordinate transcriptional regulation of enzymes involved in nitrogen metabolism. Transcriptional regulators in the network are transcriptionally modified by feedback via genetic perturbation of nitrogen metabolism. The network, genes and gene-regulatory modules identified here will prove critical to increasing agricultural productivity.	[Gaudinier, Allison; Rodriguez-Medina, Joel; Bagman, Anne-Maarit; Foret, Jessica; Tang, Michelle; Brady, Siobhan M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Gaudinier, Allison; Rodriguez-Medina, Joel; Bagman, Anne-Maarit; Foret, Jessica; Tang, Michelle; Brady, Siobhan M.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Zhang, Lifang; Olson, Andrew; Liseron-Monfils, Christophe; Ware, Doreen] Cold Spring Harbor, Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Abbitt, Shane; Shen, Bo; Frank, Mary J.] DuPont Pioneer, Johnston, IA USA; [Tang, Michelle; Li, Baohua; Runcie, Daniel E.; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kliebenstein, Daniel J.] Univ Copenhagen, DynaMo Ctr Excellence, Frederiksberg C, Denmark; [Ware, Doreen] ARS, USDA, Ithaca, NY USA	University of California System; University of California Davis; University of California System; University of California Davis; Cold Spring Harbor Laboratory; DuPont; Pioneer Hi-Bred International, Inc.; University of California System; University of California Davis; University of Copenhagen; United States Department of Agriculture (USDA)	Brady, SM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.; Brady, SM (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	sbrady@ucdavis.edu	Brady, Siobhan/AAY-1729-2021	Tang, Michelle/0000-0002-8779-8697; Brady, Siobhan/0000-0001-9424-8055; Runcie, Daniel/0000-0002-3008-9312; Rodriguez-Medina, Joel/0000-0001-8756-317X; Abbitt, Shane/0000-0003-4450-3753	DuPont Pioneer; Elsie Taylor Stocking Memorial Fellowship; Katherine Esau Graduate Summer Fellowship; University of California, Davis Dissertation Year Fellowship; UC-MEXUS CONACYT PhD Fellowship; HHMI Faculty Scholar Fellowship;  [NSF-MCB-1330337]	DuPont Pioneer; Elsie Taylor Stocking Memorial Fellowship; Katherine Esau Graduate Summer Fellowship; University of California, Davis Dissertation Year Fellowship; UC-MEXUS CONACYT PhD Fellowship; HHMI Faculty Scholar Fellowship; 	We thank N.M. Crawford for chl1-5 seeds, P. J. Etchells for wox14-1 and lbd4-1 seeds, and E. E. Sparks and P. N. Benfey for erf107-1, abf4-2, eel-1, vip1-1 and erf070 seeds. Some seed stocks were obtained from the Arabidopsis Biological Resource Center (ABRC) at Ohio State University. We thank E. A. Ainsworth and S.B. Gray for help with chlorophyll and protein assays, K. Kajala for help with RNA-seq libraries and E. M. McGinnis for help with root measurements. We thank K. Dehesh for discussions. This research was funded by DuPont Pioneer. A. G. was also supported by the Elsie Taylor Stocking Memorial Fellowship, the Katherine Esau Graduate Summer Fellowship and the University of California, Davis Dissertation Year Fellowship. J. R.-M. was supported by a UC-MEXUS CONACYT PhD Fellowship. D.J.K., M.T. and S.M.B. acknowledge funding from NSF-MCB-1330337. S.M.B. was partially funded by an HHMI Faculty Scholar Fellowship.	Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araus V, 2016, PLANT PHYSIOL, V171, P1523, DOI 10.1104/pp.15.01731; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Bouguyon E, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.15, 10.1038/NPLANTS.2015.15]; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chitwood DH, 2015, CURR OPIN PLANT BIOL, V24, P54, DOI 10.1016/j.pbi.2015.01.009; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Deplancke Bart, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4590; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Fontaine JX, 2012, PLANT CELL, V24, P4044, DOI 10.1105/tpc.112.103689; Gaudinier A, 2011, NAT METHODS, V8, P1053, DOI [10.1038/NMETH.1750, 10.1038/nmeth.1750]; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibbs DJ, 2014, MOL CELL, V53, P369, DOI 10.1016/j.molcel.2013.12.020; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Guan PZ, 2014, P NATL ACAD SCI USA, V111, P15267, DOI 10.1073/pnas.1411375111; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Kissen R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-190; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liseron-Monfils C. V., 2018, PREPRINT; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 2017, NATURE, V545, P311, DOI 10.1038/nature22077; Ma C, 2012, PLANT PHYSIOL, V160, P192, DOI 10.1104/pp.112.201962; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Marin IC, 2011, PLANTA, V233, P539, DOI 10.1007/s00425-010-1316-5; Medici A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7274; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Obertello M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-111; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Patterson K, 2010, PLANT CELL ENVIRON, V33, P1486, DOI 10.1111/j.1365-3040.2010.02158.x; Poole W, 2016, BIOINFORMATICS, V32, P430, DOI 10.1093/bioinformatics/btw438; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Ristova D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2768; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Saaty T. L., 1987, Expert Judgement and Expert Systems. Proceedings of the NATO Advanced Research Workshop, P27; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Townsley BT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00366; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Van Deun K, 2009, BIOINFORMATICS, V25, P2588, DOI 10.1093/bioinformatics/btp439; Vidal EA, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28501; Vidal EA, 2013, P NATL ACAD SCI USA, V110, P12840, DOI 10.1073/pnas.1310937110; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Xu N, 2016, PLANT CELL, V28, P485, DOI 10.1105/tpc.15.00567; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Zhang HM, 2000, J EXP BOT, V51, P51, DOI 10.1093/jexbot/51.342.51; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	64	121	129	48	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					259	+		10.1038/s41586-018-0656-3	http://dx.doi.org/10.1038/s41586-018-0656-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30356219	Green Published			2022-12-28	WOS:000449943600046
J	Brooks, HR				Brooks, Helen R.			Mitochondria: Finding the Power to Change	CELL			English	Editorial Material							REPLACEMENT; MUTATIONS											Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Castro RJ, 2016, J LAW BIOSCI, V3, P726, DOI 10.1093/jlb/lsw051; Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Mitalipov S, 2014, TRENDS ENDOCRIN MET, V25, P5, DOI 10.1016/j.tem.2013.09.001; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001	10	5	5	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					891	893		10.1016/j.cell.2018.10.035	http://dx.doi.org/10.1016/j.cell.2018.10.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388445	Bronze			2022-12-28	WOS:000449100600001
J	Provenzano, AM				Provenzano, Audrey M.			Becoming a Caregiver - Lessons from My Dad	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Provenzano, Audrey M.] Massachusetts Gen Hosp Chelsea Hlth Ctr, Chelsea, MA 02150 USA		Provenzano, AM (corresponding author), Massachusetts Gen Hosp Chelsea Hlth Ctr, Chelsea, MA 02150 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1696	1697		10.1056/NEJMp1808685	http://dx.doi.org/10.1056/NEJMp1808685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380391				2022-12-28	WOS:000448891600004
J	Wise, J				Wise, Jacqui			Medical supplies could be held up at border after Brexit, peers hear	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Audit Office, 2018, UK BORD PREP EU EX	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4640	10.1136/bmj.k4640	http://dx.doi.org/10.1136/bmj.k4640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385452				2022-12-28	WOS:000449565500014
J	Kratochwil, CF; Liang, YP; Gerwin, J; Woltering, JM; Urban, S; Henning, F; Machado-Schiaffino, G; Hulsey, CD; Meyer, A				Kratochwil, Claudius F.; Liang, Yipeng; Gerwin, Jan; Woltering, Joost M.; Urban, Sabine; Henning, Frederico; Machado-Schiaffino, Gonzalo; Hulsey, C. Darrin; Meyer, Axel			Agouti-related peptide 2 facilitates convergent evolution of stripe patterns across cichlid fish radiations	SCIENCE			English	Article							ADAPTIVE RADIATION; PIGMENTATION; MODEL	The color patterns of African cichlid fishes provide notable examples of phenotypic convergence. Across the more than 1200 East African rift lake species, melanic horizontal stripes have evolved numerous times. We discovered that regulatory changes of the gene agouti-related peptide 2 (agrp2) act as molecular switches controlling this evolutionarily labile phenotype. Reduced agrp2 expression is convergently associated with the presence of stripe patterns across species flocks. However, cis-regulatory mutations are not predictive of stripes across radiations, suggesting independent regulatory mechanisms. Genetic mapping confirms the link between the agrp2 locus and stripe patterns. The crucial role of agrp2 is further supported by a CRISPR-Cas9 knockout that reconstitutes stripes in a nonstriped cichlid. Thus, we unveil how a single gene affects the convergent evolution of a complex color pattern.	[Kratochwil, Claudius F.; Liang, Yipeng; Gerwin, Jan; Woltering, Joost M.; Urban, Sabine; Henning, Frederico; Machado-Schiaffino, Gonzalo; Hulsey, C. Darrin; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Kratochwil, Claudius F.] Univ Konstanz, Zukunftskolleg, Constance, Germany; [Kratochwil, Claudius F.; Gerwin, Jan; Urban, Sabine; Hulsey, C. Darrin; Meyer, Axel] IMPRS OB, Max Planck Inst Ornithol, Constance, Germany; [Henning, Frederico] Univ Fed Rio de Janeiro, Fed Univ Rio De Janeiro, Inst Biol, Dept Genet, Rio de Janeiro, Brazil; [Machado-Schiaffino, Gonzalo] Univ Oviedo, Dept Funct Biol, Area Genet, Oviedo, Spain	University of Konstanz; University of Konstanz; Max Planck Society; Universidade Federal do Rio de Janeiro; University of Oviedo	Kratochwil, CF; Meyer, A (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Kratochwil, CF (corresponding author), Univ Konstanz, Zukunftskolleg, Constance, Germany.; Kratochwil, CF; Meyer, A (corresponding author), IMPRS OB, Max Planck Inst Ornithol, Constance, Germany.	claudius.kratochwil@uni-konstanz.de; axel.meyer@uni-konstanz.de	Henning, Frederico/AAS-2090-2020; Henning, Frederico/M-8042-2017; Machado-Schiaffino, Gonzalo/AAE-3114-2020; Machado-Schiaffino, Gonzalo/Q-9480-2018; Kratochwil, Claudius F/B-1294-2013; Meyer, Axel/C-9826-2009	Henning, Frederico/0000-0002-5359-504X; Henning, Frederico/0000-0002-5359-504X; Machado-Schiaffino, Gonzalo/0000-0002-4049-3247; Machado-Schiaffino, Gonzalo/0000-0002-4049-3247; Kratochwil, Claudius F/0000-0002-5646-3114; Meyer, Axel/0000-0002-0888-8193; Liang, Yipeng/0000-0003-1664-7864; Woltering, Joost/0000-0002-2630-6572; Meyer, Axel/0000-0002-0474-5494; Urban, Sabine/0000-0003-4389-3075; Hulsey, C. Darrin/0000-0002-9653-6728; Gerwin, Jan/0000-0001-7897-3302	Swiss National Science Foundation [P2BSP3_148629]; Marie Curie Zukunftskolleg Incoming Fellowship Program [291784]; Baden-Wurttemberg Foundation; Deutsche Forschungsgemeinschaft (DFG) [KR 4670/2-1]; Young Scholar Fund of the University of Konstanz; China Scholarship Council (CSC); DFG; University of Konstanz; ERC Advanced Grant GenAdap [293700]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Zukunftskolleg Incoming Fellowship Program; Baden-Wurttemberg Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Young Scholar Fund of the University of Konstanz; China Scholarship Council (CSC)(China Scholarship Council); DFG(German Research Foundation (DFG)); University of Konstanz; ERC Advanced Grant GenAdap	This work was supported by the Swiss National Science Foundation (P2BSP3_148629), the Marie Curie Zukunftskolleg Incoming Fellowship Program (291784), the Baden-Wurttemberg Foundation, the Deutsche Forschungsgemeinschaft (DFG, KR 4670/2-1), and the Young Scholar Fund of the University of Konstanz (all to C.F.K.). Y.L. is funded by the China Scholarship Council (CSC). A.M. and C.D.H. are funded by DFG and University of Konstanz. Partial funding came from an ERC Advanced Grant GenAdap (no. 293700) to A.M.	Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Cal L, 2017, COMP BIOCHEM PHYS A, V211, P26, DOI 10.1016/j.cbpa.2017.06.001; Ceinos RM, 2015, PIGM CELL MELANOMA R, V28, P196, DOI 10.1111/pcmr.12335; Gould S. J., 1990, WONDERFUL LIFE BURGE; Henning F, 2014, MOL ECOL, V23, P5224, DOI 10.1111/mec.12860; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kratochwil C. F., 2018, DRYAD, DOI [10.5061/dryad.h1107nd, DOI 10.5061/DRYAD.H1107ND]; Kratochwil CF, 2015, CURR BIOL, V25, pR285, DOI 10.1016/j.cub.2015.02.051; Kratochwil CF, 2015, BIOESSAYS, V37, P213, DOI 10.1002/bies.201400142; Kuraku S, 2008, CURR OPIN GENET DEV, V18, P551, DOI 10.1016/j.gde.2008.11.002; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB., 2017, IMPROBABLE DESTINIES; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Mazo-Vargas A, 2017, P NATL ACAD SCI USA, V114, P10701, DOI 10.1073/pnas.1708149114; MEYER A, 1993, TRENDS ECOL EVOL, V8, P279, DOI 10.1016/0169-5347(93)90255-N; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Santos ME, 2012, SCIENCE, V338, P619, DOI 10.1126/science.1224818; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Turner GF, 2007, CURR BIOL, V17, pR827, DOI 10.1016/j.cub.2007.07.026; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107	24	78	78	6	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					457	+		10.1126/science.aao6809	http://dx.doi.org/10.1126/science.aao6809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361373	Green Submitted			2022-12-28	WOS:000450441900050
J	Legnani, L; Prina-Cerai, G; Delcaillau, T; Willems, S; Morandi, B				Legnani, Luca; Prina-Cerai, Gabriele; Delcaillau, Tristan; Willems, Suzanne; Morandi, Bill			Efficient access to unprotected primary amines by iron-catalyzed aminochlorination of alkenes	SCIENCE			English	Article							STEREOSPECIFIC SYNTHESIS; UNACTIVATED OLEFINS; N-H; AZIRIDINES; AMINATION; CHEMISTRY; AMMONIA; ION; HYDROAMINATION; DIAZIDATION	Primary amines are essential constituents of biologically active molecules and versatile intermediates in the synthesis of drugs and agrochemicals. However, their preparation from easily accessible alkenes remains challenging. Here, we report a general strategy to access primary amines from alkenes through an operationally simple iron-catalyzed aminochlorination reaction. A stable hydroxylamine derivative and benign sodium chloride act as the respective nitrogen and chlorine sources. The reaction proceeds at room temperature under air; tolerates a large scope of aliphatic and conjugated alkenes, including densely functionalized substrates; and provides excellent anti-Markovnikov regioselectivity with respect to the amino group. The reactivity of the 2-chloroalkylamine products, an understudied class of amphoteric molecules, enables facile access to linear or branched aliphatic amines, aziridines, aminonitriles, azido amines, and homoallylic amines.	[Legnani, Luca; Prina-Cerai, Gabriele; Delcaillau, Tristan; Willems, Suzanne; Morandi, Bill] Max Planck Inst Kohlenforsch, Mulheim, Germany; [Delcaillau, Tristan; Morandi, Bill] Swiss Fed Inst Technol, Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Morandi, B (corresponding author), Max Planck Inst Kohlenforsch, Mulheim, Germany.; Morandi, B (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	morandib@ethz.ch		Delcaillau, Tristan/0000-0001-8418-3219; Morandi, Bill/0000-0003-3968-1424; Prina Cerai, Gabriele/0000-0002-0511-0415; Legnani, Luca/0000-0002-2382-7858; Willems, Suzanne/0000-0001-7288-5539	Max Planck Society; Max-Planck-Institut fur Kohlenforschung; European Research Commission [ShuttleCat 757608]; ETH Zurich; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max-Planck-Institut fur Kohlenforschung; European Research Commission(European CommissionEuropean Commission Joint Research Centre); ETH Zurich(ETH Zurich); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	Generous funding from the Max Planck Society, the Max-Planck-Institut fur Kohlenforschung, the European Research Commission (grant agreement ShuttleCat 757608), the ETH Zurich, and the Fonds der Chemischen Industrie is acknowledged.	Andersson MA, 2002, ANGEW CHEM INT EDIT, V41, P472, DOI 10.1002/1521-3773(20020201)41:3<472::AID-ANIE472>3.0.CO;2-7; Bach T, 2001, CHEM-EUR J, V7, P2581, DOI 10.1002/1521-3765(20010618)7:12<2581::AID-CHEM25810>3.0.CO;2-O; Bach T, 2000, CHEM COMMUN, P287, DOI 10.1039/a909009f; Beller M, 2004, ANGEW CHEM INT EDIT, V43, P3368, DOI 10.1002/anie.200300616; Berger G, 2013, TETRAHEDRON LETT, V54, P545, DOI 10.1016/j.tetlet.2012.11.079; Bovino MT, 2012, ANGEW CHEM INT EDIT, V51, P3923, DOI 10.1002/anie.201109044; Cai YF, 2013, CHEM COMMUN, V49, P8054, DOI 10.1039/c3cc44421j; Cai YF, 2011, J AM CHEM SOC, V133, P5636, DOI 10.1021/ja110668c; Chemler SR, 2013, ACS CATAL, V3, P1076, DOI 10.1021/cs400138b; Correa A, 2008, CHEM SOC REV, V37, P1108, DOI 10.1039/b801794h; Cruz A, 2010, TETRAHEDRON-ASYMMETR, V21, P909, DOI 10.1016/j.tetasy.2010.05.007; Danielec H, 2006, SYNTHESIS-STUTTGART, P551, DOI 10.1055/s-2005-918500; Dauban P., 2014, COMPREHENSIVE ORGANI, P538; Defieber C, 2007, ANGEW CHEM INT EDIT, V46, P3139, DOI 10.1002/anie.200700159; Fu NK, 2017, SCIENCE, V357, P575, DOI 10.1126/science.aan6206; Geng XY, 2017, ORG LETT, V19, P4738, DOI 10.1021/acs.orglett.7b02056; Gross T, 2002, ORG LETT, V4, P2055, DOI 10.1021/ol0200605; Gui JH, 2015, SCIENCE, V348, P886, DOI 10.1126/science.aab0245; Gunanathan C, 2008, ANGEW CHEM INT EDIT, V47, P8661, DOI 10.1002/anie.200803229; HAGGIN J, 1993, CHEM ENG NEWS, V71, P23, DOI 10.1021/cen-v071n022.p023; Hennessy ET, 2014, CHEM SCI, V5, P1526, DOI 10.1039/c3sc52533c; Jagadeesh RV, 2017, SCIENCE, V358, P326, DOI 10.1126/science.aan6245; Jat JL, 2014, SCIENCE, V343, P61, DOI 10.1126/science.1245727; King ER, 2011, J AM CHEM SOC, V133, P4917, DOI 10.1021/ja110066j; Kohler DG, 2018, NAT CHEM, V10, P333, DOI [10.1038/nchem.2904, 10.1038/NCHEM.2904]; KOVACIC P, 1970, CHEM REV, V70, P639, DOI 10.1021/cr60268a002; Leemans E, 2009, SYNLETT, P1265, DOI 10.1055/s-0028-1088125; Legnani L, 2017, SYNTHESIS-STUTTGART, V49, P776, DOI 10.1055/s-0036-1588371; Legnani L, 2016, ANGEW CHEM INT EDIT, V55, P2248, DOI 10.1002/anie.201507630; Lu DF, 2016, J AM CHEM SOC, V138, P11360, DOI 10.1021/jacs.6b07221; Lu DF, 2014, J AM CHEM SOC, V136, P13186, DOI 10.1021/ja508057u; Ma ZW, 2017, ANGEW CHEM INT EDIT, V56, P9886, DOI 10.1002/anie.201705530; Miki Y, 2013, ANGEW CHEM INT EDIT, V52, P10830, DOI 10.1002/anie.201304365; MINISCI F, 1965, TETRAHEDRON LETT, P1679; MINISCI F, 1966, TETRAHEDRON LETT, P3163; Musacchio AJ, 2017, SCIENCE, V355, P727, DOI 10.1126/science.aal3010; Naredla RR, 2013, CHEM REV, V113, P6905, DOI 10.1021/cr4001385; NONHEBEL DC, 1993, CHEM SOC REV, V22, P347, DOI 10.1039/cs9932200347; Pouy MJ, 2009, J AM CHEM SOC, V131, P11312, DOI 10.1021/ja905059r; Schiesser CH, 1996, TETRAHEDRON, V52, P13265, DOI 10.1016/0040-4020(96)00809-5; Shen K, 2017, J AM CHEM SOC, V139, P13110, DOI 10.1021/jacs.7b06852; Tian JS, 2015, SYNTHESIS-STUTTGART, V47, P1709, DOI 10.1055/s-0034-1378719; Williamson KS, 2012, J AM CHEM SOC, V134, P12370, DOI 10.1021/ja3046684; Yuan YA, 2016, ANGEW CHEM INT EDIT, V55, P534, DOI 10.1002/anie.201507550; Zhu CL, 2015, CHEM SCI, V6, P3044, DOI [10.1039/C5SC00221D, 10.1039/c5sc00221d]; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	46	63	61	10	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					434	438		10.1126/science.aat3863	http://dx.doi.org/10.1126/science.aat3863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361368	Green Accepted			2022-12-28	WOS:000450441900044
J	Bajak, A				Bajak, Aleszu			Science in Colombia on the cusp of change	NATURE			English	Editorial Material									[Bajak, Aleszu] Northeastern Univ, Journalism, Boston, MA 02115 USA	Northeastern University	Bajak, A (corresponding author), Northeastern Univ, Journalism, Boston, MA 02115 USA.								0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					S109	S111		10.1038/d41586-018-07113-6	http://dx.doi.org/10.1038/d41586-018-07113-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY1HQ	30356201	Bronze			2022-12-28	WOS:000448277800008
J	Cavendish, C				Cavendish, Camilla			Social care funding: what can we learn from Germany and Japan?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cavendish, Camilla] Harvard Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA 02138 USA	Harvard University	Cavendish, C (corresponding author), Harvard Kennedy Sch, Mossavar Rahmani Ctr Business & Govt, Cambridge, MA 02138 USA.	camilla_cavendish@hks.harvard.edu							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2018	363								k4429	10.1136/bmj.k4429	http://dx.doi.org/10.1136/bmj.k4429			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PX	30361389				2022-12-28	WOS:000448896000009
J	Adamson, PC; Klausner, JD				Adamson, Paul C.; Klausner, Jeffrey D.			No benefit of chlamydia screening in primary care?	LANCET			English	Editorial Material							IMPROVEMENT		[Adamson, Paul C.; Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90025 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Klausner, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90025 USA.	jdklausner@mednet.ucla.edu	Adamson, Paul/AAR-1405-2020	Adamson, Paul/0000-0002-2776-6458				[Anonymous], SEX TRANSM DIS SURV; Bradley EH, 2004, QUAL SAF HEALTH CARE, V13, P26, DOI 10.1136/qhc.13.1.26; Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3; Guy RJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-211; Hocking JS, 2018, LANCET, V392, P1413, DOI 10.1016/S0140-6736(18)31816-6; Hysong SJ, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-9; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Low N, 2016, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD010866.PUB; National Committee for Quality Assurance, CHLAM SCREEN WOM CHL; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Regan DG, 2013, SEX TRANSM DIS, V40, P700, DOI 10.1097/OLQ.0000000000000009; Shafer MAB, 2002, JAMA-J AM MED ASSOC, V288, P2846, DOI 10.1001/jama.288.22.2846	12	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1381	1383		10.1016/S0140-6736(18)32465-6	http://dx.doi.org/10.1016/S0140-6736(18)32465-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343849				2022-12-28	WOS:000447800900011
J	Montanaro, A				Montanaro, Ashley			Computational complexity, step by step	SCIENCE			English	Editorial Material									[Montanaro, Ashley] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England	University of Bristol	Montanaro, A (corresponding author), Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England.	ashley.montanaro@bristol.ac.uk			UK EPSRC [EP/L021005/1]	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	A.M. is supported by the UK EPSRC (EP/L021005/1), is co-founder of the quantum software company PhaseCraft, and consults on quantum computing.	Barrett J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.012103; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Shor PW, 1999, SIAM REV, V41, P303, DOI 10.1137/S0036144598347011	6	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					289	289		10.1126/science.aau9555	http://dx.doi.org/10.1126/science.aau9555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337396				2022-12-28	WOS:000447680100025
J	Lam, MB; Figueroa, JF; Feyman, Y; Reimold, KE; Orav, EJ; Jha, AK				Lam, Miranda B.; Figueroa, Jose F.; Feyman, Yevgeniy; Reimold, Kimberly E.; Orav, E. John; Jha, Ashish K.			Association between patient outcomes and accreditation in US hospitals: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; MEDICARE BENEFICIARIES; READMISSION RATES; MORTALITY; STROKE; IMPROVEMENT; IMPACT	OBJECTIVES To determine whether patients admitted to US hospitals that are accredited have better outcomes than those admitted to hospitals reviewed through state surveys, and whether accreditation by The Joint Commission (the largest and most well known accrediting body with an international presence) confers any additional benefits for patients compared with other independent accrediting organizations. DESIGN Observational study. SETTING 4400 hospitals in the United States, of which 3337 were accredited (2847 by The Joint Commission) and 1063 underwent state based review between 2014 and 2017. Participants 4 242 684 patients aged 65 years and older admitted for 15 common medical and six common surgical conditions and survey respondents of the Hospital Consumer Assessment of Healthcare Provider and Systems (HCAHPS). MAIN OUTCOME MEASURES Risk adjusted mortality and readmission rates at 30 days and HCAHPS patient experience scores. Hospital admissions were identified from Medicare inpatient files for 2014, and accreditation information was obtained from the Centers for Medicare and Medicaid Services and The Joint Commission. RESULTS Patients treated at accredited hospitals had lower 30 day mortality rates (although not statistically significant lower rates, based on the prespecified P value threshold) than those at hospitals that were reviewed by a state survey agency (10.2% v 10.6%, difference 0.4% (95% confidence interval 0.1% to 0.8%), P=0.03), but nearly identical rates of mortality for the six surgical conditions (2.4% v 2.4%, 0.0% (-0.3% to 0.3%), P=0.99). Readmissions for the 15 medical conditions at 30 days were significantly lower at accredited hospitals than at state survey hospitals (22.4% v 23.2%, 0.8% (0.4% to 1.3%), P<0.001) but did not differ for the surgical conditions (15.9% v 15.6%, 0.3% (-1.2% to 1.6%), P=0.75). No statistically significant differences were seen in 30 day mortality or readmission rates (for both the medical or surgical conditions) between hospitals accredited by The Joint Commission and those accredited by other independent organizations. Patient experience scores were modestly better at state survey hospitals than at accredited hospitals (summary star rating 3.4 v 3.2, 0.2 (0.1 to 0.3), P<0.001). Among accredited hospitals, The Joint Commission did not have significantly different patient experience scores compared to other independent organizations (3.1 v 3.2, 0.1 (-0.003 to 0.2), P=0.06). CONCLUSIONS US hospital accreditation by independent organizations is not associated with lower mortality, and is only slightly associated with reduced readmission rates for the 15 common medical conditions selected in this study. There was no evidence in this study to indicate that patients choosing a hospital accredited by The Joint Commission confer any healthcare benefits over choosing a hospital accredited by another independent accrediting organization.	[Lam, Miranda B.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA; [Lam, Miranda B.; Feyman, Yevgeniy; Reimold, Kimberly E.; Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Figueroa, Jose F.; Jha, Ashish K.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Figueroa, Jose F.; Jha, Ashish K.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Orav, E. John] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Jha, AK (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Jha, AK (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA.	ajha@hsph.harvard.edu	Feyman, Yevgeniy/AAX-1606-2020; Lam, Miranda/L-2377-2019	Feyman, Yevgeniy/0000-0001-7372-7671; Reimold, Kimberly/0000-0002-4067-7222	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adams R., 2017, BUZZFEED NEWS; Armour S., HOUSE PANEL PROBES O; Armour S., 2017, WALL STREET J; Azagury D, 2016, J AM COLL SURGEONS, V223, P469, DOI 10.1016/j.jamcollsurg.2016.06.014; Barnett ML, 2017, JAMA INTERN MED, V177, P693, DOI 10.1001/jamainternmed.2016.9685; Bogh SB, 2016, INT J QUAL HEALTH C, V28, P715, DOI 10.1093/intqhc/mzw099; Bogh SB, 2015, INT J QUAL HEALTH C, V27, P336, DOI 10.1093/intqhc/mzv053; Brubakk K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0933-x; Burke LG, 2017, JAMA-J AM MED ASSOC, V317, P2105, DOI 10.1001/jama.2017.5702; Castellucci M., JOINT COMMISSION ACC; Centers for Medicare & Medicaid Services, 2013, COND COV CFCS COND P; Centers for Medicare & Medicaid Services, STAT OP MAN CHAPT 2; Chen J, 2003, HEALTH AFFAIR, V22, P243, DOI 10.1377/hlthaff.22.2.243; Falstie-Jensen AM, 2015, INT J QUAL HEALTH C, V27, P451, DOI 10.1093/intqhc/mzv070; Falstie-Jensen AM, 2015, INT J QUAL HEALTH C, V27, P165, DOI 10.1093/intqhc/mzv023; Figueroa JF, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2214; Gratwohl A, 2014, HAEMATOLOGICA, V99, P908, DOI 10.3324/haematol.2013.096461; Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005; Greenfield D, 2009, QUAL SAF HEALTH CARE, V18, P162, DOI 10.1136/qshc.2009.032359; Griffith John R, 2002, Qual Manag Health Care, V10, P29; Heuer Albert J, 2004, J Healthc Qual, V26, P46; Ingeman A, 2008, MED CARE, V46, P63, DOI 10.1097/MLR.0b013e3181484b91; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Joint Commission, FACTS ON SIT SURV PR; Joshi MS, 2003, J CLIN OUTCOMES MANA, V10, P473; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kristensen PK, 2016, INT J QUAL HEALTH C, V28, P698, DOI 10.1093/intqhc/mzw093; Lichtman JH, 2011, NEUROLOGY, V76, P1976, DOI 10.1212/WNL.0b013e31821e54f3; Lichtman JH, 2011, STROKE, V42, P3387, DOI 10.1161/STROKEAHA.111.622613; Lichtman JH, 2009, STROKE, V40, P3574, DOI 10.1161/STROKEAHA.109.561472; Lutfiyya MN, 2009, INT J QUAL HEALTH C, V21, P112, DOI 10.1093/intqhc/mzp003; McKinney M., 2010, REBOUND JOINT COMMIS; Menachemi N, 2008, JT COMM J QUAL PATIE, V34, P546, DOI 10.1016/S1553-7250(08)34069-0; Merkow RP, 2014, ANN SURG, V259, P1091, DOI 10.1097/SLA.0000000000000542; Morton JM, 2014, ANN SURG, V260, P504, DOI 10.1097/SLA.0000000000000891; Mumford V, 2013, INT J QUAL HEALTH C, V25, P606, DOI 10.1093/intqhc/mzt059; Rosenberg BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166762; Sack C, 2011, INT J QUAL HEALTH C, V23, P278, DOI 10.1093/intqhc/mzr011; Sack C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-120; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Sekimoto M, 2008, AM J INFECT CONTROL, V36, P212, DOI 10.1016/j.ajic.2007.04.276; The Joint Commission, 2015, FEE EX JOINT COMM BE; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; Wagner Laura M, 2012, Policy Polit Nurs Pract, V13, P8, DOI 10.1177/1527154412443990	44	49	51	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4011	10.1136/bmj.k4011	http://dx.doi.org/10.1136/bmj.k4011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1FN	30337294	hybrid, Green Published			2022-12-28	WOS:000448270700002
J	Laursen, L				Laursen, Lucas			A matter of trust	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2018	562	7727					S62	S63		10.1038/d41586-018-06972-3	http://dx.doi.org/10.1038/d41586-018-06972-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5RE	30333603	Bronze			2022-12-28	WOS:000447807100010
J	Malhi, GS; Mann, JJ				Malhi, Gin S.; Mann, J. John			Depression	LANCET			English	Review							SEROTONIN REUPTAKE INHIBITORS; CLINICAL-PRACTICE GUIDELINES; STRESSFUL LIFE EVENTS; NEW-ZEALAND COLLEGE; TREATMENT-RESISTANT DEPRESSION; MAJOR DEPRESSION; ANTIDEPRESSANT MEDICATION; PSYCHOLOGICAL TREATMENTS; ANXIETY DISORDERS; ADULT DEPRESSION	Major depression is a common illness that severely limits psychosocial functioning and diminishes quality of life. In 2008, WHO ranked major depression as the third cause of burden of disease worldwide and projected that the disease will rank first by 2030.1 In practice, its detection, diagnosis, and management often pose challenges for clinicians because of its various presentations, unpredictable course and prognosis, and variable response to treatment.	[Malhi, Gin S.] Univ Sydney, Sydney Med Sch Northern, Dept Acad Psychiat, Sydney, NSW, Australia; [Malhi, Gin S.] Royal North Shore Hosp, CADE Clin, Sydney, NSW, Australia; [Mann, J. John] Columbia Univ, Dept Psychiat, Mol Imaging & Neuropathol Div, New York, NY USA	University of Sydney; Royal North Shore Hospital; Columbia University	Malhi, GS (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2065, Australia.	gin.malhi@sydney.edu.au	Malhi, Gin/Z-2418-2019	Malhi, Gin/0000-0002-4524-9091	Australian Rotary Health; National Institute of Mental Health; National Health and Medical Research Council; New South Wales Ministry of Health; Ramsay Health; University of Sydney; AstraZeneca; Eli Lilly Co; Organon; Pfizer; Servier; Wyeth	Australian Rotary Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Ministry of Health; Ramsay Health; University of Sydney(University of Sydney); AstraZeneca(AstraZeneca); Eli Lilly Co(Eli Lilly); Organon; Pfizer(Pfizer); Servier(Servier); Wyeth(Wyeth)	GSM has received grant or research support from Australian Rotary Health, the National Health and Medical Research Council, New South Wales Ministry of Health, Ramsay Health, The University of Sydney, AstraZeneca, Eli Lilly & Co, Organon, Pfizer, Servier, and Wyeth; has been a speaker for AstraZeneca, Eli Lilly & Co, Janssen Cilag, Lundbeck, Pfizer, Ranbaxy, Servier, and Wyeth; and has been a consultant for AstraZeneca, Eli Lilly & Co, Janssen Cilag, Lundbeck, and Servier. JJM has received grant support from the National Institute of Mental Health, and royalties from the New York State Research Foundation for Mental Hygiene for commercial use of the Colombia Suicide Severity Rating Scale.	Adli M, 2005, EUR ARCH PSY CLIN N, V255, P387, DOI 10.1007/s00406-005-0579-5; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Angst J, 2009, J AFFECT DISORDERS, V115, P112, DOI 10.1016/j.jad.2008.09.023; [Anonymous], 2000, Am J Psychiatry, V157, P1; Anthes E, 2014, NATURE, V515, P185, DOI 10.1038/515185a; Asselmann E, 2018, ACTA PSYCHIAT SCAND, V137, P6, DOI 10.1111/acps.12792; Aubry JM, 2013, J CHEM NEUROANAT, V54, P20, DOI 10.1016/j.jchemneu.2013.09.003; Bauer M, 2000, AM J PSYCHIAT, V157, P1429, DOI 10.1176/appi.ajp.157.9.1429; Berlim MT, 2007, CAN J PSYCHIAT, V52, P46, DOI 10.1177/070674370705200108; Bigdeli TB, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.292; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Bollen J, 2017, J PSYCHOSOM RES, V94, P47, DOI 10.1016/j.jpsychores.2017.01.002; Boschloo L, 2014, PSYCHOTHER PSYCHOSOM, V83, P279, DOI 10.1159/000362563; Bromet Evelyn, 2011, BMC Med, V9, P90, DOI 10.1186/1741-7015-9-90; Brown G., 1978, SOCIAL ORIGINS DEPRE; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Cai N, 2015, CURR BIOL, V25, P1146, DOI 10.1016/j.cub.2015.03.008; Candy M, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1186/1741-7015-11-126; Cipriani Andrea, 2018, Focus (Am Psychiatr Publ), V16, P420, DOI 10.1176/appi.focus.16407; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; Cooper-Kazaz R, 2008, INT J NEUROPSYCHOPH, V11, P685, DOI 10.1017/S1461145707008206; Cuijpers P, 2014, J AFFECT DISORDERS, V159, P118, DOI 10.1016/j.jad.2014.02.026; Cuijpers P, 2014, WORLD PSYCHIATRY, V13, P56, DOI 10.1002/wps.20089; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; De Aquino JP, 2018, UNDERSTANDING DEPRES, P309, DOI DOI 10.1007/978-981-10-6580-4_25; Debonnel G, 2007, INT J NEUROPSYCHOPH, V10, P51, DOI 10.1017/S1461145705006413; DELGADO PL, 1990, ARCH GEN PSYCHIAT, V47, P411; DeRubeis RJ, 2005, CLIN PSYCHOL-SCI PR, V12, P174, DOI 10.1093/clipsy/bpi022; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Dold M, 2017, PSYCHOTHER PSYCHOSOM, V86, P283, DOI 10.1159/000477770; Egeland M, 2015, NAT REV NEUROSCI, V16, P189, DOI 10.1038/nrn3855; Entringer S, 2015, PSYCHONEUROENDOCRINO, V62, P366, DOI 10.1016/j.psyneuen.2015.08.019; Fekadu A, 2009, J CLIN PSYCHIAT, V70, P177, DOI 10.4088/JCP.08m04309; Fink M, 2013, ACTA PSYCHIAT SCAND, V127, P1, DOI 10.1111/acps.12038; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Fritz K, 2017, BIPOLAR DISORD, V19, P396, DOI 10.1111/bdi.12499; Gartlehner G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014912; Gaspersz R, 2017, J CLIN PSYCHIAT, V78, P207, DOI 10.4088/JCP.15m10221; Gibbons RD, 2008, PSYCHIAT SERV, V59, P361, DOI 10.1176/ps.2008.59.4.361; Global Burden of Disease Study C, 2015, LANCET, V386, P743, DOI [10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4, 10.1016/s0140-6736(15)60692-4]; Goldberg D, 2012, DEPRESS ANXIETY, V29, P471, DOI 10.1002/da.21939; Goldberg DP, 2014, DEPRESS ANXIETY, V31, P344, DOI 10.1002/da.22206; Goodyer IM, 2000, BRIT J PSYCHIAT, V177, P499, DOI 10.1192/bjp.177.6.499; Grande I, 2016, LANCET, V387, P1561, DOI 10.1016/S0140-6736(15)00241-X; Gururajan A, 2016, NEUROSCI BIOBEHAV R, V64, P101, DOI 10.1016/j.neubiorev.2016.02.011; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Hasin DS, 2018, JAMA PSYCHIAT, V75, P336, DOI 10.1001/jamapsychiatry.2017.4602; Heijnen WT, 2010, J CLIN PSYCHOPHARM, V30, P616, DOI 10.1097/JCP.0b013e3181ee0f5f; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Hinkelmann K, 2009, BIOL PSYCHIAT, V66, P879, DOI 10.1016/j.biopsych.2009.06.023; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Holmes EA, 2018, LANCET PSYCHIAT, V5, P237, DOI 10.1016/S2215-0366(17)30513-8; Howard DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03819-3; ICD-11, 2018, ICD11 WHO; Jakubovski E, 2016, AM J PSYCHIAT, V173, P174, DOI 10.1176/appi.ajp.2015.15030331; Jobst A, 2016, EUR PSYCHIAT, V33, P18, DOI 10.1016/j.eurpsy.2015.12.003; Kamenov K, 2017, PSYCHOL MED, V47, P414, DOI 10.1017/S0033291716002774; Karyotaki E, 2017, JAMA PSYCHIAT, V74, P351, DOI 10.1001/jamapsychiatry.2017.0044; Kaufmann C, 2017, AUST NZ J PSYCHIAT, V51, P851, DOI 10.1177/0004867417720037; Keller J, 2017, MOL PSYCHIATR, V22, P527, DOI 10.1038/mp.2016.120; Keller J, 2007, SCHIZOPHRENIA BULL, V33, P877, DOI 10.1093/schbul/sbm065; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Klengel T, 2015, NEURON, V86, P1343, DOI 10.1016/j.neuron.2015.05.036; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Knorr U, 2010, PSYCHONEUROENDOCRINO, V35, P1275, DOI 10.1016/j.psyneuen.2010.04.001; Kraus C, 2017, NEUROSCI BIOBEHAV R, V77, P317, DOI 10.1016/j.neubiorev.2017.03.007; Kuehner C, 2017, LANCET PSYCHIAT, V4, P146, DOI 10.1016/S2215-0366(16)30263-2; Leonard Brian E, 2018, Acta Neuropsychiatr, V30, P1, DOI 10.1017/neu.2016.69; Li M, 2016, PSYCHOL MED, V46, P717, DOI 10.1017/S0033291715002743; Linde K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0314-x; Lundorff M, 2017, J AFFECT DISORDERS, V212, P138, DOI 10.1016/j.jad.2017.01.030; Malhi GS, 2008, AUST NZ J PSYCHIAT, V42, P346, DOI 10.1080/00048670701881587; Malhi GS, 2018, MED J AUSTRALIA, V208, P219, DOI 10.5694/mja17.00658; Malhi GS, 2018, MED J AUSTRALIA, V208, P175, DOI 10.5694/mja17.00659; Malhi GS, 2016, BIPOLAR DISORD, V18, P631, DOI 10.1111/bdi.12455; Malhi GS, 2016, EVID-BASED MENT HEAL, V19, P1, DOI 10.1136/eb-2015-102299; Malhi GS, 2015, BIPOLAR DISORD, V17, P3, DOI 10.1111/bdi.12353; Malhi GS, 2015, AUST NZ J PSYCHIAT, V49, P1087, DOI 10.1177/0004867415617657; Malhi GS, 2014, AUST NZ J PSYCHIAT, V48, P542, DOI 10.1177/0004867413513342; Malhi GS, 2002, J NERV MENT DIS, V190, P366, DOI 10.1097/00005053-200206000-00004; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mitchell AJ, 2016, BJPSYCH OPEN, V2, P127, DOI 10.1192/bjpo.bp.115.001685; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Moller HJ, 2016, EUR ARCH PSY CLIN N, V266, P725, DOI 10.1007/s00406-016-0684-7; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Mohr DC, 2010, J CLIN PSYCHOL, V66, P394, DOI 10.1002/jclp.20659; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Moret C, 2009, J PSYCHOPHARMACOL, V23, P967, DOI 10.1177/0269881108093582; Muller VI, 2017, JAMA PSYCHIAT, V74, P47, DOI 10.1001/jamapsychiatry.2016.2783; Mulder R, 2017, PSYCHOL MED, V47, P2540, DOI 10.1017/S0033291717001106; National Institute for Health and Clinical Excellence (NICE), 2009, CG90 NICE; Nelson JC, 1997, AM J PSYCHIAT, V154, P1497, DOI 10.1176/ajp.154.11.1497; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nihalani N, 2016, DEPRESSION TREATMENT, P1; Papakostas GI, 2007, BIOL PSYCHIAT, V62, P1217, DOI 10.1016/j.biopsych.2007.03.027; Papakostas GI, 2007, J CLIN PSYCHIAT, V68, P826, DOI 10.4088/JCP.v68n0602; Parker G, 2017, BIPOLAR DISORD, V19, P235, DOI 10.1111/bdi.12501; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Peretti S, 2000, ACTA PSYCHIAT SCAND, V101, P17, DOI 10.1111/j.1600-0447.2000.tb10944.x; Peterson RE, 2018, AM J PSYCHIAT, V175, P545, DOI 10.1176/appi.ajp.2017.17060621; Philip NS, 2008, J PSYCHIATR PRACT, V14, P34, DOI 10.1097/01.pra.0000308493.93003.92; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Reynolds CF, 2016, JAMA PSYCHIAT, V73, P189, DOI 10.1001/jamapsychiatry.2015.3281; Rosenthal LJ, 2011, AM J PSYCHIAT, V168, P1035, DOI 10.1176/appi.ajp.2011.10030402; Ruhe HG, 2006, BRIT J PSYCHIAT, V189, P309, DOI 10.1192/bjp.bp.105.018325; Ruhe HG, 2006, J CLIN PSYCHIAT, V67, P1836, DOI 10.4088/JCP.v67n1203; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; RUTZ W, 1992, ACTA PSYCHIAT SCAND, V85, P83, DOI 10.1111/j.1600-0447.1992.tb01448.x; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Schmaal L, 2017, MOL PSYCHIATR, V22, P900, DOI 10.1038/mp.2016.60; SEGAL DS, 1974, BIOL PSYCHIAT, V9, P147; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sharp Trevor, 2013, Curr Top Behav Neurosci, V14, P309, DOI 10.1007/7854_2012_216; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Steinert C, 2014, J AFFECT DISORDERS, V152, P65, DOI 10.1016/j.jad.2013.10.017; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Stiles-Shields C, 2015, PSYCHOL MED, V45, P3205, DOI 10.1017/S0033291715001208; Stuart H, 2016, GLOB MENT HEALTH, V3, DOI 10.1017/gmh.2016.11; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Taylor MA, 2008, J AFFECT DISORDERS, V105, P1, DOI 10.1016/j.jad.2007.05.023; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Undurraga J, 2017, J PSYCHOPHARMACOL, V31, P1184, DOI 10.1177/0269881117711709; Verduijn J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0972-8; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wampold BE, 2015, WORLD PSYCHIATRY, V14, P270, DOI 10.1002/wps.20238; Weitz ES, 2015, JAMA PSYCHIAT, V72, P1102, DOI 10.1001/jamapsychiatry.2015.1516; Wichman CL, 2015, PRIM CARE COMPANION, DOI [10.4088/PCC.15f01776, DOI 10.4088/PCC.15F01776]; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3; Zhou XY, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv060; Zhou XY, 2015, J CLIN PSYCHIAT, V76, pE487, DOI 10.4088/JCP.14r09204	152	968	1020	132	640	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2018	392	10161					2299	2312		10.1016/S0140-6736(18)31948-2	http://dx.doi.org/10.1016/S0140-6736(18)31948-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HB4ZY	30396512				2022-12-28	WOS:000451067600029
J	Bilyard, MK; Bailey, HJ; Raich, L; Gafitescu, MA; Machida, T; Iglesias-Fernandez, J; Lee, SS; Spicer, CD; Rovira, C; Yue, WW; Davis, BG				Bilyard, Matthew K.; Bailey, Henry J.; Raich, Lluis; Gafitescu, Maria A.; Machida, Takuya; Iglesias-Fernandez, Javier; Lee, Seung Seo; Spicer, Christopher D.; Rovira, Carme; Yue, Wyatt W.; Davis, Benjamin G.			Palladium-mediated enzyme activation suggests multiphase initiation of glycogenesis	NATURE			English	Article							METABOLISM; AUTOGLUCOSYLATION; BIOSYNTHESIS; BIOGENESIS; MECHANISMS; CHEMISTRY; PROTEINS; CELLS	Biosynthesis of glycogen, the essential glucose (and hence energy) storage molecule in humans, animals and fungi(1), is initiated by the glycosyltransferase enzyme, glycogenin (GYG). Deficiencies in glycogen formation cause neurodegenerative and metabolic disease(2-4), and mouse knockout(5) and inherited human mutations(6) of GYG impair glycogen synthesis. GYG acts as a 'seed core' for the formation of the glycogen particle by catalysing its own stepwise autoglucosylation to form a covalently bound gluco-oligosaccharide chain at initiation site Tyr 195. Precise mechanistic studies have so far been prevented by an inability to access homogeneous glycoforms of this protein, which unusually acts as both catalyst and substrate. Here we show that unprecedented direct access to different, homogeneously glucosylated states of GYG can be accomplished through a palladium-mediated enzyme activation 'shunt' process using on-protein C-C bond formation. Careful mimicry of GYG intermediates recapitulates catalytic activity at distinct stages, which in turn allows discovery of triphasic kinetics and substrate plasticity in GYG's use of sugar substrates. This reveals a tolerant but 'proofread' mechanism that underlies the precision of this metabolic process. The present demonstration of direct, chemically controlled access to intermediate states of active enzymes suggests that such ligation-dependent activation could be a powerful tool in the study of mechanism.	[Bilyard, Matthew K.; Gafitescu, Maria A.; Machida, Takuya; Lee, Seung Seo; Spicer, Christopher D.; Davis, Benjamin G.] Univ Oxford, Dept Chem, Oxford, England; [Bailey, Henry J.; Yue, Wyatt W.] Univ Oxford, Struct Genom Consortium, Oxford, England; [Raich, Lluis; Iglesias-Fernandez, Javier; Rovira, Carme] Univ Barcelona, Dept Quim Inorgan & Organ, Seccio Quim Organ, Barcelona, Spain; [Raich, Lluis; Iglesias-Fernandez, Javier; Rovira, Carme] Univ Barcelona, IQTC, Barcelona, Spain; [Rovira, Carme] ICREA, Barcelona, Spain; [Lee, Seung Seo] Univ Southampton, Sch Chem, Southampton, Hants, England; [Iglesias-Fernandez, Javier] Univ Girona, Inst Quim Comp & Catalisi, Girona, Spain; [Iglesias-Fernandez, Javier] Univ Girona, Dept Quim, Girona, Spain	University of Oxford; University of Oxford; University of Barcelona; University of Barcelona; ICREA; University of Southampton; Universitat de Girona; Universitat de Girona	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Oxford, England.; Yue, WW (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	wyatt.yue@sgc.ox.ac.uk; ben.davis@chem.ox.ac.uk	Iglesias-Fernandez, Javier/AAF-1019-2019; Davis, Benjamin G/C-5281-2011; Rovira, Carme/K-5195-2014; Spicer, Chris/O-3910-2019; Lee, Seung S/K-8669-2018	Iglesias-Fernandez, Javier/0000-0001-7773-2945; Davis, Benjamin G/0000-0002-5056-407X; Rovira, Carme/0000-0003-1477-5010; Spicer, Chris/0000-0001-8787-578X; Lee, Seung S/0000-0002-8598-3303	EPSRC; MINECO [CTQ2017-85496-P]; AGAUR [2017SGR-1189]; EU [67507]; Royal Society; AbbVie [1097737]; Bayer Pharma AG; Canada Foundation for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) [115766]; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Sao Paulo Research Foundation-FAPESP; Eshelman Institute for Innovation; BSC-CNS [RES-QCM-2018-2-0025]; Merck Co.; Spanish Structures of Excellence Maria de Maeztu [MDM-2017-0767]; Boehringer Ingelheim; Janssen; MRC [1790341] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MINECO(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EU(European Commission); Royal Society(Royal Society of London); AbbVie(AbbVie); Bayer Pharma AG; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome Trust); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Eshelman Institute for Innovation; BSC-CNS; Merck Co.(Merck & Company); Spanish Structures of Excellence Maria de Maeztu; Boehringer Ingelheim(Boehringer Ingelheim); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the EPSRC (DTA to C.D.S. and M.K.B.), MINECO (CTQ2017-85496-P to C.R.), AGAUR (2017SGR-1189 to C.R.), Spanish Structures of Excellence Maria de Maeztu (MDM-2017-0767 to C.R.), EU Horizon 2020 programme, Marie Sklodowska-Curie (67507) and the Royal Society (Wolfson Research Merit Award to B.G.D.). We thank G. Hemberg for useful discussions, P. G. Schultz for provision of initial pEVOL-pIPhe plasmid, and BSC-CNS for computer resources and technical support at the MareNostrum supercomputer (RES-QCM-2018-2-0025). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant number 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust (092809/Z/10/Z).	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; ALONSO MD, 1994, FEBS LETT, V342, P38, DOI 10.1016/0014-5793(94)80580-6; ALONSO MD, 1995, FASEB J, V9, P1126, DOI 10.1096/fasebj.9.12.7672505; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; Ardevol A, 2011, ANGEW CHEM INT EDIT, V50, P10897, DOI 10.1002/anie.201104623; Ashcroft FM, 2017, CELL METAB, V26, P17, DOI 10.1016/j.cmet.2017.05.014; Bazan S, 2008, BIOCHEM BIOPH RES CO, V371, P328, DOI 10.1016/j.bbrc.2008.04.076; Boeggeman E, 2002, GLYCOBIOLOGY, V12, P395, DOI 10.1093/glycob/cwf045; Carrizo ME, 1997, GLYCOBIOLOGY, V7, P571, DOI 10.1093/glycob/7.4.571; Chaikuad A, 2011, P NATL ACAD SCI USA, V108, P21028, DOI 10.1073/pnas.1113921108; Chalker JM, 2011, ACCOUNTS CHEM RES, V44, P730, DOI 10.1021/ar200056q; Chalker JM, 2009, J AM CHEM SOC, V131, P16346, DOI 10.1021/ja907150m; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Dumas A, 2013, ANGEW CHEM INT EDIT, V52, P3916, DOI 10.1002/anie.201208626; Gibbons BJ, 2002, J MOL BIOL, V319, P463, DOI 10.1016/S0022-2836(02)00305-4; Guibe F, 1998, TETRAHEDRON, V54, P2967, DOI 10.1016/S0040-4020(97)10383-0; Hurley TD, 2005, J BIOL CHEM, V280, P23892, DOI 10.1074/jbc.M502344200; Hurley TD, 2006, BIOCHEM BIOPH RES CO, V348, P374, DOI 10.1016/j.bbrc.2006.07.106; Issoglio FM, 2012, J BIOL CHEM, V287, P1955, DOI 10.1074/jbc.M111.287813; Jbara M, 2017, ANGEW CHEM INT EDIT, V56, P10644, DOI 10.1002/anie.201702370; Lee HM, 2009, ACS CHEM BIOL, V4, P409, DOI 10.1021/cb900036s; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Li J, 2014, NAT CHEM, V6, P352, DOI [10.1038/NCHEM.1887, 10.1038/nchem.1887]; Li J, 2012, CHEMBIOCHEM, V13, P1728, DOI 10.1002/cbic.201200353; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach PJ, 2011, FEBS LETT, V585, P3216, DOI 10.1016/j.febslet.2011.09.009; Spicer CD, 2013, CHEM COMMUN, V49, P2747, DOI 10.1039/c3cc38824g; Spicer CD, 2012, J AM CHEM SOC, V134, P800, DOI 10.1021/ja209352s; Spicer CD, 2011, CHEM COMMUN, V47, P1698, DOI 10.1039/c0cc04970k; Testoni G, 2017, CELL METAB, V26, P256, DOI 10.1016/j.cmet.2017.06.008; TSUJI J, 1979, TETRAHEDRON LETT, P613; TSUJI J, 1986, TETRAHEDRON, V42, P4361, DOI 10.1016/S0040-4020(01)87277-X; Yang MY, 2014, CHEM SOC REV, V43, P6511, DOI 10.1039/c4cs00117f; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	38	29	29	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					235	+		10.1038/s41586-018-0644-7	http://dx.doi.org/10.1038/s41586-018-0644-7			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30356213	Green Accepted, Green Submitted			2022-12-28	WOS:000449943600041
J	Fletcher, D				Fletcher, Dan			Which biological systems should be engineered?	NATURE			English	Editorial Material							ESCHERICHIA-COLI; VESICLES; THERAPY; PROTEIN		[Fletcher, Dan] Univ Calif Berkeley, Bioengn & Biophys, Berkeley, CA 94720 USA; [Fletcher, Dan] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fletcher, D (corresponding author), Univ Calif Berkeley, Bioengn & Biophys, Berkeley, CA 94720 USA.; Fletcher, D (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	fletch@berkeley.edu						Abu Shah E, 2014, ELIFE, V3, DOI 10.7554/eLife.01433; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Denby CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03293-x; Dezi M, 2013, P NATL ACAD SCI USA, V110, P7276, DOI 10.1073/pnas.1303857110; Huang BN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5447; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Majumder S, 2018, PHYS BIOL, V15, DOI 10.1088/1478-3975/aa9768; MORROW JF, 1974, P NATL ACAD SCI USA, V71, P1743, DOI 10.1073/pnas.71.5.1743; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Weiss M, 2018, NAT MATER, V17, P89, DOI [10.1038/nmat5005, 10.1038/NMAT5005]; Weitz M, 2014, NAT CHEM, V6, P295, DOI [10.1038/NCHEM.1869, 10.1038/nchem.1869]	20	7	7	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					177	179		10.1038/d41586-018-07291-3	http://dx.doi.org/10.1038/d41586-018-07291-3			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA1AK	30401855	Bronze			2022-12-28	WOS:000449943600018
J	Lavine, M; Grocholski, B				Lavine, Marc; Grocholski, Brent			MIXING AND MATCHING MATERIALS	SCIENCE			English	Editorial Material																			0	2	2	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		534	535		10.1126/science.aav7390	http://dx.doi.org/10.1126/science.aav7390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385568				2022-12-28	WOS:000450460000033
J	Corcoran, RB; Chabner, BA				Corcoran, Ryan B.; Chabner, Bruce A.			Application of Cell-free DNA Analysis to Cancer Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CIRCULATING TUMOR DNA; ACQUIRED-RESISTANCE; TARGETED THERAPY; LIQUID BIOPSY; EGFR BLOCKADE; LUNG-CANCER; EVOLUTION; BLOOD; HETEROGENEITY; MUTATIONS		[Corcoran, Ryan B.] Massachusetts Gen Hosp, Ctr Canc, 149 13th St,7th Fl, Boston, MA 02129 USA; Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Corcoran, RB (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St,7th Fl, Boston, MA 02129 USA.	rbcorcoran@partners.org						Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; Alidousty C, 2017, J MOL DIAGN, V19, P801, DOI 10.1016/j.jmoldx.2017.06.004; Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Beaver JA, 2014, CLIN CANCER RES, V20, P2643, DOI 10.1158/1078-0432.CCR-13-2933; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chae YK, 2016, ONCOTARGET, V7, P65364, DOI 10.18632/oncotarget.11692; Chan KCA, 2017, NEW ENGL J MED, V377, P513, DOI [10.1056/NEJMoa1701717, 10.1056/nejmoa1701717]; Chan KCA, 2013, P NATL ACAD SCI USA, V110, P18761, DOI 10.1073/pnas.1313995110; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Chaudhuri AA, 2017, CANCER DISCOV, V7, P1394, DOI 10.1158/2159-8290.CD-17-0716; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Corcoran RB, 2018, CANCER DISCOV, V8, P428, DOI 10.1158/2159-8290.CD-17-1226; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goyal L, 2017, CANCER DISCOV, V7, P252, DOI 10.1158/2159-8290.CD-16-1000; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hazar-Rethinam M, 2018, CANCER DISCOV, V8, P417, DOI 10.1158/2159-8290.CD-17-1227; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Husain H, 2017, CLIN CANCER RES, V23, P4716, DOI 10.1158/1078-0432.CCR-17-0454; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kuderer NM, 2017, JAMA ONCOL, V3, P996, DOI 10.1001/jamaoncol.2016.4983; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; LEON SA, 1977, CANCER RES, V37, P646; Malapelle U, 2017, EXPERT REV MOL DIAGN, V17, P209, DOI 10.1080/14737159.2017.1288568; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Parikh A, 2017, ANN ONCOL, V28; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Sausen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8686; Schrock AB, 2018, CLIN CANCER RES, V24, P1881, DOI 10.1158/1078-0432.CCR-17-3103; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Strickler JH, 2018, CANCER DISCOV, V8, P164, DOI 10.1158/2159-8290.CD-17-1009; Swinkels DW, 2003, CLIN CHEM, V49, P525, DOI 10.1373/49.3.525; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Torga G, 2017, JAMA ONCOL; Wang YX, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8507; Zill OA, 2015, CANCER DISCOV, V5, P1040, DOI 10.1158/2159-8290.CD-15-0274	60	393	403	6	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1754	1765		10.1056/NEJMra1706174	http://dx.doi.org/10.1056/NEJMra1706174			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OL	30380390				2022-12-28	WOS:000448891600010
J	Di Maria, A; Fama, F				Di Maria, Alessandra; Fama, Fausto			Hemolacria - Crying Blood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Di Maria, Alessandra] Humanitas Clin & Res Ctr, Rozzano, Italy; [Fama, Fausto] Univ Hosp Messina, Messina, Italy	IRCCS Humanitas Research Hospital; AOU Policlinico Gaetano Martino	Fama, F (corresponding author), Univ Hosp Messina, Messina, Italy.	famafausto@yahoo.it	Fama', Fausto/L-3071-2015; Di Maria, Alessandra/ABE-5675-2020	Fama', Fausto/0000-0002-9017-1991; Di Maria, Alessandra/0000-0002-4889-6315					0	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1766	1766		10.1056/NEJMicm1805241	http://dx.doi.org/10.1056/NEJMicm1805241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380382				2022-12-28	WOS:000448891600011
J	Gyawali, B; Shimokata, T; Honda, K; Ando, Y				Gyawali, Bishal; Shimokata, Tomoya; Honda, Kazunori; Ando, Yuichi			Reporting harms more transparently in trials of cancer drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gyawali, Bishal; Shimokata, Tomoya; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; [Honda, Kazunori] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan	Nagoya University; Aichi Cancer Center	Gyawali, B (corresponding author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan.	bg.bishalgyawali@gmail.com	Gyawali, Bishal/H-6653-2019; Honda, Kazunori/AAW-4315-2020	Gyawali, Bishal/0000-0001-7444-8594; Ando, Yukio/0000-0001-7115-9105				Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Friedlander M, 2018, LANCET ONCOL, V19, P1126, DOI 10.1016/S1470-2045(18)30343-7; Golder S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002127; Gyawali B, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.6573; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Morschhauser F, 2018, NEW ENGL J MED, V379, P934, DOI 10.1056/NEJMoa1805104; Staehler M, 2018, ANN ONCOL, V29, P2098, DOI 10.1093/annonc/mdy329; Sternberg C, 2016, J CLIN ONCOL, V34, P2636, DOI 10.1200/JCO.2016.66.9697; Tang E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0430-4; US Food and Drug Administration, WHAT IS SER ADV EV; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1	11	18	18	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4383	10.1136/bmj.k4383	http://dx.doi.org/10.1136/bmj.k4383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385466				2022-12-28	WOS:000449565500001
J	Metzis, V; Steinhauser, S; Pakanavicius, E; Gouti, M; Stamataki, D; Ivanovitch, K; Watson, T; Rayon, T; Gharavy, SNM; Lovell-Badge, R; Luscombe, NM; Briscoe, J				Metzis, Vicki; Steinhauser, Sebastian; Pakanavicius, Edvinas; Gouti, Mina; Stamataki, Despina; Ivanovitch, Kenzo; Watson, Thomas; Rayon, Teresa; Gharavy, S. Neda Mousavy; Lovell-Badge, Robin; Luscombe, Nicholas M.; Briscoe, James			Nervous System Regionalization Entails Axial Allocation before Neural Differentiation	CELL			English	Article							HOX GENES; OVERLAPPING FUNCTIONS; REGULATORY ELEMENTS; T BRACHYURY; MOUSE; SPECIFICATION; CHROMATIN; TRANSCRIPTION; EXPRESSION; INDUCTION	Neural induction in vertebrates generates a CNS that extends the rostral-caudal length of the body. The prevailing view is that neural cells are initially induced with anterior (forebrain) identity; caudalizing signals then convert a proportion to posterior fates (spinal cord). To test this model, we used chromatin accessibility to define how cells adopt region-specific neural fates. Together with genetic and biochemical perturbations, this identified a developmental time window in which genome-wide chromatin-remodeling events preconfigure epiblast cells for neural induction. Contrary to the established model, this revealed that cells commit to a regional identity before acquiring neural identity. This "primary regionalization'' allocates cells to anterior or posterior regions of the nervous system, explaining how cranial and spinal neurons are generated at appropriate axial positions. These findings prompt a revision to models of neural induction and support the proposed dual evolutionary origin of the vertebrate CNS.	[Metzis, Vicki; Steinhauser, Sebastian; Pakanavicius, Edvinas; Gouti, Mina; Stamataki, Despina; Ivanovitch, Kenzo; Watson, Thomas; Rayon, Teresa; Gharavy, S. Neda Mousavy; Lovell-Badge, Robin; Luscombe, Nicholas M.; Briscoe, James] Francis Crick Inst, London NW1 1AT, England; [Gouti, Mina] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Luscombe, Nicholas M.] UCL, Dept Genet Evolut & Environm, UCL Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol Grad Univ, Onna, Okinawa 9040495, Japan	Francis Crick Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of London; University College London; Okinawa Institute of Science & Technology Graduate University	Briscoe, J (corresponding author), Francis Crick Inst, London NW1 1AT, England.	james.briscoe@crick.ac.uk	Gouti, Mina/D-3235-2018; ivanovitch, kenzo/AAE-3214-2022; Rayon, Teresa/AAA-6592-2020; Metzis, Vicki/AAU-5081-2020	Gouti, Mina/0000-0001-7422-1605; ivanovitch, kenzo/0000-0003-4706-7686; Rayon, Teresa/0000-0001-5173-1442; Metzis, Vicki/0000-0002-0399-1722; Lovell-Badge, Robin/0000-0001-9364-4179	Francis Crick Institute; Cancer Research UK [FC001051, FC0010110, FC001107]; UK Medical Research Council [FC001051, FC0010110, FC001107]; Wellcome [FC001051, FC0010110, FC001107, WT098326MA, 103760/Z/14/Z]; BBSRC [BB/J015539/1]; MRC [MR/L016311/1]; NIH [R01-EB016629]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016629] Funding Source: NIH RePORTER; MRC [MC_U117562207] Funding Source: UKRI	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Tatjana Sauka-Spengler, Karine Rizzoti, Jean-Francois Brunet, Bennett Novitch, Hitoshi Niwa, Myriam Hemberger, Manuela Melchionda, and Anthony Gavalas for advice and reagents. The authors also acknowledge the ENCODE Consortium and the production labs of John Stamatoyannopoulos (University of Washington) and Ross Hardison (Pennsylvania State University). We thank Alfonso Martinez-Arias and Francois Guillemot for useful discussions and the Crick Science Technology Platforms. We thank Boris Lenhard, Julien Delile, and Jens Kleinjung for critical feedback on data analysis. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001051, FC0010110, and FC001107), the UK Medical Research Council (FC001051, FC0010110, and FC001107), and the Wellcome (FC001051, FC0010110, and FC001107); J.B. (WT098326MA) and N.M.L. (103760/Z/14/Z) are funded by Wellcome, J.B. by BBSRC (BB/J015539/1), R.L.B. by NIH R01-EB016629, and N.M.L. by MRC (MR/L016311/1).	Amin S, 2016, CELL REP, V17, P3165, DOI 10.1016/j.celrep.2016.11.069; Arendt D, 2016, NAT REV NEUROSCI, V17, P61, DOI 10.1038/nrn.2015.15; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carcagno AL, 2014, J NEUROSCI, V34, P15223, DOI 10.1523/JNEUROSCI.3403-14.2014; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CONNOLLY D, 1995, TRENDS GENET, V11, P259, DOI 10.1016/S0168-9525(00)89070-8; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cordes SP, 2001, NAT REV NEUROSCI, V2, P611, DOI 10.1038/35090039; Cox WG, 1995, DEVELOPMENT, V121, P4349; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Frith TJR, 2018, ELIFE, V7, DOI 10.7554/eLife.35786; Gouti M, 2017, DEV CELL, V41, P243, DOI 10.1016/j.devcel.2017.04.002; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; Hagey DW, 2016, GENOME RES, V26, P908, DOI 10.1101/gr.203513.115; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Imrichova H, 2015, NUCLEIC ACIDS RES, V43, pW57, DOI 10.1093/nar/gkv395; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Koshida S, 1998, DEVELOPMENT, V125, P1957; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morales AV, 1996, DEV DYNAM, V206, P343, DOI 10.1002/(SICI)1097-0177(199608)206:4<343::AID-AJA1>3.0.CO;2-I; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Neijts R, 2016, GENE DEV, V30, P1937, DOI 10.1101/gad.285767.116; Niederreither K, 2000, DEVELOPMENT, V127, P75; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P83, DOI 10.1002/jez.1401200104; NIEUWKOOP PD, 1954, J EMBRYOL EXP MORPH, V2, P175; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nowotschin S, 2012, DEV BIOL, V367, P1, DOI 10.1016/j.ydbio.2012.04.012; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Skromne I, 2007, DEVELOPMENT, V134, P2147, DOI 10.1242/dev.002980; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; STOREY KG, 1992, DEVELOPMENT, V114, P729; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teng L, 2015, BIOINFORMATICS, V31, P2560, DOI 10.1093/bioinformatics/btv158; Tosches MA, 2013, CURR OPIN NEUROBIOL, V23, P1080, DOI 10.1016/j.conb.2013.09.005; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; Turner DA, 2014, DEVELOPMENT, V141, P4243, DOI 10.1242/dev.112979; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Rooijen C, 2012, DEVELOPMENT, V139, P2576, DOI 10.1242/dev.079848; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waddington C. H, 1940, ORG AND GENES; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	87	72	74	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1105	+		10.1016/j.cell.2018.09.040	http://dx.doi.org/10.1016/j.cell.2018.09.040			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30343898	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000449100600021
J	Rimmer, A				Rimmer, Abi			NHS staff get new measures to tackle violence in the workplace	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J4236	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4603	10.1136/bmj.k4603	http://dx.doi.org/10.1136/bmj.k4603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381464				2022-12-28	WOS:000449564200013
J	Rimmer, A				Rimmer, Abi			Medicine should have a part time entry route, says head of Health Education England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A., 2013, BMJ-BRIT MED J, V347, pf7681, DOI [10.1136/bmj.f7681, DOI 10.1136/BMJ.F7681]; RIMMER A, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5633; Rimmer A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1328; TORJESEN I, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I5399	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2018	363								k4575	10.1136/bmj.k4575	http://dx.doi.org/10.1136/bmj.k4575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PG	30373934				2022-12-28	WOS:000449561100015
J	Cho, C; Goto, M				Cho, Christine; Goto, Michihiko			Spinal Brucellosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cho, Christine; Goto, Michihiko] Univ Iowa Hosp, Iowa City, IA 52242 USA	University of Iowa	Cho, C (corresponding author), Univ Iowa Hosp, Iowa City, IA 52242 USA.	christine-cho@uiowa.edu	Goto, Michihiko/H-2652-2013	Goto, Michihiko/0000-0001-6612-5613					0	2	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					E28	E28		10.1056/NEJMicm1803513	http://dx.doi.org/10.1056/NEJMicm1803513			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30354953				2022-12-28	WOS:000448273500011
J	Bailey, J				Bailey, Janea.			Taking a Dive	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bailey, Janea.] Univ Iowa Hosp & Clin, Ophthalmol & Visual Sci, 200 Hawkins Dr, Iowa City, IA 52242 USA	University of Iowa	Bailey, J (corresponding author), Univ Iowa Hosp & Clin, Ophthalmol & Visual Sci, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jane-bailey@uiowa.edu		Bailey, Jane/0000-0003-2991-7093				Liu TC, 2017, CLIN ORTHOP RELAT R, V475, P315, DOI 10.1007/s11999-016-5205-5; Pink D.H., 2010, DRIVE SURPRISING TRU	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1643	1644		10.1001/jama.2018.14738	http://dx.doi.org/10.1001/jama.2018.14738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357302				2022-12-28	WOS:000448069100011
J	Kitanosono, T; Xu, PY; Kobayashi, S				Kitanosono, Taku; Xu, Pengyu; Kobayashi, Shu			Chiral Lewis acids integrated with single-walled carbon nanotubes for asymmetric catalysis in water	SCIENCE			English	Article							ENANTIOSELECTIVE SYNTHESIS; CONJUGATE ADDITIONS; DISPERSION; ALDOXIMES; LIGANDS	The development of highly reactive and stereoselective catalytic systems is required not only to improve existing synthetic methods but also to invent distinct chemical reactions. Herein, a homogenized combination of nickel-based Lewis acid-surfactant-combined catalysts and single-walled carbon nanotubes is shown to exhibit substantial activity in water. In addition to the enhanced reactivity, stereoselective performance and long-term stability were demonstrated in asymmetric conjugate addition reactions of aldoximes to furnish chiral nitrones in high yields with excellent selectivities. The practical and straightforward application of the designed catalysts in water provides an expedient, environmentally benign, and highly efficient pathway to access optically active compounds.	[Kitanosono, Taku; Xu, Pengyu; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kobayashi, S (corresponding author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Taku, Kitanosono/AAV-4016-2020; Kobayashi, Shu/E-9214-2012	Taku, Kitanosono/0000-0003-0743-1420; 	Japan Society for the Promotion of Science (JSPS) under the Global COE Program; University of Tokyo; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS) under the Global COE Program; University of Tokyo; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was partially supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) under the Global COE Program, with support from the University of Tokyo; the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and the Japan Science Technology Agency (JST).	Ajayan P. M., 1994, J AM CHEM SOC, V116, P7935; Andres R, 1999, INORG CHEM, V38, P4637, DOI 10.1021/ic9904135; Badaire S, 2004, LANGMUIR, V20, P10367, DOI 10.1021/la049096r; Bartoli G, 2007, EUR J ORG CHEM, V2007, P2037, DOI 10.1002/ejoc.200600852; Bertelsen S, 2007, J AM CHEM SOC, V129, P1536, DOI 10.1021/ja068908y; Blanch AJ, 2010, J PHYS CHEM B, V114, P9805, DOI 10.1021/jp104113d; BOLM C, 1992, CHEM BER-RECL, V125, P1169, DOI 10.1002/cber.19921250528; Cheung W, 2016, CHEM SCI, V7, P5192, DOI 10.1039/c6sc00006a; Frolov AI, 2010, CHEMPHYSCHEM, V11, P2612, DOI 10.1002/cphc.201000231; Guerini S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.233401; Han WQ, 2003, NANO LETT, V3, P681, DOI 10.1021/nl034142d; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Ishikawa S, 2005, SYNTHESIS-STUTTGART, P2176, DOI 10.1055/s-2005-869983; KARTHA VB, 1984, CAN J CHEM, V62, P128, DOI 10.1139/v84-025; Kato Y, 2009, ANGEW CHEM INT EDIT, V48, P5435, DOI 10.1002/anie.200900651; Kitanosono T., 2017, CHIRAL LEWIS ACIDS O, P299; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Kobayashi S, 1998, TETRAHEDRON LETT, V39, P5389, DOI 10.1016/S0040-4039(98)01081-8; Kocak A, 2009, RUSS J ORG CHEM+, V45, P591, DOI 10.1134/S1070428009040204; Li YM, 2001, J PHYS CHEM B, V105, P11424, DOI 10.1021/jp012085b; Lindrom U. M., 2007, ORGANIC REACTIONS WA; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Manabe K, 2000, J AM CHEM SOC, V122, P7202, DOI 10.1021/ja001420r; Monajjemi M, 2011, ELECTRONIC PROPERTIES OF CARBON NANOTUBES, P575; Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j; Nakama K, 2002, TETRAHEDRON LETT, V43, P829, DOI 10.1016/S0040-4039(01)02247-X; Nakama K, 2001, TETRAHEDRON LETT, V42, P6719, DOI 10.1016/S0040-4039(01)01346-6; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; OPPOLZER W, 1994, HELV CHIM ACTA, V77, P554, DOI 10.1002/hlca.19940770217; Shastry TA, 2013, J AM CHEM SOC, V135, P6750, DOI 10.1021/ja312235n; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X; Vanderwal CD, 2004, J AM CHEM SOC, V126, P14724, DOI 10.1021/ja045563f; White RJ, 2009, CHEM SOC REV, V38, P481, DOI 10.1039/b802654h; Xu J, 2017, LANGMUIR, V33, P5006, DOI 10.1021/acs.langmuir.7b00758; Zhang Y, 2000, CHEM PHYS LETT, V331, P35, DOI 10.1016/S0009-2614(00)01162-3	36	23	24	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					311	314		10.1126/science.aap7883	http://dx.doi.org/10.1126/science.aap7883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337405				2022-12-28	WOS:000447680100041
J	Salazar, F; Brown, GD				Salazar, Fabian; Brown, Gordon D.			A friendly danger Immune cell receptor DNGR-1 limits inflammatory tissue damage	SCIENCE			English	Editorial Material							CLEC9A; ACTIN; CTLS; MICE		[Salazar, Fabian; Brown, Gordon D.] Univ Aberdeen, MRC, Ctr Med Mycol, Aberdeen Fungal Grp,Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Brown, GD (corresponding author), Univ Aberdeen, MRC, Ctr Med Mycol, Aberdeen Fungal Grp,Inst Med Sci, Aberdeen AB25 2ZD, Scotland.	gordon.brown@abdn.ac.uk	Salazar, Fabian/AAW-2488-2020	Salazar Lizama, Fabian/0000-0001-5139-2292	Wellcome Trust; Medical Research Council Centre for Medical Mycology; University of Aberdeen; Arthritis Research UK; MRC [MR/N006364/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Medical Mycology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen; Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors receive funding from the Wellcome Trust, the Medical Research Council Centre for Medical Mycology and the University of Aberdeen, and Arthritis Research UK.	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; del Fresno C, 2018, SCIENCE, V362, P351, DOI 10.1126/science.aan8423; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Lionakis MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002865; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Srinivasan N, 2016, ELIFE, V5, DOI 10.7554/eLife.19662; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Wu SR, 2017, TRENDS IMMUNOL, V38, P231, DOI 10.1016/j.it.2017.02.005; Yang ZW, 2015, J CELL MOL MED, V19, P2513, DOI 10.1111/jcmm.12639; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	15	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					292	293		10.1126/science.aav3477	http://dx.doi.org/10.1126/science.aav3477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337399				2022-12-28	WOS:000447680100028
J	Shellard, A; Szabo, A; Trepat, X; Mayor, R				Shellard, Adam; Szabo, Andras; Trepat, Xavier; Mayor, Roberto			Supracellular contraction at the rear of neural crest cell groups drives collective chemotaxis	SCIENCE			English	Article							TISSUE MIGRATION; IN-VIVO; GUIDANCE; POLARITY; MORPHOGENESIS; CADHERIN; FORCES; CANCER	Collective cell chemotaxis, the directed migration of cell groups along gradients of soluble chemical cues, underlies various developmental and pathological processes. We use neural crest cells, a migratory embryonic stem cell population whose behavior has been likened to malignant invasion, to study collective chemotaxis in vivo. Studying Xenopus and zebrafish, we have shown that the neural crest exhibits a tensile actomyosin ring at the edge of the migratory cell group that contracts in a supracellular fashion. This contractility is polarized during collective cell chemotaxis: It is inhibited at the front but persists at the rear of the cell cluster. The differential contractility drives directed collective cell migration ex vivo and in vivo through the intercalation of rear cells. Thus, in neural crest cells, collective chemotaxis works by rear-wheel drive.	[Shellard, Adam; Szabo, Andras; Mayor, Roberto] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Trepat, Xavier] BIST, Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain; [Trepat, Xavier] Ctr Invest Biomed Red Bioingenieria Biomat & Nano, Barcelona 08028, Spain; [Trepat, Xavier] ICREA, Barcelona 08010, Spain	University of London; University College London; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; ICREA	Mayor, R (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	r.mayor@ucl.ac.uk	Trepat, Xavier/I-3912-2015	Trepat, Xavier/0000-0002-7621-5214; Szabo, Andras/0000-0002-8924-038X; Shellard, Adam/0000-0002-7609-9049; Mayor, Roberto/0000-0001-9053-9613	Medical Research Council [M010465, J000655]; Biotechnology and Biological Sciences Research Council [M008517]; Wellcome Trust [102489/Z/13/Z]; Spanish Ministry of Economy and Competitiveness/FEDER [BFU2015-65074-P]; Generalitat de Catalunya [2014-SGR-927]; CERCA program [2014-SGR-927]; European Research Council [CoG-616480]; European Commission [H2020-FETPROACT-01-2016-731957]; Marie Curie fellowship [329968]; BBSRC [BB/R00627X/1] Funding Source: UKRI; MRC [MR/J000655/1, MR/M010465/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Spanish Ministry of Economy and Competitiveness/FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CERCA program; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie fellowship(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Medical Research Council (M010465 and J000655 to R.M.), the Biotechnology and Biological Sciences Research Council (M008517 to R.M.), the Wellcome Trust (102489/Z/13/Z Wellcome Trust Ph.D. fellowship to A.Sh.), the Spanish Ministry of Economy and Competitiveness/FEDER (BFU2015-65074-P to X.T.), the Generalitat de Catalunya and CERCA program (2014-SGR-927 to X.T.), the European Research Council (CoG-616480 to X.T.), and the European Commission (project H2020-FETPROACT-01-2016-731957 to X.T.) and by a Marie Curie fellowship (329968 to A.Sz.).	Bahm I, 2017, DEVELOPMENT, V144, P2456, DOI 10.1242/dev.147926; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gilmour D, 2017, NATURE, V541, P311, DOI 10.1038/nature21348; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Kaucka M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600060; Kerosuo L, 2012, SEMIN CELL DEV BIOL, V23, P320, DOI 10.1016/j.semcdb.2012.03.010; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Leshansky AM, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/145; Majumdar R, 2014, CURR OPIN CELL BIOL, V30, P33, DOI 10.1016/j.ceb.2014.05.010; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; O'Neill PR, 2018, DEV CELL, V46, P9, DOI 10.1016/j.devcel.2018.05.029; Paluch EK, 2013, CURR OPIN CELL BIOL, V25, P582, DOI 10.1016/j.ceb.2013.05.005; Petrie RJ, 2016, CURR OPIN CELL BIOL, V42, P7, DOI 10.1016/j.ceb.2016.03.025; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Roca-Cusachs P, 2013, CURR OPIN CELL BIOL, V25, P543, DOI 10.1016/j.ceb.2013.04.010; Szabo A, 2016, J CELL BIOL, V213, P543, DOI 10.1083/jcb.201602083; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Uroz M, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0107-2; Valon L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14396; Voituriez R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028102; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Welch MD, 2015, CELL, V160, P581, DOI 10.1016/j.cell.2015.01.053; Zajac O, 2018, NAT CELL BIOL, V20, P296, DOI 10.1038/s41556-017-0027-6	31	69	69	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					339	+		10.1126/science.aau3301	http://dx.doi.org/10.1126/science.aau3301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337409	Green Accepted			2022-12-28	WOS:000447680100048
J	Arterburn, D; Wellman, R; Emiliano, A; Smith, SR; Odegaard, AO; Murali, S				Arterburn, D.; Wellman, R.; Emiliano, A.; Smith, S. R.; Odegaard, A. O.; Murali, S.			Effectiveness and Safety of Bariatric Procedures for Weight Loss	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2018	169	11					I22	I22		10.7326/P18-0016	http://dx.doi.org/10.7326/P18-0016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4WR	30383130				2022-12-28	WOS:000451806000001
J	Babayan, SA; Orton, RJ; Streicker, DG				Babayan, Simon A.; Orton, Richard J.; Streicker, Daniel G.			Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes	SCIENCE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; TO-HUMAN TRANSMISSION; BAT CORONAVIRUS; DATABASE; ORIGINS; USAGE	Identifying the animal origins of RNA viruses requires years of field and laboratory studies that stall responses to emerging infectious diseases. Using large genomic and ecological datasets, we demonstrate that animal reservoirs and the existence and identity of arthropod vectors can be predicted directly from viral genome sequences via machine learning. We illustrate the ability of these models to predict the epidemiology of diverse viruses across most human-infective families of single-stranded RNA viruses, including 69 viruses with previously elusive or never-investigated reservoirs or vectors. Models such as these, which capitalize on the proliferation of low-cost genomic sequencing, can narrow the time lag between virus discovery and targeted research, surveillance, and management.	[Babayan, Simon A.; Streicker, Daniel G.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Babayan, Simon A.] Pentlands Sci Pk, Moredun Res Inst, Penicuik EH26 0PZ, Midlothian, Scotland; [Orton, Richard J.; Streicker, Daniel G.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; Moredun Research Institute; University of Glasgow	Streicker, DG (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.; Streicker, DG (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.	daniel.streicker@glasgow.ac.uk	; Babayan, Simon/E-1807-2011	Streicker, Daniel/0000-0001-7475-2705; Babayan, Simon/0000-0002-4949-1117	Glasgow University Research Fellowship; BBSRC [BB/M012956/1]; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society [102507/Z/13/Z]; Medical Research Council [MC_UU_12014/12]; MRC [MC_UU_12014/12, MC_UU_12014/8] Funding Source: UKRI	Glasgow University Research Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.A.B. was supported by a Glasgow University Research Fellowship and the BBSRC (BB/M012956/1). D.G.S. was supported by a Sir Henry Dale Fellowship, jointly funded by the Wellcome Trust and Royal Society (102507/Z/13/Z). Additional funding was provided from the Medical Research Council (MC_UU_12014/12).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Martinez MA, 2016, TRENDS MICROBIOL, V24, P134, DOI 10.1016/j.tim.2015.11.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Di Giallonardo F, 2017, J VIROL, V91, DOI 10.1128/JVI.02381-16; Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040; Dudas G, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vev023; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; H20.ai team, 2017, R INT H2O R PACK VER; Han MG, 2006, J VIROL, V80, P12350, DOI 10.1128/JVI.00402-06; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hutcheon JM, 2006, ACTA CHIROPTEROL, V8, P1, DOI 10.3161/1733-5329(2006)8[1:AMFDTM]2.0.CO;2; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mohd HA, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0544-0; Muller Marcel A, 2014, Emerg Infect Dis, V20, P2093, DOI 10.3201/eid2012.141026; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759; Paradis E, 2006; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; R Development Core Team, 2009, R LANG ENV STAT COMP; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560; Yang Yang, 2014, Proc Natl Acad Sci U S A, V111, P12516, DOI 10.1073/pnas.1405889111; Zuur Alain F., 2009, P1	42	74	75	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		577	+		10.1126/science.aap9072	http://dx.doi.org/10.1126/science.aap9072			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385576	Green Accepted			2022-12-28	WOS:000450460000044
J	Jia, HP				Jia, Hepeng			DISCOVERY CENTRAL	NATURE			English	Editorial Material													Jia, Hepeng/AAX-9841-2020	Jia, Hepeng/0000-0001-8681-394X					0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S16	S17		10.1038/d41586-018-07209-z	http://dx.doi.org/10.1038/d41586-018-07209-z			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382230				2022-12-28	WOS:000448900900012
J	De, T; Alarcon, C; Hernandez, W; Liko, I; Cavallari, LH; Duarte, JD; Perera, MA				De, Tanima; Alarcon, Cristina; Hernandez, Wenndy; Liko, Ina; Cavallari, Larisa H.; Duarte, Julio D.; Perera, Minoli A.			Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; ATRIAL-FIBRILLATION; EPH KINASES; RISK; ANTICOAGULATION; SCORE; METAANALYSIS; DEFINITION; PREDICTION; ETHNICITY	IMPORTANCE Major warfarin-related bleeding occurs more frequently in African Americans than in other populations. Identification of potential genetic factors related to this adverse event may help identify at-risk patients. OBJECTIVE To identify genetic factors associated with warfarin-related bleeding in patients of African descent at an international normalized ratio (INR) of less than 4. DESIGN, SETTING, AND PARTICIPANTS A case-control genome-wide association study involving patients of African descent taking warfarin was conducted in a discovery cohort (University of Chicago [2009-2011] and the University of Illinois at Chicago [2002-2011]), and associations were confirmed in a replication cohort (University of Chicago [2015-2016]). Potential population stratification was examined in the discovery cohort by principal component analysis. Odds ratios (ORs) and 95% CIs were computed for bleeding risk by logistic regression analysis. Summary statistics from the discovery and the replication cohorts were analyzed with a fixed effects meta-analysis. The potential influence of single-nucleotide polymorphisms (SNPs) on gene expression was studied by luciferase expression assays. EXPOSURES Single-nucleotide polymorphisms associated with warfarin-related bleeding. MAIN OUTCOMES AND MEASURES Major bleeding-defined as bleeding requiring hospitalization, causing a decrease in hemoglobin level of more than 2 g/dL, requiring blood transfusion, or any combination of the 3-while taking warfarin at an INR of less than 4. RESULTS The discovery cohort consisted of 31 cases (mean age, 60.1 years [SD, 14.9 years], 26 women [83.9%]) and 184 warfarin-treated controls (mean age, 57.1 years [SD, 15.7 years]) with no documented bleeding. The replication cohort consisted of 40 cases (mean age, 55.6 years [SD, 17.3 years], 27 women [67.5%]), and 148 warfarin-treated controls (mean age, 55.4 years [SD, 17.1 years]; 98 women [66.2%]) with no documented bleeding. In the discovery cohort, 4 SNPs in linkage disequilibrium on chromosome 6 (rs115112393, rs16871327, rs78132896, and rs114504854) were associated with warfarin-related bleeding but did not reach genome-wide significance. The SNP rs78132896 occurred in 11 cases (35.5%) and 9 controls (4.9%) in the discovery cohort (OR, 8.31; 95% CI, 3.2-21.5; P < 6.21 x 10(-8)), and the association was confirmed in the replication cohort (the SNP was present in 14 cases [35.0%] and 7 controls [4.8%]; OR, 8.24; 95% CI, 3.1-25.3, P = 5.64 x 10(-5)). Genome-wide significance of this SNP was achieved when the cohorts were combined via meta-analysis (OR, 8.27; 95% CI, 4.18-16.38; P = 2.05 x 10(-11)). These SNPs are found only in people of African descent. In vitro luciferase expression assays demonstrated that rs16871327 (enhancer SNP) and rs78132896 (promoter SNP) risk alleles together increased EPHA7 gene (Entrez Gene 2045) transcription by a mean of 14.95 (SD, 1.7) compared with wild-type alleles (mean, 9.56 [SD, 0.84]; difference, 5.39; 95% CI, 4.1-6.6; P < .001). CONCLUSIONS AND RELEVANCE In this preliminary study involving patients of African descent taking warfarin, 4 single-nucleotide polymorphisms in linkage disequilibrium on chromosome 6 were associated with an increased risk of major bleeding at INR of less than 4. Validation of these findings in an independent prospective cohort is required.	[De, Tanima; Alarcon, Cristina; Perera, Minoli A.] Northwestern Univ, Dept Pharmacol, 303 E Chicago Ave,Ward 9-188, Chicago, IL 60611 USA; [Hernandez, Wenndy] Univ Chicago, Dept Med, Sect Genet Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Liko, Ina] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA; [Cavallari, Larisa H.; Duarte, Julio D.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA	Northwestern University; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Perera, MA (corresponding author), Northwestern Univ, Dept Pharmacol, 303 E Chicago Ave,Ward 9-188, Chicago, IL 60611 USA.	minoli.perera@northwestern.edu	Perera, Minoli/AHD-3525-2022	Perera, Minoli/0000-0002-1146-2791	National Heart, Lung, and Blood Institute [K23 HL089808-01A2, R21 HL106097]; National Institute of General Medicine [R01MD009217]; National Institutes of Health [K23GM112014]; American Heart Association Midwest Affiliate [10GRNT3750024]; University of Illinois at Chicago, College of Pharmacy, Hans Vahlteich Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106097, K23HL089808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM112014] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009217, U54MD010723] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Midwest Affiliate(American Heart Association); University of Illinois at Chicago, College of Pharmacy, Hans Vahlteich Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was funded by grants K23 HL089808-01A2 and R21 HL106097 from the National Heart, Lung, and Blood Institute, R01MD009217 from the National Institute of General Medicine, K23GM112014 from the National Institutes of Health, and 10GRNT3750024 from the American Heart Association Midwest Affiliate and by the University of Illinois at Chicago, College of Pharmacy, Hans Vahlteich Research Award.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Bunch H, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0040-x; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; Dang MTN, 2005, ANN PHARMACOTHER, V39, P1008, DOI 10.1345/aph.1E566; Dawson DW, 2007, ONCOGENE, V26, P4243, DOI 10.1038/sj.onc.1210211; Dong YC, 2013, J ENDODONT, V39, P223, DOI 10.1016/j.joen.2012.11.020; Garcia DA, 2012, CIRCULATION, V125, P2944, DOI 10.1161/CIRCULATIONAHA.111.081489; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Kooiman J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122520; Li C, 2009, BLOOD, V113, P3925, DOI 10.1182/blood-2008-09-176859; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Limdi NA, 2017, PHARMACOGENET GENOM, V27, P347, DOI 10.1097/FPC.0000000000000298; Nielsen PB, 2016, CHEST, V149, P311, DOI 10.1378/chest.15-1509; Noris P, 2012, HAEMATOL-HEMATOL J, V97, P82, DOI 10.3324/haematol.2011.050682; Pandey DK, 2005, MED CLIN N AM, V89, P739, DOI 10.1016/j.mcna.2005.02.005; Percy MJ, 2005, HEMATOL ONCOL, V23, P91, DOI 10.1002/hon.761; Perera MA, 2013, LANCET, V382, P790, DOI 10.1016/S0140-6736(13)60681-9; Persson J, 2010, EXP CELL RES, V316, P1316, DOI 10.1016/j.yexcr.2010.02.029; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2008, CHEST, V133, p257S, DOI 10.1378/chest.08-0674; Suzuki M, 2014, J CARDIOL, V64, P482, DOI 10.1016/j.jjcc.2014.03.006; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; van Loon J, 2016, EUR J HUM GENET, V24, P1035, DOI 10.1038/ejhg.2015.222; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams, 2012, COMP EFFECTIVENESS W	34	22	23	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1670	1677		10.1001/jama.2018.14955	http://dx.doi.org/10.1001/jama.2018.14955			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357299	Green Published, Bronze			2022-12-28	WOS:000448069100016
J	Oliver, D				Oliver, David			David Oliver: NHS workforce policy is not joined-up government	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 1998, BBC NEWS; BMA, 2018, UND TREND JUN DOCT T; BMA, 2018, NHS BREAK POINT; Bogdanor V., 2012, JOINED UP GOVT, DOI [10.5871/bacad/9780197263334, DOI 10.5871/BACAD/9780197263334]; Brennan S, 2018, HLTH SERV J; Care Quality Commission, 2018, STAT HLTH CAR AD SOC; Grierson J, 2018, EASING VISA RULES DO; Grierson J, 2018, GUARDIAN; Health Education England, 2018, ENH JUN DOCT WORK LI; Hervey T, 2018, IMPACT BREXIT NHS ST; House of Commons Library, 2018, NHS STAFF OV STAT; Lintern S., 2018, HANCOCK SIGNALS NEW; NHS Confederation, 2017, WILL NHS WORKF STRAT; NHS Providers, 2017, BETT FUT NHS WORKF; OLIVER D, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J4407; Royal College of Physicians, 2016, UND UND OV NHS 2016; Timmins N, 2012, NEVER AGAIN STORY HL	17	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4417	10.1136/bmj.k4417	http://dx.doi.org/10.1136/bmj.k4417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PE	30352881	Bronze			2022-12-28	WOS:000448893800002
J	Hie, B; Cho, H; Berger, B				Hie, Brian; Cho, Hyunghoon; Berger, Bonnie			Realizing private and practical pharmacological collaboration	SCIENCE			English	Article							DRUG-DISCOVERY; PRODUCTIVITY; INFORMATION	Although combining data from multiple entities could power life-saving breakthroughs, open sharing of pharmacological data is generally not viable because of data privacy and intellectual property concerns. To this end, we leverage modern cryptographic tools to introduce a computational protocol for securely training a predictive model of drug-target interactions (DTIs) on a pooled dataset that overcomes barriers to data sharing by provably ensuring the confidentiality of all underlying drugs, targets, and observed interactions. Our protocol runs within days on a real dataset of more than 1 million interactions and is more accurate than state-of-the-art DTI prediction methods. Using our protocol, we discover previously unidentified DTIs that we experimentally validated via targeted assays. Our work lays a foundation for more effective and cooperative biomedical research.	[Hie, Brian; Cho, Hyunghoon; Berger, Bonnie] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Berger, Bonnie] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Berger, B (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Berger, B (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	bab@mit.edu		Hie, Brian/0000-0003-3224-8142; Cho, Hyunghoon/0000-0002-2713-0150	NIH [R01GM081871]; Kwanjeong Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kwanjeong Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.H. and H.C. are partially supported by NIH grant R01GM081871 (to B.B.). H.C. is also partially supported by the Kwanjeong Educational Foundation.	Abadi M, 2016, CCS'16: PROCEEDINGS OF THE 2016 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P308, DOI 10.1145/2976749.2978318; Ben-Or M., 1988, 20 STOC, P1, DOI 10.1145/62212.62213; Bonawitz K, 2017, CCS'17: PROCEEDINGS OF THE 2017 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P1175, DOI 10.1145/3133956.3133982; Buzdar A, 2002, BREAST CANCER RES TR, V73, P161, DOI 10.1023/A:1015229630260; Cho H, 2018, NAT BIOTECHNOL, V36, P547, DOI 10.1038/nbt.4108; Cobanoglu MC, 2013, J CHEM INF MODEL, V53, P3399, DOI 10.1021/ci400219z; Cramer R., 2015, SECURE MULTIPARTY CO; Cressey D, 2011, NATURE, V471, P17, DOI 10.1038/471017a; Damgard I, 2012, LECT NOTES COMPUT SC, V7417, P643; Dwork C, 2006, LECT NOTES COMPUT SC, V3876, P265, DOI 10.1007/11681878_14; Glorot X., 2011, PROC 14 INT C ARTIFI, V15, P315; Hitaj B., 2017, ARXIV170207464CSCR; Hunter J., 2014, DRUG DISCOVERY WORLD; Khanna I, 2012, DRUG DISCOV TODAY, V17, P1088, DOI 10.1016/j.drudis.2012.05.007; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Levy J., 2015, AGE COLLABORATION WH; Luo YA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00680-8; Matsushima S, 2011, BIOCHEM BIOPH RES CO, V407, P557, DOI 10.1016/j.bbrc.2011.03.061; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Mohassel P, 2017, P IEEE S SECUR PRIV, P19, DOI 10.1109/SP.2017.12; Nikolaenko V., 2013, P 2013 ACM SIGSAC C, P801, DOI DOI 10.1145/2508859.2516751; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Reardon S., 2014, NATURE, DOI [10.1038/nature.2014.14672, DOI 10.1038/NATURE.2014.14672]; Shokri R, 2015, ANN ALLERTON CONF, P909, DOI 10.1109/ALLERTON.2015.7447103; Simmons S, 2016, CELL SYST, V3, P54, DOI 10.1016/j.cels.2016.04.013; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tocchini-Valentini G, 2004, J MED CHEM, V47, P1956, DOI 10.1021/jm0310582; Wang WH, 2014, BIOINFORMATICS, V30, P2923, DOI 10.1093/bioinformatics/btu403; Wilhelm M., 2017, WIRED; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Zheng XD, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1025	33	29	30	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					347	350		10.1126/science.aat4807	http://dx.doi.org/10.1126/science.aat4807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337410	Green Accepted, Green Published			2022-12-28	WOS:000447680100050
J	Normile, D				Normile, Dennis			China narrows US lead in R&D spending	SCIENCE			English	News Item																			0	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					276	276		10.1126/science.362.6412.276	http://dx.doi.org/10.1126/science.362.6412.276			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337391				2022-12-28	WOS:000447680100020
J	Katsyuba, E; Mottis, A; Zietak, M; De Franco, F; van der Velpen, V; Gariani, K; Ryu, D; Cialabrini, L; Matilainen, O; Liscio, P; Giacche, N; Stokar-Regenscheit, N; Legouis, D; de Seigneux, S; Ivanisevic, J; Raffaelli, N; Schoonjans, K; Pellicciari, R; Auwerx, J				Katsyuba, Elena; Mottis, Adrienne; Zietak, Marika; De Franco, Francesca; van der Velpen, Vera; Gariani, Karim; Ryu, Dongryeol; Cialabrini, Lucia; Matilainen, Olli; Liscio, Paride; Giacche, Nicola; Stokar-Regenscheit, Nadine; Legouis, David; de Seigneux, Sophie; Ivanisevic, Julijana; Raffaelli, Nadia; Schoonjans, Kristina; Pellicciari, Roberto; Auwerx, Johan			De novo NAD(+) synthesis enhances mitochondrial function and improves health	NATURE			English	Article							SEMIALDEHYDE DECARBOXYLASE ACMSD; KEY ENZYME; LIFE-SPAN; TRANSCUTANEOUS MEASUREMENT; GENE-EXPRESSION; C. ELEGANS; METABOLISM; TRYPTOPHAN; LONGEVITY; BIOSYNTHESIS	Nicotinamide adenine dinucleotide (NAD(+)) is a co-substrate for several enzymes, including the sirtuin family of NAD(+)-dependent protein deacylases. Beneficial effects of increased NAD(+) levels and sirtuin activation on mitochondrial homeostasis, organismal metabolism and lifespan have been established across species. Here we show that alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD), the enzyme that limits spontaneous cyclization of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde in the de novo NAD(+) synthesis pathway, controls cellular NAD(+) levels via an evolutionarily conserved mechanism in Cuenorhabditis eleguns and mouse. Genetic and pharmacological inhibition of ACMSD boosts de novo NAD(+) synthesis and sirtuin 1 activity, ultimately enhancing mitochondrial function. We also characterize two potent and selective inhibitors of ACMSD. Because expression of ACMSD is largely restricted to kidney and liver, these inhibitors may have therapeutic potential for protection of these tissues from injury. In summary, we identify ACMSD as a key modulator of cellular NAD(+) levels, sirtuin activity and mitochondrial homeostasis in kidney and liver.	[Katsyuba, Elena; Mottis, Adrienne; Gariani, Karim; Ryu, Dongryeol; Matilainen, Olli; Auwerx, Johan] Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Zietak, Marika; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lab Metab Signaling, Interfac Inst Bioengn, Lausanne, Switzerland; [Zietak, Marika] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland; [De Franco, Francesca; Liscio, Paride; Giacche, Nicola; Pellicciari, Roberto] TES Pharma, Loc Taverne, Corciano, Italy; [van der Velpen, Vera; Ivanisevic, Julijana] Univ Lausanne, Fac Biol & Med, Metabol Platform, Lausanne, Switzerland; [Cialabrini, Lucia; Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Stokar-Regenscheit, Nadine] Ecole Polytech Fed Lausanne, Histol Core Facil, Lausanne, Switzerland; [Legouis, David] Univ Hosp Geneva, Dept Anaesthesiol Pharmacol & Intens Care, Intens Care Unit, Geneva, Switzerland; [Legouis, David; de Seigneux, Sophie] Univ Geneva, Dept Internal Med Specialties, Lab Nephrol, Geneva, Switzerland; [Legouis, David; de Seigneux, Sophie] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [de Seigneux, Sophie] Univ Hosp Geneva, Dept Internal Med Specialties, Serv Nephrol, Geneva, Switzerland; [Gariani, Karim] Geneva Univ Hosp, Serv Endocrinol Diabet Hypertens & Nutr, Geneva, Switzerland; [Ryu, Dongryeol] Pusan Natl Univ, Hlth Aging Korean Med Res Ctr, Sch Korean Med, Mol & Integrat Biol Lab,Dept Korean Med Sci, Yangsan, South Korea; [Matilainen, Olli] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Stokar-Regenscheit, Nadine] F Hoffmann La Roche, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Pharmaceut Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Lausanne; Marche Polytechnic University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Pusan National University; University of Helsinki; Roche Holding	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Interfac Inst Bioengn, Lab Integrat & Syst Physiol, Lausanne, Switzerland.; Pellicciari, R (corresponding author), TES Pharma, Loc Taverne, Corciano, Italy.	rpellicciari@tespharma.com; admin.auwerx@epfl.ch	Legouis, David/ABF-8069-2020; Ivanisevic, Julijana/AAT-3901-2021; Auwerx, Johan/ABE-9307-2021; Ryu, Dongryeol/AAQ-3642-2020	Ivanisevic, Julijana/0000-0001-8267-2705; Ryu, Dongryeol/0000-0001-5905-6760; Stokar-Regenscheit, Nadine/0000-0003-4089-2026; ZIETAK, Marika/0000-0002-3437-9253; Liscio, Paride/0000-0001-8241-8563; van der Velpen, Vera/0000-0002-6502-7197; Giacche', Nicola/0000-0002-4810-3960; Schoonjans, Kristina/0000-0003-1247-4265; Legouis, David/0000-0002-2924-9737; Auwerx, Johan/0000-0002-5065-5393; Matilainen, Olli/0000-0001-9939-4828	Fondation Romande pour la Recherche sur le Diabete; KNOW consortium 'Healthy Animal-Safe Food' MSHE [05-1/KNOW2/2015]; Foundation for Polish Science; EPFL; Swiss National Science Foundation [310030B_160318]; Foundation Pierre-Mercier pour la Science	Fondation Romande pour la Recherche sur le Diabete; KNOW consortium 'Healthy Animal-Safe Food' MSHE; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); EPFL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Pierre-Mercier pour la Science	We thank P. Gonczy and the Caenorhabditis Genetics Center for providing reagents, the Bioimaging and Optics Core Facility and the Phenotyping Unit of EPFL, N. Moullan, T. Clerc and S. Bichet for technical assistance. E.K. was supported by Fondation Romande pour la Recherche sur le Diabete. M.Z. was supported by the KNOW consortium 'Healthy Animal-Safe Food' MS&HE no. 05-1/KNOW2/2015 and the Foundation for Polish Science. This work was supported by funds from EPFL and Swiss National Science Foundation (grant 310030B_160318). J.I. acknowledges funding from the Foundation Pierre-Mercier pour la Science. We thank H. Gallant-Ayala for advice on analytical methods.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Fukuoka SI, 2002, J BIOL CHEM, V277, P35162, DOI 10.1074/jbc.M200819200; Fukuwatari T, 2004, TOXICOL SCI, V81, P302, DOI 10.1093/toxsci/kfh204; Gariani K., 2016, J HEPATOL; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Gebauer J, 2016, CELL SYST, V2, P312, DOI 10.1016/j.cels.2016.04.017; Hashimoto T, 2010, BIOGERONTOLOGY, V11, P31, DOI 10.1007/s10522-009-9225-3; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.17; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; McReynolds M. R., 2017, J BIOL CHEM; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mouchiroud L., 2016, CURR PROTOC NEUROSCI, V77; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Pellicciari R, 2018, J MED CHEM, V61, P745, DOI 10.1021/acs.jmedchem.7b01254; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Saito K, 2000, AM J PHYSIOL-RENAL, V279, pF565, DOI 10.1152/ajprenal.2000.279.3.F565; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI [10.1056/NEJMoa1616361, 10.1056/nejmoa1616361]; Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Zamporlini F, 2014, FEBS J, V281, P5104, DOI 10.1111/febs.13050	45	182	188	6	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					354	+		10.1038/s41586-018-0645-6	http://dx.doi.org/10.1038/s41586-018-0645-6			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30356218	Green Accepted			2022-12-28	WOS:000450048400050
J	Turner, NC; Slamon, DJ; Ro, J; Bondarenko, I; Im, SA; Masuda, N; Colleoni, M; DeMichele, A; Loi, S; Verma, S; Iwata, H; Harbeck, N; Loibl, S; Andre, F; Puyana Theall, K; Huang, X; Giorgetti, C; Huang Bartlett, C; Cristofanilli, M				Turner, N. C.; Slamon, D. J.; Ro, J.; Bondarenko, I; Im, S-A; Masuda, N.; Colleoni, M.; DeMichele, A.; Loi, S.; Verma, S.; Iwata, H.; Harbeck, N.; Loibl, S.; Andre, F.; Puyana Theall, K.; Huang, X.; Giorgetti, C.; Huang Bartlett, C.; Cristofanilli, M.			Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOCRINE THERAPY; COMBINATION; ABEMACICLIB; PROGRESSION; LETROZOLE; WOMEN; PLUS	BACKGROUND The cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor palbociclib, in combination with fulvestrant therapy, prolongs progression-free survival among patients with hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. We report the results of a prespecified analysis of overall survival. METHODS We randomly assigned patients with hormone-receptor-positive, HER2-negative advanced breast cancer who had progression or relapse during previous endocrine therapy to receive palbociclib plus fulvestrant or placebo plus fulvestrant. We analyzed overall survival; the effect of palbociclib according to the prespecified stratification factors of presence or absence of sensitivity to endocrine therapy, presence or absence of visceral metastatic disease, and menopausal status; the efficacy of subsequent therapies after disease progression; and safety. RESULTS Among 521 patients who underwent randomization, the median overall survival was 34.9 months (95% confidence interval (CI), 28.8 to 40.0) in the palbociclib-fulvestrant group and 28.0 months (95% CI, 23.6 to 34.6) in the placebo-fulvestrant group (hazard ratio for death, 0.81; 95% CI, 0.64 to 1.03; P=0.09; absolute difference, 6.9 months). CDK416 inhibitor treatment after the completion of the trial regimen occurred in 16% of the patients in the placebo-fulvestrant group. Among 410 patients with sensitivity to previous endocrine therapy, the median overall survival was 39.7 months (95% CI, 34.8 to 45.7) in the palbociclib-fulvestrant group and 29.7 months (95% CI, 23.8 to 37.9) in the placebo-fulvestrant group (hazard ratio, 0.72; 95% CI, 0.55 to 0.94; absolute difference, 10.0 months). The median duration of subsequent therapy was similar in the two groups, and the median time to the receipt of chemotherapy was 17.6 months in the palbociclib-fulvestrant group, as compared with 8.8 months in the placebo-fulvestrant group (hazard ratio, 0.58; 95% CI, 0.47 to 0.73; P<0.001). No new safety signals were observed with 44.8 months of follow-up. CONCLUSIONS Among patients with hormone-receptor-positive, HER2-negative advanced breast cancer who had sensitivity to previous endocrine therapy, treatment with palbociclib-fulvestrant resulted in longer overall survival than treatment with placebo-fulvestrant. The differences in overall survival in the entire trial group were not significant.	[Turner, N. C.] Inst Canc Res, Fulham Rd, London SW3 6JJ, England; [Turner, N. C.] Royal Marsden Hosp, Fulham Rd, London SW3 6JJ, England; [Slamon, D. J.] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA USA; [Huang, X.] Pfizer Oncol, San Diego, CA USA; [Ro, J.] Natl Canc Ctr, Goyang Si, Gyeonggi Do, South Korea; [Im, S-A] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea; [Bondarenko, I] Dnipropetrovsk Med Acad, City Multiple Discipline Clin Hosp 4, Dnepropetrovsk, Ukraine; [Masuda, N.] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan; [Iwata, H.] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Colleoni, M.] Ist Europeo Oncol, Milan, Italy; [Giorgetti, C.] Pfizer Oncol, Milan, Italy; [DeMichele, A.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Huang Bartlett, C.] Pfizer Oncol, Collegeville, PA USA; [Loi, S.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Verma, S.] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada; [Harbeck, N.] Brustzentrum Univ Munchen, Munich, Germany; [Loibl, S.] German Breast Grp, Neu Isenburg, Germany; [Andre, F.] Inst Gustave Roussy, Villejuif, France; [Puyana Theall, K.] Pfizer Oncol, Cambridge, MA USA; [Cristofanilli, M.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer; National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital; Dnipro State Medical University; Osaka National Hospital; Aichi Cancer Center; IRCCS European Institute of Oncology (IEO); Pfizer; University of Pennsylvania; Pennsylvania Medicine; Pfizer; Peter Maccallum Cancer Center; University of Melbourne; Tom Baker Cancer Clinic; University of Calgary; University of Munich; German Breast Group; UNICANCER; Gustave Roussy; Pfizer; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Turner, NC (corresponding author), Inst Canc Res, Fulham Rd, London SW3 6JJ, England.; Turner, NC (corresponding author), Royal Marsden Hosp, Fulham Rd, London SW3 6JJ, England.	nick.turner@icr.ac.uk	Bondarenko, Igor/W-9412-2019; MASUDA, NORIKAZU/AAM-2417-2021; Bondarenko, Igor N/GQP-1497-2022; Loi, Sherene/H-1979-2016; ANDRE, Fabrice/AAL-2683-2020	Bondarenko, Igor/0000-0002-7071-2471; MASUDA, NORIKAZU/0000-0002-7302-0278; Bondarenko, Igor N/0000-0002-7071-2471; Loi, Sherene/0000-0001-6137-9171; ANDRE, Fabrice/0000-0001-5795-8357; Turner, Nicholas/0000-0001-8937-0873	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.	[Anonymous], 2018, N Engl J Med, V379, P2582, DOI 10.1056/NEJMx180043; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Cardoso F, 2017, BREAST, V31, P244, DOI 10.1016/j.breast.2016.10.001; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Dmitrienko A, 2018, NEW ENGL J MED, V378, P2115, DOI 10.1056/NEJMra1709701; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Glimm E, 2010, STAT MED, V29, P219, DOI 10.1002/sim.3748; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Hortobagyi GN, 2018, ANN ONCOL, V29, P1541, DOI 10.1093/annonc/mdy155; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Loibl S, 2017, ONCOLOGIST, V22, P1028, DOI 10.1634/theoncologist.2017-0072; O'Leary B, 2018, CANC DISCOV; O'Leary B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03215-x; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; ROBINS JM, 1991, COMMUN STAT THEORY, V20, P2609, DOI 10.1080/03610929108830654; Rugo HS, 2016, J CLIN ONCOL, V34, P3069, DOI 10.1200/JCO.2016.67.1487; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slamon DJ, 2018, J CLIN ONCOL, V36, P2465, DOI 10.1200/JCO.2018.78.9909; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sledge GW, 2017, J CLIN ONCOL, V35, P2875, DOI 10.1200/JCO.2017.73.7585; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Watkins C, 2013, PHARM STAT, V12, P348, DOI 10.1002/pst.1602	24	531	544	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2018	379	20					1926	1936		10.1056/NEJMoa1810527	http://dx.doi.org/10.1056/NEJMoa1810527			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2FL	30345905	Bronze			2022-12-28	WOS:000450049800007
J	Eder, M; Amini, S; Fratzl, P				Eder, Michaela; Amini, Shahrouz; Fratzl, Peter			Biological composites-complex structures for functional diversity	SCIENCE			English	Review							NANOSTRUCTURES; STRATEGIES; DESIGN	The bulk of Earth's biological materials consist of few base substances-essentially proteins, polysaccharides, and minerals-that assemble into large varieties of structures. Multifunctionality arises naturally from this structural complexity: An example is the combination of rigidity and flexibility in protein-based teeth of the squid sucker ring. Other examples are time-delayed actuation in plant seed pods triggered by environmental signals, such as fire and water, and surface nanostructures that combine light manipulation with mechanical protection or water repellency. Bioinspired engineering transfers some of these structural principles into technically more relevant base materials to obtain new, often unexpected combinations of material properties. Less appreciated is the huge potential of using bioinspired structural complexity to avoid unnecessary chemical diversity, enabling easier recycling and, thus, a more sustainable materials economy.	[Eder, Michaela; Amini, Shahrouz; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, Res Campus Golm, D-14424 Potsdam, Germany	Max Planck Society	Fratzl, P (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Res Campus Golm, D-14424 Potsdam, Germany.	fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Eder, Michaela/0000-0002-1461-1668; Amini, Shahrouz/0000-0002-1928-2760	DFG [DFG-EXC 1027]; Leibniz Award of the DFG	DFG(German Research Foundation (DFG)); Leibniz Award of the DFG(German Research Foundation (DFG))	Partial support was provided by the DFG Cluster of Excellence "Image-Knowledge-Gestaltung" (DFG-EXC 1027). P.F. was also supported by a Leibniz Award of the DFG.	Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Aizenberg J, 2013, ADV FUNCT MATER, V23, P4398, DOI 10.1002/adfm.201302690; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Ashby M.F., 2015, MAT SUSTAINABLE DEV, Vfirst; ASHBY MF, 1995, P R SOC-MATH PHYS SC, V450, P123, DOI 10.1098/rspa.1995.0075; Ashby MF, 2004, MATER DESIGN, V25, P51, DOI 10.1016/S0261-3069(03)00159-6; Barrows FP, 2014, NANOMATER NANOTECHNO, V4, DOI 10.5772/58289; Barthelat F, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.7; Chandler CJ, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201600646; COWLING RM, 1985, AUST J ECOL, V10, P169, DOI 10.1111/j.1442-9993.1985.tb00878.x; Darmanin T, 2015, MATER TODAY, V18, P273, DOI 10.1016/j.mattod.2015.01.001; Degtyar E, 2014, ANGEW CHEM INT EDIT, V53, P12026, DOI 10.1002/anie.201404272; Fratzl P, 2016, CHEM SOC REV, V45, P252, DOI 10.1039/c5cs00598a; Gao HL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00392-z; George A.S., 1981, NUYTSIA, V3, P239; Guerette PA, 2014, ACS NANO, V8, P7170, DOI 10.1021/nn502149u; Hiew SH, 2017, ACS BIOMATER SCI ENG, V3, P680, DOI 10.1021/acsbiomaterials.6b00284; Hu WQ, 2018, NATURE, V554, P81, DOI 10.1038/nature25443; Huss JC, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0190; Huss JC, 2018, ADV SCI, V5, DOI 10.1002/advs.201700572; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Kumar K, 2017, SOFT ROBOT, V4, P317, DOI 10.1089/soro.2017.0002; Kuprian E, 2017, PLANT CELL ENVIRON, V40, P3101, DOI 10.1111/pce.13078; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; Latza V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9313; Li L, 2015, SCIENCE, V350, P952, DOI 10.1126/science.aad1246; Li L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7322; Liu ZQ, 2017, PROG MATER SCI, V88, P467, DOI 10.1016/j.pmatsci.2017.04.013; Mazzolai Barbara, 2014, Front Bioeng Biotechnol, V2, P2, DOI 10.3389/fbioe.2014.00002; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Miserez A, 2009, ADV MATER, V21, P401, DOI 10.1002/adma.200801197; Moyroud E, 2017, NATURE, V550, P469, DOI 10.1038/nature24285; Pena-Francesch A, 2018, APL MATER, V6, DOI 10.1063/1.4985755; Polishchuk I, 2017, SCIENCE, V358, P1294, DOI 10.1126/science.aaj2156; Poppinga S, 2018, ADV MATER, V30, DOI 10.1002/adma.201703653; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Reznikov N, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.41; Studart AR, 2016, CHEM SOC REV, V45, P359, DOI 10.1039/c5cs00836k; Studart AR, 2014, NAT MATER, V13, P433, DOI 10.1038/nmat3955; Sullivan TN, 2017, MATER TODAY, V20, P377, DOI 10.1016/j.mattod.2017.02.004; Tadepalli S, 2017, CHEM REV, V117, P12705, DOI 10.1021/acs.chemrev.7b00153; Torquato S, 2003, J APPL PHYS, V94, P5748, DOI 10.1063/1.1611631; Vermerris W., 2008, PHENOLIC COMPOUND BI, P235; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Wang WD, 2018, NATURE, V559, P77, DOI 10.1038/s41586-018-0250-8; WARDROP AB, 1983, AUST J BOT, V31, P485, DOI 10.1071/BT9830485; Watson GS, 2017, ANNU REV ENTOMOL, V62, P185, DOI 10.1146/annurev-ento-031616-035020; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weinkamer R, 2016, MRS BULL, V41, P667, DOI 10.1557/mrs.2016.168; Weinkamer R, 2011, MAT SCI ENG C-MATER, V31, P1164, DOI 10.1016/j.msec.2010.12.002; Xie GY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095605	52	193	195	22	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		543	+		10.1126/science.aat8297	http://dx.doi.org/10.1126/science.aat8297			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385570	Green Submitted			2022-12-28	WOS:000450460000035
J	Kofler, N; Collins, JP; Kuzma, J; Marris, E; Esvelt, K; Nelson, MP; Newhouse, A; Rothschild, LJ; Vigliotti, VS; Semenov, M; Jacobsen, R; Dahlman, JE; Prince, S; Caccone, A; Brown, T; Schmitz, OJ				Kofler, Natalie; Collins, James P.; Kuzma, Jennifer; Marris, Emma; Esvelt, Kevin; Nelson, Michael Paul; Newhouse, Andrew; Rothschild, Lynn J.; Vigliotti, Vivian S.; Semenov, Misha; Jacobsen, Rowan; Dahlman, James E.; Prince, Shannon; Caccone, Adalgisa; Brown, Timothy; Schmitz, Oswald J.			Editing nature: Local roots of global governance Environmental gene editing demands collective oversight	SCIENCE			English	Editorial Material									[Kofler, Natalie; Caccone, Adalgisa] Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06511 USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Kuzma, Jennifer] North Carolina State Univ, Sch Publ & Int Affairs, Raleigh, NC 27695 USA; [Kuzma, Jennifer] North Carolina State Univ, Genet Engn & Soc Ctr, Raleigh, NC 27695 USA; [Marris, Emma] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Esvelt, Kevin] MIT, Media Lab, Cambridge, MA 02139 USA; [Nelson, Michael Paul] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Newhouse, Andrew] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Rothschild, Lynn J.] Brown Univ, Dept Mol & Cellular Biol & Biochem, Providence, RI 02912 USA; [Vigliotti, Vivian S.] Baylor Univ, Robbins Inst Hlth Policy & Leadership, Waco, TX 76798 USA; [Semenov, Misha] Yale Univ, Yale Sch Architecture, New Haven, CT 06511 USA; [Semenov, Misha; Schmitz, Oswald J.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Jacobsen, Rowan] MIT, Knight Sci Journalism Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Dahlman, James E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Dahlman, James E.] Emory Sch Med, Atlanta, GA 30332 USA; [Prince, Shannon] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolut, New Haven, CT 06511 USA; [Brown, Timothy] Natl Geog Soc, Washington, DC 20036 USA	Yale University; Arizona State University; Arizona State University-Tempe; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Oregon State University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Brown University; Baylor University; Yale University; Yale University; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Emory University; Harvard University; Yale University; National Geographic Society	Kofler, N (corresponding author), Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06511 USA.	natalie.kofler@yale.edu	Caccone, Adalgisa/AAE-4238-2021; Nelson, Michael Shawn/GXF-4934-2022	Caccone, Adalgisa/0000-0002-8949-9260; Newhouse, Andrew/0000-0002-9981-8309; Kuzma, Jennifer/0000-0003-4456-9613; Prince, Shannon/0000-0002-0456-6488	Yale Institute for Biospheric Studies; Yale Interdisciplinary Center for Bioethics; Franke Program in Science and the Humanities	Yale Institute for Biospheric Studies; Yale Interdisciplinary Center for Bioethics; Franke Program in Science and the Humanities	Authors thank the Yale Institute for Biospheric Studies, the Yale Interdisciplinary Center for Bioethics, and the Franke Program in Science and the Humanities for funding the 2017 Editing Nature Summit, which informed this manuscript. We are grateful for the help and support of J. and M. R. Vigliotti, I. Papangeli, G. Kaebnick, M. E. Tucker, L. Stevenson, C. A. Kroop, A. Miller, and our dearly remembered friend and colleague Calestous Juma.	Australian Academy of Science, 2017, SYNTH GEN DRIV AUSTR; Burall S, 2018, NATURE, V555, P438, DOI 10.1038/d41586-018-03269-3; CBD, PORT SYNTH BIOL; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Emerson C, 2017, SCIENCE, V358, P1135, DOI 10.1126/science.aap9026; ETC Group, 2016, RECKL DRIV GEN DRIV; Ferkany M, 2012, J AGR ENVIRON ETHIC, V25, P419, DOI 10.1007/s10806-011-9312-8; IUCN, DEV IUCN POL SYNTH B; Jasanoff S, 2018, NATURE, V555, P435, DOI 10.1038/d41586-018-03270-w; Jordan NR, 2017, EMBO REP, V18, P1683, DOI 10.15252/embr.201744394; Kaebnick GE, 2017, HASTINGS CENT REP, V47, pS60, DOI 10.1002/hast.754; Marchant GE, 2015, ISSUES SCI TECHNOL, V31, P43; Montoliu L, 2018, CRISPR J, V1, P128, DOI 10.1089/crispr.2018.29012.mon; National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI; Neuhaus CP, 2018, HASTINGS CENT REP, V48, P25, DOI 10.1002/hast.808; New Partnership for Africa's Development, 2018, GEN DRIV MAL CONTR E; O'Donnell EL, 2018, ECOL SOC, V23, DOI 10.5751/ES-09854-230107; Owen R., 2013, RESPONSIBLE INNOVATI, P27, DOI DOI 10.1002/9781118551424.CH2; Piaggio AJ, 2017, TRENDS ECOL EVOL, V32, P97, DOI 10.1016/j.tree.2016.10.016; Stilgoe J, 2013, RES POLICY, V42, P1568, DOI 10.1016/j.respol.2013.05.008; Swetlitz I., 2017, STAT NEWS       0314	21	44	44	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		527	+		10.1126/science.aat4612	http://dx.doi.org/10.1126/science.aat4612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385564				2022-12-28	WOS:000450460000026
J	Wise, J				Wise, Jacqui			Britain's deprived areas have five times as many fast food shops as rich areas	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal Society for Public Health, 2018, HLTH HIGH STREET RUN	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2018	363								k4661	10.1136/bmj.k4661	http://dx.doi.org/10.1136/bmj.k4661			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QK	30389693				2022-12-28	WOS:000449566000005
J	Awad, E; Dsouza, S; Kim, R; Schulz, J; Henrich, J; Shariff, A; Bonnefon, JF; Rahwan, I				Awad, Edmond; Dsouza, Sohan; Kim, Richard; Schulz, Jonathan; Henrich, Joseph; Shariff, Azim; Bonnefon, Jean-Francois; Rahwan, Iyad			The Moral Machine experiment	NATURE			English	Article							LIVES	With the rapid development of artificial intelligence have come concerns about how machines will make moral decisions, and the major challenge of quantifying societal expectations about the ethical principles that should guide machine behaviour. To address this challenge, we deployed the Moral Machine, an online experimental platform designed to explore the moral dilemmas faced by autonomous vehicles. This platform gathered 40 million decisions in ten languages from millions of people in 233 countries and territories. Here we describe the results of this experiment. First, we summarize global moral preferences. Second, we document individual variations in preferences, based on respondents' demographics. Third, we report cross-cultural ethical variation, and uncover three major clusters of countries. Fourth, we show that these differences correlate with modern institutions and deep cultural traits. We discuss how these preferences can contribute to developing global, socially acceptable principles for machine ethics. All data used in this article are publicly available.	[Awad, Edmond; Dsouza, Sohan; Kim, Richard; Rahwan, Iyad] MIT, Media Lab, Cambridge, MA 02139 USA; [Schulz, Jonathan; Henrich, Joseph] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Shariff, Azim] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Bonnefon, Jean-Francois] Univ Toulouse Capitole, CNRS, Toulouse Sch Econ TSM R, Toulouse, France; [Rahwan, Iyad] MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse 1 Capitole; Massachusetts Institute of Technology (MIT)	Rahwan, I (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.; Shariff, A (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.; Bonnefon, JF (corresponding author), Univ Toulouse Capitole, CNRS, Toulouse Sch Econ TSM R, Toulouse, France.; Rahwan, I (corresponding author), MIT, Inst Data Syst & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shariff@psych.ubc.ca; jean-francois.bonnefon@tse-fr.eu; irahwan@mit.edu	Henrich, Joseph/A-2403-2009; Schulz, Jonathan/AAB-2734-2020; Rahwan, Iyad/ABB-2422-2020	Schulz, Jonathan/0000-0001-5341-3819; Rahwan, Iyad/0000-0002-1796-4303	Ethics and Governance of Artificial Intelligence Fund; ANR-Labex Institute for Advanced Study in Toulouse	Ethics and Governance of Artificial Intelligence Fund; ANR-Labex Institute for Advanced Study in Toulouse(French National Research Agency (ANR))	I.R., E.A., S.D., and R.K. acknowledge support from the Ethics and Governance of Artificial Intelligence Fund. J.-F.B. acknowledges support from the ANR-Labex Institute for Advanced Study in Toulouse.	ARDECO, 2020, WORLD EC OUTLOOK DAT; Asimov I., 2004, I ROBOT; Bonnefon JF, 2016, SCIENCE, V352, P1573, DOI 10.1126/science.aaf2654; Bryson J, 2017, COMPUTER, V50, P116, DOI 10.1109/MC.2017.154; Carlsson F, 2010, ACCIDENT ANAL PREV, V42, P1814, DOI 10.1016/j.aap.2010.05.002; Conitzer V, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P1213; Cushman F, 2009, ETHICAL THEORY MORAL, V12, P9, DOI 10.1007/s10677-008-9145-3; Dadich S., 2016, WIRED; Dignum V., 2017, P 26 INT JOINT C ART, P4698, DOI 10.5555/3171837.3171945; Future of Life Institute, 2017, AS AI PRINC; Gachter S, 2016, NATURE, V531, P496, DOI 10.1038/nature17160; Gastil J, 2011, PS-POLIT SCI POLIT, V44, P711, DOI 10.1017/S1049096511001326; Graham J, 2016, CURR OPIN PSYCHOL, V8, P125, DOI 10.1016/j.copsyc.2015.09.007; Greene Joshua., 2013, MORAL TRIBES EMOTION; Haidt J., 2012, RIGHTEOUS MIND WHY G; Hainmueller J, 2014, POLIT ANAL, V22, P1, DOI 10.1093/pan/mpt024; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hofstede G., 2001, CULTURES CONSEQUENCE, DOI [10.2307/3556622, DOI 10.2307/3556622]; Inglehart Ronald, 2005, CULTURAL CHANGE DEMO; Johansson-Stenman O, 2008, J HEALTH ECON, V27, P739, DOI 10.1016/j.jhealeco.2007.10.001; Johansson-Stenman O, 2011, HEALTH ECON, V20, P723, DOI 10.1002/hec.1627; Kaufmann D, 2011, HAGUE J RULE LAW, V3, P220, DOI 10.1017/S1876404511200046; Luetge C., 2017, PHILOS TECHNOLOGY, V30, P547, DOI DOI 10.1007/S13347-017-0284-0; Milliner D., 2011, PREPRINT; Muthukrishna M., 2018, PREPRINT; Nishi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171252; Shariff A, 2017, NAT HUM BEHAV, V1, P694, DOI 10.1038/s41562-017-0202-6; Tomasello Michael, 2014, NATURAL HIST HUMAN T; WIENER N, 1960, SCIENCE, V131, P1355, DOI 10.1126/science.131.3410.1355	32	439	449	69	442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					59	+		10.1038/s41586-018-0637-6	http://dx.doi.org/10.1038/s41586-018-0637-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30356211	Green Published, Green Accepted			2022-12-28	WOS:000448900900045
J	Pich, O; Muinos, F; Sabarinathan, R; Reyes-Salazar, I; Gonzalez-Perez, A; Lopez-Bigas, N				Pich, Oriol; Muinos, Ferran; Sabarinathan, Radhakrishnan; Reyes-Salazar, Iker; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria			Somatic and Germline Mutation Periodicity Follow the Orientation of the DNA Minor Groove around Nucleosomes	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; 10-11 BP PERIODICITIES; GENE-EXPRESSION; CANCER GENOMES; SEQUENCE PERIODICITY; EUKARYOTIC GENOME; BREAST-CANCER; ORGANIZATION; PATTERNS; SELECTION	Mutation rates along the genome are highly variable and influenced by several chromatin features. Here, we addressed how nucleosomes, the most pervasive chromatin structure in eukaryotes, affect the generation of mutations. We discovered that within nucleosomes, the somatic mutation rate across several tumor cohorts exhibits a strong 10 base pair (bp) periodicity. This periodic pattern tracks the alternation of the DNA minor groove facing toward and away from the histones. The strength and phase of the mutation rate periodicity are determined by the mutational processes active in tumors. We uncovered similar periodic patterns in the genetic variation among human and Arabidopsis populations, also detectable in their divergence from close species, indicating that the same principles underlie germline and somatic mutation rates. We propose that differential DNA damage and repair processes dependent on the minor groove orientation in nucleosomebound DNA contribute to the 10-bp periodicity in AT/CG content in eukaryotic genomes.	[Pich, Oriol; Muinos, Ferran; Sabarinathan, Radhakrishnan; Reyes-Salazar, Iker; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; [Gonzalez-Perez, Abel; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Res Program Biomed Informat, Barcelona, Catalonia, Spain; [Lopez-Bigas, Nuria] ICREA, Barcelona, Spain; [Sabarinathan, Radhakrishnan; Lopez-Bigas, Nuria] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Pompeu Fabra University; ICREA; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Lopez-Bigas, N (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.; Lopez-Bigas, N (corresponding author), Univ Pompeu Fabra, Res Program Biomed Informat, Barcelona, Catalonia, Spain.; Lopez-Bigas, N (corresponding author), ICREA, Barcelona, Spain.	nuria.lopez@irbbarcelona.org	Lopez-Bigas, Nuria/F-6193-2011; Pich, Oriol/M-6865-2015	Lopez-Bigas, Nuria/0000-0003-4925-8988; Muinos, Ferran/0000-0002-4651-4168; Gonzalez-Perez, Abel/0000-0002-8582-4660; Pich, Oriol/0000-0002-1956-1882	European Research Council [682398]; Spanish Ministry of Economy and Competitiveness (MINECO/FEDER, UE) [SAF2015-66084-R]; Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain); CERCA (Generalitat de Catalunya); Ramon y Cajal contract [RYC-2013-14554]; BIST and FI PhD Fellowship	European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO/FEDER, UE); Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain); CERCA (Generalitat de Catalunya); Ramon y Cajal contract(Spanish Government); BIST and FI PhD Fellowship	The results shown here are in whole or part based upon data generated by the TCGA Research Network. N.L.-B. acknowledges funding from the European Research Council (682398) and Spanish Ministry of Economy and Competitiveness (SAF2015-66084-R, MINECO/FEDER, UE). IRB Barcelona is a recipient of a Severo Ochoa Centre of Excellence Award from the Spanish Ministry of Economy and Competitiveness (MINECO; Government of Spain) and is supported by CERCA (Generalitat de Catalunya). O.P. is supported by the BIST and FI PhD Fellowship. A.G.-P. is supported by a Ramon y Cajal contract (RYC-2013-14554).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Audit B, 2002, J MOL BIOL, V316, P903, DOI 10.1006/jmbi.2001.5363; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; Cooper David N, 2010, Hum Genomics, V4, P406; Cui F, 2010, J BIOMOL STRUCT DYN, V27, P821, DOI 10.1080/073911010010524947; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Frigola J, 2017, NAT GENET, V49, P1684, DOI 10.1038/ng.3991; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gori K., 2018, SIGFIT FLEXIBLE BAYE, DOI [10.1101/372896, DOI 10.1101/372896]; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Haradhvala NJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04002-4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herzel H, 1999, BIOINFORMATICS, V15, P187, DOI 10.1093/bioinformatics/15.3.187; Herzel H, 1998, J BIOMOL STRUCT DYN, V16, P341, DOI 10.1080/07391102.1998.10508251; Hollstein M, 2017, ONCOGENE, V36, P158, DOI 10.1038/onc.2016.192; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Iyer VR, 2012, TRENDS CELL BIOL, V22, P250, DOI 10.1016/j.tcb.2012.02.004; Jin H, 2016, NUCLEIC ACIDS RES, V44, P2047, DOI 10.1093/nar/gkw101; Kaiser VB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006207; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Langley SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004457; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HD, 2011, BIOSYSTEMS, V105, P295, DOI 10.1016/j.biosystems.2011.05.016; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Morganella S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11383; Mrazek J, 2010, J BACTERIOL, V192, P3763, DOI 10.1128/JB.00149-10; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Osakabe A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16330; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pfeifer G. P., 2017, DNA METHYLATION MUTA, P1; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Prendergast JGD, 2011, GENOME RES, V21, P1777, DOI 10.1101/gr.122275.111; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sokal R.R., 2012, BIOMETRY; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stoica P., 2004, SPECTRAL ANAL SIGNAL; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Tomkova M, 2017, BIORXIV, DOI [10.1101/111302, DOI 10.1101/111302]; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Voong LN, 2017, TRENDS GENET, V33, P495, DOI 10.1016/j.tig.2017.05.007; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136574; Yu SL, 2017, MOL CELL TOXICOL, V13, P21, DOI 10.1007/s13273-017-0002-0; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang T, 2015, PLANT PHYSIOL, V168, P1406, DOI 10.1104/pp.15.00125; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031; Zhong JL, 2016, GENOME RES, V26, P351, DOI 10.1101/gr.195602.115	81	48	48	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1074	+		10.1016/j.cell.2018.10.004	http://dx.doi.org/10.1016/j.cell.2018.10.004			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388444	Bronze, Green Accepted			2022-12-28	WOS:000449100600019
J	Pomar, L; Vouga, M; Lambert, V; Pomar, C; Hcini, N; Jolivet, A; Benoist, G; Rousset, D; Matheus, S; Malinger, G; Panchaud, A; Carles, G; Baud, D				Pomar, Leo; Vouga, Manon; Lambert, Veronique; Pomar, Celine; Hcini, Najeh; Jolivet, Anne; Benoist, Guillaume; Rousset, Dominique; Matheus, Severine; Malinger, Gustavo; Panchaud, Alice; Carles, Gabriel; Baud, David			Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERIM GUIDANCE; TERRITORIES; MANAGEMENT; SEQUELAE; INFANTS; RISK	OBJECTIVES To estimate the rates of maternal-fetal transmission of Zika virus, adverse fetal/neonatal outcomes, and subsequent rates of asymptomatic/symptomatic congenital Zika virus infections up to the first week of life. DESIGN Cohort study with prospective data collection and subsequent review of fetal/neonatal outcomes. SETTINGS Referral centre for prenatal diagnosis of the French Guiana Western Hospital. PARTICIPANTS Pregnant women at any stage of pregnancy with a laboratory confirmed symptomatic or asymptomatic Zika virus infection during the epidemic period in western French Guiana. The cohort enrolled 300 participants and prospectively followed their 305 fetuses/newborns. MAIN OUTCOME MEASURES Rate of maternal-fetal transmission of Zika virus (amniotic fluid, fetal and neonatal blood, urine, cerebrospinal fluid, and placentas); clinical, biological, and radiological outcomes (blindly reviewed); and adverse outcomes defined as moderate signs potentially related to congenital Zika syndrome (CZS), severe complications compatible with CZS, or fetal loss. Associations between a laboratory confirmed congenital Zika virus infection and adverse fetal/neonatal outcomes were evaluated. RESULTS Maternal-fetal transmission was documented in 26% (76/291) of fetuses/newborns with complete data. Among the Zika virus positive fetuses/ newborns, 45% (34/76) presented with no signs/ complications at birth, 20% (15/76) with moderate signs potentially related to CZS, 21% (16/76) with severe complications compatible with CZS, and 14% (11/76) with fetal loss. Compared with the Zika virus positive fetuses/neonates, those that were identified as negative for Zika virus (215/291) were less likely to present with severe complications (5%; 10/215) or fetal loss (0.5%; 1/215; relative risk 6.9, 95% confidence interval 3.6 to 13.3). Association between a positive Zika virus test and any adverse fetal/ neonatal outcome was also significant (relative risk 4.4, 2.9 to 6.6). The population attributable fraction estimates that a confirmed congenital Zika virus infection contributes to 47% of adverse outcomes and 61% of severe adverse outcomes observed. CONCLUSION In cases of a known maternal Zika virus infection, approximately a quarter of fetuses will become congenitally infected, of which a third will have severe complications at birth or fetal loss. The burden of CZS might be lower than initially described in South America and may not differ from other congenital infections.	[Pomar, Leo; Vouga, Manon; Pomar, Celine; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland; [Pomar, Leo; Lambert, Veronique; Pomar, Celine; Hcini, Najeh; Carles, Gabriel] Ctr Hosp Ouest Guyanais Franck Joly, Dept Obstet & Gynaecol, St Laurent Du Maroni, France; [Jolivet, Anne] Ctr Hosp Ouest Guyanais Franck Joly, Publ Hlth Dept, St Laurent Du Maroni, France; [Jolivet, Anne] Sorbonne Univ, UPMC, Univ Paris 06, INSERM,Dept Social Epidemiol,UMRS 1136,IPLESP, Paris, France; [Benoist, Guillaume] Univ Caen Normandie, Ctr Hosp Univ Caen, Serv Gynecol Obstet & Med Reprod, Caen, Basse Normandie, France; [Rousset, Dominique; Matheus, Severine] Inst Pasteur French Guiana, Natl Reference Ctr Arboviruses, Lab Virol, Cayenne, France; [Malinger, Gustavo] Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, Tel Aviv, Israel; [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Sourasky Med Ctr, Tel Aviv, Israel; [Panchaud, Alice] Lausanne Univ Hosp, Serv Clin Pharmacol, Lausanne, Switzerland; [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Panchaud, Alice] Univ Lausanne, Lausanne, Switzerland; [Panchaud, Alice] CHU Vaudois, Serv Pharm, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland.	david.baud@chuv.ch	Benoist, Guillaume/AFQ-6342-2022; Panchaud, Alice/S-6535-2019; Rousset, Dominique/S-5400-2019	Panchaud, Alice/0000-0001-6086-2401; Rousset, Dominique/0000-0002-1473-3147; Pomar, Leo/0000-0002-3021-8129; Jolivet, Anne/0000-0001-6233-1225; benoist, guillaume/0000-0002-1415-6474; Malinger, Gustavo/0000-0003-0864-206X; LAMBERT, veronique/0000-0001-6453-8983; Baud, David/0000-0001-9914-6496; Matheus, Severine/0000-0001-9171-1964				Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1; Agence regionale de sante, 2016, EM VIR ZIK AUX ANT G; Agence regionale de sante, 2016, SURV VIR ZIK AUX ANT; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181; Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Charrier R, 2017, SYNTHESE DEMOGRAPHIQ; del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Oliveira CIF, 2013, J PEDIATR GENET, V2, P85, DOI 10.3233/PGE-13052; Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102; Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Lambert VPL, 2017, ULTRASOUND OBSTET S1, V50, P1; Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354; Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005; LERUEZVILLE M, 2016, AM J OBSTET GYNECOL, V215; Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007; Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2; Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004; Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896; Pomar L, 2017, ULTRASOUND OBST GYN, V49, DOI 10.1002/uog.17510; Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022; Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; Smith GCS, 2017, BEST PRACT RES CL OB, V38, P71, DOI 10.1016/j.bpobgyn.2016.08.002; Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880; Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4	35	72	72	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4431	10.1136/bmj.k4431	http://dx.doi.org/10.1136/bmj.k4431			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381296	Green Published, hybrid			2022-12-28	WOS:000449564200005
J	Christie, B				Christie, Bryan			Scottish mesh review had serious failings	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Britton A., 2018, INVESTIGATIVE REV PR; CHRISTIE B, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1711; Torjesen I, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4570	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2018	363								k4562	10.1136/bmj.k4562	http://dx.doi.org/10.1136/bmj.k4562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PG	30373749				2022-12-28	WOS:000449561100014
J	Bintu, B; Mateo, LJ; Su, JH; Sinnott-Armstrong, NA; Parker, M; Kinrot, S; Yamaya, K; Boettiger, AN; Zhuang, XW				Bintu, Bogdan; Mateo, Leslie J.; Su, Jun-Han; Sinnott-Armstrong, Nicholas A.; Parker, Mirae; Kinrot, Seon; Yamaya, Kei; Boettiger, Alistair N.; Zhuang, Xiaowei			Super-resolution chromatin tracing reveals domains and cooperative interactions in single cells	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; MAMMALIAN GENOMES; 3D GENOME; HI-C; SPATIAL-ORGANIZATION; DROSOPHILA GENOME; COHESIN; TRANSCRIPTION; CHROMOSOME; PRINCIPLES	The spatial organization of chromatin is pivotal for regulating genome functions. We report an imaging method for tracing chromatin organization with kilobase-and nanometer-scale resolution, unveiling chromatin conformation across topologically associating domains (TADs) in thousands of individual cells. Our imaging data revealed TAD-like structures with globular conformation and sharp domain boundaries in single cells. The boundaries varied from cell to cell, occurring with nonzero probabilities at all genomic positions but preferentially at CCCTC-binding factor (CTCF)-and cohesin-binding sites. Notably, cohesin depletion, which abolished TADs at the population-average level, did not diminish TAD-like structures in single cells but eliminated preferential domain boundary positions. Moreover, we observed widespread, cooperative, multiway chromatin interactions, which remained after cohesin depletion. These results provide critical insight into the mechanisms underlying chromatin domain and hub formation.	[Bintu, Bogdan; Su, Jun-Han; Kinrot, Seon; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Bintu, Bogdan; Su, Jun-Han; Kinrot, Seon; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mateo, Leslie J.; Yamaya, Kei; Boettiger, Alistair N.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Sinnott-Armstrong, Nicholas A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Parker, Mirae] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Parker, Mirae] MIT, Dept Computat Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Stanford University; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT)	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Boettiger, AN (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	boettiger@stanford.edu; zhuang@chemistry.harvard.edu		Bintu, Bogdan/0000-0001-9096-5858; Boettiger, Alistair/0000-0002-3554-5196; Valencia, Leslie/0000-0001-7110-3187; Yamaya, Kei/0000-0002-8343-8969; Kinrot, Seon Shmuel/0000-0001-5614-0983; Parker, Mirae/0000-0002-4219-9076	National Institutes of Health; Burroughs Wellcome CASI grant; Stanford Developmental Biology Training program; Harvard MCO training program; National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship; Harvard Biophysics training program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R35GM122487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome CASI grant; Stanford Developmental Biology Training program; Harvard MCO training program; National Defense Science and Engineering Graduate Fellowship (NDSEG) Program; Stanford Graduate Fellowship(Stanford University); Harvard Biophysics training program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by the National Institutes of Health (to X.Z.) and a Burroughs Wellcome CASI grant and Searle Scholar's grant (to A.N.B.). L.J.M. is supported in part by the Stanford Developmental Biology Training program. J.-H.S. is supported in part by the Harvard MCO training program. N.A.S.-A. was supported by a National Defense Science and Engineering Graduate Fellowship (NDSEG) Program and by a Stanford Graduate Fellowship. M.P. was supported in part by an award from the Stanford Vice President for Undergraduate Research office. S.K. is supported in part by the Harvard Biophysics training program. K.Y. is supported by a Stanford Graduate Fellowship. X.Z. is a Howard Hughes Medical Institute Investigator.	Allahyar A, 2018, NAT GENET, V50, P1151, DOI 10.1038/s41588-018-0161-5; Ricci MA, 2015, CELL, V160, P1145, DOI 10.1016/j.cell.2015.01.054; Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Beliveau BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8147; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Deng WL, 2015, P NATL ACAD SCI USA, V112, P11870, DOI 10.1073/pnas.1515692112; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Krijger PHL, 2016, NAT REV MOL CELL BIO, V17, P771, DOI 10.1038/nrm.2016.138; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Olivares-Chauvet P, 2016, NATURE, V540, P296, DOI 10.1038/nature20158; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Quinodoz SA, 2018, CELL, V174, P744, DOI 10.1016/j.cell.2018.05.024; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Szabo Q, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8082; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531	45	404	414	10	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					419	+	eaau1783	10.1126/science.aau1783	http://dx.doi.org/10.1126/science.aau1783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361340	Green Accepted			2022-12-28	WOS:000450441900038
J	Marcus, A				Marcus, Adam			A scientist's fraudulent studies put patients at risk	SCIENCE			English	Editorial Material																			0	10	10	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					394	394		10.1126/science.362.6413.394-a	http://dx.doi.org/10.1126/science.362.6413.394-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361354				2022-12-28	WOS:000450441900025
J	Burnett, A; Ndovi, T				Burnett, Angela; Ndovi, Tracy			The health of forced migrants	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; ORGANIZED VIOLENCE; ASYLUM SEEKERS; REFUGEES; TORTURE; SURVIVORS; TRAUMA; PAIN		[Burnett, Angela] Freedom Torture, London, England; [Ndovi, Tracy] Survivors Speak OUT, London, England		Burnett, A (corresponding author), Freedom Torture, London, England.	aburnett@freedomfromtorture.org						[Anonymous], 2014, CHANGE RESPONDING FE; [Anonymous], 2018, MID TRENDS REP 2018; [Anonymous], 2017, GLOB TRENDS FORC DIS; [Anonymous], 2017, USEFUL LINKS REFUGEE; Bains M, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1608; Baker R., 1992, TORTURE ITS CONSEQUE, P83; Bogner D, 2007, BRIT J PSYCHIAT, V191, P75, DOI 10.1192/bjp.bp.106.030262; Bracken P., 1998, RETHINKING TRAUMA WA, P38; Burnett A, 2001, BRIT MED J, V322, P606, DOI 10.1136/bmj.322.7286.606; Burnett A, 2002, M HLTH NEEDS REFUGEE; Cohen Juliet, 2008, J Forensic Leg Med, V15, P235, DOI 10.1016/j.jflm.2007.11.001; Dawes A, 1992, M MENT HLTH REF CHIL; Department of Health, 2015, FEM GEN MUT GUID HEA; Department of Health, 2016, FEM GEN MUT RISK SAF; Dualeh M., 2002, C WORK SOM FAM LOND; EISENBRUCH M, 1991, SOC SCI MED, V33, P673, DOI 10.1016/0277-9536(91)90021-4; Fassil Y, 2015, COMMISSIONING MENTAL; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fazel Mina, 2009, Clin Child Psychol Psychiatry, V14, P297, DOI 10.1177/1359104508100128; Freedom from Torture, 2015, TAINT PEAC TORT SRI; Freedom from Torture, 2013, WE WILL MAK YOU REGR; Freedom from Torture, 2014, RAP TORT DRC SEX VIO; Geva N, 2014, PAIN, V155, P2418, DOI 10.1016/j.pain.2014.09.023; Gorst-Unsworth C, 1998, BRIT J PSYCHIAT, V172, P90, DOI 10.1192/bjp.172.1.90; Haoussou K, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5019; Higson-Smith C, 2015, UPDATING ESTIMATE RE; Human Rights Watch, 2018, 2018 WORLD REP; Maudsley H., 2011, ROYAL COLL PSYCHIAT; Morville AL, 2013, J OCCUP SCI, V20, P212, DOI 10.1080/14427591.2013.808976; Negron A, 2016, M MIGR HLTH LOND ROY; Patel N, 2004, RAPE METHOD TORTURE, P21; Pettitt J., 2013, POVERTY BARRIER RIGH; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Pross Christian, 2006, Torture, V16, P1; Refugee Action, 2013, RIGHT VOL GIV AS SEE; Remen RN, 2006, KITCHEN TABLE WISDOM; Robjant K, 2009, BRIT J PSYCHIAT, V194, P306, DOI 10.1192/bjp.bp.108.053223; Royal College of Paediatrics and Child Health, 2015, REF UN AS SEEK CHILD; Silove D, 1999, J NERV MENT DIS, V187, P200, DOI 10.1097/00005053-199904000-00002; Silove D, 2017, WORLD PSYCHIATRY, V16, P130, DOI 10.1002/wps.20438; Soares JJF, 1999, SCAND J OCCUP THER, V6, P174, DOI [DOI 10.1080/110381299443654, 10.1080/110381299443654]; UK Psychological Trauma Society, 2017, GUID TREATM PLANN SE; UN Office of the High Commissioner for Human Rights (OHCHR), 2004, MAN EFF INV DOC TORT; Williams ACD, 2010, J PAIN SYMPTOM MANAG, V40, P715, DOI 10.1016/j.jpainsymman.2010.02.018; Zimmerman C., 2003, HLTH RISKS CONSEQUEN	45	7	7	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4200	10.1136/bmj.k4200	http://dx.doi.org/10.1136/bmj.k4200			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355639				2022-12-28	WOS:000448895300005
J	Rimmer, A				Rimmer, Abi			GP trainees recruited in England surpass target	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Education England, GEN PRACT ST1 RECR F	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4437	10.1136/bmj.k4437	http://dx.doi.org/10.1136/bmj.k4437			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341060				2022-12-28	WOS:000448271300012
J	Willke, P; Bae, Y; Yang, K; Lado, JL; Ferron, A; Choi, T; Ardavan, A; Fernandez-Rossier, J; Heinrich, AJ; Lutz, CP				Willke, Philip; Bae, Yujeong; Yang, Kai; Lado, Jose L.; Ferron, Alejandro; Choi, Taeyoung; Ardavan, Arzhang; Fernandez-Rossier, Joaquin; Heinrich, Andreas J.; Lutz, Christopher P.			Hyperfine interaction of individual atoms on a surface	SCIENCE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; SINGLE NUCLEAR-SPIN; FORCE MICROSCOPY; SPECTROSCOPY; READOUT; SILICON; MAGNETS	Taking advantage of nuclear spins for electronic structure analysis, magnetic resonance imaging, and quantum devices hinges on knowledge and control of the surrounding atomic-scale environment. We measured and manipulated the hyperfine interaction of individual iron and titanium atoms placed on a magnesium oxide surface by using spin-polarized scanning tunneling microscopy in combination with single-atom electron spin resonance. Using atom manipulation to move single atoms, we found that the hyperfine interaction strongly depended on the binding configuration of the atom. We could extract atom-and position-dependent information about the electronic ground state, the state mixing with neighboring atoms, and properties of the nuclear spin. Thus, the hyperfine spectrum becomes a powerful probe of the chemical environment of individual atoms and nanostructures.	[Willke, Philip; Bae, Yujeong; Yang, Kai; Lutz, Christopher P.] IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA; [Willke, Philip; Bae, Yujeong; Choi, Taeyoung; Heinrich, Andreas J.] Inst for Basic Sci Korea, Ctr Quantum Nanosci, Seoul 03760, South Korea; [Willke, Philip; Bae, Yujeong; Choi, Taeyoung; Heinrich, Andreas J.] Ewha Womans Univ, Dept Phys, Seoul 03760, South Korea; [Lado, Jose L.; Fernandez-Rossier, Joaquin] Int Iberian Nanotechnol Lab INL, QuantaLab, P-4715310 Braga, Portugal; [Lado, Jose L.] Swiss Fed Inst Technol, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Ferron, Alejandro] Univ Nacl Nordeste, Inst Modelado & Innovac Tecnol CONICET UNNE, Fac Ciencias Exactas Nat & Agrimensura, W3404AAS, Corrientes, Argentina; [Ardavan, Arzhang] Univ Oxford, Dept Phys, Clarendon Lab, Ctr Adv Electron Spin Resonance, Oxford OX1 3PU, England	International Business Machines (IBM); Institute for Basic Science - Korea (IBS); Ewha Womans University; International Iberian Nanotechnology Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford	Lutz, CP (corresponding author), IBM Corp, Almaden Res Ctr, 650 Harry Rd, San Jose, CA 95120 USA.; Heinrich, AJ (corresponding author), Inst for Basic Sci Korea, Ctr Quantum Nanosci, Seoul 03760, South Korea.; Heinrich, AJ (corresponding author), Ewha Womans Univ, Dept Phys, Seoul 03760, South Korea.	heinrich.andreas@qns.science; cplutz@us.ibm.com	Willke, Philip/Q-3441-2018; Ferron, Alejandro/C-1072-2013; Lado, Jose/AAK-7656-2021; Ardavan, Arzhang/AAY-9214-2020; Yang, Kai/H-8288-2013; Lado, Jose/K-7934-2016; Fernandez-Rossier, Joaquin/C-3910-2009	Willke, Philip/0000-0002-7215-8419; Lado, Jose/0000-0002-9916-1589; Yang, Kai/0000-0002-5863-3666; Lado, Jose/0000-0002-9916-1589; ferron, alejandro/0000-0001-8106-4193; Ardavan, Arzhang/0000-0001-5521-2658; Heinrich, Andreas/0000-0001-6204-471X; Lutz, Christopher/0000-0002-7993-4759; Fernandez-Rossier, Joaquin/0000-0003-2297-0289; Bae, Yujeong/0000-0002-9983-8529	Office of Naval Research; Institute for Basic Science [IBS-R027-D1]; CONICET [PIP11220150100327]; FONCyT [PICT-2012-2866]; ETH Fellowship program; Fundacao para a Ciencia e a Tecnologia [PTDC/FIS-NAN/4662/2014 (016656)]; Engineering and Physical Sciences Research Council [EP/L011972/1]; Alexander von Humboldt Foundation; EPSRC [EP/J013501/1, EP/L011972/1] Funding Source: UKRI	Office of Naval Research(Office of Naval Research); Institute for Basic Science; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT(FONCyT); ETH Fellowship program; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge financial support from the Office of Naval Research. P.W., Y.B., T.C., and A.J.H. acknowledge support from the Institute for Basic Science under grant IBS-R027-D1. A.F. acknowledges funding from CONICET (PIP11220150100327) and FONCyT (PICT-2012-2866). J.L.L. is grateful for financial support from the ETH Fellowship program. J.F.-R. thanks the Fundacao para a Ciencia e a Tecnologia, under project no. PTDC/FIS-NAN/4662/2014 (016656). A. A. thanks the Engineering and Physical Sciences Research Council, under project no. EP/L011972/1. P.W. acknowledges support from the Alexander von Humboldt Foundation.	Ast CR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13009; Bae Y., 2018, ARXIV180704322CONDMA; Baumann S, 2015, SCIENCE, V350, P417, DOI 10.1126/science.aac8703; Bleaney, 2012, ELECT PARAMAGNETIC R; Blinov BB, 2004, QUANTUM INF PROCESS, V3, P45, DOI 10.1007/s11128-004-9417-3; CHANNAPPA KH, 1965, P PHYS SOC LOND, V86, P1145, DOI 10.1088/0370-1328/86/5/126; Delgado F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076804; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; KOHLER J, 1995, SCIENCE, V268, P1457, DOI 10.1126/science.268.5216.1457; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Mabbs F. E., 2013, ELECT PARAMAGNETIC R, V16; Natterer FD, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.175303; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Paul W, 2017, NAT PHYS, V13, P403, DOI [10.1038/nphys3965, 10.1038/NPHYS3965]; Paul W, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4955446; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; Vincent R, 2012, NATURE, V488, P357, DOI 10.1038/nature11341; Willke P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1543; Yang K, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.227206	26	49	51	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					336	+		10.1126/science.aat7047	http://dx.doi.org/10.1126/science.aat7047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337408	Green Submitted, Green Published			2022-12-28	WOS:000447680100047
J	Chan, CH; Li, CF; Yang, WL; Gao, Y; Lee, SW; Feng, ZZ; Huang, HY; Tsai, KKC; Flores, LG; Shao, YP; Hazle, JD; Yu, DH; Wei, WY; Sarbassov, D; Hung, MC; Nakayama, KI; Lin, HK				Chan, Chia-Hsin; Li, Chien-Feng; Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Feng, Zizhen; Huang, Hsuan-Ying; Tsai, Kelvin K. C.; Flores, Leo G.; Shao, Yiping; Hazle, John D.; Yu, Dihua; Wei, Wenyi; Sarbassov, Dos; Hung, Mien-Chie; Nakayama, Keiichi I.; Lin, Hui-Kuan			The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis (vol 149, pg 1098, 2012)	CELL			English	Correction												hklin@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Chan, Chia-Hsin/AAT-7782-2020; Sarbassov, Dos/AAS-4950-2020	Hung, Mien-Chie/0000-0003-4317-4740; Yu, Dihua/0000-0001-6231-9381; Tsai, Kelvin/0000-0002-1612-2868; Li, Chien-Feng/0000-0002-9527-7576; Sarbassov, Dos/0000-0002-6848-1133				Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065	1	22	24	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					913	914		10.1016/j.cell.2012.10.025	http://dx.doi.org/10.1016/j.cell.2012.10.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	30360292	Green Accepted, Bronze			2022-12-28	WOS:000310921200021
J	Shrank, WH; Keyser, DJ; Lovelace, JG				Shrank, William H.; Keyser, Donna J.; Lovelace, John G.			Redistributing Investment in Health and Social Services-The Evolving Role of Managed Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shrank, William H.; Lovelace, John G.] UPMC, Insurance Serv Div, Pittsburgh, PA USA; [Keyser, Donna J.] UPMC, Ctr High Value Hlth Care, 600 Grant St,40th Floor, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Keyser, DJ (corresponding author), UPMC, Ctr High Value Hlth Care, 600 Grant St,40th Floor, Pittsburgh, PA 15219 USA.	keyserd@upmc.edu						Bradley EH, 2016, HEALTH AFFAIR, V35, P760, DOI 10.1377/hlthaff.2015.0814; Butcher L., MANAGED CARE; Butler SM, RE BALANCING MED SOC; DiSalvo L., AM J MANAGED CARE; Eiken S, 2016, MEDICAID INNOVATION; New York State Department of Health, PATH VAL BAS PAYM AN; Organisation for Economic Cooperation and Development. Social spending, SOC SPEND; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Rubin J, 2016, ARE BETTER HLTH OUTC	10	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2018	320	21					2197	2198		10.1001/jama.2018.14987	http://dx.doi.org/10.1001/jama.2018.14987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4MB	30383159				2022-12-28	WOS:000452500600005
J	Basak, S; Gicheru, Y; Rao, S; Sansom, MSP; Chakrapani, S				Basak, Sandip; Gicheru, Yvonne; Rao, Shanlin; Sansom, Mark S. P.; Chakrapani, Sudha			Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; X-RAY-STRUCTURE; 5-HYDROXYTRYPTAMINE TYPE-3; LIGAND RECOGNITION; DESENSITIZATION; LOOP; PORE; MECHANISM; DOMAIN	The 5-HT3A serotonin receptor(1), a cationic pentameric ligand-gated ion channel (pLGIC), is the clinical target for management of nausea and vomiting associated with radiation and chemotherapies(2). Upon binding, serotonin induces a global conformational change that encompasses the ligand-binding extracellular domain (ECD), the transmembrane domain (TMD) and the intracellular domain (ICD), the molecular details of which are unclear. Here we present two serotonin-bound structures of the full-length 5-HT3A receptor in distinct conformations at 3.32 angstrom and 3.89 angstrom resolution that reveal the mechanism underlying channel activation. In comparison to the apo 5-HT3A receptor, serotonin-bound states underwent a large twisting motion in the ECD and TMD, leading to the opening of a 165 angstrom permeation pathway. Notably, this motion results in the creation of lateral portals for ion permeation at the interface of the TMD and ICD. Combined with molecular dynamics simulations, these structures provide novel insights into conformational coupling across domains and functional modulation.	[Basak, Sandip; Gicheru, Yvonne; Chakrapani, Sudha] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Rao, Shanlin; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford, England; [Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University; University of Oxford; Case Western Reserve University	Chakrapani, S (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.; Chakrapani, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	sudha.chakrapani@case.edu	; Basak, sandip/B-8007-2018	Rao, Shanlin/0000-0003-4892-5523; Basak, sandip/0000-0003-4018-8020	National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research; NIH [1R01GM108921, 3R01GM108921-03S1, P30EY11373]; AHA postdoctoral Fellowship [17POST33671152]; NATIONAL EYE INSTITUTE [P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM134896, R01GM131216, R01GM108921] Funding Source: NIH RePORTER	National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA postdoctoral Fellowship(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Cancer Institute's National Cryo-EM Facility at the Frederick National Laboratory for Cancer Research, and we thank them for the imaging time. We thank the Cleveland Center for Membrane and Structural Biology for the access to cryo-EM instrumentation, D. Major for assistance with hybridoma and cell culture at Department of Ophthalmology and Visual Sciences (NIH Core Grant P30EY11373), W. Boron for Xenopus oocytes and access to the oocyte rig, and G. Klesse and S. Tucker for the Channel Annotation Package methodology. This work was supported by an NIH grant (1R01GM108921), a cryo-EM supplement (3R01GM108921-03S1) to S.C. and an AHA postdoctoral Fellowship to S.B. (17POST33671152).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Basak S, 2017, ELIFE, V6, DOI [10.7554/eLife.23886.001, 10.7554/eLife.23886]; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Connolly CN, 2008, MOL MEMBR BIOL, V25, P293, DOI 10.1080/09687680801898503; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Machu TK, 2011, PHARMACOL THERAPEUT, V130, P338, DOI 10.1016/j.pharmthera.2011.02.003; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Panicker S, 2004, J BIOL CHEM, V279, P28149, DOI 10.1074/jbc.M403545200; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Papke D, 2014, J NEUROSCI, V34, P7238, DOI 10.1523/JNEUROSCI.5105-13.2014; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peters JA, 2004, BIOCHEM SOC T, V32, P547, DOI 10.1042/BST0320547; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Stevens R, 2005, J PHARMACOL EXP THER, V314, P338, DOI 10.1124/jpet.105.085076; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson AJ, 2013, BRIT J PHARMACOL, V170, P391, DOI 10.1111/bph.12287; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Trick JL, 2016, STRUCTURE, V24, P2207, DOI 10.1016/j.str.2016.10.005; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Yuan S, 2016, STRUCTURE, V24, P816, DOI 10.1016/j.str.2016.03.019; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	60	60	60	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					270	+		10.1038/s41586-018-0660-7	http://dx.doi.org/10.1038/s41586-018-0660-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401837	Green Accepted			2022-12-28	WOS:000449943600048
J	Ding, KL; Cullen, DA; Zhang, LB; Cao, Z; Roy, AD; Ivanov, IN; Cao, DM				Ding, Kunlun; Cullen, David A.; Zhang, Laibao; Cao, Zhi; Roy, Amitava D.; Ivanov, Ilia N.; Cao, Dongmei			A general synthesis approach for supported bimetallic nanoparticles via surface inorganometallic chemistry	SCIENCE			English	Article							DOUBLE COMPLEX SALT; OXYGEN REDUCTION; SELECTIVE HYDROGENATION; ALLOY NANOPARTICLES; CATALYSTS; SILICA; METALS; PD; IDENTIFICATION; DECOMPOSITION	The synthesis of ultrasmall supported bimetallic nanoparticles (between 1 and 3 nanometers in diameter) with well-defined stoichiometry and intimacy between constituent metals remains a substantial challenge. We synthesized 10 different supported bimetallic nanoparticles via surface inorganometallic chemistry by decomposing and reducing surface-adsorbed heterometallic double complex salts, which are readily obtained upon sequential adsorption of target cations and anions on a silica substrate. For example, adsorption of tetraamminepalladium(II) [Pd(NH3)(4)(2+)] followed by adsorption of tetrachloroplatinate [PtCl42-] was used to form palladium-platinum (Pd-Pt) nanoparticles. These supported bimetallic nanoparticles show enhanced catalytic performance in acetylene selective hydrogenation, which clearly demonstrates a synergistic effect between constituent metals.	[Ding, Kunlun; Zhang, Laibao] Louisiana State Univ, Dept Chem Engn, Baton Rouge, LA 70803 USA; [Cullen, David A.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Cao, Zhi] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, Taiyuan 030001, Shanxi, Peoples R China; [Cao, Zhi] Synfuels China Co Ltd, Beijing 100195, Peoples R China; [Roy, Amitava D.] Louisiana State Univ, Ctr Adv Microstruct & Devices, Baton Rouge, LA 70806 USA; [Ivanov, Ilia N.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Cao, Dongmei] Louisiana State Univ, Shared Instrumentat Facil, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Institute of Coal Chemistry, CAS; Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Louisiana State University System; Louisiana State University	Ding, KL (corresponding author), Louisiana State Univ, Dept Chem Engn, Baton Rouge, LA 70803 USA.	kunlunding@lsu.edu	Cullen, David/A-2918-2015; Zhang, Laibao/AAT-4288-2021; Cao, Zhi/E-2174-2013; ivanov, ilia/D-3402-2015	Cullen, David/0000-0002-2593-7866; Zhang, Laibao/0000-0002-2325-5124; Cao, Zhi/0000-0002-1050-2165; ivanov, ilia/0000-0002-6726-2502; Ding, Kunlun/0000-0002-3676-3814; Roy, Amitava/0000-0002-1875-6784	Louisiana State University; Louisiana Board of Regents [LEQSF(2016-17)-ENH-TR-07]	Louisiana State University; Louisiana Board of Regents	K.D. acknowledges the startup funding from Louisiana State University. Electron microscopy and UV-vis spectroscopy were conducted at the Center for Nanophase Materials Sciences, which is a DOE Office of Science User Facility. XPS was performed at the Shared Instrumentation Facility (SIF) at Louisiana State University. The Ketek seven-element detector array used in this study for x-ray measurements at CAMD was acquired with funds provided by The Louisiana Board of Regents [LEQSF(2016-17)-ENH-TR-07].	Abild-Pedersen F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016105; Agarwal N, 2017, SCIENCE, V358, P223, DOI 10.1126/science.aan6515; Alexeev OS, 2003, IND ENG CHEM RES, V42, P1571, DOI 10.1021/ie020351h; Alonso DM, 2012, CHEM SOC REV, V41, P8075, DOI 10.1039/c2cs35188a; ASM International, 1992, ASM HDB SER, V3; Boellaard E, 2002, APPL CATAL A-GEN, V224, P1, DOI 10.1016/S0926-860X(01)00670-6; Bremi J, 1999, CHEM MATER, V11, P977, DOI 10.1021/cm9806376; Bu LZ, 2016, SCIENCE, V354, P1410, DOI 10.1126/science.aah6133; CANDY JP, 1994, J MOL CATAL, V86, P179, DOI 10.1016/0304-5102(93)E0211-X; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen MS, 2005, SCIENCE, V310, P291, DOI 10.1126/science.1115800; Ding KL, 2016, ACS CATAL, V6, P5740, DOI 10.1021/acscatal.6b00098; Doerrer LH, 2010, DALTON T, V39, P3543, DOI 10.1039/b920389c; Edwards JK, 2009, SCIENCE, V323, P1037, DOI 10.1126/science.1168980; Ferrando R, 2008, CHEM REV, V108, P845, DOI 10.1021/cr040090g; Freakley SJ, 2016, SCIENCE, V351, P965, DOI 10.1126/science.aad5705; Gilroy KD, 2016, CHEM REV, V116, P10414, DOI 10.1021/acs.chemrev.6b00211; Huang XQ, 2015, SCIENCE, V348, P1230, DOI 10.1126/science.aaa8765; Jiao L, 2008, J CATAL, V260, P329, DOI 10.1016/j.jcat.2008.09.022; Kusada K, 2014, J AM CHEM SOC, V136, P1864, DOI 10.1021/ja409464g; Kyriakou G, 2012, SCIENCE, V335, P1209, DOI 10.1126/science.1215864; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Lu JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4264; MILLER JR, 1965, J CHEM SOC, P713, DOI 10.1039/jr9650000713; MILLER JR, 1961, J CHEM SOC, P4452, DOI 10.1039/jr9610004452; Nakanishi K, 1997, J POROUS MAT, V4, P67, DOI 10.1023/A:1009627216939; Niu ZQ, 2016, NAT MATER, V15, P1188, DOI [10.1038/NMAT4724, 10.1038/nmat4724]; Potemkin DI, 2014, CATAL TODAY, V235, P103, DOI 10.1016/j.cattod.2014.04.026; Potemkin DI, 2012, CHEM ENG J, V207, P683, DOI 10.1016/j.cej.2012.07.037; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Sankar M, 2012, CHEM SOC REV, V41, P8099, DOI 10.1039/c2cs35296f; Sattler JJHB, 2014, CHEM REV, V114, P10613, DOI 10.1021/cr5002436; SINFELT JH, 1987, ACCOUNTS CHEM RES, V20, P134, DOI 10.1021/ar00136a002; Studt F, 2008, SCIENCE, V320, P1320, DOI 10.1126/science.1156660; Thompson ST, 2017, J CATAL, V350, P111, DOI 10.1016/j.jcat.2017.03.019; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; Wang FL, 2018, ANGEW CHEM INT EDIT, V57, P4505, DOI 10.1002/anie.201800650; Wong A, 2017, SCIENCE, V358, P1427, DOI 10.1126/science.aao6538; Yao YG, 2018, SCIENCE, V359, P1489, DOI 10.1126/science.aan5412	39	125	127	38	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		560	+		10.1126/science.aau4414	http://dx.doi.org/10.1126/science.aau4414			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385572	Green Submitted			2022-12-28	WOS:000450460000040
J	Kinloch, IA; Suhr, J; Lou, J; Young, RJ; Ajayan, PM				Kinloch, Ian A.; Suhr, Jonghwan; Lou, Jun; Young, Robert J.; Ajayan, Pulickel M.			Composites with carbon nanotubes and graphene: An outlook	SCIENCE			English	Review							POLYMER NANOCOMPOSITES; FIBERS; REINFORCEMENT; STRENGTH; CONDUCTIVITY; INTERPHASE	Composite materials with carbon nanotube and graphene additives have long been considered as exciting prospects among nanotechnology applications. However, after nearly two decades of work in the area, questions remain about the practical impact of nanotube and graphene composites. This uncertainty stems from factors that include poor load transfer, interfacial engineering, dispersion, and viscosity-related issues that lead to processing challenges in such nanocomposites. Moreover, there has been little effort to identify selection rules for the use of nanotubes or graphene in composite matrices for specific applications. This review is a critical look at the status of composites for developing high-strength, low-density, high-conductivity materials with nanotubes or graphene. An outlook of the different approaches that can lead to practically useful nanotube and graphene composites is presented, pointing out the challenges and opportunities that exist in the field.	[Kinloch, Ian A.; Young, Robert J.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Kinloch, Ian A.; Young, Robert J.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Suhr, Jonghwan] Sungkyunkwan Univ, Sch Mech Engn, Suwon 16419, South Korea; [Suhr, Jonghwan] Sungkyunkwan Univ, Dept Energy Sci, Suwon 16419, South Korea; [Lou, Jun; Ajayan, Pulickel M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA	University of Manchester; University of Manchester; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Rice University	Ajayan, PM (corresponding author), Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.	ajayan@rice.edu	Kinloch, Ian/AAI-3965-2021	Lou, Jun/0000-0002-4351-9561; Young, Robert/0000-0001-6073-9489	U.S. Department of Energy, Office of Basic Energy Sciences [DE-SC0018193]; NSF Nanosystems Engineering Research Center for Nanotechnology-Enabled Water Treatment [ERC-1449500]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2018R1A2B2001565]; European Union's Horizon 2020 research and innovation program [785219]; EPSRC [EP/K005014/1] Funding Source: UKRI	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Nanosystems Engineering Research Center for Nanotechnology-Enabled Water Treatment; National Research Foundation of Korea (NRF) - Korea government (MSIP); European Union's Horizon 2020 research and innovation program; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	J.L. acknowledges support from the U.S. Department of Energy, Office of Basic Energy Sciences, under grant DE-SC0018193. P.M.A. and J.L. acknowledge the NSF Nanosystems Engineering Research Center for Nanotechnology-Enabled Water Treatment (ERC-1449500) for support. J.S. acknowledges support from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2018R1A2B2001565). I.A.K. and R.J.Y. acknowledge funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 785219.	Ajayan PM, 2000, ADV MATER, V12, P750, DOI 10.1002/(SICI)1521-4095(200005)12:10<750::AID-ADMA750>3.0.CO;2-6; Arlen MJ, 2008, MACROMOLECULES, V41, P8053, DOI 10.1021/ma801525f; Barber AH, 2006, ADV MATER, V18, P83, DOI 10.1002/adma.200501033; Behabtu N, 2013, SCIENCE, V339, P182, DOI 10.1126/science.1228061; Bhattacharyya S, 2008, CARBON, V46, P1037, DOI 10.1016/j.carbon.2008.03.011; Blighe FM, 2011, ADV FUNCT MATER, V21, P364, DOI 10.1002/adfm.201000940; CALVERT P, 1992, NATURE, V357, P365, DOI 10.1038/357365a0; Cao LL, 2016, SMALL, V12, P3723, DOI 10.1002/smll.201600170; Carey BJ, 2011, ACS NANO, V5, P2715, DOI 10.1021/nn103104g; Chen XM, 2015, CARBON, V82, P214, DOI 10.1016/j.carbon.2014.10.065; Chu JW, 2018, COMPOS PART A-APPL S, V113, P311, DOI 10.1016/j.compositesa.2018.07.032; Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Du JH, 2011, CARBON, V49, P1094, DOI 10.1016/j.carbon.2010.11.013; Frank O, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1247; Ganesan Y, 2011, ACS APPL MATER INTER, V3, P129, DOI 10.1021/am1011047; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Hernandez M, 2012, COMPOS SCI TECHNOL, V73, P40, DOI 10.1016/j.compscitech.2012.08.012; Koratkar NA, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2007867; Kozlov S. M., 2016, J PHYS CHEM C, V166, P7360; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li YL, 2004, SCIENCE, V304, P276, DOI 10.1126/science.1094982; Liu YD, 2014, ACS APPL MATER INTER, V6, P6069, DOI 10.1021/am405136s; Lourie O, 1998, PHYS REV LETT, V81, P1638, DOI 10.1103/PhysRevLett.81.1638; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Mao XW, 2014, NANO TODAY, V9, P405, DOI 10.1016/j.nantod.2014.06.011; Marom G, 2017, J MATER SCI, V52, P8357, DOI 10.1007/s10853-017-1113-7; Nieto A, 2017, INT MATER REV, V62, P241, DOI 10.1080/09506608.2016.1219481; Papageorgiou DG, 2017, PROG MATER SCI, V90, P75, DOI 10.1016/j.pmatsci.2017.07.004; Rai PK, 2006, J AM CHEM SOC, V128, P591, DOI 10.1021/ja055847f; Ramanathan T, 2008, NAT NANOTECHNOL, V3, P327, DOI 10.1038/nnano.2008.96; Song SH, 2013, ADV MATER, V25, P732, DOI 10.1002/adma.201202736; Terrones M, 2011, ADV MATER, V23, P5302, DOI 10.1002/adma.201102036; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Vlassiouk I, 2015, ACS APPL MATER INTER, V7, P10702, DOI 10.1021/acsami.5b01367; Wang PH, 2018, POLYMER, V150, P10, DOI 10.1016/j.polymer.2018.06.050; Wang W, 2008, PHILOS T R SOC A, V366, P1613, DOI 10.1098/rsta.2007.2175; Wang Z, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455709; Young RJ, 2018, COMPOS SCI TECHNOL, V154, P110, DOI 10.1016/j.compscitech.2017.11.007; Young RJ, 2016, J MATER SCI, V51, P344, DOI 10.1007/s10853-015-9347-8; Zang JF, 2013, NAT MATER, V12, P321, DOI [10.1038/NMAT3542, 10.1038/nmat3542]	42	434	447	76	730	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		547	553		10.1126/science.aat7439	http://dx.doi.org/10.1126/science.aat7439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385571	Green Submitted			2022-12-28	WOS:000450460000036
J	Brown, J; Behnam, R; Coddington, L; Tervo, DGR; Martin, K; Proskurin, M; Kuleshova, E; Park, J; Phillips, J; Bergs, ACF; Gottschalk, A; Dudman, JT; Karpova, AY				Brown, Jennifer; Behnam, Reza; Coddington, Luke; Tervo, D. G. R.; Martin, Kathleen; Proskurin, Mikhail; Kuleshova, Elena; Park, Junchol; Phillips, James; Bergs, Amelie C. F.; Gottschalk, Alexander; Dudman, Joshua T.; Karpova, Alla Y.			Expanding the Optogenetics Toolkit by Topological Inversion of Rhodopsins	CELL			English	Article							MEMBRANE-PROTEIN TOPOLOGY; BASAL GANGLIA; MICROBIAL RHODOPSINS; CHLORIDE CHANNELS; SILICON PROBES; ION PUMPS; CHANNELRHODOPSIN; PREDICTION; RECEPTORS; VARIANT	Targeted manipulation of activity in specific populations of neurons is important for investigating the neural circuit basis of behavior. Optogenetic approaches using light-sensitive microbial rhodopsins have permitted manipulations to reach a level of temporal precision that is enabling functional circuit dissection. As demand for more precise perturbations to serve specific experimental goals increases, a palette of opsins with diverse selectivity, kinetics, and spectral properties will be needed. Here, we introduce a novel approach of "topological engineering''-inversion of opsins in the plasma membrane-and demonstrate that it can produce variants with unique functional properties of interest for circuit neuroscience. In one striking example, inversion of a Channelrhodopsin variant converted it from a potent activator into a fast-acting inhibitor that operates as a cation pump. Our findings argue that membrane topology provides a useful orthogonal dimension of protein engineering that immediately permits as much as a doubling of the available toolkit.	[Brown, Jennifer; Behnam, Reza; Coddington, Luke; Tervo, D. G. R.; Martin, Kathleen; Proskurin, Mikhail; Kuleshova, Elena; Park, Junchol; Phillips, James; Dudman, Joshua T.; Karpova, Alla Y.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Brown, Jennifer; Phillips, James] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Proskurin, Mikhail] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Kuleshova, Elena] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117485, Russia; [Bergs, Amelie C. F.; Gottschalk, Alexander] Goethe Univ, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Bergs, Amelie C. F.; Gottschalk, Alexander] Goethe Univ, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Bergs, Amelie C. F.] Max Planck Inst Biophys, Int Max Planck Res Sch Struct & Funct Biol Membra, D-60438 Frankfurt, Germany; [Brown, Jennifer] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Martin, Kathleen] NYU, New York, NY USA	Howard Hughes Medical Institute; University of Cambridge; Johns Hopkins University; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of California System; University of California Berkeley; New York University	Dudman, JT; Karpova, AY (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	dudmanj@janelia.hhmi.org; alla@janelia.hhmi.org	Gottschalk, Alexander/D-3155-2011; Proskurin, Mikhail/AAD-8552-2022	Gottschalk, Alexander/0000-0002-1197-6119; Martin, Kathleen/0000-0002-5544-2127; Proskurin, Mikhail/0000-0003-2548-9722	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Deepika Walpita and Brenda Shields for help with dissociated neuronal cultures and K. Vicari for task illustration. We thank V. Jayaraman and L. Looger for comments on the manuscript. This work was supported by the Howard Hughes Medical Institute.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Brown J, 2014, ELIFE, V3, DOI 10.7554/eLife.02397; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chuong AS, 2014, NAT NEUROSCI, V17, P1123, DOI 10.1038/nn.3752; Coddington L. T., 2017, BIORXIV, DOI [10.1101/, DOI 10.1101/238881]; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Desmurget M, 2010, J NEUROSCI, V30, P7685, DOI 10.1523/JNEUROSCI.0163-10.2010; Dudman JT, 2016, CURR OPIN NEUROBIOL, V37, P158, DOI 10.1016/j.conb.2016.02.005; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Gallivan JP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00215; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Grote M, 2014, BBA-BIOENERGETICS, V1837, P533, DOI 10.1016/j.bbabio.2013.08.006; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Inoue K, 2015, J AM CHEM SOC, V137, P3291, DOI 10.1021/ja511788f; Jun JJ, 2017, NATURE, V551, P232, DOI 10.1038/nature24636; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Osborne JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089007; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Turano FJ, 2001, MOL BIOL EVOL, V18, P1417, DOI 10.1093/oxfordjournals.molbev.a003926; Volkov O, 2017, SCIENCE, V358, DOI 10.1126/science.aan8862; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wietek J, 2016, METHODS MOL BIOL, V1408, P141, DOI 10.1007/978-1-4939-3512-3_10; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605	59	14	16	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1131	+		10.1016/j.cell.2018.09.026	http://dx.doi.org/10.1016/j.cell.2018.09.026			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30343901	Bronze			2022-12-28	WOS:000449100600023
J	Burch, KS; Mandrus, D; Park, JG				Burch, Kenneth S.; Mandrus, David; Park, Je-Geun			Magnetism in two-dimensional van der Waals materials	NATURE			English	Review							FERROMAGNETISM; TRANSITION; SCATTERING; INSULATOR; CRYSTAL; PHYSICS; ORDER	The discovery of materials has often introduced new physical paradigms and enabled the development of novel devices. Two-dimensional magnetism, which is associated with strong intrinsic spin fluctuations, has long been the focus of fundamental questions in condensed matter physics regarding our understanding and control of new phases. Here we discuss magnetic van der Waals materials: two-dimensional atomic crystals that contain magnetic elements and thus exhibit intrinsic magnetic properties. These cleavable materials provide the ideal platform for exploring magnetism in the two-dimensional limit, where new physical phenomena are expected, and represent a substantial shift in our ability to control and investigate nanoscale phases. We present the theoretical background and motivation for investigating this class of crystals, describe the material landscape and the current experimental status of measurement techniques as well as devices, and discuss promising future directions for the study of magnetic van der Waals materials.	[Burch, Kenneth S.] Boston Coll, Phys Dept, Boston, MA USA; [Mandrus, David] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Mandrus, David] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN USA; [Park, Je-Geun] Inst for Basic Sci Korea, Ctr Correlated Electron Syst, Seoul, South Korea; [Park, Je-Geun] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea	Boston College; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Park, JG (corresponding author), Inst for Basic Sci Korea, Ctr Correlated Electron Syst, Seoul, South Korea.; Park, JG (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	jgpark10@snu.ac.kr	Park, Je Geun/K-8571-2013	Burch, Kenneth/0000-0002-7541-0245	National Science Foundation [DMR-1709987, DMR-1410428]; Institute for Basic Science (IBS) of Korea [IBS-R009-G1]; Direct For Mathematical & Physical Scien [1410428] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Institute for Basic Science (IBS) of Korea; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge useful discussions with D. Xiao and X. Xu. K.S.B. was supported by the National Science Foundation through grant DMR-1709987 and D.M. acknowledges support from the National Science Foundation under grant DMR-1410428. J.-G.P. was supported by the Institute for Basic Science (IBS) of Korea (IBS-R009-G1).	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; An K, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.107202; ANDO K, 1992, PHYS REV B, V46, P12289, DOI 10.1103/PhysRevB.46.12289; Arnold CS, 1997, REV SCI INSTRUM, V68, P4212, DOI 10.1063/1.1148368; Banerjee A, 2017, SCIENCE, V356, P1055, DOI 10.1126/science.aah6015; BEREZINSKII VL, 1971, SOV PHYS JETP-USSR, V32, P493; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Bonilla M, 2018, NAT NANOTECHNOL, V13, P289, DOI 10.1038/s41565-018-0063-9; Bozhko DA, 2016, NAT PHYS, V12, P1057, DOI [10.1038/nphys3838, 10.1038/NPHYS3838]; Burch KS, 2008, J MAGN MAGN MATER, V320, P3207, DOI 10.1016/j.jmmm.2008.08.060; Buscema M, 2015, CHEM SOC REV, V44, P3691, DOI 10.1039/c5cs00106d; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen YY, 2018, ACS APPL MATER INTER, V10, P1383, DOI 10.1021/acsami.7b14795; Deng Y., 2018, GATE TUNABLE ROOM TE; Elmers HJ, 1996, PHYS REV B, V54, P15224, DOI 10.1103/PhysRevB.54.15224; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Hellman F, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.025006; Huang B., 2018, NAT NANOTECHNOL; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Irkhin VY, 1999, PHYS REV B, V60, P2990, DOI 10.1103/PhysRevB.60.2990; Jackeli G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017205; Jiang SW, 2018, NAT MATER, V17, P406, DOI 10.1038/s41563-018-0040-6; Kim HH, 2018, NANO LETT, V18, P4885, DOI 10.1021/acs.nanolett.8b01552; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Klein DR, 2018, SCIENCE, V360, P1218, DOI 10.1126/science.aar3617; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kuo CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20904; Lado JL, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa75ed; Lange M, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.5009529; Lee JU, 2016, NANO LETT, V16, P7433, DOI 10.1021/acs.nanolett.6b03052; Lee KH, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.180401; Lee MJ, 2018, NPG ASIA MATER, V10, DOI 10.1038/s41427-018-0016-7; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Leng X, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.027001; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Miao GX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.076601; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nasu J, 2016, NAT PHYS, V12, P912, DOI [10.1038/nphys3809, 10.1038/NPHYS3809]; Nojima T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020502; O'Hara DJ, 2018, NANO LETT, V18, P3125, DOI 10.1021/acs.nanolett.8b00683; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; Park JG, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/30/301001; Plumb KW, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.041112; Roldan R, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/31/313201; Sachs B, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.201402; Samarth N, 2017, NATURE, V546, P216, DOI 10.1038/546216a; Sandilands LJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064503; Sivadas N, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.267203; Song TC, 2018, SCIENCE, V360, P1214, DOI 10.1126/science.aar4851; Tian Y, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/2/025035; Wang XZ, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/3/031009; Wang ZK, 2008, CARBON, V46, P2133, DOI 10.1016/j.carbon.2008.09.028; Williams TJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.144404; Worledge DC, 2000, J APPL PHYS, V88, P5277, DOI 10.1063/1.1315619; Xing WY, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa7034; ZAK J, 1990, J MAGN MAGN MATER, V89, P107, DOI 10.1016/0304-8853(90)90713-Z; Zhong D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603113	60	666	669	82	952	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					47	52		10.1038/s41586-018-0631-z	http://dx.doi.org/10.1038/s41586-018-0631-z			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382199	Green Submitted			2022-12-28	WOS:000448900900043
J	Dong, YY; Wang, H; Pike, ACW; Cochrane, SA; Hamedzadeh, S; Wyszynski, FJ; Bushell, SR; Royer, SF; Widdick, DA; Sajid, A; Boshoff, HI; Park, Y; Lucas, R; Liu, WM; Lee, SS; Machida, T; Minall, L; Mehmood, S; Belaya, K; Liu, WW; Chu, A; Shrestha, L; Mukhopadhyay, SMM; Strain-Damerell, C; Chalk, R; Burgess-Brown, NA; Bibb, MJ; Barry, CE; Robinson, CV; Beeson, D; Davis, BG; Carpenter, EP				Dong, Yin Yao; Wang, Hua; Pike, Ashley C. W.; Cochrane, Stephen A.; Hamedzadeh, Sadra; Wyszynski, Filip J.; Bushell, Simon R.; Royer, Sylvain F.; Widdick, David A.; Sajid, Andaleeb; Boshoff, Helena I.; Park, Yumi; Lucas, Ricardo; Liu, Wei-Min; Lee, Seung Seo; Machida, Takuya; Minall, Leanne; Mehmood, Shahid; Belaya, Katsiaryna; Liu, Wei-Wei; Chu, Amy; Shrestha, Leela; Mukhopadhyay, Shubhashish M. M.; Strain-Damerell, Claire; Chalk, Rod; Burgess-Brown, Nicola A.; Bibb, Mervyn J.; Barry, Clifton E., III; Robinson, Carol V.; Beeson, David; Davis, Benjamin G.; Carpenter, Elisabeth P.			Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design	CELL			English	Article							CONGENITAL MYASTHENIC SYNDROME; PHARMACOLOGICAL CHAPERONES; TUNICAMYCIN; INHIBITION; DISORDER; MRAY; CELL; BIOSYNTHESIS; DEGRADATION; MUTATIONS	Protein N-glycosylation is a widespread post-translational modification. The first committed step in this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 2.7.8.15). Missense DPAGT1 variants cause congenital myasthenic syndrome and disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to eu-karyotes due to DPAGT1 inhibition, preventing their clinical use. Our structures of DPAGT1 with the substrate UDP-GlcNAc and tunicamycin reveal substrate binding modes, suggest a mechanism of catalysis, provide an understanding of how mutations modulate activity (thus causing disease) and allow design of non-toxic "lipid-altered'' tunicamycins. The structure-tuned activity of these analogues against several bacterial targets allowed the design of potent antibiotics for Mycobacterium tuberculosis, enabling treatment in vitro, in cellulo and in vivo, providing a promising new class of antimicrobial drug.	[Dong, Yin Yao; Pike, Ashley C. W.; Bushell, Simon R.; Chu, Amy; Shrestha, Leela; Mukhopadhyay, Shubhashish M. M.; Strain-Damerell, Claire; Chalk, Rod; Burgess-Brown, Nicola A.; Carpenter, Elisabeth P.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Wang, Hua; Cochrane, Stephen A.; Hamedzadeh, Sadra; Wyszynski, Filip J.; Royer, Sylvain F.; Lucas, Ricardo; Liu, Wei-Min; Lee, Seung Seo; Machida, Takuya; Minall, Leanne; Davis, Benjamin G.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Cochrane, Stephen A.] Queens Univ, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland; [Widdick, David A.; Bibb, Mervyn J.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Sajid, Andaleeb; Boshoff, Helena I.; Park, Yumi; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Mehmood, Shahid; Robinson, Carol V.] Dept Chem, Oxford OX1 3QZ, England; [Belaya, Katsiaryna; Liu, Wei-Wei; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Neurosci Grp, Oxford OX3 9DS, England; [Wang, Hua] Francis Crick Inst, London, England; [Lucas, Ricardo] Univ Seville, Pharm, Seville, Spain; [Liu, Wei-Min] Fu Jen Catholic Univ, New Taipei, Taiwan; [Lee, Seung Seo] Univ Southampton, Chem, Southampton, Hants, England; [Minall, Leanne] Pfizer, Andover, MA USA; [Belaya, Katsiaryna] Univ Oxford, Surg Sci, Oxford, England; [Strain-Damerell, Claire] Diamond Light Source, Harwell, Berks, England	University of Oxford; University of Oxford; Queens University Belfast; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Francis Crick Institute; University of Sevilla; Fu Jen Catholic University; University of Southampton; Pfizer; University of Oxford; Diamond Light Source	Carpenter, EP (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.; Davis, BG (corresponding author), Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk; liz.carpenter@sgc.ox.ac.uk	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Wang, Hua/X-8965-2019; Sajid, Andaleeb/AAI-2960-2020; Lee, Seung S/K-8669-2018; Davis, Benjamin G/C-5281-2011	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Wang, Hua/0000-0001-5780-9685; Sajid, Andaleeb/0000-0001-6248-4985; Lee, Seung S/0000-0002-8598-3303; Davis, Benjamin G/0000-0002-5056-407X; Dong, Yin/0000-0001-8600-6988; Bushell, Simon/0000-0001-5477-6777; Park, Yumi/0000-0003-2237-0195; Mukhopadhyay, Shubhashish M M/0000-0003-1430-5529; Pike, Ashley/0000-0001-9661-2607; Carpenter, Liz/0000-0001-9138-2937; robinson, carol/0000-0001-7829-5505; Chu, Amy/0000-0003-4496-5616; Liu, Wei-Min/0000-0003-3607-1911	AbbVie (United States) [1097737]; Bayer Pharma AG (Germany); Canada Foundation for Innovation (Canada); Eshelman Institute for Innovation (Canada); Innovative Medicines Initiative (EU/EFPIA) (United States) [115766]; Janssen (United States); Merck KGaA Darmstadt Germany; Novartis Pharma AG (Switzerland); Ontario Ministry of Economic Development and Innovation (Canada); Pfizer (United States); Wellcome (United Kingdom) [106169/Z/14/Z]; Gates Foundation (United Kingdom); BBSRC (United Kingdom); EPSRC (United Kingdom); Wellcome [110270/A/15/Z]; MRC (United Kingdom) programme [MR/N020413/1]; MRC [MR/M006824]; Wellcome Strategic Award [WT084655MA]; BBSRC [BB/J006637/1, BB/J009725/1, BB/J004561/1]; Intramural Research Program of NIAID; Boehringer Ingelheim (Germany); Genome Canada (Canada); MSD (USA); Sao Paulo Research Foundation-FAPESP (Brazil); Takeda (Japan); Evotec Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693] Funding Source: NIH RePORTER; MRC [MR/N020413/1, MR/M006824/1] Funding Source: UKRI	AbbVie (United States)(AbbVie); Bayer Pharma AG (Germany); Canada Foundation for Innovation (Canada)(Canada Foundation for Innovation); Eshelman Institute for Innovation (Canada); Innovative Medicines Initiative (EU/EFPIA) (United States); Janssen (United States); Merck KGaA Darmstadt Germany; Novartis Pharma AG (Switzerland); Ontario Ministry of Economic Development and Innovation (Canada); Pfizer (United States)(Pfizer); Wellcome (United Kingdom); Gates Foundation (United Kingdom); BBSRC (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC (United Kingdom)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome; MRC (United Kingdom) programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Strategic Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural Research Program of NIAID; Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Genome Canada (Canada)(Genome Canada); MSD (USA); Sao Paulo Research Foundation-FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda (Japan)(Takeda Pharmaceutical Company Ltd); Evotec Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Y.Y.D., A.C.W.P., S.R.B., L.S., A.C., S.M.M.M., R.C., N.A.B.B. and E.P.C. are members of the SGC. The SGC is a registered charity (number 1097737) funded by AbbVie (United States), Bayer Pharma AG (Germany), Boehringer Ingelheim (Germany), the Canada Foundation for Innovation (Canada), Eshelman Institute for Innovation, Genome Canada (Canada), Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen (United States), Merck KGaA Darmstadt Germany, MSD (USA), Novartis Pharma AG (Switzerland), the Ontario Ministry of Economic Development and Innovation (Canada), Pfizer (United States), Sao Paulo Research Foundation-FAPESP (Brazil) and Takeda (Japan), as well as Wellcome (United Kingdom) [grant no: 106169/Z/14/Z]. B.G.D is funded by The Gates Foundation, BBSRC (United Kingdom), EPSRC (United Kingdom), Wellcome and Evotec Ltd. S.A.C is funded by the Wellcome [grant no: 110270/A/15/Z]. S.M. and C.V.R.: MRC (United Kingdom) programme grant MR/N020413/1. D.B.: MRC [grant no: MR/M006824], Wellcome Strategic Award [WT084655MA]. D.W., and M.J.B.: BBSRC [grant nos: BB/J006637/1, BB/J009725/1 and BB/J004561/1]. This work was funded, in part, by the Intramural Research Program of NIAID. We thank Diamond Light Source Ltd and their staff for access to the macromolecular crystallography beamlines. We thank all member of the SGC Biotech team, including Kasia Kupinska, Dong Wang, Katie Ellis, and Oktawia Borkowska. We thank all members and ex-members of the SGC IMP1 group, including Annamaria Tessitore, Liang Dong, Berenice Rotty, Andrew Quigley, Mariana Grieben and Chitra Shintre. We thank George Berridge for help developing assays. Brian Marsden, David Damerell, James Bray, James Crowe and Chris Sluman for computing and bioinformatics support, and Frank von Delft, Tobias Krojer and Beth MacLean for crystallography infrastructure support. We thank Danielle Weiner and Michelle Sutphin for help with treatment of animals and Michael Goodwin for help with PK analysis. We thank Steven Hoekman and Jonathan Hollick for solubility and protein binding analysis. We thank Prof. Seok-Yong Lee and his group for initial technical and scientific exchanges.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Carrera IA, 2012, AM J MED GENET A, V158A, P2027, DOI 10.1002/ajmg.a.35472; Bashi K, 2013, NEUROMUSCULAR DISORD, V23, P469, DOI 10.1016/j.nmd.2013.03.003; Belaya K, 2012, AM J HUM GENET, V91, P193, DOI 10.1016/j.ajhg.2012.05.022; Bricogne G, 2017, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Convertino M, 2016, ACS CHEM BIOL, V11, P1471, DOI 10.1021/acschembio.6b00195; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doroghazi JR, 2011, J BACTERIOL, V193, P7021, DOI 10.1128/JB.06262-11; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Hakulinen JK, 2017, NAT CHEM BIOL, V13, P265, DOI [10.1038/NCHEMBIO.2270, 10.1038/nchembio.2270]; HEIFETZ A, 1977, J BIOL CHEM, V252, P3057; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Imtiaz F, 2012, JIMD REP, V2, P107, DOI 10.1007/8904_2011_57; Iqbal Z, 2013, EUR J HUM GENET, V21, P844, DOI 10.1038/ejhg.2012.257; Ishizaki Y, 2013, J BIOL CHEM, V288, P30309, DOI 10.1074/jbc.M113.492173; ITO T, 1979, AGR BIOL CHEM TOKYO, V43, P1187, DOI 10.1080/00021369.1979.10863598; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klein A, 2015, NEUROMUSCULAR DISORD, V25, P253, DOI 10.1016/j.nmd.2014.11.013; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price NPJ, 2017, J ANTIBIOT, V70, P1122, DOI 10.1038/ja.2017.141; Price NPJ, 2017, J ANTIBIOT, V70, P1070, DOI 10.1038/ja.2017.101; Sanchez-Fernandez EM, 2016, CHEM COMMUN, V52, P5497, DOI 10.1039/c6cc01564f; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Selcen D, 2014, NEUROLOGY, V82, P1822, DOI 10.1212/WNL.0000000000000435; TAKATSUKI A, 1972, J ANTIBIOT, V25, P75, DOI 10.7164/antibiotics.25.75; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; WARD JB, 1977, FEBS LETT, V78, P151, DOI 10.1016/0014-5793(77)80294-9; Weingarten RA, 2018, MBIO, V9, DOI 10.1128/mBio.02011-17; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Widdick D, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00130-18;e00130-18, 10.1128/AAC.00130-18, 10.1128/aac.00130-18]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Wyszynski FJ, 2012, NAT CHEM, V4, P539, DOI [10.1038/NCHEM.1351, 10.1038/nchem.1351]; Yoo J, 2018, NAT STRUCT MOL BIOL, V25, P217, DOI 10.1038/s41594-018-0031-y; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	51	36	36	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1045	+		10.1016/j.cell.2018.10.037	http://dx.doi.org/10.1016/j.cell.2018.10.037			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388443	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000449100600017
J	Liu, HP; Zhang, HP; Wu, XY; Ma, DP; Wu, JH; Wang, L; Jiang, Y; Fei, YY; Zhu, CG; Tan, R; Jungblut, P; Pei, G; Dorhoi, A; Yan, QL; Zhang, F; Zheng, RJ; Liu, SY; Liang, HJ; Liu, ZH; Yang, H; Chen, JX; Wang, P; Tang, TQ; Peng, WX; Hu, ZS; Xu, Z; Huang, XC; Wang, J; Li, HH; Zhou, YL; Liu, F; Yan, DP; Kaufmann, SHE; Chen, C; Mao, ZY; Ge, BX				Liu, Haipeng; Zhang, Haiping; Wu, Xiangyang; Ma, Dapeng; Wu, Juehui; Wang, Lin; Jiang, Yan; Fei, Yiyan; Zhu, Chenggang; Tan, Rong; Jungblut, Peter; Pei, Gang; Dorhoi, Anca; Yan, Qiaoling; Zhang, Fan; Zheng, Ruijuan; Liu, Siyu; Liang, Haijiao; Liu, Zhonghua; Yang, Hua; Chen, Jianxia; Wang, Peng; Tang, Tianqi; Peng, Wenxia; Hu, Zhangsen; Xu, Zhu; Huang, Xiaochen; Wang, Jie; Li, Haohao; Zhou, Yilong; Liu, Feng; Yan, Dapeng; Kaufmann, Stefan H. E.; Chen, Chang; Mao, Zhiyong; Ge, Baoxue			Nuclear cGAS suppresses DNA repair and promotes tumorigenesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; CYCLIC GMP-AMP; HOMOLOGOUS RECOMBINATION; CYTOSOLIC DNA; HISTONE H2AX; PARP-1; CANCER; CELLS	Accurate repair of DNA double-stranded breaks by homologous recombination preserves genome integrity and inhibits tumorigenesis. Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor that activates innate immunity by initiating the STING-IRF3-type I IFN signalling cascade(1,2). Recognition of ruptured micronuclei by cGAS links genome instability to the innate immune response(3,4), but the potential involvement of cGAS in DNA repair remains unknown. Here we demonstrate that cGAS inhibits homologous recombination in mouse and human models. DNA damage induces nuclear translocation of cGAS in a manner that is dependent on importin-alpha, and the phosphorylation of cGAS at tyrosine 215-mediated by B-lymphoid tyrosine kinase-facilitates the cytosolic retention of cGAS. In the nucleus, cGAS is recruited to double-stranded breaks and interacts with PARP1 via poly(ADP-ribose). The cGAS- PARP1 interaction impedes the formation of the PARP1-Timeless complex, and thereby suppresses homologous recombination. We show that knockdown of cGAS suppresses DNA damage and inhibits tumour growth both in vitro and in vivo. We conclude that nuclear cGAS suppresses homologous-recombination-mediated repair and promotes tumour growth, and that cGAS therefore represents a potential target for cancer prevention and therapy.	[Liu, Haipeng; Wu, Xiangyang; Wu, Juehui; Wang, Lin; Zheng, Ruijuan; Liang, Haijiao; Liu, Zhonghua; Yang, Hua; Chen, Jianxia; Huang, Xiaochen; Wang, Jie; Li, Haohao; Zhou, Yilong; Liu, Feng; Ge, Baoxue] Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China; [Liu, Haipeng; Wu, Xiangyang; Ma, Dapeng; Wu, Juehui; Wang, Lin; Jiang, Yan; Yan, Qiaoling; Liu, Siyu; Liang, Haijiao; Chen, Jianxia; Wang, Peng; Tang, Tianqi; Peng, Wenxia; Zhou, Yilong; Ge, Baoxue] Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Sch Med, Shanghai, Peoples R China; [Zhang, Haiping; Hu, Zhangsen; Xu, Zhu; Mao, Zhiyong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai, Peoples R China; [Fei, Yiyan; Zhu, Chenggang] Fudan Univ, Shanghai Engn Res Ctr Ultraprecis Opt Mfg, Key Lab Micro & Nano Photon Struct, Dept Opt Sci & Engn,Minist Educ, Shanghai, Peoples R China; [Tan, Rong] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China; [Jungblut, Peter] Max Planck Inst Infect Biol, Prot Purificat Core Facil, Berlin, Germany; [Pei, Gang; Dorhoi, Anca; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Dorhoi, Anca] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Zhang, Fan; Chen, Chang] Tongji Univ, Shanghai Pulm Hosp, Dept Thorac Surg, Sch Med, Shanghai, Peoples R China; [Yan, Dapeng] Fudan Univ, MOH, MOE, Key Lab Med Mol Virol, Shanghai, Peoples R China	Tongji University; Tongji University; Tongji University; Fudan University; Central South University; Max Planck Society; Max Planck Society; Friedrich Loeffler Institute; Tongji University; Fudan University	Ge, BX (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China.; Ge, BX (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Sch Med, Shanghai, Peoples R China.; Mao, ZY (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai, Peoples R China.	zhiyong_mao@tongji.edu.cn; baoxue_ge@tongji.edu.cn	Liu, Feng/AAA-9645-2022; Liu, Siyu/GYV-4856-2022; Pei, Gang/U-4740-2017	Liu, Feng/0000-0002-4442-7028; Mao, Zhiyong/0000-0002-5298-1918; Liu, Haipeng/0000-0002-3338-6291; Wu, Xiangyang/0000-0002-0444-7120; Pei, Gang/0000-0001-5517-8496	Chinese National Program on Key Basic Research Project [2017YFA0505900, 2015CB964800]; National Natural Science Foundation of China [81770006, 81370108, 91542111, 31030028, 81622019, 31570813]; Shanghai Pujiang Program [16PJ1408600]; Shanghai Medical and Health Services Outstanding Youth Talent Program [2017YQ078]	Chinese National Program on Key Basic Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Medical and Health Services Outstanding Youth Talent Program	This project was supported by grants from the Chinese National Program on Key Basic Research Project (2017YFA0505900 to B.G. and 2015CB964800 to Z.M.) and the National Natural Science Foundation of China (81770006 and 81370108 to H.Liu, 91542111 and 31030028 to B.G., and 81622019 and 31570813 to Z.M.). H. Liu is sponsored by the Shanghai Pujiang Program (16PJ1408600) and by the Shanghai Medical and Health Services Outstanding Youth Talent Program (2017YQ078).	Caldecott KW, 2007, DNA REPAIR, V6, P443, DOI 10.1016/j.dnarep.2006.10.006; Capes-Davis A, 2013, INT J CANCER, V132, P2510, DOI 10.1002/ijc.27931; Cerbinskaite A, 2012, CANCER TREAT REV, V38, P89, DOI 10.1016/j.ctrv.2011.04.015; Chernikova SB, 2012, CANCER BIOL THER, V13, P61, DOI [10.4161.cbt.13.2.18872, 10.4161/cbt.13.2.18872]; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hu YD, 2014, CANCER DISCOV, V4, P1430, DOI 10.1158/2159-8290.CD-13-0891; Huang TH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.65; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Landry JP, 2012, ASSAY DRUG DEV TECHN, V10, P250, DOI 10.1089/adt.2011.0406; Li Z, 2016, CELL DEATH DIFFER, V23, P1765, DOI 10.1038/cdd.2016.65; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Petersen DL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317714196; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Steffen JD, 2014, CANCER RES, V74, P31, DOI 10.1158/0008-5472.CAN-13-1701; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xie S, 2015, MOL CELL, V60, P163, DOI 10.1016/j.molcel.2015.07.031; Young LM, 2015, CELL REP, V13, P451, DOI 10.1016/j.celrep.2015.09.017; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	32	269	283	18	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					131	+		10.1038/s41586-018-0629-6	http://dx.doi.org/10.1038/s41586-018-0629-6			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30356214				2022-12-28	WOS:000448900900059
J	Oransky, I				Oransky, Ivan			Volunteer watchdogs pushed a small country up the rankings	SCIENCE			English	Editorial Material																			0	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					395	395		10.1126/science.362.6413.395	http://dx.doi.org/10.1126/science.362.6413.395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361356				2022-12-28	WOS:000450441900027
J	Silveyra, JM; Ferrara, E; Huber, DL; Monson, TC				Silveyra, Josefina M.; Ferrara, Enzo; Huber, Dale L.; Monson, Todd C.			Soft magnetic materials for a sustainable and electrified world	SCIENCE			English	Review							POWER ELECTRONICS; HIGH-FREQUENCY; EDDY-CURRENT; ENERGY; LOSSES; ALLOYS; NANOCOMPOSITES; DEPENDENCE; ANISOTROPY; COMPOSITE	Soft magnetic materials are key to the efficient operation of the next generation of power electronics and electrical machines (motors and generators). Many new materials have been introduced since Michael Faraday's discovery of magnetic induction, when iron was the only option. However, as wide bandgap semiconductor devices become more common in both power electronics and motor controllers, there is an urgent need to further improve soft magnetic materials. These improvements will be necessary to realize the full potential in efficiency, size, weight, and power of high-frequency power electronics and high-rotational speed electrical machines. Here we provide an introduction to the field of soft magnetic materials and their implementation in power electronics and electrical machines. Additionally, we review the most promising choices available today and describe emerging approaches to create even better soft magnetic materials.	[Silveyra, Josefina M.] Univ Buenos Aires, CONICET, Fac Ingn, Lab Solidos Amorfos,INTECIN, Buenos Aires, DF, Argentina; [Ferrara, Enzo] Ist Nazl Ric Metrol INRIM, Turin, Italy; [Huber, Dale L.] Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA; [Monson, Todd C.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Istituto Nazionale di Ricerca Metrologica (INRIM); United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Monson, TC (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	tmonson@sandia.gov	Huber, Dale L./A-6006-2008; Ferrara, Enzo/AAH-3147-2019	Huber, Dale L./0000-0001-6872-8469; Ferrara, Enzo/0000-0001-7254-8065; Monson, Todd/0000-0002-9782-7084; Silveyra, Josefina Maria/0000-0003-0307-3419	CONICET; UBACyT [20020150200168BA]; Sandia's Laboratory Directed Research and Development program; Energy Storage program of the DOE, Office of Electricity Delivery and Energy Reliability; Center for Integrated Nanotechnologies, an Office of Science; DOE's National Nuclear Security Administration [DE-NA0003525]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; Sandia's Laboratory Directed Research and Development program(United States Department of Energy (DOE)); Energy Storage program of the DOE, Office of Electricity Delivery and Energy Reliability(United States Department of Energy (DOE)); Center for Integrated Nanotechnologies, an Office of Science; DOE's National Nuclear Security Administration(National Nuclear Security Administration)	J.M.S. acknowledges support from CONICET and UBACyT 20020150200168BA. T.C.M. and D.L.H. were funded in part by Sandia's Laboratory Directed Research and Development program. T.C.M. acknowledges partial support from the Energy Storage program of the DOE, Office of Electricity Delivery and Energy Reliability. D.L.H. acknowledges partial support from the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the DOE Office of Science. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology and Engineering Solutions of Sandia LLC, a wholly owned subsidiary of Honeywell International Inc. for the DOE's National Nuclear Security Administration under contract DE-NA0003525. This paper describes objective technical results and analysis. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the U.S. Department of Energy or the United States government.	Alabakhshizadeh A, 2013, IEEE PHOT SPEC CONF, P2845, DOI 10.1109/PVSC.2013.6745064; ALBEN R, 1978, J APPL PHYS, V49, P1653, DOI 10.1063/1.324881; ANDERSON PW, 1950, PHYS REV, V79, P350, DOI 10.1103/PhysRev.79.350; Anhalt M, 2008, J MAGN MAGN MATER, V320, pE366, DOI 10.1016/j.jmmm.2008.02.072; [Anonymous], 2013, EN CONS PROGR EN CON; [Anonymous], 2011, REV FUTURE AMORPHOUS; [Anonymous], 2016, AM MET DISTR TRANSF; [Anonymous], 2017, SUP COR EL STEEL SHE; Arnold HD, 1923, BELL SYST TECH J, V2, P101, DOI 10.1002/j.1538-7305.1923.tb03595.x; Aronhime N, 2017, JOM-US, V69, P2164, DOI 10.1007/s11837-017-2480-x; BERTOTTI G, 1988, IEEE T MAGN, V24, P621, DOI 10.1109/20.43994; BERTOTTI G, 1985, J APPL PHYS, V57, P2110, DOI 10.1063/1.334404; Bertotti G., 1998, HYSTERESIS MAGNETISM; Bhattacharya S, 2017, IEEE SPECTRUM, V54, P38, DOI 10.1109/MSPEC.2017.7951721; Bose BK, 2010, IEEE IND ELECTRON M, V4, P6, DOI 10.1109/MIE.2010.935860; Chen Y., 2015, U. S. patent, Patent No. [9,117,565, 9117565]; Cullity B.D., 2009, INTRO MAGNETIC MAT, VSecond; DeGeorge V, 2014, J ELECTRON MATER, V43, P96, DOI 10.1007/s11664-013-2835-1; Denis N, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2700471; DEVRIES M, 2005, 80 YEARS RES PHILIPS; Dimitrijev S, 2015, MRS BULL, V40, P399, DOI 10.1557/mrs.2015.89; Dobrzaski L.A., 2006, J ACHIEV MAT MANUF E, V17, P37; DORMANN JL, 1981, REV PHYS APPL, V16, P275, DOI 10.1051/rphysap:01981001606027500; DUWEZ P, 1967, J APPL PHYS, V38, P4096, DOI 10.1063/1.1709084; Fiorillo F, 2010, J MAGN MAGN MATER, V322, P1497, DOI 10.1016/j.jmmm.2009.09.038; Fiorillo F., 2016, WILEY ENCY ELECT ELE; Fiorillo F., 2004, MEASUREMENT CHARACTE; Fiorillo F., 2006, SCI HYSTERESIS, VII, P1; Fiorillo F, 2010, METROLOGIA, V47, pS114, DOI 10.1088/0026-1394/47/2/S11; Fischer P, 1998, J PHYS D APPL PHYS, V31, P649, DOI 10.1088/0022-3727/31/6/012; Flohrer S, 2006, ACTA MATER, V54, P4693, DOI 10.1016/j.actamat.2006.04.040; FUKAO T, 1989, IEEE T IND APPL, V25, P119, DOI 10.1109/28.18881; Guo D, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/1/013001; HERZER G, 1989, IEEE T MAGN, V25, P3327, DOI 10.1109/20.42292; Herzer G., 2007, HDB MAGNETISM ADV MA, DOI [10.1002/9780470022184.hmm402, DOI 10.1002/9780470022184.HMM402]; Herzer G, 2013, ACTA MATER, V61, P718, DOI 10.1016/j.actamat.2012.10.040; Hultman L. O., 2003, ELECT MACHINES DRIVE, P516; Iacopi F, 2015, MRS BULL, V40, P390, DOI 10.1557/mrs.2015.71; Jack AG, 2000, IEEE T IND APPL, V36, P1077, DOI 10.1109/28.855963; Jacobs I. S., 1963, MAGNETISM, VIII, P271; Kaplar RJ, 2017, IEEE POWER ELECTRON, V4, P36, DOI 10.1109/MPEL.2016.2643098; Kolano R, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2283918; Kolar J.W., 2010, P 2010 6 INT C INTEG, P1; Krings, 2014, THESIS; Krings A, 2017, IEEE T IND ELECTRON, V64, P2405, DOI 10.1109/TIE.2016.2613844; Krishnamurthy S, 2012, APPL POWER ELECT CO, P1414, DOI 10.1109/APEC.2012.6166005; Kroposki B, 2010, IEEE T ENERGY CONVER, V25, P901, DOI 10.1109/TEC.2010.2053975; Leary A, 2016, J MATER RES, V31, P3089, DOI 10.1557/jmr.2016.324; Leary AM, 2012, JOM-US, V64, P772, DOI 10.1007/s11837-012-0350-0; Lichte H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016102; Livingston J.D., 1959, J APPL PHYS, V30, pS120, DOI [10.1063/1.2185850, DOI 10.1063/1.2185850]; Magni A, 2012, IEEE T MAGN, V48, P3796, DOI 10.1109/TMAG.2012.2196985; Makino A, 2009, MATER TRANS, V50, P204, DOI 10.2320/matertrans.MER2008306; Matsuda T, 1996, SCIENCE, V271, P1393, DOI 10.1126/science.271.5254.1393; May JE, 2005, J ALLOY COMPD, V390, P106, DOI 10.1016/j.jallcom.2004.05.090; Mazaleyrat F, 2000, J MAGN MAGN MATER, V215, P253, DOI 10.1016/S0304-8853(00)00128-1; McCord J, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/33/333001; McCoy G. A., 1990, ENERGY EFFICIENT ELE, DOI [10.2172/6116458, DOI 10.2172/6116458]; MISCHLER WR, 1981, IEEE T POWER AP SYST, V100, P2907, DOI 10.1109/TPAS.1981.316408; Monson T. C., 2018, U. S. Patent, Patent No. [9,963,344 B2, 9963344]; NEEL L, 1949, CR HEBD ACAD SCI, V228, P664; NEEL L, 1948, ANN PHYS-PARIS, V3, P137; Nishiyama N, 2016, AIP ADV, V6, DOI 10.1063/1.4944341; Ohodnicki PR, 2008, J APPL PHYS, V103, DOI 10.1063/1.2838630; Okamoto S, 2016, IEEE T IND APPL, V52, P2261, DOI 10.1109/TIA.2016.2532279; Popovic-Gerber J, 2012, IEEE T POWER ELECTR, V27, P2338, DOI 10.1109/TPEL.2011.2171195; PRY RH, 1958, J APPL PHYS, V29, P532, DOI 10.1063/1.1723212; Roesler AW, 2010, IEEE T COMPON PACK T, V33, P359, DOI 10.1109/TCAPT.2009.2031872; RUGAR D, 1990, J APPL PHYS, V68, P1169, DOI 10.1063/1.346713; Schaefer R, 2001, IEEE T MAGN, V37, P2245, DOI 10.1109/20.951137; Setyawan AD, 2015, J APPL PHYS, V117, DOI 10.1063/1.4913936; Shoji K., 2016, JFE TECHNICAL REPORT; Shokrollahi H, 2007, J MATER PROCESS TECH, V189, P1, DOI 10.1016/j.jmatprotec.2007.02.034; Silveyra JM, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864247; Silveyra JM, 2016, J ELECTRON MATER, V45, P219, DOI 10.1007/s11664-015-3968-1; Silveyra JM, 2014, J ALLOY COMPD, V610, P180, DOI 10.1016/j.jallcom.2014.04.147; Silveyra JM, 2011, B MATER SCI, V34, P1407, DOI 10.1007/s12034-011-0336-5; SNOEK JL, 1948, PHYSICA, V14, P207, DOI 10.1016/0031-8914(48)90038-X; Souza CAC, 2016, J NON-CRYST SOLIDS, V442, P56, DOI 10.1016/j.jnoncrysol.2016.04.009; Taghvaei AH, 2009, MATER DESIGN, V30, P3989, DOI 10.1016/j.matdes.2009.05.026; Taghvaei AH, 2009, J ALLOY COMPD, V481, P681, DOI 10.1016/j.jallcom.2009.03.074; Theisen E, 2017, MRS ADV, V2, P3409, DOI 10.1557/adv.2017.552; Tiku Deepak, 2014, IEEE Power & Energy Magazine, V12, P76, DOI 10.1109/MPE.2013.2293398; Tong W., 2016, VEHICLE POWER PROPUL, DOI [10.1109/VPPC.2016.7791716, DOI 10.1109/VPPC.2016.7791716]; Turcanova J, 2009, J PHYS CONF SER, V144, DOI 10.1088/1742-6596/144/1/012065; VARGA LK, 1994, J MAGN MAGN MATER, V133, P280, DOI 10.1016/0304-8853(94)90546-0; Waide P., 2011, INT ENERGY AGENCY EN; Wang Z., 2015, EN EFF MOT DRIV SYST; Wang ZN, 2010, IEEE T MAGN, V46, P570, DOI 10.1109/TMAG.2009.2033350; Willard MA, 1998, J APPL PHYS, V84, P6773, DOI 10.1063/1.369007; WILLIAMS HJ, 1950, PHYS REV, V80, P1090, DOI 10.1103/PhysRev.80.1090; Yamazakii T., 2017, 2017011232 SAE, DOI [10.4271/2017-01-1232, DOI 10.4271/2017-01-1232]; YOSHIZAWA Y, 1988, J APPL PHYS, V64, P6044, DOI 10.1063/1.342149; Yun H, 2016, J APPL PHYS, V119, DOI 10.1063/1.4942865	94	250	255	84	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					418	+	eaao0195	10.1126/science.aao0195	http://dx.doi.org/10.1126/science.aao0195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361339	Green Submitted			2022-12-28	WOS:000450441900037
J	Agostini, M; Altenmuller, K; Appel, S; Atroshchenko, V; Bagdasarian, Z; Basilico, D; Bellini, G; Benziger, J; Bick, D; Bonfini, G; Bravo, D; Caccianiga, B; Calaprice, F; Caminata, A; Caprioli, S; Carlini, M; Cavalcante, P; Chepurnov, A; Choi, K; Collica, L; D'Angelo, D; Davini, S; Derbin, A; Ding, XF; Di Ludovico, A; Di Noto, L; Drachnev, I; Fomenko, K; Formozov, A; Franco, D; Gabriele, F; Galbiati, C; Ghiano, C; Giammarchi, M; Goretti, A; Gromov, M; Guffanti, D; Hagner, C; Houdy, T; Hungerford, E; Ianni, A; Ianni, A; Jany, A; Jeschke, D; Kobychev, V; Korablev, D; Korga, G; Kryn, D; Laubenstein, M; Litvinovich, E; Lombardi, F; Lombardi, P; Ludhova, L; Lukyanchenko, G; Lukyanchenko, L; Machulin, I; Manuzio, G; Marcocci, S; Martyn, J; Meroni, E; Meyer, M; Miramonti, L; Misiaszek, M; Muratova, V; Neumair, B; Oberauer, L; Opitz, B; Orekhov, V; Ortica, F; Pallavicini, M; Papp, L; Penek, O; Pilipenko, N; Pocar, A; Porcelli, A; Raikov, G; Ranucci, G; Razeto, A; Re, A; Redchuk, M; Romani, A; Roncin, R; Rossi, N; Schonert, S; Semenov, D; Skorokhvatov, M; Smirnov, O; Sotnikov, A; Stokes, LFF; Suvorov, Y; Tartaglia, R; Testera, G; Thurn, J; Toropova, M; Unzhakov, E; Villante, FL; Vishneva, A; Vogelaar, RB; von Feilitzsch, F; Wang, H; Weinz, S; Wojcik, M; Wurm, M; Yokley, Z; Zaimidoroga, O; Zavatarelli, S; Zuber, K; Zuzel, G				Agostini, M.; Altenmueller, K.; Appel, S.; Atroshchenko, V.; Bagdasarian, Z.; Basilico, D.; Bellini, G.; Benziger, J.; Bick, D.; Bonfini, G.; Bravo, D.; Caccianiga, B.; Calaprice, F.; Caminata, A.; Caprioli, S.; Carlini, M.; Cavalcante, P.; Chepurnov, A.; Choi, K.; Collica, L.; D'Angelo, D.; Davini, S.; Derbin, A.; Ding, X. F.; Di Ludovico, A.; Di Noto, L.; Drachnev, I.; Fomenko, K.; Formozov, A.; Franco, D.; Gabriele, F.; Galbiati, C.; Ghiano, C.; Giammarchi, M.; Goretti, A.; Gromov, M.; Guffanti, D.; Hagner, C.; Houdy, T.; Hungerford, E.; Ianni, Aldo; Ianni, Andrea; Jany, A.; Jeschke, D.; Kobychev, V.; Korablev, D.; Korga, G.; Kryn, D.; Laubenstein, M.; Litvinovich, E.; Lombardi, F.; Lombardi, P.; Ludhova, L.; Lukyanchenko, G.; Lukyanchenko, L.; Machulin, I.; Manuzio, G.; Marcocci, S.; Martyn, J.; Meroni, E.; Meyer, M.; Miramonti, L.; Misiaszek, M.; Muratova, V.; Neumair, B.; Oberauer, L.; Opitz, B.; Orekhov, V.; Ortica, F.; Pallavicini, M.; Papp, L.; Penek, O.; Pilipenko, N.; Pocar, A.; Porcelli, A.; Raikov, G.; Ranucci, G.; Razeto, A.; Re, A.; Redchuk, M.; Romani, A.; Roncin, R.; Rossi, N.; Schoenert, S.; Semenov, D.; Skorokhvatov, M.; Smirnov, O.; Sotnikov, A.; Stokes, L. F. F.; Suvorov, Y.; Tartaglia, R.; Testera, G.; Thurn, J.; Toropova, M.; Unzhakov, E.; Villante, F. L.; Vishneva, A.; Vogelaar, R. B.; von Feilitzsch, F.; Wang, H.; Weinz, S.; Wojcik, M.; Wurm, M.; Yokley, Z.; Zaimidoroga, O.; Zavatarelli, S.; Zuber, K.; Zuzel, G.		Borexino Collaboration	Comprehensive measurement of pp-chain solar neutrinos	NATURE			English	Article							OSCILLATIONS	About 99 per cent of solar energy is produced through sequences of nuclear reactions that convert hydrogen into helium, starting from the fusion of two protons (the pp chain). The neutrinos emitted by five of these reactions represent a unique probe of the Sun's internal working and, at the same time, offer an intense natural neutrino beam for fundamental physics. Here we report a complete study of the pp chain. We measure the neutrino-electron elastic-scattering rates for neutrinos produced by four reactions of the chain: the initial proton-proton fusion, the electron-capture decay of beryllium-7, the three-body proton-electron-proton (pep) fusion, here measured with the highest precision so far achieved, and the boron-8 beta decay, measured with the lowest energy threshold. We also set a limit on the neutrino flux produced by the He-3-proton fusion (hep). These measurements provide a direct determination of the relative intensity of the two primary terminations of the pp chain (pp-I and pp-II) and an indication that the temperature profile in the Sun is more compatible with solar models that assume high surface metallicity. We also determine the survival probability of solar electron neutrinos at different energies, thus probing simultaneously and with high precision the neutrino flavour-conversion paradigm, both in vacuum and in matter-dominated regimes.	[Agostini, M.; Altenmueller, K.; Appel, S.; Jeschke, D.; Neumair, B.; Oberauer, L.; Papp, L.; Schoenert, S.; von Feilitzsch, F.] Tech Univ Munich, Phys Dept, Excellence Cluster Univ, Garching, Germany; [Atroshchenko, V.; Litvinovich, E.; Lukyanchenko, G.; Lukyanchenko, L.; Machulin, I.; Orekhov, V.; Raikov, G.; Skorokhvatov, M.; Suvorov, Y.; Toropova, M.] Natl Res Ctr, Kurchatov Inst, Moscow, Russia; [Bagdasarian, Z.; Ludhova, L.; Penek, O.; Redchuk, M.] Forschungszentrum Julich, Inst Kernphys, Julich, Germany; [Basilico, D.; Bellini, G.; Bravo, D.; Caprioli, S.; Collica, L.; D'Angelo, D.; Formozov, A.; Giammarchi, M.; Lombardi, P.; Meroni, E.; Miramonti, L.; Ranucci, G.; Re, A.] Univ Milan, Dipartimento Fis, Milan, Italy; [Basilico, D.; Bellini, G.; Bravo, D.; Caprioli, S.; Collica, L.; D'Angelo, D.; Formozov, A.; Giammarchi, M.; Lombardi, P.; Meroni, E.; Miramonti, L.; Ranucci, G.; Re, A.] Ist Nazl Fis Nucl, Milan, Italy; [Benziger, J.] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA; [Bick, D.; Hagner, C.; Opitz, B.] Univ Hamburg, Inst Expt Phys, Hamburg, Germany; [Bonfini, G.; Carlini, M.; Ding, X. F.; Gabriele, F.; Ghiano, C.; Goretti, A.; Guffanti, D.; Ianni, Aldo; Laubenstein, M.; Lombardi, F.; Marcocci, S.; Razeto, A.; Roncin, R.; Rossi, N.; Stokes, L. F. F.; Tartaglia, R.; Villante, F. L.] Ist Nazl Fis Nucl, Lab Nazl Gran Sasso, Assergi, Italy; [Calaprice, F.; Di Ludovico, A.; Galbiati, C.; Ianni, Andrea] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Caminata, A.; Davini, S.; Di Noto, L.; Manuzio, G.; Pallavicini, M.; Testera, G.; Zavatarelli, S.] Univ Genoa, Dipartimento Fis, Genoa, Italy; [Caminata, A.; Davini, S.; Di Noto, L.; Manuzio, G.; Pallavicini, M.; Testera, G.; Zavatarelli, S.] Ist Nazl Fis Nucl, Genoa, Italy; [Cavalcante, P.; Vogelaar, R. B.; Yokley, Z.] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Chepurnov, A.; Formozov, A.; Gromov, M.] Lomonosov Moscow State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Choi, K.] Univ Hawaii, Dept Phys & Astron, Honolulu, HI 96822 USA; [Derbin, A.; Drachnev, I.; Muratova, V.; Pilipenko, N.; Semenov, D.; Unzhakov, E.] NRC Kurchatov Inst, St Petersburg Nucl Phys Inst, Gatchina, Russia; [Ding, X. F.; Galbiati, C.; Guffanti, D.; Marcocci, S.] Gran Sasso Sci Inst, Laquila, Italy; [Fomenko, K.; Formozov, A.; Korablev, D.; Smirnov, O.; Sotnikov, A.; Vishneva, A.; Zaimidoroga, O.] Joint Inst Nucl Res, Dubna, Russia; [Franco, D.; Houdy, T.; Kryn, D.; Roncin, R.] Univ Paris Diderot, AstroParticule & Cosmol, CNRS IN2P3, CEA IRFU,Observ Paris,Sorbonne Paris Cite, Paris, France; [Hungerford, E.; Korga, G.] Univ Houston, Dept Phys, Houston, TX USA; [Ianni, Aldo] Lab Subterraneo Canfranc, Canfranc Estacion Huesca, Spain; [Jany, A.; Misiaszek, M.; Wojcik, M.; Zuzel, G.] Jagiellonian Univ, M Smoluchowski Inst Phys, Krakow, Poland; [Kobychev, V.] Kiev Inst Nucl Res, Kiev, Ukraine; [Litvinovich, E.; Machulin, I.; Skorokhvatov, M.] Natl Res Nucl Univ MEPhI, Moscow Engn Phys Inst, Moscow, Russia; [Ludhova, L.; Penek, O.; Redchuk, M.] Rhein Westfal TH Aachen, Aachen, Germany; [Martyn, J.; Porcelli, A.; Weinz, S.; Wurm, M.] Johannes Gutenberg Univ Mainz, Inst Phys & Excellence Cluster PRISMA, Mainz, Germany; [Meyer, M.; Zuber, K.] Tech Univ Dresden, Dept Phys, Dresden, Germany; [Ortica, F.; Romani, A.] Univ Perugia, Dipartimento Chim Biol & Biotecnol, Perugia, Italy; [Ortica, F.; Romani, A.] Ist Nazl Fis Nucl, Perugia, Italy; [Pocar, A.] Univ Massachusetts, Amherst Ctr Fundamental Interact, Amherst, MA 01003 USA; [Pocar, A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Suvorov, Y.; Wang, H.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [Villante, F. L.] Univ Aquila, Dipartimento Sci Fis & Chim, Laquila, Italy; [Bravo, D.] Univ Autonoma Madrid, Ciudad Univ Cantoblanco, Madrid, Spain; [Lombardi, F.] Univ Calif San Diego, Dept Phys, San Diego, CA 92103 USA; [Marcocci, S.] Fermilab Natl Accelerator Lab, Batavia, IL USA; [Rossi, N.] Sapienza Univ Roma, Dipartimento Fis, Rome, Italy; [Rossi, N.] Ist Nazl Fis Nucl, Rome, Italy; [Suvorov, Y.] Univ Federico II Naples, Dipartimento Fis, Naples, Italy; [Suvorov, Y.] Ist Nazl Fis Nucl, Naples, Italy	Technical University of Munich; National Research Centre - Kurchatov Institute; Helmholtz Association; Research Center Julich; University of Milan; Istituto Nazionale di Fisica Nucleare (INFN); Princeton University; University of Hamburg; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); Princeton University; University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); Virginia Polytechnic Institute & State University; Lomonosov Moscow State University; University of Hawaii System; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Gran Sasso Science Institute (GSSI); Joint Institute for Nuclear Research - Russia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Universite Paris Saclay; University of Houston System; University of Houston; Jagiellonian University; National Academy of Sciences Ukraine; Institute for Nuclear Research of NASU; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); RWTH Aachen University; Johannes Gutenberg University of Mainz; Technische Universitat Dresden; University of Perugia; Istituto Nazionale di Fisica Nucleare (INFN); University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Los Angeles; University of L'Aquila; Autonomous University of Madrid; University of California System; University of California San Diego; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN)	Agostini, M (corresponding author), Tech Univ Munich, Phys Dept, Excellence Cluster Univ, Garching, Germany.		Fomenko, Kirill/P-2857-2018; Testera, Gemma/AAG-2260-2020; Lombardi, Paolo/AAF-6960-2020; Razeto, Alessandro/J-3320-2015; Ludhova, Livia/AAE-4487-2020; Smirnov, Oleg Yu/S-2971-2016; Miramonti, Lino/AAF-7880-2019; Laubenstein, Matthias/C-4851-2013; Romani, Aldo/G-8103-2012; Smirnov, Oleg/HHS-6187-2022; Unzhakov, Evgeniy V./A-4868-2019; Gromov, Maxim/T-3342-2018; Caminata, Alessio/HHC-1509-2022; Pallavicini, Marco/G-5500-2012; Kobychev, Vladislav V/B-3322-2008; Derbin, Alexander V/L-5493-2017; Ding, Xuefeng/AAF-8578-2019; Agostini, Matteo/T-4931-2019; Vishneva, Alina/U-8468-2017; Ortica, Fausto/C-1001-2013; Lombardi, Francesco/AAH-7657-2021; Galbiati, Cristiano/I-7487-2012; Machulin, Igor Nikolaevich/R-9711-2016; Vishneva, Alina/AAQ-7543-2021; choi, koun/AAN-1148-2020; Basilico, Davide/AAB-9739-2022; Davini, Stefano/HDN-4273-2022; Muratova, Valentina/AAP-4130-2021; D'Angelo, Davide/K-9164-2013; Ianni, Aldo/T-1747-2017	Razeto, Alessandro/0000-0002-0578-097X; Smirnov, Oleg Yu/0000-0002-5238-0442; Miramonti, Lino/0000-0002-2808-5363; Laubenstein, Matthias/0000-0001-5390-4343; Romani, Aldo/0000-0002-7338-0097; Unzhakov, Evgeniy V./0000-0003-2952-6412; Gromov, Maxim/0000-0003-2869-2363; Caminata, Alessio/0000-0002-5800-5504; Pallavicini, Marco/0000-0001-7309-3023; Kobychev, Vladislav V/0000-0003-0030-7451; Derbin, Alexander V/0000-0002-4351-2255; Ding, Xuefeng/0000-0001-8803-320X; Agostini, Matteo/0000-0003-1151-5301; Vishneva, Alina/0000-0002-2624-9416; Ortica, Fausto/0000-0001-8276-452X; Lombardi, Francesco/0000-0003-0229-4391; Galbiati, Cristiano/0000-0002-2409-502X; Vishneva, Alina/0000-0002-2624-9416; choi, koun/0000-0002-0932-9123; Basilico, Davide/0000-0001-5662-9236; Muratova, Valentina/0000-0001-5532-7711; D'Angelo, Davide/0000-0001-9857-8107; Bravo Berguno, David/0000-0001-9876-2684; Drachnev, Ilia/0000-0002-4064-8093; Guffanti, Daniele/0000-0002-6182-5618; Franco, Davide/0000-0001-5604-2531; Niyazova, Nelly/0000-0002-4316-3921; Villante, Francesco Lorenzo/0000-0001-7667-4499; Bagdasarian, Zara/0000-0003-0877-496X; Redchuk, Mariia/0000-0003-4779-5296; Ianni, Aldo/0000-0002-6962-3682; Penek, Omer/0000-0003-3421-1415; Lukyanchenko, Georgy/0000-0001-7449-2923; Di Noto, Lea/0000-0002-2448-6805; Formozov, Andrey/0000-0001-8935-8612; Sotnikov, Albert/0000-0001-8371-5949	INFN (Italy); NSF (USA); BMBF (Germany); MPG (Germany); RFBR [16-29-13014ofi-m, 17-02-00305A]; RSF (Russia) [17-12-01009]; NCN (Poland) [UMO 2017/26/M/ST2/00915]; Laboratori Nazionali del Gran Sasso (Italy); DFG (Germany); HGF (Germany); Russian Science Foundation [17-12-01009] Funding Source: Russian Science Foundation	INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); NSF (USA)(National Science Foundation (NSF)); BMBF (Germany)(Federal Ministry of Education & Research (BMBF)); MPG (Germany)(Max Planck Society); RFBR(Russian Foundation for Basic Research (RFBR)); RSF (Russia)(Russian Science Foundation (RSF)); NCN (Poland); Laboratori Nazionali del Gran Sasso (Italy); DFG (Germany)(German Research Foundation (DFG)); HGF (Germany); Russian Science Foundation(Russian Science Foundation (RSF))	The Borexino programme is made possible by funding from INFN (Italy), NSF (USA), BMBF, DFG, HGF and MPG (Germany), RFBR (grants 16-29-13014ofi-m and 17-02-00305A), RSF (grant 17-12-01009) (Russia), and NCN (grant number UMO 2017/26/M/ST2/00915) (Poland). We acknowledge also the computing services of the Bologna INFN-CNAF data centre and LNGS Computing and Network Service (Italy), of Julich Supercomputing Centre at FZJ (Germany), and of ACK Cyfronet AGH Cracow (Poland). We acknowledge the hospitality and support of the Laboratori Nazionali del Gran Sasso (Italy).	ABDURASHITOV JN, 1994, PHYS LETT B, V328, P234, DOI 10.1016/0370-2693(94)90454-5; Abe K, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.052010; Agostini M, 2018, ASTROPART PHYS, V97, P136, DOI 10.1016/j.astropartphys.2017.10.003; Aharmim B, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.025501; Ahmad QR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.011301; Alimonti G, 2009, NUCL INSTRUM METH A, V600, P568, DOI 10.1016/j.nima.2008.11.076; An FP, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.072006; ANSELMANN P, 1992, PHYS LETT B, V285, P376, DOI 10.1016/0370-2693(92)91521-A; Arpesella C, 2008, PHYS LETT B, V658, P101, DOI 10.1016/j.physletb.2007.09.054; Arpesella C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.091302; Asplund M, 2005, ASTR SOC P, V336, P25; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Atkinson RD, 1929, Z PHYS, V54, P656, DOI 10.1007/BF01341595; Back H, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/10/P10018; Bahcall J. N, 2000, HOW THE SUN SHINES; Bahcall J N, 1989, NEUTRINO ASTROPHYSIC; Bahcall JN, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/063; Bahcall JN, 2000, PUBL ASTRON SOC PAC, V112, P429, DOI 10.1086/316545; Bahcall JN, 2003, J HIGH ENERGY PHYS; Bellini G, 2014, NATURE, V512, P383, DOI 10.1038/nature13702; Bellini G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.051302; Bellini G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.141302; Bellini G, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.033006; Bergstrom J, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2016)132; Bethe HA, 1938, PHYS REV, V54, P248, DOI 10.1103/PhysRev.54.248; Bethe HA, 1939, PHYS REV, V55, P0434, DOI 10.1103/PhysRev.55.434; Blennow M., 2013, J HIGH ENERGY PHYS, V03; Caffau E, 2011, SOL PHYS, V268, P255, DOI 10.1007/s11207-010-9541-4; Caldwell A, 2009, COMPUT PHYS COMMUN, V180, P2197, DOI 10.1016/j.cpc.2009.06.026; Chapman G. A., 1997, ENCY PLANETARY SCI E, V748; Davis R, 2003, REV MOD PHYS, V75, P985, DOI 10.1103/RevModPhys.75.985; Esteban I, 2017, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2017)087; FOWLER WA, 1984, REV MOD PHYS, V56, P149, DOI 10.1103/RevModPhys.56.149; Franco D, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.015504; Frohlich C, 1998, GEOPHYS RES LETT, V25, P4377, DOI 10.1029/1998GL900157; Gando A, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.033001; Geant4, 2018, SIM TOOLK; Grevesse N, 1998, SPACE SCI REV, V85, P161, DOI 10.1023/A:1005161325181; Grevesse N., 1993, ORIGIN EVOLUTION ELE, V15; Haxton WC, 2013, ANNU REV ASTRON ASTR, V51, P21, DOI 10.1146/annurev-astro-081811-125539; HIRATA KS, 1989, PHYS REV LETT, V63, P16, DOI 10.1103/PhysRevLett.63.16; HOLMGREN HD, 1959, PHYS REV, V113, P1556, DOI 10.1103/PhysRev.113.1556; MIKHEEV SP, 1985, SOV J NUCL PHYS+, V42, P913; Vinyoles N, 2017, ASTROPHYS J, V835, DOI 10.3847/1538-4357/835/2/202; von Weizsacker CF, 1937, PHYS Z, V38, P176; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369	48	100	100	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					505	+		10.1038/s41586-018-0624-y	http://dx.doi.org/10.1038/s41586-018-0624-y			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356186	Green Submitted			2022-12-28	WOS:000448277800043
J	Moshiri, AS; Moxam, A				Moshiri, Ata S.; Moxam, Alexander			Syphilitic Alopecia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Moshiri, Ata S.; Moxam, Alexander] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA	University of Pennsylvania	Moshiri, AS (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	ata.moshiri@uphs.upenn.edu		Moshiri, Ata/0000-0001-6684-4503					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1657	1657		10.1056/NEJMicm1804118	http://dx.doi.org/10.1056/NEJMicm1804118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30354954				2022-12-28	WOS:000448273500010
J	Limb, M				Limb, Matthew			Hard Brexit could cripple UK science, warn top scientists	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal Society, 2018, TOP SCI APP BREX PRE	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4468	10.1136/bmj.k4468	http://dx.doi.org/10.1136/bmj.k4468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PE	30352812				2022-12-28	WOS:000448893800006
J	Dyer, C				Dyer, Clare			Cardiologist is struck off after making unwanted sexual advance towards student	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2017, BMJ-BRIT MED J, V357, P66282, DOI DOI 10.1136/BMJ.J2651	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2018	363								k4460	10.1136/bmj.k4460	http://dx.doi.org/10.1136/bmj.k4460			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OW	30348881				2022-12-28	WOS:000448892800010
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... hospital car parking	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2018, BBC NEWS JUN; NHS Digital, 2018, EST RET INF COLL ENG; Welsh Government, 2008, REF HOSP PARK CHARG	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2018	363								k4447	10.1136/bmj.k4447	http://dx.doi.org/10.1136/bmj.k4447			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OW	30348654				2022-12-28	WOS:000448892800007
J	Chesterton, LS; Blagojevic-Bucknall, M; Burton, C; Dziedzic, KS; Davenport, G; Jowett, SM; Myers, HL; Oppong, R; Rathod-Mistry, T; van der Windt, DA; Hay, EM; Roddy, E				Chesterton, Linda S.; Blagojevic-Bucknall, Milica; Burton, Claire; Dziedzic, Krysia S.; Davenport, Graham; Jowett, Sue M.; Myers, Helen L.; Oppong, Raymond; Rathod-Mistry, Trishna; van der Windt, Danielle A.; Hay, Elaine M.; Roddy, Edward			The clinical and cost-effectiveness of corticosteroid injection versus night splints for carpal tunnel syndrome (INSTINCTS trial): an open-label, parallel group, randomised controlled trial	LANCET			English	Article							LOCAL STEROID INJECTION; METHYLPREDNISOLONE; SYMPTOMS; MODERATE	Background To our knowledge, the comparative effectiveness of commonly used conservative treatments for carpal tunnel syndrome has not been evaluated previously in primary care. We aimed to compare the clinical and cost-effectiveness of night splints with a corticosteroid injection with regards to reducing symptoms and improving hand function in patients with mild or moderate carpal tunnel syndrome. Methods We did this randomised, open-label, pragmatic trial in adults (>= 18 years) with mild or moderate carpal tunnel syndrome recruited from 25 primary and community musculoskeletal clinics and services. Patients with a new episode of idiopathic mild or moderate carpal tunnel syndrome of at least 6 weeks' duration were eligible. We randomly assigned (1: 1) patients (permutated blocks of two and four by site) with an online web or third party telephone service to receive either a single injection of 20 mg methylprednisolone acetate (from 40 mg/mL) or a night-resting splint to be worn for 6 weeks. Patients and clinicians could not be masked to the intervention. The primary outcome was the overall score of the Boston Carpal Tunnel Questionnaire (BCTQ) at 6 weeks. We used intention-to-treat analysis, with multiple imputation for missing data, which was concealed to treatment group allocation. The trial is registered with the European Clinical Trials Database, number 2013-001435-48, and ClinicalTrial.gov, number NCT02038452. Findings Between April 17, 2014, and Dec 31, 2016, 234 participants were randomly assigned (118 to the night splint group and 116 to the corticosteroid injection group), of whom 212 (91%) completed the BCTQ at 6 weeks. The BCTQ score was significantly better at 6 weeks in the corticosteroid injection group (mean 2.02 [SD 0.81]) than the night splint group (2.29 [0.75]; adjusted mean difference -0.32; 95% CI -0.48 to -0.16; p= 0.0001). No adverse events were reported. Interpretation A single corticosteroid injection shows superior clinical effectiveness at 6 weeks compared with night-resting splints, making it the treatment of choice for rapid symptom response in mild or moderate carpal tunnel syndrome presenting in primary care. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Chesterton, Linda S.; Blagojevic-Bucknall, Milica; Burton, Claire; Dziedzic, Krysia S.; Davenport, Graham; Jowett, Sue M.; Myers, Helen L.; Oppong, Raymond; Rathod-Mistry, Trishna; van der Windt, Danielle A.; Hay, Elaine M.; Roddy, Edward] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Myers, Helen L.] Keele Univ, Keele Clin Trials Unit, Keele, Staffs, England; [Roddy, Edward] Staffordshire & Stoke On Trent Partnership NHS Tr, Haywood Hosp, Haywood Acad Rheumatol Ctr, Stoke On Trent, Staffs, England; [Jowett, Sue M.; Oppong, Raymond] Univ Birmingham, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England	Keele University; Keele University; University of Birmingham	Roddy, E (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	e.roddy@keele.ac.uk	Oppong, Raymond/AAV-5867-2020; Jowett, Sue/AAO-4198-2021; Burton, Claire/AAB-1782-2021	Oppong, Raymond/0000-0002-0815-4616; Jowett, Sue/0000-0001-8936-3745; Burton, Claire/0000-0003-4688-3075; Rathod-Mistry, Trishna/0000-0002-6369-4746; van der Windt, Danielle/0000-0002-7248-6703; Blagojevic-Bucknall, Milica/0000-0001-7230-7771	Arthritis Research UK; Arthritis Research UK [20105]; NIHR [KMRF-2014-03-002]; NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands; Keele Clinical Trials Unit (CTU)	Arthritis Research UK(Versus Arthritis); Arthritis Research UK(Versus Arthritis); NIHR(National Institute for Health Research (NIHR)); NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands; Keele Clinical Trials Unit (CTU)	Arthritis Research UK.; This paper presents independent research funded by an Arthritis Research UK grant (Grant Number 20105). EMH is a National Institute for Health Research (NIHR) senior investigator. KSD is part-funded by a Knowledge Mobilisation Research Fellowship (KMRF-2014-03-002) from the NIHR and the NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands. The views expressed in this paper are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care. This project was undertaken with the support of Keele Clinical Trials Unit (CTU). The authors would like to thank all staff in the CTU involved in the study. We would also like to thank participating clinicians, managerial and administrative staff at clinical sites, the NIHR Clinical Research Networks, members of the Keele Research User Group, and members of the trial steering committee and data monitoring committee.	Aroori Somaiah, 2008, Ulster Med J, V77, P6; Arthritis Research UK, SPLINTS ARTHR WRIST; Arthritis Research UK, CARPAL TUNNEL SYNDRO; Arthritis Research UK, STER INJ; Atroshi I, 1999, J HAND SURG-AM, V24A, P398, DOI 10.1053/jhsu.1999.0398; Atroshi I, 2013, ANN INTERN MED, V159, P309, DOI 10.7326/0003-4819-159-5-201309030-00004; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; Bland JDP, 2017, ORTHOPEDICS, V40, P198, DOI 10.3928/01477447-20170627-01; BMJ Group, 2017, BRIT NAT FORM BNF, P72; Burton C, 2014, BRIT J GEN PRACT, V64, P262, DOI 10.3399/bjgp14X679903; Burton CL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020166; Chesterton LS, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1264-8; Curtis L, 2017, UNIT COSTS HLTH SOCI, DOI DOI 10.22024/UNIKENT/01.02.79286; Dammers JWHH, 2006, J NEUROL, V253, P574, DOI 10.1007/s00415-005-0062-2; De Angelis MV, 2009, ACTA NEUROL SCAND, V119, P68, DOI 10.1111/j.1600-0404.2008.01072.x; Department of Health, NHS REF COSTS 2016 1; Eslamian F, 2017, J CLIN NEUROPHYSIOL, V34, P107, DOI 10.1097/WNP.0000000000000342; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Graham B, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.16.00719; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Huisstede BM, 2014, ARCH PHYS MED REHAB, V95, P2253, DOI 10.1016/j.apmr.2014.06.022; Huisstede BM, 2010, ARCH PHYS MED REHAB, V91, P981, DOI 10.1016/j.apmr.2010.03.022; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Lee JH, 2009, CLIN J PAIN, V25, P111, DOI 10.1097/AJP.0b013e3181847a19; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; NICE, 2017, POS STAT US EQ 5D 5L; Office for National Statistics, 2000, STAND OCC CLASS 2000; Padua L, 2016, LANCET NEUROL, V15, P1271, DOI 10.1016/S1474-4422(16)30231-9; Page MJ, 2012, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD010003, DOI 10.1002/14651858.CD010003.PMID:22786532]; Peters-Veluthamaningal C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-54; Sevim S, 2004, NEUROL SCI, V25, P48, DOI 10.1007/s10072-004-0229-0; So H, 2018, INT J RHEUM DIS, V21, P102, DOI 10.1111/1756-185X.13162; Spies-Dorgelo MN, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-87; The British Society for Surgery of the Hand, 2012, BSSH EV SURG TREATM; Ucan H, 2006, RHEUMATOL INT, V27, P45, DOI 10.1007/s00296-006-0163-y; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	36	44	44	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1423	1433		10.1016/S0140-6736(18)31572-1	http://dx.doi.org/10.1016/S0140-6736(18)31572-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX5PD	30343858	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000447800900025
J	Kluge, H; Kelley, E; Barkley, S; Theodorakis, PN; Yamamoto, N; Tsoy, A; Aiypkhanova, A; Ganesh, V; Hipgrave, DB; Peterson, SS; Valderas, JM; Mossialos, E				Kluge, Hans; Kelley, Ed; Barkley, Shannon; Theodorakis, Pavlos N.; Yamamoto, Naoko; Tsoy, Alexey; Aiypkhanova, Ainur; Ganesh, Vidhya; Hipgrave, David B.; Peterson, Stefan Swartling; Valderas, Jose M.; Mossialos, Elias			How primary health care can make universal health coverage a reality, ensure healthy lives, and promote wellbeing for all	LANCET			English	Editorial Material									[Kluge, Hans; Theodorakis, Pavlos N.] World Hlth Org, Reg Off Europe, Div Hlth Syst & Publ Hlth, Copenhagen, Denmark; [Kelley, Ed] World Hlth Org, Dept Serv Delivery & Safety, CH-1202 Geneva, Switzerland; [Yamamoto, Naoko] World Hlth Org, Universal Hlth Coverage & Hlth Syst, CH-1202 Geneva, Switzerland; [Tsoy, Alexey; Aiypkhanova, Ainur] Govt Kazakhstan, Minist Healthcare, Astana, Kazakhstan; [Ganesh, Vidhya; Hipgrave, David B.; Peterson, Stefan Swartling] United Nations Childrens Fund, New York, NY USA; [Valderas, Jose M.] Univ Exeter, Univ Hlth Serv & Policy Res Grp, APEx Collaborat Acad Primary Care, Exeter, Devon, England; [Mossialos, Elias] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England	World Health Organization; World Health Organization; World Health Organization; UNICEF; University of Exeter; University of London; London School Economics & Political Science	Kelley, E (corresponding author), World Hlth Org, Dept Serv Delivery & Safety, CH-1202 Geneva, Switzerland.	kelleye@who.int	Valderas, Jose M/G-7967-2014; Mossialos, Elias/ABE-1301-2021; Valderas, Jose M/Y-9814-2019	Valderas, Jose M/0000-0002-9299-1555; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		*WHO, 1978, ALM AT 1978 PRIM HLT; WHO, 2008, PHARMAFORUM 0121	3	19	19	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1372	1374		10.1016/S0140-6736(18)32482-6	http://dx.doi.org/10.1016/S0140-6736(18)32482-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343844	Green Accepted			2022-12-28	WOS:000447800900006
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			TOXIN OR TREATMENT?	SCIENCE			English	Editorial Material																			0	3	3	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					278	282		10.1126/science.362.6412.278	http://dx.doi.org/10.1126/science.362.6412.278			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337393				2022-12-28	WOS:000447680100022
J	Dyer, O				Dyer, Owen			NEJM retracts article from former researcher once hailed as heart stem cell pioneer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							C-KIT(+) CELLS											[Anonymous], 2014, Circulation, V129, pe466, DOI 10.1161/CIR.0000000000000049; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; ClinicalTrials, RECR COMB MES C KIT; Drazen JM, 2018, NEW ENGL J MED, V379, P1870, DOI [10.1056/NEJMe1813801, 10.1056/NEJMe1813802]; Stern V., 2018, STEM CELL RES INVEST; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; 2014, LANCET, V383, P1279	8	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4432	10.1136/bmj.k4432	http://dx.doi.org/10.1136/bmj.k4432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341057				2022-12-28	WOS:000448271300010
J	Leeming, J				Leeming, Jack			Strength in isolation	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2018	562	7727					S105	S107		10.1038/d41586-018-07045-1	http://dx.doi.org/10.1038/d41586-018-07045-1			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX5RE	30333605	Bronze			2022-12-28	WOS:000447807100013
J	Cotsapas, C				Cotsapas, Chris		Int Multiple Sclerosis Genetics	Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk	CELL			English	Article							GENOME-WIDE ASSOCIATION; GENETIC RISK; VARIANTS; METAANALYSIS; REPLICATION; POPULATION; LINKAGE	Multiple sclerosis is a complex neurological disease, with similar to 20% of risk heritability attributable to common genetic variants, including >230 identified by genome-wide association studies. Multiple strands of evidence suggest that much of the remaining heritability is also due to additive effects of common variants rather than epistasis between these variants or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that up to 5% of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common-variant signals, highlighting key pathogenic roles for regulatory T cell homeostasis and regulation, IFN gamma biology, and NF kappa B signaling. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS.				chris.cotsapas@yale.edu	Galimberti, Daniela/N-7209-2019; Leone, Maurizio A./J-4130-2016; Goris, An/L-5852-2019; Damotte, Vincent/ABH-4760-2020; Mascia, Elisabetta/AAN-6577-2020; Van Damme, Philip/A-6464-2009; Goris, An/F-2943-2010; Kockum, Ingrid/O-8781-2018; Piccio, Laura/AAE-1706-2020; Comi, Cristoforo/I-2117-2019; Dubois, Benedicte/A-4338-2019; Montalban, Xavier/J-5938-2016; Ferrè, Laura/AAN-5847-2020; Andlauer, Till/AAV-1893-2020; Comi, Cristoforo/A-7495-2014; Esposito, Federica/K-6537-2016; Agliardi, Cristina/K-1401-2016; D'Alfonso, Sandra/K-7295-2014; Charlesworth, Jac/J-7661-2014; Stridh, Pernilla/J-2918-2012; Jelcic, Ilijas/K-5912-2019; Zipp, Frauke/C-9968-2015; Ziegler, Andreas/G-4246-2012; Lill, Christina/J-9449-2015	Galimberti, Daniela/0000-0002-9284-5953; Leone, Maurizio A./0000-0002-6339-5738; Goris, An/0000-0002-1276-6682; Damotte, Vincent/0000-0002-7321-8575; Mascia, Elisabetta/0000-0002-8227-9943; Van Damme, Philip/0000-0002-4010-2357; Goris, An/0000-0002-1276-6682; Kockum, Ingrid/0000-0002-0867-4726; Piccio, Laura/0000-0002-8760-109X; Comi, Cristoforo/0000-0002-6862-9468; Dubois, Benedicte/0000-0003-0604-8702; Montalban, Xavier/0000-0002-0098-9918; Ferrè, Laura/0000-0002-0559-5301; Andlauer, Till/0000-0002-2917-5889; Comi, Cristoforo/0000-0002-6862-9468; Cusi, Daniele/0000-0002-1006-7597; Sellebjerg, Finn/0000-0002-1333-9623; McCauley, Jacob/0000-0002-1805-1733; Esposito, Federica/0000-0003-2550-0805; Thorner, Lise Wegner/0000-0003-4391-4956; Booth, David/0000-0001-8580-2384; Hysi, Pirro/0000-0001-5752-2510; Agliardi, Cristina/0000-0003-2022-3386; D'Alfonso, Sandra/0000-0002-3983-9925; Comabella Lopez, Manuel/0000-0002-2373-6657; Rapa, Anna/0000-0002-5523-5224; Charlesworth, Jac/0000-0001-6201-3518; Fitzgerald, Kathryn/0000-0003-3137-0322; Van Duijn, Cornelia/0000-0002-2374-9204; Stridh, Pernilla/0000-0003-4855-0039; Ullum, Henrik/0000-0001-7306-9058; Sospedra, Mireia/0000-0001-8333-7423; martinelli boneschi, filippo/0000-0002-9955-1368; Jelcic, Ilijas/0000-0003-3090-7319; Baranzini, Sergio/0000-0003-0067-194X; Dardiotis, Efthimios/0000-0003-2957-641X; Gasperi, Christiane/0000-0002-0524-6005; Zipp, Frauke/0000-0002-1231-1928; Ziegler, Andreas/0000-0002-8386-5397; Saarela, Janna/0000-0002-0853-6219; Sondergaard, Helle Bach/0000-0001-9435-0658; Cotsapas, Chris/0000-0002-7772-5910; Lill, Christina/0000-0002-2805-1307; D'hooghe, Marie/0000-0002-0917-4176	NHMRC [APP605511]; Research Foundation Flanders (FWO-Vlaanderen) [G.0734.15]; Research Fund KU Leuven [C24/16/045]; US National Institute of Neurological Disorders and Stroke, National Institutes of Health [U01-NS069208]; German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" [KKNMS]) [01GI0916, 01G10917]; Munich Cluster for Systems Neurology (SyNergy); Helmholtz Zentrum Munchen-German Research Center for Environmental Health - BMBF; State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; German Ministry for Education and Research [01EY1103]; Heinz Nixdorf Foundation Germany; BMBF; Deutsche Forschungsgemeinschaft (DFG) [ER 155/6-1, ER 155/6-2]; Italian Foundation for Multiple Sclerosis (FISM grants, special project "Immunochip") [2011/R/1, 2015/R/10]; Fondazione Cariplo [2010-0728]; Norway; Odda MS Society; Research Council of Norway [240102_Harbo]; Swedish Medical Research Council; Swedish Research Council for Health, Working Life, and Welfare; Knut and Alice Wallenberg Foundation; AFA insurance; Swedish Brain Foundation; Swedish Association for Persons with Neurological Disabilities; AstraZeneca Science for Life grant [085475/B/08/Z, 085475/Z/08/Z]; Medical Research Council; Wellcome Trust [068545/Z/02]; (Wellcome Trust); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre, UK Medical Research Council [G1100125]; UK MS Society [861/07]; NHS Blood and Transplant - Wellcome Trust; European Union; Biomedical Research Centre based at Guy's and St. Thomas's NHS Foundation Trust; King's College London; NIHR Oxford Biomedical Research Centre Programme; UK MS Society Tissue Bank [910/09]; USA; US National Multiple Sclerosis Society [RG-4680-A-1]; NIH [R01-NS096212, R01-NS049477, R01-NS026799]; MRC [G1100125] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, U01NS069208, R01NS096212, R01NS049477] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Research Fund KU Leuven(KU Leuven); US National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" [KKNMS])(Federal Ministry of Education & Research (BMBF)); Munich Cluster for Systems Neurology (SyNergy); Helmholtz Zentrum Munchen-German Research Center for Environmental Health - BMBF; State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Heinz Nixdorf Foundation Germany; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Italian Foundation for Multiple Sclerosis (FISM grants, special project "Immunochip"); Fondazione Cariplo(Fondazione Cariplo); Norway; Odda MS Society; Research Council of Norway(Research Council of Norway); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Research Council for Health, Working Life, and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); AFA insurance; Swedish Brain Foundation; Swedish Association for Persons with Neurological Disabilities; AstraZeneca Science for Life grant(AstraZeneca); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); (Wellcome Trust)(Wellcome Trust); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre, UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MS Society; NHS Blood and Transplant - Wellcome Trust(Wellcome Trust); European Union(European Commission); Biomedical Research Centre based at Guy's and St. Thomas's NHS Foundation Trust; King's College London(General Electric); NIHR Oxford Biomedical Research Centre Programme; UK MS Society Tissue Bank; USA; US National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Australia; Sample collection and genotyping was supported by NHMRC project grant APP605511.; Belgium; B.D., R.L., and P.V.D. are Clinical Investigators of the Research Foundation Flanders (FWO-Vlaanderen). A.G. and B.D. are supported by the Research Fund KU Leuven (C24/16/045) and the Research Foundation Flanders (FWO-Vlaanderen) (G.0734.15). The SiGN study was funded by a cooperative agreement grant from the US National Institute of Neurological Disorders and Stroke, National Institutes of Health (U01-NS069208).; Germany; We would like to thank Verena Grummel and Nadine Miksch for technical support. We thank Sabine Fleischer for continuous and extensive support with biobanking logistics. This work was supported by the German Ministry for Education and Research (BMBF, "German Competence Network Multiple Sclerosis" [KKNMS]) [01GI0916, 01G10917] and the Munich Cluster for Systems Neurology (SyNergy). The KORA study was initiated and financed by the Helmholtz Zentrum Munchen-German Research Center for Environmental Health, which is funded by the BMBF and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The popgen 2.0 network is supported by a grant from the German Ministry for Education and Research (01EY1103). The Heinz Nixdorf Recall Study was supported by the Heinz Nixdorf Foundation Germany, the BMBF, and the Deutsche Forschungsgemeinschaft (DFG; ER 155/6-1, ER 155/6-2).; Italy; Sample collection and genotyping was supported by the Italian Foundation for Multiple Sclerosis (FISM grants, special project "Immunochip" 2011/R/1, 2015/R/10) and Fondazione Cariplo (grant 2010-0728).; Norway; The Norwegian MS and control samples were collected and funded in collaboration between the multiple sclerosis research group in at Oslo University Hospital/University in Oslo, the Norwegian MS Registry and Biobank in Bergen, and the Norwegian Bone Marrow Registry, supported by the Oslo MS Association, Bergen MS Society, Odda MS Society, and the Research Council of Norway (grant 240102_Harbo).; Sweden; Sample collection and genotyping was supported by the Swedish Medical Research Council; Swedish Research Council for Health, Working Life, and Welfare; Knut and Alice Wallenberg Foundation; AFA insurance; Swedish Brain Foundation; the Swedish Association for Persons with Neurological Disabilities; and AstraZeneca Science for Life grant.; UK; This study makes use of data generated as part of the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z and 085475/Z/08/Z), including data from the British 1958 Birth Cohort DNA collection (funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02) and the UK National Blood Service controls (funded by the Wellcome Trust). The study was supported by the Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre, UK Medical Research Council (G1100125) and the UK MS Society (861/07). We thank the NIHR and NHS Blood and Transplant. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, and the NIHR-funded BioResource, Clinical Research Facility, and Biomedical Research Centre based at Guy's and St. Thomas's NHS Foundation Trust in partnership with King's College London. We thank the volunteers from the Oxford Biobank (https://www.exfordblobank.org.uk/) for their participation. The recall process was supported by the NIHR Oxford Biomedical Research Centre Programme. The recall process was supported by the NIHR Oxford Biomedical Research Centre Programme. We thank Neil Robertson, Sam Loveless, Richard Reynolds, and John Zajicek for contributing case samples from the UK. The study makes use of material from the UK MS Society Tissue Bank (grant no 910/09) provided by Richard Reynolds.; USA; We thank the Biorepository Facility and the Center for Genome Technology laboratory personnel (specifically Sandra West, Simone Clarke, Daniela Martinez, and Patrice Whitehead) within the John P. Hussman Institute for Human Genomics at the University of Miami for centralized DNA handling and genotyping for this project. Related funding support is from the US National Multiple Sclerosis Society (grant RG-4680-A-1) and the NIH (R01-NS096212, R01-NS049477, and R01-NS026799). The IMSGC wishes to acknowledge William and Lois Edgerly, John and Elaine Carlos, Martha Crowninshield, and William and Cindy Fowler, whose enduring committments were critical in creation of the consortium.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Andlauer TFM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501678; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Binder MD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005853; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Dankowski T, 2015, GENET EPIDEMIOL, V39, P601, DOI 10.1002/gepi.21933; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; House IG, 2015, IMMUNOL CELL BIOL, V93, P575, DOI 10.1038/icb.2015.1; Housley WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9223; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Mancuso N, 2016, NAT GENET, V48, P30, DOI 10.1038/ng.3446; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Martinelli-Boneschi F, 2012, MULT SCLER J, V18, P1384, DOI 10.1177/1352458512439118; Moutsianas L, 2015, NAT GENET, V47, P1107, DOI 10.1038/ng.3395; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nischwitz S, 2010, J NEUROIMMUNOL, V227, P162, DOI 10.1016/j.jneuroim.2010.06.003; Pankratz N, 2016, NAT GENET, V48, P867, DOI 10.1038/ng.3607; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; R Development Core Team, 2017, R LANG ENV STAT COMP; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schoech A, 2017, BIORXIV, DOI [10.1101/188086, DOI 10.1101/188086]; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Westerlind H, 2014, BRAIN, V137, P770, DOI 10.1093/brain/awt356; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zeng J, 2018, NAT GENET, V50, P746, DOI 10.1038/s41588-018-0101-4	47	69	70	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	2018	175	6					1679	+		10.1016/j.cell.2018.09.049	http://dx.doi.org/10.1016/j.cell.2018.09.049			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HC4KG	30343897	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000451771700024
J	Harrington, LB; Burstein, D; Chen, JS; Paez-Espino, D; Ma, E; Witte, IP; Cofsky, JC; Kyrpides, NC; Banfield, JF; Doudna, JA				Harrington, Lucas B.; Burstein, David; Chen, Janice S.; Paez-Espino, David; Ma, Enbo; Witte, Isaac P.; Cofsky, Joshua C.; Kyrpides, Nikos C.; Banfield, Jillian F.; Doudna, Jennifer A.			Programmed DNA destruction by miniature CRISPR-Cas14 enzymes	SCIENCE			English	Article							RNA; TOOL; CLASSIFICATION; DIVERSITY; EVOLUTION; CLEAVAGE; VERSION	CRISPR-Cas systems provide microbes with adaptive immunity to infectious nucleic acids and are widely employed as genome editing tools. These tools use RNA-guided Cas proteins whose large size (950 to 1400 amino acids) has been considered essential to their specific DNA- or RNA-targeting activities. Here we present a set of CRISPR-Cas systems from uncultivated archaea that contain Cas14, a family of exceptionally compact RNA-guided nucleases (400 to 700 amino acids). Despite their small size, Cas14 proteins are capable of targeted single-stranded DNA (ssDNA) cleavage without restrictive sequence requirements. Moreover, target recognition by Cas14 triggers nonspecific cutting of ssDNA molecules, an activity that enables high-fidelity single-nucleotide polymorphism genotyping (Cas14-DETECTR). Metagenomic data show that multiple CRISPR-Cas14 systems evolved independently and suggest a potential evolutionary origin of single-effector CRISPR-based adaptive immunity.	[Harrington, Lucas B.; Chen, Janice S.; Ma, Enbo; Witte, Isaac P.; Cofsky, Joshua C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Burstein, David; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Paez-Espino, David; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Banfield, Jillian F.; Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Harrington, Lucas B.; Chen, Janice S.] Mammoth Biosci, San Francisco, CA 94107 USA; [Burstein, David] Tel Aviv Univ, Sch Mol Cell Biol & Biotechnol, IL-69978 Tel Aviv, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Tel Aviv University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Kyrpides, Nikos C./A-6305-2014; Burstein, David/Y-7993-2019	Kyrpides, Nikos C./0000-0002-6131-0462; Burstein, David/0000-0002-6219-1880; Witte, Isaac/0000-0002-3879-0306; Chen, Janice/0000-0003-4797-3056; Banfield, Jill/0000-0001-8203-8771; Cofsky, Joshua/0000-0001-5403-8555	Paul Allen Frontiers Group; U.S. National Science Foundation Graduate Research Fellowships; Frontiers Science award from the Paul Allen Institute; National Science Foundation [MCB-1244557]; Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area - U.S. Department of Energy [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295] Funding Source: NIH RePORTER	Paul Allen Frontiers Group; U.S. National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Frontiers Science award from the Paul Allen Institute; National Science Foundation(National Science Foundation (NSF)); Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area - U.S. Department of Energy; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.B. was supported by a grant from the Paul Allen Frontiers Group. L.B.H., J.C.C., and J.S.C. were supported by U.S. National Science Foundation Graduate Research Fellowships. J.A.D. is an investigator of the Howard Hughes Medical Institute. This work was supported in part by a Frontiers Science award from the Paul Allen Institute to J.A.D. and J.F.B., a grant from the National Science Foundation (MCB-1244557 to J.A.D.), the Lawrence Berkeley National Laboratory's Sustainable Systems Scientific Focus Area funded by the U.S. Department of Energy (DE-AC02-05CH11231 to J.F.B.), and the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Biswas A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2627-0; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Castelle CJ, 2015, CURR BIOL, V25, P690, DOI 10.1016/j.cub.2015.01.014; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Chen JS, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0078; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Harrington LB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01408-4; Harrington LB, 2017, CELL, V170, P1224, DOI 10.1016/j.cell.2017.07.037; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Knott GJ, 2017, NAT STRUCT MOL BIOL, V24, P825, DOI 10.1038/nsmb.3466; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li SY, 2018, CELL RES, V28, P491, DOI 10.1038/s41422-018-0022-x; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Probst AJ, 2017, ENVIRON MICROBIOL, V19, P459, DOI 10.1111/1462-2920.13362; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Yoshida M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00075; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	42	412	450	88	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2018	362	6416			SI		839	+		10.1126/science.aav4294	http://dx.doi.org/10.1126/science.aav4294			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7TZ	30337455	Green Accepted, Green Submitted			2022-12-28	WOS:000450488500055
J	Xie, Q; Wu, TP; Gimple, RC; Li, Z; Prager, BC; Wu, QL; Yu, Y; Wang, PC; Wang, YS; Gorkin, DU; Zhang, C; Dowiak, AV; Lin, KX; Zeng, C; Sui, YH; Kim, LJY; Miller, TE; Jiang, L; Lee, CH; Huang, Z; Fang, XG; Zhai, K; Mack, SC; Sander, M; Bao, SD; Kerstetter-Fogle, AE; Sloan, AE; Xiao, AZ; Rich, JN				Xie, Qi; Wu, Tao P.; Gimple, Ryan C.; Li, Zheng; Prager, Briana C.; Wu, Qiulian; Yu, Yang; Wang, Pengcheng; Wang, Yinsheng; Gorkin, David U.; Zhang, Cheng; Dowiak, Alexis V.; Lin, Kaixuan; Zeng, Chun; Sui, Yinghui; Kim, Leo J. Y.; Miller, Tyler E.; Jiang, Li; Lee, Christine H.; Huang, Zhi; Fang, Xiaoguang; Zhai, Kui; Mack, Stephen C.; Sander, Maike; Bao, Shideng; Kerstetter-Fogle, Amber E.; Sloan, Andrew E.; Xiao, Andrew Z.; Rich, Jeremy N.			N-6-methyladenine DNA Modification in Glioblastoma	CELL			English	Article							READ ALIGNMENT; STEM-CELL; METHYLATION; HYPOMETHYLATION; TRANSCRIPTION; GENES; N-6-METHYLDEOXYADENOSINE; VISUALIZATION; N-6-ADENINE; ELEMENTS	Genetic drivers of cancer can be dysregulated through epigenetic modifications of DNA. Although the critical role of DNA 5-methylcytosine (5mC) in the regulation of transcription is recognized, the functions of other non-canonical DNA modifica-tions remain obscure. Here, we report the identifi-cation of novel N-6-methyladenine (N-6-mA) DNA modifications in human tissues and implicate this epigenetic mark in human disease, specifically the highly malignant brain cancer glioblastoma. Glioblastoma markedly upregulated N-6-mA levels, which co-localized with heterochromatic histone modifications, predominantly H3K9me3. N-6-mA levels were dynamically regulated by the DNA demethylase ALKBH1, depletion of which led to transcriptional silencing of oncogenic pathways through decreasing chromatin accessibility. Targeting the N-6-mA regulator ALKBH1 in patient-derived human glioblastoma models inhibited tumor cell proliferation and extended the survival of tumorbearing mice, supporting this novel DNA modification as a potential therapeutic target for glioblastoma. Collectively, our results uncover a novel epigenetic node in cancer through the DNA modification N-6-mA.	[Xie, Qi; Gimple, Ryan C.; Prager, Briana C.; Wu, Qiulian; Kim, Leo J. Y.; Jiang, Li; Rich, Jeremy N.] Univ Calif San Diego, Div Regenerat Med, Dept Med, La Jolla, CA 92037 USA; [Wu, Tao P.; Li, Zheng; Lin, Kaixuan; Xiao, Andrew Z.] Yale Sch Med, Dept Genet, New Haven, CT 06520 USA; [Wu, Tao P.; Li, Zheng; Lin, Kaixuan; Xiao, Andrew Z.] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Gimple, Ryan C.; Prager, Briana C.; Kim, Leo J. Y.; Miller, Tyler E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44120 USA; [Prager, Briana C.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA; [Yu, Yang; Wang, Pengcheng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Gorkin, David U.; Zhang, Cheng; Dowiak, Alexis V.] Univ Calif San Diego, Dept Cellular & Mol Med, Ctr Epigen, San Diego, CA 92037 USA; [Zeng, Chun; Sui, Yinghui; Sander, Maike] Univ Calif San Diego, Dept Pediat, Pediat Diabet Res Ctr, San Diego, CA 92093 USA; [Zeng, Chun; Sui, Yinghui; Sander, Maike] Univ Calif San Diego, Dept Cellular & Mol Med, Pediat Diabet Res Ctr, San Diego, CA 92093 USA; [Lee, Christine H.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Huang, Zhi; Fang, Xiaoguang; Zhai, Kui; Bao, Shideng] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Mack, Stephen C.] Texas Childrens Hosp, Div Hematol & Oncol, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kerstetter-Fogle, Amber E.; Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Kerstetter-Fogle, Amber E.; Sloan, Andrew E.] Univ Hosp, Dept Neurol Surg, Cleveland Med Ctr, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA; [Wu, Tao P.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA	University of California System; University of California San Diego; Yale University; Yale University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University of California System; University of California Riverside; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Case Western Reserve University; Cleveland Clinic Foundation; Baylor College of Medicine; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Louis Stokes Cleveland Veterans Affairs Medical Center; University of California System; University of California San Diego; Baylor College of Medicine	Rich, JN (corresponding author), Univ Calif San Diego, Div Regenerat Med, Dept Med, La Jolla, CA 92037 USA.; Xiao, AZ (corresponding author), Yale Sch Med, Dept Genet, New Haven, CT 06520 USA.; Xiao, AZ (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.; Rich, JN (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA.	andrew.xiao@yale.edu; drjeremyrich@gmail.com	Sloan, Andrew/AAE-9842-2020; Gimple, Ryan/AAU-8944-2020; li, zheng/AAI-1750-2020; Wang, Yin/HCI-9352-2022; Rich, Jeremy/AAM-1445-2021; Wu, Tao/A-1063-2013	li, zheng/0000-0002-4987-0205; Wu, Tao/0000-0002-9859-4534; Zeng, Chun/0000-0001-9034-7873; Wang, Pengcheng/0000-0003-4581-983X; Lee, Lee-Poturalski, Christine/0000-0002-3383-6360; Dowiak, Alexis/0000-0002-6554-8013; Xie, Qi/0000-0002-2370-2078; Zhai, Kui/0000-0003-4725-190X	Ludwig Family Foundation; CPRIT scholar award; Alex's Lemonade Stand Foundation young investigator award; BEAR Necessities Pediatric Cancer Foundation; Children's Cancer Research Fund; Baylor College of Medicine [NS089272, A217956-01, CA187780]; Coulter Foundation; Ferry Foundation; Kimble Foundation; Gerald Kaufman Jr. Foundation; Peter D. Cristal Chair at University Hospitals;  [DK104202];  [DK112155];  [DK078803];  [DK068471];  [CA184090];  [NS091080];  [NS099175];  [CA217065];  [CA203101];  [R01GM114205];  [CA197718];  [CA154130];  [CA169117];  [CA171652];  [NS087913];  [NS103434]; NATIONAL CANCER INSTITUTE [R01CA187780, R01CA169117, F30CA203101, F30CA217066, F30CA217065, R35CA197718, R01CA184090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK112155, R01DK078803, R01DK068471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114205, T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091080, R01NS087913, R01NS099175, R01NS089272, R01NS103434] Funding Source: NIH RePORTER	Ludwig Family Foundation; CPRIT scholar award; Alex's Lemonade Stand Foundation young investigator award; BEAR Necessities Pediatric Cancer Foundation; Children's Cancer Research Fund; Baylor College of Medicine; Coulter Foundation; Ferry Foundation; Kimble Foundation; Gerald Kaufman Jr. Foundation; Peter D. Cristal Chair at University Hospitals; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank JingTian Zhou (Bioinformatics and Systems Biology, UCSD) for analysis of bisulfite sequencing. We thank Erik Sulman (MD Anderson Cancer Center) for providing the GSC23 glioblastoma cell model. We thank our funding sources: DK104202, DK112155, DK078803, and DK068471 (to M.S.); CA184090, NS091080, and NS099175 (to S.B.); CA217066 (to B.C.P.); CA217065 (to R.C.G.); CA203101 (to L.J.Y.K.); R01GM114205-01 and the Ludwig Family Foundation (to A.Z.X.); CA197718, CA154130, CA169117, CA171652, NS087913, NS089272, and NS103434 (to J.N.R.); a CPRIT scholar award, an Alex's Lemonade Stand Foundation young investigator award, a Rally research grant, a BEAR Necessities Pediatric Cancer Foundation grant, a Children's Cancer Research Fund award, and a Baylor College of Medicine junior faculty award (to S.C.M.); and A217956-01, CA187780, NS089272, as well as the Coulter Foundation, Ferry Foundation, Kimble Foundation, Gerald Kaufman Jr. Foundation, and the Peter D. Cristal Chair at University Hospitals (to A.E.S.). The graphical abstract was prepared in part using images from Servier Medical Art by Servier (https://smart.servier.com/), which is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/).	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fu Y, 2015, CELL, V161, P879, DOI 10.1016/j.cell.2015.04.010; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu P, 2010, MOL CELL BIOL, V30, P4245, DOI 10.1128/MCB.00218-10; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; O'Brown ZK, 2016, ADV EXP MED BIOL, V945, P213, DOI 10.1007/978-3-319-43624-1_10; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROGERS JC, 1995, PLANT J, V7, P221, DOI 10.1046/j.1365-313X.1995.7020221.x; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soneson C., 2016, F1000RES, V4, DOI [10.12688/F1000RESEARCH.7563.2. F1000Research, DOI 10.12688/F1000RESEARCH.7563.2]; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; VANYUSHIN BF, 1968, NATURE, V218, P1066, DOI 10.1038/2181066a0; Widschwendter M, 2004, CANCER RES, V64, P4472, DOI 10.1158/0008-5472.CAN-04-0238; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zhang SW, 2017, J ADV CERAM, V6, P1, DOI 10.1007/s40145-016-0209-x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268; Zhu SJ, 2018, GENOME RES, V28, P1067, DOI 10.1101/gr.231068.117	59	151	152	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2018	175	5					1228	+		10.1016/j.cell.2018.10.006	http://dx.doi.org/10.1016/j.cell.2018.10.006			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HA5PX	30392959	hybrid, Green Accepted			2022-12-28	WOS:000450328800010
J	Torjesen, I				Torjesen, Ingrid			Medical conflicts of interest: when a declaration isn't enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												itorjesen@bmj.com						FDA, 2013, GUID CLIN INV IND FD; Great Ormond Street Hospital for Children NHS Foundation Trust, 2018, MAN DECL INT EMPL GU; NHS England, 2017, MAN CONFL INT NHS	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2018	363								k4660	10.1136/bmj.k4660	http://dx.doi.org/10.1136/bmj.k4660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2CX	30401785				2022-12-28	WOS:000450040400003
J	Voelker, R				Voelker, Rebecca			New Treatment for Certain Types of Leukemia and Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1746	1746		10.1001/jama.2018.16523	http://dx.doi.org/10.1001/jama.2018.16523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398587				2022-12-28	WOS:000449461800005
J	Arango-Ferreira, C; Castano, J				Arango-Ferreira, Catalina; Castano, Jorge			Parinaud's Oculoglandular Syndrome in Cat Scratch Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Arango-Ferreira, Catalina; Castano, Jorge] Univ Antioquia, Medellin, Colombia	Universidad de Antioquia	Arango-Ferreira, C (corresponding author), Univ Antioquia, Medellin, Colombia.	catarango52@hotmail.com							0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18							e31	10.1056/NEJMicm1804942	http://dx.doi.org/10.1056/NEJMicm1804942			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380392				2022-12-28	WOS:000448891600012
J	Deng, YJ; Yu, YJ; Song, YC; Zhang, JZ; Wang, NZ; Sun, ZY; Yi, YF; Wu, YZ; Wu, SW; Zhu, JY; Wang, J; Chen, XH; Zhang, YB				Deng, Yujun; Yu, Yijun; Song, Yichen; Zhang, Jingzhao; Wang, Nai Zhou; Sun, Zeyuan; Yi, Yangfan; Wu, Yi Zheng; Wu, Shiwei; Zhu, Junyi; Wang, Jing; Chen, Xian Hui; Zhang, Yuanbo			Gate-tunable room-temperature ferromagnetism in two-dimensional Fe3GeTe2	NATURE			English	Article							FINITE-SIZE; MAGNETIC-PROPERTIES; BEHAVIOR; SPINTRONICS; ANISOTROPY; CRYSTAL; FILMS	Materials research has driven the development of modern nano-electronic devices. In particular, research in magnetic thin films has revolutionized the development of spintronic devices(1,2) because identifying new magnetic materials is key to better device performance and design. Van der Waals crystals retain their chemical stability and structural integrity down to the monolayer and, being atomically thin, are readily tuned by various kinds of gate modulation(3,4). Recent experiments have demonstrated that it is possible to obtain two-dimensional ferromagnetic order in insulating Cr2Ge2Te6 ( ref. (5)) and CrI3 ( ref. (6)) at low temperatures. Here we develop a device fabrication technique and isolate monolayers from the layered metallic magnet Fe3GeTe2 to study magnetotransport. We find that the itinerant ferromagnetism persists in Fe3GeTe2 down to the monolayer with an out-of-plane magnetocrystalline anisotropy. The ferromagnetic transition temperature, T-c, is suppressed relative to the bulk T-c of 205 kelvin in pristine Fe3GeTe2 thin flakes. An ionic gate, however, raises T-c to room temperature, much higher than the bulk T-c. The gate-tunable room-temperature ferromagnetism in two-dimensional Fe3GeTe2 opens up opportunities for potential voltage-controlled magnetoelectronics(7-11) based on atomically thin van der Waals crystals.	[Deng, Yujun; Yu, Yijun; Song, Yichen; Sun, Zeyuan; Yi, Yangfan; Wu, Yi Zheng; Wu, Shiwei; Wang, Jing; Zhang, Yuanbo] Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China; [Deng, Yujun; Yu, Yijun; Song, Yichen; Sun, Zeyuan; Yi, Yangfan; Wu, Yi Zheng; Wu, Shiwei; Wang, Jing; Zhang, Yuanbo] Fudan Univ, Dept Phys, Shanghai, Peoples R China; [Deng, Yujun; Yu, Yijun; Song, Yichen; Wang, Nai Zhou; Sun, Zeyuan; Yi, Yangfan; Wu, Yi Zheng; Wu, Shiwei; Wang, Jing; Chen, Xian Hui; Zhang, Yuanbo] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing, Jiangsu, Peoples R China; [Deng, Yujun; Yu, Yijun; Song, Yichen; Wu, Shiwei; Zhang, Yuanbo] Fudan Univ, Inst Nanoelect Devices & Quantum Comp, Shanghai, Peoples R China; [Zhang, Jingzhao; Zhu, Junyi] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Wang, Nai Zhou; Chen, Xian Hui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Wang, Nai Zhou; Chen, Xian Hui] Univ Sci & Technol China, Dept Phys, Hefei, Anhui, Peoples R China; [Wang, Nai Zhou; Chen, Xian Hui] Univ Sci & Technol China, Key Lab Strongly Coupled Quantum Matter Phys, Hefei, Anhui, Peoples R China	Fudan University; Fudan University; Nanjing University; Fudan University; Chinese University of Hong Kong; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, YB (corresponding author), Fudan Univ, State Key Lab Surface Phys, Shanghai, Peoples R China.; Zhang, YB (corresponding author), Fudan Univ, Dept Phys, Shanghai, Peoples R China.; Zhang, YB (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Nanjing, Jiangsu, Peoples R China.; Zhang, YB (corresponding author), Fudan Univ, Inst Nanoelect Devices & Quantum Comp, Shanghai, Peoples R China.	zhyb@fudan.edu.cn	Wu, yizheng/P-2395-2014; Wang, Jing/E-5925-2012; Wu, Shiwei/F-4542-2010; Yu, Yijun/F-3648-2015; Zhang, Jingzhao/N-9485-2018	Wu, yizheng/0000-0002-9289-1271; Wang, Jing/0000-0002-4674-9485; Wu, Shiwei/0000-0001-9838-9066; Yu, Yijun/0000-0002-4006-8072; Zhang, Jingzhao/0000-0002-4347-2361; Sun, Zeyuan/0000-0002-4742-8640; Deng, Yujun/0000-0001-7407-2603	National Key Research Program of China [2016YFA0300703, 2018YFA0305600]; NSF of China [U1732274, 11527805, 11425415, 11421404, 11774065]; Shanghai Municipal Science and Technology Commission [18JC1410300]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB30000000]; China Postdoc Innovation Talent Support Program; 'Strategic Priority Research Program' of the Chinese Academy of Sciences [XDB04040100]; National Basic Research Program of China (973 Program) [2012CB922002]; National Natural Science Foundation of China [11534010]; Key Research Program of Frontier Sciences, CAS [QYZDY-SSW-SLH021]; Chinese University of Hong Kong (CUHK) [4053084]; University Grants Committee of Hong Kong [24300814]; CUHK; National Basic Research Program of China [2014CB921601]	National Key Research Program of China; NSF of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoc Innovation Talent Support Program; 'Strategic Priority Research Program' of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Sciences, CAS; Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); University Grants Committee of Hong Kong; CUHK(Chinese University of Hong Kong); National Basic Research Program of China(National Basic Research Program of China)	We thank X. Jin, B. Lian and G. Chen for discussions. Part of the sample fabrication was conducted at Fudan Nano-fabrication Laboratory. Y.D., Y. Yu, Y.S., J.W. and Y.Z. acknowledge support from National Key Research Program of China (grant nos. 2016YFA0300703, 2018YFA0305600), NSF of China (grant nos U1732274, 11527805, 11425415 and 11421404), Shanghai Municipal Science and Technology Commission (grant no. 18JC1410300), and Strategic Priority Research Program of Chinese Academy of Sciences (grant no. XDB30000000). Y. Yu also acknowledges support from China Postdoc Innovation Talent Support Program. N.Z.W. and X.H.C. acknowledge support from the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (grant no. XDB04040100) and the National Basic Research Program of China (973 Program; grant no. 2012CB922002). X.H.C. also acknowledges support from the National Natural Science Foundation of China (grant no. 11534010) and the Key Research Program of Frontier Sciences, CAS (grant no. QYZDY-SSW-SLH021). J. Zhu acknowledges financial support from Chinese University of Hong Kong (CUHK) under grant no. 4053084, from the University Grants Committee of Hong Kong under grant no. 24300814, and the Start-up Funding of CUHK. J.W. also acknowledges support from the NSF of China (grant no. 11774065). Z.S., Y. Yi and S.W. acknowledge support from the National Basic Research Program of China (grant no. 2014CB921601).	Abrikosov N.K., 1985, IAN SSSR NEORG MATER, V21, P1680; Albertini OR, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.214109; Ambrose T, 1996, J APPL PHYS, V79, P5920, DOI 10.1063/1.362172; ARROTT A, 1957, PHYS REV, V108, P1394, DOI 10.1103/PhysRev.108.1394; Bhatti S, 2017, MATER TODAY, V20, P530, DOI 10.1016/j.mattod.2017.07.007; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bonilla M, 2018, NAT NANOTECHNOL, V13, P289, DOI 10.1038/s41565-018-0063-9; Chen B, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124711; Deiseroth HJ, 2006, EUR J INORG CHEM, P1561, DOI 10.1002/ejic.200501020; Desai SB, 2016, ADV MATER, V28, P4053, DOI 10.1002/adma.201506171; Elmers HJ, 1996, PHYS REV B, V54, P15224, DOI 10.1103/PhysRevB.54.15224; Evtushinsky DV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236402; FISHER ME, 1972, PHYS REV LETT, V28, P1516, DOI 10.1103/PhysRevLett.28.1516; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hellman F, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.025006; Henkel M, 1998, PHYS REV LETT, V80, P4783, DOI 10.1103/PhysRevLett.80.4783; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Huang B, 2018, NAT NANOTECHNOL, V13, P544, DOI 10.1038/s41565-018-0121-3; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; HUANG F, 1993, J APPL PHYS, V73, P6760, DOI 10.1063/1.352477; HUANG F, 1994, PHYS REV B, V49, P3962, DOI 10.1103/PhysRevB.49.3962; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/NMAT2804, 10.1038/nmat2804]; Jiang SW, 2018, NAT MATER, V17, P406, DOI 10.1038/s41563-018-0040-6; Klein DR, 2018, SCIENCE, V360, P1218, DOI 10.1126/science.aar3617; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lei B, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.020503; Lei B, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.060501; Liu SS, 2017, NPJ 2D MATER APPL, V1, DOI 10.1038/s41699-017-0039-x; Magda GZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14714; Matsukura F, 2015, NAT NANOTECHNOL, V10, P209, DOI [10.1038/NNANO.2015.22, 10.1038/nnano.2015.22]; May AF, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.014411; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; OHNO H, 1992, PHYS REV LETT, V68, P2664, DOI 10.1103/PhysRevLett.68.2664; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; PARKIN SSP, 1980, PHILOS MAG B, V41, P65, DOI 10.1080/13642818008245370; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; PRANGE RE, 1979, PHYS REV B, V19, P4691, DOI 10.1103/PhysRevB.19.4691; RITCHIE DS, 1973, PHYS REV B, V7, P480, DOI 10.1103/PhysRevB.7.480; Scharf B, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.127403; Song TC, 2018, SCIENCE, V360, P1214, DOI 10.1126/science.aar4851; STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007; Tan C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04018-w; Ueno K, 2008, J APPL PHYS, V103, DOI 10.1063/1.2834247; Verchenko VY, 2015, INORG CHEM, V54, P8598, DOI 10.1021/acs.inorgchem.5b01260; Xiang HJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224429; Xiang HJ, 2013, DALTON T, V42, P823, DOI 10.1039/c2dt31662e; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Yu YJ, 2015, NAT NANOTECHNOL, V10, P270, DOI [10.1038/NNANO.2014.323, 10.1038/nnano.2014.323]; Zhang RJ, 2001, PHYS REV LETT, V86, P2665, DOI 10.1103/PhysRevLett.86.2665; Zhao C, 2017, NAT NANOTECHNOL, V12, P757, DOI [10.1038/nnano.2017.68, 10.1038/NNANO.2017.68]; Zhao SYF, 2018, NANO LETT, V18, P460, DOI 10.1021/acs.nanolett.7b04396; Zhong D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603113; Zhuang HL, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054429; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	60	1081	1085	150	1896	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					94	+		10.1038/s41586-018-0626-9	http://dx.doi.org/10.1038/s41586-018-0626-9			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30349002	Green Submitted			2022-12-28	WOS:000448900900051
J	Mann, S; Hollier, LM; McKay, K; Brown, H				Mann, Susan; Hollier, Lisa M.; McKay, Kimberlee; Brown, Haywood			What We Can Do about Maternal Mortality - And How to Do It Quickly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		[Mann, Susan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Mann, Susan] Harvard Med Sch, Boston, MA 02115 USA; [Hollier, Lisa M.] Baylor Coll Med, Houston, TX 77030 USA; [Hollier, Lisa M.] Amer Coll Obstetricians & Gynecologists, 409 12th St SW, Washington, DC 20024 USA; [McKay, Kimberlee] Avera Hlth, Sioux Falls, SD USA; [McKay, Kimberlee] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Brown, Haywood] Univ S Florida, Morsani Coll Med, Tampa, FL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Baylor College of Medicine; University of South Dakota; State University System of Florida; University of South Florida	Mann, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Mann, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							American College of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, V125, P502, DOI DOI 10.1097/01.AOG.0000460770.99574.9F; Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; D'Alton ME, 2014, OBSTET GYNECOL, V123, P973, DOI 10.1097/AOG.0000000000000219; Mann S, 2017, NEW ENGL J MED, V376, P1304, DOI 10.1056/NEJMp1700485; Pratt SD, 2007, JT COMM J QUAL PATIE, V33, P720	5	24	25	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1689	1691		10.1056/NEJMp1810649	http://dx.doi.org/10.1056/NEJMp1810649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380396				2022-12-28	WOS:000448891600001
J	Chen, RJ; Yin, P; Wang, LJ; Liu, C; Niu, Y; Wang, WD; Jiang, YX; Liu, YN; Liu, JM; Qi, JL; You, JL; Kan, HD; Zhou, MG				Chen, Renjie; Yin, Peng; Wang, Lijun; Liu, Cong; Niu, Yue; Wang, Weidong; Jiang, Yixuan; Liu, Yunning; Liu, Jiangmei; Qi, Jinlei; You, Jinling; Kan, Haidong; Zhou, Maigeng			Association between ambient temperature and mortality risk and burden: time series study in 272 main Chinese cities	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLD; WEATHER; HEAT; MORBIDITY; EXTREMES; CLIMATE; IMPACT	OBJECTIVE To examine the association between temperature and cause specific mortality, and to quantify the corresponding disease burden attributable to non-optimum ambient temperatures. DESIGN Time series analysis. SETTING 272 main cities in China. POPULATION Non-accidental deaths in 272 cities covered by the Disease Surveillance Point System of China, from January 2013 to December 2015. MAIN OUTCOME MEASURES Daily numbers of deaths from all non-accidental causes and main cardiorespiratory diseases. Potential effect modifiers included demographic, climatic, geographical, and socioeconomic characteristics. The analysis used distributed lag non-linear models to estimate city specific associations, and multivariate meta-regression analysis to obtain the effect estimates at national and regional levels. RESULTS 1 826 186 non-accidental deaths from total causes were recorded in the study period. Temperature and mortality consistently showed inversely J shaped associations. At the national average level, relative to the minimum mortality temperature (22.8 degrees C, 79.1st centile), the mortality risk of extreme cold temperature (at -1.4 degrees C, the 2.5th centile) lasted for more than 14 days, whereas the risk of extreme hot temperature (at 29.0 degrees C, the 97.5th centile) appeared immediately and lasted for two to three days. 14.33% of non-accidental total mortality was attributable to non-optimum temperatures, of which moderate cold (ranging from -1.4 to 22.8 degrees C), moderate heat (22.8 to 29.0 degrees C), extreme cold (-6.4 to -1.4 degrees C), and extreme heat (29.0 to 31.6 degrees C) temperatures corresponded to attributable fractions of 10.49%, 2.08%, 1.14%, and 0.63%, respectively. The attributable fractions were 17.48% for overall cardiovascular disease, 18.76% for coronary heart disease, 16.11% for overall stroke, 14.09% for ischaemic stroke, 18.10% for haemorrhagic stroke, 10.57% for overall respiratory disease, and 12.57% for chronic obstructive pulmonary diseases. The mortality risk and burden were more prominent in the temperate monsoon and subtropical monsoon climatic zones, in specific subgroups (female sex, age = 75 years, and = 9 years spent in education), and in cities characterised by higher urbanisations rates and shorter durations of central heating. CONCLUSION This nationwide study provides a comprehensive picture of the non-linear associations between ambient temperature and mortality from all natural causes and main cardiorespiratory diseases, as well as the corresponding disease burden that is mainly attributable to moderate cold temperatures in China. The findings on vulnerability characteristics can help improve clinical and public health practices to reduce disease burden associated with current and future abnormal weather.	[Chen, Renjie; Liu, Cong; Niu, Yue; Wang, Weidong; Jiang, Yixuan; Kan, Haidong] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Shanghai, Peoples R China; [Chen, Renjie; Liu, Cong; Niu, Yue; Wang, Weidong; Jiang, Yixuan; Kan, Haidong] Fudan Univ, NHC Key Lab Hlth Technol Assessment, Shanghai, Peoples R China; [Chen, Renjie; Kan, Haidong] Fudan Univ, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai, Peoples R China; [Yin, Peng; Wang, Lijun; Liu, Yunning; Liu, Jiangmei; Qi, Jinlei; You, Jinling; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, 27 Nanwei Rd, Beijing 100050, Peoples R China; [Kan, Haidong] Fudan Univ, Inst Reprod & Dev, Shanghai Inst Planned Res, Key Lab Reprod Regulat Natl Populat & Family Plan, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Fudan University	Zhou, MG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, 27 Nanwei Rd, Beijing 100050, Peoples R China.	maigengzhou@126.com	Zhou, Maigeng/HCH-7703-2022; Kan, Haidong/AGU-0328-2022; Yin, Peng/AFP-5157-2022		National Natural Science Foundation of China [91643205, 91743111]; China Medical Board Collaborating Programme [16-250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Board Collaborating Programme	The study was supported by the National Natural Science Foundation of China (91643205 and 91743111), and China Medical Board Collaborating Programme (16-250). The funders were not involved in the research and preparation of the article, including study design; collection, analysis, and interpretation of data; writing of the article; nor in the decision to submit it for publication.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Cai J, 2016, SCI TOTAL ENVIRON, V568, P271, DOI 10.1016/j.scitotenv.2016.06.030; Chen RJ, 2018, EPIDEMIOLOGY, V29, P482, DOI 10.1097/EDE.0000000000000829; Chen RJ, 2017, AM J RESP CRIT CARE, V196, P73, DOI [10.1164/rccm.201609-1862OC, 10.1164/rccm.201609-1862oc, 10.1164/rccm.201612-2427OC]; Dear K, 2015, LANCET, V386, P320, DOI 10.1016/S0140-6736(15)60897-2; Dixon PG, 2018, INT J BIOMETEOROL, V62, P685, DOI 10.1007/s00484-016-1265-1; Donaldson GC, 2002, BRIT MED J, V324, P89, DOI 10.1136/bmj.324.7329.89; Fares Auda, 2013, N Am J Med Sci, V5, P266, DOI 10.4103/1947-2714.110430; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; GASPARRINI A, 2014, BMC MED RES METHODOL, V14; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gasparrini A, 2017, LANCET PLANET HEALTH, V1, pE360, DOI 10.1016/S2542-5196(17)30156-0; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Guo YM, 2014, EPIDEMIOLOGY, V25, P781, DOI 10.1097/EDE.0000000000000165; Guo YM, 2013, ENVIRON RES, V120, P55, DOI 10.1016/j.envres.2012.09.001; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Hintsala H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099973; Imai C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050454; Kim Y, 2016, ENVIRON HEALTH PERSP, V124, P75, DOI 10.1289/ehp.1409392; Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10433-8; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Liu Y, 2015, INT J ENV RES PUB HE, V12, P439, DOI 10.3390/ijerph120100439; Ma WJ, 2014, ENVIRON RES, V134, P127, DOI 10.1016/j.envres.2014.07.007; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Moghadamnia MT, 2017, PEERJ, V5, DOI 10.7717/peerj.3574; Song XP, 2017, SCI TOTAL ENVIRON, V586, P241, DOI 10.1016/j.scitotenv.2017.01.212; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; von Klot S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-74; Yang J, 2016, ENVIRON INT, V92-93, P232, DOI 10.1016/j.envint.2016.04.001; Yang J, 2015, HEART, V101, P1966, DOI 10.1136/heartjnl-2015-308062; Yin P, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1849; Zanobetti A, 2013, EPIDEMIOLOGY, V24, P809, DOI 10.1097/01.ede.0000434432.06765.91; Zeka A, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-104; Zheng G., 2018, THE CLIMATE OF CHINA; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	38	179	197	29	123	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k3965	10.1136/bmj.k4306	http://dx.doi.org/10.1136/bmj.k4306			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381293	hybrid, Green Published			2022-12-28	WOS:000449564200002
J	Dyer, C				Dyer, Clare			Judge rules that man at risk of septic shock within weeks should have colostomy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4601	10.1136/bmj.k4601	http://dx.doi.org/10.1136/bmj.k4601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381413				2022-12-28	WOS:000449564200012
J	Lupini, AR; Oxley, MP; Kalinin, SV				Lupini, Andrew R.; Oxley, Mark P.; Kalinin, Sergei V.			Pushing the limits of electron ptychography	SCIENCE			English	Editorial Material							MICROSCOPY; RESOLUTION		[Lupini, Andrew R.; Oxley, Mark P.; Kalinin, Sergei V.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Lupini, AR (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	arl1000@ornl.gov						Brown HG, 2017, ULTRAMICROSCOPY, V182, P169, DOI 10.1016/j.ultramic.2017.07.002; Crewe AV, 2004, MICROSC MICROANAL, V10, P414, DOI 10.1017/S1431927604040085; D'Alfonso AJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064101; HOPPE W, 1982, ULTRAMICROSCOPY, V10, P187, DOI 10.1016/0304-3991(82)90038-9; Jesse S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26348; Jiang Y, 2018, NATURE, V559, P343, DOI 10.1038/s41586-018-0298-5; Maiden AM, 2012, ULTRAMICROSCOPY, V120, P64, DOI 10.1016/j.ultramic.2012.06.001; Miao JW, 2015, SCIENCE, V348, P530, DOI 10.1126/science.aaa1394; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; RODENBURG JM, 1992, PHILOS T R SOC A, V339, P521, DOI 10.1098/rsta.1992.0050; Rosenauer A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.096101; Shibata N, 2012, NAT PHYS, V8, P611, DOI [10.1038/nphys2337, 10.1038/NPHYS2337]; Yang H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12532	14	9	9	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					399	+		10.1126/science.aau7620	http://dx.doi.org/10.1126/science.aau7620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361359	Green Submitted			2022-12-28	WOS:000450441900030
J	Rubin, R				Rubin, Rita			Addressing Youth Substance Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1630	1630		10.1001/jama.2018.16201	http://dx.doi.org/10.1001/jama.2018.16201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357281				2022-12-28	WOS:000448069100030
J	Nam, Y; Ki, DK; Soler-Delgado, D; Morpurgo, AF				Nam, Youngwoo; Ki, Dong-Keun; Soler-Delgado, David; Morpurgo, Alberto F.			A family of finite-temperature electronic phase transitions in graphene multilayers	SCIENCE			English	Article							BILAYER; TRANSPORT; STATES	Suspended Bernal-stacked graphene multilayers up to an unexpectedly large thickness exhibit a broken-symmetry ground state whose origin remains to be understood. We show that a finite-temperature second-order phase transition occurs in multilayers whose critical temperature (T-c) increases from 12 kelvins (K) in bilayers to 100 K in heptalayers. A comparison of the data with a phenomenological model inspired by a mean-field approach suggests that the transition is associated with the appearance of a self-consistent valley-and spin-dependent staggered potential that changes sign from one layer to the next, appearing at T-c and increasing upon cooling. The systematic evolution with thickness of several measured quantities imposes constraints on any microscopic theory aiming to analyze the nature of electronic correlations in this system.	[Nam, Youngwoo; Ki, Dong-Keun; Soler-Delgado, David; Morpurgo, Alberto F.] Univ Geneva, DQMP, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland; [Nam, Youngwoo; Ki, Dong-Keun; Soler-Delgado, David; Morpurgo, Alberto F.] Univ Geneva, GAP, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland; [Nam, Youngwoo] Gyeongsang Natl Univ, Dept Phys, Jinju Daero 501, Jinju Si, South Korea; [Ki, Dong-Keun] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China	University of Geneva; University of Geneva; Gyeongsang National University; University of Hong Kong	Morpurgo, AF (corresponding author), Univ Geneva, DQMP, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.; Morpurgo, AF (corresponding author), Univ Geneva, GAP, 24 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	alberto.morpurgo@unige.ch	Ki, DongKeun/I-2613-2016	Ki, DongKeun/0000-0002-4638-2038; Soler-Delgado, David/0000-0003-2135-2323; Nam, Youngwoo/0000-0003-1187-0063	Swiss National Science Foundation; NCCR QSIT; EU Graphene Flagship Project	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR QSIT; EU Graphene Flagship Project	Financial support from the Swiss National Science Foundation, the NCCR QSIT, and the EU Graphene Flagship Project is also gratefully acknowledged.	Bao W, 2011, NAT PHYS, V7, P948, DOI [10.1038/NPHYS2103, 10.1038/nphys2103]; Berciaud S, 2014, NANO LETT, V14, P4548, DOI 10.1021/nl501578m; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Brandt N. B., 1988, SEMIMETALS; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; Das Sarma S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121406; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Elias DC, 2011, NAT PHYS, V7, P701, DOI [10.1038/nphys2049, 10.1038/NPHYS2049]; Ezawa Z. F., 2008, QUANTUM HALL EFFECTS, V2nd; Falson J, 2015, NAT PHYS, V11, P347, DOI [10.1038/NPHYS3259, 10.1038/nphys3259]; Fradkin E., 2013, FIELD THEORIES CONDE; GONZALEZ J, 1994, NUCL PHYS B, V424, P595, DOI 10.1016/0550-3213(94)90410-3; Grushina AL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7419; Guinea F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245426; Henni Y, 2016, NANO LETT, V16, P3710, DOI 10.1021/acs.nanolett.6b01041; Jain JK, 2007, COMPOSITE FERMIONS, P1; Ki DK, 2014, NANO LETT, V14, P2135, DOI 10.1021/nl5003922; Ki DK, 2013, NANO LETT, V13, P5165, DOI 10.1021/nl402462q; Koshino M, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.235311; Koshino M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115315; Koshino M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085425; Lemonik Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201408; Li JA, 2011, NAT PHYS, V7, P38, DOI 10.1038/NPHYS1822; Mayorov AS, 2012, NANO LETT, V12, P4629, DOI 10.1021/nl301922d; MERMIN ND, 1966, PHYS REV LETT, V17, P1133, DOI 10.1103/PhysRevLett.17.1133; Morpurgo A., 2018, HARVARD DATAVERSE; Nam Y, 2016, 2D MATER, V3, DOI 10.1088/2053-1583/3/4/045014; Nandkishore R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156803; Partoens B, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.193402; Polini M, 2007, SOLID STATE COMMUN, V143, P58, DOI 10.1016/j.ssc.2007.04.035; San-Jose P, 2014, NANO LETT, V14, P2052, DOI 10.1021/nl500230a; Velasco J, 2012, NAT NANOTECHNOL, V7, P156, DOI [10.1038/nnano.2011.251, 10.1038/NNANO.2011.251]; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776; Yoon C, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa659a; Yoshioka D., 2002, QUANTUM HALL EFFECT; Zhang F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.186804; Zhang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156801; Zhang F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041402; Zhu MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14552	49	28	29	6	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					324	328		10.1126/science.aar6855	http://dx.doi.org/10.1126/science.aar6855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337406	Green Submitted, Green Accepted			2022-12-28	WOS:000447680100044
J	Voosen, P				Voosen, Paul			NASA's asteroid explorer Dawn soon to go dark	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					275	275		10.1126/science.362.6412.275	http://dx.doi.org/10.1126/science.362.6412.275			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337390				2022-12-28	WOS:000447680100019
J	Eidhof, I; van de Warrenburg, BP; Schenck, A				Eidhof, Ilse; van de Warrenburg, Bart P.; Schenck, Annette			SnapShot: Biology of Genetic Ataxias	CELL			English	Editorial Material							DNA-REPAIR; DISEASE		[Eidhof, Ilse; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands; [van de Warrenburg, Bart P.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Eidhof, I (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, Nijmegen, Netherlands.		van de Warrenburg, Bart PC/D-1935-2010; Schenck, Annette/E-4514-2012	van de Warrenburg, Bart PC/0000-0003-4412-1616; Schenck, Annette/0000-0002-6918-3314; Eidhof, Ilse/0000-0002-1567-3078	E-RARE-3 Joint Transnational Call grant "Preparing therapies for autosomal recessive ataxias" (ZonMW) [9003037604]; Radboudumc/Donders institute junior researcher fellowship; E-RARE-3 Joint Transnational Call grant "Preparing therapies for autosomal recessive ataxias" (PREPARE)	E-RARE-3 Joint Transnational Call grant "Preparing therapies for autosomal recessive ataxias" (ZonMW); Radboudumc/Donders institute junior researcher fellowship; E-RARE-3 Joint Transnational Call grant "Preparing therapies for autosomal recessive ataxias" (PREPARE)	This research is supported by the E-RARE-3 Joint Transnational Call grant "Preparing therapies for autosomal recessive ataxias" (PREPARE; ZonMW, 9003037604) and a Radboudumc/Donders institute junior researcher fellowship to B.P.v.d.W. and A.S., who contributed equally.	Bettencourt C, 2014, JAMA NEUROL, V71, P831, DOI 10.1001/jamaneurol.2014.756; Eidhof I, 437582 BIORXIV, DOI [10.1101/437582, DOI 10.1101/437582]; Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016	9	2	2	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					890	+	e1	10.1016/j.cell.2018.10.017	http://dx.doi.org/10.1016/j.cell.2018.10.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340048	Bronze			2022-12-28	WOS:000447780800029
J	Kroemer, G; Lopez-Otin, C; Madeo, F; de Cabo, R				Kroemer, Guido; Lopez-Otin, Carlos; Madeo, Frank; de Cabo, Rafael			Carbotoxicity-Noxious Effects of Carbohydrates	CELL			English	Review							ENDOGENOUS FRUCTOSE PRODUCTION; PLASMA MANNOSE LEVELS; BETA-HYDROXYBUTYRATE; METABOLIC SYNDROME; KETOGENIC DIET; LIFE-SPAN; TRIOSEPHOSPHATE ISOMERASE; HEPATIC STEATOSIS; POTENTIAL-ROLE; GLUCOSE	Modern nutrition is often characterized by the excessive intake of different types of carbohydrates ranging from digestible polysaccharides to refined sugars that collectively mediate noxious effects on human health, a phenomenon that we refer to as "carbotoxicity.'' Epidemiological and experimental evidence combined with clinical intervention trials underscore the negative impact of excessive carbohydrate uptake, as well as the beneficial effects of reducing carbs in the diet. We discuss the molecular, cellular, and neuroendocrine mechanisms that link exaggerated carbohydrate intake to disease and accelerated aging as we outline dietary and pharmacologic strategies to combat carbotoxicity.	[Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellise Ligue Canc 11, Paris, France; [Kroemer, Guido] Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, Villejuif, France; [Kroemer, Guido] INSERM, U1138, Paris, France; [Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kroemer, Guido] Univ Paris 06, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, Stockholm, Sweden; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc, Madrid, Spain; [Madeo, Frank] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Graz, Austria; [Madeo, Frank] BioTechMed Graz, Graz, Austria; [de Cabo, Rafael] NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellise Ligue Canc 11, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, Villejuif, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Kroemer, G (corresponding author), Univ Paris 06, Paris, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, Stockholm, Sweden.; de Cabo, R (corresponding author), NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.	kroemer@orange.fr; decabora@grc.nia.nih.gov	KROEMER, Guido/B-4263-2013; López-Otín, Carlos/AAB-2106-2020; de Cabo, Rafael Carlos/J-5230-2016; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; López-Otín, Carlos/0000-0001-6964-1904; de Cabo, Rafael Carlos/0000-0003-2830-5693; Madeo, Frank/0000-0002-5070-1329	Ligue contre le Cancer; Agence National de la Recherche (ANR); Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix); European Commission (ArtForce); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); LeDucq Foundation; LabEx Immuno-Oncology; RHU Torino Lumiere; Seerave Foundation; SIRICs SOCRATE; CARPEM; European Research Council (DeAge); Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (Ciberonc); Progeria Research Foundation; Austrian Science Fund FWF (Austria) [P23490-B20, P29262, P24381, P29203, P27893]; DKplus Metabolic and Cardiovascular Diseases [W1226]; Bundesministerium fur Wissenschaft, Forschung und Wirtschaft; Karl-Franzens University; NAWI Graz; Bio-TechMed-Graz flagship project "EPIAge"; National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000363] Funding Source: NIH RePORTER	Ligue contre le Cancer(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Chancelerie des universites de Paris (Legs Poix); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Fondation Carrefour; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Inserm (HTE); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; RHU Torino Lumiere; Seerave Foundation; SIRICs SOCRATE; CARPEM; European Research Council (DeAge); Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (Ciberonc); Progeria Research Foundation; Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); DKplus Metabolic and Cardiovascular Diseases; Bundesministerium fur Wissenschaft, Forschung und Wirtschaft; Karl-Franzens University; NAWI Graz; Bio-TechMed-Graz flagship project "EPIAge"; National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	G.K. is supported by the Ligue contre le Cancer, Agence National de la Recherche (ANR), Canceropole Ile-de-France, Chancelerie des universites de Paris (Legs Poix), a donation by Elior, the European Commission (ArtForce), European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR), Fondation Carrefour, Institut National du Cancer (INCa), Inserm (HTE), LeDucq Foundation, the LabEx Immuno-Oncology, the RHU Torino Lumiere, the Seerave Foundation, the SIRICs SOCRATE, and CARPEM. C.L.-O. is supported by grants from European Research Council (DeAge), Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (Ciberonc), and Progeria Research Foundation. F.M. is grateful to the Austrian Science Fund FWF (Austria; P23490-B20, P29262, P24381, P29203, and P27893) and DKplus Metabolic and Cardiovascular Diseases (W1226), as well as to Bundesministerium fur Wissenschaft, Forschung und Wirtschaft, and the Karl-Franzens University for grants "Unkonventionelle Forschung'' and "flysleep.'' We acknowledge support from NAWI Graz and the Bio-TechMed-Graz flagship project "EPIAge.'' R.d.C. is funded by the Intramural Research Program of the National Institute on Aging, NIH.	Ahmed SH, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0699-3; Andres-Hernando A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14181; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Bell GA, 2012, EUR J EPIDEMIOL, V27, P593, DOI 10.1007/s10654-012-9714-6; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Birkeland KI, 2017, LANCET DIABETES ENDO, V5, P709, DOI 10.1016/S2213-8587(17)30258-9; Brewer Rachel A, 2016, Nutr Healthy Aging, V4, P31, DOI 10.3233/NHA-160007; Brown-Borg HM, 2017, CELL METAB, V26, P458, DOI 10.1016/j.cmet.2017.08.020; Caminhotto RD, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0184-4; Celotto AM, 2006, GENETICS, V174, P1237, DOI 10.1534/genetics.106.063206; Chia CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167241; Chiu CJ, 2007, AM J CLIN NUTR, V86, P1210, DOI 10.1093/ajcn/86.4.1210; Chiu S, 2018, CURR OPIN CLIN NUTR, V21, P277, DOI 10.1097/MCO.0000000000000469; Choi JM, 2013, P NATL ACAD SCI USA, V110, P10171, DOI 10.1073/pnas.1300457110; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Di Lorenzo C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00064; Di Pino A, 2016, J CLIN LIPIDOL, V10, P1098, DOI 10.1016/j.jacl.2016.07.001; Elia M, 2017, CURR PHARM DESIGN, V23, P5691, DOI 10.2174/1381612823666170809101517; FIOLET T, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K322; Forshaw R, 2014, BRIT DENT J, V216, P529, DOI 10.1038/sj.bdj.2014.353; Frimat M, 2017, CLIN SCI, V131, P1069, DOI 10.1042/CS20160823; Gelino S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006135; Gnerer JP, 2006, P NATL ACAD SCI USA, V103, P14987, DOI 10.1073/pnas.0606887103; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; Gupta P, 2016, PHARMACOL RES, V113, P636, DOI 10.1016/j.phrs.2016.09.029; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Heussinger N, 2018, CLIN NUTR, V37, P2246, DOI 10.1016/j.clnu.2017.11.001; Hu Y, 2014, AM J CLIN NUTR, V100, P959, DOI 10.3945/ajcn.114.086918; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Jameel F, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-195; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jang S, 2010, J NUTR, V140, P1892, DOI 10.3945/jn.110.123273; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2017, ADV NUTR, V8, P412, DOI 10.3945/an.116.014654; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kender Z, 2014, EXP CLIN ENDOCR DIAB, V122, P316, DOI 10.1055/s-0034-1371818; Lanaspa MA, 2018, P NATL ACAD SCI USA, V115, P3138, DOI 10.1073/pnas.1713837115; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee S, 2016, CELL METAB, V24, P172, DOI 10.1016/j.cmet.2016.05.026; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Luo S, 2015, P NATL ACAD SCI USA, V112, P6509, DOI 10.1073/pnas.1503358112; Lyssiotis CA, 2013, NATURE, V502, P181, DOI 10.1038/502181a; Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Mardinoglu A, 2018, CELL METAB, V27, P559, DOI 10.1016/j.cmet.2018.01.005; Mardinoglu A, 2017, CELL METAB, V26, P281, DOI 10.1016/j.cmet.2017.07.006; Mirtschink P, 2015, NATURE, V522, P444, DOI 10.1038/nature14508; Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924; Navarro SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117534; Newman JC, 2017, CELL METAB, V26, P547, DOI 10.1016/j.cmet.2017.08.004; Offermanns S, 2017, TRENDS ENDOCRIN MET, V28, P227, DOI [10.1016/J.tem.2016.11.007, 10.1016/j.tem.2016.11.007]; Oppelt SA, 2017, BRAIN RES, V1657, P312, DOI 10.1016/j.brainres.2016.12.022; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Pepino MY, 2015, PHYSIOL BEHAV, V152, P450, DOI 10.1016/j.physbeh.2015.06.024; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Rendeiro C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09589; Roberts MN, 2017, CELL METAB, V26, P539, DOI 10.1016/j.cmet.2017.08.005; Roncal-Jimenez CA, 2016, AM J PHYSIOL-RENAL, V311, pF722, DOI 10.1152/ajprenal.00306.2016; Rubio-Patino C, 2018, CELL METAB, V27, P828, DOI 10.1016/j.cmet.2018.02.009; Sainsbury E, 2018, DIABETES RES CLIN PR, V139, P239, DOI 10.1016/j.diabres.2018.02.026; Saslow LR, 2017, NUTR DIABETES, V7, DOI 10.1038/s41387-017-0006-9; Sharma SP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100633; Si JP, 2017, EXP THER MED, V14, P765, DOI 10.3892/etm.2017.4552; Siegel KR, 2012, DIABETES RES CLIN PR, V96, P76, DOI 10.1016/j.diabres.2011.11.014; Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Strohle A, 2011, NUTR RES, V31, P429, DOI 10.1016/j.nutres.2011.05.003; Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; Veronese N, 2018, AM J CLIN NUTR, V107, P436, DOI 10.1093/ajcn/nqx082; Vlassara H, 2016, DIABETOLOGIA, V59, P2181, DOI 10.1007/s00125-016-4053-x; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wang B. H., 2018, BRAIN RES, P106; Wang QD, 2017, CELL DEATH DIFFER, V24, P458, DOI 10.1038/cdd.2016.142; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yubero-Serrano EM, 2015, CLIN J AM SOC NEPHRO, V10, P759, DOI 10.2215/CJN.07750814; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	91	64	65	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					605	614		10.1016/j.cell.2018.07.044	http://dx.doi.org/10.1016/j.cell.2018.07.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340032	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000447780800002
J	Girard, TD; Exline, MC; Carson, SS; Hough, CL; Rock, P; Gong, MN; Douglas, IS; Malhotra, A; Owens, RL; Feinstein, DJ; Khan, B; Pisani, MA; Hyzy, RC; Schmidt, GA; Schweickert, WD; Hite, RD; Bowton, DL; Masica, AL; Thompson, JL; Chandrasekhar, R; Pun, BT; Strength, C; Boehm, LM; Jackson, JC; Pandharipande, PP; Brummel, NE; Hughes, CG; Patel, MB; Stollings, JL; Bernard, GR; Dittus, RS; Ely, EW				Girard, T. D.; Exline, M. C.; Carson, S. S.; Hough, C. L.; Rock, P.; Gong, M. N.; Douglas, I. S.; Malhotra, A.; Owens, R. L.; Feinstein, D. J.; Khan, B.; Pisani, M. A.; Hyzy, R. C.; Schmidt, G. A.; Schweickert, W. D.; Hite, R. D.; Bowton, D. L.; Masica, A. L.; Thompson, J. L.; Chandrasekhar, R.; Pun, B. T.; Strength, C.; Boehm, L. M.; Jackson, J. C.; Pandharipande, P. P.; Brummel, N. E.; Hughes, C. G.; Patel, M. B.; Stollings, J. L.; Bernard, G. R.; Dittus, R. S.; Ely, E. W.		MIND-USA Investigators	Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; TERM COGNITIVE IMPAIRMENT; AGITATION-SEDATION SCALE; ILL PATIENTS; INTRAVENOUS HALOPERIDOL; EARLY EXERCISE/MOBILITY; ABCDEF BUNDLE; DOUBLE-BLIND	BACKGROUND There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute respiratory failure or shock and hypoactive or hyperactive delirium to receive intravenous boluses of haloperidol (maximum dose, 20 mg daily), ziprasidone (maximum dose, 40 mg daily), or placebo. The volume and dose of a trial drug or placebo was halved or doubled at 12-hour intervals on the basis of the presence or absence of delirium, as detected with the use of the Confusion Assessment Method for the ICU, and of side effects of the intervention. The primary end point was the number of days alive without delirium or coma during the 14-day intervention period. Secondary end points included 30-day and 90-day survival, time to freedom from mechanical ventilation, and time to ICU and hospital discharge. Safety end points included extrapyramidal symptoms and excessive sedation. RESULTS Written informed consent was obtained from 1183 patients or their authorized representatives. Delirium developed in 566 patients (48%), of whom 89% had hypoactive delirium and 11% had hyperactive delirium. Of the 566 patients, 184 were randomly assigned to receive placebo, 192 to receive haloperidol, and 190 to receive ziprasidone. The median duration of exposure to a trial drug or placebo was 4 days (interquartile range, 3 to 7). The median number of days alive without delirium or coma was 8.5 (95% confidence interval [CI], 5.6 to 9.9) in the placebo group, 7.9 (95% CI, 4.4 to 9.6) in the haloperidol group, and 8.7 (95% CI, 5.9 to 10.0) in the ziprasidone group (P = 0.26 for overall effect across trial groups). The use of haloperidol or ziprasidone, as compared with placebo, had no significant effect on the primary end point (odds ratios, 0.88 [95% CI, 0.64 to 1.21] and 1.04 [95% CI, 0.73 to 1.48], respectively). There were no significant between-group differences with respect to the secondary end points or the frequency of extrapyramidal symptoms. CONCLUSIONS The use of haloperidol or ziprasidone, as compared with placebo, in patients with acute respiratory failure or shock and hypoactive or hyperactive delirium in the ICU did not significantly alter the duration of delirium.	[Girard, T. D.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA USA; [Exline, M. C.] Ohio State Univ, Dept Med, Wexner Med Ctr, Pulm Crit Care & Sleep Med Div, Columbus, OH 43210 USA; [Hite, R. D.] Cleveland Clin Fdn, Resp Inst, Dept Crit Care Med, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Carson, S. S.] Univ N Carolina, Sch Med, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27515 USA; [Bowton, D. L.] Wake Forest Baptist Hlth, Dept Anesthesiol, Sect Crit Care, Winston Salem, NC USA; [Feinstein, D. J.] Cone Hlth Syst, Greensboro, NC USA; [Hough, C. L.] Univ Washington, Sch Med, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Rock, P.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Gong, M. N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Crit Care Med, Bronx, NY 10467 USA; [Douglas, I. S.] Denver Hlth Med Ctr, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO USA; [Malhotra, A.; Owens, R. L.] Univ Calif San Diego, Dept Med, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA; [Khan, B.] Indiana Univ Sch Med, Dept Med, Div Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46202 USA; [Pisani, M. A.] Yale Univ, Sch Med, Dept Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA; [Hyzy, R. C.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Schmidt, G. A.] Univ Iowa Hosp & Clin, Dept Med, Div Pulm Crit Care & Occupat Med, Iowa City, IA 52242 USA; [Schweickert, W. D.] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Masica, A. L.] Ctr Clin Effectiveness Baylor Scott & White Hlth, Dallas, TX USA; [Thompson, J. L.; Chandrasekhar, R.; Pun, B. T.; Strength, C.; Boehm, L. M.; Jackson, J. C.; Pandharipande, P. P.; Brummel, N. E.; Hughes, C. G.; Patel, M. B.; Stollings, J. L.; Bernard, G. R.; Dittus, R. S.; Ely, E. W.] Vanderbilt Univ, Sch Med, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN 37212 USA; [Chandrasekhar, R.; Strength, C.; Jackson, J. C.; Brummel, N. E.; Dittus, R. S.; Ely, E. W.] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Brummel, N. E.; Ely, E. W.] Vanderbilt Univ, Sch Med, Ctr Qual Aging, Nashville, TN 37212 USA; [Strength, C.; Jackson, J. C.; Brummel, N. E.; Bernard, G. R.; Ely, E. W.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Dittus, R. S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Thompson, J. L.; Chandrasekhar, R.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Jackson, J. C.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Pandharipande, P. P.; Hughes, C. G.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Anesthesiol Crit Care Med, Nashville, TN 37212 USA; [Patel, M. B.] Vanderbilt Univ, Sch Med, Dept Surg, Div Trauma & Surg Crit Care, Nashville, TN 37212 USA; [Stollings, J. L.] Vanderbilt Univ, Sch Med, Dept Pharmaceut Serv, Nashville, TN 37212 USA; [Boehm, L. M.] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; [Pandharipande, P. P.; Hughes, C. G.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Anesthesia Serv, Nashville, TN USA; [Jackson, J. C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Res Serv, Nashville, TN USA; [Patel, M. B.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Surg Serv, Nashville, TN USA; [Dittus, R. S.; Ely, E. W.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr Serv, Nashville, TN USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Wake Forest Baptist Medical Center; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Denver Health Medical Center; University of California System; University of California San Diego; Indiana University System; Indiana University Bloomington; Yale University; University of Michigan System; University of Michigan; University of Iowa; University of Pennsylvania; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ely, EW (corresponding author), Vanderbilt Univ, Crit Illness Brain Dysfunct & Survivorship CIBS C, 2525 West End Ave,Suite 450, Nashville, TN 37203 USA.	wes.ely@vumc.org	Ely, E. Wesley/Z-2018-2019; Brummel, Nathan/AAB-5466-2020; Girard, Timothy/I-3008-2019; Bowton, David/AAZ-2916-2020; Douglas, Ivor S/AAC-6245-2021; Boehm, Leanne/R-8510-2018	Ely, E. Wesley/0000-0003-3957-2172; Girard, Timothy/0000-0002-9833-4871; Douglas, Ivor S/0000-0002-4541-1431; Brummel, Nathan/0000-0003-4308-0015; Boehm, Leanne/0000-0003-0127-6677; Schmidt, Gregory/0000-0002-5013-6323; Pandharipande, Pratik/0000-0002-1389-8580; Hite, Robert Duncan/0000-0002-2625-8750; Anders, Megan/0000-0001-5962-4377	National Institutes of Health [AG035117, TR000445]; Department of Veterans Affairs Geriatric Research Education and Clinical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, K12HL137943, K24HL132093, K24HL132105, T32HL134632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Geriatric Research Education and Clinical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (AG035117 and TR000445) from the National Institutes of Health and by the Department of Veterans Affairs Geriatric Research Education and Clinical Center.	Balas MC, 2013, CRIT CARE MED, V41, pS116, DOI 10.1097/CCM.0b013e3182a17064; Barnes-Daly MA, 2017, CRIT CARE MED, V45, P171, DOI 10.1097/CCM.0000000000002149; Brummel NE, 2014, INTENS CARE MED, V40, P370, DOI 10.1007/s00134-013-3136-0; Burry L, 2018, COCHRANE DB SYST REV, V6; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; DUDLEY DL, 1979, GEN HOSP PSYCHIAT, V1, P240, DOI 10.1016/0163-8343(79)90025-2; Ely EW, 2017, CRIT CARE MED, V45, P321, DOI 10.1097/CCM.0000000000002175; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2004, CRIT CARE MED, V32, P106, DOI 10.1097/01.CCM.0000098033.94737.84; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Klein PMC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6652; Mac Sweeney R, 2010, QJM-INT J MED, V103, P243, DOI 10.1093/qjmed/hcp194; Morandi A, 2017, CRIT CARE MED, V45, pE1111, DOI 10.1097/CCM.0000000000002640; Page VJ, 2013, LANCET RESP MED, V1, P515, DOI 10.1016/S2213-2600(13)70166-8; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel RP, 2009, CRIT CARE MED, V37, P825, DOI 10.1097/CCM.0b013e31819b8608; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Pun BT, 2018, CRIT CARE MED; R Core Team, 2018, R LANG ENV STAT COMP; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; RIKER RR, 1994, CRIT CARE MED, V22, P433, DOI 10.1097/00003246-199403000-00013; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; SETTLE EC, 1983, J CLIN PSYCHIAT, V44, P440; Shehabi Y, 2018, CRIT CARE MED, V46, P490, DOI 10.1097/CCM.0000000000002902; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; TESAR GE, 1985, J CLIN PSYCHOPHARM, V5, P344, DOI 10.1097/00004714-198505060-00009; Tesar GE, 1986, J INTENSIVE CARE MED, V1, P137; Vasilevskis EE, 2018, MED CARE, V56, P890, DOI 10.1097/MLR.0000000000000975; Wolters AE, 2014, CRIT CARE, V18, DOI 10.1186/cc13929; Woodward ND, 2007, SCHIZOPHR RES, V89, P211, DOI 10.1016/j.schres.2006.08.021	42	216	223	4	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2018	379	26					2506	2516		10.1056/NEJMoa1808217	http://dx.doi.org/10.1056/NEJMoa1808217			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HF6MK	30346242	Green Accepted, Bronze, Green Published, Green Submitted			2022-12-28	WOS:000454351100006
J	Johnson, MO; Wolf, MM; Madden, MZ; Andrejeva, G; Sugiura, A; Contreras, DC; Maseda, D; Liberti, MV; Paz, K; Kishton, RJ; Johnson, ME; de Cubas, AA; Wu, PS; Li, GB; Zhang, YL; Newcomb, DC; Wells, AD; Restifo, NP; Rathmell, WK; Locasale, JW; Davila, ML; Blazar, BR; Rathmell, JC				Johnson, Marc O.; Wolf, Melissa M.; Madden, Matthew Z.; Andrejeva, Gabriela; Sugiura, Ayaka; Contreras, Diana C.; Maseda, Damian; Liberti, Maria V.; Paz, Katelyn; Kishton, Rigel J.; Johnson, Matthew E.; de Cubas, Aguirre A.; Wu, Pingsheng; Li, Gongbo; Zhang, Yongliang; Newcomb, Dawn C.; Wells, Andrew D.; Restifo, Nicholas P.; Rathmell, W. Kimryn; Locasale, Jason W.; Davila, Marco L.; Blazar, Bruce R.; Rathmell, Jeffrey C.			Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism	CELL			English	Article							T-HELPER-1 CELL; T-CELLS; ACTIVATION; ANTIGEN; GROWTH; INHIBITION; CHROMATIN; PROTEINS; BALANCE; BIOLOGY	Activated T cells differentiate into functional subsets with distinct metabolic programs. Glutaminase (GLS) converts glutamine to glutamate to support the tricarboxylic acid cycle and redox and epigenetic reactions. Here, we identify a key role for GLS in T cell activation and specification. Though GLS deficiency diminished initial T cell activation and proliferation and impaired differentiation of Th17 cells, loss of GLS also increased Tbet to promote differentiation and effector function of CD4 Th1 and CD8 CTL cells. This was associated with altered chromatin accessibility and gene expression, including decreased PIK3IP1 in Th1 cells that sensitized to IL-2-mediated mTORC1 signaling. In vivo, GLS null T cells failed to drive Th17-inflammatory diseases, and Th1 cells had initially elevated function but exhausted over time. Transient GLS inhibition, however, led to increased Th1 and CTL T cell numbers. Glutamine metabolism thus has distinct roles to promote Th17 but constrain Th1 and CTL effector cell differentiation.	[Johnson, Marc O.; Wolf, Melissa M.; Madden, Matthew Z.; Andrejeva, Gabriela; Sugiura, Ayaka; Contreras, Diana C.; Maseda, Damian; Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Johnson, Marc O.; Liberti, Maria V.; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Paz, Katelyn; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Kishton, Rigel J.; Restifo, Nicholas P.] NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA; [Johnson, Matthew E.; Wells, Andrew D.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Johnson, Matthew E.; Wells, Andrew D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [de Cubas, Aguirre A.; Rathmell, W. Kimryn] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN 37232 USA; [Wu, Pingsheng; Newcomb, Dawn C.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Li, Gongbo; Zhang, Yongliang; Davila, Marco L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL 33612 USA; [Newcomb, Dawn C.; Rathmell, W. Kimryn; Rathmell, Jeffrey C.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Infect Immunol & Inflammat, Vanderbilt Ctr Immunobiol, Nashville, TN 37232 USA	Vanderbilt University; Duke University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Vanderbilt University; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University	Rathmell, JC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Rathmell, JC (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Infect Immunol & Inflammat, Vanderbilt Ctr Immunobiol, Nashville, TN 37232 USA.	jeff.rathmell@vumc.org	Locasale, Jason W/ABE-6505-2020; Maseda, Damian/AGG-9235-2022; Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019	Locasale, Jason W/0000-0002-7766-3502; Contreras Healey, Diana C/0000-0001-6981-8386; Andrejeva, Gabriela/0000-0002-3508-7682; M Wolf, Melissa/0000-0003-2038-6978; Liberti, Maria/0000-0002-4120-3686; Madden, Matthew/0000-0003-4062-4427; Sugiura, Ayaka/0000-0001-5326-5019; Restifo, Nicholas P./0000-0003-4229-4580; Maseda, Damian/0000-0003-0722-6881	National Institutes of Health [R01 HL136664, R01 DK105550, R01 CA217987, R01CA193256, P30CA01423]; NATIONAL CANCER INSTITUTE [R01CA198482, P01CA142106, ZIABC010763, R01CA193256, T32CA009138, R01CA217987] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979, R01HL122554, R01HL136664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680, S10OD021630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Rathmell lab and H. Hu (University of Alabama, Birmingham) for providing MSCV-PIK3IP-IRES-Thy1.1 and control retroviral constructs, T. Dileepan and M. K. Jenkins (University of Minnesota) for providing reagents for 2W immunization and tetramer staining, and J. Cools (VIB) for providing pMx-U6 plasmids. Some CB839 for in vitro studies was generously provided by Calithera Biosciences. This research was funded by the National Institutes of Health R01 HL136664 (J.C.R.), R01 DK105550 (J.C.R.), R01 CA217987 (J.C.R., W.K.R.), R01CA193256 (J.W.L.), and P30CA01423 (J.W.L.).	[Anonymous], 2017, R LANG ENV STAT COMP; Blazar BR, 1998, BLOOD, V92, P3949, DOI 10.1182/blood.V92.10.3949.422k26_3949_3959; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Davila ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061338; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeFrances MC, 2012, EUR J IMMUNOL, V42, P2754, DOI 10.1002/eji.201141653; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Knox JJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00217; Li GB, 2017, METHODS MOL BIOL, V1514, P111, DOI 10.1007/978-1-4939-6548-9_9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Nakajima H, 2014, CANCER SCI, V105, P1093, DOI 10.1111/cas.12484; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Panoskaltsis-Mortari A, 2007, AM J RESP CRIT CARE, V176, P713, DOI 10.1164/rccm.200702-335OC; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Siska PJ, 2016, J IMMUNOL METHODS, V438, P51, DOI 10.1016/j.jim.2016.08.013; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tajan M, 2018, CELL METAB, V28, P721, DOI 10.1016/j.cmet.2018.07.005; Takahashi S, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1283-3; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei HR, 2016, J IMMUNOL, V196, P3537, DOI 10.4049/jimmunol.1501896; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xu T, 2017, NATURE, V548, P228, DOI 10.1038/nature23475; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Yuan Q, 2014, NAT NEUROSCI, V17, P81, DOI 10.1038/nn.3581	53	266	280	12	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2018	175	7					1780	+		10.1016/j.cell.2018.10.001	http://dx.doi.org/10.1016/j.cell.2018.10.001			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HE3GZ	30392958	Bronze, Green Accepted			2022-12-28	WOS:000453242200010
J	Parker, CC; James, ND; Brawley, CD; Clarke, NW; Hoyle, AP; Ali, A; Ritchie, AWS; Attard, G; Chowdhury, S; Cross, W; Dearnaley, DP; Gillessen, S; Gilson, C; Jones, RJ; Langley, RE; Malik, ZI; Mason, MD; Matheson, D; Millman, R; Russell, JM; Thalmann, GN; Amos, CL; Alonzi, R; Bahl, A; Birtle, A; Din, O; Douis, H; Eswar, C; Gale, J; Gannon, MR; Jonnada, S; Khaksar, S; Lester, JF; O'Sullivan, JM; Parikh, OA; Pedley, ID; Pudney, DM; Sheehan, DJ; Srihari, NN; Tran, ATH; Parmar, MKB; Sydes, MR				Parker, Christopher C.; James, Nicholas D.; Brawley, Christopher D.; Clarke, Noel W.; Hoyle, Alex P.; Ali, Adnan; Ritchie, Alastair W. S.; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P.; Gillessen, Silke; Gilson, Clare; Jones, Robert J.; Langley, Ruth E.; Malik, Zafar I.; Mason, Malcolm D.; Matheson, David; Millman, Robin; Russell, J. Martin; Thalmann, George N.; Amos, Claire L.; Alonzi, Roberto; Bahl, Amit; Birtle, Alison; Din, Omar; Douis, Hassan; Eswar, Chinnamani; Gale, Joanna; Gannon, Melissa R.; Jonnada, Sai; Khaksar, Sara; Lester, Jason F.; O'Sullivan, Joe M.; Parikh, Omi A.; Pedley, Ian D.; Pudney, Delia M.; Sheehan, Denise J.; Srihari, Narayanan Nair; Tran, Anna T. H.; Parmar, Mahesh K. B.; Sydes, Matthew R.		Systemic Therapy Adv Metastatic	Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial	LANCET			English	Article							ANDROGEN DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; RADIATION-THERAPY; MEN; SURVIVAL; BONE; TIME	Background Based on previous findings, we hypothesised that radiotherapy to the prostate would improve overall survival in men with metastatic prostate cancer, and that the benefit would be greatest in patients with a low metastatic burden. We aimed to compare standard of care for metastatic prostate cancer, with and without radiotherapy. Methods We did a randomised controlled phase 3 trial at 117 hospitals in Switzerland and the UK. Eligible patients had newly diagnosed metastatic prostate cancer. We randomly allocated patients open-label in a 1: 1 ratio to standard of care (control group) or standard of care and radiotherapy (radiotherapy group). Randomisation was stratified by hospital, age at randomisation, nodal involvement, WHO performance status, planned androgen deprivation therapy, planned docetaxel use (from December, 2015), and regular aspirin or non-steroidal anti-inflammatory drug use. Standard of care was lifelong androgen deprivation therapy, with up-front docetaxel permitted from December, 2015. Men allocated radiotherapy received either a daily (55 Gy in 20 fractions over 4 weeks) or weekly (36 Gy in six fractions over 6 weeks) schedule that was nominated before randomisation. The primary outcome was overall survival, measured as the number of deaths; this analysis had 90% power with a one-sided a of 2.5% for a hazard ratio (HR) of 0.75. Secondary outcomes were failure-free survival, progression-free survival, metastatic progression-free survival, prostate cancer-specific survival, and symptomatic local event-free survival. Analyses used Cox proportional hazards and flexible parametric models, adjusted for stratification factors. The primary outcome analysis was by intention to treat. Two prespecified subgroup analyses tested the effects of prostate radiotherapy by baseline metastatic burden and radiotherapy schedule. This trial is registered with ClinicalTrials.gov, number NCT00268476. Findings Between Jan 22, 2013, and Sept 2, 2016, 2061 men underwent randomisation, 1029 were allocated the control and 1032 radiotherapy. Allocated groups were balanced, with a median age of 68 years (IQR 63-73) and median amount of prostate-specific antigen of 97 ng/mL (33-315). 367 (18%) patients received early docetaxel. 1082 (52%) participants nominated the daily radiotherapy schedule before randomisation and 979 (48%) the weekly schedule. 819 (40%) men had a low metastatic burden, 1120 (54%) had a high metastatic burden, and the metastatic burden was unknown for 122 (6%). Radiotherapy improved failure-free survival (HR 0.76, 95% CI 0.68-0.84; p<0.0001) but not overall survival (0.92, 0.80-1.06; p=0266). Radiotherapy was well tolerated, with 48 (5%) adverse events (Radiation Therapy Oncology Group grade 3-4) reported during radiotherapy and 37 (4%) after radiotherapy. The proportion reporting at least one severe adverse event (Common Terminology Criteria for Adverse Events grade 3 or worse) was similar by treatment group in the safety population (398 [38%] with control and 380 [39%] with radiotherapy). Interpretation Radiotherapy to the prostate did not improve overall survival for unselected patients with newly diagnosed metastatic prostate cancer. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Parker, Christopher C.; Dearnaley, David P.] Royal Marsden Hosp, Acad Urol Unit, London, England; [Parker, Christopher C.; Dearnaley, David P.] Inst Canc Res, London, England; [James, Nicholas D.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Brawley, Christopher D.; Ritchie, Alastair W. S.; Gilson, Clare; Langley, Ruth E.; Millman, Robin; Amos, Claire L.; Parmar, Mahesh K. B.; Sydes, Matthew R.] UCL, MRC Clin Trials Unit, London WC1V 9LV, England; [Clarke, Noel W.; Hoyle, Alex P.; Ali, Adnan] Christie Hosp, Dept Surg, Genito Urinary Canc Res Grp, Manchester, Lancs, England; [Clarke, Noel W.; Hoyle, Alex P.] Salford Royal Hosp, Dept Urol, Manchester, Lancs, England; [Tran, Anna T. H.] Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England; [Ali, Adnan] Univ Manchester, FASTMAN Genito Urinary Canc Res Grp, Div Canc Sci, Manchester, Lancs, England; [Ali, Adnan] Univ Manchester, Belfast Manchester Movember Ctr Excellence, Manchester Canc Res Ctr, Manchester, Lancs, England; [Attard, Gerhardt] UCL, UCL Canc Inst, London, England; [Chowdhury, Simon] Guys & St Thomas NHS Fdn Trust, Dept Med Oncol, London, England; [Cross, William] St James Univ Hosp, Dept Urol, Leeds, W Yorkshire, England; [Gillessen, Silke] Univ Manchester, Div Canc Sci, Manchester, Lancs, England; [Gillessen, Silke] The Christie, Manchester, Lancs, England; [Gillessen, Silke] Kantonsspital, Div Oncol & Haematol, St Gallen, Switzerland; [Jones, Robert J.] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Russell, J. Martin] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Malik, Zafar I.; Eswar, Chinnamani] Clatterbridge Canc Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Mason, Malcolm D.] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales; [Matheson, David] Univ Wolverhampton, Fac Educ Hlth & Wellbeing, Wolverhampton, England; [Thalmann, George N.] Inselspital Bern, Univ Hosp, Dept Urol, Bern, Switzerland; [Alonzi, Roberto] Mt Vernon Canc Ctr, London, England; [Bahl, Amit] Bristol Haematol & Oncol Ctr, Bristol, Avon, England; [Birtle, Alison] Lancashire Teaching Hosp, Rosemere Canc Ctr, Preston, Lancs, England; [Birtle, Alison] Univ Manchester, Sch Canc Sci, Manchester, Lancs, England; [Din, Omar] Sheffield Teaching Hosp NHS Fdn Trust, Weston Pk Canc Ctr, Dept Clin Oncol, Sheffield, S Yorkshire, England; [Douis, Hassan] Univ Hosp Birmingham NHS Fdn Trust, Dept Radiol, Birmingham, W Midlands, England; [Gale, Joanna] Queen Alexandra Hosp, Portsmouth Oncol Ctr, Portsmouth, Hants, England; [Gannon, Melissa R.] London Sch Hyg & Trop Med, Dept Hlth Serv Res, London, England; [Jonnada, Sai] Gloucestershire Hosp NHS Fdn Trust, Dept Oncol, Gloucester, England; [Khaksar, Sara] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; [Lester, Jason F.] Velindre Canc Ctr, Cardiff, S Glam, Wales; [O'Sullivan, Joe M.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Parikh, Omi A.] East Lancashire Hosp NHS Trust, Dept Clin Oncol, Blackburn, Lancs, England; [Pedley, Ian D.] Freeman Rd Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; [Pudney, Delia M.] Singleton Hosp, Clin Oncol, Swansea, W Glam, Wales; [Sheehan, Denise J.] Royal Devon & Exeter Hosp, Exeter Oncol Ctr, Exeter, Devon, England; [Srihari, Narayanan Nair] Shrewsbury & Telford Hosp NHS Trust, Dept Oncol, Shrewsbury, Salop, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Birmingham; Medical Research Council Clinical Trials Unit; University of London; University College London; Christie NHS Foundation Trust; Christie Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; Christie NHS Foundation Trust; University of Manchester; University of Manchester; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Saint James's University Hospital; University of Manchester; Christie NHS Foundation Trust; Christie Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Beatson Oncology Centre; University of Glasgow; University of Glasgow; Cardiff University; University of Wolverhampton; University of Bern; University Hospital of Bern; Mount Vernon Cancer Centre; Bristol Haematology & Oncology Centre; University of Manchester; University of Sheffield; University of Birmingham; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of London; London School of Hygiene & Tropical Medicine; Gloucestershire Hospitals NHS Foundation Trust; Royal Surrey County Hospital; Velindre Cancer Centre; Queens University Belfast; Newcastle Freeman Hospital; Newcastle University - UK; Singleton Hospital; University of Exeter	Sydes, MR (corresponding author), UCL, MRC Clin Trials Unit, London WC1V 9LV, England.; Parker, CC (corresponding author), Royal Marsden Hosp, Acad Urol Unit, Sutton SM2 5PT, Surrey, England.	chris.parker@icr.ac.uk; mrcctu.stampede-publications@ucl.ac.uk	James, Nick/AAL-6802-2020; Mason, Malcolm D/H-6979-2013; Sydes, Matthew/C-3373-2008; Gillessen, Silke/C-6093-2019	Sydes, Matthew/0000-0002-9323-1371; O'Sullivan, Joe/0000-0001-6999-2739; Rogers, Paul/0000-0003-2593-2595; Gillessen, Silke/0000-0001-5746-6555; James, Nicholas/0000-0002-7314-8204; Brawley, Christopher/0000-0003-3641-278X	Cancer Research UK; UK Medical Research Council; Swiss Group for Clinical Cancer Research; Astellas; Clovis Oncology; Janssen; Novartis; Pfizer; Sanofi-Aventis; MRC [G0701945] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss Group for Clinical Cancer Research; Astellas(Astellas Pharmaceuticals); Clovis Oncology; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK, UK Medical Research Council, Swiss Group for Clinical Cancer Research, Astellas, Clovis Oncology, Janssen, Novartis, Pfizer, and Sanofi-Aventis.	Badwe R, 2015, LANCET ONCOL, V16, P1380, DOI 10.1016/S1470-2045(15)00135-7; Barthel FMS, 2009, STATA J, V9, P505, DOI 10.1177/1536867X0900900401; Boeve LMS, 2019, EUR UROL, V75, P410, DOI 10.1016/j.eururo.2018.09.008; Burdett S, SYSTEMATIC REV METAA; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Culp SH, 2014, EUR UROL, V65, P1058, DOI 10.1016/j.eururo.2013.11.012; Dearnaley D, 2016, LANCET ONCOL, V17, P1047, DOI 10.1016/S1470-2045(16)30102-4; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Fizazi K, 2015, EUR UROL, V67, P904, DOI 10.1016/j.eururo.2014.08.076; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Fossati N, 2015, EUR UROL, V67, P3, DOI 10.1016/j.eururo.2014.08.056; Gratzke C, 2014, EUR UROL, V66, P602, DOI 10.1016/j.eururo.2014.04.009; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mejean A, 2018, NEW ENGL J MED, V379, P417, DOI 10.1056/NEJMoa1803675; Mickisch GHJ, 2001, LANCET, V358, P966, DOI 10.1016/S0140-6736(01)06103-7; Parker CC, 2013, CLIN ONCOL-UK, V25, P318, DOI 10.1016/j.clon.2013.01.005; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Rusthoven CG, 2016, J CLIN ONCOL, V34, P2835, DOI 10.1200/JCO.2016.67.4788; Rydzewska LHM, 2017, EUR J CANCER, V84, P88, DOI 10.1016/j.ejca.2017.07.003; Slotman BJ, 2015, LANCET, V385, P36, DOI 10.1016/S0140-6736(14)61085-0; Sooriakumaran P, 2017, BJU INT, V120, pE8, DOI 10.1111/bju.13925; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Sydes MR, 2018, ANN ONCOL, V29, P1235, DOI 10.1093/annonc/mdy072; Sydes MR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-168; Vale CL, 2016, LANCET ONCOL, V17, P243, DOI 10.1016/S1470-2045(15)00489-1; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7	31	622	631	2	41	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2018	392	10162					2353	2366		10.1016/S0140-6736(18)32486-3	http://dx.doi.org/10.1016/S0140-6736(18)32486-3			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4PH	30355464	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000451785200024
J	Sajadi, E; Palomaki, T; Fei, ZY; Zhao, WJ; Bement, P; Olsen, C; Luescher, S; Xu, XD; Folk, JA; Cobden, DH				Sajadi, Ebrahim; Palomaki, Tauno; Fei, Zaiyao; Zhao, Wenjin; Bement, Philip; Olsen, Christian; Luescher, Silvia; Xu, Xiaodong; Folk, Joshua A.; Cobden, David H.			Gate-induced superconductivity in a monolayer topological insulator	SCIENCE			English	Article							CRITICAL-FIELD; QUANTUM; TRANSITION; STATE	The layered semimetal tungsten ditelluride (WTe2) has recently been found to be a two-dimensional topological insulator (2D TI) when thinned down to a single monolayer, with conducting helical edge channels. We found that intrinsic superconductivity can be induced in this monolayer 2D TI by mild electrostatic doping at temperatures below 1 kelvin. The 2D TI-superconductor transition can be driven by applying a small gate voltage. This discovery offers possibilities for gate-controlled devices combining superconductivity and nontrivial topological properties, and could provide a basis for quantum information schemes based on topological protection.	[Sajadi, Ebrahim; Bement, Philip; Olsen, Christian; Luescher, Silvia; Folk, Joshua A.] Univ British Columbia, Stewart Blusson Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada; [Sajadi, Ebrahim; Bement, Philip; Olsen, Christian; Luescher, Silvia; Folk, Joshua A.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Palomaki, Tauno; Fei, Zaiyao; Zhao, Wenjin; Xu, Xiaodong; Cobden, David H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Xu, Xiaodong] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of British Columbia; University of British Columbia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Folk, JA (corresponding author), Univ British Columbia, Stewart Blusson Quantum Matter Inst, Vancouver, BC V6T 1Z4, Canada.; Folk, JA (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.; Cobden, DH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jfolk@physics.ubc.ca; cobden@uw.edu	Zhao, Wenjin/AAQ-9365-2020; Folk, Joshua A/E-6287-2017	Zhao, Wenjin/0000-0003-0016-5684; Folk, Joshua A/0000-0003-4455-5609; Fei, Zaiyao/0000-0002-5433-2778; Bement, Phillip/0000-0001-9895-8804; Sajadi, Ebrahim/0000-0002-5623-3167	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0002197, DE-SC0018171]; AFOSR [FA9550-14-1-0277]; NSF EFRI 2DARE [1433496]; NSF MRSEC [1719797]; Canada Foundation for Innovation; National Science and Engineering Research Council; CIFAR; SBQMI; Directorate For Engineering [1433496] Funding Source: National Science Foundation	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF EFRI 2DARE; NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR(Canadian Institute for Advanced Research (CIFAR)); SBQMI; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	T.P., Y.F., W.Z., X.X., and D.H.C. were supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering, awards DE-SC0002197 (D.H.C.) and DE-SC0018171 (X.X.); AFOSR FA9550-14-1-0277; NSF EFRI 2DARE 1433496; and NSF MRSEC 1719797. E.S., P.B., C.O., S.L., and J.A.F. were supported by the Canada Foundation for Innovation, the National Science and Engineering Research Council, CIFAR, and SBQMI.	Ali MN, 2014, NATURE, V514, P205, DOI 10.1038/nature13763; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; CHENG Y, 1990, J APPL PHYS, V67, P5038, DOI 10.1063/1.344716; Costanzo D, 2016, NAT NANOTECHNOL, V11, P339, DOI [10.1038/NNANO.2015.314, 10.1038/nnano.2015.314]; Das Sarma S, 2015, NPJ QUANTUM INFORM, V1, DOI 10.1038/npjqi.2015.1; Deng LZ, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.054513; Fatemi V, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.041410; Fei ZY, 2017, NAT PHYS, V13, P677, DOI [10.1038/NPHYS4091, 10.1038/nphys4091]; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu YJ, 2017, NPJ QUANTUM MATER, V2, DOI 10.1038/s41535-017-0056-1; Goldman AM, 2010, INT J MOD PHYS B, V24, P4081, DOI 10.1142/S0217979210056451; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Jia ZY, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041108; Jung SG, 2017, SUPERCOND SCI TECH, V30, DOI 10.1088/1361-6668/aa766c; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kang DF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8804; Kapitulnik  A., 2017, ARXIV171207215CONDMA; Kapitulnik A., 2017, ARXIV171207215; KLEMM RA, 1975, PHYS REV B, V12, P877, DOI 10.1103/PhysRevB.12.877; Klemm RA, 2015, PHYSICA C, V514, P86, DOI 10.1016/j.physc.2015.02.023; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kusmartseva AF, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.236401; Li LJ, 2016, NATURE, V529, P185, DOI 10.1038/nature16175; Lu JM, 2015, SCIENCE, V350, P1353, DOI 10.1126/science.aab2277; Lv HY, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/37004; MacNeill D, 2017, NAT PHYS, V13, P300, DOI [10.1038/NPHYS3933, 10.1038/nphys3933]; MAKI K, 1966, PHYS REV, V148, P362, DOI 10.1103/PhysRev.148.362; Morosan E, 2006, NAT PHYS, V2, P544, DOI 10.1038/nphys360; Peng L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00745-8; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Saito Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.94; Saito Y, 2016, SUPERCOND SCI TECH, V29, DOI 10.1088/0953-2048/29/9/093001; Sato M, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa6ac7; Soluyanov AA, 2015, NATURE, V527, P495, DOI 10.1038/nature15768; Tang SJ, 2017, NAT PHYS, V13, P683, DOI [10.1038/NPHYS4174, 10.1038/nphys4174]; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Tsen AW, 2016, NAT PHYS, V12, P208, DOI 10.1038/NPHYS3579; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Wang Q Y, 2012, CHINESE PHYS LETT, V29, P4; Wu SF, 2018, SCIENCE, V359, P76, DOI 10.1126/science.aan6003; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Zomer PJ, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4886096	43	188	192	29	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2018	362	6417					922	+		10.1126/science.aar4426	http://dx.doi.org/10.1126/science.aar4426			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB5TC	30361385	Green Submitted, Bronze			2022-12-28	WOS:000451124500036
J	Biton, M; Haber, AL; Rogel, N; Burgin, G; Beyaz, S; Schnell, A; Ashenberg, O; Su, CW; Smillie, C; Shekhar, K; Chen, ZJ; Wu, CA; Ordovas-Montanes, J; Alvarez, D; Herbst, RH; Zhang, M; Tirosh, I; Dionne, D; Nguyen, LT; Xifaras, ME; Shalek, AK; von Andrian, UH; Graham, DB; Rozenblatt-Rosen, O; Shi, HN; Kuchroo, V; Yilmaz, OH; Regev, A; Xavier, RJ				Biton, Moshe; Haber, Adam L.; Rogel, Noga; Burgin, Grace; Beyaz, Semir; Schnell, Alexandra; Ashenberg, Orr; Su, Chien-Wen; Smillie, Christopher; Shekhar, Karthik; Chen, Zuojia; Wu, Chuan; Ordovas-Montanes, Jose; Alvarez, David; Herbst, Rebecca H.; Zhang, Mei; Tirosh, Itay; Dionne, Danielle; Nguyen, Lan T.; Xifaras, Michael E.; Shalek, Alex K.; von Andrian, Ulrich H.; Graham, Daniel B.; Rozenblatt-Rosen, Orit; Shi, Hai Ning; Kuchroo, Vijay; Yilmaz, Omer H.; Regev, Aviv; Xavier, Ramnik J.			T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation	CELL			English	Article							RNA-SEQ; MUCOSAL IMMUNITY; EPITHELIAL-CELLS; EXPRESSION; SPECIFICITY; CRYPT; MAPS; MICE	In the small intestine, a niche of accessory cell types supports the generation of mature epithelial cell types from intestinal stem cells (ISCs). It is unclear, however, if and how immune cells it the niche affect ISC fate or the balance between self-rei and differentiation. Here, we use single cell RNA sequencing (scRNA-seq) to identify MHC class II (MHCII) machinery enrichment in two subsets of Lgr(5+) ISCs. We show that MHCII+ Lgr(5+) ISCs are non-conventional antigen-presenting cells in co-cultures with CD4( +) T helper (Th) cells. Stimulation of intestinal organoids with key Th cytokines affects Lgr(5+) ISC renewal and differentiation in opposing ways: pro-inflammatory signals promote differentiation, while regulatory cells and cytokines reduce it. In vivo genetic perturbation of Th cells or MHCII expression on Lgr(5+) ISCs impacts epithelial cell differentiation and IEC fate during infection. These interactions between Th cells and Lgr(5+) ISCs, thus, orchestrate, tissue-wide responses to external signals.	[Biton, Moshe; Haber, Adam L.; Rogel, Noga; Burgin, Grace; Ashenberg, Orr; Smillie, Christopher; Shekhar, Karthik; Herbst, Rebecca H.; Tirosh, Itay; Dionne, Danielle; Nguyen, Lan T.; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Biton, Moshe; Haber, Adam L.; Rogel, Noga; Burgin, Grace; Ashenberg, Orr; Smillie, Christopher; Shekhar, Karthik; Herbst, Rebecca H.; Tirosh, Itay; Dionne, Danielle; Nguyen, Lan T.; Rozenblatt-Rosen, Orit; Regev, Aviv] MIT, Cambridge, MA 02142 USA; [Biton, Moshe; Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Beyaz, Semir; Xifaras, Michael E.; Yilmaz, Omer H.; Regev, Aviv] MIT, Dept Biol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Beyaz, Semir] Harvard Med Sch, Boston Childrens Hosp, Divis Hematol Oncol, Boston, MA 02115 USA; [Beyaz, Semir] Harvard Med Sch, Harvard Stem Cell Inst, Howard Hughes Med Inst, Dept Pediat Oncol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Beyaz, Semir] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Schnell, Alexandra; Chen, Zuojia; Wu, Chuan; Kuchroo, Vijay] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA USA; [Su, Chien-Wen; Zhang, Mei; Shi, Hai Ning] Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Su, Chien-Wen; Zhang, Mei; Shi, Hai Ning] Harvard Med Sch, Charlestown, MA 02129 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.] MIT, IMES, Cambridge, MA 02139 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.; Graham, Daniel B.; Kuchroo, Vijay; Yilmaz, Omer H.; Xavier, Ramnik J.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.; Graham, Daniel B.; Kuchroo, Vijay; Yilmaz, Omer H.; Xavier, Ramnik J.] MIT, Cambridge, MA 02142 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Ordovas-Montanes, Jose; Shalek, Alex K.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Alvarez, David] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Alvarez, David] Harvard Med Sch, Ctr Immune Imaging, Boston, MA 02115 USA; [Herbst, Rebecca H.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02114 USA; [Tirosh, Itay] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Yilmaz, Omer H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA; [Xavier, Ramnik J.] MIT, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Regev, A (corresponding author), MIT, Dept Biol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Xavier, RJ (corresponding author), Broad Inst Harvard, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), MIT, Cambridge, MA 02142 USA.; Regev, A (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA.; Xavier, RJ (corresponding author), MIT, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, Cambridge, MA 02139 USA.	aregev@broadinstitute.org; xavier@molbio.mgh.harvard.edu	Shalek, Alex/Y-2434-2019; Chen, Zuojia/AAM-9465-2020; Rozenblatt-Rosen, Orit/HDN-4182-2022; Wu, Chuan/H-6379-2013	Shalek, Alex/0000-0001-5670-8778; Su, Chien-Wen/0000-0002-5457-9295; Ordovas-Montanes, Jose/0000-0001-5444-5601; Smillie, Chris/0000-0002-7606-3433; Biton, Moshe/0000-0001-8330-1674; Schnell, Alexandra/0000-0003-3442-7750; Dionne, Danielle/0000-0002-8338-4323; Wu, Chuan/0000-0003-2288-353X	Human Frontiers Science Program; Sidney Kimmel Scholar Award; Pew-Stewart Trust Scholar Award; Pew-Stewart Scholars Program; Sloan Fellowship in Chemistry; Searle Scholars Program; Beckman Young Investigator Program; Klarman Cell Observatory; HHMI; NIH [DK043351, DK114784, DK117263, CA211184, AG045144, 1DP2OD0 20839]; Helmsley Charitable Trust; Crohn's and Colitis Foundation; Broadnext10; NATIONAL CANCER INSTITUTE [ZIABC011801, U54CA224068, R01CA211184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY028625] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC2DK114784, P30DK043351, R01DK117263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG045144, R00AG045144] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Sidney Kimmel Scholar Award; Pew-Stewart Trust Scholar Award; Pew-Stewart Scholars Program; Sloan Fellowship in Chemistry; Searle Scholars Program; Beckman Young Investigator Program; Klarman Cell Observatory; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Crohn's and Colitis Foundation; Broadnext10; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Leslie Gaffney and Anna Hupalowska for help with figures, Tim Tickle for help with the Single Cell Portal, Alexandra-Chloe Villani for discussions, the Broad Flow Cytometry Facility (Patricia Rogers, Stephanie Saldi and Chelsea Otis), and the Histology facility at the Koch Institute (Kathleen Cormier, Charlene Condon and Michael Brown). M.B. was supported by a postdoctoral fellowship from the Human Frontiers Science Program. O.H.Y. is the recipient of the Sidney Kimmel Scholar Award, the Pew-Stewart Trust Scholar Award, and is a member in the American Federation of Aging Research. A.S.K. is the recipient of by Pew-Stewart Scholars Program, a Sloan Fellowship in Chemistry, the Searle Scholars Program, and the Beckman Young Investigator Program. Work was supported by the Klarman Cell Observatory (A.R. and R.J.X.), HHMI (A.R.), Broadnext10 (A.R. and R.J.X.), NIH DK043351, DK114784, and DK117263 (R.J.X.), Helmsley Charitable Trust and Crohn's and Colitis Foundation (R.J.X.), NIH CA211184 and AG045144 (O.H.Y.), and NIH New Innovator Award 1DP2OD0 20839 (A.K.S.).	Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; BLAND PW, 1986, IMMUNOLOGY, V58, P1; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; BUJA A, 1992, MULTIVAR BEHAV RES, V27, P509, DOI 10.1207/s15327906mbr2704_2; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chinen T, 2010, J EXP MED, V207, P2323, DOI 10.1084/jem.20101235; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Degirmenci B, 2018, NATURE, V558, P449, DOI 10.1038/s41586-018-0190-3; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Farin HF, 2014, J EXP MED, V211, P1388, DOI 10.1084/jem.20130753; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Howie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073610; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; KAISERLIAN D, 1989, EUR J IMMUNOL, V19, P1513, DOI 10.1002/eji.1830190827; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nusse YM, 2018, NATURE, V559, P109, DOI 10.1038/s41586-018-0257-1; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shi HN, 1997, PARASITE IMMUNOL, V19, P363, DOI 10.1046/j.1365-3024.1997.d01-223.x; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang T, 2012, J LEUKOCYTE BIOL, V91, P449, DOI 10.1189/jlb.1011498; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	65	215	221	10	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2018	175	5					1307	+		10.1016/j.cell.2018.10.008	http://dx.doi.org/10.1016/j.cell.2018.10.008			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HA5PX	30392957	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000450328800015
J	Hagai, T; Chen, X; Miragaia, RJ; Rostom, R; Gomes, T; Kunowska, N; Henriksson, J; Park, JE; Proserpio, V; Donati, G; Bossini-Castillo, L; Braga, FAV; Naamati, G; Fletcher, J; Stephenson, E; Vegh, P; Trynka, G; Kondova, I; Dennis, M; Haniffa, M; Nourmohammad, A; Lassig, M; Teichmann, SA				Hagai, Tzachi; Chen, Xi; Miragaia, Ricardo J.; Rostom, Raghd; Gomes, Tomas; Kunowska, Natalia; Henriksson, Johan; Park, Jong-Eun; Proserpio, Valentina; Donati, Giacomo; Bossini-Castillo, Lara; Braga, Felipe A. Vieira; Naamati, Guy; Fletcher, James; Stephenson, Emily; Vegh, Peter; Trynka, Gosia; Kondova, Ivanela; Dennis, Mike; Haniffa, Muzlifah; Nourmohammad, Armita; Laessig, Michael; Teichmann, Sarah A.			Gene expression variability across cells and species shapes innate immunity	NATURE			English	Article							NATURAL-SELECTION; READ ALIGNMENT; GENOME BROWSER; RNA-SEQ; EVOLUTION; HETEROGENEITY; DIVERGENCE; RECONSTRUCTION; DETERMINANTS; CONSERVATION	As the first line of defence against pathogens, cells mount an innate immune response, which varies widely from cell to cell. The response must be potent but carefully controlled to avoid self-damage. How these constraints have shaped the evolution of innate immunity remains poorly understood. Here we characterize the innate immune response's transcriptional divergence between species and variability in expression among cells. Using bulk and single-cell transcriptomics in fibroblasts and mononuclear phagocytes from different species, challenged with immune stimuli, we map the architecture of the innate immune response. Transcriptionally diverging genes, including those that encode cytokines and chemokines, vary across cells and have distinct promoter structures. Conversely, genes that are involved in the regulation of this response, such as those that encode transcription factors and kinases, are conserved between species and display low cell-to-cell variability in expression. We suggest that this expression pattern, which is observed across species and conditions, has evolved as a mechanism for fine-tuned regulation to achieve an effective but balanced response.	[Hagai, Tzachi; Chen, Xi; Miragaia, Ricardo J.; Rostom, Raghd; Gomes, Tomas; Kunowska, Natalia; Henriksson, Johan; Park, Jong-Eun; Bossini-Castillo, Lara; Braga, Felipe A. Vieira; Trynka, Gosia; Teichmann, Sarah A.] Wellcome Sanger Inst, Cambridge, England; [Hagai, Tzachi; Rostom, Raghd; Naamati, Guy; Teichmann, Sarah A.] EMBL European Bioinformat Inst, Cambridge, England; [Miragaia, Ricardo J.] Univ Minho, Ctr Biol Engn, Braga, Portugal; [Proserpio, Valentina; Donati, Giacomo] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Proserpio, Valentina] IIGM, Turin, Italy; [Donati, Giacomo] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Braga, Felipe A. Vieira] Wellcome Sanger Inst, Open Targets, Cambridge, England; [Fletcher, James; Stephenson, Emily; Vegh, Peter; Haniffa, Muzlifah] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Kondova, Ivanela] Biomed Primate Res Ctr, Anim Sci Dept, Div Pathol & Microbiol, Rijswijk, Netherlands; [Dennis, Mike] Natl Infect Serv, Publ Hlth England, Res Dept, Porton Down, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, Dept Dermatol, Newcastle Upon Tyne, Tyne & Wear, England; [Haniffa, Muzlifah] Newcastle Hosp NHS Fdn Trust, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Nourmohammad, Armita] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Nourmohammad, Armita] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Laessig, Michael] Univ Cologne, Inst Biol Phys, Cologne, Germany; [Teichmann, Sarah A.] Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Universidade do Minho; University of Turin; Italian Institute for Genomic Medicine (IIGM); University of Turin; Wellcome Trust Sanger Institute; Newcastle University - UK; Public Health England; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Max Planck Society; University of Washington; University of Washington Seattle; University of Cologne; University of Cambridge	Hagai, T; Teichmann, SA (corresponding author), Wellcome Sanger Inst, Cambridge, England.; Hagai, T; Teichmann, SA (corresponding author), EMBL European Bioinformat Inst, Cambridge, England.; Teichmann, SA (corresponding author), Univ Cambridge, Cavendish Lab, Theory Condensed Matter Grp, Cambridge, England.	tzachi@ebi.ac.uk; st9@sanger.ac.uk	Chen, Xi/F-2057-2019; Hagai, Tzachi/AAL-8758-2021; Proserpio, Valentina/AAB-3630-2019; Bossini-Castillo, Lara/G-1234-2016	Chen, Xi/0000-0003-2648-3146; Proserpio, Valentina/0000-0003-2071-4206; Bossini-Castillo, Lara/0000-0002-5471-5824; Vegh, Peter/0000-0002-0133-3240; DONATI, Giacomo/0000-0002-0370-8288; Naamati, Guy/0000-0002-0523-4071; Tzachi, Hagai/0000-0002-4575-6624	ERC; EU FET-OPEN grant [664918]; Wellcome Sanger core funding [WT206194]; HFSP Long-Term Fellowship; EMBO; Fondazione Umberto Veronesi; MRC [MR/N014995/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); EU FET-OPEN grant; Wellcome Sanger core funding; HFSP Long-Term Fellowship; EMBO(European Molecular Biology Organization (EMBO)); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Eling, M. Fumagalli, Y. Gilad, O. Laufman, A. Marcovitz, J. Marioni, K. Meyer, M. Muffato, D. Odom, O. Stegle, A. Stern, M. Stubbington, V. Svensson and M. Ward for discussions; G. Emerton, A. Jinat, L. Mamanova, K. Polanski, A. Fullgrabe, N. George, S. Barnett, R. Boyd, S. Patel and C. Gomez for technical assistance; the Hipsci consortium for human fibroblast lines; and members of the Teichmann laboratory for support at various stages. This project was supported by ERC grants (ThDEFINE, ThSWITCH) and an EU FET-OPEN grant (MRG-GRAMMAR No 664918) and Wellcome Sanger core funding (Grant No WT206194). T.H. was supported by an HFSP Long-Term Fellowship and by EMBO Long-Term and Advanced fellowships. V.P. is funded by Fondazione Umberto Veronesi.	Avraham R, 2015, CELL, V162, P1309, DOI 10.1016/j.cell.2015.08.027; Barber MF, 2017, GENOME BIOL EVOL, V9, P1757, DOI 10.1093/gbe/evx120; Barreiro LB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001249; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Braun BA, 2015, P NATL ACAD SCI USA, V112, P8036, DOI 10.1073/pnas.1501844112; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960; Calderone A, 2015, NUCLEIC ACIDS RES, V43, pD588, DOI 10.1093/nar/gku830; Capra JA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002567; Choo SW, 2016, GENOME RES, V26, P1312, DOI 10.1101/gr.203521.115; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; Faure AJ, 2017, CELL SYST, V5, P471, DOI 10.1016/j.cels.2017.10.003; Franz KM, 2017, MOL CELL, V66, P750, DOI 10.1016/j.molcel.2017.05.009; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Haberle V, 2016, SEMIN CELL DEV BIOL, V57, P11, DOI 10.1016/j.semcdb.2016.01.014; Halehalli RR, 2015, BIOINFORMATICS, V31, P1025, DOI 10.1093/bioinformatics/btu763; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Herrero J, 2016, DATABASE-OXFORD, DOI [10.1093/database/bav096, 10.1093/database/baw053]; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Johnson WE, 2009, IMMUNOGENETICS, V61, P163, DOI 10.1007/s00251-009-0358-y; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Kolodziejczyk AA, 2015, CELL STEM CELL, V17, P471, DOI 10.1016/j.stem.2015.09.011; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levin M, 2016, NATURE, V531, P637, DOI 10.1038/nature16994; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malfavon-Borja R, 2013, P NATL ACAD SCI USA, V110, pE583, DOI 10.1073/pnas.1216542110; Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nourmohammad A, 2017, CELL REP, V20, P1385, DOI 10.1016/j.celrep.2017.07.033; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Porritt RA, 2015, TRENDS IMMUNOL, V36, P150, DOI 10.1016/j.it.2015.02.002; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Reilly SK, 2016, ANNU REV GENOM HUM G, V17, P45, DOI 10.1146/annurev-genom-090314-045935; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sackton TB, 2017, MOL BIOL EVOL, V34, P857, DOI 10.1093/molbev/msw285; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/nmeth.3542, 10.1038/NMETH.3542]; Schroder K, 2012, P NATL ACAD SCI USA, V109, pE944, DOI 10.1073/pnas.1110156109; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Xu L, 2016, P NATL ACAD SCI USA, V113, P10950, DOI 10.1073/pnas.1604939113; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	79	85	87	0	36	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					197	+		10.1038/s41586-018-0657-2	http://dx.doi.org/10.1038/s41586-018-0657-2			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30356220	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000449943600033
J	Tso, GHW; Reales-Calderon, JA; Tan, ASM; Sem, XH; Le, GTT; Tan, TG; Lai, GC; Srinivasan, KG; Yurieva, M; Liao, W; Poidinger, M; Zolezzi, F; Rancati, G; Pavelka, N				Tso, Gloria Hoi Wan; Reales-Calderon, Jose Antonio; Tan, Alrina Shin Min; Sem, XiaoHui; Giang Thi Thu Le; Tan, Tze Guan; Lai, Ghee Chuan; Srinivasan, K. G.; Yurieva, Marina; Liao, Webber; Poidinger, Michael; Zolezzi, Francesca; Rancati, Giulia; Pavelka, Norman			Experimental evolution of a fungal pathogen into a gut symbiont	SCIENCE			English	Article							FLO8 TRANSCRIPTION FACTOR; CANDIDA-ALBICANS; VISUALIZATION; PROTECTION; VIRULENCE; STRAINS; PASSAGE; HOST	Gut microbes live in symbiosis with their hosts, but how mutualistic animal-microbe interactions emerge is not understood. By adaptively evolving the opportunistic fungal pathogen Candida albicans in the mouse gastrointestinal tract, we selected strains that not only had lost their main virulence program but also protected their new hosts against a variety of systemic infections. This protection was independent of adaptive immunity, arose as early as a single day postpriming, was dependent on increased innate cytokine responses, and was thus reminiscent of "trained immunity." Because both the microbe and its new host gain some advantages from their interaction, this experimental system might allow direct study of the evolutionary forces that govern the emergence of mutualism between a mammal and a fungus.	[Tso, Gloria Hoi Wan; Reales-Calderon, Jose Antonio; Tan, Alrina Shin Min; Sem, XiaoHui; Giang Thi Thu Le; Tan, Tze Guan; Lai, Ghee Chuan; Srinivasan, K. G.; Yurieva, Marina; Liao, Webber; Poidinger, Michael; Zolezzi, Francesca; Pavelka, Norman] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove Immunos 04, Singapore 138648, Singapore; [Rancati, Giulia] ASTAR, Inst Med Biol, 8A Biomed Grove,Immunos 05, Singapore 138648, Singapore; [Sem, XiaoHui] FIND, Campus Biotech,Chemin Mines 9, CH-1202 Geneva, Switzerland; [Giang Thi Thu Le] ASTAR, SBIC, 11 Biopolis Way,01-02 Helios, Singapore 138667, Singapore; [Yurieva, Marina] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Foundation For Innovative New Diagnostics; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Jackson Laboratory	Pavelka, N (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove Immunos 04, Singapore 138648, Singapore.	norman_pavelka@immunol.a-star.edu.sg	Yurieva, Marina/V-2432-2018; Pavelka, Norman/G-4577-2018; TSO, Gloria HOI WAN/C-4749-2009; REALES-CALDERON, JOSE ANTONIO/H-8788-2015; TSO, Gloria HOI WAN/Q-2881-2018	Pavelka, Norman/0000-0003-4542-9970; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502; Lai, Ghee Chuan/0000-0002-8591-077X; Yurieva, Marina/0000-0002-5761-0382; REALES-CALDERON, JOSE ANTONIO/0000-0002-0464-7325; Poidinger, Michael/0000-0002-1047-2277; TSO, Gloria HOI WAN/0000-0003-3658-539X	Agency for Science, Technology, and Research (A*STAR) [JCO/1437a00117, JCO/1437a00119]; SIgN	Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); SIgN	We thank A. Tan, Y. S. Lim, and N. Tay for technical assistance; Singapore Immunology Network (SIgN) Mouse Core for providing mice; IMCB Advanced Molecular Pathology Laboratory for histology service; C. B. Ong for veterinary pathology evaluation; J. Berman for C. albicans strains; and M. G. Netea, Y. Wang, and G. De Libero for scientific discussions and feedback on the manuscript. Sequencing was performed by the Genome Institute of Singapore Genome Technology and Biology Group, Singapore. This study was supported by Agency for Science, Technology, and Research (A*STAR) Investigatorship awards JCO/1437a00117 to N.P. and JCO/1437a00119 to G.R. and by core funding from SIgN.	Abbey DA, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0100-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bohm L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006699; Brunke S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004478; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Forche A, 2009, GENETICS, V182, P799, DOI 10.1534/genetics.109.103325; Gale CA, 2009, MICROBIOL-SGM, V155, P3847, DOI 10.1099/mic.0.033233-0; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Hirakawa MP, 2015, GENOME RES, V25, P413, DOI 10.1101/gr.174623.114; Hoang KL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01444; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; King KC, 2016, ISME J, V10, P1915, DOI 10.1038/ismej.2015.259; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Liu JY, 2015, MICROBIOL RES, V178, P1, DOI 10.1016/j.micres.2015.05.007; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Luttich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064482; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Pande K, 2013, NAT GENET, V45, P1088, DOI 10.1038/ng.2710; Pavelka N., 2018, OPEN SCI FRAMEWORK; Pavelka N., 2018, OPEN SCI FRAMEWORK, DOI [10.17605/OSF.IO/TCQYH, DOI 10.17605/OSF.IO/TCQYH]; Pierce JV, 2012, MBIO, V3, DOI 10.1128/mBio.00117-12; POPE LM, 1979, INFECT IMMUN, V25, P702, DOI 10.1128/IAI.25.2.702-707.1979; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; R Core Team, 2016, R VERS 3 3; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Relman DA, 2008, NAT REV MICROBIOL, V6, P721, DOI 10.1038/nrmicro1990; Sasse Christoph, 2012, Methods Mol Biol, V845, P3, DOI 10.1007/978-1-61779-539-8_1; SEELIG MS, 1966, AM J MED, V40, P887, DOI 10.1016/0002-9343(66)90204-X; Sem X, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00186; Skrzypek MS, 2017, NUCLEIC ACIDS RES, V45, pD592, DOI 10.1093/nar/gkw924; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Wartenberg A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004824; Zhu J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002719	40	112	113	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		589	+		10.1126/science.aat0537	http://dx.doi.org/10.1126/science.aat0537			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385579				2022-12-28	WOS:000450460000047
J	Downing, NS; McMullan, CJ; Rennke, HG; Levy, BD; Loscalzo, J				Downing, Nicholas S.; McMullan, Ciaran J.; Rennke, Helmut G.; Levy, Bruce D.; Loscalzo, Joseph			Complements from the Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION-RELATED GLOMERULONEPHRITIS; POSTSTREPTOCOCCAL GLOMERULONEPHRITIS		[Downing, Nicholas S.; McMullan, Ciaran J.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Rennke, Helmut G.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Med, BTM 3016,60 Fenwood Rd, Boston, MA 02115 USA.	blevy@bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Levy, Bruce David/0000-0001-9515-5731				Bu R, 2015, AM J NEPHROL, V41, P98, DOI 10.1159/000377684; Glassock RJ, 2015, AM J KIDNEY DIS, V65, P826, DOI 10.1053/j.ajkd.2015.01.023; MEZZANO S, 1986, CLIN NEPHROL, V26, P61; Nasr SH, 2013, KIDNEY INT, V83, P792, DOI 10.1038/ki.2012.407; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; Satoskar AA, 2017, CLIN J AM SOC NEPHRO, V12, P39, DOI 10.2215/CJN.05070516; Wang SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003386	7	1	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1767	1773		10.1056/NEJMcps1802644	http://dx.doi.org/10.1056/NEJMcps1802644			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380383				2022-12-28	WOS:000448891600013
J	Cohen, D				Cohen, Deborah			Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cohen D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k4035	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4586	10.1136/bmj.k4586	http://dx.doi.org/10.1136/bmj.k4586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377211				2022-12-28	WOS:000449563200009
J	Ridyard, E				Ridyard, Edward			Charging for hospital car parking risks demoralising the NHS workforce The NHS is run on goodwill, yet unfair car parking charges show a thorough disregard for staff	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ridyard, Edward] North Yorkshire Deanery, Ophthalmol, Leeds, W Yorkshire, England		Ridyard, E (corresponding author), North Yorkshire Deanery, Ophthalmol, Leeds, W Yorkshire, England.	edward-ridyard@doctors.org.uk							0	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4529	10.1136/bmj.k4529	http://dx.doi.org/10.1136/bmj.k4529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377162				2022-12-28	WOS:000449563200004
J	Ribeiro, CD; Koopmans, MP; Haringhuizen, GB				Ribeiro, Carolina dos S.; Koopmans, Marion P.; Haringhuizen, George B.			Threats to timely sharing of pathogen sequence data	SCIENCE			English	Editorial Material									[Ribeiro, Carolina dos S.; Haringhuizen, George B.] Netherlands Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Ribeiro, Carolina dos S.] Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Koopmans, Marion P.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Ribeiro, CD (corresponding author), Netherlands Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.; Ribeiro, CD (corresponding author), Vrije Univ Amsterdam, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands.	ribeirocds@hotmail.com		dos Santos Ribeiro, Carolina/0000-0002-7148-0430	European Union [643476]	European Union(European Commission)	This study was done under the framework of the EU COMPARE project. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement no. 643476.	Ando K., 2014, MICROBIOL CULT COLLE, V30, P85; [Anonymous], 2009, ECCO CORE MAT TRANSF; ATCC, 2011, MAT TRANSF AGR; CBD, 2011, NAG PROT ACC GEN RES; Convention on Biological Diversity, 2018, 14 M PROV AG; Convention on Biological Diversity AHTEG on Digital Sequence Information on Genetic Resources, PEER REV FACT FIND S; Laird S. A., 2017, FACT FIND SCOP STUD; Modjarrad K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001935; NITE, 2017, BIL REL AS NAT; Reichman J., 2016, GLOBAL INTELLECTUAL, V678; Reichman J.H., 2018, WHY NAGOYA PROTOCOL; TRUST, 2016, TRANSP US FRIENDL SY; WHO, EXT EV PAND INFL PRE	13	25	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					404	406		10.1126/science.aau5229	http://dx.doi.org/10.1126/science.aau5229			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361362	Green Published			2022-12-28	WOS:000450441900033
J	McCaw, ZR; Wei, LJ; Kim, DH				McCaw, Zachary R.; Wei, Lee-Jen; Kim, Dae Hyun			Gene Expression-Guided Adjuvant Chemotherapy in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[McCaw, Zachary R.; Wei, Lee-Jen] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Kim, Dae Hyun] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Wei, LJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	wei@-hsph.-harvard.-edu	McCaw, Zachary/GPW-8740-2022; Wei, Lee-Jen/CAI-0175-2022					Cheng D, 2017, JAMA ONCOL, V3, P1430, DOI 10.1001/jamaoncol.2017.0737; Hasegawa T, 2016, NEW ENGL J MED, V375, P1097, DOI 10.1056/NEJMc1608323; Merchant FM, 2018, JAMA; Uno H, 2015, ANN INTERN MED, V163, P127, DOI 10.7326/M14-1741	4	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1681	1681						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1GI	30358968				2022-12-28	WOS:000448273500018
J	Neilan, TG; Price, MC; Sanborn, DY; Gainor, JF; Chen, A				Neilan, Tomas G.; Price, Melissa C.; Sanborn, Danita Y.; Gainor, Justin F.; Chen, Athena			Case 33-2018: A 57-Year-Old Man with Confusion, Fever, Malaise, and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONBACTERIAL THROMBOTIC ENDOCARDITIS; LEFT-VENTRICULAR THROMBUS; MAGNETIC-RESONANCE; DIAGNOSIS; CRITERIA; ECHOCARDIOGRAPHY; CLASSIFICATION; REVISION; AUTOPSY; VALVE		[Neilan, Tomas G.; Sanborn, Danita Y.; Gainor, Justin F.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Price, Melissa C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Chen, Athena] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Neilan, Tomas G.; Sanborn, Danita Y.; Gainor, Justin F.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Price, Melissa C.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Chen, Athena] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Neilan, TG (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Neilan, TG (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Gainor, Justin/T-5411-2019					Davison P, 2010, EUR J ECHOCARDIOGR, V11, pI26, DOI 10.1093/ejechocard/jeq120; DEPPISCH LM, 1976, AM HEART J, V92, P723, DOI 10.1016/S0002-8703(76)80008-7; Edoute Y, 1997, AM J MED, V102, P252, DOI 10.1016/S0002-9343(96)00457-3; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; GIN KG, 1993, J AM COLL CARDIOL, V22, P1994, DOI 10.1016/0735-1097(93)90789-4; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Gross L, 1936, ARCH INTERN MED, V58, P620, DOI 10.1001/archinte.1936.00170140045004; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282; Hojnik M, 1996, CIRCULATION, V93, P1579, DOI 10.1161/01.CIR.93.8.1579; Homma S, 2005, CIRCULATION, V112, P1063, DOI 10.1161/CIRCULATIONAHA.104.524371; Hoover J, 2015, NEW ENGL J MED, V373, P1883, DOI 10.1056/NEJMc1510993; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; KIM HS, 1977, ARCH PATHOL LAB MED, V101, P65; Lamas CC, 1997, CLIN INFECT DIS, V25, P713, DOI 10.1086/513765; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; LOPEZ JA, 1987, AM HEART J, V113, P773, DOI 10.1016/0002-8703(87)90719-8; MACDONALD RA, 1957, ANN INTERN MED, V46, P255, DOI 10.7326/0003-4819-46-2-255; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Singhal AB, 2002, STROKE, V33, P1267, DOI 10.1161/01.STR.0000015029.91577.36; Srichai MB, 2006, AM HEART J, V152, P75, DOI 10.1016/j.ahj.2005.08.021; Unlu O, 2017, ANNU REV MED, V68, P287, DOI 10.1146/annurev-med-042915-102529; VAITKUS PT, 1993, J AM COLL CARDIOL, V22, P1004, DOI 10.1016/0735-1097(93)90409-T; Weinsaft JW, 2008, J AM COLL CARDIOL, V52, P148, DOI 10.1016/j.jacc.2008.03.041	27	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1658	1669		10.1056/NEJMcpc1802830	http://dx.doi.org/10.1056/NEJMcpc1802830			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30354952				2022-12-28	WOS:000448273500012
J	Tyner, JW; Tognon, CE; Bottomly, D; Wilmot, B; Kurtz, SE; Savage, SL; Long, N; Schultz, AR; Traer, E; Abel, M; Agarwal, A; Blucher, A; Borate, U; Bryant, J; Burke, R; Carlos, A; Carpenter, R; Carroll, J; Chang, BH; Coblentz, C; d'Almeida, A; Cook, R; Danilov, A; Dao, KHT; Degnin, M; Devine, D; Dibb, J; Edwards, VDK; Eide, CA; English, I; Glover, J; Henson, R; Ho, H; Jemal, A; Johnson, K; Johnson, R; Junio, B; Kaempf, A; Leonard, J; Lin, CW; Liu, SQ; Lo, P; Loriaux, MM; Luty, S; Macey, T; MacManiman, J; Martinez, J; Mori, M; Nelson, D; Nichols, C; Peters, J; Ramsdill, J; Rofelty, A; Schuff, R; Searles, R; Segerdell, E; Smith, RL; Spurgeon, SE; Sweeney, T; Thapa, A; Visser, C; Wagner, J; Watanabe-Smith, K; Werth, K; Wolf, J; White, L; Yates, A; Zhang, HJ; Cogle, CR; Collins, RH; Connolly, DC; Deininger, MW; Drusbosky, L; Hourigan, CS; Jordan, CT; Kropf, P; Lin, TL; Martinez, ME; Medeiros, BC; Pallapati, RR; Pollyea, DA; Swords, RT; Watts, JM; Weir, SJ; Wiest, DL; Winters, RM; McWeeney, SK; Druker, BJ				Tyner, Jeffrey W.; Tognon, Cristina E.; Bottomly, Daniel; Wilmot, Beth; Kurtz, Stephen E.; Savage, Samantha L.; Long, Nicola; Schultz, Anna Reister; Traer, Elie; Abel, Melissa; Agarwal, Anupriya; Blucher, Aurora; Borate, Uma; Bryant, Jade; Burke, Russell; Carlos, Amy; Carpenter, Richie; Carroll, Joseph; Chang, Bill H.; Coblentz, Cody; d'Almeida, Amanda; Cook, Rachel; Danilov, Alexey; Dao, Kim-Hien T.; Degnin, Michie; Devine, Deirdre; Dibb, James; Edwards, David K., V; Eide, Christopher A.; English, Isabel; Glover, Jason; Henson, Rachel; Ho, Hibery; Jemal, Abdusebur; Johnson, Kara; Johnson, Ryan; Junio, Brian; Kaempf, Andy; Leonard, Jessica; Lin, Chenwei; Liu, Selina Qiuying; Lo, Pierrette; Loriaux, Marc M.; Luty, Samuel; Macey, Tara; MacManiman, Jason; Martinez, Jacqueline; Mori, Motomi; Nelson, Dylan; Nichols, Ceilidh; Peters, Jill; Ramsdill, Justin; Rofelty, Angela; Schuff, Robert; Searles, Robert; Segerdell, Erik; Smith, Rebecca L.; Spurgeon, Stephen E.; Sweeney, Tyler; Thapa, Aashis; Visser, Corinne; Wagner, Jake; Watanabe-Smith, Kevin; Werth, Kristen; Wolf, Joelle; White, Libbey; Yates, Amy; Zhang, Haijiao; Cogle, Christopher R.; Collins, Robert H.; Connolly, Denise C.; Deininger, Michael W.; Drusbosky, Leylah; Hourigan, Christopher S.; Jordan, Craig T.; Kropf, Patricia; Lin, Tara L.; Martinez, Micaela E.; Medeiros, Bruno C.; Pallapati, Rachel R.; Pollyea, Daniel A.; Swords, Ronan T.; Watts, Justin M.; Weir, Scott J.; Wiest, David L.; Winters, Ryan M.; McWeeney, Shannon K.; Druker, Brian J.			Functional genomic landscape of acute myeloid leukaemia	NATURE			English	Article							INTERNAL TANDEM DUPLICATION; TRANS-RETINOIC ACID; MYELODYSPLASTIC SYNDROME; CLONAL HEMATOPOIESIS; GENE-EXPRESSION; FLT3 INHIBITOR; TET2 MUTATIONS; CANCER; AML; PHARMACOKINETICS	The implementation of targeted therapies for acute myeloid leukaemia (AML) has been challenging because of the complex mutational patterns within and across patients as well as a dearth of pharmacologic agents for most mutational events. Here we report initial findings from the Beat AML programme on a cohort of 672 tumour specimens collected from 562 patients. We assessed these specimens using whole-exome sequencing, RNA sequencing and analyses of ex vivo drug sensitivity. Our data reveal mutational events that have not previously been detected in AML. We show that the response to drugs is associated with mutational status, including instances of drug sensitivity that are specific to combinatorial mutational events. Integration with RNA sequencing also revealed gene expression signatures, which predict a role for specific gene networks in the drug response. Collectively, we have generated a dataset-accessible through the Beat AML data viewer (Vizome)-that can be leveraged to address clinical, genomic, transcriptomic and functional analyses of the biology of AML.	[Tyner, Jeffrey W.; Savage, Samantha L.; Schultz, Anna Reister; Abel, Melissa; Bryant, Jade; d'Almeida, Amanda; Edwards, David K., V; MacManiman, Jason; Martinez, Jacqueline; Rofelty, Angela; Zhang, Haijiao] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Tyner, Jeffrey W.; Tognon, Cristina E.; Bottomly, Daniel; Wilmot, Beth; Kurtz, Stephen E.; Savage, Samantha L.; Long, Nicola; Schultz, Anna Reister; Traer, Elie; Abel, Melissa; Agarwal, Anupriya; Blucher, Aurora; Borate, Uma; Bryant, Jade; Burke, Russell; Carlos, Amy; Carpenter, Richie; Carroll, Joseph; Chang, Bill H.; Coblentz, Cody; d'Almeida, Amanda; Cook, Rachel; Danilov, Alexey; Dao, Kim-Hien T.; Degnin, Michie; Devine, Deirdre; Dibb, James; Edwards, David K., V; Eide, Christopher A.; English, Isabel; Glover, Jason; Henson, Rachel; Ho, Hibery; Jemal, Abdusebur; Johnson, Kara; Johnson, Ryan; Junio, Brian; Kaempf, Andy; Leonard, Jessica; Lin, Chenwei; Liu, Selina Qiuying; Lo, Pierrette; Loriaux, Marc M.; Luty, Samuel; Macey, Tara; MacManiman, Jason; Martinez, Jacqueline; Mori, Motomi; Nichols, Ceilidh; Peters, Jill; Rofelty, Angela; Searles, Robert; Segerdell, Erik; Smith, Rebecca L.; Spurgeon, Stephen E.; Sweeney, Tyler; Thapa, Aashis; Visser, Corinne; Wagner, Jake; Watanabe-Smith, Kevin; Werth, Kristen; Wolf, Joelle; White, Libbey; Zhang, Haijiao; McWeeney, Shannon K.; Druker, Brian J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Tognon, Cristina E.; Kurtz, Stephen E.; Long, Nicola; Borate, Uma; Burke, Russell; Carpenter, Richie; Coblentz, Cody; Cook, Rachel; Danilov, Alexey; Dao, Kim-Hien T.; Degnin, Michie; Devine, Deirdre; Dibb, James; Eide, Christopher A.; English, Isabel; Ho, Hibery; Johnson, Kara; Johnson, Ryan; Junio, Brian; Leonard, Jessica; Liu, Selina Qiuying; Lo, Pierrette; Luty, Samuel; Macey, Tara; Nichols, Ceilidh; Peters, Jill; Smith, Rebecca L.; Spurgeon, Stephen E.; Sweeney, Tyler; Thapa, Aashis; Visser, Corinne; Wagner, Jake; Watanabe-Smith, Kevin; Werth, Kristen; Druker, Brian J.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Tognon, Cristina E.; Eide, Christopher A.; Druker, Brian J.] Howard Hughes Med Inst, Portland, OR USA; [Bottomly, Daniel; Wilmot, Beth; Blucher, Aurora; Segerdell, Erik; White, Libbey; Yates, Amy; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [Wilmot, Beth; Ramsdill, Justin; Schuff, Robert; Yates, Amy; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA; [Agarwal, Anupriya] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Carlos, Amy; Henson, Rachel; Lin, Chenwei; Searles, Robert] Oregon Hlth & Sci Univ, Integrated Genom Labs, Portland, OR 97201 USA; [Carroll, Joseph] Oregon Hlth & Sci Univ, Technol Transfer & Business Dev, Portland, OR 97201 USA; [Chang, Bill H.; Glover, Jason; Jemal, Abdusebur; Wolf, Joelle] Oregon Hlth & Sci Univ, Dept Pediat, Div Hematol & Oncol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [Kaempf, Andy; Mori, Motomi] Oregon Hlth & Sci Univ, Biostat Shared Resource, Portland, OR 97201 USA; [Loriaux, Marc M.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Mori, Motomi] Oregon Hlth & Sci Univ, Portland State Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Nelson, Dylan] Oregon State Univ, High Throughput Screening Serv Lab, Corvalis, OR USA; [Cogle, Christopher R.; Drusbosky, Leylah] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL USA; [Collins, Robert H.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Hematol Oncol, Dallas, TX 75390 USA; [Connolly, Denise C.] Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Connolly, Denise C.; Winters, Ryan M.] Fox Chase Canc Ctr, Biosample Repository Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Deininger, Michael W.] Univ Utah, Dept Internal Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA; [Hourigan, Christopher S.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Jordan, Craig T.; Pollyea, Daniel A.] Univ Colorado, Div Hematol, Denver, CO 80202 USA; [Kropf, Patricia] Fox Chase Canc Ctr, Bone Marrow Transplant Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Lin, Tara L.] Univ Kansas, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA; [Martinez, Micaela E.; Pallapati, Rachel R.] Univ Miami, Sylvester Comprehens Canc Ctr, Clin Res Serv, Miami, FL USA; [Medeiros, Bruno C.] Stanford Univ, Dept Med Hematol, Stanford, CA 94305 USA; [Swords, Ronan T.; Watts, Justin M.] Univ Miami, Dept Hematol, Miami Sylvester Comprehens Canc Ctr, Miami, FL USA; [Weir, Scott J.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Weir, Scott J.] Univ Kansas, Med Ctr, Dept Med, Div Med Oncol, Kansas City, KS 66103 USA; [Wiest, David L.] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Portland State University; Oregon State University; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; Fox Chase Cancer Center; Fox Chase Cancer Center; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Colorado System; University of Colorado Denver; Fox Chase Cancer Center; University of Kansas; University of Miami; Stanford University; University of Miami; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center	McWeeney, SK; Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Druker, BJ (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA.; Druker, BJ (corresponding author), Howard Hughes Med Inst, Portland, OR USA.; McWeeney, SK (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Div Bioinformat & Computat Biol, Portland, OR 97201 USA.; McWeeney, SK (corresponding author), Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97201 USA.	mcweeney@ohsu.edu; drukerb@ohsu.edu	Hourigan, Christopher S/C-7588-2012; English, Isabel Aronson/ABF-2235-2021; Lin, Chen/GRR-2799-2022; jordan, craig/D-7666-2014	Hourigan, Christopher S/0000-0002-6189-8067; English, Isabel Aronson/0000-0002-0566-9585; Watanabe-Smith, Kevin/0000-0003-4231-8562; Weir, Scott/0000-0002-8020-434X; jordan, craig/0000-0003-0869-3465; Wiest, David/0000-0002-0792-3188; Yates, Amy/0000-0002-0664-7185; Blucher, Aurora/0000-0001-6460-010X; Medeiros, Bruno/0000-0001-6972-8137; Lin, Tara/0000-0002-0242-6449; Long, Nicola/0000-0002-9010-8167; Segerdell, Erik/0000-0002-9611-1279; Savage Stevens, Samantha/0000-0003-3961-2197; Druker, Brian/0000-0001-8331-8206; Eide, Christopher/0000-0001-8835-8928; Edwards, David/0000-0003-2708-9562; Lo, Pierrette/0000-0001-9221-4222; White, Libbey/0000-0003-4409-083X	Leukemia & Lymphoma Society [2400-13]; Knight Cancer Research Institute (Oregon Health & Science University, OHSU); National Cancer Institute [1R01CA183947, 1U01CA217862, 1U54CA224019, 1U01CA214116, 3P30CA069533-18S5]; NIH/NCATS [CTSA UL1TR002369]; National Library of Medicine Informatics Training Grant [T15LM007088]; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Intramural Research Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health; Therapy Acceleration Grant; NATIONAL CANCER INSTITUTE [R01CA214428, U01CA217862, P30CA069533, R01CA183974, U54CA224019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000152, UL1TR002369, UL1TR002366, KL2TR002370] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110985] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007088] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Knight Cancer Research Institute (Oregon Health & Science University, OHSU); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Library of Medicine Informatics Training Grant; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; Intramural Research Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Therapy Acceleration Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank all of our patients at all sites for donating precious time and tissue. DNA and RNA quality assessments, library creation and short read sequencing assays were performed by the OHSU Massively Parallel Sequencing Shared Resource. S. Sheela, C. Lai, K. Lindblad and K. Oetjen helped with study coordination at NIH. B. Sawicki and C. Cline helped with study coordination at the University of Florida. S. Ravencroft helped with patient sample shipping and data entry and K. Schorno provided project management and support of activities at the University of Kansas Cancer Center. J. Taw helped with patient sample shipping and S. Patel helped with data entry at Stanford University. Funding for this project was provided, in part, by a Therapy Acceleration Grant to B.J.D. and J.W.T. from The Leukemia & Lymphoma Society and by support provided by the Knight Cancer Research Institute (Oregon Health & Science University, OHSU). Supported by grants from the National Cancer Institute (1U01CA217862, 1U54CA224019, 1U01CA214116, 3P30CA069533-18S5) and NIH/NCATS CTSA UL1TR002369 (S.K.M., B.W.). A.S.B. was supported by the National Library of Medicine Informatics Training Grant (T15LM007088). J.W.T. received grants from the V Foundation for Cancer Research, the Gabrielle's Angel Foundation for Cancer Research, and the National Cancer Institute (1R01CA183947). C.R.C. received a Scholar in Clinical Research Award from The Leukemia & Lymphoma Society (2400-13), was distinguished with a Pierre Chagnon Professorship in Stem Cell Biology and Blood & Marrow Transplant and a UF Research Foundation Professorship. This work was supported in part by the Intramural Research Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health.	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blucher AS, 2017, TRENDS PHARMACOL SCI, V38, P1085, DOI 10.1016/j.tips.2017.08.006; Buffalo V., 2012, QRQC QUICK READ QUAL; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Canisius S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1114-x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DeAngelo DJ, 2006, BLOOD, V108, P3674, DOI 10.1182/blood-2006-02-005702; Deininger MWN, 2017, NAT REV CANCER, V17, P425, DOI 10.1038/nrc.2017.40; DiNardo CL, 2018, LANCET ONCOL, V19, P216, DOI 10.1016/S1470-2045(18)30010-X; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fraley C, 2003, J CLASSIF, V20, P263, DOI 10.1007/s00357-003-0015-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Huang Q, 2008, BRIT J HAEMATOL, V142, P489, DOI 10.1111/j.1365-2141.2008.07205.x; Huntley MA, 2013, BIOINFORMATICS, V29, P3220, DOI 10.1093/bioinformatics/btt551; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Itzykson R, 2011, LEUKEMIA, V25, P1147, DOI 10.1038/leu.2011.71; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Koboldt D., 2015, RELEASE NOTE VARSCAN; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Konopleva M, 2016, CANCER DISCOV, V6, P1106, DOI 10.1158/2159-8290.CD-16-0313; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Kurtz SE, 2017, P NATL ACAD SCI USA, V114, pE7554, DOI 10.1073/pnas.1703094114; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lundberg P, 2014, BLOOD, V123, P2220, DOI 10.1182/blood-2013-11-537167; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Memorial Sloan Kettering, 2016, VCF2MAF VERS 1 6  6; Memorial Sloan Kettering, 2016, MAF2VCF VERS 1 6 6; Nakao M, 1996, LEUKEMIA, V10, P1911; O'Farrell AM, 2003, CLIN CANCER RES, V9, P5465; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Parker HS, 2014, PEERJ, V2, DOI 10.7717/peerj.561; Parsana P., 2017, ADDRESSING CONFOUNDI; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pison G, 1999, COMPUT STAT DATA AN, V30, P381, DOI 10.1016/S0167-9473(98)00102-9; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; SEER, 2018, CANC STAT FACTS LEUK; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Slovak M. L., 2013, PRINCIPLES CLIN CYTO, P23; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tse KF, 2000, LEUKEMIA, V14, P1766, DOI 10.1038/sj.leu.2401905; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wei T., 2017, CORRPLOT VISUALIZATI; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zheng XW, 2016, THEOR POPUL BIOL, V107, P65, DOI 10.1016/j.tpb.2015.09.004; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	86	493	498	4	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					526	+		10.1038/s41586-018-0623-z	http://dx.doi.org/10.1038/s41586-018-0623-z			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30333627	Green Accepted			2022-12-28	WOS:000448277800046
J	Pickkers, P; Mehta, RL; Murray, PT; Joannidis, M; Molitoris, BA; Kellum, JA; Bachler, M; Hoste, EAJ; Hoiting, O; Krell, K; Ostermann, M; Rozendaal, W; Valkonen, M; Brealey, D; Beishuizen, A; Meziani, F; Murugan, R; de Geus, H; Payen, D; van den Berg, E; Arend, J				Pickkers, Peter; Mehta, Ravindra L.; Murray, Patrick T.; Joannidis, Michael; Molitoris, Bruce A.; Kellum, John A.; Bachler, Mirjam; Hoste, Eric A. J.; Hoiting, Oscar; Krell, Kenneth; Ostermann, Marlies; Rozendaal, Wim; Valkonen, Miia; Brealey, David; Beishuizen, Albertus; Meziani, Ferhat; Murugan, Raghavan; de Geus, Hilde; Payen, Didier; van den Berg, Erik; Arend, Jacques		STOP-Aki Investigators	Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; RENAL-FUNCTION; SEPTIC SHOCK; INFLAMMATION; DEPHOSPHORYLATION; PROGRESSION; FILTRATION; MARKER	IMPORTANCE Sepsis-associated acute kidney injury (AKI) adversely affects long-term kidney outcomes and survival. Administration of the detoxifying enzyme alkaline phosphatase may improve kidney function and survival. OBJECTIVE To determine the optimal therapeutic dose, effect on kidney function, and adverse effects of a human recombinant alkaline phosphatase in patients who are critically ill with sepsis-associated AKI. DESIGN, SETTING, AND PARTICIPANTS The STOP-AKI trial was an international (53 recruiting sites), randomized, double-blind, placebo-controlled, dose-finding, adaptive phase 2a/2b study in 301 adult patients admitted to the intensive care unit with a diagnosis of sepsis and AKI. Patients were enrolled between December 2014 and May 2017, and follow-up was conducted for 90 days. The final date of follow-up was August 14, 2017. INTERVENTIONS In the intention-to-treat analysis, in part 1 of the trial, patients were randomized to receive recombinant alkaline phosphatase in a dosage of 0.4 mg/kg (n = 31), 0.8 mg/kg (n = 32), or 1.6 mg/kg (n = 29) or placebo (n = 30), once daily for 3 days, to establish the optimal dose. The optimal dose was identified as 1.6 mg/kg based on modeling approaches and adverse events. In part 2, 1.6 mg/kg (n = 82) was compared with placebo (n = 86). MAIN OUTCOMES AND MEASURES The primary end point was the time-corrected area under the curve of the endogenous creatinine clearance for days 1 through 7, divided by 7 to provide a mean daily creatinine clearance (AUC(1-7) ECC). Incidence of fatal and nonfatal (serious) adverse events ([S]AEs) was also determined. RESULTS Overall, 301 patients were enrolled (men, 70.7%; median age, 67 years [interquartile range {IQR}, 59-73]). From day 1 to day 7, median ECC increased from 26.0 mL/min (IQR, 8.8 to 59.5) to 65.4 mL/min (IQR, 26.7 to 115.4) in the recombinant alkaline phosphatase 1.6-mg/kg group vs from 35.9 mL/min (IQR, 12.2 to 82.9) to 61.9 mL/min (IQR, 22.7 to 115.2) in the placebo group (absolute difference, 9.5 mL/min [95% CI, -23.9 to 25.5]; P = .47). Fatal adverse events occurred in 26.3% of patients in the 0.4-mg/kg recombinant alkaline phosphatase group; 17.1% in the 0.8-mg/kg group, 17.4% in the 1.6-mg/kg group, and 29.5% in the placebo group. Rates of nonfatal SAEs were 21.0% for the 0.4-mg/kg recombinant alkaline phosphatase group, 14.3% for the 0.8-mg/kg group, 25.7% for the 1.6-mg/kg group, and 20.5% for the placebo group. CONCLUSIONS AND RELEVANCE Among patients who were critically ill with sepsis-associated acute kidney injury, human recombinant alkaline phosphatase compared with placebo did not significantly improve short-term kidney function. Further research is necessary to assess other clinical outcomes.	[Pickkers, Peter] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Intens Care Med, POB 9101,Internal Post 710-0, NL-6500 HB Nijmegen, Netherlands; [Mehta, Ravindra L.] Univ Calif San Diego, Med Ctr, Dept Med, San Diego, CA 92103 USA; [Murray, Patrick T.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Joannidis, Michael] Med Univ Innsbruck, Div Intens Care & Emergency Med, Dept Internal Med, Innsbruck, Austria; [Molitoris, Bruce A.] Indiana Univ, Indianapolis, IN 46204 USA; [Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA; [Bachler, Mirjam] Med Univ Innsbruck, Dept Gen & Surg Crit Care Med, Innsbruck, Austria; [Hoste, Eric A. J.] Univ Ghent, Intens Care, Ghent, Belgium; [Hoste, Eric A. J.] Clin Res Fdn Flanders, Brussels, Belgium; [Hoiting, Oscar] Canisius Wilhelmina Hosp, Intens Care, Nijmegen, Netherlands; [Krell, Kenneth] Eastern Idaho Reg Med Ctr, Internal Med, Idaho Falls, ID USA; [Ostermann, Marlies] Kings Coll London, Guys & St Thomas Hosp, London, England; [Rozendaal, Wim] Jeroen Bosch Hosp, Intens Care, Shertogenbosch, Netherlands; [Valkonen, Miia] Univ Helsinki, Cent Hosp, Div Anesthesia & Intens Care Med, Helsinki, Finland; [Brealey, David] UCL, Hosp Natl Inst, Hlth Res Biomed Res Ctr, Div Crit Care, London, England; [Brealey, David] Univ Coll Hosp, Bloomsbury Inst Intens Care Med, London, England; [Beishuizen, Albertus] Medisch Spectrum Twente, Intens Care, Enschede, Netherlands; [Meziani, Ferhat] Univ Strasbourg, Nouvel Hop Civil, Hop Univ Strasbourg, Fac Med,Serv Reanimat, Strasbourg, France; [Murugan, Raghavan] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA; [de Geus, Hilde] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Payen, Didier] Univ Paris 07, INSERM, Unite Mixte Rech 1160, Paris, France; [Payen, Didier] Hop Lariboisiere, AP HP, Dept Anaesthesiol & Crit Care, Paris, France; [van den Berg, Erik; Arend, Jacques] AM Pharma BV, Clin Dept, Bunnik, Netherlands	Radboud University Nijmegen; University of California System; University of California San Diego; University College Dublin; Medical University of Innsbruck; Indiana University System; Indiana University-Purdue University Indianapolis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Innsbruck; Ghent University; Canisius-Wilhelmina Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Jeroen Bosch Ziekenhuis; University of Helsinki; Helsinki University Central Hospital; University of London; University College London; University of London; University College London; Medical Spectrum Twente; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Pickkers, P (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Intens Care Med, POB 9101,Internal Post 710-0, NL-6500 HB Nijmegen, Netherlands.	peter.pickkers@radboudumc.nl	Kellum, John/AAP-3072-2020; Brealey, David/AAL-1777-2021; Ostermann, Marlies/AAH-8160-2021; Sauer, Martin/GZK-4547-2022; Joannidis, Michael/AAZ-8790-2020; Kellum, John A/HCH-2944-2022; Pickkers, P./H-8080-2014; Mehta, Ravindra/ACD-4769-2022; Hoste, Eric/A-6353-2008; Betbese, Antoni/H-3419-2013; Ostermann, Marlies/B-8777-2015	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Pickkers, P./0000-0002-1104-4303; Mehta, Ravindra/0000-0002-0908-2968; Hoste, Eric/0000-0001-9301-8055; Murugan, Raghavan/0000-0002-6823-6365; antonio, artigas/0000-0002-8029-1017; Brealey, David/0000-0002-1982-3379; Monica, Rocco/0000-0001-8380-3607; Betbese, Antoni/0000-0002-9059-4046; Galeiras, Rita/0000-0002-8551-3731; QUENOT, Jean-Pierre/0000-0003-2351-682X; Ostermann, Marlies/0000-0001-9500-9080; Nichol, Alistair/0000-0002-4689-1238; Tomasa, Teresa M/0000-0001-8033-8527; Martinez-Sagasti, Fernando/0000-0001-8599-1250	AM-Pharma	AM-Pharma	This work was supported by AM-Pharma.	Acute Kidney Injury Network, AKIN STUD; Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; BAUMANN TJ, 1987, CLIN PHARMACY, V6, P393; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Billings FT, 2014, NEPHRON CLIN PRACT, V127, P89, DOI 10.1159/000363725; Carlier M, 2015, INTENS CARE MED, V41, P427, DOI 10.1007/s00134-014-3641-9; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Kellum JA, 2018, NAT REV NEPHROL, V14, P217, DOI 10.1038/nrneph.2017.184; Kellum JA, 2017, AM J RESP CRIT CARE, V195, P784, DOI 10.1164/rccm.201604-0799OC; Kellum JA, 2016, AM J RESP CRIT CARE, V193, P281, DOI 10.1164/rccm.201505-0995OC; Khundmiri SJ, 1997, AM J PHYSIOL-RENAL, V273, pF849, DOI 10.1152/ajprenal.1997.273.6.F849; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; National Kidney Foundation, 2009, CKD EPI CREAT EQ; Okusa MD, 2014, KIDNEY INT, V85, P39, DOI 10.1038/ki.2013.378; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Peters E, 2015, BRIT J PHARMACOL, V172, P4932, DOI 10.1111/bph.13261; Peters E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012371; Peters E, 2016, TOXICOL APPL PHARM, V313, P88, DOI 10.1016/j.taap.2016.10.015; Peters E, 2016, CLIN PHARMACOKINET, V55, P1227, DOI 10.1007/s40262-016-0399-y; Peters E, 2015, INT J PHARMACEUT, V495, P122, DOI 10.1016/j.ijpharm.2015.08.090; Peters E, 2014, NEPHRON CLIN PRACT, V127, P144, DOI 10.1159/000363256; Peters E, 2014, AM J KIDNEY DIS, V63, P1038, DOI 10.1053/j.ajkd.2013.11.027; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Pickering JW, 2012, CRIT CARE, V16, DOI 10.1186/cc11391; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Wu J, 2018, STAT METHODS MED RES, V27, P2694, DOI 10.1177/0962280216684528	36	86	88	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2018	320	19					1998	2009		10.1001/jama.2018.14283	http://dx.doi.org/10.1001/jama.2018.14283			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB0FC	30357272	hybrid, Green Published			2022-12-28	WOS:000450686800014
J	Allwood, AC; Rosing, MT; Flannery, DT; Hurowitz, JA; Heirwegh, CM				Allwood, Abigail C.; Rosing, Minik T.; Flannery, David T.; Hurowitz, Joel A.; Heirwegh, Christopher M.			Reassessing evidence of life in 3,700-million-year-old rocks of Greenland	NATURE			English	Article							STROMATOLITE REEF; PILBARA CRATON; CARBON; EARTH; GEOCHEMISTRY; BELT; OLD	The Palaeoarchean supracrustal belts in Greenland contain Earth's oldest rocks and are a prime target in the search for the earliest evidence of life on Earth. However, metamorphism has largely obliterated original rock textures and compositions, posing a challenge to the preservation of biological signatures. A recent study of 3,700-million-year-old rocks of the Isua supracrustal belt in Greenland described a rare zone in which low deformation and a closed metamorphic system allowed preservation of primary sedimentary features, including putative conical and domical stromatolites' (laminated accretionary structures formed by microbially mediated sedimentation). The morphology, layering, mineralogy, chemistry and geological context of the structures were attributed to the formation of microbial mats in a shallow marine environment by 3,700 million years ago, at the start of Earth's rock record. Here we report new research that shows a non-biological, post-depositional origin for the structures. Three-dimensional analysis of the morphology and orientation of the structures within the context of host rock fabrics, combined with texture-specific analyses of major and trace element chemistry, show that the 'stromatolites' are more plausibly interpreted as part of an assemblage of deformation structures formed in carbonate-altered metasediments long after burial. The investigation of the structures of the Isua supracrustal belt serves as a cautionary tale in the search for signs of past life on Mars, highlighting the importance of three-dimensional, integrated analysis of morphology, rock fabrics and geochemistry at appropriate scales.	[Allwood, Abigail C.; Flannery, David T.; Heirwegh, Christopher M.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA; [Rosing, Minik T.] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Hurowitz, Joel A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Allwood, AC (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91125 USA.; Hurowitz, JA (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	abigail.c.allwood@jpl.nasa.gov; joel.hurowitz@stonybrook.edu		Flannery, David/0000-0001-8982-496X	NASA; Stony Brook University-Brookhaven National Laboratory Seed Grant program	NASA(National Aeronautics & Space Administration (NASA)); Stony Brook University-Brookhaven National Laboratory Seed Grant program	Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). Funding for the work was provided by the NASA Mars 2020 PIXL flight project. We thank the Government of Greenland, Ministry of Mineral Resources for provision of access to the field sites, sampling permits and specifically geologist A. Juul-Nielsen for accompanying us on the field expedition, participating in discussions to determine an acceptable sampling strategy, and approving the final sample collection; T. Elam for providing the PIQUANT quantification code and descriptions of its architecture for the PIXL prototype; J. Thieme and E. Fogelqvist for assistance with data collection and reduction at the SRX beamline; T. Rasbury and K. Wooton for assistance with sample digestion and REE + Y analysis; I. Burch for field assistance including sample acquisition; K. Bourke for cutting and polishing the rock samples; and I. Fast for assistance in the field. J.A.H. acknowledges partial support from the Stony Brook University-Brookhaven National Laboratory Seed Grant program.	Allwood A, 2013, ASTROBIOLOGY, V13, P203, DOI 10.1089/ast.2012.0931; Allwood AC, 2007, PRECAMBRIAN RES, V158, P198, DOI 10.1016/j.precamres.2007.04.013; Allwood AC, 2009, P NATL ACAD SCI USA, V106, P9548, DOI 10.1073/pnas.0903323106; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Bau M, 1996, PRECAMBRIAN RES, V79, P37, DOI 10.1016/0301-9268(95)00087-9; Chen-Wiegart YCK, 2016, AIP CONF PROC, V1764, DOI 10.1063/1.4961138; De Andrade V, 2011, NUCL INSTRUM METH A, V649, P46, DOI 10.1016/j.nima.2010.11.154; Elam WT, 2002, RADIAT PHYS CHEM, V63, P121, DOI 10.1016/S0969-806X(01)00227-4; Fedo CM, 2001, SEDIMENT GEOL, V141, P61, DOI 10.1016/S0037-0738(01)00068-9; Heirwegh CM, 2018, POWDER DIFFR, V33, P162, DOI 10.1017/S0885715618000416; Li L, 2017, PROC SPIE, V10389, DOI 10.1117/12.2272585; Lindsay JF, 2005, PRECAMBRIAN RES, V143, P1, DOI 10.1016/j.precamres.2005.09.003; Machel H. G., 2004, GEOLOGICAL SOC LONDO, V235, P7, DOI DOI 10.1144/GSL.SP.2004.235.01.02; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Nutman A., 2017, TECHNICAL REPORT; Nutman AP, 2010, PRECAMBRIAN RES, V183, P725, DOI 10.1016/j.precamres.2010.08.006; Planavsky N, 2010, GEOCHIM COSMOCHIM AC, V74, P6387, DOI 10.1016/j.gca.2010.07.021; QING HU, 1994, SEDIMENTOLOGY, V41, P787, DOI 10.1111/j.1365-3091.1994.tb01424.x; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; SCHIDLOWSKI M, 1979, GEOCHIM COSMOCHIM AC, V43, P189, DOI 10.1016/0016-7037(79)90238-2; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Sugitani K, 2010, ASTROBIOLOGY, V10, P899, DOI 10.1089/ast.2010.0513; van Zuilen MA, 2002, NATURE, V418, P627, DOI 10.1038/nature00934; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0	25	70	71	4	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					241	+		10.1038/s41586-018-0610-4	http://dx.doi.org/10.1038/s41586-018-0610-4			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30333621				2022-12-28	WOS:000449943600042
J	Ruhe, ZC; Subramanian, P; Song, KH; Nguyen, JY; Stevens, TA; Low, DA; Jensen, GJ; Hayes, CS				Ruhe, Zachary C.; Subramanian, Poorna; Song, Kiho; Nguyen, Josephine Y.; Stevens, Taylor A.; Low, David A.; Jensen, Grant J.; Hayes, Christopher S.			Programmed Secretion Arrest and Receptor-Triggered Toxin Export during Antibacterial Contact-Dependent Growth Inhibition	CELL			English	Article							MEMBRANE PROTEASE OMPT; FILAMENTOUS HEMAGGLUTININ; BORDETELLA-PERTUSSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DELIVERY-SYSTEMS; INNER MEMBRANE; CDI; TRANSLOCATION; REQUIRES	Contact-dependent growth inhibition (CDI) entails receptor-mediated delivery of CdiA-derived toxins into Gram-negative target bacteria. Using electron cryotomography, we show that each CdiA effector protein forms a filament extending similar to 33 nm from the cell surface. Remarkably, the extracellular filament represents only the N-terminal half of the effector. A programmed secretion arrest sequesters the C-terminal half of CdiA, including the toxin domain, in the periplasm prior to target-cell recognition. Upon binding receptor, CdiA secretion resumes, and the periplasmic FHA-2 domain is transferred to the target-cell outer membrane. The C-terminal toxin region of CdiA then penetrates into the target-cell periplasm, where it is cleaved for subsequent translocation into the cytoplasm. Our findings suggest that the FHA-2 domain assembles into a transmembrane conduit for toxin transport into the periplasm of target bacteria. We propose that receptor-triggered secretion ensures that FHA-2 export is closely coordinated with integration into the target-cell outer membrane.	[Ruhe, Zachary C.; Nguyen, Josephine Y.; Low, David A.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Subramanian, Poorna; Stevens, Taylor A.; Jensen, Grant J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Song, Kiho; Low, David A.; Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn, Santa Barbara, CA 93106 USA; [Jensen, Grant J.] Howard Hughes Med Inst, Pasadena, CA 91125 USA	University of California System; University of California Santa Barbara; California Institute of Technology; University of California System; University of California Santa Barbara; Howard Hughes Medical Institute	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.; Jensen, GJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Hayes, CS (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn, Santa Barbara, CA 93106 USA.; Jensen, GJ (corresponding author), Howard Hughes Med Inst, Pasadena, CA 91125 USA.	jensen@caltech.edu; chayes@lifesci.ucsb.edu			National Institutes of Health [GM117930, GM122588]; National Science Foundation [MCB 1545720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122588, R01GM117930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chuan Hong, Rick Huang, and Zhiheng Yu at the HHMI Janelia CryoEM Facility for help with the Titan Krios microscope operation and data collection and Thomas Silhavy for providing antisera. This work was supported by grants GM117930 (C.S.H.) and GM122588 (G.J.J.) from National Institutes of Health and grant MCB 1545720 (C.S.H. and D.A.L.) from the National Science Foundation.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2011, VIRULENCE, V2, P356, DOI 10.4161/viru.2.4.16463; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Beck CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005925; Cao ZP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.183; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Garcia-Bayona L, 2017, ELIFE, V6, DOI 10.7554/eLife.24869; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Housden NG, 2012, BIOCHEM SOC T, V40, P1475, DOI 10.1042/BST20120255; Iancu CV, 2006, NAT PROTOC, V1, P2813, DOI 10.1038/nprot.2006.432; Jamet A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004592; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Koskiniemi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120265; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Kramer RA, 2001, FEBS LETT, V505, P426, DOI 10.1016/S0014-5793(01)02863-0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; MAKHOV AM, 1994, J MOL BIOL, V241, P110, DOI 10.1006/jmbi.1994.1478; Mastronarde DN., 2006, FIDUCIAL MARKER HYBR, DOI [10.1007/978-0-387-69008-7_6, DOI 10.1007/978-0-387-69008-7_6]; Melvin JA, 2015, MBIO, V6, DOI 10.1128/mBio.01189-15; Michalska K, 2018, MOL MICROBIOL, V109, P509, DOI 10.1111/mmi.14007; Neil RB, 2009, INFECT IMMUN, V77, P2285, DOI 10.1128/IAI.01502-08; Noel CR, 2012, MOL MICROBIOL, V86, P988, DOI 10.1111/mmi.12036; Pathak DT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003891; RELMAN DA, 1989, P NATL ACAD SCI USA, V86, P2637, DOI 10.1073/pnas.86.8.2637; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Ruhe ZC, 2017, MBIO, V8, DOI 10.1128/mBio.00290-17; Ruhe ZC, 2015, MOL MICROBIOL, V98, P175, DOI 10.1111/mmi.13114; Ruhe ZC, 2014, MOL MICROBIOL, V94, P466, DOI 10.1111/mmi.12779; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Scheller EV, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv079; Shiomi D, 2013, MOL MICROBIOL, V87, P1029, DOI 10.1111/mmi.12148; Souza DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7453; Tivol WF, 2008, MICROSC MICROANAL, V14, P375, DOI 10.1017/S1431927608080781; Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033; Vassallo C, 2015, P NATL ACAD SCI USA, V112, pE2939, DOI 10.1073/pnas.1503553112; Vassallo CM, 2017, ELIFE, V6, DOI 10.7554/eLife.29397; Webb JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057609; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Willett JLE, 2015, J MOL BIOL, V427, P3754, DOI 10.1016/j.jmb.2015.09.010; Willett JLE, 2015, P NATL ACAD SCI USA, V112, P11341, DOI 10.1073/pnas.1512124112; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	58	43	44	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					921	+		10.1016/j.cell.2018.10.033	http://dx.doi.org/10.1016/j.cell.2018.10.033			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388452	Green Accepted, Bronze			2022-12-28	WOS:000449100600008
J	Tasic, B; Yao, ZZ; Graybuck, LT; Smith, KA; Nguyen, TN; Bertagnolli, D; Goldy, J; Garren, E; Economo, MN; Viswanathan, S; Penn, O; Bakken, T; Menon, V; Miller, J; Fong, O; Hirokawa, KE; Lathia, K; Rimorin, C; Tieu, M; Larsen, R; Casper, T; Barkan, E; Kroll, M; Parry, S; Shapovalova, NV; Hirschstein, D; Pendergraft, J; Sullivan, HA; Kim, TK; Szafer, A; Dee, N; Groblewski, P; Wickersham, I; Cetin, A; Harris, JA; Levi, BP; Sunkin, SM; Madisen, L; Daigle, TL; Looger, L; Bernard, A; Phillips, J; Lein, E; Hawrylycz, M; Svoboda, K; Jones, AR; Koch, C; Zeng, HK				Tasic, Bosiljka; Yao, Zizhen; Graybuck, Lucas T.; Smith, Kimberly A.; Thuc Nghi Nguyen; Bertagnolli, Darren; Goldy, Jeff; Garren, Emma; Economo, Michael N.; Viswanathan, Sarada; Penn, Osnat; Bakken, Trygve; Menon, Vilas; Miller, Jeremy; Fong, Olivia; Hirokawa, Karla E.; Lathia, Kanan; Rimorin, Christine; Tieu, Michael; Larsen, Rachael; Casper, Tamara; Barkan, Eliza; Kroll, Matthew; Parry, Sheana; Shapovalova, Nadiya V.; Hirschstein, Daniel; Pendergraft, Julie; Sullivan, Heather A.; Kim, Tae Kyung; Szafer, Aaron; Dee, Nick; Groblewski, Peter; Wickersham, Ian; Cetin, Ali; Harris, Julie A.; Levi, Boaz P.; Sunkin, Susan M.; Madisen, Linda; Daigle, Tanya L.; Looger, Loren; Bernard, Amy; Phillips, John; Lein, Ed; Hawrylycz, Michael; Svoboda, Karel; Jones, Allan R.; Koch, Christof; Zeng, Hongkui			Shared and distinct transcriptomic cell types across neocortical areas	NATURE			English	Article							CAJAL-RETZIUS CELLS; VISUAL-CORTEX; RNA-SEQ; MOUSE; NEURONS; ADULT; EXPRESSION; CLASSIFICATION; SPECIFICATION; MECHANISMS	The neocortex contains a multitude of cell types that are segregated into layers and functionally distinct areas. To investigate the diversity of cell types across the mouse neocortex, here we analysed 23,822 cells from two areas at distant poles of the mouse neocortex: the primary visual cortex and the anterior lateral motor cortex. We define 133 transcriptomic cell types by deep, single-cell RNA sequencing. Nearly all types of GABA (gamma-aminobutyric acid)-containing neurons are shared across both areas, whereas most types of glutamatergic neurons were found in one of the two areas. By combining single-cell RNA sequencing and retrograde labelling, we match transcriptomic types of glutamatergic neurons to their long-range projection specificity. Our study establishes a combined transcriptomic and projectional taxonomy of cortical cell types from functionally distinct areas of the adult mouse cortex.	[Tasic, Bosiljka; Yao, Zizhen; Graybuck, Lucas T.; Smith, Kimberly A.; Thuc Nghi Nguyen; Bertagnolli, Darren; Goldy, Jeff; Garren, Emma; Penn, Osnat; Bakken, Trygve; Menon, Vilas; Miller, Jeremy; Fong, Olivia; Hirokawa, Karla E.; Lathia, Kanan; Rimorin, Christine; Tieu, Michael; Larsen, Rachael; Casper, Tamara; Barkan, Eliza; Kroll, Matthew; Parry, Sheana; Shapovalova, Nadiya V.; Hirschstein, Daniel; Pendergraft, Julie; Kim, Tae Kyung; Szafer, Aaron; Dee, Nick; Groblewski, Peter; Cetin, Ali; Harris, Julie A.; Levi, Boaz P.; Sunkin, Susan M.; Madisen, Linda; Daigle, Tanya L.; Bernard, Amy; Phillips, John; Lein, Ed; Hawrylycz, Michael; Jones, Allan R.; Koch, Christof; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA 98109 USA; [Economo, Michael N.; Viswanathan, Sarada; Menon, Vilas; Looger, Loren; Svoboda, Karel] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Sullivan, Heather A.; Wickersham, Ian] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tasic, B (corresponding author), Allen Inst Brain Sci, Seattle, WA 98109 USA.	bosiljkat@alleninstitute.org	Bakken, Trygve E./R-4622-2017; Menon, Vilas/AAG-4109-2021	Bakken, Trygve E./0000-0003-3373-7386; Menon, Vilas/0000-0002-4096-8601; Bernard, Amy/0000-0003-2540-1153; Barkan, Eliza/0000-0001-7871-4327; Nguyen, Thuc Nghi/0000-0002-6466-5883; Economo, Michael/0000-0001-9893-1505; Sullivan, Heather/0000-0001-6668-9996; Hirokawa, Karla/0000-0002-9954-5515; Dee, Nick/0000-0002-2831-9254	Allen Institute for Brain Science; US National Institutes of Health [R01EY023173, U01MH105982]; NATIONAL EYE INSTITUTE [R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105982, U19MH114830] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Chillon Rodrigues for providing CAV2-Cre, A. Karpova for providing rAAV2-retro, A. Williford for technical assistance, and the Transgenic Colony Management and Animal Care teams for animal husbandry. This work was funded by the Allen Institute for Brain Science, and by US National Institutes of Health grants R01EY023173 and U01MH105982 to H.Z. We thank the Allen Institute founder, P. G. Allen, for his vision, encouragement and support.	Abellan A, 2010, CEREB CORTEX, V20, P1788, DOI 10.1093/cercor/bhp242; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Ayoub AE, 2009, CEREB CORTEX, V19, P1705, DOI 10.1093/cercor/bhp025; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cadwell CR, 2016, NAT BIOTECHNOL, V34, P199, DOI 10.1038/nbt.3445; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Cardin JA, 2010, J NEUROSCI, V30, P3652, DOI 10.1523/JNEUROSCI.5279-09.2010; Chatterjee S, 2018, NAT NEUROSCI, V21, P638, DOI 10.1038/s41593-018-0091-7; Chen TW, 2017, NEURON, V94, P866, DOI 10.1016/j.neuron.2017.05.005; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand S, 2016, J NEUROSCI, V36, P12144, DOI 10.1523/JNEUROSCI.1741-16.2016; Economo MN, 2018, NATURE, V563, P79, DOI 10.1038/s41586-018-0642-9; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Frazer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14219; Fuster J, 2015, PREFRONTAL CORTEX; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; He M, 2016, NEURON, V92, P555, DOI 10.1016/j.neuron.2016.10.009; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hilscher MM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001392; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hoerder-Suabedissen A, 2018, CEREB CORTEX, V28, P1882, DOI 10.1093/cercor/bhy036; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Kirischuk S, 2014, NEUROSCIENCE, V275, P33, DOI 10.1016/j.neuroscience.2014.06.009; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Kopatz J, 2013, GLIA, V61, P1122, DOI 10.1002/glia.22501; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Linderman G.C., 2017, PREPRINT; Liu HS, 2009, NEURON, V62, P281, DOI 10.1016/j.neuron.2009.02.025; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Pedraza M, 2014, P NATL ACAD SCI USA, V111, P8613, DOI 10.1073/pnas.1323816111; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Svoboda K, 2018, CURR OPIN NEUROBIOL, V49, P33, DOI 10.1016/j.conb.2017.10.023; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Tasic B., 2017, DECODING NEURAL CIRC, P437, DOI [10.1007/978-3-319-57363, DOI 10.1007/978-3-319-57363]; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Team RC., 2013, R LANG ENV STAT COMP; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Vue TY, 2013, J NEUROSCI, V33, P8442, DOI 10.1523/JNEUROSCI.5786-12.2013; Wang QX, 2017, J COMP NEUROL, V525, P1317, DOI 10.1002/cne.24047; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	87	610	612	10	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					72	+		10.1038/s41586-018-0654-5	http://dx.doi.org/10.1038/s41586-018-0654-5			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382198	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000448900900047
J	Pimiento, C				Pimiento, Catalina			Our shallow-water origins	SCIENCE			English	Editorial Material							EXTINCTION; DIVERSITY; RECOVERY; PATTERNS		[Pimiento, Catalina] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales; [Pimiento, Catalina] Smithsonian Trop Res Inst, Panama City, Panama	Swansea University; Smithsonian Institution; Smithsonian Tropical Research Institute	Pimiento, C (corresponding author), Swansea Univ, Dept Biosci, Swansea, W Glam, Wales.; Pimiento, C (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	cpimiento@swansea.ac.uk						Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bellwood DR, 2017, BIOL REV, V92, P878, DOI 10.1111/brv.12259; Brazeau MD, 2015, NATURE, V520, P490, DOI 10.1038/nature14438; BRETT CE, 1993, LETHAIA, V26, P25, DOI 10.1111/j.1502-3931.1993.tb01507.x; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; Jones KR, 2018, CURR BIOL, V28, P2506, DOI 10.1016/j.cub.2018.06.010; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Pimiento C, 2017, NAT ECOL EVOL, V1, P1100, DOI 10.1038/s41559-017-0223-6; Sallan L, 2018, SCIENCE, V362, P460, DOI 10.1126/science.aar3689; Sansom RS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2245; Whalen CD, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0883	13	0	1	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					402	+		10.1126/science.aau8461	http://dx.doi.org/10.1126/science.aau8461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361361	Green Accepted			2022-12-28	WOS:000450441900032
J	O'Dowd, A				O'Dowd, Adrian			Tackling antimicrobial resistance should be "top five" priority for UK government, MPs urge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health and Social Care Committee, 2018, ANT RES	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2018	363								k4444	10.1136/bmj.k4444	http://dx.doi.org/10.1136/bmj.k4444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OW	30348645				2022-12-28	WOS:000448892800006
J	Atroshi, I				Atroshi, Isam			Steroid injection or wrist splint for first-time carpal tunnel syndrome?	LANCET			English	Editorial Material							SYMPTOMS		[Atroshi, Isam] Lund Univ, Dept Clin Sci, Lund, Sweden; [Atroshi, Isam] Lund Univ, Dept Orthopaed, Lund, Sweden; [Atroshi, Isam] Hassleholm Kristianstad, Dept Orthopaed, SE-28125 Hassleholm, Sweden	Lund University; Lund University	Atroshi, I (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.; Atroshi, I (corresponding author), Lund Univ, Dept Orthopaed, Lund, Sweden.; Atroshi, I (corresponding author), Hassleholm Kristianstad, Dept Orthopaed, SE-28125 Hassleholm, Sweden.	isam.atroshi@skane.se						Atroshi I, 1999, J HAND SURG-AM, V24A, P398, DOI 10.1053/jhsu.1999.0398; Atroshi I, 2013, ANN INTERN MED, V159, P309, DOI 10.7326/0003-4819-159-5-201309030-00004; Atroshi I, 2011, ARCH INTERN MED, V171, P943, DOI 10.1001/archinternmed.2011.203; Chesterton LS, 2018, LANCET, V392, P1423, DOI 10.1016/S0140-6736(18)31572-1; Chung VCH, 2016, CAN MED ASSOC J, V188, P867, DOI 10.1503/cmaj.151003; Hobby JL, 2005, J HAND SURG-BRIT EUR, V30B, P599, DOI 10.1016/j.jhsb.2005.07.005; Huisstede BM, 2018, ARCH PHYS MED REHAB, V99, P1609, DOI 10.1016/j.apmr.2018.03.003; Page MJ, 2012, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858.CD010003, DOI 10.1002/14651858.CD010003.PMID:22786532]; Sears ED, 2016, J HAND SURG-AM, V41, P367, DOI 10.1016/j.jhsa.2015.11.021	9	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1383	1384		10.1016/S0140-6736(18)31929-9	http://dx.doi.org/10.1016/S0140-6736(18)31929-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343850	hybrid			2022-12-28	WOS:000447800900012
J	Bravyi, S; Gosset, D; Konig, R				Bravyi, Sergey; Gosset, David; Koenig, Robert			Quantum advantage with shallow circuits	SCIENCE			English	Article							POLYNOMIAL-TIME; COMPUTATION; COMPLEXITY; COMMUNICATION; ALGORITHMS; SUPREMACY	Quantum effects can enhance information-processing capabilities and speed up the solution of certain computational problems. Whether a quantum advantage can be rigorously proven in some setting or demonstrated experimentally using near-term devices is the subject of active debate. We show that parallel quantum algorithms running in a constant time period are strictly more powerful than their classical counterparts; they are provably better at solving certain linear algebra problems associated with binary quadratic forms. Our work gives an unconditional proof of a computational quantum advantage and simultaneously pinpoints its origin: It is a consequence of quantum nonlocality. The proposed quantum algorithm is a suitable candidate for near-future experimental realizations, as it requires only constant-depth quantum circuits with nearest-neighbor gates on a two-dimensional grid of qubits (quantum bits).	[Bravyi, Sergey; Gosset, David] IIBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Koenig, Robert] Tech Univ Munich, D-85748 Garching, Germany; [Gosset, David] Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON N2L 3G1, Canada; [Gosset, David] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada	Technical University of Munich; University of Waterloo; University of Waterloo	Konig, R (corresponding author), Tech Univ Munich, D-85748 Garching, Germany.	robert.koenig@tum.de			IBM Research Frontiers Institute; Technical University of Munich-Institute for Advanced Study - German Excellence Initiative; European Union Seventh Framework Programme [291763]	IBM Research Frontiers Institute(International Business Machines (IBM)); Technical University of Munich-Institute for Advanced Study - German Excellence Initiative; European Union Seventh Framework Programme(European Commission)	Supported by the IBM Research Frontiers Institute (S.B. and D.G.) and by the Technical University of Munich-Institute for Advanced Study, funded by the German Excellence Initiative and the European Union Seventh Framework Programme under grant agreement 291763 (R.K.).	Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Aaronson S, 2005, P ROY SOC A-MATH PHY, V461, P3473, DOI 10.1098/rspa.2005.1546; Aaronson S., 2017, P 32 COMP COMPL C CC; Aaronson S., 2010, P 42 ACM S THEOR COM, P141; Ambainis A, 2007, SIAM J COMPUT, V37, P210, DOI 10.1137/S0097539705447311; Barrett J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.012103; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bernstein E, 1997, SIAM J COMPUT, V26, P1411, DOI 10.1137/S0097539796300921; Boixo S, 2018, NAT PHYS, V14, P595, DOI 10.1038/s41567-018-0124-x; Bombin H, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/8/083002; Brassard G, 2003, FOUND PHYS, V33, P1593, DOI 10.1023/A:1026009100467; Bremner MJ, 2017, QUANTUM-AUSTRIA, V1, DOI 10.22331/q-2017-04-25-8; Browne D, 2010, C QUANT COMP COMM CR, P35; Cleve R, 2000, ANN IEEE SYMP FOUND, P526, DOI 10.1109/SFCS.2000.892140; de Wolf R, 2002, THEOR COMPUT SCI, V287, P337, DOI 10.1016/S0304-3975(02)00377-8; Eldar L., 2017, 58 ANN S FDN COMP SC, P427; Farhi E., 2016, ARXIV160207674QUANTP; Gao X, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.040502; Gottesman D., 1999, P 22 INT C GROUP THE, P32; Gottesman D, 2014, QUANTUM INF COMPUT, V14, P1338; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Hoyer P., 2005, THEORY COMPUT, V1, P83; Li Y, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021050; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Montanaro A, 2016, NPJ QUANTUM INFORM, V2, DOI 10.1038/npjqi.2015.23; Moore C, 2002, SIAM J COMPUT, V31, P799, DOI 10.1137/S0097539799355053; Pastawski F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.080501; Raussendorf R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022312; Reichardt B. W., 2008, P 40 ACM STOC, P103; Shor PW, 1999, SIAM REV, V41, P303, DOI 10.1137/S0036144598347011; Temme K, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.180509; Terhal BM, 2004, QUANTUM INFORM COMPU, V4, P134	36	115	117	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					308	+		10.1126/science.aar3106	http://dx.doi.org/10.1126/science.aar3106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337404	Green Submitted			2022-12-28	WOS:000447680100040
J	Iacobucci, G				Iacobucci, Gareth			Brexit: hospitals told to identify contracts that could be affected by "no deal"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cooper C., 2018, UK HOSP YET START PL; House of Commons Public Accounts Committee, 2018, PRIC INCR GEN MED	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4426	10.1136/bmj.k4426	http://dx.doi.org/10.1136/bmj.k4426			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341069				2022-12-28	WOS:000448271300007
J	Lee, JSM				Lee, Jet-Sing M.			Leaving my comfort zone	SCIENCE			English	Editorial Material								I never thought I would venture far from home. I was a mediocre high school student from a workingclass family, and I didn't think traveling the world was in the cards for me. For my undergTad degTee, I only applied to universities within an hour of my hometown in the United Kingdom. When I decided to pursue a Ph.D., I staved at the same university I still wasn't convinced I was a gTeat student (even though I was near the top of my class), and staving seemed like the safe option. It allowed me to remain close to friends, and I was familiar with the department, which put me in a good position to pick my supervisor wisely. A few years later, as I was considering a postdoc, I was tempted to once again stay close to home, in the comfort of my Ph.D. lab. My experience there had been very positive, and previous doctoral students had stayed on, so why shouldn't I? It would have been so easy. But I hope to run my own lab one day, and I knew that seeing a different approach to science would be valuable.	[Lee, Jet-Sing M.] Kyoto Univ, Chem, Kyoto, Japan	Kyoto University	Lee, JSM (corresponding author), Kyoto Univ, Chem, Kyoto, Japan.		Lee, Jet-Sing M./Q-2689-2019	Lee, Jet-Sing M./0000-0002-6740-8700					0	0	0	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					370	370		10.1126/science.362.6412.370	http://dx.doi.org/10.1126/science.362.6412.370			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337412	Bronze			2022-12-28	WOS:000447680100053
J	Lienart, S; Merceron, R; Vanderaa, C; Lambert, F; Colau, D; Stockis, J; van der Woning, B; De Haard, H; Saunders, M; Coulie, PG; Savvides, SN; Lucas, S				Lienart, Stephanie; Merceron, Romain; Vanderaa, Christophe; Lambert, Fanny; Colau, Didier; Stockis, Julie; van der Woning, Bas; De Haard, Hans; Saunders, Michael; Coulie, Pierre G.; Savvides, Savvas N.; Lucas, Sophie			Structural basis of latent TGF-beta 1 presentation and activation by GARP on human regulatory T cells	SCIENCE			English	Article							TGF-BETA; PROTEINS; SURFACE	Transforming growth factor-beta 1 (TGF-beta 1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T-regs) suppress immune cells within close proximity by activating latent TGF-beta 1 presented by GARP (glycoprotein A repetitions predominant) to integrin alpha V beta 8 on their surface. We solved the crystal structure of GARP: latent TGF-beta 1 bound to an antibody that stabilizes the complex and blocks release of active TGF-beta 1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-beta 1, to chaperone and orient the cytokine for binding and activation by alpha V beta 8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-beta 1 activation and immunosuppression by T-regs.	[Lienart, Stephanie; Vanderaa, Christophe; Lambert, Fanny; Stockis, Julie; Coulie, Pierre G.; Lucas, Sophie] UCLouvain, de Duve Inst, B-1200 Brussels, Belgium; [Merceron, Romain; Savvides, Savvas N.] Univ Ghent, Dept Biochem & Microbiol, B-9052 Ghent, Belgium; [Merceron, Romain; Savvides, Savvas N.] VIB Ctr Inflammat Res, B-9052 Ghent, Belgium; [Colau, Didier] Ludwig Canc Res, Brussels, Belgium; [Stockis, Julie; Coulie, Pierre G.; Lucas, Sophie] Walloon Excellence Lifesci & Biotechnol, B-1300 Wavre, Belgium; [van der Woning, Bas; De Haard, Hans; Saunders, Michael] Argenx, B-9052 Zwijnaarde, Belgium	Universite Catholique Louvain; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; WELBIO	Lucas, S (corresponding author), UCLouvain, de Duve Inst, B-1200 Brussels, Belgium.; Savvides, SN (corresponding author), Univ Ghent, Dept Biochem & Microbiol, B-9052 Ghent, Belgium.; Savvides, SN (corresponding author), VIB Ctr Inflammat Res, B-9052 Ghent, Belgium.; Lucas, S (corresponding author), Walloon Excellence Lifesci & Biotechnol, B-1300 Wavre, Belgium.	savvas.savvides@ugent.be; sophie.lucas@uclouvain.be		Vanderaa, Christophe/0000-0001-7443-5427; Stockis, Julie/0000-0003-4911-6891; Lienart, Stephanie/0000-0002-5825-6979; Lucas, Sophie/0000-0003-1287-7996	WELBIO [BF-2014-01]; ERC [TARG-SUP 682818]; VIB; Televie fellowship (F.R.S.-FNRS)	WELBIO(WELBIO); ERC(European Research Council (ERC)European Commission); VIB; Televie fellowship (F.R.S.-FNRS)	This work was supported by grants from WELBIO (grant BF-2014-01) and the ERC (Consolidator grant TARG-SUP 682818) to S.Lu., and from the VIB to S.N.S. S.Li. was supported by a Televie fellowship (F.R.S.-FNRS).	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2015, CURR OPIN STRUC BIOL, V30, P89, DOI 10.1016/j.sbi.2015.02.001; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dong XC, 2017, NATURE, V542, P55, DOI 10.1038/nature21035; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Hinck A. P., 2016, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a022103, DOI 10.1101/CSHPERSPECT.A022103]; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Qin Y, 2018, CELL, V174, P156, DOI 10.1016/j.cell.2018.05.027; Robertson IB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021907; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Stockis J, 2017, P NATL ACAD SCI USA, V114, pE10161, DOI 10.1073/pnas.1710680114; Stockis J, 2017, MOL BIOSYST, V13, P1925, DOI 10.1039/c7mb00251c; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Wu BX, 2017, J BIOL CHEM, V292, P18091, DOI 10.1074/jbc.M117.797613	24	79	88	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2018	362	6417					952	+		10.1126/science.aau2909	http://dx.doi.org/10.1126/science.aau2909			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB5TC	30361387				2022-12-28	WOS:000451124500044
J	Mizuhashi, K; Ono, W; Matsushita, Y; Sakagami, N; Takahashi, A; Saunders, TL; Nagasawa, T; Kronenberg, HM; Ono, N				Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki; Sakagami, Naoko; Takahashi, Akira; Saunders, Thomas L.; Nagasawa, Takashi; Kronenberg, Henry M.; Ono, Noriaki			Resting zone of the growth plate houses a unique class of skeletal stem cells	NATURE			English	Article							BONE-FORMATION; IN-VIVO; DIFFERENTIATION; CHONDROCYTES; PTHRP; HEMATOPOIESIS; MOUSE	Skeletal stem cells regulate bone growth and homeostasis by generating diverse cell types, including chondrocytes, osteoblasts and marrow stromal cells. The emerging concept postulates that there exists a distinct type of skeletal stem cell that is closely associated with the growth plate(1-4), which is a type of cartilaginous tissue that has critical roles in bone elongation(5) . The resting zone maintains the growth plate by expressing parathyroid hormonerelated protein (PTHrP), which interacts with Indian hedgehog (Ihh) that is released from the hypertrophic zone(6-10), and provides a source of other chondrocytes(11) . However, the identity of skeletal stem cells and how they are maintained in the growth plate are unknown. Here we show, in a mouse model, that skeletal stem cells are formed among PTHrP-positive chondrocytes within the resting zone of the postnatal growth plate. PTHrP-positive chondrocytes expressed a panel of markers for skeletal stem and progenitor cells, and uniquely possessed the properties of skeletal stem cells in cultured conditions. Cell-lineage analysis revealed that PTHrP-positive chondrocytes in the resting zone continued to form columnar chondrocytes in the long term; these chondrocytes underwent hypertrophy, and became osteoblasts and marrow stromal cells beneath the growth plate. Transit-amplifying chondrocytes in the proliferating zone-which was concertedly maintained by a forward signal from undifferentiated cells (PTHrP) and a reverse signal from hypertrophic cells (Ihh)-provided instructive cues to maintain the cell fates of PTHrP-positive chondrocytes in the resting zone. Our findings unravel a type of somatic stem cell that is initially unipotent and acquires multipotency at the post-mitotic stage, underscoring the malleable nature of the skeletal cell lineage. This system provides a model in which functionally dedicated stem cells and their niches are specified postnatally, and maintained throughout tissue growth by a tight feedback regulation system.	[Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki; Sakagami, Naoko; Takahashi, Akira; Ono, Noriaki] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Sch Med, Transgen Anim Model Core, Ann Arbor, MI USA; [Nagasawa, Takashi] Osaka Univ, Sch Med, Grad Sch Frontier Biosci, Lab Stem Cell Biol & Dev Immunol, Suita, Osaka, Japan; [Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Kronenberg, Henry M.] Harvard Med Sch, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Osaka University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ono, N (corresponding author), Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA.	noriono@umich.edu	; Matsushita, Yuki/H-3188-2015	Nagasawa, Takashi/0000-0002-1085-0960; Ono, Wanida/0000-0002-0358-1897; Matsushita, Yuki/0000-0001-9577-3249; Saunders, Thom/0000-0003-2015-101X	NIH [R01DE026666, R00DE022564, R03DE027421, P01DK011794]; 2017 Fred F. Schudy Memorial Research Award from the American Association of Orthodontists Foundation; University of Michigan MCubed 2.0 Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE027421, R00DE022564, R01DE026666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2017 Fred F. Schudy Memorial Research Award from the American Association of Orthodontists Foundation; University of Michigan MCubed 2.0 Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Holcomb and M. Curtis of Carl Zeiss Microscopy for assistance in imaging, G. Gavrilina and W. Fillipak of the University of Michigan Transgenic Animal Model Core for assistance with transgenesis. This research was supported by NIH R01DE026666 and R00DE022564 (to N.O.), R03DE027421 (to W.O.), P01DK011794 (to H.M.K.), 2017 Fred F. Schudy Memorial Research Award from the American Association of Orthodontists Foundation (to N.O.) and University of Michigan MCubed 2.0 Grant (to N.O. and W.O.).	Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chen XS, 2006, J BONE MINER RES, V21, P113, DOI 10.1359/JBMR.051005; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Ono N, 2016, CURR OPIN GENET DEV, V40, P103, DOI 10.1016/j.gde.2016.06.012; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111	18	165	180	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					254	+		10.1038/s41586-018-0662-5	http://dx.doi.org/10.1038/s41586-018-0662-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401834	Green Accepted			2022-12-28	WOS:000449943600045
J	Shi, HL; Zhang, XL; Weng, YL; Lu, ZY; Liu, YJ; Lu, ZK; Li, JN; Hao, PL; Zhang, Y; Zhang, F; Wu, Y; Delgado, JY; Su, YJ; Patel, MJ; Cao, XH; Shen, B; Huang, XX; Ming, GL; Zhuang, XX; Song, HJ; He, CA; Zhou, T				Shi, Hailing; Zhang, Xuliang; Weng, Yi-Lan; Lu, Zongyang; Liu, Yajing; Lu, Zhike; Li, Jianan; Hao, Piliang; Zhang, Yu; Zhang, Feng; Wu, You; Delgado, Jary Y.; Su, Yijing; Patel, Meera J.; Cao, Xiaohua; Shen, Bin; Huang, Xingxu; Ming, Guo-li; Zhuang, Xiaoxi; Song, Hongjun; He, Chuan; Zhou, Tao			m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1	NATURE			English	Article							MESSENGER-RNA METHYLATION; FAT MASS; DNA DEMETHYLATION; PROTEIN-SYNTHESIS; SEQ; N-6-METHYLADENOSINE; TRANSLATION; ENRICHMENT; IMPACTS; CAMKII	N-6-methyladenosine (m(6)A), the most prevalent internal RNA modification on mammalian messenger RNAs, regulates the fates and functions of modified transcripts through m(6)A-specific binding proteins(1-5). In the nervous system, m(6)A is abundant and modulates various neural functions(6-11). Whereas m(6)A marks groups of mRNAs for coordinated degradation in various physiological processes(12-15), the relevance of m(6)A for mRNA translation in vivo remains largely unknown. Here we show that, through its binding protein YTHDF1, m(6)A promotes protein translation of target transcripts in response to neuronal stimuli in the adult mouse hippocampus, thereby facilitating learning and memory. Mice with genetic deletion of Ythdf1 show learning and memory defects as well as impaired hippocampal synaptic transmission and long-term potentiation. Re-expression of YTHDF1 in the hippocampus of adult Ythdf1-knockout mice rescues the behavioural and synaptic defects, whereas hippocampus-specific acute knockdown of Ythdf1 or MettI3, which encodes the catalytic component of the m(6)A methyltransferase complex, recapitulates the hippocampal deficiency. Transcriptome-wide mapping of YTHDF1-binding sites and m(6)A sites on hippocampal mRNAs identified key neuronal genes. Nascent protein labelling and tether reporter assays in hippocampal neurons showed that YTHDF1 enhances protein synthesis in a neuronal-stimulus-dependent manner. In summary, YTHDF1 facilitates translation of m(6)A-methylated neuronal mRNAs in response to neuronal stimulation, and this process contributes to learning and memory.	[Shi, Hailing; Lu, Zhike; He, Chuan] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Shi, Hailing; Lu, Zhike; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Shi, Hailing; Lu, Zhike; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Shi, Hailing; Lu, Zhike; He, Chuan] Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Zhang, Xuliang; Lu, Zongyang; Liu, Yajing; Li, Jianan; Hao, Piliang; Zhang, Yu; Huang, Xingxu; Zhou, Tao] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhang, Xuliang] Zhejiang Univ, Lab Anim Ctr, Hangzhou, Zhejiang, Peoples R China; [Weng, Yi-Lan; Zhang, Feng; Su, Yijing; Ming, Guo-li; Song, Hongjun] Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weng, Yi-Lan; Zhang, Feng; Su, Yijing; Ming, Guo-li; Song, Hongjun] Univ Penn, Mahoney Inst Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, You] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Delgado, Jary Y.; Patel, Meera J.; Zhuang, Xiaoxi] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Cao, Xiaohua] East China Normal Univ, Sch Life Sci, Key Lab Brain Funct Genom, Minist Educ,Shanghai Key Lab Brain Funct Genom, Shanghai, Peoples R China; [Shen, Bin] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Ming, Guo-li] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Song, Hongjun] Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; ShanghaiTech University; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Tongji University; University of Chicago; East China Normal University; Nanjing Medical University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	He, CA (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.; He, CA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; He, CA (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.; He, CA (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Zhou, T (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Song, HJ (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Mahoney Inst Neurosci, Perelman Sch Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	shongjun@pennmedicine.upenn.edu; chuanhe@uchicago.edu; zhoutao@shanghaitech.edu.cn	Shen, Bin/ABD-5084-2021; Zongyang, Lu/AAG-5625-2021; zhou, tao/AAH-9986-2020; Shi, Hailing/AAW-5351-2021	Shen, Bin/0000-0002-8946-8448; Shi, Hailing/0000-0001-7355-378X; Ming, Guo-li/0000-0002-2517-6075; zhang, xuliang/0000-0002-8952-8009; Zhang, Feng/0000-0003-2887-8184; huang, xingxu/0000-0001-8934-1247	National Key RAMP;D Program of China [2016YFA0500903]; National Institute of Health [HG008935, GM113194, DA043361]; National Natural Science Foundation of China [31500866, 31471077]; Simons Foundation Autism Research Initiative (SFARI); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Shanghai Rising-Star Program; Startup Foundation of ShanghaiTech University; Zhejiang Public Welfare Technology Application Research Project [2018C37118]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097370, R37NS047344, R56NS047344, R01NS047344, P01NS097206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043361, T32DA043469] Funding Source: NIH RePORTER	National Key RAMP;D Program of China; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Simons Foundation Autism Research Initiative (SFARI); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Shanghai Rising-Star Program; Startup Foundation of ShanghaiTech University; Zhejiang Public Welfare Technology Application Research Project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Key R&D Program of China (2016YFA0500903 to X.H.), the National Institute of Health (HG008935 and GM113194 to C.H.; DA043361 to X. Zhuang), the National Natural Science Foundation of China (31500866 to T.Z. and 31471077 to X.C.), the Simons Foundation Autism Research Initiative (SFARI) to H. Song, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) to G.-I.M. C.H. is an investigator of the Howard Hughes Medical Institute. T.Z. is sponsored by the Shanghai Rising-Star Program. X.H. is sponsored by the Startup Foundation of ShanghaiTech University. X. Zhang is sponsored by Zhejiang Public Welfare Technology Application Research Project (2018C37118). We thank P. Cao, and X. Wang for discussions; Z. Qiu and T. Cheng for help with primary neuron culture; M. Wu for suggestions on proteomics data analyses; and J. Tauler, P. J. Hsu, and A.C. Zhu for editing help.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chiu SL, 2017, NEURON, V93, P1405, DOI 10.1016/j.neuron.2017.02.031; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Franklin K, 2004, MOUSE BRAIN STEREOTA; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Ivanova I, 2017, MOL CELL, V67, P1059, DOI 10.1016/j.molcel.2017.08.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Li LP, 2017, HUM MOL GENET, V26, P2398, DOI 10.1093/hmg/ddx128; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Su YJ, 2017, NAT NEUROSCI, V20, P476, DOI 10.1038/nn.4494; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Walters BJ, 2017, NEUROPSYCHOPHARMACOL, V42, P1502, DOI 10.1038/npp.2017.31; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Widagdo J, 2016, J NEUROSCI, V36, P6771, DOI 10.1523/JNEUROSCI.4053-15.2016; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	46	223	238	15	148	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					249	+		10.1038/s41586-018-0666-1	http://dx.doi.org/10.1038/s41586-018-0666-1			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401835	Green Accepted			2022-12-28	WOS:000449943600044
J	Polonsky, TS; Bakris, GL				Polonsky, Tamar S.; Bakris, George L.			Ambulatory Blood Pressure Monitoring	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WHITE-COAT; HYPERTENSION		[Polonsky, Tamar S.; Bakris, George L.] Univ Chicago Med, Dept Med, Chicago, IL USA		Polonsky, TS (corresponding author), 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.	tpolonsky@medicine.bsd.uchicago.edu						Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231; Centers for Medicare and Medicaid Services Disproportionate Share Hospital (DSH), NON TRADITIONAL REF; de la Sierra A, 2018, CIRCULATION, V137, P2651, DOI 10.1161/CIRCULATIONAHA.118.034619; Mancia G, 2009, HYPERTENSION, V54, P226, DOI 10.1161/HYPERTENSIONAHA.109.129882; Parati G, 2014, J HYPERTENS, V32, P1359, DOI 10.1097/HJH.0000000000000221; Pickering TG, 2002, HYPERTENSION, V40, P795, DOI 10.1161/01.HYP.0000038733.08436.98; Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539; Salles GF, 2016, HYPERTENSION, V67, P693, DOI 10.1161/HYPERTENSIONAHA.115.06981; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	10	4	4	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1807	1808		10.1001/jama.2018.14856	http://dx.doi.org/10.1001/jama.2018.14856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398582				2022-12-28	WOS:000449461800019
J	Escobar, H				Escobar, Herton			STANDING FIRM	NATURE			English	Editorial Material								Sao Paulo carries the scientific weight of a financially stricken country, but how much more can it endure?											0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S22	S23		10.1038/d41586-018-07211-5	http://dx.doi.org/10.1038/d41586-018-07211-5			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JJ2XE	30382232				2022-12-28	WOS:000494024500003
J	Mallapaty, S				Mallapaty, Smriti			COUNTING CAPITAL COSTS	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S1	S1		10.1038/d41586-018-07204-4	http://dx.doi.org/10.1038/d41586-018-07204-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382226				2022-12-28	WOS:000448900900008
J	Rimmer, A				Rimmer, Abi			Bullying in the workplace: almost 40% of doctors think it is a problem, BMA finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2018, BULL HAR ADDR IT CRE	1	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4637	10.1136/bmj.k4637	http://dx.doi.org/10.1136/bmj.k4637			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385478				2022-12-28	WOS:000449565500013
J	Rypdal, M; Fredriksen, HB; Rypdal, K; Steene, RJ				Rypdal, Martin; Fredriksen, Hege-Beate; Rypdal, Kristoffer; Steene, Rebekka J.			Emergent constraints on climate sensitivity	NATURE			English	Letter									[Rypdal, Martin; Fredriksen, Hege-Beate; Rypdal, Kristoffer; Steene, Rebekka J.] UiT, Dept Math & Stat, Tromso, Norway	UiT The Arctic University of Tromso	Rypdal, M (corresponding author), UiT, Dept Math & Stat, Tromso, Norway.	martin.rypdal@uit.no	Rypdal, Martin/AAA-2973-2020	Rypdal, Martin/0000-0003-0053-665X				Cox PM, 2018, NATURE, V553, P319, DOI 10.1038/nature25450; Fredriksen HB, 2017, J CLIMATE, V30, P7157, DOI 10.1175/JCLI-D-16-0877.1; Geoffroy O, 2013, J CLIMATE, V26, P1841, DOI 10.1175/JCLI-D-12-00195.1; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324	4	8	8	5	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					E4	E5		10.1038/s41586-018-0639-4	http://dx.doi.org/10.1038/s41586-018-0639-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382206				2022-12-28	WOS:000448900900002
J	Sallan, L; Friedman, M; Sansom, RS; Bird, CM; Sansom, IJ				Sallan, Lauren; Friedman, Matt; Sansom, Robert S.; Bird, Charlotte M.; Sansom, Ivan J.			The nearshore cradle of early vertebrate diversification	SCIENCE			English	Article							EXTINCTION; RADIATION; EVOLUTION	Ancestral vertebrate habitats are subject to controversy and obscured by limited, often contradictory paleontological data. We assembled fossil vertebrate occurrence and habitat datasets spanning the middle Paleozoic (480 million to 360 million years ago) and found that early vertebrate clades, both jawed and jawless, originated in restricted, shallow intertidal-subtidal environments. Nearshore divergences gave rise to body plans with different dispersal abilities: Robust fishes shifted shoreward, whereas gracile groups moved seaward. Fresh waters were invaded repeatedly, but movement to deeper waters was contingent upon form and short-lived until the later Devonian. Our results contrast with the onshore-offshore trends, reef-centered diversification, and mid-shelf clustering observed for benthic invertebrates. Nearshore origins for vertebrates may be linked to the demands of their mobility and may have influenced the structure of their early fossil record and diversification.	[Sallan, Lauren] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Friedman, Matt] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Sansom, Robert S.] Univ Manchester, Sch Earth & Environm Sci, Manchester M13 9PT, Lancs, England; [Bird, Charlotte M.; Sansom, Ivan J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	University of Pennsylvania; University of Michigan System; University of Michigan; University of Manchester; University of Birmingham	Sallan, L (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.; Sansom, IJ (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England.	lsallan@upenn.edu; i.j.sansom@bham.ac.uk	Sallan, Lauren/AGZ-1308-2022	Sallan, Lauren/0000-0002-4441-1456; Sansom, Robert/0000-0003-1926-2556; Bird, Charlotte/0000-0003-3451-327X	University of Pennsylvania; Palaeontological Association Undergraduate Research Bursary; University of Birmingham; BBSRC [BB/N015827/1] Funding Source: UKRI	University of Pennsylvania; Palaeontological Association Undergraduate Research Bursary; University of Birmingham; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of Pennsylvania (L.S.), a Palaeontological Association Undergraduate Research Bursary (C.M.B.), and the University of Birmingham (I.J.S).	Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; Andreev PS, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1245664; Armstrong HA, 2014, GEOL SOC AM SPEC PAP, V505, P287, DOI 10.1130/2014.2505(14); BOUCOT AJ, 1983, PALAEOGEOGR PALAEOCL, V41, P251, DOI 10.1016/0031-0182(83)90091-3; BOUCOT AJ, 1999, PALEOCOMMUNITIES CAS; Brazeau MD, 2015, NATURE, V520, P490, DOI 10.1038/nature14438; BRETT CE, 1993, LETHAIA, V26, P25, DOI 10.1111/j.1502-3931.1993.tb01507.x; Chamberlin TC, 1900, J GEOL, V8, P400, DOI 10.1086/620831; Claverie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112732; Davies NS, 2009, PALAIOS, V24, P717, DOI 10.2110/palo.2009.p09-040r; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Janvier P., 1996, EARLY VERTEBRATES; Kiessling W, 2010, SCIENCE, V327, P196, DOI 10.1126/science.1182241; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Marss T., 2007, HDB PALEOICHTHYOLO B, V1B, P1; PBDB, 2018, DAT WER DOWNL PAL DA; Pimiento C, 2017, NAT ECOL EVOL, V1, P1100, DOI 10.1038/s41559-017-0223-6; Revell LJ, 2014, EVOLUTION, V68, P743, DOI 10.1111/evo.12300; Sallan L., 2018, DRYAD, DOI [10.5061/dryad.g08m87q, DOI 10.5061/DRYAD.G08M87Q]; Sansom IJ, 2001, SYST ASSOC SPEC VOL, V61, P156; Sansom RS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2245; Sansom RS, 2009, PALAEONTOLOGY, V52, P1257, DOI 10.1111/j.1475-4983.2009.00895.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Smith MP, 2002, GEOL SOC SPEC PUBL, V194, P69, DOI 10.1144/GSL.SP.2002.194.01.06; Vega GC, 2012, P ROY SOC B-BIOL SCI, V279, P2323, DOI 10.1098/rspb.2012.0075	28	30	31	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					460	463		10.1126/science.aar3689	http://dx.doi.org/10.1126/science.aar3689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361374	Green Published, Green Submitted			2022-12-28	WOS:000450441900051
J	Zeng, WZ; Marshall, KL; Min, S; Daou, I; Chapleau, MW; Abboud, FM; Liberles, SD; Patapoutian, A				Zeng, Wei-Zheng; Marshall, Kara L.; Min, Soohong; Daou, Ihab; Chapleau, Mark W.; Abboud, Francois M.; Liberles, Stephen D.; Patapoutian, Ardem			PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex	SCIENCE			English	Article							BAROREFLEX FAILURE; AUTONOMIC CONTROL; PROPOSED ROLE; HEART-RATE; ARTERIAL; HYPERTENSION; DENERVATION; CHANNEL; MICE; VARIABILITY	Activation of stretch-sensitive baroreceptor neurons exerts acute control over heart rate and blood pressure. Although this homeostatic baroreflex has been described for more than 80 years, the molecular identity of baroreceptor mechanosensitivity remains unknown. We discovered that mechanically activated ion channels PIEZO1 and PIEZO2 are together required for baroreception. Genetic ablation of both Piezo1 and Piezo2 in the nodose and petrosal sensory ganglia of mice abolished drug-induced baroreflex and aortic depressor nerve activity. Awake, behaving animals that lack Piezos had labile hypertension and increased blood pressure variability, consistent with phenotypes in baroreceptor-denervated animals and humans with baroreflex failure. Optogenetic activation of Piezo2-positive sensory afferents was sufficient to initiate baroreflex in mice. These findings suggest that PIEZO1 and PIEZO2 are the long-sought baroreceptor mechanosensors critical for acute blood pressure control.	[Zeng, Wei-Zheng; Marshall, Kara L.; Daou, Ihab; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Neurosci Dept, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Min, Soohong; Liberles, Stephen D.] Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Chapleau, Mark W.; Abboud, Francois M.] Univ Iowa, Carver Coll Med, Dept Internal Med & Mol Physiol & Biophys, Abboud Cardiovasc Res Ctr, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Neurosci Dept, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu	Min, Soohong/AEK-2200-2022; Min, Soohong/I-1607-2018	Min, Soohong/0000-0003-0683-2935; Patapoutian, Ardem/0000-0003-0726-7034; Liberles, Stephen/0000-0002-2177-9741; Chapleau, Mark/0000-0001-6961-931X; Marshall, Kara/0000-0003-1722-7941	NIH [R01 DE022358, R35 NS105067, DP1 AT009497, OT2 OD023848, P01 HL14388]; George Hewitt Foundation for Medical Research; National Center for Complementary & Integrative Health [DP1AT009497] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL014388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS105067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [OT2OD023848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Hewitt Foundation for Medical Research; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R01 DE022358 and R35 NS105067 to A.P. W.-Z.Z. was supported by a postdoctoral fellowship from the George Hewitt Foundation for Medical Research. S.D.L. was supported by NIH grants DP1 AT009497 and OT2 OD023848. M.W.C and F.M.A were supported by NIH grant P01 HL14388. A.P. and S.D.L. are investigators of the Howard Hughes Medical Institute.	Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Heusser K, 2005, HYPERTENSION, V45, P834, DOI 10.1161/01.HYP.0000160355.93303.72; ITO CS, 1981, CIRC RES, V48, P576, DOI 10.1161/01.RES.48.4.576; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Ketch T, 2002, CIRCULATION, V105, P2518, DOI 10.1161/01.CIR.0000017186.52382.F4; KIRCHHEIM HR, 1976, PHYSIOL REV, V56, P100, DOI 10.1152/physrev.1976.56.1.100; La Rovere MT, 1998, LANCET, V351, P478; Lau OC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02704-9; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Marshall KL, 2015, CELL REP, V11, P851, DOI 10.1016/j.celrep.2015.04.001; Martinka P, 2005, AM J PHYSIOL-REG I, V288, pR767, DOI 10.1152/ajpregu.00445.2004; Mortara A, 1997, CIRCULATION, V96, P3450; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Oosting J, 1997, J HYPERTENS, V15, P391, DOI 10.1097/00004872-199715040-00010; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; ROBERTSON D, 1993, NEW ENGL J MED, V329, P1449, DOI 10.1056/NEJM199311113292003; Rodrigues FL, 2011, EXP PHYSIOL, V96, P853, DOI 10.1113/expphysiol.2011.057067; Thakore P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02703-w; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wehrwein Erica A, 2013, Handb Clin Neurol, V117, P89, DOI 10.1016/B978-0-444-53491-0.00008-0; Wenker IC, 2017, J NEUROSCI, V37, P4565, DOI 10.1523/JNEUROSCI.3922-16.2017; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162	26	169	177	8	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					464	467		10.1126/science.aau6324	http://dx.doi.org/10.1126/science.aau6324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361375	Green Accepted			2022-12-28	WOS:000450441900052
J	Vox, F; Folkers, KM; Turi, A; Caplan, AL				Vox, Ford; Folkers, Kelly McBride; Turi, Angela; Caplan, Arthur L.			Medical Crowdfunding for Scientifically Unsupported or Potentially Dangerous Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							THERAPY		[Vox, Ford] Shepherd Ctr, Brain Injury Rehabil, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA; [Folkers, Kelly McBride; Turi, Angela; Caplan, Arthur L.] NYU, Sch Med, Div Med Eth, New York, NY USA	New York University	Vox, F (corresponding author), Shepherd Ctr, Brain Injury Rehabil, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	ford.vox@shepherd.org		Caplan, Art/0000-0002-4061-8011				Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425; Crawford C, 2017, J HEAD TRAUMA REHAB, V32, pE27, DOI 10.1097/HTR.0000000000000256; Federspil Giovanni, 2003, Ann Intern Med, V139, pW76; Martinho AM, 2017, REGEN MED, V12, P419, DOI [10.2217/rme-2017-0002, 10.2217/rme-2017-0015]; Snyder J, 2018, JAMA-J AM MED ASSOC, V319, P1935, DOI 10.1001/jama.2018.3057; Woolley S., 2017, BLOOMBERG NEWS	6	29	29	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1705	1706		10.1001/jama.2018.10264	http://dx.doi.org/10.1001/jama.2018.10264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357284	Green Published, Bronze			2022-12-28	WOS:000448069100020
J	Erondu, NA; Martin, J; Marten, R; Ooms, G; Yates, R; Heymann, DL				Erondu, Ngozi A.; Martin, Jerry; Marten, Robert; Ooms, Gorik; Yates, Robert; Heymann, David L.			Building the case for embedding global health security into universal health coverage: a proposal for a unified health system that includes public health	LANCET			English	Article							LOW-INCOME; EBOLA; COUNTRIES; DISEASE; INSURANCE; LESSONS; REFORMS; CARE	In the wake of the recent west African Ebola epidemic, there is global consensus on the need for strong health systems; however, agreement is less apparent on effective mechanisms for establishing and maintaining these systems, particularly in resource-constrained settings and in the presence of multiple and sustained stresses (eg, conflict, famine, climate change, and globalisation). The construction of the International Health Regulations (2005) guidelines and the WHO health systems frame-work, has resulted in the separation of public health functions and health-care services, which are interdependent in actuality and must be integrated to ensure a continuous, unbroken national health system. By analysing efforts to strengthen health systems towards attaining universal health coverage and investments to improve global health security, we examine areas of overlap and offer recommendations for construction of a unified national health system that includes public health. One way towards achieving universal health coverage is to broaden the definition of a health system.	[Erondu, Ngozi A.; Heymann, David L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Marten, Robert; Ooms, Gorik] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Martin, Jerry] DAI Global Hlth, Bethesda, MD USA; [Erondu, Ngozi A.; Yates, Robert; Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Erondu, NA (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.	ngozi.erondu@lshtm.ac.uk	; Ooms, Gorik/A-2537-2015	Erondu, Ngozi/0000-0003-0268-6838; Ooms, Gorik/0000-0002-9804-0128				[Anonymous], 2009, MOR MON HLTH MOR HLT; [Anonymous], 2016, 69 WORLD HLTH ASS; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Barugahare J, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0055-3; Beattie A, 2016, BMJ GLOB HEALTH, V1, pI12, DOI 10.1136/bmjgh-2016-000190; Centre on Global Health Security Working Group on Health Financing, 2014, SHAR RESP HLTH COH G; De Paepe P, 2007, CAD SAUDE PUBLICA, V23, pS273, DOI 10.1590/S0102-311X2007001400016; Ghebreyesus TA, 2017, LANCET GLOB HEALTH, V5, pE839, DOI 10.1016/S2214-109X(17)30295-4; Green A, 2016, LANCET, V388, P2463, DOI 10.1016/S0140-6736(16)32219-X; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Maher D, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-14; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Mcintyre D, 2017, HEALTH ECON POLICY L, V12, P125, DOI [10.1017/s1744133116000414, 10.1017/S1744133116000414]; Meheus F, 2017, HEALTH ECON POLICY L, V12, P159, DOI 10.1017/S1744133116000438; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236; Tangcharoensathien V, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-25; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; van Olmen J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-774; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; Watabe A, 2017, HEALTH PROMOT INT, V32, P702, DOI 10.1093/heapro/daw010; WHO, 2016, INT HLTH REG 2005, V3rd. ed.; WHO, 2010, MONITORING BUILDING; WHO, 2013, IHR MON FRAM QUEST M; WHO, 2007, EV BUS STRENGTH HLTH	32	29	30	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1482	1486		10.1016/S0140-6736(18)32332-8	http://dx.doi.org/10.1016/S0140-6736(18)32332-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343862				2022-12-28	WOS:000447800900029
J	Haghbayan, H; Coomes, EA; Cheema, AN				Haghbayan, Hourmazd; Coomes, Eric A.; Cheema, Asim N.			External left atrium compression by spinal osteophytes	LANCET			English	Editorial Material									[Haghbayan, Hourmazd; Coomes, Eric A.; Cheema, Asim N.] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada; [Haghbayan, Hourmazd] Univ Laval, Dept Social & Prevent Med, Laval, PQ, Canada; [Cheema, Asim N.] St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON, Canada	University of Toronto; Laval University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Haghbayan, H (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada.	hourmazd.haghbayan@mail.utoronto.ca	Cheema, Asim N./AAA-7676-2020	Cheema, Asim N./0000-0002-3174-8957					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					E12	E12		10.1016/S0140-6736(18)32282-7	http://dx.doi.org/10.1016/S0140-6736(18)32282-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343863				2022-12-28	WOS:000447800900001
J	Hone, T; Macinko, J; Millett, C				Hone, Thomas; Macinko, James; Millett, Christopher			Revisiting Alma-Ata: what is the role of primary health care in achieving the Sustainable Development Goals?	LANCET			English	Review							MIDDLE-INCOME COUNTRIES; UNIVERSAL HEALTH; SOCIAL DETERMINANTS; INTERSECTORAL ACTION; POPULATION HEALTH; DISEASE-CONTROL; PUBLIC-HEALTH; CHILD HEALTH; MORTALITY; SYSTEMS	The Sustainable Development Goals (SDGs) are now steering the global health and development agendas. Notably, the SDGs contain no mention of primary health care, reflecting the disappointing implementation of the Alma-Ata declaration of 1978 over the past four decades. The draft Astana declaration (Alma-Ata 2 . 0), released in June, 2018, restates the key principles of primary health care and renews these as driving forces for achieving the SDGs, emphasising universal health coverage. We use accumulating evidence to show that countries that reoriente their health systems towards primary care are better placed to achieve the SDGs than those with hospital-focused systems or low investment in health. We then argue that an even bolder approach, which fully embraces the Alma-Ata vision of primary health care, could deliver substantially greater SDG progress, by addressing the wider determinants of health, promoting equity and social justice throughout society, empowering communities, and being a catalyst for advancing and amplifying universal health coverage and synergies among SDGs.	[Hone, Thomas; Millett, Christopher] Imperial Coll London, Sch Publ Hlth, Publ Hlth Policy Evaluat Unit, London W2 1PG, England; [Macinko, James] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Macinko, James] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Millett, Christopher] Univ Sao Paulo, Ctr Epidemiol Studies Hlth & Nutr, Sao Paulo, Brazil	Imperial College London; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universidade de Sao Paulo	Hone, T (corresponding author), Imperial Coll London, Sch Publ Hlth, Publ Hlth Policy Evaluat Unit, London W2 1PG, England.	thomas.hone12@imperial.ac.uk		Macinko, James/0000-0001-8055-5441; Millett, Christopher/0000-0002-0793-9884; Hone, Thomas/0000-0003-0703-6973	National Institute of Health Research (NIHR) [RP 2014-04-032]; Joint Health Systems Research Initiative; NIHR School of Public Health Research; MRC [MR/P014593/1] Funding Source: UKRI	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Joint Health Systems Research Initiative; NIHR School of Public Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CM is funded by a National Institute of Health Research (NIHR) Research Professorship (RP 2014-04-032). TH is funded through a project grant under the Joint Health Systems Research Initiative between the UK Department for International Development, UK Medical Research Council, Wellcome Trust, and UK Economic and Social Research Council. The Public Health Policy Evaluation Unit at Imperial College London is grateful for support from the NIHR School of Public Health Research. We are also grateful to the Pan American Health Organization (Brazilian office) for supporting wider ongoing collaborative efforts.	Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-81; Anaf J, 2014, AUST NZ J PUBL HEAL, V38, P553, DOI 10.1111/1753-6405.12284; Andermann A, 2016, CAN MED ASSOC J, V188, pE474, DOI 10.1503/cmaj.160177; [Anonymous], 2018, LANCET, V391, P1, DOI 10.1016/S0140-6736(18)30003-5; [Anonymous], 2012, LANCET, V379, P193, DOI 10.1016/S0140-6736(12)60081-6; [Anonymous], 2009, LANCET, V373, P2083, DOI 10.1016/S0140-6736(09)61128-4; [Anonymous], 2018, LANCET, V391, P2475; [Anonymous], 2016, GLOB ALL VACC IMM 20; Atun R, 2016, J GLOB HEALTH, V6; Bacigalupe A, 2010, J EPIDEMIOL COMMUN H, V64, P504, DOI 10.1136/jech.2010.110437; Baldwin SB, 2011, HEALTH HUM RIGHTS, V13, P36; Barker I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j84; Barroy H, 2018, INBUDGET MATTERS HLT; Baum F, 2014, HEALTH PROMOT INT, V29, P130, DOI 10.1093/heapro/dau032; Baum Fran, 2007, Promot Educ, V14, P90, DOI 10.1177/10253823070140022002; Baum FE, 2016, GAC SANIT, V30, P405, DOI 10.1016/j.gaceta.2016.05.014; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Benach J, 2007, EMPLOYMENT CONDITION; Bendavid E, 2014, PEDIATRICS, V134, pE1551, DOI 10.1542/peds.2014-2320; Bhattarai N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1203; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bitton A, 2017, J GEN INTERN MED, V32, P566, DOI 10.1007/s11606-016-3898-5; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P372, DOI 10.1016/S0140-6736(13)60988-5; Bor J, 2017, LANCET, V389, P1475, DOI 10.1016/S0140-6736(17)30571-8; Bossert Thomas., 2014, DECENTRALIZING HLTH, P199; Broberg M, 2018, INT J HUM RIGHTS, V22, P664, DOI 10.1080/13642987.2017.1408591; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Carter R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1571-7; Castro AR, 2017, EUR J GEN PRACT, V23, P59, DOI 10.1080/13814788.2017.1284791; Chan M, 2008, LANCET, V372, P865, DOI 10.1016/S0140-6736(08)61372-0; Munoz DC, 2017, INT J PUBLIC HEALTH, V62, P219, DOI 10.1007/s00038-016-0872-2; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Cylus J, 2015, UK HLTH SYST REV; Davletov K, 2018, EUR J PUBLIC HEALTH, V28, P587, DOI 10.1093/eurpub/cky094; de Leeuw E, 2017, HEALTH PROMOT INT, V32, P606, DOI 10.1093/heapro/dax041; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Donkin A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000603; Eckelman MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157014; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Ferguson HB, 2007, PAED CHILD HEALT-CAN, V12, P701, DOI 10.1093/pch/12.8.701; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filippidis FT, 2017, JAMA PEDIATR, V171, P1100, DOI 10.1001/jamapediatrics.2017.2536; Food and Agriculture Organization of the UN International Fund for Agricultural Development UNICEF World Food Programme WHO, 2017, STAT FOOD SEC NUTR W; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gillam S, 2008, BMJ-BRIT MED J, V336, P536, DOI 10.1136/bmj.39469.432118.AD; Global Conference on Primary Care, 2018, DECL AST; Gruskin S, 2010, J PUBLIC HEALTH POL, V31, P129, DOI 10.1057/jphp.2010.7; Gwatkin DR, 2017, LANCET GLOB HEALTH, V5, pE371, DOI 10.1016/S2214-109X(17)30080-3; Helmke I, 2011, B WORLD HEALTH ORGAN, V89, P710, DOI 10.2471/BLT.11.041011; Hoffman SJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2041-6; Hone T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002306; Hone T, 2017, HEALTH AFFAIR, V36, P149, DOI 10.1377/hlthaff.2016.0966; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Jamison DT, 2018, LANCET, V391, P1108, DOI 10.1016/S0140-6736(17)32906-9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kaner EFS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kringos DE, 2015, BUILDING PRIMARY CAR, V38, P172; Kringos DS, 2013, SOC SCI MED, V99, P9, DOI 10.1016/j.socscimed.2013.09.017; Kringos DS, 2013, HEALTH AFFAIR, V32, P686, DOI 10.1377/hlthaff.2012.1242; Kroneman Madelon, 2016, Health Syst Transit, V18, P1; Kruk ME, 2010, SOC SCI MED, V70, P904, DOI 10.1016/j.socscimed.2009.11.025; Labonte R, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24997; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lee MC, 2016, FAM MED COMMUNITY HE, V4, P57, DOI 10.15212/FMCH.2015.0134; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Liddell C, 2010, ENERG POLICY, V38, P2987, DOI 10.1016/j.enpol.2010.01.037; Lin HL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-529; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Vazquez ML, 2009, REV PANAM SALUD PUBL, V26, P360; Macinko James, 2015, N Engl J Med, V372, P2177, DOI 10.1056/NEJMp1501140; Macinko J, 2009, J AMBUL CARE MANAG, V32, P150, DOI 10.1097/JAC.0b013e3181994221; Mackenbach JP, 2018, P NATL ACAD SCI USA, V115, P6440, DOI 10.1073/pnas.1800028115; Malik A, 2018, LANCET PLANET HEALTH, V2, pE27, DOI 10.1016/S2542-5196(17)30180-8; Mann V, 2010, B WORLD HEALTH ORGAN, V88, P727, DOI 10.2471/BLT.09.064469; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M., 2013, HLTH ALL POLICIES SE; Marmot M, 2013, LANCET, V382, P1227, DOI 10.1016/S0140-6736(13)61791-2; Marmot M, 2011, B WORLD HEALTH ORGAN, V89, P702, DOI 10.2471/BLT.11.094862; McCoy DC, 2012, HEALTH POLICY PLANN, V27, P449, DOI 10.1093/heapol/czr077; Moreno-Serra R, 2015, J R STAT SOC A STAT, V178, P101, DOI 10.1111/rssa.12048; Moscrop A, 2014, BRIT J GEN PRACT, V64, pE672, DOI 10.3399/bjgp14X682009; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Navarro V, 2006, LANCET, V368, P1033, DOI 10.1016/S0140-6736(06)69341-0; Nay O, 2016, LANCET, V387, P2236, DOI 10.1016/S0140-6736(16)00580-8; Nutting Paul A, 2003, Ann Fam Med, V1, P149, DOI 10.1370/afm.63; Ortu G, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0361-8; Ostlin P., 2009, TRANSFORMING HLTH SY; Peden M., 2004, WORLD REPORT ROAD TR; People's Health Movement, 2000, PEOPL CHART HLTH; Perry HB, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010907; Perry HB, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010906; Pettigrew LM, 2015, LANCET, V386, P2119, DOI 10.1016/S0140-6736(15)00949-6; Pinto AD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1350-0; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Pruss-Ustun A, 2017, J PUBLIC HEALTH-UK, V39, P464, DOI 10.1093/pubmed/fdw085; Rantala R, 2014, HEALTH PROMOT INT, V29, P92, DOI 10.1093/heapro/dau047; Rao M, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23693; Rasella D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002570; Reeves A, 2015, LANCET, V386, P274, DOI 10.1016/S0140-6736(15)60574-8; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosero-Bixby L, 2004, SOC SCI MED, V58, P1271, DOI 10.1016/S0277-9536(03)00322-8; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Saltman R., 2006, DECENTRALIZATION HLT; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Sen G, 2008, Glob Public Health, V3 Suppl 1, P1, DOI 10.1080/17441690801900795; Sheeran J, 2008, LANCET, V371, P180, DOI 10.1016/S0140-6736(07)61870-4; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2011, J EPIDEMIOL COMMUN H, V65, P653, DOI 10.1136/jech.2009.102780; Stigler F, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30315-4; Szatkowski L, 2012, J EPIDEMIOL COMMUN H, V66, P791, DOI 10.1136/jech.2010.120154; Taket A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e757; Tammes P, 2018, BRIT J GEN PRACT, V68, pE146, DOI 10.3399/bjgp18X694829; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2017, GLOB FUND FIGHT AIDS; Thomson H, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060584; UNICEF, 2018, UNICEF STRAT PLAN 20; US Agency for International Development, 2015, USAIDS VIS HLTH SYST; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wagstaff A, 2014, WORLD BANK RES OBSER, V29, P137, DOI 10.1093/wbro/lku008; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2007, EV BUS TRENGTH HLTH; WHO, 2016, URB GRE APAC HLTH; WHO, 2015, ROADM ACT 2014 2019; WHO, 2014, PREV DIARRH BETT WAT; WHO, INT C PRIMARY HLTH C; WHO, 2003, POV AND HLTH; WHO, 2008, PHARMAFORUM 0121; WHO Regional Office for Europe, 2016, INT DIET PHYS ACT WE; WHO (World Health Organization), 2016, BURNING OPPORTUNITY; World Health Organization, 2018, KEY LEARN HLTH ALL P; World Health Organization, 2016, GLOB REP URB HLTH EQ; World Health Organization, 2016, SHANGH DECL PROM HLT; World Health Organization, 2010, GEND WOM PRIM HLTH C; World Health Organization, 2011, RIO POL DECL SOC DET; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2016, WORK HLTH GROWTH INV; World Health Organization Commission on Social Determinants of Health, CLOS GAP GEN HLTH EQ; 2013, WORLD MAL REP 2013, P1	153	100	106	3	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1461	1472		10.1016/S0140-6736(18)31829-4	http://dx.doi.org/10.1016/S0140-6736(18)31829-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343860	Green Submitted			2022-12-28	WOS:000447800900027
J	Gerber, LR; Runge, MC; Maloney, RF; Iacona, GD; Drew, CA; Avery-Gomm, S; Brazill-Boast, J; Crouse, D; Epanchin-Niell, RS; Hall, SB; Maguire, LA; Male, T; Morgan, D; Newman, J; Possingham, HP; Rumpff, L; Weiss, KCB; Wilson, RS; Zablan, MA				Gerber, Leah R.; Runge, Michael C.; Maloney, Richard F.; Iacona, Gwenllian D.; Drew, C. Ashton; Avery-Gomm, Stephanie; Brazill-Boast, James; Crouse, Deborah; Epanchin-Niell, Rebecca S.; Hall, Sarah B.; Maguire, Lynn A.; Male, Tim; Morgan, Don; Newman, Jeff; Possingham, Hugh P.; Rumpff, Libby; Weiss, Katherine C. B.; Wilson, Robyn S.; Zablan, Marilet A.			Endangered species recovery: A resource allocation problem	SCIENCE			English	Editorial Material							CONSERVATION		[Gerber, Leah R.; Iacona, Gwenllian D.] Arizona State Univ, Ctr Biodivers Outcomes, Tempe, AZ 85287 USA; [Runge, Michael C.] US Geol Survey, Patuxent Wildlife Res Ctr, 12100 Beech Forest Rd, Laurel, MD 20708 USA; [Maloney, Richard F.] Dept Conservat, Biodivers Grp, Christchurch 8140, New Zealand; [Iacona, Gwenllian D.; Avery-Gomm, Stephanie; Possingham, Hugh P.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Iacona, Gwenllian D.; Avery-Gomm, Stephanie; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Drew, C. Ashton] KDV Decis Anal LLC, 1414 Links Dr, Morrisville, NY 27560 USA; [Brazill-Boast, James] Off Environm & Heritage, Conservat Programs Branch, Reg Operat Divis, Sydney, NSW, Australia; [Crouse, Deborah; Morgan, Don; Newman, Jeff] US Fish & Wildlife Serv, Ecol Serv, Div Restorat & Recovery, 5275 Leesburg Pike, Falls Church, VA 22041 USA; [Epanchin-Niell, Rebecca S.] Resources Future Inc, 1616 P St NW, Washington, DC 20036 USA; [Hall, Sarah B.; Zablan, Marilet A.] US Fish & Wildlife Serv, Ecol Serv, Restorat & Endangered Species Classificat Program, 911 NE 11th Avenue, Portland, OR 97232 USA; [Maguire, Lynn A.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Male, Tim] Environm Policy Innovat Ctr, 7003 Woodland Ave, Takoma Pk, MD 20912 USA; [Possingham, Hugh P.] Nature Conservancy, 4245 North Fairfax Dr, Suite 100, Arlington, VA 22203 USA; [Possingham, Hugh P.] Univ Melbourne, Sch Biosci, Melbourne, Vic 3010, Australia; [Weiss, Katherine C. B.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Weiss, Katherine C. B.] Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA; [Wilson, Robyn S.] Ohio State Univ, Coll Food Agr & Environm Sci, Sch Environm & Nat Resources, Columbus, OH 43210 USA	Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey; University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; United States Department of the Interior; US Fish & Wildlife Service; Resources for the Future; United States Department of the Interior; US Fish & Wildlife Service; Duke University; Nature Conservancy; University of Melbourne; Arizona State University; Arizona State University-Tempe; University System of Ohio; Ohio State University	Gerber, LR (corresponding author), Arizona State Univ, Ctr Biodivers Outcomes, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	POSSINGHAM, HUGH/R-8310-2019; Brazill-Boast, James/R-6195-2019; Possingham, Hugh/B-1337-2008	POSSINGHAM, HUGH/0000-0001-7755-996X; Possingham, Hugh/0000-0001-7755-996X; Gerber, Leah/0000-0002-6763-6842; Iacona, Gwenllian/0000-0002-7408-3895; Weiss, Katherine C. B./0000-0002-0034-2460; Rumpff, Libby/0000-0001-9400-8086	National Socio-Environmental Synthesis Center (SESYNC)-NSF award [DBI-1052875]; Arizona State University Center for Biodiversity Outcomes; Australian Research Council Centre of Excellence for Environmental Decisions	National Socio-Environmental Synthesis Center (SESYNC)-NSF award(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Arizona State University Center for Biodiversity Outcomes; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This work benefited from support from the National Socio-Environmental Synthesis Center (SESYNC)-NSF award DBI-1052875. C.A.D. was supported in part by a research contract from the Arizona State University Center for Biodiversity Outcomes. S.A.-G., H.P.P., and G.D.I. were supported by the Australian Research Council Centre of Excellence for Environmental Decisions. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. government. The findings and conclusions in this article are those of the author(s) and do not necessarily represent the views of the U.S. Fish and Wildlife Service.	Bennett JR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2693; Boyd J, 2015, REV ENV ECON POLICY, V9, P23, DOI 10.1093/reep/reu014; Drew A. I., 2017, RECOVERY PRIORITIZAT; Evans DM., 2016, ISSUES ECOLOGY; GAO, 2005, GAO PUBL, VGAO-05-133; Gerber LR, 2016, P NATL ACAD SCI USA, V113, P3563, DOI 10.1073/pnas.1525085113; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Keeney RL, 1992, VALUE FOCUSED THINKI; Office of Environment & Heritage (OEH), 2016, MOR PLANTS AN SAV EX; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Runge MC, 2011, J FISH WILDL MANAG, V2, P220, DOI 10.3996/082011-JFWM-045; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Vucetich JA, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00045; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x	15	25	25	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					284	286		10.1126/science.aat8434	http://dx.doi.org/10.1126/science.aat8434			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337394				2022-12-28	WOS:000447680100023
J	Dalugge, D; Remy, S				Daluegge, D.; Remy, S.			Human Cortical Dendrites: Stretched to Perform Better?	CELL			English	Editorial Material							NEURONS; INPUT; PLASTICITY	Most functional properties of human dendrites have been inferred from data obtained in model organisms. In this issue, Beaulieu-Laroche et al. record directly from human dendrites of cortical neurons and show that the considerably larger human neurons differ from rat neurons in the way they process synaptic signals.	[Daluegge, D.; Remy, S.] German Ctr Neurodegenerat Dis Helmholtz Assoc DZN, Neuronal Networks Grp, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Remy, S.] Univ Bonn, Med Ctr, Dept Epileptol, Sigmund Freud Str 25, D-53125 Bonn, Germany	University of Bonn	Remy, S (corresponding author), German Ctr Neurodegenerat Dis Helmholtz Assoc DZN, Neuronal Networks Grp, Sigmund Freud Str 25, D-53127 Bonn, Germany.; Remy, S (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, Sigmund Freud Str 25, D-53125 Bonn, Germany.	stefan.remy@dzne.de						Beaulieu-Laroche L, 2018, CELL, V175, P643, DOI 10.1016/j.cell.2018.08.045; Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; Eyal G, 2016, ELIFE, V5, DOI 10.7554/eLife.16553; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Molnar G, 2016, ELIFE, V5, DOI 10.7554/eLife.18167; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013	9	1	1	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					635	637		10.1016/j.cell.2018.09.052	http://dx.doi.org/10.1016/j.cell.2018.09.052			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340035	Bronze			2022-12-28	WOS:000447780800005
J	Fukunaga, R; Han, BW; Hung, JH; Xu, J; Weng, ZP; Zamore, PD				Fukunaga, Ryuya; Han, Bo W.; Hung, Jui-Hung; Xu, Jia; Weng, Zhiping; Zamore, Phillip D.			Dicer Partner Proteins Tune the Length of Mature miRNAs in Flies and Mammals (vol 151, pg 533, 2012)	CELL			English	Correction												phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Fukunaga, Ryuya/AAK-8609-2020; Xu, Jia/F-7750-2012; Hung, Jui-Hung/G-2673-2012	Fukunaga, Ryuya/0000-0002-5814-8206; Hung, Jui-Hung/0000-0003-2208-9213; Han, Bo/0000-0001-9501-8702; Zamore, Phillip/0000-0002-4505-9618				Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027	1	7	8	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					912	912		10.1016/j.cell.2012.10.029	http://dx.doi.org/10.1016/j.cell.2012.10.029			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	30360291	Green Accepted, Bronze			2022-12-28	WOS:000310921200020
J	Juge, PA; Lee, JS; Ebstein, E; Furukawa, H; Dobrinskikh, E; Gazal, S; Kannengiesser, C; Ottaviani, S; Oka, S; Tohma, S; Tsuchiya, N; Rojas-Serrano, J; Gonzalez-Perez, MI; Mejia, M; Buendia-Roldan, I; Falfan-Valencia, R; Ambrocio-Ortiz, E; Manali, E; Papiris, SA; Karageorgas, T; Boumpas, D; Antoniou, K; van Moorsel, CHM; van der Vis, J; de Man, YA; Grutters, JC; Wang, Y; Borie, R; Wemeau-Stervinou, L; Wallaert, B; Flipo, RM; Nunes, H; Valeyre, D; Saidenberg-Kermanac'h, N; Boissier, MC; Marchand-Adam, S; Frazier, A; Richette, P; Allanore, Y; Sibilia, J; Dromer, C; Richez, C; Schaeverbeke, T; Liote, H; Thabut, G; Nathan, N; Amselem, S; Soubrier, M; Cottin, V; Clement, A; Deane, K; Walts, AD; Fingerlin, T; Fischer, A; Ryu, JH; Matteson, EL; Niewold, TB; Assayag, D; Gross, A; Wolters, P; Schwarz, MI; Holers, M; Solomon, JJ; Doyle, T; Rosas, IO; Blauwendraat, C; Nalls, MA; Debray, MP; Boileau, C; Crestani, B; Schwartz, DA; Dieude, P				Juge, P. -A.; Lee, J. S.; Ebstein, E.; Furukawa, H.; Dobrinskikh, E.; Gazal, S.; Kannengiesser, C.; Ottaviani, S.; Oka, S.; Tohma, S.; Tsuchiya, N.; Rojas-Serrano, J.; Gonzalez-Perez, M. I.; Mejia, M.; Buendia-Roldan, I.; Falfan-Valencia, R.; Ambrocio-Ortiz, E.; Manali, E.; Papiris, S. A.; Karageorgas, T.; Boumpas, D.; Antoniou, K.; van Moorsel, C. H. M.; van der Vis, J.; de Man, Y. A.; Grutters, J. C.; Wang, Y.; Borie, R.; Wemeau-Stervinou, L.; Wallaert, B.; Flipo, R. -M.; Nunes, H.; Valeyre, D.; Saidenberg-Kermanac'h, N.; Boissier, M. -C.; Marchand-Adam, S.; Frazier, A.; Richette, P.; Allanore, Y.; Sibilia, J.; Dromer, C.; Richez, C.; Schaeverbeke, T.; Liote, H.; Thabut, G.; Nathan, N.; Amselem, S.; Soubrier, M.; Cottin, V.; Clement, A.; Deane, K.; Walts, A. D.; Fingerlin, T.; Fischer, A.; Ryu, J. H.; Matteson, E. L.; Niewold, T. B.; Assayag, D.; Gross, A.; Wolters, P.; Schwarz, M. I.; Holers, M.; Solomon, J. J.; Doyle, T.; Rosas, I. O.; Blauwendraat, C.; Nalls, M. A.; Debray, M. -P.; Boileau, C.; Crestani, B.; Schwartz, D. A.; Dieude, P.			MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; POLYMORPHISM; ASSOCIATION; MORTALITY; SUSCEPTIBILITY; CLASSIFICATION; PREDICTORS; PNEUMONIA; CRITERIA; COHORT	BACKGROUND Given the phenotypic similarities between rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) (hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we hypothesized that the strongest risk factor for the development of idiopathic pulmonary fibrosis, the gain-of-function MUC5B promoter variant rs35705950, would also contribute to the risk of ILD among patients with RA. METHODS Using a discovery population and multiple validation populations, we tested the association of the MUC5B promoter variant rs35705950 in 620 patients with RA-ILD, 614 patients with RA without ILD, and 5448 unaffected controls. RESULTS Analysis of the discovery population revealed an association of the minor allele of the MUC5B promoter variant with RA-ILD when patients with RA-ILD were compared with unaffected controls (adjusted odds ratio, 3.8; 95% confidence interval [CI], 2.8 to 5.2; P = 9.7x10(-17)). The MUC5B promoter variant was also significantly overrepresented among patients with RA-ILD, as compared with unaffected controls, in an analysis of the multiethnic case series (adjusted odds ratio, 5.5; 95% CI, 4.2 to 7.3; P = 4.7x10(-35)) and in a combined analysis of the discovery population and the multiethnic case series (adjusted odds ratio, 4.7; 95% CI, 3.9 to 5.8; P = 1.3x10(-49)). In addition, the MUC5B promoter variant was associated with an increased risk of ILD among patients with RA (adjusted odds ratio in combined analysis, 3.1; 95% CI, 1.8 to 5.4; P = 7.4x10(-5)), particularly among those with evidence of usual interstitial pneumonia on high-resolution computed tomography (adjusted odds ratio in combined analysis, 6.1; 95% CI, 2.9 to 13.1; P = 2.5x10(-6)). However, no significant association with the MUC5B promoter variant was observed for the diagnosis of RA alone. CONCLUSIONS We found that the MUC5B promoter variant was associated with RA-ILD and more specifically associated with evidence of usual interstitial pneumonia on imaging.	[Juge, P. -A.; Ebstein, E.; Ottaviani, S.; Dieude, P.] Hop Bichat Claude Bernard, AP HP, Dept Rheumatol, Paris, France; [Kannengiesser, C.; Boileau, C.] Hop Bichat Claude Bernard, AP HP, Dept Genet, Paris, France; [Borie, R.; Crestani, B.] Hop Bichat Claude Bernard, AP HP, Dept Pulmonol A, Paris, France; [Thabut, G.] Hop Bichat Claude Bernard, AP HP, Dept Pulmonol B, Paris, France; [Debray, M. -P.] Hop Bichat Claude Bernard, AP HP, Dept Radiol, Paris, France; [Juge, P. -A.; Kannengiesser, C.; Borie, R.; Thabut, G.; Crestani, B.; Dieude, P.] Univ Paris Diderot, Dept Hosp Univ Fibrose Inflammat Remodelage, INSERM, UMR 1152, Paris, France; [Juge, P. -A.] Arthrit Rech & Dev, Paris, France; [Frazier, A.; Richette, P.] Hop Lariboisiere, AP HP, Serv Rhumatol, Paris, France; [Allanore, Y.] Hop Cochin, AP HP, Serv Rhumatol A, Paris, France; [Allanore, Y.] INSERM, Unite 1016, UMR 8104, Paris, France; [Liote, H.] Hop Tenon, AP HP, Serv Pneumol, Paris, France; [Nathan, N.; Amselem, S.; Clement, A.] Ctr Reference Malad Resp Rares, AP HP, Serv Pneumol Pediat, Paris, France; [Nathan, N.; Amselem, S.; Clement, A.] INSERM, UMR S933, Paris, France; [Amselem, S.] Hop Trousseau, AP HP, Dept Genet, Paris, France; [Wemeau-Stervinou, L.; Wallaert, B.] Ctr Hosp Reg Univ CHRULille, Serv Pneumol & Immuno Allergol, Ctr Competence Malad Pulm Rares, Federatif Hosp Univ Immune Mediated Inflammatory, Lille, France; [Flipo, R. -M.] Ctr Hosp Univ CHU Lille, Serv Rhumatol, Lille, France; [Nunes, H.; Valeyre, D.] Hop Avicenne, AP HP, Dept Pulmonol, INSERM,UMR 1125, Bobigny, France; [Saidenberg-Kermanac'h, N.; Boissier, M. -C.] Hop Avicenne, AP HP, Dept Rheumatol, INSERM,UMR 1125, Bobigny, France; [Saidenberg-Kermanac'h, N.; Boissier, M. -C.] Hop Avicenne, AP HP, INSERM, UMR 1125, Bobigny, France; [Saidenberg-Kermanac'h, N.; Boissier, M. -C.] Univ Paris 13, Sorbonne Paris Cite, Bobigny, France; [Marchand-Adam, S.] CHRU Tours, Dept Pulmonol, Tours, France; [Sibilia, J.] Univ Strasbourg, Serv Rhumatol, Hop Hautepierre, INSERM,UMR S1109,CHRU Strasbourg, Strasbourg, France; [Sibilia, J.] Univ Strasbourg, Lab Immunorhumatol Mol, Ctr Rech Hist Idees, Federat Med Translat Strasbourg, Strasbourg, France; [Dromer, C.] CHU Bordeaux, Serv Pneumol, Bordeaux, France; [Richez, C.; Schaeverbeke, T.] CHU Bordeaux, Serv Rhumatol, Bordeaux, France; [Richez, C.; Schaeverbeke, T.] CHU Bordeaux, Bordeaux, France; [Richez, C.; Schaeverbeke, T.] CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France; [Soubrier, M.] CHU Clermont Ferrand, Serv Rhumatol, Ctr Rech Nutr Humaine Auvergne, INRA,UMR 1019,Unite Nutr Humaine, Clermont Ferrand, France; [Cottin, V.] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Hop Louis Pradel, Ctr Natl Reference Malad Pulm Rares, Lyon, France; [Cottin, V.] Univ Claude Bernard Lyon 1, INRA, UMR 754, Lyon, France; [Lee, J. S.; Dobrinskikh, E.; Deane, K.; Walts, A. D.; Fischer, A.; Schwarz, M. I.; Holers, M.; Schwartz, D. A.] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Schwartz, D. A.] Univ Colorado, Dept Immunol & Microbiol, Sch Med, Aurora, CO USA; [Fingerlin, T.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Solomon, J. J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Furukawa, H.; Oka, S.; Tsuchiya, N.] Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, Tsukuba, Ibaraki, Japan; [Furukawa, H.; Oka, S.; Tohma, S.] Natl Hosp Org Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Gazal, S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Doyle, T.; Rosas, I. O.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Gazal, S.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Rojas-Serrano, J.; Gonzalez-Perez, M. I.; Mejia, M.; Buendia-Roldan, I.] Inst Nacl Enfermedades Resp Ismael Cosio, Interstitial Lung Dis & Rheumatol Unit, Mexico City, DF, Mexico; [Falfan-Valencia, R.; Ambrocio-Ortiz, E.] Inst Nacl Enfermedades Resp Ismael Cosio, HLA Lab, Mexico City, DF, Mexico; [Manali, E.; Papiris, S. A.] Natl & Kapodistrian Univ Athens, Pulm Med Dept 2, Univ Hosp Athens Attikon, Athens, Greece; [Karageorgas, T.; Boumpas, D.] Natl & Kapodistrian Univ Athens, Rheumatol & Clin Immunol Unit, Dept Internal Med 4, Univ Hosp Athens Attikon, Athens, Greece; [Antoniou, K.] Univ Crete, Dept Resp Med, Fac Med, Iraklion, Greece; [Antoniou, K.] Univ Crete, Lab Mol & Cellular Pneumonol, Fac Med, Iraklion, Greece; [van Moorsel, C. H. M.; van der Vis, J.; de Man, Y. A.; Grutters, J. C.] St Antonius Hosp, St Antonius ILD Ctr Excellence, Nieuwegein, Netherlands; [Wang, Y.] Nanjing Univ, Dept Med Genet, Sch Med, Nanjing, Jiangsu, Peoples R China; [Ryu, J. H.] Mayo Clin, Div Pulm & Crit Care Med, Coll Med & Sci, Rochester, MN USA; [Matteson, E. L.] Mayo Clin, Div Rheumatol, Coll Med & Sci, Rochester, MN USA; [Niewold, T. B.] NYU, Colton Ctr Autoimmun, Sch Med, New York, NY USA; [Assayag, D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Gross, A.; Wolters, P.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Blauwendraat, C.; Nalls, M. A.] NIA, Data Tecn Int, Glen Echo, Bethesda, MD 20892 USA; [Blauwendraat, C.; Nalls, M. A.] NIA, Lab Neurogenet, Bethesda, MD 20892 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Universite Paris 13; CHU Tours; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Clermont Ferrand; INRAE; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; University of Tsukuba; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; University of Crete; University of Crete; St. Antonius Hospital Utrecht; Nanjing University; Mayo Clinic; Mayo Clinic; New York University; McGill University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Schwartz, DA (corresponding author), Univ Colorado, 12631 E 17th Ave,B178, Aurora, CO 80045 USA.; Dieude, P (corresponding author), Hop Bichat Claude Bernard, Serv Rhumatol, 46 Rue Henri Huchard, F-75018 Paris, France.	david.schwartz@ucdenver.edu; philippe.dieude@aphp.fr	Tsuchiya, Naoyuki/CAA-4545-2022; Nathan, Nadia/P-1030-2019; Nunes, Hilario/AAM-8127-2020; PAPIRIS, SPYROS/AAD-1825-2020; Falfán-Valencia, Ramcés/M-7331-2018; Assayag, Deborah/ABE-4299-2021; Lee, Joyce/ABC-9834-2021; Juge, Pierre-Antoine/AGZ-0658-2022; Gazal, Steven/AAK-3764-2020	Tsuchiya, Naoyuki/0000-0002-6776-5580; Nathan, Nadia/0000-0001-5149-7975; Falfán-Valencia, Ramcés/0000-0001-6877-8124; Lee, Joyce/0000-0002-5758-8365; Buendia, Ivette/0000-0002-8230-0749; Dieude, Philippe/0000-0002-4814-0307; Sibilia, Jean/0000-0002-1601-4795; Nunes, Hilario/0000-0003-2896-7347; walts, avram/0000-0003-0076-8098; Valeyre, dominique/0000-0003-4470-1776; Saidenberg-Kermanac'h, Nathalie/0000-0002-2613-9751; KARAGEORGAS, THEOFANIS/0000-0002-8335-5020	Societe Francaise de Rhumatologie; Fondation Arthritis; Departement Hospitalo-Universitaire Fibrose Inflammation Remodelage; National Heart, Lung, and Blood Institute [UH2/3-HL123442, R01-HL097163, R21/R33-HL120770, P01-HL092870, K23-HL138131]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23-AR051461]; National Institute of Allergy and Infectious Diseases [U01AI101981]; U.S. Department of Defense [W81XWH-17-1-0597]; National Center for Advancing Translational Science [UCSF-CTI KL2TR000143]; Nina Ireland Program for Lung Health; Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services [AG000949-02]; Japanese Society for the Promotion of Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097163, R21HL120770, K23HL138131, R33HL120770, UH2HL123442, P01HL092870, UH3HL123442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000949] Funding Source: NIH RePORTER	Societe Francaise de Rhumatologie; Fondation Arthritis; Departement Hospitalo-Universitaire Fibrose Inflammation Remodelage; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Defense(United States Department of Defense); National Center for Advancing Translational Science; Nina Ireland Program for Lung Health; Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from Societe Francaise de Rhumatologie; Fondation Arthritis; Departement Hospitalo-Universitaire Fibrose Inflammation Remodelage; National Heart, Lung, and Blood Institute (UH2/3-HL123442, R01-HL097163, R21/R33-HL120770, P01-HL092870, and K23-HL138131); National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR051461); National Institute of Allergy and Infectious Diseases (U01AI101981); U.S. Department of Defense (W81XWH-17-1-0597); National Center for Advancing Translational Science (UCSF-CTI KL2TR000143); the Nina Ireland Program for Lung Health; the Intramural Research Program of the National Institute on Aging, part of the National Institutes of Health, Department of Health and Human Services (Z01-AG000949-02); and the Japanese Society for the Promotion of Science.	Akiyama M, 2016, RHEUMATOL INT, V36, P881, DOI 10.1007/s00296-016-3478-3; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Assayag D, 2014, MEDICINA-BUENOS AIRE, V74, P158; Assayag D, 2014, RESPIROLOGY, V19, P493, DOI 10.1111/resp.12234; Assayag D, 2014, RADIOLOGY, V270, P583, DOI 10.1148/radiol.13130187; Bernstein EJ, 2016, THORAX, V71, P1082, DOI 10.1136/thoraxjnl-2016-208932; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070621; Duchemann B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02419-2016; Fautrel B, 2016, JOINT BONE SPINE, V83, P461, DOI 10.1016/j.jbspin.2015.05.010; Fingerlin TE, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0377-2; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gabbay E, 1997, AM J RESP CRIT CARE, V156, P528, DOI 10.1164/ajrccm.156.2.9609016; Helling BA, 2017, AM J RESP CELL MOL, V57, P91, DOI 10.1165/rcmb.2017-0046OC; Horimasu Y, 2015, RESPIROLOGY, V20, P439, DOI 10.1111/resp.12466; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Hyldgaard C, 2017, ANN RHEUM DIS, V76, P1700, DOI 10.1136/annrheumdis-2017-211138; Johnson C, 2017, RESP MED, V130, P52, DOI 10.1016/j.rmed.2017.07.010; Juge PA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02314-2016; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kelly CA, 2014, RHEUMATOLOGY, V53, P1676, DOI 10.1093/rheumatology/keu165; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; Lee MG, 2015, INFLAMM RES, V64, P463, DOI 10.1007/s00011-015-0829-6; Ley B, 2017, LANCET RESP MED, V5, P639, DOI [10.1016/S2213-2600(17)30216-3, 10.1016/s2213-2600(17)30216-3]; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Olson AL, 2011, AM J RESP CRIT CARE, V183, P372, DOI 10.1164/rccm.201004-0622OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Restrepo JF, 2015, CLIN RHEUMATOL, V34, P1529, DOI 10.1007/s10067-015-3025-8; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Saag KG, 1996, ARTHRITIS RHEUM-US, V39, P1711, DOI 10.1002/art.1780391014; Seibold Max A, 2011, N Engl J Med, V364, P1503, DOI 10.1056/NEJMoa1013660; Solomon JJ, 2016, EUR RESPIR J, V47, P588, DOI 10.1183/13993003.00357-2015; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; van der Vis JJ, 2016, RESPIROLOGY, V21, P712, DOI 10.1111/resp.12728; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504; Zhu QQ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001901	42	199	203	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2018	379	23					2209	2219		10.1056/NEJMoa1801562	http://dx.doi.org/10.1056/NEJMoa1801562			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD1HA	30345907	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000452259200006
J	McInnes, IB; Siebert, S				McInnes, Iain B.; Siebert, Stefan			The extending scope of kinase inhibition in immune diseases	LANCET			English	Editorial Material							PSORIATIC-ARTHRITIS; ADALIMUMAB; PLACEBO		[McInnes, Iain B.; Siebert, Stefan] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	McInnes, IB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland.	iain.mcinnes@glasgow.ac.uk						Baeten D, 2018, ANN RHEUM DIS, V77, P1295, DOI 10.1136/annrheumdis-2018-213328; Burmester GR, 2018, LANCET, V391, P2503, DOI 10.1016/S0140-6736(18)31115-2; Cafaro G, 2018, CLIN RHEUMATOL, V37, P859, DOI 10.1007/s10067-018-4012-7; Genovese MC, 2018, LANCET, V391, P2513, DOI 10.1016/S0140-6736(18)31116-4; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease P, 2018, LANCET, V392, P2367, DOI 10.1016/S0140-6736(18)32483-8; Nikiphorou E, 2018, ARTHRIT CARE RES, V70, P1257, DOI 10.1002/acr.23468; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Siebert S, 2019, ANN RHEUM DIS, V78, P1015, DOI 10.1136/annrheumdis-2018-213654; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Van den Bosch F, 2018, LANCET, V391, P2285, DOI 10.1016/S0140-6736(18)30949-8; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; van der Heijde D, 2017, ANN RHEUM DIS, V76, P1340, DOI 10.1136/annrheumdis-2016-210322; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; van Mens LJJ, 2018, CURR OPIN RHEUMATOL, V30, P79, DOI 10.1097/BOR.0000000000000457; Winthrop KL, 2017, NAT REV RHEUMATOL, V13, P234, DOI 10.1038/nrrheum.2017.23	18	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2018	392	10162					2328	2331		10.1016/S0140-6736(18)32600-X	http://dx.doi.org/10.1016/S0140-6736(18)32600-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4PH	30360966	Green Accepted			2022-12-28	WOS:000451785200005
J	Ferner, RE; McGettigan, P				Ferner, Robin E.; McGettigan, Patricia			Adverse drug reactions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SAFETY; RISK; PHARMACOVIGILANCE; EXPERIENCES; THERAPY; CANCER		[Ferner, Robin E.] City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [McGettigan, Patricia] Queen Mary Univ London, William Harvey Res Inst, London EC1M 6BQ, England	University of Birmingham; University of London; Queen Mary University London	Ferner, RE (corresponding author), City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Abrahamsen B, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3365; Adams A., INTRO YELLOW CARD HO; Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Alfirevic A, 2012, CLIN PHARMACOL THER, V92, P376, DOI 10.1038/clpt.2012.107; Anton R, 2017, CLIN PHARMACOL THER, V102, P283, DOI 10.1002/cpt.604; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Bankowski Z, 1999, REPORTING ADVERSE DR; Bouvy JC, 2015, DRUG SAFETY, V38, P437, DOI 10.1007/s40264-015-0281-0; Butt TF, 2012, DRUG SAFETY, V35, P1159, DOI 10.2165/11631950-000000000-00000; Centers for Disease Control and Prevention, IS IT REALL PEN ALL; Chan SW, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2224; Choi Ji Hui, 2017, Obstet Gynecol Sci, V60, P314, DOI 10.5468/ogs.2017.60.3.314; COULTER DM, 1987, BRIT MED J, V294, P1521, DOI 10.1136/bmj.294.6586.1521; CPRD, WELC CLIN PRACT RES; Crandall JP, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000438; Danlos FX, 2018, EUR J CANCER, V91, P21, DOI 10.1016/j.ejca.2017.12.008; eMC, 2017, AL AC 70MG TABL; European Medicines Agency, COND MARK AUTH; European Medicines Agency, 2017, SGLT2 INGH INF POT R; European Medicines Agency and Heads of Medicines Agencies, 2017, GUID GOOD PHARM PRAC; Eurosurveillance editorial team, 2010, EUR MED AG UPD REV P, V15, DOI [10.2807/ese.15.38.19670-en, DOI 10.2807/ESE.15.38.19670-EN]; Ferner RE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6456; Flexman AM, 2007, LANCET, V369, P1972, DOI 10.1016/S0140-6736(07)60918-0; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Hassel JC, 2017, CANCER TREAT REV, V57, P36, DOI 10.1016/j.ctrv.2017.05.003; Hauben M, 2007, DRUG SAFETY, V30, P645, DOI 10.2165/00002018-200730080-00001; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hodkinson A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003436; Katory M, 2005, DIS COLON RECTUM, V48, P1442, DOI 10.1007/s10350-005-0027-7; Laties A, 2006, J SEX MED, V3, P12, DOI 10.1111/j.1743-6109.2005.00194.x; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Medicines and Healthcare products Regulatory Agency, 2007, PUBL ASS REP; Medicines and Healthcare products Regulatory Agency, CLOZ REM POT FAT RIS; Medicines and Healthcare products Regulatory Agency, 2015, BISPH VER RAR REP OS; Medsafe. Post-finasteride syndrome, 2016, PRESCRIBER UPDATE, V37, P8; MHRA UK public assessment report, 2013, AW CREAM CONT SOD LA; Mostaghim SR, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3837; Mouton JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172830; Muller H, 2012, AM J MED, V125, pE3, DOI 10.1016/j.amjmed.2012.01.031; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0553-2; Paus S, 2003, MOVEMENT DISORD, V18, P659, DOI 10.1002/mds.10417; Pierce CE, 2017, DRUG SAFETY, V40, P317, DOI 10.1007/s40264-016-0491-0; Pirmohamed M, 1998, BRIT MED J, V316, P1295, DOI 10.1136/bmj.316.7140.1295; Pituskin E, 2017, J CLIN ONCOL, V35, P870, DOI 10.1200/JCO.2016.68.7830; Ramsay HM, 2003, ARCH DIS CHILD, V88, P1056, DOI 10.1136/adc.88.12.1056; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Root AA, 2016, BRIT J CLIN PHARMACO, V82, P512, DOI 10.1111/bcp.12983; Rosenstock J, 2015, DIABETES CARE, V38, P1638, DOI 10.2337/dc15-1380; Schaapveld M, 2015, NEW ENGL J MED, V373, P2499, DOI 10.1056/NEJMoa1505949; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Snodgrass Amanda J, 2010, Pharmacotherapy, V30, P112, DOI 10.1592/phco.30.1.112; Sorup FKH, 2015, PHARM MED, V29, P211, DOI [10.1007/s40290-015-0102-x, DOI 10.1007/s40290-015-0102-x]; SWERDLOW AJ, 1992, BRIT MED J, V304, P1137, DOI 10.1136/bmj.304.6835.1137; University of Birmingham, HLTH IMPR NETW THIN; US Food and Drug Administration, PAT FAST TRACK; US Food and Drug Administration, 2018, TITL 21 FOOD DRUGS; US Food and Drug Administration, NEWS EV FDA UNV PLAN; van Hunsel F, 2012, DRUG SAFETY, V35, P45, DOI 10.2165/11594320-000000000-00000; Vukadinovic D, 2018, CLIN PHARM THER; Wei L, 2017, BRIT J CLIN PHARMACO, V83, P1298, DOI 10.1111/bcp.13205; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	69	16	16	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2018	363								k4051	10.1136/bmj.k4051	http://dx.doi.org/10.1136/bmj.k4051			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2CX	30401691				2022-12-28	WOS:000450040400001
J	Son, JS; Choi, S; Kim, K; Kim, SM; Choi, D; Lee, G; Jeong, SM; Park, SY; Kim, YY; Yun, JM; Park, SM				Son, Joung Sik; Choi, Seulggie; Kim, Kyuwoong; Kim, Sung Min; Choi, Daein; Lee, Gyeongsil; Jeong, Su-Min; Park, Seong Yong; Kim, Yeon-Yong; Yun, Jae-Moon; Park, Sang Min			Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASE-LINE PREHYPERTENSION; ALL-CAUSE MORTALITY; TASK-FORCE; RISK; METAANALYSIS; MANAGEMENT; STROKE; IMPACT; ASIA	IMPORTANCE Among young adults, the association of the 2017 American College of Cardiology/American Heart Association (ACC/AHA) High Blood Pressure Clinical Practice Guidelines with risk of cardiovascular disease (CVD) later in life is uncertain. OBJECTIVE To determine the association of blood pressure categories before age 40 years with risk of CVD later in life. DESIGN, SETTING, AND PARTICIPANTS This population-based cohort study from the Korean National Health Insurance Service consisted of 2 488 101 adults aged 20 through 39 years with blood pressure measurements taken twice from 2002 through 2005. Starting from January 1, 2006, participants were followed up until the date of CVD diagnosis, death, or December 31, 2015. EXPOSURES Participants were categorized by blood pressure readings: normal (systolic, <120 mm Hg; diastolic, <80 mm Hg), elevated (sytolic, 120-129 mm Hg; diastolic, <80 mm Hg), stage 1 hypertension (systolic, 130-139 mm Hg; diastolic, 80-89 mm Hg), and stage 2 hypertension (systolic, >= 40 mm Hg; diastolic, >= 90 mm Hg). MAIN OUTCOMES AND MEASURES The primary outcome was CVD defined as 2 or more days of hospitalization due to CVD or death due to CVD. The secondary outcomes were coronary heart disease (CHD) and stroke. RESULTS The study population consisted of 2 488 101 participants (median age, 31 years [interquartile range, 27-36 years], 789 870 women [31.7%]). A total of 44 813 CVD events were observed during a median follow-up duration of 10 years. Men with baseline stage 1 hypertension compared with those with normal blood pressure had higher risk of CVD (incidence, 215 vs 164 per 100000 person-years; difference, 51 per 100000 person-years [95% CI, 48-55]; adjusted hazard ratio [HR], 1.25 [95% CI, 1.21-1.28]), CHD (incidence, 134 vs 103 per 100000 person-years; difference, 31 per 100000 person-years [95% CI, 28-33]; adjusted HR, 1.23 [95% CI, 1.19-1.27]), and stroke (incidence, 90 vs 67 per 100000 person-years; difference, 23 per 100000 person-years [95% CI, 21-26]; adjusted HR, 1.30 [95% CI, 1.25-1.36]). Women with baseline stage 1 hypertension compared with those with normal blood pressure had increased risk of CVD (incidence, 131 vs 91 per 100000 person-years; difference, 40 per 100000 person-years [95% CI, 35-45]; adjusted HR, 1.27 [95% CI, 1.21-1.34]), CHD (incidence, 56 vs 42 per 100000 person-years; difference, 14 per 100000 person-years [95% CI, 11-18]; adjusted HR, 1.16 [95% CI, 1.08-1.25]), and stroke (incidence, 79 vs 51 per 100000 person-years; difference, 28 per 100000 person-years [95% CI, 24-32]; adjusted HR [1.37, 95% CI, 1.29-1.46]). Results for state 2 hypertension were consistent. CONCLUSIONS AND RELEVANCE Among Korean young adults, stage 1 and stage 2 hypertension, compared with normal blood pressure, were associated with increased risk of subsequent cardiovascular disease events. Young adults with hypertension, defined by the 2017 ACC/AHA criteria, may be at increased risk of cardiovascular disease.	[Son, Joung Sik; Jeong, Su-Min; Yun, Jae-Moon; Park, Sang Min] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Choi, Seulggie; Kim, Kyuwoong; Kim, Sung Min; Park, Sang Min] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Choi, Daein] Pyeongchang Bongpyeong Publ Hlth Ctr, Pyeongchang, South Korea; [Lee, Gyeongsil] Chung Ang Univ Hosp, Hlth Promot Ctr, Dept Family Med, Seoul, South Korea; [Park, Seong Yong; Kim, Yeon-Yong] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; National Health Insurance Service	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med & Biomed Sci, 101 Daehak Ro, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019	Son, Joung Sik/0000-0003-2460-3378; Choi, Daein/0000-0001-7135-3784	Ministry of Health andWelfare of Korea [20170322652-00]; Basic Science Research Program through the National Research Foundation - Ministry of Education of Korea [2017R1D1A1B03033721]; Brain Korea 21-plus education program from the National Research Foundation of Korea	Ministry of Health andWelfare of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation - Ministry of Education of Korea; Brain Korea 21-plus education program from the National Research Foundation of Korea	This study was supported by grants 20170322652-00 from the Ministry of Health andWelfare of Korea and 2017R1D1A1B03033721 from the Basic Science Research Program through the National Research Foundation funded by the Ministry of Education of Korea. Dr S Choi and Messrs K Kim and SM Kim received grants from the Brain Korea 21-plus education program from the National Research Foundation of Korea. This study used NHIS data (NHIS-2017-2-463) from the Korean NHIS.	Arima H, 2012, HYPERTENSION, V59, P1118, DOI 10.1161/HYPERTENSIONAHA.111.187252; Choi S, 2018, JAMA INTERN MED, V178, P1060, DOI 10.1001/jamainternmed.2018.2310; Colantonio LD, 2018, J AM COLL CARDIOL, V72, P1187, DOI 10.1016/j.jacc.2018.05.074; Conen D, 2007, BMJ-BRIT MED J, V335, P432, DOI 10.1136/bmj.39269.672188.AE; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Gan S. K. E., 2003, SMJ Singapore Medical Journal, V44, P448; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Harrell H., 2001, REGRESSION MODELING, DOI [10.1007/978-1-4757-3462-1, DOI 10.1007/978-1-4757-3462-1]; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850; Huang YL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001519; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Huang YL, 2014, NEUROLOGY, V82, P1153, DOI 10.1212/WNL.0000000000000268; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Kim K, 2018, EUR HEART J, V39, P1523, DOI 10.1093/eurheartj/ehx761; Lee M, 2011, NEUROLOGY, V77, P1330, DOI 10.1212/WNL.0b013e3182315234; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Moon Jong Youn, 2013, J Prev Med Public Health, V46, P353, DOI 10.3961/jpmph.2013.46.6.353; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murakami Y, 2008, HYPERTENSION, V51, P1483, DOI 10.1161/HYPERTENSIONAHA.107.102459; Na J.Y., 2013, KOREAN J LEG MED, V37, P198, DOI DOI 10.7580/14M.2013.37.4.198; Paige E, 2017, AM J EPIDEMIOL, V186, P899, DOI 10.1093/aje/kwx149; Pool ER, 2018, JAMA CARDIOL, DOI [10.1001/jamacardio.2018.2763, DOI 10.1001/JAMACARDIO.2018.2763]; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Shen L, 2013, AM J CARDIOL, V112, P266, DOI 10.1016/j.amjcard.2013.03.023; Sundstrom Johan, 2011, BMJ, V342, pd643, DOI 10.1136/bmj.d643; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang SJ, 2013, INT J CARDIOL, V168, P4857, DOI 10.1016/j.ijcard.2013.07.063; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339	35	129	130	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1783	1792		10.1001/jama.2018.16501	http://dx.doi.org/10.1001/jama.2018.16501			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398603	Bronze, Green Published			2022-12-28	WOS:000449461800016
J	Zheng, YY; Zhu, JH; Liu, YY; Lai, WG; Lin, CY; Qiu, KF; Wu, JY; Yao, WM				Zheng, Yayuan; Zhu, Jianhong; Liu, Yuyu; Lai, Weiguang; Lin, Chunyu; Qiu, Kaifen; Wu, Junyan; Yao, Weimin			Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADDING FLUTICASONE PROPIONATE/SALMETEROL; PARALLEL-GROUP; DOUBLE-BLIND; COPD; TIOTROPIUM; BENEFITS; EFFICACY; SAFETY	OBJECTIVE To compare the rate of moderate to severe exacerbations between triple therapy and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease (COPD). DESIGN Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES PubMed, Embase, Cochrane databases, and clinical trial registries searched from inception to April 2018. ELIGIBILITY CRITERIA Randomised controlled trials comparing triple therapy with dual therapy or monotherapy in patients with COPD were eligible. Efficacy and safety outcomes of interest were also available. DATA EXTRACTION AND SYNTHESIS Data were collected independently. Meta-analyses were conducted to calculate rate ratios, hazard ratios, risk ratios, and mean differences with 95% confidence intervals. Quality of evidence was summarised in accordance with GRADE methodology (grading of recommendations assessment, development, and evaluation). RESULTS 21 trials (19 publications) were included. Triple therapy consisted of a long acting muscarinic antagonist (LAMA), long acting beta agonist (LABA), and inhaled corticosteroid (ICS). Triple therapy was associated with a significantly reduced rate of moderate or severe exacerbations compared with LAMA monotherapy (rate ratio 0.71, 95% confidence interval 0.60 to 0.85), LAMA and LABA (0.78, 0.70 to 0.88), and ICS and LABA (0.77, 0.66 to 0.91). Trough forced expiratory volume in 1 second (FEV1) and quality of life were favourable with triple therapy. The overall safety profile of triple therapy is reassuring, but pneumonia was significantly higher with triple therapy than with dual therapy of LAMA and LABA (relative risk 1.53, 95% confidence interval 1.25 to 1.87). CONCLUSIONS Use of triple therapy resulted in a lower rate of moderate or severe exacerbations of COPD, better lung function, and better health related quality of life than dual therapy or monotherapy in patients with advanced COPD.	[Zheng, Yayuan] Guangdong Med Univ, Lab Physiol Sci, Zhanjiang, Peoples R China; [Zheng, Yayuan] Guangdong Med Univ, Dept Pharm, Affiliated Hosp, Zhanjiang, Peoples R China; [Zhu, Jianhong; Qiu, Kaifen; Wu, Junyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Liu, Yuyu] Guangdong Med Univ, Dept Pharmacol, Zhanjiang, Peoples R China; [Lai, Weiguang; Lin, Chunyu; Yao, Weimin] Guangdong Med Univ, Dept Resp Med, Affiliated Hosp, 57 South Renmin Ave, Zhanjiang 524001, Peoples R China	Guangdong Medical University; Guangdong Medical University; Sun Yat Sen University; Guangdong Medical University; Guangdong Medical University	Yao, WM (corresponding author), Guangdong Med Univ, Dept Resp Med, Affiliated Hosp, 57 South Renmin Ave, Zhanjiang 524001, Peoples R China.	yaoweimin2014@yeah.net		Zhu, Jianhong/0000-0002-8320-891X; Wu, Junyan/0000-0003-0870-382X				Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; ADDITION TO, COCHRANE DATABASE SY; ADDITION TO, 2016, COCHRANE DATABASE SY, V6; Bremner PR, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0724-0; Brusselle G, 2015, INT J CHRONIC OBSTR, V10, P2207, DOI 10.2147/COPD.S91694; Cazzola M, 2007, PULM PHARMACOL THER, V20, P556, DOI 10.1016/j.pupt.2006.06.001; Frith PA, 2015, THORAX, V70, P519, DOI 10.1136/thoraxjnl-2014-206670; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Global Strategy for the Diagnosis Management and Prevention of COPD, 2017, GLOBAL INITIATIVE FO; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hanania NA, 2012, RESP MED, V106, P91, DOI 10.1016/j.rmed.2011.09.002; HIGGINS JPT, COCHRANE HANDBOOK FO; HIGGINS JPT, 2011, BMJ BRIT MED J, V343; HORITA N, 2017, COCHRANE DATABASE SY, V2; Hoshino M, 2013, RESPIRATION, V86, P280, DOI 10.1159/000351116; Hoshino M, 2011, RESPIROLOGY, V16, P95, DOI 10.1111/j.1440-1843.2010.01869.x; Ismaila AS, 2017, ADV THER, V34, P2163, DOI 10.1007/s12325-017-0604-x; Jung KS, 2012, RESP MED, V106, P382, DOI 10.1016/j.rmed.2011.09.004; Kwak MS, 2015, INT J CHRONIC OBSTR, V10, P2365, DOI 10.2147/COPD.S93191; Lee SD, 2016, RESPIROLOGY, V21, P119, DOI 10.1111/resp.12646; LIBERATI A, 2009, BMJ-BRIT MED J, V339, pB270; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Lipson DA, 2017, AM J RESP CRIT CARE, V196, P438, DOI 10.1164/rccm.201703-0449OC; Liu Y, 2014, EUR J INTERN MED, V25, P491, DOI 10.1016/j.ejim.2014.04.007; Malerba M, 2018, THER ADV RESPIR DIS, V12, DOI 10.1177/1753466618760779; Maltais F, 2013, EUR RESPIR J, V42, P539, DOI 10.1183/09031936.00074113; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Melani AS, 2012, RESP MED, V106, P757, DOI 10.1016/j.rmed.2012.03.003; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Rodrigo GJ, 2009, RESP MED, V103, P1421, DOI 10.1016/j.rmed.2009.05.020; Rojas-Reyes MX, 2016, R J, V6; Siler TM, 2016, COPD, V13, P1, DOI 10.3109/15412555.2015.1034256; Siler TM, 2015, RESP MED, V109, P1493, DOI 10.1016/j.rmed.2015.09.008; Simeone JC, 2017, INT J CHRONIC OBSTR, V12, P73, DOI 10.2147/COPD.S122013; Simeone JC, 2016, PLOS ONE, V12, P73; Singh D, 2016, LANCET, V388, P963, DOI 10.1016/S0140-6736(16)31354-X; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1473, DOI 10.1001/jama.2018.2757; Sousa AR, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.31; Vestbo J, 2017, LANCET, V389, P1919, DOI 10.1016/S0140-6736(17)30188-5; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC; Xia N, 2015, COCHRANE DATABASE SY, V10, DOI 10.1371/journal.pone.0137904; Xia N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137904	43	47	52	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 6	2018	363								k4388	10.1136/bmj.k4388	http://dx.doi.org/10.1136/bmj.k4388			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2CX	30401700	hybrid, Green Published			2022-12-28	WOS:000450040400002
J	Brown, PT; Stolpe, MB; Caldeira, K				Brown, Patrick T.; Stolpe, Martin B.; Caldeira, Ken			Assumptions for emergent constraints	NATURE			English	Letter							VARIABILITY		[Brown, Patrick T.; Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Stolpe, Martin B.] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, Zurich, Switzerland	Carnegie Institution for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich	Brown, PT (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	pbrown@carnegiescience.edu	Caldeira, Ken/E-7914-2011	Caldeira, Ken/0000-0002-4591-643X				Brockwell P., 1996, INTRO TIME SERIES FO; Cheung AH, 2017, J CLIMATE, V30, P4763, DOI [10.1175/JCLI-D-16-0712.1, 10.1175/jcli-d-16-0712.1]; Cox PM, 2018, NATURE, V553, P319, DOI 10.1038/nature25450; Foster G, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009373; Frankcombe LM, 2015, J CLIMATE, V28, P8184, DOI 10.1175/JCLI-D-15-0069.1; LEITH CE, 1975, J ATMOS SCI, V32, P2022, DOI 10.1175/1520-0469(1975)032<2022:CRAFD>2.0.CO;2; Mann ME, 2014, GEOPHYS RES LETT, V41, P3211, DOI 10.1002/2014GL059233; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Wilks D. S, 2011, STAT METHODS ATMOSPH, V100	10	7	7	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					E1	E3		10.1038/s41586-018-0638-5	http://dx.doi.org/10.1038/s41586-018-0638-5			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382203				2022-12-28	WOS:000448900900001
J	Dyer, C				Dyer, Clare			Drug company charged over substandard parenteral nutrition used in babies	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4649	10.1136/bmj.k4649	http://dx.doi.org/10.1136/bmj.k4649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385500				2022-12-28	WOS:000449565500015
J	Iacobucci, G				Iacobucci, Gareth			Swedish company launches NHS partnership in bid to enter GP app market	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2227	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4596	10.1136/bmj.k4596	http://dx.doi.org/10.1136/bmj.k4596			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377158				2022-12-28	WOS:000449563200010
J	Hassoun, A				Hassoun, Ali			Clostridium difficile associated disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; UNITED-STATES; INFECTION; FIDAXOMICIN; DIARRHEA; VANCOMYCIN; RECURRENCE; TRANSPLANT; ADULTS		[Hassoun, Ali] Alabama Infect Dis Ctr, Huntsville, AL 35801 USA		Hassoun, A (corresponding author), Alabama Infect Dis Ctr, Huntsville, AL 35801 USA.	ali_hasoun@yahoo.com						Abrahamian FM, 2017, ANN EMERG MED, V70, P19, DOI 10.1016/j.annemergmed.2016.12.013; [Anonymous], 2011, MED LETT DRUGS THER, V53; [Anonymous], 2004, INS MALPR FIN REP HO; Arriola V, 2016, INFECT CONT HOSP EP, V37, P1408, DOI 10.1017/ice.2016.194; Bafeta A, 2017, ANN INTERN MED, V167, P34, DOI 10.7326/M16-2810; Beinortas T, 2018, LANCET INFECT DIS, V18, P1035, DOI 10.1016/S1473-3099(18)30285-8; Chapman BC, 2016, J TRAUMA ACUTE CARE, V81, P756, DOI 10.1097/TA.0000000000001195; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Dingle KE, 2017, LANCET INFECT DIS, V17, P411, DOI 10.1016/S1473-3099(16)30514-X; Donnelly JP, 2015, AM J TRANSPLANT, V15, P2970, DOI 10.1111/ajt.13491; Drekonja DM, 2011, ANN INTERN MED, V155, P839, DOI 10.7326/0003-4819-155-12-201112200-00007; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Goldstein EJC, 2011, ANTIMICROB AGENTS CH, V55, P5194, DOI 10.1128/AAC.00625-11; Jaber MR, 2008, AM J GASTROENTEROL, V103, P3195, DOI 10.1111/j.1572-0241.2008.02198.x; Lancaster JW, 2012, CLIN THER, V34, P1, DOI 10.1016/j.clinthera.2011.12.003; Lee CH, 2016, J ANTIMICROB CHEMOTH, V71, P2964, DOI 10.1093/jac/dkw246; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/ciy149, 10.1093/cid/cix1085]; Nelson RL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub5; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P1443, DOI 10.1111/j.1572-0241.2007.01780.x; Paudel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124483; Phatharacharukul P, 2015, DIGEST DIS SCI, V60, P2913, DOI 10.1007/s10620-015-3714-9; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Public Health England, 2013, CLOSTR DIFF INF GUID; Razik R, 2016, AM J GASTROENTEROL, V111, P1141, DOI 10.1038/ajg.2016.187; Sanchez TH, 2005, CLIN INFECT DIS, V41, P1621, DOI 10.1086/498027; Schroeder MS, 2005, AM FAM PHYSICIAN, V71, P921; Shen NT, 2017, GASTROENTEROLOGY, V152, P1889, DOI 10.1053/j.gastro.2017.02.003; Stevens VW, 2017, JAMA INTERN MED, V177, P546, DOI 10.1001/jamainternmed.2016.9045; Tschudin-Sutter S, 2018, CLIN MICROBIOL INFEC, V24, P1051, DOI 10.1016/j.cmi.2018.02.020; US Food and Drug Administration, 2012, CLOSTR DIFF ASS DIAR; Whitman CB, 2012, ANN PHARMACOTHER, V46, P219, DOI 10.1345/aph.1Q481; Zacharioudakis Ioannis M, 2014, Biol Blood Marrow Transplant, V20, P1650, DOI 10.1016/j.bbmt.2014.06.001	40	0	1	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2018	363								k4369	10.1136/bmj.k4369	http://dx.doi.org/10.1136/bmj.k4369			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PG	30373736				2022-12-28	WOS:000449561100001
J	Gante, HF				Gante, Hugo F.			How fish get their stripes-again and again	SCIENCE			English	Editorial Material							PATTERN EVOLUTION; ZEBRAFISH		[Gante, Hugo F.] Indiana State Univ, Coll Arts & Sci, Ctr Genom Advocacy TCGA, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University; International Genomics Consortium	Gante, HF (corresponding author), Indiana State Univ, Coll Arts & Sci, Ctr Genom Advocacy TCGA, Dept Biol, Terre Haute, IN 47809 USA.	hugo.gante@indstate.edu		Gante, Hugo/0000-0002-0321-3023				Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Eskova A, 2017, DEVELOPMENT, V144, P2059, DOI 10.1242/dev.143495; Haupaix N, 2018, SCIENCE, V361, P1216, DOI 10.1126/science.aar4777; Kratochwil CF, 2018, SCIENCE, V362, P457, DOI 10.1126/science.aao6809; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Meier JI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14363; Patterson LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6299; Quigley AK, 2004, DEVELOPMENT, V131, P6053, DOI 10.1242/dev.01526; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; Salzburger W, 2018, NAT REV GENET, V19, P705, DOI 10.1038/s41576-018-0043-9; Santos ME, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6149; Spiewak JE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007538; Walderich B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11462; Watanabe M, 2015, TRENDS GENET, V31, P88, DOI 10.1016/j.tig.2014.11.005	15	4	4	4	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					396	397		10.1126/science.aav3373	http://dx.doi.org/10.1126/science.aav3373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361357				2022-12-28	WOS:000450441900028
J	Crisp, N; Iro, E				Crisp, Nigel; Iro, Elizabeth			Putting nursing and midwifery at the heart of the Alma-Ata vision	LANCET			English	Editorial Material							EDUCATION		[Crisp, Nigel] Nursing Now, London W1G 0RN, England; [Crisp, Nigel] Houses Parliament, House Lords, London, England; [Iro, Elizabeth] World Hlth Org, CH-1211 Geneva 27, Switzerland	World Health Organization	Iro, E (corresponding author), World Hlth Org, CH-1211 Geneva 27, Switzerland.	iroe@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		All Party Parliamentary Group on Global Health, 2016, TRIPL IMP NURS; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Crisp N, 2018, LANCET, V391, P920, DOI 10.1016/S0140-6736(18)30494-X; Jolly P, 2013, ACAD MED, V88, P468, DOI 10.1097/ACM.0b013e318285199d; Laurent M., 2018, COCHRANE DATABASE SY, V7; Nair M, 2010, MED EDUC, V44, P856, DOI 10.1111/j.1365-2923.2010.03747.x; Omaswa F, 2015, AFRICAN HLTH LEADERS, P109; Rippon S., 2015, HEAD HANDS HEART ASS; Vinayak S, 2018, J INTERPROF CARE, V32, P641, DOI 10.1080/13561820.2018.1470499; WHO, 2014, HLTH POL FRAM COUNTR; WHO, 2020, GLOB STRAT HUM RES H; World Health Organization, 2018, TIM DEL REP WHO IND; World Health Organization (WHO), 2017, WORK HLTH 5 YEAR ACT; World Health Organization (WHO), 1978, ALM AT INT C PRIM HL	14	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1377	1379		10.1016/S0140-6736(18)32341-9	http://dx.doi.org/10.1016/S0140-6736(18)32341-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343847				2022-12-28	WOS:000447800900009
J	Macdougall, IC; White, C; Anker, SD; Bhandari, S; Farrington, K; Kalra, PA; McMurray, JJV; Murray, H; Tomson, CRV; Wheeler, DC; Winearls, CG; Ford, I				Macdougall, Iain C.; White, Claire; Anker, Stefan D.; Bhandari, Sunil; Farrington, Kenneth; Kalra, Philip A.; McMurray, John J. V.; Murray, Heather; Tomson, Charles R. V.; Wheeler, David C.; Winearls, Christopher G.; Ford, Ian		PIVOTAL Investigators Comm	Intravenous Iron in Patients Undergoing Maintenance Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; INFECTION; SAFETY; SUPPLEMENTATION; HEMOGLOBIN; MORTALITY; DIALYSIS; OUTCOMES; ALPHA; TIME	BACKGROUND Intravenous iron is a standard treatment for patients undergoing hemodialysis, but comparative data regarding clinically effective regimens are limited. METHODS In a multicenter, open-label trial with blinded end-point evaluation, we randomly assigned adults undergoing maintenance hemodialysis to receive either high-dose iron sucrose, administered intravenously in a proactive fashion (400 mg monthly, unless the ferritin concentration was >700 mu g per liter or the transferrin saturation was >= 40%), or low-dose iron sucrose, administered intravenously in a reactive fashion (0 to 400 mg monthly, with a ferritin concentration of <200 mu g per liter or a transferrin saturation of <20% being a trigger for iron administration). The primary end point was the composite of nonfatal myocardial infarction, nonfatal stroke, hospitalization for heart failure, or death, assessed in a time-to-first-event analysis. These end points were also analyzed as recurrent events. Other secondary end points included death, infection rate, and dose of an erythropoiesis-stimulating agent. Noninferiority of the high-dose group to the low-dose group would be established if the upper boundary of the 95% confidence interval for the hazard ratio for the primary end point did not cross 1.25. RESULTS A total of 2141 patients underwent randomization (1093 patients to the high-dose group and 1048 to the low-dose group). The median follow-up was 2.1 years. Patients in the high-dose group received a median monthly iron dose of 264 mg (interquartile range [25th to 75th percentile], 200 to 336), as compared with 145 mg (interquartile range, 100 to 190) in the low-dose group. The median monthly dose of an erythropoiesis-stimulating agent was 29,757 IU in the high-dose group and 38,805 IU in the low-dose group (median difference, -7539 IU; 95% confidence interval [CI], -9485 to -5582). A total of 320 patients (29.3%) in the high-dose group had a primary end-point event, as compared with 338 (32.3%) in the low-dose group (hazard ratio, 0.85; 95% CI, 0.73 to 1.00; P<0.001 for noninferiority; P=0.04 for superiority). In an analysis that used a recurrent-events approach, there were 429 events in the high-dose group and 507 in the low-dose group (rate ratio, 0.77; 95% CI, 0.66 to 0.92). The infection rate was the same in the two groups. CONCLUSIONS Among patients undergoing hemodialysis, a high-dose intravenous iron regimen administered proactively was superior to a low-dose regimen administered reactively and resulted in lower doses of erythropoiesis-stimulating agent being administered.	[Macdougall, Iain C.; White, Claire] Kings Coll Hosp London, Dept Renal Med, London, England; [Wheeler, David C.] UCL, London, England; [Bhandari, Sunil] East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [Bhandari, Sunil] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Farrington, Kenneth] Lister Hosp, Stevenage, Herts, England; [Farrington, Kenneth] Univ Hertfordshire, Hatfield, Herts, England; [Kalra, Philip A.] Salford Royal NHS Fdn Trust, Dept Renal Med, Salford, Lancs, England; [McMurray, John J. V.] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Murray, Heather; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Level 11,Boyd Orr Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Tomson, Charles R. V.] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Winearls, Christopher G.] Oxford Univ Hosp NHS Fdn Trust, Oxford Kidney Unit, Churchill Hosp, Oxford, England; [Anker, Stefan D.] Charite Univ Med Berlin, German Ctr Cardiovasc Res Partner Site Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Div Cardiol & Metab,Dept Cardiol, Berlin, Germany	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; University of Hull; University of York - UK; Lister Hospital; University of Hertfordshire; Salford Royal NHS Foundation Trust; University of Glasgow; University of Glasgow; Newcastle Freeman Hospital; Newcastle University - UK; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ford, I (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Level 11,Boyd Orr Bldg, Glasgow G12 8QQ, Lanark, Scotland.	ian.ford@glasgow.ac.uk	Murray, Heather/GQY-8016-2022; Ford, Ian/ABE-6145-2020; Mark, Patrick/N-5536-2014; mcmurray, John/B-2467-2013; Hall, Matthew/AAB-8228-2019	Mark, Patrick/0000-0003-3387-2123; mcmurray, John/0000-0002-6317-3975; Hall, Matthew/0000-0002-3900-1735; Maxwell, Alexander P./0000-0002-6110-7253; Tomson, Charles/0000-0002-0224-8726; Khwaja, Arif/0000-0002-4690-3649; Bell, Samira/0000-0001-9100-1575; Barratt, Jonathan/0000-0002-9063-7229; Power, Albert/0000-0003-2283-5431	Kidney Research UK; Vifor Fresenius Medical Care Renal Pharma	Kidney Research UK(Kidney Research UK (KRUK)); Vifor Fresenius Medical Care Renal Pharma	Supported by Kidney Research UK, which was supported by an unrestricted grant from Vifor Fresenius Medical Care Renal Pharma.	Anker SD, 2018, EUR J HEART FAIL, V20, P125, DOI 10.1002/ejhf.823; [Anonymous], 2018, US DOPPS DIALYSIS OU; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Coyne DW, 2012, KIDNEY INT, V82, P235, DOI 10.1038/ki.2012.76; Cross JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16670; Cunha GJL, 2018, EUR J INTERN MED, V52, P1, DOI 10.1016/j.ejim.2018.04.013; Dalal J, 2017, INDIAN HEART J, V69, P736, DOI 10.1016/j.ihj.2017.10.009; Del Vecchio L, 2016, CLIN KIDNEY J, V9, P260, DOI 10.1093/ckj/sfv142; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Ganguli A, 2009, RENAL FAILURE, V31, P106, DOI 10.1080/08860220802599106; Ghosh D, 2000, BIOMETRICS, V56, P554, DOI 10.1111/j.0006-341X.2000.00554.x; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hougen I, 2018, CLIN J AM SOC NEPHRO, V13, P457, DOI 10.2215/CJN.05390517; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Kshirsagar AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078930; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Macdougall IC, 2018, AM J NEPHROL, V48, P260, DOI 10.1159/000493551; Macdougall IC, 2016, KIDNEY INT, V89, P28, DOI 10.1016/j.kint.2015.10.002; Miskulin DC, 2014, CLIN J AM SOC NEPHRO, V9, P1930, DOI 10.2215/CJN.03370414; Nairz M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00110; Neven E, 2011, NEPHROL DIAL TRANSPL, V26, P1137, DOI 10.1093/ndt/gfq858; NICE, 2015, MOT NEUR DIS BRIEF P; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Qian C, 2016, CAN J CARDIOL, V32, P151, DOI 10.1016/j.cjca.2015.06.009; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stefanova D, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00253-18; Wish JB, 2018, AM J NEPHROL, V47, P72, DOI 10.1159/000486968	33	210	217	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2019	380	5					447	458		10.1056/NEJMoa1810742	http://dx.doi.org/10.1056/NEJMoa1810742			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HJ4HS	30365356	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000457135700008
J	Schmid, P; Adams, S; Rugo, HS; Schneeweiss, A; Barrios, CH; Iwata, H; Dieras, V; Hegg, R; Im, SA; Wright, GS; Henschel, V; Molinero, L; Chui, SY; Funke, R; Husain, A; Winer, EP; Loi, S; Emens, LA				Schmid, P.; Adams, S.; Rugo, H. S.; Schneeweiss, A.; Barrios, C. H.; Iwata, H.; Dieras, V.; Hegg, R.; Im, S. -A.; Wright, G. Shaw; Henschel, V.; Molinero, L.; Chui, S. Y.; Funke, R.; Husain, A.; Winer, E. P.; Loi, S.; Emens, L. A.		IMpassion 130 Trial Investigators	Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ANTI-PD-L1 ANTIBODY; PREDICTIVE-VALUE; CHEMOTHERAPY; EXPRESSION; SURVIVAL	BACKGROUND Unresectable locally advanced or metastatic triple-negative (hormone-receptor-negative and human epidermal growth factor receptor 2 [HER2]-negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)paclitaxel may enhance the anticancer activity of atezolizumab. METHODS In this phase 3 trial, we randomly assigned (in a 1: 1 ratio) patients with untreated metastatic triple-negative breast cancer to receive atezolizumab plus nab-paclitaxel or placebo plus nab-paclitaxel; patients continued the intervention until disease progression or an unacceptable level of toxic effects occurred. Stratification factors were the receipt or nonreceipt of neoadjuvant or adjuvant taxane therapy, the presence or absence of liver metastases at baseline, and programmed death ligand 1 (PD-L1) expression at baseline (positive vs. negative). The two primary end points were progression-free survival (in the intention-to-treat population and PD-L1-positive subgroup) and overall survival (tested in the intention-to-treat population; if the finding was significant, then it would be tested in the PD-L1-positive subgroup). RESULTS Each group included 451 patients (median follow-up, 12.9 months). In the intention-to-treat analysis, the median progression-free survival was 7.2 months with atezolizumab plus nab-paclitaxel, as compared with 5.5 months with placebo plus nab-paclitaxel (hazard ratio for progression or death, 0.80; 95% confidence interval [CI], 0.69 to 0.92; P = 0.002); among patients with PD-L1-positive tumors, the median progression-free survival was 7.5 months and 5.0 months, respectively (hazard ratio, 0.62; 95% CI, 0.49 to 0.78; P<0.001). In the intention-to-treat analysis, the median overall survival was 21.3 months with atezolizumab plus nab-paclitaxel and 17.6 months with placebo plus nab-paclitaxel (hazard ratio for death, 0.84; 95% CI, 0.69 to 1.02; P = 0.08); among patients with PD-L1-positive tumors, the median overall survival was 25.0 months and 15.5 months, respectively (hazard ratio, 0.62; 95% CI, 0.45 to 0.86). No new adverse effects were identified. Adverse events that led to the discontinuation of any agent occurred in 15.9% of the patients who received atezolizumab plus nab-paclitaxel and in 8.2% of those who received placebo plus nab-paclitaxel. CONCLUSIONS Atezolizumab plus nab-paclitaxel prolonged progression-free survival among patients with metastatic triple-negative breast cancer in both the intention-to-treat population and the PD-L1-positive subgroup. Adverse events were consistent with the known safety profiles of each agent.	[Schmid, P.] Queen Mary Univ London, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England; [Emens, L. A.] Univ Pittsburgh, Med Ctr, Canc Ctr, 5117 Ctr Ave,Rm G 27b, Pittsburgh, PA 15213 USA; [Adams, S.] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY 10003 USA; [Rugo, H. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Molinero, L.; Chui, S. Y.; Funke, R.] Genentech Inc, San Francisco, CA USA; [Schneeweiss, A.] Univ Hosp Heidelberg, Heidelberg, Germany; [Barrios, C. H.] Pontifical Cathol Univ Rio Grande Sul, Hosp Sao Lucas, Ctr Pesquisa Oncol, Porto Alegre, RS, Brazil; [Hegg, R.] Univ Sao Paulo, Sao Paulo, Brazil; [Iwata, H.] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan; [Dieras, V.] Inst Curie, Dept Med Oncol, Paris, France; [Im, S. -A.] Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Canc Res Inst, Seoul, South Korea; [Wright, G. Shaw] Florida Canc Specialists & Res Inst, New Port Richey, FL USA; [Henschel, V.; Husain, A.] Roche, Basel, Switzerland; [Winer, E. P.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loi, S.] Univ Melbourne, Peter Maccallum Canc Ctr, Melbourne, Vic, Australia; [Emens, L. A.] Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD USA	University of London; Queen Mary University London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; University of California System; University of California San Francisco; Roche Holding; Genentech; Ruprecht Karls University Heidelberg; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade de Sao Paulo; Aichi Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Seoul National University (SNU); Seoul National University Hospital; Florida Cancer Specialists; Roche Holding; Harvard University; Dana-Farber Cancer Institute; Peter Maccallum Cancer Center; University of Melbourne	Schmid, P (corresponding author), Queen Mary Univ London, Barts Canc Inst, Charterhouse Sq, London EC1M 6BQ, England.; Emens, LA (corresponding author), Univ Pittsburgh, Med Ctr, Canc Ctr, 5117 Ctr Ave,Rm G 27b, Pittsburgh, PA 15213 USA.	p.schmid@qmul.ac.uk; emensla@upmc.edu	Liedke, Pedro/L-5063-2019; Schmid, Peter/AAE-2788-2019; Schneeweiss, Andreas/HHS-4098-2022	Liedke, Pedro/0000-0002-8298-4765; Hegg, Roberto/0000-0002-6453-8155; Adams, Sylvia/0000-0003-4737-1952	F. Hoffmann-La Roche/Genentech, a member of the Roche Group	F. Hoffmann-La Roche/Genentech, a member of the Roche Group	Supported by F. Hoffmann-La Roche/Genentech, a member of the Roche Group.	Adams S, JAMA ONCOL; ADAMS S, 2018, CANCER RES S, V78; Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; [Anonymous], 2018, TECENTRIQ ATEZOLIZUM; Bonotto M, 2014, ONCOLOGIST, V19, P608, DOI 10.1634/theoncologist.2014-0002; Brahmer JR, 2018, J CLIN ONCOL, V36, P1714, DOI 10.1200/JCO.2017.77.6385; Cardoso F, 2018, ANN ONCOL, V29, P1634, DOI 10.1093/annonc/mdy192; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; den Brok WD, 2017, BREAST CANCER RES TR, V161, P549, DOI 10.1007/s10549-016-4080-9; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; Emens LA, 2018, JAMA ONCOL; Emens LA, 2015, CANCER IMMUNOL RES, V3, P436, DOI 10.1158/2326-6066.CIR-15-0064; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gobbini E, 2018, EUR J CANCER, V96, P17, DOI 10.1016/j.ejca.2018.03.015; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Jotte RM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA9000; Liu SV, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9092; LOI S, 2017, ANN ONCOL S, V28; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Miles DW, 2013, ANN ONCOL, V24, P2773, DOI 10.1093/annonc/mdt276; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Molinero L, 2018, CANC RES S, V78; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Soliman HH, 2017, ONCOTARGETS THER, V10, P101, DOI 10.2147/OTT.S122974; Vennapusa B, 2018, APPL IMMUNOHISTOCHEM; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yardley DA, 2018, ANN ONCOL, V29, P1763, DOI 10.1093/annonc/mdy201	30	2088	2155	38	291	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2018	379	22					2108	2121		10.1056/NEJMoa1809615	http://dx.doi.org/10.1056/NEJMoa1809615			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9HQ	30345906	Bronze			2022-12-28	WOS:000451402500006
J	Fuchs, VR				Fuchs, Victor R.			How to Make US Health Care More Equitable and Less Costly Begin by Replacing Employment-Based Insurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Fuchs, Victor R.] Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Cooper Z, PRICE AINT RIGHT HOS; Emanuel EJ, COMPREHENSIVE CURE U; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P24, DOI 10.1377/hlthaff.12.suppl_1.24; Himmelstein DU, 2014, HEALTH AFFAIR, V33, P1586, DOI 10.1377/hlthaff.2013.1327; Long M, TRENDS EMPLOYER SPON; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Shoven JB, DEDICATED VAT SOLUTI	8	7	7	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2071	2072		10.1001/jama.2018.16475	http://dx.doi.org/10.1001/jama.2018.16475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30398514				2022-12-28	WOS:000451395000008
J	Mashtalir, N; D'Avino, AR; Michel, BC; Luo, J; Pan, J; Otto, JE; Zullow, HJ; McKenzie, ZM; Kubiak, RL; Pierre, RS; Valencia, AM; Poynter, SJ; Cassel, SH; Ranish, JA; Kadoch, C				Mashtalir, Nazar; D'Avino, Andrew R.; Michel, Brittany C.; Luo, Jie; Pan, Joshua; Otto, Jordan E.; Zullow, Hayley J.; McKenzie, Zachary M.; Kubiak, Rachel L.; Pierre, Roodolph St.; Valencia, Alfredo M.; Poynter, Steven J.; Cassel, Seth H.; Ranish, Jeffrey A.; Kadoch, Cigall			Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes	CELL			English	Article							BAF COMPLEX; TRANSCRIPTION; SWI2/SNF2; PROTEINS; ROLES	Mammalian SWI/SNF (mSWI/SNF) ATP-dependent chromatin remodeling complexes are multi-subunit molecular machines that play vital roles in regulating genomic architecture and are frequently disrupted in human ca; and developmental disorders. To date, the modular organization and path- ways of assembly of these chromatin regulators remain unknown, presenting a major barrier to structural and functional determination. Here, we elucidate the architecture and assembly pathway across three classes of mSWI/SNF complexes-canonical BRG1/BRM-associated factor (BAF), polybromo-associated BAF (PBAF), and newly defined ncBAF complexes-and define the requirement of each subunit for complex formation and stability. Using affinity purification of endogenous complexes from mammalian and Drosophila cells coupled with cross-linking mass spectrometry (CX-MS) and mutagenesis, we uncover three distinct and evolutionailry conserved modules, their organization, and the temporal incorporation of these modules into each complete mSWI/SNF complex class. Finally, we map human disease-associated mutations within subunits and modules, defining specific topological regions that are affected upon subunit perturbation.	[Mashtalir, Nazar; D'Avino, Andrew R.; Michel, Brittany C.; Pan, Joshua; Otto, Jordan E.; Zullow, Hayley J.; McKenzie, Zachary M.; Kubiak, Rachel L.; Pierre, Roodolph St.; Valencia, Alfredo M.; Poynter, Steven J.; Cassel, Seth H.; Kadoch, Cigall] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Mashtalir, Nazar; D'Avino, Andrew R.; Michel, Brittany C.; Pan, Joshua; Otto, Jordan E.; Zullow, Hayley J.; McKenzie, Zachary M.; Kubiak, Rachel L.; Pierre, Roodolph St.; Valencia, Alfredo M.; Poynter, Steven J.; Cassel, Seth H.; Kadoch, Cigall] Harvard Med Sch, Boston, MA 02215 USA; [Mashtalir, Nazar; D'Avino, Andrew R.; Michel, Brittany C.; Pan, Joshua; Otto, Jordan E.; Zullow, Hayley J.; Pierre, Roodolph St.; Valencia, Alfredo M.; Poynter, Steven J.; Cassel, Seth H.; Kadoch, Cigall] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Michel, Brittany C.; Pan, Joshua; Zullow, Hayley J.; Cassel, Seth H.] Harvard Med Sch, Biol & Biomed Sci Grad Program, Boston, MA 02215 USA; [Luo, Jie; Ranish, Jeffrey A.] Inst Syst Biol, Seattle, WA 98109 USA; [Otto, Jordan E.; Pierre, Roodolph St.; Valencia, Alfredo M.; Poynter, Steven J.] Harvard Univ, Chem Biol Program, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Institute for Systems Biology (ISB); Harvard University	Kadoch, C (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.; Kadoch, C (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.; Kadoch, C (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	cigall_kadoch@dfci.harvard.edu		D'Avino, Andrew/0000-0002-8962-5175; Valencia, Alfredo/0000-0003-2432-9890; Luo, Jie/0000-0003-2815-2682; Pan, Joshua/0000-0002-7745-1497	NIH DP2 New Innovator Award [1DP2CA195762-01]; American Cancer Society Research Scholar Award [RSG-14-051-01-DMC]; Pew-Stewart Scholars in Cancer Research Grant; NIH [R01 GM110064, P50 GM076547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM110064] Funding Source: NIH RePORTER	NIH DP2 New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Award(American Cancer Society); Pew-Stewart Scholars in Cancer Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all members of the Kadoch laboratory for helpful discussions and advice. We thank Dr. Steven Gygi for very helpful advice and guidance pertaining to mass spectrometry experiments and all members of the Taplin Mass Spectrometry Facility (Harvard Medical School). We thank G. R. Crabtree and A. Gomez for human PBRM1 cDNA. This work was supported in part by awards from the NIH DP2 New Innovator Award 1DP2CA195762-01 (to C.K.), American Cancer Society Research Scholar Award RSG-14-051-01-DMC (to C.K.), the Pew-Stewart Scholars in Cancer Research Grant (to C.K.), NIH R01 GM110064 (to J.A.R.), and P50 GM076547 (to J.A.R).	Alpsoy A, 2018, J BIOL CHEM, V293, P3892, DOI 10.1074/jbc.RA117.001065; Bartholomew B, 2014, CURR OPIN STRUC BIOL, V24, P150, DOI 10.1016/j.sbi.2014.01.010; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bogershausen N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00252; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hohmann AF, 2016, NAT CHEM BIOL, V12, P672, DOI 10.1038/nchembio.2115; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Lopez AJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00100; Marom R, 2017, HUM MUTAT, V38, P1365, DOI 10.1002/humu.23282; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; Murawska M, 2011, TRANSCR-AUSTIN, V2, P244, DOI 10.4161/trns.2.6.17840; Nakayama RT, 2017, NAT GENET, V49, P1613, DOI 10.1038/ng.3958; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Priam P, 2017, NAT GENET, V49, P753, DOI 10.1038/ng.3812; Riffle M, 2016, J PROTEOME RES, V15, P2863, DOI 10.1021/acs.jproteome.6b00274; Sen P, 2017, CELL REP, V18, P2135, DOI 10.1016/j.celrep.2017.02.017; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Sokpor G, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00243; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu RC, 2014, CANCER BIOL THER, V15, P655, DOI 10.4161/cbt.28411; Xia X, 2016, NAT STRUCT MOL BIOL, V23, P722, DOI 10.1038/nsmb.3259; Yan L, 2017, J MOL BIOL, V429, P1650, DOI 10.1016/j.jmb.2017.04.008; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	43	266	273	9	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2018	175	5					1272	+		10.1016/j.cell.2018.09.032	http://dx.doi.org/10.1016/j.cell.2018.09.032			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HA5PX	30343899	Green Accepted, Bronze			2022-12-28	WOS:000450328800013
J	Gostin, LO				Gostin, Lawrence O.			Public Health Emergency Preparedness: Globalizing Risk, Localizing Threats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.	gostin@law.georgetown.edu							0	5	5	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1743	1744		10.1001/jama.2018.16491	http://dx.doi.org/10.1001/jama.2018.16491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398590	Green Published, Bronze			2022-12-28	WOS:000449461800003
J	Schendel, DE; Thorsteinsson, E				Schendel, Diana E.; Thorsteinsson, Erla			Cumulative Incidence of Autism Into Adulthood for Birth Cohorts in Denmark, 1980-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SPECTRUM DISORDER; PREVALENCE; CHILDREN		[Schendel, Diana E.; Thorsteinsson, Erla] Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res iPSYCH, Aarhus, Denmark	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Schendel, DE (corresponding author), Aarhus Univ, Dept Publ Hlth, Bartholins Alle 2,Bldg 1260, DK-8000 Aarhus C, Denmark.	diana.schendel@ph.au.dk	Romanova, Raisa/O-5724-2018	Schendel, Diana/0000-0002-8588-1227	European Commission Directorate-General for Health and Consumers Protection [SANCO/2014/C2/035]; Lundbeck Foundation (iPSYCH)	European Commission Directorate-General for Health and Consumers Protection; Lundbeck Foundation (iPSYCH)	This study was supported in part by a contract from the European Commission Directorate-General for Health and Consumers Protection (SANCO/2014/C2/035) and an unrestricted grant from the Lundbeck Foundation (iPSYCH).	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Xu GF, 2018, JAMA-J AM MED ASSOC, V319, P81, DOI 10.1001/jama.2017.17812	6	42	42	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1811	1813		10.1001/jama.2018.11328	http://dx.doi.org/10.1001/jama.2018.11328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398592	Green Published, Bronze			2022-12-28	WOS:000449461800020
J	Dyer, O				Dyer, Owen			US doctors criticise CDC's response to "mystery" polio-like disease in children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Barbare S, 2018, COLORADO DEP PUBLIC; Centers for Disease Control and Prevention, 2018, AFM INV; Cohen E, 2018, CNN; Karlamangla S., 2018, LOS ANGELES TIMES	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4633	10.1136/bmj.k4633	http://dx.doi.org/10.1136/bmj.k4633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385454				2022-12-28	WOS:000449565500012
J	Nordling, L				Nordling, Linda			THE CAPE OF CHANGE	NATURE			English	Editorial Material																			0	0	0	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S2	S3		10.1038/d41586-018-07205-3	http://dx.doi.org/10.1038/d41586-018-07205-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382229				2022-12-28	WOS:000448900900009
J	Perkel, JM				Perkel, Jeffrey M.			BY JUPYTER, IT ALL MAKES SENSE	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	124	123	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					145	146		10.1038/d41586-018-07196-1	http://dx.doi.org/10.1038/d41586-018-07196-1			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30375502				2022-12-28	WOS:000448900900064
J	Arie, S				Arie, Sophie			Yemen: charities can't agree on likelihood of famine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4574	10.1136/bmj.k4574	http://dx.doi.org/10.1136/bmj.k4574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381440				2022-12-28	WOS:000449564200010
J	Ehmke, H				Ehmke, Heimo			The mechanotransduction of blood pressure	SCIENCE			English	Editorial Material							BARORECEPTOR; CHANNELS; PIEZO2		[Ehmke, Heimo] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Ehmke, Heimo] German Ctr Cardiovasc Res, Deutsch Zentrum Herz Kreislaufforsch, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research	Ehmke, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany.; Ehmke, H (corresponding author), German Ctr Cardiovasc Res, Deutsch Zentrum Herz Kreislaufforsch, Hamburg, Germany.	ehmke@uke.de						Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Eckberg D, 1992, HUMAN BAROREFLEXES H; Freeman R, 2018, J AM COLL CARDIOL, V72, P1294, DOI 10.1016/j.jacc.2018.05.079; Lau OC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11947; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lohmeier TE, 2015, PHYSIOLOGY, V30, P148, DOI 10.1152/physiol.00035.2014; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Ma S, 2018, CELL, V173, P443, DOI 10.1016/j.cell.2018.02.047; Murthy SE, 2017, NAT REV MOL CELL BIO, V18, P771, DOI 10.1038/nrm.2017.92; Nonomura K, 2017, NATURE, V541, P176, DOI 10.1038/nature20793; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Sun H, 2009, J PHARMACOL EXP THER, V331, P851, DOI 10.1124/jpet.109.160473; Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324	13	3	4	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					398	399		10.1126/science.aav3495	http://dx.doi.org/10.1126/science.aav3495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361358				2022-12-28	WOS:000450441900029
J	Fairall, L; Cornick, R; Bateman, E				Fairall, Lara; Cornick, Ruth; Bateman, Eric			Empowering frontline providers to deliver universal primary healthcare using the Practical Approach to Care Kit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBERCULOSIS CASE DETECTION; ANTIRETROVIRAL TREATMENT; EDUCATIONAL OUTREACH; DEVELOPING-COUNTRIES; RANDOMIZED-TRIAL; DISEASE; NURSES		[Fairall, Lara; Cornick, Ruth; Bateman, Eric] Univ Cape Town, Lung Inst, Knowledge Translat Unit, Cape Town, South Africa; [Fairall, Lara; Cornick, Ruth; Bateman, Eric] Univ Cape Town, Dept Med, Cape Town, South Africa	University of Cape Town; University of Cape Town	Fairall, L (corresponding author), Univ Cape Town, Lung Inst, Knowledge Translat Unit, Cape Town, South Africa.; Fairall, L (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.	Lara.Fairall@uct.ac.za						Awotiwon A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001079; Bachmann MO, 2018, J THORAC DIS, V10, P4667, DOI 10.21037/jtd.2018.07.34; Cornick R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001088; Cornick R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000962; Das J, 2018, BMJ-BRIT MED J, V361, P1716; English M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001991; Fairall L, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2517-7; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairall L, 2010, TROP MED INT HEALTH, V15, P277, DOI 10.1111/j.1365-3156.2009.02455.x; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fairall LR, 2017, SAMJ S AFR MED J, V107, P278, DOI [10.7196/SAMJ.2017.v107i4.12413, 10.7196/samj.2017.v107i4.12413]; Fairall LR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002178; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Feyissa YM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001108; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; Ivers N, 2014, CAN FAM PHYSICIAN, V60, P258; Murdoch J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000945; Nelson EAS, 2004, ANN TROP PAEDIATR, V24, P117, DOI 10.1179/027249304225013394; Petersen I, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2518-6; Picken S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000957; Simelane ML, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001124; Sodhi S, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S11; South African National Department of Health, 2018, FIN ID CLIN MAN; Stein J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-240; Tsima BM, 2016, J MULTIDISCIP HEALTH, V9, DOI 10.2147/JMDH.S112466; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wattrus C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001016; World Health Organization, 2017, TRACK UN HLTH CONV 2; World Health Organization, 2017, ESSE MED LIST; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	33	6	6	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4451	10.1136/bmj.k4451	http://dx.doi.org/10.1136/bmj.k4451			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355721	Green Published, hybrid			2022-12-28	WOS:000448895300012
J	Kmietowicz, Z				Kmietowicz, Zosia			ACE inhibitors are linked to increased lung cancer risk, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cronin-Fenton D, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4337; Hicks BM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4209	2	2	2	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4471	10.1136/bmj.k4471	http://dx.doi.org/10.1136/bmj.k4471			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355572				2022-12-28	WOS:000448895300016
J	Fan, VY; Bloom, DE; Ogbuoji, O; Prettner, K; Yamey, G				Fan, Victoria Y.; Bloom, David E.; Ogbuoji, Osondu; Prettner, Klaus; Yamey, Gavin			Valuing health as development: going beyond gross domestic product	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fan, Victoria Y.] Univ Hawaii Manoa, Myron B Thompson Sch Social Work, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Bloom, David E.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Ogbuoji, Osondu; Yamey, Gavin] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Prettner, Klaus] Univ Hohenheim, Stuttgart, Germany	University of Hawaii System; University of Hawaii Manoa; Harvard University; Harvard T.H. Chan School of Public Health; Duke University; University Hohenheim	Yamey, G (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	gavin.yamey@duke.edu	Fan, Victoria/AGG-4359-2022	Fan, Victoria/0000-0001-7755-9425; Prettner, Klaus/0000-0002-8971-8750	Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; Bill and Melinda Gates Foundation [OPP1151682]; Harvard University; University of Washington; Qatar Foundation; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard University; University of Washington(University of Washington); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We have read and understood BMJ policy on declaration of interests. GY declares that he was a member of the Lancet Commission on Investing in Health, discussed in this article; the commission was funded by the Norwegian Agency for Development Cooperation, the United Kingdom Department for International Development, the Bill and Melinda Gates Foundation, Harvard University, and the University of Washington. GY also declares that he was a member of the Investing in Health Forum at the 2016 World Innovation Summit for Health, funded by the Qatar Foundation. GY and OO were supported by a grant from the Bill and Melinda Gates Foundation [OPP1151682].	Anand S, 1994, HUMAN DEV INDEX METH; Anand S, 2008, J ECON LIT, V46, P57, DOI 10.1257/jel.46.1.57; [Anonymous], 2000, DEV FREEDOM; [Anonymous], 2017, PERS WELLB UK APR 20; [Anonymous], 2016, ECONOMIST; Berrett D., 2011, CHRON HIGH ED; Center for Bhutan Studies and GNH Research, COMP JUST HARM SOC 2; Dickinson E. GDP, 2011, FOREIGN POLICY; Dorji T., 2012, BUSINESS BHUTAN  JUN; Fitoussi J-P, 2009, REPORT COMMISSION ME; Jamison D, 2016, INVESTING HLTH ECONO; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jones CI, 2016, AM ECON REV, V106, P2426, DOI 10.1257/aer.20110236; Karlan D, 2016, MANAGE SCI, V62, P3393, DOI 10.1287/mnsc.2015.2296; Kennedy RF, 1968, KENNEDY SPEECHES REM; Kim JY, 2013, LANCET, V382, pE33, DOI 10.1016/S0140-6736(13)62374-0; Kuznets S., 1962, NEW REPUBLIC, V20, P21; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; Manyika J, 2015, CAN LONG TERM GLOBAL; Mutikani L., 2018, REUTERS; Nordhaus WD, 2002, HLTH NATIONS CONTRIB, DOI [10.3386/w8818, DOI 10.3386/W8818]; Oxford Poverty and Human Development Initiative, BHUT GROSS NAT HAPP; Ravallion M., MASHUP INDICES DEV; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Stiglitz J., 2010, MIS MEASURING OUR LI; ul Haq M., READINGS HUMAN DEV; United Nations Development Programme, 2016, TECHN NOT HUM DEV RE; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257	28	6	6	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4371	10.1136/bmj.k4371	http://dx.doi.org/10.1136/bmj.k4371			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8PE	30352788	hybrid, Green Published			2022-12-28	WOS:000448893800001
J	Dyer, C				Dyer, Clare			Law on gross negligence manslaughter is flawed, says leading medical lawyer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department of Health and Social Care, 2018, WILL REV GROSS NEGL; DYER C, 2018, BMJ-BRIT MED J, V361, P91484, DOI DOI 10.1136/BMJ.K2572; Dyer C, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3612; Dyer C, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3510	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4412	10.1136/bmj.k4412	http://dx.doi.org/10.1136/bmj.k4412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337429				2022-12-28	WOS:000448270700010
J	Coll-Seck, A; Clark, H; Bahl, R; Peterson, S; Costello, A; Lucas, T				Coll-Seck, Awa; Clark, Helen; Bahl, Rajiv; Peterson, Stefan; Costello, Anthony; Lucas, Tamara			Framing an agenda for children thriving in the SDG era: a WHO-UNICEF-Lancet Commission on Child Health and Wellbeing	LANCET			English	Editorial Material									[Coll-Seck, Awa] Minist State, Dakar, Senegal; [Clark, Helen] Helen Clark Fdn, Auckland, New Zealand; [Bahl, Rajiv] WHO, Maternal Newborn Child & Adolescent Hlth Dept, Geneva, Switzerland; [Peterson, Stefan] United Nations Childrens Fund, New York, NY USA; [Costello, Anthony] Inst Global Hlth, London WC1N 1EH, England; [Lucas, Tamara] The Lancet, London, England	World Health Organization; UNICEF	Costello, A (corresponding author), Inst Global Hlth, London WC1N 1EH, England.	anthony.costello@ucl.ac.uk			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Black MM, 2017, LANCET, V389, P77, DOI 10.1016/S0140-6736(16)31389-7; Costello A, 2016, GRAND CONVERGENCE CH; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Hazel E, 2016, AM J TROP MED HYG, V94, P568, DOI 10.4269/ajtmh.94-3intro1; Temmerman M, 2015, BMJ-BRIT MED J, V351; UNICEF, 2017, GLOB NUTR REP 2017 N; UNICEF  WHO  World Bank  and UN DESA/Population Division, 2015, LEVELS TRENDS CHILD; United Nations, 2017, SUSTAINABLE DEV GOAL; World Health Organization, 2017, INH SUST WORLD ATL C	9	12	12	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2019	393	10167					109	112		10.1016/S0140-6736(18)32821-6	http://dx.doi.org/10.1016/S0140-6736(18)32821-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HH0VD	30396513	Bronze			2022-12-28	WOS:000455437100007
J	Moore, K; Colombo, N; Scambia, G; Kim, BG; Oaknin, A; Friedlander, M; Lisyanskaya, A; Floquet, A; Leary, A; Sonke, GS; Gourley, C; Banerjee, S; Oza, A; Gonzalez-Martin, A; Aghajanian, C; Bradley, W; Mathews, C; Liu, J; Lowe, ES; Bloomfield, R; DiSilvestro, P				Moore, K.; Colombo, N.; Scambia, G.; Kim, B. -G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A.; Gonzalez-Martin, A.; Aghajanian, C.; Bradley, W.; Mathews, C.; Liu, J.; Lowe, E. S.; Bloomfield, R.; DiSilvestro, P.			Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; THERAPY; BEVACIZUMAB; CARCINOMA	BACKGROUND Most women with newly diagnosed advanced ovarian cancer have a relapse within 3 years after standard treatment with surgery and platinum-based chemotherapy. The benefit of the oral poly(adenosine diphosphate-ribose) polymerase inhibitor olaparib in relapsed disease has been well established, but the benefit of olaparib as maintenance therapy in newly diagnosed disease is uncertain. METHODS We conducted an international, randomized, double-blind, phase 3 trial to evaluate the efficacy of olaparib as maintenance therapy in patients with newly diagnosed advanced (International Federation of Gynecology and Obstetrics stage III or IV) high-grade serous or endometrioid ovarian cancer, primary peritoneal cancer, or fallopian-tube cancer (or a combination thereof) with a mutation in BRCA1, BRCA2, or both (BRCA1/2) who had a complete or partial clinical response after platinumbased chemotherapy. The patients were randomly assigned, in a 2:1 ratio, to receive olaparib tablets (300 mg twice daily) or placebo. The primary end point was progression-free survival. RESULTS Of the 391 patients who underwent randomization, 260 were assigned to receive olaparib and 131 to receive placebo. A total of 388 patients had a centrally confirmed germline BRCA1/2 mutation, and 2 patients had a centrally confirmed somatic BRCA1/2 mutation. After a median follow-up of 41 months, the risk of disease progression or death was 70% lower with olaparib than with placebo (Kaplan-Meier estimate of the rate of freedom from disease progression and from death at 3 years, 60% vs. 27%; hazard ratio for disease progression or death, 0.30; 95% confidence interval, 0.23 to 0.41; P<0.001). Adverse events were consistent with the known toxic effects of olaparib. CONCLUSIONS The use of maintenance therapy with olaparib provided a substantial benefit with regard to progression-free survival among women with newly diagnosed advanced ovarian cancer and a BRCA1/2 mutation, with a 70% lower risk of disease progression or death with olaparib than with placebo.	[Moore, K.] Univ Oklahoma, Stephenson Canc Ctr, 800 NE 10th St, Oklahoma City, OK 73104 USA; [Colombo, N.] Univ Milano Bicocca, European Inst Oncol, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Scambia, G.] Fdn Policlin Univ A Gemelli IRCCS Univ Cattolica, Rome, Italy; [Kim, B. -G.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Oaknin, A.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain; [Gonzalez-Martin, A.] MD Anderson Canc Ctr Madrid, Madrid, Spain; [Friedlander, M.] Univ New South Wales, Sch Clin, Prince Wales Hosp, Randwick, NSW, Australia; [Lisyanskaya, A.] St Petersburg City Oncol Dispensary, St Petersburg, Russia; [Floquet, A.; Leary, A.] Grp Invest Nationaux Etud Canc Ovariens, Paris, France; [Floquet, A.] Inst Bergonie, Comprehens Canc Ctr, Bordeaux, France; [Leary, A.] Gustave Roussy Canc Campus, Villejuif, France; [Sonke, G. S.] Netherlands Canc Inst, Amsterdam, Netherlands; [Gourley, C.] Univ Edinburgh, Inst Genet & Mol Med, Canc Res UK Edinburgh Ctr, Edinburgh, Midlothian, Scotland; [Banerjee, S.] Royal Marsden NHS Fdn Trust, London, England; [Banerjee, S.] Inst Canc Res, London, England; [Bloomfield, R.] AstraZeneca, Cambridge, England; [Oza, A.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Aghajanian, C.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Bradley, W.] Froedtert & Med Coll Wisconsin, Milwaukee, WI USA; [Mathews, C.; DiSilvestro, P.] Women & Infants Hosp Rhode Isl, Providence, RI USA; [Liu, J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lowe, E. S.] AstraZeneca, Gaithersburg, MD USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS European Institute of Oncology (IEO); University of Milano-Bicocca; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sungkyunkwan University (SKKU); Samsung Medical Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); University of Texas System; UTMD Anderson Cancer Center; University of New South Wales Sydney; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; Netherlands Cancer Institute; University of Edinburgh; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Memorial Sloan Kettering Cancer Center; Women & Infants Hospital Rhode Island; Harvard University; Dana-Farber Cancer Institute; AstraZeneca	Moore, K (corresponding author), Univ Oklahoma, Stephenson Canc Ctr, 800 NE 10th St, Oklahoma City, OK 73104 USA.	kathleen-moore@ouhsc.edu	Pereira, Rodrigo Perez/U-6223-2019; Colombo, Nicoletta/AAB-8319-2019; de Azevedo, Sergio Jobim/P-5115-2015; Miquel, Josep Maria/AAG-3508-2019; Lisyanskaya, Alla/CAG-2889-2022; Martín, Antonio González/AAC-5935-2020	Lisyanskaya, Alla/0000-0002-4495-9681; Martín, Antonio González/0000-0001-8376-9576; Oza, Amit/0000-0002-9510-8641; OAKNIN, ANA/0000-0002-3592-7194; Banerjee, Susana/0000-0002-8840-7934; Sonke, Gabe/0000-0001-8088-9628; friedlander, michael/0000-0003-3090-795X	AstraZeneca; Merck	AstraZeneca(AstraZeneca); Merck(Merck & Company)	Supported by AstraZeneca and Merck.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; AstraZeneca, 2016, GLOB POL BIOETH; AstraZeneca, 2018, LYNP OL TABL OR US P; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Coleman RL, 2017, LANCET, V390, P1949, DOI 10.1016/S0140-6736(17)32440-6; Gourley C, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.5533; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Ledermann JA, 2016, LANCET ONCOL, V17, P1579, DOI 10.1016/S1470-2045(16)30376-X; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Norquist BM, 2018, CLIN CANCER RES, V24, P777, DOI 10.1158/1078-0432.CCR-17-1327; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Osoba D, 2005, EUR J CANCER, V41, P280, DOI 10.1016/j.ejca.2004.10.017; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pujade-Lauraine E, 2017, LANCET ONCOL, V18, P1274, DOI 10.1016/S1470-2045(17)30469-2; Rodon J, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.12011	15	1212	1255	15	144	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2018	379	26					2495	2505		10.1056/NEJMoa1810858	http://dx.doi.org/10.1056/NEJMoa1810858			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HF6MK	30345884	Green Published, Bronze			2022-12-28	WOS:000454351100005
J	Hu, HM; Mu, QH; Bao, ZS; Chen, YY; Liu, YW; Chen, J; Wang, KY; Wang, Z; Nam, Y; Jiang, BB; Sa, JK; Cho, HJ; Her, NG; Zhang, CB; Zhao, Z; Zhang, Y; Zeng, F; Wu, F; Kang, X; Liu, YQ; Qian, ZH; Wang, ZL; Huang, RY; Wang, QW; Zhang, W; Qiu, XG; Li, WB; Nam, DH; Fan, XL; Wang, JG; Jiang, T				Hu, Huimin; Mu, Quanhua; Bao, Zhaoshi; Chen, Yiyun; Liu, Yanwei; Chen, Jing; Wang, Kuanyu; Wang, Zheng; Nam, Yoonhee; Jiang, Biaobin; Sa, Jason K.; Cho, Hee-Jin; Her, Nam-Gu; Zhang, Chuanbao; Zhao, Zheng; Zhang, Ying; Zeng, Fan; Wu, Fan; Kang, Xun; Liu, Yuqing; Qian, Zenghui; Wang, Zhiliang; Huang, Ruoyu; Wang, Qiangwei; Zhang, Wei; Qiu, Xiaoguang; Li, Wenbin; Nam, Do-Hyun; Fan, Xiaolong; Wang, Jiguang; Jiang, Tao			Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor	CELL			English	Article							RNA-SEQ; GENOMIC CHARACTERIZATION; REVEALS; EVOLUTION; GLIOMAS; GENE; CHEMORESISTANCE; ARCHITECTURE; PROGRESSION; ACTIVATION	Low-grade gliomas almost invariably progress into secondary glioblastoma (sGBM) with limited therapeutic option and poorly understood mechanism. By studying the mutational landscape of 188 sGBMs, we find significant enrichment of TP53 mutations, somatic hypermutation, MET-exon-14-skipping (METex14), PTPRZ1-MET (ZM) fusions, and MET amplification. Strikingly, METex14 frequently co-occurs with ZM fusion and is present in similar to 14% of cases with significantly worse prognosis Subsequent studies show that METex14 promotes glioma progression by prolonging MET activity. Furthermore, we describe a MET kinase inhibitor, PLB-1001, that demonstrates remarkable potency in selectively inhibiting MET-altered tumor cells in pre-clinical models. Importantly, this compound also shows blood-brain barrier permeability and is subsequently applied in a phase I clinical trial that enrolls MET-altered chemo-resistant glioma patients. Encouragingly, PLB-1001 achieves partial response in at least two advanced sGBM patients with rarely significant side effects, underscoring the clinical potential for precisely treating gliomas using this therapy.	[Hu, Huimin; Bao, Zhaoshi; Liu, Yanwei; Chen, Jing; Wang, Kuanyu; Wang, Zheng; Zhao, Zheng; Zhang, Ying; Zeng, Fan; Wu, Fan; Liu, Yuqing; Qian, Zenghui; Wang, Zhiliang; Huang, Ruoyu; Wang, Qiangwei; Jiang, Tao] Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Mu, Quanhua; Jiang, Biaobin; Wang, Jiguang] Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Hong Kong, Peoples R China; [Chen, Yiyun; Nam, Yoonhee; Jiang, Biaobin; Wang, Jiguang] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Bao, Zhaoshi; Zhang, Chuanbao; Zhang, Wei; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Liu, Yanwei; Qiu, Xiaoguang] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiotherapy, Beijing 100050, Peoples R China; [Kang, Xun; Li, Wenbin] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100050, Peoples R China; [Fan, Xiaolong] Beijing Normal Univ, Lab Neurosci & Brain Dev, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Jiang, Tao] Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing 100069, Peoples R China; [Jiang, Tao] China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China; [Sa, Jason K.; Cho, Hee-Jin; Her, Nam-Gu; Nam, Do-Hyun] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Mu, Quanhua; Chen, Yiyun; Wang, Jiguang] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Biaobin] Hong Kong Univ Sci & Technol, Inst Adv Study, Hong Kong, Hong Kong, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Capital Medical University; Capital Medical University; Capital Medical University; Beijing Normal University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Jiang, T (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing 100050, Peoples R China.; Wang, JG (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Hong Kong, Peoples R China.; Wang, JG (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.; Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China.; Fan, XL (corresponding author), Beijing Normal Univ, Lab Neurosci & Brain Dev, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.; Jiang, T (corresponding author), Beijing Inst Brain Disorders, Ctr Brain Tumor, Beijing 100069, Peoples R China.; Jiang, T (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China.; Jiang, T (corresponding author), Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea.; Wang, JG (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Hong Kong, Hong Kong, Peoples R China.	xfan@bnu.edu.cn; jgwang@ust.hk; taojiang1964@163.com	WU, FAN/GRX-1654-2022; Wang, Peng/GLS-8034-2022; jiang, tao/GWC-7108-2022; Her, Nam-Gu/AGY-5470-2022; Wang, Jiguang/B-2717-2012	Wang, Qiang-Wei/0000-0002-7308-049X; Sa, Jason Kyungha/0000-0002-3251-5004; Wang, Jiguang/0000-0002-6923-4097; Jiang, Biaobin/0000-0002-9995-4925; Chen, Yiyun/0000-0003-3886-2100	National Key Research and Development Plan [2016YFC0902500]; Natural Science Foundation of China (NSFC)/Research Grants Council (RGC), Hong Kong, China Joint Research Scheme [81761168038, N_HKUST606/17]; National Natural Science Foundation of China [81502495, 81502606, 81702460]; Capital Foundation of Medical Developments [2016-1-1072]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201708]; Beijing Nova Program [Z171100001117022]; Beijing Administration of Hospitals' Youth Program [QML20160502]; Collaborative Research Fund (CRF), Hong Kong [C6002-17GF]; Hong Kong Epigenomics Project [LKCCFL18SC01-E]; Korea Health Technology R&D project through KHIDI - Ministry of Health & Welfare, Republic of Korea [HI14C3418]; BDBI Lab	National Key Research and Development Plan; Natural Science Foundation of China (NSFC)/Research Grants Council (RGC), Hong Kong, China Joint Research Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Foundation of Medical Developments; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Administration of Hospitals' Youth Program; Collaborative Research Fund (CRF), Hong Kong; Hong Kong Epigenomics Project; Korea Health Technology R&D project through KHIDI - Ministry of Health & Welfare, Republic of Korea; BDBI Lab	This work is a pilot study from the Chinese Glioma Genome Atlas (CGGA) and Asian Glioma Genome Atlas (AGGA) Research Networks. The authors would like to especially thank all contributors to CGGA and AGGA. The authors thank Dr. Fei Sun from HKUST for helpful comments and acknowledge TCGA research network, Gregory M. Kiez and Mehmet Kutman Foundation, and the Yale University Department of Neurosurgery for providing access to sequencing data. This work was supported by grants from National Key Research and Development Plan (2016YFC0902500); Natural Science Foundation of China (NSFC)/Research Grants Council (RGC), Hong Kong, China Joint Research Scheme (81761168038 to T.J. and N_HKUST606/17 to J.W.); National Natural Science Foundation of China (81502495, 81502606, and 81702460); Capital Foundation of Medical Developments (2016-1-1072); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201708); Beijing Nova Program (Z171100001117022); and Beijing Administration of Hospitals' Youth Program (QML20160502). J.W. was also supported by Collaborative Research Fund (CRF), Hong Kong (C6002-17GF); Hong Kong Epigenomics Project (LKCCFL18SC01-E); and HKUST start-up and initiation grants and received substantial support from BDBI Lab. D.-H.N. was supported by the grant of Korea Health Technology R&D project through KHIDI funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3418).	Abate F, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0097-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bai H, 2016, NAT GENET, V48, P59, DOI 10.1038/ng.3457; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Bender S, 2016, NAT MED, V22, P1314, DOI 10.1038/nm.4204; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Huang MG, 2016, J CLIN INVEST, V126, P1801, DOI 10.1172/JCI84876; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lai AZ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004839; Lee JK, 2018, NAT GENET, V50, P1399, DOI 10.1038/s41588-018-0209-6; Lee JK, 2017, NAT GENET, V49, P594, DOI 10.1038/ng.3806; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21141; Liu XW, 2016, J CLIN ONCOL, V34, P794, DOI 10.1200/JCO.2015.62.0674; Liu YW, 2014, ONCOTARGET, V5, P12593, DOI 10.18632/oncotarget.2518; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mazor T, 2017, P NATL ACAD SCI USA, V114, P10743, DOI 10.1073/pnas.1708914114; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vigna E, 1999, ONCOGENE, V18, P4275, DOI 10.1038/sj.onc.1202791; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zeng AL, 2017, ONCOGENE, V36, P5369, DOI 10.1038/onc.2017.134; Zhang YW, 2002, ONCOGENE, V21, P217, DOI 10.1038/sj/onc/1205004	50	142	154	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	2018	175	6					1665	+		10.1016/j.cell.2018.09.038	http://dx.doi.org/10.1016/j.cell.2018.09.038			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HC4KG	30343896	Bronze			2022-12-28	WOS:000451771700023
J	Azoulay, E; Lemiale, V; Mokart, D; Nseir, S; Argaud, L; Pene, F; Kontar, L; Bruneel, F; Klouche, K; Barbier, F; Reignier, J; Berrahil-Meksen, L; Louis, G; Constantin, JM; Mayaux, J; Wallet, F; Kouatchet, A; Peigne, V; Theodose, I; Perez, P; Girault, C; Jaber, S; Oziel, J; Nyunga, M; Terzi, N; Bouadma, L; Lebert, C; Lautrette, A; Bige, N; Raphalen, JH; Papazian, L; Darmon, M; Chevret, S; Demoule, A				Azoulay, Elie; Lemiale, Virginie; Mokart, Djamel; Nseir, Saad; Argaud, Laurent; Pene, Frederic; Kontar, Loay; Bruneel, Fabrice; Klouche, Kada; Barbier, Francois; Reignier, Jean; Berrahil-Meksen, Lilia; Louis, Guillaume; Constantin, Jean-Michel; Mayaux, Julien; Wallet, Florent; Kouatchet, Achille; Peigne, Vincent; Theodose, Igor; Perez, Pierre; Girault, Christophe; Jaber, Samir; Oziel, Johanna; Nyunga, Martine; Terzi, Nicolas; Bouadma, Lila; Lebert, Christine; Lautrette, Alexandre; Bige, Naike; Raphalen, Jean-Herle; Papazian, Laurent; Darmon, Michael; Chevret, Sylvie; Demoule, Alexandre			Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure The HIGH Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; NONINVASIVE VENTILATION; CANNULA OXYGEN; HYPOXEMIC PATIENTS; THERAPY; INTUBATION; PREOXYGENATION; HEMATOLOGY; DISTRESS; SURGERY	IMPORTANCE High-flow nasal oxygen therapy is increasingly used for acute hypoxemic respiratory failure (AHRF). OBJECTIVE To determine whether high-flow oxygen therapy decreases mortality among immunocompromised patients with AHRF compared with standard oxygen therapy. DESIGN, SETTING, AND PARTICIPANTS The HIGH randomized clinical trial enrolled 776 adult immunocompromised patients with AHRF (PaO2 < 60mmHg or SpO(2) < 90% on room air, or tachypnea > 30/min or labored breathing or respiratory distress, and need for oxygen < 6 L/min) at 32 intensive care units (ICUs) in France between May 19, 2016, and December 31, 2017. INTERVENTIONS Patients were randomized 1: 1 to continuous high-flow oxygen therapy (n = 388) or to standard oxygen therapy (n = 388). MAIN OUTCOMES AND MEASURES The primary outcomewas day-28 mortality. Secondary outcomes included intubation and mechanical ventilation by day 28, PaO2: FIO2 ratio over the 3 days after intubation, respiratory rate, ICU and hospital lengths of stay, ICU-acquired infections, and patient comfort and dyspnea. RESULTS Of 778 randomized patients (median age, 64 [IQR, 54-71] years; 259 [33.3%] women), 776 (99.7%) completed the trial. At randomization, median respiratory rate was 33/min (IQR, 28-39) vs 32 (IQR, 27-38) and PaO2: FIO2 was 136 (IQR, 96-187) vs 128 (IQR, 92-164) in the intervention and control groups, respectively. Median SOFA score was 6 (IQR, 4-8) in both groups. Mortality on day 28 was not significantly different between groups (35.6% vs 36.1%; difference, -0.5%[95% CI, -7.3% to + 6.3%]; hazard ratio, 0.98 [95% CI, 0.77 to 1.24]; P =.94). Intubation rate was not significantly different between groups (38.7% vs 43.8%; difference, -5.1% [95% CI, -12.3% to + 2.0%]). Compared with controls, patients randomized to high-flow oxygen therapy had a higher PaO2: FIO2 (150 vs 119; difference, 19.5 [95% CI, 4.4 to 34.6]) and lower respiratory rate after 6 hours (25/min vs 26/min; difference, -1.8/min [95% CI, -3.2 to -0.2]). No significant difference was observed in ICU length of stay (8 vs 6 days; difference, 0.6 [95% CI, -1.0 to + 2.2]), ICU-acquired infections (10.0% vs 10.6%; difference, -0.6%[95% CI, -4.6 to + 4.1]), hospital length of stay (24 vs 27 days; difference, -2 days [95% CI, -7.3 to + 3.3]), or patient comfort and dyspnea scores. CONCLUSIONS AND RELEVANCE Among critically ill immunocompromised patients with acute respiratory failure, high-flow oxygen therapy did not significantly decrease day-28 mortality compared with standard oxygen therapy.	[Azoulay, Elie; Lemiale, Virginie; Theodose, Igor; Chevret, Sylvie] Hop St Louis, AP HP, Med Intens Care Unit, 1 Ave Claude Vellefaux, F-75010 Paris, France; [Azoulay, Elie; Lemiale, Virginie; Theodose, Igor; Chevret, Sylvie] Hop St Louis, AP HP, Dept Biostat, Paris, France; [Mokart, Djamel] Paoli Calmettes Inst, Intens Care Unit, Marseille, France; [Nseir, Saad] CHU Lille, Crit Care Ctr, Lille, France; [Argaud, Laurent] Hop Edouard Herriot, Med Intens Care Unit, Hosp Civils Lyon, Lyon, France; [Pene, Frederic] Univ Paris 05, Hop Cochin, AP HP, Med Intens Care Unit, Paris, France; [Kontar, Loay] Amiens Univ Hosp, Med Intens Care Unit, INSERM, U1088, Amiens, France; [Bruneel, Fabrice] Andre Mignot Hosp, Med Intens Care Unit, Versailles, France; [Klouche, Kada] CHU Montpellier, Med Intens Care Unit, Montpellier, France; [Barbier, Francois] CHR Orleans, La Source Hosp, Med Intens Care Unit, Orleans, France; [Reignier, Jean] CHU Nantes, Med Intens Care Unit, Hotel Dieu, Nantes, France; [Berrahil-Meksen, Lilia] Inst Gustave Roussy, Intens Care Unit, Villejuif, France; [Louis, Guillaume] CHR Metz Thionville, Intens Care Unit, Metz, France; [Constantin, Jean-Michel] CHU Clermont Ferrand, Dept Perioperat Med, Clermont Ferrand, France; [Mayaux, Julien; Demoule, Alexandre] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Med Intens Care Unit & Resp Div, Paris, France; [Wallet, Florent] Lyon Sud Med Ctr, Intens Care Unit, Lyon, France; [Kouatchet, Achille] CHRU, Med Intens Care Unit, Angers, France; [Peigne, Vincent] Ctr Hosp Metropole Savoie, Intens Care Unit, Chambery, France; [Perez, Pierre] Hop Brabois, Med Intens Care Unit, Vandoeuvre Les Nancy, France; [Girault, Christophe] Hop Charles Nicolle, Med Intens Care Unit, Rouen, France; [Jaber, Samir] Montpellier Univ Hosp, PhyMedExp, INSERM U 1046, CNRS 34295, Montpellier, France; [Oziel, Johanna] Avicenne Univ Hosp, Med Intens Care Unit, Bobigny, France; [Nyunga, Martine] Roubaix Hosp, Intens Care Unit, Roubaix, France; [Terzi, Nicolas] CHU Grenoble Alpes, Med Intens Care Unit, Grenoble, France; [Bouadma, Lila] CHU Bichat, Med Intens Care Unit, Paris, France; [Lebert, Christine] Ctr Hosp, Intens Care Unit, Dept Les Oudairies, La Roche Sur Yon, France; [Lautrette, Alexandre] Gabriel Montpied Univ Hosp, Med Intens Care Unit, Clermont Ferrand, France; [Bige, Naike] CHU St Antoine, Med Intens Care Unit, Paris, France; [Raphalen, Jean-Herle] Hop Necker Enfants Malad, Dept Anesthesia & Crit Care, Paris, France; [Papazian, Laurent] Aix Marseille Univ, Fac Med, Hop Nord, AP HP,Reanimat Detresses Resp & Infect, Marseille, France; [Darmon, Michael] Hop Cochin, Resp Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); Universite de Lille - ISITE; CHU Lille; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Centre Hospitalier de Versailles; Universite de Montpellier; CHU de Montpellier; Centre Hospitalier Regional d'Orleans; Nantes Universite; CHU de Nantes; UNICANCER; Gustave Roussy; CHR Metz-Thionville; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de Nancy; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHD Vendee; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Azoulay, E (corresponding author), Hop St Louis, AP HP, Med Intens Care Unit, 1 Ave Claude Vellefaux, F-75010 Paris, France.; Azoulay, E (corresponding author), Hop St Louis, AP HP, Dept Biostat, Paris, France.	elie.azoulay@aphp.fr	Louis, Guillaume/AAF-4340-2021; Carmen, Team3/Y-7384-2019; TERZI, Nicolas/AAD-4348-2019; Demoule, Alexandre/ABG-4915-2021	Louis, Guillaume/0000-0002-4208-8122; Carmen, Team3/0000-0002-3614-0924; TERZI, Nicolas/0000-0003-4036-6245; Demoule, Alexandre/0000-0002-0432-7217; wallet, florent/0000-0003-3174-6246; Lab, Carmen/0000-0002-5935-3236	French Ministry of Health [P150912 HIGH]	French Ministry of Health	All financial support for this study was provided by the French Ministry of Health (P150912 HIGH). Supplies for high-flow oxygen therapy were provided by Fisher & Paykel France.	Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Azoulay E, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2492-z; Azoulay E, 2017, INTENS CARE MED, V43, P1808, DOI 10.1007/s00134-017-4947-1; Azoulay E, 2015, BLOOD REV, V29, P359, DOI 10.1016/j.blre.2015.04.002; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Azoulay E, 2010, AM J RESP CRIT CARE, V182, P1038, DOI 10.1164/rccm.201001-0018OC; Bellani G, 2017, AM J RESP CRIT CARE, V195, P67, DOI 10.1164/rccm.201606-1306OC; Brainard J, 2017, J CRIT CARE, V40, P225, DOI 10.1016/j.jcrc.2017.04.023; Canet E, 2011, CRIT CARE, V15, DOI 10.1186/cc10091; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Corley A, 2015, INTENS CARE MED, V41, P887, DOI 10.1007/s00134-015-3765-6; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Frat JP, 2016, LANCET RESP MED, V4, P646, DOI 10.1016/S2213-2600(16)30093-5; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Futier E, 2016, INTENS CARE MED, V42, P1888, DOI 10.1007/s00134-016-4594-y; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Harpaz R, 2016, JAMA-J AM MED ASSOC, V316, P2547, DOI 10.1001/jama.2016.16477; Hernandez G, 2016, JAMA-J AM MED ASSOC, V315, P1354, DOI 10.1001/jama.2016.2711; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Israni AK, 2018, AM J TRANSPLANT, V18, P434, DOI 10.1111/ajt.14563; Jaber S, 2016, INTENS CARE MED, V42, P1877, DOI 10.1007/s00134-016-4588-9; Jones PG, 2016, RESP CARE, V61, P291, DOI 10.4187/respcare.04252; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lemiale Virginie, 2017, Crit Care Med, V45, pe274, DOI 10.1097/CCM.0000000000002085; Lemiale V, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1097-0; Lemiale V, 2015, JAMA-J AM MED ASSOC, V314, P1711, DOI 10.1001/jama.2015.12402; Ruan PK, 2008, STAT MED, V27, P5709, DOI 10.1002/sim.3402; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Simon M, 2016, RESP CARE, V61, P1160, DOI 10.4187/respcare.04413; STEPHAN F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI [DOI 10.1001/JAMA.2015.5213, 10.1001/jama.2015.5213]; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vourc'h M, 2015, INTENS CARE MED, V41, P1538, DOI 10.1007/s00134-015-3796-z; Weyand CM, 2014, NEW ENGL J MED, V371, P1653, DOI [10.1056/NEJMcp1214825, 10.1056/NEJMc1409206]	34	140	146	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2099	2107		10.1001/jama.2018.14282	http://dx.doi.org/10.1001/jama.2018.14282			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30357270	Green Published, Bronze			2022-12-28	WOS:000451395000017
J	Hu, FB; Willett, WC				Hu, Frank B.; Willett, Walter C.			Current and Future Landscape of Nutritional Epidemiologic Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hu, Frank B.; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA; [Hu, Frank B.; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hu, Frank B.; Willett, Walter C.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hu, FB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	fhu@hsph.harvard.edu			National Institutes of Health [HL60712, HL118264, DK112940]; California Walnut Commission	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Walnut Commission	Dr Hu's research is funded by National Institutes of Health grants HL60712, HL118264, and DK112940. He reported receiving research support from the California Walnut Commission and personal fees from Standard Process, Diet Quality Photo Navigation, and Metagenics. No other disclosures were reported.	Cornelis Marilyn C, 2013, Curr Nutr Rep, V2, DOI 10.1007/s13668-013-0052-4; Jacobson MF, 2018, JAMA-J AM MED ASSOC, V320, P341, DOI 10.1001/jama.2018.7434; Millen BE, 2016, ADV NUTR, V7, P438, DOI 10.3945/an.116.012120; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Wang DD, 2018, LANCET DIABETES ENDO, V6, P416, DOI 10.1016/S2213-8587(18)30037-8; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640; Yuan CZ, 2018, AM J EPIDEMIOL, V187, P1051, DOI 10.1093/aje/kwx328	9	23	24	3	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2073	2074		10.1001/jama.2018.16166	http://dx.doi.org/10.1001/jama.2018.16166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30383165				2022-12-28	WOS:000451395000009
J	Medarov, BI; Khan, MMHS; Modi, A				Medarov, Boris I.; Khan, Malik M. H. S.; Modi, Aakash			Multiple Lung Masses in a Young Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BENIGN METASTASIZING LEIOMYOMA; PATIENT; UTERUS		[Medarov, Boris I.; Khan, Malik M. H. S.; Modi, Aakash] Albany Med Coll, Div Pulm Crit Care & Sleep Med, 16 New Scotland, Albany, NY 12208 USA	Albany Medical College	Medarov, BI (corresponding author), Albany Med Coll, Div Pulm Crit Care & Sleep Med, 16 New Scotland, Albany, NY 12208 USA.	MedaroB@amc.edu	Medarov, Boris/AAH-8864-2021	Medarov, Boris/0000-0002-8132-7122; Khan, Malik/0000-0001-9010-5129				Arai T, 2000, CHEST, V117, P921, DOI 10.1378/chest.117.3.921; HAGUE WM, 1986, BRIT J OBSTET GYNAEC, V93, P455, DOI 10.1111/j.1471-0528.1986.tb08653.x; Hann M, 2017, OCHSNER J, V17, P284; HORSTMANN JP, 1977, CANCER-AM CANCER SOC, V39, P314, DOI 10.1002/1097-0142(197701)39:1<314::AID-CNCR2820390148>3.0.CO;2-N; Jautzke G, 1996, PATHOL RES PRACT, V192, P215, DOI 10.1016/S0344-0338(96)80224-X; Kayser K, 2000, VIRCHOWS ARCH, V437, P284, DOI 10.1007/s004280000207; Lee SR, 2017, J THORAC DIS, V9, pE1, DOI 10.21037/jtd.2016.11.112; Lewis EI, 2013, FERTIL STERIL, V99, P2017, DOI 10.1016/j.fertnstert.2013.01.147; Schneider T, 2001, CHIRURG, V72, P308, DOI 10.1007/s001040051311; Steiner PE, 1939, AM J PATHOL, V15, P89	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2141	2142		10.1001/jama.2018.14770	http://dx.doi.org/10.1001/jama.2018.14770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30347043				2022-12-28	WOS:000451395000023
J	Schretter, CE; Vielmetter, J; Bartos, I; Marka, Z; Marka, S; Argade, S; Mazmanian, SK				Schretter, Catherine E.; Vielmetter, Jost; Bartos, Imre; Marka, Zsuzsa; Marka, Szabolcs; Argade, Sulabha; Mazmanian, Sarkis K.			A gut microbial factor modulates locomotor behaviour in Drosophila	NATURE			English	Article							FLIGHT INITIATION; OCTOPAMINE; TYRAMINE; HOMEOSTASIS; PREFERENCE; MUTUALISM; INGESTION; DOPAMINE; PATTERN; PROTEIN	While research into the biology of animal behaviour has primarily focused on the central nervous system, cues from peripheral tissues and the environment have been implicated in brain development and function'. There is emerging evidence that bidirectional communication between the gut and the brain affects behaviours including anxiety, cognition, nociception and social interaction(1-9). Coordinated locomotor behaviour is critical for the survival and propagation of animals, and is regulated by internal and external sensory inputs(1)(0,11). However, little is known about how the gut microbiome influences host locomotion, or the molecular and cellular mechanisms involved. Here we report that germ-free status or antibiotic treatment results in hyperactive locomotor behaviour in the fruit fly Drosophila melanogaster. Increased walking speed and daily activity in the absence of a gut microbiome are rescued by mono-colonization with specific bacteria, including the fly commensal Lactobacillus brevis. The bacterial enzyme xylose isomerase from L. brevis recapitulates the locomotor effects of microbial colonization by modulating sugar metabolism in flies. Notably, thermogenetic activation of octopaminergic neurons or exogenous administration of octopamine, the invertebrate counterpart of noradrenaline, abrogates the effects of xylose isomerase on Drosophila locomotion. These findings reveal a previously unappreciated role for the gut microbiome in modulating locomotion, and identify octopaminergic neurons as mediators of peripheral microbial cues that regulate motor behaviour in animals.	[Schretter, Catherine E.; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Vielmetter, Jost] CALTECH, Beckman Inst, Prot Express Ctr, Pasadena, CA 91125 USA; [Bartos, Imre; Marka, Zsuzsa; Marka, Szabolcs] Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA; [Argade, Sulabha] Univ Calif San Diego, GlycoAnalyt Core, San Diego, CA 92103 USA	California Institute of Technology; California Institute of Technology; Columbia University; University of California System; University of California San Diego	Schretter, CE; Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	cschrett@caltech.edu; sarkis@caltech.adu	Marka, Szabolcs/ABE-7493-2021; Bartos, Imre/AAD-6024-2019	Schretter, Catherine/0000-0002-3957-6838; Bartos, Imre/0000-0001-5607-3637	Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; NIH [NS085910]; Heritage Medical Research Institute; Center for Environmental Microbial Interactions at Caltech; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER	Caltech Beckman Institute; Arnold and Mabel Beckman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heritage Medical Research Institute; Center for Environmental Microbial Interactions at Caltech; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Chu, G. Sharon, W.-L. Wu, J. K. Scarpa, E. D. Hoopfer and the Mazmanian laboratory for critiques; A. A. Aravin and K. Fejes Toth for use of their laboratory space; D. J. Anderson, H. A. Lester, V. Gradinaru and M.-F. Chesselet for discussions; A. R. Sandoval, M. Meyerowitz and M. Smalley for technical support; Y. Garcia-Flores for administrative support; D. C. Hall for creating custom Python scripts; W.-J. Lee for the L. brevis<SUP>FW</SUP>, L. plantarum<SUP>WJL</SUP> and Acetobacter pomorum bacterial strains; the Yale Coli Genetic Stock Center for wild-type and mutant E. coli strains; M. H. Dickinson, D. J. Anderson, A. A. Aravin, and K. Fejes T.th for fly lines; the GlycoAnalytics Core for help with carbohydrate analysis; and M. Fischbach and M. Funabashi for the pGID023 vector and advice. Imaging was performed in the Biological Imaging Facility, with the support of the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation. C.E.S. was partially supported by the Center for Environmental Microbial Interactions at Caltech. This project was funded by grants from the NIH (NS085910) and the Heritage Medical Research Institute to S.K.M.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; Blacher E, 2017, J IMMUNOL, V198, P572, DOI 10.4049/jimmunol.1601247; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Chakrabarti S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004659; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Fischer C, 2017, ELIFE, V6, DOI 10.7554/eLife.18855; Gacias M, 2016, ELIFE, V5, DOI 10.7554/eLife.13442; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Han DD, 2000, DEVELOPMENT, V127, P573; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; Kim EK, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00938-13; KIMURA K, 1990, J NEUROSCI, V10, P403; KLAASSEN LW, 1985, J NEUROBIOL, V16, P227, DOI 10.1002/neu.480160307; Lee KA, 2013, CELL, V153, P797, DOI 10.1016/j.cell.2013.04.009; Lee WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067308; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Lendrum J. E., 2017, PREPRINT; LIU W, 2017, SCI REP, V7; Luczynski P, 2017, ELIFE, V6, DOI 10.7554/eLife.25887; Mann K, 2013, NEURON, V79, P754, DOI 10.1016/j.neuron.2013.06.018; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martino M. E., 2015, Genome Announcements, V3, pe01382; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; Qi W, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0179-x; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Selkrig J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28764-5; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Tissot M, 2000, PROG NEUROBIOL, V62, P89, DOI 10.1016/S0301-0082(99)00069-6; van Breugel F, 2014, J EXP BIOL, V217, P1737, DOI 10.1242/jeb.098665; WeiselEichler A, 1996, J COMP PHYSIOL A, V179, P103, DOI 10.1007/BF00193438; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Wolf FW, 2002, J NEUROSCI, V22, P11035; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wong ACN, 2017, CURR BIOL, V27, P2397, DOI 10.1016/j.cub.2017.07.022; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; YAMANAKA K, 1968, BIOCHIM BIOPHYS ACTA, V151, P670, DOI 10.1016/0005-2744(68)90015-6; Yang Z, 2015, P NATL ACAD SCI USA, V112, P5219, DOI 10.1073/pnas.1417838112; Yu Y, 2016, ELIFE, V5, DOI 10.7554/eLife.15693	68	121	140	26	179	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					402	+		10.1038/s41586-018-0634-9	http://dx.doi.org/10.1038/s41586-018-0634-9			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30356215	Green Accepted			2022-12-28	WOS:000450048400060
J	Chapman, M; Peake, SL; Bellomo, R; Davies, A; Deane, A; Horowitz, M; Hurford, S; Lange, K; Little, L; Mackle, D; O'Connor, S; Presneill, J; Ridley, E; Williams, P; Young, P				Chapman, Marianne; Peake, Sandra L.; Bellomo, Rinaldo; Davies, Andrew; Deane, Adam; Horowitz, Michael; Hurford, Sally; Lange, Kylie; Little, Lorraine; Mackle, Diane; O'Connor, Stephanie; Presneill, Jeffrey; Ridley, Emma; Williams, Patricia; Young, Paul		TARGET Investigators ANZICS	Energy-Dense versus Routine Enteral Nutrition in the Critically Ill	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE UNITS; ACUTE LUNG INJURY; PARENTERAL-NUTRITION; CALORIE DELIVERY; MULTICENTER; PREVALENCE; GUIDELINES; PROVISION; OUTCOMES; BLIND	Background The effect of delivering nutrition at different calorie levels during critical illness is uncertain, and patients typically receive less than the recommended amount. Methods We conducted a multicenter, double-blind, randomized trial, involving adults undergoing mechanical ventilation in 46 Australian and New Zealand intensive care units (ICUs), to evaluate energy-dense (1.5 kcal per milliliter) as compared with routine (1.0 kcal per milliliter) enteral nutrition at a dose of 1 ml per kilogram of ideal body weight per hour, commencing at or within 12 hours of the initiation of nutrition support and continuing for up to 28 days while the patient was in the ICU. The primary outcome was all-cause mortality within 90 days. Results There were 3957 patients included in the modified intention-to-treat analysis (1971 in the 1.5-kcal group and 1986 in the 1.0-kcal group). The volume of enteral nutrition delivered during the trial was similar in the two groups; however, patients in the 1.5-kcal group received a mean (SD) of 1863478 kcal per day as compared with 1262 +/- 313 kcal per day in the 1.0-kcal group (mean difference, 601 kcal per day; 95% confidence interval [CI], 576 to 626). By day 90, a total of 523 of 1948 patients (26.8%) in the 1.5-kcal group and 505 of 1966 patients (25.7%) in the 1.0-kcal group had died (relative risk, 1.05; 95% CI, 0.94 to 1.16; P=0.41). The results were similar in seven predefined subgroups. Higher calorie delivery did not affect survival time, receipt of organ support, number of days alive and out of the ICU and hospital or free of organ support, or the incidence of infective complications or adverse events. Conclusions In patients undergoing mechanical ventilation, the rate of survival at 90 days associated with the use of an energy-dense formulation for enteral delivery of nutrition was not higher than that with routine enteral nutrition.	[Chapman, Marianne; Peake, Sandra L.; Bellomo, Rinaldo; Davies, Andrew; Little, Lorraine; O'Connor, Stephanie; Presneill, Jeffrey; Ridley, Emma; Williams, Patricia] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic, Australia; [Davies, Andrew] Frankston Hosp, Melbourne, Vic, Australia; [Deane, Adam; Presneill, Jeffrey] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Deane, Adam; Presneill, Jeffrey] Univ Melbourne, Melbourne, Vic, Australia; [Ridley, Emma] Alfred Hosp, Melbourne, Vic, Australia; [Chapman, Marianne; Peake, Sandra L.; Deane, Adam; Horowitz, Michael; Lange, Kylie; O'Connor, Stephanie; Williams, Patricia] Univ Adelaide, Adelaide, SA, Australia; [Peake, Sandra L.; Williams, Patricia] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Chapman, Marianne; Horowitz, Michael; O'Connor, Stephanie] Royal Adelaide Hosp, Adelaide, SA, Australia; [Chapman, Marianne; Horowitz, Michael; Lange, Kylie] Natl Hlth & Med Res Council Ctr Res Excellence Tr, Adelaide, SA, Australia; [Hurford, Sally; Mackle, Diane; Young, Paul] Med Res Inst New Zealand, Wellington, New Zealand; [Young, Paul] Wellington Hosp, Wellington, New Zealand	Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Frankston Hospital; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Adelaide; Royal Adelaide Hospital; Medical Research Institute Of New Zealand	Peake, SL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care Med, 28 Woodville Rd, Woodville, SA 5011, Australia.	sandra.peake@sa.gov.au	Ridley, Emma J./H-2864-2019; Williams, Patricia/AAH-6571-2019; Deane, Adam/AAF-7370-2020; Horowitz, Michael/AAY-3397-2021; Presneill, Jeffrey/B-4894-2012	Ridley, Emma J./0000-0002-7922-5717; Deane, Adam/0000-0002-7620-5577; Horowitz, Michael/0000-0002-0942-0306; Young, Paul/0000-0002-3428-3083; Green, Cameron/0000-0001-8949-3590; Presneill, Jeffrey/0000-0001-7177-7667; Barlow-Armstrong, Jewel/0000-0001-7350-0397	National Health and Medical Research Institute of Australia; Health Research Council of New Zealand	National Health and Medical Research Institute of Australia(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand)	Funded by National Health and Medical Research Institute of Australia and the Health Research Council of New Zealand; TARGET ClinicalTrials.gov number, NCT02306746.	Al-Dorzi HM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1539-3; Alberda Cathy, 2009, Intensive Care Med, V35, P1728, DOI 10.1007/s00134-009-1567-4; Arabi YM, 2015, NEW ENGL J MED, V372, P2398, DOI 10.1056/NEJMoa1502826; Braunschweig CA, 2015, JPEN-PARENTER ENTER, V39, P13, DOI 10.1177/0148607114528541; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cade JF, 2016, CRIT CARE RESUSC, V18, P224; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chapman MJ, 2011, GUT, V60, P1336, DOI 10.1136/gut.2010.227934; De Beaux I, 2001, ANAESTH INTENS CARE, V29, P619, DOI 10.1177/0310057X0102900611; Doig GS, 2015, LANCET RESP MED, V3, P943, DOI 10.1016/S2213-2600(15)00418-X; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Hart Graeme K, 2008, Crit Care Resusc, V10, P83; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Heyland DK, 2015, CLIN NUTR, V34, P659, DOI 10.1016/j.clnu.2014.07.008; Kar P, 2016, JPEN-PARENTER ENTER, V40, P1050, DOI 10.1177/0148607115588333; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; McClave SA, 2016, JPEN-PARENTER ENTER, V40, P159, DOI [10.1177/0148607115621863, 10.1097/CCM.0000000000001525]; Parikh HG, 2016, CRIT CARE RESUSC, V18, P17; Passier RHA, 2013, INTENS CARE MED, V39, P1221, DOI 10.1007/s00134-013-2934-8; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Peake S, 2018, CRIT CARE RESUSC, V20, P15; Peake SL, 2014, AM J CLIN NUTR, V100, P616, DOI 10.3945/ajcn.114.086322; Peake SL, 2012, CRIT CARE RESUSC, V14, P148; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Ridley EJ, 2017, CLIN NUTR; Ridley EJ, 2018, JPEN-PARENTER ENTER, V42, P1349, DOI 10.1002/jpen.1163; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Wei XJ, 2015, CRIT CARE MED, V43, P1569, DOI 10.1097/CCM.0000000000001000; WELCH IM, 1988, GASTROENTEROLOGY, V94, P401, DOI 10.1016/0016-5085(88)90428-3; Williams P, 2018, CRIT CARE RESUSC, V20, P6; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	34	152	155	4	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 8	2018	379	19					1823	1834		10.1056/NEJMoa1811687	http://dx.doi.org/10.1056/NEJMoa1811687			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5UT	30346225	Bronze			2022-12-28	WOS:000449495700008
J	Melville, S; Byrd, JB				Melville, Sarah; Byrd, James Brian			Out-of-Office Blood Pressure Monitoring in 2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TASMINH4		[Melville, Sarah] St Johns Hosp, HHN, CardioVasc Res New Brunswick, St John, NB, Canada; [Melville, Sarah] IMPART Investigator Team Canada, St John, NB, Canada; [Byrd, James Brian] Univ Michigan, Med Sch, Dept Med, 5570C MSRB 2,1150 W Med Ctr Dr,SPC 5678, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Byrd, JB (corresponding author), Univ Michigan, Med Sch, Dept Med, 5570C MSRB 2,1150 W Med Ctr Dr,SPC 5678, Ann Arbor, MI 48109 USA.	jbbyrd@med.umich.edu	Byrd, James Brian/H-6674-2019	Byrd, James Brian/0000-0002-0509-3520; Melville, Sarah/0000-0003-4867-3979	New Brunswick Health Research Foundation; National Heart, Lung, and Blood Institute	New Brunswick Health Research Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Ms Melville reports funding support from the New Brunswick Health Research Foundation (operating grant: Health Research Value Demonstration Initiative) provided directly to her professional supervisors, Keith R. Brunt, PhD (IMPART investigator team Canada) and Sohrab Lutchmedial, MD, FRCPC (CardioVascular Research New Brunswick, Saint John Regional Hospital, Horizon Health Network). Dr Byrd reported receiving funding from the National Heart, Lung, and Blood Institute.	Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231; de la Sierra A, 2018, CIRCULATION, V137, P2651, DOI 10.1161/CIRCULATIONAHA.118.034619; Franssen M, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0494-5; Jin Jill, 2017, JAMA, V318, P310, DOI 10.1001/jama.2017.6670; McManus RJ, 2018, LANCET, V391, P949, DOI 10.1016/S0140-6736(18)30309-X; Tucker KL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002389; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016	7	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1805	1806		10.1001/jama.2018.14865	http://dx.doi.org/10.1001/jama.2018.14865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398589				2022-12-28	WOS:000449461800018
J	Thakkar, AB; Desai, SP				Thakkar, Anjali B.; Desai, Sukumar P.			Swan, Ganz, and Their Catheter: Its Evolution Over the Past Half Century	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PULMONARY-ARTERY CATHETER; CRITICALLY-ILL PATIENTS; RIGHT HEART CATHETERIZATION; RANDOMIZED CONTROLLED-TRIAL; CARDIAC-OUTPUT; DOPPLER-ECHOCARDIOGRAPHY; BLOOD-FLOW; CARE; MEDICINE	Jeremy Swan and William Ganz developed their eponymous pulmonary artery (PA) catheter in the 1970s and, in the process, revolutionized measurement of cardiac output, pressures within the left side of the heart, and resistance in systemic and pulmonary circulations. Their invention enabled diagnostic measurements at the bedside and contributed to the birth of critical care medicine; technologic advances preceding the PA catheter generally could not be used at the bedside and required patients to be stable enough to be taken to the catheterization laboratory. Swan and Ganz worked in the same department but had quite dissimilar backgrounds and personalities. This article describes their lives and careers, the state of intensive care before and after their catheter was introduced, and the natural life cycle the PA catheter faced as new, less invasive technology arrived to replace it.	[Thakkar, Anjali B.] Univ Calif San Francisco, Med Ctr, Dept Med, 505 Parnassus Ave, San Francisco, CA 94143 USA; [Desai, Sukumar P.] Harvard Med Sch, Boston, MA USA; [Desai, Sukumar P.] Brigham & Womens Hosp, Dept Anesthesia, 75 Francis St, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Desai, SP (corresponding author), Brigham & Womens Hosp, Dept Anesthesia, 75 Francis St, Boston, MA 02115 USA.	sdesai@partners.org						Alkhouli M, 2014, J CARD FAIL, V20, P716, DOI 10.1016/j.cardfail.2014.07.002; Altman LW, 1998, WHO GOES 1 STORY SEL; [Anonymous], HEART ARTERIES VEINS; [Anonymous], 2005, IRISH TIMES; Bourassa MG, 2005, CAN J CARDIOL, V21, P1011; BRANTHWAITE MA, 1968, J APPL PHYSIOL, V24, P434, DOI 10.1152/jappl.1968.24.3.434; Cedars-Sinai Medical Center, 1980, HJC SWAN VID; Cedars-Sinai Medical Center, 1980, US SWANG CATH CARD S; Chatterjee K, 2009, CIRCULATION, V119, P147, DOI 10.1161/CIRCULATIONAHA.108.811141; Compton F, 2008, ANESTH ANALG, V106, P171, DOI 10.1213/01.ane.0000297440.52059.2c; CONNOLLY DC, 1954, CIRC RES, V2, P434; CONNORS AF, 1985, CHEST, V88, P567, DOI 10.1378/chest.88.4.567; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Courmand A, 1941, P SOC EXP BIOL MED, V46, P462; de Wilde RBP, 2006, ANAESTHESIA, V61, P743, DOI 10.1111/j.1365-2044.2006.04712.x; DEXTER L, 1947, J CLIN INVEST, V26, P554, DOI 10.1172/JCI101840; Fick A, 1870, VERH PHYS MED GES WU, V2, P16; FORRESTER JS, 1976, NEW ENGL J MED, V295, P1356, DOI 10.1056/NEJM197612092952406; FRITTS HW, 1958, P NATL ACAD SCI USA, V44, P1079, DOI 10.1073/pnas.44.10.1079; FRONEK A, 1959, Cesk Fysiol, V8, P189; Fye, 2015, CARING HEART MAYO CL; Fye W.B., 1996, AM CARDIOLOGY HIST S; Fye WB, 2011, CIRCULATION, V124, P1886, DOI 10.1161/CIRCULATIONAHA.111.033597; Hamilton WF, 1932, AM J PHYSIOL, V99, P534, DOI 10.1152/ajplegacy.1932.99.3.534; Harvey S, 2005, LANCET, V366, P472, DOI 10.1016/S0140-6736(05)67061-4; HEISS HW, 1992, CLIN CARDIOL, V15, P547, DOI 10.1002/clc.4960150715; HELLEMS HK, 1949, J APPL PHYSIOL, V2, P24, DOI 10.1152/jappl.1949.2.1.24; Jacka MJ, 2002, CRIT CARE MED, V30, P1197, DOI 10.1097/00003246-200206000-00003; Jeremy Swan M. D., 2005, THESIS; KOMADINA KH, 1991, CHEST, V100, P1647, DOI 10.1378/chest.100.6.1647; Lee AJ, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/475151; Marik PE, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-38; Maugh T.A., 2009, LOS ANGELES TIMES; MUHIUDEEN IA, 1991, ANESTHESIOLOGY, V74, P9, DOI 10.1097/00000542-199101000-00003; Oransky I, 2005, LANCET, V365, P1132, DOI 10.1016/S0140-6736(05)71865-1; Oxorn DC, 2008, HEART, V94, P1236, DOI 10.1136/hrt.2008.148510; PERRINO AC, 1993, YALE J BIOL MED, V66, P397; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; Richard C, 2003, JAMA-J AM MED ASSOC, V290, P2713, DOI 10.1001/jama.290.20.2713; ROBIN ED, 1985, ANN INTERN MED, V103, P445, DOI 10.7326/0003-4819-103-3-445; ROBIN ED, 1987, CHEST, V92, P727, DOI 10.1378/chest.92.4.727; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; Sangkum L, 2016, J ANESTH, V30, P461, DOI 10.1007/s00540-016-2154-9; SAVINO JS, 1991, ANESTHESIOLOGY, V75, P445, DOI 10.1097/00000542-199109000-00011; Schwann NM, 2011, ANESTH ANALG, V113, P994, DOI 10.1213/ANE.0b013e31822c94a8; SHOEMAKER WC, 1994, CRIT CARE MED, V22, P1907; Snelders S, 2006, B HIST MED, V80, P95, DOI 10.1353/bhm.2006.0041; Squara P, 2002, CHEST, V121, P2009, DOI 10.1378/chest.121.6.2009; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Stewart S., 2009, CEDARS SINAI MED CTR; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; SWAN HJC, 1979, CAN MED ASSOC J, V121, P868; Wheeler AP, 2006, NEW ENGL J MED, V354, P2213; Wiener RS, 2007, JAMA-J AM MED ASSOC, V298, P423, DOI 10.1001/jama.298.4.423; Yu DT, 2003, CRIT CARE MED, V31, P2734, DOI 10.1097/01.CCM.0000098028.68323.64; Zarychanski R, 2009, CRIT CARE CLIN, V25, P201, DOI 10.1016/j.ccc.2008.10.003	56	8	8	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					636	+		10.7326/M17-2145	http://dx.doi.org/10.7326/M17-2145			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4UP	30398637				2022-12-28	WOS:000449399700007
J	Kmietowicz, Z				Kmietowicz, Zosia			Don't blacklist surgery for common hand conditions, says royal college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; IACOBUCCI G, 2018, BMJ-BRIT MED J, V362, P67052, DOI DOI 10.1136/BMJ.K2903; Korthals-de Bos IBC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-86; Shewring DJ, 2018, BMJ	4	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2018	363								k4653	10.1136/bmj.k4653	http://dx.doi.org/10.1136/bmj.k4653			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QK	30389656				2022-12-28	WOS:000449566000003
J	McGee, D				McGee, David			Shifting summer rains Trace-element records in Chinese caves reveal the effects of climate change on Asian monsoons	SCIENCE			English	Editorial Material							SEASONAL TRANSITIONS; EVENT		[McGee, David] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	McGee, D (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	davidmcg@mit.edu			NSF [EAR-1434138]	NSF(National Science Foundation (NSF))	I thank G. Roe for helpful discussion and acknowledge funding related to this topic from NSF EAR-1434138.	Beck JW, 2018, SCIENCE, V360, P877, DOI 10.1126/science.aam5825; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Chiang JCH, 2017, GEOPHYS RES LETT, V44, P3788, DOI 10.1002/2017GL072739; Chiang JCH, 2015, QUATERNARY SCI REV, V108, P111, DOI 10.1016/j.quascirev.2014.11.009; Clemens SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05814-0; Goldsmith Y, 2017, P NATL ACAD SCI USA, V114, P1817, DOI 10.1073/pnas.1616708114; Liu ZY, 2014, QUATERNARY SCI REV, V83, P115, DOI 10.1016/j.quascirev.2013.10.021; Owen RA, 2016, EARTH PLANET SC LETT, V443, P129, DOI 10.1016/j.epsl.2016.03.027; Pausata FSR, 2011, NAT GEOSCI, V4, P474, DOI [10.1038/NGEO1169, 10.1038/ngeo1169]; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wortham BE, 2017, EARTH PLANET SC LETT, V463, P310, DOI 10.1016/j.epsl.2017.01.034; Zhang HB, 2018, SCIENCE, V362, P580, DOI 10.1126/science.aat9393	12	0	0	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		518	520		10.1126/science.aav5280	http://dx.doi.org/10.1126/science.aav5280			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385558				2022-12-28	WOS:000450460000020
J	Po-Chedley, S; Proistosescu, C; Armour, KC; Santer, BD				Po-Chedley, Stephen; Proistosescu, Cristian; Armour, Kyle C.; Santer, Benjamin D.			Climate constraint reflects forced signal	NATURE			English	Letter							EMERGENT CONSTRAINTS; SENSITIVITY		[Po-Chedley, Stephen; Santer, Benjamin D.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Proistosescu, Cristian] Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; [Armour, Kyle C.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Armour, Kyle C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Po-Chedley, S (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	pochedley1@llnl.gov	Po-Chedley, Stephen/O-3450-2019; Santer, Benjamin D/F-9781-2011; Santer, Ben/ABA-1099-2021; Po-Chedley, Stephen/E-9706-2013	Po-Chedley, Stephen/0000-0002-0390-238X				Bender FAM, 2010, CLIM DYNAM, V35, P875, DOI 10.1007/s00382-010-0777-3; Caldwell PM, 2018, J CLIMATE, V31, P3921, DOI 10.1175/JCLI-D-17-0631.1; Cox PM, 2018, NATURE, V553, P319, DOI 10.1038/nature25450; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Kiehl JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031383; Kirk-Davidoff DB, 2009, ATMOS CHEM PHYS, V9, P813, DOI 10.5194/acp-9-813-2009; Klein SA, 2015, CURR CLIM CHANGE REP, V1, P276, DOI 10.1007/s40641-015-0027-1; Langen PL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024136; LEITH CE, 1975, J ATMOS SCI, V32, P2022, DOI 10.1175/1520-0469(1975)032<2022:CRAFD>2.0.CO;2; Schwartz SE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008746; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; WIGLEY TML, 1990, NATURE, V344, P324, DOI 10.1038/344324a0	12	5	5	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					E6	E9		10.1038/s41586-018-0640-y	http://dx.doi.org/10.1038/s41586-018-0640-y			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382205				2022-12-28	WOS:000448900900003
J	Rimmer, A				Rimmer, Abi			Medicine's gender pay gap: five minutes with ... Jane Dacre The former president of the Royal College of Physicians is leading a review into the gender pay gap in medicine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Dowd A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4221; Rimmer A, 2016, BMJ-BRIT MED J, V353, pi1915, DOI [10.1136/bmj.i191527044638, DOI 10.1136/BMJ.I191527044638]	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4559	10.1136/bmj.k4559	http://dx.doi.org/10.1136/bmj.k4559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377157				2022-12-28	WOS:000449563200005
J	Ren, SC; Wang, YL; Yue, FG; Cheng, XF; Dang, RZ; Qiao, QC; Sun, XQ; Li, X; Jiang, Q; Yao, JW; Qin, H; Wang, GZ; Liao, X; Gao, D; Xia, JX; Zhang, J; Hu, B; Yan, JA; Wang, YJ; Xu, M; Han, YY; Tang, XD; Chen, XW; He, C; Hu, ZA				Ren, Shuancheng; Wang, Yaling; Yue, Faguo; Cheng, Xiaofang; Dang, Ruozhi; Qiao, Qicheng; Sun, Xueqi; Li, Xin; Jiang, Qian; Yao, Jiwei; Qin, Han; Wang, Guanzhong; Liao, Xiang; Gao, Dong; Xia, Jianxia; Zhang, Jun; Hu, Bo; Yan, Junan; Wang, Yanjiang; Xu, Min; Han, Yunyun; Tang, Xiangdong; Chen, Xiaowei; He, Chao; Hu, Zhian			The paraventricular thalamus is a critical thalamic area for wakefulness	SCIENCE			English	Article							NUCLEUS; MIDLINE; INTRALAMINAR; PROJECTIONS; SLEEP; RAT; SPECIFICITY; CIRCUIT	Clinical observations indicate that the paramedian region of the thalamus is a critical node for controlling wakefulness. However, the specific nucleus and neural circuitry for this function remain unknown. Using in vivo fiber photometry or multichannel electrophysiological recordings in mice, we found that glutamatergic neurons of the paraventricular thalamus (PVT) exhibited high activities during wakefulness. Suppression of PVT neuronal activity caused a reduction in wakefulness, whereas activation of PVT neurons induced a transition from sleep to wakefulness and an acceleration of emergence from general anesthesia. Moreover, our findings indicate that the PVT-nucleus accumbens projections and hypocretin neurons in the lateral hypothalamus to PVT glutamatergic neurons' projections are the effector pathways for wakefulness control. These results demonstrate that the PVT is a key wakefulness-controlling nucleus in the thalamus.	[Ren, Shuancheng; Wang, Yaling; Yue, Faguo; Cheng, Xiaofang; Dang, Ruozhi; Qiao, Qicheng; Sun, Xueqi; Li, Xin; Wang, Guanzhong; Xia, Jianxia; Zhang, Jun; He, Chao; Hu, Zhian] Third Mil Med Univ, Dept Physiol, Collaborat Innovat Ctr Brain Sci, Chongqing 400038, Peoples R China; [Yue, Faguo; Jiang, Qian; Gao, Dong] Third Mil Med Univ, Daping Hosp, Dept Sleep & Psychol, Chongqing 400042, Peoples R China; [Yao, Jiwei; Qin, Han; Liao, Xiang; Yan, Junan; Chen, Xiaowei] Third Mil Med Univ, Brain Res Ctr, Chongqing 400038, Peoples R China; [Wang, Yanjiang] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China; [Xu, Min] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai 200031, Peoples R China; [Han, Yunyun] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Neurobiol, Wuhan 430030, Hubei, Peoples R China; [Han, Yunyun] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Tang, Xiangdong] Sichuan Univ, West China Hosp, Sleep Med Ctr,Translat Neurosci Ctr, Lab Anaesthesia & Critical Care Med,Sleep Med Ctr, Chengdu 610041, Sichuan, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Sichuan University	He, C; Hu, ZA (corresponding author), Third Mil Med Univ, Dept Physiol, Collaborat Innovat Ctr Brain Sci, Chongqing 400038, Peoples R China.; Chen, XW (corresponding author), Third Mil Med Univ, Brain Res Ctr, Chongqing 400038, Peoples R China.	xiaowei_chen@tmmu.edu.cn; hechaochongqing@163.com; zhianhu@aliyun.com	Wang, Yanjiang/F-3703-2012; Han, Yunyun/O-2092-2013; Xu, Min/AGD-5135-2022; Han, Yunyun/AAG-4427-2021	Wang, Yanjiang/0000-0002-6227-6112; Han, Yunyun/0000-0003-2336-167X; Xu, Min/0000-0002-6936-7543; Han, Yunyun/0000-0003-2336-167X; ren, shuancheng/0000-0002-5678-5842; Liao, Xiang/0000-0001-6324-5206; Hu, Bo/0000-0003-4036-1508; Tang, Xiangdong/0000-0001-6876-3328	National Natural Science Foundation of China [31771192, 31500862, 81671106]; 973 Program [2015CB759500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	Supported by the National Natural Science Foundation of China (31771192 to Z.H., 31500862 to C.H., and 81671106 to X.W.C.) and "973 Program" (2015CB759500 to X.W.C.).	Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Fogerson PM, 2016, NEURON, V92, P687, DOI 10.1016/j.neuron.2016.10.024; Frassoni C, 1997, EXP BRAIN RES, V115, P95, DOI 10.1007/PL00005689; Gent TC, 2018, NAT NEUROSCI, V21, P974, DOI 10.1038/s41593-018-0164-7; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Hermann DM, 2008, STROKE, V39, P62, DOI 10.1161/STROKEAHA.107.494955; Honig A, 2016, J CLIN NEUROSCI, V34, P81, DOI 10.1016/j.jocn.2016.05.014; Honjoh S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04497-x; JASPER H, 1949, ELECTROEN CLIN NEURO, V1, P405, DOI 10.1016/0013-4694(49)90213-8; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Kirouac GJ, 2005, BRAIN RES, V1059, P179, DOI 10.1016/j.brainres.2005.08.035; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Li S, 2012, BRAIN STRUCT FUNCT, V217, P257, DOI 10.1007/s00429-011-0360-7; Luo YJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03889-3; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; PERCHERON G, 1973, Z NEUROL, V205, P1, DOI 10.1007/BF00315956; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Vertes RP, 2008, J COMP NEUROL, V508, P212, DOI 10.1002/cne.21679; Vertes RP, 2015, NEUROSCI BIOBEHAV R, V54, P89, DOI 10.1016/j.neubiorev.2015.01.014; Vijn PCM, 1998, BRIT J ANAESTH, V81, P415, DOI 10.1093/bja/81.3.415; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Zhang XB, 2017, SCIENCE, V356, P853, DOI 10.1126/science.aam7100; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	26	120	143	22	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					429	+		10.1126/science.aat2512	http://dx.doi.org/10.1126/science.aat2512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361367				2022-12-28	WOS:000450441900043
J	Cuneo, CN				Cuneo, C. Nicholas			Learning Empathy from My '97 Camry	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cuneo, C. Nicholas] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Cuneo, C. Nicholas] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Cuneo, C. Nicholas] Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Boston Medical Center	Cuneo, CN (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Cuneo, CN (corresponding author), Childrens Hosp, Dept Med, Boston, MA 02115 USA.; Cuneo, CN (corresponding author), Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA.			Cuneo, Charles/0000-0002-5824-2243					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1596	1597		10.1056/NEJMp1808397	http://dx.doi.org/10.1056/NEJMp1808397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30354957				2022-12-28	WOS:000448273500004
J	Ma, WL; Alonso-Gonzalez, P; Li, SJ; Nikitin, AY; Yuan, J; Martin-Sanchez, J; Taboada-Gutierrez, J; Amenabar, I; Li, PN; Velez, S; Tollan, C; Dai, ZG; Zhang, YP; Sriram, S; Kalantar-Zadeh, K; Lee, ST; Hillenbrand, R; Bao, QL				Ma, Weiliang; Alonso-Gonzalez, Pablo; Li, Shaojuan; Nikitin, Alexey Y.; Yuan, Jian; Martin-Sanchez, Javier; Taboada-Gutierrez, Javier; Amenabar, Iban; Li, Peining; Velez, Saul; Tollan, Christopher; Dai, Zhigao; Zhang, Yupeng; Sriram, Sharath; Kalantar-Zadeh, Kourosh; Lee, Shuit-Tong; Hillenbrand, Rainer; Bao, Qiaoliang			In-plane anisotropic and ultra-low-loss polaritons in a natural van der Waals crystal	NATURE			English	Article							BORON-NITRIDE; GRAPHENE PLASMONS; PHONON-POLARITONS	Polaritons-hybrid light-matter excitations-enable nanoscale control of light. Particularly large polariton field confinement and long lifetimes can be found in graphene and materials consisting of two-dimensional layers bound by weak van der Waals forces(1,2) (vdW materials). These polaritons can be tuned by electric fields(3,4) or by material thickness(5), leading to applications including nanolasers(6), tunable infrared and terahertz detectors(7), and molecular sensors(8). Polaritons with anisotropic propagation along the surface of vdW materials have been predicted, caused by in-plane anisotropic structural and electronic properties(9). In such materials, elliptic and hyperbolic in-plane polariton dispersion can be expected (for example, plasmon polaritons in black phosphorus(9)), the latter leading to an enhanced density of optical states and ray-like directional propagation along the surface. However, observation of anisotropic polariton propagation in natural materials has so far remained elusive. Here we report anisotropic polariton propagation along the surface of alpha-MoO3, a natural vdW material. By infrared nano-imaging and nano-spectroscopy of semiconducting alpha-MoO3 flakes and disks, we visualize and verify phonon polaritons with elliptic and hyperbolic in-plane dispersion, and with wavelengths (up to 60 times smaller than the corresponding photon wavelengths) comparable to those of graphene plasmon polaritons and boron nitride phonon polaritons(3-5). From signal oscillations in real-space images we measure polariton amplitude lifetimes of 8 picoseconds, which is more than ten times larger than that of graphene plasmon polaritons at room temperature(10). They are also a factor of about four larger than the best values so far reported for phonon polaritons in isotopically engineered boron nitride(11) and for graphene plasmon polaritons at low temperatures(12). In-plane anisotropic and ultra-low-loss polaritons in vdW materials could enable directional and strong light-matter interactions, nanoscale directional energy transfer and integrated flat optics in applications ranging from biosensing to quantum nanophotonics.	[Ma, Weiliang; Li, Shaojuan; Yuan, Jian; Lee, Shuit-Tong; Bao, Qiaoliang] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou, Peoples R China; [Ma, Weiliang; Li, Shaojuan; Yuan, Jian; Lee, Shuit-Tong; Bao, Qiaoliang] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou, Peoples R China; [Alonso-Gonzalez, Pablo; Martin-Sanchez, Javier; Taboada-Gutierrez, Javier] Univ Oviedo, Dept Fis, Oviedo, Spain; [Nikitin, Alexey Y.] DIPC, Donostia San Sebastian, Spain; [Nikitin, Alexey Y.; Hillenbrand, Rainer] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Amenabar, Iban; Li, Peining; Velez, Saul; Tollan, Christopher; Hillenbrand, Rainer] CIC nanoGUNE, Donostia San Sebastian, Spain; [Velez, Saul] Swiss Fed Inst Technol, Dept Mat, Zurich, Switzerland; [Dai, Zhigao; Zhang, Yupeng; Bao, Qiaoliang] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Dai, Zhigao; Zhang, Yupeng; Bao, Qiaoliang] Monash Univ, ARC Ctr Excellence Future Low Energy Elect Techno, Clayton, Vic, Australia; [Sriram, Sharath] RMIT Univ, Funct Mat & Microsyst Res Grp, Melbourne, Vic, Australia; [Sriram, Sharath] RMIT Univ, MicroNano Res Facil, Melbourne, Vic, Australia; [Kalantar-Zadeh, Kourosh] UNSW, Sch Chem Engn, Kensington, NSW, Australia; [Hillenbrand, Rainer] Univ Basque Country, Donostia San Sebastian, Spain	Soochow University - China; Soochow University - China; University of Oviedo; Basque Foundation for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich; Monash University; Monash University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); University of New South Wales Sydney; University of Basque Country	Bao, QL (corresponding author), Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Suzhou, Peoples R China.; Bao, QL (corresponding author), Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou, Peoples R China.; Alonso-Gonzalez, P (corresponding author), Univ Oviedo, Dept Fis, Oviedo, Spain.; Hillenbrand, R (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao, Spain.; Hillenbrand, R (corresponding author), CIC nanoGUNE, Donostia San Sebastian, Spain.; Bao, QL (corresponding author), Monash Univ, Dept Mat Sci & Engn, Clayton, Vic, Australia.; Bao, QL (corresponding author), Monash Univ, ARC Ctr Excellence Future Low Energy Elect Techno, Clayton, Vic, Australia.; Hillenbrand, R (corresponding author), Univ Basque Country, Donostia San Sebastian, Spain.	pabloalonso@uniovi.es; r.hillenbrand@nanogune.eu; qiaoliang.bao@monash.edu	Kalantar-Zadeh, Kourosh/K-8461-2015; Martín-Sánchez, Javier/T-7153-2017; Alonso-González, Pablo/B-8101-2013; Hillenbrand, Rainer/N-3428-2016; Taboada-Gutiérrez, Javier/AAX-3962-2020; Zhang, Yupeng/J-8393-2012; Dai, Zhigao/B-5209-2018; Nikitin, Alexey/ABG-1886-2020; Kalantar-zadeh, Kourosh/O-3868-2018; kalantar-zadeh, Kourosh/O-3697-2018; Bao, Qiaoliang/A-6383-2009; Nikitin, Alexey/C-4010-2009; Sriram, Sharath/C-6200-2011; Velez, Saul/I-4826-2015	Kalantar-Zadeh, Kourosh/0000-0001-6109-132X; Martín-Sánchez, Javier/0000-0002-6601-9447; Alonso-González, Pablo/0000-0002-4597-9326; Hillenbrand, Rainer/0000-0002-1904-4551; Taboada-Gutiérrez, Javier/0000-0001-7401-9722; Zhang, Yupeng/0000-0003-2351-5579; Dai, Zhigao/0000-0002-3105-4605; Nikitin, Alexey/0000-0002-2327-0164; Kalantar-zadeh, Kourosh/0000-0001-6109-132X; kalantar-zadeh, Kourosh/0000-0001-6109-132X; Bao, Qiaoliang/0000-0002-6971-789X; Nikitin, Alexey/0000-0002-2327-0164; Sriram, Sharath/0000-0002-8365-7504; Tollan, Christopher/0000-0002-7769-9919; Velez, Saul/0000-0002-0019-2271	National Natural Science Foundation of China [51222208, 51290273, 51601131, 61604102, 51702219, 91433107]; Youth 973 programme [2015CB932700]; National Key Research and Development Program [2016YFA0201900]; ARC [DP140101501, IH150100006, FT150100450, CE170100039]; Natural Science Foundation of Jiangsu Province [BK20150053]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Suzhou Nano Science and Technology; Spanish Ministry of Economy, Industry and Competitiveness (Maria de Maeztu Units of Excellence Programme) [MAT2015-65525-R, FIS2014-60195-JIN, MAT2017-88358-C3-3-R, MAT2014-53432-C5-4-R, MDM-2016-0618]; Australian Research Council (ARC) Centre of Excellence in Future Low-Energy Electronics Technologies (FLEET); European Research Council [715496]; Clarin Programme from the Government of the Principality of Asturias; Marie Curie-COFUND grant [PA-18-ACB17-29]; Marie Sklodowska-Cuire individual fellowship [SGPCM-705960]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth 973 programme; National Key Research and Development Program; ARC(Australian Research Council); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Collaborative Innovation Center of Suzhou Nano Science and Technology; Spanish Ministry of Economy, Industry and Competitiveness (Maria de Maeztu Units of Excellence Programme); Australian Research Council (ARC) Centre of Excellence in Future Low-Energy Electronics Technologies (FLEET)(Australian Research Council); European Research Council(European Research Council (ERC)European Commission); Clarin Programme from the Government of the Principality of Asturias; Marie Curie-COFUND grant; Marie Sklodowska-Cuire individual fellowship	We thank S. C. Dhanabalan and J. S. Ponraj for their efforts in the early stages of this project. We thank M.H. Lu, L. Liu, C.W. Qiu and L. Wang for suggestions, and H. Yan and Q. Xing for their assistance with micro-FTIR measurements. We thank Quantum Design China (Beijing laboratory) for technical support of some s-SNOM measurements. This work was performed in part at the Melbourne Centre for Nanofabrication (MCN) in the Victorian Node of the Australian National Fabrication Facility (ANFF). We acknowledge support from the National Natural Science Foundation of China (grant numbers 51222208, 51290273, 51601131, 61604102, 51702219 and 91433107), the Youth 973 programme (2015CB932700), the National Key Research and Development Program (2016YFA0201900), ARC (DP140101501, IH150100006, FT150100450 and CE170100039), the Natural Science Foundation of Jiangsu Province (BK20150053), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Collaborative Innovation Center of Suzhou Nano Science and Technology, and the Spanish Ministry of Economy, Industry and Competitiveness (national projects MAT2015-65525-R, FIS2014-60195-JIN, MAT2017-88358-C3-3-R, MAT2014-53432-C5-4-R, and the project MDM-2016-0618 of the Maria de Maeztu Units of Excellence Programme). Q.B. acknowledges support from the Australian Research Council (ARC) Centre of Excellence in Future Low-Energy Electronics Technologies (FLEET). P.A.-G. acknowledges support from the European Research Council under Starting Grant 715496, 2DNANOPTICA. J.M.-S. acknowledges support through the Clarin Programme from the Government of the Principality of Asturias and a Marie Curie-COFUND grant (PA-18-ACB17-29). P.L. acknowledges support from a Marie Sklodowska-Cuire individual fellowship (SGPCM-705960).	Basov DN, 2016, SCIENCE, V354, DOI 10.1126/science.aag1992; Cai XH, 2015, NANO LETT, V15, P4295, DOI 10.1021/acs.nanolett.5b00137; Caldwell JD, 2015, NANOPHOTONICS-BERLIN, V4, P44, DOI 10.1515/nanoph-2014-0003; Caldwell JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6221; Chakraborty S, 2016, SCIENCE, V351, P246, DOI 10.1126/science.aad2930; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Cortes CL, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/6/063001; Dai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7963; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Dai SY, 2017, NANO LETT, V17, P5285, DOI 10.1021/acs.nanolett.7b01587; de Castro IA, 2017, ADV MATER, V29, DOI 10.1002/adma.201701619; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Giles AJ, 2018, NAT MATER, V17, P134, DOI 10.1038/NMAT5047; Gomez-Diaz JS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.233901; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Hu F, 2017, NANO LETT, V17, P5423, DOI 10.1021/acs.nanolett.7b02029; Huth F, 2011, NAT MATER, V10, P352, DOI [10.1038/NMAT3006, 10.1038/nmat3006]; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lajaunie L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115141; Li PN, 2018, SCIENCE, V359, P892, DOI 10.1126/science.aaq1704; Li PN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8507; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Low T, 2017, NAT MATER, V16, P182, DOI [10.1038/NMAT4792, 10.1038/nmat4792]; Low T, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.106802; Mazor Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045120; Ni GX, 2018, NATURE, V557, P530, DOI 10.1038/s41586-018-0136-9; Nikitin, 2017, WORLD SCI HDB METAMA, P307; Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781; Podolskiy VA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201101; PY MA, 1977, NUOVO CIMENTO B, V38, P271, DOI 10.1007/BF02723496; Rodrigo D, 2015, SCIENCE, V349, P165, DOI 10.1126/science.aab2051; Song JCW, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.205443; Takayama O, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa8bdd; Tilley D. R, 1982, SURFACE POLARITONS E; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Yoxall E, 2015, NAT PHOTONICS, V9, P674, DOI [10.1038/nphoton.2015.166, 10.1038/NPHOTON.2015.166]; Zheng ZB, 2018, ADV MATER, V30, DOI 10.1002/adma.201705318	37	327	328	37	673	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					557	+		10.1038/s41586-018-0618-9	http://dx.doi.org/10.1038/s41586-018-0618-9			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356185	Green Submitted			2022-12-28	WOS:000448277800052
J	Riller, U; Poelchau, MH; Rae, ASP; Schulte, FM; Collins, GS; Melosh, HJ; Grieve, RAF; Morgan, JV; Gulick, SPS; Lofi, J; Diaw, A; McCall, N; Kring, DA				Riller, Ulrich; Poelchau, Michael H.; Rae, Auriol S. P.; Schulte, Felix M.; Collins, Gareth S.; Melosh, H. Jay; Grieve, Richard A. F.; Morgan, Joanna V.; Gulick, Sean P. S.; Lofi, Johanna; Diaw, Abdoulaye; McCall, Naoma; Kring, David A.		IODP-ICODP Expedition 364	Rock fluidization during peak-ring formation of large impact structures	NATURE			English	Article							ACOUSTIC FLUIDIZATION; CHICXULUB CRATER; SIMULATIONS; DEFORMATION; VREDEFORT; ASYMMETRY; COLLAPSE; EXAMPLE; SUDBURY; TARGET	Large meteorite impact structures on the terrestrial bodies of the Solar System contain pronounced topographic rings, which emerged from uplifted target (crustal) rocks within minutes of impact. To flow rapidly over large distances, these target rocks must have weakened drastically, but they subsequently regained sufficient strength to build and sustain topographic rings. The mechanisms of rock deformation that accomplish such extreme change in mechanical behaviour during cratering are largely unknown and have been debated for decades. Recent drilling of the approximately 200-km-diameter Chicxulub impact structure in Mexico has produced a record of brittle and viscous deformation within its peak-ring rocks. Here we show how catastrophic rock weakening upon impact is followed by an increase in rock strength that culminated in the formation of the peak ring during cratering. The observations point to quasi-continuous rock flow and hence acoustic fluidization as the dominant physical process controlling initial cratering, followed by increasingly localized faulting.	[Riller, Ulrich; Schulte, Felix M.] Univ Hamburg, Inst Geol, Hamburg, Germany; [Poelchau, Michael H.] Univ Freiburg, Dept Geol, Freiburg, Germany; [Rae, Auriol S. P.; Collins, Gareth S.; Morgan, Joanna V.] Imperial Coll London, Dept Earth Sci & Engn, London, England; [Melosh, H. Jay] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Grieve, Richard A. F.] Western Univ, Ctr Planetary Sci & Explorat, London, ON, Canada; [Gulick, Sean P. S.; McCall, Naoma] Univ Texas Austin, Inst Geophys, Austin, TX USA; [Gulick, Sean P. S.; McCall, Naoma] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX USA; [Lofi, Johanna; Diaw, Abdoulaye] Univ Montpellier, CNRS, Geosci Montpellier, Montpellier, France; [Kring, David A.] Univ Space Res Assoc, Lunar & Planetary Inst, Houston, TX USA	University of Hamburg; University of Freiburg; Imperial College London; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Western University (University of Western Ontario); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universities Space Research Association (USRA)	Riller, U (corresponding author), Univ Hamburg, Inst Geol, Hamburg, Germany.	ulrich.riller@uni-hamburg.de	Tomioka, Naotaka/B-1888-2011; Rae, Auriol/ABB-1816-2021; (VUB), VRIJE UNIVERSITEIT BRUSSEL/B-4895-2008; Lofi, Johanna/I-5159-2018; Coolen, Marco/B-8263-2015; Pickersgill, Annemarie/N-1871-2017	Tomioka, Naotaka/0000-0001-5725-9513; (VUB), VRIJE UNIVERSITEIT BRUSSEL/0000-0002-4585-7687; Lofi, Johanna/0000-0002-0602-595X; Perez Cruz, Ligia Lucina/0000-0001-6991-5143; Riller, Ulrich/0000-0002-3803-6792; Ocampo Torres, Ruben/0000-0003-3107-8954; Wittmann, Axel/0000-0001-7572-0801; Coolen, Marco/0000-0002-0417-920X; Rae, Auriol/0000-0003-3420-4135; Pickersgill, Annemarie/0000-0001-5452-2849; Ferriere, Ludovic/0000-0002-9082-6230	German Science Foundation [527, 1006, Ri 916/16-1, PO 1815/2-1]; National Science Foundation [OCE-1737351, OCE-1450528, OCE-1736826]; Natural Environment Research Council [NE/P011195/1, NE/P005217/1]; European Consortium for Ocean Research Drilling (ECORD); ICDP; IODP [364]; NERC [NE/P006736/1, NE/P011195/1, NE/P005217/1] Funding Source: UKRI; STFC [ST/N000803/1] Funding Source: UKRI; Natural Environment Research Council [NE/P006736/1] Funding Source: researchfish	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Consortium for Ocean Research Drilling (ECORD); ICDP; IODP; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Priority Programs 527 and 1006 of the German Science Foundation (grants Ri 916/16-1 and PO 1815/2-1), National Science Foundation grants (OCE-1737351, OCE-1450528 and OCE-1736826), and Natural Environment Research Council (grants NE/P011195/1 and NE/P005217/1). The Chicxulub drilling expedition was funded by the European Consortium for Ocean Research Drilling (ECORD) and the IODP as Expedition 364 with co-funding from the ICDP. The Yucatan State Government and Universidad Nacional Autonoma de Mexico (UNAM) provided logistical support. This research used samples and data provided by IODP. Samples can be requested at http://web.iodp.tamu.edu/sdrm.We are grateful for assistance from the staff of the IODP Core Repository in Bremen, Germany, during the Onshore Science Party. We thank B. Ivanov and C. Koeberl for constructive reviews and S. Teuber for assistance in figure preparation. This is UTIG contribution number 3,278.	AHRENS TJ, 1993, J GEOPHYS RES-PLANET, V98, P1185, DOI 10.1029/92JE02679; BERTHE D, 1979, J STRUCT GEOL, V1, P31, DOI 10.1016/0191-8141(79)90019-1; Buhl E, 2013, J STRUCT GEOL, V56, P20, DOI 10.1016/j.jsg.2013.08.007; Christeson GL, 2018, EARTH PLANET SC LETT, V495, P1, DOI 10.1016/j.epsl.2018.05.013; Collins GS, 2014, J GEOPHYS RES-PLANET, V119, P2600, DOI 10.1002/2014JE004708; Collins GS, 2008, EARTH PLANET SC LETT, V270, P221, DOI 10.1016/j.epsl.2008.03.032; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Collins GS, 2002, ICARUS, V157, P24, DOI 10.1006/icar.2002.6822; CROFT S. K., 1981, MULTIRING BASINS FOR, P227; FUJIWARA A, 1977, ICARUS, V31, P277, DOI 10.1016/0019-1035(77)90038-0; Grady D.E., 1987, FRACTURE MECH ROCKS, P429; Grieve R, 2000, ANNU REV EARTH PL SC, V28, P305, DOI 10.1146/annurev.earth.28.1.305; Grieve R.A.F., 1981, LUNAR PLANETARY SCI, P37; Grieve RAF, 2008, METEORIT PLANET SCI, V43, P855, DOI 10.1111/j.1945-5100.2008.tb01086.x; Gulick S, 2017, PROC INT OCEAN DISCO, V364, P1, DOI DOI 10.14379/IODP.PROC.364.106.2017; Gulick SPS, 2008, NAT GEOSCI, V1, P131, DOI 10.1038/ngeo103; Ivanov B. A., 1996, P 27 LUN PLAN SCI C, P589; Ivanov BA, 2005, SOLAR SYST RES+, V39, P381, DOI 10.1007/s11208-005-0051-0; Ivanov BA, 2002, GEOL SOC AM SPEC PAP, V356, P619; Johnson BC, 2016, J GEOPHYS RES-EARTH, V121, P881, DOI 10.1002/2015JF003751; Kenkmann T, 2003, EARTH PLANET SC LETT, V214, P43, DOI 10.1016/S0012-821X(03)00359-5; Kenkmann T, 2002, GEOLOGY, V30, P231, DOI 10.1130/0091-7613(2002)030<0231:FWS>2.0.CO;2; Kenkmann T., 2013, IMPACT CRATERING PRO, P60, DOI DOI 10.1002/9781118447307.CH5; Kring DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13161; Melosh HJ, 1999, ANNU REV EARTH PL SC, V27, P385, DOI 10.1146/annurev.earth.27.1.385; MELOSH HJ, 1979, J GEOPHYS RES, V84, P7513, DOI 10.1029/JB084iB13p07513; MELOSH HJ, 1992, J GEOPHYS RES-PLANET, V97, P14735, DOI 10.1029/92JE01632; Melosh HJ, 1996, NATURE, V379, P601, DOI 10.1038/379601a0; Morgan J., 2017, PROC INT OCEAN DISCO, V364, DOI [10.14379/iodp.proc.364.2017, DOI 10.14379/IODP.PROC.364.2017]; Morgan JV, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008015; Morgan JV, 2016, SCIENCE, V354, P878, DOI 10.1126/science.aah6561; Morgan JV, 2000, EARTH PLANET SC LETT, V183, P347, DOI 10.1016/S0012-821X(00)00307-1; Neumann GA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500852; OKEEFE JD, 1993, J GEOPHYS RES-PLANET, V98, P17011, DOI 10.1029/93JE01330; Ortner H, 2002, COMPUT GEOSCI-UK, V28, P1193, DOI 10.1016/S0098-3004(02)00038-9; PETIT JP, 1987, J STRUCT GEOL, V9, P597, DOI 10.1016/0191-8141(87)90145-3; Rae ASP, 2017, METEORIT PLANET SCI, V52, P1330, DOI 10.1111/maps.12825; Senft LE, 2009, EARTH PLANET SC LETT, V287, P471, DOI 10.1016/j.epsl.2009.08.033; Spray JG, 1997, GEOLOGY, V25, P579, DOI 10.1130/0091-7613(1997)025<0579:S>2.3.CO;2; Wunnemann K, 2003, PLANET SPACE SCI, V51, P831, DOI 10.1016/j.pss.2003.08.001	40	49	50	4	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					511	+		10.1038/s41586-018-0607-z	http://dx.doi.org/10.1038/s41586-018-0607-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356184	Green Accepted			2022-12-28	WOS:000448277800044
J	Slomski, A				Slomski, Anita			Benefits May Persist After Antihypertensive and Statin Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1631	1631		10.1001/jama.2018.16205	http://dx.doi.org/10.1001/jama.2018.16205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357296				2022-12-28	WOS:000448069100034
J	Falk, A; Hermle, J				Falk, Armin; Hermle, Johannes			Relationship of gender differences in preferences to economic development and gender equality	SCIENCE			English	Article							SEX-DIFFERENCES; PERSONALITY-TRAITS; RISK; HERITABILITY; BEHAVIOR; CULTURE; ORIGINS; WOMEN; SELF		[Falk, Armin] Univ Bonn, Dept Econ, D-53113 Bonn, Germany; [Falk, Armin] Univ Bonn, Behav & Inequal Res Inst Briq, D-53113 Bonn, Germany; [Hermle, Johannes] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	University of Bonn; University of Bonn; University of California System; University of California Berkeley	Falk, A (corresponding author), Univ Bonn, Dept Econ, D-53113 Bonn, Germany.; Falk, A (corresponding author), Univ Bonn, Behav & Inequal Res Inst Briq, D-53113 Bonn, Germany.; Hermle, J (corresponding author), Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA.	armin.falk@briq-institute.org; j.hermle@berkeley.edu		Falk, Armin/0000-0002-7284-3002; Hermle, Johannes/0000-0003-0852-3597	European Research Council through ERC [209214]	European Research Council through ERC(European Research Council (ERC))	Supported by the European Research Council through ERC #209214 (A.F.).	Almas I, 2016, MANAGE SCI, V62, P2149, DOI 10.1287/mnsc.2015.2244; Ashraf Q, 2013, AM ECON REV, V103, P1, DOI 10.1257/aer.103.1.1; Bertrand M, 2011, HBK ECON, V4, P1543, DOI 10.1016/S0169-7218(11)02415-4; Buser T, 2014, Q J ECON, V129, P1409, DOI 10.1093/qje/qju009; BUSS DM, 1995, AM PSYCHOL, V50, P164, DOI 10.1037/0003-066X.50.3.164; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI 10.1037//0022-3514.81.2.322; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; DeLeire T, 2004, J LABOR ECON, V22, P925, DOI 10.1086/423159; Doepke M, 2009, Q J ECON, V124, P1541, DOI 10.1162/qjec.2009.124.4.1541; Duflo E, 2012, J ECON LIT, V50, P1051, DOI 10.1257/jel.50.4.1051; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Falk A., 2016, 9674 IZA; Falk A, 2018, Q J ECON, V133, P1645, DOI 10.1093/qje/qjy013; Fernandez R, 2004, Q J ECON, V119, P1249, DOI 10.1162/0033553042476224; Fernandez R, 2009, AM ECON J-MACROECON, V1, P146, DOI 10.1257/mac.1.1.146; Geary DC, 1999, CURR DIR PSYCHOL SCI, V8, P115, DOI 10.1111/1467-8721.00027; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Guimond S, 2006, J PERS SOC PSYCHOL, V90, P221, DOI 10.1037/0022-3514.90.2.221; Guimond S, 2007, J PERS SOC PSYCHOL, V92, P1118, DOI 10.1037/0022-3514.92.6.1118; Guimond S, 2008, SOC PERSONAL PSYCHOL, V2, P494, DOI 10.1111/j.1751-9004.2007.00036.x; Haushofer J, 2014, SCIENCE, V344, P862, DOI 10.1126/science.1232491; Inglehart R., 2015, SILENT REVOLUTION CH; Inglehart R. F., 2003, RISING TIDE GENDER E; Maccoby E.E., 1974, PSYCHOL SEX DIFFEREN; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schwartz SH, 2005, J PERS SOC PSYCHOL, V89, P1010, DOI 10.1037/0022-3514.89.6.1010; Tanaka T, 2010, AM ECON REV, V100, P557, DOI 10.1257/aer.100.1.557; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Yuki M, 2003, SOC PSYCHOL QUART, V66, P166, DOI 10.2307/1519846; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106	35	103	105	10	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412							eaas9899	10.1126/science.aas9899	http://dx.doi.org/10.1126/science.aas9899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337384	Green Submitted, Bronze			2022-12-28	WOS:000447680100039
J	Mayor, S				Mayor, Susan			BMJ Awards: nominations open with six new categories for 2019	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4434	10.1136/bmj.k4434	http://dx.doi.org/10.1136/bmj.k4434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341063				2022-12-28	WOS:000448271300011
J	Wallis, CJD; Detsky, AS; Fan, E				Wallis, Christopher J. D.; Detsky, Allan S.; Fan, Eddy			Establishing the Effectiveness of Procedural Interventions The Limited Role of Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wallis, Christopher J. D.] Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada; [Detsky, Allan S.; Fan, Eddy] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.; Fan, Eddy] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Fan, Eddy] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	allan.detsky@sinaihealthsystem.ca						BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Bothwell LE, 2016, NEW ENGL J MED, V374, P2175, DOI 10.1056/NEJMms1604593; Carragee EJ, 2010, JAMA-J AM MED ASSOC, V303, P1309, DOI 10.1001/jama.2010.402; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Ibrahim AM, 2017, JAMA-J AM MED ASSOC, V318, P327, DOI 10.1001/jama.2017.6584; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; US Food and Drug Administration, 2018, DEV DEV PROC STEP 3; Wright JD, 2017, JAMA-J AM MED ASSOC, V318, P1545, DOI 10.1001/jama.2017.13696	10	23	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2018	320	23					2421	2422		10.1001/jama.2018.16329	http://dx.doi.org/10.1001/jama.2018.16329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HE7FX	30383172				2022-12-28	WOS:000453596700012
J	Borducchi, EN; Liu, JY; Nkolola, JP; Cadena, AM; Yu, WH; Fischinger, S; Broge, T; Abbink, P; Mercado, NB; Chandrashekar, A; Jetton, D; Peter, L; McMahan, K; Moseley, ET; Bekerman, E; Hesselgesser, J; Li, WJ; Lewis, MG; Alter, G; Geleziunas, R; Barouch, DH				Borducchi, Erica N.; Liu, Jinyan; Nkolola, Joseph P.; Cadena, Anthony M.; Yu, Wen-Han; Fischinger, Stephanie; Broge, Thomas; Abbink, Peter; Mercado, Noe B.; Chandrashekar, Abishek; Jetton, David; Peter, Lauren; McMahan, Katherine; Moseley, Edward T.; Bekerman, Elena; Hesselgesser, Joseph; Li, Wenjun; Lewis, Mark G.; Alter, Galit; Geleziunas, Romas; Barouch, Dan H.			Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys (vol 563, pg 360, 2018)	NATURE			English	Correction													; Mercado, Noe/ABE-8247-2020	Jetton, David/0000-0002-1615-9986; Mercado, Noe/0000-0001-7769-7326; Peter, Lauren/0000-0002-2105-7503				Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6	1	11	11	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2018	564	7734					E8	E8		10.1038/s41586-018-0721-y	http://dx.doi.org/10.1038/s41586-018-0721-y			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1KR	30397346	Bronze			2022-12-28	WOS:000452269400006
J	Arterburn, D; Wellman, R; Emiliano, A; Smith, SR; Odegaard, AO; Murali, S; Williams, N; Coleman, KJ; Courcoulas, A; Coley, RY; Anau, J; Pardee, R; Toh, S; Janning, C; Cook, A; Sturtevant, J; Horgan, C; McTigue, KM				Arterburn, David; Wellman, Robert; Emiliano, Ana; Smith, Steven R.; Odegaard, Andrew O.; Murali, Sameer; Williams, Neely; Coleman, Karen J.; Courcoulas, Anita; Coley, R. Yates; Anau, Jane; Pardee, Roy; Toh, Sengwee; Janning, Cheri; Cook, Andrea; Sturtevant, Jessica; Horgan, Casie; McTigue, Kathleen M.		PCORNET Bariatric Study	Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss A PCORnet Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LAPAROSCOPIC-SLEEVE-GASTRECTOMY; Y GASTRIC BYPASS; MORBID-OBESITY; SURGERY; OUTCOMES; PATIENT; METAANALYSIS; SELECTION; TRIAL	Background: There has been a dramatic shift in use of bariatric procedures, but little is known about their long-term comparative effectiveness. Objective: To compare weight loss and safety among bariatric procedures. Design: Retrospective observational cohort study, January 2005 to September 2015. (ClinicalTrials.gov: NCT02741674) Setting: 41 health systems in the National Patient-Centered Clinical Research Network. Participants: 65 093 patients aged 20 to 79 years with body mass index (BMI) of 35 kg/m(2) or greater who had bariatric procedures. Intervention: 32 208 Roux-en-Y gastric bypass (RYGB), 29 693 sleeve gastrectomy (SG), and 3192 adjustable gastric banding (AGB) procedures. Measurements: Estimated percent total weight loss (TWL) at 1, 3, and 5 years; 30-day rates of major adverse events. Results: Total numbers of eligible patients with weight measures at 1, 3, and 5 years were 44 978 (84%), 20 783 (68%), and 7159 (69%), respectively. Thirty-day rates of major adverse events were 5.0% for RYGB, 2.6% for SG, and 2.9% for AGB. One- year mean TWLs were 31.2% (95% CI, 31.1% to 31.3%) for RYGB, 25.2% (CI, 25.1% to 25.4%) for SG, and 13.7% (CI, 13.3% to 14.0%) for AGB. At 1 year, RYGB patients lost 5.9 (CI, 5.8 to 6.1) percentage points more weight than SG patients and 17.7 (CI, 17.3 to 18.1) percentage points more than AGB patients, and SG patients lost 12.0 (CI, 11.6 to 12.5) percentage points more than AGB patients. Five-year mean TWLs were 25.5% (CI, 25.1% to 25.9%) for RYGB, 18.8% (CI, 18.0% to 19.6%) for SG, and 11.7% (CI, 10.2% to 13.1%) for AGB. Patients with diabetes, those with BMI less than 50 kg/m(2), those aged 65 years or older, African American patients, and Hispanic patients lost less weight than patients without those characteristics. Limitation: Potential unobserved confounding due to nonrandomized design; electronic health record databases had missing outcome data. Conclusion: Adults lost more weight with RYGB than with SG or AGB at 1, 3, and 5 years; however, RYGB had the highest 30-day rate of major adverse events. Small subgroup differences in weight loss outcomes were observed.	[Arterburn, David; Wellman, Robert; Coley, R. Yates; Anau, Jane; Pardee, Roy; Cook, Andrea] Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98108 USA; [Emiliano, Ana] Rockefeller Univ, Hosp 431, Lab Biochem Genet & Metab, Box 179,1200 York Ave, New York, NY 10065 USA; [Smith, Steven R.] Florida Hosp, Translat Res Inst Metab & Diabet, 301 East Princeton St, Orlando, FL 32804 USA; [Odegaard, Andrew O.] Univ Calif Irvine, Sch Med, Dept Epidemiol, 224 Irvine Hall, Irvine, CA 92697 USA; [Murali, Sameer; Coleman, Karen J.] Kaiser Permanente Southern Calif, 100 South Los Robles, Pasadena, CA USA; [Williams, Neely] Community Partners Network, 850 West Trinity Lane, Nashville, TN 37207 USA; [Courcoulas, Anita] Univ Pittsburgh, Dept Surg, 3800 Blvd Allies,Suite 390, Pittsburgh, PA 15213 USA; [McTigue, Kathleen M.] Univ Pittsburgh, Ctr Res Hlth Care, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA; [Toh, Sengwee; Sturtevant, Jessica; Horgan, Casie] Harvard Med Sch, Dept Populat Med, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Toh, Sengwee; Sturtevant, Jessica; Horgan, Casie] Harvard Pilgrim Hlth Care Inst, 401 Pk Dr,Suite 401, Boston, MA 02215 USA; [Janning, Cheri] Duke Clin & Translat Sci Inst, 701 West Trinity Ave,111, Durham, NC 27701 USA; [Murali, Sameer] Kaiser Permanente Southern Calif, 17296 Slover Ave, Fontana, CA 92337 USA	Kaiser Permanente; Rockefeller University; Adventist Health Services; AdventHealth; University of California System; University of California Irvine; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Kaiser Permanente	Arterburn, D (corresponding author), Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98108 USA.	david.e.arterburn@kp.org	Smith, Steven/HDM-9496-2022; Toh, Sengwee/D-7567-2017	Toh, Sengwee/0000-0002-5160-0810; Smith, Steven/0000-0002-5098-8147	Patient-Centered Outcomes Research Institute [OBS-1505-30683]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Patient-Centered Outcomes Research Institute via contract OBS-1505-30683.	Angrisani L, 2017, OBES SURG, V27, P2279, DOI 10.1007/s11695-017-2666-x; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Arterburn D, 2014, JAMA SURG, V149, P1279, DOI 10.1001/jamasurg.2014.1674; Arterburn D, 2013, SURG OBES RELAT DIS, V9, P837, DOI 10.1016/j.soard.2013.05.006; Arterburn DE, 2010, CLIN MED RES, V8, P126, DOI 10.3121/cmr.2010.880; Arterburn DE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3961; Balla A, 2017, J LAPAROENDOSC ADV S, V27, P1165, DOI 10.1089/lap.2017.0059; Barzin Maryam, 2016, Gastroenterol Hepatol Bed Bench, V9, pS62; Brethauer SA, 2015, SURG OBES RELAT DIS, V11, P489, DOI 10.1016/j.soard.2015.02.003; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Coleman KJ, 2014, SURG OBES RELAT DIS, V10, P396, DOI 10.1016/j.soard.2014.02.044; Courcoulas AP, 2015, SURG OBES RELAT DIS, V11, P1109, DOI 10.1016/j.soard.2015.01.011; El Chaar M, 2015, OBES SURG, V25, P254, DOI 10.1007/s11695-014-1388-6; Ferrer-Marquez M, 2017, OBES SURG, V27, P303, DOI 10.1007/s11695-016-2274-1; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Helmio M, 2014, SCAND J SURG, V103, P175, DOI 10.1177/1457496913509984; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Ibrahim AM, 2017, JAMA SURG, V152, P629, DOI 10.1001/jamasurg.2017.0542; Inge TH, 2018, SURG OBES RELAT DIS, V14, P1374, DOI 10.1016/j.soard.2018.04.002; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Li JF, 2016, OBES SURG, V26, P429, DOI 10.1007/s11695-015-1996-9; Macht R, 2016, OBES SURG, V26, P1635, DOI 10.1007/s11695-016-2164-6; Maciejewski ML, 2016, JAMA SURG, V151, P1046, DOI 10.1001/jamasurg.2016.2317; Osland E, 2017, SURG LAPARO ENDO PER, V27, P8, DOI 10.1097/SLE.0000000000000374; Peterli R, 2018, JAMA-J AM MED ASSOC, V319, P255, DOI 10.1001/jama.2017.20897; Ponce J, 2016, SURG OBES RELAT DIS, V12, P1637, DOI 10.1016/j.soard.2016.08.488; Reames BN, 2014, DARTMOUTH ATLAS HLTH; Reames BN, 2014, JAMA-J AM MED ASSOC, V312, P959, DOI 10.1001/jama.2014.7651; Salminen P, 2018, JAMA-J AM MED ASSOC, V319, P241, DOI 10.1001/jama.2017.20313; Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869; Smetana GW, 2017, ANN INTERN MED, V166, P808, DOI 10.7326/M17-0698; Sudan R, 2017, SURG OBES RELAT DIS, V13, P826, DOI 10.1016/j.soard.2017.01.021; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Toh S, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.8323; Weinstein AL, 2014, OBES SURG, V24, P1933, DOI 10.1007/s11695-014-1270-6; Yip S, 2013, OBES SURG, V23, P1994, DOI 10.1007/s11695-013-1030-z; Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2	41	120	122	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2018	169	11					741	+		10.7326/M17-2786	http://dx.doi.org/10.7326/M17-2786			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4WR	30383139	Green Accepted			2022-12-28	WOS:000451806000003
J	Cooper, DJ; Nichol, AD; Bailey, M; Bernard, S; Cameron, PA; Pili-Floury, S; Forbes, A; Gantner, D; Higgins, AM; Huet, O; Kasza, J; Murray, L; Newby, L; Presneill, JJ; Rashford, S; Rosenfeld, JV; Stephenson, M; Vallance, S; Varma, D; Webb, SAR; Trapani, T; McArthur, C				Cooper, D. James; Nichol, Alistair D.; Bailey, Michael; Bernard, Stephen; Cameron, Peter A.; Pili-Floury, Sebastien; Forbes, Andrew; Gantner, Dashiell; Higgins, Alisa M.; Huet, Olivier; Kasza, Jessica; Murray, Lynne; Newby, Lynette; Presneill, Jeffrey J.; Rashford, Stephen; Rosenfeld, Jeffrey V.; Stephenson, Michael; Vallance, Shirley; Varma, Dinesh; Webb, Steven A. R.; Trapani, Tony; McArthur, Colin		POLAR Trial Investigators ANZICS	Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury The POLAR Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; MANAGEMENT; PATHOPHYSIOLOGY; RESUSCITATION; GUIDELINES; SALINE	IMPORTANCE After severe traumatic brain injury, induction of prophylactic hypothermia has been suggested to be neuroprotective and improve long-term neurologic outcomes. OBJECTIVE To determine the effectiveness of early prophylactic hypothermia compared with normothermic management of patients after severe traumatic brain injury. DESIGN, SETTING, AND PARTICIPANTS The Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury-Randomized Clinical Trial (POLAR-RCT) was a multicenter randomized trial in 6 countries that recruited 511 patients both out-of-hospital and in emergency departments after severe traumatic brain injury. The first patient was enrolled on December 5. 2010, and the last on November 10.2017. The final date of follow-up was May 15, 2018. INTERVENTIONS There were 266 patients randomized to the prophylactic hypothermia group and 245 to normothermic management. Prophylactic hypothermia targeted the early induction of hypothermia (33 degrees C-35 degrees C) for at least 72 hours and up to 7 days if intracranial pressures were elevated, followed by gradual rewarming. Normothermia targeted 37 degrees C, using surface-cooling wraps when required. Temperature was managed in both groups for 7 days. All other care was at the discretion of the treating physician. MAIN OUTCOMES AND MEASURES The primary outcome was favorable neurologic outcomes or independent living (Glasgow Outcome Scale-Extended score, 5-8 [scale range, 1-8]) obtained by blinded assessors 6 months after injury. RESULTS Among 511 patients who were randomized. 500 provided ongoing consent (mean age, 34.5 years [SD. 13.4); 402 men [80.2%]) and 466 completed the primary outcome evaluation. Hypothermia was initiated rapidly after injury (median, 1.8 hours [IQR, 1.0-2.7 hours]) and rewarming occurred slowly (median, 22.5 hours [IQR, 16-27 hours)). Favorable outcomes (Glasgow Outcome Scale-Extended score, 5-8) at 6 months occurred in 117 patients (48.8%) in the hypothermia group and 111(49.1%) in the normothermia group (risk difference, 0.4% [95% CI, -9.4% to 8.7%]; relative risk with hypothermia, 0.99 [95% CI, 0.82-1.19]; P = .94). In the hypothermia and normothermia groups, the rates of pneumonia were 55.0% vs 51.3%, respectively, and rates of increased intracranial bleeding were 18.1% vs 15.4%, respectively. CONCLUSIONS AND RELEVANCE Among patients with severe traumatic brain injury, early prophylactic hypothermia compared with normothermia did not improve neurologic outcomes at 6 months. These findings do not support the use of early prophylactic hypothermia for patients with severe traumatic brain injury.	[Cooper, D. James; Nichol, Alistair D.; Bailey, Michael; Gantner, Dashiell; Higgins, Alisa M.; Huet, Olivier; Murray, Lynne; Newby, Lynette; Presneill, Jeffrey J.; Stephenson, Michael; Vallance, Shirley; Webb, Steven A. R.; Trapani, Tony; McArthur, Colin] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Cooper, D. James; Nichol, Alistair D.; Bernard, Stephen; Gantner, Dashiell; Vallance, Shirley; Trapani, Tony] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair D.] St Vincents Univ Hosp, Univ Coll Dublin, Clin Res Ctr, Irish Crit Care Clin Trials Network, Dublin, Ireland; [Nichol, Alistair D.] St Vincents Univ Hosp, Dept Anaesthesia & Intens Care Med, Dublin, Ireland; [Nichol, Alistair D.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Bernard, Stephen; Stephenson, Michael] Ambulance Victoria, Melbourne, Vic, Australia; [Cameron, Peter A.; Forbes, Andrew; Kasza, Jessica] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cameron, Peter A.; Gantner, Dashiell] Monash Univ, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic, Australia; [Cameron, Peter A.] Hamad Med Corp, Emergency Med, Dhueta, Qatar; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Pili-Floury, Sebastien] CHU Besancon, Serv Reanimat Chirurg, Pole Anesthesie & Reanimat, Besancon, France; [Huet, Olivier] CHRU Brest, Hop La Cavale Blanche, Dept Anaesthesia & Intens Care Med, Brest, France; [Huet, Olivier] Univ Bretagne Occidenta, UFR Med & Sci Sante, Brest, France; [Newby, Lynette; McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Presneill, Jeffrey J.] Royal Melbourne Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Presneill, Jeffrey J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Rashford, Stephen] Queensland Ambulance Serv, Brisbane, Qld, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Neurosurg, Melbourne, Vic, Australia; [Rashford, Stephen; Varma, Dinesh] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD 20814 USA; [Varma, Dinesh] Alfred Hosp, Radiol, Melbourne, Vic, Australia; [Webb, Steven A. R.] Royal Perth Hosp, Intens Care Unit, Perth, WA, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Monash University; Monash University; Hamad Medical Corporation; Florey Institute of Neuroscience & Mental Health; Universite de Franche-Comte; CHU Besancon; CHU Brest; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Auckland City Hospital; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Uniformed Services University of the Health Sciences - USA; Florey Institute of Neuroscience & Mental Health; Royal Perth Hospital; University of Western Australia	Cooper, DJ (corresponding author), Monash Univ, ANZIC Res Ctr, 553 St Kilda Rd,Level 3, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Haenggi, Matthias/A-8073-2008; Cooper, D. James/G-7961-2013; Haenggi, Matthias/O-2642-2019; /AAB-3060-2019; Higgins, Alisa/AAM-8088-2020; Presneill, Jeffrey/B-4894-2012	Haenggi, Matthias/0000-0001-5845-031X; Cooper, D. James/0000-0002-5872-9051; Haenggi, Matthias/0000-0001-5845-031X; Higgins, Alisa/0000-0001-8295-7559; Forbes, Andrew/0000-0003-4269-914X; Nichol, Alistair/0000-0002-4689-1238; Myburgh, John/0000-0003-4088-7016; Abdurraheim, Nuri/0000-0001-9498-4853; Alsolamy, Sami/0000-0002-0127-0307; Presneill, Jeffrey/0000-0001-7177-7667	National Health and Medical Research Council of Australia [545901, 1121037]; Victorian Neurotrauma Initiative (VNI) [VNI D162]; Teaching Hospital of Besancon, France; Health Research Board of Ireland Clinical Trial Network Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Neurotrauma Initiative (VNI); Teaching Hospital of Besancon, France; Health Research Board of Ireland Clinical Trial Network Program	This trial was supported by grants from the National Health and Medical Research Council of Australia (545901 and 1121037); the Victorian Neurotrauma Initiative (VNI for the Transport Accident Commission, Victoria, Australia) (VNI D162); the Teaching Hospital of Besancon, France; and Health Research Board of Ireland Clinical Trial Network Program.	Access Economics Pty Limited for the Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bramlett HM, 2012, THER HYPOTHERMIA TEM, V2, P14, DOI 10.1089/ther.2012.0002; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dengler B, 2015, J CRIT CARE, V30, P823, DOI 10.1016/j.jcrc.2015.03.027; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Liu YH, 2015, EXP THER MED, V9, P464, DOI 10.3892/etm.2014.2130; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Nichol AD, 2011, LANCET NEUROL, V10, P405, DOI 10.1016/S1474-4422(11)70085-0; Olah E, 2018, J NEUROTRAUM, V35, P2407, DOI 10.1089/neu.2018.5649; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Presneill J, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2610-y; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Smrcka M, 2005, ACT NEUR S, V95, P273; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	33	128	137	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2018	320	21					2211	2220		10.1001/jama.2018.17075	http://dx.doi.org/10.1001/jama.2018.17075			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4MB	30357266	Green Published, Bronze			2022-12-28	WOS:000452500600012
J	Wisotzki, L; Bacon, R; Brinchmann, J; Cantalupo, S; Richter, P; Schaye, J; Schmidt, KB; Urrutia, T; Weilbacher, PM; Akhlaghi, M; Bouche, N; Contini, T; Guiderdoni, B; Herenz, EC; Inami, H; Kerutt, J; Leclercq, F; Marino, RA; Maseda, M; Monreal-Ibero, A; Nanayakkara, T; Richard, J; Saust, R; Steinmetz, M; Wendt, M				Wisotzki, L.; Bacon, R.; Brinchmann, J.; Cantalupo, S.; Richter, P.; Schaye, J.; Schmidt, K. B.; Urrutia, T.; Weilbacher, P. M.; Akhlaghi, M.; Bouche, N.; Contini, T.; Guiderdoni, B.; Herenz, E. C.; Inami, H.; Kerutt, J.; Leclercq, F.; Marino, R. A.; Maseda, M.; Monreal-Ibero, A.; Nanayakkara, T.; Richard, J.; Saust, R.; Steinmetz, M.; Wendt, M.			Nearly all the sky is covered by Lyman-alpha emission around high-redshift galaxies (vol 562, pg 229, 2018)	NATURE			English	Correction									[Akhlaghi, M.] Univ Lyon 1, Univ Lyon, ENS Lyon, CNRS,Ctr Rech Astrophys Lyon, St Genis Laval, France; [Akhlaghi, M.] Leiden Univ, Leiden Observ, Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Leiden University; Leiden University - Excl LUMC	Akhlaghi, M (corresponding author), Univ Lyon 1, Univ Lyon, ENS Lyon, CNRS,Ctr Rech Astrophys Lyon, St Genis Laval, France.; Akhlaghi, M (corresponding author), Leiden Univ, Leiden Observ, Leiden, Netherlands.		Nanayakkara, Themiya/AAT-6271-2020; Contini, Thierry/AAQ-1509-2021; Steinmetz, Matthias/Q-7785-2019; Ibero, Ana Monreal/L-8370-2018; Brinchmann, Jarle/M-2616-2015	Nanayakkara, Themiya/0000-0003-2804-0648; Steinmetz, Matthias/0000-0001-6516-7459; Ibero, Ana Monreal/0000-0002-6455-2491; Brinchmann, Jarle/0000-0003-4359-8797				Wisotzki L, 2018, NATURE, V562, P229, DOI 10.1038/s41586-018-0564-6	1	1	1	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2018	563	7733								10.1038/s41586-018-0664-3	http://dx.doi.org/10.1038/s41586-018-0664-3			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC1YT	30377312	Bronze			2022-12-28	WOS:000451599900010
J	Sievers, QL; Petzold, G; Bunker, RD; Renneville, A; Slabicki, M; Liddicoat, BJ; Abdulrahman, W; Mikkelsen, T; Ebert, BL; Thoma, NH				Sievers, Quinlan L.; Petzold, Georg; Bunker, Richard D.; Renneville, Aline; Slabicki, Mikolaj; Liddicoat, Brian J.; Abdulrahman, Wassim; Mikkelsen, Tarjei; Ebert, Benjamin L.; Thoma, Nicolas H.			Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN	SCIENCE			English	Article							UBIQUITIN LIGASE; IKAROS; GENE; DEGRADATION; RECRUITMENT; COMPLEX; KINASE	The small molecules thalidomide, lenalidomide, and pomalidomide induce the ubiquitination and proteasomal degradation of the transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) by recruiting a Cys(2)-His(2) (C2H2) zinc finger domain to Cereblon (CRBN), the substrate receptor of the CRL4(CRBN) E3 ubiquitin ligase. We screened the human C2H2 zinc finger proteome for degradation in the presence of thalidomide analogs, identifying 11 zinc finger degrons. Structural and functional characterization of the C2H2 zinc finger degrons demonstrates how diverse zinc finger domains bind the permissive drug-CRBN interface. Computational zinc finger docking and biochemical analysis predict that more than 150 zinc fingers bind the drug-CRBN complex in vitro, and we show that selective zinc finger degradation can be achieved through compound modifications. Our results provide a rationale for therapeutically targeting transcription factors that were previously considered undruggable.	[Sievers, Quinlan L.; Renneville, Aline; Slabicki, Mikolaj; Liddicoat, Brian J.; Mikkelsen, Tarjei; Ebert, Benjamin L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Sievers, Quinlan L.; Renneville, Aline; Slabicki, Mikolaj; Liddicoat, Brian J.; Ebert, Benjamin L.] Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Petzold, Georg; Bunker, Richard D.; Abdulrahman, Wassim; Thoma, Nicolas H.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Slabicki, Mikolaj] Natl Ctr Tumor Dis, Div Translat Oncol, Heidelberg, Germany; [Slabicki, Mikolaj] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Abdulrahman, Wassim] LeadXpro AG Pk InnovAARE, CH-5232 Villigen, Switzerland; [Mikkelsen, Tarjei] 10x Genom, 7068 Koll Ctr Pkwy 401, Pleasanton, CA 94566 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Friedrich Miescher Institute for Biomedical Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute	Ebert, BL (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Ebert, BL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.; Thoma, NH (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.; Ebert, BL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	benajmin_ebert@dfci.harvard.edu; nicolas.thoma@fmi.ch	Mikkelsen, Tarjei S/A-1306-2007; Ebert, Benjamin/ABD-6546-2021; Renneville, Aline/AAW-5451-2020	Mikkelsen, Tarjei S/0000-0002-8133-3135; Ebert, Benjamin/0000-0003-0197-5451; Renneville, Aline/0000-0003-0805-9640; Liddicoat, Brian/0000-0003-3644-2241; Petzold, Georg/0000-0001-5649-1716; Bunker, Richard/0000-0001-8866-5290; Slabicki, Mikolaj/0000-0001-6317-9296; Sievers, Quinlan/0000-0003-4875-0022; Thoma, Nicolas/0000-0003-2685-906X	NIH [R01HL082945, P01CA108631]; Howard Hughes Medical Institute; Edward P. Evans Foundation; Leukemia and Lymphoma Society; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [666068]; National Institute of General Medical Sciences [T32GM007753]; Human Frontier Science Program (HFSP Long-Term Fellowship) [LT000210/2014]; European Molecular Biology Organization (EMBO Advanced Fellowship) [aALTF 761-2016]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [702642]; National Health and Medical Research Council [APP1124979]; NATIONAL CANCER INSTITUTE [P01CA108631, P50CA206963, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, R01HL082941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Edward P. Evans Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program (HFSP Long-Term Fellowship); European Molecular Biology Organization (EMBO Advanced Fellowship); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	B.L.E. received funding from the NIH (R01HL082945 and P01CA108631), the Howard Hughes Medical Institute, the Edward P. Evans Foundation, and the Leukemia and Lymphoma Society. N.H.T. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement 666068). Q.L.S. was supported by award T32GM007753 from the National Institute of General Medical Sciences. G.P. was supported by the Human Frontier Science Program (HFSP Long-Term Fellowship LT000210/2014) and the European Molecular Biology Organization (EMBO Advanced Fellowship aALTF 761-2016). M.S. received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement 702642. B.J.L. was supported by the National Health and Medical Research Council (Early Career Fellowships Grant APP1124979).	Abdulrahman W, 2009, ANAL BIOCHEM, V385, P383, DOI 10.1016/j.ab.2008.10.044; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; An J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15398; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Blanc E., 2011, BUSTER VERSION 2 11; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Conomos D, 2014, NAT STRUCT MOL BIOL, V21, P760, DOI 10.1038/nsmb.2877; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Dykes IM, 2014, CIRC RES, V115, P23, DOI 10.1161/CIRCRESAHA.115.303300; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fink EC, 2015, BLOOD, V126, P2366, DOI 10.1182/blood-2015-07-567958; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Hagner PR, 2015, BLOOD, V126, P779, DOI 10.1182/blood-2015-02-628669; Jin XJ, 2010, J BIOL CHEM, V285, P30539, DOI 10.1074/jbc.M110.129551; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Matyskiela ME, 2018, J MED CHEM, V61, P535, DOI 10.1021/acs.jmedchem.6b01921; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morinaga T, 2005, NUCLEIC ACIDS RES, V33, P4191, DOI 10.1093/nar/gki734; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Schneider RK, 2014, CANCER CELL, V26, P509, DOI 10.1016/j.ccr.2014.08.001; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Tickle I.J., 2017, STARANISO; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Vallecillo-Garcia P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01120-3; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Waterman D. G., 2013, CCP4 NEWSLETTER PROT, V49, P16; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	43	177	181	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		558	+	eaat0572	10.1126/science.aat0572	http://dx.doi.org/10.1126/science.aat0572			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385546	Green Accepted			2022-12-28	WOS:000450460000038
J	Perkel, JM				Perkel, Jeffrey M.			Web service makes big data available to neuroscientists	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008				Vogelstein JT, 2018, NAT METHODS, V15, P846, DOI 10.1038/s41592-018-0181-1	1	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					143	143		10.1038/d41586-018-07195-2	http://dx.doi.org/10.1038/d41586-018-07195-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30377329				2022-12-28	WOS:000448900900062
J	Murphy, F				Murphy, Flynn			PRIMARY CARE China's plan for 500 000 new GPs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												flynnpmurphy@gmail.com						China Joint Study Partnership: World Bank Group World Health Organization Ministry of Finance National Health and Family Planning Commission Ministry of Human Resources and Social Security, 2016, DEEP HLTH REF CHIN B; Han XL, 2014, CHINESE MED J-PEKING, V127, P4287, DOI 10.3760/cma.j.issn.0366-6999.20141663; Huang YZ., 2002, HARV HLTH POLICY REV, V3, P1; Li Donald, 2016, J Family Med Prim Care, V5, P1, DOI 10.4103/2249-4863.184614; Market Line, 2018, CHIN IN DEPTH PESTLE; Rithmire M, 2018, CHINA QUESTIONS CRIT, DOI [10.4159/9780674982703-017, DOI 10.4159/9780674982703-017]; Seto KC, 2013, WHAT SHOULD WE UNDER; Shaoze W, 2016, WILL VIOLENCE DOCTOR; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wee SL, 2018, CHINAS HLTH CARE CRI; World Health Organization, 2008, CHIN VILL DOCT TAK G; Xiaodong W, 2018, CHINA TRAIN 500 000; Xu SC, 2017, ENDEAVOUR, V41, P136, DOI 10.1016/j.endeavour.2017.06.004; Yue Z., 2017, CHINA DAILY	14	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2018	363								k4015	10.1136/bmj.k4015	http://dx.doi.org/10.1136/bmj.k4015			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8QD	30366963				2022-12-28	WOS:000448896600001
J	Hicks, BM; Filion, KB; Yin, H; Sakr, L; Udell, JA; Azoulay, L				Hicks, Blanaid M.; Filion, Kristian B.; Yin, Hui; Sakr, Lama; Udell, Jacob A.; Azoulay, Laurent			Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MARGINAL STRUCTURAL MODELS; RECEPTOR BLOCKERS; BRADYKININ; BLOCKADE; SYSTEM; SCORES; METAANALYSIS; PERFORMANCE; REGRESSION; SURVIVAL	OBJECTIVE To determine whether the use of angiotensin converting enzyme inhibitors (ACEIs), compared with use of angiotensin receptor blockers, is associated with an increased risk of lung cancer. DESIGN Population based cohort study. SETTING United Kingdom Clinical Practice Research Datalink. PARTICIPANTS A cohort of 992 061 patients newly treated with antihypertensive drugs between 1 January 1995 and 31 December 2015 was identified and followed until 31 December 2016. MAIN OUTCOME MEASURES Cox proportional hazards models were used to estimate adjusted hazard ratios with 95% confidence intervals of incident lung cancer associated with the time varying use of ACEIs, compared with use of angiotensin receptor blockers, overall, by cumulative duration of use, and by time since initiation. RESULTS The cohort was followed for a mean of 6.4 (SD 4.7) years, generating 7952 incident lung cancer events (crude incidence 1.3 (95% confidence interval 1.2 to 1.3) per 1000 person years). Overall, use of ACEIs was associated with an increased risk of lung cancer (incidence rate 1.6 v1.2 per 1000 person years; hazard ratio 1.14, 95% confidence interval 1.01 to 1.29), compared with use of angiotensin receptor blockers. Hazard ratios gradually increased with longer durations of use, with an association evident after five years of use (hazard ratio 1.22, 1.06 to 1.40) and peaking after more than 10 years of use (1.31, 1.08 to 1.59). Similar findings were observed with time since initiation. CONCLUSIONS In this population based cohort study, the use of ACEIs was associated with an increased risk of lung cancer. The association was particularly elevated among people using ACEIs for more than five years. Additional studies, with long term follow-up, are needed to investigate the effects of these drugs on incidence of lung cancer.	[Hicks, Blanaid M.; Filion, Kristian B.; Yin, Hui; Azoulay, Laurent] Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Hicks, Blanaid M.; Filion, Kristian B.; Azoulay, Laurent] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Hicks, Blanaid M.] Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Filion, Kristian B.] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Sakr, Lama] Jewish Gen Hosp, Dept Med, Div Pulm Dis, Montreal, PQ, Canada; [Udell, Jacob A.] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Udell, Jacob A.] Univ Toronto, Womens Coll Hosp, Dept Med, Cardiovasc Div, Toronto, ON, Canada; [Udell, Jacob A.] Univ Toronto, Toronto Gen Hosp, Peter Munk Cardiac Ctr, Dept Med,Cardiovasc Div, Toronto, ON, Canada; [Azoulay, Laurent] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Queens University Belfast; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McGill University	Azoulay, L (corresponding author), Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.; Azoulay, L (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Azoulay, L (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; FRQS; McGill University; Fonds de recherche du Quebec - Sante (FRQS); Cancer Research UK population research fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); FRQS; McGill University; Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec); Cancer Research UK population research fellowship	This study was funded by a Foundation Scheme grant from the Canadian Institutes of Health Research. BMH holds a Cancer Research UK population research fellowship. KBF holds a chercheur-boursier junior 2 award from the Fonds de recherche du Quebec - Sante (FRQS) and is the recipient of a William Dawson scholar award from McGill University. JAU holds a Heart and Stroke Foundation of Canada national new investigator/Ontario clinician scientist (phase I) award. LA holds a chercheur-boursier senior award from the FRQS and is the recipient of a William Dawson scholar award from McGill University. The funding source had no influence on the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Azoulay L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050893; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Fretheim A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-21; Friis S, 2001, CANCER-AM CANCER SOC, V92, P2462, DOI 10.1002/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L; Gokhale M, 2016, PHARMACOEPIDEM DR S, V25, P512, DOI 10.1002/pds.3977; Golias Ch, 2007, Hippokratia, V11, P124; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hallas J, 2012, BRIT J CLIN PHARMACO, V74, P180, DOI 10.1111/j.1365-2125.2012.04170.x; Heinzl H, 1996, STAT MED, V15, P2589, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2589::AID-SIM373>3.0.CO;2-O; Heran BS, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003823.PUB2; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Ishihara K, 2001, JPN J PHARMACOL, V87, P318, DOI 10.1254/jjp.87.318; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Matakidou A, 2005, BRIT J CANCER, V93, P825, DOI 10.1038/sj.bjc.6602769; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Miao LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21359; Munoz M, 2014, AMINO ACIDS, V46, P1727, DOI 10.1007/s00726-014-1736-9; National Health Service, 2017, READ COD; National Health Service Digital, 2015, PRESCR DISP COMM STA; National Institute for Health and Care Excellence, 2016, HYP AD DIAGN MAN; NHS Business Services Authority, 2017, DICT MED DEV; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenthal T, 2009, J HUM HYPERTENS, V23, P623, DOI 10.1038/jhh.2009.21; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Schafer J., 1997, ANAL INCOMPLETE MULT, DOI [10.1201/9781439821862, DOI 10.1201/9781439821862]; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SETHI T, 1991, CANCER RES, V51, P3621; Shen J, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316656679; Singh JSS, 2017, HEART, V103, P1569, DOI 10.1136/heartjnl-2017-311295; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stewart JM, 2003, CURR PHARM DESIGN, V9, P2036, DOI 10.2174/1381612033454171; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Sun FZ, 2018, J CANCER, V9, P2123, DOI 10.7150/jca.24665; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; TRIFILIEFF A, 1993, EUR RESPIR J, V6, P576; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497; Zhang J, 2015, INT J CLIN EXP MED, V8, P12656	52	122	127	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4209	10.1136/bmj.k4209	http://dx.doi.org/10.1136/bmj.k4209			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355745	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000448895300006
J	Siemieniuk, RAC; Chu, DK; Kim, LHY; Guell-Rous, MR; Alhazzani, W; Soccal, PM; Karanicolas, PJ; Farhoumand, PD; Siemieniuk, JLK; Satia, I; Irusen, EM; Refaat, MM; Mikita, JS; Smith, M; Cohen, DN; Vandvik, PO; Agoritsas, T; Lytvyn, L; Guyatt, GH				Siemieniuk, Reed A. C.; Chu, Derek K.; Kim, Lisa Ha-Yeon; Guell-Rous, Maria-Rosa; Alhazzani, Waleed; Soccal, Paola M.; Karanicolas, Paul J.; Farhoumand, Pauline D.; Siemieniuk, Jillian L. K.; Satia, Imran; Irusen, Elvis M.; Refaat, Marwan M.; Mikita, J. Stephen; Smith, Maureen; Cohen, Dian N.; Vandvik, Per O.; Agoritsas, Thomas; Lytvyn, Lyubov; Guyatt, Gordon H.			Oxygen therapy for acutely ill medical patients: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; TASK-FORCE; MANAGEMENT; STROKE; ADULTS; GRADE; PROFESSIONALS; ELEVATION; EMERGENCY; CONSENSUS		[Siemieniuk, Reed A. C.; Alhazzani, Waleed; Agoritsas, Thomas; Lytvyn, Lyubov; Guyatt, Gordon H.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada; [Chu, Derek K.; Kim, Lisa Ha-Yeon; Alhazzani, Waleed; Satia, Imran; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada; [Guell-Rous, Maria-Rosa] Hosp Santa Creu & Sant Pau, Dept Pneumol, Barcelona 08041, Catalonia, Spain; [Soccal, Paola M.] Geneva Univ Hosp, Div Pulm Med, CH-1211 Geneva, Switzerland; [Soccal, Paola M.] Univ Geneva, Fac Med, CH-1206 Geneva, Switzerland; [Karanicolas, Paul J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON M4N 3M5, Canada; [Farhoumand, Pauline D.; Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, CH-1205 Geneva, Switzerland; [Siemieniuk, Jillian L. K.] Alberta Hlth Serv, Calgary, AB T1Y 6J4, Canada; [Irusen, Elvis M.] Stellenbosch Univ, Div Pulmonol, ZA-7505 Cape Town, South Africa; [Irusen, Elvis M.] Stellenbosch Univ, Div Med Intens Care, ZA-7505 Cape Town, South Africa; [Refaat, Marwan M.] Amer Univ Beirut, Fac Med, Dept Internal Med, Beirut 11072020, Lebanon; [Refaat, Marwan M.] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut 11072020, Lebanon; [Refaat, Marwan M.] Amer Univ Beirut, Med Ctr, Beirut 11072020, Lebanon; [Vandvik, Per O.] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1205 Geneva, Switzerland	McMaster University; McMaster University; Hospital of Santa Creu i Sant Pau; University of Geneva; University of Geneva; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Geneva; Alberta Health Services (AHS); University of Calgary; Stellenbosch University; Stellenbosch University; American University of Beirut; American University of Beirut; American University of Beirut; University of Oslo; University of Geneva	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4K1, Canada.	reed.siemieniuk@medportal.ca	Irusen, Elvis/AAU-4571-2020; Farhoumand, Pauline Darbellay/I-7869-2016; Satia, Imran/ABA-2872-2020; Refaat, Marwan/AAI-2179-2021; T, E/HII-8943-2022; Agoritsas, Thomas/F-4321-2014	Satia, Imran/0000-0003-4206-6000; Agoritsas, Thomas/0000-0002-6182-9969; Chu, Derek/0000-0001-8269-4496; Darbellay Farhoumand, Pauline/0000-0003-4108-4266				Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 1920, BMJ-BRIT MED J, Vi, P150; Aside LM, 2018, JAMA-J AM MED ASSOC, V319, P2190, DOI 10.1001/jama.2018.5725; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Beasley R, 2015, RESPIROLOGY, V20, P1182, DOI 10.1111/resp.12620; Blodgett AN., 1890, BOSTON MED SURG J, V123, P481, DOI [10.1056/NEJM189011201232101, DOI 10.1056/NEJM189011201232101]; Burls A, 2010, EMERG MED J, V27, P283, DOI 10.1136/emj.2009.077370; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Hale KE, 2008, EMERG MED J, V25, P773, DOI 10.1136/emj.2008.059287; Hofmann R, 2017, NEW ENGL J MED, V377, P1240, DOI 10.1056/NEJMoa1706222; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kallstrom Thomas J, 2002, Respir Care, V47, P717; Kobayashi A, 2018, EUR J NEUROL, V25, P425, DOI 10.1111/ene.13539; O'Driscoll BR, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2016-209729; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; SIEMIENIUK RA, 2016, BMJ-BRIT MED J, V354, DOI DOI 10.1136/BMJ.I5191; Wetterslev J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008884.pub2	23	120	131	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4169	10.1136/bmj.k4169	http://dx.doi.org/10.1136/bmj.k4169			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355567				2022-12-28	WOS:000448895300004
J	Slomski, A				Slomski, Anita			Fish Oil in Pregnancy Stimulates Growth in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1631	1631		10.1001/jama.2018.15678	http://dx.doi.org/10.1001/jama.2018.15678			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357292				2022-12-28	WOS:000448069100004
J	O'Dowd, A				O'Dowd, Adrian			MPs call for 10 year social care plan to match the imminent NHS long term plan	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4424	10.1136/bmj.k4424	http://dx.doi.org/10.1136/bmj.k4424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341061				2022-12-28	WOS:000448271300006
J	Boyden, E; Guo, S; Klein, R; Rico, B; Ruta, V				Boyden, Edward; Guo, Su; Klein, Rudiger; Rico, Beatriz; Ruta, Vanessa			Building a Better Brain	CELL			English	Editorial Material									[Boyden, Edward] MIT, Cambridge, MA 02139 USA; [Guo, Su] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Klein, Rudiger] Max Planck Inst Neurobiol, Planegg, Germany; [Rico, Beatriz] Kings Coll London, London, England; [Ruta, Vanessa] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; Max Planck Society; University of London; King's College London; Rockefeller University	Boyden, E (corresponding author), MIT, Cambridge, MA 02139 USA.		Klein, Ruediger/C-6147-2008	Klein, Ruediger/0000-0002-3109-0163					0	0	0	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					633	634		10.1016/j.cell.2018.10.010	http://dx.doi.org/10.1016/j.cell.2018.10.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340034	Bronze			2022-12-28	WOS:000447780800004
J	Josselyn, SA; Frankland, PW				Josselyn, Sheena A.; Frankland, Paul W.			Fear Extinction Requires Reward	CELL			English	Editorial Material							DROSOPHILA; DOPAMINE	Learning theorists long hypothesized that appetitive and aversive motivational states influence one another antagonistically. Here, Felsenberg et al. show that the activity of neurons in Drosophila known to be important in appetitive conditioning is necessary for the extinction of aversive conditioning, thereby uncovering biological evidence for this opponent-process.	[Josselyn, Sheena A.] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Josselyn, Sheena A.] Canadian Inst Adv Res CIFAR, Brain Mind & Consciousness Program, Toronto, ON M5G 1M1, Canada; [Frankland, Paul W.] Canadian Inst Adv Res CIFAR, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Canadian Institute for Advanced Research (CIFAR); Canadian Institute for Advanced Research (CIFAR)	Josselyn, SA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada.; Josselyn, SA; Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Josselyn, SA; Frankland, PW (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada.; Josselyn, SA; Frankland, PW (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada.; Josselyn, SA (corresponding author), Canadian Inst Adv Res CIFAR, Brain Mind & Consciousness Program, Toronto, ON M5G 1M1, Canada.; Frankland, PW (corresponding author), Canadian Inst Adv Res CIFAR, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada.	sheena.josselyn@sickkids.ca; paul.frankland@sickkids.ca						Badrinarayan A, 2012, J NEUROSCI, V32, P15779, DOI 10.1523/JNEUROSCI.3557-12.2012; Felsenberg J, 2017, NATURE, V544, P240, DOI 10.1038/nature21716; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Konosrki J, 1967, INTEGRATIVE ACTIVITY; Luo R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04784-7; Owald D, 2015, CURR OPIN NEUROBIOL, V35, P178, DOI 10.1016/j.conb.2015.10.002; Owald D, 2015, NEURON, V86, P417, DOI 10.1016/j.neuron.2015.03.025; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2013, CURR OPIN NEUROBIOL, V23, P324, DOI 10.1016/j.conb.2013.01.005	9	5	5	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					639	640		10.1016/j.cell.2018.09.036	http://dx.doi.org/10.1016/j.cell.2018.09.036			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340037	Bronze			2022-12-28	WOS:000447780800007
J	Mayor, S				Mayor, Susan			Less than half of women are diagnosed with ovarian cancer within a month of seeing a doctor, finds survey	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Ovarian Cancer Coalition, 2018, EV WOM STUD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4419	10.1136/bmj.k4419	http://dx.doi.org/10.1136/bmj.k4419			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337296				2022-12-28	WOS:000448270700012
J	Krag, M; Marker, S; Perner, A; Wetterslev, J; Wise, MP; Schefold, JC; Keus, F; Guttormsen, AB; Bendel, S; Borthwick, M; Lange, T; Rasmussen, BS; Siegemund, M; Bundgaard, H; Elkmann, T; Jensen, JV; Nielsen, RD; Liboriussen, L; Bestle, MH; Elkjaer, JM; Palmqvist, DF; Backlund, M; Laake, JH; Badstolokken, PM; Gronlund, J; Breum, O; Walli, A; Winding, R; Iversen, S; Jarnvig, IL; White, JO; Brand, B; Madsen, MB; Quist, L; Thornberg, KJ; Moller, A; Wiis, J; Granholm, A; Anthon, CT; Meyhoff, TS; Hjortrup, PB; Aagaard, SR; Andreasen, JB; Sorensen, CA; Haure, P; Hauge, J; Hollinger, A; Scheuzger, J; Tuchscherer, D; Vuilliomenet, T; Takala, J; Jakob, SM; Vang, ML; Paelestik, KB; Andersen, KLD; van der Horst, ICC; Dieperink, W; Fjolner, J; Kjer, CKW; Solling, C; Solling, CG; Karttunen, J; Morgan, MPG; Sjobo, B; Engstrom, J; Agerholm-Larsen, B; Moller, MH				Krag, M.; Marker, S.; Perner, A.; Wetterslev, J.; Wise, M. P.; Schefold, J. C.; Keus, F.; Guttormsen, A. B.; Bendel, S.; Borthwick, M.; Lange, T.; Rasmussen, B. S.; Siegemund, M.; Bundgaard, H.; Elkmann, T.; Jensen, J. V.; Nielsen, R. D.; Liboriussen, L.; Bestle, M. H.; Elkjaer, J. M.; Palmqvist, D. F.; Backlund, M.; Laake, J. H.; Badstolokken, P. M.; Gronlund, J.; Breum, O.; Walli, A.; Winding, R.; Iversen, S.; Jarnvig, I. -L.; White, J. O.; Brand, B.; Madsen, M. B.; Quist, L.; Thornberg, K. J.; Moller, A.; Wiis, J.; Granholm, A.; Anthon, C. T.; Meyhoff, T. S.; Hjortrup, P. B.; Aagaard, S. R.; Andreasen, J. B.; Sorensen, C. A.; Haure, P.; Hauge, J.; Hollinger, A.; Scheuzger, J.; Tuchscherer, D.; Vuilliomenet, T.; Takala, J.; Jakob, S. M.; Vang, M. L.; Paelestik, K. B.; Andersen, K. L. D.; van der Horst, I. C. C.; Dieperink, W.; Fjolner, J.; Kjer, C. K. W.; Solling, C.; Solling, C. G.; Karttunen, J.; Morgan, M. P. G.; Sjobo, B.; Engstrom, J.; Agerholm-Larsen, B.; Moller, M. H.		SUP-ICU Trial Grp	Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRESS-ULCER PROPHYLAXIS; PROTON-PUMP INHIBITORS; INTENSIVE-CARE-UNIT; SCORE	BACKGROUND Prophylaxis for gastrointestinal stress ulceration is frequently given to patients in the intensive care unit (ICU), but its risks and benefits are unclear. METHODS In this European, multicenter, parallel-group, blinded trial, we randomly assigned adults who had been admitted to the ICU for an acute condition (i.e., an unplanned admission) and who were at risk for gastrointestinal bleeding to receive 40 mg of intravenous pantoprazole (a proton-pump inhibitor) or placebo daily during the ICU stay. The primary outcome was death by 90 days after randomization. RESULTS A total of 3298 patients were enrolled; 1645 were randomly assigned to the pantoprazole group and 1653 to the placebo group. Data on the primary outcome were available for 3282 patients (99.5%). At 90 days, 510 patients (31.1%) in the pantoprazole group and 499 (30.4%) in the placebo group had died (relative risk, 1.02; 95% confidence interval [CI], 0.91 to 1.13; P = 0.76). During the ICU stay, at least one clinically important event (a composite of clinically important gastrointestinal bleeding, pneumonia, Clostridium difficile infection, or myocardial ischemia) had occurred in 21.9% of patients assigned to pantoprazole and 22.6% of those assigned to placebo (relative risk, 0.96; 95% CI, 0.83 to 1.11). In the pantoprazole group, 2.5% of patients had clinically important gastrointestinal bleeding, as compared with 4.2% in the placebo group. The number of patients with infections or serious adverse reactions and the percentage of days alive without life support within 90 days were similar in the two groups. CONCLUSIONS Among adult patients in the ICU who were at risk for gastrointestinal bleeding, mortality at 90 days and the number of clinically important events were similar in those assigned to pantoprazole and those assigned to placebo.	[Krag, M.; Marker, S.; Perner, A.; Jarnvig, I. -L.; White, J. O.; Brand, B.; Madsen, M. B.; Quist, L.; Thornberg, K. J.; Moller, A.; Wiis, J.; Granholm, A.; Anthon, C. T.; Meyhoff, T. S.; Hjortrup, P. B.; Moller, M. H.] Rigshosp, Dept Intens Care, Bispebjerg, Denmark; [Wetterslev, J.; Engstrom, J.] Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Bispebjerg, Denmark; [Nielsen, R. D.; Solling, C.] Rigshosp, Dept Neurointens Care, Bispebjerg, Denmark; [Palmqvist, D. F.] Frederiksberg Univ Hosp, Frederiksberg, Denmark; [Lange, T.] Univ Copenhagen, Sect Biostat, Copenhagen, Denmark; [Krag, M.; Marker, S.; Perner, A.; Wetterslev, J.; Lange, T.; Rasmussen, B. S.; Agerholm-Larsen, B.; Moller, M. H.] Aalborg Univ, Ctr Res Intens Care, Aalborg Univ Hosp, Aalborg, Denmark; [Rasmussen, B. S.; Aagaard, S. R.; Andreasen, J. B.; Sorensen, C. A.; Haure, P.; Hauge, J.] Randers Cent Hosp, Randers, Denmark; [Bundgaard, H.; Vang, M. L.; Paelestik, K. B.; Andersen, K. L. D.] Aarhus Univ Hosp, Norrebrogade, Denmark; [Breum, O.] Aarhus Univ Hosp, Skejby, Denmark; [Jensen, J. V.; Kjer, C. K. W.] Zealand Univ Hosp, Koge, Denmark; [Liboriussen, L.; Solling, C. G.] Viborg Hosp, Viborg, Denmark; [Bestle, M. H.] Univ Copenhagen, Nordsjaellands Hosp, Hillerod, Denmark; [Elkjaer, J. M.] Holbaek Cent Hosp, Holbaek, Denmark; [Walli, A.] Zealand Univ Hosp, Roskilde, Denmark; [Winding, R.] Herning Hosp, Herning, Denmark; [Iversen, S.] Slagelse Hosp, Slagelse, Denmark; [Lange, T.] Peking Univ, Ctr Stat Sci, Beijing, Peoples R China; [Wise, M. P.; Morgan, M. P. G.] Univ Wales Hosp, Cardiff, S Glam, Wales; [Borthwick, M.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Schefold, J. C.; Takala, J.; Jakob, S. M.] Univ Bern, Inselspital, Bern Univ Hosp, Bern, Switzerland; [Hollinger, A.; Scheuzger, J.; Tuchscherer, D.; Vuilliomenet, T.] Basel Univ Hosp, Basel, Switzerland; [Keus, F.; van der Horst, I. C. C.; Dieperink, W.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Guttormsen, A. B.; Sjobo, B.] Univ Bergen, Haukeland Univ Hosp, Bergen, Norway; [Laake, J. H.] Oslo Univ Hosp, Oslo, Norway; [Badstolokken, P. M.] Akershus Univ Hosp, Oslo, Norway; [Bendel, S.; Karttunen, J.] Kuopio Univ Hosp, Kuopio, Finland; [Backlund, M.] Helsinki Univ Hosp, Helsinki, Finland; [Gronlund, J.] Turku Univ Hosp, Turku, Finland	Rigshospitalet; Rigshospitalet; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Copenhagen; Holbaek Hospital; Aarhus University; Peking University; Cardiff University; Oxford University Hospitals NHS Foundation Trust; University of Bern; University Hospital of Bern; University of Basel; University of Groningen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Turku	Perner, A (corresponding author), Rigshosp, Dept Intens Care, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	anders.perner@regionh.dk	Madsen, Martin/ABA-5798-2021; Laake, Jon Henrik/L-3224-2019; Fjølner, Jesper/AAC-1269-2020; Siegemund, Martin/AAM-8929-2020; Møller, Morten Hylander/AAQ-6891-2020; Hollinger, Alexa/AAW-8981-2020; Wetterslev, Jørn/ABF-1251-2020; Moller, Kirsten/A-4751-2009; Granholm, Anders/AAW-7623-2020	Madsen, Martin/0000-0003-0186-8971; Laake, Jon Henrik/0000-0001-6157-5359; Fjølner, Jesper/0000-0003-3371-0503; Siegemund, Martin/0000-0002-2013-4140; Møller, Morten Hylander/0000-0002-6378-9673; Hollinger, Alexa/0000-0001-6799-1652; Wetterslev, Jørn/0000-0001-7778-1771; Moller, Kirsten/0000-0003-3058-1072; Granholm, Anders/0000-0001-5799-7655; Marker, Soren/0000-0003-3602-4541; Krag, Mette/0000-0002-5246-8727; Schefold, Joerg C./0000-0001-9162-5724; Hoppu, Sanna/0000-0001-8738-7604; Borthwick, Mark/0000-0002-3249-1508; Poulsen, Lone Musaeus/0000-0002-7030-3395; Bestle, Morten/0000-0001-6585-2659; Dieperink, Willem/0000-0003-2738-7471; Solling, Christoffer/0000-0003-0721-926X; Moller, Anders/0000-0002-1288-6326; Lange, Theis/0000-0001-6807-8347; Morgan, Matt/0000-0002-2357-7190; Rasmussen, Bodil Steen/0000-0003-2190-145X; Perner, Anders/0000-0002-4668-0123; Pfortmueller, Carmen/0000-0003-0326-2770; Madsen, Martin/0000-0001-5832-2262	Innovation Fund Denmark [4108-00011A]; Rigshospitalet; Capital Region of Denmark; Regions of Denmark; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Ehrenreich's Foundation; Aase and Ejnar Danielsens Foundation; Danish Society of Anesthesiology and Intensive Care Medicine; Danish Medical Association; European Society of Intensive Care Medicine; Ferring Pharmaceuticals; Fresenius Kabi; CSL Behring; Orion Pharma; Abbott Nutrition International; B. Braun Medical; CSEM; Edwards Lifesciences Services; Kenta Biotech; Maquet Critical Care; Omnicare Clinical Research; Nestle; Pierre Fabre Pharma; Pfizer; Bard Medica; Abbott; Anandic Medical Systems; PanGas Healthcare; Bracco; Hamilton Medical; Getinge Group Maquet; Drager; Teleflex Medical; GlaxoSmithKline; Merck Sharp and Dohme; Eli Lilly; Baxter; Astellas; AstraZeneca; Novartis; Covidien; Nycomed	Innovation Fund Denmark; Rigshospitalet; Capital Region of Denmark; Regions of Denmark; Scandinavian Society of Anaesthesiology and Intensive Care Medicine; Ehrenreich's Foundation; Aase and Ejnar Danielsens Foundation; Danish Society of Anesthesiology and Intensive Care Medicine; Danish Medical Association; European Society of Intensive Care Medicine; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Fresenius Kabi; CSL Behring; Orion Pharma; Abbott Nutrition International; B. Braun Medical; CSEM; Edwards Lifesciences Services; Kenta Biotech; Maquet Critical Care; Omnicare Clinical Research; Nestle(Nestle SA); Pierre Fabre Pharma; Pfizer(Pfizer); Bard Medica; Abbott(Abbott Laboratories); Anandic Medical Systems; PanGas Healthcare; Bracco; Hamilton Medical; Getinge Group Maquet; Drager; Teleflex Medical; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp and Dohme(Merck & Company); Eli Lilly(Eli Lilly); Baxter; Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Novartis(Novartis); Covidien; Nycomed	Supported by Innovation Fund Denmark (4108-00011A), Rigshospitalet, the Capital Region of Denmark, the Regions of Denmark, the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Ehrenreich's Foundation, the Aase and Ejnar Danielsens Foundation, the Danish Society of Anesthesiology and Intensive Care Medicine, the Danish Medical Association, and the European Society of Intensive Care Medicine.; Dr. Perner reports receiving grant support from Ferring Pharmaceuticals, Fresenius Kabi, and CSL Behring; Dr. Schefold, receiving grant support from Orion Pharma, Abbott Nutrition International, B. Braun Medical, CSEM, Edwards Lifesciences Services, Kenta Biotech, Maquet Critical Care, Omnicare Clinical Research, Nestle, Pierre Fabre Pharma, Pfizer, Bard Medica, Abbott, Anandic Medical Systems, PanGas Healthcare, Bracco, Hamilton Medical, Fresenius Kabi, Getinge Group Maquet, Drager, Teleflex Medical, GlaxoSmithKline, Merck Sharp and Dohme, Eli Lilly, Baxter, Astellas, AstraZeneca, CSL Behring, Novartis, Covidien, and Nycomed; Dr. Elkmann, owning stock in Teva; Dr. Madsen, receiving grant support, paid to Copenhagen University Hospital, and provision of medication from CSL Behring; Dr. Takala, receiving grant support from Orion Pharma, Abbott Nutrition International, B. Braun Medical, CSEM, Edwards Lifesciences Services, Kenta Biotech, Maquet Critical Care, Omnicare Clinical Research, Nestle, Pierre Fabre Pharma, Pfizer, Bard Medica, Abbott, Anandic Medical Systems, PanGas Healthcare, Bracco, Hamilton Medical, Fresenius Kabi, Getinge Group Maquet, Drager, Teleflex Medical, GlaxoSmithKline, Merck Sharp and Dohme, Eli Lilly, Baxter, Astellas, AstraZeneca, CSL Behring, Novartis, Covidien, and Nycomed; Dr. Jakob, receiving grant support, paid to his institution, from Edwards Lifesciences Services, Maquet Critical Care, and Nestle, and grant support from Orion Pharma, Abbott Nutrition International, B. Braun Medical, CSRM, Kenta Biotech, Omnicare Clinical Research, Pierre Fabre Pharma, Pfizer, Bard Medica, Abbott, Anandic Medical Systems, PanGas Healthcare, Bracco, Hamilton Medical, Fresnius Kabi, Getinge Group Maquet, Drager, Teleflex Medical, GlaxoSmithKline, Merck Sharp and Dohme, Eli Lilly, Baxter, Astellas, AstraZeneca, CSL Behring, Novartis, Covidien, and Nycomed. No other potential conflict of interest relevant to this article was reported.	Alhazzani W, 2018, INTENS CARE MED, V44, P1, DOI 10.1007/s00134-017-5005-8; [Anonymous], 1998, Fed Regist, V63, P49583; Barletta JF, 2015, J INTENSIVE CARE MED, V30, P217, DOI 10.1177/0885066613516574; Barletta JF, 2014, ANN PHARMACOTHER, V48, P1276, DOI 10.1177/1060028014540513; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Cook D, 1999, CRIT CARE MED, V27, P2812, DOI 10.1097/00003246-199912000-00034; Cook D, 2018, NEW ENGL J MED, V378, P2506, DOI 10.1056/NEJMra1605507; Cook DJ, 2001, CRIT CARE, V5, P369; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jakobsen JC, 2015, J BIOMETRICS BIOSTAT, V6, P227, DOI DOI 10.4172/2155; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Krag M, 2017, ACTA ANAESTH SCAND, V61, P859, DOI 10.1111/aas.12917; Krag M, 2015, ACTA ANAESTH SCAND, V59, P576, DOI 10.1111/aas.12508; Krag M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1331-3; Krag M, 2016, CURR OPIN CRIT CARE, V22, P186, DOI 10.1097/MCC.0000000000000290; Krag M, 2015, INTENS CARE MED, V41, P833, DOI 10.1007/s00134-015-3725-1; Krag M, 2014, INTENS CARE MED, V40, P11, DOI 10.1007/s00134-013-3125-3; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MacLaren R, 2014, JAMA INTERN MED, V174, P564, DOI 10.1001/jamainternmed.2013.14673; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Ridgeon EE, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1726-x; Venkatesh B, 2018, NEW ENGL J MED, V378, P797, DOI 10.1056/NEJMoa1705835; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	24	151	158	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2018	379	23					2199	2208		10.1056/NEJMoa1714919	http://dx.doi.org/10.1056/NEJMoa1714919			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD1HA	30354950	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000452259200005
J	Perkins, GD; Mistry, D; Gates, S; Gao, F; Snelson, C; Hart, N; Camporota, L; Varley, J; Cade, C; Paramasivam, E; Hoddell, B; McAuley, DF; Walsh, TS; Blackwood, B; Rose, L; Lamb, SE; Petrou, S; Young, DC; Lall, R				Perkins, Gavin D.; Mistry, Dipesh; Gates, Simon; Gao, Fang; Snelson, Catherine; Hart, Nicholas; Camporota, Luigi; Varley, James; Cade, Coralie; Paramasivam, Elankumaran; Hoddell, Beverley; McAuley, Daniel F.; Walsh, Timothy S.; Blackwood, Bronagh; Rose, Louise; Lamb, Sarah E.; Petrou, Stavros; Young, Duncan; Lall, Ranjit		Breathe Collaborators	Effect of Protocolized Weaning With Early Extubation to Noninvasive Ventilation vs Invasive Weaning on Time to Liberation From Mechanical Ventilation Among Patients With Respiratory Failure The Breathe Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OUTCOMES; PNEUMONIA; MORTALITY; TUBE	IMPORTANCE In adults in whom weaning from invasive mechanical ventilation is difficult, noninvasive ventilation may facilitate early liberation, but there is uncertainty about its effectiveness in a general intensive care patient population. OBJECTIVE To investigate among patients with difficulty weaning the effects of protocolized weaning with early extubation to noninvasive ventilation on time to liberation from ventilation compared with protocolized invasive weaning. DESIGN, SETTING, AND PARTICIPANTS Randomized, allocation-concealed, open-label, multicenter clinical trial enrolling patients between March 2013 and October 2016 from 41 intensive care units in the UK National Health Service. Follow-up continued until April 2017. Adults who received invasive mechanical ventilation for more than 48 hours and in whom a spontaneous breathing trial failed were enrolled. INTERVENTIONS Patients were randomized to receive either protocolized weaning via early extubation to noninvasive ventilation (n = 182) or protocolized standard weaning (continued invasive ventilation until successful spontaneous breathing trial, followed by extubation) (n = 182). MAIN OUTCOMES AND MEASURES Primary outcome was time from randomization to successful liberation from all forms of mechanical ventilation among survivors, measured in days, with the minimal clinically important difference defined as 1 day. Secondary outcomes were duration of invasive and total ventilation (days), reintubation or tracheostomy rates, and survival. RESULTS Among 364 randomized patients (mean age, 63.1 [SD, 14.8] years; 50.5% male), 319 were evaluable for the primary effectiveness outcome (41 died before liberation, 2 withdrew, and 2 were discharged with ongoing ventilation). The median time to liberation was 4.3 days in the noninvasive group vs 4.5 days in the invasive group (adjusted hazard ratio, 1.1; 95% CI, 0.89-1.40). Competing risk analysis accounting for deaths had a similar result (adjusted hazard ratio, 1.1; 95% CI, 0.86-1.34). The noninvasive group received less invasive ventilation (median, 1 day vs 4 days; incidence rate ratio, 0.6; 95% CI, 0.47-0.87) and fewer total ventilator days (median, 3 days vs 4 days; incidence rate ratio. 0.8; 95% CI, 0.62-1.0). There was no significant difference in reintubation, tracheostomy rates, or survival. Adverse events occurred in 45 patients (24.7%) in the noninvasive group compared with 47 (25.8%) in the invasive group. CONCLUSIONS AND RELEVANCE Among patients requiring mechanical ventilation in whom a spontaneous breathing trial had failed, early extubation to noninvasive ventilation did not shorten time to liberation from any ventilation.	[Perkins, Gavin D.; Mistry, Dipesh; Gates, Simon; Hoddell, Beverley; Petrou, Stavros; Lall, Ranjit] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Perkins, Gavin D.; Gao, Fang] Univ Hosp Birmingham NHS Fdn Trust, Heartlands Hosp, Birmingham, W Midlands, England; [Gates, Simon; Gao, Fang] Univ Birmingham, Canc Res United Kingdom Clin Trials Unit, Birmingham, W Midlands, England; [Snelson, Catherine] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England; [Hart, Nicholas; Camporota, Luigi] Guys & St Thomas NHS Fdn Trust, London, England; [Varley, James] Addenbrookes Hosp, Cambridge, England; [Cade, Coralie] Peterborough & Stamford Hosp NHS Fdn Trust, Peterborough, Cambs, England; [Paramasivam, Elankumaran] Leeds Teaching Hosp, Leeds, W Yorkshire, England; [McAuley, Daniel F.; Blackwood, Bronagh] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Walsh, Timothy S.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rose, Louise] Univ Toronto, Toronto, ON, Canada; [Rose, Louise] Kings Coll London, London, England; [Lamb, Sarah E.; Young, Duncan] Univ Oxford, Oxford, England	University of Warwick; Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham; University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Leeds; Queens University Belfast; University of Edinburgh; University of Toronto; University of London; King's College London; University of Oxford	Perkins, GD (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	g.d.perkins@warwick.ac.uk	Perkins, Gavin/E-7613-2010; Blackwood, Bronagh/GPS-9197-2022; Petrou, Stavros/ABD-8323-2021; Hart, Nicholas/O-7076-2015; Smith, Fang G/H-8451-2018; Camporota, Luigi/G-2390-2017	Petrou, Stavros/0000-0003-3121-6050; Hart, Nicholas/0000-0002-6863-585X; Rose, Louise/0000-0003-1700-3972; Perkins, Gavin/0000-0003-3027-7548; Smith, Fang G/0000-0002-8095-0609; Camporota, Luigi/0000-0001-5600-1676; Lamb, Sarah/0000-0003-4349-7195; McAuley, Daniel/0000-0002-3283-1947; Lall, Ranjit/0000-0003-1737-2866	NIHR Health Technology Assessment Programme [HTA 10/134]; Intensive Care Foundation; Heart of England NHS Foundation Trust; University of Warwick; MRC [G0700452, G0501681] Funding Source: UKRI	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Intensive Care Foundation; Heart of England NHS Foundation Trust; University of Warwick; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the NIHR Health Technology Assessment Programme (project HTA 10/134) and supported by the Intensive Care Foundation. The trial was co-sponsored by the Heart of England NHS Foundation Trust and the University of Warwick.	Beduneau G, 2017, AM J RESP CRIT CARE, V195, P772, DOI 10.1164/rccm.201602-0320OC; Blackwood B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006904.pub3; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Burns KEA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004127.pub3; Chandra D, 2012, AM J RESP CRIT CARE, V185, P152, DOI 10.1164/rccm.201106-1094OC; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Costa DK, 2017, CHEST, V152, P304, DOI 10.1016/j.chest.2017.03.054; Davidson AC, 2016, THORAX, V71, P1, DOI 10.1136/thoraxjnl-2015-208209; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; Esteban A, 1997, AM J RESP CRIT CARE, V156, P459, DOI 10.1164/ajrccm.156.2.9610109; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P70, DOI 10.1164/rccm.200209-1074OC; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Gao F, 2016, HEART LUNG, V45, P363, DOI 10.1016/j.hrtlng.2016.04.006; Girard TD, 2017, AM J RESP CRIT CARE, V195, P120, DOI 10.1164/rccm.201610-2075ST; Girault C, 1999, AM J RESP CRIT CARE, V160, P86, DOI 10.1164/ajrccm.160.1.9802120; Girault C, 2011, AM J RESP CRIT CARE, V184, P672, DOI 10.1164/rccm.201101-0035OC; INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014, DOI 10.1128/JCM.27.9.2014-2018.1989; Jeong BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122810; Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071; Osadnik CR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004104.pub4; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Prasad SBN, 2009, INDIAN J CRIT CARE M, V13, P207, DOI 10.4103/0972-5229.60173; Rose L, 2014, AM J CRIT CARE, V23, pE54, DOI 10.4037/ajcc2014539; Rothaar Robert C, 2003, Curr Opin Crit Care, V9, P59, DOI 10.1097/00075198-200302000-00011; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Thille AW, 2013, CURR OPIN CRIT CARE, V19, P57, DOI 10.1097/MCC.0b013e32835c5095; Wagner D P, 1989, Am Rev Respir Dis, V140, pS14; Walsh TS, 2004, BRIT J ANAESTH, V92, P793, DOI 10.1093/bja/aeh139; Zou Shi-hai, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P120	30	44	47	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2018	320	18					1881	1888		10.1001/jama.2018.13763	http://dx.doi.org/10.1001/jama.2018.13763			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA1BH	30347090	Green Published, Bronze			2022-12-28	WOS:000449945900015
J	Wayant, C; Scott, J; Vassar, M				Wayant, Cole; Scott, Jared; Vassar, Matt			Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wayant, Cole; Scott, Jared; Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, 1111W 17th St, Tulsa, OK 74107 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Wayant, C (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, 1111W 17th St, Tulsa, OK 74107 USA.	cole.wayant@okstate.edu	Vassar, Matt/AAD-5385-2020; Wayant, Cole/X-3972-2018	Wayant, Cole/0000-0001-8829-8179; Vassar, Ben Matthew/0000-0003-2859-6152				Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Head ML, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002106, DOI 10.1371/JOURNAL.PBIO.1002106]; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124	5	27	28	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1813	1815		10.1001/jama.2018.12288	http://dx.doi.org/10.1001/jama.2018.12288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398593	Bronze, Green Published			2022-12-28	WOS:000449461800021
J	Mimica, B; Dunn, BA; Tombaz, T; Bojja, VPTNCS; Whitlock, JR				Mimica, Bartul; Dunn, Benjamin A.; Tombaz, Tuce; Bojja, V. P. T. N. C. Srikanth; Whitlock, Jonathan R.			Efficient cortical coding of 3D posture in freely behaving rats	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; MOTOR CORTEX; ASSOCIATION CORTEX; REFERENCE FRAMES; ARM MOVEMENTS; NEURONS; MICROSTIMULATION; NAVIGATION; PREMOTOR; SIGNALS	Animals constantly update their body posture to meet behavioral demands, but little is known about the neural signals on which this depends. We therefore tracked freely foraging rats in three dimensions while recording from the posterior parietal cortex (PPC) and the frontal motor cortex (M2), areas critical for movement planning and navigation. Both regions showed strong tuning to posture of the head, neck, and back, but signals for movement were much less dominant. Head and back representations were organized topographically across the PPC and M2, and more neurons represented postures that occurred less often. Simultaneous recordings across areas were sufficiently robust to decode ongoing behavior and showed that spiking in the PPC tended to precede that in M2. Both the PPC and M2 strongly represent posture by using a spatially organized, energetically efficient population code.	[Mimica, Bartul; Dunn, Benjamin A.; Tombaz, Tuce; Bojja, V. P. T. N. C. Srikanth; Whitlock, Jonathan R.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Mimica, B; Whitlock, JR (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway.	bartul.mimica@ntnu.no; whitlock@ntnu.no		Mimica, Bartul/0000-0001-6404-0560; Bojja, V.P.T.N.C. Srikanth/0000-0002-4809-3168	European Research Council ("RAT MIRROR CELL") [335328]; Research Council of Norway (FRIPRO Young Research Talents) [239963]; Kavli Foundation; Center of Excellence scheme of the Research Council of Norway (Center for Neural Computation)	European Research Council ("RAT MIRROR CELL"); Research Council of Norway (FRIPRO Young Research Talents)(Research Council of Norway); Kavli Foundation; Center of Excellence scheme of the Research Council of Norway (Center for Neural Computation)	This study was supported by research grants from the European Research Council ("RAT MIRROR CELL," starting grant agreement 335328), the Research Council of Norway (FRIPRO Young Research Talents, grant agreement 239963), the Kavli Foundation, and the Center of Excellence scheme of the Research Council of Norway (Center for Neural Computation).	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Chen XD, 2013, NEURON, V80, P1310, DOI 10.1016/j.neuron.2013.09.006; Critchley M., 1953, PARIETAL LOBES; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Cutrell EB, 2002, EXP BRAIN RES, V144, P103, DOI 10.1007/s00221-002-1032-x; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Esposito MS, 2014, NATURE, V508, P351, DOI 10.1038/nature13023; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Ganguli D, 2014, NEURAL COMPUT, V26, P2103, DOI 10.1162/NECO_a_00638; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hanks TD, 2015, NATURE, V520, P220, DOI 10.1038/nature14066; Hardcastle K, 2017, NEURON, V94, P375, DOI 10.1016/j.neuron.2017.03.025; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HYVARINEN J, 1981, BRAIN RES, V206, P287, DOI 10.1016/0006-8993(81)90533-3; Klam F, 2003, EUR J NEUROSCI, V18, P995, DOI 10.1046/j.1460-9568.2003.02813.x; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Markowitz JE, 2018, CELL, V174, P44, DOI 10.1016/j.cell.2018.04.019; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Mimica B., 2018, EFFICIENT CORTICAL C, DOI [10.11582/2018.00028, DOI 10.11582/2018.00028]; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearce TM, 2012, SCIENCE, V337, P984, DOI 10.1126/science.1220642; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Stepniewska I, 2005, P NATL ACAD SCI USA, V102, P4878, DOI 10.1073/pnas.0501048102; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; Wilson JJ, 2018, CURR BIOL, V28, P1744, DOI 10.1016/j.cub.2018.04.021; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	51	53	53	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		584	+		10.1126/science.aau2013	http://dx.doi.org/10.1126/science.aau2013			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385578	Green Submitted			2022-12-28	WOS:000450460000046
J	Kuehn, B				Kuehn, Bridget			Obesity Rates Increasing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1632	1632		10.1001/jama.2018.15094	http://dx.doi.org/10.1001/jama.2018.15094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357306				2022-12-28	WOS:000448069100035
J	Rubin, R				Rubin, Rita			Smartphones Can Recruit Pregnant Women for Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1630	1630		10.1001/jama.2018.15735	http://dx.doi.org/10.1001/jama.2018.15735			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357279				2022-12-28	WOS:000448069100003
J	Assefa, Y; Tesfaye, D; Van Damme, W; Hill, PS				Assefa, Yibeltal; Tesfaye, Dessalegn; Van Damme, Wim; Hill, Peter S.			Effectiveness and sustainability of a diagonal investment approach to strengthen the primary health-care system in Ethiopia	LANCET			English	Review							ALMA-ATA DECLARATION; EXTENSION PROGRAM; DEVELOPING-COUNTRIES; AVAILABILITY; SERVICES; LESSONS; PEPFAR; POLICY; MEXICO; ZONE	Weakness of primary health-care (PHC) systems has represented a challenge to the achievement of the targets of disease control programmes (DCPs) despite the availability of substantial development assistance for health, in resource-poor settings. Since 2005, Ethiopia has embraced a diagonal investment approach to strengthen its PHC systems and concurrently scale up DCPs. This approach has led to a substantial improvement in PHC-system capacity that has contributed to increased coverage of DCPs and improved health status, although gaps in equity and quality in health services remain to be addressed. Since 2013, Ethiopia has had a decline in development assistance for health. Nevertheless, the Ethiopian Government has been able to compensate for this decline by increasing domestic resources. We argue that the diagonal investment approach can effectively strengthen PHC systems, achieve DCP targets, and sustain the gains. These goals can be achieved if a visionary and committed leadership coordinates its development partners and mobilises the local community, to ensure financial support to health services and improve population health. The lessons learnt from Ethiopia's efforts to improve its health services indicate that global-health initiatives should have a proactive and balanced investment approach to concurrently strengthen PHC systems, achieve programme targets, and sustain the gains, in resource-poor settings.	[Assefa, Yibeltal; Hill, Peter S.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia; [Tesfaye, Dessalegn] US Agcy Int Dev, Addis Ababa, Ethiopia; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium	University of Queensland; United States Agency for International Development (USAID); Institute of Tropical Medicine (ITM)	Assefa, Y (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia.	y.alemu@uq.edu.au	Van Damme, Wim/F-7404-2011; Hill, Peter Stewart/AAL-8053-2020; Assefa, Yibeltal/ABI-8057-2020; Assefa, Yibeltal/N-5984-2016	Van Damme, Wim/0000-0002-6344-3007; Hill, Peter Stewart/0000-0001-7091-5108; Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492				African strategies for health, 2016, HLTH FIN PROF ETH; [Anonymous], 2018, LANCET, V391, P1, DOI 10.1016/S0140-6736(18)30003-5; Assefa Y, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000318; Associacion Para Una Sociedad Mas Justa, 2016, GANGS HOND; Banteyerga H, 2005, SYSTEM WIDE EFFECTS; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Bayou NB, 2013, ETHIOP J HEALTH SCI, V23, P79; Belay H., 2014, ASSESSMENT HLTH MANA; Berman P, 2018, HEALTH SYST REFORM, V4, P227, DOI 10.1080/23288604.2018.1448240; Bilal N. K, 2011, YES AFRICA CAN SUCCE, V2011, P433; Black RE, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010908; British Broadcasting Corporation, 2018, ETH DECL NAT STAT EM; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Drug Administration and Control Authority, 2010, STAND TREATM GUID HL; Ethiopia Federal Ministry of Health, 2017, ETH HLTH ACC 2013 14; Ethiopia Federal Ministry of Health, 2010, HLTH SECT DEV PROG 4; Ethiopia Federal Ministry of Health, 2016, HLTH SECT TRANSF PLA; Ethiopia Federal Ministry of Health, 2015, HLTH SECT TRANSF PLA; Ethiopia Federal Ministry of Health (FMOH), 2014, ETH 5 NAT HLTH ACC 2; Ethiopian Public Health Institute, 2015, 2 BSC BAS EPHIS STRA; Ethiopian Public Health Institute Ethiopia Federal Ministry of Health WHO, 2017, SERV AV READ ASS 201; Ethiopian Standard Agency, 2012, PRIM HOSP REQ; Ethiopian Standard Agency, 2012, HLTH POSTR; Ethiopian Standard Agency, 2012, HLTH CTR REQ; Federal HIV/ AIDS Prevention and Control Office, 2014, HIV AIDS STRAT PLAN; Feleke S, 2015, ETHIOPIAS COMMUNITY; Food Medicine and Healthcare Administration and Control Authority of Ethiopia, 2014, STAND TREATM GUID PR; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Gavi the Vaccine Alliance, 2018, GAV SUPP ETH; Gedif T, 2016, SPECIAL B 18 ANN REV; Getachew T, 2017, ETHIOP J HEALTH DEV, V31, P384; Ghebreyesus TA, 2009, B WORLD HEALTH ORGAN, V87, P495, DOI 10.2471/BLT.09.050709; Glassman A, 2012, ETHIOPIAS AIDS SPEND; Global Alliance for Vaccines Initiative, 2007, HLTH SYST STRENGTH E; Hall JJ, 2003, MED J AUSTRALIA, V178, P17, DOI 10.5694/j.1326-5377.2003.tb05033.x; Health Management Information System Reform Team, 2008, HLTH MAN INF SYST HM; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; Hiwotu TM, 2016, AFR J LAB MED, V3, P1; Japan Center for International Exchange, 2015, CAS STUD GLOB FUND C; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Kassie GM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00014; Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576; Knoema, 2016, ETH CURR EXP HLTH; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Magnussen L, 2004, HEALTH AFFAIR, V23, P167, DOI 10.1377/hlthaff.23.3.167; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mohan P., 2007, AFRICA REGION FINDIN; Mullan F, 2012, HEALTH AFFAIR, V31, P1561, DOI 10.1377/hlthaff.2012.0219; NAVARRO V, 1984, INT J HEALTH SERV, V14, P159, DOI 10.2190/9A9A-3ECR-M3N5-YJHH; Office of the Inspector General of The Global Fund, 2017, AUD REP GLOB FUND GR; Ooms G, 2014, HDB GLOBAL HLTH POLI, P441; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Ooms G, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000217; Palen J, 2012, JAIDS-J ACQ IMM DEF, V60, pS113, DOI 10.1097/QAI.0b013e31825d28d7; Participedia, 2017, COMM BAS HLTH INS ET; President's Emergency Plan for AIDS Relief, 2012, ETH OP PLAN REP FY 2; President's Emergency Plan for AIDS Relief Ethiopia, 2017, ETH COUNTR REG OP PL; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Rosenzweig S., 2007, FOLLOWING FUNDING HI; Ruducha J, 2017, LANCET GLOB HEALTH, V5, pE1142, DOI 10.1016/S2214-109X(17)30331-5; Ryan L., 2009, 5 YEAR EVALUATION GL; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Samuel Girma, 2007, Ethiopian Journal of Health Development, V21, P216; Science Speaks, 2012, SCI SPEAKS; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Taddesse D, 2015, DEV PRACT, V25, P1043, DOI 10.1080/09614524.2015.1069794; Tadesse M, 2015, COUNTDOWN 2015 ETHIO; Teklehaimanot H, 2016, HLTH DEV ARMY NETWOR; Teklehaimanot HD, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-39; Tesfaye D., 2015, STUDY ETHIOPIA PUBLI; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2017, RES REP 2017; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2016, COUNTR IMP REP; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2018, ETH OV; The National Bank of Ethiopia, 2014, NAT BANK ETH 2013 14; The World Health Organization, 2018, SUST DEV GOALS SDGS; United States Agency for International Development, 2018, PRES EM PLAN AIDS RE; United States Agency for International Development, 2014, HLTH CAR FIN REF ET; Waddington C., 2012, ROADMAP ENHANCING IM; WALSH JA, 1980, SOC SCI MED-MED ECON, V14, P145, DOI 10.1016/0160-7995(80)90034-9; Wang H., 2016, ETHIOPIA HLTH EXTENS; WHO, 2008, PHARMAFORUM 0121; Workie N.W, 2013, HLTH EXTENSION PROGR; World Health Organization, 2010, CAS STUD SCAL ED TRA; World Health Organization, 2007, GLOB FUND STRAT APPR; World Health Organization & Global Health Workforce Alliance, 2008, COUNTR CAS STUD ETH; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yitayal M, 2014, J MULTIDISCIP HEALTH, V7, P201, DOI 10.2147/JMDH.S62294; Zelelew H., 2012, HLTH CARE FINANCING	93	27	28	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1473	1481		10.1016/S0140-6736(18)32215-3	http://dx.doi.org/10.1016/S0140-6736(18)32215-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343861				2022-12-28	WOS:000447800900028
J	Malik, SM; Bhutta, ZA				Malik, Sadia M.; Bhutta, Zulfiqar A.			Reform of primary health care in Pakistan	LANCET			English	Editorial Material									[Malik, Sadia M.] York Univ, Dept Econ, Fac Liberal Arts & Profess Studies, Toronto, ON M3J 1P3, Canada; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	York University - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Malik, SM (corresponding author), York Univ, Dept Econ, Fac Liberal Arts & Profess Studies, Toronto, ON M3J 1P3, Canada.	smmalik@yorku.ca	Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X				Akseer N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1608; Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Government of Pakistan, POV RED STRAT PAP PR; Government of Pakistan, NAT HLTH VIS 2016 20, P2016; Government of Pakistan, 2013, PAK MILL DEV GOALS R; National Institute of Pakistan Studies, 2017, PAK DEM HLTH SURV KE; UNICEF, 2018, EV CHILD AL URG NEED; World Bank, 2016, HLTH EQ FIN PROT REP	8	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1375	1377		10.1016/S0140-6736(18)32275-X	http://dx.doi.org/10.1016/S0140-6736(18)32275-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343846				2022-12-28	WOS:000447800900008
J	Dyer, O				Dyer, Owen			Cannabis: Canada sees queues and shortages as it legalises recreational use	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Canada, 2016, SUMM RES CAN STUD TO; Statistics Canada, 2018, NAT CANN SURV	2	0	0	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4421	10.1136/bmj.k4421	http://dx.doi.org/10.1136/bmj.k4421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337281				2022-12-28	WOS:000448270700014
J	Quigley, DA; Dang, HX; Zhao, SG; Lloyd, P; Aggarwal, R; Alumkal, JJ; Foye, A; Kothari, V; Perry, MD; Bailey, AM; Playdle, D; Barnard, TJ; Zhang, L; Zhang, J; Youngren, JF; Cieslik, MP; Parolia, A; Beer, TM; Thomas, G; Chi, KN; Gleave, M; Lack, NA; Zoubeidi, A; Reiter, RE; Rettig, MB; Witte, O; Ryan, CJ; Fong, L; Kim, W; Friedlander, T; Chou, J; Li, HL; Das, R; Li, H; Moussavi-Baygi, R; Goodarzi, H; Gilbert, LA; Lara, PN; Evans, CP; Goldstein, TC; Stuart, JM; Tomlins, SA; Spratt, DE; Cheetham, RK; Cheng, DT; Farh, K; Gehring, JS; Hakenberg, J; Liao, A; Febbo, PG; Shon, J; Sickler, B; Batzoglou, S; Knudsen, KE; He, HSH; Huang, JT; Wyatt, AW; Dehm, SM; Ashworth, A; Chinnaiyan, AM; Maher, CA; Small, EJ; Feng, FY				Quigley, David A.; Dang, Ha X.; Zhao, Shuang G.; Lloyd, Paul; Aggarwal, Rahul; Alumkal, Joshi J.; Foye, Adam; Kothari, Vishal; Perry, Marc D.; Bailey, Adina M.; Playdle, Denise; Barnard, Travis J.; Zhang, Li; Zhang, Jin; Youngren, Jack F.; Cieslik, Marcin P.; Parolia, Abhijit; Beer, Tomasz M.; Thomas, George; Chi, Kim N.; Gleave, Martin; Lack, Nathan A.; Zoubeidi, Amina; Reiter, Robert E.; Rettig, Matthew B.; Witte, Owen; Ryan, Charles J.; Fong, Lawrence; Kim, Won; Friedlander, Terence; Chou, Jonathan; Li, Haolong; Das, Rajdeep; Li, Hui; Moussavi-Baygi, Ruhollah; Goodarzi, Hani; Gilbert, Luke A.; Lara, Primo N., Jr.; Evans, Christopher P.; Goldstein, Theodore C.; Stuart, Joshua M.; Tomlins, Scott A.; Spratt, Daniel E.; Cheetham, R. Keira; Cheng, Donavan T.; Farh, Kyle; Gehring, Julian S.; Hakenberg, Jorg; Liao, Arnold; Febbo, Philip G.; Shon, John; Sickler, Brad; Batzoglou, Serafim; Knudsen, Karen E.; He, Housheng H.; Huang, Jiaoti; Wyatt, Alexander W.; Dehm, Scott M.; Ashworth, Alan; Chinnaiyan, Arul M.; Maher, Christopher A.; Small, Eric J.; Feng, Felix Y.			Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (vol 174, pg 758, 2018)	CELL			English	Correction												arul@med.umich.edu; christophermaher@wustl.edu; eric.small@ucsf.edu; felix.feng@ucsf.edu	zhao, shuangling/HCI-6255-2022; Spratt, Daniel/AAM-4612-2020; Gilbert, Luke/AAC-5300-2019	Zhang, Li/0000-0002-3617-2627; Stuart, Joshua/0000-0002-2171-565X; Huang, Jiaoti/0000-0003-1195-1998	NATIONAL CANCER INSTITUTE [R01CA205001] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA205001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Quigley DA, 2018, CELL, V174, P758, DOI 10.1016/j.cell.2018.06.039	1	43	44	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					889	889		10.1016/j.cell.2018.10.019	http://dx.doi.org/10.1016/j.cell.2018.10.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340047	Green Submitted, Bronze			2022-12-28	WOS:000447780800028
J	Gong, HR; Li, J; Xu, A; Tang, YT; Ji, WX; Gao, RG; Wang, SH; Yu, L; Tian, CL; Li, JW; Yen, HY; Lam, SM; Shui, GH; Yang, XN; Sun, YN; Li, XM; Jia, MZ; Yang, C; Jiang, B; Lou, ZY; Robinson, CV; Wong, LL; Guddat, LW; Sun, F; Wang, Q; Rao, ZH				Gong, Hongri; Li, Jun; Xu, Ao; Tang, Yanting; Ji, Wenxin; Gao, Ruogu; Wang, Shuhui; Yu, Lu; Tian, Changlin; Li, Jingwen; Yen, Hsin-Yung; Lam, Sin Man; Shui, Guanghou; Yang, Xiuna; Sun, Yuna; Li, Xuemei; Jia, Minze; Yang, Cheng; Jiang, Biao; Lou, Zhiyong; Robinson, Carol V.; Wong, Luet-Lok; Guddat, Luke W.; Sun, Fei; Wang, Quan; Rao, Zihe			An electron transfer path connects subunits of a mycobacterial respiratory supercomplex	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; CU,ZN SUPEROXIDE-DISMUTASE; BEAM-INDUCED MOTION; PARACOCCUS-DENITRIFICANS; CRYSTAL-STRUCTURE; SUPRAMOLECULAR ORGANIZATION; CORYNEBACTERIUM-GLUTAMICUM; TERMINAL OXIDASE; COMPLEX; TUBERCULOSIS	We report a 3.5-angstrom-resolution cryo-electron microscopy structure of a respiratory supercomplex isolated from Mycobacterium smegmatis. It comprises a complex III dimer flanked on either side by individual complex IV subunits. Complex III and IV associate so that electrons can be transferred from quinol in complex III to the oxygen reduction center in complex IV by way of a bridging cytochrome subunit. We observed a superoxide dismutase-like subunit at the periplasmic face, which may be responsible for detoxification of superoxide formed by complex III. The structure reveals features of an established drug target and provides a foundation for the development of treatments for human tuberculosis.	[Gong, Hongri; Xu, Ao; Tang, Yanting; Yang, Cheng; Rao, Zihe] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300353, Peoples R China; [Gong, Hongri; Xu, Ao; Tang, Yanting; Yang, Cheng; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300353, Peoples R China; [Li, Jun; Wang, Shuhui; Yang, Xiuna; Jiang, Biao; Rao, Zihe] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China; [Li, Jun; Wang, Shuhui; Yang, Xiuna; Rao, Zihe] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Xu, Ao; Ji, Wenxin; Gao, Ruogu; Sun, Yuna; Li, Xuemei; Jia, Minze; Sun, Fei; Wang, Quan; Rao, Zihe] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Ji, Wenxin; Gao, Ruogu; Sun, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Lu; Tian, Changlin] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China; [Tian, Changlin] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Li, Jingwen; Yen, Hsin-Yung; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England; [Yen, Hsin-Yung] OMass Technol, Begbroke Sci Pk,Woodstock Rd, Yarnton OX5 1PF, Kidlington, England; [Lam, Sin Man; Shui, Guanghou] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Lou, Zhiyong; Rao, Zihe] Tsinghua Univ, Lab Struct Biol, Beijing 100084, Peoples R China; [Wong, Luet-Lok] Univ Oxford, Inorgan Chem Lab, Dept Chem, South Parks Rd, Oxford OX1 3QR, England; [Guddat, Luke W.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	Nankai University; Nankai University; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Oxford; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tsinghua University; University of Oxford; University of Queensland	Rao, ZH (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300353, Peoples R China.; Rao, ZH (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300353, Peoples R China.; Rao, ZH (corresponding author), ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China.; Rao, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Sun, F; Wang, Q; Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Sun, F (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Rao, ZH (corresponding author), Tsinghua Univ, Lab Struct Biol, Beijing 100084, Peoples R China.	feisun@ibp.ac.cn; wangq@ibp.ac.cn; raozh@tsinghua.edu.cn	Guddat, Luke/AAI-2930-2021; Rao, Zihe/HCH-6944-2022	, Yanting/0000-0002-8656-3220; Lam, Sin Man/0000-0001-9037-904X; robinson, carol/0000-0001-7829-5505; Shui, Guanghou/0000-0002-1621-9643; Yu, Lu/0000-0003-4852-0008; Gong, Hongri/0000-0002-2596-7635; Ji, Wenxin/0000-0002-3671-1301; Wang, Quan/0000-0001-5148-5210; Yang, Xiuna/0000-0003-3443-9815; Li, Jun/0000-0003-3165-3699	National Key Research and Development Program of China [2017YFC0840300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020200]; State Key Development Program for Basic Research of the Ministry of Science and Technology of China (973 Project) [2014CB542800, 2014CBA02003, 2014CB910700]; National Natural Science Foundation of China [813300237, 81520108019]	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Development Program for Basic Research of the Ministry of Science and Technology of China (973 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Research and Development Program of China (grant 2017YFC0840300), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant XDB08020200), the State Key Development Program for Basic Research of the Ministry of Science and Technology of China (973 Project Grants 2014CB542800 and 2014CBA02003 to Z.R. and 2014CB910700 to F. S.), and the National Natural Science Foundation of China (Grant Nos. 813300237 and 81520108019).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bengtsson J, 1999, J BIOL CHEM, V274, P26179, DOI 10.1074/jbc.274.37.26179; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Bhattacharya S., 2015, REACTIVE OXYGEN SPEC, P17, DOI [10.1007/978-81-322-2035-0_2, DOI 10.1007/978-81-322-2035-0_2]; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; CHANCE B, 1957, METHOD ENZYMOL, V4, P273, DOI 10.1016/0076-6879(57)04060-4; Chavez JD, 2018, CELL SYST, V6, P136, DOI 10.1016/j.cels.2017.10.017; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; D'Orazio M, 2001, BIOCHEM J, V359, P17, DOI 10.1042/0264-6021:3590017; Davies KM, 2018, P NATL ACAD SCI USA, V115, P3024, DOI 10.1073/pnas.1720702115; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esser L, 2016, J BIOL CHEM, V291, P25019, DOI 10.1074/jbc.M116.744391; FEE JA, 1980, P NATL ACAD SCI-BIOL, V77, P147, DOI 10.1073/pnas.77.1.147; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; de Oca LYJGM, 2012, J BIOENERG BIOMEMBR, V44, P473, DOI 10.1007/s10863-012-9454-z; Graf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34098; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kao WC, 2016, BBA-BIOENERGETICS, V1857, P1705, DOI 10.1016/j.bbabio.2016.07.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim MS, 2015, J BIOL CHEM, V290, P14350, DOI 10.1074/jbc.M114.624312; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lam SM, 2014, J LIPID RES, V55, P289, DOI 10.1194/jlr.M044826; LEMMA E, 1993, ARCH MICROBIOL, V159, P574, DOI 10.1007/BF00249037; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Li XJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00092-14; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lim L, 2012, CELL DEATH DIFFER, V19, P416, DOI 10.1038/cdd.2011.105; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; LU P, 2018, SCI REP UK, V8; Lu P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20989-8; Magalon A, 2012, ADV MICROB PHYSIOL, V61, P217, DOI 10.1016/B978-0-12-394423-8.00006-8; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Melo AMP, 2016, BBA-BIOENERGETICS, V1857, P190, DOI 10.1016/j.bbabio.2015.11.001; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Millett F, 2009, METHOD ENZYMOL, V456, P95, DOI 10.1016/S0076-6879(08)04405-4; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Moore AL, 2008, BIOCHEM SOC T, V36, P1022, DOI 10.1042/BST0361022; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SARASTE M, 1991, EUR J BIOCHEM, V195, P517, DOI 10.1111/j.1432-1033.1991.tb15732.x; Sartain MJ, 2009, GLYCOBIOLOGY, V19, P38, DOI 10.1093/glycob/cwn102; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shimada S, 2017, EMBO J, V36, P291, DOI 10.15252/embj.201695021; Shui GH, 2012, EMBO MOL MED, V4, P27, DOI 10.1002/emmm.201100185; Smollett KL, 2009, MICROBIOL-SGM, V155, P186, DOI 10.1099/mic.0.022889-0; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; SONE N, 1982, BIOCHIM BIOPHYS ACTA, V682, P216, DOI 10.1016/0005-2728(82)90101-3; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Sun C, 2018, NATURE, V557, P123, DOI 10.1038/s41586-018-0061-y; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Suthammarak W, 2013, AGING CELL, V12, P1132, DOI 10.1111/acel.12144; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	95	73	75	8	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2018	362	6418					1020	+	eaat8923	10.1126/science.aat8923	http://dx.doi.org/10.1126/science.aat8923			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC2CE	30361386	Bronze, Green Submitted			2022-12-28	WOS:000451609000036
J	Charles, A				Charles, Andrew			A new opportunity after migraine treatment failure?	LANCET			English	Editorial Material							GUIDELINE		[Charles, Andrew] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, 635 Charles Young Dr,Suite 575, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Charles, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Goldberg Migraine Program, 635 Charles Young Dr,Suite 575, Los Angeles, CA 90095 USA.	acharles@ucla.edu			Takeda	Takeda(Takeda Pharmaceutical Company Ltd)	I have received personal fees from Amgen for consulting on educational materials, for serving as a reviewer for the Amgen Competitive Grants Program not involving erenumab, and for serving as a principal investigator on remote monitoring of migraine studies not involving any specific treatment. I have received personal fees from Alder, Biohaven, eNeura, and Eli Lilly for consulting on advisory boards. I have received grant support from Takeda for basic laboratory research investigating potential migraine therapies. I am Treasurer of the American Headache Society.	Charles A, 2017, NEW ENGL J MED, V377, P553, DOI 10.1056/NEJMcp1605502; Dodick DW, 2018, JAMA-J AM MED ASSOC, V319, P1999, DOI 10.1001/jama.2018.4853; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; GOADSBY PJ, 1993, ANN NEUROL, V33, P48, DOI 10.1002/ana.410330109; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Hepp Z, 2017, CEPHALALGIA, V37, P470, DOI 10.1177/0333102416678382; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; Reuter U, 2018, LANCET, V392, P2280, DOI 10.1016/S0140-6736(18)32534-0; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Stauffer VL, 2018, JAMA NEUROL, V75, P1080, DOI 10.1001/jamaneurol.2018.1212; Tepper SJ, 2018, HEADACHE, V58, P238, DOI 10.1111/head.13379; Young WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054074	13	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2018	392	10161					2241	2242		10.1016/S0140-6736(18)32606-0	http://dx.doi.org/10.1016/S0140-6736(18)32606-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HB4ZY	30360967				2022-12-28	WOS:000451067600005
J	El Khamali, R; Mouaci, A; Valera, S; Cano-Chervel, M; Pinglis, C; Sanz, C; Allal, A; Attard, V; Malardier, J; Delfino, M; D'Anna, F; Rostini, P; Aguilard, S; Berthias, K; Cresta, B; Iride, F; Reynaud, V; Suard, J; Syja, W; Vankiersbilck, C; Chevalier, N; Inthavong, K; Forel, JM; Baumstarck, K; Papazian, L				El Khamali, Radia; Mouaci, Atika; Valera, Sabine; Cano-Chervel, Marion; Pinglis, Camille; Sanz, Celine; Allal, Amel; Attard, Valerie; Malardier, Julie; Delfino, Magali; D'Anna, Fifina; Rostini, Pierre; Aguilard, Stephan; Berthias, Karine; Cresta, Beatrice; Iride, Frederic; Reynaud, Valerie; Suard, Jeremie; Syja, Wlady; Vankiersbilck, Cecile; Chevalier, Nicole; Inthavong, Karen; Forel, Jean-Marie; Baumstarck, Karine; Papazian, Laurent		SISTRESSREA Study Grp	Effects of a Multimodal Program Including Simulation on Job Strain Among Nurses Working in Intensive Care Units A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COPENHAGEN PSYCHOSOCIAL QUESTIONNAIRE; BURNOUT SYNDROME; MUSCULOSKELETAL SYMPTOMS; DEMAND-CONTROL; HEALTH; EMERGENCY; OUTCOMES; STRESS; STAFF	IMPORTANCE Nurses working in an intensive care unit (ICU) are exposed to occupational stressors that can increase the risk of stress reactions, long-term absenteeism, and turnover. OBJECTIVE To evaluate the effects of a program including simulation in reducing work-related stress and work-related outcomes among ICU nurses. DESIGN, SETTING, AND PARTICIPANTS Multicenter randomized clinical trial performed at 8 adult ICUs in France from February 8, 2016, through April 29, 2017. A total of 198 ICU nurses were included and followed up for 1 year until April 30, 2018. INTERVENTIONS The ICU nurses who had at least 6 months of ICU experience were randomized to the intervention group (n = 101) or to the control group (n = 97). The nurses randomized to the intervention group received a 5-day course involving a nursing theory recap and situational role-play using simulated scenarios (based on technical dexterity, clinical approach, decision making, aptitude to teamwork, and task prioritization), which were followed by debriefing sessions on attitude and discussion of practices. MAIN OUTCOMES AND MEASURES The primary outcome was the prevalence of job strain assessed by combining a psychological demand score greater than 21 (score range, 9 [best] to 36 [worst]) with a decision latitude score less than 72 (score range, 24 [worst] to 96 [best]) using the Job Content Questionnaire and evaluated at 6 months. There were 7 secondary outcomes including absenteeism and turnover. RESULTS Among 198 ICU nurses who were randomized (95 aged <= 30 years [48%] and 115 women [58%]), 182 (92%) completed the trial for the primary outcome. The trial was stopped for efficacy at the scheduled interim analysis after enrollment of 198 participants. The prevalence of job strain at 6 months was lower in the intervention group than in the control group (13% vs 67%, respectively; between-group difference, 54%[95% CI, 40%-64%]; P < .001). Absenteeism during the 6-month follow-up period was 1% in the intervention group compared with 8% in the control group (between-group difference, 7% [95% CI, 1%-15%]; P = .03). Four nurses (4%) from the intervention group left the ICU during the 6-month follow-up period compared with 12 nurses (12%) from the control group (between-group difference, 8%[95% CI, 0%-17%]; P = .04). CONCLUSIONS AND RELEVANCE Among ICU nurses, an intervention that included education, role-play, and debriefing resulted in a lower prevalence of job strain at 6 months compared with nurses who did not undergo this program. Further research is needed to understand which components of the program may have contributed to this result and to evaluate whether this program is cost-effective.	[El Khamali, Radia; Mouaci, Atika; Valera, Sabine; Cano-Chervel, Marion; Sanz, Celine; Allal, Amel; Attard, Valerie; Malardier, Julie; Vankiersbilck, Cecile; Forel, Jean-Marie; Papazian, Laurent] Hop Nord Reanimat Detresses Resp & Infect Severes, AP HM, Marseille, France; [El Khamali, Radia; Mouaci, Atika; Valera, Sabine; Cano-Chervel, Marion; Pinglis, Camille; Sanz, Celine; Allal, Amel; Attard, Valerie; Malardier, Julie; Vankiersbilck, Cecile; Forel, Jean-Marie; Baumstarck, Karine; Papazian, Laurent] Aix Marseille Univ, Fac Med, Ctr Etud & Rech Serv Sante & Qual, Marseille, France; [Delfino, Magali; D'Anna, Fifina; Rostini, Pierre] AP HM, Ctr Enseignement Soins Urgence, Marseille, France; [Aguilard, Stephan] Hop Timone Reanimat Urgences & Med, AP HM, Marseille, France; [Aguilard, Stephan; Berthias, Karine; Cresta, Beatrice; Iride, Frederic; Suard, Jeremie; Syja, Wlady] Aix Marseille Univ, Marseille, France; [Berthias, Karine] Hop Timone Reanimat Polyvalente & Neurochirurg, AP HM, Marseille, France; [Cresta, Beatrice] Hop La Timone, AP HM, Unite Reanimat Chirurg Cardiovasc, Marseille, France; [Iride, Frederic] Hop Nord Reanimat Polyvalente & Traumatol, AP HM, Marseille, France; [Reynaud, Valerie] Reanimat Ctr Hosp, Aix En Provence, France; [Suard, Jeremie] Hop Concept Reanimat Polyvalente, AP HM, Marseille, France; [Syja, Wlady] Hop Concept Reanimat Polyvalente & Pathol Foie, AP HM, Marseille, France; [Chevalier, Nicole; Inthavong, Karen] AP HM, Marseille, France; [Baumstarck, Karine] AP HM, Unite Aide Methodol Rech Clin, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Hop Nord Marseille, Med Intens Reanimat, Chemin Bourrely, F-13015 Marseille, France.	laurent.papazian@ap-hm.fr	inthavong, kiao/B-3526-2012	inthavong, kiao/0000-0003-0476-0237	French Ministry of Health (Programme Hospitalier de Recherche Infirmiere et Paramedicale [PHRIP]) [PHRIP 14-0061]; Assistance Publique-Hopitaux de Marseille	French Ministry of Health (Programme Hospitalier de Recherche Infirmiere et Paramedicale [PHRIP]); Assistance Publique-Hopitaux de Marseille	This research was funded by grant PHRIP 14-0061 from the French Ministry of Health (Programme Hospitalier de Recherche Infirmiere et Paramedicale [PHRIP]) and by funding from the Assistance Publique-Hopitaux de Marseille.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aycock N, 2009, CLIN J ONCOL NURS, V13, P183, DOI 10.1188/09.CJON.183-191; Azoulay E, 2011, AM J RESP CRIT CARE, V184, P1099, DOI 10.1164/rccm.201109-1638ED; Begue C, 2016, OCCUP MED-OXFORD, V66, P128, DOI 10.1093/occmed/kqv147; Bellagamba G, 2015, INT J OCCUP MED ENV, V28, P357, DOI 10.13075/ijomeh.1896.00121; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Crowe S, 2018, NURSE EDUC PRACT, V29, P70, DOI 10.1016/j.nepr.2017.11.017; Dupret E, 2012, SCAND J PUBLIC HEALT, V40, P482, DOI 10.1177/1403494812453888; Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a; Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC; Gosselin E, 2016, NURS CRIT CARE, V21, P137, DOI 10.1111/nicc.12064; Haute Autorite de Sante, GOOD PRACT SIM TRAIN; Josephson M, 1997, OCCUP ENVIRON MED, V54, P681, DOI 10.1136/oem.54.9.681; Kameg Kirstyn, 2010, Issues Ment Health Nurs, V31, P315, DOI 10.3109/01612840903420331; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Lee SJ, 2014, AM J IND MED, V57, P214, DOI 10.1002/ajim.22274; Leiter MP, 2015, BRIT J HEALTH PSYCH, V20, P223, DOI 10.1111/bjhp.12124; Mealer Meredith, 2016, Am J Respir Crit Care Med, V194, pP1, DOI 10.1164/rccm.1941P1; Missen K, 2014, J ADV NURS, V70, P2419, DOI 10.1111/jan.12464; Moss M, 2016, AM J CRIT CARE, V25, P368, DOI 10.4037/ajcc2016133; Niedhammer I, 2006, Sante Publique, V18, P413; Pai HC, 2016, NURS EDUC TODAY, V45, P156, DOI 10.1016/j.nedt.2016.07.011; Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC; Portoghese I, 2015, J NURS MANAGE, V23, P754, DOI 10.1111/jonm.12205; Robbins JR, 2017, BURNS, V43, P1441, DOI 10.1016/j.burns.2017.04.017; Sexton JB, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-44; Shrader Sarah, 2013, J Allied Health, V42, pe1; Stocker M, 2012, INTENS CARE MED, V38, P99, DOI 10.1007/s00134-011-2371-5; Trousselard M, 2016, INT ARCH OCC ENV HEA, V89, P221, DOI 10.1007/s00420-015-1065-7	30	36	37	3	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2018	320	19					1988	1997		10.1001/jama.2018.14284	http://dx.doi.org/10.1001/jama.2018.14284			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB0FC	30357264	Bronze, Green Published			2022-12-28	WOS:000450686800013
J	Curtin, NA; Bartlam-Brooks, HLA; Hubel, TY; Lowe, JC; Gardner-Medwin, AR; Bennitt, E; Amos, SJ; Lorenc, M; West, TG; Wilson, AM				Curtin, Nancy A.; Bartlam-Brooks, Hattie L. A.; Hubel, Tatjana Y.; Lowe, John C.; Gardner-Medwin, Anthony R.; Bennitt, Emily; Amos, Stephen J.; Lorenc, Maja; West, Timothy G.; Wilson, Alan M.			Remarkable muscles, remarkable locomotion in desert-dwelling wildebeest	NATURE			English	Article							ENERGY-CONVERSION; EFFICIENCY; ENERGETICS; FIBERS; COST; BIOMECHANICS; ADJUSTMENTS; MECHANICS; RECOVERY; TORTOISE	Large mammals that live in arid and/or desert environments can cope with seasonal and local variations in rainfall, food and climate1 by moving long distances, often without reliable water or food en route. The capacity of an animal for this long-distance travel is substantially dependent on the rate of energy utilization and thus heat production during locomotion-the cost of transport(2,3,4). The terrestrial cost of transport is much higher than for flying (7.5 times) and swimming (20 times)4. Terrestrial migrants are usually large(1,2,3) with anatomical specializations for economical locomotion(5,6,7,8,9), because the cost of transport reduces with increasing size and limb length(5,6,7). Here we used GPS-tracking collars10 with movement and environmental sensors to show that blue wildebeest (Connochaetes taurinus, 220 kg) that live in a hot arid environment in Northern Botswana walked up to 80 km over five days without drinking. They predominantly travelled during the day and locomotion appeared to be unaffected by temperature and humidity, although some behavioural thermoregulation was apparent. We measured power and efficiency of work production (mechanical work and heat production) during cyclic contractions of intact muscle biopsies from the forelimb flexor carpi ulnaris of wildebeest and domestic cows (Bos taurus, 760 kg), a comparable but relatively sedentary ruminant. The energetic costs of isometric contraction (activation and force generation) in wildebeest and cows were similar to published values for smaller mammals. Wildebeest muscle was substantially more efficient (62.6%) than the same muscle from much larger cows (41.8%) and comparable measurements that were obtained from smaller mammals (mouse (34%)11 and rabbit (27%)). We used the direct energetic measurements on intact muscle fibres to model the contribution of high working efficiency of wildebeest muscle to minimizing thermoregulatory challenges during their long migrations under hot arid conditions.	[Curtin, Nancy A.; Bartlam-Brooks, Hattie L. A.; Hubel, Tatjana Y.; Lowe, John C.; Amos, Stephen J.; Lorenc, Maja; West, Timothy G.; Wilson, Alan M.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Gardner-Medwin, Anthony R.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Bennitt, Emily] Univ Botswana, Okavango Res Inst, Maun, Botswana	University of London; University of London Royal Veterinary College; University of London; University College London; University of Botswana	Curtin, NA; Wilson, AM (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England.	ncurtin@rvc.ac.uk; awilson@rvc.ac.uk	Bennitt, Emily/AAB-6032-2020	Lorenc, Maja/0000-0003-2665-0135; Wilson, Alan/0000-0001-9914-3455; Bartlam-Brooks, Hattie/0000-0002-1507-1712	EPSRC [EP/H013016/1]; BBSRC [BB/J018007/1]; ERC [323041]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission)	We thank R. Woledge for contributing to early design of experiments; C. Barclay for helping us to fabricate the thermocouple elements; our field assistants, N. Terry and M. Claase; A. R. Wilson for logistical support and editorial contributions; M. Flyman (Department of Wildlife and National Parks) for his support and enthusiasm and J. O'Connor and P. O'Riordan (Dawn Meats, Bedford) for enabling cow muscle collection. Funding was provided by the EPSRC (EP/H013016/1), BBSRC (BB/J018007/1) and ERC (323041). A Botswana Research Permit EWT 8/36/4 was held by A.M.W. and A.M.W. was a registered Botswana veterinarian.	ALEXANDER RM, 1982, J ZOOL, V198, P293, DOI 10.1111/j.1469-7998.1982.tb02077.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; Barclay CJ, 2015, COMPR PHYSIOL, V5, P961, DOI 10.1002/cphy.c140038; Barclay CJ, 2010, J PHYSIOL-LONDON, V588, P3819, DOI 10.1113/jphysiol.2010.192799; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; BARCLAY CJ, 1994, J EXP BIOL, V193, P65; Bertram JEA, 2005, J EXP BIOL, V208, P979, DOI 10.1242/jeb.01498; BUTLER PJ, 1993, J EXP BIOL, V179, P159; CURTIN NA, 1991, J EXP BIOL, V158, P343; CURTIN NA, 1993, J EXP BIOL, V183, P137; Dewhirst OP, 2016, ECOL EVOL, V6, P6210, DOI 10.1002/ece3.2359; ESTES R, 1991, BEHAV GUIDE AFRICAN, V64; Hedenstrom A, 2003, ANIM BEHAV, V66, P631, DOI 10.1006/anbe.2003.2234; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; Hetem RS, 2007, J EXP ZOOL PART A, V307A, P342, DOI 10.1002/jez.389; Hetem RS, 2016, BIOL REV, V91, P187, DOI 10.1111/brv.12166; Hetem RS, 2010, J COMP PHYSIOL B, V180, P1111, DOI 10.1007/s00360-010-0480-z; Hill AV., 1965, TRAILS TRIALS PHYSL; Hubel TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11034; Hubel TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11033; Kohn TA, 2011, J EXP BIOL, V214, P4041, DOI 10.1242/jeb.061572; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; KRETZSCHMAR KM, 1975, PROC R SOC SER B-BIO, V190, P315, DOI 10.1098/rspb.1975.0095; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; MACFARLANE WV, 1971, NATURE, V234, P483, DOI 10.1038/234483a0; MALOIY G M O, 1973, Zeitschrift fuer Tierzuechtung und Zuechtungsbiologie, V90, P219; MALOIY GMO, 1970, AM J PHYSIOL, V219, P1522, DOI 10.1152/ajplegacy.1970.219.5.1522; PHILLIPS SK, 1993, J PHYSIOL-LONDON, V460, P693, DOI 10.1113/jphysiol.1993.sp019494; Rumble J. R., 2017, CRC HDB CHEM PHYS; Schmidt-Nielsen K., 1965, DESERT ANIMALS PHYSL; TAYLOR CR, 1982, J EXP BIOL, V97, P1; TUCKER VA, 1975, AM SCI, V63, P413; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; West TG, 2013, J EXP BIOL, V216, P2974, DOI 10.1242/jeb.083667; WILLIAMS TL, 1981, J PHYSIOL-LONDON, V310, P307, DOI 10.1113/jphysiol.1981.sp013551; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson AM, 2018, NATURE, V554, P183, DOI 10.1038/nature25479; Wilson AM, 2003, NATURE, V421, P35, DOI 10.1038/421035a; Woledge R C, 1985, Monogr Physiol Soc, V41, P1; WOLEDGE RC, 1968, J PHYSIOL-LONDON, V197, P685, DOI 10.1113/jphysiol.1968.sp008582	40	19	19	8	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					393	+		10.1038/s41586-018-0602-4	http://dx.doi.org/10.1038/s41586-018-0602-4			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30356212	Green Accepted, Green Submitted			2022-12-28	WOS:000450048400058
J	van Sloten, TT; Tafflet, M; Perier, MC; Dugravot, A; Climie, RED; Singh-Manoux, A; Empana, JP				van Sloten, Thomas T.; Tafflet, Muriel; Perier, Marie-Cecile; Dugravot, Aline; Climie, Rachel E. D.; Singh-Manoux, Archana; Empana, Jean-Philippe			Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRITISH CIVIL-SERVANTS; HEALTH; METAANALYSIS; MORTALITY; DISEASE	IMPORTANCE There is consistent evidence of the association between ideal cardiovascular health and lower incident cardiovascular disease (CVD); however, most studies used a single measure of cardiovascular health. OBJECTIVE To examine how cardiovascular health changes over time and whether these changes are associated with incident CVD. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study in a UK general community (Whitehall II), with examinations of cardiovascular health from 1985/1988 (baseline) and every 5 years thereafter until 2015/2016 and follow-up for incident CVD until March 2017. EXPOSURES Using the 7 metrics of the American Heart Association (nonsmoking; and ideal levels of body mass index, physical activity, diet, blood pressure, fasting blood glucose, and total cholesterol), participants with 0 to 2, 3 to 4, and 5 to 7 ideal metrics were categorized as having low, moderate, and high cardiovascular health. Change in cardiovascular health over 10 years between 1985/1988 and 1997/1999 was considered. MAIN OUTCOME AND MEASURE Incident CVD (coronary heart disease and stroke). RESULTS The study population included 9256 participants without prior CVD (mean [SD] age at baseline, 44.8 [6.0] years; 2941 [32%] women), of whom 6326 had data about cardiovascular health change. Over a median follow-up of 18.9 years after 1997/1999, 1114 incident CVD events occurred. In multivariable analysis and compared with individuals with persistently low cardiovascular health (consistently low group, 13.5% of participants; CVD incident rate per 1000 person-years, 9.6 [95% CI, 8.4-10.9]), there was no significant association with CVD risk in the low to moderate group (6.8% of participants; absolute rate difference per 1000 person-years, -1.9 [95% CI, -3.9 to 0.1]; HR, 0.84 [95% CI, 0.66-1.08]), the low to high group, (0.3% of participants; absolute rate difference per 1000 person-years, -7.7 [95% CI, -11.5 to -3.9]; HR, 0.19 [95% CI, 0.03-1.35]), and the moderate to low group (18.0% of participants; absolute rate difference per 1000 person-years, -1.3 [95% CI, -3.0 to 0.3]; HR, 0.96 [95% CI, 0.80-1.15]). A lower CVD risk was observed in the consistently moderate group (38.9% of participants; absolute rate difference per 1000 person-years, -4.2 [95% CI, -5.5 to -2.8]; HR, 0.62 [95% CI, 0.53-0.74]), the moderate to high group (5.8% of participants; absolute rate difference per 1000 person-years, -6.4 [95% CI, -8.0 to -4.7]; HR, 0.39 [95% CI, 0.27-0.56]), the high to low group (1.9% of participants; absolute rate difference per 1000 person-years, -5.3 [95% CI, -7.8 to -2.8]; HR, 0.49 [95% CI, 0.29-0.83]), the high to moderate group (9.3% of participants; absolute rate difference per 1000 person-years, -4.5 [95% CI, -6.2 to -2.9]; HR, 0.66 [95% CI, 0.51-0.85]), and the consistently high group (5.5% of participants; absolute rate difference per 1000 person-years, -5.6 [95% CI, -7.4 to -3.9]; HR, 0.57 [95% CI, 0.40-0.80]). CONCLUSIONS AND RELEVANCE Among a group of participants without CVD who received follow-up over a median 18.9 years, there was no consistent relationship between direction of change in category of a composite metric of cardiovascular health and risk of CVD.	[van Sloten, Thomas T.; Tafflet, Muriel; Perier, Marie-Cecile; Climie, Rachel E. D.; Empana, Jean-Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [van Sloten, Thomas T.; Tafflet, Muriel; Perier, Marie-Cecile; Climie, Rachel E. D.; Empana, Jean-Philippe] Paris Cardiovasc Res Ctr, INSERM, UMR S970, Integrat Epidemiol Cardiovasc Dis Team 4, Paris, France; [van Sloten, Thomas T.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med, Maastricht, Netherlands; [Dugravot, Aline; Singh-Manoux, Archana] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Dugravot, Aline; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Climie, Rachel E. D.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Climie, Rachel E. D.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; University of Tasmania; Menzies Institute for Medical Research; Baker Heart and Diabetes Institute	Empana, JP (corresponding author), Paris Descartes Univ, Paris Cardiovasc Res Ctr, INSERM, U970, 56 Rue Leblanc, F-75015 Paris, France.	jean-philippe.empana@inserm.fr	Empana, Jean-Philippe/AAF-6923-2021; Singh-Manoux, Archana/F-6804-2013	Empana, Jean-Philippe/0000-0002-1469-7772; Singh-Manoux, Archana/0000-0002-1244-5037; van Sloten, Thomas/0000-0003-2870-482X; Climie, Rachel/0000-0002-7960-360X	National Institute on Aging [R56AG056477, R01AG034454]; British Heart Foundation [32334]; UK Medical Research Council (MRC) [K013351, R024227]; Prestige and Marie Curie Fellowship; Lefoulon Delalande Fellowship; High Blood Pressure Research Council of Australia Franco-Aus exchange grant; Agence Nationale de la Recherche; MRC [MR/K013351/1, MR/R024227/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG056477, R56AG056477, RF1AG062553] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Prestige and Marie Curie Fellowship; Lefoulon Delalande Fellowship; High Blood Pressure Research Council of Australia Franco-Aus exchange grant; Agence Nationale de la Recherche(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Whitehall II study is supported by grants from the National Institute on Aging (R56AG056477; R01AG034454), the British Heart Foundation (32334), and the UK Medical Research Council (MRC, K013351 and R024227). Dr Climie is supported by a Prestige and Marie Curie Fellowship, a Lefoulon Delalande Fellowship, and a High Blood Pressure Research Council of Australia Franco-Aus exchange grant. Dr van Sloten is supported by a grant from the Agence Nationale de la Recherche.	Aatola H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000532; Britton A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-83; Enserro DM, 2018, J AM HEART ASSOC, V7, DOI [10.1161/jaha.118.008741, 10.1161/JAHA.118.008741]; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gaye B, 2016, SCI REP-UK, V6, DOI 10.1038/srep18951; Gaye B, 2017, J AM COLL CARDIOL, V69, P3015, DOI 10.1016/j.jacc.2017.05.011; Guo LL, 2017, CLIN CARDIOL, V40, P1339, DOI 10.1002/clc.22836; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Hwang SJ, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.006209; Kivimaki M, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00003; Kivimaki M, 2017, EPIDEMIOLOGY, V28, P735, DOI 10.1097/EDE.0000000000000688; Kronish IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052771; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Shah AM, 2015, CIRCULATION, V132, P1979, DOI 10.1161/CIRCULATIONAHA.115.017882; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Yeboah J, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007385	18	31	31	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1793	1804		10.1001/jama.2018.16975	http://dx.doi.org/10.1001/jama.2018.16975			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398604	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000449461800017
J	Cavalleri, A				Cavalleri, Andrea			Disorder at the border The photoinduced phase transition in vanadium oxide involves ultrafast loss of coherence	SCIENCE			English	Editorial Material									[Cavalleri, Andrea] Univ Oxford, Dept Phys, Oxford, England; [Cavalleri, Andrea] Max Planck Inst Struct & Dynam Matter, Hamburg, Germany	University of Oxford; Max Planck Society	Cavalleri, A (corresponding author), Univ Oxford, Dept Phys, Oxford, England.; Cavalleri, A (corresponding author), Max Planck Inst Struct & Dynam Matter, Hamburg, Germany.	andrea.cavalleri@mpsd.mpg.de						Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Cavalleri A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161102; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Kubler C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116401; Morrison VR, 2014, SCIENCE, V346, P445, DOI 10.1126/science.1253779; Wall S, 2018, SCIENCE, V362, P572, DOI 10.1126/science.aau3873	7	2	2	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		525	526		10.1126/science.aav2019	http://dx.doi.org/10.1126/science.aav2019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385563				2022-12-28	WOS:000450460000025
J	Zhang, HB; Griffiths, ML; Chiang, JCH; Kong, WW; Wu, ST; Atwood, A; Huang, JH; Cheng, H; Ning, YF; Xie, SC				Zhang, Hongbin; Griffiths, Michael L.; Chiang, John C. H.; Kong, Wenwen; Wu, Shitou; Atwood, Alyssa; Huang, Junhua; Cheng, Hai; Ning, Youfeng; Xie, Shucheng			East Asian hydroclimate modulated by the position of the westerlies during Termination I	SCIENCE			English	Article							SUMMER MONSOON PRECIPITATION; NORTH-ATLANTIC CLIMATE; ICE-AGE TERMINATIONS; SEASONAL TRANSITIONS; LAST DEGLACIATION; TRACE-ELEMENT; TIBETAN PLATEAU; INDIAN MONSOON; CAVE RECORDS; VARIABILITY	Speleothem oxygen isotope records have revolutionized our understanding of the paleo East Asian monsoon, yet there is fundamental disagreement on what they represent in terms of the hydroclimate changes. We report a multiproxy speleothem record of monsoon evolution during the last deglaciation from the middle Yangtze region, which indicates a wetter central eastern China during North Atlantic cooling episodes, despite the oxygen isotopic record suggesting a weaker monsoon. We show that this apparent contradiction can be resolved if the changes are interpreted as a lengthening of the Meiyu rains and shortened post-Meiyu stage, in accordance with a recent hypothesis. Model simulations support this interpretation and further reveal the role of the westerlies in communicating the North Atlantic influence to the East Asian climate.	[Zhang, Hongbin; Xie, Shucheng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Hongbin; Huang, Junhua] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Wuhan 430074, Hubei, Peoples R China; [Griffiths, Michael L.] William Paterson Univ, Dept Environm Sci, Wayne, NJ 07470 USA; [Chiang, John C. H.; Kong, Wenwen; Atwood, Alyssa] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Chiang, John C. H.; Kong, Wenwen; Atwood, Alyssa] Univ Calif Berkeley, Berkeley Atmospher Sci Ctr, Berkeley, CA 94720 USA; [Wu, Shitou] Georg August Univ Goettingen, Fac Geosci & Geog, Dept Geochem, D-37077 Gottingen, Germany; [Wu, Shitou] Chinese Acad Sci, Inst Geol & Geophys, Beijing 100029, Peoples R China; [Atwood, Alyssa] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Cheng, Hai; Ning, Youfeng] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Shaanxi, Peoples R China; [Cheng, Hai] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Xie, Shucheng] China Univ Geosci, Sch Earth Sci, Dept Geog, Wuhan 430074, Hubei, Peoples R China	China University of Geosciences; China University of Geosciences; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Gottingen; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; University System of Georgia; Georgia Institute of Technology; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; China University of Geosciences	Xie, SC (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Hubei, Peoples R China.; Griffiths, ML (corresponding author), William Paterson Univ, Dept Environm Sci, Wayne, NJ 07470 USA.; Xie, SC (corresponding author), China Univ Geosci, Sch Earth Sci, Dept Geog, Wuhan 430074, Hubei, Peoples R China.	griffithsm@wpunj.edu; xiecug@163.com	Chiang, John/AAK-6169-2021; Wu, Shitou/Z-1500-2019; Xie, Shucheng/E-6713-2011; CHENG, HAI/H-3413-2017; Kong, Wenwen/Y-8516-2019	Wu, Shitou/0000-0002-8420-9877; CHENG, HAI/0000-0002-5305-9458; Kong, Wenwen/0000-0003-2999-8081; , Shucheng/0000-0002-5763-2928; Griffiths, Michael/0000-0003-4051-7568; Chiang, John/0000-0001-7723-9544	Key R&D Project of Ministry of Science and Technology [2016YFA0601100]; Chinese National Natural Science Foundation [41330103, 41773135]; 111 Program (Ministry of Education of China) [B08030]; U.S. National Science Foundation [AGS-1405479]; 111 Program (National Bureau for Foreign Experts)	Key R&D Project of Ministry of Science and Technology; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 111 Program (Ministry of Education of China); U.S. National Science Foundation(National Science Foundation (NSF)); 111 Program (National Bureau for Foreign Experts)	This work was supported by the Key R&D Project of Ministry of Science and Technology (grant no. 2016YFA0601100), the Chinese National Natural Science Foundation (grants 41330103 and 41773135), the 111 Program (National Bureau for Foreign Experts and Ministry of Education of China; grant B08030), and the U.S. National Science Foundation (grant AGS-1405479).	An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; [Anonymous], 2013, ENCY QUATERNARY SCI, DOI DOI 10.1016/B978-0-444-53643-3.00369-1; Atwood A., 2015, THESIS; Babamoradi H, 2013, CHEMOMETR INTELL LAB, V120, P97, DOI 10.1016/j.chemolab.2012.10.007; Belli R, 2017, GEOCHIM COSMOCHIM AC, V199, P247, DOI 10.1016/j.gca.2016.10.024; Bereiter B, 2015, GEOPHYS RES LETT, V42, P542, DOI 10.1002/2014GL061957; Bernal JP, 2016, EARTH PLANET SC LETT, V450, P186, DOI 10.1016/j.epsl.2016.06.008; Breecker DO, 2017, EARTH PLANET SC LETT, V458, P58, DOI 10.1016/j.epsl.2016.10.042; Cai YJ, 2015, P NATL ACAD SCI USA, V112, P2954, DOI 10.1073/pnas.1424035112; Chen CJ, 2018, J HYDROL, V561, P896, DOI 10.1016/j.jhydrol.2018.04.061; Chen FH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11186; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cheng H, 2016, NATURE, V534, P640, DOI 10.1038/nature18591; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chiang JCH, 2017, GEOPHYS RES LETT, V44, P3788, DOI 10.1002/2017GL072739; Chiang JCH, 2015, QUATERNARY SCI REV, V108, P111, DOI 10.1016/j.quascirev.2014.11.009; Cruz FW, 2007, GEOCHIM COSMOCHIM AC, V71, P2250, DOI 10.1016/j.gca.2007.02.005; Day CC, 2013, GEOCHIM COSMOCHIM AC, V120, P612, DOI 10.1016/j.gca.2013.05.044; Day JA, 2015, J CLIMATE, V28, P4330, DOI 10.1175/JCLI-D-14-00393.1; Deplazes G, 2013, NAT GEOSCI, V6, P213, DOI 10.1038/ngeo1712; Ding YH, 2005, METEOROL ATMOS PHYS, V89, P117, DOI 10.1007/s00703-005-0125-z; Dong JG, 2015, PALAEOGEOGR PALAEOCL, V435, P127, DOI 10.1016/j.palaeo.2015.06.013; Dong JG, 2010, HOLOCENE, V20, P257, DOI 10.1177/0959683609350393; Drysdale RN, 2009, SCIENCE, V325, P1527, DOI 10.1126/science.1170371; Dutt S, 2015, GEOPHYS RES LETT, V42, P5526, DOI 10.1002/2015GL064015; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Eggins SM, 1998, APPL SURF SCI, V127, P278, DOI 10.1016/S0169-4332(97)00643-0; Fairchild I. J., 2012, SPELEOTHEM SCI PROCE, V3; Fairchild IJ, 2009, QUATERNARY SCI REV, V28, P449, DOI 10.1016/j.quascirev.2008.11.007; Fairchild IJ, 2000, CHEM GEOL, V166, P255, DOI 10.1016/S0009-2541(99)00216-8; Frisia S, 2011, GEOCHIM COSMOCHIM AC, V75, P380, DOI 10.1016/j.gca.2010.10.021; Genty D, 2006, QUATERNARY SCI REV, V25, P2118, DOI 10.1016/j.quascirev.2006.01.030; Goldsmith Y, 2017, P NATL ACAD SCI USA, V114, P1817, DOI 10.1073/pnas.1616708114; Griffiths ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11719; Griffiths ML, 2010, EARTH PLANET SC LETT, V292, P27, DOI 10.1016/j.epsl.2010.01.002; Hsu HH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017909; Hsu HH, 2007, J CLIMATE, V20, P4443, DOI 10.1175/JCLI4246.1; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; Huang HM, 2001, CHEM GEOL, V175, P429; Jiang XY, 2014, QUATERNARY RES, V82, P146, DOI 10.1016/j.yqres.2014.05.001; Johnson KR, 2006, EARTH PLANET SC LETT, V244, P394, DOI 10.1016/j.epsl.2006.01.064; Kathayat G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24374; Kong W, 2017, J CLIMATE, V30, P3343, DOI 10.1175/JCLI-D-16-0087.1; LeGrande AN, 2009, CLIM PAST, V5, P441, DOI 10.5194/cp-5-441-2009; Li G, 2014, J CLIMATE, V27, P1765, DOI 10.1175/JCLI-D-13-00337.1; Li XL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20776-5; Liu YH, 2013, NAT GEOSCI, V6, P117, DOI [10.1038/ngeo1708, 10.1038/NGEO1708]; Liu ZY, 2014, QUATERNARY SCI REV, V83, P115, DOI 10.1016/j.quascirev.2013.10.021; Ma ZB, 2012, QUATERNARY SCI REV, V41, P83, DOI 10.1016/j.quascirev.2012.03.006; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mohtadi M, 2014, NATURE, V509, P76, DOI 10.1038/nature13196; Molnar P, 2010, ANNU REV EARTH PL SC, V38, P77, DOI 10.1146/annurev-earth-040809-152456; Mudelsee M, 2003, MATH GEOL, V35, P651, DOI 10.1023/B:MATG.0000002982.52104.02; Muller W, 2009, J ANAL ATOM SPECTROM, V24, P209, DOI 10.1039/b805995k; Owen RA, 2016, EARTH PLANET SC LETT, V443, P129, DOI 10.1016/j.epsl.2016.03.027; Pausata FSR, 2011, NAT GEOSCI, V4, P474, DOI [10.1038/NGEO1169, 10.1038/ngeo1169]; Polyak VJ, 2012, GEOLOGY, V40, P1023, DOI 10.1130/G33226.1; Pu JB, 2015, BOREAS, V44, P603, DOI 10.1111/bor.12117; Sinclair DJ, 2011, CHEM GEOL, V283, P119, DOI 10.1016/j.chemgeo.2010.05.022; Sinha A, 2005, GEOLOGY, V33, P813, DOI 10.1130/G21498.1; Tang L, 2015, HOLOCENE, V25, P844, DOI 10.1177/0959683615571426; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xie SC, 2013, GEOLOGY, V41, P827, DOI 10.1130/G34318.1; Yang Y, 2010, SCI CHINA EARTH SCI, V53, P633, DOI 10.1007/s11430-010-0025-z; Yatagai A, 2009, SOLA, V5, P137, DOI 10.2151/sola.2009-035; Yeh T.-C., 1959, ATMOSPHERE SEA MOTIO, P249; Yu G., 2000, LAKE RECORDS CHINA P, P196; Yu RC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021270; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zaarur S, 2018, EARTH PLANET SC LETT, V496, P10, DOI 10.1016/j.epsl.2018.05.025; Zhang HB, 2016, EARTH PLANET SC LETT, V453, P243, DOI 10.1016/j.epsl.2016.08.008	75	122	145	34	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		580	+		10.1126/science.aat9393	http://dx.doi.org/10.1126/science.aat9393			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385577	Green Submitted			2022-12-28	WOS:000450460000045
J	Magill, SS; O'Leary, E; Janelle, SJ; Thompson, DL; Dumyati, G; Nadle, J; Wilson, LE; Kainer, MA; Lynfield, R; Greissman, S; Ray, SM; Beldavs, Z; Gross, C; Bamberg, W; Sievers, M; Concannon, C; Buhr, N; Warnke, L; Maloney, M; Ocampo, V; Brooks, J; Oyewumi, T; Sharmin, S; Richards, K; Rainbow, J; Samper, M; Hancock, EB; Leaptrot, D; Scalise, E; Badrun, F; Phelps, R; Edwards, JR				Magill, S. S.; O'Leary, E.; Janelle, S. J.; Thompson, D. L.; Dumyati, G.; Nadle, J.; Wilson, L. E.; Kainer, M. A.; Lynfield, R.; Greissman, S.; Ray, S. M.; Beldavs, Z.; Gross, C.; Bamberg, W.; Sievers, M.; Concannon, C.; Buhr, N.; Warnke, L.; Maloney, M.; Ocampo, V.; Brooks, J.; Oyewumi, T.; Sharmin, S.; Richards, K.; Rainbow, J.; Samper, M.; Hancock, E. B.; Leaptrot, D.; Scalise, E.; Badrun, F.; Phelps, R.; Edwards, J. R.		Emerging Infect Program Hosp	Changes in Prevalence of Health Care-Associated Infections in US Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL-SITE INFECTIONS; ACQUIRED PNEUMONIA; UNITED-STATES; DIFFICILE INFECTION; SURVEILLANCE; EPIDEMIOLOGY	BACKGROUND A point-prevalence survey that was conducted in the United States in 2011 showed that 4% of hospitalized patients had a health care-associated infection. We repeated the survey in 2015 to assess changes in the prevalence of health care-associated infections during a period of national attention to the prevention of such infections. METHODS At Emerging Infections Program sites in 10 states, we recruited up to 25 hospitals in each site area, prioritizing hospitals that had participated in the 2011 survey. Each hospital selected 1 day on which a random sample of patients was identified for assessment. Trained staff reviewed medical records using the 2011 definitions of health care-associated infections. We compared the percentages of patients with health care-associated infections and performed multivariable log-binomial regression modeling to evaluate the association of survey year with the risk of health care-associated infections. RESULTS In 2015, a total of 12,299 patients in 199 hospitals were surveyed, as compared with 11,282 patients in 183 hospitals in 2011. Fewer patients had health care-associated infections in 2015 (394 patients [3.2%; 95% confidence interval {CI}, 2.9 to 3.5]) than in 2011 (452 [4.0%; 95% CI, 3.7 to 4.4]) (P<0.001), largely owing to reductions in the prevalence of surgical-site and urinary tract infections. Pneumonia, gastrointestinal infections (most of which were due to Clostridium difficile [now Clostridioides difficile]), and surgical-site infections were the most common health care-associated infections. Patients' risk of having a health care-associated infection was 16% lower in 2015 than in 2011 (risk ratio, 0.84; 95% CI, 0.74 to 0.95; P = 0.005), after adjustment for age, presence of devices, days from admission to survey, and status of being in a large hospital. CONCLUSIONS The prevalence of health care-associated infections was lower in 2015 than in 2011. To continue to make progress in the prevention of such infections, prevention strategies against C. difficile infection and pneumonia should be augmented. (Funded by the Centers for Disease Control and Prevention.)	[Magill, S. S.; O'Leary, E.; Gross, C.; Brooks, J.; Leaptrot, D.; Scalise, E.; Badrun, F.; Phelps, R.; Edwards, J. R.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,H16-3, Atlanta, GA 30329 USA; [Ray, S. M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Gross, C.; Brooks, J.; Leaptrot, D.; Scalise, E.] CACI, Atlanta, GA USA; [Badrun, F.] Eagle Med Serv, Atlanta, GA USA; [Janelle, S. J.; Bamberg, W.; Oyewumi, T.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Thompson, D. L.; Sievers, M.; Sharmin, S.] New Mexico Dept Hlth, Santa Fe, NM USA; [Thompson, D. L.] Presbyterian Healthcare Serv, Albuquerque, NM USA; [Hancock, E. B.] Univ New Mexico, Albuquerque, NM 87131 USA; [Dumyati, G.; Concannon, C.] New York Emerging Infect Program, Rochester, NY USA; [Dumyati, G.; Concannon, C.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Nadle, J.] Calif Emerging Infect Program, Oakland, CA USA; [Wilson, L. E.; Buhr, N.; Richards, K.] Maryland Dept Hlth, Baltimore, MD USA; [Kainer, M. A.] Tennessee Dept Hlth, Nashville, TN USA; [Lynfield, R.; Warnke, L.; Rainbow, J.] Minnesota Dept Hlth, St Paul, MN USA; [Greissman, S.; Maloney, M.] Connecticut Emerging Infect Program, New Haven, CT USA; [Greissman, S.; Maloney, M.] Connecticut Emerging Infect Program, Hartford, CT USA; [Ray, S. M.] Georgia Emerging Infect Program, Decatur, GA USA; [Beldavs, Z.; Ocampo, V.; Samper, M.] Oregon Hlth Author, Portland, OR USA	Centers for Disease Control & Prevention - USA; Emory University; Colorado Department of Public Health & Environment; New Mexico Department of Health; University of New Mexico; University of Rochester; California Emerging Infections Program; Tennessee Department Health; Minnesota Department of Health (MHD)	Magill, SS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,H16-3, Atlanta, GA 30329 USA.	smagill@cdc.gov		Ray, Susan/0000-0002-6327-088X; Ocampo, Valerie/0000-0001-9529-4790; Kainer, Marion/0000-0001-7678-8744; O'Leary, Erin/0000-0002-6511-5728	CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the CDC.	[Anonymous], 2015, HEALTHC FAC HAI REP; [Anonymous], 2013, ANTIBIOTIC RESISTANC; [Anonymous], 2016, NAT STAT HEALTHC ASS; [Anonymous], 2015, NAT ACT PLAN COMB AN; Baker D, 2018, AM J INFECT CONTROL, V46, P2, DOI 10.1016/j.ajic.2017.08.036; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Ewan VC, 2017, LANCET RESP MED, V5, P771, DOI 10.1016/S2213-2600(17)30296-5; Garcia R, 2017, AM J INFECT CONTROL, V45, P1143, DOI 10.1016/j.ajic.2017.03.006; Giuliano KK, 2018, AM J INFECT CONTROL, V46, P322, DOI 10.1016/j.ajic.2017.09.005; HCUP Nationwide Inpatient Sample (NIS), 2014, HEALTHC COST UT PROJ; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Houchens R, 201404 US AG HEALTHC; Klompas M, 2016, INFECT CONT HOSP EP, V37, P825, DOI 10.1017/ice.2016.101; Magill SS, 2015, EMERG INFECT DIS, V21, P1537, DOI 10.3201/eid2109.150508; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Metersky ML, 2016, JAMA-J AM MED ASSOC, V316, P2427, DOI 10.1001/jama.2016.16226; National Healthcare Safety Network, 2015, VAL MAN; NHSN, 2017, NHSN E NEWS      JUN, V12; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Polage CR, 2015, JAMA INTERN MED, V175, P1792, DOI 10.1001/jamainternmed.2015.4114; RHAME FS, 1981, AM J EPIDEMIOL, V113, P1; Saint S, 2016, NEW ENGL J MED, V374, P2111, DOI 10.1056/NEJMoa1504906; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Schweizer ML, 2015, JAMA-J AM MED ASSOC, V313, P2162, DOI 10.1001/jama.2015.5387; See I, 2016, INFECT CONT HOSP EP, V37, P818, DOI 10.1017/ice.2016.74; The White House, 2014, NAT STRAT COMB ANT R	28	460	478	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1732	1744		10.1056/NEJMoa1801550	http://dx.doi.org/10.1056/NEJMoa1801550			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OL	30380384	Bronze, Green Accepted			2022-12-28	WOS:000448891600008
J	Young, NS				Young, Neal S.			Aplastic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ALTERNATIVE DONOR TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; ANTITHYMOCYTE GLOBULIN; T-CELLS; IMMUNOSUPPRESSIVE THERAPY; MYELODYSPLASTIC SYNDROME; CLONAL HEMATOPOIESIS		[Young, Neal S.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Young, NS (corresponding author), Mark Hatfield Clin Res Ctr, 10 Ctr Dr, Bethesda, MD 20892 USA.	youngns@mail.nih.gov			Intramural NIH HHS [Z01 HL002315-22, Z01 HL002315-21] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aalbers AM, 2012, BLOOD, V119, P3060, DOI 10.1182/blood-2011-10-383182; Ades L, 2004, BLOOD, V103, P2490, DOI 10.1182/blood-2003-07-2546; Alter BP, 2017, BLOOD, V130, P2257, DOI 10.1182/blood-2017-05-781799; Arai Y, 2016, HAEMATOLOGICA, V101, P644, DOI 10.3324/haematol.2015.139469; Babushok DV, 2017, BLOOD ADV, V1, P1900, DOI 10.1182/bloodadvances.2017010918; Bacigalupo A, 2017, BLOOD, V129, P1428, DOI 10.1182/blood-2016-08-693481; Bacigalupo A, 2016, SEMIN HEMATOL, V53, P115, DOI 10.1053/j.seminhematol.2016.01.002; Bacigalupo A, 2015, HAEMATOLOGICA, V100, P696, DOI 10.3324/haematol.2014.115345; Bar C, 2015, HAEMATOLOGICA, V100, P1267, DOI 10.3324/haematol.2015.129239; Bat T, 2018, BRIT J HAEMATOL, V182, P730, DOI 10.1111/bjh.14862; Bennett JM, 2009, HAEMATOL-HEMATOL J, V94, P264, DOI 10.3324/haematol.13755; Bernard C, 2016, AUTOIMMUN REV, V15, P82, DOI 10.1016/j.autrev.2015.09.005; Bierings M, 2018, BRIT J HAEMATOL, V180, P100, DOI 10.1111/bjh.15006; Bluteau O, 2018, BLOOD, V131, P717, DOI 10.1182/blood-2017-09-806489; Buchbinder D, 2012, BIOL BLOOD MARROW TR, V18, P1776, DOI 10.1016/j.bbmt.2012.06.018; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Champlin RE, 2007, BLOOD, V109, P4582, DOI 10.1182/blood-2006-10-052308; Chen JC, 2005, CLIN MED RES, V3, P102, DOI 10.3121/cmr.3.2.102; Chen JC, 2015, BLOOD, V126, P2621, DOI 10.1182/blood-2015-06-652453; Cheng Y, 2018, CLIN TRANSPLANT, V32, P32; Clay J, 2014, BIOL BLOOD MARROW TR, V20, P1711, DOI 10.1016/j.bbmt.2014.06.028; Cooper JN, 2017, BLOOD, V130, P2363, DOI 10.1182/blood-2017-07-794362; Cremers EMP, 2016, EUR J CANCER, V54, P49, DOI 10.1016/j.ejca.2015.11.013; de Latour RP, 2018, BLOOD, V132, P750, DOI 10.1182/blood-2018-01-829630; de Latour RP, 2016, BLOOD, V127, P2971, DOI 10.1182/blood-2016-01-583625; de Masson A, 2013, MEDICINE, V92, P69, DOI 10.1097/MD.0b013e3182899e78; Deng XZ, 2018, HEMATOLOGY, V23, P154, DOI 10.1080/10245332.2017.1375064; Desmond R, 2014, BLOOD, V123, P1818, DOI 10.1182/blood-2013-10-534743; DeZern AE, 2017, BIOL BLOOD MARROW TR, V23, P498, DOI 10.1016/j.bbmt.2016.12.628; Dufour C, 2015, BRIT J HAEMATOL, V171, P585, DOI 10.1111/bjh.13614; Dufour C, 2015, BRIT J HAEMATOL, V169, P565, DOI 10.1111/bjh.13297; Dufour C, 2014, HAEMATOLOGICA, V99, P1574, DOI 10.3324/haematol.2014.106096; Dumitriu B, 2015, BLOOD, V125, P706, DOI 10.1182/blood-2014-10-607572; Eapen M, 2010, HEMATOL-AM SOC HEMAT, P43, DOI 10.1182/asheducation-2010.1.43; Eapen M, 2011, BLOOD, V118, P2618, DOI 10.1182/blood-2011-05-354001; Ebens CL, 2018, BIOL BLOOD MARROW TR, V24, P765, DOI 10.1016/j.bbmt.2017.11.031; Eckrich MJ, 2014, AM J HEMATOL, V89, P125, DOI 10.1002/ajh.23594; Esteves I, 2015, BONE MARROW TRANSPL, V50, P685, DOI 10.1038/bmt.2015.20; Feng XM, 2004, BLOOD, V104, P2425, DOI 10.1182/blood-2004-05-1839; Fioredda F, 2018, BR J HAEMATOL; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Gargiulo L, 2017, BLOOD, V129, P388, DOI 10.1182/blood-2016-09-740845; Giammarco S, 2018, BLOOD, V131, P1989, DOI 10.1182/blood-2017-09-807859; Giudice V, 2018, HAEMATOLOGICA, V103, P759, DOI 10.3324/haematol.2017.176701; Gonzalez-Casas R, 2009, ALIMENT PHARM THER, V30, P436, DOI 10.1111/j.1365-2036.2009.04060.x; Gross SA, 2010, CHEM-BIOL INTERACT, V184, P165, DOI 10.1016/j.cbi.2009.12.015; Gupta V, 2010, HAEMATOL-HEMATOL J, V95, P2119, DOI 10.3324/haematol.2010.026682; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Hosokawa K, 2016, J IMMUNOL, V196, P1568, DOI 10.4049/jimmunol.1501739; Hsu AP, 2013, BLOOD, V121, P3830, DOI 10.1182/blood-2012-08-452763; Imi T, 2018, BLOOD ADV, V2, P1000, DOI 10.1182/bloodadvances.2017013953; Issaragrisil S, 2006, BLOOD, V107, P1299, DOI 10.1182/blood-2005-01-0161; Jerez A, 2013, BLOOD, V122, P2453, DOI 10.1182/blood-2013-04-494930; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; Kaufman DW, 1991, DRUG ETIOLOGY AGRANU; Keel SB, 2016, HAEMATOLOGICA, V101, P1343, DOI 10.3324/haematol.2016.149476; Kekre N, 2017, HAEMATOLOGICA, V102, P1291, DOI 10.3324/haematol.2017.164459; Kim SY, 2014, HAEMATOLOGICA, V99, P1868, DOI 10.3324/haematol.2014.108977; Koh KN, 2012, BRIT J HAEMATOL, V157, P139, DOI 10.1111/j.1365-2141.2011.08924.x; Kordasti S, 2016, BLOOD, V128, P1193, DOI 10.1182/blood-2016-03-703702; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kulasekararaj AG, 2014, BLOOD, V124, P2698, DOI 10.1182/blood-2014-05-574889; Kuwatsuka Y, 2016, BIOL BLOOD MARROW TR, V22, P1836, DOI 10.1016/j.bbmt.2016.07.002; Liu CY, 2014, GENET MOL RES, V13, P4083, DOI 10.4238/2014.May.30.3; Lu Y, 2018, BIOL BLOOD MARROW TR; Luzzatto L, 2018, BR J HAEMATOL; Maciejewski JP, 2004, LEUKEMIA LYMPHOMA, V45, P433, DOI 10.1080/10428190310001602363; Maciejewski JP, 1996, BLOOD, V88, P1983, DOI 10.1182/blood.V88.6.1983.bloodjournal8861983; Mackarel J, 2017, BRIT J HAEMATOL, V177, P806, DOI 10.1111/bjh.14097; Malcovati L, 2017, BLOOD, V129, P3371, DOI 10.1182/blood-2017-01-763425; Marsh JC, 2014, BONE MARROW TRANSPL, V49, P42, DOI 10.1038/bmt.2013.115; Michniacki TF, 2018, J CLIN IMMUNOL, V38, P166, DOI 10.1007/s10875-018-0480-4; Narita A, 2015, HAEMATOLOGICA, V100, P1546, DOI 10.3324/haematol.2015.132530; Nazha A, 2015, HAEMATOLOGICA, V100, pE434, DOI 10.3324/haematol.2015.130112; Ogawa S, 2016, BLOOD, V128, P337, DOI 10.1182/blood-2016-01-636381; Olnes MJ, 2012, NEW ENGL J MED, V367, P11, DOI 10.1056/NEJMoa1200931; Pagliuca S, 2017, BIOL BLOOD MARROW TR, V23, P1939, DOI 10.1016/j.bbmt.2017.08.004; Peinemann F, 2009, HAEMATOL-HEMATOL J, V94, P1732, DOI 10.3324/haematol.2009.007583; Pezeshki A, 2017, PEDIAT BLOOD CANC, V64, P64; Purev E, 2017, BRIT J HAEMATOL, V176, P950, DOI 10.1111/bjh.14448; Robinson TM, 2016, SEMIN HEMATOL, V53, P90, DOI 10.1053/j.seminhematol.2016.01.005; Samarasinghe S, 2012, BRIT J HAEMATOL, V157, P339, DOI 10.1111/j.1365-2141.2012.09066.x; Saracco P, 2008, BRIT J HAEMATOL, V140, P197, DOI 10.1111/j.1365-2141.2007.06903.x; Savage SA, 2017, SEMIN HEMATOL, V54, P105, DOI 10.1053/j.seminhematol.2017.04.004; Scheinberg P, 2014, AM J HEMATOL, V89, P571, DOI 10.1002/ajh.23692; Scheinberg P, 2012, BLOOD, V120, P1185, DOI 10.1182/blood-2011-12-274019; Scheinberg P, 2012, BLOOD, V119, P345, DOI 10.1182/blood-2011-05-352328; Scheinberg P, 2011, NEW ENGL J MED, V365, P430, DOI 10.1056/NEJMoa1103975; Scheinberg P, 2010, JAMA-J AM MED ASSOC, V304, P1358, DOI 10.1001/jama.2010.1376; Scheinberg P, 2008, J PEDIATR-US, V153, P814, DOI 10.1016/j.jpeds.2008.06.004; Schrezenmeier H, 2007, BLOOD, V110, P1397, DOI 10.1182/blood-2007-03-081596; Seo A, 2017, BLOOD, V130, P875, DOI 10.1182/blood-2017-02-768036; Smith JNP, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00330; Solomou EE, 2006, BLOOD, V107, P3983, DOI 10.1182/blood-2005-10-4201; Thota S, 2017, BR J HAEMATOL; Tichelli A, 1999, ANN INTERN MED, V130, P193, DOI 10.7326/0003-4819-130-3-199902020-00004; Townsley DM, 2017, NEW ENGL J MED, V376, P1540, DOI 10.1056/NEJMoa1613878; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245; Wlodarski MW, 2017, SEMIN HEMATOL, V54, P81, DOI 10.1053/j.seminhematol.2017.05.002; Xu LP, 2017, BONE MARROW TRANSPL, V52, P381, DOI 10.1038/bmt.2016.281; Xu LP, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0398-y; Xu LP, 2016, BRIT J HAEMATOL, V175, P265, DOI 10.1111/bjh.14225; Yang C, 1991, Chin Med Sci J, V6, P65; Yoshida N, 2014, HAEMATOLOGICA, V99, P1784, DOI 10.3324/haematol.2014.109355; Yoshizato T, 2015, NEW ENGL J MED, V373, P35, DOI 10.1056/NEJMoa1414799; Zhao X, 2018, EXP HEMATOL, V58, P39, DOI 10.1016/j.exphem.2017.09.006; ZOUMBOS NC, 1985, NEW ENGL J MED, V312, P257, DOI 10.1056/NEJM198501313120501	110	240	267	9	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1643	1656		10.1056/NEJMra1413485	http://dx.doi.org/10.1056/NEJMra1413485			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1GI	30354958	Green Accepted			2022-12-28	WOS:000448273500009
J	Huang, ZX; Ma, JY; Zhou, B				Huang, Zhenxiao; Ma, Jingying; Zhou, Bing			Chronic unilateral nasal congestion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTROCHOANAL POLYPS; CHILDREN		[Huang, Zhenxiao; Ma, Jingying; Zhou, Bing] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Zhou, B (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	entzhou@263.net						Basak S, 1998, INT J PEDIATR OTORHI, V46, P197, DOI 10.1016/S0165-5876(98)00160-8; Bellanti JA, 2000, ALLERGY ASTHMA PROC, V21, P367, DOI 10.2500/108854100778249088; Chen JM, 1989, J OTOLARYNGOL, V18; ELGUINDY A, 1994, J LARYNGOL OTOL, V108, P1055, DOI 10.1017/S0022215100128877; Kennedy DW, 2012, THIEME, DOI [10.1055/b-002-85513, DOI 10.1055/B-002-85513]; Lopatin Andrey, 1997, Rhinology (Utrecht), V35, P79; Lund V, 2011, RHINOLOGY, P1; Maldonado M, 2004, RHINOLOGY, V42, P178; Metin Onerci T, 2010, NASAL POLYPOSIS; Ozdek A, 2002, INT J PEDIATR OTORHI, V65, P213, DOI 10.1016/S0165-5876(02)00153-2; Yaman H, 2010, CLIN EXP OTORHINOLAR, V3, P110, DOI 10.3342/ceo.2010.3.2.110	11	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k3971	10.1136/bmj.k3971	http://dx.doi.org/10.1136/bmj.k3971			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355566				2022-12-28	WOS:000448895300001
J	Slomski, A				Slomski, Anita			Repetitive TMS for Treating Depression in Veterans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1631	1631		10.1001/jama.2018.16203	http://dx.doi.org/10.1001/jama.2018.16203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357294				2022-12-28	WOS:000448069100032
J	[Anonymous]				[Anonymous]			Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care (vol 362, k2505, 2018)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Vinogradova Y, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2505	1	51	52	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4413	10.1136/bmj.k4413	http://dx.doi.org/10.1136/bmj.k4413			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337336	Green Accepted, Green Published			2022-12-28	WOS:000448270700011
J	Singh, G; Kucukural, A; Cenik, C; Leszyk, JD; Shaffer, SA; Weng, ZP; Moore, MJ				Singh, Guramrit; Kucukural, Alper; Cenik, Can; Leszyk, John D.; Shaffer, Scott A.; Weng, Zhiping; Moore, Melissa J.			The Cellular EJC Interactome Reveals Higher-Order mRNP Structure and an EJC-SR Protein Nexus (vol 151, pg 750, 2012)	CELL			English	Correction												melissa.moore@umassmed.edu	Kucukural, Alper/T-3563-2018; Kucukural, Alper/AAJ-7758-2020	Kucukural, Alper/0000-0001-9983-394X; Kucukural, Alper/0000-0001-9983-394X				Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007	1	9	9	2	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 9	2012	151	4					915	916		10.1016/j.cell.2012.10.032	http://dx.doi.org/10.1016/j.cell.2012.10.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	035CV	30360293	Bronze, Green Accepted			2022-12-28	WOS:000310921200022
J	Lai, BB; Gao, WW; Cui, KR; Xie, WL; Tang, QS; Jin, WF; Hu, GQ; Ni, B; Zhao, KJ				Lai, Binbin; Gao, Weiwu; Cui, Kairong; Xie, Wanli; Tang, Qingsong; Jin, Wenfei; Hu, Gangqing; Ni, Bing; Zhao, Keji			Principles of nucleosome organization revealed by single-cell micrococcal nuclease sequencing (vol 562, pg 281, 2018)	NATURE			English	Correction													Hu, Gangqing/ABA-3507-2020; Lai, Binbin/I-6249-2015; Jin, Wenfei/V-9944-2019; Jin, Wenfei/H-5330-2011	Jin, Wenfei/0000-0002-0028-3739; Jin, Wenfei/0000-0002-0028-3739	Intramural NIH HHS [ZIA HL005801] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Lai BB, 2018, NATURE, V562, P281, DOI 10.1038/s41586-018-0567-3	1	1	1	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2018	564	7735					E17	E17		10.1038/s41586-018-0690-1	http://dx.doi.org/10.1038/s41586-018-0690-1			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE0QP	30401810	Green Accepted, Bronze			2022-12-28	WOS:000452972600005
J	Orning, P; Weng, D; Starheim, K; Ratner, D; Best, Z; Lee, B; Brooks, A; Xia, SY; Wu, H; Kelliher, MA; Berger, SB; Gough, PJ; Bertin, J; Proulx, MM; Goguen, JD; Kayagaki, N; Fitzgerald, KA; Lien, E				Orning, Pontus; Weng, Dan; Starheim, Kristian; Ratner, Dmitry; Best, Zachary; Lee, Bettina; Brooks, Alexandria; Xia, Shiyu; Wu, Hao; Kelliher, Michelle A.; Berger, Scott B.; Gough, Peter J.; Bertin, John; Proulx, Megan M.; Goguen, Jon D.; Kayagaki, Nobuhiko; Fitzgerald, Katherine A.; Lien, Egil			Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death	SCIENCE			English	Article							NF-KAPPA-B; YERSINIA-PESTIS; ACTIVATION; CASPASE-1; PYROPTOSIS; NECROSIS; GSDMD; TRIF; PHOSPHORYLATION; COLONIZATION	Limited proteolysis of gasdermin D (GSDMD) generates an N-terminal pore-forming fragment that controls pyroptosis in macrophages. GSDMD is processed via inflammasome-activated caspase-1 or -11. It is currently unknown whether macrophage GSDMD can be processed by other mechanisms. Here, we describe an additional pathway controlling GSDMD processing. The inhibition of TAK1 or I kappa B kinase (IKK) by the Yersinia effector protein YopJ elicits RIPK1- and caspase-8-dependent cleavage of GSDMD, which subsequently results in cell death. GSDMD processing also contributes to the NLRP3 inflammasome-dependent release of interleukin-1 beta (IL-1 beta). Thus, caspase-8 acts as a regulator of GSDMD-driven cell death. Furthermore, this study establishes the importance of TAK1 and IKK activity in the control of GSDMD cleavage and cytotoxicity.	[Orning, Pontus; Weng, Dan; Starheim, Kristian; Ratner, Dmitry; Best, Zachary; Brooks, Alexandria; Lien, Egil] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Program Innate Immun,Med Sch, Worcester, MA 01605 USA; [Orning, Pontus; Starheim, Kristian; Fitzgerald, Katherine A.; Lien, Egil] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Weng, Dan] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Jiangsu, Peoples R China; [Lee, Bettina; Kayagaki, Nobuhiko] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Xia, Shiyu; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Xia, Shiyu; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Kelliher, Michelle A.] Univ Massachusetts, Dept Canc Biol, Med Sch, Worcester, MA 01605 USA; [Berger, Scott B.; Gough, Peter J.; Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA; [Proulx, Megan M.; Goguen, Jon D.] Univ Massachusetts, Dept Microbiol & Physiol, Med Sch, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; Norwegian University of Science & Technology (NTNU); Nanjing University of Science & Technology; Roche Holding; Genentech; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Massachusetts System; University of Massachusetts Worcester; GlaxoSmithKline; University of Massachusetts System; University of Massachusetts Worcester	Lien, E (corresponding author), Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Program Innate Immun,Med Sch, Worcester, MA 01605 USA.; Lien, E (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.	egil.lien@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Xia, Shiyu/P-8621-2019	Xia, Shiyu/0000-0001-9024-0689; Proulx, Megan/0000-0002-9524-8302; , Hao/0000-0002-7281-8579; Brooks, Alexandria/0000-0002-1119-2568; Orning, Pontus/0000-0002-6177-6916; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [AI07538, AI129527, AI067497, AI083713, AI095213, AI139914, AI075118, HL092610]; Norwegian Cancer Society [7699133, B05035/001]; UMass Medical School Summer Undergraduate Research Experience Program; Research Council of Norway Center of Excellence [223255/F50]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067497, R01AI075118, T32AI095213, F30AI129237, R21AI128547, R01AI139914, R01AI083713, T32AI007538, R01AI124491, R37AI067497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Cancer Society(Norwegian Cancer Society); UMass Medical School Summer Undergraduate Research Experience Program; Research Council of Norway Center of Excellence(Research Council of Norway); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grants AI07538 and AI129527 (to E.L.), AI067497 and AI083713 (to K.A.F.), AI095213 (to D.R.), AI139914 (to H.W.), AI075118 (to M.A.K.), and HL092610 (to A.B.); the Norwegian Cancer Society grants 7699133 (to K.S.) and B05035/001 (to E.L.); the UMass Medical School Summer Undergraduate Research Experience Program funding to Z.B.; and the Research Council of Norway Center of Excellence Funding Scheme project 223255/F50 (to P.O., E.L., K.A.F., and K.S.).	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Berger SB, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.9; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Boucher D, 2018, J EXP MED, V215, P827, DOI 10.1084/jem.20172222; Chen KW, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6676; Denault J.-B., 2003, CURR PROTOC PROTEIN, V30; Denecker G, 2002, INFECT IMMUN, V70, P3510, DOI 10.1128/IAI.70.7.3510-3520.2002; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; He CX, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00239-17; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Lee BL, 2018, J EXP MED, V215, P2279, DOI 10.1084/jem.20180589; Lei XB, 2014, J VIROL, V88, P9830, DOI 10.1128/JVI.01425-14; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Malireddi RKS, 2018, J EXP MED, V215, P1023, DOI 10.1084/jem.20171922; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Peterson LW, 2017, J EXP MED, V214, P3171, DOI 10.1084/jem.20170347; Peterson LW, 2016, J IMMUNOL, V197, P4110, DOI 10.4049/jimmunol.1601294; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Ratner D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006035; Ratner D, 2017, J LEUKOCYTE BIOL, V101, P165, DOI 10.1189/jlb.4MR0716-330R; Ratner D, 2016, J BIOL CHEM, V291, P9894, DOI 10.1074/jbc.M115.697698; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2; Vladimer GI, 2012, IMMUNITY, V37, P96, DOI 10.1016/j.immuni.2012.07.006; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Zhang Y, 2010, INFECT IMMUN, V78, P2329, DOI 10.1128/IAI.00094-10; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039	57	410	434	9	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2018	362	6418					1064	+		10.1126/science.aau2818	http://dx.doi.org/10.1126/science.aau2818			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC2CE	30361383	Green Accepted			2022-12-28	WOS:000451609000048
J	[Anonymous]				[Anonymous]			Influenza Vaccine for 2018-2019 (Reprinted from The Medical Letter on Drugs and Therapeutics vol 60, pg 169-173, 2018)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2143	2144		10.1001/jama.2018.17725	http://dx.doi.org/10.1001/jama.2018.17725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30398515				2022-12-28	WOS:000451395000024
J	Ting, SY; Bosch, DE; Mangiameli, SM; Radey, MC; Huang, S; Park, YJ; Kelly, KA; Filip, SK; Goo, YA; Eng, JK; Allaire, M; Veesler, D; Wiggins, PA; Peterson, SB; Mougous, JD				Ting, See-Yeun; Bosch, Dustin E.; Mangiameli, Sarah M.; Radey, Matthew C.; Huang, Shuo; Park, Young-Jun; Kelly, Katherine A.; Filip, Szymon Krzysztof; Goo, Young Ah; Eng, Jimmy K.; Allaire, Marc; Veesler, David; Wiggins, Paul A.; Peterson, S. Brook; Mougous, Joseph D.			Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins	CELL			English	Article							VI SECRETION SYSTEM; CELL-DIVISION; GENOME SEQUENCE; PSEUDOMONAS-AERUGINOSA; GTPASE ACTIVITY; EFFECTORS; FILAMENTS; PUTIDA; GENE; GUT	ADP-ribosylation of proteins can profoundly impact their function and serves as an effective mechanism by which bacterial toxins impair eukaryotic cell processes. Here, we report the discovery that bacteria also employ ADP-ribosylating toxins against each other during interspecies competition. We demonstrate that one such toxin from Serratia proteamaculans interrupts the division of competing cells by modifying the essential bacterial tubulin-like protein, FtsZ, adjacent to its protomer interface, blocking its capacity to polymerize. The structure of the toxin in complex with its immunity determinant revealed two distinct modes of inhibition: active site occlusion and enzymatic removal of ADP-ribose modifications. We show that each is sufficient to support toxin immunity; however, the latter additionally provides un- precedented broad protection against non-cognate ADP-ribosylating effectors. Our findings reveal how an interbacterial arms race has produced a unique solution for safeguarding the integrity of bacterial cell division machinery against inactivating post-translational modifications.	[Ting, See-Yeun; Radey, Matthew C.; Huang, Shuo; Kelly, Katherine A.; Wiggins, Paul A.; Peterson, S. Brook; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Sch Med, Seattle, WA 98195 USA; [Bosch, Dustin E.] Univ Washington, Dept Pathol, Sch Med, Seattle, WA 98195 USA; [Mangiameli, Sarah M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Park, Young-Jun; Veesler, David; Mougous, Joseph D.] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA; [Filip, Szymon Krzysztof; Goo, Young Ah] Northwestern Univ, Prote Ctr Excellence, Chicago, IL 60611 USA; [Eng, Jimmy K.] Univ Washington, Prote Resource, Seattle, WA 98195 USA; [Allaire, Marc] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA; [Wiggins, Paul A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Mougous, Joseph D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Northwestern University; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Sch Med, Seattle, WA 98195 USA.; Mougous, JD (corresponding author), Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA.; Mougous, JD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	mougous@uw.edu	Filip, Szymon/J-8866-2019; Park, Young-Jun/AAF-6249-2021; Ting, See-Yeun/AAY-6883-2021; Eng, Jimmy K/I-4202-2012; Ting, See-Yeun/Y-9684-2019; Peterson, Snow/AAD-2307-2019; Veesler, David/HCH-3986-2022	Filip, Szymon/0000-0003-2175-6176; Park, Young-Jun/0000-0003-2901-6949; Ting, See-Yeun/0000-0001-8472-7204; Eng, Jimmy K/0000-0001-6352-6737; Bosch, Dustin/0000-0002-7430-2939; Wiggins, Paul/0000-0002-8316-4339	NIH [CA060553, GM108569]; University of Washington Proteomics Resource [UWPR95794]; Howard Hughes Medical Institute;  [DE-AC02-05CH11231];  [R01GM120553];  [HHSN272201700059C];  [AI080609]; Div Of Molecular and Cellular Bioscience [1151043] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120553, P41GM108569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Proteomics Resource(University of Washington); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; ; ; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Harold Erickson, Joe Lutkenhaus, and Caroline Harwood for providing reagents, Rachel Klevit and Samuel Miller for sharing equipment, Maria Janowska for technical assistance, Fernando Moreno-Herrero for helpful discussion, and Simon Dove for critical reading of the manuscript. We acknowledge support from the NIH to the Northwestern Proteomics Core Facility (CA060553 and GM108569), the University of Washington Proteomics Resource (UWPR95794), D.V. (R01GM120553 and HHSN272201700059C), and J.D.M. (AI080609). The Berkeley Center for Structural Biology is supported in part by the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract DE-AC02-05CH11231. D.V. is a Pew Biomedical Scholar, and J.D.M. is an HHMI Investigator.	Abebe-Akele F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1697-8; AKTORIES K, 1992, MOL MICROBIOL, V6, P2905, DOI 10.1111/j.1365-2958.1992.tb01749.x; APPLEYARD RK, 1954, GENETICS, V39, P440; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Berthold CL, 2009, P NATL ACAD SCI USA, V106, P14247, DOI 10.1073/pnas.0905906106; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Bleves S, 2016, TRENDS MICROBIOL, V24, P773, DOI 10.1016/j.tim.2016.08.002; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cianfanelli FR, 2016, TRENDS MICROBIOL, V24, P51, DOI 10.1016/j.tim.2015.10.005; Cohen MS, 2018, NAT CHEM BIOL, V14, P236, DOI [10.1038/NCHEMBIO.2568, 10.1038/nchembio.2568]; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; Diniz JA, 2015, CELL MICROBIOL, V17, P1742, DOI 10.1111/cmi.12532; Edwards D. H., 1993, BACTERIAL GROWTH LYS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Haeusser DP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004217; Heller DM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007007; HONJO T, 1969, COLD SPRING HARB SYM, V34, P603, DOI 10.1101/SQB.1969.034.01.069; Jankevicius G, 2016, MOL CELL, V64, P1109, DOI 10.1016/j.molcel.2016.11.014; Jones AM, 2017, EMERG TOP LIFE SCI, V1, P75, DOI 10.1042/ETLS20160019; Kiro R, 2013, P NATL ACAD SCI USA, V110, P19549, DOI 10.1073/pnas.1314096110; Krupka Marcin, 2018, F1000Res, V7, P235, DOI 10.12688/f1000research.13504.1; LaCourse KD, 2018, NAT MICROBIOL, V3, P440, DOI 10.1038/s41564-018-0113-y; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Mangiameli SM, 2017, ELIFE, V6, DOI 10.7554/eLife.19848; Moore DA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00553-16; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2016, P NATL ACAD SCI USA, V113, pE5044, DOI 10.1073/pnas.1608858113; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Speare L, 2018, P NATL ACAD SCI USA, V115, pE8528, DOI 10.1073/pnas.1808302115; Stylianidou S, 2016, MOL MICROBIOL, V102, P690, DOI 10.1111/mmi.13486; Sun J, 2015, NAT STRUCT MOL BIOL, V22, P672, DOI 10.1038/nsmb.3064; Tang HZ, 2011, J BACTERIOL, V193, P6789, DOI 10.1128/JB.06201-11; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Verster AJ, 2017, CELL HOST MICROBE, V22, P411, DOI 10.1016/j.chom.2017.08.010; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995	51	59	64	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2018	175	5					1380	+		10.1016/j.cell.2018.09.037	http://dx.doi.org/10.1016/j.cell.2018.09.037			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HA5PX	30343895	Green Accepted, Bronze			2022-12-28	WOS:000450328800020
J	Chang, L; Azzolin, L; Di Biagio, D; Zanconato, F; Battilana, G; Xiccato, RL; Aragona, M; Giulitti, S; Panciera, T; Gandin, A; Sigismondo, G; Krijgsveld, J; Fassan, M; Brusatin, G; Cordenonsi, M; Piccolo, S				Chang, Lei; Azzolin, Luca; Di Biagio, Daniele; Zanconato, Francesca; Battilana, Giusy; Xiccato, Romy Lucon; Aragona, Mariaceleste; Giulitti, Stefano; Panciera, Tito; Gandin, Alessandro; Sigismondo, Gianluca; Krijgsveld, Jeroen; Fassan, Matteo; Brusatin, Giovanna; Cordenonsi, Michelangelo; Piccolo, Stefano			The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ	NATURE			English	Article							WW DOMAIN; YAP/TAZ; EXPRESSION; PLURIPOTENCY; HOMEOSTASIS	Inactivation of ARID1A and other components of the nuclear SWI/SNF protein complex occurs at very high frequencies in a variety of human malignancies, suggesting a widespread role for the SWI/SNF complex in tumour suppression(1). However, the underlying mechanisms remain poorly understood. Here we show that ARID1A-containing SWI/SNF complex (ARID1A-SWI/SNF) operates as an inhibitor of the pro-oncogenic transcriptional coactivators YAP and TAZ(2). Using a combination of gain- and loss-of-function approaches in several cellular contexts, we show that YAP/TAZ are necessary to induce the effects of the inactivation of the SWI/SNF complex, such as cell proliferation, acquisition of stem cell-like traits and liver tumorigenesis. We found that YAP/TAZ form a complex with SWI/SNF; this interaction is mediated by ARID1A and is alternative to the association of YAP/TAZ with the DNA-binding platform TEAD. Cellular mechanotransduction regulates the association between ARID1A-SWI/SNF and YAP/TAZ. The inhibitory interaction of ARID1A-SWI/SNF and YAP/TAZ is predominant in cells that experience low mechanical signalling, in which loss of ARID1A rescues the association between YAP/TAZ and TEAD. At high mechanical stress, nuclear F-actin binds to ARID1A-SWI/SNF, thereby preventing the formation of the ARID1A-SWI/SNF-YAP/TAZ complex, in favour of an association between TEAD and YAP/TAZ. We propose that a dual requirement must be met to fully enable the YAP/TAZ responses: promotion of nuclear accumulation of YAP/TAZ, for example, by loss of Hippo signalling, and inhibition of ARID1A-SWI/SNF, which can occur either through genetic inactivation or because of increased cell mechanics. This study offers a molecular framework in which mechanical signals that emerge at the tissue level together with genetic lesions activate YAP/TAZ to induce cell plasticity and tumorigenesis.	[Chang, Lei; Azzolin, Luca; Di Biagio, Daniele; Zanconato, Francesca; Battilana, Giusy; Xiccato, Romy Lucon; Aragona, Mariaceleste; Giulitti, Stefano; Panciera, Tito; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Dept Mol Med, Padua, Italy; [Gandin, Alessandro; Brusatin, Giovanna] Univ Padua, Dept Ind Engn, Padua, Italy; [Gandin, Alessandro; Brusatin, Giovanna] Univ Padua, INSTM, Padua, Italy; [Sigismondo, Gianluca; Krijgsveld, Jeroen] German Canc Res Ctr, Heidelberg, Germany; [Sigismondo, Gianluca; Krijgsveld, Jeroen] Heidelberg Univ, Heidelberg, Germany; [Fassan, Matteo] Dept Med DIMED, Surg Pathol & Cytopathol Unit, Padua, Italy; [Piccolo, Stefano] FIRC Inst Mol Oncol, IFOM, Padua, Italy	University of Padua; University of Padua; University of Padua; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; IFOM - FIRC Institute of Molecular Oncology	Cordenonsi, M; Piccolo, S (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.; Piccolo, S (corresponding author), FIRC Inst Mol Oncol, IFOM, Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Aragona, Mariaceleste/AAB-7307-2021; Fassan, Matteo/F-5152-2012; CORDENONSI, MICHELANGELO/K-7692-2016	Aragona, Mariaceleste/0000-0002-2239-3541; Fassan, Matteo/0000-0001-6515-5482; CORDENONSI, MICHELANGELO/0000-0002-8253-5724; PICCOLO, STEFANO/0000-0002-2037-0004; Panciera, Tito/0000-0002-9272-5716	AIRC Special Program Molecular Clinical Oncology '5 per mille'; AIRC PI-Grant; MIUR-FARE grant; Epigenetics Flagship project CNR-MIUR grants; European Research Council (ERC) under the European Union [670126]	AIRC Special Program Molecular Clinical Oncology '5 per mille'(Fondazione AIRC per la ricerca sul cancro); AIRC PI-Grant(Fondazione AIRC per la ricerca sul cancro); MIUR-FARE grant; Epigenetics Flagship project CNR-MIUR grants; European Research Council (ERC) under the European Union(European Research Council (ERC))	We thank A. Fujimura for help with neuron preparation; G. Della Giustina for micropattern fabrication; V. Guzzardo for histology; C. Frasson and G. Basso for FACS; D. M. Livingston for HMECs and plasmids; D. J. Pan, M. Giovannini, Z. Wang, P. Chambon, and I. De Curtis and R. Brambilla for gifts of mice; R. Treisman for ACTB (encoding beta-actin) cDNAs; L. Naldini for plasmids; S. Dupont for performing the initial experiments leading to biochemical identification of SWI/SNF and for the protocol to perform F-actin pull-down; Gianluca Grenci and Mona Suryana (MBI-Singapore) and the MBI microfabrication facility team for the supply of quartz masks. This work is supported by AIRC Special Program Molecular Clinical Oncology '5 per mille', by an AIRC PI-Grant, by a MIUR-FARE grant, and by Epigenetics Flagship project CNR-MIUR grants to S.P. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (DENOVOSTEM grant agreement No 670126 to S.P.).	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ege N, 2018, CELL SYST, V6, P692, DOI 10.1016/j.cels.2018.05.006; Eroglu E, 2014, CELL, V156, P1259, DOI 10.1016/j.cell.2014.01.053; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Grosse R, 2013, NAT REV MOL CELL BIO, V14, P693, DOI 10.1038/nrm3681; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Plessner M, 2015, J BIOL CHEM, V290, P11209, DOI 10.1074/jbc.M114.627166; Rafiee MR, 2016, MOL CELL, V64, P624, DOI 10.1016/j.molcel.2016.09.019; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Wang H, 2016, MOL CELL, V63, P277, DOI 10.1016/j.molcel.2016.05.038; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	37	150	154	7	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					265	+		10.1038/s41586-018-0658-1	http://dx.doi.org/10.1038/s41586-018-0658-1			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401838	Green Accepted			2022-12-28	WOS:000449943600047
J	Borlaug, BA; Anstrom, KJ; Lewis, GD; Shah, SJ; Levine, JA; Koepp, GA; Givertz, MM; Felker, GM; LeWinter, MM; Mann, DL; Margulies, KB; Smith, AL; Tang, WHW; Whellan, DJ; Chen, HH; Davila-Roman, VG; McNulty, S; Desvigne-Nickens, P; Hernandez, AF; Braunwald, E; Redfield, MM				Borlaug, Barry A.; Anstrom, Kevin J.; Lewis, Gregory D.; Shah, Sanjiv J.; Levine, James A.; Koepp, Gabe A.; Givertz, Michael M.; Felker, G. Michael; LeWinter, Martin M.; Mann, Douglas L.; Margulies, Kenneth B.; Smith, Andrew L.; Tang, W. H. Wilson; Whellan, David J.; Chen, Horng H.; Davila-Roman, Victor G.; McNulty, Steven; Desvigne-Nickens, Patrice; Hernandez, Adrian F.; Braunwald, Eugene; Redfield, Margaret M.		Natl Heart Lung Blood Inst Heart	Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEMODYNAMICS; NITRATE; COMORBIDITIES	IMPORTANCE There are few effective treatments for heart failure with preserved ejection fraction (HFpEF). Short-term administration of inorganic nitrite or nitrate preparations has been shown to enhance nitric oxide signaling, which may improve aerobic capacity in HFpEF. OBJECTIVE To determine the effect of 4 weeks' administration of inhaled, nebulized inorganic nitrite on exercise capacity in HFpEF. DESIGN, SETTING, AND PARTICIPANTS Multicenter, double-blind, placebo-controlled, 2-treatment, crossover trial of 105 patients with HFpEF. Participants were enrolled from July 22, 2016, to September 12, 2017, at 17 US sites, with final date of follow-up of January 2, 2018. INTERVENTIONS Inorganic nitrite or placebo administered via micronebulizer device. During each 6-week phase of the crossover study, participants received no study drug for 2 weeks (baseline/washout) followed by study drug (nitrite or placebo) at 46 mg 3 times a day for 1 week followed by 80 mg 3 times a day for 3 weeks. MAIN OUTCOMES AND MEASURES The primary end point was peak oxygen consumption (mL/kg/min). Secondary end points included daily activity levels assessed by accelerometry, health status as assessed by the Kansas City Cardiomyopathy Questionnaire (score range, 0-100, with higher scores reflecting better quality of life), functional class, cardiac filling pressures assessed by echocardiography, N-terminal fragment of the prohormone brain natriuretic peptide levels, other exercise indices, adverse events, and tolerability. Outcomes were assessed after treatment for 4 weeks. RESULTS Among 105 patients who were randomized (median age, 68 years; 56% women), 98 (93%) completed the trial. During the nitrite phase, there was no significant difference in mean peak oxygen consumption as compared with the placebo phase (13.5 vs 13.7 mL/kg/min; difference, -0.20 [95% CI, -0.56 to 0.16]; P = .27). There were no significant between-treatment phase differences in daily activity levels (5497 vs 5503 accelerometry units; difference, -15 [95% CI, -264 to 234]; P = .91), Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (62.6 vs 61.9; difference, 1.1 [95% CI, -1.4 to 3.5]; P = .39), functional class (2.5 vs 2.5; difference, 0.1 [95% CI, -0.1 to 0.2]; P = .43), echocardiographic E/e' ratio (16.4 vs 16.6; difference, 0.1 [95% CI, -1.2 to 1.3]; P = .93), or N-terminal fragment of the prohormone brain natriuretic peptide levels (520 vs 533 pg/mL; difference, 11 [95% CI, -53 to 75]; P = .74). Worsening heart failure occurred in 3 participants (2.9%) during the nitrite phase and 8 (7.6%) during the placebo phase. CONCLUSIONS AND RELEVANCE Among patients with HFpEF, administration of inhaled inorganic nitrite for 4 weeks, compared with placebo, did not result in significant improvement in exercise capacity.	[Borlaug, Barry A.; Chen, Horng H.; Redfield, Margaret M.] Mayo Clin, Rochester, MN USA; [Anstrom, Kevin J.; Felker, G. Michael; McNulty, Steven; Hernandez, Adrian F.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Lewis, Gregory D.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Shah, Sanjiv J.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Levine, James A.; Koepp, Gabe A.] Mayo Clin, Scottsdale, AZ USA; [Givertz, Michael M.; Braunwald, Eugene] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [LeWinter, Martin M.] Univ Vermont, Med Ctr, Burlington, VT USA; [Mann, Douglas L.; Davila-Roman, Victor G.] Washington Univ, St Louis, MO USA; [Margulies, Kenneth B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Andrew L.] Emory Univ, Emory Sch Med, Atlanta, GA 30322 USA; [Tang, W. H. Wilson] Cleveland Clin, Cleveland, OH 44106 USA; [Whellan, David J.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Desvigne-Nickens, Patrice] NHLBI, Bldg 10, Bethesda, MD 20892 USA	Mayo Clinic; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Vermont; University of Vermont Medical Center; Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Emory University; Cleveland Clinic Foundation; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Borlaug, BA (corresponding author), Mayo Clin & Mayo Fdn, 200 First St SW, Rochester, MN 55905 USA.	borlaug.barry@mayo.edu	Felker, Michael/AAX-2288-2021; Hernandez, Adrian F/A-7818-2016; Mann, Douglas Lowell/AAQ-3524-2021; Shah, Sanjiv J./AFQ-9480-2022	Hernandez, Adrian F/0000-0003-3387-9616; Felker, Gary/0000-0002-5931-1239; Borlaug, Barry/0000-0001-9375-0596; Shah, Sanjiv/0000-0002-5655-8201; Tang, W. H. Wilson/0000-0002-8335-735X	Heart Failure Clinical Research Network - NHLBI/NIH [U10 HL084904, U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338]; Savara Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110342, U10HL110297, U10HL110262, U01HL084904, U10HL110338, U10HL110312, U10HL110336, U10HL110302, U10HL110309, U10HL110337] Funding Source: NIH RePORTER	Heart Failure Clinical Research Network - NHLBI/NIH; Savara Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Heart Failure Clinical Research Network, which is supported by the NHLBI/NIH (grants U10 HL084904 [awarded to the coordinating center], U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, and U10 HL110338 [awarded to the regional clinical centers]) and Savara Therapeutics.	Borlaug BA, 2016, CIRC RES, V119, P880, DOI 10.1161/CIRCRESAHA.116.309184; Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Eggebeen J, 2016, JACC-HEART FAIL, V4, P428, DOI 10.1016/j.jchf.2015.12.013; Eisman AS, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004750; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Guazzi M, 2005, J AM COLL CARDIOL, V46, P1883, DOI 10.1016/j.jacc.2005.07.051; Houstis NE, 2018, CIRCULATION, V137, P148, DOI 10.1161/CIRCULATIONAHA.117.029058; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Obokata M, 2018, EUR HEART J, V39, P2810, DOI 10.1093/eurheartj/ehy268; Obokata M, 2017, CIRCULATION, V136, P6, DOI 10.1161/CIRCULATIONAHA.116.026807; Pandey A, 2015, CIRC-HEART FAIL, V8, P33, DOI 10.1161/CIRCHEARTFAILURE.114.001615; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pieske B, 2017, EUR HEART J, V38, P1119, DOI 10.1093/eurheartj/ehw593; Reddy YNV, 2018, JACC-HEART FAIL, V6, P665, DOI 10.1016/j.jchf.2018.03.003; Reddy YNV, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.003862; Reddy YNV, 2017, J AM COLL CARDIOL, V69, P113, DOI 10.1016/j.jacc.2016.09.975; Redfield MM, 2017, NEW ENGL J MED, V376, P897, DOI 10.1056/NEJMc1615918; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Shaltout HA, 2017, NITRIC OXIDE-BIOL CH, V69, P78, DOI 10.1016/j.niox.2017.05.005; Simon MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89620; Snipelisky D, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.003878; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Weiss K, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004129; Zamani P, 2017, CIRC RES, V120, P1151, DOI 10.1161/CIRCRESAHA.116.309832; Zamani P, 2015, CIRCULATION, V131, P371, DOI 10.1161/CIRCULATIONAHA.114.012957	28	139	140	2	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1764	1773		10.1001/jama.2018.14852	http://dx.doi.org/10.1001/jama.2018.14852			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398602	Bronze, Green Published			2022-12-28	WOS:000449461800014
J	Mohanty, AK; Vivekanandhan, S; Pin, JM; Misra, M				Mohanty, Amar K.; Vivekanandhan, Singaravelu; Pin, Jean-Mathieu; Misra, Manjusri			Composites from renewable and sustainable resources: Challenges and innovations	SCIENCE			English	Review							NATURAL FIBER COMPOSITES; BLENDS; PERFORMANCE; CELLULOSE; OIL; POLYETHYLENE; MANUFACTURE; POLYMERS; LIGNIN; FUTURE	Interest in constructing composite materials from biosourced, recycled materials; waste resources; and their combinations is growing. Biocomposites have attracted the attention of automakers for the design of lightweight parts. Hybrid biocomposites made of petrochemical-based and bioresourced materials have led to technological advances in manufacturing. Greener biocomposites from plant-derived fiber and crop-derived plastics with higher biobased content are continuously being developed. Biodegradable composites have shown potential for major uses in sustainable packaging. Recycled plastic materials originally destined for landfills can be redirected and repurposed for blending in composite applications, thus leading to reduced dependence on virgin petro-based materials. Studies on compatibility of recycled and waste materials with other components in composite structure for improved interface and better mechanical performance pose major scientific challenges. This research holds the promise of advancing a key global sustainability goal.	[Mohanty, Amar K.; Pin, Jean-Mathieu; Misra, Manjusri] Univ Guelph, Dept Plant Agr, Bioprod Discovery & Dev Ctr, Guelph, ON N1G 2W1, Canada; [Mohanty, Amar K.; Misra, Manjusri] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada; [Vivekanandhan, Singaravelu] VHNSN Coll Autonomous, Dept Phys, Sustainable Mat & Nanotechnol Lab, Virudunagar 626001, Tamil Nadu, India	University of Guelph; University of Guelph	Mohanty, AK (corresponding author), Univ Guelph, Dept Plant Agr, Bioprod Discovery & Dev Ctr, Guelph, ON N1G 2W1, Canada.; Mohanty, AK (corresponding author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.	mohanty@uoguelph.ca		Singaravelu, Vivekanandhan/0000-0001-8831-4888	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canada/University of Guelph Bioeconomy for Industrial Uses Research Program; Agriculture and Agri-Food Canada; Competitive Green Technologies through AgriInnovation Program; Ontario Ministry of Research, Innovation and Science (MRIS), Canada [ORF-RE07]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canada/University of Guelph Bioeconomy for Industrial Uses Research Program; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Competitive Green Technologies through AgriInnovation Program; Ontario Ministry of Research, Innovation and Science (MRIS), Canada	This work is financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Discovery Grants; the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA), Canada/University of Guelph Bioeconomy for Industrial Uses Research Program; the Agriculture and Agri-Food Canada and Competitive Green Technologies through AgriInnovation Program; and the Ontario Research Fund, Research Excellence Program, Round-7 (ORF-RE07) from the Ontario Ministry of Research, Innovation and Science (MRIS), Canada.	Ackrill S., 2018, COFFEETALK; Akampumuza O, 2017, POLYM COMPOSITE, V38, P2553, DOI 10.1002/pc.23847; Alvarez-Chavez CR, 2012, J CLEAN PROD, V23, P47, DOI 10.1016/j.jclepro.2011.10.003; [Anonymous], 2016, NAT MATER, V15, P113, DOI 10.1038/nmat4562; [Anonymous], 2017, NAT MAT, V16, P691; [Anonymous], 2017, NEW PLAST EC RETH FU; Bakare IO, 2010, MATER DESIGN, V31, P4274, DOI 10.1016/j.matdes.2010.04.013; Bali A., 2018, BIOPLASTIC MAG, V13, P14; Bourmaud A, 2018, PROG MATER SCI, V97, P347, DOI 10.1016/j.pmatsci.2018.05.005; Bourrnaud A, 2015, IND CROP PROD, V64, P251, DOI 10.1016/j.indcrop.2014.09.033; Chen GQ, 2012, CHEM REV, V112, P2082, DOI 10.1021/cr200162d; Das O, 2016, WASTE MANAGE, V49, P560, DOI 10.1016/j.wasman.2015.12.007; Eagan JM, 2017, SCIENCE, V355, P814, DOI 10.1126/science.aah5744; European Bioplastics, 2018, BIOPL FACTS FIG; Fang W, 2017, GREEN CHEM, V19, P1794, DOI 10.1039/c6gc03206k; Gallos A, 2017, RSC ADV, V7, P34638, DOI 10.1039/c7ra05240e; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Graichen FHM, 2017, IND CROP PROD, V106, P74, DOI 10.1016/j.indcrop.2016.10.036; Hosseini N, 2016, EUR POLYM J, V79, P63, DOI 10.1016/j.eurpolymj.2016.04.012; Idrees M, 2018, ACS SUSTAIN CHEM ENG, V6, P13940, DOI 10.1021/acssuschemeng.8b02283; Kun D, 2017, EUR POLYM J, V93, P618, DOI 10.1016/j.eurpolymj.2017.04.035; Liptow C, 2012, J IND ECOL, V16, P420, DOI 10.1111/j.1530-9290.2011.00405.x; Liu WJ, 2015, CHEM REV, V115, P12251, DOI 10.1021/acs.chemrev.5b00195; Lu J, 2008, POLYMER, V49, P1285, DOI 10.1016/j.polymer.2008.01.028; Madbouly SA, 2014, GREEN CHEM, V16, P1911, DOI [10.1039/c3gc41503a, 10.1039/C3GC41503A]; Malnati P., 2018, PLASTICS ENG; Matsuzaki R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23058; Oksman K, 2000, APPL COMPOS MATER, V7, P403, DOI 10.1023/A:1026546426764; Oksman K, 2016, COMPOS PART A-APPL S, V83, P2, DOI 10.1016/j.compositesa.2015.10.041; Pickering KL, 2016, COMPOS PART A-APPL S, V83, P98, DOI 10.1016/j.compositesa.2015.08.038; Rahman MM, 2018, COMPOS SCI TECHNOL, V162, P110, DOI 10.1016/j.compscitech.2018.04.023; Rajinipriya M, 2018, ACS SUSTAIN CHEM ENG, V6, P2807, DOI 10.1021/acssuschemeng.7b03437; Schneiderman DK, 2017, MACROMOLECULES, V50, P3733, DOI 10.1021/acs.macromol.7b00293; Sheldon RA, 2014, GREEN CHEM, V16, P950, DOI [10.1039/c3gc41935e, 10.1039/C3GC41935E]; Tachibana Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08249; Turku I, 2017, COMPOS STRUCT, V161, P469, DOI 10.1016/j.compstruct.2016.11.073; Vivekanandhan S., 2013, LIQUID GASEOUS SOLID; Xu YW, 2015, IND ENG CHEM RES, V54, P6108, DOI 10.1021/acs.iecr.5b00882; Zhan M, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.44013	39	404	415	86	659	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		536	542		10.1126/science.aat9072	http://dx.doi.org/10.1126/science.aat9072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385569				2022-12-28	WOS:000450460000034
J	Jerby-Arnon, L; Shah, P; Cuoco, MS; Rodman, C; Su, MJ; Melms, JC; Leeson, R; Kanodia, A; Mei, S; Lin, JR; Wang, S; Rabasha, B; Liu, D; Zhang, G; Margolais, C; Ashenberg, O; Ott, PA; Buchbinder, EI; Haq, R; Hodi, FS; Boland, GM; Sullivan, RJ; Frederick, DT; Miao, B; Moll, T; Flaherty, KT; Herlyn, M; Jenkins, RW; Thummalapalli, R; Kowalczyk, MS; Canadas, I; Schilling, B; Cartwright, ANR; Luoma, AM; Malu, S; Hwu, P; Bernatchez, C; Forget, MA; Barbie, DA; Shalek, AK; Tirosh, I; Sorger, PK; Wucherpfennig, K; Van Allen, EM; Schadendorf, D; Johnson, BE; Rotem, A; Rozenblatt-Rosen, O; Garraway, LA; Yoon, CH; Izar, B; Regev, A				Jerby-Arnon, Livnat; Shah, Parin; Cuoco, Michael S.; Rodman, Christopher; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Rabasha, Bokang; Liu, David; Zhang, Gao; Margolais, Claire; Ashenberg, Orr; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Rizwan; Hodi, F. Stephen; Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie T.; Miao, Benchun; Moll, Tabea; Flaherty, Keith T.; Herlyn, Meenhard; Jenkins, Russell W.; Thummalapalli, Rohit; Kowalczyk, Monika S.; Canadas, Israel; Schilling, Bastian; Cartwright, Adam N. R.; Luoma, Adrienne M.; Malu, Shruti; Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andree; Barbie, David A.; Shalek, Alex K.; Tirosh, Itay; Sorger, Peter K.; Wucherpfennig, Kai; Van Allen, Eliezer M.; Schadendorf, Dirk; Johnson, Bruce E.; Rotem, Asaf; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin; Regev, Aviv			A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade	CELL			English	Article							IDENTIFICATION; SENSITIVITY; MELANOMA	Immune checkpoint inhibitors (ICIs) produce durable responses in some melanoma patients, but many patients derive no clinical benefit, and the molecular underpinnings of such resistance remain elusive. Here, we leveraged single-cell RNA sequencing (scRNA-seq) from 33 melanoma tumors and computational analyses to interrogate malignant cell states that promote immune evasion. We identified a resistance program expressed by malignant cells that is associated with T cell exclusion and immune evasion. The program is expressed prior to immunotherapy, characterizes cold niches in situ, and predicts clinical responses to anti-PD-1 therapy in an independent cohort of 112 melanoma patients. CDK4/6-inhibition represses this program in individual malignant cells, induces senescence, and reduces melanoma tumor outgrowth in mouse models in vivo when given in combination with immunotherapy. Our study provides a high-resolution landscape of ICI-resistant cell states, identifies clinically predictive signatures, and suggests new therapeutic strategies to over-come immunotherapy resistance.	[Jerby-Arnon, Livnat; Cuoco, Michael S.; Rodman, Christopher; Ashenberg, Orr; Kowalczyk, Monika S.; Shalek, Alex K.; Tirosh, Itay; Rotem, Asaf; Rozenblatt-Rosen, Orit; Garraway, Levi A.; Izar, Benjamin; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Shah, Parin; Su, Mei-Ju; Melms, Johannes C.; Leeson, Rachel; Kanodia, Abhay; Mei, Shaolin; Rabasha, Bokang; Liu, David; Margolais, Claire; Ott, Patrick A.; Buchbinder, Elizabeth I.; Haq, Rizwan; Hodi, F. Stephen; Jenkins, Russell W.; Thummalapalli, Rohit; Canadas, Israel; Malu, Shruti; Barbie, David A.; Van Allen, Eliezer M.; Johnson, Bruce E.; Rotem, Asaf; Garraway, Levi A.; Yoon, Charles H.; Izar, Benjamin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Su, Mei-Ju; Leeson, Rachel; Kanodia, Abhay; Johnson, Bruce E.; Rotem, Asaf; Garraway, Levi A.; Izar, Benjamin] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA; [Mei, Shaolin; Lin, Jia-Ren; Wang, Shu; Sorger, Peter K.; Izar, Benjamin] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Boland, Genevieve M.; Sullivan, Ryan J.; Frederick, Dennie T.; Miao, Benchun; Moll, Tabea; Flaherty, Keith T.; Jenkins, Russell W.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Kowalczyk, Monika S.] Celsius Therapeut, Cambridge, MA USA; [Schilling, Bastian; Schadendorf, Dirk] Univ Duisburg Essen, West German Canc Ctr, Univ Hosp Essen, Dept Dermatol, Essen, Germany; [Schilling, Bastian; Schadendorf, Dirk] German Canc Consortium, Essen, Germany; [Schilling, Bastian] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany; [Cartwright, Adam N. R.; Luoma, Adrienne M.; Wucherpfennig, Kai; Izar, Benjamin] Dana Farber Canc Inst, Ctr Immunol & Virol, Boston, MA 02115 USA; [Hwu, Patrick; Bernatchez, Chantale; Forget, Marie-Andree] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Garraway, Levi A.; Izar, Benjamin] Harvard, Ludwig Ctr Canc Res, Boston, MA 02115 USA; [Garraway, Levi A.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA; [Yoon, Charles H.] Brigham & Womens Hosp, Dept Surg Oncol, 75 Francis St, Boston, MA 02115 USA; [Regev, Aviv] MIT, Ludwig Ctr Canc Res, Boston, MA USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; The Wistar Institute; The Wistar Institute; Harvard University; Massachusetts General Hospital; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Izar, B (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Izar, B (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Izar, B (corresponding author), Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA.; Izar, B (corresponding author), Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA.; Izar, B (corresponding author), Dana Farber Canc Inst, Ctr Immunol & Virol, Boston, MA 02115 USA.; Izar, B (corresponding author), Harvard, Ludwig Ctr Canc Res, Boston, MA 02115 USA.	benjamin_izar@dfci.harvard.edu	Nadeem, Sohail/I-5248-2013; Rozenblatt-Rosen, Orit/HDN-4182-2022; Boland, Genevieve/AAP-2767-2021; Shah, Parin/J-6018-2019; Schadendorf, Dirk/AAE-8206-2019; Shalek, Alex/Y-2434-2019; Schilling, Bastian/AAY-8646-2020; Liu, David/ABF-1275-2020	Nadeem, Sohail/0000-0002-1052-011X; Shah, Parin/0000-0003-4648-7830; Shalek, Alex/0000-0001-5670-8778; Schilling, Bastian/0000-0001-8859-4103; Liu, David/0000-0003-0346-5033; Kanodia, Abhay Rajkumar/0000-0002-7645-002X; Cuoco, Michael/0000-0003-2163-5120; Thummalapalli, Rohit/0000-0002-8865-0299; Sorger, Peter/0000-0002-3364-1838; Mei, Shaolin/0000-0002-2193-764X; Melms, Johannes/0000-0002-5410-6586; Schadendorf, Dirk/0000-0003-3524-7858; Wang, Shu/0000-0002-1178-1143	CRI; NCI [K08-CA222663, 1U24CA180922, R33-CA202820]; DFCI Claudia Adams Barr Program for Innovative Cancer Research; Burroughs Wellcome Fund Career Award for Medical Scientists; SITC Translational Fellowship; Klarman Cell Observatory; STARR Cancer Consortium; Koch Institute NCI [P30-CA14051]; Ludwig Center at Harvard; Ludwig Center at MIT; AMRF; Broad Institute; NATIONAL CANCER INSTITUTE [P30CA010815, R33CA202820, P30CA014051, U24CA180922, R01CA173750, K08CA222663, T32CA207021] Funding Source: NIH RePORTER	CRI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DFCI Claudia Adams Barr Program for Innovative Cancer Research; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); SITC Translational Fellowship; Klarman Cell Observatory; STARR Cancer Consortium; Koch Institute NCI; Ludwig Center at Harvard; Ludwig Center at MIT; AMRF; Broad Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Meromit Singer for discussions; Leslie Gaffney for help with artwork; and Laura Dellostritto, Karla Helvie, Nichole Straub, and the CCPM members at DFCI. L.J.-A. is a CRI Irvington Fellow supported by the CRI and a fellow of the Eric and Wendy Schmidt postdoctoral program. B.I. was supported by NCI grant K08-CA222663, DFCI Claudia Adams Barr Program for Innovative Cancer Research, the Burroughs Wellcome Fund Career Award for Medical Scientists, and the SITC Translational Fellowship. A. Regev is an HHMI Investigator. Work was supported by the Klarman Cell Observatory, STARR Cancer Consortium, NCI grants 1U24CA180922 and R33-CA202820, Koch Institute NCI Support (core) grant P30-CA14051, Ludwig Centers at Harvard and MIT, AMRF, and the Broad Institute. Processed scRNA-seq data are available at https://portals.broadinstitute.org/single_cell/study/melanoma-immunotherapy-resistance and under accession number GEO: GSE115978. Raw scRNA-seq data will be deposited in dbGAP.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Ester M., 1996, DENSITY BASED ALGORI, V96, P226; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Gordy JT, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0189-y; HOLM S, 1979, SCAND J STAT, V6, P65; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lesterhuis WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12298; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Oki S., 2018, INTEGRATIVE ANAL TRA; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schaer DA, 2018, CELL REP, V22, P2978, DOI 10.1016/j.celrep.2018.02.053; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0	39	503	516	12	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					984	+		10.1016/j.cell.2018.09.006	http://dx.doi.org/10.1016/j.cell.2018.09.006			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388455	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000449100600013
J	Koh, A; Molinaro, A; Stahlman, M; Khan, MT; Schmidt, C; Manneras-Holm, L; Wu, H; Carreras, A; Jeong, H; Olofsson, LE; Bergh, PO; Gerdes, V; Hartstra, A; de Brauw, M; Perkins, R; Nieuwdorp, M; Bergstrom, G; Backhed, F				Koh, Ara; Molinaro, Antonio; Stahlman, Marcus; Khan, Muhammad Tanweer; Schmidt, Caroline; Manneras-Holm, Louise; Wu, Hao; Carreras, Alba; Jeong, Heeyoon; Olofsson, Louise E.; Bergh, Per-Olof; Gerdes, Victor; Hartstra, Annick; de Brauw, Maurits; Perkins, Rosie; Nieuwdorp, Max; Bergstrom, Goran; Backhed, Fredrik			Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1	CELL			English	Article							GUT MICROBIOTA; SERUM METABOLOME; AMINO-ACIDS; PROTEIN; ACTIVATION; PATHWAY; AUTOPHOSPHORYLATION; OBESITY; IMPACT; IDENTIFICATION	Interactions between the gut microbiota, diet, and the host potentially contribute to the development of metabolic diseases. Here, we identify imidazole propionate as a microbially produced histidine-derived metabolite that is present at higher concentrations in subjects with versus without type 2 diabetes. We show that imidazole propionate is produced from histidine in a gut simulator at higher concentrations when using fecal microbiota from subjects with versus without type 2 diabetes and that it impairs glucose tolerance when administered to mice. We further show that imidazole propionate impairs insulin signaling at the level of insulin receptor substrate through the activation of p38 gamma MAPK, which promotes p62 phosphorylation and, subsequently, activation of mechanistic target of rapamycin complex 1 (mTORC1). We also demonstrate increased activation of p62 and mTORC1 in liver from subjects with type 2 diabetes. Our findings indicate that the microbial metabolite imidazole propionate may contribute to the pathogenesis of type 2 diabetes.	[Koh, Ara; Molinaro, Antonio; Stahlman, Marcus; Khan, Muhammad Tanweer; Schmidt, Caroline; Manneras-Holm, Louise; Wu, Hao; Carreras, Alba; Olofsson, Louise E.; Bergh, Per-Olof; Perkins, Rosie; Nieuwdorp, Max; Bergstrom, Goran; Backhed, Fredrik] Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Koh, Ara; Molinaro, Antonio; Stahlman, Marcus; Khan, Muhammad Tanweer; Schmidt, Caroline; Manneras-Holm, Louise; Wu, Hao; Carreras, Alba; Olofsson, Louise E.; Bergh, Per-Olof; Perkins, Rosie; Nieuwdorp, Max; Bergstrom, Goran; Backhed, Fredrik] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Schmidt, Caroline; Bergstrom, Goran] Sahlgrens Univ Hosp, Dept Physiol, Gothenburg, Sweden; [Jeong, Heeyoon] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, South Korea; [Gerdes, Victor; de Brauw, Maurits] Slotervaart Hosp, Amsterdam, Netherlands; [Hartstra, Annick; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Nieuwdorp, Max] Free Univ Amsterdam, VU Univ Med Ctr, Amsterdam, Netherlands; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Pohang University of Science & Technology (POSTECH); Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.; Backhed, F (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Backhed, F (corresponding author), Univ Copenhagen, Fac Hlth Sci, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	fredrik@wlab.gu.se	Molinaro, Antonio/AAL-3566-2020; Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818; Wu, Hao/0000-0003-1314-4954; Koh, Ara/0000-0001-7673-034X; Olofsson, Louise/0000-0002-2302-2005; Molinaro, Antonio/0000-0003-3432-2238; Bergstrom, Goran/0000-0003-4289-5722	Novo Nordisk Foundation [NNF15OC0016798]; Swedish Diabetes Foundation; Swedish Heart Lung Foundation; Goran Gustafsson's Foundation; IngaBritt och Arne Lundberg's Foundation; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research; FP7 [305312]; Region Vastra Gotaland [2017-01996_3]; Sahlgrenska University Hospital, JPI [2017-01996_3]; Leducq Foundation [17CVD01]; Wenner-Gren Foundations; ZONMW-VIDI grant [016.146.327]; CVON Young Talent grant; ERC Consolidator Grant (European Research Council) [615362]; Swedish Research Council	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Goran Gustafsson's Foundation; IngaBritt och Arne Lundberg's Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); FP7; Region Vastra Gotaland; Sahlgrenska University Hospital, JPI; Leducq Foundation(Leducq Foundation); Wenner-Gren Foundations; ZONMW-VIDI grant; CVON Young Talent grant; ERC Consolidator Grant (European Research Council)(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank Sung Ho Ryu (Pohang University of Science and Technology, Republic of Korea) and Ying Shiuan Lee for providing materials. We also thank Marie-Louise Ekholm for assistance with the population-based study and Manuela Kramer, Carina Arvidsson, Sara Nordin-Larsson, Ulrica Enquist, and Caroline Wennberg for technical assistance. We are grateful to Anna Hallen for producing the graphical abstract. The computations for metagenomics analyses were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX). This study was supported by the Novo Nordisk Foundation (NNF15OC0016798) the Swedish Research Council, Swedish Diabetes Foundation, Swedish Heart Lung Foundation, Goran Gustafsson's Foundation, IngaBritt och Arne Lundberg's Foundation, Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, the FP7 sponsored program METACARDIS (305312), the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital, JPI (A healthy diet for a healthy life; 2017-01996_3), and a grant from a Transatlantic Networks of Excellence Award from the Leducq Foundation (17CVD01) A.K. is supported by a postdoctoral grant from the Wenner-Gren Foundations. M.N. is supported by a ZONMW-VIDI grant 2013 (016.146.327) and CVON Young Talent grant 2012. F.B. is Torsten Soderberg Professor in Medicine and recipient of an ERC Consolidator Grant (European Research Council, Consolidator grant 615362-METABASE).	Anjani K, 2015, J HEPATOL, V62, P905, DOI 10.1016/j.jhep.2014.11.002; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Beenstock J, 2014, J BIOL CHEM, V289, P23546, DOI 10.1074/jbc.M114.578237; Bender RA, 2012, MICROBIOL MOL BIOL R, V76, P565, DOI 10.1128/MMBR.00014-12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blagosklonny MV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.506; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Caba M., 2016, MED CHEM RES, V25, P173; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen Q, 2009, NUTRITION, V25, P340, DOI 10.1016/j.nut.2008.08.012; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gonzalez-Teran B, 2016, EMBO J, V35, P536, DOI 10.15252/embj.201591857; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kikuchi M, 2017, NEPHRON, V135, P51, DOI 10.1159/000450619; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kim YM, 2012, MOL CELL, V46, P833, DOI 10.1016/j.molcel.2012.04.007; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leontieva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.178; Linares JF, 2015, CELL REP, V12, P1339, DOI 10.1016/j.celrep.2015.07.045; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011; Mojtahedi MC, 2011, J GERONTOL A-BIOL, V66, P1218, DOI 10.1093/gerona/glr120; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin L. Q., 2011, J NUTR, V747; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SCHRODER I, 1991, J BIOL CHEM, V266, P13572; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Tzatsos A, 2009, J BIOL CHEM, V284, P22525, DOI 10.1074/jbc.M109.027748; VANDERHEIDEN C, 1972, CLIN CHIM ACTA, V39, P201, DOI 10.1016/0009-8981(72)90317-8; Wallner S, 2012, BIOCHEMISTRY-US, V51, P6139, DOI 10.1021/bi300411n; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037103; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	68	305	324	23	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					947	+		10.1016/j.cell.2018.09.055	http://dx.doi.org/10.1016/j.cell.2018.09.055			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30401435	Bronze			2022-12-28	WOS:000449100600010
J	Tanaka, M; Sun, FM; Li, YL; Mooney, R				Tanaka, Masashi; Sun, Fangmiao; Li, Yulong; Mooney, Richard			A mesocortical dopamine circuit enables the cultural transmission of vocal behaviour	NATURE			English	Article							ZEBRA FINCHES; SONG; IDENTIFICATION; ENHANCEMENT; NEURONS; PATHWAY; ORIGIN; MODEL; HVC	The cultural transmission of behaviour depends on the ability of the pupil to identify and emulate an appropriate tutor(1-4). How the brain of the pupil detects a suitable tutor and encodes the behaviour of the tutor is largely unknown. Juvenile zebra finches readily copy the songs of the adult tutors that they interact with, but not the songs that they listen to passively through a speaker(5,6), indicating that social cues generated by the tutor facilitate song imitation. Here we show that neurons in the midbrain periaqueductal grey of juvenile finches are selectively excited by a singing tutor and-by releasing dopamine in the cortical song nucleus HVC-help to encode the song representations of the tutor used for vocal copying. Blocking dopamine signalling in the HVC of the pupil during tutoring blocked copying, whereas pairing stimulation of periaqueductal grey terminals in the HVC with a song played through a speaker was sufficient to drive copying. Exposure to a singing tutor triggered the rapid emergence of responses to the tutor song in the HVC of the pupil and a rapid increase in the complexity of the song of the pupil, an early signature of song copying(7,8). These findings reveal that a dopaminergic mesocortical circuit detects the presence of a tutor and helps to encode the performance of the tutor, facilitating the cultural transmission of vocal behaviour.	[Tanaka, Masashi; Mooney, Richard] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Sun, Fangmiao; Li, Yulong] Peking Univ, State Key Lab Membrane Biol, Sch Life Sci, Beijing, Peoples R China; [Sun, Fangmiao; Li, Yulong] PKU IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Li, Yulong] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan	Duke University; Peking University; Tohoku University	Mooney, R (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu	Tanaka, Masashi/Q-7587-2018; Tanaka, Masashi/T-8438-2019; Core, Vector/CAF-4832-2022	Tanaka, Masashi/0000-0002-3076-8606; Tanaka, Masashi/0000-0002-3076-8606; Li, Yulong/0000-0002-9166-9919; Mooney, Richard/0000-0002-3308-1367	JSPS Postdoctoral Fellowship for Research Abroad; National Basic Research Program of China 973 Program [2015CB856402]; American BRAIN Initiative [1U01NS103558-01]; NSF [IOS-1354962]; NIH [1R01-NS-099288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS103558, R01NS099288] Funding Source: NIH RePORTER	JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Basic Research Program of China 973 Program(National Basic Research Program of China); American BRAIN Initiative; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Hatfield for constructing AAV2/9-CAG-GRAB<INF>DA1h</INF>; S. Nowicki, S. Peters, C. Sturdy, F. Wang and S. Soderling for critical discussion and for reading earlier versions of this manuscript. This work was supported by JSPS Postdoctoral Fellowship for Research Abroad (M.T.), the National Basic Research Program of China 973 Program Grant 2015CB856402 (Y.L.), the American BRAIN Initiative project 1U01NS103558-01 (Y.L.), NIH Grant 1R01-NS-099288 (R.M.) and NSF IOS-1354962 (R.M.).	Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Chen YN, 2016, P NATL ACAD SCI USA, V113, P6641, DOI 10.1073/pnas.1522306113; Cho JR, 2017, NEURON, V94, P1205, DOI 10.1016/j.neuron.2017.05.020; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Deregnaucourt S, 2013, J PHYSIOL-PARIS, V107, P210, DOI 10.1016/j.jphysparis.2012.08.003; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Feher O, 2009, NATURE, V459, P564, DOI 10.1038/nature07994; Flores JA, 2006, NEUROPSYCHOPHARMACOL, V31, P1475, DOI 10.1038/sj.npp.1300946; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Hamaguchi K, 2012, J NEUROSCI, V32, P11671, DOI 10.1523/JNEUROSCI.1666-12.2012; Hisey E, 2018, NAT NEUROSCI, V21, P589, DOI 10.1038/s41593-018-0092-6; Kingsbury MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020720; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1964, SCIENCE, V146, P1483, DOI 10.1126/science.146.3650.1483; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Roberts TF, 2017, NAT NEUROSCI, V20, P978, DOI 10.1038/nn.4563; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Sun FM, 2018, CELL, V174, P481, DOI 10.1016/j.cell.2018.06.042; Tanaka M, 2016, P NATL ACAD SCI USA, V113, pE1720, DOI 10.1073/pnas.1523754113; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Whiten A, 2017, ANNU REV PSYCHOL, V68, P129, DOI 10.1146/annurev-psych-010416-044108; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321	31	53	53	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					117	+		10.1038/s41586-018-0636-7	http://dx.doi.org/10.1038/s41586-018-0636-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30333629	Green Accepted			2022-12-28	WOS:000448900900056
J	Wagner, FB; Mignardot, JB; Le Goff-Mignardot, CG; Demesmaeker, R; Komi, S; Capogrosso, M; Rowald, A; Seanez, I; Caban, M; Pirondini, E; Vat, M; McCracken, LA; Heimgartner, R; Fodor, I; Watrin, A; Seguin, P; Paoles, E; Van Den Keybus, K; Eberle, G; Schurch, B; Pralong, E; Becce, F; Prior, J; Buse, N; Buschman, R; Neufeld, E; Kuster, N; Carda, S; von Zitzewitz, J; Delattre, V; Denison, T; Lambert, H; Minassian, K; Bloch, J; Courtine, G				Wagner, Fabien B.; Mignardot, Jean-Baptiste; Le Goff-Mignardot, Camille G.; Demesmaeker, Robin; Komi, Salif; Capogrosso, Marco; Rowald, Andreas; Seanez, Ismael; Caban, Miroslav; Pirondini, Elvira; Vat, Molywan; McCracken, Laura A.; Heimgartner, Roman; Fodor, Isabelle; Watrin, Anne; Seguin, Perrine; Paoles, Edoardo; Van Den Keybus, Katrien; Eberle, Gregoire; Schurch, Brigitte; Pralong, Etienne; Becce, Fabio; Prior, John; Buse, Nicholas; Buschman, Rik; Neufeld, Esra; Kuster, Niels; Carda, Stefano; von Zitzewitz, Joachim; Delattre, Vincent; Denison, Tim; Lambert, Hendrik; Minassian, Karen; Bloch, Jocelyne; Courtine, Gregoire			Targeted neurotechnology restores walking in humans with spinal cord injury	NATURE			English	Article							EPIDURAL ELECTRICAL-STIMULATION; RANDOMIZED CLINICAL-TRIAL; ACTIVITY-BASED THERAPY; CIRCUIT REORGANIZATION; MOTOR FUNCTION; RECOVERY; LOCOMOTION; NEUROMODULATION; PLASTICITY; EXCITABILITY	Spinal cord injury leads to severe locomotor deficits or even complete leg paralysis. Here we introduce targeted spinal cord stimulation neurotechnologies that enabled voluntary control of walking in individuals who had sustained a spinal cord injury more than four years ago and presented with permanent motor deficits or complete paralysis despite extensive rehabilitation. Using an implanted pulse generator with real-time triggering capabilities, we delivered trains of spatially selective stimulation to the lumbosacral spinal cord with timing that coincided with the intended movement. Within one week, this spatiotemporal stimulation had re-established adaptive control of paralysed muscles during overground walking. Locomotor performance improved during rehabilitation. After a few months, participants regained voluntary control over previously paralysed muscles without stimulation and could walk or cycle in ecological settings during spatiotemporal stimulation. These results establish a technological framework for improving neurological recovery and supporting the activities of daily living after spinal cord injury.	[Wagner, Fabien B.; Mignardot, Jean-Baptiste; Le Goff-Mignardot, Camille G.; Demesmaeker, Robin; Komi, Salif; Rowald, Andreas; Seanez, Ismael; Pirondini, Elvira; McCracken, Laura A.; Heimgartner, Roman; Seguin, Perrine; Minassian, Karen; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet & Brain Mind Inst, Lausanne, Switzerland; [Wagner, Fabien B.; Mignardot, Jean-Baptiste; Le Goff-Mignardot, Camille G.; Demesmaeker, Robin; Komi, Salif; Rowald, Andreas; Seanez, Ismael; Pirondini, Elvira; McCracken, Laura A.; Heimgartner, Roman; Fodor, Isabelle; Seguin, Perrine; Van Den Keybus, Katrien; Eberle, Gregoire; Schurch, Brigitte; Carda, Stefano; Minassian, Karen; Bloch, Jocelyne; Courtine, Gregoire] Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Lausanne, Switzerland; [Capogrosso, Marco] Univ Fribourg, Dept Neurosci & Movement Sci, Platform Translat Neurosci, Fribourg, Switzerland; [Caban, Miroslav; Watrin, Anne; Paoles, Edoardo; von Zitzewitz, Joachim; Delattre, Vincent; Lambert, Hendrik] GTXmedical, Lausanne, Switzerland; [Caban, Miroslav] Swiss Fed Inst Technol EPFL, Inst Bioengn, Lausanne, Switzerland; [Pirondini, Elvira] Univ Geneva, Dept Radiol & Med Informat, Geneva, Switzerland; [Vat, Molywan; Pralong, Etienne; Bloch, Jocelyne; Courtine, Gregoire] Lausanne Univ Hosp CHUV, Dept Neurosurg, Lausanne, Switzerland; [Becce, Fabio] Lausanne Univ Hosp CHUV, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Prior, John] Lausanne Univ Hosp CHUV, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland; [Buse, Nicholas; Buschman, Rik; Denison, Tim] Medtronic, Minneapolis, MN USA; [Neufeld, Esra; Kuster, Niels] Fdn Res Informat Technol Soc ITIS, Zurich, Switzerland; [Kuster, Niels] Swiss Fed Inst Technol ETHZ, Dept Informat Technol & Elect Engn, Zurich, Switzerland; [Denison, Tim] Univ Oxford, Dept Engn Sci, Oxford, England; [Bloch, Jocelyne; Courtine, Gregoire] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Fribourg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medtronic; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Lausanne	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet & Brain Mind Inst, Lausanne, Switzerland.; Courtine, G (corresponding author), Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Lausanne, Switzerland.; Courtine, G (corresponding author), Lausanne Univ Hosp CHUV, Dept Neurosurg, Lausanne, Switzerland.; Courtine, G (corresponding author), Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	Seanez-Gonzalez, Ismael/N-1746-2014; Wagner, Fabien/ABC-4084-2020; Becce, Fabio/I-6781-2019; Seáñez, Ismael/AAS-7910-2021; PRIOR, John O/I-5364-2017; Bloch, Jocelyne/A-9668-2017	Seanez-Gonzalez, Ismael/0000-0003-0068-7124; Wagner, Fabien/0000-0002-9582-6109; Becce, Fabio/0000-0001-8444-8504; Seáñez, Ismael/0000-0003-0068-7124; PRIOR, John O/0000-0003-1429-1374; Demesmaeker, Robin/0000-0003-0856-0929; Carda, Stefano/0000-0001-7849-1290; Bloch, Jocelyne/0000-0002-6405-1590; McCracken, Laura/0000-0003-1663-2558; courtine, gregoire/0000-0002-5744-4142; Minassian, Karen/0000-0003-4197-6141; Denison, Timothy/0000-0002-5404-4004; Kuster, Niels/0000-0002-5827-3728; Rowald, Andreas/0000-0001-5493-195X; Komi, Salif/0000-0002-2655-6213	International Foundation for Research in Paraplegia (IRP); Wings for Life; Wyss Center for Neuroengineering; European Union's Horizon 2020 [785907]; Eurostars [E10889]; GTXmedical; National Center of Competence in Research (NCCR) Robotics of the Swiss National Foundation; Commission of Technology and Innovation Innosuisse (CTI) [25761.1]; Voirol Foundation; Firmenich Foundation; Pictet Group Charitable Foundation; Panacee Foundation; riders4riders; SOFMER; Whitaker International Scholars Program; H2020-MSCA-COFUND-2015 EPFL Fellows program [665667]	International Foundation for Research in Paraplegia (IRP); Wings for Life; Wyss Center for Neuroengineering; European Union's Horizon 2020; Eurostars; GTXmedical; National Center of Competence in Research (NCCR) Robotics of the Swiss National Foundation; Commission of Technology and Innovation Innosuisse (CTI); Voirol Foundation; Firmenich Foundation; Pictet Group Charitable Foundation; Panacee Foundation; riders4riders; SOFMER; Whitaker International Scholars Program; H2020-MSCA-COFUND-2015 EPFL Fellows program	See Supplementary Notes. Support: International Foundation for Research in Paraplegia (IRP), Wings for Life, Wyss Center for Neuroengineering, European Union's Horizon 2020 No. 785907 (Human Brain Project SGA2), Eurostars No. E10889, GTXmedical, National Center of Competence in Research (NCCR) Robotics of the Swiss National Foundation, the Commission of Technology and Innovation Innosuisse (CTI) No. 25761.1, Voirol Foundation, Firmenich Foundation, Pictet Group Charitable Foundation, Panacee Foundation, riders4riders, SOFMER (to P.S.), the Whitaker International Scholars Program (to I.S.) and the H2020-MSCA-COFUND-2015 EPFL Fellows program (No. 665667 to F.B.W.).	Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; ASANUMA H, 1989, JPN J PHYSIOL, V39, P1, DOI 10.2170/jjphysiol.39.1; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; BAROLAT G, 1986, APPL NEUROPHYSIOL, V49, P307; Behrman AL, 2017, J NEUROL PHYS THER, V41, pS39, DOI 10.1097/NPT.0000000000000184; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; Capogrosso M, 2018, NAT PROTOC, V13, P2031, DOI 10.1038/s41596-018-0030-9; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Cappellini G, 2010, J NEUROPHYSIOL, V104, P3064, DOI 10.1152/jn.00318.2010; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Cote MP, 2017, J NEUROTRAUM, V34, P1841, DOI 10.1089/neu.2016.4577; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Dietz V, 2010, NAT REV NEUROL, V6, P167, DOI 10.1038/nrneurol.2009.227; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Field-Fote Edelle C, 2005, J Neurol Phys Ther, V29, P127; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Formento E, 2018, NAT NEUROSCI, V21, P1728, DOI 10.1038/s41593-018-0262-6; Gerasimenko Y, 2008, EXP NEUROL, V209, P417, DOI 10.1016/j.expneurol.2007.07.015; Gill ML, 2018, NAT MED, V24, P1677, DOI 10.1038/s41591-018-0175-7; Gourab K, 2010, CLIN NEUROPHYSIOL, V121, P2017, DOI 10.1016/j.clinph.2010.05.012; Grahn PJ, 2017, MAYO CLIN PROC, V92, P544, DOI 10.1016/j.mayocp.2017.02.014; Herrity AN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26602-2; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jones ML, 2014, ARCH PHYS MED REHAB, V95, P2239, DOI 10.1016/j.apmr.2014.07.400; Mignardot JB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3621; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2016, NEUROTHERAPEUTICS, V13, P284, DOI 10.1007/s13311-016-0421-y; Moraud EM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18293-y; Moraud EM, 2016, NEURON, V89, P814, DOI 10.1016/j.neuron.2016.01.009; Nishimura Y, 2013, NEURON, V80, P1301, DOI 10.1016/j.neuron.2013.08.028; Perez MA, 2003, J NEUROSCI, V23, P2014; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; SHARRARD W J, 1964, Ann R Coll Surg Engl, V35, P106; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Urbin MA, 2017, J NEUROPHYSIOL, V118, P2171, DOI 10.1152/jn.00111.2017; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; West CR, 2018, JAMA NEUROL, V75, P630, DOI 10.1001/jamaneurol.2017.5055; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001	46	398	424	29	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					65	+		10.1038/s41586-018-0649-2	http://dx.doi.org/10.1038/s41586-018-0649-2			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382197				2022-12-28	WOS:000448900900046
J	Kontorinis, G; Tyagi, A; Crowther, JA				Kontorinis, Georgios; Tyagi, Alok; Crowther, John A.			Recurrent vertigo associated with headaches	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENIERES-DISEASE; MIGRAINE		[Kontorinis, Georgios; Crowther, John A.] Queen Elizabeth Univ Hosp, Dept Otolaryngol, Glasgow, Lanark, Scotland; [Tyagi, Alok] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neurol, Glasgow, Lanark, Scotland	Queen Elizabeth University Hospital (QEUH); Queen Elizabeth University Hospital (QEUH); University of Glasgow	Kontorinis, G (corresponding author), Queen Elizabeth Univ Hosp, Dept Otolaryngol, Glasgow, Lanark, Scotland.	gkontorinis@gmail.com						Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Cohen JM, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0502-3; Flossmann E, 2003, BRAIN, V126, P1940, DOI 10.1093/brain/awg197; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Ibekwe TS, 2008, J NATL MED ASSOC, V100, P334, DOI 10.1016/S0027-9684(15)31246-3; Kontorinis G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3601; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Maldonado Fernandez M, 2015, COCHRANE DB SYST REV, V6; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Obermann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00257; Radtke A, 2002, NEUROLOGY, V59, P1700, DOI 10.1212/01.WNL.0000036903.22461.39; Robertson JJ, 2016, J EMERG MED, V51, P508, DOI 10.1016/j.jemermed.2015.10.044	12	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k1807	10.1136/bmj.k1807	http://dx.doi.org/10.1136/bmj.k1807			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381443				2022-12-28	WOS:000449564200015
J	Moeller, AH; Suzuki, TA; Phifer-Rixey, M; Nachman, MW				Moeller, Andrew H.; Suzuki, Taichi A.; Phifer-Rixey, Megan; Nachman, Michael W.			Transmission modes of the mammalian gut microbiota	SCIENCE			English	Article							PATHOGENS; VIRULENCE; EVOLUTION; DISEASE; SHAPES; HEALTH	Mammals house a diversity of bacteria that affect health in various ways, but the routes by which bacterial lineages are transmitted between hosts remain poorly understood. We experimentally determined microbiota transmission modes by deriving 17 inbred mouse lines from two wild populations and monitoring their gut microbiotas for up to 11 host generations. Individual-and population-level microbiota compositions were maintained within mouse lines throughout the experiment, indicating predominantly vertical inheritance of the microbiota. However, certain bacterial taxa tended to be exchanged horizontally between mouse lines. Consistent with evolutionary theory, the degree of horizontal transmission predicted bacterial genera with pathogenic representatives responsible for human infections and hospitalizations.	[Moeller, Andrew H.] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Moeller, Andrew H.; Suzuki, Taichi A.; Phifer-Rixey, Megan; Nachman, Michael W.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Moeller, Andrew H.; Suzuki, Taichi A.; Phifer-Rixey, Megan; Nachman, Michael W.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Phifer-Rixey, Megan] Monmouth Univ, Dept Biol, West Long Branch, NJ 07764 USA; [Moeller, Andrew H.] Cornell Univ, Dept Ecol & Evolutionary Biol, New York, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Monmouth University; Cornell University	Moeller, AH (corresponding author), Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA.; Moeller, AH; Nachman, MW (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.; Moeller, AH; Nachman, MW (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Moeller, AH (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, New York, NY 14853 USA.	andrew.moeller@berkeley.edu; mnachman@berkeley.edu		Phifer-Rixey, Megan/0000-0002-3804-6229; Suzuki, Taichi/0000-0001-7800-8596	NIH [RO1 GM074245]; Miller research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miller research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH RO1 GM074245 to M.W.N. and by a Miller research fellowship to A.H.M.	Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; de Roode JC, 2008, P NATL ACAD SCI USA, V105, P7489, DOI 10.1073/pnas.0710909105; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; GORCZYNSKI RM, 1980, P NATL ACAD SCI-BIOL, V77, P2871, DOI 10.1073/pnas.77.5.2871; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI [10.2307/2410731, 10.1111/j.1558-5646.1996.tb03560.x]; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Moeller AH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500997; Pagan I, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004293; Perofsky AC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.2274; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tung J, 2015, ELIFE, V4, DOI 10.7554/eLife.05224; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031	21	120	128	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					453	456		10.1126/science.aat7164	http://dx.doi.org/10.1126/science.aat7164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361372				2022-12-28	WOS:000450441900049
J	Deng, M; Gui, X; Kim, J; Xie, L; Chen, WN; Li, ZL; He, LC; Chen, YZ; Chen, HY; Luo, WG; Lu, ZG; Xie, JJ; Churchill, H; Xu, YX; Zhou, Z; Wu, GJ; Yu, CY; John, S; Hirayasu, K; Nguyen, N; Liu, XY; Huang, FF; Li, LK; Deng, H; Tang, HD; Sadek, AH; Zhang, LB; Huang, T; Zou, YZ; Chen, B; Zhu, H; Arase, H; Xia, NS; Jiang, YX; Collins, R; You, MJ; Homsi, J; Unni, N; Lewis, C; Chen, GQ; Fu, YX; Liao, XC; An, ZQ; Zheng, JK; Zhang, NY; Zhang, CC				Deng, Mi; Gui, Xun; Kim, Jaehyup; Xie, Li; Chen, Weina; Li, Zunling; He, Licai; Chen, Yuanzhi; Chen, Heyu; Luo, Weiguang; Lu, Zhigang; Xie, Jingjing; Churchill, Hywyn; Xu, Yixiang; Zhou, Zhan; Wu, Guojin; Yu, Chenyi; John, Samuel; Hirayasu, Kouyuki; Nam Nguyen; Liu, Xiaoye; Huang, Fangfang; Li, Leike; Deng, Hui; Tang, Haidong; Sadek, Ali H.; Zhang, Lingbo; Huang, Tao; Zou, Yizhou; Chen, Benjamin; Zhu, Hong; Arase, Hisashi; Xia, Ningshao; Jiang, Youxing; Collins, Robert; You, M. James; Homsi, Jade; Unni, Nisha; Lewis, Cheryl; Chen, Guo-Qiang; Fu, Yang-Xin; Liao, X. Charlene; An, Zhiqiang; Zheng, Junke; Zhang, Ningyan; Zhang, Cheng Cheng			LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; INHIBITORY RECEPTOR ILT3; IN-VIVO; IMMUNE PRIVILEGE; MICE; EXPRESSION; CANCER; TRANSPLANTATION	Immune checkpoint blockade therapy has been successful in treating some types of cancer but has not shown clinical benefits for treating leukaemia(1). This result suggests that leukaemia uses unique mechanisms to evade this therapy. Certain immune inhibitory receptors that are expressed by normal immune cells are also present on leukaemia cells. Whether these receptors can initiate immune-related primary signalling in tumour cells remains unknown. Here we use mouse models and human cells to show that LILRB4, an immunoreceptor tyrosine-based inhibition motif-containing receptor and a marker of monocytic leukaemia, supports tumour cell infiltration into tissues and suppresses T cell activity via a signalling pathway that involves APOE, LILRB4, SHP-2, uPAR and ARG1 in acute myeloid leukaemia (AML) cells. Deletion of LILRB4 or the use of antibodies to block LILRB4 signalling impeded AML development. Thus, LILRB4 orchestrates tumour invasion pathways in monocytic leukaemia cells by creating an immunosuppressive microenvironment. LILRB4 represents a compelling target for the treatment of monocytic AML.	[Deng, Mi; Li, Zunling; He, Licai; Chen, Heyu; Luo, Weiguang; Lu, Zhigang; Xie, Jingjing; Zhou, Zhan; Wu, Guojin; Nam Nguyen; Liu, Xiaoye; Huang, Fangfang; Sadek, Ali H.; Zhang, Lingbo; Jiang, Youxing; Zhang, Cheng Cheng] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Gui, Xun; Chen, Yuanzhi; Xu, Yixiang; Yu, Chenyi; Li, Leike; Deng, Hui; An, Zhiqiang; Zhang, Ningyan] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA; [Kim, Jaehyup; Chen, Weina; Churchill, Hywyn; Tang, Haidong; Fu, Yang-Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Xie, Li; Chen, Guo-Qiang; Zheng, Junke] Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol,Chinese Minist Educ, Shanghai, Peoples R China; [Li, Zunling; Xie, Jingjing] Binzhou Med Univ, Basic Med Sch, Taishan Immunol Program, Yantai, Peoples R China; [He, Licai] Wenzhou Med Univ, Sch Lab Med & Life Sci, Minist Educ, Key Lab Lab Med, Wenzhou, Peoples R China; [Chen, Yuanzhi; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, Xiamen, Peoples R China; [Luo, Weiguang; Zou, Yizhou] Cent S Univ, Xiangya Med Sch, Dept Immunol, Changsha, Peoples R China; [Lu, Zhigang] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Lu, Zhigang] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai, Peoples R China; [Yu, Chenyi; Zhang, Lingbo] Cent S Univ, Xiangya Med Sch, Changsha, Hunan, Peoples R China; [John, Samuel] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Hirayasu, Kouyuki; Arase, Hisashi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Res Inst Microbial Dis & Lab Immunochem, Dept Immunochem, Osaka, Japan; [Huang, Fangfang] Xiamen Univ, Zhongshan Hosp, Dept Hematol, Xiamen, Peoples R China; [Huang, Tao; Liao, X. Charlene] Immune Onc Therapeut, Palo Alto, CA USA; [Chen, Benjamin] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Zhu, Hong] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Zhu, Hong; Lewis, Cheryl] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Collins, Robert; Homsi, Jade; Unni, Nisha] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Div Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shanghai Jiao Tong University; Binzhou Medical University; Wenzhou Medical University; Xiamen University; Central South University; Fudan University; Fudan University; Central South University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Osaka University; Xiamen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Zhang, CC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.; An, ZQ; Zhang, NY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Brown Fdn Inst Mol Med, Texas Therapeut Inst, Houston, TX 77030 USA.; Zheng, JK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol,Chinese Minist Educ, Shanghai, Peoples R China.	zhiqiang.an@uth.tmc.edu; zhengjunke@sjtu.edu.cn; ningyan.zhang@uth.tmc.edu; alec.zhang@utsouthwestern.edu	Zhang, Cheng/GRS-8698-2022; Kim, Jaehyup/N-5800-2015; Liu, Xiaoye/K-1040-2019; Chen, Yuanzhi/GPP-6933-2022; Kim, Jaehyup/Q-6869-2019; xie, jing/GRY-1689-2022; Tang, Haidong/P-1729-2019; Arase, Hisashi/C-8442-2009; Deng, Mi/K-8699-2012	Kim, Jaehyup/0000-0003-0373-5080; Liu, Xiaoye/0000-0001-5031-0822; Chen, Yuanzhi/0000-0003-3627-5551; Kim, Jaehyup/0000-0003-0373-5080; Tang, Haidong/0000-0002-1512-2655; Arase, Hisashi/0000-0002-1153-3166; Gui, Xun/0000-0002-5070-3527; Li, Leike/0000-0002-1379-1396; Deng, Mi/0000-0003-4291-0144; Xia, Ningshao/0000-0003-0179-5266; An, Zhiqiang/0000-0001-9309-2335; chen, guo qiang/0000-0003-4936-2363; Lu, Zhigang/0000-0002-2880-7848; Zhang, Ningyan/0000-0002-4348-2180	National Cancer Institute [1R01CA172268, 5P30CA142543]; Leukemia & Lymphoma Society [1024-14, TRP-6024-14]; March of Dimes Foundation [1-FY14-201]; Cancer Prevention and Research Institute of Texas [RP140402, DP150056, RP180435, PR150551, RR150072]; Robert A. Welch Foundation [I-1834, AU-0042-20030616]; National Natural Science Foundation of China [81570093, 81422001, 81721004]; National Basic Research Program of China [2014CB965000]; China Scholarship Council [201608330307]; NATIONAL CANCER INSTITUTE [P30CA142543, R01CA172268] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); March of Dimes Foundation(March of Dimes); Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the National Cancer Institute (1R01CA172268 and 5P30CA142543), the Leukemia & Lymphoma Society (1024-14 and TRP-6024-14), the March of Dimes Foundation (1-FY14-201), the Cancer Prevention and Research Institute of Texas (RP140402, DP150056, RP180435, PR150551, and RR150072), the Robert A. Welch Foundation (I-1834 and AU-0042-20030616), the National Natural Science Foundation of China (81570093, 81422001, and 81721004), the National Basic Research Program of China (2014CB965000), and the China Scholarship Council (201608330307) for support. We also thank G. Salazar for editing the manuscript and Y. Dang for RStudio coding.	Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Baumgartner B, 2002, LEUKEMIA, V16, P2062, DOI 10.1038/sj.leu.2402641; Bene MC, 2004, LEUKEMIA, V18, P394, DOI 10.1038/sj.leu.2403250; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Colovai AI, 2007, CYTOM PART B-CLIN CY, V72B, P354, DOI 10.1002/cyto.b.20164; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Curran EK, 2017, TRENDS IMMUNOL, V38, P513, DOI 10.1016/j.it.2017.04.004; de Goeje PL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014242; Deng M, 2014, BLOOD, V124, P924, DOI 10.1182/blood-2014-01-549162; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dobrowolska H, 2013, CYTOM PART B-CLIN CY, V84B, P21, DOI 10.1002/cyto.b.21050; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Ha S, 2011, GLYCOBIOLOGY, V21, P1087, DOI 10.1093/glycob/cwr047; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Hu J, 2014, AM J PATHOL, V184, P3384, DOI 10.1016/j.ajpath.2014.08.003; Ilkovitch D, 2009, BLOOD, V113, P4729, DOI 10.1182/blood-2008-08-176438; Kang XL, 2016, CELL CYCLE, V15, P25, DOI 10.1080/15384101.2015.1121324; Kang XL, 2015, NAT CELL BIOL, V17, P665, DOI 10.1038/ncb3158; Lu ZG, 2017, NAT MED, V23, P79, DOI 10.1038/nm.4252; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Mussai F, 2013, BLOOD, V122, P749, DOI 10.1182/blood-2013-01-480129; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; STRAUS DJ, 1980, MEDICINE, V59, P409, DOI 10.1097/00005792-198011000-00002; Su SC, 2016, EXPERT OPIN THER TAR, V20, P551, DOI 10.1517/14728222.2016.1113260; Suciu-Foca N, 2007, J IMMUNOL, V178, P7432, DOI 10.4049/jimmunol.178.11.7432; Trowsdale J, 2015, IMMUNOL REV, V267, P117, DOI 10.1111/imr.12314; Vlad G, 2010, INT REV IMMUNOL, V29, P119, DOI 10.3109/08830180903281185; Wang AY, 2000, EUR J BIOCHEM, V267, P3248, DOI 10.1046/j.1432-1327.2000.01350.x; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zheng JK, 2011, CELL STEM CELL, V9, P119, DOI 10.1016/j.stem.2011.06.003; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716	40	105	111	7	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					605	+		10.1038/s41586-018-0615-z	http://dx.doi.org/10.1038/s41586-018-0615-z			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30333625	Green Accepted			2022-12-28	WOS:000448277800061
J	Stewart, CJ; Ajami, NJ; O'Brien, JL; Hutchinson, DS; Smith, DP; Wong, MC; Ross, MC; Lloyd, RE; Doddapaneni, H; Metcalf, GA; Muzny, D; Gibbs, RA; Vatanen, T; Huttenhower, C; Xavier, RJ; Rewers, M; Hagopian, W; Toppari, J; Ziegler, AG; She, JX; Akolkar, B; Lernmark, A; Hyoty, H; Vehik, K; Krischer, JP; Petrosino, JF				Stewart, Christopher J.; Ajami, Nadim J.; O'Brien, Jacqueline L.; Hutchinson, Diane S.; Smith, Daniel P.; Wong, Matthew C.; Ross, Matthew C.; Lloyd, Richard E.; Doddapaneni, HarshaVardhan; Metcalf, Ginger A.; Muzny, Donna; Gibbs, Richard A.; Vatanen, Tommi; Huttenhower, Curtis; Xavier, Ramnik J.; Rewers, Marian; Hagopian, William; Toppari, Jorma; Ziegler, Anette-G.; She, Jin-Xiong; Akolkar, Beena; Lernmark, Ake; Hyoty, Heikki; Vehik, Kendra; Krischer, Jeffrey P.; Petrosino, Joseph F.			Temporal development of the gut microbiome in early childhood from the TEDDY study	NATURE			English	Article							INTESTINAL MICROBIOTA; ENVIRONMENTAL DETERMINANTS; QUALITY-CONTROL; BREAST-MILK; INFANT; EXPOSURE; RISK; ESTABLISHMENT; DISEASE; PROGRESSION	The development of the microbiome from infancy to childhood is dependent on a range of factors, with microbial-immune crosstalk during this time thought to be involved in the pathobiology of later life diseases(1-9) such as persistent islet autoimmunity and type 1 diabetes(10-12). However, to our knowledge, no studies have performed extensive characterization of the microbiome in early life in a large, multi-centre population. Here we analyse longitudinal stool samples from 903 children between 3 and 46 months of age by 16S rRNA gene sequencing (n = 12,005) and metagenomic sequencing (n = 10,867), as part of the The Environmental Determinants of Diabetes in the Young (TEDDY) study. We show that the developing gut microbiome undergoes three distinct phases of microbiome progression: a developmental phase (months 3-14), a transitional phase (months 15-30), and a stable phase (months 31-46). Receipt of breast milk, either exclusive or partial, was the most significant factor associated with the microbiome structure. Breastfeeding was associated with higher levels of Bifidobacterium species (B. breve and B. bifidum), and the cessation of breast milk resulted in faster maturation of the gut microbiome, as marked by the phylum Firmicutes. Birth mode was also significantly associated with the microbiome during the developmental phase, driven by higher levels of Bacteroides species (particularly B. fragilis) in infants delivered vaginally. Bacteroides was also associated with increased gut diversity and faster maturation, regardless of the birth mode. Environmental factors including geographical location and household exposures (such as siblings and furry pets) also represented important covariates. A nested case-control analysis revealed subtle associations between microbial taxonomy and the development of islet autoimmunity or type 1 diabetes. These data determine the structural and functional assembly of the microbiome in early life and provide a foundation for targeted mechanistic investigation into the consequences of microbial-immune crosstalk for long-term health.	[Stewart, Christopher J.; Ajami, Nadim J.; O'Brien, Jacqueline L.; Hutchinson, Diane S.; Smith, Daniel P.; Wong, Matthew C.; Ross, Matthew C.; Lloyd, Richard E.; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Stewart, Christopher J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Doddapaneni, HarshaVardhan; Metcalf, Ginger A.; Muzny, Donna; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Vatanen, Tommi; Huttenhower, Curtis; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rewers, Marian] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Hagopian, William] Pacific Northwest Res Inst, Seattle, WA USA; [Toppari, Jorma] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku, Finland; [Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Ziegler, Anette-G.] Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany; [Ziegler, Anette-G.] Tech Univ Munich, Forschergrp Diabet, Klinikum Rechts Isar, Munich, Germany; [Ziegler, Anette-G.] Helmholtz Zentrum Munchen, Forschergrp Diabet eV, Munich, Germany; [She, Jin-Xiong] Augusta Univ, Ctr Biotechnol & Genom Med, Med Coll Georgia, Augusta, GA USA; [Akolkar, Beena] NIDDK, Bethesda, MD 20892 USA; [Lernmark, Ake] Lund Univ, Skane Univ Hosp, Dept Clin Sci, CRC, Malmo, Sweden; [Hyoty, Heikki] Univ Tampere, Fac Med & Biosci, Dept Virol, Tampere, Finland; [Hyoty, Heikki] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Vehik, Kendra; Krischer, Jeffrey P.] Univ S Florida, Hlth Informat Inst, Morsani Coll Med, Tampa, FL USA	Baylor College of Medicine; Newcastle University - UK; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Lund University; Skane University Hospital; Tampere University; Pirkanmaa Hospital District; State University System of Florida; University of South Florida	Stewart, CJ; Petrosino, JF (corresponding author), Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Stewart, CJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	christopher.stewart@ncl.ac.uk; jpetrosi@bcm.edu	Lernmark, Åke/F-8140-2015; Vatanen, Tommi/J-5458-2018; Stewart, Christopher/M-4615-2017; Petrosino, Joseph F./AAF-1621-2019	Lernmark, Åke/0000-0003-1735-0499; Vatanen, Tommi/0000-0003-0949-1291; Stewart, Christopher/0000-0002-6033-338X; doddapaneni, harshavardhan/0000-0002-2433-633X; Kurppa, Kalle/0000-0003-4757-2164; Hyoty, Heikki/0000-0003-0370-4145	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C]; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Child Health and Human Development (NICHD); National Institute of Environmental Health Sciences (NIEHS); Centers for Disease Control and Prevention (CDC); JDRF [2-SRA-2016-247-S-B, 2-SRA-2018-548-S-B]; NIH/NCATS Clinical and Translational Science Awards [UL1 TR000064, UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR001427, UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK112243, UC4DK106955, U01DK063863, UC4DK117483, UC4DK063821, UC4DK095300, U01DK063865, U01DK063829, UC4DK100238, U01DK063821, UC4DK063865, U01DK063790, U01DK063861, UC4DK063836, U01DK063836, UC4DK063829, UC4DK063863, UC4DK063861] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); JDRF(Juvenile Diabetes Research Foundation); NIH/NCATS Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the following members of the CMMR for their support in samples processing: T. Ayvaz, T. Bauch, L. Kusic, L. Railey, R. Berry, A. Tamegnon, E. Zavala, H. Moreno and N. Truong. In addition, we acknowledge the contribution of the Human Genome Sequencing Center at Baylor College of Medicine for their support in the data generation aspects of this work. We apologize to authors of existing work that we could not cite because of space constraints. This research was performed on behalf of the TEDDY Study Group, which is funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Centers for Disease Control and Prevention (CDC), and JDRF. This work supported in part by the NIH/NCATS Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082). R.J.X. was supported by funding from JDRF (2-SRA-2016-247-S-B and 2-SRA-2018-548-S-B).	Aagaard K, 2016, EMBO REP, V17, P1679, DOI 10.15252/embr.201643483; Abdulkadir B, 2016, NEONATOLOGY, V109, P239, DOI 10.1159/000442936; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Aron-Wisnewsky J, 2016, NAT REV NEPHROL, V12, P169, DOI 10.1038/nrneph.2015.191; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn CS, 2004, BRIT MED J, V328, P1223, DOI 10.1136/bmj.38069.512245.FE; Bergstrom A, 2014, APPL ENVIRON MICROB, V80, P2889, DOI 10.1128/AEM.00342-14; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gohir W, 2015, PEDIATR RES, V77, P196, DOI 10.1038/pr.2014.169; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P166, DOI 10.1097/01.mpg.0000189346.25172.fd; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025792, 10.1371/journal.pone.0014764]; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koplin JJ, 2012, ALLERGY, V67, P1415, DOI 10.1111/all.12015; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Krischer J, 2007, PEDIATR DIABETES, V8, P286; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lachin JM, 2008, STAT MED, V27, P2509, DOI 10.1002/sim.3057; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laursen MF, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00069-15; Lee HS, 2014, DIABETES-METAB RES, V30, P424, DOI 10.1002/dmrr.2510; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martinez RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146296; Mayer-Davis EJ, 2006, DIABETES CARE, V29, P2231, DOI 10.2337/dc06-0974; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mueller NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23133; Normand AC, 2011, OCCUP ENVIRON MED, V68, P849, DOI 10.1136/oem.2010.061879; O'Callaghan A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00925; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Schloss PD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-25; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Soeorg H, 2017, PEDIATR RES, V82, P759, DOI 10.1038/pr.2017.150; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sordillo JE, 2017, J ALLERGY CLIN IMMUN, V139, P482, DOI 10.1016/j.jaci.2016.08.045; Stewart CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17141; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2; Vehik K, 2013, DIABETES-METAB RES, V29, P557, DOI 10.1002/dmrr.2427; Virtanen SM, 2014, JAMA PEDIATR, V168, P755, DOI 10.1001/jamapediatrics.2014.296; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yuan C, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2385	72	675	695	27	213	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					583	+		10.1038/s41586-018-0617-x	http://dx.doi.org/10.1038/s41586-018-0617-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356187	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000448277800057
J	Allen, LN; Barkley, S; De Maeseneer, J; van Weel, C; Kluge, H; de Wit, N; Greenhalgh, T				Allen, Luke N.; Barkley, Shannon; De Maeseneer, Jan; van Weel, Chris; Kluge, Hans; de Wit, Niek; Greenhalgh, Trisha			Unfulfilled potential of primary care in Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-HEALTH-CARE; SOCIAL DETERMINANTS; GENERAL-PRACTICE; COUNTRIES; SYSTEMS; EPIDEMIOLOGY; ORGANIZATION		[Allen, Luke N.; Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Barkley, Shannon] WHO, Primary Healthcare Serv, Geneva, Switzerland; [De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, Ghent, Belgium; [van Weel, Chris] Radboud Univ Nijmegen, Dept Primary & Community Care, Radboud Inst Hlth Sci, Gen Practice, Nijmegen, Netherlands; [van Weel, Chris] Australian Natl Univ, Dept Hlth Serv Res & Policy, Gen Practice, Canberra, ACT, Australia; [Kluge, Hans] WHO Europe, Div Hlth Syst & Publ Hlth, Copenhagen, Denmark; [de Wit, Niek] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Gen Practice, Utrecht, Netherlands	University of Oxford; World Health Organization; Ghent University; Radboud University Nijmegen; Australian National University; World Health Organization; Utrecht University; Utrecht University Medical Center	Allen, LN (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.	luke.allen@phc.ox.ac.uk	van Weel, Chris/D-4375-2009; Greenhalgh, Trisha/B-1825-2015	van Weel, Chris/0000-0003-3653-4701; Greenhalgh, Trisha/0000-0003-2369-8088; Allen, Luke/0000-0003-2750-3575				Allen L., 2018, PLOS GLOBAL HLT 1009; Allen LN, BR J GEN PRACT; Allen L, 2018, LANCET PUBLIC HEALTH, V3, pE466, DOI 10.1016/S2468-2667(18)30186-5; [Anonymous], 2017, GPS DEEP END DEEP EN; [Anonymous], 2014, HLTH AFF HLTH POLICY; Baird B, 2016, UNDERSTANDING PRESSU; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; British Medical Association, 2017, FUND GEN PRACT ENGL; Bruce D, 2015, LONDON J PRIM CARE, V7, P44, DOI 10.1080/17571472.2015.11494376; Caley M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4627; Contel JC, 2015, INT J INTEGR CARE, V15; Crisp N, 2016, LANCET, V388, pE24, DOI 10.1016/S0140-6736(16)31801-3; De Maeseneer J, 2017, FAMILY MED PRIMARY C; De Roo L, COMMUNITY HLTH CTR B; de Waard AKM, 2018, EUR J PREV CARDIOL, V25, P1326, DOI 10.1177/2047487318780751; DeMaeseneer J, 2007, PRIMARY HLTH CARE ST; Gourevitch Marc N, 2012, Am J Prev Med, V42, pS180, DOI 10.1016/j.amepre.2012.03.012; Grosvenor Developments, HLTH NEW TOWNS BART; Grumbach K, 2015, J AM BOARD FAM MED, V28, P170, DOI 10.3122/jabfm.2015.02.150011; Health OECD, 2016, POL STUD BETT WAYS P; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Hollander M, 2018, EUR J PUBLIC HEALTH, DOI [10.1093/eurpub/cky112_30016426, DOI 10.1093/EURPUB/CKY11230016426]; Koo Denise, 2012, Am J Public Health, V102 Suppl 3, pS307, DOI 10.2105/AJPH.2012.300824; Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422; Kringos DS, 2013, HEALTH AFFAIR, V32, P686, DOI 10.1377/hlthaff.2012.1242; Lember M, 2015, OBSERVATORY STUDIES, V38, P172; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; MURRAY SA, 1994, BRIT MED J, V308, P698, DOI 10.1136/bmj.308.6930.698; National Institutes of Health, 2018, CHANG LANDSC FEE SER; NHS England, 5 YEAR FORW VIEW; Nichols LM, 2018, HEALTH AFFAIR, V37, P1223, DOI 10.1377/hlthaff.2018.0039; Pelone F, 2013, INT J QUAL HEALTH C, V25, P381, DOI 10.1093/intqhc/mzt020; Primary Health Care Performance Initiative, THE MEAS GAP; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Schafer Willemijn L A, 2013, Qual Prim Care, V21, P67; Scutchfield F Douglas, 2012, Am J Public Health, V102 Suppl 3, pS312, DOI 10.2105/AJPH.2012.300724; Sebo P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017958; Senior T, 2018, BRIT J GEN PRACT, V68, P387, DOI 10.3399/bjgp18X698237; Sessums LL, 2017, JAMA INTERN MED, V177, P1560, DOI 10.1001/jamainternmed.2017.4991; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stigler F, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30315-4; van Weel C, 2008, LANCET, V372, P871, DOI 10.1016/S0140-6736(08)61376-8; van Weel C, 2017, EUR J GEN PRACT, V24, P39, DOI 10.1080/13814788.2017.1397624; van Weel C, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000057; Watt G, 2004, BRIT J GEN PRACT, V54, P939; Watt G, 2012, OCCAS PAP R COLL GEN; World Health Organization, 2008, 2008 WORLD HLTH REP	50	7	7	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4469	10.1136/bmj.k4469	http://dx.doi.org/10.1136/bmj.k4469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8PQ	30355571	Green Published			2022-12-28	WOS:000448895300014
J	Hoekzema, GS; Stevermer, JJ				Hoekzema, Grant S.; Stevermer, James J.			Characterization of Licensees During the First Year of Missouri's Assistant Physician Licensure Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PERFORMANCE		[Hoekzema, Grant S.] Mercy Hosp St Louis, Dept Family Med, 12680 Olive Blvd,Ste 300, St Louis, MO 63141 USA; [Stevermer, James J.] Univ Missouri Hlth, Dept Family & Community Med, Columbia, MO USA	Saint Johns Mercy Medical Center; University of Missouri System; University of Missouri Columbia	Hoekzema, GS (corresponding author), Mercy Hosp St Louis, Dept Family Med, 12680 Olive Blvd,Ste 300, St Louis, MO 63141 USA.	grant.hoekzema@mercy.net						Cuddy MM, 2017, ACAD MED, V92, P1780, DOI 10.1097/ACM.0000000000001747; Missouri Department of Health and Senior Services, 2016, BIENN REP; Norcini JJ, 2014, ACAD MED, V89, P1157, DOI 10.1097/ACM.0000000000000310; US Department of Health and Human Services, HRSA DAT WAR FIND SH	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1706	1707		10.1001/jama.2018.11191	http://dx.doi.org/10.1001/jama.2018.11191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357285	Green Published, Bronze			2022-12-28	WOS:000448069100021
J	Dyer, O				Dyer, Owen			Chinese government fines vaccine company 1bn pound for string of violations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Murphy F, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3244	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k4420	10.1136/bmj.k4420	http://dx.doi.org/10.1136/bmj.k4420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337293				2022-12-28	WOS:000448270700013
J	Budin, I; de Rond, T; Chen, Y; Chan, LJG; Petzold, CJ; Keasling, JD				Budin, Itay; de Rond, Tristan; Chen, Yan; Chan, Leanne Jade G.; Petzold, Christopher J.; Keasling, Jay D.			Viscous control of cellular respiration by membrane lipid composition	SCIENCE			English	Article							LATERAL DIFFUSION-COEFFICIENTS; ESCHERICHIA-COLI; INNER-MEMBRANE; HOMEOVISCOUS ADAPTATION; PHOSPHOLIPID-VESICLES; BIOLOGICAL-MEMBRANES; NADH DEHYDROGENASE; TERMINAL OXIDASES; ELECTRON-TRANSFER; KINETIC EVIDENCE	Lipid composition determines the physical properties of biological membranes and can vary substantially between and within organisms. We describe a specific role for the viscosity of energy-transducing membranes in cellular respiration. Engineering of fatty acid biosynthesis in Escherichia coil allowed us to titrate inner membrane viscosity across a 10-fold range by controlling the abundance of unsaturated or branched lipids. These fluidizing lipids tightly controlled respiratory metabolism, an effect that can be explained with a quantitative model of the electron transport chain (ETC) that features diffusion-coupled reactions between enzymes and electron carriers (quinones). Lipid unsaturation also modulated mitochondrial respiration in engineered budding yeast strains. Thus, diffusion in the ETC may serve as an evolutionary constraint for lipid composition in respiratory membranes.	[Budin, Itay; de Rond, Tristan; Chen, Yan; Chan, Leanne Jade G.; Petzold, Christopher J.; Keasling, Jay D.] Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA; [Budin, Itay; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [de Rond, Tristan] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chen, Yan; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Biol Syst & Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Keasling, Jay D.] Tech Univ Denmark, Novo Nordisa Fdn Ctr Sustainabil, Lyngby, Denmark; [Keasling, Jay D.] Shenzhen Inst Adv Technol, Inst Synthet Biol, Ctr Synthet Biochem, Shenzhen, Peoples R China; [de Rond, Tristan] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Chan, Leanne Jade G.] Calico Life Sci, San Francisco, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Technical University of Denmark; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of California System; University of California San Diego; Scripps Institution of Oceanography	Budin, I; Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.; Budin, I; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Tech Univ Denmark, Novo Nordisa Fdn Ctr Sustainabil, Lyngby, Denmark.; Keasling, JD (corresponding author), Shenzhen Inst Adv Technol, Inst Synthet Biol, Ctr Synthet Biochem, Shenzhen, Peoples R China.	budin@berkeley.edu; keasling@berkeley.edu	Chen, Yan/M-9814-2018; de Rond, Tristan/AAE-6701-2019; Keasling, Jay/J-9162-2012	Chen, Yan/0000-0002-1125-313X; de Rond, Tristan/0000-0002-5203-4662; Keasling, Jay/0000-0003-4170-6088; Petzold, Christopher/0000-0002-8270-5228	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; National Science Foundation [MCB-1442724, MCB-1715681]; Miller Institute for Basic Research	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Miller Institute for Basic Research	This work was part of the DOE Joint BioEnergy Institute supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. This work was also supported by National Science Foundation grants MCB-1442724 and MCB-1715681 to J.D.K, and a Junior Fellowship to I.B. from the Miller Institute for Basic Research.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; ANDERSEN KB, 1980, J BACTERIOL, V144, P114, DOI 10.1128/JB.144.1.114-123.1980; Batth TS, 2014, METAB ENG, V26, P48, DOI 10.1016/j.ymben.2014.08.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Bjorklof K, 2000, FEBS LETT, V467, P105, DOI 10.1016/S0014-5793(00)01130-3; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; BURSTEIN C, 1979, EUR J BIOCHEM, V94, P387, DOI 10.1111/j.1432-1033.1979.tb12905.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Cha HJ, 1999, APPL ENVIRON MICROB, V65, P409; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; Cicuta P, 2007, J PHYS CHEM B, V111, P3328, DOI 10.1021/jp0702088; Covino R, 2016, MOL CELL, V63, P49, DOI 10.1016/j.molcel.2016.05.015; CRONAN JE, 1973, J BIOL CHEM, V248, P1188; Degreif D, 2017, METAB ENG, V41, P46, DOI 10.1016/j.ymben.2017.03.002; FATO R, 1986, BIOCHEMISTRY-US, V25, P3378, DOI 10.1021/bi00359a043; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; GUPTE S, 1984, P NATL ACAD SCI-BIOL, V81, P2606, DOI 10.1073/pnas.81.9.2606; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Haushalter RW, 2014, METAB ENG, V26, P111, DOI 10.1016/j.ymben.2014.09.002; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; KEIZER J, 1985, BIOPHYS J, V47, P79, DOI 10.1016/S0006-3495(85)83879-0; Khebnikov A., 2001, MICROBIOLOGY, V147, P3241; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KITA K, 1984, J BIOL CHEM, V259, P3368; KITA K, 1984, J BIOL CHEM, V259, P3375; Koepke SJ, 2016, J ELECTROCHEM SOC, V163, pH292, DOI 10.1149/2.0681605jes; KOPPEL DE, 1980, BIOPHYS J, V30, P187, DOI 10.1016/S0006-3495(80)85087-9; KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x; KUBALSKI A, 1995, BBA-BIOMEMBRANES, V1238, P177, DOI 10.1016/0005-2736(95)00126-N; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Llorente-Garcia I, 2014, BBA-BIOENERGETICS, V1837, P811, DOI 10.1016/j.bbabio.2014.01.020; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Marchal D, 1998, BIOPHYS J, V74, P1937, DOI 10.1016/S0006-3495(98)77902-0; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; MILON A, 1984, BIOCHIM BIOPHYS ACTA, V777, P331, DOI 10.1016/0005-2736(84)90435-8; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Muro E, 2014, MOL BIOL CELL, V25, P1819, DOI 10.1091/mbc.E13-09-0516; Nenninger A, 2014, MOL MICROBIOL, V92, P1142, DOI 10.1111/mmi.12619; NEWTON NA, 1972, J BACTERIOL, V109, P69, DOI 10.1128/JB.109.1.69-73.1972; Oppenheimer N, 2017, BIOPHYS J, V113, P440, DOI 10.1016/j.bpj.2017.06.013; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; RICH PR, 1981, FEBS LETT, V130, P173, DOI 10.1016/0014-5793(81)81113-1; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SUURKUUSK J, 1976, BIOCHEMISTRY-US, V15, P1393, DOI 10.1021/bi00652a007; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7	69	87	89	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2018	362	6419					1186	+		10.1126/science.aat7925	http://dx.doi.org/10.1126/science.aat7925			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD4OD	30361388	Green Submitted			2022-12-28	WOS:000452506300062
J	Latorre, E; Kale, S; Casares, L; Gomez-Gonzalez, M; Uroz, M; Valon, L; Nair, RV; Garreta, E; Montserrat, N; del Campo, A; Ladoux, B; Arroyo, M; Trepat, X				Latorre, Ernest; Kale, Sohan; Casares, Laura; Gomez-Gonzalez, Manuel; Uroz, Marina; Valon, Leo; Nair, Roshna, V; Garreta, Elena; Montserrat, Nuria; del Campo, Aranzazu; Ladoux, Benoit; Arroyo, Marino; Trepat, Xavier			Active superelasticity in three-dimensional epithelia of controlled shape	NATURE			English	Article							CELL; MECHANICS; CONSTRICTION; DISEASE	Fundamental biological processes are carried out by curved epithelial sheets that enclose a pressurized lumen. How these sheets develop and withstand three-dimensional deformations has remained unclear. Here we combine measurements of epithelial tension and shape with theoretical modelling to show that epithelial sheets are active superelastic materials. We produce arrays of epithelial domes with controlled geometry. Quantification of luminal pressure and epithelial tension reveals a tensional plateau over several-fold areal strains. These extreme strains in the tissue are accommodated by highly heterogeneous strains at a cellular level, in seeming contradiction to the measured tensional uniformity. This phenomenon is reminiscent of superelasticity, a behaviour that is generally attributed to microscopic material instabilities in metal alloys. We show that in epithelial cells this instability is triggered by a stretch-induced dilution of the actin cortex, and is rescued by the intermediate filament network. Our study reveals a type of mechanical behaviour-which we term active superelasticity -that enables epithelial sheets to sustain extreme stretching under constant tension.	[Latorre, Ernest; Casares, Laura; Gomez-Gonzalez, Manuel; Uroz, Marina; Valon, Leo; Garreta, Elena; Montserrat, Nuria; Arroyo, Marino; Trepat, Xavier] BIST, Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Latorre, Ernest; Kale, Sohan; Arroyo, Marino] Univ Politecn Catalunya BarcelonaTech, LaCaN, Barcelona, Spain; [Nair, Roshna, V; del Campo, Aranzazu] INM Leibniz Inst Neue Mat, Saarbrucken, Germany; [Montserrat, Nuria; Trepat, Xavier] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona, Spain; [del Campo, Aranzazu] Saarland Univ, Chem Dept, Saarbrucken, Germany; [Ladoux, Benoit] Univ Paris Diderot, IJM, CNRS UMR 7592, Paris, France; [Ladoux, Benoit] Natl Univ Singapore, Mechanobiol Inst MBI, Singapore, Singapore; [Trepat, Xavier] Univ Barcelona, Unitat Biofis & Bioenginyeria, Barcelona, Spain; [Trepat, Xavier] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Universitat Politecnica de Catalunya; Leibniz Institut fur Neue Materialien (INM); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Saarland University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; National University of Singapore; University of Barcelona; ICREA	Arroyo, M; Trepat, X (corresponding author), BIST, Inst Bioengn Catalonia IBEC, Barcelona, Spain.; Arroyo, M (corresponding author), Univ Politecn Catalunya BarcelonaTech, LaCaN, Barcelona, Spain.; Trepat, X (corresponding author), Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona, Spain.; Trepat, X (corresponding author), Univ Barcelona, Unitat Biofis & Bioenginyeria, Barcelona, Spain.; Trepat, X (corresponding author), ICREA, Barcelona, Spain.	marino.arroyo@upc.edu; xtrepat@ibecbarcelona.eu	Gómez-González, Manuel/AAA-9922-2021; Garreta, Elena/AAQ-4739-2020; Trepat, Xavier/I-3912-2015; Arroyo, Marino/B-5696-2008	Gómez-González, Manuel/0000-0002-5091-0411; Garreta, Elena/0000-0002-1071-9794; Trepat, Xavier/0000-0002-7621-5214; Arroyo, Marino/0000-0003-1647-940X; Latorre, Ernest/0000-0001-9034-3290; Uroz, Marina/0000-0003-4124-8048; Vakkeel, Roshna/0000-0003-2690-4756; Ladoux, Benoit/0000-0003-2086-1556; Kale, Sohan/0000-0002-9985-3526	Spanish Ministry of Economy and Competitiveness/FEDER [BFU2015-65074-P, DPI2015-71789-R, SAF2017-89782-R, SAF2015-72617-EXP, RYC-2014-16242]; Generalitat de Catalunya [2014-SGR-927, 2017-FI-B1-00068, 2014-SGR-1471, 2017 SGR 1306]; CERCA program [2014-SGR-927, 2017-FI-B1-00068, 2014-SGR-1471, 2017 SGR 1306]; European Research Council [CoG-616480, CoG-681434, CoG-617233, StG-640525]; European Commission [H2020-FETPROACT-01-2016-731957]; Instituto de Salud Carlos III (CardioCell, TerCel ); Deutsche Forschung Gemeinschaft [SFB 1027]; Obra Social 'La Caixa'; Severo Ochoa Award of Excellence from the MINECO;  [LABAE16006]	Spanish Ministry of Economy and Competitiveness/FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CERCA program; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Instituto de Salud Carlos III (CardioCell, TerCel ); Deutsche Forschung Gemeinschaft(German Research Foundation (DFG)); Obra Social 'La Caixa'(La Caixa Foundation); Severo Ochoa Award of Excellence from the MINECO(Spanish Government); 	We thank N. Castro for technical assistance; C. Perez-Gonzalez, A. Labernadie, R. Sunyer and A. Torres-Sanchez for discussions and G. Charras for providing cells; J. Colombelli, L. Bardia and A. Llado (IRB) for assistance with laser ablation and photoactivation; N. Borges from Embryotools S.L. for fixation of mouse blastocysts. This work was supported by the Spanish Ministry of Economy and Competitiveness/FEDER (BFU2015-65074-P to X.T., DPI2015-71789-R to M.A., SAF2017-89782-R to N.M., SAF2015-72617-EXP to N.M., RYC-2014-16242 to N.M.), the Generalitat de Catalunya and CERCA program (2014-SGR-927 to X.T., 2017-FI-B1-00068 to E.L., 2014-SGR-1471 to M.A., 2017 SGR 1306 to N.M., 'ICREA Academia' award to M.A.), the European Research Council (CoG-616480 to X.T., CoG-681434 to M.A., CoG-617233 to B.L., StG-640525 to N.M.), European Commission (project H2020-FETPROACT-01-2016-731957 to M.A., A.d.C. and X.T.), LABAE16006 to N.M., Instituto de Salud Carlos III (CardioCell, TerCel to N.M.), the Deutsche Forschung Gemeinschaft (SFB 1027 to A.d.C.) and Obra Social 'La Caixa'. IBEC is the recipient of a Severo Ochoa Award of Excellence from the MINECO.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alt S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0520; Alvarez-Gonzalez B, 2015, BIOPHYS J, V108, P821, DOI 10.1016/j.bpj.2014.11.3478; Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bergert M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12814; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Chugh P, 2017, NAT CELL BIOL, V19, P689, DOI 10.1038/ncb3525; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Das S, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3615640; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; del Alamo JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069850; Edelstein Arthur D, 2014, J Biol Methods, V1; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hannezo E, 2014, P NATL ACAD SCI USA, V111, P27, DOI 10.1073/pnas.1312076111; Harris AR, 2012, P NATL ACAD SCI USA, V109, P16449, DOI 10.1073/pnas.1213301109; He B, 2014, NATURE, V508, P392, DOI 10.1038/nature13070; Hilbrant M, 2016, ELIFE, V5, DOI 10.7554/eLife.13834; Hildebrand S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10102-w; Jirasek M., 2002, INELASTIC ANAL STRUC; Krishna Vedula Sri Ram, 2014, Nature Materials, V13, P87, DOI 10.1038/NMAT3814; LEIGHTON J, 1969, SCIENCE, V163, P472, DOI 10.1126/science.163.3866.472; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Lubarda VA, 2012, SOFT MATTER, V8, P10288, DOI 10.1039/c2sm25740h; Maitre JL, 2013, CURR BIOL, V23, pR626, DOI 10.1016/j.cub.2013.06.019; Mertz AF, 2013, P NATL ACAD SCI USA, V110, P842, DOI 10.1073/pnas.1217279110; Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101; Nier V, 2015, P NATL ACAD SCI USA, V112, P9546, DOI 10.1073/pnas.1501278112; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Salbreux G, 2012, TRENDS CELL BIOL, V22, P536, DOI 10.1016/j.tcb.2012.07.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Style RW, 2014, SOFT MATTER, V10, P4047, DOI 10.1039/c4sm00264d; Style RW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3728; Suarez C, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.106; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; TANNER C, 1983, BIOPHYS J, V43, P183, DOI 10.1016/S0006-3495(83)84339-2; Turlier H, 2014, BIOPHYS J, V106, P114, DOI 10.1016/j.bpj.2013.11.014; Vedula SRK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7111; Vincent R, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.248103; Wayman C.M., 1998, SHAPE MEMORY MAT; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wyatt TPJ, 2015, P NATL ACAD SCI USA, V112, P5726, DOI 10.1073/pnas.1420585112; Yu YS, 2012, APPL MATH MECH-ENGL, V33, P1095, DOI 10.1007/s10483-012-1608-x; Yu YS, 2009, J COLLOID INTERF SCI, V339, P489, DOI 10.1016/j.jcis.2009.08.001	45	125	125	5	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					203	+		10.1038/s41586-018-0671-4	http://dx.doi.org/10.1038/s41586-018-0671-4			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30401836	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000449943600034
J	Kam, TI; Mao, XB; Park, H; Chou, SC; Karuppagounder, SS; Umanah, GE; Yun, SP; Brahmachari, S; Panicker, N; Chen, R; Andrabi, SA; Qi, C; Poirier, GG; Pletnikova, O; Troncoso, JC; Bekris, LM; Leverenz, JB; Pantelyat, A; Ko, HS; Rosenthal, LS; Dawson, TM; Dawson, VL				Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Chou, Shih-Ching; Karuppagounder, Senthilkumar S.; Umanah, George Essien; Yun, Seung Pil; Brahmachari, Saurav; Panicker, Nikhil; Chen, Rong; Andrabi, Shaida A.; Qi, Chen; Poirier, Guy G.; Pletnikova, Olga; Troncoso, Juan C.; Bekris, Lynn M.; Leverenz, James B.; Pantelyat, Alexander; Ko, Han Seok; Rosenthal, Liana S.; Dawson, Ted M.; Dawson, Valina L.			Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease	SCIENCE			English	Article							CELL-DEATH; MECHANISMS; AGGREGATION; STRAINS; PROTEIN	The pathologic accumulation and aggregation of alpha-synuclein (alpha-syn) underlies Parkinson's disease (PD). The molecular mechanisms by which pathologic alpha-syn causes neurodegeneration in PD are not known. Here, we found that pathologic alpha-syn activates poly(adenosine 5'-diphosphate-ribose) (PAR) polymerase-1 (PARP-1), and PAR generation accelerates the formation of pathologic alpha-syn, resulting in cell death via parthanatos. PARP inhibitors or genetic deletion of PARP-1 prevented pathologic alpha-syn toxicity. In a feed-forward loop, PAR converted pathologic alpha-syn to a more toxic strain. PAR levels were increased in the cerebrospinal fluid and brains of patients with PD, suggesting that PARP activation plays a role in PD pathogenesis. Thus, strategies aimed at inhibiting PARP-1 activation could hold promise as a disease-modifying therapy to prevent the loss of dopamine neurons in PD.	[Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Chou, Shih-Ching; Karuppagounder, Senthilkumar S.; Umanah, George Essien; Yun, Seung Pil; Brahmachari, Saurav; Panicker, Nikhil; Chen, Rong; Andrabi, Shaida A.; Qi, Chen; Ko, Han Seok; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21205 USA; [Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Chou, Shih-Ching; Karuppagounder, Senthilkumar S.; Umanah, George Essien; Yun, Seung Pil; Brahmachari, Saurav; Panicker, Nikhil; Chen, Rong; Andrabi, Shaida A.; Qi, Chen; Ko, Han Seok; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Karuppagounder, Senthilkumar S.; Umanah, George Essien; Yun, Seung Pil; Brahmachari, Saurav; Panicker, Nikhil; Chen, Rong; Andrabi, Shaida A.; Qi, Chen; Troncoso, Juan C.; Pantelyat, Alexander; Ko, Han Seok; Rosenthal, Liana S.; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kam, Tae-In; Mao, Xiaobo; Park, Hyejin; Karuppagounder, Senthilkumar S.; Yun, Seung Pil; Brahmachari, Saurav; Panicker, Nikhil; Chen, Rong; Ko, Han Seok; Dawson, Ted M.; Dawson, Valina L.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Chou, Shih-Ching; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Qi, Chen] Shanghai Jiao Tong Univ, Dept Neurol, Xin Hua Hosp, Sch Med, Shanghai 200092, Peoples R China; [Poirier, Guy G.] Univ Laval, Fac Med, Ctr Rech, CHU Quebec Pavillon,CHUL, Quebec City, PQ G1V 4G2, Canada; [Pletnikova, Olga; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol Neuropathol, Baltimore, MD 21205 USA; [Bekris, Lynn M.] Cleveland Clin, Lerner Res Inst, Genom Med, Cleveland, OH 44195 USA; [Leverenz, James B.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Neurol Inst, Cleveland, OH 44195 USA; [Leverenz, James B.] Cleveland Clin, Dept Neurol, Cleveland, OH 44195 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Andrabi, Shaida A.] Univ Alabama Birmingham, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Shanghai Jiao Tong University; Laval University; Johns Hopkins University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Dawson, TM; Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21205 USA.; Dawson, TM; Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.; Dawson, TM; Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Dawson, TM; Dawson, VL (corresponding author), Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Dawson, TM; Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Mao, Xiaobo/A-7362-2010; Karuppagounder, Senthilkumar/I-6752-2013; Dawson, Valina/Y-9757-2019; Panicker, Nikhil/A-2770-2019	Mao, Xiaobo/0000-0001-6587-556X; Karuppagounder, Senthilkumar/0000-0002-3281-9913; Panicker, Nikhil/0000-0003-1752-4284; Umanah, George Kwabena Essien/0000-0002-1506-6139; Poirier, Guy/0000-0002-4869-1424; Kam, Tae-In/0000-0002-7241-4902; Pantelyat, Alexander/0000-0002-6427-7485	NIH/NINDS [P50NS38377, R37NS067525, NS082205, U01NS082133, U01NS097049]; JPB Foundation; Jane and Lee Seidman Fund;  [U01 NS100610]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082205, P50NS038377, U01NS082133, U01NS097049, R37NS067525, R01NS107404, U01NS100610] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); JPB Foundation; Jane and Lee Seidman Fund; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH/NINDS (P50NS38377, R37NS067525, NS082205, U01NS082133, and U01NS097049) and the JPB Foundation and by U01 NS100610 and the Jane and Lee Seidman Fund to J.B.L. We acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with the Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs M-2016. T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases.	Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Baba M, 1998, AM J PATHOL, V152, P879; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brundin P, 2017, J NEUROSCI, V37, P9808, DOI 10.1523/JNEUROSCI.1788-16.2017; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Dawson TM, 2017, ANNU REV PHARMACOL, V57, P437, DOI 10.1146/annurev-pharmtox-010716-105001; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kam TI, 2016, ELIFE, V5, DOI 10.7554/eLife.18691; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Peng C, 2018, NEUROBIOL DIS, V109, P209, DOI 10.1016/j.nbd.2017.07.018; Sisay Mekonnen, 2017, Gynecol Oncol Res Pract, V4, P18, DOI 10.1186/s40661-017-0055-8; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang W, 2016, P NATL ACAD SCI USA, V113, P9587, DOI 10.1073/pnas.1610099113; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	30	211	218	8	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		557	+	eaat8407	10.1126/science.aat8407	http://dx.doi.org/10.1126/science.aat8407			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385548	Green Accepted			2022-12-28	WOS:000450460000037
J	Richman, B				Richman, Barak			Health Regulation for the Digital Age - Correcting the Mismatch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Richman, Barak] Duke Univ, Sch Law, Durham, NC 27706 USA	Duke University	Richman, B (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.							[Anonymous], 2018, TRANSF FDAS APPR DIG; Farr C., 2017, CNBC; Hsu T, 2018, NY TIMES; Wingfield N, 2018, NY TIMES	4	7	8	3	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1694	1695		10.1056/NEJMp1806848	http://dx.doi.org/10.1056/NEJMp1806848			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380380				2022-12-28	WOS:000448891600003
J	Henstridge, M; Pfeiffer, C; Wang, D; Boltasseva, A; Shalaev, VM; Grbic, A; Merlin, R				Henstridge, M.; Pfeiffer, C.; Wang, D.; Boltasseva, A.; Shalaev, V. M.; Grbic, A.; Merlin, R.			Synchrotron radiation from an accelerating light pulse	SCIENCE			English	Article							GENERATION	Synchrotron radiation-namely, electromagnetic radiation produced by charges moving in a curved path-is regularly generated at large-scale facilities where giga-electron volt electrons move along kilometer-long circular paths. We use a metasurface to bend light and demonstrate synchrotron radiation produced by a subpicosecond pulse, which moves along a circular arc of radius 100 micrometers inside a nonlinear crystal. The emitted radiation, in the terahertz frequency range, results from the nonlinear polarization induced by the pulse. The generation of synchrotron radiation from a pulse revolving about a circular trajectory holds promise for the development of on-chip terahertz sources.	[Henstridge, M.; Pfeiffer, C.; Wang, D.; Boltasseva, A.; Shalaev, V. M.; Grbic, A.; Merlin, R.] Univ Michigan, Ctr Photon & Multiscale Nanomat, Ann Arbor, MI 48109 USA; [Henstridge, M.; Merlin, R.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Pfeiffer, C.; Grbic, A.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Wang, D.; Boltasseva, A.; Shalaev, V. M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Wang, D.; Boltasseva, A.; Shalaev, V. M.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Merlin, R (corresponding author), Univ Michigan, Ctr Photon & Multiscale Nanomat, Ann Arbor, MI 48109 USA.; Merlin, R (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	merlin@umich.edu	Wang, Di/S-2463-2016; Boltasseva, Alexandra/C-1674-2019; Shalaev, Vladimir M./B-9331-2019	Wang, Di/0000-0002-3536-7027; Boltasseva, Alexandra/0000-0001-8905-2605; Shalaev, Vladimir M./0000-0001-8976-1102; Henstridge, Meredith/0000-0002-7561-0802; Pfeiffer, Carl/0000-0003-1868-7800	MRSEC Program of the National Science Foundation [DMR-1120923]; Air Force Office of Scientific Research under MURI grant [FA9550-14-1-0389]	MRSEC Program of the National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Air Force Office of Scientific Research under MURI grant	This work was supported by the MRSEC Program of the National Science Foundation under grant DMR-1120923 and the Air Force Office of Scientific Research under MURI grant FA9550-14-1-0389. The LiTaO<INF>3</INF> substrates were prepared at the Lurie Nanofabrication Facility, University of Michigan, and the metasurface was fabricated at the Birck Nanotechnology Center, Purdue University.	Afanasiev G. N., 2005, VAVILOV CHERENKOV SY; Ardavan A, 2004, J APPL PHYS, V96, P4614, DOI 10.1063/1.1787591; Ardavan H, 2003, J OPT SOC AM A, V20, P2137, DOI 10.1364/JOSAA.20.002137; Barker AS, 1970, PHYS REV B-SOLID ST, V2, P4233, DOI 10.1103/PhysRevB.2.4233; Blewett JP, 1998, J SYNCHROTRON RADIAT, V5, P135, DOI 10.1107/S0909049597043306; BLEWETT JP, 1946, PHYS REV, V69, P87, DOI 10.1103/PhysRev.69.87; BOLOTOVSKII BM, 1990, USP FIZ NAUK+, V160, P141, DOI 10.3367/UFNr.0160.199006d.0141; Courvoisier F, 2012, OPT LETT, V37, P1736, DOI 10.1364/OL.37.001736; Devlin RC, 2016, P NATL ACAD SCI USA, V113, P10473, DOI 10.1073/pnas.1611740113; Dolev I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.113903; ELDER FR, 1947, PHYS REV, V71, P829, DOI 10.1103/PhysRev.71.829.5; Ginzburg V. L., 1996, Physics-Uspekhi, V39, P973, DOI 10.1070/PU1996v039n10ABEH000171; GINZBURG VL, 1959, SOV PHYS JETP-USSR, V9, P1300; GINZBURG VL, 1965, ANNU REV ASTRON ASTR, V3, P297, DOI 10.1146/annurev.aa.03.090165.001501; Grbic A, 2008, SCIENCE, V320, P511, DOI 10.1126/science.1154753; Greenfield E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213902; Henstridge M, 2018, OPTICA, V5, P678, DOI 10.1364/OPTICA.5.000678; Hu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08705-4; Iwanenko D, 1944, PHYS REV, V65, P343, DOI 10.1103/PhysRev.65.343; JACKSON JD, 1999, CLASSICAL ELECTRODYN, pCH14; Kaminer I, 2015, NAT PHYS, V11, P261, DOI 10.1038/NPHYS3196; Kaminer I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.163901; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Polynkin P, 2009, SCIENCE, V324, P229, DOI 10.1126/science.1169544; Siviloglou GA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213901; Siviloglou GA, 2007, OPT LETT, V32, P979, DOI 10.1364/OL.32.000979; Stevens TE, 2001, SCIENCE, V291, P627, DOI 10.1126/science.291.5504.627; Wahlstrand JK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.054301; WULLE T, 1993, PHYS REV LETT, V70, P1401, DOI 10.1103/PhysRevLett.70.1401; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhang P, 2012, OPT LETT, V37, P2820, DOI 10.1364/OL.37.002820; Zrelov V. P., 1970, CHERENKOV RAD HIGH E, P31	34	21	23	6	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					439	+		10.1126/science.aat5915	http://dx.doi.org/10.1126/science.aat5915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361369				2022-12-28	WOS:000450441900045
J	Rae, JWB; Burke, A; Robinson, LF; Adkins, JF; Chen, T; Cole, C; Greenop, R; Li, T; Littley, EFM; Nita, DC; Stewart, JA; Taylor, BJ				Rae, J. W. B.; Burke, A.; Robinson, L. F.; Adkins, J. F.; Chen, T.; Cole, C.; Greenop, R.; Li, T.; Littley, E. F. M.; Nita, D. C.; Stewart, J. A.; Taylor, B. J.			CO2 storage and release in the deep Southern Ocean on millennial to centennial timescales	NATURE			English	Article							LAST ICE-AGE; ANTARCTIC SEA-ICE; CORAL DESMOPHYLLUM-DIANTHUS; ATMOSPHERIC CO2; BORON ISOTOPE; SCLERACTINIAN CORALS; MASS-SPECTROMETRY; SATURATION STATE; GLACIAL CYCLES; CLIMATE-CHANGE	The cause of changes in atmospheric carbon dioxide (CO2) during the recent ice ages is yet to be fully explained. Most mechanisms for glacial-interglacial CO2 change have centred on carbon exchange with the deep ocean, owing to its large size and relatively rapid exchange with the atmosphere(1). The Southern Ocean is thought to have a key role in this exchange, as much of the deep ocean is ventilated to the atmosphere in this region(2). However, it is difficult to reconstruct changes in deep Southern Ocean carbon storage, so few direct tests of this hypothesis have been carried out. Here we present deep-sea coral boron isotope data that track the pH-and thus the CO2 chemistry-of the deep Southern Ocean over the past forty thousand years. At sites closest to the Antarctic continental margin, and most influenced by the deep southern waters that form the ocean's lower overturning cell, we find a close relationship between ocean pH and atmospheric CO2: during intervals of low CO2, ocean pH is low, reflecting enhanced ocean carbon storage; and during intervals of rising CO2, ocean pH rises, reflecting loss of carbon from the ocean to the atmosphere. Correspondingly, at shallower sites we find rapid (millennial-to centennial-scale) decreases in pH during abrupt increases in CO2, reflecting the rapid transfer of carbon from the deep ocean to the upper ocean and atmosphere. Our findings confirm the importance of the deep Southern Ocean in ice-age CO2 change, and show that deep-ocean CO2 release can occur as a dynamic feedback to rapid climate change on centennial timescales.	[Rae, J. W. B.; Burke, A.; Cole, C.; Greenop, R.; Littley, E. F. M.; Nita, D. C.; Stewart, J. A.; Taylor, B. J.] Univ St Andrews, Sch Earth & Environm Sci, St Andrews, Fife, Scotland; [Robinson, L. F.; Chen, T.; Li, T.; Stewart, J. A.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Adkins, J. F.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Chen, T.; Li, T.] Nanjing Univ, Sch Earth Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Nita, D. C.] Babes Bolyai Univ, Fac Environm Sci & Engn, Cluj Napoca, Romania	University of St Andrews; University of Bristol; California Institute of Technology; Nanjing University; Babes Bolyai University from Cluj	Rae, JWB (corresponding author), Univ St Andrews, Sch Earth & Environm Sci, St Andrews, Fife, Scotland.	jwbr@st-andrews.ac.uk	Nita, Dan C./N-8510-2018; Nita, Dan/R-3303-2019; Adkins, Jess/GYI-8778-2022; Rae, James/R-3812-2017	Nita, Dan C./0000-0002-9492-0734; Nita, Dan/0000-0002-9492-0734; Rae, James/0000-0003-3904-2526; Cole, Catherine/0000-0003-2397-0520; Littley, Eloise/0000-0003-1442-7585; Burke, Andrea/0000-0002-3754-1498; Li, Tao/0000-0002-9975-152X; Stewart, Joseph/0000-0003-3092-5058	NERC Standard Grant [NE/N003861/1, NE/M004619/1]; NOAA Climate and Global Change VSP Fellowship; NERC Strategic Environmental Science Capital Grant; Marie Curie Career Integration Grant [CIG14-631752]; ERC; NSF [OCE-1503129]; NERC; NERC [NE/N003861/1, NE/M004619/1] Funding Source: UKRI	NERC Standard Grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NOAA Climate and Global Change VSP Fellowship; NERC Strategic Environmental Science Capital Grant; Marie Curie Career Integration Grant; ERC(European Research Council (ERC)European Commission); NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC Standard Grant NE/N003861/1 to J.W.B.R. and L.F.R., an NOAA Climate and Global Change VSP Fellowship to J.W.B.R, NERC Standard Grant NE/M004619/1 to A.B. and J.W.B.R., a NERC Strategic Environmental Science Capital Grant to A.B. and J.W.B.R., Marie Curie Career Integration Grant CIG14-631752 to A.B., an ERC consolidator grant to L.F.R., NSF grant OCE-1503129 to J.F.A., and NERC studentships to B.T. and E.L.	Abernathey R, 2015, GEOPHYS RES LETT, V42, P10357, DOI 10.1002/2015GL066238; Abram NJ, 2013, QUATERNARY SCI REV, V79, P168, DOI 10.1016/j.quascirev.2013.01.011; Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Al-Ammar AS, 2000, SPECTROCHIM ACTA B, V55, P629, DOI 10.1016/S0584-8547(00)00197-X; Allison N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6741; Anagnostou E, 2012, EARTH PLANET SC LETT, V349, P251, DOI 10.1016/j.epsl.2012.07.006; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bereiter B, 2018, NATURE, V553, P39, DOI 10.1038/nature25152; Bereiter B, 2015, GEOPHYS RES LETT, V42, P542, DOI 10.1002/2014GL061957; BOYLE EA, 1981, EARTH PLANET SC LETT, V53, P11, DOI 10.1016/0012-821X(81)90022-4; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Burke A, 2015, PALEOCEANOGRAPHY, V30, P1021, DOI 10.1002/2015PA002778; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Burke A, 2010, DEEP-SEA RES PT I, V57, P1510, DOI 10.1016/j.dsr.2010.07.010; Charles CD, 2010, QUATERNARY SCI REV, V29, P399, DOI 10.1016/j.quascirev.2009.09.021; Chen TY, 2015, SCIENCE, V349, P1537, DOI 10.1126/science.aac6159; Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Foster GL, 2013, CHEM GEOL, V358, P1, DOI 10.1016/j.chemgeo.2013.08.027; Gagnon AC, 2007, EARTH PLANET SC LETT, V261, P280, DOI 10.1016/j.epsl.2007.07.013; Gagnon AC, 2013, GEOCHIM COSMOCHIM AC, V105, P240, DOI 10.1016/j.gca.2012.11.038; Galbraith ED, 2017, NAT GEOSCI, V10, P295, DOI [10.1038/NGEO2914, 10.1038/ngeo2914]; Galbraith E, 2019, CLIM DYNAM, V52, P653, DOI 10.1007/s00382-018-4157-8; Jaccard SL, 2016, NATURE, V530, P207, DOI 10.1038/nature16514; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Key R. M., 2015, 162 ORNLCDIAC, DOI [10.3334/CDIAC/OTG.NDP093_GLODAPv2, DOI 10.3334/CDIAC/OTG.NDP093_GLODAPV2, DOI 10.3334/CDIAC/0TG.NDP093_GL0DAPV2]; KISS E, 1988, ANAL CHIM ACTA, V211, P243, DOI 10.1016/S0003-2670(00)83684-3; Kohler P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6520; Lemarchand D, 2002, CHEM GEOL, V182, P323, DOI 10.1016/S0009-2541(01)00329-1; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Margolin AR, 2014, DEEP-SEA RES PT II, V99, P237, DOI 10.1016/j.dsr2.2013.06.008; Markle BR, 2017, NAT GEOSCI, V10, P36, DOI [10.1038/NGEO2848, 10.1038/ngeo2848]; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; McCulloch M. T., 2018, BORON ISOTOPES, P145; McCulloch M, 2012, GEOCHIM COSMOCHIM AC, V87, P21, DOI 10.1016/j.gca.2012.03.027; Misra S, 2014, GEOCHIM COSMOCHIM AC, V140, P531, DOI 10.1016/j.gca.2014.05.047; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Rae JWB, 2018, ADV ISOTOP GEOCHEM, P107, DOI 10.1007/978-3-319-64666-4_5; Rae JWB, 2014, PALEOCEANOGRAPHY, V29, P645, DOI 10.1002/2013PA002570; Rae JWB, 2011, EARTH PLANET SC LETT, V302, P403, DOI 10.1016/j.epsl.2010.12.034; Rickaby REM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001762; Roberts J, 2016, P NATL ACAD SCI USA, V113, P514, DOI 10.1073/pnas.1511252113; Robinson LF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001138; Rollion-Bard C, 2011, CR GEOSCI, V343, P397, DOI 10.1016/j.crte.2011.05.003; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; Spooner PT, 2016, QUAT GEOCHRONOL, V31, P28, DOI 10.1016/j.quageo.2015.10.004; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stewart JA, 2016, CHEM GEOL, V447, P148, DOI 10.1016/j.chemgeo.2016.10.029; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Trotter J, 2011, EARTH PLANET SC LETT, V303, P163, DOI 10.1016/j.epsl.2011.01.030; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Wang XT, 2017, P NATL ACAD SCI USA, V114, P3352, DOI 10.1073/pnas.1615718114; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Yu JM, 2014, QUATERNARY SCI REV, V90, P80, DOI 10.1016/j.quascirev.2014.02.018; Yu JM, 2013, QUATERNARY SCI REV, V76, P39, DOI 10.1016/j.quascirev.2013.06.020	62	88	90	14	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					569	+		10.1038/s41586-018-0614-0	http://dx.doi.org/10.1038/s41586-018-0614-0			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30356182	Green Submitted, Green Accepted			2022-12-28	WOS:000448277800054
J	Torjesen, I				Torjesen, Ingrid			Bullying and harassment cost NHS over 2bn pound a year, study suggests	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kline R, 2019, PUBLIC MONEY MANAGE, V39, P166, DOI 10.1080/09540962.2018.1535044	1	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4463	10.1136/bmj.k4463	http://dx.doi.org/10.1136/bmj.k4463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355582				2022-12-28	WOS:000448895300013
J	Curry, SJ				Curry, Susan J.		US Prevent Serv Task Force	Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults US Preventive Services Task Force Final Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED-CONTROLLED-TRIAL; PRIMARY-CARE; DOMESTIC VIOLENCE; MENTAL-HEALTH; UNITED-STATES; RISK-FACTORS; INTERVENTION; PREVALENCE; WOMEN; MISTREATMENT	IMPORTANCE Intimate partner violence (IPV) and abuse of older or vulnerable adults are common in the United States but often remain undetected. In addition to the immediate effects of IPV, such as injury and death, there are other health consequences, many with long-term effects, including development of mental health conditions such as depression, posttraumatic stress disorder, anxiety disorders, substance abuse, and suicidal behavior; sexually transmitted infections; unintended pregnancy; and chronic pain and other disabilities. Long-term negative health effects from elder abuse include death, higher risk of nursing home placement, and adverse psychological consequences. OBJECTIVE To update the US Preventive Services Task Force (USPSTF) 2013 recommendation on screening for IPV, elder abuse, and abuse of vulnerable adults. EVIDENCE REVIEW The USPSTF commissioned a review of the evidence on screening for IPV in adolescents, women, and men; for elder abuse; and for abuse of vulnerable adults. FINDINGS The USPSTF concludes with moderate certainty that screening for IPV in women of reproductive age and providing or referring women who screen positive to ongoing support services has a moderate net benefit. There is adequate evidence that available screening instruments can identify IPV in women. The evidence does not support the effectiveness of brief interventions or the provision of information about referral options in the absence of ongoing supportive intervention components. The evidence demonstrating benefit of ongoing support services is predominantly found in studies of pregnant or postpartum women. The benefits and harms of screening for elder abuse and abuse of vulnerable adults are uncertain, and the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends that clinicians screen for IPV in women of reproductive age and provide or refer women who screen positive to ongoing support services. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for abuse and neglect in all older or vulnerable adults. (I statement)	[Curry, Susan J.] Univ Iowa, 111 Jessup Hall, Iowa City, IA 52242 USA	University of Iowa	Curry, SJ (corresponding author), Univ Iowa, 111 Jessup Hall, Iowa City, IA 52242 USA.	chair@uspstf.net	Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997; Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Acierno R, 2017, J ELDER ABUSE NEGL, V29, P254, DOI 10.1080/08946566.2017.1365031; Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Administration for Community Living (ACL), PROT RIGHTS PREV AB; Alvarez C, 2017, TRAUMA VIOLENCE ABUS, V18, P479, DOI 10.1177/1524838016637080; [Anonymous], 2013, Obstet Gynecol, V122, P187, DOI 10.1097/AOG.0b013e31829d2351; [Anonymous], 2012, Obstet Gynecol, V119, P412, DOI 10.1097/AOG.0b013e318249ff74; [Anonymous], 2011, CLIN PREV SERV WOM C; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; Breiding M. J., 2014, INTIMATE PARTNER VIO; Burnes D, 2015, J AM GERIATR SOC, V63, P1906, DOI 10.1111/jgs.13601; Burnett J, 2016, J ELDER ABUSE NEGL, V28, P59, DOI 10.1080/08946566.2016.1142920; Canadian Task Force for Preventive Health Care, 2013, DOM AB; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Casteel C, 2008, INJURY PREV, V14, P87, DOI 10.1136/ip.2007.016451; CDC, INTIMATE PARTNER VIO; Centers for Disease Control and Prevention (CDC), INT PARTN VIOL CONSQ; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Community Preventive Services Task Force, PRIM PREV RED INT PA; Desmarais SL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-132; Dicola D, 2016, AM FAM PHYSICIAN, V94, P646; Dong XQ, 2013, GERONTOLOGY, V59, P132, DOI 10.1159/000341652; Durborow N, 2010, COMPENDIUM STATE STA; El-Mohandes AAE, 2008, OBSTET GYNECOL, V112, P611, DOI 10.1097/AOG.0b013e3181834b10; Feltner C., 2018, AHRQ PUBLICATION; Feltner C, 2018, JAMA-J AM MED ASSOC, V320, P1688, DOI 10.1001/jama.2018.13212; Fulmer T, 2012, GERODONTOLOGY, V29, P96, DOI 10.1111/j.1741-2358.2010.00405.x; Futures Without Violence, PREV ASS RESP DOM VI; Hall J.E., 2016, ELDER ABUSE SURVEILL; Health Resources and Services Administration, 2017, HRSA STRAT ADDR INT; Health Resources & Services Administration (HRSA), 2017, WOM PREV SERV GUID; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Houry D, 2002, ANN EMERG MED, V39, P56, DOI 10.1067/mem.2002.117759; Institute of Medicine and National Research Council, 2014, ELD AB ITS PREV WORK; Kennedy RD, 2005, FAM MED, V37, P481; Kiely M, 2011, OBSTET GYNECOL, V117, P1232; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Lachs MS, 2015, NEW ENGL J MED, V373, P1947, DOI 10.1056/NEJMra1404688; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; Miller E, 2016, CONTRACEPTION, V94, P58, DOI 10.1016/j.contraception.2016.02.009; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; Mills TJ, 2006, J EMERG MED, V31, P447, DOI 10.1016/j.jemermed.2005.12.029; Moyer VA, 2013, ANN INTERN MED, V159, P289, DOI 10.7326/0003-4819-159-4-201308200-00667; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; National Domestic Violence Hotline, RES VICT SURV; Pavey AR, 2014, J PEDIATR-US, V165, P1034, DOI 10.1016/j.jpeds.2014.06.060; Rhodes KV, 2015, JAMA-J AM MED ASSOC, V314, P466, DOI 10.1001/jama.2015.8369; Schulman EA, 2012, NEUROLOGY, V78, P433, DOI 10.1212/WNL.0b013e318245d21c; Shah PS, 2010, J WOMENS HEALTH, V19, P2017, DOI 10.1089/jwh.2010.2051; Sharps PW, 2016, J WOMENS HEALTH, V25, P1129, DOI 10.1089/jwh.2015.5547; Siu AL, 2016, ANN INTERN MED, V164, P360, DOI 10.7326/M15-2957; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Smith S.G., 2018, NATL INTIMATE PARTNE; Smith SG, 2017, NATL INTIMATE PARTNE; Teaster PB, 2007, 2004 SURVEY STATE AD; Thackeray JD, 2010, PEDIATRICS, V125, P1094, DOI 10.1542/peds.2010-0451; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; U. S. Preventive Services Task Force, 2008, SCREEN ILL DRUG US U; US Department of Veterans Affairs (VA), INT PARTN VIOL IPV A; World Health Organisation, 2013, RESPONDING INTIMATE; Zlotnick C, 2011, ARCH WOMEN MENT HLTH, V14, P55, DOI 10.1007/s00737-010-0195-x	62	138	139	3	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1678	1687		10.1001/jama.2018.14741	http://dx.doi.org/10.1001/jama.2018.14741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX8UQ	30357305	Bronze			2022-12-28	WOS:000448069100017
J	Phelps, DL; Watterberg, KL; Nolen, TL; Cole, CA; Cotten, CM; Oh, W; Poindexter, BB; Zaterka-Baxter, KM; Das, A; Lacy, CB; Scorsone, AM; Walsh, MC; Bell, EF; Kennedy, KA; Schibler, K; Sokol, GM; Laughon, MM; Lakshminrusiinha, S; Truog, WE; Garg, M; Carlo, WA; Laptook, AR; Van Meurs, KP; Carlton, DP; Graf, A; DeMauro, SB; Brion, LP; Shankaran, S; Orge, FH; Olson, RJ; Mintz-Hittner, H; Yang, MB; Haider, KM; Wallace, DK; Chung, M; Hug, D; Tsui, I; Cogen, MS; Donahue, JP; Gaynon, M; Hutchinson, AK; Bremer, DL; Quinn, G; He, YG; Lucas, WR; Winter, TW; Kicklighter, SD; Kumar, K; Chess, PR; Colaizy, TT; Hibbs, AM; Ambalavanan, N; Harmon, HM; McGowan, EC; Higgins, RD				Phelps, Dale L.; Watterberg, Kristi L.; Nolen, Tracy L.; Cole, Carol A.; Cotten, C. Michael; Oh, William; Poindexter, Brenda B.; Zaterka-Baxter, Kristin M.; Das, Abhik; Lacy, Conra Backstrom; Scorsone, Ann Marie; Walsh, Michele C.; Bell, Edward F.; Kennedy, Kathleen A.; Schibler, Kurt; Sokol, Gregory M.; Laughon, Matthew M.; Lakshminrusiinha, Satyanarayana; Truog, William E.; Garg, Meena; Carlo, Waldemar A.; Laptook, Abbot R.; Van Meurs, Krisa P.; Carlton, David P.; Graf, Amanda; DeMauro, Sara B.; Brion, Luc P.; Shankaran, Seetha; Orge, Faruk H.; Olson, Richard J.; Mintz-Hittner, Helen; Yang, Michael B.; Haider, Kathryn M.; Wallace, David K.; Chung, Mina; Hug, Denise; Tsui, Irena; Cogen, Martin S.; Donahue, John P.; Gaynon, Michael; Hutchinson, Amy K.; Bremer, Don L.; Quinn, Graham; He, Yu-Guang; Lucas Jr, William R.; Winter, Timothy W.; Kicklighter, Stephen D.; Kumar, Kartik; Chess, Patricia R.; Colaizy, Tarah T.; Hibbs, Anna Marie; Ambalavanan, Namasivayam; Harmon, Heidi M.; McGowan, Elisabeth C.; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst C; Neonatal Res Network	Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants < 28 Weeks' Gestational Age A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INOSITOL SUPPLEMENTATION; PHARMACOKINETICS; SAFETY; RISK	IMPORTANCE Previous studies of myo-inositol in preterm infants with respiratory distress found reduced severity of retinopathy of prematurity (ROP) and less frequent ROP, death, and intraventricular hemorrhage. However, no large trials have tested its efficacy or safety. OBJECTIVE To test the adverse events and efficacy of myo-inositol to reduce type 1 ROP among infants younger than 28 weeks' gestational age. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial included 638 infants younger than 28 weeks' gestational age enrolled from 18 neonatal intensive care centers throughout the United States from April 17, 2014, to September 4, 2015; final date of follow-up was February 12, 2016. The planned enrollment of 1760 participants would permit detection of an absolute reduction in death or type 1 ROP of 7% with 90% power. The trial was terminated early due to a statistically significantly higher mortality rate in the myo-inositol group. INTERVENTIONS A 40-mg/kg dose of myo-inositol was given every 12 hours (initially intravenously, then enterally when feeding; n = 317) or placebo (n = 321) for up to 10 weeks. MAIN OUTCOMES AND MEASURES Type 1 ROP or death before determination of ROP outcome was designated as unfavorable. The designated favorable outcome was survival without type 1 ROP. RESULTS Among 638 infants (mean, 26 weeks' gestational age; 50% male), 632 (99%) received the trial drug or placebo and 589 (92%) had a study outcome. Death or type 1 ROP occurred more often in the myo-inositol group vs the placebo group (29% vs 21%, respectively; adjusted risk difference, 7% [95% CI, 0%-13%]; adjusted relative risk, 1.41 [95% CI, 1.08-1.83], P = .01). All-cause death before 55 weeks' postmenstrual age occurred in 18% of the myo-inositol group and in 11% of the placebo group (adjusted risk difference, 6% [95% CI, 0%-11%]; adjusted relative risk, 1.66 [95% CI, 1.14-2.43], P = .007). The most common serious adverse events up to 7 days of receiving the ending dose were necrotizing enterocolitis (6% for myo-inositol vs 4% for placebo), poor perfusion or hypotension (7% vs 4%, respectively), intraventricular hemorrhage (10% vs 9%), systemic infection (16% vs 11%), and respiratory distress (15% vs 13%). CONCLUSIONS AND RELEVANCE Among premature infants younger than 28 weeks' gestational age, treatment with myo-inositol for up to 10 weeks did not reduce the risk of type 1 ROP or death vs placebo. These findings do not support the use of myo-inositol among premature infants; however, the early termination of the trial limits definitive conclusions.	[Phelps, Dale L.; Cole, Carol A.; Scorsone, Ann Marie; Chess, Patricia R.] Univ Rochester, Sch Med & Dent, New York, NY USA; [Watterberg, Kristi L.; Lacy, Conra Backstrom] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Nolen, Tracy L.; Zaterka-Baxter, Kristin M.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Cotten, C. Michael; Wallace, David K.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Oh, William; Laptook, Abbot R.; McGowan, Elisabeth C.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Poindexter, Brenda B.; Schibler, Kurt] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Poindexter, Brenda B.; Schibler, Kurt; Yang, Michael B.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Poindexter, Brenda B.; Sokol, Gregory M.; Harmon, Heidi M.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Walsh, Michele C.; Hibbs, Anna Marie] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Bell, Edward F.; Colaizy, Tarah T.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Kennedy, Kathleen A.; Kumar, Kartik] Univ Texas Hlth Sci Ctr Houston, Div Neonatal Perinatal Med, Houston, TX 77030 USA; [Laughon, Matthew M.] Univ N Carolina, Dept Pediat, Div Neonatal Perinatal Med, Chapel Hill, NC USA; [Lakshminrusiinha, Satyanarayana] SUNY Buffalo, Dept Pediat, Buffalo, NY USA; [Truog, William E.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Truog, William E.; Hug, Denise] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Garg, Meena] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Carlo, Waldemar A.; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Van Meurs, Krisa P.] Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Carlton, David P.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Carlton, David P.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Graf, Amanda] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [DeMauro, Sara B.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [DeMauro, Sara B.] Univ Penn, Philadelphia, PA 19104 USA; [Brion, Luc P.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Shankaran, Seetha] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Orge, Faruk H.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Ophthalmol, Cleveland, OH 44106 USA; [Olson, Richard J.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Mintz-Hittner, Helen] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Yang, Michael B.] Cincinnati Childrens Hosp Med Ctr, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Haider, Kathryn M.] Indiana Univ, Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Chung, Mina] Univ Rochester, Sch Med & Dent, Dept Ophthalmol, Rochester, NY USA; [Hug, Denise] Childrens Mercy Hosp, Dept Ophthalmol, Kansas City, MO 64108 USA; [Tsui, Irena] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; [Cogen, Martin S.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Donahue, John P.] Brown Univ, Women & Infants Hosp, Alpert Med Sch, Providence, RI USA; [Gaynon, Michael] Stanford Univ, Sch Med, Dept Ophthalmol, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Gaynon, Michael] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Hutchinson, Amy K.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Hutchinson, Amy K.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Bremer, Don L.] Nationwide Childrens Hosp, Dept Ophthalmol, Columbus, OH USA; [Quinn, Graham] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Quinn, Graham] Univ Penn, Philadelphia, PA USA; [He, Yu-Guang] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX USA; [Lucas Jr, William R.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA; [Winter, Timothy W.] Univ New Mexico, Dept Surg, Div Ophthalmol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Kicklighter, Stephen D.] WakeMed Hlth & Hosp, Dept Pediat, Div Neonatol, Raleigh, NC USA; [Higgins, Rosemary D.] NIH, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 10, Bethesda, MD 20892 USA	University of Rochester; University of New Mexico; University of New Mexico's Health Sciences Center; Research Triangle Institute; Duke University; Brown University; Women & Infants Hospital Rhode Island; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University-Purdue University Indianapolis; Research Triangle Institute; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Iowa; University of Texas System; University of Texas Health Science Center Houston; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; Stanford University; Lucile Packard Children's Hospital (LPCH); Emory University; Children's Healthcare of Atlanta (CHOA); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Iowa; University of Texas System; University of Texas Health Science Center Houston; Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; University of Rochester; Children's Mercy Hospital; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; Brown University; Women & Infants Hospital Rhode Island; Stanford University; Lucile Packard Children's Hospital (LPCH); Emory University; Children's Healthcare of Atlanta (CHOA); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Phelps, DL (corresponding author), Div Neonatol, 601 Elmwood Ave,Box 651, Rochester, NY 14642 USA.	dale_Phelps@urmc.rochester.edu	DeMauro, Sara/ABD-6568-2021; Das, Abhik/AAF-1883-2020; Ambalavanan, Namasivayam/AAI-4088-2020; Ambalavanan, Namasivayam/AAL-3832-2020; Truog, William/R-5576-2019	DeMauro, Sara/0000-0003-1647-4000; Das, Abhik/0000-0003-2722-0479; Ambalavanan, Namasivayam/0000-0003-0731-9092; Nolen, Tracy/0000-0003-2512-343X; Harmon, Heidi/0000-0003-2413-1278; Bell, Edward/0000-0002-5568-0889; Lakshminrusimha, Satyan/0000-0001-6098-2155; Olson, Richard/0000-0003-1897-7437	National Institutes of Health [U10 HD36790, UG1 HD27904, UG1 HD21364, UG1 HD68284, UG1 HD27853, UG1 HD40492, UG1 HD27851, UG1 HD27856, UG1 HD87229, UG1 HD68278, UG1 HD27880, UG1 HD34216, UG1 HD68270, UG1 HD53109, UG1 HD53089, UG1 HD68244, UG1 HD68263, UG1 HD40689, UG1 HD21385]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Eye Institute; National Center for Advancing Translational Sciences [UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR442, UL1 TR454, UL1 TR1117]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD021364, UG1HD040689, UG1HD034216, UG1HD027851, U10HD036790, UG1HD068278, UG1HD027880, UG1HD068263, UG1HD087229, UG1HD027856, UG1HD027904, UG1HD027853, UG1HD068284, UG1HD040492, UG1HD068270, UG1HD053089, UG1HD053109, UG1HD068244, UG1HD021385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by grants U10 HD36790, UG1 HD27904, UG1 HD21364, UG1 HD68284, UG1 HD27853, UG1 HD40492, UG1 HD27851, UG1 HD27856, UG1 HD87229, UG1 HD68278, UG1 HD27880, UG1 HD34216, UG1 HD68270, UG1 HD53109, UG1 HD53089, UG1 HD68244, UG1 HD68263, UG1 HD40689, and UG1 HD21385 from the National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Eye Institute and by grants UL1 TR41, UL1 TR42, UL1 TR77, UL1 TR93, UL1 TR442, UL1 TR454, and UL1 TR1117 from the National Center for Advancing Translational Sciences. Abbott Nutrition Division (Abbott Laboratories) provided the myo-inositol.	Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996; Friedman CA, 2000, J PEDIAT OPHTH STRAB, V37, P79; GARNER A, 1984, PEDIATRICS, V74, P127; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guadagnino Emanuel, 2012, PDA J Pharm Sci Technol, V66, P116, DOI 10.5731/pdajpst.2012.00853; HALLMAN M, 1990, LUNG, V168, P877, DOI 10.1007/BF02718223; HALLMAN M, 1986, ARCH DIS CHILD, V61, P1076, DOI 10.1136/adc.61.11.1076; HALLMAN M, 1987, J PEDIATR-US, V110, P604, DOI 10.1016/S0022-3476(87)80561-9; HALLMAN M, 1992, NEW ENGL J MED, V326, P1233, DOI 10.1056/NEJM199205073261901; Hallman M., 2015, NEOREVIEWS, V16, pe84, DOI [DOI 10.1542/neo.16-2-e84, 10.1542/neo.16-2-e84, DOI 10.1542/NEO.16-2-E84]; Howlett A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000366.pub2; Hylander M A, 2001, J Perinatol, V21, P356, DOI 10.1038/sj.jp.7210548; Kennedy KA, 2014, J PERINATOL, V34, P311, DOI 10.1038/jp.2014.12; Manske C, 2016, APPL ENVIRON MICROB, V82, P5000, DOI 10.1128/AEM.01018-16; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Ogden T., 1994, BASIC SCI RENTINAL D, V1, P10; PALMER EA, 1991, OPHTHALMOLOGY, V98, P1628; Phelps DL, 2016, PEDIATR RES, V80, P209, DOI 10.1038/pr.2016.97; Phelps DL, 2013, PEDIATR RES, V74, P721, DOI 10.1038/pr.2013.162; Reynolds JD, 2002, ARCH OPHTHALMOL-CHIC, V120, P1470, DOI 10.1001/archopht.120.11.1470; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Zhao JX, 2014, AAPS PHARMSCITECH, V15, P1398, DOI 10.1208/s12249-014-0167-y; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	27	19	19	2	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1649	1658		10.1001/jama.2018.14996	http://dx.doi.org/10.1001/jama.2018.14996			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357297	Green Published, Bronze			2022-12-28	WOS:000448069100014
J	Tanne, JH				Tanne, Janice Hopkins			Serious illness often means financial disaster for Americans, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Blumenthal D., 2018, DEALING SERIOUS ILLN; Schneider EC, HLTH CARE AM EXPERIE	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4464	10.1136/bmj.k4464	http://dx.doi.org/10.1136/bmj.k4464			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PE	30352844				2022-12-28	WOS:000448893800005
J	Harrigan, P; Madhani, HD; El-Samad, H				Harrigan, Patrick; Madhani, Hiten D.; El-Samad, Hana			Real-Time Genetic Compensation Defines the Dynamic Demands of Feedback Control	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; NEGATIVE FEEDBACK; CELL FATE; SIGNALING PATHWAY; MATING PHEROMONE; YEAST; EXPRESSION; PROTEIN; OSCILLATIONS; ALPHA	Biological signaling networks use feedback control to dynamically adjust their operation in real time. Traditional static genetic methods such as gene knockouts or rescue experiments can often identify the existence of feedback interactions but are unable to determine what feedback dynamics are required. Here, we implement a new strategy, closed-loop optogenetic compensation (CLOC), to address this problem. Using a custom-built hardware and software infrastructure, CLOC monitors, in real time, the output of a pathway deleted for a feedback regulator. A minimal model uses these measurements to calculate and deliver-on the fly-an optogenetically enabled transcriptional input designed to compensate for the effects of the feedback deletion. Application of CLOC to the yeast pheromone response pathway revealed surprisingly distinct dynamic requirements for three well-studied feedback regulators. CLOC, a marriage of control theory and traditional genetics, presents a broadly applicable methodology for defining the dynamic function of biological feedback regulators.	[Harrigan, Patrick; Madhani, Hiten D.; El-Samad, Hana] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Madhani, Hiten D.; El-Samad, Hana] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD; El-Samad, H (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Madhani, HD; El-Samad, H (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com; hana.el-samad@ucsf.edu			DARPA [HR0011-16-2-0045]; Paul Allen Frontiers Group; NIH [R01GM71801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801, T32GM067547] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Paul Allen Frontiers Group; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ignacio Zuleta for advice regarding the design and construction of the automated closed-loop control device and software and Eric Chow and the Center for Advanced Technology at UCSF for help with its fabrication. This work was funded in part by DARPA (HR0011-16-2-0045), the Paul Allen Frontiers Group (to H.E.-S.), and the NIH (R01GM71801 to H.D.M). Both H.E.-S. and H.D.M. are Chan-Zuckerberg Investigators.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Borrelli F., 2017, P 40 IEEE C DECISION; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Del Vecchio D, 2017, CELL SYST, V4, P109, DOI 10.1016/j.cels.2016.12.001; DIETZEL C, 1987, MOL CELL BIOL, V7, P4169, DOI 10.1128/MCB.7.12.4169; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Fiore G, 2016, ACS SYNTH BIOL, V5, P154, DOI 10.1021/acssynbio.5b00135; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lugagne JB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01498-0; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; McCullagh E, 2010, NAT CELL BIOL, V12, P954, DOI 10.1038/ncb2097; Metodiev MV, 2002, SCIENCE, V296, P1483, DOI 10.1126/science.1070540; Milias-Argeitis A, 2011, NAT BIOTECHNOL, V29, P1114, DOI 10.1038/nbt.2018; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; NAKAYAMA N, 1988, MOL CELL BIOL, V8, P3777, DOI 10.1128/MCB.8.9.3777; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rothermel BA, 1997, J BIOL CHEM, V272, P19801, DOI 10.1074/jbc.272.32.19801; Rullan M, 2017, BIORXIV, DOI [10.1101/142893, DOI 10.1101/142893]; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Uhlendorf J, 2012, P NATL ACAD SCI USA, V109, P14271, DOI 10.1073/pnas.1206810109; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Yumerefendi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128443	41	39	40	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					877	+	e10	10.1016/j.cell.2018.09.044	http://dx.doi.org/10.1016/j.cell.2018.09.044			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340045	Bronze, Green Accepted			2022-12-28	WOS:000447780800026
J	Zoller, B; Little, SC; Gregor, T				Zoller, Benjamin; Little, Shawn C.; Gregor, Thomas			Diverse Spatial Expression Patterns Emerge from Unified Kinetics of Transcriptional Bursting	CELL			English	Article							LIVING DROSOPHILA EMBRYOS; GENE-EXPRESSION; CONTROL ELEMENTS; MAMMALIAN GENES; NOISE; REVEALS; SEGMENTATION; INFORMATION; ENHANCERS; DYNAMICS	How transcriptional bursting relates to gene regulation is a central question that has persisted for more than a decade. Here, we measure nascent transcriptional activity in early Drosophila embryos and characterize the variability in absolute activity levels across expression boundaries. We demonstrate that boundary formation follows a common transcription principle: a single control parameter determines the distribution of transcriptional activity, regardless of gene identity, boundary position, or enhancer-promoter architecture. We infer the underlying bursting kinetics and identify the key regulatory parameter as the fraction of time a gene is in a transcriptionally active state. Unexpectedly, both the rate of polymerase initiation and the switching rates are tightly constrained across all expression levels, predicting synchronous patterning outcomes at all positions in the embryo. These results point to a shared simplicity underlying the apparently complex transcriptional processes of early embryonic patterning and indicate a path to general rules in transcriptional regulation.	[Zoller, Benjamin; Gregor, Thomas] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Zoller, Benjamin; Gregor, Thomas] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Little, Shawn C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Little, Shawn C.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Little, Shawn C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gregor, Thomas] Inst Pasteur, Dept Dev & Stem Cell Biol, F-75015 Paris, France	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; University of Pennsylvania; Pennsylvania Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.; Gregor, T (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X	Swiss National Science Foundation early Postdoc Mobility fellowship; National Institutes of Health [U01 EB021239, U01 DA047730, R01 GM097275]; National Science Foundation [PHY-1734030]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA047730] Funding Source: NIH RePORTER	Swiss National Science Foundation early Postdoc Mobility fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. Bartman, W. Bialek, P. Francois, M. Levo, J. Mozziconacci, F. Naef, A. Raj, T. Sokolowski, G. Tkacik, and E. Wieschaus for insightful discussion and valuable comments on the manuscript. B.Z. was partially supported by the Swiss National Science Foundation early Postdoc Mobility fellowship. This study was funded by grants from the National Institutes of Health (U01 EB021239, U01 DA047730, and R01 GM097275) and the National Science Foundation (PHY-1734030).	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bartman CR, 2016, MOL CELL, V62, P237, DOI 10.1016/j.molcel.2016.03.007; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; Blythe SA, 2016, ELIFE, V5, DOI 10.7554/eLife.20148; Blythe SA, 2015, CELL, V160, P1169, DOI 10.1016/j.cell.2015.01.050; Bothma JP, 2014, P NATL ACAD SCI USA, V111, P10598, DOI 10.1073/pnas.1410022111; Briscoe J, 2015, DEVELOPMENT, V142, P3996, DOI 10.1242/dev.129452; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Brown CR, 2014, P NATL ACAD SCI USA, V111, P17893, DOI 10.1073/pnas.1417527111; Carey LB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001528; Chen HT, 2018, NAT GENET, V50, P1296, DOI 10.1038/s41588-018-0175-z; Choubey S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004345; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Dey SS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145704; Dubuis JO, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.72; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Estrada J, 2016, CELL, V166, P234, DOI 10.1016/j.cell.2016.06.012; Fukaya T, 2017, CURR BIOL, V27, P1387, DOI 10.1016/j.cub.2017.03.069; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gregor T, 2014, TRENDS GENET, V30, P364, DOI 10.1016/j.tig.2014.06.002; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; Izeddin I, 2014, ELIFE, V3, DOI 10.7554/eLife.02230; JACOB Y, 1991, P NATL ACAD SCI USA, V88, P5912, DOI 10.1073/pnas.88.13.5912; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Kaizu K, 2014, BIOPHYS J, V106, P976, DOI 10.1016/j.bpj.2013.12.030; Keren L, 2015, GENOME RES, V25, P1893, DOI 10.1101/gr.191635.115; KORNBERG TB, 1993, CURR OPIN GENET DEV, V3, P585, DOI 10.1016/0959-437X(93)90094-6; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Larson DR, 2013, ELIFE, V2, DOI 10.7554/eLife.00750; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Li CX, 2018, CELL SYST, V6, P409, DOI 10.1016/j.cels.2018.01.012; Lionnet T, 2012, EMBO REP, V13, P313, DOI 10.1038/embor.2012.31; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Lucas T, 2013, CURR BIOL, V23, P2135, DOI 10.1016/j.cub.2013.08.053; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Molina N, 2013, P NATL ACAD SCI USA, V110, P20563, DOI 10.1073/pnas.1312310110; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Nicolas D, 2018, P NATL ACAD SCI USA, V115, P7153, DOI 10.1073/pnas.1722330115; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; PANKRATZ MJ, 1992, SCIENCE, V255, P986, DOI 10.1126/science.1546296; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rieckh G, 2014, BIOPHYS J, V106, P1194, DOI 10.1016/j.bpj.2014.01.014; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; Scholes C, 2017, CELL SYST, V4, P97, DOI 10.1016/j.cels.2016.11.012; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Senecal A, 2014, CELL REP, V8, P75, DOI 10.1016/j.celrep.2014.05.053; Sidje RB, 1998, ACM T MATH SOFTWARE, V24, P130, DOI 10.1145/285861.285868; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; Tkacik G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002774; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Xu H, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.128101; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zoller B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156257; Zopf CJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003161	78	53	54	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					835	+	e25	10.1016/j.cell.2018.09.056	http://dx.doi.org/10.1016/j.cell.2018.09.056			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340044	Green Accepted, Bronze			2022-12-28	WOS:000447780800023
J	Roque, JB; Kuroda, Y; Gottemann, LT; Sarpong, R				Roque, Jose B.; Kuroda, Yusuke; Gottemann, Lucas T.; Sarpong, Richmond			Deconstructive diversification of cyclic amines	NATURE			English	Article							RING-CONTRACTION; OXIDATION; FUNCTIONALIZATION; PEPTIDES; ACIDS	Deconstructive functionalization involves carbon-carbon (C-C) bond cleavage followed by bond construction on one or more of the constituent carbons. For example, ozonolysis(1) and olefin metathesis(2,3) have allowed each carbon in C=C double bonds to be viewed as a functional group. Despite the substantial advances in deconstructive functionalization involving the scission of C=C double bonds, there are very few methods that achieve C(sp(3))-C(sp(3)) single-bond cleavage and functionalization, especially in relatively unstrained cyclic systems. Here we report a deconstructive strategy to transform saturated nitrogen heterocycles such as piperidines and pyrrolidines, which are important moieties in bioactive molecules, into halogen-containing acyclic amine derivatives through sequential C(sp(3))-N and C(sp(3))-C(sp(3)) single-bond cleavage followed by C(sp(3))-halogen bond formation. The resulting acyclic haloamines are versatile intermediates that can be transformed into various structural motifs through substitution reactions. In this way we achieve the skeletal remodelling of cyclic amines, an example of scaffold hopping. We demonstrate this deconstructive strategy by the late-stage diversification of proline-containing peptides.	[Roque, Jose B.; Kuroda, Yusuke; Gottemann, Lucas T.; Sarpong, Richmond] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sarpong, R (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rsarpong@berkeley.edu		Sarpong, Richmond/0000-0002-0028-6323; Kuroda, Yusuke/0000-0003-0952-7098; Roque, Jose/0000-0002-5449-1584	National Institutes of Health (NIH) [NIGMS RO1 086374]; NIH [NIGMS RO1 086374]; Japan Society for the Promotion of Science (JSPS); LMU PROSA; DAAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086374] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); LMU PROSA; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH; NIGMS RO1 086374). J.B.R. thanks the NIH for a graduate diversity supplement fellowship (NIGMS RO1 086374). Y.K. thanks the Japan Society for the Promotion of Science (JSPS) for an Overseas Research Fellowship. L.T.G. thanks LMU PROSA and DAAD for financial support. We thank J. Derrick for assistance with electrochemical measurements.	Aldmairi AH, 2017, TETRAHEDRON LETT, V58, P3690, DOI 10.1016/j.tetlet.2017.07.058; ANDERSON JM, 1970, J AM CHEM SOC, V92, P1651, DOI 10.1021/ja00709a039; BAILEY PS, 1958, CHEM REV, V58, P925, DOI 10.1021/cr50023a005; Bandarage UK, 2010, TETRAHEDRON LETT, V51, P6415, DOI 10.1016/j.tetlet.2010.09.142; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chen WJ, 2018, NAT CHEM, V10, P165, DOI [10.1038/NCHEM.2871, 10.1038/nchem.2871]; Dai C, 2012, J ORG CHEM, V77, P4425, DOI 10.1021/jo300162c; Edwards J. O, 1971, J ORG CHEM, V36, P4089, DOI [10.1021/jo00825a018, DOI 10.1021/JO00825A018]; Galloway WRJD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1081; HAN GH, 1994, TETRAHEDRON LETT, V35, P5813, DOI 10.1016/S0040-4039(00)78191-3; Henninot A, 2018, J MED CHEM, V61, P1382, DOI 10.1021/acs.jmedchem.7b00318; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hu Y, 2017, J MED CHEM, V60, P1238, DOI 10.1021/acs.jmedchem.6b01437; Ito R, 2005, J AM CHEM SOC, V127, P834, DOI 10.1021/ja045603f; Kaname M, 2008, TETRAHEDRON LETT, V49, P2786, DOI 10.1016/j.tetlet.2008.02.127; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lin SX, 2017, SCIENCE, V355, P597, DOI 10.1126/science.aal3316; Osberger TJ, 2016, NATURE, V537, P214, DOI 10.1038/nature18941; PO HN, 1976, COORDIN CHEM REV, V20, P171, DOI 10.1016/S0010-8545(00)80324-0; Reddy DN, 2011, J ORG CHEM, V76, P680, DOI 10.1021/jo101955q; Roque JB, 2018, SCIENCE, V361, P171, DOI 10.1126/science.aat6365; Sengupta S, 2017, TETRAHEDRON LETT, V58, P1357, DOI 10.1016/j.tetlet.2017.02.069; SHAWCROSS AP, 1990, J HETEROCYCLIC CHEM, V27, P367, DOI 10.1002/jhet.5570270249; SHECHTER Y, 1975, BIOCHEMISTRY-US, V14, P4497, DOI 10.1021/bi00691a025; Sun HM, 2012, DRUG DISCOV TODAY, V17, P310, DOI 10.1016/j.drudis.2011.10.024; Tan XQ, 2017, ORG LETT, V19, P1634, DOI 10.1021/acs.orglett.7b00439; Vougioukalakis GC, 2010, CHEM REV, V110, P1746, DOI 10.1021/cr9002424; Wang F, 2018, ORG LETT, V20, P864, DOI 10.1021/acs.orglett.7b04029; Wang ZT, 2012, J AM CHEM SOC, V134, P4258, DOI 10.1021/ja210361z; Yu C, 2017, J ORG CHEM, V82, P6615, DOI 10.1021/acs.joc.7b00681	30	95	96	11	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2018	564	7735					244	248		10.1038/s41586-018-0700-3	http://dx.doi.org/10.1038/s41586-018-0700-3			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HE0QP	30382193	Green Submitted, Green Accepted			2022-12-28	WOS:000452972600048
J	Shi, Z; Graber, ZT; Baumgart, T; Stone, HA; Cohen, AE				Shi, Zheng; Graber, Zachary T.; Baumgart, Tobias; Stone, Howard A.; Cohen, Adam E.			Cell Membranes Resist Flow	CELL			English	Article							INDUCED CALCIUM TRANSIENTS; FLUID-MOSAIC MODEL; ENDOTHELIAL-CELLS; CHANNEL PIEZO1; SHEAR-STRESS; TENSION; DIFFUSION; SHAPE; EXOCYTOSIS; PROTEINS	The fluid-mosaic model posits a liquid-like plasma membrane, which can flow in response to tension gradients. It is widely assumed that membrane flow transmits local changes in membrane tension across the cell in milliseconds, mediating long-range signaling. Here, we show that propagation of membrane tension occurs quickly in cell-attached blebs but is largely suppressed in intact cells. The failure of tension to propagate in cells is explained by a fluid dynamical model that incorporates the flow resistance from cytoskeleton-bound transmembrane proteins. Perturbations to tension propagate diffusively, with a diffusion coefficient D-sigma similar to 0.024 mu m(2)/s in HeLa cells. In primary endothelial cells, local increases in membrane tension lead only to local activation of mechanosensitive ion channels and to local vesicle fusion. Thus, membrane tension is not a mediator of long-range intracellular signaling, but local variations in tension mediate distinct processes in sub-cellular domains.	[Shi, Zheng; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Graber, Zachary T.; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Shi, Zheng; Cohen, Adam E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; University of Pennsylvania; Princeton University; Howard Hughes Medical Institute	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Cohen, AE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	cohen@chemistry.harvard.edu		Shi, Zheng/0000-0002-5214-1871	Gordon and Betty Moore Foundation; Howard Hughes Medical Institute; NIH [R01 GM 09755, U54CA193417]; NSF [CBET-1509347, DMS 1614907]; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shahinoor Begum and Melinda Lee for help with neuron culture. We thank Katherine Williams, He Tian, Peng Zou, Yoav Adam, Linlin Fan, Sami Farhi, and Veena Venkatachalam for help with molecular cloning and plasmid preparation. We thank Sean Buchanan from Lee Rubin's lab and Harry McNamara for providing primary mouse brain endothelial cells and giving advice on the culturing protocols. We thank Xiaowei Zhuang's lab for providing NIH 3T3 fibroblasts. We thank Guido Guidotti, Boris Martinac, Charles Cox, Allen Liu, and Comert Kural for helpful comments. This work was supported by the Gordon and Betty Moore Foundation and the Howard Hughes Medical Institute. Z.T.G. and T.B. were supported by NIH grant R01 GM 09755 and NIH grant U54CA193417. H.A.S. was supported by NSF grants CBET-1509347 and DMS 1614907.	Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; BUSSELL SJ, 1995, BIOPHYS J, V68, P1836, DOI 10.1016/S0006-3495(95)80360-7; Bussonnier M, 2014, BIOPHYS J, V107, P854, DOI 10.1016/j.bpj.2014.07.008; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; DONAHUE BS, 1987, CELL CALCIUM, V8, P437, DOI 10.1016/0143-4160(87)90027-3; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Fogelson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084524; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Gauthier NC, 2009, MOL BIOL CELL, V20, P3261, DOI 10.1091/mbc.E09-01-0071; GEIGER RV, 1992, AM J PHYSIOL, V262, pC1411, DOI 10.1152/ajpcell.1992.262.6.C1411; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; He LJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208470; Heinrich M, 2010, P NATL ACAD SCI USA, V107, P7208, DOI 10.1073/pnas.0913997107; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; HOCHMUTH RM, 1973, BIOPHYS J, V13, P747, DOI 10.1016/S0006-3495(73)86021-7; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; HOWELLS ID, 1974, J FLUID MECH, V64, P449, DOI 10.1017/S0022112074002503; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; KOLLER A, 1991, AM J PHYSIOL, V260, pH862, DOI 10.1152/ajpheart.1991.260.3.H862; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Kozlov MM, 2007, BIOPHYS J, V93, P3811, DOI 10.1529/biophysj.107.110411; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lewis A. H, 2015, MECH SENSITIVITY PIE, V4; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lieber AD, 2015, BIOPHYS J, V108, P1599, DOI 10.1016/j.bpj.2015.02.007; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7; Maritzen T, 2018, NEUROSCI RES, V127, P45, DOI 10.1016/j.neures.2017.09.013; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Mueller J, 2017, CELL, V171, P188, DOI 10.1016/j.cell.2017.07.051; Mumtaz S, 2011, CELL CALCIUM, V49, P66, DOI 10.1016/j.ceca.2010.11.010; NEEDHAM D, 1992, BIOPHYS J, V61, P1664, DOI 10.1016/S0006-3495(92)81970-7; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Ofera N, 2011, P NATL ACAD SCI USA, V108, P20394, DOI 10.1073/pnas.1105333108; pat X, 2017, MECHANOCHEMICAL FEED, DOI 10.1101/201509; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pontes B, 2017, SEMIN CELL DEV BIOL, V71, P30, DOI 10.1016/j.semcdb.2017.08.030; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Romer W., 2007, NATURE, V450, P670; Rosholm KR, 2017, NAT CHEM BIOL, V13, P724, DOI 10.1038/nchembio.2372; Sadegh S, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011031; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saha S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0145; Saotome K, 2018, NATURE, V554, P481, DOI 10.1038/nature25453; SCHWARZ G, 1992, J PHYSIOL-LONDON, V458, P527, DOI 10.1113/jphysiol.1992.sp019432; Schweitzer Y, 2014, BIOPHYS J, V106, P84, DOI 10.1016/j.bpj.2013.11.009; Sens P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/27/273103; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shen HY, 2012, CELL, V150, P1300, DOI 10.1016/j.cell.2012.08.017; Shi Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6974; Shillcock JC, 2005, NAT MATER, V4, P225, DOI 10.1038/nmat1333; Shin W, 2018, CELL, V173, P934, DOI 10.1016/j.cell.2018.02.062; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Wen PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12604; Winkler B, 2016, PHYSICA D, V318, P26, DOI 10.1016/j.physd.2015.09.011; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110; ZAKHAROVA OM, 1995, BBA-BIOMEMBRANES, V1236, P177, DOI 10.1016/0005-2736(95)00047-7; Zeng B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02094-y	85	137	138	1	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2018	175	7					1769	+		10.1016/j.cell.2018.09.054	http://dx.doi.org/10.1016/j.cell.2018.09.054			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HE3GZ	30392960	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000453242200009
J	Boeri, L; Sharma, V; Karnes, RJ				Boeri, Luca; Sharma, Vidit; Karnes, R. Jeffrey			Radiotherapy for newly diagnosed oligometastatic prostate cancer	LANCET			English	Editorial Material							THERAPY; GUIDELINES; SURVIVAL		[Boeri, Luca; Sharma, Vidit; Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN 55905 USA; [Boeri, Luca] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dept Urol, Milan, Italy	Mayo Clinic; IRCCS Ca Granda Ospedale Maggiore Policlinico	Karnes, RJ (corresponding author), Mayo Clin, Dept Urol, Rochester, MN 55905 USA.	karnes.r@mayo.edu	Boeri, Luca/AAC-4848-2022					Bayne CE, 2016, EUR UROL, V69, P775, DOI 10.1016/j.eururo.2015.04.036; Boeve LMS, 2019, EUR UROL, V75, P410, DOI 10.1016/j.eururo.2018.09.008; Carroll PH, 2018, J NATL COMPR CANC NE, V16, P620, DOI 10.6004/jnccn.2018.0036; Cornford P, 2017, EUR UROL, V71, P630, DOI 10.1016/j.eururo.2016.08.002; Culp SH, 2014, EUR UROL, V65, P1058, DOI 10.1016/j.eururo.2013.11.012; Leyh-Bannurah SR, 2017, EUR UROL, V72, P118, DOI 10.1016/j.eururo.2017.03.020; Loppenberg B, 2017, EUR UROL, V72, P14, DOI 10.1016/j.eururo.2016.04.031; Parker CC, 2018, LANCET, V392, P2353, DOI 10.1016/S0140-6736(18)32486-3; Pompe RS, 2018, PROSTATE, V78, P1; Rusthoven CG, 2016, J CLIN ONCOL, V34, P2835, DOI 10.1200/JCO.2016.67.4788; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747	11	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2018	392	10162					2327	2328		10.1016/S0140-6736(18)32598-4	http://dx.doi.org/10.1016/S0140-6736(18)32598-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HC4PH	30355465	Green Published, hybrid			2022-12-28	WOS:000451785200004
J	van der Heijde, D; Baraliakos, X; Gensler, LS; Maksymowych, WP; Tseluyko, V; Nadashkevich, O; Abi-Saab, W; Tasset, C; Meuleners, L; Besuyen, R; Hendrikx, T; Mozaffarian, N; Liu, K; Greer, JM; Deodhar, A; Landewe, R				van der Heijde, Desiree; Baraliakos, Xenofon; Gensler, Lianne S.; Maksymowych, Walter P.; Tseluyko, Vira; Nadashkevich, Oleg; Abi-Saab, Walid; Tasset, Chantal; Meuleners, Luc; Besuyen, Robin; Hendrikx, Thijs; Mozaffarian, Neelufar; Liu, Ke; Greer, Joy M.; Deodhar, Atul; Landewe, Robert			Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial	LANCET			English	Article							RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; JAK INHIBITORS; DISEASE; SPONDYLOARTHRITIS; GLPG0634/GS-6034; METHOTREXATE	Background At present, biological disease-modifying anti-rheumatic drugs (DMARDs) are the only treatment recommended for patients with ankylosing spondylitis who have not responded to first-line treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). The TORTUGA trial investigated the efficacy and safety of filgotinib, an oral selective Janus kinase 1 (JAK1) inhibitor, for the treatment of patients with active ankylosing spondylitis. Methods In this completed, randomised, double-blind, placebo-controlled, phase 2 trial, we enrolled adult patients from 30 sites in seven countries (Belgium, Bulgaria, Czech Republic, Estonia, Poland, Spain, and Ukraine). Eligible patients had active ankylosing spondylitis and an inadequate response or intolerance to two or more NSAIDs. Patients were randomly assigned (1: 1) with an interactive web-based response system to receive filgotinib 200 mg or placebo orally once daily for 12 weeks. Randomisation was stratified by current use of conventional synthetic DMARDs and previous receipt of anti-tumour necrosis factor therapy. The patients, study team, and study sponsor were masked to treatment assignment. The primary endpoint was the change from baseline in ankylosing spondylitis disease activity score (ASDAS) at week 12, which was assessed in the full analysis set (ie, all randomised patients who received at least one dose of study drug). Safety was assessed according to actual treatment received. This trial is registered with ClinicalTrials.gov, number NCT03117270. Findings Between March 7, 2017, and July 2, 2018, 263 patients were screened and 116 randomly assigned to filgotinib (n=58) or placebo (n=58). 55 (95%) patients in the filgotinib group and 52 (90%) in the placebo group completed the study; three (5%) patients in the filgotinib group and six (10%) in the placebo group discontinued treatment. The mean ASDAS change from baseline to week 12 was -1.47 (SD 1.04) in the filgotinib group and -0.57 (0.82) in the placebo group, with a least squares mean difference between groups of -0.85 (95% CI -1.17 to -0.53; p<0.0001). Treatment-emergent adverse events were reported in 18 patients in each group, the most common being nasopharyngitis (in two patients in the filgotinib group and in four patients in the placebo group). Treatment-emergent adverse events led to permanent treatment discontinuation in two patients (a case of grade 3 pneumonia in the filgotinib group and of high creatine kinase in the placebo group). No deaths were reported during the study. Interpretation Filgotinib is efficacious and safe for the treatment of patients with active ankylosing spondylitis who have not responded to first-line pharmacological therapy with NSAIDs. Further investigation of filgotinib for ankylosing spondylitis is warranted. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands; [Baraliakos, Xenofon] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany; [Gensler, Lianne S.] Univ Calif San Francisco, Div Rheumatol, San Francisco, CA USA; [Maksymowych, Walter P.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tseluyko, Vira] Kharkiv Med Acad Postgrad Educ, Dept Rheumatol, Kharkov, Ukraine; [Nadashkevich, Oleg] Lviv Natl Med Univ, Lvov, Ukraine; [Abi-Saab, Walid; Tasset, Chantal; Meuleners, Luc] Galapagos NV, Mechelen, Belgium; [Besuyen, Robin; Hendrikx, Thijs] Galapagos BV, Leiden, Netherlands; [Mozaffarian, Neelufar; Liu, Ke; Greer, Joy M.] Gilead Sci, Foster City, CA USA; [Deodhar, Atul] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Landewe, Robert] Univ Amsterdam, Med Ctr, Dept Rheumatol & Clin Immunol, Amsterdam, Netherlands; [Landewe, Robert] Zuyderland Hosp, Dept Rheumatol, Heerlen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rheumazentrum Ruhrgebiet; Ruhr University Bochum; University of California System; University of California San Francisco; University of Alberta; Kharkiv Medical Academy of Postgraduate Education; Danylo Halytsky Lviv National Medical University; Galapagos NV; Galapagos NV; Gilead Sciences; Oregon Health & Science University; University of Amsterdam	van der Heijde, D (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.	mail@dvanderheijde.nl	van der Heijde, Désirée/I-6774-2019; Baraliakos, Xenofon/AAF-7346-2019; LANDEWE, ROBERT B.M./ABD-7388-2021	van der Heijde, Désirée/0000-0002-5781-158X; Baraliakos, Xenofon/0000-0002-9475-9362; LANDEWE, ROBERT B.M./0000-0002-0577-6620; Maksymowych, Walter/0000-0002-1291-1755	Galapagos; Gilead Sciences	Galapagos(Galapagos NV); Gilead Sciences(Gilead Sciences)	Galapagos and Gilead Sciences.	Baeten D, 2018, ANN RHEUM DIS, V77, P1295, DOI 10.1136/annrheumdis-2018-213328; Baker KF, 2018, ANN RHEUM DIS, V77, P175, DOI 10.1136/annrheumdis-2017-211555; Bengtsson K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1315-z; Braun J, 2015, ANN RHEUM DIS; Eriksson JK, 2017, ANN RHEUM DIS, V76, P364, DOI 10.1136/annrheumdis-2016-209315; Genovese M, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1541-z; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Jethwa H, 2016, CLIN EXP IMMUNOL, V183, P30, DOI 10.1111/cei.12670; Kavanaugh A, 2017, ANN RHEUM DIS, V76, P1009, DOI 10.1136/annrheumdis-2016-210105; Landewe R, 2014, ANN RHEUM DIS, V73, P39, DOI 10.1136/annrheumdis-2013-204231; Landewe R, 2009, ANN RHEUM DIS, V68, P863, DOI 10.1136/ard.2008.091793; Martindale J, 2015, BEST PRACT RES CL RH, V29, P512, DOI 10.1016/j.berh.2015.04.002; Maxwell LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005468.pub2; Mease P, 2018, LANCET, V392, P2367, DOI 10.1016/S0140-6736(18)32483-8; Namour F, 2015, CLIN PHARMACOKINET, V54, P859, DOI 10.1007/s40262-015-0240-z; Schwartz DM, 2017, NAT REV DRUG DISCOV, V16, P843, DOI 10.1038/nrd.2017.201; Scott IC, 2018, DRUG SAFETY, V41, P645, DOI 10.1007/s40264-018-0651-5; Sieper J, 2017, LANCET, V390, P73, DOI 10.1016/S0140-6736(16)31591-4; Sieper J, 2015, ANN RHEUM DIS, V74, P1051, DOI 10.1136/annrheumdis-2013-204963; Stolwijk C, 2016, ARTHRIT CARE RES, V68, P1320, DOI 10.1002/acr.22831; Stolwijk C, 2015, ANN RHEUM DIS, V74, P65, DOI 10.1136/annrheumdis-2013-203582; Tanaka Y, 2015, J BIOCHEM, V158, P173, DOI 10.1093/jb/mvv069; Tsui FWL, 2014, APPL CLIN GENET, V7, P105, DOI 10.2147/TACG.S37325; van der Heijde D, 2018, ANN RHEUM DIS, V77, P70, DOI 10.1136/annrheumdis-2018-eular.7889; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; van der Heijde D, 2017, ANN RHEUM DIS, V76, P1340, DOI 10.1136/annrheumdis-2016-210322; van der Heijde D, 2017, ANN RHEUM DIS, V76, P978, DOI 10.1136/annrheumdis-2016-210770; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Veale DJ, 2019, RHEUMATOLOGY, V58, P197, DOI 10.1093/rheumatology/key070; Verden A, 2018, DRUG SAFETY, V41, P357, DOI 10.1007/s40264-017-0622-2; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Wanders AJB, 2004, ARTHRIT RHEUM-ARTHR, V51, P1, DOI 10.1002/art.20075; Westhovens R, 2017, ANN RHEUM DIS, V76, P998, DOI 10.1136/annrheumdis-2016-210104	33	140	142	8	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2018	392	10162					2378	2387		10.1016/S0140-6736(18)32463-2	http://dx.doi.org/10.1016/S0140-6736(18)32463-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4PH	30360970	Green Published			2022-12-28	WOS:000451785200026
J	Reuter, U; Goadsby, PJ; Lanteri-Minet, M; Wen, SH; Hours-Zesiger, P; Ferrari, MD; Klatt, J				Reuter, Uwe; Goadsby, Peter J.; Lanteri-Minet, Michel; Wen, Shihua; Hours-Zesiger, Peggy; Ferrari, Michel D.; Klatt, Jan			Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study	LANCET			English	Article							PROPHYLACTIC MEDICATIONS; MANAGEMENT; PATTERNS; TRIAL	Background A substantial proportion of patients with migraine does not respond to, or cannot tolerate, oral preventive treatments. Erenumab is a novel CGRP-receptor antibody with preventive efficacy in migraine. We assessed its efficacy and tolerability in patients with episodic migraine in whom previous treatment with two-to-four migraine preventives had been unsuccessful. Methods LIBERTY was a 12-week, double-blind, placebo-controlled randomised study at 59 sites in 16 countries. Eligible patients were aged 18-65 years and had a history of episodic migraine with or without aura for at least 12 months, had migraine for an average of 4-14 days per month during the 3 months before screening, and had been treated unsuccessfully (in terms of either efficacy or tolerability, or both) with between two and four preventive treatments. Eligible participants were randomly assigned (1:1) to receive either erenumab 140 mg (via two 70 mg injections) or placebo every 4 weeks subcutaneously for 12 weeks. Randomisation was by interactive response technology and was stratified by monthly frequency of migraine headache (4-7 vs 8-14 migraine days per month) during the baseline phase. Cenduit generated the randomisation list and assigned participants to groups. Participants, investigators, people doing various assessments, and the study sponsor were masked to treatment assignment. The primary endpoint was the proportion of patients achieving a 50% or greater reduction in the mean number of monthly migraine days during weeks 9-12. Efficacy was measured in the full analysis set, which included all randomly assigned patients who started their assigned treatment and completed at least one post-baseline monthly migraine day measurement. Safety and tolerability were assessed by recording adverse events and by physical examination, assessment of vital signs, clinical laboratory assessments, and electrocardiography. Safety was assessed in all randomly assigned patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT03096834. The trial is closed to new participants, but the open-label extension phase is ongoing. Findings Between March 20, 2017, and Oct 27, 2017, 246 participants were randomly assigned, 121 to the erenumab group and 125 to the placebo group. 95 of 246 (39%) participants had previously unsuccessfully tried two preventive drugs, 93 (38%) had tried three, and 56 (23%) had tried four. At week 12, 36 (30%) patients in the erenumab had a 50% or greater reduction from baseline in the mean number of monthly migraine days, compared with 17 (14%) in the placebo group (odds ratio 2.7 [95% CI 1.4-5.2]; p=0.002). The tolerability and safety profiles of erenumab and placebo were similar. The most frequent treatment-emergent adverse event was injection site pain, which occurred in seven (6%) participants in both groups. Interpretation Compared with placebo, erenumab was efficacious in patients with episodic migraine who previously did not respond to or tolerate between two and four previous migraine preventive treatments. Erenumab might be an option for patients with difficult-to-treat migraine who have high unmet needs and few treatment options. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[Reuter, Uwe] Charite Univ Med Berlin, Dept Neurol, Charitepl 1, D-10117 Berlin, Germany; [Goadsby, Peter J.] Kings Coll London, NIHR Wellcome Trust, Kings Clin Res Facil, London, England; [Lanteri-Minet, Michel] Univ Cote Azur, CHU Nice, Pain Dept, Nice, France; [Lanteri-Minet, Michel] Univ Cote Azur, CHU Nice, FHU InvoPain, Nice, France; [Lanteri-Minet, Michel] Auvergne Univ, INSERM, U1107, Migraine & Trigeminal Pain, Clermont Ferrand, France; [Wen, Shihua] Novartis, E Hanover, NJ USA; [Hours-Zesiger, Peggy; Klatt, Jan] Novartis Pharmaceut, Basel, Switzerland; [Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Novartis; Novartis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Reuter, U (corresponding author), Charite Univ Med Berlin, Dept Neurol, Charitepl 1, D-10117 Berlin, Germany.	uwe.reuter@charite.de	Ferrari, Michel D./ABE-3758-2021; Goadsby, Peter J/Z-1970-2019	Ferrari, Michel D./0000-0001-9691-9449; Goadsby, Peter J/0000-0003-3260-5904; Reuter, Uwe/0000-0002-8527-0725; LANTERI-MINET, Michel/0000-0001-6717-9234	Novartis Pharma	Novartis Pharma	Novartis Pharma.	Ashina M, 2018, CEPHALALGIA, V38, P1611, DOI 10.1177/0333102418788347; Berger A, 2012, PAIN PRACT, V12, P541, DOI 10.1111/j.1533-2500.2012.00530.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2006, NEUROLOGIST, V12, P204, DOI 10.1097/01.nrl.0000219666.65101.a9; Blumenfeld AM, 2013, HEADACHE, V53, P644, DOI 10.1111/head.12055; Diener HC, 2008, CEPHALALGIA, V28, P1003, DOI 10.1111/j.1468-2982.2008.01660.x; Dodick DW, 2018, CEPHALALGIA, V38, P1026, DOI 10.1177/0333102418759786; Edvinsson L, 2018, NAT REV NEUROL, V14, P338, DOI 10.1038/s41582-018-0003-1; Goadsby PJ, 2017, NEW ENGL J MED, V377, P2123, DOI 10.1056/NEJMoa1705848; Goadsby PJ, 2017, CEPHALALGIA, V37, P13; Goadsby PJ, 2010, LANCET NEUROL, V9, P285, DOI 10.1016/S1474-4422(10)70005-3; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Hepp Z, 2017, CEPHALALGIA, V37, P470, DOI 10.1177/0333102416678382; Hepp Z, 2014, J MANAGE CARE PHARM, V20, P22, DOI 10.18553/jmcp.2014.20.1.22; Kawata AK, 2017, HEADACHE, V57, P1385, DOI 10.1111/head.13162; Macedo A, 2008, EUR J PAIN, V12, P68, DOI 10.1016/j.ejpain.2007.03.002; Messina R, 2017, CEPHALALGIA, V37, P120; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Shi LC, 2016, J PHARMACOL EXP THER, V356, P223, DOI 10.1124/jpet.115.227793; Silberstein Steven D, 2005, Rev Neurol Dis, V2, P167; Steiner TJ, 2007, J HEADACHE PAIN, V8, pS2, DOI 10.1007/s10194-007-0428-1; Tepper S, 2017, LANCET NEUROL, V16, P425, DOI 10.1016/S1474-4422(17)30083-2; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Zhang Q, 2018, NEUROLOGY, V90	25	213	221	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	2018	392	10161					2280	2287		10.1016/S0140-6736(18)32534-0	http://dx.doi.org/10.1016/S0140-6736(18)32534-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB4ZY	30360965	Green Submitted			2022-12-28	WOS:000451067600026
J	Ransom, RC; Carter, AC; Salhotra, A; Leavitt, T; Marecic, O; Murphy, MP; Lopez, ML; Wei, YN; Marshall, CD; Shen, EZ; Jones, RE; Sharir, A; Klein, OD; Chan, CKF; Wan, DC; Chang, HY; Longaker, MT				Ransom, Ryan C.; Carter, Ava C.; Salhotra, Ankit; Leavitt, Tripp; Marecic, Owen; Murphy, Matthew P.; Lopez, Michael L.; Wei, Yuning; Marshall, Clement D.; Shen, Ethan Z.; Jones, Ruth Ellen; Sharir, Amnon; Klein, Ophir D.; Chan, Charles K. F.; Wan, Derrick C.; Chang, Howard Y.; Longaker, Michael T.			Mechanoresponsive stem cells acquire neural crest fate in jaw regeneration	NATURE			English	Article							PROGENITOR; ORIGIN; RETROTRANSPOSITION; DIFFERENTIATION; SPECIFICATION; DYNAMICS	During both embryonic development and adult tissue regeneration, changes in chromatin structure driven by master transcription factors lead to stimulus-responsive transcriptional programs. A thorough understanding of how stem cells in the skeleton interpret mechanical stimuli and enact regeneration would shed light on how forces are transduced to the nucleus in regenerative processes. Here we develop a genetically dissectible mouse model of mandibular distraction osteogenesis-which is a process that is used in humans to correct an undersized lower jaw that involves surgically separating the jaw bone, which elicits new bone growth in the gap. We use this model to show that regions of newly formed bone are clonally derived from stem cells that reside in the skeleton. Using chromatin and transcriptional profiling, we show that these stem-cell populations gain activity within the focal adhesion kinase (FAK) signalling pathway, and that inhibiting FAK abolishes new bone formation. Mechanotransduction via FAK in skeletal stem cells during distraction activates a gene-regulatory program and retrotransposons that are normally active in primitive neural crest cells, from which skeletal stem cells arise during development. This reversion to a developmental state underlies the robust tissue growth that facilitates stem-cell-based regeneration of adult skeletal tissue.	[Ransom, Ryan C.; Salhotra, Ankit; Leavitt, Tripp; Marecic, Owen; Murphy, Matthew P.; Lopez, Michael L.; Marshall, Clement D.; Shen, Ethan Z.; Jones, Ruth Ellen; Chan, Charles K. F.; Wan, Derrick C.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Ransom, Ryan C.; Salhotra, Ankit; Marecic, Owen; Chan, Charles K. F.; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Carter, Ava C.; Wei, Yuning; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Sharir, Amnon; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Sharir, Amnon; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Longaker, MT (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.; Longaker, MT (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu; longaker@stanford.edu	Murphy, Matthew/ABD-5403-2021	Murphy, Matthew/0000-0003-0885-4089; Sharir, Amnon/0000-0003-4687-5155; Ransom, Ryan/0000-0001-6696-1793; Jones, Ruth Ellen/0000-0002-0588-9609; Carter, Ava/0000-0002-1892-8742; Salhotra, Ankit/0000-0001-6107-6656; Leavitt, Tripp/0000-0001-7829-2646; Wan, Derrick/0000-0003-4666-1683	National Institutes of Health (NIH) [R01DE026730, U24DE026914, K08DE024269]; Child Health Research Institute (CHRI) at Stanford University; Hagey Laboratory for Pediatric Regenerative Medicine; Steinhart/Reed Award; NIH [P50-HG007735]; Scleroderma Research Foundation; Gunn-Oliver Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024269, R01DE026730, U24DE026914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG049958, R00AG049958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Institute (CHRI) at Stanford University; Hagey Laboratory for Pediatric Regenerative Medicine; Steinhart/Reed Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Gunn-Oliver Fund; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Wysocka for her review of the manuscript and helpful suggestions. We thank the Stanford Functional Genomics Facility, Stanford Cell Sciences Imaging Facility, Lorry Lokey Imaging Facility, and Stanford Shared FACS Facility Cores. We thank D. J. Hunter and D. Atashroo for their respective contributions to the design of the distraction device. This work was supported by the National Institutes of Health (NIH) grants R01DE026730 (to M.T.L. and R.C.R.), U24DE026914 (to M.T.L.) and K08DE024269 (to D.C.W.); the Child Health Research Institute (CHRI) at Stanford University (D.C.W.); The Hagey Laboratory for Pediatric Regenerative Medicine (M.T.L.); the Steinhart/Reed Award (M.T.L); the Gunn-Oliver Fund (M.T.L.); and NIH grant P50-HG007735 and the Scleroderma Research Foundation (H.Y.C.). H.Y.C. is an Investigator of the Howard Hughes Medical Institute.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Alvarado AS, 2009, NATURE, V460, P39, DOI 10.1038/460039a; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bell S, 2017, BIOPHYS J, V112, P2439, DOI 10.1016/j.bpj.2017.04.048; Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114; Brinkley JF, 2016, DEVELOPMENT, V143, P2677, DOI 10.1242/dev.135434; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; Ge YJ, 2017, CELL, V169, P636, DOI 10.1016/j.cell.2017.03.042; Hojo H, 2016, DEV CELL, V37, P238, DOI 10.1016/j.devcel.2016.04.002; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P263; Ivancevic AM, 2016, GENOME BIOL EVOL, V8, P3301, DOI 10.1093/gbe/evw243; Kaucka M, 2017, ELIFE, V6, DOI 10.7554/eLife.25902; Kaucka M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600060; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Khansa I, 2017, PLAST RECONSTR SURG, V139, DOI 10.1097/PRS.0000000000003167; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Mashanov Vladimir S, 2012, Mob Genet Elements, V2, P244; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1, DOI 10.1097/00006534-199289010-00001; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Minoux M, 2017, SCIENCE, V355, DOI 10.1126/science.aal2913; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Purnell Beverly A, 2017, Science, V355, P592, DOI 10.1126/science.355.6325.592-a; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Roensch K, 2013, SCIENCE, V342, P1375, DOI 10.1126/science.1241796; Rogers CD, 2013, DEV BIOL, V374, P255, DOI 10.1016/j.ydbio.2012.12.009; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Tahiri Y, 2014, PLAST RECONSTR SURG, V133, p352E, DOI 10.1097/01.prs.0000438049.29258.a8; Tanaka HV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11069; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	41	86	90	7	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2018	563	7732					514	+		10.1038/s41586-018-0650-9	http://dx.doi.org/10.1038/s41586-018-0650-9			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB3OD	30356216	Green Accepted			2022-12-28	WOS:000450960000045
J	Kraft-Todd, GT; Bollinger, B; Gillingham, K; Lamp, S; Rand, DG				Kraft-Todd, Gordon T.; Bollinger, Bryan; Gillingham, Kenneth; Lamp, Stefan; Rand, David G.			Credibility-enhancing displays promote the provision of non-normative public goods	NATURE			English	Article							PROSOCIALITY; EVOLUTION; IMPACT; WORDS	Promoting the adoption of public goods that are not yet widely accepted is particularly challenging. This is because most tools for increasing cooperation-such as reputation concerns' and information about social norms(2) -are typically effective only for behaviours that are commonly practiced, or at least generally agreed upon as being desirable. Here we examine how advocates can successfully promote non-normative (that is, rare or unpopular) public goods. We do so by applying the cultural evolutionary theory of credibility-enhancing display(3), which argues that beliefs are spread more effectively by actions than by words alone-because actions provide information about the actor's true beliefs. Based on this logic, people who themselves engage in a given behaviour will be more effective advocates for that behaviour than people who merely extol its virtues-specifically because engaging in a behaviour credibly signals a belief in its value. As predicted, a field study of a programme that promotes residential solar panel installation in 58 towns in the United States-comprising 1.4 million residents in total-found that community organizers who themselves installed through the programme recruited 62.8% more residents to install solar panels than community organizers who did not. This effect was replicated in three pre-registered randomized survey experiments (total n = 1,805). These experiments also support the theoretical prediction that this effect is specifically driven by subjects' beliefs about what the community organizer believes about solar panels (that is, second-order beliefs), and demonstrate generalizability to four other highly non-normative behaviours. Our findings shed light on how to spread non-normative prosocial behaviours, offer an empirical demonstration of credibility-enhancing displays and have substantial implications for practitioners and policy-makers.	[Kraft-Todd, Gordon T.] Yale Univ, Dept Psychol, POB 11A Yale Stn, New Haven, CT 06520 USA; [Bollinger, Bryan] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Gillingham, Kenneth] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Lamp, Stefan] Univ Toulouse Capitole, Toulouse Sch Econ, Toulouse, France; [Rand, David G.] MIT, Sloan Sch, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rand, David G.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Yale University; Duke University; Yale University; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kraft-Todd, GT (corresponding author), Yale Univ, Dept Psychol, POB 11A Yale Stn, New Haven, CT 06520 USA.; Rand, DG (corresponding author), MIT, Sloan Sch, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Rand, DG (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	gordon.kraft-todd@yale.edu; drand@mit.edu	Kraft-Todd, Gordon/O-5520-2016; Bollinger, Bryan/ABH-5961-2020	Kraft-Todd, Gordon/0000-0003-1220-9269; Bollinger, Bryan/0000-0001-8596-6418	US Department of Energy [DE-EE0006128]; Templeton World Charity Foundation [TWCF0209]; Defense Advanced Research Projects Agency NGS2 programme [D17AC00005]	US Department of Energy(United States Department of Energy (DOE)); Templeton World Charity Foundation(Templeton World Charity Foundation); Defense Advanced Research Projects Agency NGS2 programme	This research was made possible by US Department of Energy (award DE-EE0006128), the Templeton World Charity Foundation (grant no. TWCF0209) and the Defense Advanced Research Projects Agency NGS2 programme (grant no. D17AC00005). The authors thank S. Carattini, C. Moya and M. Hoffman for their helpful feedback on drafts of this manuscript, and D. Banko and C. Borden for research assistance.	[Anonymous], 2018, ATTITUDES PERSUASION; Arechar AA, 2017, J ECON SCI ASSOC-JES, V3, P1, DOI 10.1007/s40881-017-0035-0; Attari SZ, 2016, CLIMATIC CHANGE, V138, P325, DOI 10.1007/s10584-016-1713-2; Bollinger B, 2012, MARKET SCI, V31, P900, DOI 10.1287/mksc.1120.0727; BRYAN JH, 1970, CHILD DEV, V41, P747, DOI 10.1111/j.1467-8624.1970.tb01028.x; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL, P151; Cialdini RB, 2009, INFLUENCE PSYCHOL PE; Graziano M, 2015, J ECON GEOGR, V15, P815, DOI 10.1093/jeg/lbu036; Grove J, 2011, SOLARIZE GUIDEBOOK C; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Imai K, 2013, J R STAT SOC A STAT, V176, P5, DOI 10.1111/j.1467-985X.2012.01032.x; Jordan JJ, 2017, PSYCHOL SCI, V28, P356, DOI 10.1177/0956797616685771; Kraft-Todd G, 2015, CURR OPIN BEHAV SCI, V3, P96, DOI 10.1016/j.cobeha.2015.02.006; Lanman JA, 2017, RELIG BRAIN BEHAV, V7, P3, DOI 10.1080/2153599X.2015.1117011; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Rogers J., 2014, SOLAR POWER RISE; Tankard ME, 2016, SOC ISS POLICY REV, V10, P181, DOI 10.1111/sipr.12022; Willard AK, 2017, EVOL HUM BEHAV, V38, P604, DOI 10.1016/j.evolhumbehav.2017.01.002	20	49	49	5	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					245	+		10.1038/s41586-018-0647-4	http://dx.doi.org/10.1038/s41586-018-0647-4			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA1AK	30356217	Green Submitted			2022-12-28	WOS:000449943600043
J	Horwitz, MEM; Molina, RL; Snowden, JM				Horwitz, Mara E. Murray; Molina, Rose L.; Snowden, Jonathan M.			Postpartum Care in the United States - New Policies for a New Paradigm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Horwitz, Mara E. Murray] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Horwitz, Mara E. Murray] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Molina, Rose L.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Snowden, Jonathan M.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Beth Israel Deaconess Medical Center; Oregon Health & Science University; Portland State University	Horwitz, MEM (corresponding author), Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA.; Horwitz, MEM (corresponding author), Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.			Molina, Rose/0000-0001-7977-7960; Murray Horwitz, Mara/0000-0001-6142-0285				Burtle A, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4020030; Henderson V, 2016, MATERN CHILD HLTH J, V20, pS132, DOI 10.1007/s10995-016-2044-7; Stuebe A, 2018, OBSTET GYNECOL, V131, pE140, DOI 10.1097/AOG.0000000000002633; Stumbras K, 2016, MATERN CHILD HLTH J, V20, pS103, DOI 10.1007/s10995-016-2053-6; WHO, 2012, WHO RECOMMENDATIONS	5	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1691	1693		10.1056/NEJMp1806516	http://dx.doi.org/10.1056/NEJMp1806516			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8OL	30380385				2022-12-28	WOS:000448891600002
J	Hocking, JS; Temple-Smith, M; Guy, R; Donovan, B; Braat, S; Law, M; Gunn, J; Regan, D; Vaisey, A; Bulfone, L; Kaldor, J; Fairley, CK; Low, N				Hocking, Jane S.; Temple-Smith, Meredith; Guy, Rebecca; Donovan, Basil; Braat, Sabine; Law, Matthew; Gunn, Jane; Regan, David; Vaisey, Alaina; Bulfone, Liliana; Kaldor, John; Fairley, Christopher K.; Low, Nicola		ACCEPt Consortium	Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial	LANCET			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ECOLOGICAL ANALYSIS; GENITAL CHLAMYDIA; UNITED-STATES; TRACHOMATIS; PREVALENCE; NOTIFICATION; ATTENDERS	Background Screening young adults who are sexually active for genital Chlamydia trachomatis infection is promoted in several high-income countries, but its effectiveness at the population level is highly debated. We aimed to investigate the effects of opportunistic chlamydia testing in primary care on the estimated chlamydia prevalence in the population aged 16-29 years in Australia. Methods We did a cluster-randomised controlled trial. Clusters were rural towns with a minimum of 500 women and men aged 16-29 years and no more than six primary care clinics. We randomly allocated each cluster using a computer-generated minimisation algorithm to receive a multifaceted, clinic-based chlamydia testing intervention or to continue usual care. The intervention included computerised reminders to test patients, an education package, payments for chlamydia testing, and feedback on testing rates. The primary outcome was chlamydia prevalence, estimated before randomisation (survey 1) and at the end of the trial (survey 2) in patients aged 16-29 years who attended the clinics. Analyses were done by intention to treat. General practitioners and clinic staff were aware of group allocation, whereas patients and laboratory staff who performed the chlamydia tests were not. This trial was completed on Dec 31, 2015, and is registered (ACTRN12610000297022). Findings Between Dec 14, 2010, and Sept 14, 2015, 26 clusters (63 clinics) received the chlamydia testing intervention and 26 (67 clinics) continued usual care. Over a mean duration of 3.1 years (SD 0.3), 93 828 young adults attended intervention clinics and 86 527 attended control clinics. The estimated chlamydia prevalence decreased from 5.0% (95% CI 3.8 to 6.2) at survey 1 to 3.4% (2.7 to 4.1) at survey 2 in the intervention clusters (difference -1.6%, 95% CI -2.9 to -0.3) and from 4.6% (95% CI 3.5 to 5.7) at survey 1 to 3.4% (2.4 to 4.5) at survey 2 in the control clusters (difference -1.1%, -2.7 to 0.5). The unadjusted odds ratio for the difference between intervention and control clusters was 0.9 (95% CI 0.5 to 1.5). Interpretation These findings, in conjunction with evidence about the feasibility of sustained uptake of opportunistic testing in primary care, indicate that sizeable reductions in chlamydia prevalence might not be achievable. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[Hocking, Jane S.; Braat, Sabine; Vaisey, Alaina] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Temple-Smith, Meredith; Gunn, Jane] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Guy, Rebecca; Donovan, Basil; Law, Matthew; Regan, David; Kaldor, John] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Donovan, Basil] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Bulfone, Liliana] Deakin Univ, Burwood, Vic, Australia; [Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Melbourne; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Deakin University; Monash University; University of Bern	Hocking, JS (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia.	jhocking@unimelb.edu.au	Donovan, Basil J/K-1246-2012; Hocking, Jane/AAD-5203-2021; Braat, Sabine/AAQ-3753-2021	Donovan, Basil J/0000-0001-8851-4126; Hocking, Jane/0000-0001-9329-8501; Guy, Rebecca/0000-0002-2929-4634; Bulfone, Liliana/0000-0001-6406-5231; Law, Matthew/0000-0002-3540-8837; BRAAT, SABINE/0000-0003-1997-3999; Gunn, Jane/0000-0001-8836-7525; Christopher, Fairley/0000-0001-9081-1664	Australian Government Department of Health; National Health and Medical Research Council; Victorian Department of Health and Human Services; New South Wales Ministry of Health	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Health and Human Services; New South Wales Ministry of Health	Australian Government Department of Health, National Health and Medical Research Council, Victorian Department of Health and Human Services, and New South Wales Ministry of Health.	Andersen B, 2011, SEX TRANSM INFECT, V87, P156, DOI 10.1136/sti.2010.042192; Australasian Sexual Health Alliance, 2014, AUSTR STI MAN GUID U; Australian Bureau of Statistics, 2011, AUSTR STAT GEOGR STA, V5; Australian Bureau of Statistics, REG POP GROWTH AUSTR; Australian Bureau of Statistics, CENS POP HOUS SOC IN; Australian Bureau of Statistics, 2020, TABL 59 EST RES POP; Australian Government Department of Health, 2016, EXP PRESCR 12 MONTHS; Australian Government. Department of Health, AUSTR INFL SURV REP; Bender N, 2011, SEX TRANSM INFECT, V87, P601, DOI 10.1136/sextrans-2011-050205; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Chandra NL, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.5.30453; Chen MY, 2004, INT J STD AIDS, V15, P762, DOI 10.1258/0956462042395113; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; de Wit GA, 2015, SEX TRANSM INFECT, V91, P423, DOI 10.1136/sextrans-2014-051677; Guy RJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-211; Herzog SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-187; Hocking J, 2003, AUST NZ J PUBL HEAL, V27, P405, DOI 10.1111/j.1467-842X.2003.tb00417.x; Hocking J, 2013, LANCET; Hoover Karen W, 2014, MMWR Suppl, V63, P80; Kirby Institute, 2017, VIR HEP MAPP PROJ NA; Low N, 2016, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD010866.PUB; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Pimenta JM, 2003, SEX TRANSM INFECT, V79, P22, DOI 10.1136/sti.79.1.22; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Reynolds R, 2010, AUST J RURAL HEALTH, V18, P159, DOI 10.1111/j.1440-1584.2010.01134.x; Royal Australian College of General Practitioners (RACGP), 2016, GUID PREV ACT GEN PR; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; Trojian TH, 2009, AM FAM PHYSICIAN, V79, P583; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Yeung AH, 2014, MED J AUSTRALIA, V200, P170, DOI 10.5694/mja13.10729	34	43	43	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1413	1422		10.1016/S0140-6736(18)31816-6	http://dx.doi.org/10.1016/S0140-6736(18)31816-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX5PD	30343857				2022-12-28	WOS:000447800900024
J	Tkalcic, H; Pham, TS				Tkalcic, Hrvoje; Thanh-Son Pham			Shear properties of Earth's inner core constrained by a detection of J waves in global correlation wavefield	SCIENCE			English	Article							PKJKP; VISCOSITY; CODA; ATTENUATION; MECHANISM; PERIODS; MODEL; IRON	Seismic J waves, shear waves that traverse Earth's inner core, provide direct constraints on the inner core's solidity and shear properties. However, these waves have been elusive in the direct seismic wavefield because of their small amplitudes. We devised a new method to detect J waves in the earthquake coda correlation wavefield. They manifest through the similarity with other compressional core-sensitive signals. The inner core is solid, but relatively soft, with shear-wave speeds and shear moduli of 3.42 +/- 0.02 kilometers per second and 149.0 +/- 1.6 gigapascals (GPa) near the inner core boundary and 3.58 +/- 0.02 kilometers per second and 167.4 +/- 1.6 GPa in Earth's center. The values are 2.5% lower than the widely used Preliminary Earth Reference Model. This provides new constraints on the dynamical interpretation of Earth's inner core.	[Tkalcic, Hrvoje; Thanh-Son Pham] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia	Australian National University	Tkalcic, H (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia.	hrvoje.tkalcic@anu.edu.au	Phạm, Thanh-Son/S-9293-2018; Pham, Thanh-Son/ABD-9325-2020; Tkalcic, Hrvoje/E-8465-2013; Pham, Thanh-Son/N-5476-2019	Phạm, Thanh-Son/0000-0002-9057-4416; Pham, Thanh-Son/0000-0002-9057-4416; Tkalcic, Hrvoje/0000-0001-7072-490X; Pham, Thanh-Son/0000-0002-9057-4416	AuScope initiative; National Collaborative Research Infrastructure Strategy (NCRIS), an Australian Commonwealth Government Program; AuScope Excellence in Research Achievement	AuScope initiative; National Collaborative Research Infrastructure Strategy (NCRIS), an Australian Commonwealth Government Program(Australian GovernmentDepartment of Industry, Innovation and Science); AuScope Excellence in Research Achievement	The synthetic experiment was performed on the ANU Terrawulf cluster, a computational facility developed with support from the AuScope initiative. AuScope Ltd. is funded under the National Collaborative Research Infrastructure Strategy (NCRIS), an Australian Commonwealth Government Program. H.T.'s travel was partially supported through the AuScope Excellence in Research Achievement travel bursary award.	Andrews J, 2006, GEOPHYS J INT, V167, P204, DOI 10.1111/j.1365-246X.2006.03022.x; Belonoshko AB, 2007, SCIENCE, V316, P1603, DOI 10.1126/science.1141374; Belonoshko AB, 2017, NAT GEOSCI, V10, P312, DOI [10.1038/NGEO2892, 10.1038/ngeo2892]; Bergman MI, 2018, J GEOPHYS RES-SOL EA, V123, P189, DOI 10.1002/2017JB014881; Birch F, 1940, AM J SCI, V238, P192; Boue P, 2014, EARTH PLANET SC LETT, V391, P137, DOI 10.1016/j.epsl.2014.01.047; Buffett BA, 1997, NATURE, V388, P571, DOI 10.1038/41534; Cao AM, 2005, SCIENCE, V308, P1453, DOI 10.1126/science.1109134; Cormier VF, 2015, GEOPHYS RES LETT, V42, P7459, DOI 10.1002/2015GL065367; Deguen R, 2012, EARTH PLANET SC LETT, V333, P211, DOI 10.1016/j.epsl.2012.04.038; Deuss A, 2000, GEOPHYS J INT, V142, P67, DOI 10.1046/j.1365-246x.2000.00147.x; DOORNBOS DJ, 1974, GEOPHYS J ROY ASTR S, V38, P397, DOI 10.1111/j.1365-246X.1974.tb04131.x; DZIEWONSKI AM, 1971, NATURE, V234, P465, DOI 10.1038/234465a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FEARN DR, 1981, NATURE, V292, P232, DOI 10.1038/292232a0; Jackson I, 2000, J GEOPHYS RES-SOL EA, V105, P23605, DOI 10.1029/2000JB900131; JULIAN BR, 1972, NATURE, V235, P317, DOI 10.1038/235317a0; KANAMORI H, 1977, REV GEOPHYS, V15, P105, DOI 10.1029/RG015i001p00105; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Koot L, 2011, EARTH PLANET SC LETT, V308, P343, DOI 10.1016/j.epsl.2011.06.004; Lehmann I., 1936, PUBLICATIONS BUREAU, V14, P87; Martorell B, 2013, SCIENCE, V342, P466, DOI 10.1126/science.1243651; Okal EA, 1998, EARTH PLANET SC LETT, V164, P23, DOI 10.1016/S0012-821X(98)00210-6; Pham TS, 2018, GEOPHYS RES LETT, V45, P3035, DOI 10.1002/2018GL077244; Sens-Schonfelder C, 2015, GEOPHYS RES LETT, V42, P7483, DOI 10.1002/2015GL065108; Shearer PM, 2011, GEOPHYS J INT, V185, P1379, DOI 10.1111/j.1365-246X.2011.05011.x; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; Sumita I, 1996, GEOPHYS J INT, V124, P502, DOI 10.1111/j.1365-246X.1996.tb07034.x; Tkalic H., 2017, EARTHS INNER CORE RE; Van Orman JA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021209; Vocadlo L, 2010, INT YEAR PLANET EART, P397, DOI 10.1007/978-90-481-2737-5_12; Wookey J, 2008, NATURE, V454, P873, DOI 10.1038/nature07131	32	37	37	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					329	332		10.1126/science.aau7649	http://dx.doi.org/10.1126/science.aau7649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337407				2022-12-28	WOS:000447680100045
J	Wehner, S; Elkouss, D; Hanson, R				Wehner, Stephanie; Elkouss, David; Hanson, Ronald			Quantum internet: A vision for the road ahead	SCIENCE			English	Review							KEY DISTRIBUTION; HERALDED ENTANGLEMENT; ATOMIC ENSEMBLES; BIT COMMITMENT; NETWORK; STATE; SECURITY; COMMUNICATION; CRYPTOGRAPHY; TELEPORTATION		[Wehner, Stephanie; Elkouss, David; Hanson, Ronald] Delft Univ Technol, QuTech, POB 5046, NL-2600 GA Delft, Netherlands; [Hanson, Ronald] Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands	Delft University of Technology; Delft University of Technology	Wehner, S (corresponding author), Delft Univ Technol, QuTech, POB 5046, NL-2600 GA Delft, Netherlands.	s.d.c.wehner@tudelft.nl	Hanson, Ronald/B-9555-2008; Elkouss, David/F-8869-2012	Elkouss, David/0000-0003-2023-2768	ERC Starting Grant; NWO VIDI Grant; ERC Consolidator Grant; NWO VICI Grant; NWO Zwaartekracht Grant QSC; EU H2020 FETFLAG Quantum Internet Alliance	ERC Starting Grant; NWO VIDI Grant(Netherlands Organization for Scientific Research (NWO)); ERC Consolidator Grant; NWO VICI Grant(Netherlands Organization for Scientific Research (NWO)); NWO Zwaartekracht Grant QSC; EU H2020 FETFLAG Quantum Internet Alliance	D.E. and S.W. are funded by an ERC Starting Grant (S.W.) and an NWO VIDI Grant (S.W.). R.H. is funded by an ERC Consolidator Grant and an NWO VICI Grant. R.H. and S.W. are also supported by the NWO Zwaartekracht Grant QSC. D.E., R.H., and S.W. are also funded by the EU H2020 FETFLAG Quantum Internet Alliance.	Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Aharanov D., 2008, P INNOVATIONS COMPUT, P453; Aharon N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033027; Aharonov D., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P705, DOI 10.1145/335305.335404; Ambainis A., 2004, P IEEE COMPLEXITY, DOI [10.1109/CCC.2004.1313848, DOI 10.1109/CCC.2004.1313848]; Andrews RW, 2014, NAT PHYS, V10, P321, DOI [10.1038/nphys2911, 10.1038/NPHYS2911]; Arrazola JM, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.062305; Awschalom DD, 2018, NAT PHOTONICS, V12, P516, DOI 10.1038/s41566-018-0232-2; Azuma K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7787; Ballance CJ, 2015, NATURE, V528, P384, DOI 10.1038/nature16184; Barrett J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.010503; Barz S, 2012, SCIENCE, V335, P303, DOI 10.1126/science.1214707; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bennett CH., 1984, P IEEE INT C COMP SY, P175; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Biham E, 1996, PHYS REV A, V54, P2651, DOI 10.1103/PhysRevA.54.2651; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Branciard C, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.010301; Braunstein SL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130502; Broadbent A., 2009, 50 ANN IEEE S FDN CO, P517; Buhrman H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167902; Buhrman H, 2010, REV MOD PHYS, V82, P665, DOI 10.1103/RevModPhys.82.665; Burrows M, 2006, USENIX ASSOCIATION 7TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P335; Castelvecchi D, 2018, NATURE, V554, P289; CERF VG, 1974, IEEE T COMMUN, VCO22, P637, DOI 10.1109/TCOM.1974.1092259; Chailloux A., 2009, FOCS 09 50 ANN IEEE; Chailloux A., 2011, P 52T ANN S FDN COMP, DOI [10.1109/FOCS.2011.42, DOI 10.1109/FOCS.2011.42]; Childs AM, 2005, QUANTUM INF COMPUT, V5, P456; Christandl M, 2005, LECT NOTES COMPUT SC, V3788, P217; Cleve R, 1999, PHYS REV LETT, V83, P648, DOI 10.1103/PhysRevLett.83.648; Courtland R, 2016, IEEE SPECTRUM, V53, P11, DOI 10.1109/MSPEC.2016.7572523; Crepeau C., 2002, P 34 ANN ACM S THEOR, DOI 10.1145/509907.510000; Crepeau C., 2005, P ADV CRYPTOL EUROCR, P285; Crepeau C, 2011, LECT NOTES COMPUT SC, V7073, P407, DOI 10.1007/978-3-642-25385-0_22; Damgard I, 2014, THEOR COMPUT SCI, V560, P12, DOI 10.1016/j.tcs.2014.09.014; Damgard IB, 2008, SIAM J COMPUT, V37, P1865, DOI 10.1137/060651343; Delteil A, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.177401; Delteil A, 2016, NAT PHYS, V12, P218, DOI 10.1038/NPHYS3605; Denchev Vasil S., 2008, SIGACT News, V39, P77, DOI 10.1145/1412700.1412718; Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818; Diamanti E, 2016, NPJ QUANTUM INFORM, V2, DOI 10.1038/npjqi.2016.25; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dupuis F, 2015, IEEE T INFORM THEORY, V61, P1093, DOI 10.1109/TIT.2014.2371464; Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Extance A, 2017, FIBRE SYSTEMS; Ganz M, 2017, QUANTUM INF PROCESS, V16, DOI 10.1007/s11128-017-1528-8; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; Gottesman D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.070503; Hassidim, 2005, P 37 ANN ACM S THEOR, P481, DOI DOI 10.1145/1060590.1060662; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Hillery M, 1999, PHYS REV A, V59, P1829, DOI 10.1103/PhysRevA.59.1829; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; Hucul D, 2015, NAT PHYS, V11, P37, DOI [10.1038/nphys3150, 10.1038/NPHYS3150]; Inlek IV, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.250502; Jiang L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.032325; Kalb N, 2017, SCIENCE, V356, P928, DOI 10.1126/science.aan0070; Kalb N, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.220501; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Konig R, 2012, IEEE T INFORM THEORY, V58, P1962, DOI 10.1109/TIT.2011.2177772; Kurz C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6527; Lo HK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230504; Lo HK, 1997, PHYS REV A, V56, P1154, DOI 10.1103/PhysRevA.56.1154; Lo HK, 1997, PHYS REV LETT, V78, P3410, DOI 10.1103/PhysRevLett.78.3410; Lo HK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130503; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; Mayers D, 1997, PHYS REV LETT, V78, P3414, DOI 10.1103/PhysRevLett.78.3414; Mayers D, 1998, ANN IEEE SYMP FOUND, P503, DOI 10.1109/SFCS.1998.743501; Mochon C., 2007, ARXIV07114114QUANTPH; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Muhammad S, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021047; Munro WJ, 2012, NAT PHOTONICS, V6, P777, DOI [10.1038/NPHOTON.2012.243, 10.1038/nphoton.2012.243]; Munro WJ, 2015, IEEE J SEL TOP QUANT, V21, DOI 10.1109/JSTQE.2015.2392076; Muralidharan S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.250501; Ng NHY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2268; Nickerson NH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041041; Northup TE, 2014, NAT PHOTONICS, V8, P356, DOI 10.1038/nphoton.2014.53; Pant M, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.012304; Peev M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075001; Pfister C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-00961-2; Pirandola S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15043; Probst S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.157001; Reiserer A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021040; Reiserer A, 2015, REV MOD PHYS, V87, DOI 10.1103/RevModPhys.87.1379; Ribeiro J., 2015, ARXIV150407171QUANTP; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Rudolph T, 2017, APL PHOTONICS, V2, DOI 10.1063/1.4976737; Salvail L, 2010, J COMPUT SECUR, V18, P61, DOI 10.3233/JCS-2010-0373; Sangouard N, 2011, REV MOD PHYS, V83, P33, DOI 10.1103/RevModPhys.83.33; Sasaki M, 2011, OPT EXPRESS, V19, P10387, DOI 10.1364/OE.19.010387; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Simon C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190503; Stockill R, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.010503; Stucki D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123001; Takeoka M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6235; Tan TR, 2015, NATURE, V528, P380, DOI 10.1038/nature16186; Tani S., 2005, P 22 ANN S THEOR ASP, P581; Tanji H, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043601; Tanzilli S, 2005, NATURE, V437, P116, DOI 10.1038/nature04009; Vallone G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.040502; Van Meter R, 2013, IEEE COMMUN MAG, V51, P64, DOI 10.1109/MCOM.2013.6576340; Wallman JJ, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103032; Wang S, 2014, OPT EXPRESS, V22, P21739, DOI 10.1364/OE.22.021739; Wehner S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220502; Wilde MM., 2013, QUANTUM INFORM THEOR; Yin J, 2017, SCIENCE, V356, P1140, DOI 10.1126/science.aan3211	111	626	628	39	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412							eaam9288	10.1126/science.aam9288	http://dx.doi.org/10.1126/science.aam9288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337383				2022-12-28	WOS:000447680100035
J	Abraham, G; Ghazanfar, MA; Bajpai, A				Abraham, G.; Ghazanfar, M. A.; Bajpai, A.			An unusual cause of shortness of breath and palpitations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL PRESENTATION; CARDIAC MYXOMAS; TUMORS; HEART		[Abraham, G.; Ghazanfar, M. A.; Bajpai, A.] Epsom Gen Hosp, Cardiol, Epsom, Surrey, England			george.abraham@nhs.net		Abraham, George/0000-0003-1442-4835				Aggarwal S, 2007, AM HEART J, V154, P1102, DOI 10.1016/j.ahj.2007.07.032; Boutayeb A., 2017, CLIN SURG, V2, P1498; Hoffmeier A, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0205; LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027; Pinede L, 2001, MEDICINE, V80, P159, DOI 10.1097/00005792-200105000-00002; Reynen K, 1996, AM J CARDIOL, V77, P107, DOI 10.1016/S0002-9149(97)89149-7; Shi L, 2017, EUR J PEDIATR, V176, P253, DOI 10.1007/s00431-016-2833-4; VIDAILLET HJ, 1987, BRIT HEART J, V57, P247; Wang ZJ, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0420-4; Yekehtaz Habibeh, 2013, J Tehran Heart Cent, V8, P169; Yusuf SW, 2018, BMJ BEST PRACTICE GU	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2018	363								k3883	10.1136/bmj.k3883	http://dx.doi.org/10.1136/bmj.k3883			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FN	30337276				2022-12-28	WOS:000448270700001
J	Wittekamp, BH; Plantinga, NL; Cooper, B; Lopez-Contreras, J; Coll, P; Mancebo, J; Wise, MP; Morgan, MPG; Depuydt, P; Boelens, J; Dugernier, T; Verbelen, V; Jorens, PG; Verbrugghe, W; Malhotra-Kumar, S; Damas, P; Meex, C; Leleu, K; van den Abeele, AM; de Matos, AFGP; Mendez, SF; Gomez, AV; Tomic, V; Sifrer, F; Villarreal, E; Ramos, JR; Aragao, I; Santos, C; Sperning, RHM; Coppadoro, P; Nardi, G; Brun-Buisson, C; Bonten, MJM				Wittekamp, Bastiaan H.; Plantinga, Nienke L.; Cooper, Ben S.; Lopez-Contreras, Joaquin; Coll, Pere; Mancebo, Jordi; Wise, Matt P.; Morgan, Matt P. G.; Depuydt, Pieter; Boelens, Jerina; Dugernier, Thierry; Verbelen, Valerie; Jorens, Philippe G.; Verbrugghe, Walter; Malhotra-Kumar, Surbhi; Damas, Pierre; Meex, Cecile; Leleu, Kris; van den Abeele, Anne-Marie; Gomes Pimenta de Matos, Ana Filipa; Fernandez Mendez, Sara; Vergara Gomez, Andrea; Tomic, Viktorija; Sifrer, Franc; Villarreal, Esther; Ruiz Ramos, Jesus; Aragao, Irene; Santos, Claudia; Sperning, Roberta H. M.; Coppadoro, Patrizia; Nardi, Giuseppe; Brun-Buisson, Christian; Bonten, Marc J. M.			Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNITS; SELECTIVE DECONTAMINATION; DIGESTIVE-TRACT; INTESTINAL-TRACT; OROPHARYNX; MORTALITY; BACTERIA; ICUS	IMPORTANCE The effects of chlorhexidine (CHX) mouthwash, selective oropharyngeal decontamination (SOD), and selective digestive tract decontamination (SDD) on patient outcomes in ICUs with moderate to high levels of antibiotic resistance are unknown. OBJECTIVE To determine associations between CHX 2%, SOD, and SDD and the occurrence of ICU-acquired bloodstream infections with multidrug-resistant gram-negative bacteria (MDRGNB) and 28-day mortality in ICUs with moderate to high levels of antibiotic resistance. DESIGN, SETTING, ANDPARTICIPANTS RandomizedtrialconductedfromDecember1,2013, toMay 31, 2017, in 13 European ICUs where at least 5% of bloodstream infections are caused by extendedspectrum beta-lactamase-producingEnterobacteriaceae. Patientswithanticipatedmechanicalventilation of more than 24 hourswere eligible. The final date of follow-upwas September 20, 2017. INTERVENTIONS Standard carewas daily CHX 2% bodywashings and a hand hygiene improvement program. Following a baseline period from 6 to 14 months, each ICUwas assigned in random order to 3 separate 6-month intervention periods with either CHX 2% mouthwash, SOD (mouthpaste with colistin, tobramycin, and nystatin), or SDD (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. MAIN OUTCOMES AND MEASURES The occurrence of ICU-acquired bloodstream infection with MDRGNB (primary outcome) and 28-day mortality (secondary outcome) during each intervention period compared with the baseline period. RESULTS A total of 8665 patients (median age, 64.1 years; 5561 men [64.2%]) were included in the study (2251, 2108, 2224, and 2082 in the baseline, CHX, SOD, and SDD periods, respectively). ICU-acquired bloodstream infection with MDRGNB occurred among 144 patients (154 episodes) in 2.1%, 1.8%, 1.5%, and 1.2% of included patients during the baseline, CHX, SOD, and SDD periods, respectively. Absolute risk reductions were 0.3%(95% CI, -0.6% to 1.1%), 0.6%(95% CI, -0.2% to 1.4%), and 0.8%(95% CI, 0.1% to 1.6%) for CHX, SOD, and SDD, respectively, compared with baseline. Adjusted hazard ratios were 1.13 (95% CI, 0.68-1.88), 0.89 (95% CI, 0.55-1.45), and 0.70 (95% CI, 0.43-1.14) during the CHX, SOD, and SDD periods, respectively, vs baseline. Crude mortality risks on day 28 were 31.9%, 32.9%, 32.4%, and 34.1% during the baseline, CHX, SOD, and SDD periods, respectively. Adjusted odds ratios for 28-day mortality were 1.07 (95% CI, 0.86-1.32), 1.05 (95% CI, 0.85-1.29), and 1.03 (95% CI, 0.80-1.32) for CHX, SOD, and SDD, respectively, vs baseline. CONCLUSIONS AND RELEVANCE Among patients receiving mechanical ventilation in ICUs with moderate to high antibiotic resistance prevalence, use of CHX mouthwash, SOD, or SDD was not associated with reductions in ICU-acquired bloodstream infections caused by MDRGNB compared with standard care.	[Wittekamp, Bastiaan H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Huispostnummer Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands; [Wittekamp, Bastiaan H.] Univ Med Ctr Utrecht, Intens Care Ctr, Utrecht, Netherlands; [Plantinga, Nienke L.; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Med Microbiol & Julius Ctr Hlth Sci & Primary Car, Utrecht, Netherlands; [Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Lopez-Contreras, Joaquin] Univ Autonoma Barcelona, Infect Diseases Internal Med, Hosp St Pau, Barcelona, Spain; [Coll, Pere] Univ Autonoma Barcelona, Hosp St Pau, Dept Microbiol, Barcelona, Spain; [Mancebo, Jordi] Univ Autonoma Barcelona, Hosp St Pau, Dept Intens Care, Barcelona, Spain; [Wise, Matt P.; Morgan, Matt P. G.] Univ Hosp Wales, Adult Crit Care, Cardiff, S Glam, Wales; [Depuydt, Pieter] Ghent Univ Hosp, Intens Care, Ghent, Belgium; [Boelens, Jerina] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium; [Dugernier, Thierry] Clin St Pierre, Dept Intens Care Med, Ottignies, Belgium; [Verbelen, Valerie] Clin St Pierre, Microbiol Dept, Ottignies, Belgium; [Jorens, Philippe G.; Verbrugghe, Walter] Univ Antwerp, Antwerp Univ Hosp, Intens Care Med, Antwerp, Belgium; [Malhotra-Kumar, Surbhi] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst, Antwerp, Belgium; [Damas, Pierre] CHU Liege, Dept Intens Care Med, Liege, Belgium; [Meex, Cecile] CHU Liege, Clin Microbiol, Liege, Belgium; [Leleu, Kris] AZ Sint Jan Bruges, Anesthesiol & Crit Care, Brugge, Belgium; [van den Abeele, Anne-Marie] St Lucas Hosp Ghent, Microbiol Lab, Ghent, Belgium; [Gomes Pimenta de Matos, Ana Filipa] Ctr Hosp Tras os Montes os Montes & Alto Douro, Serv Med Intens, Vila Real, Portugal; [Fernandez Mendez, Sara] Hosp Clin Barcelona, Med Intens Care Unit, Barcelona, Spain; [Vergara Gomez, Andrea] Hosp Clin Barcelona, Microbiol Dept, Barcelona, Spain; [Tomic, Viktorija] Univ Clin Resp & Allerg Dis, Lab Resp Microbiol, Golnik, Slovenia; [Sifrer, Franc] Univ Clin Resp & Allerg Dis, Intens Care Unit, Golnik, Slovenia; [Villarreal, Esther; Ruiz Ramos, Jesus] Hosp Univ La Fe, Intens Care Unit, Valencia, Spain; [Aragao, Irene] CHP, Intens Care UCIP, Hosp Santo Antonio, Porto, Portugal; [Santos, Claudia] CHP, Microbiol Lab, Hosp Santo Antonio, Porto, Portugal; [Sperning, Roberta H. M.] Azienda Osped San Camillo Forlanini, Dept Microbiol, Rome, Italy; [Coppadoro, Patrizia] Azienda Osped San Camillo Forlanini, Intens Care Unit, Rome, Italy; [Nardi, Giuseppe] Osped Infermi RIMINI AUSL Romagna, Dept Anesthesia & Intens Care, Rimini, Italy; [Brun-Buisson, Christian] CHU Henri Mondor, Med Intens Care & Infect Control Unit, Paris, France; [Brun-Buisson, Christian] Univ Paris Est Creteil, Paris, France	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Oxford; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Cardiff University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Antwerp; University of Antwerp; University of Liege; University of Liege; Ghent University; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari i Politecnic La Fe; Azienda Ospedaliera San Camillo-Forlanini; Azienda Ospedaliera San Camillo-Forlanini; AUSL della Romagna; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Wittekamp, BH (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Huispostnummer Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	b.h.j.wittekamp@umcutrecht.nl	RUIZ, JESUS/AAM-9339-2021; Cooper, Ben/HGC-7082-2022; Ramos, Jesús Ruiz/V-1919-2019	RUIZ, JESUS/0000-0002-0008-641X; Aragao, Irene/0000-0001-5750-2739; Leleu, Kris/0000-0002-8184-4648; VERGARA, ANDREA/0000-0002-5046-4490; dos Santos, Claudia/0000-0002-6446-8791; Lopez-Contreras, Joaquin/0000-0002-3166-4016; Cooper, Ben/0000-0002-9445-7217	European Commission under the Seventh Framework Programme (FP7-HEALTH-2011-single-stage) [282512]	European Commission under the Seventh Framework Programme (FP7-HEALTH-2011-single-stage)	This study was funded by the European Commission under the Seventh Framework Programme (FP7-HEALTH-2011-single-stage, grant agreement number 282512).	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; Duncan EM, 2014, J CRIT CARE, V29, P634, DOI 10.1016/j.jcrc.2014.03.013; Hua F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub3; Klompas M, 2014, JAMA INTERN MED, V174, P751, DOI 10.1001/jamainternmed.2014.359; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Labeau SO, 2011, LANCET INFECT DIS, V11, P845, DOI 10.1016/S1473-3099(11)70127-X; Le Gall JR, 2005, CRIT CARE, V9, pR645, DOI 10.1186/cc3821; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Oostdijk EAN, 2017, JAMA-J AM MED ASSOC, V317, P1583, DOI 10.1001/jama.2017.1282; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Plantinga NL, 2018, CLIN MICROBIOL INFEC, V24, P505, DOI 10.1016/j.cmi.2017.08.019; Plantinga NL, 2016, INTENS CARE MED, V42, P620, DOI 10.1007/s00134-016-4217-7; Price R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2197; Scott RD, 2009, DIRECT MED COSTS HEA; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; World Health Organization, 2009, WHO GUID HAND HYG HL	21	84	84	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2018	320	20					2087	2098		10.1001/jama.2018.13765	http://dx.doi.org/10.1001/jama.2018.13765			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB9ET	30347072	Green Published, Bronze			2022-12-28	WOS:000451395000016
J	Butkus, R; Doherty, R; Bornstein, SS				Butkus, Renee; Doherty, Robert; Bornstein, Sue S.		Hlth Public Policy Comm Amer	Reducing Firearm Injuries and Deaths in the United States: A Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							STORAGE PRACTICES; GUN OWNERSHIP; DOMESTIC VIOLENCE; LAWS; YOUTH; RATES; ASSOCIATION; RISK	For more than 20 years, the American College of Physicians (ACP) has advocated for the need to address firearm-related injuries and deaths in the United States. Yet, firearm violence continues to be a public health crisis that requires the nation's immediate attention. The policy recommendations in this paper build on, strengthen, and expand current ACP policies approved by the Board of Regents in April 2014, based on analysis of ap-proaches that the evidence suggests will be effective in reducing deaths and injuries from firearm-related violence.	[Butkus, Renee] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Bornstein, Sue S.] Texas Med Home Initiat, 3111 Beverly Dr, Dallas, TX 75205 USA	American College of Physicians	Butkus, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.				ACP operating budget	ACP operating budget	Financial support for the development of this position paper came exclusively from the ACP operating budget.	[Anonymous], 2007, HOM TRENDS US INT HO; [Anonymous], 2010, NAT INST CRIM BACK G; Bangalore S, 2013, AM J MED, V126, P873, DOI 10.1016/j.amjmed.2013.04.012; Butkus R, 2014, ANN INTERN MED, V160, P821, DOI 10.7326/M13-1960; Butkus R, 2014, ANN INTERN MED, V160, P858, DOI 10.7326/M14-0216; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Cook PJ, 2013, REDUCING GUN VIOLENC; Cooper A., 2011, HOMICIDE TRENDS US 1; Cummings P, 1997, JAMA-J AM MED ASSOC, V278, P1084, DOI 10.1001/jama.278.13.1084; Daniels Jeff, 2018, CNBC; Diez C, 2017, ANN INTERN MED, V167, P536, DOI 10.7326/M16-2849; Donohue JJ, 2017, WORKING PAPER; Durlauf SN, 2016, EUR ECON REV, V81, P32, DOI 10.1016/j.euroecorev.2015.07.020; Everytown for Gun Safety, 2017, MASS SHOOTINGS US 20; Everytown for Gun Safety, 2018, CONC CARR REC S446 O; Everytown for Gun Safety Support Fund, 2018, FAT GAPS MISS REC FE; Giffords Law Center to Prevent Gun Violence, 2013, 2013 STAT SCOR WHY G; Giffords Law Center to Prevent Gun Violence, 2013, CAL MOD 20 YEARS PUT; Goode E., 2013, NEW YORK TIMES; Greenberg Andy, 2013, FORBES; Greene E, 2007, BEHAV SCI LAW, V25, P405, DOI 10.1002/bsl.766; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Henry J. Kaiser Family Foundation, 2014, NUMBER DEATHS DUE IN; Johnson RM, 2006, ARCH PEDIAT ADOL MED, V160, P788, DOI 10.1001/archpedi.160.8.788; Koper CS, 2013, REDUCING GUN VIOLENC; Koper CS, 2004, UPDATED ASSESSMENT F; Koper CS, 2007, CRIME GUN RISK FACTO; Langton L., 2012, FIREARMS STOLEN HOUS; Mayors Against Illegal Guns, 2013, COAL AN ATF TRAC DAT; Mayors Against Illegal Guns, 2013, REP LOST STOL GUNS; MCGONIGAL MD, 1993, J TRAUMA, V35, P532, DOI 10.1097/00005373-199310000-00006; Miller M, 2005, ACCIDENT ANAL PREV, V37, P661, DOI 10.1016/j.aap.2005.02.003; Miller M, 2017, ANN INTERN MED, V166, P233, DOI 10.7326/M16-1590; Nance ML, 1997, J PEDIATR SURG, V32, P949, DOI 10.1016/S0022-3468(97)90375-4; Nelson DE, 1996, JAMA-J AM MED ASSOC, V275, P1744, DOI 10.1001/jama.275.22.1744; Nordstrom D L, 2001, Inj Prev, V7, P112, DOI 10.1136/ip.7.2.112; Parker Kim, 2017, AM COMPLEX RELATIONS; Perez E., 2014, CNN; Pinholt EM, 2014, J AM GERIATR SOC, V62, P1142, DOI 10.1111/jgs.12836; Police Executive Research Forum, 2010, GUNS CRIM BREAK NEW GUNS CRIM BREAK NEW; Quinnipiac University, 2018, QUINN U POLL US SUPP; RAND Corporation, 2020, EFF MIN AG REQ; Richmond TS, 2004, J TRAUMA, V57, P1356, DOI 10.1097/01.TA.0000141886.22472.F5; Roth J, 1997, IMPACT EVALUATION PU; Rudolph KE, 2015, AM J PUBLIC HEALTH, V105, pE49, DOI 10.2105/AJPH.2015.302703; Sorenson SB, 2004, AM J PUBLIC HEALTH, V94, P1412, DOI 10.2105/AJPH.94.8.1412; Sperry T., 2014, CNN; Swanson J.W., 2017, LAW CONT PROB, V80, P179, DOI 10.1097/AOG.0000000000004391; U.S. Bureau of Alcohol Tobacco Firearms and Explosives, 2013, 3 PRINT TECHN FIR; U.S. Bureau of Alcohol Tobacco Firearms and Explosives, 2000, FOLL GUN ENF FED LAW; U.S. Bureau of Alcohol Tobacco Firearms and Explosives, 2018, DONT LIE OTH GUY; U.S. Government Accountability Office, 2012, GAO12684; Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Wintemute GJ, 2013, INJURY PREV, V19, P412, DOI 10.1136/injuryprev-2012-040715; Zeoli AM, 2018, AM J EPIDEMIOL, V187, P2365, DOI [10.1093/aje/kwy174, 10.1093/aje/kwx362]	58	56	56	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2018	169	10					704	+		10.7326/M18-1530	http://dx.doi.org/10.7326/M18-1530			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HB0FB	30383132				2022-12-28	WOS:000450686700016
J	Qamar, A; Braunwald, E				Qamar, Arman; Braunwald, Eugene			Treatment of Hypertension Addressing a Global Health Problem	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE		[Qamar, Arman; Braunwald, Eugene] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, TIMI Study Grp,Cardiovasc Div, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Braunwald, E (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, 60 Fenwood Rd,7th Floor, Boston, MA 02115 USA.	ebraunwald@partners.org			National Heart, Lung, and Blood Institute T32 postdoctoral training grant [T32HL007604]; American Heart Association Strategically Focused Research Network in Vascular Disease grant [18SFRN3390085, 18SFRN33960262]; Daiichi Sankyo; AstraZeneca; Duke University; GlaxoSmithKline; Merck; Novartis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute T32 postdoctoral training grant; American Heart Association Strategically Focused Research Network in Vascular Disease grant; Daiichi Sankyo(Daiichi Sankyo Company Limited); AstraZeneca(AstraZeneca); Duke University; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Novartis(Novartis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Qamar is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant (T32HL007604) and the American Heart Association Strategically Focused Research Network in Vascular Disease grant (18SFRN3390085 and 18SFRN33960262). Dr Braunwald reported research grants to his institution from Duke University for his role as chair of the NHLBI-sponsored Heart Failure Network and study drug supplied by Savara Inc; grant support to his institution from Daiichi Sankyo, AstraZeneca, GlaxoSmithKline, Merck, Novartis, and Duke University; personal fees from consultancies with Theravance, Cardurion, and MyoKardia; uncompensated consultancies and lectures with Merck and Novartis; uncompensated lectures for The Medicines Company; and personal fees for lectures from Medscape.	[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Son JS, 2018, JAMA-J AM MED ASSOC, V320, P1783, DOI 10.1001/jama.2018.16501; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003; Weiss S, 1930, NEW ENGL J MED, V202, P891, DOI 10.1056/NEJM193005082021901; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Yano Y, 2018, JAMA-J AM MED ASSOC, V320, P1774, DOI 10.1001/jama.2018.13551	10	25	25	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1751	1752		10.1001/jama.2018.16579	http://dx.doi.org/10.1001/jama.2018.16579			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398610				2022-12-28	WOS:000449461800009
J	Iacobucci, G				Iacobucci, Gareth			Mental health funding to rise by at least 2bn pound a year by 2023-24, chancellor announces	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2018	363								k4576	10.1136/bmj.k4576	http://dx.doi.org/10.1136/bmj.k4576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ6PG	30373777				2022-12-28	WOS:000449561100016
J	Brainard, J				Brainard, Jeffrey			RETHINKING RETRACTIONS	SCIENCE			English	Editorial Material																			0	47	48	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					390	393		10.1126/science.362.6413.390	http://dx.doi.org/10.1126/science.362.6413.390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361352				2022-12-28	WOS:000450441900023
J	Nielsen, KB				Nielsen, Kathrine Bjerregaard			Putting my grad school angst to use	SCIENCE			English	Editorial Material								My phone rings right when I'm about to leave work, as if the person on the other end has been debating the call all day. On the line is a graduate student. At first they are hesitant to talk, but they loosen up when I assure them their question is reasonable and their dilemma is common. The emotion in their voice makes it clear that just going over university guidelines won't be enough. We talk for about 30 minutes, discussing the details of their research. But I am not the student's supervisor or academic adviser. I am a research integrity officer-and I relate to this anxious voice because, not too long ago, it could have been me.	[Nielsen, Kathrine Bjerregaard] Tech Univ Denmark, Lyngby, Denmark	Technical University of Denmark	Nielsen, KB (corresponding author), Tech Univ Denmark, Lyngby, Denmark.	SciCareerEditor@aaas.org							0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					494	494		10.1126/science.362.6413.494	http://dx.doi.org/10.1126/science.362.6413.494			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361376				2022-12-28	WOS:000450441900053
J	Sverden, E; Markar, SR; Agreus, L; Lagergren, J				Sverden, Emma; Markar, Sheraz R.; Agreus, Lars; Lagergren, Jesper			PRACTICE POINTER Acute upper gastrointestinal bleeding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HELICOBACTER-PYLORI ERADICATION; PROTON-PUMP INHIBITOR; PEPTIC-ULCER; HIGH-RISK; MANAGEMENT; ENDOSCOPY; PREVENTION; HEMORRHAGE; MORTALITY; METAANALYSIS		[Sverden, Emma; Markar, Sheraz R.; Lagergren, Jesper] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Sverden, Emma] Soder Sjukhuset, Dept Upper Gastrointestinal Surg, Stockholm, Sweden; Imperial Coll, Dept Surg & Canc, London, England; [Agreus, Lars] Karolinska Inst, Karolinska Univ Hosp, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; Univ Newcastle, Callaghan, NSW, Australia; [Lagergren, Jesper] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England; [Lagergren, Jesper] Guys & St Thomas NHS Fdn Trust, London, England	Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; Imperial College London; Karolinska Institutet; Karolinska University Hospital; University of Newcastle; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Sverden, E (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.; Sverden, E (corresponding author), Soder Sjukhuset, Dept Upper Gastrointestinal Surg, Stockholm, Sweden.	emma.s.eklund@gmail.com						Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Bellotto F, 2005, AM J MED, V118, P548, DOI 10.1016/j.amjmed.2005.01.026; Bennett C, 2014, COCHRANE DB SYST REV; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; British Society of Gastroenterology, 2007, UK COMP AUD UPP GAST; BURNETT A, 2017, BMJ-BRIT MED J, V357, P88205, DOI DOI 10.1136/BMJ.J2216; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chang SS, 2015, GUT LIVER, V9, P346, DOI 10.5009/gnl13451; Cheung KS, 2017, GUT, DOI [10.1136/gutjnl-2017-314605.29089382, DOI 10.1136/GUTJNL-2017-314605.29089382]; Cho SH, 2018, CLIN GASTROENTEROL H, V16, P370, DOI 10.1016/j.cgh.2017.06.029; Deltenre P, 2015, EUR J GASTROEN HEPAT, V27, pE1, DOI 10.1097/MEG.0000000000000403; Dworzynski K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3412; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Ghassemi KA, 2013, CURR GASTROENTEROL R, V15, P333, DOI DOI 10.1007/S11894-013-0333-5; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gralnek IM, 2015, ENDOSCOPY, V47, pA1, DOI 10.1055/s-0034-1393172; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Iwamoto J, 2010, DIGEST DIS SCI, V55, P2270, DOI 10.1007/s10620-009-1009-8; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kim JJ, 2014, HELICOBACTER, V19, P98, DOI 10.1111/hel.12114; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Laursen SB, 2017, GASTROINTEST ENDOSC, V85, P936, DOI 10.1016/j.gie.2016.08.049; Lim LG, 2011, ENDOSCOPY, V43, P300, DOI 10.1055/s-0030-1256110; Lohse N, 2015, BRIT J ANAESTH, V114, P901, DOI 10.1093/bja/aev100; Ma L, 1998, J CLIN GASTROENTEROL, V27, pS80, DOI 10.1097/00004836-199800001-00013; Manno D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1421; Park SJ, 2018, GASTROINTEST ENDOSC, V87, P457, DOI 10.1016/j.gie.2017.07.024; Perel P, 2013, COCHRANE DB SYST REV; Rahman R, 2016, ANN GASTROENTEROL, V29, P312, DOI 10.20524/aog.2016.0045; Rehman Ahmer, 2009, Gastrointest Endosc, V69, pe55, DOI 10.1016/j.gie.2009.03.002; Rockey DC, 2017, J INVEST MED, V65, P759, DOI 10.1136/jim-2016-000375; Rotondano G, 2014, GASTROENTEROL CLIN N, V43, P643, DOI 10.1016/j.gtc.2014.08.001; Sachar H, 2014, JAMA INTERN MED, V174, P1755, DOI 10.1001/jamainternmed.2014.4056; Salem MR, 2014, ANESTH ANALG, V118, P569, DOI 10.1213/ANE.0b013e3182917f11; Siau K, 2017, J ROY COLL PHYS EDIN, V47, P218, DOI 10.4997/JRCPE.2017.303; Sostres Carlos, 2011, Gastrointest Endosc Clin N Am, V21, P567, DOI 10.1016/j.giec.2011.07.004; Spiegel BMR, 2001, ARCH INTERN MED, V161, P1393, DOI 10.1001/archinte.161.11.1393; Sreedharan A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub3; Sung JJY, 2014, AM J GASTROENTEROL, V109, P1005, DOI 10.1038/ajg.2014.105; Sung JJY, 2010, AM J GASTROENTEROL, V105, P84, DOI 10.1038/ajg.2009.507; Sverden E, 2017, ANN SURG; Sverden E, 2018, GASTROINTEST ENDOSC, V88, P242, DOI 10.1016/j.gie.2017.11.035; Thung I, 2016, ALIMENT PHARM THER, V43, P514, DOI 10.1111/apt.13497; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Wehbeh A, 2015, DIGEST DIS SCI, V60, P2077, DOI 10.1007/s10620-015-3604-1; Wong GLH, 2009, GASTROENTEROLOGY, V137, P525, DOI 10.1053/j.gastro.2009.05.006	51	4	4	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2018	363								k4023	10.1136/bmj.k4023	http://dx.doi.org/10.1136/bmj.k4023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PX	30361444				2022-12-28	WOS:000448896000001
J	Young-Fadok, TM				Young-Fadok, Tonia M.			Diverticulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; COLONIC DIVERTICULITIS; PERFORATED DIVERTICULITIS; PRIMARY ANASTOMOSIS; UNCOMPLICATED DIVERTICULITIS; SIGMOID DIVERTICULITIS; COMPUTED-TOMOGRAPHY; LAPAROSCOPIC LAVAGE; ELECTIVE COLECTOMY; PROSPECTIVE COHORT	An otherwise healthy 57-year-old man presents with a 48-hour history of pain in the left lower quadrant. He has had three previous episodes of sigmoid diverticulitis that were confirmed by computed tomographic (CT) scan and treated nonsurgically. He has localized tenderness in the left lower quadrant. The body temperature is 101.8 degrees F (38.8 degrees C), the heart rate 110 beats per minute, and the white-cell count 15,600 per cubic millimeter. A CT scan of the abdomen and pelvis with oral and intravenous contrast material shows microperforation of the middle portion of the sigmoid colon, air bubbles in the adjacent colonic mesentery, thickening of the sigmoid wall, and pericolonic fat stranding, without free fluid. How would you manage this patient's condition?	[Young-Fadok, Tonia M.] Mayo Clin, Div Colon & Rectal Surg, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA	Mayo Clinic; Mayo Clinic Phoenix	Young-Fadok, TM (corresponding author), Mayo Clin, Div Colon & Rectal Surg, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA.	youngfadok.tonia@mayo.edu						Abraha I, 2017, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD009277.PUB2; ALDOORI WH, 1994, AM J CLIN NUTR, V60, P757, DOI 10.1093/ajcn/60.5.757; Ambrosetti P, 2000, DIS COLON RECTUM, V43, P1363, DOI 10.1007/BF02236631; Ambrosetti P, 2005, DIS COLON RECTUM, V48, P787, DOI 10.1007/s10350-004-0853-z; Anaya DA, 2005, ARCH SURG-CHICAGO, V140, P681, DOI 10.1001/archsurg.140.7.681; Angenete E, 2016, ANN SURG, V263, P117, DOI 10.1097/SLA.0000000000001061; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Bianchi M, 2011, ALIMENT PHARM THER, V33, P902, DOI 10.1111/j.1365-2036.2011.04606.x; Biondo S, 2012, AM J SURG, V204, P172, DOI 10.1016/j.amjsurg.2011.09.027; Bridoux V, 2017, J AM COLL SURGEONS, V225, P798, DOI 10.1016/j.jamcollsurg.2017.09.004; Broderick-Villa G, 2005, ARCH SURG-CHICAGO, V140, P576, DOI 10.1001/archsurg.140.6.576; Cao Y, 2018, GUT, V67, P466, DOI 10.1136/gutjnl-2016-313082; Carter F, 2017, COCHRANE DB SYST REV, V10, pCD009839; Cauley CE, 2018, DIS COLON RECTUM, V61, P586, DOI 10.1097/DCR.0000000000001080; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Chapman JR, 2006, ANN SURG, V243, P876, DOI 10.1097/01.sla.0000219682.98158.11; Cirocchi R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000334; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Dickerson EC, 2017, RADIOLOGY, V285, P850, DOI 10.1148/radiol.2017161374; Etzioni DA, 2009, ANN SURG, V249, P210, DOI 10.1097/SLA.0b013e3181952888; Feingold D, 2014, DIS COLON RECTUM, V57, P284, DOI 10.1097/DCR.0000000000000075; Gaertner WB, 2013, DIS COLON RECTUM, V56, P622, DOI 10.1097/DCR.0b013e31828545e3; Gawlick U, 2012, J TRAUMA ACUTE CARE, V72, P807, DOI 10.1097/TA.0b013e31824ef90b; Hjern F, 2008, BRIT J SURG, V95, P758, DOI 10.1002/bjs.6137; Hjern F, 2011, BRIT J SURG, V98, P997, DOI 10.1002/bjs.7477; Hjern F, 2012, AM J GASTROENTEROL, V107, P296, DOI 10.1038/ajg.2011.352; Jacobs DO, 2007, NEW ENGL J MED, V357, P2057, DOI 10.1056/NEJMcp073228; Klarenbeek BR, 2010, ANN SURG, V251, P670, DOI 10.1097/SLA.0b013e3181d3447d; Lameris W, 2008, EUR RADIOL, V18, P2498, DOI 10.1007/s00330-008-1018-6; Morris AM, 2014, JAMA-J AM MED ASSOC, V311, P287, DOI 10.1001/jama.2013.282025; PAINTER NS, 1975, CLIN GASTROENTEROL, V4, P1; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Regenbogen SE, 2014, JAMA SURG, V149, P292, DOI 10.1001/jamasurg.2013.5477; Ribas Y, 2010, INT J COLORECTAL DIS, V25, P1363, DOI 10.1007/s00384-010-0967-9; Ridgway PF, 2009, COLORECTAL DIS, V11, P941, DOI 10.1111/j.1463-1318.2008.01737.x; Ritz JP, 2011, SURGERY, V149, P606, DOI 10.1016/j.surg.2010.10.005; Salem L, 2004, J AM COLL SURGEONS, V199, P904, DOI 10.1016/j.jamcollsurg.2004.07.029; Schultz JK, 2017, BRIT J SURG, V104, P1382, DOI 10.1002/bjs.10567; Schwenk W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003145.pub2; Schwesinger WH, 2000, ARCH SURG-CHICAGO, V135, P558, DOI 10.1001/archsurg.135.5.558; Shabanzadeh DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009092.pub2; Sharma PV, 2014, ANN SURG, V259, P263, DOI 10.1097/SLA.0000000000000294; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Stollman N, 2013, J CLIN GASTROENTEROL, V47, P621, DOI 10.1097/MCG.0b013e31828003f6; Strate LL, 2008, JAMA-J AM MED ASSOC, V300, P907, DOI 10.1001/jama.300.8.907; Strate LL, 2017, GASTROENTEROLOGY, V152, P1023, DOI 10.1053/j.gastro.2016.12.038; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Tabbara M, 2010, SURGERY, V148, P919, DOI 10.1016/j.surg.2010.02.015; Thaler K, 2003, DIS COLON RECTUM, V46, P385, DOI 10.1007/s10350-004-6560-y; Unlu C, 2012, INT J COLORECTAL DIS, V27, P419, DOI 10.1007/s00384-011-1308-3; Van Arendonk KJ, 2013, JAMA SURG, V148, P316, DOI 10.1001/jamasurg.2013.1010; van de Wall BJM, 2017, LANCET GASTROENTEROL, V2, P13, DOI 10.1016/S2468-1253(16)30109-1; Vennix S, 2015, LANCET, V386, P1269, DOI 10.1016/S0140-6736(15)61168-0; Weizman AV, 2011, CAN J GASTROENTEROL, V25, P385, DOI 10.1155/2011/795241	54	32	32	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1635	1642		10.1056/NEJMcp1800468	http://dx.doi.org/10.1056/NEJMcp1800468			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1GI	30354951				2022-12-28	WOS:000448273500008
J	Arie, S				Arie, Sophie			Ebola: WHO expresses "very serious concern" about Congo outbreak	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4430	10.1136/bmj.k4430	http://dx.doi.org/10.1136/bmj.k4430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341056				2022-12-28	WOS:000448271300009
J	Liang, KW; Smith, ER; Aoi, Y; Stoltz, KL; Katagi, H; Woodfin, AR; Rendleman, EJ; Marshall, SA; Murray, DC; Wang, L; Ozark, PA; Mishra, RK; Hashizume, R; Schiltz, GE; Shilatifard, A				Liang, Kaiwei; Smith, Edwin R.; Aoi, Yuki; Stoltz, Kristen L.; Katagi, Hiroaki; Woodfin, Ashley R.; Rendleman, Emily J.; Marshall, Stacy A.; Murray, David C.; Wang, Lu; Ozark, Patrick A.; Mishra, Rama K.; Hashizume, Rintaro; Schiltz, Gary E.; Shilatifard, Ali			Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; COMPLEX SEC; P-TEFB; C-MYC; PROTEIN-DEGRADATION; 7SK SNRNP; HIV-1 TAT; IN-VIVO	The super elongation complex (SEC) is required for robust and productive transcription through release of RNA polymerase II (Pol II) with its P-TEFb module and promoting transcriptional processivity with its ELL2 subunit. Malfunction of SEC contributes to multiple human diseases including cancer. Here, we identify peptidomimetic lead compounds, KL-1 and its structural homolog KL-2, which disrupt the interaction between the SEC scaffolding protein AFF4 and P-TEFb, resulting in impaired release of Pol II from promoter-proximal pause sites and a reduced average rate of processive transcription elongation. SEC is required for induction of heat-shock genes and treating cells with KL-1 and KL-2 attenuates the heat-shock response from Drosophila to human. SEC inhibition downregulates MYC and MYC-dependent transcriptional programs in mammalian cells and delays tumor progression in a mouse xenograft model of MYC-driven cancer, indicating that small-molecule disruptors of SEC could be used for targeted therapy of MYC-induced cancer.	[Liang, Kaiwei; Smith, Edwin R.; Aoi, Yuki; Stoltz, Kristen L.; Woodfin, Ashley R.; Rendleman, Emily J.; Marshall, Stacy A.; Murray, David C.; Wang, Lu; Ozark, Patrick A.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA; [Liang, Kaiwei; Smith, Edwin R.; Aoi, Yuki; Stoltz, Kristen L.; Woodfin, Ashley R.; Rendleman, Emily J.; Marshall, Stacy A.; Murray, David C.; Wang, Lu; Ozark, Patrick A.; Hashizume, Rintaro; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Stoltz, Kristen L.; Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Katagi, Hiroaki; Hashizume, Rintaro] Northwestern Univ, Feinberg Sch Med, Dept Neurosurg, Chicago, IL 60611 USA; [Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, 303 E Super St, Chicago, IL 60611 USA; [Smith, Edwin R.; Hashizume, Rintaro; Schiltz, Gary E.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St, Chicago, IL 60611 USA; [Liang, Kaiwei] Wuhan Univ, Sch Basic Med Sci, Wuhan 430071, Hubei, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Wuhan University	Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA.; Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.; Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St, Chicago, IL 60611 USA.	ash@northwestern.edu	Aoi, Yuki/L-7948-2018	Aoi, Yuki/0000-0002-0252-9536; Liang, Kaiwei/0000-0002-6021-353X; Ozark, Patrick/0000-0002-4047-5102; Woodfin, Ashley/0000-0003-4154-6002; Katagi, Hiroaki/0000-0003-3620-9116	NATIONAL CANCER INSTITUTE [T32CA070085, R50CA211428, R01CA214035, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093079] Funding Source: NIH RePORTER; NCI NIH HHS [R50 CA211428, T32 CA070085, R01 CA214035, P30 CA060553] Funding Source: Medline; NINDS NIH HHS [R01 NS093079] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen FX, 2018, NAT REV MOL CELL BIO, V19, P464, DOI 10.1038/s41580-018-0010-5; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong N, 2017, MOL CELL, V66, P546, DOI 10.1016/j.molcel.2017.04.016; Fong N, 2015, MOL CELL, V60, P256, DOI 10.1016/j.molcel.2015.09.026; Fong N, 2014, GENE DEV, V28, P2663, DOI 10.1101/gad.252106.114; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Hu DQ, 2013, MOL CELL, V51, P493, DOI 10.1016/j.molcel.2013.07.003; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Izumi K, 2015, NAT GENET, V47, P338, DOI 10.1038/ng.3229; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Liang KW, 2015, MOL CELL, V60, P435, DOI 10.1016/j.molcel.2015.09.021; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu M, 2012, MOL CELL, V46, P325, DOI 10.1016/j.molcel.2012.03.007; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McNamara RP, 2016, CELL CYCLE, V15, P2115, DOI 10.1080/15384101.2016.1181241; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wan LL, 2017, NATURE, V543, P265, DOI 10.1038/nature21687; Wang L, 2017, GENE DEV, V31, P2056, DOI 10.1101/gad.306092.117; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	67	50	50	5	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					766	+	e17	10.1016/j.cell.2018.09.027	http://dx.doi.org/10.1016/j.cell.2018.09.027			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340042	Bronze, Green Accepted			2022-12-28	WOS:000447780800018
J	Ablain, J; Xu, MS; Rothschild, H; Jordan, RC; Mito, JK; Daniels, BH; Bell, CF; Joseph, NM; Wu, H; Bastian, BC; Zon, LI; Yeh, I				Ablain, Julien; Xu, Mengshu; Rothschild, Harriet; Jordan, Richard C.; Mito, Jeffrey K.; Daniels, Brianne H.; Bell, Caitlin F.; Joseph, Nancy M.; Wu, Hong; Bastian, Boris C.; Zon, Leonard I.; Yeh, Iwei			Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma	SCIENCE			English	Article							TERT PROMOTER MUTATIONS; KIT GENE MUTATION; BRAF MUTATIONS; ONCOGENIC MUTATIONS; MALIGNANT-MELANOMA; LEGIUS SYNDROME; WHOLE-GENOME; NRAS; ACTIVATION; PROTEIN	Melanomas originating from mucosal surfaces have low mutation burden, genomic instability, and poor prognosis. To identify potential driver genes, we sequenced hundreds of cancer-related genes in 43 human mucosal melanomas, cataloging point mutations, amplifications, and deletions. The SPRED1 gene, which encodes a negative regulator of mitogen-activated protein kinase (MAPK) signaling, was inactivated in 37% of the tumors. Four distinct genotypes were associated with SPRED1 loss. Using a rapid, tissue-specific CRISPR technique to model these genotypes in zebrafish, we found that SPRED1 functions as a tumor suppressor, particularly in the context of KIT mutations. SPRED1 knockdown caused MAPK activation, increased cell proliferation, and conferred resistance to drugs inhibiting KIT tyrosine kinase activity. These findings provide a rationale for MAPK inhibition in SPRED1-deficient melanomas and introduce a zebrafish modeling approach that can be used more generally to dissect genetic interactions in cancer.	[Ablain, Julien; Rothschild, Harriet; Mito, Jeffrey K.; Zon, Leonard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Ablain, Julien; Rothschild, Harriet; Mito, Jeffrey K.; Zon, Leonard I.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Ablain, Julien; Rothschild, Harriet; Mito, Jeffrey K.; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Xu, Mengshu; Jordan, Richard C.; Daniels, Brianne H.; Bastian, Boris C.; Yeh, Iwei] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Xu, Mengshu; Bastian, Boris C.; Yeh, Iwei] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Jordan, Richard C.; Daniels, Brianne H.; Joseph, Nancy M.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Jordan, Richard C.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Mito, Jeffrey K.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Bell, Caitlin F.] Stanford Univ, Dept Med, Med Ctr, Stanford, CA 94305 USA; [Wu, Hong] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Zon, Leonard I.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Zon, Leonard I.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zon, Leonard I.] Harvard Univ, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Stanford University; Fox Chase Cancer Center; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University	Zon, LI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Zon, LI (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Zon, LI (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Yeh, I (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.; Yeh, I (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.; Zon, LI (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Zon, LI (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.; Zon, LI (corresponding author), Harvard Univ, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu; iwei.yeh@ucsf.edu		Bell, Caitlin/0000-0001-7352-142X; Ablain, Julien/0000-0002-4509-3568; Rothschild, Harriet/0000-0001-5311-2872	Melanoma Research Foundation; Dermatology Foundation; Melanoma Research Alliance; Ellison Foundation; Starr Foundation; V Foundation; Terry Patters Melanoma Foundation; National Cancer Institute [1R35CA220481, R01CA103846, K99CA201465, U24CA196067, T32HL007627]; NATIONAL CANCER INSTITUTE [K99CA201465, R01CA103846, U24CA196067, R35CA220481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Melanoma Research Foundation; Dermatology Foundation; Melanoma Research Alliance; Ellison Foundation(Lawrence Ellison Foundation); Starr Foundation; V Foundation; Terry Patters Melanoma Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was provided by the Melanoma Research Foundation, the Dermatology Foundation, the Melanoma Research Alliance, the Ellison Foundation, the Starr Foundation, the V Foundation, the Terry Patters Melanoma Foundation, and the National Cancer Institute (1R35CA220481 to B.C.B., R01CA103846 to L.I.Z., K99CA201465 to J.A., U24CA196067 to R.C.J., and T32HL007627 to J.K.M.). L.I.Z. is a Howard Hughes Medical Institute Investigator.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Altieri L, 2017, J AM ACAD DERMATOL, V76, P250, DOI 10.1016/j.jaad.2016.08.007; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulmann S, 2014, MODERN PATHOL, V27, P1386, DOI 10.1038/modpathol.2013.211; Barrett AW, 1997, ARCH ORAL BIOL, V42, P77, DOI 10.1016/S0003-9969(96)00113-6; Byrd-Miles Katina, 2007, J Drugs Dermatol, V6, P10; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chi ZH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-85; Chraybi M, 2013, HUM PATHOL, V44, P1902, DOI 10.1016/j.humpath.2013.01.025; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; CLEMMENSEN OJ, 1991, HISTOPATHOLOGY, V18, P237, DOI 10.1111/j.1365-2559.1991.tb00831.x; Cohen Y, 2012, OR SURG OR MED OR PA, V114, P778, DOI 10.1016/j.oooo.2012.09.001; Colombino M, 2013, DERMATOLOGY, V226, P279, DOI 10.1159/000350683; Cosgarea I, 2017, ONCOTARGET, V8, P40683, DOI 10.18632/oncotarget.16542; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dahlman KB, 2012, CANCER DISCOV, V2, P791, DOI 10.1158/2159-8290.CD-12-0097; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dunzendorfer-Matt T, 2016, P NATL ACAD SCI USA, V113, P7497, DOI 10.1073/pnas.1607298113; Furney SJ, 2013, J PATHOL, V230, P261, DOI 10.1002/path.4204; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Greaves WO, 2013, J MOL DIAGN, V15, P220, DOI 10.1016/j.jmoldx.2012.10.002; Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Helmke BM, 2004, GASTROENTEROLOGY, V127, P1815, DOI 10.1053/j.gastro.2004.08.051; Hintzsche JD, 2017, MELANOMA RES, V27, P189, DOI 10.1097/CMR.0000000000000345; Hirata Y, 2016, J BIOL CHEM, V291, P3124, DOI 10.1074/jbc.M115.703710; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hou JY, 2017, CANCER-AM CANCER SOC, V123, P1333, DOI 10.1002/cncr.30473; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jangard M, 2015, MELANOMA RES, V25, P185, DOI 10.1097/CMR.0000000000000148; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kirchoff DD, 2016, AM SURGEON, V82, P1; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Hou-Yong, 2010, Zhonghua Yi Xue Za Zhi, V90, P3399; Lyu J, 2018, J PATHOL, V244, P358, DOI 10.1002/path.5017; Lyu J, 2016, J ORAL PATHOL MED, V45, P295, DOI 10.1111/jop.12358; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Ni SJ, 2012, HUM PATHOL, V43, P801, DOI 10.1016/j.humpath.2011.08.005; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Oesper L, 2014, BIOINFORMATICS, V30, P3532, DOI 10.1093/bioinformatics/btu651; Pappa KI, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/303791; Rouzbahman M, 2015, J LOW GENIT TRACT DI, V19, P350, DOI 10.1097/LGT.0000000000000142; Santi R, 2015, J CLIN PATHOL, V68, P130, DOI 10.1136/jclinpath-2014-202572; Sari SO, 2017, PATHOLOGY, V49, P55, DOI 10.1016/j.pathol.2016.09.065; Satzger I, 2008, BRIT J CANCER, V99, P2065, DOI 10.1038/sj.bjc.6604791; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheng XA, 2016, EUR J CANCER, V65, P156, DOI 10.1016/j.ejca.2016.06.019; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Tseng D, 2014, J AM ACAD DERMATOL, V71, P229, DOI 10.1016/j.jaad.2014.03.033; Turri-Zanoni M, 2013, HEAD NECK-J SCI SPEC, V35, P1066, DOI 10.1002/hed.23079; van Engen-van Grunsven ACH, 2014, GYNECOL ONCOL, V134, P10, DOI 10.1016/j.ygyno.2014.04.056; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yang HM, 2017, MODERN PATHOL, V30, P286, DOI 10.1038/modpathol.2016.179; Yeh I, 2016, J PATHOL, V240, P282, DOI 10.1002/path.4775; Yelamos O, 2016, J INVEST DERMATOL, V136, P1858, DOI 10.1016/j.jid.2016.05.094; Yun J, 2011, APMIS, V119, P330, DOI 10.1111/j.1600-0463.2011.02737.x; ZAK FG, 1974, ANN OTO RHINOL LARYN, V83, P515, DOI 10.1177/000348947408300414; Zebary A, 2013, BRIT J CANCER, V109, P559, DOI 10.1038/bjc.2013.373	68	74	74	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2018	362	6418					1055	+		10.1126/science.aau6509	http://dx.doi.org/10.1126/science.aau6509			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC2CE	30385465	Green Accepted			2022-12-28	WOS:000451609000046
J	Levine, M; Fraser, M				Levine, Mark; Fraser, Michael			Elements of a Comprehensive Public Health Response to the Opioid Crisis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							STATES		[Levine, Mark] Vermont Dept Hlth, Burlington, VT 05402 USA; [Fraser, Michael] Assoc State & Terr Hlth Officials, Arlington, VA USA; [Levine, Mark] Vermont Dept Hlth, Hlth, 108 Cherry St,POB 70, Burlington, VT 05402 USA; [Fraser, Michael] ASTHO, 2231 Crystal Dr,Suite 450, Arlington, VA 22202 USA		Levine, M (corresponding author), Vermont Dept Hlth, Hlth, 108 Cherry St,POB 70, Burlington, VT 05402 USA.	Mark.Levine@vermont.gov						Association of State and Territorial Health Offices, 2018, PREV OP MIS STAT TER; Butler JC, 2017, J PUBLIC HEALTH MAN, V23, P531, DOI 10.1097/PHH.0000000000000631; Johns Hopkins Bloomberg School of Public Health, 2017, OP EP EV IMP; Murphy Kelly., 2016, FINDING SOLUTIONS PR; National Safety Council, 2018, PRESCR NAT 2018; Pitt AL, 2018, AM J PUBLIC HEALTH, V108, P1394, DOI 10.2105/AJPH.2018.304590; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Trust for America's Health, 2017, PAIN NAT; U.S. Department of Health and Human Services, 2018, WHAT IS US OP EP; Wickramatilake S, 2017, PUBLIC HEALTH REP, V132, P171, DOI 10.1177/0033354916688206	10	6	6	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2018	169	10					712	+		10.7326/M18-1757	http://dx.doi.org/10.7326/M18-1757			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HB0FB	30398529				2022-12-28	WOS:000450686700019
J	Roustit, M; Giai, J; Gaget, O; Khouri, C; Mouhib, M; Lotito, A; Blaise, S; Seinturier, C; Subtil, F; Paris, A; Cracowski, C; Imbert, B; Carpentier, P; Vohra, S; Cracowski, JL				Roustit, Matthieu; Giai, Joris; Gaget, Olivier; Khouri, Charles; Mouhib, Myriam; Lotito, Adrien; Blaise, Sophie; Seinturier, Christophe; Subtil, Fabien; Paris, Adeline; Cracowski, Claire; Imbert, Bernard; Carpentier, Patrick; Vohra, Sunita; Cracowski, Jean-Luc			On-Demand Sildenafil as a Treatment for Raynaud Phenomenon A Series of n-of-1 Trials	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMIC-SCLEROSIS; CLINICAL-TRIALS; CONDITION SCORE; DIAGNOSIS; BLOCKERS	Background: Treatment of Raynaud phenomenon (RP) with phosphodiesterase-5 inhibitors has shown moderate efficacy. Adverse effects decrease the risk-benefit profile of these drugs, and patients may not be willing to receive long-term treatment. On-demand single doses before or during exposure to cold may be a good alternative. Objective: To assess the efficacy and safety of on-demand sildenafil in RP. Design: Series of randomized, double-blind, n-of-1 trials. (ClinicalTrials. gov: NCT02050360) Setting: Outpatients at a French university hospital. Participants: Patients with primary or secondary RP. Intervention: Each trial consisted of a multiple crossover study in a single patient. Repeated blocks of 3 periods of on-demand treatment were evaluated: 1 week of placebo, 1 week of sildenafil at 40 mg per dose, and 1 week of sildenafil at 80 mg per dose, with a maximum of 2 doses daily. Measurements: Raynaud Condition Score (RCS) and frequency and daily duration of attacks. Skin blood flow in response to cooling also was assessed with laser speckle contrast imaging. Mixed-effects models were used and parameters were estimated in a Bayesian framework to determine individual and aggregated efficacy. Results: 38 patients completed 2 to 5 treatment blocks. On the basis of aggregated data, the probability that sildenafil at 40 mg or 80 mg was more effective than placebo was greater than 90% for all outcomes (except for RCS with sildenafil, 80 mg). However, the aggregated effect size was not clinically relevant. Yet, substantial heterogeneity in sildenafil's efficacy was observed among participants, with clinically relevant efficacy in some patients. Limitation: The response to sildenafil was substantially heterogeneous among patients. Conclusion: Despite a high probability that sildenafil is superior to placebo, substantial heterogeneity was observed in patient response and aggregated results did not show that on-demand sildenafil has clinically relevant efficacy. In this context, the use of n-of-1 trials may be an original and relevant approach in RP.	[Roustit, Matthieu; Gaget, Olivier; Khouri, Charles; Mouhib, Myriam; Lotito, Adrien; Blaise, Sophie; Seinturier, Christophe; Paris, Adeline; Cracowski, Claire; Imbert, Bernard; Carpentier, Patrick; Cracowski, Jean-Luc] Univ Grenoble Alpes, Grenoble, France; [Roustit, Matthieu; Gaget, Olivier; Khouri, Charles; Mouhib, Myriam; Lotito, Adrien; Blaise, Sophie; Seinturier, Christophe; Paris, Adeline; Cracowski, Claire; Imbert, Bernard; Carpentier, Patrick; Cracowski, Jean-Luc] Grenoble Alpes Univ Hosp, Grenoble, France; [Giai, Joris; Subtil, Fabien] Univ Lyon, Lyon, France; [Giai, Joris; Subtil, Fabien] Hosp Civils Lyon, Lyon, France; [Vohra, Sunita] Univ Alberta, Dept Pediat, Fac Med & Dent, 1702 Coll Plaza,8215 112 St Northwest, Edmonton, AB T6G 2C8, Canada; [Roustit, Matthieu; Khouri, Charles; Mouhib, Myriam; Paris, Adeline; Cracowski, Claire; Cracowski, Jean-Luc] CHU Grenoble Alpes, Unite Pharmacol Clin, Ctr Invest Clin Grenoble, Inserm CIC1406,CS 10217, F-38043 Grenoble 09, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Lyon; University of Alberta; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Roustit, M (corresponding author), CHU Grenoble Alpes, Unite Pharmacol Clin, Ctr Invest Clin Grenoble, Inserm CIC1406,CS 10217, F-38043 Grenoble 09, France.	MRoustit@chu-grenoble.fr	Blaise, Sophie/AAD-4476-2019; Giai, Joris/AAN-7522-2020; Blaise, Sophie/AAS-2389-2020; , CRACOWSKI/M-6946-2014; Roustit, Matthieu/M-6927-2014	Blaise, Sophie/0000-0001-7238-112X; Giai, Joris/0000-0003-2424-8046; Blaise, Sophie/0000-0001-7238-112X; , CRACOWSKI/0000-0003-0787-1469; Khouri, Charles/0000-0002-8427-8573; Roustit, Matthieu/0000-0003-4475-1626	GIRCI (Groupement Interregional de Recherche Clinique et d'Innovation) Auvergne Rhone-Alpes, Clinical Research and Innovation Group; Pfizer; Association des Sclerodermiques de France (French Scleroderma Patients Association); Grenoble Alpes University Hospital	GIRCI (Groupement Interregional de Recherche Clinique et d'Innovation) Auvergne Rhone-Alpes, Clinical Research and Innovation Group; Pfizer(Pfizer); Association des Sclerodermiques de France (French Scleroderma Patients Association); Grenoble Alpes University Hospital	This study was funded by a young investigator grant from GIRCI (Groupement Interregional de Recherche Clinique et d'Innovation) Auvergne Rhone-Alpes, Clinical Research and Innovation Group, 2012 (to Dr. Roustit); Pfizer, who also supplied sildenafil; Association des Sclerodermiques de France (French Scleroderma Patients Association); and Grenoble Alpes University Hospital.	Chung L, 2009, ARTHRITIS RHEUM-US, V60, P870, DOI 10.1002/art.24351; Ennis H, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002069.pub5; Gabler NB, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1447-5; Goh NS, 2017, ARTHRITIS RHEUMATOL, V69, P1670, DOI 10.1002/art.40130; Hachulla E, 2016, ANN RHEUM DIS, V75, P1009, DOI 10.1136/annrheumdis-2014-207001; Herrick AL, 2012, NAT REV RHEUMATOL, V8, P469, DOI 10.1038/nrrheum.2012.96; Khanna PP, 2010, ANN RHEUM DIS, V69, P588, DOI 10.1136/ard.2009.107706; Khouri C, 2016, BRIT J CLIN PHARMACO, V82, P6, DOI 10.1111/bcp.12912; Kowal-Bielecka O, 2017, ANN RHEUM DIS, V76, P1327, DOI 10.1136/annrheumdis-2016-209909; LEROY EC, 1992, CLIN EXP RHEUMATOL, V10, P485; MARICQ HR, 1988, J RHEUMATOL, V15, P454; Maricq HR, 1997, J RHEUMATOL, V24, P879; Merkel PA, 2002, ARTHRITIS RHEUM-US, V46, P2410, DOI 10.1002/art.10486; National Cancer Institute, 2009, NIH PUBLICATION; Nikles J, 2011, J CLIN EPIDEMIOL, V64, P471, DOI 10.1016/j.jclinepi.2010.05.009; Pauling JD, 2015, J RHEUMATOL, V42, P1163, DOI 10.3899/jrheum.141437; Punja S, 2016, J CLIN EPIDEMIOL, V76, P47, DOI 10.1016/j.jclinepi.2016.03.023; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Roustit M, 2012, CLIN PHARMACOL THER, V91, P813, DOI 10.1038/clpt.2011.302; Roustit M, 2010, MICROVASC RES, V80, P505, DOI 10.1016/j.mvr.2010.05.012; Roustit M, 2013, ANN RHEUM DIS, V72, P1696, DOI 10.1136/annrheumdis-2012-202836; Roustit M, 2013, TRENDS PHARMACOL SCI, V34, P373, DOI 10.1016/j.tips.2013.05.007; Roustit M, 2011, AM J PHYSIOL-HEART C, V301, pH324, DOI 10.1152/ajpheart.00246.2011; Ruaro B, 2014, ANN RHEUM DIS, V73, P1181, DOI 10.1136/annrheumdis-2013-203514; Seibold JR, 2017, ARTHRITIS RHEUMATOL, V69, P2256, DOI 10.1002/art.40307; Stewart M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006687.pub3; Thompson AE, 2001, ARTHRITIS RHEUM-US, V44, P1841, DOI 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8; US Food and Drug Administration, 2010, GUID US BAYES STAT M; Vohra S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1738; Zucker DR, 2010, J CLIN EPIDEMIOL, V63, P1312, DOI 10.1016/j.jclinepi.2010.04.020; Zucker DR, 1997, J CLIN EPIDEMIOL, V50, P401, DOI 10.1016/S0895-4356(96)00429-5	31	18	19	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 20	2018	169	10					694	+		10.7326/M18-0517	http://dx.doi.org/10.7326/M18-0517			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HB0FB	30383134				2022-12-28	WOS:000450686700015
J	Moffitt, JR; Bambah-Mukku, D; Eichhorn, SW; Vaughn, E; Shekhar, K; Perez, JD; Rubinstein, ND; Hao, J; Regev, A; Dulac, C; Zhuang, XW				Moffitt, Jeffrey R.; Bambah-Mukku, Dhananjay; Eichhorn, Stephen W.; Vaughn, Eric; Shekhar, Karthik; Perez, Julio D.; Rubinstein, Nimrod D.; Hao, Junjie; Regev, Aviv; Dulac, Catherine; Zhuang, Xiaowei			Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region	SCIENCE			English	Article							GENE-EXPRESSION; STRIA TERMINALIS; BED NUCLEUS; NEURONS; CIRCUITS; AREA; SPECIFICATION; REPRODUCTION; ARCHITECTURE; BEHAVIOR	The hypothalamus controls essential social behaviors and homeostatic functions. However, the cellular architecture of hypothalamic nuclei-including the molecular identity, spatial organization, and function of distinct cell types-is poorly understood. Here, we developed an imaging-based in situ cell-type identification and mapping method and combined it with single-cell RNA-sequencing to create a molecularly annotated and spatially resolved cell atlas of the mouse hypothalamic preoptic region. We profiled similar to 1 million cells, identified similar to 70 neuronal populations characterized by distinct neuromodulatory signatures and spatial organizations, and defined specific neuronal populations activated during social behaviors in male and female mice, providing a high-resolution framework for mechanistic investigation of behavior circuits. The approach described opens a new avenue for the construction of cell atlases in diverse tissues and organisms.	[Moffitt, Jeffrey R.; Bambah-Mukku, Dhananjay; Eichhorn, Stephen W.; Vaughn, Eric; Perez, Julio D.; Rubinstein, Nimrod D.; Hao, Junjie; Regev, Aviv; Dulac, Catherine; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Moffitt, Jeffrey R.; Eichhorn, Stephen W.; Hao, Junjie; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Moffitt, Jeffrey R.; Eichhorn, Stephen W.; Hao, Junjie; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Moffitt, Jeffrey R.; Bambah-Mukku, Dhananjay; Eichhorn, Stephen W.; Vaughn, Eric; Perez, Julio D.; Rubinstein, Nimrod D.; Hao, Junjie; Dulac, Catherine; Zhuang, Xiaowei] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Bambah-Mukku, Dhananjay; Vaughn, Eric; Perez, Julio D.; Rubinstein, Nimrod D.; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Shekhar, Karthik; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Koch Inst Integrat Canc Biol, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Dulac, C; Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Zhuang, XW (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Dulac, C; Zhuang, XW (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu; zhuang@chemistry.harvard.edu		Moffitt, Jeffrey/0000-0002-3836-3101; Dulac, Catherine/0000-0001-5024-5418; Bambah-Mukku, Dhananjay/0000-0001-5822-6326; Regev, Aviv/0000-0003-3293-3158; /0000-0002-6410-4699	National Institutes of Health [R01MH113094, R01MH111502, R01HD082131]; National Institutes of Health Pathway to Independence Award [K99HD092542, K99EY028625]; Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD092542, R01HD082131] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY028625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111502, R01MH113094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Cell Observatory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is in part supported by the National Institutes of Health (R01MH113094 to X.Z and C.D.; R01MH111502 to C.D., X.Z., and A.R.; and R01HD082131 to C.D.). D.B.-M. and K.S. are supported in part by the National Institutes of Health Pathway to Independence Award (K99HD092542 to D.B-M. and K99EY028625 to K.S.). A.R. was supported by the Klarman Cell Observatory. A.R., C.D., and X.Z. are Howard Hughes Medical Institute Investigators.	Abbott SBG, 2017, J PHYSIOL-LONDON, V595, P6569, DOI 10.1113/JP274667; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Andero R, 2014, NEURON, V83, P444, DOI 10.1016/j.neuron.2014.05.028; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Augustine V, 2018, NATURE, V555, P204, DOI 10.1038/nature25488; Blackshaw S, 2010, J NEUROSCI, V30, P14925, DOI 10.1523/JNEUROSCI.4499-10.2010; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burnett LC, 2017, J CLIN INVEST, V127, P293, DOI 10.1172/JCI88648; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chung S, 2017, NATURE, V545, P477, DOI 10.1038/nature22350; Crosetto N, 2015, NAT REV GENET, V16, P57, DOI 10.1038/nrg3832; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Fang YY, 2018, NEURON, V98, P192, DOI 10.1016/j.neuron.2018.02.019; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; George JT, 2012, ENDOCRINOLOGY, V153, P5130, DOI 10.1210/en.2012-1429; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hellier V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02797-2; Horii-Hayashi N, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/256389; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Kohl J, 2018, NATURE, V556, P326, DOI 10.1038/s41586-018-0027-0; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Leib DE, 2017, NEURON, V96, P1272, DOI 10.1016/j.neuron.2017.11.041; Lein E, 2017, SCIENCE, V358, P64, DOI 10.1126/science.aan6827; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Li HJ, 2017, CELL, V171, P1206, DOI 10.1016/j.cell.2017.10.019; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marlin BJ, 2017, DEV NEUROBIOL, V77, P169, DOI 10.1002/dneu.22452; McHenry JA, 2017, NAT NEUROSCI, V20, P449, DOI 10.1038/nn.4487; Moffitt J.R., 2018, DRYAD, DOI [10.5061/dryad.8t8s248, DOI 10.5061/DRYAD.8T8S248]; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P14456, DOI 10.1073/pnas.1617699113; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P11046, DOI 10.1073/pnas.1612826113; Padilla SL, 2018, CELL REP, V24, P271, DOI 10.1016/j.celrep.2018.06.037; Pandey S, 2018, CURR BIOL, V28, P1052, DOI 10.1016/j.cub.2018.02.040; Park SG, 2018, NAT NEUROSCI, V21, P364, DOI 10.1038/s41593-018-0072-x; Paul A, 2017, CELL, V171, P522, DOI 10.1016/j.cell.2017.08.032; Perez JD, 2015, ELIFE, V4, DOI 10.7554/eLife.07860; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Romanov RA, 2017, NAT NEUROSCI, V20, P176, DOI 10.1038/nn.4462; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Scott N, 2015, NATURE, V525, P519, DOI 10.1038/nature15378; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sherin JE, 1998, J NEUROSCI, V18, P4705; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Simerly R. B., 2004, RAT NERVOUS SYSTEM, P335; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Sokolowski K, 2015, NEURON, V86, P403, DOI 10.1016/j.neuron.2015.03.022; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Tan CL, 2016, CELL, V167, P47, DOI 10.1016/j.cell.2016.08.028; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; TESKEY GC, 1988, PHARMACOL BIOCHEM BE, V31, P43; Tsuneoka Y, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00026; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; WANG GP, 2018, SCI REP UK, V8; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Wei YC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02648-0; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Wu TJ, 1997, J NEUROBIOL, V33, P983, DOI 10.1002/(SICI)1097-4695(199712)33:7<983::AID-NEU9>3.0.CO;2-4; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zelikowsky M, 2018, CELL, V173, P1265, DOI 10.1016/j.cell.2018.03.037; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhao ZD, 2017, P NATL ACAD SCI USA, V114, P2042, DOI 10.1073/pnas.1616255114	97	396	401	13	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2018	362	6416			SI		792	+	eaau5324	10.1126/science.aau5324	http://dx.doi.org/10.1126/science.aau5324			94	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7TZ	30385464	Green Accepted, Green Published			2022-12-28	WOS:000450488500043
J	Ramirez, PT; Frumovitz, M; Pareja, R; Lopez, A; Vieira, M; Ribeiro, R; Buda, A; Yan, XJ; Yao, SZ; Chetty, NE; Isla, D; Tamura, MRAO; Zhu, T; Robledo, KP; Gebski, V; Asher, R; Behan, V; Nicklin, JL; Coleman, RL; Obermair, A				Ramirez, Pedro T.; Frumovitz, Michael; Pareja, Rene; Lopez, Aldo; Vieira, Marcelo; Ribeiro, Reitan; Buda, Alessandro; Yan, Xiaojian; Yao Shuzhong; Chetty, Naven; Isla, David; Tamura, Mariano; Zhu, Tao; Robledo, Kristy P.; Gebski, Val; Asher, Rebecca; Behan, Vanessa; Nicklin, James L.; Coleman, Robert L.; Obermair, Andreas			Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; LAPAROSCOPIC-ASSISTED RESECTION; GYNECOLOGIC-ONCOLOGY; PATHOLOGICAL OUTCOMES; SURVIVAL OUTCOMES; RECTAL-CANCER; SURGERY; METAANALYSIS; LAPAROTOMY; EXPERIENCE	BACKGROUND There are limited data from retrospective studies regarding whether survival outcomes after laparoscopic or robot-assisted radical hysterectomy (minimally invasive surgery) are equivalent to those after open abdominal radical hysterectomy (open surgery) among women with early-stage cervical cancer. METHODS In this trial involving patients with stage IA1 (lymphovascular invasion), IA2, or IB1 cervical cancer and a histologic subtype of squamous-cell carcinoma, adenocarcinoma, or adenosquamous carcinoma, we randomly assigned patients to undergo minimally invasive surgery or open surgery. The primary outcome was the rate of disease-free survival at 4.5 years, with noninferiority claimed if the lower boundary of the two-sided 95% confidence interval of the between-group difference (minimally invasive surgery minus open surgery) was greater than -7.2 percentage points (i.e., closer to zero). RESULTS A total of 319 patients were assigned to minimally invasive surgery and 312 to open surgery. Of the patients who were assigned to and underwent minimally invasive surgery, 84.4% underwent laparoscopy and 15.6% robot-assisted surgery. Overall, the mean age of the patients was 46.0 years. Most patients (91.9%) had stage I131 disease. The two groups were similar with respect to histologic subtypes, the rate of lymphovascular invasion, rates of parametrial and lymph-node involvement, tumor size, tumor grade, and the rate of use of adjuvant therapy. The rate of disease-free survival at 4.5 years was 86.0% with minimally invasive surgery and 96.5% with open surgery, a difference of-10.6 percentage points (95% confidence interval (CI), -16.4 to -4.7). Minimally invasive surgery was associated with a lower rate of diseasefree survival than open surgery (3-year rate, 91.2% vs. 97.1%; hazard ratio for disease recurrence or death from cervical cancer, 3.74; 95% CI, 1.63 to 8.58), a difference that remained after adjustment for age, body-mass index, stage of disease, lymphovascular invasion, and lymph-node involvement; minimally invasive surgery was also associated with a lower rate of overall survival (3-year rate, 93.8% vs. 99.0%; hazard ratio for death from any cause, 6.00; 95% CI, 1.77 to 20.30). CONCLUSIONS In this trial, minimally invasive radical hysterectomy was associated with lower rates of disease-free survival and overall survival than open abdominal radical hysterectomy among women with early-stage cervical cancer.	[Ramirez, Pedro T.; Frumovitz, Michael; Coleman, Robert L.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362,1515 Holcombe Blvd, Houston, TX 77030 USA; [Pareja, Rene] Inst Nacl Cancerol, Dept Gynecol Oncol, Bogota, Colombia; [Pareja, Rene] Clin Oncol Astorga, Medellin, Colombia; [Lopez, Aldo] Inst Nacl Enfermedades Neoplas, Dept Gynecol Surg, Lima, Peru; [Vieira, Marcelo] Barretos Canc Hosp, Dept Gynecol Oncol, Barretos, Brazil; [Ribeiro, Reitan] Erasto Gaertner Hosp, Dept Surg Oncol, Curitiba, Parana, Brazil; [Tamura, Mariano] Albert Einstein Hosp, Dept Gynecol Oncol, Sao Paulo, Brazil; [Buda, Alessandro] San Gerardo Hosp, Dept Obstet & Gynecol, Unit Gynecol Oncol Surg, Monza, Italy; [Yan, Xiaojian] Wenzhou Med Univ, Dept Gynecol, Affiliated Hosp 1, Wenzhou, Peoples R China; [Yao Shuzhong] Sun Yat Sen Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhu, Tao] Zhejiang Canc Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China; [Chetty, Naven] Mater Hlth Serv Brisbane, Dept Gynecol Oncol, South Brisbane, Australia; [Robledo, Kristy P.; Gebski, Val; Asher, Rebecca] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW, Australia; [Behan, Vanessa; Obermair, Andreas] Univ Queensland, Queensland Ctr Gynaecol Canc Res, Brisbane, Qld, Australia; [Behan, Vanessa; Obermair, Andreas] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Nicklin, James L.] Royal Brisbane & Womens Hosp, Dept Gynaecol Oncol, Herston, Qld, Australia; [Isla, David] Inst Nacl Cancerol, Dept Gynecol Oncol, Mexico City, DF, Mexico	University of Texas System; UTMD Anderson Cancer Center; Instituto Nacional de Enfermedades Neoplasicas; Hospital de Cancer de Barretos; Hospital Israelita Albert Einstein; San Gerardo Hospital; Wenzhou Medical University; Sun Yat Sen University; Zhejiang Cancer Hospital; Mater Health Services; University of Sydney; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; Instituto Nacional de Cancerologia (INCAN)	Ramirez, PT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1362,1515 Holcombe Blvd, Houston, TX 77030 USA.	peramire@mdanderson.org	Ribeiro, Reitan/GRJ-5411-2022; Nicklin, James L/F-8035-2013; Buda, Alessandro/AGH-1805-2022; Ribeiro, Reitan/GLR-5977-2022	Ribeiro, Reitan/0000-0002-4323-3854; Nicklin, James L/0000-0001-5857-3723; Buda, Alessandro/0000-0002-7093-6862; Gebski, Val/0000-0001-8748-1844; Chetty, Naven/0000-0002-7158-7123; Obermair, Andreas/0000-0003-2199-1117; Robledo, Kristy/0000-0003-0213-7652	Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center; Medtronic	Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center; Medtronic(Medtronic)	Supported by a departmental research fund in the Department of Gynecologic Oncology and Reproductive Medicine, University of Texas M.D. Anderson Cancer Center, and by a grant from Medtronic.	Bogani G, 2014, J MINIM INVAS GYN, V21, P857, DOI 10.1016/j.jmig.2014.03.018; Cao TF, 2015, J LAPAROENDOSC ADV S, V25, P990, DOI 10.1089/lap.2015.0390; Cibula D, 2018, INT J GYNECOL CANCER, V28, P641, DOI 10.1097/IGC.0000000000001216; Conrad LB, 2015, INT J GYNECOL CANCER, V25, P1121, DOI 10.1097/IGC.0000000000000450; Diver E, 2017, J MINIM INVAS GYN, V24, P402, DOI 10.1016/j.jmig.2016.12.005; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fleshman J, 2015, JAMA-J AM MED ASSOC, V314, P1346, DOI 10.1001/jama.2015.10529; Frumovitz M, 2007, OBSTET GYNECOL, V110, P96, DOI 10.1097/01.AOG.0000268798.75353.04; Gebski V, 2018, INT J EPIDEMIOL; Harrell FE, 1986, P 11 ANN SAS US GROU, P823; Janda M, 2017, JAMA-J AM MED ASSOC, V317, P1224, DOI 10.1001/jama.2017.2068; Klein J.P., 2003, SURVIVAL ANAL TECHNI, V92; Kong TW, 2016, J OBSTET GYNAECOL RE, V42, P77, DOI 10.1111/jog.12840; Lee EJ, 2011, EUR J OBSTET GYN R B, V156, P83, DOI 10.1016/j.ejogrb.2010.12.016; Lin F, 2014, MED SCI MONITOR, V20, P2497, DOI 10.12659/MSM.891179; Malzoni M, 2009, ANN SURG ONCOL, V16, P1316, DOI 10.1245/s10434-009-0342-7; Nam JH, 2012, ANN ONCOL, V23, P903, DOI 10.1093/annonc/mdr360; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Obermair A, 2008, J MINIM INVAS GYN, V15, P584, DOI 10.1016/j.jmig.2008.06.013; Park DA, 2017, EJSO-EUR J SURG ONC, V43, P994, DOI 10.1016/j.ejso.2016.07.017; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; PIVER MS, 1974, OBSTET GYNECOL, V44, P265; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Sert BM, 2016, EJSO-EUR J SURG ONC, V42, P513, DOI 10.1016/j.ejso.2015.12.014; Shah CA, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e82; Shazly SAM, 2015, GYNECOL ONCOL, V138, P457, DOI 10.1016/j.ygyno.2015.06.009; Soliman PT, 2011, GYNECOL ONCOL, V123, P333, DOI 10.1016/j.ygyno.2011.08.001; Stevenson ARL, 2015, JAMA-J AM MED ASSOC, V314, P1356, DOI 10.1001/jama.2015.12009; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3; Wang YZ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1818-4; Zhao Y, 2017, J LAPAROENDOSC ADV S, V27, P1132, DOI 10.1089/lap.2017.0022	31	895	1004	10	167	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2018	379	20					1895	1904		10.1056/NEJMoa1806395	http://dx.doi.org/10.1056/NEJMoa1806395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2FL	30380365	Bronze			2022-12-28	WOS:000450049800004
J	Bruhn, WE; Fracica, EA; Makary, MA				Bruhn, William E.; Fracica, Elizabeth A.; Makary, Martin A.			Group Purchasing Organizations, Health Care Costs, and Drug Shortages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bruhn, William E.; Makary, Martin A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Fracica, Elizabeth A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Makary, Martin A.] Johns Hopkins Univ, Dept Hlth Policy & Management, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Makary, MA (corresponding author), Johns Hopkins Univ, 600 Wolfe St,Blalock 665, Baltimore, MD 21287 USA.	mmakary1@jhmi.edu	Bruhn, William/AAG-3127-2019	Fracica, Elizabeth/0000-0003-0218-9954				Burns LR, 2014, HOSPITAL SUPP CHAIN; Committee on Oversight and Government Reform, 2012, FDAS CONTRI DRUG S; Healthcare Supply Chain Association, A PRIMER GROUP PURC; Hiltzik M, 2005, LOS ANGELES TIMES; Kohn LT, 2010, GROUP PURCHASING ORG; Litan RE, 2010, HARVARD BUSINESS REV; Litan Robert E, 2011, J Contemp Health Law Policy, V28, P23; Schneller ES, 2009, VALUE GROUP PURC; US Government Accountability Office, 2016, DRUG SHORTAGES CERT	9	14	14	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2018	320	18					1859	1860		10.1001/jama.2018.13604	http://dx.doi.org/10.1001/jama.2018.13604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA1BH	30347037				2022-12-28	WOS:000449945900008
J	Romera, M; Talatchian, P; Tsunegi, S; Araujo, FA; Cros, V; Bortolotti, P; Trastoy, J; Yakushiji, K; Fukushima, A; Kubota, H; Yuasa, S; Ernoult, M; Vodenicarevic, D; Hirtzlin, T; Locatelli, N; Querlioz, D; Grollier, J				Romera, Miguel; Talatchian, Philippe; Tsunegi, Sumito; Araujo, Flavio Abreu; Cros, Vincent; Bortolotti, Paolo; Trastoy, Juan; Yakushiji, Kay; Fukushima, Akio; Kubota, Hitoshi; Yuasa, Shinji; Ernoult, Maxence; Vodenicarevic, Damir; Hirtzlin, Tifenn; Locatelli, Nicolas; Querlioz, Damien; Grollier, Julie			Vowel recognition with four coupled spin-torque nano-oscillators	NATURE			English	Article							PHASE-LOCKING; SYNCHRONIZATION; DYNAMICS	In recent years, artificial neural networks have become the flagship algorithm of artificial intelligence'. In these systems, neuron activation functions are static, and computing is achieved through standard arithmetic operations. By contrast, a prominent branch of neuroinspired computing embraces the dynamical nature of the brain and proposes to endow each component of a neural network with dynamical functionality, such as oscillations, and to rely on emergent physical phenomena, such as synchronization(2-6), for solving complex problems with small networks(7-11). This approach is especially interesting for hardware implementations, because emerging nanoelectronic devices can provide compact and energy-efficient nonlinear auto-oscillators that mimic the periodic spiking activity of biological neurons(12-16). The dynamical couplings between oscillators can then be used to mediate the synaptic communication between the artificial neurons. One challenge for using nanodevices in this way is to achieve learning, which requires fine control and tuning of their coupled oscillations(17); the dynamical features of nanodevices can be difficult to control and prone to noise and variability(18). Here we show that the outstanding tunability of spintronic nano-oscillators-that is, the possibility of accurately controlling their frequency across a wide range, through electrical current and magnetic field-can be used to address this challenge. We successfully train a hardware network of four spin-torque nanooscillators to recognize spoken vowels by tuning their frequencies according to an automatic real-time learning rule. We show that the high experimental recognition rates stem from the ability of these oscillators to synchronize. Our results demonstrate that non-trivial pattern classification tasks can be achieved with small hardware neural networks by endowing them with nonlinear dynamical features such as oscillations and synchronization.	[Romera, Miguel; Talatchian, Philippe; Araujo, Flavio Abreu; Cros, Vincent; Bortolotti, Paolo; Trastoy, Juan; Ernoult, Maxence; Grollier, Julie] Univ Paris Saclay, Univ Paris Sud, Unite Mixte Phys,Thales, CNRS, Palaiseau, France; [Tsunegi, Sumito; Yakushiji, Kay; Fukushima, Akio; Kubota, Hitoshi; Yuasa, Shinji] Spintron Res Ctr, Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki, Japan; [Ernoult, Maxence; Vodenicarevic, Damir; Hirtzlin, Tifenn; Locatelli, Nicolas; Querlioz, Damien] Univ Paris Saclay, Univ Paris Sud, Ctr Nanosci & Nanotechnol, CNRS, Orsay, France; [Araujo, Flavio Abreu] UC Louvain, Inst Condensed Matter & Nanosci, Louvain La Neuve, Belgium	Centre National de la Recherche Scientifique (CNRS); Thales Group; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Advanced Industrial Science & Technology (AIST); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Universite Catholique Louvain	Grollier, J (corresponding author), Univ Paris Saclay, Univ Paris Sud, Unite Mixte Phys,Thales, CNRS, Palaiseau, France.; Querlioz, D (corresponding author), Univ Paris Saclay, Univ Paris Sud, Ctr Nanosci & Nanotechnol, CNRS, Orsay, France.	damien.querlioz@u-psud.fr; julie.grollier@cnrs-thales.fr	Talatchian, Philippe/ABC-2860-2021; Araujo, Flavio Abreu/AAE-2128-2019; Tsunegi, Sumito/J-9626-2018; Yakushiji, Kay/K-3040-2018; romera, miguel/Q-8226-2016; Yuasa, Shinji/H-2804-2016; Locatelli, Nicolas/AAP-4146-2021; Araujo, Flavio M Abreu/K-4532-2014	Talatchian, Philippe/0000-0003-2034-6140; Tsunegi, Sumito/0000-0003-3357-1507; Yakushiji, Kay/0000-0002-1616-1613; romera, miguel/0000-0002-4814-3743; Yuasa, Shinji/0000-0003-1093-9057; Locatelli, Nicolas/0000-0003-1966-5195; Araujo, Flavio M Abreu/0000-0001-7157-3197	European Research Council ERC [bioSPINspired 682955]; French National Research Agency (ANR) [MEMOS ANR-14-CE26-0021]; ANR as part of the 'Investissements d'Avenir' programme (Labex NanoSaclay) [ANR-10-LABX-0035]	European Research Council ERC(European Research Council (ERC)); French National Research Agency (ANR)(French National Research Agency (ANR)); ANR as part of the 'Investissements d'Avenir' programme (Labex NanoSaclay)	This work was supported by the European Research Council ERC under grant bioSPINspired 682955, the French National Research Agency (ANR) under grant MEMOS ANR-14-CE26-0021, and a public grant overseen by the ANR as part of the 'Investissements d'Avenir' programme (Labex NanoSaclay, reference ANR-10-LABX-0035).	Borisyuk R, 2000, BIOSYSTEMS, V58, P265, DOI 10.1016/S0303-2647(00)00131-3; Csaba G, 2013, IEEE T MAGN, V49, P4447, DOI 10.1109/TMAG.2013.2244202; Tran DX, 2014, PROC INT CONF ADV, P239, DOI 10.1109/ATC.2014.7043391; Fang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11259; Fang Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601114; Gajek M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694270; Grollier J, 2016, P IEEE, V104, P2024, DOI 10.1109/JPROC.2016.2597152; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Houshang A, 2016, NAT NANOTECHNOL, V11, P280, DOI [10.1038/nnano.2015.280, 10.1038/NNANO.2015.280]; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jouppi NP, 2017, 44TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA 2017), P1, DOI 10.1145/3079856.3080246; Kaka S, 2005, NATURE, V437, P389, DOI 10.1038/nature04035; Kumar S, 2017, NATURE, V548, P318, DOI 10.1038/nature23307; Lebrun R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15825; Livi P, 2009, IEEE INT SYMP CIRC S, P2898, DOI 10.1109/ISCAS.2009.5118408; Locatelli N, 2014, NAT MATER, V13, P11, DOI [10.1038/nmat3823, 10.1038/NMAT3823]; Louis S, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2694847; Macia F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/9/095301; Mancoff FB, 2005, NATURE, V437, P393, DOI 10.1038/nature04036; Parihar A., 2017, 2017 INT JOINT C NEU, P3415; Pickett MD, 2013, NAT MATER, V12, P114, DOI [10.1038/nmat3510, 10.1038/NMAT3510]; Pikovsky A, 2015, CHAOS, V25, DOI 10.1063/1.4922971; Pufall MR, 2015, IEEE J EXPLOR SOLID-, V1, P76, DOI 10.1109/JXCDC.2015.2468070; Qiao N, 2016, BIOMED CIRC SYST C, P552, DOI 10.1109/BioCAS.2016.7833854; Romera M, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4972346; Sharma AA, 2015, IEEE J EXPLOR SOLID-, V1, P58, DOI 10.1109/JXCDC.2015.2448417; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Slavin A, 2009, IEEE T MAGN, V45, P1875, DOI 10.1109/TMAG.2008.2009935; Sussillo D, 2014, CURR OPIN NEUROBIOL, V25, P156, DOI 10.1016/j.conb.2014.01.008; Tomita Yasumoto, 2013, 2013 Symposium on VLSI Circuits, pC238; Torrejon J, 2017, NATURE, V547, P428, DOI 10.1038/nature23011; Tsunegi S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.063009; Tulapurkar AA, 2005, NATURE, V438, P339, DOI 10.1038/nature04207; Vassilieva E, 2011, IEEE T NEURAL NETWOR, V22, P84, DOI 10.1109/TNN.2010.2086476; Vodenicarevic D, 2017, SCI REP-UK, V7, DOI 10.1038/srep44772; Vodenicarevic D, 2016, IEEE IJCNN, P2015, DOI 10.1109/IJCNN.2016.7727447; Wijekoon JHB, 2008, NEURAL NETWORKS, V21, P524, DOI 10.1016/j.neunet.2007.12.037; Yogendra K, 2016, IEEE T ELECTRON DEV, V63, P1674, DOI 10.1109/TED.2016.2523423	39	238	239	11	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 8	2018	563	7730					230	+		10.1038/s41586-018-0632-y	http://dx.doi.org/10.1038/s41586-018-0632-y			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA1AK	30374193	Green Submitted			2022-12-28	WOS:000449943600040
J	Torjesen, I				Torjesen, Ingrid			Using HPV test in cervical screening may allow some women to stop earlier	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Malagon T, 2018, LANCET ONCOL, V19, P1569, DOI 10.1016/S1470-2045(18)30536-9	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2018	363								k4656	10.1136/bmj.k4656	http://dx.doi.org/10.1136/bmj.k4656			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QK	30389705				2022-12-28	WOS:000449566000004
J	Dillard, KE; Brown, MW; Johnson, NV; Xiao, YB; Dolan, A; Hernandez, E; Dahlhauser, SD; Kim, Y; Myler, LR; Anslyn, EV; Ke, AL; Finkelstein, IJ				Dillard, Kaylee E.; Brown, Maxwell W.; Johnson, Nicole V.; Xiao, Yibei; Dolan, Adam; Hernandez, Erik; Dahlhauser, Samuel D.; Kim, Yoori; Myler, Logan R.; Anslyn, Eric V.; Ke, Ailong; Finkelstein, Ilya J.			Assembly and Translocation of a CRISPR-Cas Primed Acquisition Complex	CELL			English	Article							SPACER ACQUISITION; ESCHERICHIA-COLI; FOREIGN DNA; SURVEILLANCE COMPLEX; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; RNA-POLYMERASE; SYSTEM; CASCADE; DEGRADATION	CRISPR-Cas systems confer an adaptive immunity against viruses. Following viral injection, Cas1-Cas2 integrates segments of the viral genome (spacers) into the CRISPR locus. In type I CRISPR-Cas systems, efficient "primed'' spacer acquisition and viral degradation (interference) require both the Cascade complex and the Cas3 helicase/nuclease. Here, we present single-molecule characterization of the Thermobifida fusca (Tfu) primed acquisition complex (PAC). We show that TfuCascade rapidly samples non-specific DNA via facilitated one-dimensional diffusion. Cas3 loads at target-bound Cascade and the Cascade/Cas3 complex translocates via a looped DNA intermediate. Cascade/Cas3 complexes stall at diverse protein roadblocks, resulting in a double strand break at the stall site. In contrast, Cas1-Cas2 samples DNA transiently via 3D collisions. Moreover, Cas1-Cas2 associates with Cascade and translocates with Cascade/Cas3, forming the PAC. PACs can displace different protein roadblocks, suggesting a mechanism for long-range spacer acquisition. This work provides a molecular basis for the coordinated steps in CRISPR-based adaptive immunity.	[Dillard, Kaylee E.; Brown, Maxwell W.; Johnson, Nicole V.; Kim, Yoori; Myler, Logan R.; Finkelstein, Ilya J.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Dillard, Kaylee E.; Brown, Maxwell W.; Johnson, Nicole V.; Kim, Yoori; Myler, Logan R.; Finkelstein, Ilya J.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Xiao, Yibei; Dolan, Adam; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hernandez, Erik; Dahlhauser, Samuel D.; Anslyn, Eric V.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Finkelstein, Ilya J.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Cornell University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Finkelstein, IJ (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Finkelstein, IJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Finkelstein, IJ (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ilya@finkelsteinlab.org		Johnson, Nicole/0000-0003-4351-125X; Kim, Yoori/0000-0001-9942-2817; Dahlhauser, Samuel/0000-0002-4034-5172	Welch Foundation [F-1808]; NIH [R01GM124141, R35GM118174, F31GM125201, F99CA212452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124141, F31GM125201] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are very grateful to Dr. Irina Artsimovitch and Dr. Robert Landick, Jeffrey Schaub, James Rybarski, and Fatema Saifuddin for providing materials. This work was supported by the Welch Foundation (F-1808 to I.J.F.), the NIH (R01GM124141 to I.J.F. and R35GM118174 to A.K.), and NIH fellowships (F31GM125201 to K.E.D. and. F99CA212452 to L.M.). Y.K. is an HHMI graduate student fellow. We apologize to all our colleagues whose work could not be cited due to editorial constraints.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Finkelstein IJ, 2013, ANNU REV BIOPHYS, V42, P241, DOI 10.1146/annurev-biophys-083012-130304; Finkelstein IJ, 2010, NATURE, V468, P983, DOI 10.1038/nature09561; Gallardo IF, 2015, LANGMUIR, V31, P10310, DOI 10.1021/acs.langmuir.5b02416; Globyte V., 2018, BIORXIV, DOI [10.1101/264879, DOI 10.1101/264879]; Gong B, 2014, P NATL ACAD SCI USA, V111, P16359, DOI 10.1073/pnas.1410806111; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Jung C, 2017, CELL, V170, P35, DOI 10.1016/j.cell.2017.05.044; Kim Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01984-x; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Krivoy A, 2018, NUCLEIC ACIDS RES, V46, P4087, DOI 10.1093/nar/gky219; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Kunne T, 2016, MOL CELL, V63, P852, DOI 10.1016/j.molcel.2016.07.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Loeff L, 2018, MOL CELL, V70, P385, DOI 10.1016/j.molcel.2018.03.031; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Tay M, 2015, PROTEIN SCI, V24, P236, DOI 10.1002/pro.2609; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Xiao YB, 2017, CELL, V170, P48, DOI 10.1016/j.cell.2017.06.012; Xue CY, 2017, CELL REP, V21, P3717, DOI 10.1016/j.celrep.2017.11.110; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	45	43	45	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					934	+		10.1016/j.cell.2018.09.039	http://dx.doi.org/10.1016/j.cell.2018.09.039			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30343903	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000449100600009
J	Kotler, E; Segal, E				Kotler, Eran; Segal, Eran			The Helix Twist: Damage and Repair Follows the DNA Minor Groove	CELL			English	Editorial Material								Mutation frequencies vary along the genome, but the factors determining this variability are only partially understood. Pich et al. unravel a similar to 10 bp periodicity in mutation rates at nucleosome-proximal regions that follows minor groove orientation. Opposing differential DNA damage and repair processes could shape genetic divergence irrespective of selection.	[Kotler, Eran; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Kotler, Eran; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Kotler, E; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel.; Kotler, E; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.	eran.kotler@weizmann.ac.il; eran.segal@weizmann.ac.il	Segal, Eran/AAF-4855-2019		Crown Human Genome Center; Else Kroener Fresenius Foundation; Adelis Foundation; European Research Council; Israel Science Foundation	Crown Human Genome Center; Else Kroener Fresenius Foundation; Adelis Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	E.S. is supported by the Crown Human Genome Center, the Else Kroener Fresenius Foundation, D.L. Schwarz, J.N. Halpern, L. Steinberg, J. Benattar, Aliza Moussaieff, Adelis Foundation, and grants funded by the European Research Council and the Israel Science Foundation.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], TITLE ERROR; Azmi IF, 2017, ELIFE, V6, DOI 10.7554/eLife.22512; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	8	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					902	904		10.1016/j.cell.2018.10.034	http://dx.doi.org/10.1016/j.cell.2018.10.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388449	Bronze			2022-12-28	WOS:000449100600005
J	Naik, S; Larsen, SB; Cowley, CJ; Fuchs, E				Naik, Shruti; Larsen, Samantha B.; Cowley, Christopher J.; Fuchs, Elaine			Two to Tango: Dialog between Immunity and Stem Cells in Health and Disease	CELL			English	Review							REGULATORY T-CELLS; HEMATOPOIETIC STEM; SKELETAL-MUSCLE; MATERNAL INFECTION; INNATE; INFLAMMATION; MACROPHAGES; NICHE; REGENERATION; PROGENITORS	Stem cells regenerate tissues in homeostasis and under stress. By taking cues from their microenvironment or "niche,'' they smoothly transition between these states. Immune cells have surfaced as prominent members of stem cell niches across the body. Here, we draw parallels between different stem cell niches to explore the context-specific interactions that stem cells have with tissue-resident and recruited immune cells. We also highlight stem cells' innate ability to sense and respond to stress and the enduring memory that forms from such encounters. This fascinating crosstalk holds great promise for novel therapies in inflammatory diseases and regenerative medicine.	[Naik, Shruti; Larsen, Samantha B.; Cowley, Christopher J.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA; [Naik, Shruti] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Naik, Shruti] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University	Naik, S; Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Chemers Neustein Lab Mammalian Cell Biol &, New York, NY 10065 USA.; Naik, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Naik, S (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA.	shruti.naik@nyumc.org; fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Larsen, Samantha/0000-0001-6392-2350	Damon Runyon Dale F. Frey Award [DFS-30-18]; Ruth L Kirschstein Predoctoral Individual NRSA Fellowship [1F31AR068920-01A1]; NIH [R01-AR050452, R01-AR31737]; L'Oreal For Women in Science Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR068920, R01AR031737, R01AR050452] Funding Source: NIH RePORTER	Damon Runyon Dale F. Frey Award; Ruth L Kirschstein Predoctoral Individual NRSA Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Oreal For Women in Science Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Sigrid Knemeyer for illustrating our figures. We are also grateful to the many friends and colleagues in the stem cell and immunology fields whose work inspired us to write this review. Given the reference constraints, we regret that we could not cite all of the worthy papers on this topic. However, we have tried to present a balanced view of the field, attempting to clarify areas of seeming discrepancies and presenting the exciting areas of research that await us all. S.N. is a recipient of the Damon Runyon Dale F. Frey Award for Breakthrough Scientists (DFS-30-18). S.B.L. is the recipient of a Ruth L Kirschstein Predoctoral Individual NRSA Fellowship (1F31AR068920-01A1). E.F. is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants from the NIH (R01-AR050452 and R01-AR31737, E.F.) and a L'Oreal For Women in Science Fellowship (S.N.).	Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Ayyaz A, 2015, NAT CELL BIOL, V17, P736, DOI 10.1038/ncb3174; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biton M., 2017, BIORXIV; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Bowers E, 2018, NAT MED, V24, P95, DOI 10.1038/nm.4448; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Castellana D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002002; Chakrabarti R, 2018, SCIENCE, V360, P1421, DOI 10.1126/science.aan4153; Chen CC, 2015, CELL, V161, P277, DOI 10.1016/j.cell.2015.02.016; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Du HQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00522-7; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Hofmeister BT, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1288-x; Holmberg FEO, 2017, EMBO MOL MED, V9, P558, DOI 10.15252/emmm.201607260; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jiang HY, 2016, BRAIN BEHAV IMMUN, V58, P165, DOI 10.1016/j.bbi.2016.06.005; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064; Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Matsumura H., 2016, INFLAMM BOWEL DIS, V20, P1829; Metchnikoff E., 1893, LECT COMP PATHOLOGY; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Nosbaum A, 2016, J IMMUNOL, V196, P2010, DOI 10.4049/jimmunol.1502139; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Tan DWM, 2014, CURR TOP DEV BIOL, V107, P77, DOI 10.1016/B978-0-12-416022-4.00003-2; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Vahedi G, 2013, IMMUNOL REV, V252, P24, DOI 10.1111/imr.12037; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Xia PY, 2018, IMMUNITY, V48, P688, DOI 10.1016/j.immuni.2018.03.016; Yang H, 2017, CELL, V169, P483, DOI 10.1016/j.cell.2017.03.038; Yang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep07820; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085; Zindl CL, 2010, SCIENCE, V328, P697, DOI 10.1126/science.1190310	87	105	106	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					908	920		10.1016/j.cell.2018.08.071	http://dx.doi.org/10.1016/j.cell.2018.08.071			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388451	Green Accepted, Bronze			2022-12-28	WOS:000449100600007
J	Dyer, C				Dyer, Clare			British man with CJD gets experimental treatment in world first	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		In the matter of the Mental Capacity Act, 2005, EWCOP 29	1	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4608	10.1136/bmj.k4608	http://dx.doi.org/10.1136/bmj.k4608			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PY	30381386				2022-12-28	WOS:000449564200014
J	Kessler, DS; MacNeill, SJ; Tallon, D; Lewis, G; Peters, TJ; Hollingworth, W; Round, J; Burns, A; Chew-Graham, CA; Anderson, IM; Shepherd, T; Campbell, J; Dickens, CM; Carter, M; Jenkinson, C; Macleod, U; Gibson, H; Davies, S; Wiles, NJ				Kessler, David S.; MacNeill, Stephanie J.; Tallon, Deborah; Lewis, Glyn; Peters, Tim J.; Hollingworth, William; Round, Jeff; Burns, Alison; Chew-Graham, Carolyn A.; Anderson, Ian M.; Shepherd, Tom; Campbell, John; Dickens, Chris M.; Carter, Mary; Jenkinson, Caroline; Macleod, Una; Gibson, Helen; Davies, Simon; Wiles, Nicola J.			Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; DISORDER; MEDICATIONS; COMBINATION; OUTCOMES	OBJECTIVE To investigate the effectiveness of combining mirtazapine with serotonin-noradrenaline reuptake inhibitor (SNRI) or selective serotonin reuptake inhibitor (SSRI) antidepressants for treatment resistant depression in primary care. DESIGN Two parallel group multicentre phase III randomised placebo controlled trial. SETTING 106 general practices in four UK sites; Bristol, Exeter, Hull, and Keele/North Staffs, August 2013 to October 2015. PARTICIPANTS 480 adults aged 18 or more years who scored 14 or more on the Beck depression inventory, second revision, fulfilled ICD-10 (international classification of diseases, 10th revision) criteria for depression, and had used an SSRI or SNRI for at least six weeks but were still depressed. 241 were randomised to mirtazapine and 239 to placebo, both given in addition to usual SSRI or SNRI treatment. Participants were stratified by centre and minimised by baseline Beck depression inventory score, sex, and current psychological therapy. They were followed up at 12, 24, and 52 weeks. 431 (89.8%) were included in the (primary) 12 week follow-up. MAIN OUTCOME MEASURES Depressive symptoms at 12 weeks after randomisation, measured using the Beck depression inventory II score as a continuous variable. Secondary outcomes included measures of anxiety, quality of life, and adverse effects at 12, 24, and 52 weeks. RESULTS Beck depression inventory II scores at 12 weeks were lower in the mirtazapine group after adjustment for baseline scores and minimisation or stratification variables, although the confidence interval included the null (mean (SD) scores at 12 weeks: 18.0 (12.3) in the mirtazapine group, 19.7 (12.4) in the placebo group; adjusted difference between means -1.83 (95% confidence interval -3.92 to 0.27); P= 0.09). Adverse effects were more common in the mirtazapine group and were associated with the participants stopping the trial drug. CONCLUSION This study did not find evidence of a clinically important benefit for mirtazapine in addition to an SSRI or SNRI over placebo in a treatment resistant group of primary care patients with depression. This remains an area of important unmet need where evidence of effective treatment options is limited.	[Kessler, David S.; Tallon, Deborah; Peters, Tim J.; Hollingworth, William; Round, Jeff; Burns, Alison; Wiles, Nicola J.] Univ Bristol Sch Med, Populat Hlth Sci, Bristol BS8 2BN, Avon, England; [MacNeill, Stephanie J.] Univ Bristol Sch Med, Bristol Randomised Trials Collaborat, Populat Hlth Sci, Bristol, Avon, England; [Lewis, Glyn] UCL, Div Psychiat, London, England; [Chew-Graham, Carolyn A.; Shepherd, Tom] Keele Univ, Primary Care & Hlth Sci, Keele, Staffs, England; [Anderson, Ian M.] Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Campbell, John; Dickens, Chris M.; Carter, Mary; Jenkinson, Caroline] Univ Exeter, Exeter Med Sch, Exeter, Devon, England; [Macleod, Una; Gibson, Helen] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Davies, Simon] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Bristol; University of Bristol; University of London; University College London; Keele University; University of Manchester; University of Exeter; University of Hull; University of York - UK; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Kessler, DS (corresponding author), Univ Bristol Sch Med, Populat Hlth Sci, Bristol BS8 2BN, Avon, England.	david.kessler@bristol.ac.uk	Kessler, david/ABB-6489-2021; Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245; kessler, david/0000-0001-5333-132X; Peters, Tim/0000-0003-2881-4180; Round, Jeff/0000-0002-3103-6984; Shepherd, Tom/0000-0002-8311-7452; Campbell, John/0000-0002-6752-3493; Wiles, Nicola/0000-0002-5250-3553; Davies, Simon/0000-0003-0095-5993; Hollingworth, William/0000-0002-0840-6254; Jenkinson, Caroline/0000-0002-9978-185X; CHEW-GRAHAM, CAROLYN/0000-0002-9722-9981	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme [11/129/76]; NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust; University of Bristol	This research was funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project 11/129/76) and supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or Department of Health. The funding source had no role in study design, data collection, data analysis, interpretation of data, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 1992, ICD 10; [Anonymous], 2016, VALUING HLTH RELATED; Beck A.T., 1996, MANUAL BECK DEPRESSI; Blier P, 2010, AM J PSYCHIAT, V167, P281, DOI 10.1176/appi.ajp.2009.09020186; Blier P, 2009, EUR NEUROPSYCHOPHARM, V19, P457, DOI 10.1016/j.euroneuro.2009.01.015; Button KS, 2015, PSYCHOL MED, V45, P3269, DOI 10.1017/S0033291715001270; Carpenter LL, 2002, BIOL PSYCHIAT, V51, P183, DOI 10.1016/S0006-3223(01)01262-8; Cleare A, 2015, J PSYCHOPHARMACOL, V29, P459, DOI 10.1177/0269881115581093; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Fekadu A, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1679-x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; MacNeill SP. TJ, 2016, MIR TRIAL MIRTAZAPIN; Mathers CD., 2005, EVIDENCE INFORM POLI; [National Collaborating Centre for Mental Health National Institute for Health and Clinical Excellence], 2010, NICE GUID TREAT MAN; Prescribing and Medicines Team Health and Social Care Information Centre, 2015, PERSCR DISP COMM, P2004; Rocha FL, 2013, J AFFECT DISORDERS, V144, P1, DOI 10.1016/j.jad.2012.04.048; Rush AJ, 2011, AM J PSYCHIAT, V168, P689, DOI 10.1176/appi.ajp.2011.10111645; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; StataCorp, 2015, STAT STAT SOFTW REL; Thomas L, 2013, BRIT J GEN PRACT, V63, pE852, DOI 10.3399/bjgp13X675430; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uher R, 2009, BRIT J PSYCHIAT, V195, P202, DOI 10.1192/bjp.bp.108.061960; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wiles N, 2013, LANCET, V381, P375, DOI 10.1016/S0140-6736(12)61552-9	28	29	29	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4218	10.1136/bmj.k4218	http://dx.doi.org/10.1136/bmj.k4218			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ6PY	30381374	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000449564200001
J	Corces, MR; Granja, JM; Shams, S; Louie, BH; Seoane, JA; Zhou, WD; Silva, TC; Groeneveld, C; Wong, CK; Cho, SW; Satpathy, AT; Mumbach, MR; Hoadley, KA; Robertson, AG; Sheffield, NC; Felau, I; Castro, MAA; Berman, BP; Staudt, LM; Zenklusen, JC; Laird, PW; Curtis, C; Greenleaf, WJ; Chang, HY				Corces, M. Ryan; Granja, Jeffrey M.; Shams, Shadi; Louie, Bryan H.; Seoane, Jose A.; Zhou, Wanding; Silva, Tiago C.; Groeneveld, Clarice; Wong, Christopher K.; Cho, Seung Woo; Satpathy, Ansuman T.; Mumbach, Maxwell R.; Hoadley, Katherine A.; Robertson, A. Gordon; Sheffield, Nathan C.; Felau, Ina; Castro, Mauro A. A.; Berman, Benjamin P.; Staudt, Louis M.; Zenklusen, Jean C.; Laird, Peter W.; Curtis, Christina; Greenleaf, William J.; Chang, Howard Y.		Canc Genome Atlas Anal Network	The chromatin accessibility landscape of primary human cancers	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ENHANCER; REVEALS; BINDING; TUMORS; METHYLOME; CRISPR; RISK	We present the genome-wide chromatin accessibility profiles of 410 tumor samples spanning 23 cancer types from The Cancer Genome Atlas (TCGA). We identify 562,709 transposase-accessible DNA elements that substantially extend the compendium of known cis-regulatory elements. Integration of ATAC-seq (the assay for transposase-accessible chromatin using sequencing) with TCGA multi-omic data identifies a large number of putative distal enhancers that distinguish molecular subtypes of cancers, uncovers specific driving transcription factors via protein-DNA footprints, and nominates long-range gene-regulatory interactions in cancer. These data reveal genetic risk loci of cancer predisposition as active DNA regulatory elements in cancer, identify gene-regulatory interactions underlying cancer immune evasion, and pinpoint noncoding mutations that drive enhancer activation and may affect patient survival. These results suggest a systematic approach to understanding the noncoding genome in cancer to advance diagnosis and therapy.	[Corces, M. Ryan; Granja, Jeffrey M.; Shams, Shadi; Louie, Bryan H.; Cho, Seung Woo; Satpathy, Ansuman T.; Mumbach, Maxwell R.; Greenleaf, William J.; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Granja, Jeffrey M.; Seoane, Jose A.; Mumbach, Maxwell R.; Curtis, Christina; Greenleaf, William J.; Chang, Howard Y.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Granja, Jeffrey M.; Greenleaf, William J.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Zhou, Wanding] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Silva, Tiago C.; Berman, Benjamin P.] Cedars Sinai Med Ctr, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Silva, Tiago C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, BR-14040905 Ribeirao Preto, SP, Brazil; [Groeneveld, Clarice] Univ Fed Parana, Polytech Ctr, Bioinformat & Syst Biol Lab, BR-80060000 Curitiba, PR, Brazil; [Wong, Christopher K.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Hoadley, Katherine A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Robertson, A. Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Sheffield, Nathan C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Staudt, Louis M.; Zenklusen, Jean C.] NCI, NIH, Bethesda, MD 20892 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Sci, Menlo Pk, CA 94025 USA; [Greenleaf, William J.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Van Andel Institute; Cedars Sinai Medical Center; Universidade de Sao Paulo; Universidade Federal do Parana; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Greenleaf, WJ; Chang, HY (corresponding author), Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Greenleaf, WJ; Chang, HY (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA.; Greenleaf, WJ (corresponding author), Stanford Univ, Dept Appl Sci, Menlo Pk, CA 94025 USA.; Greenleaf, WJ (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Chang, HY (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.; Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	wjg@stanford.edu; howchang@stanford.edu	Jones, Steven J/C-3621-2009; BERMAN, BENJAMIN/AAT-3720-2021; Castro, Mauro A. A./A-5467-2008; Sheffield, Nathan/ABG-8124-2020; Corces, M. Ryan/ABG-6947-2020; Laird, Peter W/G-8683-2012; Cho, Seung Woo/B-2441-2019; Chedraoui Silva, Tiago/S-1449-2017; Staudt, Louis/AAC-5324-2019; Silva, Tiago Chedraoui/AAD-2280-2020; Doane, Ashley Stephen/A-6442-2015; Seoane, Jose A./A-5926-2011; Zhou, Wanding/K-3709-2016	Jones, Steven J/0000-0003-3394-2208; BERMAN, BENJAMIN/0000-0002-2099-9005; Castro, Mauro A. A./0000-0003-4942-8131; Sheffield, Nathan/0000-0001-5643-4068; Corces, M. Ryan/0000-0001-7465-7652; Laird, Peter W/0000-0001-9117-3641; Cho, Seung Woo/0000-0001-9091-0937; Chedraoui Silva, Tiago/0000-0003-1343-6850; Doane, Ashley Stephen/0000-0002-1489-1786; Seoane, Jose A./0000-0002-3856-9177; Hoadley, Katherine/0000-0002-1216-477X; Tarnuzzer, Roy/0000-0002-3725-4173; Groeneveld, Clarice/0000-0001-5222-2586; Zhou, Wanding/0000-0001-9126-1932; Louie, Bryan/0000-0001-6922-5396; , Chris/0000-0001-6012-7001	National Cancer Institute, NIH [R35-CA209919, P50-HG007735]; Parker Institute for Cancer Immunotherapy; NIH [K99-AG059918]; NIH Genomic Data Analysis Networks [1U24CA210974-01, 1U24CA210949-01, 1U24CA210978-01, 1U24CA210952-01, 1U24CA210989-01, 1U24CA210990-01, 1U24CA210950-01, 1U24CA210969-01, 1U24CA210988-01]; NATIONAL CANCER INSTITUTE [U24CA210988, U24CA210949, U24CA210978, U24CA210989, U24CA210990, U24CA210974, U24CA210950, U24CA210952, R35CA209919, U24CA210969] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG059918] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parker Institute for Cancer Immunotherapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Genomic Data Analysis Networks(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the National Cancer Institute, NIH grants R35-CA209919 (to H.Y.C.), P50-HG007735 (to H.Y.C. and W.J.G.), and the Parker Institute for Cancer Immunotherapy (H.Y.C.). M.R.C. is supported by NIH K99-AG059918. Additional support through the NIH Genomic Data Analysis Networks 1U24CA210974-01 (J. Zhu), 1U24CA210949-01 (J. N. Weinstein), 1U24CA210978-01 (R. Beroukhim), 1U24CA210952-01 (S. J. Jones), 1U24CA210989-01 (O. Elemento), 1U24CA210990-01 (J. Stuart), 1U24CA210950-01 (R. Akbani), 1U24CA210969-01 (P.W.L.), and 1U24CA210988-01 (K.A.H.). W.J.G. is a Chan-Zuckerberg Biohub Investigator. H.Y.C. is an Investigator of the Howard Hughes Medical Institute.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Almamun M, 2015, EPIGENETICS-US, V10, P882, DOI 10.1080/15592294.2015.1078050; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Baek S, 2017, CELL REP, V19, P1710, DOI 10.1016/j.celrep.2017.05.003; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen H, 2018, CELL, V173, P386, DOI 10.1016/j.cell.2018.03.027; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Eom YH, 2016, J BREAST CANCER, V19, P252, DOI 10.4048/jbc.2016.19.3.252; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He YP, 2017, P NATL ACAD SCI USA, V114, pE1633, DOI 10.1073/pnas.1618353114; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim HS, 2018, NATURE, V556, P510, DOI 10.1038/s41586-018-0048-8; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Makowski MM, 2016, PROTEOMICS, V16, P417, DOI 10.1002/pmic.201500327; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schuijers J, 2018, CELL REP, V23, P349, DOI 10.1016/j.celrep.2018.03.056; Shen H, 2018, CELL REP, V23, P3392, DOI 10.1016/j.celrep.2018.05.039; Silva T. C., 2017, 148726 BIORXIV, DOI [10.1101/148726, DOI 10.1101/148726]; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Werner S, 2013, J BIOL CHEM, V288, P22993, DOI 10.1074/jbc.M113.456293; Yao LJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0668-3; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhou WD, 2018, NAT GENET, V50, P591, DOI 10.1038/s41588-018-0073-4	54	417	423	11	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					420	+	eaav1898	10.1126/science.aav1898	http://dx.doi.org/10.1126/science.aav1898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361341	Green Accepted, Green Submitted			2022-12-28	WOS:000450441900039
J	Dixon, J; Street, A; Allwood, D				Dixon, Jennifer; Street, Andrew; Allwood, Dominique			NHS AT 70 Productivity in the NHS: why it matters and what to do next	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; GROWTH		[Dixon, Jennifer; Allwood, Dominique] Hlth Fdn, London, England; [Street, Andrew] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England	University of London; London School Economics & Political Science	Dixon, J (corresponding author), Hlth Fdn, London, England.	jennifer.dixon@health.org.uk		Street, Andrew David/0000-0002-2540-0364				Black N, 2017, J HEALTH SERV RES PO, V22, P73, DOI 10.1177/1355819616685739; Bloom N, 2011, 12052 HARV BUS SCH; Bloom N, 2012, AM ECON REV, V102, P167, DOI 10.1257/aer.102.1.167; Bojke C, 2017, 146 U YORK CTR HLTH; Bojke C, 2017, HEALTH ECON, V26, P547, DOI 10.1002/hec.3338; Braun T, 2015, J PUBLIC HEALTH-UK, V37, P138, DOI 10.1093/pubmed/fdu043; Castelli A, 2018, PRODUCTIVITY ENGLISH; Davies E, 2016, PRESSURE WHAT COMMON; Dyess SM, 2017, J CONTIN EDUC NURS, V48, P373, DOI 10.3928/00220124-20170712-10; Eurostat, EUR SYST ACC ESA 201; House of Commons Public Accounts Committee, 2016, MAN SUPPL NHS CLIN S; Jones B., 2015, BUILDING FDN IMPROVE; Kraindler J, 2018, FALSE EC ANAL NHS FU; Krugman P., 1994, AGE DIMINISHING EXPE; Kumar S, 2002, AM ECON REV, V92, P527, DOI 10.1257/00028280260136381; Lalfond S, 2017, A YEAR OF PLENTY; Lee T, 2018, SECURING FUTURE FUND; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Mays N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1849; MCA, FLOW COACH AC; Moberly Tom, 2018, BMJ, V361, pk2210, DOI 10.1136/bmj.k2210; National Audit Office, 2018, SUST TRANSF NHS; NHS Employers, 2018, NHS HLTH WELLB FRAM; Niezen MGH, 2014, HEALTH POLICY, V117, P151, DOI 10.1016/j.healthpol.2014.04.016; Office for National Statistics, 2016, METH NAT ACC; Steventon A., 2018, EMERGENCY HOSP ADMIS; Susskind D, 2017, FUTURE PROFESSIONS; Wise J, 2018, TELEGRAPH	29	5	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2018	363								k4301	10.1136/bmj.k4301	http://dx.doi.org/10.1136/bmj.k4301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8QD	30366910				2022-12-28	WOS:000448896600002
J	Zhu, YJ; Nachtrab, G; Keyes, PC; Allen, WE; Luo, LQ; Chen, XK				Zhu, Yingjie; Nachtrab, Gregory; Keyes, Piper C.; Allen, William E.; Luo, Liqun; Chen, Xiaoke			Dynamic salience processing in paraventricular thalamus gates associative learning	SCIENCE			English	Article							NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; PARIETAL CORTEX; PRIORITY MAP; REWARD; ATTENTION; BEHAVIOR; MAINTENANCE; PROJECTIONS; CIRCUITS	The salience of behaviorally relevant stimuli is dynamic and influenced by internal state and external environment. Monitoring such changes is critical for effective learning and flexible behavior, but the neuronal substrate for tracking the dynamics of stimulus salience is obscure. We found that neurons in the paraventricular thalamus (PVT) are robustly activated by a variety of behaviorally relevant events, including novel ("unfamiliar") stimuli, reinforcing stimuli and their predicting cues, as well as omission of the expected reward. PVT responses are scaled with stimulus intensity and modulated by changes in homeostatic state or behavioral context. Inhibition of the PVT responses suppresses appetitive or aversive associative learning and reward extinction. Our findings demonstrate that the PVT gates associative learning by providing a dynamic representation of stimulus salience.	[Zhu, Yingjie; Nachtrab, Gregory; Keyes, Piper C.; Allen, William E.; Luo, Liqun; Chen, Xiaoke] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zhu, Yingjie] Chinese Acad Sci, Shenzhen Inst Adv Technol, Brain Cognit & Brain Dis Inst, Guangdong Prov Key Lab Brain Connectome & Behav, Shenzhen 518055, Peoples R China; [Keyes, Piper C.; Allen, William E.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Stanford University; Howard Hughes Medical Institute; Stanford University	Chen, XK (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	xkchen@stanford.edu		Luo, Liqun/0000-0001-5467-9264; Zhu, Yingjie/0000-0002-0783-0897; chen, xiaoke/0000-0001-9032-9093	Whitehall Foundation; Ajinomoto Innovation Alliance Program; Terman Fellowship; Friminich Scholarship; Stanford Neuroscience Institute's Neurochoice Initiative; Stanford University; National Alliance for Research on Schizophrenia and Depression Young Investigator Grant from the Brain and Behavior Research Foundation; National Natural Science Foundation of China [31741058]; Thousand Youth Talents Plan; National Institute on Drug Abuse [5T32DA035165-02]; Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowship; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA035165] Funding Source: NIH RePORTER	Whitehall Foundation; Ajinomoto Innovation Alliance Program; Terman Fellowship; Friminich Scholarship; Stanford Neuroscience Institute's Neurochoice Initiative; Stanford University(Stanford University); National Alliance for Research on Schizophrenia and Depression Young Investigator Grant from the Brain and Behavior Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Plan; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Fannie and John Hertz Foundation Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from The Whitehall Foundation, Ajinomoto Innovation Alliance Program, Terman Fellowship, Friminich Scholarship, the Stanford Neuroscience Institute's Neurochoice Initiative, and start-up funding from Stanford University (to X.C.). Y.Z. is partially supported by a National Alliance for Research on Schizophrenia and Depression Young Investigator Grant from the Brain and Behavior Research Foundation, National Natural Science Foundation of China (grant 31741058), and The Thousand Youth Talents Plan. G.N. is supported by a training grant from the National Institute on Drug Abuse (5T32DA035165-02). W.E.A. is supported by a Fannie and John Hertz Foundation Fellowship and a NSF Graduate Research Fellowship. L.L. is an investigator of the Howard Hughes Medical Institute.	Acsady L, 2017, NAT NEUROSCI, V20, P901, DOI 10.1038/nn.4583; Allen WE, 2017, SCIENCE, V357, P1149, DOI 10.1126/science.aan6747; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bolkan SS, 2017, NAT NEUROSCI, V20, P987, DOI 10.1038/nn.4568; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi EA, 2017, J NEUROSCI, V37, P3018, DOI 10.1523/JNEUROSCI.3320-16.2017; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Do-Monte FH, 2017, NEURON, V94, P388, DOI 10.1016/j.neuron.2017.03.036; Do-Monte FH, 2015, NATURE, V519, P460, DOI 10.1038/nature14030; Dong XW, 2017, BRAIN STRUCT FUNCT, V222, P3927, DOI 10.1007/s00429-017-1445-8; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Ghazizadeh A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00378; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Hall G, 2017, J EXP PSYCHOL-ANIM L, V43, P48, DOI 10.1037/xan0000129; Hsu DT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00073; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Lin SC, 2008, NEURON, V59, P138, DOI 10.1016/j.neuron.2008.04.031; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Menon V., 2015, BRAIN MAPPING ENCY R, P561, DOI [10.1016/B978-0-12-397025-1.00052-X, DOI 10.1016/B978-0-12-397025-1.00052-X]; Millan EZ, 2017, PROG BRAIN RES, V235, P113, DOI 10.1016/bs.pbr.2017.07.006; Ogawa M, 2013, NEURON, V77, P251, DOI 10.1016/j.neuron.2012.11.006; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Parsons MP, 2007, J COMP NEUROL, V500, P1050, DOI 10.1002/cne.21224; Penzo MA, 2015, NATURE, V519, P455, DOI 10.1038/nature13978; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Schmitt LI, 2017, NATURE, V545, P219, DOI 10.1038/nature22073; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Tian J, 2016, NEURON, V91, P1374, DOI 10.1016/j.neuron.2016.08.018; Toth LJ, 2002, NATURE, V415, P165, DOI 10.1038/415165a; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wagner MJ, 2017, NATURE, V544, P96, DOI 10.1038/nature21726; Zhu YJ, 2016, NATURE, V530, P219, DOI 10.1038/nature16954	39	80	82	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					423	+		10.1126/science.aat0481	http://dx.doi.org/10.1126/science.aat0481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361366	Green Accepted			2022-12-28	WOS:000450441900042
J	Barbour, V				Barbour, Virginia			Virginia Barbour: Queen of open access	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barbour, Virginia] Comm Publicat Eth, Eastleigh, Hants, England; [Barbour, Virginia] Queensland Univ Technol, Brisbane, Qld, Australia; [Barbour, Virginia] Australasian Open Access Strategy Grp, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Barbour, V (corresponding author), Queensland Univ Technol, Brisbane, Qld, Australia.; Barbour, V (corresponding author), Australasian Open Access Strategy Grp, Brisbane, Qld, Australia.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4148	10.1136/bmj.k4148	http://dx.doi.org/10.1136/bmj.k4148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355729				2022-12-28	WOS:000448895300002
J	Kuehn, B				Kuehn, Bridget			Chronic Pain Prevalence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	19	19	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1632	1632		10.1001/jama.2018.16009	http://dx.doi.org/10.1001/jama.2018.16009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357307				2022-12-28	WOS:000448069100005
J	Gill, ME; Peters, AHFM				Gill, Mark E.; Peters, Antoine H. F. M.			Toward human egg-like cells in vitro Human precursor egg-like cells are produced in mouse ovary organoids to study infertility	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS; PRIMORDIAL GERM-CELL; FATE; RECONSTITUTION; SPECIFICATION; INDUCTION		[Gill, Mark E.; Peters, Antoine H. F. M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Peters, Antoine H. F. M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Peters, AHFM (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.; Peters, AHFM (corresponding author), Univ Basel, Fac Sci, CH-4056 Basel, Switzerland.	antoine.peters@fmi.ch	Peters, Antoine/ABA-6283-2020	Gill, Mark/0000-0002-2069-958X; Peters, Antoine/0000-0002-0311-1887	Novartis Research Foundation; European Research Counsel [ERC 695288]	Novartis Research Foundation; European Research Counsel	The authors receive funding from the Novartis Research Foundation and the European Research Counsel (ERC 695288-Totipotency).	Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Hikabe O, 2016, NATURE, V539, P299, DOI 10.1038/nature20104; Hill JR, 2014, ANNU REV ANIM BIOSCI, V2, P307, DOI 10.1146/annurev-animal-022513-114109; Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964; Inoue A, 2017, NATURE, V547, P419, DOI 10.1038/nature23262; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kobayashi T, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162594; Li L, 2017, CELL STEM CELL, V20, P858, DOI 10.1016/j.stem.2017.03.007; Nagaoka SI, 2017, COLD SH Q B, V82, P213, DOI 10.1101/sqb.2017.82.033803; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; von Meyenn F, 2015, CELL, V161, P1248, DOI 10.1016/j.cell.2015.05.039; Yamashiro C, 2018, SCIENCE, V362, P356, DOI 10.1126/science.aat1674; Yokobayashi S, 2017, BIOL REPROD, V96, P1154, DOI 10.1093/biolre/iox038; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918	15	0	1	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					291	292		10.1126/science.aav3479	http://dx.doi.org/10.1126/science.aav3479			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337398				2022-12-28	WOS:000447680100027
J	O'Dowd, A				O'Dowd, Adrian			Doctors need to improve their conversations with dying patients, says RCP	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4330	10.1136/bmj.k4330	http://dx.doi.org/10.1136/bmj.k4330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341062				2022-12-28	WOS:000448271300003
J	Negnevitsky, V; Marinelli, M; Mehta, KK; Lo, HY; Fluhmann, C; Home, JP				Negnevitsky, V.; Marinelli, M.; Mehta, K. K.; Lo, H. -Y.; Fluhmann, C.; Home, J. P.			Repeated multi-qubit readout and feedback with a mixed-species trapped-ion register	NATURE			English	Article							QUANTUM ERROR-CORRECTION; LOGIC GATES; REALIZATION; SPECTROSCOPY; SET	Quantum error correction is essential for realizing the full potential of large-scale quantum information processing devices(1,2). Fundamental to its experimental realization is the repetitive detection of errors via projective measurements of quantum correlations among qubits, as well as corrections using conditional feedback(3). Repetitive application of such tasks requires that they neither induce unwanted crosstalk nor impede further control operations, which is challenging owing to the need to dissipatively couple qubits to the classical world for detection and reinitialization. For trapped ions, state readout involves scattering large numbers of resonant photons, which increases the probability of stray light causing errors on nearby qubits and leads to undesirable recoil heating of the ion motion. Here we demonstrate up to 50 sequential measurements of correlations between two beryllium ion microwave qubits using an ancillary optical qubits in a calcium ion, and implement feedback that allows us to stabilize two-qubit subspaces as well as Bell states, a class of maximally entangled states. Multiqubit mixed-species gates are used to transfer information within the register from the qubits to the ancilla, enabling readout with negligible crosstalk to the data qubits. Heating of the ion motion during detection is mitigated by recooling all three ions using light that interacts with only the calcium ion, known as sympathetic cooling. A key element of our experimental setup is a powerful classical control system that features flexible in-sequence processing for feedback control. The methods employed here provide essential tools for scaling trapped-ion quantum computing, quantum-state control and entanglement-enhanced quantum metrology(1).	[Negnevitsky, V.; Marinelli, M.; Mehta, K. K.; Lo, H. -Y.; Fluhmann, C.; Home, J. P.] Swiss Fed Inst Technol, Inst Quantum Elect, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Negnevitsky, V; Marinelli, M; Home, JP (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, Zurich, Switzerland.	nvlad@phys.ethz.ch; mmatteo@phys.ethz.ch; jhome@phys.ethz.ch			Swiss National Science Foundation [200020_165555]; National Centre of Competence in Research for Quantum Science and Technology (QSIT) [51NF40-160591]; ETH Zurich Postdoctoral Fellowship; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via the US Army Research Office [W911NF-16-1-0070]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research for Quantum Science and Technology (QSIT); ETH Zurich Postdoctoral Fellowship; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via the US Army Research Office	We thank D. Kienzler, L. de Clercq and D. Nadlinger for contributions to the apparatus, J. Alonso for discussions and M. Grau and T.-L. Nguyen for reading the manuscript. We acknowledge support from the Swiss National Science Foundation through research grant 200020_165555 and through grant 51NF40-160591 from the National Centre of Competence in Research for Quantum Science and Technology (QSIT). K.K.M. is supported by an ETH Zurich Postdoctoral Fellowship. This research is partly based on work supported by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), via the US Army Research Office grant W911NF-16-1-0070. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the ODNI, IARPA or the US Government. The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the view of the US Army Research Office.	Ballance CJ, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060504; Ballance CJ, 2015, NATURE, V528, P384, DOI 10.1038/nature16184; Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Brown NC, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.052301; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Cory DG, 1998, PHYS REV LETT, V81, P2152, DOI 10.1103/PhysRevLett.81.2152; Cramer J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11526; de Clercq LE, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.080502; Gaebler JP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060505; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; Home JP, 2013, ADV ATOM MOL OPT PHY, V62, P231, DOI 10.1016/B978-0-12-408090-4.00004-9; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Keitch B, 2017, PROGRAMMABLE SCALABL; Kienzler D, 2015, SCIENCE, V347, P53, DOI 10.1126/science.1261033; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Ralph TC, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012113; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Riste D, 2013, NATURE, V502, P350, DOI 10.1038/nature12513; Roos CF, 2000, PHYS REV LETT, V85, P5547, DOI 10.1103/PhysRevLett.85.5547; Schafer VM, 2018, NATURE, V555, P75, DOI 10.1038/nature25737; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042322; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Sun L, 2014, NATURE, V511, P444, DOI 10.1038/nature13436; Tan TR, 2015, NATURE, V528, P380, DOI 10.1038/nature16186	38	72	72	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2018	563	7732					527	+		10.1038/s41586-018-0668-z	http://dx.doi.org/10.1038/s41586-018-0668-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB3OD	30397345	Green Submitted			2022-12-28	WOS:000450960000047
J	Wang, XJ; Malhi, H				Wang, Xiao Jing; Malhi, Harmeet			Nonalcoholic Fatty Liver Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEPATIC STEATOSIS; UNITED-STATES; WEIGHT-LOSS; VITAMIN-E; STEATOHEPATITIS; CIRRHOSIS; FIBROSIS; DIAGNOSIS; TRANSPLANTATION; UTILITY		[Wang, Xiao Jing; Malhi, Harmeet] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Wang, XJ (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.				American College of Physicians; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111378] Funding Source: NIH RePORTER	American College of Physicians; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American College of Physicians.	Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; Browning JD, 2011, AM J CLIN NUTR, V93, P1048, DOI 10.3945/ajcn.110.007674; Caussy C, 2018, HEPATOLOGY, V68, P763, DOI 10.1002/hep.29797; Caussy C, 2017, J CLIN INVEST, V127, P2697, DOI 10.1172/JCI93465; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalasani NP, 2009, CONTEMP CLIN TRIALS, V30, P88, DOI 10.1016/j.cct.2008.09.003; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Crossan C, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19090; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Dunn W, 2006, GASTROENTEROLOGY, V131, P1057, DOI 10.1053/j.gastro.2006.08.020; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; Heimbach JK, 2013, AM J TRANSPLANT, V13, P363, DOI 10.1111/j.1600-6143.2012.04318.x; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Lefebvre E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158156; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Loomba R, 2018, HEPATOLOGY; Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011; Mittal S, 2016, CLIN GASTROENTEROL H, V14, P124, DOI 10.1016/j.cgh.2015.07.019; Mosko JD, 2011, CLIN GASTROENTEROL H, V9, P897, DOI 10.1016/j.cgh.2011.07.007; Musso G, 2011, ANN MED, V43, P413, DOI 10.3109/07853890.2011.579152; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Noureddin M, 2013, HEPATOLOGY, V58, P1930, DOI 10.1002/hep.26455; Park H, 2011, J GASTROENTEROL, V46, P101, DOI 10.1007/s00535-010-0291-8; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Rinella ME, 2016, NAT REV GASTRO HEPAT, V13, P196, DOI 10.1038/nrgastro.2016.3; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Ryan MC, 2013, J HEPATOL, V59, P138, DOI 10.1016/j.jhep.2013.02.012; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Subichin M, 2015, SURG OBES RELAT DIS, V11, P137, DOI 10.1016/j.soard.2014.06.015; Sung KC, 2016, J HEPATOL, V65, P791, DOI 10.1016/j.jhep.2016.05.026; Torres DM, 2012, CLIN GASTROENTEROL H, V10, P837, DOI 10.1016/j.cgh.2012.03.011; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong VWS, 2013, J HEPATOL, V59, P536, DOI 10.1016/j.jhep.2013.04.013; Yalamanchili K, 2010, LIVER TRANSPLANT, V16, P431, DOI 10.1002/lt.22004; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yoneda M, 2010, RADIOLOGY, V256, P640, DOI 10.1148/radiol.10091662; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Zamora-Valdes D, 2018, HEPATOLOGY, V68, P485, DOI 10.1002/hep.29848	49	59	61	4	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					ITC65	ITC80		10.7326/AITC201811060	http://dx.doi.org/10.7326/AITC201811060			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4UP	30398639				2022-12-28	WOS:000449399700001
J	Malapit, CA; Bour, JR; Brigham, CE; Sanford, MS				Malapit, Christian A.; Bour, James R.; Brigham, Conor E.; Sanford, Melanie S.			Base-free nickel-catalysed decarbonylative Suzuki-Miyaura coupling of acid fluorides	NATURE			English	Article							SENSITIVE BORONIC ACIDS; ARYL FLUORIDES; PALLADIUM; TRANSMETALATION; PROTODEBORONATION; POLYFLUOROPHENYL; 2-HETEROARYL; THIOESTERS; BORYLATION; CLEAVAGE	The Suzuki-Miyaura cross-coupling of organoboron nucleophiles with aryl halide electrophiles is one of the most widely used carbon-carbon bond-forming reactions in organic and medicinal chemistry(1,2). A key challenge associated with these transformations is that they generally require the addition of an exogenous base, the role of which is to enable transmetallation between the organoboron nucleophile and the metal catalyst(3). This requirement limits the substrate scope of the reaction because the added base promotes competitive decomposition of many organoboron substrates(3-5). As such, considerable research has focused on strategies for mitigating base-mediated side reactions(6-12). Previous efforts have primarily focused either on designing strategically masked organoboron reagents (to slow base-mediated decomposition)(6-8) or on developing highly active palladium precatalysts (to accelerate cross-coupling relative to base-mediated decomposition pathways)(10-12). An attractive alternative approach involves identifying combinations of catalyst and electrophile that enable Suzuki-Miyaura-type reactions to proceed without an exogenous base(12-14). Here we use this approach to develop a nickel-catalysed coupling of aryl boronic acids with acid fluorides(15-17), which are formed in situ from readily available carboxylic acids(18-22). This combination of catalyst and electrophile enables a mechanistic manifold in which a 'transmetallation-active' aryl nickel fluoride intermediate is generated directly in the catalytic cycle(13,16). As such, this transformation does not require an exogenous base and is applicable to a wide range of base-sensitive boronic acids and biologically active carboxylic acids.	[Malapit, Christian A.; Bour, James R.; Brigham, Conor E.; Sanford, Melanie S.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, MS (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	mssanfor@umich.edu		Malapit, Christian/0000-0002-8471-4208; Bour, James/0000-0002-0372-7323	National Institutes of Health NIGMS [GM073836]; Danish National Research Foundation (Carbon Dioxide Activation Center; CADIAC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073836] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Danish National Research Foundation (Carbon Dioxide Activation Center; CADIAC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge financial support from National Institutes of Health NIGMS (GM073836) and the Danish National Research Foundation (Carbon Dioxide Activation Center; CADIAC). We acknowledge J. Kampf for X-ray crystallographic analyses of 2b and 3.	Amatore C, 2012, ANGEW CHEM INT EDIT, V51, P1379, DOI 10.1002/anie.201107202; Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Bulfield D, 2017, J ORG CHEM, V82, P13188, DOI 10.1021/acs.joc.7b02267; Carrow BP, 2011, J AM CHEM SOC, V133, P2116, DOI 10.1021/ja1108326; Chen LY, 2018, ACS CATAL, V8, P2989, DOI 10.1021/acscatal.8b00341; Chen LY, 2017, J AM CHEM SOC, V139, P12418, DOI 10.1021/jacs.7b07687; Cox PA, 2017, J AM CHEM SOC, V139, P13156, DOI 10.1021/jacs.7b07444; Cox PA, 2016, J AM CHEM SOC, V138, P9145, DOI 10.1021/jacs.6b03283; Edwards JT, 2017, NATURE, V545, P213, DOI 10.1038/nature22307; Fawcett A, 2017, SCIENCE, V357, DOI 10.1126/science.aan3679; Goossen LJ, 2006, SCIENCE, V313, P662, DOI 10.1126/science.1128684; Graham TJA, 2012, ORG LETT, V14, P1616, DOI 10.1021/ol300364s; Guo L, 2018, ACCOUNTS CHEM RES, V51, P1185, DOI 10.1021/acs.accounts.8b00023; Ichiishi N, 2018, ORG LETT, V20, P44, DOI 10.1021/acs.orglett.7b03305; Keaveney ST, 2018, ANGEW CHEM INT EDIT, V57, P4073, DOI 10.1002/anie.201800644; Kinzel T, 2010, J AM CHEM SOC, V132, P14073, DOI 10.1021/ja1073799; Knapp DM, 2009, J AM CHEM SOC, V131, P6961, DOI 10.1021/ja901416p; Lennox AJJ, 2013, ANGEW CHEM INT EDIT, V52, P7362, DOI 10.1002/anie.201301737; Liu XW, 2015, J AM CHEM SOC, V137, P12470, DOI 10.1021/jacs.5b08103; Masson-Makdissi J, 2018, ORG LETT, V20, P4094, DOI 10.1021/acs.orglett.8b01646; Molander GA, 2003, J ORG CHEM, V68, P4302, DOI 10.1021/jo0342368; Muto K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8508; Ogiwara Y, 2018, ORG LETT, V20, P4204, DOI 10.1021/acs.orglett.8b01582; Ohashi M, 2013, EUR J ORG CHEM, V2013, P443, DOI 10.1002/ejoc.201201405; Robbins DW, 2012, ORG LETT, V14, P4266, DOI 10.1021/ol301570t; Schaub T, 2006, J AM CHEM SOC, V128, P15964, DOI 10.1021/ja064068b; Shi SC, 2016, ANGEW CHEM INT EDIT, V55, P6959, DOI 10.1002/anie.201601914; Suzuki A, 2011, ANGEW CHEM INT EDIT, V50, P6722, DOI 10.1002/anie.201101379; Thomas AA, 2016, SCIENCE, V352, P329, DOI 10.1126/science.aad6981; Tobisu M, 2011, J AM CHEM SOC, V133, P19505, DOI 10.1021/ja207759e; Wang J, 2016, ANGEW CHEM INT EDIT, V55, P9676, DOI 10.1002/anie.201605463; Zhang YD, 2004, J AM CHEM SOC, V126, P15964, DOI 10.1021/ja044113k; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	33	151	150	14	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					100	104		10.1038/s41586-018-0628-7	http://dx.doi.org/10.1038/s41586-018-0628-7			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30356210	Green Accepted			2022-12-28	WOS:000448900900052
J	Muller, LSM; Cosentino, RO; Forstner, KU; Guizetti, J; Wedel, C; Kaplan, N; Janzen, CJ; Arampatzi, P; Vogel, J; Steinbiss, S; Otto, TD; Saliba, AE; Sebra, RP; Siegel, TN				Mueller, Laura S. M.; Cosentino, Raul O.; Foerstner, Konrad U.; Guizetti, Julien; Wedel, Carolin; Kaplan, Noam; Janzen, Christian J.; Arampatzi, Panagiota; Vogel, Joerg; Steinbiss, Sascha; Otto, Thomas D.; Saliba, Antoine-Emmanuel; Sebra, Robert P.; Siegel, T. Nicolai			Genome organization and DNA accessibility control antigenic variation in trypanosomes	NATURE			English	Article							EXPRESSION SITE; WIDE ANALYSIS; REGULATORY ELEMENTS; GENE-EXPRESSION; BRUCEI; TRANSCRIPTION; COHESIN; CTCF; ASSEMBLIES; PROMOTERS	Many evolutionarily distant pathogenic organisms have evolved similar survival strategies to evade the immune responses of their hosts. These include antigenic variation, through which an infecting organism prevents clearance by periodically altering the identity of proteins that are visible to the immune system of the host(1). Antigenic variation requires large reservoirs of immunologically diverse antigen genes, which are often generated through homologous recombination, as well as mechanisms to ensure the expression of one or very few antigens at any given time. Both homologous recombination and gene expression are affected by three-dimensional genome architecture and local DNA accessibility(2,3). Factors that link three-dimensional genome architecture, local chromatin conformation and antigenic variation have, to our knowledge, not yet been identified in any organism. One of the major obstacles to studying the role of genome architecture in antigenic variation has been the highly repetitive nature and heterozygosity of antigen-gene arrays, which has precluded complete genome assembly in many pathogens. Here we report the de novo haplotype-specific assembly and scaffolding of the long antigen-gene arrays of the model protozoan parasite Trypanosoma brucei, using long-read sequencing technology and conserved features of chromosome folding(4). Genome-wide chromosome conformation capture (Hi-C) reveals a distinct partitioning of the genome, with antigen-encoding subtelomeric regions that are folded into distinct, highly compact compartments. In addition, we performed a range of analyses-Hi-C, fluorescence in situ hybridization, assays for transposase-accessible chromatin using sequencing and single-cell RNA sequencing-that showed that deletion of the histone variants H3.V and H4.V increases antigen-gene clustering, DNA accessibility across sites of antigen expression and switching of the expressed antigen isoform, via homologous recombination. Our analyses identify histone variants as a molecular link between global genome architecture, local chromatin conformation and antigenic variation.	[Mueller, Laura S. M.; Cosentino, Raul O.; Siegel, T. Nicolai] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Expt Parasitol, Munich, Germany; [Mueller, Laura S. M.; Cosentino, Raul O.; Siegel, T. Nicolai] Ludwig Maximilians Univ Munchen, Dept Physiol Chem, Biomed Ctr Munich, Planegg Martinsried, Germany; [Mueller, Laura S. M.; Cosentino, Raul O.; Guizetti, Julien; Wedel, Carolin; Siegel, T. Nicolai] Univ Wurzburg, Res Ctr Infect Dis, Wurzburg, Germany; [Foerstner, Konrad U.] ZB MED Informat Ctr Life Sci, Cologne, Germany; [Foerstner, Konrad U.] TH Koln, Fac Informat Sci & Commun Studies, Cologne, Germany; [Foerstner, Konrad U.; Arampatzi, Panagiota] Univ Wurzburg, Inst Mol Infect Biol, Core Unit Syst Med, Wurzburg, Germany; [Kaplan, Noam] Technion Israel Inst Technol, Dept Physiol Biophys & Syst Biol, Rappaport Fac Med, Haifa, Israel; [Janzen, Christian J.] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Vogel, Joerg; Saliba, Antoine-Emmanuel] Helmholtz Inst RNA Based Infect Res, Wurzburg, Germany; [Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, RNA Biol Grp, Wurzburg, Germany; [Steinbiss, Sascha; Otto, Thomas D.] Wellcome Trust Sanger Inst, Cambridge, England; [Otto, Thomas D.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Ctr Immunobiol, Glasgow, Lanark, Scotland; [Sebra, Robert P.] Icahn Sch Med Mt Sinai, Icahn Inst, New York, NY 10029 USA; [Sebra, Robert P.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Guizetti, Julien] Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Heidelberg, Germany	University of Munich; University of Munich; University of Wurzburg; University of Wurzburg; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Wurzburg; University of Wurzburg; Wellcome Trust Sanger Institute; University of Glasgow; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg	Siegel, TN (corresponding author), Ludwig Maximilians Univ Munchen, Dept Vet Sci, Expt Parasitol, Munich, Germany.; Siegel, TN (corresponding author), Ludwig Maximilians Univ Munchen, Dept Physiol Chem, Biomed Ctr Munich, Planegg Martinsried, Germany.; Siegel, TN (corresponding author), Univ Wurzburg, Res Ctr Infect Dis, Wurzburg, Germany.	n.siegel@lmu.de	Saliba, Antoine-Emmanuel/AAC-1252-2022; Guizetti, Julien/AAF-3793-2020; Förstner, Konrad U./B-1531-2010; Otto, Thomas/ABE-7632-2020; Kaplan, Noam/K-4383-2019; Vogel, Jörg/D-5574-2011; Siegel, Tim Nicolai/F-2502-2013	Guizetti, Julien/0000-0002-8762-4259; Förstner, Konrad U./0000-0002-1481-2996; Kaplan, Noam/0000-0001-9940-1987; Vogel, Jörg/0000-0003-2220-1404; Saliba, Antoine-Emmanuel/0000-0001-8539-2784; Steinbiss, Sascha/0000-0002-2151-0574; Otto, Thomas/0000-0002-1246-7404; Cosentino, Raul Oscar/0000-0003-2124-8198; ARAMPATZI, PANAGIOTA/0000-0001-7925-8984; Siegel, Tim Nicolai/0000-0002-1715-7907; Muller, Laura SM/0000-0001-7912-7271; Kaufhold-Wedel, Carolin/0000-0001-6730-2220	Young Investigator Program of the Research Center for Infectious Diseases (ZINF) at the University of Wurzburg, Germany; German Research Foundation [SI 1610/2-1, SI 1610/3-1]; Center for Integrative Protein Science (CIPSM); ERC [3D_Tryps 715466]; German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; Georg Forster Fellowship (Humboldt Foundation) - Wellcome Trust [098051]; Wellcome Trust [098051]	Young Investigator Program of the Research Center for Infectious Diseases (ZINF) at the University of Wurzburg, Germany; German Research Foundation(German Research Foundation (DFG)); Center for Integrative Protein Science (CIPSM); ERC(European Research Council (ERC)European Commission); German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg; Georg Forster Fellowship (Humboldt Foundation) - Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank S. Gorski and members of the Siegel laboratory for critical reading of the manuscript. We thank T. Achmedov for scRNA-seq technical assistance, M. Berriman, G. Ramasamy, P. Myler and L. Barquist for assistance with the genome assembly, J. Dekker, M. Imakaev, J. M. Belton and B. R. Lajoie for advice on Hi-C experimental design and analysis, K. Ersfeld for advice on epitope tagging of SCC1 and FISH, S. Kirchner and A. R. Batista for suggestions on ATAC-seq, T. Straub and F. Goth for providing server space and all members of the Engstler, Janzen, Kramer, Morriswood and Ladurner laboratories for valuable discussions. We thank C. Clayton and L. Glover for reagents and M. Urbiniak for sharing unpublished SCC1 data. This work was funded by the Young Investigator Program of the Research Center for Infectious Diseases (ZINF) at the University of Wurzburg, Germany, the German Research Foundation (SI 1610/2-1 and SI 1610/3-1), the Center for Integrative Protein Science (CIPSM) and by an ERC Starting Grant (3D_Tryps 715466). L.S.M.M. was supported by a grant of the German Excellence Initiative to the Graduate School of Life Science, University of Wurzburg. R.O.C. was supported by a Georg Forster Fellowship (Humboldt Foundation). T.D.O. was funded by Wellcome Trust grant: 098051.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Belaghzal H, 2017, METHODS, V123, P56, DOI 10.1016/j.ymeth.2017.04.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaves I, 1998, P NATL ACAD SCI USA, V95, P12328, DOI 10.1073/pnas.95.21.12328; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Glover L, 2016, P NATL ACAD SCI USA, V113, P7225, DOI 10.1073/pnas.1600344113; Gluenz E, 2008, MOL MICROBIOL, V69, P666, DOI 10.1111/j.1365-2958.2008.06320.x; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Heger P, 2012, P NATL ACAD SCI USA, V109, P17507, DOI 10.1073/pnas.1111941109; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hogenbirk MA, 2016, P NATL ACAD SCI USA, V113, pE3649, DOI 10.1073/pnas.1602025113; Horn D, 1997, MOL BIOCHEM PARASIT, V84, P189, DOI 10.1016/S0166-6851(96)02794-6; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McAndrew M, 1998, EXP PARASITOL, V90, P65, DOI 10.1006/expr.1998.4317; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Millau JF, 2011, BIOCHEM CELL BIOL, V89, P505, DOI [10.1139/o11-052, 10.1139/O11-052]; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mugnier MR, 2015, SCIENCE, V347, P1470, DOI 10.1126/science.aaa4502; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Otto Thomas D, 2018, Wellcome Open Res, V3, P52, DOI 10.12688/wellcomeopenres.14571.1; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pinger J, 2018, NAT MICROBIOL, V3, P932, DOI 10.1038/s41564-018-0187-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Siegel TN, 2008, MOL MICROBIOL, V67, P762, DOI 10.1111/j.1365-2958.2007.06079.x; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Steinbiss S, 2016, NUCLEIC ACIDS RES, V44, pW29, DOI 10.1093/nar/gkw292; Van Bortle K, 2012, ANNU REV CELL DEV BI, V28, P163, DOI 10.1146/annurev-cellbio-101011-155824; Wedel C, 2017, EMBO J, V36, P2581, DOI 10.15252/embj.201695323; Wedel C, 2017, EXP PARASITOL, V180, P2, DOI 10.1016/j.exppara.2017.03.003; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491	60	83	83	0	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					121	+		10.1038/s41586-018-0619-8	http://dx.doi.org/10.1038/s41586-018-0619-8			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30333624	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000448900900057
J	Resplandy, L; Keeling, RF; Eddebbar, Y; Brooks, MK; Wang, R; Bopp, L; Long, MC; Dunne, JP; Koeve, W; Oschlies, A				Resplandy, L.; Keeling, R. F.; Eddebbar, Y.; Brooks, M. K.; Wang, R.; Bopp, L.; Long, M. C.; Dunne, J. P.; Koeve, W.; Oschlies, A.			Quantification of ocean heat uptake from changes in atmospheric O-2 and CO2 composition (Publication with Expression of Concern. See vol. 573, pg. 614, 2019)	NATURE			English	Article; Publication with Expression of Concern							GLOBAL OCEAN; CARBON BUDGET; ANTHROPOGENIC CO2; CLIMATE; FLUXES; MODEL; VARIABILITY; SENSITIVITY; FORMULATION; CONSISTENT	The ocean is the main source of thermal inertia in the climate system(1). During recent decades, ocean heat uptake has been quantified by using hydrographic temperature measurements and data from the Argo float program, which expanded its coverage after 2007(2,3). However, these estimates all use the same imperfect ocean dataset and share additional uncertainties resulting from sparse coverage, especially before 2007(4,5). Here we provide an independent estimate by using measurements of atmospheric oxygen (O-2) and carbon dioxide (CO2)-levels of which increase as the ocean warms and releases gases-as a whole-ocean thermometer. We show that the ocean gained 1.33 +/- 0.20 x 10(22) joules of heat per year between 1991 and 2016, equivalent to a planetary energy imbalance of 0.83 +/- 0.11 watts per square metre of Earth's surface. We also find that the ocean-warming effect that led to the outgassing of O-2 and CO2 can be isolated from the direct effects of anthropogenic emissions and CO2 sinks. Our result-which relies on high-precision O-2 measurements dating back to 1991(6)-suggests that ocean warming is at the high end of previous estimates, with implications for policy-relevant measurements of the Earth response to climate change, such as climate sensitivity to greenhouse gases(7) and the thermal component of sea-level rise(8).	[Resplandy, L.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Resplandy, L.] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Keeling, R. F.; Eddebbar, Y.; Brooks, M. K.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Wang, R.] Fudan Univ, Dept Environm Sci & Engn, Shanghai, Peoples R China; [Bopp, L.] Sorbonne Univ, PSL Res Univ, CNRS, LMD IPSL,ENS,Ecole Polytech, Paris, France; [Long, M. C.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA; [Dunne, J. P.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Koeve, W.; Oschlies, A.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany	Princeton University; Princeton University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Fudan University; Centre National de la Recherche Scientifique (CNRS); Ecole des Ponts ParisTech; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Resplandy, L (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.; Resplandy, L (corresponding author), Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA.	laurer@princeton.edu	Dunne, John P/F-8086-2012; Oschlies, Andreas/F-9749-2012; bopp, laurent/ABF-5302-2020; Koeve, Wolfgang/B-6362-2008	Dunne, John P/0000-0002-8794-0489; Oschlies, Andreas/0000-0002-8295-4013; bopp, laurent/0000-0003-4732-4953; Koeve, Wolfgang/0000-0002-2298-9230	Climate Program Office of the National Oceanic and Atmospheric Administration (NOAA) [NA13OAR4310219]; Princeton Environmental Institute; National Science Foundation (NSF); US NSF; NOAA [1304270, NA15OAR4320071]	Climate Program Office of the National Oceanic and Atmospheric Administration (NOAA); Princeton Environmental Institute; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); US NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	We thank M. Winton for useful suggestions. L.R. acknowledges support from the Climate Program Office of the National Oceanic and Atmospheric Administration (NOAA), grant NA13OAR4310219, and from the Princeton Environmental Institute. The National Center for Atmospheric Research (NCAR) is sponsored by the National Science Foundation (NSF). We also thank the people who maintain the APO time series at Scripps and the groups developing the models CESM, GFDL, IPSL and UViC, used in this study. The Scripps O<INF>2</INF> program has been supported by a series of grants from the US NSF and the NOAA, most recently 1304270 and NA15OAR4320071. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF and NOAA. We thank the staff at the Cape Grim Baseline Air Pollution Station of the Canadian Greenhouse Gas program for collection of air samples.	Abraham JP, 2013, REV GEOPHYS, V51, P450, DOI 10.1002/rog.20022; Allan RP, 2014, GEOPHYS RES LETT, V41, P5588, DOI 10.1002/2014GL060962; Andres RJ, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23616; Aumont O, 2015, GEOSCI MODEL DEV, V8, P2465, DOI 10.5194/gmd-8-2465-2015; Ballantyne AP, 2015, BIOGEOSCIENCES, V12, P2565, DOI 10.5194/bg-12-2565-2015; Battle M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017411; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Boyer T, 2016, J CLIMATE, V29, P4817, DOI 10.1175/JCLI-D-15-0801.1; Bronselaer B, 2017, GEOPHYS RES LETT, V44, P12298, DOI 10.1002/2017GL074435; Cazenave A, 2018, EARTH SYST SCI DATA, V10, P1551, DOI 10.5194/essd-10-1551-2018; Cheng LJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601545; Cheng LJ, 2016, B AM METEOROL SOC, V97, P923, DOI 10.1175/BAMS-D-15-00031.1; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Desbruyeres DG, 2016, GEOPHYS RES LETT, V43, P10356, DOI 10.1002/2016GL070413; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Eddebbar Y. A., 2017, GLOBAL BIOGEOCHEM CY, V31; Forster PM, 2016, ANNU REV EARTH PL SC, V44, P85, DOI 10.1146/annurev-earth-060614-105156; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Hamme RC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015273; Hamme RC, 2008, TELLUS B, V60, P706, DOI 10.1111/j.1600-0889.2008.00376.x; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Helm KP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049513; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Ishii M, 2017, SOLA, V13, P163, DOI 10.2151/sola.2017-030; Ito T, 2016, NAT GEOSCI, V9, P443, DOI [10.1038/ngeo2717, 10.1038/NGEO2717]; Ito T, 2017, GEOPHYS RES LETT, V44, P4214, DOI 10.1002/2017GL073613; Jickells TD, 2017, GLOBAL BIOGEOCHEM CY, V31, P289, DOI 10.1002/2016GB005586; Johnson G. C., 2017, AM METEOROL SOC B, V98, pS66; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Keeling CD, 2011, TELLUS B, V63, P1, DOI 10.1111/j.1600-0889.2010.00507.x; Keeling R. F., 2000, CARBON CYCLE, P134; Keeling RF, 2007, TELLUS B, V59, P3, DOI 10.1111/j.1600-0889.2006.00196.x; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keeling RF., 2014, TREATISE GEOCHEMISTR, P385, DOI [DOI 10.1016/B978-0-08-095975-7.00420-4, 10.1016/B978-0-08-095975-7.00420-4]; Keller DP, 2012, GEOSCI MODEL DEV, V5, P1195, DOI 10.5194/gmd-5-1195-2012; Keller DP, 2016, GEOPHYS RES LETT, V43, P6469, DOI 10.1002/2016GL069630; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Loeb NG, 2012, NAT GEOSCI, V5, P110, DOI [10.1038/NGEO1375, 10.1038/ngeo1375]; Long MC, 2016, GLOBAL BIOGEOCHEM CY, V30, P381, DOI 10.1002/2015GB005310; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; OESCHGER H, 1975, TELLUS, V27, P168, DOI 10.1111/j.2153-3490.1975.tb01671.x; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Palmer MD, 2017, CURR CLIM CHANGE REP, V3, P78, DOI 10.1007/s40641-016-0053-7; Resplandy L, 2017, CLIM DYNAM, V49, P4317, DOI 10.1007/s00382-017-3839-y; Resplandy L, 2015, J GEOPHYS RES-OCEANS, V120, P384, DOI 10.1002/2014JC010463; Rietbroek R, 2016, P NATL ACAD SCI USA, V113, P1504, DOI 10.1073/pnas.1519132113; Riser SC, 2016, NAT CLIM CHANGE, V6, P145, DOI [10.1038/nclimate2872, 10.1038/NCLIMATE2872]; Ritz SP, 2011, QUATERNARY SCI REV, V30, P3728, DOI 10.1016/j.quascirev.2011.09.021; Rodenbeck C, 2008, TELLUS B, V60, P685, DOI 10.1111/j.1600-0889.2008.00375.x; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; Schmidtko S, 2017, NATURE, V542, P335, DOI 10.1038/nature21399; Seferian R, 2012, J CLIMATE, V25, P3894, DOI 10.1175/JCLI-D-11-00291.1; Severinghaus J. P., 1995, THESIS; Somes CJ, 2016, GEOPHYS RES LETT, V43, P4500, DOI 10.1002/2016GL068335; Stephens BB, 1998, GLOBAL BIOGEOCHEM CY, V12, P213, DOI 10.1029/97GB03500; Talley LD, 2016, ANNU REV MAR SCI, V8, P185, DOI 10.1146/annurev-marine-052915-100829; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2016, J CLIMATE, V29, P7495, DOI 10.1175/JCLI-D-16-0339.1; Vose RS, 2012, B AM METEOROL SOC, V93, P1677, DOI 10.1175/BAMS-D-11-00241.1; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Wang R, 2015, GEOPHYS RES LETT, V42, P10745, DOI 10.1002/2015GL066753	70	31	33	0	120	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					105	+		10.1038/s41586-018-0651-8	http://dx.doi.org/10.1038/s41586-018-0651-8			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382201	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000448900900053
J	Vangay, P; Johnson, AJ; Ward, TL; Al-Ghalith, GA; Shields-Cutler, RR; Hillmann, BM; Lucas, SK; Beura, LK; Thompson, EA; Till, LM; Batres, R; Paw, B; Pergament, SL; Saenyakul, P; Xiong, M; Kim, AD; Kim, G; Masopust, D; Martens, EC; Angkurawaranon, C; McGready, R; Kashyap, PC; Culhane-Pera, KA; Knights, D				Vangay, Pajau; Johnson, Abigail J.; Ward, Tonya L.; Al-Ghalith, Gabriel A.; Shields-Cutler, Robin R.; Hillmann, Benjamin M.; Lucas, Sarah K.; Beura, Lalit K.; Thompson, Emily A.; Till, Lisa M.; Batres, Rodolfo; Paw, Bwei; Pergament, Shannon L.; Saenyakul, Pimpanitta; Xiong, Mary; Kim, Austin D.; Kim, Grant; Masopust, David; Martens, Eric C.; Angkurawaranon, Chaisiri; McGready, Rose; Kashyap, Purna C.; Culhane-Pera, Kathleen A.; Knights, Dan			US Immigration Westernizes the Human Gut Microbiome	CELL			English	Article							BODY-MASS INDEX; CARBOHYDRATE-ACTIVE ENZYMES; CHILDREN; DIETARY; ENVIRONMENT; DATABASE; HMONG	Many US immigrant populations develop metabolic diseases post immigration, but the causes are not well understood. Although the microbiome plays a role in metabolic disease, there have been no studies measuring the effects of US immigration on the gut microbiome. We collected stool, dietary recalls, and anthropometrics from 514 Hmong and Karen individuals living in Thailand and the United States, including first- and second-generation immigrants and 19 Karen individuals sampled before and after immigration, as well as from 36 US-born European American individuals. Using 16S and deep shotgun metagenomic DNA sequencing, we found that migration from a non-Western country to the United States is associated with immediate loss of gut microbiome diversity and function in which US-associated strains and functions displace native strains and functions. These effects increase with duration of US residence and are compounded by obesity and across generations.	[Vangay, Pajau; Al-Ghalith, Gabriel A.; Knights, Dan] Univ Minnesota, Bioinformat & Computat Biol Program, Minneapolis, MN 55455 USA; [Johnson, Abigail J.; Ward, Tonya L.; Shields-Cutler, Robin R.; Knights, Dan] Univ Minnesota, Biotechnol Inst, Minneapolis, MN 55455 USA; [Hillmann, Benjamin M.; Knights, Dan] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Lucas, Sarah K.; Beura, Lalit K.; Thompson, Emily A.; Masopust, David] Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN 55455 USA; [Till, Lisa M.; Kashyap, Purna C.] Mayo Clin, Dept Internal Med, Div Gastroenterol & Hepatol, Rochester, MN 55902 USA; [Batres, Rodolfo; Paw, Bwei; Pergament, Shannon L.; Saenyakul, Pimpanitta; Xiong, Mary; Culhane-Pera, Kathleen A.] West Side Community Hlth Serv, Somali Latino & Hmong Partnership Hlth & Wellnes, St Paul, MN 55106 USA; [Kim, Austin D.] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA; [Kim, Grant] Univ Minnesota, Coll Biol Sci, Minneapolis, MN 55455 USA; [Martens, Eric C.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Angkurawaranon, Chaisiri] Chiang Mai Univ, Fac Med, Dept Family Med, Chiang Mai 50200, Thailand; [McGready, Rose] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot 63110, Thailand; [McGready, Rose] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Old Rd Campus, Oxford OX3 7BN, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Macalester College; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; Chiang Mai University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Knights, D (corresponding author), Univ Minnesota, Bioinformat & Computat Biol Program, Minneapolis, MN 55455 USA.; Knights, D (corresponding author), Univ Minnesota, Biotechnol Inst, Minneapolis, MN 55455 USA.; Knights, D (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	dknights@umn.edu	Angkurawaranon, Chaisiri/I-6140-2015; masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019; McGready, Rose/A-3290-2014	Angkurawaranon, Chaisiri/0000-0003-4206-9164; McGready, Rose/0000-0003-1621-3257; Johnson, Abigail/0000-0002-5998-4724; Vangay, Pajau/0000-0002-9231-0692; Lucas, Sarah/0000-0003-1676-5801	University of Minnesota Clinical and Translational Science Institute; University of Minnesota Healthy Foods, Healthy Lives Institute; University of Minnesota Office of Diversity; Graduate School at the University of Minnesota; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114007] Funding Source: NIH RePORTER	University of Minnesota Clinical and Translational Science Institute; University of Minnesota Healthy Foods, Healthy Lives Institute; University of Minnesota Office of Diversity; Graduate School at the University of Minnesota(University of Minnesota System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all of the participants in this study. We also thank the members of our community advisory boards, who provided critical feedback throughout the study: Bu Bu, Jamiey Cha, Yoha Christiansen, Pa Chua Vang, Duachi Her, Ku Ku Paw Lynn, Mayly Lochungvu, Mudah Takoni, Aye Mi San, Yeng Moua, Ko Nay Oo, Donna Vue Lee, Houa Vue-Her, Pakou Xiong, and Shoua Yang. Our work in Thailand would not have been possible without Ntxawm Lis, Yi Lis, Blooming Zion, Htoo Lay Paw, Moo Kho Paw, See Thoj, and Wirachon Yangyuenkun. We also thank Nurul Quratulaini Abd Salim Nast, Dominique Sabas, and Max Abramson for their assistance in the lab. We thank Ryan Hunter for his advice and assistance with planning. This work was supported by the University of Minnesota Clinical and Translational Science Institute; the University of Minnesota Healthy Foods, Healthy Lives Institute; the University of Minnesota Office of Diversity; and the Graduate School at the University of Minnesota.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Al-Ghalith G, 2017, ZENODO; Al-Ghalith G. A., 2018, AKRONYMER ENABLES DA; Al-Ghalith GA, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00202-17; Allen M. L., 2011, PARTNERS RES CURRICU; Arcan C, 2014, J ACAD NUTR DIET, V114, P375, DOI 10.1016/j.jand.2013.11.019; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Britten P, 2013, PROC FOOD SCI, V2, P172, DOI 10.1016/j.profoo.2013.04.025; Bureau of Population Refugees and Migration, 2004, US REFUGEE ADM PROGR, V2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Careyva B, 2015, J HEALTH CARE POOR U, V26, P421, DOI 10.1353/hpu.2015.0046; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; DAHLQVIST A, 1963, J PHYSIOL-LONDON, V167, P193, DOI 10.1113/jphysiol.1963.sp007141; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dawson-Hahn E, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0953; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Febinia C. A., 2017, GUT MICROBIOTA BALI; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Heney Jessica H, 2014, R I Med J (2013), V98, P43; Hervey K, 2009, J HEALTH CARE POOR U, V20, P246, DOI 10.1353/hpu.0.0118; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; KOOIMAN P, 1971, CARBOHYD RES, V20, P329, DOI 10.1016/S0008-6215(00)81387-7; Kwok L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093631; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Minnesota Department of Health, 2017, REF HLTH STAT; Mishra A, 2009, J MATER CHEM, V19, P8528, DOI 10.1039/b911150f; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Mulasi-Pokhriyal U, 2012, PUBLIC HEALTH NUTR, V15, P176, DOI 10.1017/S1368980011001649; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Pangsri P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1565-7; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Pfeifer M. E., 2013, STATE HMONG AM COMMU; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Schulfer AF, 2018, NAT MICROBIOL, V3, P234, DOI 10.1038/s41564-017-0075-5; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; SPEEK AJ, 1991, FOOD CHEM, V40, P251, DOI 10.1016/0308-8146(91)90110-A; SUBRAHMANYAN V, 1956, ARCH BIOCHEM BIOPHYS, V60, P27, DOI 10.1016/0003-9861(56)90392-7; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Tatusova T., 2013, NCBI HDB; Tippett K. S., 1999, Nutrition Today, V34, P33, DOI 10.1097/00017285-199901000-00007; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; UN, 2017, INT MIGR REP 2017; US Department of Agriculture Agricultural Research Service, USDA FOOD COMP DAT; Van Rossum G., 2011, PYTHON LANGUAGE REFE; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	61	310	319	5	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					962	+		10.1016/j.cell.2018.10.029	http://dx.doi.org/10.1016/j.cell.2018.10.029			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388453	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000449100600011
J	Khandwala, YS; Baker, VL; Shaw, GM; Stevenson, DK; Lu, Y; Eisenberg, ML				Khandwala, Yash S.; Baker, Valerie L.; Shaw, Gary M.; Stevenson, David K.; Lu, Ying; Eisenberg, Michael L.			Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; INCREASED RISK; PRETERM; SPERM; FRACTIONS; FATHERS; DISEASE; RATIO	OBJECTIVE To evaluate the impact of advanced paternal age on maternal and perinatal outcomes in the United States. DESIGN Retrospective, population based cohort study. Setting US. POPULATION 40 529 905 documented live births between 2007 and 2016. MAIN OUTCOME MEASURES Primary perinatal outcomes were gestational age, birth weight, Apgar score at five minutes, admission to a neonatal intensive care unit, need for postpartum antibiotics, and seizures. Primary maternal outcomes were gestational diabetes and pre-eclampsia. Secondary outcome was the number of preventable perinatal events. RESULTS Higher paternal age was associated with an increased risk of premature birth, low birth weight, and low Apgar score. After adjustment for maternal age, infants born to fathers aged 45 years or older had 14% higher odds of premature birth (odds ratio 1.14, 95% confidence interval 1.13 to 1.15), independent of gestational age, and 18% higher odds of seizures (1.18, 0.97 to 1.44) compared with infants of fathers aged 25 to 34 years. The odds of gestational diabetes was 34% higher (1.34, 1.29 to 1.38) in mothers with the oldest partners. 13.2% (95% confidence interval 12.5% to 13.9%) of premature births and 18.2% (17.5% to 18.9%) of gestational diabetes in births associated with older fathers were estimated to be attributable to advanced paternal age. CONCLUSIONS Advanced paternal age is associated with negative effects on both mothers and offspring. Given the relatively low prevalence of advanced paternal age in the US, population level impacts are currently modest. Nevertheless, as advanced paternal age has doubled in the US over the past generation, further investigation is warranted of the impact on birth outcomes and public health.	[Khandwala, Yash S.; Eisenberg, Michael L.] Stanford Univ, Sch Med, Dept Urol, 300 Pasteur Dr, Stanford, CA 94305 USA; [Baker, Valerie L.; Eisenberg, Michael L.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Shaw, Gary M.; Stevenson, David K.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Lu, Ying] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Eisenberg, ML (corresponding author), Stanford Univ, Sch Med, Dept Urol, 300 Pasteur Dr, Stanford, CA 94305 USA.; Eisenberg, ML (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	eisenberg@stanford.edu	郑, 丽丽/HGE-2239-2022	Lu, Ying/0000-0002-7698-8962; Shaw, Gary/0000-0001-7438-4914	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbasi J, 2017, JAMA-J AM MED ASSOC, V317, P2049, DOI 10.1001/jama.2017.1566; Alio AP, 2012, AM J MENS HEALTH, V6, P427, DOI 10.1177/1557988312440718; Andersen AMN, 2004, AM J EPIDEMIOL, V160, P1214, DOI 10.1093/aje/kwh332; Andersen AMN, 2017, FERTIL STERIL, V107, P312, DOI 10.1016/j.fertnstert.2016.12.019; Astolfi P, 2006, EPIDEMIOLOGY, V17, P218, DOI 10.1097/01.ede.0000197053.61176.f4; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; CAUGHEY AB, 2010, AM J OBSTET GYNECOL, V202; Chen XK, 2008, HUM REPROD, V23, P1290, DOI 10.1093/humrep/dem403; Conti SL, 2016, ASIAN J ANDROL, V18, P420, DOI 10.4103/1008-682X.175097; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Crow JF, 2003, SCIENCE, V301, P606, DOI 10.1126/science.1088552; D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525; Frans EM, 2008, ARCH GEN PSYCHIAT, V65, P1034, DOI 10.1001/archpsyc.65.9.1034; Harlap S, 2002, EPIDEMIOLOGY, V13, P660, DOI 10.1097/00001648-200211000-00010; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hurley EG, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.07.034; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Kaveh M., 2012, Journal of Family and Reproductive Health, V6, P125; Khandwala YS, 2017, HUM REPROD, V32, P2110, DOI 10.1093/humrep/dex267; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li JJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006689; MacInnis N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22895; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Marcus M, 1998, FERTIL STERIL, V70, P270, DOI 10.1016/S0015-0282(98)00149-6; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Miozzo M, 2002, BIOL NEONATE, V81, P217, DOI 10.1159/000056752; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; PARKER JD, 1992, AM J EPIDEMIOL, V136, P399, DOI 10.1093/oxfordjournals.aje.a116512; Parks JC, 2017, FERTIL STERIL, V108, pE24, DOI 10.1016/j.fertnstert.2017.07.088; Paulson RJ, 2002, JAMA-J AM MED ASSOC, V288, P2320, DOI 10.1001/jama.288.18.2320; Puleo CM, 2012, AUTISM, V16, P367, DOI 10.1177/1362361311427154; Reichman NE, 2006, AM J PUBLIC HEALTH, V96, P862, DOI 10.2105/AJPH.2005.066324; Schoendorf KC, 2006, AM J OBSTET GYNECOL, V194, P911, DOI 10.1016/j.ajog.2005.11.020; Shah PS, 2010, AM J OBSTET GYNECOL, V202, P103, DOI 10.1016/j.ajog.2009.08.026; Sharma R, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0028-x; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Sipos A, 2004, BMJ-BRIT MED J, V329, P1070, DOI 10.1136/bmj.38243.672396.55; Strom-Roum EM, 2013, HUM REPROD, V28, P3126, DOI 10.1093/humrep/det299; Sun YL, 2006, EPIDEMIOLOGY, V17, P473, DOI 10.1097/01.ede.0000220690.43455.22; Tough SC, 2003, CAN J PUBLIC HEALTH, V94, P88, DOI 10.1007/BF03404578; Vestergaard M, 2005, EUR J EPIDEMIOL, V20, P1003, DOI 10.1007/s10654-005-4250-2; Waller DK, 2008, AM J MED GENET A, V146A, P2385, DOI 10.1002/ajmg.a.32485; Wiener-Megnazi Z, 2012, ASIAN J ANDROL, V14, P69, DOI 10.1038/aja.2011.69; Yamauchi Y, 2011, ASIAN J ANDROL, V13, P31, DOI 10.1038/aja.2010.75; Zhu JL, 2005, EPIDEMIOLOGY, V16, P259, DOI 10.1097/01.ede.0000152526.63279.da	47	84	87	4	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2018	363								k4372	10.1136/bmj.k4372	http://dx.doi.org/10.1136/bmj.k4372			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ6PY	30381468	hybrid, Green Published			2022-12-28	WOS:000449564200004
J	Chen, HY; Fishbach, M; Holz, DE				Chen, Hsin-Yu; Fishbach, Maya; Holz, Daniel E.			A two per cent Hubble constant measurement from standard sirens within five years	NATURE			English	Article							CHALLENGE LIGHTCONE SIMULATION; GALAXY LUMINOSITY FUNCTION	Gravitational-wave detections provide a novel way to determine the Hubble constant(1-3), which is the current rate of expansion of the Universe. This 'standard siren' method, with the absolute distance calibration provided by the general theory of relativity, was used to measure the Hubble constant using the gravitational-wave detection of the binary neutron-star merger, GW170817, by the Laser Interferometer Gravitational-Wave Observatory (LIGO) and Virgo(4), combined with optical identification of the host galaxy(5,6) NGC 4993. This independent measurement is of particular interest given the discrepancy between the value of the Hubble constant determined using type Ia supernovae via the local distance ladder (73.24 +/- 1.74 kilometres per second per megaparsec) and the value determined from cosmic microwave background observations (67.4 +/- 0.5 kilometres per second per megaparsec): these values differ(7,8) by about 3 sigma. Local distance ladder observations may achieve a precision of one per cent within five years, but at present there are no indications that further observations will substantially reduce the existing discrepancies(9). Here we show that additional gravitational-wave detections by LIGO and Virgo can be expected to constrain the Hubble constant to a precision of approximately two per cent within five years and approximately one per cent within a decade. This is because observing gravitational waves from the merger of two neutron stars, together with the identification of a host galaxy, enables a direct measurement of the Hubble constant independent of the systematics associated with other available methods. In addition to clarifying the discrepancy between existing low-redshift (local ladder) and high-redshift (cosmic microwave background) measurements, a precision measurement of the Hubble constant is of crucial value in elucidating the nature of dark energy(10,11).	[Chen, Hsin-Yu] Harvard Univ, Black Hole Initiat, Cambridge, MA 02138 USA; [Chen, Hsin-Yu; Fishbach, Maya; Holz, Daniel E.] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Holz, Daniel E.] Univ Chicago, Enrico Fermi Inst, Dept Phys, Chicago, IL 60637 USA; [Holz, Daniel E.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Holz, Daniel E.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Holz, Daniel E.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA	Harvard University; University of Chicago; University of Chicago; University of Chicago; Stanford University; Stanford University	Chen, HY (corresponding author), Harvard Univ, Black Hole Initiat, Cambridge, MA 02138 USA.; Chen, HY (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA.	hsinyuchen@fas.harvard.edu		Fishbach, Maya/0000-0002-1980-5293	NSF CAREER [PHY-1151836]; NSF [PHY-1708081]; Kavli Institute for Cosmological Physics at the University of Chicago through NSF [PHY-1125897]; Black Hole Initiative at Harvard University, through the John Templeton Foundation; NSF Graduate Research Fellowship Program [DGE-1746045]; University of Chicago Research Computing Center	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Kavli Institute for Cosmological Physics at the University of Chicago through NSF(National Science Foundation (NSF)); Black Hole Initiative at Harvard University, through the John Templeton Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); University of Chicago Research Computing Center	We acknowledge discussions with L. Blackburn, R. Essick, W. Farr and J. Gair. We were supported in part by NSF CAREER grant PHY-1151836 and NSF grant PHY-1708081. We were also supported by the Kavli Institute for Cosmological Physics at the University of Chicago through NSF grant PHY-1125897 and an endowment from the Kavli Foundation. We acknowledge the University of Chicago Research Computing Center for support of this work. H.-Y.C. was supported in part by the Black Hole Initiative at Harvard University, through a grant from the John Templeton Foundation. M.F. was supported by the NSF Graduate Research Fellowship Program under grant DGE-1746045.	Abbott BP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.161101; Abbott BP, 2017, NATURE, V551, P85, DOI 10.1038/nature24471; Abbott BP, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa91c9; Abbott BP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.221101; Abbott BP, 2016, ASTROPHYS J LETT, V832, DOI 10.3847/2041-8205/832/2/L21; Abbott BP, 2016, LIVING REV RELATIV, V19, DOI 10.1007/lrr-2016-1; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Aghanim N., 2018, COSMOLOGICAL PARAMET; Belczynski K, 2016, NATURE, V534, P512, DOI 10.1038/nature18322; Belczynski K, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/2/108; Carretero J., 2017, P 2017 EUR PHYS SOC, V488; Carrick J, 2015, MON NOT R ASTRON SOC, V450, P317, DOI 10.1093/mnras/stv547; Chen H. -Y., 2016, FINDING ONE IDENTIFY; Chen H. -Y., 2017, DISTANCE MEASURES GR; Coulter DA, 2017, SCIENCE, V358, P1556, DOI 10.1126/science.aap9811; Crocce M, 2015, MON NOT R ASTRON SOC, V453, P1513, DOI 10.1093/mnras/stv1708; Dalal N, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.063006; Del Pozzo W, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.043011; Di Valentino E., 2018, COSMOLOGICAL IMPACT; Dominik M, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/263; Fishbach M, 2017, ASTROPHYS J LETT, V851, DOI 10.3847/2041-8213/aa9bf6; Fong W, 2013, ASTROPHYS J, V776, DOI 10.1088/0004-637X/776/1/18; Fosalba P, 2015, MON NOT R ASTRON SOC, V448, P2987, DOI 10.1093/mnras/stv138; Fosalba P, 2015, MON NOT R ASTRON SOC, V447, P1319, DOI 10.1093/mnras/stu2464; Gonzalez RE, 2006, ASTRON ASTROPHYS, V445, P51, DOI 10.1051/0004-6361:20053277; Guidorzi C, 2017, ASTROPHYS J LETT, V851, DOI 10.3847/2041-8213/aaa009; Hirata CM, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.124046; Holz DE, 2005, ASTROPHYS J, V629, P15, DOI 10.1086/431341; Holz DE, 2005, ASTROPHYS J, V631, P678, DOI 10.1086/432085; Hu W, 2005, ASTR SOC P, V339, P215; Karki S, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4967303; Kourkchi E, 2017, ASTROPHYS J, V843, DOI 10.3847/1538-4357/aa76db; Li LX, 1998, ASTROPHYS J, V507, pL59, DOI 10.1086/311680; Liske J, 2003, MON NOT R ASTRON SOC, V344, P307, DOI 10.1046/j.1365-8711.2003.06826.x; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Nissanke S., 2013, DETERMINING HUBBLE C; Norberg P, 2002, MON NOT R ASTRON SOC, V336, P907, DOI 10.1046/j.1365-8711.2002.05831.x; Riess AG, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaadb7; Riess AG, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/1/56; SCHECHTER P, 1976, ASTROPHYS J, V203, P297, DOI 10.1086/154079; Schutz BF, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/12/125023; SCHUTZ BF, 1986, NATURE, V323, P310, DOI 10.1038/323310a0; Scolnic DM, 2018, ASTROPHYS J, V859, DOI 10.3847/1538-4357/aab9bb; Soares-Santos M, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa9059; Veitch J, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.042003; Vitale S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.021303	46	195	198	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 25	2018	562	7728					545	+		10.1038/s41586-018-0606-0	http://dx.doi.org/10.1038/s41586-018-0606-0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY1HQ	30333628	Green Submitted			2022-12-28	WOS:000448277800049
J	Dyer, C				Dyer, Clare			Surgeon is struck off after tribunal says that sanctions would not work	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4476	10.1136/bmj.k4476	http://dx.doi.org/10.1136/bmj.k4476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355699				2022-12-28	WOS:000448895300017
J	Slomski, A				Slomski, Anita			] No Cardiovascular Protection From Omega-3 Fatty Acids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1631	1631		10.1001/jama.2018.16204	http://dx.doi.org/10.1001/jama.2018.16204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357295				2022-12-28	WOS:000448069100033
J	Adameyko, I				Adameyko, Igor			Supracellular contractions propel migration	SCIENCE			English	Editorial Material							NEURAL CREST; CELLS		[Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Adameyko, Igor] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria	Karolinska Institutet; Medical University of Vienna	Adameyko, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.; Adameyko, I (corresponding author), Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria.	igor.adameyko@ki.se		Adameyko, Igor/0000-0001-5471-0356				Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chang LH, 2011, DEVELOPMENT, V138, P3803, DOI 10.1242/dev.062257; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Li L, 2013, BURNS TRAUMA, V1, DOI 10.4103/2321-3868.113331; McLennan R, 2015, DEVELOPMENT, V142, P2014, DOI 10.1242/dev.117507; Nogare DD, 2014, DEVELOPMENT, V141, P3188, DOI 10.1242/dev.106690; O'Neill PR, 2018, DEV CELL, V46, P9, DOI 10.1016/j.devcel.2018.05.029; Olson HM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00083; Plou J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30683-4; Sehring IM, 2015, ELIFE, V4, DOI 10.7554/eLife.09206; Shellard A, 2018, SCIENCE, V362, P339, DOI 10.1126/science.aau3301; Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075; Stichel D, 2017, NPJ SYST BIOL APPL, V3, DOI 10.1038/s41540-017-0006-3; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382	15	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					290	291		10.1126/science.aav3376	http://dx.doi.org/10.1126/science.aav3376			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337397				2022-12-28	WOS:000447680100026
J	del Fresno, C; Saz-Leal, P; Enamorado, M; Wculek, SK; Martinez-Cano, S; Blanco-Menendez, N; Schulz, O; Gallizioli, M; Miro-Mur, F; Cano, E; Planas, A; Sancho, D				del Fresno, Carlos; Saz-Leal, Paula; Enamorado, Michel; Wculek, Stefanie K.; Martinez-Cano, Sarai; Blanco-Menendez, Noelia; Schulz, Oliver; Gallizioli, Mattia; Miro-Mur, Francesc; Cano, Eva; Planas, Anna; Sancho, David			DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment	SCIENCE			English	Article							SYSTEMIC CANDIDIASIS; T-CELLS; F-ACTIN; RECEPTOR; MICE; INFECTION; INFLAMMATION; IMMUNITY; DECTIN-1; ANTIGENS	Host injury triggers feedback mechanisms that limit tissue damage. Conventional type 1 dendritic cells (cDC1s) express dendritic cell natural killer lectin group receptor-1 (DNGR-1), encoded by the gene Clec9a, which senses tissue damage and favors cross-presentation of dead-cell material to CD8(+) T cells. Here we find that DNGR-1 additionally reduces hostdamaging inflammatory responses induced by sterile and infectious tissue injury in mice. DNGR-1 deficiency leads to exacerbated caerulein-induced necrotizing pancreatitis and increased pathology during systemic Candida albicans infection without affecting fungal burden. This effect is B and T cell-independent and attributable to increased neutrophilia in DNGR-1-deficient settings. Mechanistically, DNGR-1 engagement activates SHP-1 and inhibits MIP-2 (encoded by Cxcl2) production by cDC1s during Candida infection. This consequently restrains neutrophil recruitment and promotes disease tolerance. Thus, DNGR1-mediated sensing of injury by cDC1s serves as a rheostat for the control of tissue damage, innate immunity, and immunopathology.	[del Fresno, Carlos; Saz-Leal, Paula; Enamorado, Michel; Wculek, Stefanie K.; Martinez-Cano, Sarai; Blanco-Menendez, Noelia; Sancho, David] CNIC, Immunobiol Lab, Madrid, Spain; [Schulz, Oliver] Francis Crick Inst, Immunobiol Lab, London, England; [Gallizioli, Mattia; Miro-Mur, Francesc; Planas, Anna] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Cano, Eva] Inst Salud Carlos III, Chron Dis Programme CROSADIS, Madrid, Spain; [Planas, Anna] CSIC, IIBB, Dept Brain Ischemia & Neurodegenerat, Barcelona, Spain; [Enamorado, Michel] NIAID, Mucosal Immunol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Francis Crick Institute; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	del Fresno, C; Sancho, D (corresponding author), CNIC, Immunobiol Lab, Madrid, Spain.	cdelfresno@cnic.es; dsancho@cnic.es	Del Fresno, Carlos/ABD-7766-2020; Miro-Mur, Francesc A./AAT-3013-2020; Wculek, Stefanie K/F-9626-2016; Sancho, David/D-3433-2009; Gallizioli, Mattia/L-3602-2019; Del Fresno Sánchez, CArlos/AAY-1525-2021; Cano, Eva/A-2049-2010; Planas, Anna/J-5991-2014	Del Fresno, Carlos/0000-0003-1771-7254; Miro-Mur, Francesc A./0000-0003-3936-2693; Wculek, Stefanie K/0000-0001-5565-8561; Sancho, David/0000-0003-2890-3984; Gallizioli, Mattia/0000-0001-9245-914X; Cano, Eva/0000-0003-2750-6135; Planas, Anna/0000-0002-6147-1880; Schulz, Oliver/0000-0002-1493-3341; Enamorado Escalona, Neris Michel/0000-0001-7748-454X	AECC Foundation; Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) [BES-2015-072699]; CNIC International Ph.D. Programme fellowship "la Caixa"-Severo Ochoa [OSLC-CNIC-2013-04]; European Molecular Biology Organization (EMBO) Long-Term Fellowship [ALTF 438-2016]; CNIC-International Postdoctoral Programme Fellowship [17230-2016]; CNIC; MCIU [SAF2016-79040-R]; Agencia Estatal de Investigacion; Fondos Europeos de Desarrollo Regional (FEDER); Immunothercan-CM from Comunidad de Madrid [B2017/BMD-3733]; FIS-Instituto de Salud Carlos III [RD16/0015/0018-REEM]; MICINN; FEDER; Acteria Foundation; Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation [201723]; European Commission [635122-PROCROP H2020]; European Research Council (ERC-2016-Consolidator Grant) [725091]; MCIU; Pro-CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]	AECC Foundation; Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU)(Spanish Government); CNIC International Ph.D. Programme fellowship "la Caixa"-Severo Ochoa; European Molecular Biology Organization (EMBO) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); CNIC-International Postdoctoral Programme Fellowship; CNIC; MCIU; Agencia Estatal de Investigacion; Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Immunothercan-CM from Comunidad de Madrid; FIS-Instituto de Salud Carlos III(Instituto de Salud Carlos III); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FEDER(European Commission); Acteria Foundation; Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC-2016-Consolidator Grant); MCIU; Pro-CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government)	C.d.F. is supported by the AECC Foundation as the recipient of an "Ayuda Fundacion Cientifica AECC a personal investigador en cancer." P.S.-L. is funded by grant BES-2015-072699 from the Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU). M.E. is the recipient of a CNIC International Ph.D. Programme fellowship "la Caixa"-Severo Ochoa OSLC-CNIC-2013-04. S.K.W. is supported by a European Molecular Biology Organization (EMBO) Long-Term Fellowship (grant ALTF 438-2016) and a CNIC-International Postdoctoral Programme Fellowship (grant 17230-2016). Work in the D.S. laboratory is funded by the CNIC and grant SAF2016-79040-R from MCIU, Agencia Estatal de Investigacion, and Fondos Europeos de Desarrollo Regional (FEDER); B2017/BMD-3733 Immunothercan-CM from Comunidad de Madrid; RD16/0015/0018-REEM from FIS-Instituto de Salud Carlos III, MICINN, and FEDER; Acteria Foundation; Constantes y Vitales prize (Atresmedia); La Marato de TV3 Foundation (201723); the European Commission (635122-PROCROP H2020); and the European Research Council (ERC-2016-Consolidator Grant 725091). The CNIC is supported by the MCIU and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505).	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Balish E, 1999, J LEUKOCYTE BIOL, V66, P144, DOI 10.1002/jlb.66.1.144; Ben Mkaddem S, 2014, J CLIN INVEST, V124, P3945, DOI 10.1172/JCI74572; Blanco-Menendez N, 2015, J IMMUNOL, V195, P4466, DOI 10.4049/jimmunol.1402874; Dejima T, 2011, INFECT IMMUN, V79, P4503, DOI 10.1128/IAI.05799-11; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110; Freedman TS, 2015, ELIFE, V4, DOI 10.7554/eLife.09183; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iborra S, 2016, IMMUNITY, V45, P788, DOI 10.1016/j.immuni.2016.09.012; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Lionakis MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002865; Majer O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002811; Marraco SAF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00331; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Schulz O, 2018, CELL REP, V24, P419, DOI 10.1016/j.celrep.2018.06.038; Steele CW, 2015, J PATHOL, V237, P85, DOI 10.1002/path.4555; Wu SR, 2017, TRENDS IMMUNOL, V38, P231, DOI 10.1016/j.it.2017.02.005; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	31	54	54	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					351	+		10.1126/science.aan8423	http://dx.doi.org/10.1126/science.aan8423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337411				2022-12-28	WOS:000447680100051
J	Di Nisio, M; Wichers, I; Middeldorp, S				Di Nisio, Marcello; Wichers, Iris; Middeldorp, Saskia			Treatment of Lower Extremity Superficial Thrombophlebitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VEIN-THROMBOSIS; FONDAPARINUX; PREVENTION		[Di Nisio, Marcello; Middeldorp, Saskia] Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [Wichers, Iris] Dutch Coll Gen Practitioners, Dept Guideline Dev & Sci, Utrecht, Netherlands	University of Amsterdam	Di Nisio, M (corresponding author), Univ G dAnnunzio, Dept Med & Aging Sci, Via Vestini 31, I-66013 Chieti, Italy.	mdinisio@unich.it	Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				Beyer-Westendorf J, 2017, LANCET HAEMATOL, V4, pE105, DOI 10.1016/S2352-3026(17)30014-5; Cannegieter SC, 2015, BLOOD, V125, P229, DOI 10.1182/blood-2014-06-577783; Decousus H, 2010, NEW ENGL J MED, V363, P1222, DOI 10.1056/NEJMoa0912072; Di Nisio M, 2018, COCHRANE DB SYST REV, V2; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Spirkoska A, 2015, ANGIOLOGY, V66, P381, DOI 10.1177/0003319714533183	6	8	9	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2018	320	22					2367	2368		10.1001/jama.2018.16623	http://dx.doi.org/10.1001/jama.2018.16623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD9GV	30383173				2022-12-28	WOS:000452870700021
J	Martincorena, I; Fowler, JC; Wabik, A; Lawson, ARJ; Abascal, F; Hall, MWJ; Cagan, A; Murai, K; Mahbubani, K; Stratton, MR; Fitzgerald, RC; Handford, PA; Campbell, PJ; Saeb-Parsy, K; Jones, PH				Martincorena, Inigo; Fowler, Joanna C.; Wabik, Agnieszka; Lawson, Andrew R. J.; Abascal, Federico; Hall, Michael W. J.; Cagan, Alex; Murai, Kasumi; Mahbubani, Krishnaa; Stratton, Michael R.; Fitzgerald, Rebecca C.; Handford, Penny A.; Campbell, Peter J.; Saeb-Parsy, Kourosh; Jones, Philip H.			Somatic mutant clones colonize the human esophagus with age	SCIENCE			English	Article							SQUAMOUS-CELL CARCINOMA; MUTATIONAL PROCESSES; BARRETTS-ESOPHAGUS; CANCER-RISK; NOTCH1; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION; SIGNATURES; LANDSCAPE	The extent to which cells in normal tissues accumulate mutations throughout life is poorly understood. Some mutant cells expand into clones that can be detected by genome sequencing. We mapped mutant clones in normal esophageal epithelium from nine donors (age range, 20 to 75 years). Somatic mutations accumulated with age and were caused mainly by intrinsic mutational processes. We found strong positive selection of clones carrying mutations in 14 cancer genes, with tens to hundreds of clones per square centimeter. In middle-aged and elderly donors, clones with cancer-associated mutations covered much of the epithelium, with NOTCH1 and TP53 mutations affecting 12 to 80% and 2 to 37% of cells, respectively. Unexpectedly, the prevalence of NOTCH1 mutations in normal esophagus was several times higher than in esophageal cancers. These findings have implications for our understanding of cancer and aging.	[Martincorena, Inigo; Fowler, Joanna C.; Wabik, Agnieszka; Lawson, Andrew R. J.; Abascal, Federico; Hall, Michael W. J.; Cagan, Alex; Murai, Kasumi; Stratton, Michael R.; Campbell, Peter J.; Jones, Philip H.] Wellcome Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Hall, Michael W. J.; Fitzgerald, Rebecca C.] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge CB2 0XZ, England; [Mahbubani, Krishnaa; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Biomed Campus, Cambridge CB2 2QQ, England; [Mahbubani, Krishnaa; Saeb-Parsy, Kourosh] Univ Cambridge, Cambridge NIHR Biomed Res Ctr, Biomed Campus, Cambridge CB2 2QQ, England; [Handford, Penny A.] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Cambridge	Martincorena, I; Jones, PH (corresponding author), Wellcome Sanger Inst, Hinxton CB10 1SA, Cambs, England.	im3@sanger.ac.uk; pj3@sanger.ac.uk	Mahbubani, Krishnaa T/A-5403-2009; Abascal, Federico/F-2267-2016	Mahbubani, Krishnaa T/0000-0002-1327-2334; Stratton, Michael/0000-0001-6035-153X; Abascal, Federico/0000-0002-6201-1587; Hall, Michael/0000-0003-2904-6902; Fowler, Joanna/0000-0001-7546-369X; Martincorena, Inigo/0000-0003-1122-4416; Jones, Philip H/0000-0002-5904-795X; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Fitzgerald, Rebecca/0000-0002-3434-3568; Wabik, Agnieszka/0000-0001-7231-2343; Lawson, Andrew/0000-0003-3592-1005	Cancer Research UK [C57387/A21777]; Cancer Research UK program [C609/A17257]; MRC Centenary grant; Wellcome Trust; MRC; MRC [MC_UU_12022/2, MC_UU_12022/3] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Cancer Research UK program(Cancer Research UK); MRC Centenary grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I.M. is funded by Cancer Research UK (C57387/A21777). P.J.C. is a Wellcome Trust Senior Clinical Fellow. This work was funded by a Cancer Research UK program grant to P.H.J. (C609/A17257), an MRC Centenary grant, Wellcome Trust core funding to the Wellcome Sanger Institute, and an MRC grant-in-aid to the MRC Cancer Unit.	Alcolea MP, 2015, CELL CYCLE, V14, P9, DOI 10.4161/15384101.2014.988027; Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhaduri A, 2015, DEV CELL, V35, P444, DOI 10.1016/j.devcel.2015.10.023; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Brash DE, 2015, SCIENCE, V348, P867, DOI 10.1126/science.aac4435; Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Center; Disease Working Group: Duke University; Memorial Sloan Kettering Cancer Center; National Cancer Institute; University of Texas MD Anderson Cancer Center; Yonsei University College of Medicine; Data Coordination Center: CSRA Inc.; Project Team: National Institutes of Health, 2017, NATURE, V541, P169; Chang J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15290; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerstung M, 2014, BIOINFORMATICS, V30, P1198, DOI 10.1093/bioinformatics/btt750; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Martinez P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02621-x; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Raine K. M., 2015, CURR PROTOC BIOINFOR, V52, P15, DOI [10.1002/0471250953.bi1507s52Medline, DOI 10.1002/0471250953.BI1507S52MEDLINE]; Raine Keiran M, 2016, Curr Protoc Bioinformatics, V56, DOI 10.1002/cpbi.17; Risques RA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007108; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Sakamoto K, 2012, LAB INVEST, V92, P688, DOI 10.1038/labinvest.2012.9; Sawada G, 2016, GASTROENTEROLOGY, V150, P1171, DOI 10.1053/j.gastro.2016.01.035; SMITH JM, 1962, PROC R SOC SER B-BIO, V157, P115, DOI 10.1098/rspb.1962.0065; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Yamashita S, 2018, P NATL ACAD SCI USA, V115, P1328, DOI 10.1073/pnas.1717340115; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017	50	483	486	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2018	362	6417					911	+		10.1126/science.aau3879	http://dx.doi.org/10.1126/science.aau3879			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB5TC	30337457	Green Submitted, Green Accepted			2022-12-28	WOS:000451124500034
J	Hawkes, N				Hawkes, Nigel			"Shocking" number of clinical trials are never reported, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Goldacre B, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3218; House of Commons Science and Technology Committee, 2018, RES INT CLIN TRIALS	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4582	10.1136/bmj.k4582	http://dx.doi.org/10.1136/bmj.k4582			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377163				2022-12-28	WOS:000449563200008
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Clinical records, plain English, and professional terminology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Academy of Medical Royal Colleges, 2018, PLEAS WRIT ME WRIT O; Lanchester J, 2014, HOW TO SPEAK MONEY; NHS England, 2018, PLANN NEXT 10 YEARS; NHS England, 2015, PAT ONL OFF PAT ACC	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2018	363								k4487	10.1136/bmj.k4487	http://dx.doi.org/10.1136/bmj.k4487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PU	30377152	Bronze			2022-12-28	WOS:000449563200001
J	Kmietowicz, Z				Kmietowicz, Zosia			UK campaigners call for legislative shake up to tackle "dirty air crisis"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		UK Health Alliance on Climate Change, 2018, MOV AIR QUAL CRIS RE	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 29	2018	363								k4532	10.1136/bmj.k4532	http://dx.doi.org/10.1136/bmj.k4532			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6PG	30369482				2022-12-28	WOS:000449561100005
J	Li, LB; Lin, RB; Krishna, R; Li, H; Xiang, SC; Wu, H; Li, JP; Zhou, W; Chen, BL				Li, Libo; Lin, Rui-Biao; Krishna, Rajamani; Li, Hao; Xiang, Shengchang; Wu, Hui; Li, Jinping; Zhou, Wei; Chen, Banglin			Ethane/ethylene separation in a metal-organic framework with iron-peroxo sites	SCIENCE			English	Article							HIGHLY SELECTIVE ADSORPTION; COORDINATION SITES; POROUS MATERIALS; PI-COMPLEXATION; ETHANE; ETHYLENE; PROPANE; BINDING; HYDROCARBONS; PROPYLENE	The separation of ethane from its corresponding ethylene is an important, challenging, and energy-intensive process in the chemical industry. Here we report a microporous metal-organic framework, iron(III) peroxide 2,5-dioxido-1,4-benzenedicarboxylate [Fe-2(O-2)(dobdc) (dobdc(4-): 2,5-dioxido-1,4-benzenedicarboxylate)], with iron (Fe)-peroxo sites for the preferential binding of ethane over ethylene and thus highly selective separation of C2H6/C2H4. Neutron powder diffraction studies and theoretical calculations demonstrate the key role of Fe-peroxo sites for the recognition of ethane. The high performance of Fe-2(O-2) (dobdc) for the ethane/ethylene separation has been validated by gas sorption isotherms, ideal adsorbed solution theory calculations, and simulated and experimental breakthrough curves. Through a fixed-bed column packed with this porous material, polymer-grade ethylene (99.99% pure) can be straightforwardly produced from ethane/ethylene mixtures during the first adsorption cycle, demonstrating the potential of Fe-2(O-2)(dobdc) for this important industrial separation with a low energy cost under ambient conditions.	[Li, Libo; Li, Jinping] Taiyuan Univ Technol, Coll Chem & Chem Engn, Taiyuan 030024, Shanxi, Peoples R China; [Li, Libo; Lin, Rui-Biao; Li, Hao; Chen, Banglin] Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA; [Krishna, Rajamani] Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Li, Hao; Xiang, Shengchang] Fujian Normal Univ, Coll Mat Sci & Engn, Fujian Prov Key Lab Polymer Mat, Fuzhou 350007, Fujian, Peoples R China; [Wu, Hui; Zhou, Wei] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Li, Libo; Li, Jinping] Shanxi Key Lab Gas Energy Efficient & Clean Utili, Taiyuan 030024, Shanxi, Peoples R China	Taiyuan University of Technology; University of Texas System; University of Texas at San Antonio (UTSA); University of Amsterdam; Fujian Normal University; National Institute of Standards & Technology (NIST) - USA	Li, JP (corresponding author), Taiyuan Univ Technol, Coll Chem & Chem Engn, Taiyuan 030024, Shanxi, Peoples R China.; Chen, BL (corresponding author), Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA.; Zhou, W (corresponding author), NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA.; Li, JP (corresponding author), Shanxi Key Lab Gas Energy Efficient & Clean Utili, Taiyuan 030024, Shanxi, Peoples R China.	jpli211@hotmail.com; wzhou@nist.gov; banglin.chen@utsa.edu	Li, Jinping/D-6496-2015; Zhou, Wei/C-6504-2008; Chen, Banglin/F-5461-2010; Li, Hao/Q-6739-2019; Krishna, Rajamani/A-1098-2012; Wu, Hui/C-6505-2008; Lin, Rui-Biao/P-5798-2014; Xiang, Shengchang/F-9210-2010; Li, Libo/X-5637-2018	Zhou, Wei/0000-0002-5461-3617; Chen, Banglin/0000-0001-8707-8115; Li, Hao/0000-0003-2630-7070; Krishna, Rajamani/0000-0002-4784-8530; Wu, Hui/0000-0003-0296-5204; Lin, Rui-Biao/0000-0003-3267-220X; Xiang, Shengchang/0000-0001-6016-2587; Li, Libo/0000-0001-7147-9838	National Natural Science Foundation of China [21606163]; Natural Science Foundation of Shanxi [201601D021042]; Welch Foundation [AX-1730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); Welch Foundation(The Welch Foundation)	We gratefully acknowledge the financial support from the National Natural Science Foundation of China (21606163), the Natural Science Foundation of Shanxi (201601D021042), and the Welch Foundation (AX-1730).	Aguado S, 2012, J AM CHEM SOC, V134, P14635, DOI 10.1021/ja305663k; Bereciartua PJ, 2017, SCIENCE, V358, P1068, DOI 10.1126/science.aao0092; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Bloch ED, 2011, J AM CHEM SOC, V133, P14814, DOI 10.1021/ja205976v; Cadiau A, 2016, SCIENCE, V353, P137, DOI 10.1126/science.aaf6323; Chen YW, 2018, CHEM ENG SCI, V175, P110, DOI 10.1016/j.ces.2017.09.032; Cho J, 2011, NATURE, V478, P502, DOI 10.1038/nature10535; Chu S, 2017, NAT MATER, V16, P16, DOI 10.1038/nmat4834; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Gucuyener C, 2010, J AM CHEM SOC, V132, P17704, DOI 10.1021/ja1089765; He YB, 2012, ENERG ENVIRON SCI, V5, P9107, DOI 10.1039/c2ee22858k; Kim J, 2012, LANGMUIR, V28, P11923, DOI 10.1021/la302230z; Li BY, 2014, J AM CHEM SOC, V136, P8654, DOI 10.1021/ja502119z; Li KH, 2009, J AM CHEM SOC, V131, P10368, DOI 10.1021/ja9039983; Li LB, 2017, J AM CHEM SOC, V139, P7733, DOI 10.1021/jacs.7b04268; Li ZY, 2017, J AM CHEM SOC, V139, P15251, DOI 10.1021/jacs.7b09365; Liang WW, 2016, CHEM ENG SCI, V148, P275, DOI 10.1016/j.ces.2016.04.016; Liao PQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9697; Lin JYS, 2016, SCIENCE, V353, P121, DOI 10.1126/science.aag2267; Mersmann A, 2000, CHEM ENG TECHNOL, V23, P937, DOI 10.1002/1521-4125(200011)23:11<937::AID-CEAT937>3.0.CO;2-P; Meyers RA, 2005, HDB PETROCHEMICALS P; Murray LJ, 2010, J AM CHEM SOC, V132, P7856, DOI 10.1021/ja1027925; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Queen WL, 2012, DALTON T, V41, P4180, DOI 10.1039/c2dt12138g; Ren T, 2006, ENERGY, V31, P425, DOI 10.1016/j.energy.2005.04.001; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Xiao DJ, 2014, NAT CHEM, V6, P590, DOI [10.1038/NCHEM.1956, 10.1038/nchem.1956]; YANG RT, 1995, AICHE J, V41, P509, DOI 10.1002/aic.690410309; Yang SH, 2015, NAT CHEM, V7, P121, DOI 10.1038/nchem.2114; Zhai QG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13645	32	501	517	77	801	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					443	+		10.1126/science.aat0586	http://dx.doi.org/10.1126/science.aat0586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361370				2022-12-28	WOS:000450441900046
J	McCook, A				McCook, Alison			One publisher, more than 7000 retractions	SCIENCE			English	Editorial Material																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					393	393		10.1126/science.362.6413.393	http://dx.doi.org/10.1126/science.362.6413.393			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361353				2022-12-28	WOS:000450441900024
J	Keating, D; Marigowda, G; Burr, L; Daines, C; Mall, MA; McKone, EF; Ramsey, BW; Rowe, SM; Sass, LA; Tullis, E; McKee, CM; Moskowitz, SM; Robertson, S; Savage, J; Simard, C; Van Goor, F; Waltz, D; Xuan, FJ; Young, T; Taylor-Cousar, JL				Keating, Dominic; Marigowda, Gautham; Burr, Lucy; Daines, Cori; Mall, Marcus A.; McKone, Edward F.; Ramsey, Bonnie W.; Rowe, Steven M.; Sass, Laura A.; Tullis, Elizabeth; McKee, Charlotte M.; Moskowitz, Samuel M.; Robertson, Sarah; Savage, Jessica; Simard, Christopher; Van Goor, Fredrick; Waltz, David; Xuan, Fengjuan; Young, Tim; Taylor-Cousar, Jennifer L.		VX16-445-001 Study Grp	VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TEZACAFTOR-IVACAFTOR; G551D MUTATION; CFTR	BACKGROUND VX-445 is a next-generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore Phe508del CFTR protein function in patients with cystic fibrosis when administered with tezacaftor and ivacaftor (VX-445-tezacaftor-ivacaftor). METHODS We evaluated the effects of VX-445-tezacaftor-ivacaftor on Phe508del CFTR protein processing, trafficking, and chloride transport in human bronchial epithelial cells. On the basis of in vitro activity, a randomized, placebo-controlled, double-blind, dose-ranging, phase 2 trial was conducted to evaluate oral VX-445-tezacaftor-ivacaftor in patients heterozygous for the Phe508del CFTR mutation and a minimal-function mutation (Phe508del-MF) and in patients homozygous for the Phe508del CFTR mutation (Phe508del-Phe508del) after tezacaftor-ivacaftor run-in. Primary end points were safety and absolute change in percentage of predicted forced expiratory volume in 1 second (FEV1) from baseline. RESULTS In vitro, VX-445-tezacaftor-ivacaftor significantly improved Phe508del CFTR protein processing, trafficking, and chloride transport to a greater extent than any two of these agents in dual combination. In patients with cystic fibrosis, VX-445-tezacaftor-ivacaftor had an acceptable safety and side-effect profile. Most adverse events were mild or moderate. The treatment also resulted in an increased percentage of predicted FEV1 of up to 13.8 points in the Phe508del-MF group (P<0.001). In patients in the Phe508del-Phe508del group, who were already receiving tezacaftor-ivacaftor, the addition of VX-445 resulted in an 11.0-point increase in the percentage of predicted FEV1 (P<0.001). In both groups, there was a decrease in sweat chloride concentrations and improvement in the respiratory domain score on the Cystic Fibrosis Questionnaire-Revised. CONCLUSIONS The use of VX-445-tezacaftor-ivacaftor to target Phe508del CFTR protein resulted in increased CFTR function in vitro and translated to improvements in patients with cystic fibrosis with one or two Phe508del alleles. This approach has the potential to treat the underlying cause of cystic fibrosis in approximately 90% of patients.	[Keating, Dominic] Alfred Hosp, Melbourne, Vic, Australia; [Burr, Lucy] Mater Hosp, Brisbane, Qld, Australia; [Marigowda, Gautham; McKee, Charlotte M.; Moskowitz, Samuel M.; Robertson, Sarah; Savage, Jessica; Simard, Christopher; Van Goor, Fredrick; Waltz, David; Xuan, Fengjuan; Young, Tim] Vertex Pharmaceut, Boston, MA USA; [Daines, Cori] Banner Univ, Med Ctr, Tucson, AZ USA; [Mall, Marcus A.] Univ Med Berlin, Berlin, Germany; [Mall, Marcus A.] Berlin Inst Hlth, Berlin, Germany; [Mall, Marcus A.] German Ctr Lung Res, Giessen, Germany; [McKone, Edward F.] St Vincents Univ Hosp, Dublin, Ireland; [McKone, Edward F.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Ramsey, Bonnie W.] Seattle Childrens Hosp, Seattle, WA USA; [Rowe, Steven M.] Univ Alabama Birmingham, Birmingham, AL USA; [Sass, Laura A.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Tullis, Elizabeth] St Michaels Hosp, Toronto, ON, Canada; [Taylor-Cousar, Jennifer L.] Natl Jewish Hlth, 1400 Jackson St,J318, Denver, CO 80206 USA	Florey Institute of Neuroscience & Mental Health; Vertex Pharmaceuticals; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Seattle Children's Hospital; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; National Jewish Health	Taylor-Cousar, JL (corresponding author), Natl Jewish Hlth, 1400 Jackson St,J318, Denver, CO 80206 USA.	taylor-cousarj@njhealth.org	Keating, Dominic T/H-8961-2019; Mall, Marcus A./AAA-1498-2022; Burr, Lucy D/F-8296-2015	Keating, Dominic T/0000-0001-6150-6927; Mall, Marcus A./0000-0002-4057-2199; Majoor, Christof/0000-0003-2677-9684; Middleton, Peter G/0000-0003-3361-4941; Burr, Lucy D/0000-0003-4010-3787	Vertex Pharmaceuticals from the Cystic Fibrosis Foundation; National Institutes of Health [P30DK072482, R35HL135816, U54TR001368]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, U54TR001356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, P30DK089507] Funding Source: NIH RePORTER	Vertex Pharmaceuticals from the Cystic Fibrosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Vertex Pharmaceuticals, which received funding from the Cystic Fibrosis Foundation for the development of VX-445. The National Institutes of Health provided grant support to the University of Alabama at Birmingham (P30DK072482, R35HL135816, and U54TR001368).	Davies JC, 2018, NEW ENGL J MED, V379, P1599, DOI 10.1056/NEJMoa1807119; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rowe SM, 2017, NEW ENGL J MED, V377, P2024, DOI 10.1056/NEJMoa1709847; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547	7	331	335	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1612	1620		10.1056/NEJMoa1807120	http://dx.doi.org/10.1056/NEJMoa1807120			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1GI	30334692	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000448273500006
J	Rutten-Jacobs, LC; Larsson, SC; Malik, R; Rannikmae, K; Sudlow, CL; Dichgans, M; Markus, HS; Traylor, M				Rutten-Jacobs, Loes Ca; Larsson, Susanna C.; Malik, Rainer; Rannikmae, Kristiina; Sudlow, Cathie L.; Dichgans, Martin; Markus, Hugh S.; Traylor, Matthew			Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-STROKE; PRIMARY PREVENTION; SEX-DIFFERENCES; SCORE; AGE; EPIDEMIOLOGY; DISEASE	OBJECTIVE To evaluate the associations of a polygenic risk score and healthy lifestyle with incident stroke. DESIGN Prospective population based cohort study. SETTING UK Biobank Study, UK. PARTICIPANTS 306 473 men and women, aged 40-73 years, recruited between 2006 and 2010. MAIN OUTCOME MEASURE Hazard ratios for a first stroke, estimated using Cox regression. A polygenic risk score of 90 single nucleotide polymorphisms previously associated with stroke was constructed at P<1.10(-5) to test for an association with incident stroke. Adherence to a healthy lifestyle was determined on the basis of four factors: non-smoker, healthy diet, body mass index <30 kg/m(2), and regular physical exercise. RESULTS During a median follow-up of 7.1 years (2138443 person years), 2077 incident strokes (1541 ischaemic stroke, 287 intracerebral haemorrhage, and 249 subarachnoid haemorrhage) were ascertained. The risk of incident stroke was 35% higher among those at high genetic risk (top third of polygenic score) compared with those at low genetic risk (bottom third): hazard ratio 1.35 (95% confidence interval 1.21 to 1.50), P=3.9.10(-8). Unfavourable lifestyle (0 or 1 healthy lifestyle factors) was associated with a 66% increased risk of stroke compared with a favourable lifestyle (3 or 4 healthy lifestyle factors): 1.66 (1.45 to 1.89), P=1.19.10(-13). The association with lifestyle was independent of genetic risk stratums. CONCLUSION In this cohort study, genetic and lifestyle factors were independently associated with incident stroke. These results emphasise the benefit of entire populations adhering to a healthy lifestyle, independent of genetic risk.	[Rutten-Jacobs, Loes Ca] German Ctr Neurodegenerat Dis DZNE, Populat Hlth Sci, Sigmund Freud Str 27, D-53127 Bonn, Germany; [Rutten-Jacobs, Loes Ca; Markus, Hugh S.; Traylor, Matthew] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Larsson, Susanna C.] Karolinska Inst, Inst Environm Med, Unit Nutr Epidemiol, Stockholm, Sweden; [Malik, Rainer; Dichgans, Martin] Univ Hosp, Inst Stroke & Dementia Res ISD, LMU Munich, Munich, Germany; [Rannikmae, Kristiina; Sudlow, Cathie L.] Univ Edinburgh, Ctr Med Informat, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Rannikmae, Kristiina; Sudlow, Cathie L.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Dichgans, Martin] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cambridge; Karolinska Institutet; University of Munich; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Rutten-Jacobs, LC (corresponding author), German Ctr Neurodegenerat Dis DZNE, Populat Hlth Sci, Sigmund Freud Str 27, D-53127 Bonn, Germany.; Rutten-Jacobs, LC (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.	Loes.Rutten-jacobs@dzne.de	Larsson, Susanna C./F-6065-2015; Dichgans, Martin/HCH-3247-2022; Rutten-Jacobs, Loes/C-7746-2013	Larsson, Susanna C./0000-0003-0118-0341; Dichgans, Martin/0000-0002-0654-387X; Rutten-Jacobs, Loes/0000-0003-3223-885X; Malik, Rainer/0000-0001-9212-2520; Sudlow, Cathie/0000-0002-7725-7520	British Heart Foundation [RG/16/4/32218, FS/15/61/31626]; Scottish funding Council; European Union's Horizon 2020 research and innovation programme [666881]; DFG [CRC 1123]; Munich Cluster for Systems Neurology [EXC 1010]; National Institute for Health Research (NIHR); Cambridge Universities NIHR Comprehensive Biomedical Research Centre; MRC [MR/S004130/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Scottish funding Council; European Union's Horizon 2020 research and innovation programme; DFG(German Research Foundation (DFG)); Munich Cluster for Systems Neurology; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge Universities NIHR Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was in part supported by a British Heart Foundation programme grant (RG/16/4/32218). LCAR-J was supported by a British Heart Foundation immediate research fellowship (FS/15/61/31626). CLS is chief scientist for UK Biobank. The main sources of funding for CLS's salary are UK Biobank and the Scottish funding Council. MD received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 666881 (SVDs@ target) and from the DFG through the CRC 1123 (B3) and the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). HSM is supported by a National Institute for Health Research (NIHR) senior investigator award, and his work is supported by the Cambridge Universities NIHR Comprehensive Biomedical Research Centre. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The MEGASTROKE project received funding from sources specified at www.megastroke.org/acknowledgments.html.	Abraham G, 2016, EUR HEART J, V37, P3267, DOI 10.1093/eurheartj/ehw450; Andersen KK, 2010, STROKE, V41, P2768, DOI 10.1161/STROKEAHA.110.595785; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; BRASS LM, 1992, STROKE, V23, P221, DOI 10.1161/01.STR.23.2.221; Bycroft C., 2017, BIORXIV, P166298, DOI DOI 10.1136/heartjnl-2013-303950; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Colpani V, 2018, EUR J EPIDEMIOL, V33, P831, DOI 10.1007/s10654-018-0374-z; Fava C, 2015, EUR J HUM GENET, V23, P969, DOI 10.1038/ejhg.2014.212; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Ibrahim-Verbaas CA, 2014, STROKE, V45, P403, DOI 10.1161/STROKEAHA.113.003044; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Larsson SC, 2015, NEUROLOGY, V84, P2224, DOI 10.1212/WNL.0000000000001637; Larsson SC, 2014, NEUROLOGY, V83, P1699, DOI 10.1212/WNL.0000000000000954; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Connell J, 2016, NAT GENET, V48, P817, DOI 10.1038/ng.3583; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rutten-Jacobs LCA, 2018, STROKE, V49, P1340, DOI 10.1161/STROKEAHA.118.020811; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Sudlow C, 2017, DEFINITIONS ACUTE MY; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tada H, 2014, STROKE, V45, P2856, DOI 10.1161/STROKEAHA.114.006072; Touze E, 2008, STROKE, V39, P16, DOI 10.1161/STROKEAHA.107.484618; Traylor M, 2016, STROKE, V47, P1174, DOI 10.1161/STROKEAHA.115.011625; Traylor M, 2015, STROKE, V46, P3042, DOI 10.1161/STROKEAHA.115.009816; von Sarnowski B, 2013, STROKE, V44, P119, DOI 10.1161/STROKEAHA.112.665190; Zhang YR, 2011, ARCH INTERN MED, V171, P1811, DOI 10.1001/archinternmed.2011.443	32	102	105	6	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4168	10.1136/bmj.k4168	http://dx.doi.org/10.1136/bmj.k4168			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355576	Green Published, hybrid			2022-12-28	WOS:000448895300003
J	Ghebreyesus, TA; Fore, H; Birtanov, Y; Jakab, Z				Ghebreyesus, Tedros Adhanom; Fore, Henrietta; Birtanov, Yelzhan; Jakab, Zsuzsanna			Primary health care for the 21st century, universal health coverage, and the Sustainable Development Goals	LANCET			English	Editorial Material									[Ghebreyesus, Tedros Adhanom] World Hlth Org, Geneva, Switzerland; [Fore, Henrietta] United Nations Childrens Fund, New York, NY USA; [Birtanov, Yelzhan] Govt Kazakhstan, Minist Healthcare, Astana, Kazakhstan; [Jakab, Zsuzsanna] World Hlth Org, Reg Off Europe, DK-2100 Copenhagen, Denmark	World Health Organization; UNICEF; World Health Organization	Jakab, Z (corresponding author), World Hlth Org, Reg Off Europe, DK-2100 Copenhagen, Denmark.	eurd@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; *WHO, 1978, ALM AT 1978 PRIM HLT; WHO, 2008, PHARMAFORUM 0121; World Health Organization, 2018, TIM DEL REP WHO IND; World Health Organization, 2018, WORLD REP AG HLTH; World Health Organization, 2019, WORLD HLTH STAT MON	6	24	25	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1371	1372		10.1016/S0140-6736(18)32556-X	http://dx.doi.org/10.1016/S0140-6736(18)32556-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343843				2022-12-28	WOS:000447800900005
J	Gross, J; Williams, B; Fade, P; Brett, SJ				Gross, Jamie; Williams, Barry; Fade, Premila; Brett, Stephen J.			Intensive care: balancing risk and benefit to facilitate informed decisions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY-OF-LIFE; CRITICAL ILLNESS; FRAILTY; ICU; DISABILITY; MORTALITY; RECOVERY; OUTCOMES; IMPACT; OLDER		[Gross, Jamie; Fade, Premila] London North West Univ Healthcare NHS Trust, Watford Rd, Harrow HA1 3UJ, Middx, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Ctr Perioperat Med & Crit Care Res, Du Cane Rd, London W12 0HS, England	Imperial College London	Gross, J (corresponding author), London North West Univ Healthcare NHS Trust, Watford Rd, Harrow HA1 3UJ, Middx, England.	j.gross@nhs.net						Azoulay E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1887-7; Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639; Bernacki R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009032; Carey I, 2015, BMJ SUPPORT PALLIAT, V5, P12, DOI 10.1136/bmjspcare-2013-000634; Chamberlain AM, 2016, J AM GERIATR SOC, V64, P285, DOI 10.1111/jgs.13944; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cooper C, 2016, AGE AGEING, V45, P148, DOI [10.1093/ageing/afu148, 10.1093/ageing/afv154]; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Department of Health, 2008, END LIF CAR STRAT PR; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Flaatten H, 2017, INTENS CARE MED, V43, P1820, DOI 10.1007/s00134-017-4940-8; Fried TR, 2007, J GEN INTERN MED, V22, P495, DOI 10.1007/s11606-007-0104-9; Griffith DM, 2018, CRIT CARE MED, V46, P594, DOI 10.1097/CCM.0000000000002952; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Guidelines for the Provision of Intensive Care Services (GPICS), 2015, JOINT GUID INT CAR S; Herridge Margaret S, 2009, Crit Care Med, V37, pS457, DOI 10.1097/CCM.0b013e3181b6f35c; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Institute for Public Policy Research, END LIF CAR ENGL; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Khandelwal N, 2015, CRIT CARE MED, V43, P1102, DOI 10.1097/CCM.0000000000000852; Le Guen J, 2016, AGE AGEING, V45, P303, DOI 10.1093/ageing/afv191; Lone NI, 2016, AM J RESP CRIT CARE, V194, P198, DOI 10.1164/rccm.201511-2234OC; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; NHS England, 2010, STAT WORK AR CRIT CA; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Reade MC, 2014, NEW ENGL J MED, V370, P444, DOI 10.1056/NEJMra1208705; Reay H., 2014, J INTENSIVE CARE SOC, V15, P288, DOI [10.1177/175114371401500405, DOI 10.1177/175114371401500405]; Scottish Government, REAL MED; Sukantarat KT, 2003, UPD INT CAR, V39, P51; van Oostrom SH, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0595-0; Wade DM, 2015, BRIT J HEALTH PSYCH, V20, P613, DOI 10.1111/bjhp.12109	32	12	12	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4135	10.1136/bmj.k4135	http://dx.doi.org/10.1136/bmj.k4135			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341067	Green Published			2022-12-28	WOS:000448271300001
J	Da Mesquita, S; Louveau, A; Vaccari, A; Smirnov, I; Cornelison, RC; Kingsmore, KM; Contarino, C; Onengut-Gumuscu, S; Farber, E; Raper, D; Viar, KE; Powell, RD; Baker, W; Dabhi, N; Bai, R; Cao, R; Hu, S; Rich, SS; Munson, JM; Lopes, MB; Overall, CC; Acton, ST; Kipnis, J				Da Mesquita, Sandro; Louveau, Antoine; Vaccari, Andrea; Smirnov, Igor; Cornelison, R. Chase; Kingsmore, Kathryn M.; Contarino, Christian; Onengut-Gumuscu, Suna; Farber, Emily; Raper, Daniel; Viar, Kenneth E.; Powell, Romie D.; Baker, Wendy; Dabhi, Nisha; Bai, Robin; Cao, Rui; Hu, Song; Rich, Stephen S.; Munson, Jennifer M.; Lopes, M. Beatriz; Overall, Christopher C.; Acton, Scott T.; Kipnis, Jonathan			Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease (vol 560, pg 185, 2018)	NATURE			English	Correction													Lopes, Maria/GXF-7507-2022; Da Mesquita, Sandro/A-7365-2010; Hu, Song/ABD-6256-2021; Kipnis, Jonathan/AGG-9735-2022	Da Mesquita, Sandro/0000-0002-0786-5010; Hu, Song/0000-0002-5760-8012; Kipnis, Jonathan/0000-0002-3714-517X; Kingsmore, Kathryn/0000-0002-9923-4709	NCI NIH HHS [R37 CA222563] Funding Source: Medline; NIA NIH HHS [R01 AG034113, RF1 AG057496] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8	1	6	6	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2018	564	7734					E7	E7		10.1038/s41586-018-0689-7	http://dx.doi.org/10.1038/s41586-018-0689-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1KR	30397347	Bronze			2022-12-28	WOS:000452269400005
J	Hammadah, M; Kim, JH; Tahhan, AS; Kindya, B; Liu, C; Ko, YA; Al Mheid, I; Wilmot, K; Ramadan, R; Alkhoder, A; Choudhary, F; Gafeer, MM; Abdelhadi, N; Pimple, P; Sandesara, P; Lima, BB; Shah, AJ; Ward, L; Kutner, M; Bremner, JD; Sheps, DS; Raggi, P; Sperling, LS; Vaccarino, V; Quyyumi, AA				Hammadah, Muhammad; Kim, Jeong Hwan; Tahhan, Ayman Samman; Kindya, Bryan; Liu, Chang; Ko, Yi-An; Al Mheid, Ibhar; Wilmot, Kobina; Ramadan, Ronnie; Alkhoder, Ayman; Choudhary, Fahad; Gafeer, Mohamad Mazen; Abdelhadi, Naser; Pimple, Pratik; Sandesara, Pratik; Lima, Bruno B.; Shah, Amit J.; Ward, Laura; Kutner, Michael; Bremner, J. Douglas; Sheps, David S.; Raggi, Paolo; Sperling, Laurence S.; Vaccarino, Viola; Quyyumi, Arshed A.			Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; STRESS TEST; EARLY-DIAGNOSIS; MENTAL STRESS; I MEASUREMENT; T ASSAY; RISK; ASSOCIATION; PREVALENCE; MORTALITY	Background: Many patients with coronary artery disease (CAD) are routinely referred for surveillance stress testing despite recommendations against it. Objective: To determine whether low levels of resting high-sensitivity cardiac troponin I (hs-cTnI) can identify persons without inducible myocardial ischemia. Design: Observational study. Setting: A university-affiliated hospital network. Patients: Persons with stable CAD: 589 in the derivation group and 118 in the validation cohort. Measurements: Presence of inducible myocardial ischemia was determined by myocardial perfusion imaging with technetium-99m single-photon emission computed tomography during either treadmill or pharmacologic stress testing. Resting plasma hs-cTnI was measured within 1 week of the stress test, and the negative predictive value (NPV) for inducible ischemia was calculated. The derivation cohort was followed for 3 years for incident cardiovascular death and myocardial infarction. Results: In the derivation cohort, 10 of 101 patients with an hs-cTnI level below 2.5 pg/mL had inducible myocardial ischemia (NPV, 90% [95% CI, 83% to 95%]) and 3 of 101 had inducible ischemia involving at least 10% of the myocardium (NPV, 97% [CI, 92% to 99%]). In the validation cohort, 4 of 32 patients with an hs-cTnI level below 2.5 pg/mL had inducible ischemia (NPV, 88% [CI, 71% to 96%]) and 2 of 32 had ischemia of 10% or greater (NPV, 94% [CI, 79% to 99%]). After a median follow-up of 3 years in the derivation cohort, no adverse events occurred in patients with an hs-cTnI level below 2.5 pg/mL, compared with 33 (7%) cardiovascular deaths or incident myocardial infarctions among those with an hs-cTnI level of 2.5 pg/mL or greater. Limitation: The data may not be applicable to a population without known CAD or to persons with unstable angina, and the modest sample sizes warrant further validation in a larger cohort. Conclusion: Very low hs-cTnI levels may be useful in excluding inducible myocardial ischemia in patients with stable CAD.	[Hammadah, Muhammad; Kim, Jeong Hwan; Tahhan, Ayman Samman; Kindya, Bryan; Liu, Chang; Al Mheid, Ibhar; Wilmot, Kobina; Ramadan, Ronnie; Alkhoder, Ayman; Choudhary, Fahad; Gafeer, Mohamad Mazen; Abdelhadi, Naser; Sandesara, Pratik; Lima, Bruno B.; Bremner, J. Douglas; Quyyumi, Arshed A.] Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, 1462 Clifton Rd Northeast,Suite 507, Atlanta, GA 30322 USA; [Sperling, Laurence S.] Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, 1365 Clifton Rd Northeast,Bldg A,Suite 2200, Atlanta, GA 30322 USA; [Bremner, J. Douglas] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 12 Execut Pk Dr Northeast,Room 385, Atlanta, GA 30322 USA; [Ko, Yi-An; Kutner, Michael] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, 1518 Clifton Rd Northeast,Mailstop 1518-002-3AA, Atlanta, GA 30322 USA; [Pimple, Pratik] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd Northeast, Atlanta, GA 30322 USA; [Ward, Laura] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd Northeast,Mailstop 1518-002-3AA, Atlanta, GA 30322 USA; [Shah, Amit J.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd Northeast,Room 3053, Atlanta, GA 30322 USA; [Vaccarino, Viola] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, 1518 Clifton Rd Northeast,Room 3011, Atlanta, GA 30322 USA; [Sheps, David S.] Univ Florida, Dept Epidemiol, 2004 Mowry Rd,Room 4234,POB 100231, Gainesville, FL 32610 USA; [Raggi, Paolo] Univ Alberta, Mazankowski Alberta Heart Inst, 4A7-050,8440-112 St, Edmonton, AB T6G 2B7, Canada	Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; State University System of Florida; University of Florida; University of Alberta	Quyyumi, AA (corresponding author), Emory Univ, Sch Med, Emory Clin Cardiovasc Res Inst, 1462 Clifton Rd Northeast,Suite 507, Atlanta, GA 30322 USA.	aquyyum@emory.edu	Lima, Bruno/AAB-2807-2021; Lima, Bruno/GWQ-4050-2022; , Viola/AAW-5600-2020	Lima, Bruno/0000-0001-5540-932X; Shah, Amit/0000-0001-9099-9687	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109413, P01HL086773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health.	Ahmed W, 2013, JACC-CARDIOVASC IMAG, V6, P72, DOI 10.1016/j.jcmg.2012.08.014; Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Aw TC, 2013, CLIN CHIM ACTA, V422, P26, DOI 10.1016/j.cca.2013.03.034; Axelsson A, 2013, BIOMARKERS, V18, P304, DOI 10.3109/1354750X.2013.776635; Beatty AL, 2013, JAMA INTERN MED, V173, P763, DOI 10.1001/jamainternmed.2013.116; Bradley SM, 2015, CIRC-CARDIOVASC QUAL, V8, P486, DOI 10.1161/CIRCOUTCOMES.114.001561; Chapman AR, 2017, JAMA-J AM MED ASSOC, V318, P1913, DOI 10.1001/jama.2017.17488; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Falkensammer J, 2012, CLIN CHIM ACTA, V413, P1678, DOI 10.1016/j.cca.2012.05.014; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; Hammadah M, 2018, JACC-CARDIOVASC IMAG, V11, P603, DOI 10.1016/j.jcmg.2016.11.021; Hammadah M, 2017, PSYCHOSOM MED, V79, P311, DOI 10.1097/PSY.0000000000000442; Holly TA, 2010, J NUCL CARDIOL, V17, P941, DOI 10.1007/s12350-010-9246-y; Jaffe AS, 2013, REV ESP CARDIOL, V66, P687, DOI 10.1016/j.rec.2013.04.020; KATUS HA, 1991, AM J CARDIOL, V67, P1360, DOI 10.1016/0002-9149(91)90466-X; Kavsak PA, 2011, CLIN CHEM, V57, P1146, DOI 10.1373/clinchem.2011.164574; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Kimble Laura P, 2002, Heart Dis, V4, P206, DOI 10.1097/00132580-200207000-00002; Kitagawa N, 2015, J CARDIOVASC COMPUT, V9, P209, DOI 10.1016/j.jcct.2015.01.015; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Lazzarino AI, 2013, J AM COLL CARDIOL, V62, P1694, DOI 10.1016/j.jacc.2013.05.070; Lee G, 2016, AM HEART J, V173, P8, DOI 10.1016/j.ahj.2015.11.010; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Middleton N, 2006, EXP PHYSIOL, V91, P511, DOI 10.1113/expphysiol.2005.032631; Ndrepepa G, 2011, AM J CARDIOL, V108, P639, DOI 10.1016/j.amjcard.2011.04.012; Neumayr G, 2001, AM J CARDIOL, V87, P369, DOI 10.1016/S0002-9149(00)01382-5; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; Oemrawsingh RM, 2016, ATHEROSCLEROSIS, V247, P135, DOI 10.1016/j.atherosclerosis.2016.02.012; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Peterson T, 2014, CIRC-CARDIOVASC IMAG, V7, P439, DOI 10.1161/CIRCIMAGING.113.000833; QUYYUMI AA, 1993, J AM COLL CARDIOL, V21, P700, DOI 10.1016/0735-1097(93)90103-8; Ramadan R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000321; Reckord N, 2017, CURR PHARM BIOTECHNO, V18, P508, DOI 10.2174/1389201018666170601082145; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; Sabatine MS, 2009, EUR HEART J, V30, P162, DOI 10.1093/eurheartj/ehn504; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shah BR, 2010, J AM COLL CARDIOL, V56, P1328, DOI 10.1016/j.jacc.2010.03.093; Shaw L, 2013, JACC-CARDIOVASC IMAG, V6, P745, DOI 10.1016/j.jcmg.2013.05.001; Sou SM, 2016, CLIN BIOCHEM, V49, P421, DOI 10.1016/j.clinbiochem.2015.12.005; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Tahhan AS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007914; Tanglay Y, 2015, AM J MED, V128, P638, DOI 10.1016/j.amjmed.2015.01.009; Thygesen K, 2012, EUR HEART J, V33, P2252, DOI 10.1093/eurheartj/ehs154; Vaccarino V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003630; Walkers F, 2000, HEART DIS TXB CARDIO, P273; White HD, 2011, J AM COLL CARDIOL, V58, P2356, DOI 10.1016/j.jacc.2011.09.001; Wongpraparut N, 2015, CLIN CARDIOL, V38, P293, DOI 10.1002/clc.22392; Zeller T, 2014, EUR HEART J, V35, P271, DOI 10.1093/eurheartj/eht406	54	11	12	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2018	169	11					751	+		10.7326/M18-0670	http://dx.doi.org/10.7326/M18-0670			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4WR	30398528	Green Accepted			2022-12-28	WOS:000451806000004
J	Jin, S; Huang, M; Kwon, Y; Zhang, LN; Li, BW; Oh, S; Dong, JC; Luo, D; Biswal, M; Cunning, BV; Bakharev, PV; Moon, I; Yoo, WJ; Camacho-Mojica, DC; Kim, YJ; Lee, SH; Wang, B; Seong, WK; Saxena, M; Ding, F; Shin, HJ; Ruoff, RS				Jin, Sunghwan; Huang, Ming; Kwon, Youngwoo; Zhang, Leining; Li, Bao-Wen; Oh, Sangjun; Dong, Jichen; Luo, Da; Biswal, Mandakini; Cunning, Benjamin V.; Bakharev, Pavel V.; Moon, Inyong; Yoo, Won Jong; Camacho-Mojica, Dulce C.; Kim, Yong-Jin; Lee, Sun Hwa; Wang, Bin; Seong, Won Kyung; Saxena, Manav; Ding, Feng; Shin, Hyung-Joon; Ruoff, Rodney S.			Colossal grain growth yields single-crystal metal foils by contact-free annealing	SCIENCE			English	Article							SURFACE-ENERGY; THIN-FILMS; MOLECULAR-DYNAMICS; DOMAIN-STRUCTURE; LAYER GRAPHENE; GIANT GRAINS; COPPER; BOUNDARY; HYDROGEN; RECRYSTALLIZATION	Single-crystal metals have distinctive properties owing to the absence of grain boundaries and strong anisotropy. Commercial single-crystal metals are usually synthesized by bulk crystal growth or by deposition of thin films onto substrates, and they are expensive and small. We prepared extremely large single-crystal metal foils by "contact-free annealing" from commercial polycrystalline foils. The colossal grain growth (up to 32 square centimeters) is achieved by minimizing contact stresses, resulting in a preferred in-plane and out-of-plane crystal orientation, and is driven by surface energy minimization during the rotation of the crystal lattice followed by "consumption" of neighboring grains. Industrial-scale production of single-crystalmetal foils is possible as a result of this discovery.	[Jin, Sunghwan; Huang, Ming; Kwon, Youngwoo; Zhang, Leining; Li, Bao-Wen; Dong, Jichen; Luo, Da; Biswal, Mandakini; Cunning, Benjamin V.; Bakharev, Pavel V.; Camacho-Mojica, Dulce C.; Kim, Yong-Jin; Lee, Sun Hwa; Wang, Bin; Seong, Won Kyung; Saxena, Manav; Ding, Feng; Shin, Hyung-Joon; Ruoff, Rodney S.] IBS, CMCM, Ulsan 44919, South Korea; [Huang, Ming; Zhang, Leining; Ding, Feng; Shin, Hyung-Joon; Ruoff, Rodney S.] UNIST, Sch Mat Sci & Engn, Ulsan 44919, South Korea; [Oh, Sangjun; Ruoff, Rodney S.] UNIST, Dept Chem, Ulsan 44919, South Korea; [Moon, Inyong; Yoo, Won Jong] Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Gyeonggi Do 16419, South Korea; [Ruoff, Rodney S.] UNIST, Sch Energy & Chem Engn, Ulsan 44919, South Korea	Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Sungkyunkwan University (SKKU); Ulsan National Institute of Science & Technology (UNIST)	Shin, HJ; Ruoff, RS (corresponding author), IBS, CMCM, Ulsan 44919, South Korea.; Shin, HJ; Ruoff, RS (corresponding author), UNIST, Sch Mat Sci & Engn, Ulsan 44919, South Korea.; Ruoff, RS (corresponding author), UNIST, Dept Chem, Ulsan 44919, South Korea.; Ruoff, RS (corresponding author), UNIST, Sch Energy & Chem Engn, Ulsan 44919, South Korea.	shinhj@unist.ac.kr; ruofflab@gmail.com	Zhang, Leining/GWS-8146-2022; Lee, Sun Hwa/N-6779-2014; Jin, Sunghwan/AAI-7497-2021; Yoo, Won Jong/AAR-2052-2021; DING, FENG/D-5938-2011; Ruoff, Rodney/ABE-6532-2020; Huang, Ming/AFP-2590-2022; Saxena, Manav/F-2001-2016; SHIN, Hyung-Joon/A-6028-2009; Wang, Bin/E-4424-2019; Luo, Da/ABW-0504-2022; Huang, Ming/A-6968-2015; Jin, Sunghwan/AAB-3022-2019; Luo, Da/AFX-4147-2022	Lee, Sun Hwa/0000-0003-1368-1274; Yoo, Won Jong/0000-0002-3767-7969; DING, FENG/0000-0001-9153-9279; Ruoff, Rodney/0000-0002-6599-6764; Huang, Ming/0000-0002-9188-4619; Saxena, Manav/0000-0003-4636-3942; SHIN, Hyung-Joon/0000-0002-6750-118X; Wang, Bin/0000-0001-9576-2646; Luo, Da/0000-0002-9128-6782; Huang, Ming/0000-0002-9188-4619; Jin, Sunghwan/0000-0003-3750-8599; Luo, Da/0000-0002-9128-6782; Camacho-Mojica, Dulce/0000-0002-7932-9655; Cunning, Benjamin/0000-0001-8278-1995	 [IBS-R019-D1]		This work was supported by IBS-R019-D1.	Ajmal M, 2012, CRYSTENGCOMM, V14, P1463, DOI 10.1039/c1ce06026k; Arblaster JW, 2012, PLATIN MET REV, V56, P181, DOI 10.1595/147106712X646113; Bauer R, 2011, PHILOS MAG, V91, P437, DOI 10.1080/14786435.2010.525541; Bennett TA, 2011, MICROSC MICROANAL, V17, P362, DOI 10.1017/S1431927611000377; Betanda YA, 2015, ADV ENG MATER, V17, P1568, DOI 10.1002/adem.201500071; BETTERIDGE W, 1979, PROG MATER SCI, V24, P51; BLANKENSHIP CP, 1994, SCRIPTA METALL MATER, V31, P647, DOI 10.1016/0956-716X(94)90204-6; Brown L, 2014, NANO LETT, V14, P5706, DOI 10.1021/nl502445j; Chapman D., 2016, COPPER DEV ASS RESOU, V122, P1; Cho YC, 2010, CRYST GROWTH DES, V10, P2780, DOI 10.1021/cg1003808; Fujikawa T, 2001, JPN J APPL PHYS 1, V40, P2191, DOI 10.1143/JJAP.40.2191; Fukai Y, 1995, J ALLOY COMPD, V231, P35, DOI 10.1016/0925-8388(95)01834-4; Gol'tsov VA, 2006, PHYS MET METALLOGR+, V102, P318, DOI 10.1134/S0031918X06090122; Gottstein G., 2010, GRAIN BOUNDARY MIGRA, V2nd; Hahn TA, 1972, AIP C P, V3, P87, DOI [10.1063/1.2948578, DOI 10.1063/1.2948578]; Han GH, 2011, NANO LETT, V11, P4144, DOI 10.1021/nl201980p; Homer ER, 2015, SCI REP-UK, V5, DOI 10.1038/srep15476; Hu BS, 2012, CARBON, V50, P57, DOI 10.1016/j.carbon.2011.08.002; Huang M, 2018, ACS NANO, V12, P6117, DOI 10.1021/acsnano.8b02444; Humphreys F.J., 2004, RECRYSTALLIZATION RE, DOI 10.1016/B978-0-08-044164-1.X5000-2; Iwasaki T, 2011, NANO LETT, V11, P79, DOI 10.1021/nl102834q; Jensen J. E., 1980, 10200R BNL; Jiang Q, 2004, J PHYS-CONDENS MAT, V16, P521, DOI 10.1088/0953-8984/16/4/001; Kallinteris GC, 1997, PHYS REV B, V55, P2150, DOI 10.1103/PhysRevB.55.2150; Khlebnikova YV, 2007, PHYS MET METALLOGR+, V103, P609, DOI 10.1134/S0031918X07060105; Kim DW, 2012, NAT NANOTECHNOL, V7, P29, DOI [10.1038/nnano.2011.198, 10.1038/NNANO.2011.198]; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Lewis F., 1960, PLATIN MET REV, V4, P132; Mi X, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155436; Mills KC., 2002, RECOMMENDED VALUES T, DOI 10.1533/9781845690144; MULLINS WW, 1957, J APPL PHYS, V28, P333, DOI 10.1063/1.1722742; Murr LE, 2004, J MATER SCI, V39, P1153, DOI 10.1023/B:JMSC.0000013870.09241.c0; Ogawa Y, 2012, J PHYS CHEM LETT, V3, P219, DOI 10.1021/jz2015555; Omori T, 2013, SCIENCE, V341, P1500, DOI 10.1126/science.1238017; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Reed-Hill R. E., 1992, PWS KENT SERIES ENG; Seah CM, 2014, CARBON, V70, P1, DOI 10.1016/j.carbon.2013.12.073; Seita M, 2010, ACTA MATER, V58, P6513, DOI 10.1016/j.actamat.2010.08.014; Shvindlerman LS, 2001, RECRYSTALLIZATION AND GRAIN GROWTH, VOLS 1 AND 2, P177; Suwas S, 2014, ENG MATER PROCESS, P1, DOI 10.1007/978-1-4471-6314-5; THOMPSON CV, 1984, APPL PHYS LETT, V44, P603, DOI 10.1063/1.94842; Tschopp MA, 2007, PHILOS MAG, V87, P3871, DOI 10.1080/14786430701455321; Nguyen VL, 2015, ADV MATER, V27, P1376, DOI 10.1002/adma.201404541; Varykhalov A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035437; WAMPLER WR, 1976, PHILOS MAG, V34, P129, DOI 10.1080/14786437608228179; Wang B, 2016, ACS NANO, V10, P1404, DOI 10.1021/acsnano.5b06842; Wang Y, 2011, ACS NANO, V5, P9927, DOI 10.1021/nn203700w; WOLF D, 1990, ACTA METALL MATER, V38, P781, DOI 10.1016/0956-7151(90)90030-K; Wright SI, 2011, MICROSC MICROANAL, V17, P316, DOI 10.1017/S1431927611000055; Zhang B, 2012, ACS NANO, V6, P2471, DOI 10.1021/nn204827h; Zhao ZJ, 2015, SMALL, V11, P1418, DOI 10.1002/smll.201402483; Zhou XW, 2001, ACTA MATER, V49, P4005, DOI 10.1016/S1359-6454(01)00287-7	55	119	121	22	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2018	362	6418					1021	+		10.1126/science.aao3373	http://dx.doi.org/10.1126/science.aao3373			70	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HC2CE	30337454				2022-12-28	WOS:000451609000037
J	Hwang, KO; Thomas, EJ; Petersen, LA				Hwang, Kevin O.; Thomas, Eric J.; Petersen, Laura A.			Use of Home Blood Pressure Results for Assessing the Quality of Care for Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hwang, Kevin O.; Thomas, Eric J.] Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, UTHlth McGovern Med Sch, 6410 Fannin,UPB 1100-41, Houston, TX 77030 USA; [Petersen, Laura A.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Ctr Innovat Qual Effectiveness & Safety, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Hwang, KO (corresponding author), Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, UTHlth McGovern Med Sch, 6410 Fannin,UPB 1100-41, Houston, TX 77030 USA.	kevin.o.hwang@uth.tmc.edu		Hwang, Kevin/0000-0002-2932-512X	US Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (HSR&D) by the Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]; Michael E. DeBakey VA Medical Center; VA HSRD [IIR 15-438]	US Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (HSR&D) by the Center for Innovations in Quality, Effectiveness and Safety(US Department of Veterans Affairs); Michael E. DeBakey VA Medical Center(US Department of Veterans Affairs); VA HSRD	The work reported here was supported by the US Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (HSR&D) by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413), Michael E. DeBakey VA Medical Center, and VA HSR&D IIR 15-438.	Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231; Gorostidi M, 2015, HYPERTENS RES, V38, P1, DOI 10.1038/hr.2014.149; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Little P, 2002, BRIT MED J, V325, P258, DOI 10.1136/bmj.325.7358.258; Niiranen TJ, 2011, HYPERTENSION, V57, P1081, DOI 10.1161/HYPERTENSIONAHA.110.162123; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Tucker KL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002389; Whelton PK, 2017, HYPERTENSION, V71, pe13, DOI [10.1161/HYPERTENSIONAHA.115.0710827001299, DOI 10.1161/HYP.0000000000000065]	8	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1753	1754		10.1001/jama.2018.12365	http://dx.doi.org/10.1001/jama.2018.12365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398609				2022-12-28	WOS:000449461800010
J	Martin, SA; Chiodo, LM; Bosse, JD; Wilson, A				Martin, Stephen A.; Chiodo, Lisa M.; Bosse, Jordon D.; Wilson, Amanda			The Next Stage of Buprenorphine Care for Opioid Use Disorder	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; UNOBSERVED HOME INDUCTION; MAINTENANCE THERAPY; PSYCHOSOCIAL INTERVENTIONS; PRESCRIBING BUPRENORPHINE; SUBSTITUTION TREATMENT; OVERDOSE DEATHS; UNITED-STATES; DEPENDENCE; BENZODIAZEPINE	Buprenorphine has been used internationally for the treatment of opioid use disorder (OUD) since the 1990s and has been available in the United States for more than a decade. Initial practice recommendations were intentionally conservative, were based on expert opinion, and were influenced by methadone regulations. Since 2003, the American crisis of OUD has dramatically worsened, and much related empirical research has been undertaken. The findings in several important areas conflict with initial clinical practice that is still prevalent. This article reviews research findings in the following 7 areas: location of buprenorphine induction, combining buprenorphine with a benzodiazepine, relapse during buprenorphine treatment, requirements for counseling, uses of drug testing, use of other substances during buprenorphine treatment, and duration of buprenorphine treatment. For each area, evidence for needed updates and modifications in practice is provided. These modifications will facilitate more successful, evidence-based treatment and care for patients with OUD.	[Martin, Stephen A.] Univ Massachusetts, Sch Med, Barre, MA USA; [Martin, Stephen A.] Barre Family Hlth Ctr, Barre, MA USA; [Martin, Stephen A.; Chiodo, Lisa M.; Bosse, Jordon D.; Wilson, Amanda] CleanSlate Res & Educ Fdn, Florence, MA USA; [Chiodo, Lisa M.; Bosse, Jordon D.] Univ Massachusetts, Coll Nursing, 228 Skinner Hall,651 North Pleasant St, Amherst, MA 01003 USA; [Martin, Stephen A.] UMassMemorial Hlth Care, Barre Family Hlth Ctr, 151 Worcester Rd, Barre, MA 01005 USA; [Wilson, Amanda] 46 Sovereign Way, Florence, MA 01062 USA	University of Massachusetts System; University of Massachusetts System; University of Massachusetts Amherst	Martin, SA (corresponding author), UMassMemorial Hlth Care, Barre Family Hlth Ctr, 151 Worcester Rd, Barre, MA 01005 USA.	stmartin@gmail.com	Martin, Stephen A/L-9381-2013; Bosse, Jordon D/AAH-2028-2021	Martin, Stephen A/0000-0002-0356-5440; Bosse, Jordon/0000-0003-3547-9077	CleanSlate Research and Education Foundation	CleanSlate Research and Education Foundation	By the CleanSlate Research and Education Foundation.	Abrahamsson T, 2017, DRUG ALCOHOL DEPEN, V174, P58, DOI 10.1016/j.drugalcdep.2017.01.013; Alderks C.E., 2017, TRENDS USE METHADONE; Alford DP, 2007, J GEN INTERN MED, V22, P171, DOI 10.1007/s11606-006-0023-1; American Society of Addiction Medicine, 2017, ASAM APPR US DRUG TE; American Society of Addiction Medicine, 2015, NAT PRACT GUID US ME; Andrilla CHA, 2017, ANN FAM MED, V15, P359, DOI 10.1370/afm.2099; Bakker A, 2017, J PSYCHOPHARMACOL, V31, P62, DOI 10.1177/0269881116675508; Bebinger M., 2015, WBUR COMMONHEAL 1113; Bentzley BS, 2015, J SUBST ABUSE TREAT, V56, P48, DOI 10.1016/j.jsat.2015.04.002; Bentzley BS, 2015, J SUBST ABUSE TREAT, V52, P48, DOI 10.1016/j.jsat.2014.12.011; Bhatraju EP, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-017-0072-2; Burns RM, 2016, SUBST ABUS, V37, P63, DOI 10.1080/08897077.2015.1080208; Center for Substance Abuse Treatment, 2004, CLIN GUID US BUPR TR; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Cunningham CO, 2013, AM J ADDICTION, V22, P352, DOI 10.1111/j.1521-0391.2013.12032.x; Cunningham CO, 2011, J SUBST ABUSE TREAT, V40, P349, DOI 10.1016/j.jsat.2010.12.002; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Ding KY, 2016, 2016 NORW I PUBL HLT; Dugosh K, 2016, J ADDICT MED, V10, P93, DOI 10.1097/ADM.0000000000000193; Dupouy J, 2017, ANN FAM MED, V15, P355, DOI 10.1370/afm.2098; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Friedmann PD, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-10; Gabrielson R, 2016, NY TIMES, pMM34; Glass I., 2011, THIS AM LIFE    0325; Gryczynski J, 2014, J SUBST ABUSE TREAT, V46, P356, DOI 10.1016/j.jsat.2013.10.004; Gunderson EW, 2011, J ADDICT MED, V5, P304, DOI 10.1097/ADM.0b013e31821ee8fe; Hartzler B, 2010, J SUBST ABUSE TREAT, V39, P114, DOI 10.1016/j.jsat.2010.05.008; Heikman PK, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1415-y; Heit HA, 2014, PATIENT CENTERED URI; Howland RH, 2015, J PSYCHOSOC NURS MEN, V53, P11, DOI 10.3928/02793695-20151117-01; Hser YI, 2015, HARVARD REV PSYCHIAT, V23, P76, DOI 10.1097/HRP.0000000000000052; Hutchinson E, 2014, ANN FAM MED, V12, P128, DOI 10.1370/afm.1595; Jones CM, 2014, MMWR-MORBID MORTAL W, V63, P881; Jones CM, 2018, OPIOID EPIDEMIC HHS; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Kelly JF, 2015, AM J MED, V128, P8, DOI 10.1016/j.amjmed.2014.07.043; Knopf A., 2017, ALCOHOLISM DRUG ABUS, V29, P3; Larochelle MR, 2018, ANN INTERN MED, V169, P137, DOI 10.7326/M17-3107; Lee JD, 2014, J ADDICT MED, V8, P299, DOI 10.1097/ADM.0000000000000059; Lofwall MR, 2014, J ADDICT MED, V8, P315, DOI 10.1097/ADM.0000000000000045; Massachusetts Department of Public Health Bureau of Sub-stance Abuse Services, 2013, PRACT GUID RESP REL; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Mund B, 2018, J LAW MED ETHICS, V46, P279, DOI 10.1177/1073110518782935; National Institute on Drug Abuse, 2012, PRINC EFF TREATM PRI; National Institute on Drug Abuse, 2013, SEEK DRUG AB TREATM; Nielsen S, 2007, ADDICTION, V102, P616, DOI 10.1111/j.1360-0443.2006.01731.x; Paone D, 2015, DRUG ALCOHOL DEPEN, V155, P298, DOI 10.1016/j.drugalcdep.2015.08.007; Park TW, 2017, J ADDICT MED, V11, P87, DOI 10.1097/ADM.0000000000000292; Park TW, 2014, PSYCHIAT SERV, V65, P4, DOI 10.1176/appi.ps.201300419; Posternak MA, 2001, AM J ADDICTION, V10, P48; Reckitt Benckiser Healthcare, 2017, SUBOXONE CIII BUPR H; Rees VW, 2015, SUMMARY OPIOID OVERD; Reynaud M, 1998, AM J PSYCHIAT, V155, P448; Reynaud M, 1998, ADDICTION, V93, P1385, DOI 10.1046/j.1360-0443.1998.93913859.x; Ruan XL, 2017, DRUG RES, V67, P189, DOI 10.1055/s-0042-119946; Salsitz E., 2017, FREQUENTLY ASKED QUE; Sansone Randy A, 2015, Innov Clin Neurosci, V12, P32; Schuman-Olivier Z, 2013, DRUG ALCOHOL DEPEN, V132, P580, DOI 10.1016/j.drugalcdep.2013.04.006; Schwartz RP, 2016, J ADDICT MED, V10, P283, DOI 10.1097/ADM.0000000000000236; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049; Sohler NL, 2010, J SUBST ABUSE TREAT, V38, P153, DOI 10.1016/j.jsat.2009.08.001; Starrels JL, 2012, J GEN INTERN MED, V27, P1521, DOI 10.1007/s11606-012-2165-7; Substance Abuse and Mental Health Services Administration, 2018, TIP 63 MED OP US DIS; Substance Abuse and Mental Health Services Administration, 2014, RES 2013 NAT SURV DR; The BDN Editorial Board, 2016, BANGOR DAILY NE 0421; The Pew Charitable Trusts, 2017, CAS MED ASS TREATM M; Tofighi B, 2016, J ADDICT MED, V10, P309, DOI 10.1097/ADM.0000000000000198; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293; U. S. Food and Drug Administration, 2017, FDA DRUG SAF COMM FD; United States Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; Visconti AJ, 2015, J URBAN HEALTH, V92, P758, DOI 10.1007/s11524-015-9967-y; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Wakeman SE, 2017, J ADDICT MED, V11, P1, DOI 10.1097/ADM.0000000000000275; Warner Margaret, 2016, Natl Vital Stat Rep, V65, P1; World Health Organisation, 2003, ADHERENCE LONG TERM; World Health Organization, 2009, GUID PSYCH ASS PHARM; Zhu YM, 2018, DRUG ALCOHOL DEPEN, V187, P221, DOI 10.1016/j.drugalcdep.2018.02.019	77	79	79	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					628	+		10.7326/M18-1652	http://dx.doi.org/10.7326/M18-1652			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ4UP	30357262				2022-12-28	WOS:000449399700006
J	Sharaf, RN; Diamond, LC				Sharaf, Ravi N.; Diamond, Lisa C.			A Letter to Our Daughter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sharaf, Ravi N.] Weill Cornell Med, Dept Med, Div Gastroenterol, Jay Monahan Ctr Gastrointestinal Hlth, New York, NY USA; [Sharaf, Ravi N.] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA; [Diamond, Lisa C.] Mem Sloan Kettering Canc Ctr, Hosp Med Serv, Immigrant Hlth & Canc Dispar Serv, Psychiat & Behav Sci,Med, 485 Lexington Ave,Second Floor, New York, NY 10017 USA; [Diamond, Lisa C.] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Diamond, LC (corresponding author), Mem Sloan Kettering Canc Ctr, Hosp Med Serv, Immigrant Hlth & Canc Dispar Serv, Psychiat & Behav Sci,Med, 485 Lexington Ave,Second Floor, New York, NY 10017 USA.	diamondl@mskcc.org		Diamond, Lisa/0000-0002-2175-6224	National Cancer Institute [5K07CA184037, 3P30CA008748, K07CA216326, R01 CA211723]; Patient-Centered Outcomes Research Institute [AD-1409-23627]; Patient-Centered Outcomes Research Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr Diamond reported salary support from grants 5K07CA184037 and 3P30CA008748 from the National Cancer Institute and AD-1409-23627 from the Patient-Centered Outcomes Research Institute. Dr Sharaf reported receiving salary support from grants K07CA216326 and R01 CA211723 from the National Cancer Institute and an Improving Healthcare Systems Award from the Patient-Centered Outcomes Research Institute. He is a paid consultant for the Institute for Clinical and Economic Review.		0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1755	1756		10.1001/jama.2018.14956	http://dx.doi.org/10.1001/jama.2018.14956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398607	Green Accepted			2022-12-28	WOS:000449461800011
J	d'Enfert, C				d'Enfert, Christophe			Evolving a pathogen to be protective The deadly fungus Candida albicans can be pushed to protect its mammalian host	SCIENCE			English	Editorial Material							COMMENSAL FUNGI; INFECTION		[d'Enfert, Christophe] Inst Pasteur, INRA, Unite Biol & Pathogenicite Fong, 25 Rue Docteur Roux, Paris, France	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	d'Enfert, C (corresponding author), Inst Pasteur, INRA, Unite Biol & Pathogenicite Fong, 25 Rue Docteur Roux, Paris, France.	christophe.denfert@pasteur.fr						Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695; Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ropars J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04787-4; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tso GHW, 2018, SCIENCE, V362, P589, DOI 10.1126/science.aat0537; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003	13	2	2	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		523	524		10.1126/science.aav3374	http://dx.doi.org/10.1126/science.aav3374			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385561				2022-12-28	WOS:000450460000023
J	Larson, RC				Larson, Richard C.			What are you waiting for?	SCIENCE			English	Editorial Material									[Larson, Richard C.] MIT, Inst Data Syst & Soc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Larson, RC (corresponding author), MIT, Inst Data Syst & Soc, Cambridge, MA 02139 USA.	SciCareerEditor@aaas.org							0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		610	610		10.1126/science.362.6414.610	http://dx.doi.org/10.1126/science.362.6414.610			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385581				2022-12-28	WOS:000450460000050
J	Voosen, P				Voosen, Paul			MOMENTS TO SPARE California's new earthquake warning system delivers just seconds of notice. Even that is a victory	SCIENCE			English	Editorial Material																			0	1	1	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		514	517		10.1126/science.362.6414.514	http://dx.doi.org/10.1126/science.362.6414.514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385557				2022-12-28	WOS:000450460000019
J	Gao, ZY; Davis, C; Thomas, AM; Economo, MN; Abrego, AM; Svoboda, K; De Zeeuw, CI; Li, N				Gao, Zhenyu; Davis, Courtney; Thomas, Alyse M.; Economo, Michael N.; Abrego, Amada M.; Svoboda, Karel; De Zeeuw, Chris I.; Li, Nuo			A cortico-cerebellar loop for motor planning	NATURE			English	Article							ANTICIPATORY ACTIVITY; PERSISTENT ACTIVITY; PREFRONTAL CORTEX; INTENDED MOVEMENT; INTERNAL-MODELS; PREMOTOR CORTEX; TRANSGENIC MICE; CELL ACTIVITY; INFORMATION; DIRECTION	Persistent and ramping neural activity in the frontal cortex anticipates specific movements(1-6). Preparatory activity is distributed across several brain regions(7,8), but it is unclear which brain areas are involved and how this activity is mediated by multi-regional interactions. The cerebellum is thought to be primarily involved in the short-timescale control of movement(9-12); however, roles for this structure in cognitive processes have also been proposed(13-16). In humans, cerebellar damage can cause defects in planning and working memory(13). Here we show that persistent representation of information in the frontal cortex during motor planning is dependent on the cerebellum. Mice performed a sensory discrimination task in which they used short-term memory to plan a future directional movement. A transient perturbation in the medial deep cerebellar nucleus (fastigial nucleus) disrupted subsequent correct responses without hampering movement execution. Preparatory activity was observed in both the frontal cortex and the cerebellar nuclei, seconds before the onset of movement. The silencing of frontal cortex activity abolished preparatory activity in the cerebellar nuclei, and fastigial activity was necessary to maintain cortical preparatory activity. Fastigial output selectively targeted the behaviourally relevant part of the frontal cortex through the thalamus, thus closing a cortico-cerebellar loop. Our results support the view that persistent neural dynamics during motor planning is maintained by neural circuits that span multiple brain regions(17), and that cerebellar computations extend beyond online motor control(13-15,18).	[Gao, Zhenyu; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Davis, Courtney; Thomas, Alyse M.; Abrego, Amada M.; Li, Nuo] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Economo, Michael N.; Svoboda, Karel; Li, Nuo] Janelia Res Campus, Ashburn, VA 20147 USA; [De Zeeuw, Chris I.] Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Baylor College of Medicine; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Li, N (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Li, N (corresponding author), Janelia Res Campus, Ashburn, VA 20147 USA.	nuol@bcm.edu		Economo, Michael/0000-0001-9893-1505; Thomas, Alyse/0000-0002-6070-4769	Robert and Janice McNair Foundation; Whitehall Foundation; Alfred P. Sloan Foundation; Searle Scholars Program; National Institutes of Health [NS104781]; Simons Collaboration on the Global Brain; Dutch Organization for Medical Sciences; Erasmus MC fellowship; ERC-PoC; Howard Hughes Medical Institute; ERC-advanced; Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS104781] Funding Source: NIH RePORTER	Robert and Janice McNair Foundation; Whitehall Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Collaboration on the Global Brain; Dutch Organization for Medical Sciences; Erasmus MC fellowship; ERC-PoC; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ERC-advanced(European Research Council (ERC)); Life Sciences(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Sillitoe for L7-cre mice; J. Medina, H. Inagaki, Z. Guo and M. Ahrens for comments on the manuscript; S. Druckmann for discussion; T. Pluntke and M. Inagaki for animal training; and J. White and H. Hasanbegovic for dystonia scoring. This work was funded by the Robert and Janice McNair Foundation (N.L.), the Whitehall Foundation (N.L.), the Alfred P. Sloan Foundation (N.L.), the Searle Scholars Program (N.L.), the National Institutes of Health NS104781 (N.L.), the Simons Collaboration on the Global Brain (K.S. and N.L.), the Dutch Organization for Medical Sciences (C.I.D.Z.), Life Sciences (Z.G. and C.I.D.Z.), an Erasmus MC fellowship (Z.G.), the ERC-advanced and ERC-PoC (C.I.D.Z.) and the Howard Hughes Medical Institute (K.S., M.E. and N.L.).	Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Chen TW, 2017, NEURON, V94, P866, DOI 10.1016/j.neuron.2017.05.005; Dong H.W., 2008, ALLEN REFERENCE ATLA; Economo M. N., 2017, PREPRINT; Fried I, 2011, NEURON, V69, P548, DOI 10.1016/j.neuron.2010.11.045; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Guo ZCV, 2017, NATURE, V545, P181, DOI 10.1038/nature22324; Guo ZCV, 2014, NEURON, V81, P179, DOI 10.1016/j.neuron.2013.10.020; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Herzfeld DJ, 2015, NATURE, V526, P439, DOI 10.1038/nature15693; Inagaki H. K., 2017, PREPRINT; Inagaki HK, 2018, J NEUROSCI, V38, P4163, DOI 10.1523/JNEUROSCI.3152-17.2018; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kalmbach BE, 2009, LEARN MEMORY, V16, P86, DOI 10.1101/lm.1178309; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li N, 2016, NATURE, V532, P459, DOI 10.1038/nature17643; Li N, 2015, NATURE, V519, P51, DOI 10.1038/nature14178; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mcelvain LE, 2018, NEUROSCIENCE, V368, P152, DOI 10.1016/j.neuroscience.2017.08.034; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Murakami M, 2014, NAT NEUROSCI, V17, P1574, DOI 10.1038/nn.3826; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Proville RD, 2014, NAT NEUROSCI, V17, P1233, DOI 10.1038/nn.3773; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Rossi MA, 2016, NAT NEUROSCI, V19, P742, DOI 10.1038/nn.4285; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Svoboda K, 2018, CURR OPIN NEUROBIOL, V49, P33, DOI 10.1016/j.conb.2017.10.023; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Wagner MJ, 2017, NATURE, V544, P96, DOI 10.1038/nature21726; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	39	163	165	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					113	+		10.1038/s41586-018-0633-x	http://dx.doi.org/10.1038/s41586-018-0633-x			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30333626	Green Accepted			2022-12-28	WOS:000448900900055
J	O'Meara, S				O'Meara, Sarah			Taking the silk road to high-tech growth	NATURE			English	Editorial Material																			0	0	0	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S25	S27		10.1038/d41586-018-07202-6	http://dx.doi.org/10.1038/d41586-018-07202-6			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382224				2022-12-28	WOS:000448900900013
J	Scott, CL; Guilliams, M				Scott, Charlotte L.; Guilliams, Martin			Tissue Unit-ed: Lung Cells Team up to Drive Alveolar Macrophage Development	CELL			English	Editorial Material							LIVER	Using single-cell RNA sequencing of both immune and non-immune cells in the developing lung, Cohen et al. map candidate cell-cell interactions during alveolar macrophage development. This revealed potential cross-talk between epithelial cells, ILC2s, basophils, and the developing macrophages, which were validated both in vitro and in vivo.	[Scott, Charlotte L.; Guilliams, Martin] VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Scott, Charlotte L.; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Scott, Charlotte L.] Univ Glasgow, Coll Med, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Glasgow	Scott, CL; Guilliams, M (corresponding author), VIB UGent Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium.; Scott, CL; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.; Scott, CL (corresponding author), Univ Glasgow, Coll Med, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	charlotte.scott@irc.vib-ugent.be; martin.guilliams@irc.vib-ugent.be	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570				Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Cohen M, 2018, CELL, V175, P1031, DOI 10.1016/j.cell.2018.09.009; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017	8	5	5	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					898	900		10.1016/j.cell.2018.10.031	http://dx.doi.org/10.1016/j.cell.2018.10.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388447	Bronze			2022-12-28	WOS:000449100600003
J	Taipale, J				Taipale, Jussi			The chromatin of cancer	SCIENCE			English	Editorial Material							GENOME; LANDSCAPE		[Taipale, Jussi] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland	University of Cambridge; Karolinska Institutet; University of Helsinki	Taipale, J (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.; Taipale, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.; Taipale, J (corresponding author), Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland.	ajt208@cam.ac.uk						Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Palin K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06132-1; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Sud A, 2017, NAT REV CANCER, V17, P692, DOI 10.1038/nrc.2017.82; Sur I, 2016, NAT REV CANCER, V16, P483, DOI 10.1038/nrc.2016.62; Taipale J, 2018, EMBO J, V37, DOI 10.15252/embj.201696114; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	15	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					401	402		10.1126/science.aav3494	http://dx.doi.org/10.1126/science.aav3494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361360	Green Published			2022-12-28	WOS:000450441900031
J	Rimmer, A				Rimmer, Abi			BMA secures government commitments on junior doctor contract	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2018, JUN DOCT CONTR REV; Wise J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2444	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4450	10.1136/bmj.k4450	http://dx.doi.org/10.1136/bmj.k4450			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PE	30352809				2022-12-28	WOS:000448893800004
J	Iacobucci, G				Iacobucci, Gareth			Update on STPs: Five minutes with ... Anna Charles	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		King's Fund, SUST TRANSF PARTN LO	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4428	10.1136/bmj.k4428	http://dx.doi.org/10.1136/bmj.k4428			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341094				2022-12-28	WOS:000448271300008
J	Soldner, F; Jaenisch, R				Soldner, Frank; Jaenisch, Rudolf			Stem Cells, Genome Editing, and the Path to Translational Medicine	CELL			English	Review							IN-VITRO; GENETIC-VARIATION; ALZHEIMERS-DISEASE; IDENTIFY COMPOUNDS; SELF-ORGANIZATION; DNA METHYLATION; BRAIN ORGANOIDS; NEURONS; MOUSE; MODEL	The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the central nervous system and explore how advances in human pluripotent stem cells (hPSCs) coincide with evolutions in genome engineering and genomic technologies to provide realistic opportunities to tackle some of the most devastating complex disorders.	[Soldner, Frank; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 31 Ames St, Cambridge, MA 02139 USA.	jaenisch@wi.mit.edu			NIH [R37HD045022, R01-NS088538, R01-MH104610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Jaenisch lab as well as many other colleagues for stimulating discussions and Brandi Mattson for help with editing the manuscript. We apologize to many whose work we did not adequately describe or cite due to space constraints. Work in our lab is supported by NIH grants R37HD045022, R01-NS088538, and R01-MH104610.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Ardhanareeswaran K, 2017, NAT REV NEUROL, V13, P265, DOI 10.1038/nrneurol.2017.45; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Brownjohn PW, 2017, STEM CELL REP, V8, P870, DOI 10.1016/j.stemcr.2017.02.006; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cohen MA, 2018, STEM CELL REP, V10, P1445, DOI 10.1016/j.stemcr.2018.03.004; Cohen MA, 2016, P NATL ACAD SCI USA, V113, P1570, DOI 10.1073/pnas.1525518113; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dawson TM, 2018, NAT NEUROSCI, V21, P1370, DOI 10.1038/s41593-018-0236-8; DeBoever C, 2017, CELL STEM CELL, V20, P533, DOI 10.1016/j.stem.2017.03.009; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Espuny-Camacho I, 2017, NEURON, V93, P1066, DOI 10.1016/j.neuron.2017.02.001; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Finkbeiner S, 2015, NEURON, V86, P160, DOI 10.1016/j.neuron.2015.02.023; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gupta RM, 2017, CELL, V170, P522, DOI 10.1016/j.cell.2017.06.049; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Habib N, 2017, NAT METHODS, V14, P955, DOI [10.1038/NMETH.4407, 10.1038/nmeth.4407]; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Hoffman GE, 2019, MOL PSYCHIATR, V24, P49, DOI 10.1038/s41380-018-0029-1; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Ilic D, 2017, STEM CELLS, V35, P17, DOI 10.1002/stem.2450; Imamura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34904; Ishikawa T, 2016, HUM MOL GENET, V25, P5188, DOI 10.1093/hmg/ddw339; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Javed AO, 2018, CELL REP, V25, P368, DOI 10.1016/j.celrep.2018.09.032; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Karnuta JM, 2018, HUM MOL GENET, V27, pR219, DOI 10.1093/hmg/ddy167; Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7; Kaufmann M, 2015, J BIOMOL SCREEN, V20, P1101, DOI 10.1177/1087057115588287; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403; Klann TS, 2018, CURR OPIN BIOTECH, V52, P32, DOI 10.1016/j.copbio.2018.02.004; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kondo T, 2017, CELL REP, V21, P2304, DOI 10.1016/j.celrep.2017.10.109; Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lewis CM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0489-y; Li M, 2017, STEM CELLS, V35, P158, DOI 10.1002/stem.2463; Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2; Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liu XS, 2018, CELL, V172, P979, DOI 10.1016/j.cell.2018.01.012; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Masaki H, 2016, CELL STEM CELL, V19, P587, DOI 10.1016/j.stem.2016.10.013; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McNeish J, 2015, CELL STEM CELL, V17, P8, DOI 10.1016/j.stem.2015.06.013; Mehat MS, 2018, OPHTHALMOLOGY, V125, P1765, DOI 10.1016/j.ophtha.2018.04.037; Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86; Menasche P, 2018, J AM COLL CARDIOL, V71, P429, DOI 10.1016/j.jacc.2017.11.047; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Murakami N, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0286-y; Nagashima F, 2014, STEM CELLS DEV, V23, P2129, DOI 10.1089/scd.2013.0251; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pashos EE, 2017, CELL STEM CELL, V20, P558, DOI 10.1016/j.stem.2017.03.017; Pihlstrom L, 2018, HAND CLINIC, V145, P309, DOI 10.1016/B978-0-12-802395-2.00022-5; Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ronaldson-Bouchard K, 2018, CELL STEM CELL, V22, P310, DOI 10.1016/j.stem.2018.02.011; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Schaid DJ, 2018, NAT REV GENET, V19, P491, DOI 10.1038/s41576-018-0016-z; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartzentruber J, 2018, NAT GENET, V50, P54, DOI 10.1038/s41588-017-0005-8; Senthil G, 2017, MOL PSYCHIATR, V22, P1659, DOI 10.1038/mp.2017.29; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soares FAC, 2014, STEM CELL REP, V3, P931, DOI 10.1016/j.stemcr.2014.11.006; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; Srikanth P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0122-x; Stachowiak EK, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0054-x; Studer L, 2015, CELL STEM CELL, V16, P591, DOI 10.1016/j.stem.2015.05.004; Sullivan SE, 2017, BRAIN RES, V1656, P98, DOI 10.1016/j.brainres.2015.10.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Thakore PI, 2015, NAT METHODS, V12, P1143, DOI 10.1038/nmeth.3630; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tousley A, 2016, J HUNTINGTONS DIS, V5, P99, DOI 10.3233/JHD-160199; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019; Wamstad JA, 2014, TRENDS CELL BIOL, V24, P294, DOI 10.1016/j.tcb.2013.10.008; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang XC, 2016, ELIFE, V5, DOI 10.7554/eLife.10557; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Warren CR, 2017, CELL STEM CELL, V20, P547, DOI 10.1016/j.stem.2017.01.010; Warren CR, 2017, CELL STEM CELL, V20, P431, DOI 10.1016/j.stem.2017.03.021; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Windrem MS, 2017, CELL STEM CELL, V21, P195, DOI 10.1016/j.stem.2017.06.012; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu J, 2016, NATURE, V540, P51, DOI 10.1038/nature20573; Xie N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165499; Xu XH, 2017, STEM CELL REP, V8, P619, DOI 10.1016/j.stemcr.2017.01.022; Xu XH, 2013, STEM CELL RES, V10, P213, DOI 10.1016/j.scr.2012.11.005; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhang YW, 2005, ONCOGENE, V24, P101, DOI 10.1038/sj.onc.1208181; Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	168	70	72	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					615	632		10.1016/j.cell.2018.09.010	http://dx.doi.org/10.1016/j.cell.2018.09.010			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340033	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000447780800003
J	Guo, FS; Day, BM; Chen, YC; Tong, ML; Mansikkamaki, A; Layfield, RA				Guo, Fu-Sheng; Day, Benjamin M.; Chen, Yan-Cong; Tong, Ming-Liang; Mansikkamaki, Akseli; Layfield, Richard A.			Magnetic hysteresis up to 80 kelvin in a dysprosium metallocene single-molecule magnet	SCIENCE			English	Article							2ND-ORDER PERTURBATION-THEORY; BASIS-SETS; BLOCKING; SYMMETRY; PSEUDOPOTENTIALS; TEMPERATURE; STRATEGIES; REACTIVITY; ENERGY; ATOMS	Single-molecule magnets (SMMs) containing only one metal center may represent the lower size limit for molecule-based magnetic information storage materials. Their current drawback is that all SMMs require liquid-helium cooling to show magnetic memory effects. We now report a chemical strategy to access the dysprosium metallocene cation [(Cp-iPr5)Dy(Cp*)](+) (Cp-iPr5, penta-iso-propylcyclopentadienyl; Cp*, pentamethylcyclopentadienyl), which displays magnetic hysteresis above liquid-nitrogen temperatures. An effective energy barrier to reversal of the magnetization of U-eff = 1541 wave number is also measured. The magnetic blocking temperature of T-B = 80 kelvin for this cation overcomes an essential barrier toward the development of nanomagnet devices that function at practical temperatures.	[Guo, Fu-Sheng; Day, Benjamin M.; Layfield, Richard A.] Univ Sussex, Sch Life Sci, Dept Chem, Falmer BN1 9QJ, England; [Day, Benjamin M.] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England; [Chen, Yan-Cong; Tong, Ming-Liang] Sun Yat Sen Univ, Sch Chem, Minist Educ, Key Lab Bioinorgan & Synthet Chem, Guangzhou 510275, Guangdong, Peoples R China; [Mansikkamaki, Akseli] Univ Jyvaskyla, Dept Chem, Nanosci Ctr, POB 35, FI-40014 Jyvaskyla, Finland	University of Sussex; University of Manchester; Sun Yat Sen University; University of Jyvaskyla	Layfield, RA (corresponding author), Univ Sussex, Sch Life Sci, Dept Chem, Falmer BN1 9QJ, England.; Tong, ML (corresponding author), Sun Yat Sen Univ, Sch Chem, Minist Educ, Key Lab Bioinorgan & Synthet Chem, Guangzhou 510275, Guangdong, Peoples R China.; Mansikkamaki, A (corresponding author), Univ Jyvaskyla, Dept Chem, Nanosci Ctr, POB 35, FI-40014 Jyvaskyla, Finland.	tongml@mail.sysu.edu.cn; akseli.mansikkamaki@iyu.fi; r.layfield@sussex.ac.uk	Tong, Ming-Liang/H-9698-2014; Chen, Yan-Cong/K-1900-2013; Mansikkamäki, Akseli/L-9296-2019; Chen, Yan-Cong/ABE-1168-2020	Tong, Ming-Liang/0000-0003-4725-0798; Chen, Yan-Cong/0000-0001-5047-3445; Mansikkamäki, Akseli/0000-0003-0401-4373; Cador, Olivier/0000-0003-2064-6223; Layfield, Richard/0000-0002-6020-0309	European Research Council (CoG grant) [646740]; EPSRC [EP/M022064/1]; NSF China [21620102002, 91422302]; National Key Research and Development Program of China [2018YFA0306001]; Academy of Finland [282499, 289172]; EPSRC [EP/M022064/2] Funding Source: UKRI	European Research Council (CoG grant); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Academy of Finland(Academy of Finland); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the European Research Council (CoG grant 646740), the EPSRC (EP/M022064/1), the NSF China (projects 21620102002 and 91422302), the National Key Research and Development Program of China (2018YFA0306001), and the Academy of Finland (projects 282499 and 289172).	Adamo C, 1999, J CHEM PHYS, V110, P6158, DOI 10.1063/1.478522; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; ANDERSSON K, 1990, J PHYS CHEM-US, V94, P5483, DOI 10.1021/j100377a012; Aquilante F, 2016, J COMPUT CHEM, V37, P506, DOI 10.1002/jcc.24221; Bain GA, 2008, J CHEM EDUC, V85, P532, DOI 10.1021/ed085p532; Benelli C., 2015, INTRO MOL MAGNETISM; Cendrowski-Guillaume SM, 2000, ORGANOMETALLICS, V19, P5654, DOI 10.1021/om000558f; Chen YC, 2016, J AM CHEM SOC, V138, P2829, DOI 10.1021/jacs.5b13584; Chibotaru LF, 2013, ADV CHEM PHYS, V153, P397; Chibotaru LF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739763; Connelly SJ, 2013, ORGANOMETALLICS, V32, P7478, DOI 10.1021/om400970j; Day BM, 2018, ACCOUNTS CHEM RES, V51, P1880, DOI 10.1021/acs.accounts.8b00270; Demir S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01553-w; DOLG M, 1989, THEOR CHIM ACTA, V75, P173, DOI 10.1007/BF00528565; DOLG M, 1993, THEOR CHIM ACTA, V85, P441, DOI 10.1007/BF01112983; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Ernzerhof M, 1999, J CHEM PHYS, V110, P5029, DOI 10.1063/1.478401; Evans WJ, 2004, J AM CHEM SOC, V126, P14533, DOI 10.1021/ja0463886; Filatov M, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2338033; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Frost JM, 2016, CHEM SCI, V7, P2470, DOI 10.1039/c5sc03224e; Gatteschi D, 2003, ANGEW CHEM INT EDIT, V42, P268, DOI 10.1002/anie.200390099; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Goodwin CAP, 2017, J AM CHEM SOC, V139, P18714, DOI 10.1021/jacs.7b11535; Goodwin CAP, 2017, NATURE, V548, P439, DOI 10.1038/nature23447; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Guo FS, 2017, ANGEW CHEM INT EDIT, V56, P11445, DOI 10.1002/anie.201705426; Guo YN, 2011, DALTON T, V40, P9953, DOI 10.1039/c1dt10474h; Gupta SK, 2016, CHEM SCI, V7, P5181, DOI 10.1039/c6sc00279j; Harriman KLM, 2017, CHEM SCI, V8, P231, DOI 10.1039/c6sc01224h; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Iwahara N, 2018, PHYS REV B, V98, DOI 10.1103/PhysRevB.98.054436; Iwahara N, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.174438; Kilpatrick AFR, 2018, CHEM COMMUN, V54, P7085, DOI 10.1039/c8cc03516d; Kutzelnigg W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137315; Latendresse TP, 2017, J AM CHEM SOC, V139, P14877, DOI 10.1021/jacs.7b08690; Le Roy JJ, 2014, J AM CHEM SOC, V136, P8003, DOI 10.1021/ja5022552; Le Roy JJ, 2013, J AM CHEM SOC, V135, P3502, DOI 10.1021/ja310642h; Liu FP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16098; Liu JL, 2018, CHEM SOC REV, V47, P2431, DOI 10.1039/c7cs00266a; Malmqvist PA, 2002, CHEM PHYS LETT, V357, P230, DOI 10.1016/S0009-2614(02)00498-0; McClain KR, 2018, CHEM SCI, V9, P8492, DOI 10.1039/c8sc03907k; Moseley DH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04896-0; Peng DL, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-011-1081-y; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pugh T, 2017, CHEM SCI, V8, P2073, DOI 10.1039/c6sc04465d; Pugh T, 2016, ANGEW CHEM INT EDIT, V55, P11082, DOI 10.1002/anie.201604346; Pugh T, 2016, CHEM SCI, V7, P2128, DOI 10.1039/c5sc03755g; Pugh T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8492; Rinehart JD, 2011, J AM CHEM SOC, V133, P14236, DOI 10.1021/ja206286h; Roos B.O., 1987, ADV CHEM PHYS, V69, P399, DOI DOI 10.1002/9780470142943.CH7; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; ROOS BO, 1982, CHEM PHYS, V66, P197, DOI 10.1016/0301-0104(82)88019-1; Roos BO., 2016, MULTICONFIGURATIONAL; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shiddiq M, 2016, NATURE, V531, P348, DOI 10.1038/nature16984; Shiozaki T, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633329; SHRIVASTAVA KN, 1983, PHYS STATUS SOLIDI B, V117, P437, DOI 10.1002/pssb.2221170202; SIEGBAHN P, 1980, PHYS SCRIPTA, V21, P323, DOI 10.1088/0031-8949/21/3-4/014; SIEGBAHN PEM, 1981, J CHEM PHYS, V74, P2384, DOI 10.1063/1.441359; SITZMANN H, 1989, Z NATURFORSCH B, V44, P1293, DOI 10.1515/znb-1989-1025; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; Ungur L., 2015, COMPUTATIONAL MODELL; Ungur L, 2017, CHEM-EUR J, V23, P3708, DOI 10.1002/chem.201605102; Ungur L, 2016, INORG CHEM, V55, P10043, DOI 10.1021/acs.inorgchem.6b01353; Ungur L, 2014, ANGEW CHEM INT EDIT, V53, P4413, DOI 10.1002/anie.201310451; Ungur L, 2013, INORG CHEM, V52, P6328, DOI 10.1021/ic302568x; Weigand A, 2010, THEOR CHEM ACC, V126, P117, DOI 10.1007/s00214-009-0584-2; WIDMARK PO, 1990, THEOR CHIM ACTA, V77, P291, DOI 10.1007/BF01120130; Woodruff DN, 2013, CHEM REV, V113, P5110, DOI 10.1021/cr400018q; Yang J, 2005, THEOR CHEM ACC, V113, P212, DOI 10.1007/s00214-005-0629-0; Zhang P, 2015, DALTON T, V44, P3923, DOI 10.1039/c4dt03329a	75	987	996	23	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2018	362	6421			SI		1400	+		10.1126/science.aav0652	http://dx.doi.org/10.1126/science.aav0652			111	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HF0IS	30337456	Green Accepted, Bronze			2022-12-28	WOS:000453845000058
J	Baraliakos, X; Braun, J				Baraliakos, Xenofon; Braun, Juergen			Learning from the youngsters: ixekizumab in active ankylosing spondylitis	LANCET			English	Editorial Material							AXIAL SPONDYLOARTHRITIS; SECUKINUMAB; CRITERIA		[Baraliakos, Xenofon; Braun, Juergen] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, D-44649 Herne, Germany	Rheumazentrum Ruhrgebiet; Ruhr University Bochum	Baraliakos, X (corresponding author), Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, D-44649 Herne, Germany.	xenofon.baraliakos@elisabethgruppe.de	Braun, Jürgen/AFT-8107-2022; Baraliakos, Xenofon/AAF-7346-2019	Baraliakos, Xenofon/0000-0002-9475-9362				Baeten D, 2015, NEW ENGL J MED, V373, P2534, DOI 10.1056/NEJMoa1505066; Baraliakos X, 2014, ANN RHEUM DIS, V73, P710, DOI 10.1136/annrheumdis-2012-202698; Braun J, 2017, ANN RHEUM DIS, V76, P1070, DOI 10.1136/annrheumdis-2016-209730; Deodhar A, 2016, ANN RHEUM DIS, V75, P791, DOI 10.1136/annrheumdis-2015-208852; Kivitz AJ, 2018, RHEUMATOL THER, V5, P447, DOI 10.1007/s40744-018-0123-5; Liu L, 2016, J INFLAMM RES, V9, P39, DOI [10.2147/JIR.S100940, 10.3993/jfbim00203]; Rademacher J, 2018, EXPERT OPIN EMERG DR, V23, P83, DOI 10.1080/14728214.2018.1445719; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Sieper J, 2016, NAT REV RHEUMATOL, V12, P282, DOI 10.1038/nrrheum.2016.42; van der Heijde D, 2018, LANCET, V392, P2441, DOI 10.1016/S0140-6736(18)31946-9; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	11	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2018	392	10163					2415	2416		10.1016/S0140-6736(18)32340-7	http://dx.doi.org/10.1016/S0140-6736(18)32340-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HD5RO	30360968				2022-12-28	WOS:000452587800004
J	Hara, H; Seregin, SS; Yang, DH; Fukase, K; Chamaillard, M; Alnemri, ES; Inohara, N; Chen, GY; Nunez, G				Hara, Hideki; Seregin, Sergey S.; Yang, Dahai; Fukase, Koichi; Chamaillard, Mathias; Alnemri, Emad S.; Inohara, Naohiro; Chen, Grace Y.; Nunez, Gabriel			The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection	CELL			English	Article							LISTERIA-MONOCYTOGENES INFECTION; INDUCED CELL-DEATH; INNATE IMMUNITY; STAPHYLOCOCCUS-AUREUS; ACTIVATION DOWNSTREAM; CASPASE-1 ACTIVATION; CRYSTAL-STRUCTURE; HOST-DEFENSE; GASDERMIN D; SUSCEPTIBILITY	The activator and composition of the NLRP6 inflammasome remain poorly understood. We find that lipoteichoic acid (LTA), a molecule produced by Gram-positive bacteria, binds and activates NLRP6. In response to cytosolic LTA or infection with Listeria monocytogenes, NLRP6 recruited caspase-11 and caspase-1 via the adaptor ASC. NLRP6 activation by LTA induced processing of caspase-11, which promoted caspase-1 activation and interleukin-1 beta (IL-1 beta)/IL-18 maturation in macrophages. NIrp6(-/-) and Casp11(-/-) mice were less susceptible to L. monocytogenes infection, which was associated with reduced pathogen loads and impaired IL-18 production. Administration of IL-18 to NIrp6(-/-) or Casp11(-/-) mice restored the susceptibility of mutant mice to L. monocytogenes infection. These results reveal a previously unrecognized innate immunity pathway triggered by cytosolic LTA that is sensed by NLRP6 and exacerbates systemic Gram-positive pathogen infection via the production of IL-18.	[Hara, Hideki; Yang, Dahai; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Hara, Hideki; Yang, Dahai; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Seregin, Sergey S.; Chen, Grace Y.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Chamaillard, Mathias] Univ Lille, CIIL, CNRS, Inserm,U1019,CHRU Lille,Inst Pasteur Lille,UMR 82, F-59000 Lille, France; [Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Osaka University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Jefferson University	Hara, H; Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.; Hara, H; Nunez, G (corresponding author), Univ Michigan, Sch Med, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	hhara@med.umich.edu; gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014; Hara, Hideki/Y-2735-2018; Chamaillard, Mathias/L-6542-2013	Chamaillard, Mathias/0000-0002-0243-9717	Japanese Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; National Cancer Institute [F32CA200144]; National Institutes of Health [R01AI063331, R01DK091191, R01CA166879, AR055398]; University of Michigan's Cancer Center Support Grant; Institut National du Cancer grant [Plbio-2012-106]; NATIONAL CANCER INSTITUTE [R01CA166879, F32CA200144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI063331, R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER	Japanese Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center Support Grant; Institut National du Cancer grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Millennium Pharmaceuticals for Nlrp6<SUP>-/-</SUP> mice, R.E. Vance (University of California, Berkeley) for Gsdmd<SUP>-/-</SUP> mice, T.-D. Kanneganti (St. Jude Children's Research Hospital) for Casp1<SUP>-/-</SUP> mice, S.L. Masters (the Walter and Eliza Hall Institute of Medical Research) and M.A. Gavrilin (The Ohio State University) for THP-1 mutant cells, J.B. Bliska (Stony Brook University) for Yersinia mutant, G.N. Barber (University of Miami Miller School of Medicine) for Sting<SUP>-/-</SUP> BM cells, R.A. Flavell (Yale University School of Medicine) for NLRP6 plasmid, A. Grundling (Imperial College London) for Listeria lmo0927 mutant, J. Whitfield (University of Michigan) for ELISA assays, J. Delproposto (University of Michigan) for BLI analysis, L. Haynes, and C. Reynolds (University of Michigan) for animal husbandry. H.H. was supported by a Japanese Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and S.S. by training grant F32CA200144 from the National Cancer Institute. This work was supported by National Institutes of Health grants R01AI063331 and R01DK091191 to G.N. and R01CA166879 to G.Y.C., Institut National du Cancer grant (Plbio-2012-106) to M.C., National Institutes of Health grant AR055398 to E.S.A., and funds to the Rogel Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant.	Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; BERCHE P, 1988, INFECTION, V16, pS145, DOI 10.1007/BF01639738; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Bottai D, 2017, CURR TOP MICROBIOL, V404, P235, DOI 10.1007/82_2015_5015; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cao ZP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.183; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; FUKASE K, 1992, B CHEM SOC JPN, V65, P2643, DOI 10.1246/bcsj.65.2643; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Hara H, 2008, J IMMUNOL, V180, P7859, DOI 10.4049/jimmunol.180.12.7859; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hertzen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035218; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kolb-Maurer A, 2003, FEMS IMMUNOL MED MIC, V35, P255, DOI 10.1016/S0928-8244(02)00470-4; Lee BL, 2018, J EXP MED, V215, P2279, DOI 10.1084/jem.20180589; Lee J, 2001, J BIOL CHEM, V276, P32956, DOI 10.1074/jbc.M104700200; Lemire P, 2017, CELL REP, V21, P3653, DOI 10.1016/j.celrep.2017.12.026; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Lochner M, 2008, INFECT IMMUN, V76, P3881, DOI 10.1128/IAI.01651-07; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Maekawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11813; Maltez VI, 2015, IMMUNITY, V43, P987, DOI 10.1016/j.immuni.2015.10.010; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Man SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45126; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Mueller NJ, 2002, INFECT IMMUN, V70, P2657, DOI 10.1128/IAI.70.5.2657-2664.2002; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nandi A, 2016, MICROB PATHOGENESIS, V97, P131, DOI 10.1016/j.micpath.2016.06.007; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pinheiro J, 2017, VIRULENCE, V8, P993, DOI 10.1080/21505594.2016.1244589; Py BF, 2014, CELL REP, V6, P1122, DOI 10.1016/j.celrep.2014.02.015; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rauch I, 2017, IMMUNITY, V46, P649, DOI 10.1016/j.immuni.2017.03.016; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seregin SS, 2017, MUCOSAL IMMUNOL, V10, P434, DOI 10.1038/mi.2016.55; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Tsuchiya K, 2014, EUR J IMMUNOL, V44, P3696, DOI 10.1002/eji.201444673; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Tsuneyoshi N, 2005, J IMMUNOL, V174, P340, DOI 10.4049/jimmunol.174.1.340; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	72	123	130	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	2018	175	6					1651	+		10.1016/j.cell.2018.09.047	http://dx.doi.org/10.1016/j.cell.2018.09.047			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HC4KG	30392956	Green Accepted, Bronze			2022-12-28	WOS:000451771700022
J	Hampton, T				Hampton, Tracy			Researchers Reprogram Cells In Vivo to Restore Vision in Mice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1745	1745		10.1001/jama.2017.12866	http://dx.doi.org/10.1001/jama.2017.12866			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398581				2022-12-28	WOS:000449461800004
J	Voelker, R				Voelker, Rebecca			Preventive Migraine Drug Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1746	1746		10.1001/jama.2018.16485	http://dx.doi.org/10.1001/jama.2018.16485			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398586				2022-12-28	WOS:000449461800006
J	Cox, PM; Williamson, MS; Nijsse, FJMM; Huntingford, C				Cox, Peter M.; Williamson, Mark S.; Nijsse, Femke J. M. M.; Huntingford, Chris			Cox et al. reply	NATURE			English	Letter									[Cox, Peter M.; Williamson, Mark S.; Nijsse, Femke J. M. M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford, Oxon, England	University of Exeter; UK Centre for Ecology & Hydrology (UKCEH)	Cox, PM (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.	p.m.cox@exeter.ac.uk	Cox, Peter Michae;/B-3299-2012; Huntingford, Christopher/A-4307-2008	Cox, Peter Michae;/0000-0002-0679-2219; Huntingford, Christopher/0000-0002-5941-7770; Nijsse, Femke/0000-0002-6674-5350				Brown PT, 2018, NATURE, V563, pE1, DOI 10.1038/s41586-018-0638-5; Cox PM, 2018, NATURE, V553, P319, DOI 10.1038/nature25450; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Geoffroy O, 2013, J CLIMATE, V26, P1841, DOI 10.1175/JCLI-D-12-00195.1; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; MacMynowski DG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048623; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Po-Chedley S, 2018, NATURE, V563, pE6, DOI 10.1038/s41586-018-0640-y; Rypdal M, 2018, NATURE, V563, pE4, DOI 10.1038/s41586-018-0639-4; Williamson M. S., DYN STAT CLIM SYST	10	6	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					E10	E15		10.1038/s41586-018-0641-x	http://dx.doi.org/10.1038/s41586-018-0641-x			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382204				2022-12-28	WOS:000448900900004
J	Duran, P; Thiergart, T; Garrido-Oter, R; Agler, M; Kemen, E; Schulze-Lefert, P; Hacquard, S				Duran, Paloma; Thiergart, Thorsten; Garrido-Oter, Ruben; Agler, Matthew; Kemen, Eric; Schulze-Lefert, Paul; Hacquard, Stephane			Microbial Interkingdom Interactions in Roots Promote Arabidopsis Survival	CELL			English	Article							BAYESIAN CLASSIFIER; PLANT; FUNGAL; SEQUENCES; CONVERGENCE; NUTRITION; SYMBIOSIS; THALIANA; BACTERIA; TOOL	Roots of healthy plants are inhabited by soil-derived bacteria, fungi, and oomycetes that have evolved independently in distinct kingdoms of life. How these microorganisms interact and to what extent those interactions affect plant health are poorly understood. We examined root-associated microbial communities from three Arabidopsis thaliana populations and detected mostly negative correlations between bacteria and filamentous microbial eukaryotes. We established microbial culture collections for reconstitution experiments using germ-free A. thaliana. In plants inoculated with mono- or multi-kingdom synthetic microbial consortia, we observed a profound impact of the bacterial root microbiota on fungal and oomycetal community structure and diversity. We demonstrate that the bacterial microbiota is essential for plant survival and protection against root-derived filamentous eukaryotes. Deconvolution of 2,862 binary bacterial-fungal interactions ex situ, combined with community perturbation experiments in planta, indicate that biocontrol activity of bacterial root commensals is a redundant trait that maintains microbial interkingdom balance for plant health.	[Duran, Paloma; Thiergart, Thorsten; Garrido-Oter, Ruben; Agler, Matthew; Kemen, Eric; Schulze-Lefert, Paul; Hacquard, Stephane] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Garrido-Oter, Ruben; Kemen, Eric; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Cluster Excellence Plant Sci CEPLAS, D-50829 Cologne, Germany; [Agler, Matthew] Friedrich Schiller Univ, Inst Microbiol, D-07743 Jena, Germany; [Kemen, Eric] Univ Tubingen, IMIT ZMBP, Dept Microbial Interact, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society; University of Cologne; Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen	Schulze-Lefert, P; Hacquard, S (corresponding author), Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany.; Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Cluster Excellence Plant Sci CEPLAS, D-50829 Cologne, Germany.	schlef@mpipz.mpg.de; hacquard@mpipz.mpg.de	Agler, Matthew T/A-8963-2011; Schulze-Lefert, Paul/B-6707-2011; Agler, Matthew/AFQ-5078-2022	Agler, Matthew T/0000-0003-0732-094X; Agler, Matthew/0000-0003-0732-094X; Kemen, Eric/0000-0002-7924-116X	European Research Council; Max Planck Society; Deutsche Forschungsgemeinschaft	European Research Council(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Kremer and S. Y. He for sharing the FlowPot utilization protocol before publication. We thank Neysan Donnelly for scientific English editing. This work was supported by funds to S. H. from a European Research Council starting grant (MICRORULES) and funds to P. S.-L. from the Max Planck Society, a European Research Council advanced grant (ROOTMICROBIOTA), and the "Cluster of Excellence on Plant Sciences" program funded by the Deutsche Forschungsgemeinschaft.	Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Almario J, 2017, P NATL ACAD SCI USA, V114, pE9403, DOI 10.1073/pnas.1710455114; Bai Y, 2015, NATURE, V528, P364, DOI 10.1038/nature16192; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deshpande V, 2016, MYCOLOGIA, V108, P1, DOI 10.3852/14-293; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Faust Karoline, 2016, F1000Res, V5, P1519; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hassani MA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0445-0; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Joergensen RG, 2006, J PLANT NUTR SOIL SC, V169, P295, DOI 10.1002/jpln.200521941; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Keim J, 2014, FUNGAL DIVERS, V66, P99, DOI 10.1007/s13225-014-0289-2; Kia SH, 2017, ISME J, V11, P777, DOI 10.1038/ismej.2016.140; Kremer J., 2018, FLOWPOT AXENIC PLANT, V2018, P254953, DOI [10.1101/254953, DOI 10.1101/254953]; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Figueroa-Lopez AM, 2014, J BASIC MICROB, V54, pS125, DOI 10.1002/jobm.201200594; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Ruggeberg M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120718; Santhanam R, 2015, P NATL ACAD SCI USA, V112, pE5013, DOI 10.1073/pnas.1505765112; Shakya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; van der Heijden MGA, 2016, ISME J, V10, P389, DOI 10.1038/ismej.2015.120; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhalnina K, 2018, NAT MICROBIOL, V3, P470, DOI 10.1038/s41564-018-0129-3	41	346	367	86	414	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					973	+		10.1016/j.cell.2018.10.020	http://dx.doi.org/10.1016/j.cell.2018.10.020			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388454	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000449100600012
J	Kmietowicz, Z				Kmietowicz, Zosia			Infants of older fathers are at greater risk of birth complications	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Brown HK, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4466; Khandwala YS, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4372	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4595	10.1136/bmj.k4595	http://dx.doi.org/10.1136/bmj.k4595			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385455				2022-12-28	WOS:000449565500009
J	Rossi, M; Mason, D; Chen, JX; Tsaturyan, Y; Schliesser, A				Rossi, Massimiliano; Mason, David; Chen, Junxin; Tsaturyan, Yeghishe; Schliesser, Albert			Measurement-based quantum control of mechanical motion	NATURE			English	Article							FEEDBACK-CONTROL; GROUND-STATE; OSCILLATOR; CAVITY; FORCE; LIMIT; RESONATOR; VACUUM; NOISE	Controlling a quantum system by using observations of its dynamics is complicated by the backaction of the measurement process-that is, the unavoidable quantum disturbance caused by coupling the system to a measurement apparatus. An efficient measurement is one that maximizes the amount of information gained per disturbance incurred. Real-time feedback can then be used to cancel the backaction of the measurement and to control the evolution of the quantum state. Such measurement-based quantum control has been demonstrated in the clean settings of cavity and circuit quantum electrodynamics, but its application to motional degrees of freedom has remained elusive. Here we demonstrate measurement-based quantum control of the motion of a millimetre-sized membrane resonator. An optomechanical transducer resolves the zero-point motion of the resonator in a fraction of its millisecond-scale coherence time, with an overall measurement efficiency close to unity. An electronic feedback loop converts this position record to a force that cools the resonator mode to its quantum ground state (residual thermal occupation of about 0.29). This occupation is nine decibels below the quantum-backaction limit of sideband cooling and six orders of magnitude below the equilibrium occupation of the thermal environment. We thus realize a long-standing goal in the field, adding position and momentum to the degrees of freedom that are amenable to measurement-based quantum control, with potential applications in quantum information processing and gravitational-wave detectors.	[Rossi, Massimiliano; Mason, David; Chen, Junxin; Tsaturyan, Yeghishe; Schliesser, Albert] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Rossi, Massimiliano; Mason, David; Chen, Junxin; Schliesser, Albert] Univ Copenhagen, Niels Bohr Inst, Ctr Hybrid Quantum Networks Hy Q, Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute	Schliesser, A (corresponding author), Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark.; Schliesser, A (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Hybrid Quantum Networks Hy Q, Copenhagen, Denmark.	albert.schliesser@nbi.ku.dk	Rossi, Massimiliano/AAO-5491-2020; Schliesser, Albert/C-5619-2014; Mason, David/P-2268-2018; Rossi, Massimiliano/GPX-0715-2022	Rossi, Massimiliano/0000-0001-8992-3378; Schliesser, Albert/0000-0003-4317-5030; Mason, David/0000-0002-8208-4310; Rossi, Massimiliano/0000-0001-8992-3378; Chen, Junxin/0000-0001-5550-6592; Tsaturyan, Yeghishe/0000-0002-8324-5112	European Union's Horizon 2020 research and innovation programme (European Research Council (ERC) project Q-CEOM) [638765]; FET proactive project HOT [732894]; Danish Council for Independent Research; Carlsberg Foundation	European Union's Horizon 2020 research and innovation programme (European Research Council (ERC) project Q-CEOM); FET proactive project HOT; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation)	We acknowledge discussions with K. Hammerer, E. Zeuthen and D. Vitali, and early-stage sample fabrication by Y. Seis. This work was supported by funding from the European Union's Horizon 2020 research and innovation programme (European Research Council (ERC) project Q-CEOM, grant agreement no. 638765 and FET proactive project HOT, grant agreement no. 732894), a starting grant from the Danish Council for Independent Research and the Carlsberg Foundation.	Abbott B, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/073032; Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Black ED, 2001, AM J PHYS, V69, P79, DOI 10.1119/1.1286663; Bowen W. P., 2016, QUANTUM OPTOMECHANIC, V103, P161; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Bushev P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043003; Chan J, 2011, NATURE, V478, P89, DOI 10.1038/nature10461; Chu YW, 2017, SCIENCE, V358, P199, DOI 10.1126/science.aao1511; Clark JB, 2017, NATURE, V541, P191, DOI 10.1038/nature20604; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Cohadon PF, 1999, PHYS REV LETT, V83, P3174, DOI 10.1103/PhysRevLett.83.3174; Courty JM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.083601; Doherty AC, 1999, PHYS REV A, V60, P2700, DOI 10.1103/PhysRevA.60.2700; Doherty AC, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012105; Doherty AC, 2012, PHILOS T R SOC A, V370, P5338, DOI 10.1098/rsta.2011.0531; Garbini JL, 1996, J APPL PHYS, V80, P1951, DOI 10.1063/1.363085; Gavartin E, 2012, NAT NANOTECHNOL, V7, P509, DOI [10.1038/nnano.2012.97, 10.1038/NNANO.2012.97]; Genes C, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033804; Gorodetksy ML, 2010, OPT EXPRESS, V18, P23236, DOI 10.1364/OE.18.023236; Hofer SG, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.033822; Hofer SG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170404; Jacobs K., 2014, QUANTUM MEASUREMENT; Jain V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.243601; Jayich AM, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095008; Kampel NS, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021008; Kleckner D, 2006, NATURE, V444, P75, DOI 10.1038/nature05231; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Lee KH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123604; Leonhardt U., 1997, MEASURING QUANTUM ST; Li TC, 2011, NAT PHYS, V7, P527, DOI [10.1038/nphys1952, 10.1038/NPHYS1952]; Mancini S, 1998, PHYS REV LETT, V80, P688, DOI 10.1103/PhysRevLett.80.688; Martynov DV, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.112004; Neuhaus L., 2017, 2017 C LAS EL EUR EU, DOI [10.1109/CLEOE-EQEC.2017.8087380, DOI 10.1109/CLEOE-EQEC.2017.8087380]; Nielsen WHP, 2017, P NATL ACAD SCI USA, V114, P62, DOI 10.1073/pnas.1608412114; Peterson RW, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063601; Poggio M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017201; Purdy TP, 2017, SCIENCE, V356, P1265, DOI 10.1126/science.aag1407; Ringbauer M, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aabb8d; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schreppler S, 2014, SCIENCE, V344, P1486, DOI 10.1126/science.1249850; Szorkovszky A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213603; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Tsaturyan Y, 2017, NAT NANOTECHNOL, V12, P776, DOI [10.1038/nnano.2017.101, 10.1038/NNANO.2017.101]; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vinante A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.033601; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wieczorek W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.223601; Wilson DJ, 2015, NATURE, V524, P325, DOI 10.1038/nature14672; Wiseman HM, 2009, QUANTUM MEASUREMENT; Zhang J, 2017, PHYS REP, V679, P1, DOI 10.1016/j.physrep.2017.02.003	52	181	181	15	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					53	+		10.1038/s41586-018-0643-8	http://dx.doi.org/10.1038/s41586-018-0643-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY8RS	30382202	Green Submitted			2022-12-28	WOS:000448900900044
J	McCook, A				McCook, Alison			Fallout for co-authors	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					394	395		10.1126/science.362.6413.394-b	http://dx.doi.org/10.1126/science.362.6413.394-b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361355				2022-12-28	WOS:000450441900026
J	Ripka, F; Kubler, H; Low, R; Pfau, T				Ripka, Fabian; Kuebler, Harald; Loew, Robert; Pfau, Tilman			A room-temperature single-photon source based on strongly interacting Rydberg atoms	SCIENCE			English	Article							NONLINEAR OPTICS; QUANTUM-DOT; FLUORESCENCE; MOLECULE	Tailored quantum states of light can be created via a transfer of collective quantum states of matter to light modes. Such collective quantum states emerge in interacting many-body systems if thermal fluctuations are overcome by sufficient interaction strengths. Therefore, ultracold temperatures or strong confinement are typically required. We show that the exaggerated interactions between Rydberg atoms allow for collective quantum states even above room temperature. The emerging Rydberg interactions lead both to suppression of multiple Rydberg state excitations and destructive interference due to polariton dephasing. We experimentally implemented a four-wave mixing scheme to demonstrate an on-demand single-photon source. The combination of glass cell technology, identical atoms, and operation around room temperature promises scalability and integrability. This approach has the potential for various applications in quantum information processing and communication.	[Ripka, Fabian; Kuebler, Harald; Loew, Robert; Pfau, Tilman] Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, Phys Inst 5, D-70569 Stuttgart, Germany	University of Stuttgart	Pfau, T (corresponding author), Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, Phys Inst 5, D-70569 Stuttgart, Germany.	t.pfau@physik.uni-stuttgart.de	Loew, Robert/I-8206-2014; Pfau, Tilman/G-1774-2011; Kubler, Harald/C-4814-2017	Pfau, Tilman/0000-0003-3272-3468; Kubler, Harald/0000-0001-5110-5337; Ripka, Fabian/0000-0002-6855-4777	ERC [267100]; BMBF within Q.com-Q [16KIS0129]	ERC(European Research Council (ERC)European Commission); BMBF within Q.com-Q(Federal Ministry of Education & Research (BMBF))	Supported by the ERC under contract 267100 and the BMBF within Q.com-Q (project 16KIS0129).	Atutov SN, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.053401; Baluktsian T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.123001; Bariani F, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.041802; Beveratos A, 2002, EUR PHYS J D, V18, P191, DOI 10.1140/epjd/e20020023; Brunel C, 1999, PHYS REV LETT, V83, P2722, DOI 10.1103/PhysRevLett.83.2722; Busche H, 2017, NAT PHYS, V13, P655, DOI [10.1038/NPHYS4058, 10.1038/nphys4058]; DIEDRICH F, 1987, PHYS REV LETT, V58, P203, DOI 10.1103/PhysRevLett.58.203; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Firstenberg O, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152003; Huber B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.243001; Katz O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04458-4; KIMBLE HJ, 1977, PHYS REV LETT, V39, P691, DOI 10.1103/PhysRevLett.39.691; Kubler H, 2010, NAT PHOTONICS, V4, P112, DOI 10.1038/NPHOTON.2009.260; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Low R, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/11/113001; Lounis B, 2000, NATURE, V407, P491, DOI 10.1038/35035032; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Michler P, 2000, NATURE, V406, P968, DOI 10.1038/35023100; Michler P, 2000, SCIENCE, V290, P2282, DOI 10.1126/science.290.5500.2282; Mohapatra AK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.113003; Muller MM, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053412; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Ripka F, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.053429; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Saffman M, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.065403; Shu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12783; Weber S, 2017, J PHYS B-AT MOL OPT, V50, DOI 10.1088/1361-6455/aa743a	31	81	82	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413					446	448		10.1126/science.aau1949	http://dx.doi.org/10.1126/science.aau1949			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7DR	30361371	Green Submitted			2022-12-28	WOS:000450441900047
J	Feltner, C; Wallace, I; Berkman, N; Kistler, CE; Middleton, JC; Barclay, C; Higginbotham, L; Green, JT; Jonas, DE				Feltner, Cynthia; Wallace, Ina; Berkman, Nancy; Kistler, Christine E.; Middleton, Jennifer Cook; Barclay, Collen; Higginbotham, Laura; Green, Joshua T.; Jonas, Daniel E.			Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED-CONTROLLED-TRIAL; HEALTH-CARE SETTINGS; FEMALE VHA PATIENTS; DOMESTIC VIOLENCE; CLINICAL-TRIAL; ADVOCACY INTERVENTION; EMERGENCY-DEPARTMENT; CHINESE WOMEN; ACCURACY; RECOMMENDATION	IMPORTANCE Intimate partner violence (IPV), elder abuse, and abuse of vulnerable adults are common and result in adverse health outcomes. OBJECTIVE To review the evidence on screening and interventions for IPV, elder abuse, and abuse of vulnerable adults to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, Cochrane Library, EMBASE, and trial registries through October 4, 2017; references; experts; literature surveillance through August 1, 2018. STUDY SELECTION English-language randomized clinical trials (RCTs), studies evaluating test accuracy, and cohort studies with a concurrent control group assessing harms. DATA EXTRACTION AND SYNTHESIS Dual review of titles and abstracts, full-text articles, and study quality; qualitative synthesis of findings. Data were not pooled, primarily because of heterogeneity of populations, interventions, and outcomes. MAIN OUTCOMES AND MEASURES Abuse or neglect, morbidity caused by abuse, test accuracy, and harms. RESULTS Thirty studies were included (N = 14 959). Three RCTs (n = 3759) compared IPV screening with no screening; none found significant improvements in outcomes (eg, IPV or quality of life) over 3 to 18 months and 2 (n = 935) reported no harms of screening. Nine studies assessed tools to detect any past-year or current IPV in women; for past-year IPV (5 studies [n = 6331]), sensitivity of 5 tools ranged from 65% to 87% and specificity ranged from 80% to 95%. The accuracy of 5 tools (4 studies [n = 1795]) for detecting current abuse varied widely; sensitivity ranged from 46% to 94% and specificity ranged from 38% to 95%. Eleven RCTs (n = 6740) evaluated interventions for women with screen-detected IPV. Two enrolling pregnant women (n = 575) found significantly less IPV among women in the intervention group: 1 home visiting intervention (standardized mean difference [SMD], -0.34 [95% CI, -0.59 to -0.08]) and 1 behavioral counseling intervention for multiple risks (IPV, smoking, depression, tobacco exposure) (SMD, -0.40 [95% CI, -0.68 to -0.12]). No studies evaluated screening or interventions for elder abuse or abuse of vulnerable adults. One study assessing a screening tool for elder abuse had poor accuracy (sensitivity, 46% and specificity, 73% for detecting physical or verbal abuse). CONCLUSIONS AND RELEVANCE Although available screening tools may reasonably identify women experiencing IPV, trials of IPV screening in adult women did not show a reduction in IPV or improvement in quality of life over 3 to 18 months. Limited evidence suggested that home visiting and behavioral counseling interventions that address multiple risk factors may lead to reduced IPV among pregnant or postpartum women. No studies assessed screening or treatment for elder abuse and abuse of vulnerable adults.	[Feltner, Cynthia; Wallace, Ina; Berkman, Nancy; Middleton, Jennifer Cook; Barclay, Collen; Jonas, Daniel E.] Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC 27515 USA; [Feltner, Cynthia; Jonas, Daniel E.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Feltner, Cynthia; Kistler, Christine E.; Middleton, Jennifer Cook; Barclay, Collen; Jonas, Daniel E.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd,CB 7295, Chapel Hill, NC 27599 USA; [Wallace, Ina; Berkman, Nancy; Green, Joshua T.] RTI Int, Res Triangle Pk, NC USA; [Kistler, Christine E.; Higginbotham, Laura] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill	Feltner, C (corresponding author), Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, 725 Martin Luther King Jr Blvd,CB 7295, Chapel Hill, NC 27599 USA.	cindy_feltner@med.unc.edu		Wallace, Ina/0000-0002-0194-4041; Berkman, Nancy/0000-0003-3617-1082	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I, 5]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 5, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; CDC (Cent. Dis. Control Prev.), 2015, INT PARTN VIOL DEF; Centers for Disease Control and Prevention (CDC), 2015, INT PARTN VIOL CONS; Chen PH, 2005, FAM PRACT, V22, P617, DOI 10.1093/fampra/cmi075; Dubowitz H, 2008, PEDIATRICS, V121, pE85, DOI 10.1542/peds.2007-0904; El-Mohandes AAE, 2008, OBSTET GYNECOL, V112, P611, DOI 10.1097/AOG.0b013e3181834b10; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Ernst Amy A, 2004, Violence Vict, V19, P375, DOI 10.1891/088667004780905688; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Florida Department of Children and Families. Adult Services Program Office, 2007, COMP DEF FLOR STAT 4; Fulmer T, 2012, GERODONTOLOGY, V29, P96, DOI 10.1111/j.1741-2358.2010.00405.x; Gerard M, 2000, RN, V63, P52; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Iverson KM, 2015, J TRAUMA STRESS, V28, P79, DOI 10.1002/jts.21985; Iverson KM, 2013, J GEN INTERN MED, V28, P1288, DOI 10.1007/s11606-013-2534-x; Kiely M, 2011, OBSTET GYNECOL, V117, P1232; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Klevens J, 2015, JAMA-J AM MED ASSOC, V314, P515, DOI 10.1001/jama.2015.6755; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; Koziol-McLain J, 2001, AM J PREV MED, V21, P93, DOI 10.1016/S0749-3797(01)00325-7; Koziol-McLain J, 2010, ANN EMERG MED, V56, P413, DOI 10.1016/j.annemergmed.2010.05.001; Lock J., 2008, THESIS; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Miller E, 2016, CONTRACEPTION, V94, P58, DOI 10.1016/j.contraception.2016.02.009; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; Mills TJ, 2006, J EMERG MED, V31, P447, DOI 10.1016/j.jemermed.2005.12.029; Moyer VA, 2013, ANN INTERN MED, V159, P289, DOI 10.7326/0003-4819-159-4-201308200-00667; Nelson H, 2004, PREVENTIVE SERVICES; Nelson HD, 2012, SCREENING WOMEN INTI; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Paranjape A, 2003, J WOMEN HEALTH GEN-B, V12, P233, DOI 10.1089/154099903321667573; Paranjape A, 2006, J NATL MED ASSOC, V98, P1663; Rhodes KV, 2015, JAMA-J AM MED ASSOC, V314, P466, DOI 10.1001/jama.2015.8369; Saftlas AF, 2014, ANN EPIDEMIOL, V24, P144, DOI 10.1016/j.annepidem.2013.10.006; Sharps PW, 2016, J WOMENS HEALTH, V25, P1129, DOI 10.1089/jwh.2015.5547; Smith SG, 2018, NATL INTIMATE PARTNE; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Tiwari A, 2012, INT J NURS STUD, V49, P645, DOI 10.1016/j.ijnurstu.2011.12.005; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; U. S. Preventive Services Task Force (USPSTF), 2015, PROC MAN METH PROC; Wathen CN, 2008, WOMEN HEALTH ISS, V18, P423, DOI 10.1016/j.whi.2008.08.003; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131; Zink T, 2007, CLIN PEDIATR, V46, P127, DOI 10.1177/0009922806290029; Zlotnick C, 2011, ARCH WOMEN MENT HLTH, V14, P55, DOI 10.1007/s00737-010-0195-x	49	66	66	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1688	1701		10.1001/jama.2018.13212	http://dx.doi.org/10.1001/jama.2018.13212			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX8UQ	30357304	Bronze			2022-12-28	WOS:000448069100018
J	Thornton, J				Thornton, Jacqui			MPs slam "outrageous" 25% uptake of flu vaccine among social care staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Science and Technology Committee, 2018, FLU VACC PROGR ENGL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2018	363								k4423	10.1136/bmj.k4423	http://dx.doi.org/10.1136/bmj.k4423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY1FS	30341054				2022-12-28	WOS:000448271300005
J	Aers, XP; Leroy, BP; Defesche, JC; Shadid, S				Aers, Xavier-Philippe; Leroy, Bart P.; Defesche, Joep C.; Shadid, Samyah			Abetalipoproteinemia From Previously Unreported Gene Mutations	ANNALS OF INTERNAL MEDICINE			English	Letter									[Aers, Xavier-Philippe; Leroy, Bart P.; Shadid, Samyah] Ghent Univ Hosp, Ghent, Belgium; [Aers, Xavier-Philippe; Leroy, Bart P.; Shadid, Samyah] Univ Ghent, Ghent, Belgium; [Defesche, Joep C.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands	Ghent University; Ghent University Hospital; Ghent University; University of Amsterdam; Academic Medical Center Amsterdam	Aers, XP (corresponding author), Ghent Univ Hosp, Ghent, Belgium.; Aers, XP (corresponding author), Univ Ghent, Ghent, Belgium.							Burnett JR, 2015, EUR J HUM GENET, V23, DOI 10.1038/ejhg.2014.224; Desomer L, 2015, ENDOSCOPY, V47, pE223, DOI 10.1055/s-0034-1391832; Lee J, 2014, J INHERIT METAB DIS, V37, P333, DOI 10.1007/s10545-013-9665-4; Paquette M, 2016, J CLIN LIPIDOL, V10, P1030, DOI 10.1016/j.jacl.2016.01.003; Peretti N, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-24	5	4	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2019	170	3					211	+		10.7326/L18-0358	http://dx.doi.org/10.7326/L18-0358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HK2IZ	30398540				2022-12-28	WOS:000457735100015
J	Kong, L; Sochacki, KA; Wang, HB; Fang, SM; Canagarajah, B; Kehr, AD; Rice, WJ; Strub, MP; Taraska, JW; Hinshaw, JE				Kong, Leopold; Sochacki, Kem A.; Wang, Huaibin; Fang, Shunming; Canagarajah, Bertram; Kehr, Andrew D.; Rice, William J.; Strub, Marie-Paule; Taraska, Justin W.; Hinshaw, Jenny E.			Cryo-EM of the dynamin polymer assembled on lipid membrane (vol 560, pg 258, 2018)	NATURE			English	Correction														Rice, William/0000-0002-5187-255X	Intramural NIH HHS [Z01 DK060100] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Kong L, 2018, NATURE, V560, P258, DOI 10.1038/s41586-018-0378-6	1	0	0	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2018	564	7734					E6	E6		10.1038/s41586-018-0612-2	http://dx.doi.org/10.1038/s41586-018-0612-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HD1KR	30377313	Bronze, Green Accepted			2022-12-28	WOS:000452269400004
J	Goligher, EC; Tomlinson, G; Hajage, D; Wijeysundera, DN; Fan, E; Juni, P; Brodie, D; Slutsky, AS; Combes, A				Goligher, Ewan C.; Tomlinson, George; Hajage, David; Wijeysundera, Duminda N.; Fan, Eddy; Juni, Peter; Brodie, Daniel; Slutsky, Arthur S.; Combes, Alain			Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VENTILATION; SUPPORT; CARE	IMPORTANCE Bayesian analysis of clinical trial data may provide useful information to aid in study interpretation, especially when trial evidence suggests that the benefits of an intervention are uncertain, such as in a trial that evaluated early extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS). OBJECTIVE To demonstrate the potential utility of Bayesian analyses by estimating the posterior probability, under various assumptions, that early ECMO was associated with reduced mortality in patients with very severe ARDS in a randomized clinical trial (RCT). DESIGN AND EVIDENCE A post hoc Bayesian analysis of data from an RCT (ECMO to Rescue Lung Injury in Severe ARDS [EOLIA]) that included 249 patients with very severe ARDS who had been randomized to receive early ECMO (n = 124; mortality at 60 days, 35%) vs initial conventional lung-protective ventilation with the option for rescue ECMO (n = 125, mortality at 60 days, 46%). The trial was designed to detect an absolute risk reduction (ARR) of 20%, relative risk (RR) of 0.67. Statistical prior distributions were specified to represent varying levels of preexisting enthusiasm or skepticism for ECMO and by Bayesian meta-analysis of previously published studies (with downweighting to account for differences and quality between studies). The RR, credible interval (Crl), ARR, and probability of clinically important mortality benefit (varying from RR less than 1 to RR less than 0.67 and ARR from 2% or more to 20% or more) were estimated with Bayesian modeling. FINDINGS Combining a minimally informative prior distribution with the findings of the EOLIA trial, the posterior probability of RR less than 1 for mortality at 60 days after randomization was 96%(RR, 0.78 [95% Crl, 0.56-1.04]); the posterior probability of RR less than 0.67 was 18%, the probability of ARR of 2% or more was 92%, and the probability of ARR of 20% or more was 2%. With a moderately enthusiastic prior, equivalent to information from a trial of 264 patients with an RR of 0.78, the estimated RR was 0.78 (95% Crl, 0.63-0.96), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 8%, the probability of ARR of 2% or more was 97%, and the probability of ARR of 20% or more was 0%. With a strongly skeptical prior, equivalent to information from a trial of 264 patients with an RR of 1.0, the estimated RR was 0.88 (95% Crl, 0.71-1.09), the probability of RR less than 1 was 88%, the probability of RR less than 0.67 was 0%, the probability of ARR of 2% or more was 78%, and the probability of ARR of 20% or more was 0%. If the prior was informed by previous studies, the estimated RR was 0.71 (95% Crl, 0.55-0.94), the probability of RR less than 1 was 99%, the probability of RR less than 0.67 was 48%, the probability of ARR of 2% or more was 98%, and the probability of ARR of 20% or more was 4%. CONCLUSIONS AND RELEVANCE Post hoc Bayesian analysis of data from a randomized clinical trial of early extracorporeal membrane oxygenation compared with conventional lung-protective ventilation with the option for rescue extracorporeal membrane oxygenation among patients with very severe acute respiratory distress syndrome provides information about the posterior probability of mortality benefit under a broad set of assumptions that may help inform interpretation of the study findings.	[Goligher, Ewan C.; Fan, Eddy; Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Goligher, Ewan C.; Tomlinson, George; Fan, Eddy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Goligher, Ewan C.; Tomlinson, George] Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Tomlinson, George; Wijeysundera, Duminda N.; Fan, Eddy; Juni, Peter] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hajage, David] Sorbonne Univ, Hop Univ Pitie Salpetriere Charles Foix, AP HP,Ctr Pharmacoepidemiol, Dept Biostat Sante Publ & Informat Med,Unite Rech, Paris, France; [Wijeysundera, Duminda N.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada; [Wijeysundera, Duminda N.; Juni, Peter] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr,Dept Med, Toronto, ON, Canada; [Brodie, Daniel] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Brodie, Daniel] New York Presbyterian Hosp, New York, NY USA; [Slutsky, Arthur S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Ctr Biomed Res, Toronto, ON, Canada; [Combes, Alain] Sorbonne Univ, INSERM, Unite Mixte Rech, Inst Cardiometab & Nutr, Paris, France; [Combes, Alain] Hop La Pitie Salpetriere, AP HP, Inst Cardiol, Serv Med Intens Reanimat, Paris, France	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Columbia University; NewYork-Presbyterian Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Goligher, EC (corresponding author), Toronto Gen Hosp, 585 Univ Ave,Peter Munk Bldg,11th Floor,Room 192, Toronto, ON M5G 2N2, Canada.	ewan.goligher@utoronto.ca	Wijeysundera, Duminda/L-3350-2018; Juni, Peter/Q-8700-2016; Hajage, David/D-5226-2014; Slutsky, Arthur/M-3325-2019; Tomlinson, George/L-5432-2016	Wijeysundera, Duminda/0000-0002-5897-8605; Juni, Peter/0000-0002-5985-0670; Hajage, David/0000-0002-8475-4090; Tomlinson, George/0000-0002-9328-6399; Goligher, Ewan/0000-0002-0990-6701	Canadian Institutes of Health Research; department of anesthesia at the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); department of anesthesia at the University of Toronto(University of Toronto)	This work is supported by a new investigator award from the Canadian Institutes of Health Research (Drs Fan and Wijeysundera) and a merit award from the department of anesthesia at the University of Toronto (Dr Wijeysundera).	Allmark Peter, 2004, Med Health Care Philos, V7, P321; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Bland JM, 1998, BRIT MED J, V317, P1151; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Combes A, 2018, NEW ENGL J MED, V378, P1965, DOI 10.1056/NEJMoa1800385; Dalton HJ, 2010, CRIT CARE MED, V38, P1484, DOI 10.1097/CCM.0b013e3181e08fff; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Gattinoni L, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2098-6; Hardin CC, 2018, NEW ENGL J MED, V378, P2032, DOI 10.1056/NEJMe1802676; Harrington D, 2018, NEW ENGL J MED, V378, P2031, DOI 10.1056/NEJMe1805123; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Johnson SR, 2010, J CLIN EPIDEMIOL, V63, P355, DOI 10.1016/j.jclinepi.2009.06.003; Kass R.E., 1989, STAT SCI, V4, P310, DOI DOI 10.1214/SS/1177012386; Li XH, 2018, AM J RESP CRIT CARE, V197, P991, DOI 10.1164/rccm.201711-2216CP; Lilford RJ, 2003, BRIT MED J, V326, P980, DOI 10.1136/bmj.326.7396.980; Mi MY, 2018, NEW ENGL J MED, V379, P884, DOI 10.1056/NEJMclde1804601; Munshi Laveena, 2014, Ann Am Thorac Soc, V11, P802, DOI 10.1513/AnnalsATS.201401-012OC; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pham T, 2013, AM J RESP CRIT CARE, V187, P276, DOI 10.1164/rccm.201205-0815OC; Plummer M, 2004, JAGS; Quintana M, 2017, JAMA-J AM MED ASSOC, V318, P1605, DOI 10.1001/jama.2017.15574; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; SPIEGELHALTER DJ, 1993, STAT MED, V12, P1501, DOI 10.1002/sim.4780121516; United States Census Bureau, US WORLD POP CLOCK; US Food and Drug Administration, GUID US BAYES STAT M; Vincent JL, 2017, INTENS CARE MED, V43, P1869, DOI 10.1007/s00134-017-4930-x; Wijeysundera DN, 2009, J CLIN EPIDEMIOL, V62, P13, DOI 10.1016/j.jclinepi.2008.07.006	31	226	238	3	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2018	320	21					2251	2259		10.1001/jama.2018.14276	http://dx.doi.org/10.1001/jama.2018.14276			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4MB	30347031	Green Submitted			2022-12-28	WOS:000452500600016
J	Mease, P; Coates, LC; Helliwell, PS; Stanislavchuk, M; Rychlewska-Hanczewska, A; Dudek, A; Abi-Saab, W; Tasset, C; Meuleners, L; Harrison, P; Besuyen, R; Van der Aa, A; Mozaffarian, N; Greer, JM; Kunder, R; Van den Bosch, F; Gladman, DD				Mease, Philip; Coates, Laura C.; Helliwell, Philip S.; Stanislavchuk, Mykola; Rychlewska-Hanczewska, Anna; Dudek, Anna; Abi-Saab, Walid; Tasset, Chantal; Meuleners, Luc; Harrison, Pille; Besuyen, Robin; Van der Aa, Annegret; Mozaffarian, Neelufar; Greer, Joy M.; Kunder, Rebecca; Van den Bosch, Filip; Gladman, Dafna D.			Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial	LANCET			English	Article							RHEUMATOID-ARTHRITIS; TOFACITINIB; JAK1; GLPG0634/GS-6034; RECOMMENDATIONS; METHOTREXATE; EPIDEMIOLOGY; MONOTHERAPY; MANAGEMENT; BIOLOGICS	Background The Janus kinase 1 (JAK1) pathway has been implicated in the pathogenesis of psoriatic arthritis. We aimed to investigate the efficacy and safety of filgotinib, a selective JAK1 inhibitor, for the treatment of psoriatic arthritis. Methods The EQUATOR trial was a randomised, double-blind, placebo-controlled phase 2 trial that enrolled adults from 25 sites in seven countries (Belgium, Bulgaria, Czech Republic, Estonia, Poland, Spain, and Ukraine). Patients (aged >= 18 years) had active moderate-to-severe psoriatic arthritis (defined as at least five swollen joints and at least five tender joints) fulfilling Classification for psoriatic arthritis (CASPAR) criteria, active or a documented history of plaque psoriasis, and an insufficient response or intolerance to at least one conventional synthetic disease-modifying anti-rheumatic drug (csDMARD). Patients continued to take csDMARDs during the study if they had received this treatment for at least 12 weeks before screening and were on a stable dose for at least 4 weeks before baseline. Using an interactive web-based system, we randomly allocated patients (1: 1) to filgotinib 200 mg or placebo orally once daily for 16 weeks (stratified by current use of csDMARDs and previous use of anti-tumour necrosis factor). Patients, study team, and sponsor were masked to treatment assignment. The primary endpoint was proportion of patients achieving 20% improvement in American College of Rheumatology response criteria (ACR20) at week 16 in the full analysis set (patients who received at least one dose of study drug), which was compared between groups with the Cochran-Mantel-Haenszel test and non-responder imputation method. This trial is registered with ClincalTrials.gov, number NCT03101670. Findings Between March 9, and Sept 27, 2017, 191 patients were screened and 131 were randomly allocated to treatment (65 to filgotinib and 66 to placebo). 60 (92%) patients in the filgotinib group and 64 (97%) patients in the placebo group completed the study; five patients (8%) in the filgotinib group and two patients (3%) in the placebo group discontinued treatment. 52 (80%) of 65 patients in the filgotinib group and 22 (33%) of 66 in the placebo group achieved ACR20 at week 16 (treatment difference 47% [95% CI 30.2-59.6], p<0.0001). 37 (57%) patients who received filgotinib and 39 (59%) patients who received placebo had at least one treatment-emergent adverse event. Six participants had an event that was grade 3 or worse. The most common events were nasopharyngitis and headache, occurring at similar proportions in each group. One serious treatment-emergent adverse event was reported in each group (pneumonia and hip fracture after a fall), one of which (pneumonia) was fatal in the filgotinib group. Interpretation Filgotinib is efficacious for the treatment of active psoriatic arthritis, and no new safety signals were identified. Copyright (c) 2018 Elsevier Ltd. All rights reserved.	[Mease, Philip] Swedish Providence St Joseph Hlth Syst, Seattle, WA 98122 USA; [Mease, Philip] Univ Washington, Seattle, WA 98195 USA; [Coates, Laura C.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Helliwell, Philip S.] Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Stanislavchuk, Mykola] Natl Pirogov Mem Med Univ, Vinnytsya, Ukraine; [Rychlewska-Hanczewska, Anna] Ai Ctr Med, Poznan, Poland; [Dudek, Anna] Ctr Med AMED, Warsaw, Poland; [Abi-Saab, Walid; Tasset, Chantal; Meuleners, Luc; Harrison, Pille; Van der Aa, Annegret] Galapagos NV, Mechelen, Belgium; [Besuyen, Robin] Galapagos BV, Leiden, Netherlands; [Mozaffarian, Neelufar; Greer, Joy M.; Kunder, Rebecca] Gilead Sci, Foster City, CA USA; [Van den Bosch, Filip] Ghent Univ Hosp, Ghent, Belgium; [Van den Bosch, Filip] Univ Ghent, VIB UGent Ctr Inflammat Res, Ghent, Belgium; [Gladman, Dafna D.] Univ Toronto, Toronto, ON, Canada; [Gladman, Dafna D.] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada	Swedish Medical Center; University of Washington; University of Washington Seattle; University of Oxford; National Pirogov Memorial Medical University Vinnytsya; Galapagos NV; Galapagos NV; Gilead Sciences; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Mease, P (corresponding author), Swedish Providence St Joseph Hlth Syst, Seattle, WA 98122 USA.	pmease@philipmease.com	Stanislavchuk, Mykola/GRX-8902-2022	Harrison, Pille/0000-0003-4117-6910; Elewaut, Dirk/0000-0002-7468-974X	Galapagos; Gilead Sciences	Galapagos(Galapagos NV); Gilead Sciences(Gilead Sciences)	Galapagos and Gilead Sciences.	Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Coates LC, 2016, ARTHRITIS RHEUMATOL, V68, P1060, DOI 10.1002/art.39573; D'Angelo S, 2017, OPEN ACCESS RHEUMATO, V9, DOI 10.2147/OARRR.S56073; D'Angiolella LS, 2018, PHARMACOECONOMICS, V36, P567, DOI 10.1007/s40273-018-0618-5; Genovese M, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1541-z; Gladman D, 2017, NEW ENGL J MED, V377, P1525, DOI 10.1056/NEJMoa1615977; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gossec L, 2016, ANN RHEUM DIS, V75, P499, DOI 10.1136/annrheumdis-2015-208337; Gudu T, 2018, EXPERT REV CLIN IMMU, V14, P405, DOI 10.1080/1744666X.2018.1468252; Kavanaugh A, 2017, ANN RHEUM DIS, V76, P1009, DOI 10.1136/annrheumdis-2016-210105; Kawalec P, 2015, EXPERT REV PHARM OUT, V15, P125, DOI 10.1586/14737167.2015.965154; Kerschbaumer A, 2017, ANN RHEUM DIS, V76, P2038, DOI 10.1136/annrheumdis-2017-211433; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease P, 2018, ANN RHEUM DIS, V77, P890, DOI 10.1136/annrheumdis-2017-212687; Mease PJ, 2017, ANN RHEUM DIS, V76, P79, DOI 10.1136/annrheumdis-2016-209709; Mease PJ, 2011, J RHEUMATOL, V38, P2461, DOI 10.3899/jrheum.110546; Merola JF, 2017, SEMIN ARTHRITIS RHEU, V47, P29, DOI 10.1016/j.semarthrit.2017.02.001; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Nash P, 2018, ANN RHEUM DIS, V77, P690, DOI 10.1136/annrheumdis-2017-211568; Ogdie A, 2015, RHEUM DIS CLIN N AM, V41, P545, DOI 10.1016/j.rdc.2015.07.001; Peluso R, 2015, CLIN RHEUMATOL, V34, P745, DOI 10.1007/s10067-014-2652-9; Robin-Jagerschmidt C, 2017, ANN RHEUM DIS, V76, P118, DOI 10.1136/annrheumdis-2017-eular.1977; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; US Food and Drug Administration, 2018, 207924 FDA NDA; van der Heijde D, 2018, LANCET, V392, P2378, DOI 10.1016/S0140-6736(18)32463-2; Van Rompaey L, 2013, J IMMUNOL, V191, P3568, DOI 10.4049/jimmunol.1201348; Vermeire S, 2017, LANCET, V389, P266, DOI 10.1016/S0140-6736(16)32537-5; Wells AF, 2018, RHEUMATOLOGY, V57, P1253, DOI 10.1093/rheumatology/key032; Westhovens R, 2017, ANN RHEUM DIS, V76, P998, DOI 10.1136/annrheumdis-2016-210104; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745; Wu DX, 2018, RHEUMATOLOGY, V57, P563, DOI 10.1093/rheumatology/kex452	32	115	120	2	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2018	392	10162					2367	2377		10.1016/S0140-6736(18)32483-8	http://dx.doi.org/10.1016/S0140-6736(18)32483-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4PH	30360969	Green Submitted, Green Accepted			2022-12-28	WOS:000451785200025
J	Fatemi, V; Wu, SF; Cao, Y; Bretheau, L; Gibson, QD; Watanabe, K; Taniguchi, T; Cava, RJ; Jarillo-Herrero, P				Fatemi, Valla; Wu, Sanfeng; Cao, Yuan; Bretheau, Landry; Gibson, Quinn D.; Watanabe, Kenji; Taniguchi, Takashi; Cava, Robert J.; Jarillo-Herrero, Pablo			Electrically tunable low-density superconductivity in a monolayer topological insulator	SCIENCE			English	Article							MAJORANA FERMIONS; FLUCTUATION; FERROMAGNETISM; CONDUCTIVITY; TRANSITION; STATES; ORDER; FIELD; GAP	Turning on superconductivity in a topologically nontrivial insulator may provide a route to search for non-Abelian topological states. However, existing demonstrations of superconductor-insulator switches have involved only topologically trivial systems. Here we report reversible, in situ electrostatic on-off switching of superconductivity in the recently established quantum spin Hall insulator monolayer tungsten ditelluride (WTe2). Fabricated into a van der Waals field-effect transistor, the monolayer's ground state can be continuously gate-tuned from the topological insulating to the superconducting state, with critical temperatures T-c up to similar to 1 kelvin. Our results establish monolayer WTe2 as a material platform for engineering nanodevices that combine superconducting and topological phases of matter.	[Fatemi, Valla; Wu, Sanfeng; Cao, Yuan; Jarillo-Herrero, Pablo] MIT, Dept Phys, Cambridge, MA 02139 USA; [Bretheau, Landry] Ecole Polytech, Lab Solides Irradies, CNRS, CEA, F-91128 Palaiseau, France; [Gibson, Quinn D.] Univ Liverpool, Dept Chem, Liverpool L69 7ZX, Merseyside, England; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Adv Mat Lab, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Cava, Robert J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; University of Liverpool; National Institute for Materials Science; Princeton University	Wu, SF; Jarillo-Herrero, P (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	swu02@mit.edu; pjarillo@mit.edu	Watanabe, Kenji/ABB-2135-2021; Bretheau, Landry/Q-5468-2018; Jarillo-Herrero, Pablo/E-3755-2013	Watanabe, Kenji/0000-0003-3701-8119; Bretheau, Landry/0000-0001-5628-934X; /0000-0003-3648-7706; Jarillo-Herrero, Pablo/0000-0001-8217-8213; /0000-0002-9000-4501	AFOSR [FA9550-16-1-0382]; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4541]; Center for Excitonics, an Energy Frontier Research Center - DOE, Basic Energy Sciences Office [DE-SC0001088]; NSF [ECS-0335765, DMR-0819762]; MIT Pappalardo Fellowship in Physics; NSF MRSEC grant [DMR-1420541]; Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI [JP15K21722, JP25106006]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation's EPiQS Initiative; Center for Excitonics, an Energy Frontier Research Center - DOE, Basic Energy Sciences Office; NSF(National Science Foundation (NSF)); MIT Pappalardo Fellowship in Physics; NSF MRSEC grant(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Elemental Strategy Initiative by the MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported through AFOSR grant no. FA9550-16-1-0382 as well as the Gordon and Betty Moore Foundation's EPiQS Initiative through grant no. GBMF4541 to P. J.-H. Device nanofabrication was partly supported by the Center for Excitonics, an Energy Frontier Research Center funded by the DOE, Basic Energy Sciences Office, under award no. DE-SC0001088. This work made use of the Materials Research Science and Engineering Center's Shared Experimental Facilities supported by NSF under award no. DMR-0819762. Sample fabrication was performed partly at the Harvard Center for Nanoscale Science supported by the NSF under grant no. ECS-0335765. S. W. acknowledges the support of the MIT Pappalardo Fellowship in Physics. The WT<INF>02</INF> crystal growth performed at Princeton University was supported by an NSF MRSEC grant, DMR-1420541. Growth of BN crystals was supported by the Elemental Strategy Initiative conducted by the MEXT, Japan, and JSPS KAKENHI grant nos. JP15K21722 and JP25106006.	Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; Ali MN, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/67002; ASLAMAZO.LG, 1968, PHYS LETT A, VA 26, P238, DOI 10.1016/0375-9601(68)90623-3; Bauer E., 2012, LECT NOTES PHYS SERI, V847; Bocquillon E, 2017, NAT NANOTECHNOL, V12, P137, DOI [10.1038/NNANO.2016.159, 10.1038/nnano.2016.159]; Bretheau L, 2017, NAT PHYS, V13, P756, DOI [10.1038/nphys4110, 10.1038/NPHYS4110]; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Chang W, 2015, NAT NANOTECHNOL, V10, P232, DOI [10.1038/NNANO.2014.306, 10.1038/nnano.2014.306]; de la Barrera SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03888-4; DORIN VV, 1993, PHYS REV B, V48, P12951, DOI 10.1103/PhysRevB.48.12951; Einaga M, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012036; Fei ZY, 2017, NAT PHYS, V13, P677, DOI [10.1038/NPHYS4091, 10.1038/nphys4091]; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Hart S, 2014, NAT PHYS, V10, P638, DOI [10.1038/NPHYS3036, 10.1038/nphys3036]; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; He QL, 2017, SCIENCE, V357, P294, DOI 10.1126/science.aag2792; Hor YS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057001; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Jia ZY, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.041108; Kang DF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8804; KLEMM RA, 1975, PHYS REV B, V12, P877, DOI 10.1103/PhysRevB.12.877; Kong PP, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/36/362204; Larkin A., 2005, THEORY FLUCTUATIONS; Larkin A. I., 2005, INT SERIES MONOGRAPH; MAKI K, 1968, PROG THEOR PHYS, V39, P897, DOI 10.1143/PTP.39.897; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Pan XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8805; Parendo KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197004; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qian XF, 2014, SCIENCE, V346, P1344, DOI 10.1126/science.1256815; Sacepe B, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1586; Saito Y, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.94; Saito Y, 2016, SUPERCOND SCI TECH, V29, DOI 10.1088/0953-2048/29/9/093001; Sun HH, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.257003; Tang SJ, 2017, NAT PHYS, V13, P683, DOI [10.1038/NPHYS4174, 10.1038/nphys4174]; THOMPSON RS, 1970, PHYS REV B-SOLID ST, V1, P327, DOI 10.1103/PhysRevB.1.327; Thoutam LR, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.046602; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; Wray LA, 2010, NAT PHYS, V6, P855, DOI [10.1038/NPHYS1762, 10.1038/nphys1762]; Wu S., 2018, REPLICATION DATA ELE, DOI [10.7910/DVN/UFGFY2, DOI 10.7910/DVN/UFGFY2]; Wu S., 2018, REPLICATION DATA ELE; Wu SF, 2018, SCIENCE, V359, P76, DOI 10.1126/science.aan6003; Xi XX, 2016, NAT PHYS, V12, P139, DOI [10.1038/NPHYS3538, 10.1038/nphys3538]; Ye JT, 2012, SCIENCE, V338, P1193, DOI 10.1126/science.1228006; Zhang JL, 2011, P NATL ACAD SCI USA, V108, P24, DOI 10.1073/pnas.1014085108; Zheng FP, 2016, ADV MATER, V28, P4845, DOI 10.1002/adma.201600100	48	205	211	40	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2018	362	6417					926	+		10.1126/science.aar4642	http://dx.doi.org/10.1126/science.aar4642			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB5TC	30361384	Bronze, Green Submitted			2022-12-28	WOS:000451124500037
J	Munoz-Canoves, P; Huch, M				Munoz-Canoves, Pura; Huch, Meritxell			Defining adult stem cells	NATURE			English	Editorial Material							SATELLITE CELLS; EPITHELIAL-CELLS	Adult tissues must maintain themselves and regenerate after damage. But are these crucial functions mediated by dedicated populations of stem cells, or do differentiated cells adopt stem-cell-like properties according to an organ's needs? Here, two scientists present evidence from both sides of the debate.	[Munoz-Canoves, Pura] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Munoz-Canoves, Pura] ICREA, Barcelona 08003, Spain; [Munoz-Canoves, Pura] Spanish Natl Ctr Cardiovasc Res, Madrid, Spain; [Huch, Meritxell] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Huch, Meritxell] Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	Pompeu Fabra University; ICREA; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Cambridge	Munoz-Canoves, P (corresponding author), Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona 08003, Spain.; Munoz-Canoves, P (corresponding author), ICREA, Barcelona 08003, Spain.; Munoz-Canoves, P (corresponding author), Spanish Natl Ctr Cardiovasc Res, Madrid, Spain.	pura.munoz@upf.edu; m.huch@gurdon.cam.ac.uk	Munoz-Canoves, Pura/B-3889-2015					BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Chivu-Economescu M, 2017, CURR STEM CELL RES T, V12, P124, DOI 10.2174/1574888X10666151026114241; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Clevers H, 2018, ANNU REV BIOCHEM, V87, P1015, DOI 10.1146/annurev-biochem-062917-012341; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Pappenheim A., 1896, EUR J PATHOL, V145, P587; Pini V, 2017, CURR STEM CELL REP, V3, P137, DOI 10.1007/s40778-017-0076-6; Ramalho-Santos Miguel, 2007, Cell Stem Cell, V1, P35, DOI 10.1016/j.stem.2007.05.013; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tetteh PW, 2015, TRENDS CELL BIOL, V25, P100, DOI 10.1016/j.tcb.2014.09.003	15	8	8	4	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					328	329		10.1038/d41586-018-07175-6	http://dx.doi.org/10.1038/d41586-018-07175-6			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA2EY	30378594	Green Accepted			2022-12-28	WOS:000450048400040
J	Naik, RP; Smith-Whitley, K; Hassell, KL; Umeh, NI; de Montalembert, M; Sahota, P; Haywood, C; Jenkins, J; Lloyd-Puryear, MA; Joiner, CH; Bonham, VL; Kato, GJ				Naik, Rakhi P.; Smith-Whitley, Kim; Hassell, Kathryn L.; Umeh, Nkeiruka I.; de Montalembert, Mariane; Sahota, Puneet; Haywood, Carlton, Jr.; Jenkins, Jean; Lloyd-Puryear, Michele A.; Joiner, Clinton H.; Bonham, Vence L.; Kato, Gregory J.			Clinical Outcomes Associated With Sickle Cell Trait A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC KIDNEY-DISEASE; AFRICAN-AMERICANS; VENOUS THROMBOEMBOLISM; RISK-FACTOR; ATHEROSCLEROSIS RISK; SCREENING PROGRAMS; UNITED-STATES; D-DIMER; CHILDREN; HEMOGLOBIN	Background: Although sickle cell trait (SCT) is largely a benign carrier state, it may increase risk for certain clinical outcomes. Purpose: To evaluate associations between SCT and clinical outcomes in children and adults. Data Sources: English-language searches of PubMed, CINAHL, the Cochrane Library, Current Contents Connect, Scopus, and Embase (1 January 1970 to 30 June 2018) and bibliographies of review articles. Study Selection: Observational controlled studies (published in English) in children or adults that examined an association between SCT and any of 24 clinical outcomes specified a priori in the following 6 categories: exertion-related injury; renal, vascular, pediatric, and surgery-or trauma-related outcomes; and overall mortality. Data Extraction: A single reviewer extracted study data, which was checked by another; 2 reviewers independently assessed study quality; and strength of evidence was assessed by consensus. Data Synthesis: Of 7083 screened studies, 41 met inclusion criteria. High-strength evidence supported a positive association between SCT and risk for pulmonary embolism, proteinuria, and chronic kidney disease. Moderate-strength evidence supported a positive association between SCT and exertional rhabdomyolysis and a null association between SCT and deep venous thrombosis, heart failure or cardiomyopathy, stroke, and pediatric height or weight. Absolute risks for thromboembolism and rhabdomyolysis were small. For the remaining 15 clinical outcomes, data were insufficient or strength of evidence was low. Limitation: Publication bias was possible, and high-quality evidence was scant. Conclusion: Sickle cell trait is a risk factor for a few adverse health outcomes, such as pulmonary embolism, kidney disease, and exertional rhabdomyolysis, but does not seem to be associated with such complications as heart failure and stroke. Insufficient data or low-strength evidence exists for most speculated complications of SCT.	[Naik, Rakhi P.; Haywood, Carlton, Jr.] Johns Hopkins Univ, 1830 East Monument St,Suite 7300, Baltimore, MD 21205 USA; [Smith-Whitley, Kim; Sahota, Puneet] Childrens Hosp Philadelphia, 11th Floor Colket Bldg,3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Smith-Whitley, Kim; Sahota, Puneet] Univ Penn, 3535 Market St,2nd Floor, Philadelphia, PA 19104 USA; [Hassell, Kathryn L.] Univ Colorado Denver, Sch Med, Denver, CO USA; [Umeh, Nkeiruka I.; Jenkins, Jean; Bonham, Vence L.] NHGRI, NIH, Bethesda, MD 20892 USA; [de Montalembert, Mariane] Hop Univ Necker Enfants Malad, Paris, France; [Haywood, Carlton, Jr.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA; [Lloyd-Puryear, Michele A.] Amer Coll Med Genet & Genom, Bethesda, MD USA; [Joiner, Clinton H.] Emory Univ, Sch Med, 1405 Clifton Rd, Atlanta, GA USA; [Kato, Gregory J.] Univ Pittsburgh, Sch Med, Vasc Med Inst, 200 Lothrop St, Pittsburgh, PA 15261 USA; [Umeh, Nkeiruka I.; Jenkins, Jean; Bonham, Vence L.] NHGRI, 31 Ctr Dr, Bethesda, MD 20892 USA; [Hassell, Kathryn L.] Univ Colorado, 13121 East 17th Ave,C 222 Educ 2 South,Room 3211, Aurora, CO 80045 USA; [de Montalembert, Mariane] Hop Necker Enfants Malad, 149 Rue Sevres, F-75015 Paris, France; [Lloyd-Puryear, Michele A.] 7101 Wisconsin Ave 1101, Bethesda, MD 20814 USA	Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Johns Hopkins University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Colorado System; University of Colorado Anschutz Medical Campus; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Bonham, VL (corresponding author), NHGRI, 31 Ctr Dr, Bethesda, MD 20892 USA.	bonhamv@nih.gov	Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217	Division of Intramural Research at NHGRI [ZIAHG200394]; National Heart, Lung, and Blood Institute [K08HL125100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125100] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200394] Funding Source: NIH RePORTER	Division of Intramural Research at NHGRI; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	In part by grant ZIAHG200394 from the Division of Intramural Research at NHGRI (Mr. Bonham) and grant K08HL125100 from the National Heart, Lung, and Blood Institute (Dr. Naik).	Ahmed SG, 2015, BLOOD TRANSFUS-ITALY, V13, P639, DOI 10.2450/2015.0335-14; Ajayi A.A., 2004, Eur J Intern Med, V15, P312, DOI 10.1016/j.ejim.2004.06.003; Al Harbi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159215; Aloni MN, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22143; American Society of Hematology, 2012, STAT SCREEN SICKL CE; Amin C, 2015, BRIT J HAEMATOL, V171, P638, DOI 10.1111/bjh.13641; ASHCROFT MT, 1976, LANCET, V2, P784; ASHCROFT MT, 1976, BRIT MED J, V1, P1371, DOI 10.1136/bmj.1.6022.1371; ASHCROFT MT, 1978, ARCH DIS CHILD, V53, P596, DOI 10.1136/adc.53.7.596; ATLAS SA, 1974, JAMA-J AM MED ASSOC, V229, P1078; Austin H, 2007, BLOOD, V110, P908, DOI 10.1182/blood-2006-11-057604; BALGIR RS, 1993, MAN INDIA, V73, P363; Barmate N, 2010, MEDICO LEGAL UPDATE, V10, P82; Beachum L., 2016, WASHINGTON POST; Bello NA, 2017, BLOOD, V129, P799, DOI 10.1182/blood-2016-08-705541; Benson JM, 2010, SEMIN PERINATOL, V34, P134, DOI 10.1053/j.semperi.2009.12.006; Bonham VL, 2010, NEW ENGL J MED, V363, P997, DOI 10.1056/NEJMp1007639; BOWMAN JE, 1977, PHYLON, V38, P117, DOI 10.2307/274676; BOWMAN JE, 1972, J AMER MED ASSOC, V222, P1650, DOI 10.1001/jama.1972.03210130042017; CASTRO O, 1987, GENET EPIDEMIOL, V4, P307, DOI 10.1002/gepi.1370040409; Caughey MC, 2014, STROKE, V45, P2863, DOI 10.1161/STROKEAHA.114.006110; Derebail VK, 2014, J AM SOC NEPHROL, V25, P819, DOI 10.1681/ASN.2013060575; Derebail VK, 2010, J AM SOC NEPHROL, V21, P413, DOI 10.1681/ASN.2009070705; Deuster PA, 2013, EUR J APPL PHYSIOL, V113, P1997, DOI 10.1007/s00421-013-2622-y; Djaiani GN, 1999, ANESTH ANALG, V89, P598, DOI 10.1097/00000539-199909000-00010; Dueker ND, 2017, ETHNIC DIS, V27, P11, DOI 10.18865/ed.27.1.11; Etyang AO, 2018, AM J EPIDEMIOL, V187, P199, DOI 10.1093/aje/kwx232; Folsom AR, 2015, J THROMB HAEMOST, V13, P2, DOI 10.1111/jth.12787; Folsom AR, 2015, THROMB RES, V136, P781, DOI 10.1016/j.thromres.2015.08.013; FREIREMAIA N, 1981, HUM HERED, V31, P70, DOI 10.1159/000153180; Goldsmith JC, 2012, AM J HEMATOL, V87, P340, DOI 10.1002/ajh.22271; GOZAL D, 1994, J PEDIATR-US, V124, P211, DOI 10.1016/S0022-3476(94)70305-1; Grant AM, 2011, AM J PREV MED, V41, pS435, DOI 10.1016/j.amepre.2011.09.012; HELLER P, 1979, NEW ENGL J MED, V300, P1001, DOI 10.1056/NEJM197905033001801; Hicks PJ, 2011, KIDNEY INT, V80, P1339, DOI 10.1038/ki.2011.286; Hyacinth HI, 2018, JAMA NEUROL, V75, P802, DOI 10.1001/jamaneurol.2018.0571; Jordan LB, 2011, AM J PREV MED, V41, pS406, DOI 10.1016/j.amepre.2011.09.014; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; KRAMER MS, 1978, NEW ENGL J MED, V299, P686, DOI 10.1056/NEJM197809282991303; Liem RI, 2017, BLOOD, V129, P723, DOI 10.1182/blood-2016-07-727719; LONSDORFER A, 1989, CLIN CHIM ACTA, V181, P239, DOI 10.1016/0009-8981(89)90229-5; MCCORMACK MK, 1975, PEDIATRICS, V56, P1021; Mukendi K, 2015, CARDIOVASC J AFR, V26, P125, DOI 10.5830/CVJA-2014-076; NAGHMAEREHAN, 1981, CLIN PEDIATR, V20, P705, DOI 10.1177/000992288102001103; Naik RP, 2017, J AM SOC NEPHROL, V28, P2180, DOI 10.1681/ASN.2016101086; Naik RP, 2016, BLOOD, V127, P2261, DOI 10.1182/blood-2016-01-694422; Naik RP, 2015, HEMATOL-AM SOC HEMAT, P160, DOI 10.1182/asheducation-2015.1.160; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Nasrullah A, 1997, AM J OPHTHALMOL, V123, P783, DOI 10.1016/S0002-9394(14)71127-4; Nelson DA, 2016, NEW ENGL J MED, V375, P435, DOI 10.1056/NEJMoa1516257; Ojodu J, 2014, MMWR-MORBID MORTAL W, V63, P1155; OLI JM, 1985, TROP GEOGR MED, V37, P309; Oli JM, 2004, DIABETIC MED, V21, P483, DOI 10.1111/j.1464-5491.2004.1134.x; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Qamra S, 2011, ANN HUM BIOL, V38, P685, DOI 10.3109/03014460.2011.608378; STARK AD, 1980, INT J EPIDEMIOL, V9, P325, DOI 10.1093/ije/9.4.325; STATIUSVANEPS LW, 1970, LANCET, V1, P450; Stein Rob, 2010, WASHINGTON POST; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Tsaras G, 2009, AM J MED, V122, P507, DOI 10.1016/j.amjmed.2008.12.020; Viswanathan M, 2012, J CLIN EPIDEMIOL, V65, P163, DOI 10.1016/j.jclinepi.2011.05.008; Westerman MP, 2002, AM J HEMATOL, V69, P89, DOI 10.1002/ajh.10021; World Health Organization, 2010, SICKL CELL DIS STRAT	63	51	52	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					619	+		10.7326/M18-1161	http://dx.doi.org/10.7326/M18-1161			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4UP	30383109	Green Accepted			2022-12-28	WOS:000449399700005
J	Voelker, R				Voelker, Rebecca			Test Detects One in a Million Cancer Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1746	1746		10.1001/jama.2018.16483	http://dx.doi.org/10.1001/jama.2018.16483			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398585				2022-12-28	WOS:000449461800007
J	Yano, Y; Reis, JP; Colangelo, LA; Shimbo, D; Viera, AJ; Allen, NB; Gidding, SS; Bress, AP; Greenland, P; Muntner, P; Lloyd-Jones, DM				Yano, Yuichiro; Reis, Jared P.; Colangelo, Laura A.; Shimbo, Daichi; Viera, Anthony J.; Allen, Norrina B.; Gidding, Samuel S.; Bress, Adam P.; Greenland, Philip; Muntner, Paul; Lloyd-Jones, Donald M.			Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERY RISK DEVELOPMENT; MIDDLE-AGE; DISEASE; HYPERTENSION; MORTALITY; IMPACT; DEFINITIONS; PREVENTION; COMMITTEE; STROKE	IMPORTANCE Little is known regarding the association between level of blood pressure (BP) in young adulthood and cardiovascular disease (CVD) events by middle age. OBJECTIVE To assess whether young adults who developed hypertension, defined by the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline, before age 40 years have higher risk for CVD events compared with those who maintained normal BP. DESIGN, SETTING, AND PARTICIPANTS Analyses were conducted in the prospective cohort Coronary Artery Risk Development in Young Adults (CARDIA) study, started in March 1985. CARDIA enrolled 5115 African American and white participants aged 18 to 30 years from 4 US field centers (Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California). Outcomes were available through August 2015. EXPOSURES Using the highest BP measured from the first examination to the examination closest to, but not after, age 40 years, each participant was categorized as having normal BP (untreated systolic BP[SBP]<120 mm Hg and diastolic BP[DBP]<80 mm Hg; n = 2574); elevated BP(untreated SBP 120-129 mm Hg and DBP<80 mm Hg; n = 445); stage 1 hypertension (untreated SBP 130-139 mm Hg or DBP 80-89 mm Hg; n = 1194); or stage 2 hypertension (SBP >= 140 mm Hg, DBP >= 90 mm Hg, or taking antihypertensive medication; n = 638). MAIN OUTCOMES AND MEASURES CVD events: fatal and nonfatal coronary heart disease (CHD), heart failure, stroke, transient ischemic attack, or intervention for peripheral artery disease (PAD). RESULTS The final cohort included 4851 adults (mean age when follow-up for outcomes began, 35.7 years [SD, 3.6]; 2657 women [55%]; 2441 African American [50%]; 206 taking antihypertensive medication [4%]). Over a median follow-up of 18.8 years, 228 incident CVD events occurred (CHD, 109; stroke, 63; heart failure, 48; PAD, 8). CVD incidence rates for normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension were 1.37 (95% CI, 1.07-1.75), 2.74 (95% CI, 1.78-4.20), 3.15 (95% CI, 2.47-4.02), and 8.04 (95% CI, 6.45-10.03) per 1000 person-years, respectively. After multivariable adjustment, hazard ratios for CVD events for elevated BP, stage 1 hypertension, and stage 2 hypertension vs normal BP were 1.67 (95% CI, 1.01-2.77), 1.75 (95% CI, 1.22-2.53), and 3.49 (95% CI, 2.42-5.05), respectively. CONCLUSIONS AND RELEVANCE Among young adults, those with elevated blood pressure, stage 1 hypertension, and stage 2 hypertension before age 40 years, as defined by the blood pressure classification in the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines, had significantly higher risk for subsequent cardiovascular disease events compared with those with normal blood pressure before age 40 years. The ACC/AHA blood pressure classification system may help identify young adults at higher risk for cardiovascular disease events.	[Yano, Yuichiro] Duke Univ, Dept Community & Family Med, 2200 W Main St,Erwin Sq Bldg,Suite 600, Durham, NC 27705 USA; [Reis, Jared P.] NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Colangelo, Laura A.; Allen, Norrina B.; Greenland, Philip; Lloyd-Jones, Donald M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Shimbo, Daichi] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Viera, Anthony J.] Duke Univ, Dept Community & Family Med, Durham, NC USA; [Gidding, Samuel S.] Alfred I DuPont Hosp Children, Nemours Cardiac Ctr, Wilmington, DE USA; [Bress, Adam P.] Univ Utah, Dept Populat Hlth Sci, Div Hlth Syst Innovat & Res, Salt Lake City, UT USA; [Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwestern University; Feinberg School of Medicine; Columbia University; Duke University; Nemours Alfred I. duPont Hospital for Children; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham	Yano, Y (corresponding author), Duke Univ, Dept Community & Family Med, 2200 W Main St,Erwin Sq Bldg,Suite 600, Durham, NC 27705 USA.	yyano@jichi.jp	Greenland, Philip/ABD-5528-2021	Allen, Norrina/0000-0002-6993-4384; Lloyd-Jones, Donald/0000-0003-0847-6110; Gidding, Samuel/0000-0002-8557-7225	NHLBI [AG0005, HHSN268201300025C, HHSN268201300026C, K24-HL125704]; University of Alabama at Birmingham; Northwestern University [HHSN268201300027C]; University of Minnesota [HHSN268201300028C]; Kaiser Foundation Research Institute [HHSN268201300029C]; Johns Hopkins University School of Medicine [HHSN268200900041C]; National Institute of General Medical Sciences of the NIH [P20GM104357]; American Heart Association [15SFRN2390002]; Intramural Research Program of the National Institute on Aging (NIA); NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham; Northwestern University; University of Minnesota(University of Minnesota System); Kaiser Foundation Research Institute; Johns Hopkins University School of Medicine(Johns Hopkins University); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) was conducted and supported by grants HHSN268201300025C and HHSN268201300026C from NHLBI in collaboration with the University of Alabama at Birmingham, HHSN268201300027C from Northwestern University, HHSN268201300028C from the University of Minnesota, HHSN268201300029C from the Kaiser Foundation Research Institute, HHSN268200900041C from Johns Hopkins University School of Medicine, P20GM104357 from the National Institute of General Medical Sciences of the NIH (Dr Yano), 15SFRN2390002 from the American Heart Association (Dr Muntner), K24-HL125704 from NHLBI (Dr Shimbo), and by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Carson AP, 2013, HYPERTENSION, V62, P1015, DOI 10.1161/HYPERTENSIONAHA.113.01539; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Domanski M, 2002, JAMA-J AM MED ASSOC, V287, P2677, DOI 10.1001/jama.287.20.2677; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray L, 2011, J AM COLL CARDIOL, V58, P2396, DOI 10.1016/j.jacc.2011.07.045; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Jacobs DR, 2012, HYPERTENSION, V59, P219, DOI 10.1161/HYPERTENSIONAHA.111.184101; Liu K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002275; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Muntner P, 2018, J AM COLL CARDIOL, V71, P109, DOI 10.1016/j.jacc.2017.10.073; National Heart Lung and Blood Institute, CARDIA COR ART RISK; PAFFENBARGER RS, 1971, AM J EPIDEMIOL, V94, P524, DOI 10.1093/oxfordjournals.aje.a121351; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Society of Actuaries and Association of Life Insurance Medical Directors of America, 1980, BLOOD PRESS STUD 197, V7979; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Whelton PK, 2018, HYPERTENSION, V71, P1269, DOI 10.1161/HYP.0000000000000066; Yano Y, 2017, JAMA CARDIOL, V2, P381, DOI 10.1001/jamacardio.2016.5678; Yano Y, 2015, J AM COLL CARDIOL, V65, P327, DOI 10.1016/j.jacc.2014.10.060; Zanchetti A, 2015, CIRC RES, V116, P1058, DOI 10.1161/CIRCRESAHA.116.303641	30	166	170	5	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1774	1782		10.1001/jama.2018.13551	http://dx.doi.org/10.1001/jama.2018.13551			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398601	Bronze, Green Published			2022-12-28	WOS:000449461800015
J	Chen, GF				Chen, Guifen			Identifying posture cells in the brain The parietal cortex represents body posture and other factors in spatial awareness	SCIENCE			English	Editorial Material							POSTERIOR; SPACE; RAT; NAVIGATION; NEURONS		[Chen, Guifen] UCL, Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Chen, GF (corresponding author), UCL, Neurosci Physiol & Pharmacol, London, England.	guifen.chen@ucl.ac.uk	Chen, Guifen/AAQ-5044-2020	Chen, Guifen/0000-0002-5459-660X				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Bicanski A, 2018, ELIFE, V7, DOI 10.7554/eLife.33752; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Mimica B, 2018, SCIENCE, V362, P584, DOI 10.1126/science.aau2013; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; Wilson JJ, 2018, CURR BIOL, V28, P1744, DOI 10.1016/j.cub.2018.04.021	14	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		520	521		10.1126/science.aav3819	http://dx.doi.org/10.1126/science.aav3819			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385559	Green Submitted			2022-12-28	WOS:000450460000021
J	Laursen, NS; Friesen, RHE; Zhu, XY; Jongeneelen, M; Blokland, S; Vermond, J; van Eijgen, A; Tang, C; van Diepen, H; Obmolova, G; Kolfschoten, MV; Zuijdgeest, D; Straetemans, R; Hoffman, RMB; Nieusma, T; Pallesen, J; Turner, HL; Bernard, SM; Ward, AB; Luo, JQ; Poon, LLM; Tretiakova, AP; Wilson, JM; Limberis, MP; Vogels, R; Brandenburg, B; Kolkman, JA; Wilson, IA				Laursen, Nick S.; Friesen, Robert H. E.; Zhu, Xueyong; Jongeneelen, Mandy; Blokland, Sven; Vermond, Jan; van Eijgen, Alida; Tang, Chan; van Diepen, Harry; Obmolova, Galina; Kolfschoten, Marijn van der Neut; Zuijdgeest, David; Straetemans, Roel; Hoffman, Ryan M. B.; Nieusma, Travis; Pallesen, Jesper; Turner, Hannah L.; Bernard, Steffen M.; Ward, Andrew B.; Luo, Jinquan; Poon, Leo L. M.; Tretiakova, Anna P.; Wilson, James M.; Limberis, Maria P.; Vogels, Ronald; Brandenburg, Boerries; Kolkman, Joost A.; Wilson, Ian A.			Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin	SCIENCE			English	Article							A VIRUSES; NEUTRALIZING ANTIBODIES; ELECTRON-MICROSCOPE; IMAGES; RECOGNITION; REFINEMENT; EFFICIENT; SELECTION; VACCINES; INSIGHTS	Broadly neutralizing antibodies against highly variable pathogens have stimulated the design of vaccines and therapeutics. We report the use of diverse camelid single-domain antibodies to influenza virus hemagglutinin to generate multidomain antibodies with impressive breadth and potency. Multidomain antibody MD3606 protects mice against influenza A and B infection when administered intravenously or expressed locally from a recombinant adeno-associated virus vector. Crystal and single-particle electron microscopy structures of these antibodies with hemagglutinins from influenza A and B viruses reveal binding to highly conserved epitopes. Collectively, our findings demonstrate that multidomain antibodies targeting multiple epitopes exhibit enhanced virus cross-reactivity and potency. In combination with adeno-associated virus-mediated gene delivery, they may provide an effective strategy to prevent infection with influenza virus and other highly variable pathogens.	[Laursen, Nick S.; Zhu, Xueyong; Hoffman, Ryan M. B.; Nieusma, Travis; Pallesen, Jesper; Turner, Hannah L.; Bernard, Steffen M.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Friesen, Robert H. E.; Obmolova, Galina; Luo, Jinquan] Janssen Res & Dev, Spring House, PA 19002 USA; [Jongeneelen, Mandy; Blokland, Sven; Tang, Chan; Kolfschoten, Marijn van der Neut; Zuijdgeest, David; Vogels, Ronald; Brandenburg, Boerries] Janssen Vaccines & Prevent, Archimedesweg 4-6, NL-2333 CN Leiden, Netherlands; [Vermond, Jan; van Eijgen, Alida; van Diepen, Harry] Janssen Prevent Ctr, Archimedesweg 6, NL-2333 CN Leiden, Netherlands; [Straetemans, Roel] Janssen Pharmaceut Co Johnson & Johnson, Quantitat Sci, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Poon, Leo L. M.] Univ Hong Kong, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Poon, Leo L. M.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Tretiakova, Anna P.; Wilson, James M.; Limberis, Maria P.] Univ Penn, Dept Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [Kolkman, Joost A.] Janssen Infect Dis, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Laursen, Nick S.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark; [Friesen, Robert H. E.] Ablynx, Technol Pk 21, B-9052 Zwijnaarde, Belgium; [Tretiakova, Anna P.] Pfizer, Rare Dis Res Unit, 610 Main St, Cambridge, MA 02139 USA	Scripps Research Institute; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Hong Kong; University of Hong Kong; University of Pennsylvania; Scripps Research Institute; Aarhus University; Pfizer	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Kolkman, JA (corresponding author), Janssen Infect Dis, Turnhoutseweg 30, B-2340 Beerse, Belgium.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jkolkman@its.jnj.com; wilson@scripps.edu	Poon, Leo/AAP-6887-2020; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Zhu, Xueyong/ABE-3068-2021; Wilson, James M/F-9220-2011; Laursen, Nick Stub/Q-5051-2017; Poon, Leo/C-4382-2009	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Wilson, James M/0000-0002-9630-3131; Laursen, Nick Stub/0000-0002-7512-2649; Brandenburg, Boerries/0000-0002-5025-3802; Vermond, Jan/0000-0002-5766-8912; Poon, Leo/0000-0002-9101-7953; van Diepen, Harry/0000-0002-4822-7445	NIH [R56 AI117675, R56 AI127371]; Janssen; Defense Advanced Research Projects Agency, Department of Defense [64047-LS-DRP. 02]; Theme-based Research Scheme, Research Grants Council of the Hong Kong [T11-705/14N]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104, P41GM103393]; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R56AI127371, R56AI117675, T32AI007354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Defense Advanced Research Projects Agency, Department of Defense(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Theme-based Research Scheme, Research Grants Council of the Hong Kong; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by NIH grants R56 AI117675 and R56 AI127371 (to I.A.W.), by a grant from Janssen, and in part by the Defense Advanced Research Projects Agency, Department of Defense (grant 64047-LS-DRP. 02 to J.M.W.) and the Theme-based Research Scheme, Research Grants Council of the Hong Kong (ref. T11-705/14N). X-ray diffraction data were collected at the Advanced Photon Source (APS) beamlines 23ID-B, 23ID-D, and 17-ID and at the Stanford Synchrotron Radiation Lightsource (SSRL) BL12-2. Use of the APS was supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. GM/CA CAT is funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIGMS (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS, NIAID, or NIH.	Adam VS, 2014, CLIN VACCINE IMMUNOL, V21, P1528, DOI 10.1128/CVI.00572-14; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krah S, 2016, IMMUNOPHARM IMMUNOT, V38, P21, DOI 10.3109/08923973.2015.1102934; Kramer RA, 2005, EUR J IMMUNOL, V35, P2131, DOI 10.1002/eji.200526134; Kramer RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng058; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Limberis MP, 2006, P NATL ACAD SCI USA, V103, P12993, DOI 10.1073/pnas.0601433103; Limberis MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006299; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popp Maximilian Wei-Lin, 2015, Methods Mol Biol, V1266, P185, DOI 10.1007/978-1-4939-2272-7_13; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2014, J VIROL, V88, P13580, DOI 10.1128/JVI.02289-14; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	46	101	107	6	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		598	+		10.1126/science.aaq0620	http://dx.doi.org/10.1126/science.aaq0620			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385580	Green Accepted			2022-12-28	WOS:000450460000049
J	Woolhouse, M				Woolhouse, Mark			Sources of human viruses Machine learning predicts the hosts and vectors of RNA viruses that can infect humans	SCIENCE			English	Editorial Material									[Woolhouse, Mark] Univ Edinburgh, Ashworth Labs, Usher Inst, Edinburgh EH9 3FL, Midlothian, Scotland	University of Edinburgh	Woolhouse, M (corresponding author), Univ Edinburgh, Ashworth Labs, Usher Inst, Edinburgh EH9 3FL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk		Woolhouse, Mark/0000-0003-3765-8167				[Anonymous], 2009, SUSTAINING GLOBAL SU; Babayan SA, 2018, SCIENCE, V362, P577, DOI 10.1126/science.aap9072; Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463; Geoghegan JL, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170189; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w; Kim B, 2017, J BIOINF COMPUT BIOL, V15, DOI 10.1142/S0219720016500244; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; WHO, 2018, RES DEV BLUEPR ACT P; Woolhouse MEJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.17; Woolhouse MEJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab0191; Woolhouse MEJ, 2017, BIOCHEMIST, V39, P8	15	2	2	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		524	525		10.1126/science.aav4265	http://dx.doi.org/10.1126/science.aav4265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7KM	30385562				2022-12-28	WOS:000450460000024
J	Hurley, R				Hurley, Richard			Medical cannabis: "restrictive" guidance lets patients down, say campaigners	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HAWKES N, 2018, BMJ-BRIT MED J, V362, P76556, DOI DOI 10.1136/BMJ.K2957; Iacobucci G, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4354; Smyth C, 2018, TIMES	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2018	363								k4654	10.1136/bmj.k4654	http://dx.doi.org/10.1136/bmj.k4654			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QG	30385431				2022-12-28	WOS:000449565500016
J	Sade-Feldman, M; Yizhak, K; Bjorgaard, SL; Ray, JP; de Boer, CG; Jenkins, RW; Lieb, DJ; Chen, JH; Frederick, DT; Barzily-Rokni, M; Freeman, SS; Reuben, A; Hoover, PJ; Villani, AC; Ivanova, E; Portell, A; Lizotte, PH; Aref, AR; Eliane, JP; Hammond, MR; Vitzthum, H; Blackmon, SM; Li, B; Gopalakrishnan, V; Reddy, SM; Cooper, ZA; Paweletz, CP; Barbie, DA; Stemmer-Rachamimov, A; Flaherty, KT; Wargo, JA; Boland, GM; Sullivan, RJ; Getz, G; Hacohen, N				Sade-Feldman, Moshe; Yizhak, Keren; Bjorgaard, Stacey L.; Ray, John P.; de Boer, Carl G.; Jenkins, Russell W.; Lieb, David J.; Chen, Jonathan H.; Frederick, Dennie T.; Barzily-Rokni, Michal; Freeman, Samuel S.; Reuben, Alexandre; Hoover, Paul J.; Villani, Alexandra-Chloe; Ivanova, Elena; Portell, Andrew; Lizotte, Patrick H.; Aref, Amir R.; Eliane, Jean-Pierre; Hammond, Marc R.; Vitzthum, Hans; Blackmon, Shauna M.; Li, Bo; Gopalakrishnan, Vancheswaran; Reddy, Sangeetha M.; Cooper, Zachary A.; Paweletz, Cloud P.; Barbie, David A.; Stemmer-Rachamimov, Anat; Flaherty, Keith T.; Wargo, Jennifer A.; Boland, Genevieve M.; Sullivan, Ryan J.; Getz, Gad; Hacohen, Nir			Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma	CELL			English	Article							PD-1 BLOCKADE; ANTITUMOR-ACTIVITY; CLINICAL-RESPONSE; CTLA-4 BLOCKADE; READ ALIGNMENT; TUMOR-CELLS; EXPRESSION; ANTI-PD-1; PROMOTES; LYMPHOCYTES	Treatment of cancer has been revolutionized by immune checkpoint blockade therapies. Despite the high rate of response in advanced melanoma, the majority of patients succumb to disease. To identify factors associated with success or failure of checkpoint therapy, we profiled transcriptomes of 16,291 individual immune cells from 48 tumor samples of melanoma patients treated with checkpoint inhibitors. Two distinct states of CD8(+) T cells were defined by clustering and associated with patient tumor regression or progression. A single transcription factor, TCF7, was visualized within CD8(+) T cells in fixed tumor samples and predicted positive clinical outcome in an independent cohort of checkpoint-treated patients. We delineated the epigenetic landscape and clonality of these T cell states and demonstrated enhanced antitumor immunity by targeting novel combinations of factors in exhausted cells. Our study of immune cell transcriptomes from tumors demonstrates a strategy for identifying predictors, mechanisms, and targets for enhancing checkpoint immunotherapy.	[Sade-Feldman, Moshe; Bjorgaard, Stacey L.; Jenkins, Russell W.; Frederick, Dennie T.; Barzily-Rokni, Michal; Villani, Alexandra-Chloe; Hammond, Marc R.; Vitzthum, Hans; Blackmon, Shauna M.; Flaherty, Keith T.; Boland, Genevieve M.; Sullivan, Ryan J.; Getz, Gad; Hacohen, Nir] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA; [Sade-Feldman, Moshe; Yizhak, Keren; Bjorgaard, Stacey L.; Ray, John P.; de Boer, Carl G.; Lieb, David J.; Chen, Jonathan H.; Freeman, Samuel S.; Hoover, Paul J.; Villani, Alexandra-Chloe; Li, Bo; Getz, Gad; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sade-Feldman, Moshe; Jenkins, Russell W.; Villani, Alexandra-Chloe; Ivanova, Elena; Portell, Andrew; Lizotte, Patrick H.; Aref, Amir R.; Paweletz, Cloud P.; Barbie, David A.; Flaherty, Keith T.; Sullivan, Ryan J.; Hacohen, Nir] HMS, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Jenkins, Russell W.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chen, Jonathan H.; Eliane, Jean-Pierre; Stemmer-Rachamimov, Anat; Getz, Gad] HMS, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Freeman, Samuel S.] HMS, Dept Biomed Informat, Boston, MA USA; [Reuben, Alexandre; Gopalakrishnan, Vancheswaran; Reddy, Sangeetha M.; Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Hoover, Paul J.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Ivanova, Elena; Portell, Andrew; Lizotte, Patrick H.; Aref, Amir R.; Paweletz, Cloud P.] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02115 USA; [Li, Bo] Harvard Med Sch, Dept Virol, Boston, MA USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Boland, Genevieve M.] HMS, Massachusetts Gen Hosp, Dept Surg, Boston, MA USA; [Getz, Gad] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Getz, G; Hacohen, N (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02115 USA.; Getz, G; Hacohen, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Hacohen, N (corresponding author), HMS, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA.; Getz, G (corresponding author), HMS, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA.; Getz, G (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	gadgetz@broadinstitute.org; nhacohen@mgh.harvard.edu	Gopalakrishnan, Vancheswaran/S-9550-2019; Reddy, Sangeetha/GNZ-8658-2022; Boland, Genevieve/AAP-2767-2021; Ray, John/F-3187-2015	Gopalakrishnan, Vancheswaran/0000-0002-8704-035X; de Boer, Carl/0000-0001-8935-5921; Freeman, Samuel/0000-0001-8285-0057; Ivanova, Elena/0000-0002-5069-4974; Ray, John/0000-0001-7294-4260; Cooper, Zachary/0000-0003-1059-0940; Portell, Andrew/0000-0002-0757-909X; Reddy, Sangeetha/0000-0002-8401-1481	NIH Shared Instrumentation program [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]; Broad Next-10; Cancer Research Institute (Clinic and Laboratory Integration Program); Adelson Medical Research Foundation; Sanofi; Arthur; Sandra; Sarah Irving; MGH; NIH/NHGRI [5U54HG003067]; NIH/NCI [R01CA208756, U54CA224068]; Institute for Medical Research Israel-Canada; Tosteson & Fund for Medical Discovery fellowships; Broad-ISF fellowship; NIH [F32AI129249, 1T32CA207021-01]; John R. Svenson Fellowship; NCI [R01 CA190394-01, U01 CA214381]; Expect Miracles Foundation; Weizmann award for Women in Science; NATIONAL CANCER INSTITUTE [R01CA190394, R01CA208756, U01CA214381, T32CA207021, U54CA224068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI129249] Funding Source: NIH RePORTER	NIH Shared Instrumentation program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Next-10; Cancer Research Institute (Clinic and Laboratory Integration Program); Adelson Medical Research Foundation; Sanofi; Arthur; Sandra; Sarah Irving; MGH; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute for Medical Research Israel-Canada; Tosteson & Fund for Medical Discovery fellowships; Broad-ISF fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John R. Svenson Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Expect Miracles Foundation; Weizmann award for Women in Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Genomics Platform of the Broad Institute of Harvard and MIT for the whole-exome sequencing performed in this study. All cytometric findings reported here were performed in the MGH Department of Pathology Flow and Image Cytometry Research Core, which obtained support from the NIH Shared Instrumentation program with grants 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1. Additional thanks to Natasha Mathur of the Belfer Center for applied Cancer Sciences for assistance with immunofluorescence staining. The research was supported by grants from Broad Next-10 (N.H.), Cancer Research Institute (Clinic and Laboratory Integration Program, N.H.), Adelson Medical Research Foundation (N.H), Sanofi (N.H.), the David P. Ryan, MD, Chair funded by a gift from Arthur, Sandra, and Sarah Irving (N.H.), the Paul C. Zamecnick, MD, Chair in Oncology at MGH (G.G.), NIH/NHGRI (5U54HG003067, PIs: Stacey Gabriel and Eric S. Lander), NIH/NCI (R01CA208756, PI: N.H.; U54CA224068, PIs: Ryan Corcoran and K.T.F.). We also thank the following grants for their support: Institute for Medical Research Israel-Canada (M.S.-F.), Tosteson & Fund for Medical Discovery fellowships (M.S.-F.), the Broad-ISF fellowship (K.Y.) Weizmann award for Women in Science (K.Y.), NIH award number F32AI129249 (J.P.R.), 1T32CA207021-01 (J.H.C.), Robert A. and Renee E. Belfer (R.W.J.), John R. Svenson Fellowship (R.W.J.), NCI-R01 CA190394-01 (D.A.B.), NCI-U01 CA214381 (D.A.B., R.W.J.), and the Expect Miracles Foundation (C.P.P.).	Allard B, 2013, CLIN CANCER RES, V19, P5626, DOI 10.1158/1078-0432.CCR-13-0545; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bastid J, 2015, CANCER IMMUNOL RES, V3, P254, DOI 10.1158/2326-6066.CIR-14-0018; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Canale FP, 2018, CANCER RES, V78, P115, DOI 10.1158/0008-5472.CAN-16-2684; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hurton LV, 2016, P NATL ACAD SCI USA, V113, pE7788, DOI 10.1073/pnas.1610544113; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mami-Chouaib F, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0399-6; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Shum T, 2017, CANCER DISCOV, V7, P1238, DOI 10.1158/2159-8290.CD-17-0538; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Waugh KA, 2016, J IMMUNOL, V197, P1477, DOI 10.4049/jimmunol.1600589; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Young A, 2014, CANCER DISCOV, V4, P879, DOI 10.1158/2159-8290.CD-14-0341; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	65	736	749	18	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					998	+		10.1016/j.cell.2018.10.038	http://dx.doi.org/10.1016/j.cell.2018.10.038			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388456	Green Accepted, Bronze			2022-12-28	WOS:000449100600014
J	Moberly, T				Moberly, Tom			THE BIG PICTURE Protesters warn of Brexit effects on NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2018	363								k4470	10.1136/bmj.k4470	http://dx.doi.org/10.1136/bmj.k4470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PQ	30355570				2022-12-28	WOS:000448895300015
J	Gurol-Urganci, I; Geary, RS; Mamza, JB; Duckett, J; El-Hamamsy, D; Dolan, L; Tincello, DG; van der Meulen, J				Gurol-Urganci, IPek; Geary, Rebecca S.; Mamza, Jil B.; Duckett, Jonathan; El-Hamamsy, Dina; Dolan, Lucia; Tincello, Douglas G.; van der Meulen, Jan			Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PELVIC ORGAN PROLAPSE; SURGICAL-PROCEDURES; TUTORIAL	IMPORTANCE There is concern about outcomes of midurethral mesh sling insertion for women with stress urinary incontinence. However, there is little evidence on long-term outcomes. OBJECTIVE To examine long-term mesh removal and reoperation rates in women who had a midurethral mesh sling insertion for stress urinary incontinence. DESIGN, SETTING, AND PARTICIPANTS This population-based retrospective cohort study included 95 057 women aged 18 years or older who had a first-ever midurethral mesh sling insertion for stress urinary incontinence in the National Health Service hospitals in England between April 1, 2006, and December 31, 2015. Women were followed up until April 1, 2016. EXPOSURES Patient and hospital factors and retropubic or transobturator mesh sling insertions. MAIN OUTCOMES AND MEASURES The primary outcome was the risk of midurethral mesh sling removal (partial or total) and secondary outcomes were reoperation for stress urinary incontinence and any reoperation including mesh removal, calculated with death as competing risk. A multivariable Fine-Gray model was used to calculate subdistribution hazard ratios as estimates of relative risk. RESULTS The study population consisted of 95 057 women (median age, 51 years; interquartile range, 44-61 years) with first midurethral mesh sling insertion, including 60 194 with retropubic insertion and 34 863 with transobturator insertion. The median follow-up time was 5.5 years (interquartile range, 3.2-7.5 years). The rate of midurethral mesh sling removal was 1.4% (95% CI, 1.3%-1.4%) at 1 year, 2.7% (95% CI, 2.6%-2.8%) at 5 years, and 3.3% (95% CI, 3.2%-3.4%) at 9 years. Risk of removal declined with age. The 9-year removal risk after transobturator insertion (2.7% [95% CI, 2.4%-2.9%]) was lower than the risk after retropubic insertion (3.6% [95% CI, 3.5%-3.8%]; subdistribution hazard ratio, 0.72 [95% CI, 0.62-0.84]). The rate of reoperation for stress urinary incontinence was 1.3% (95% CI, 1.3%-1.4%) at 1 year, 3.5% (95% CI, 3.4%-3.6%) at 5 years, and 4.5% (95% CI, 4.3%-4.7%) at 9 years. The rate of any reoperation, including mesh removal, was 2.6% (95% CI, 2.5%-2.7%) at 1 year, 5.5% (95% CI, 5.4%-5.7%) at 5 years, and 6.9% (95% CI, 6.7%-7.1%) at 9 years. CONCLUSIONS AND RELEVANCE Among women undergoing midurethral mesh sling insertion, the rate of mesh sling removal at 9 years was estimated as 3.3%. These findings may guide women and their surgeons when making decisions about surgical treatment of stress urinary incontinence.	[Gurol-Urganci, IPek; Geary, Rebecca S.; Mamza, Jil B.; van der Meulen, Jan] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England; [Gurol-Urganci, IPek; Geary, Rebecca S.; Mamza, Jil B.; van der Meulen, Jan] Royal Coll Obstetricians & Gynaecologists, Lindsay Stewart Ctr Audit & Clin Informat, London, England; [Duckett, Jonathan] Medway Hosp, Gillingham, Kent, England; [El-Hamamsy, Dina] Univ Hosp Leicester, Leicester Gen Hosp, Dept Obstet & Gynaecol, Leicester, Leics, England; [Dolan, Lucia] Belfast City Hosp, Dept Gynaecol, Lisburn Rd, Belfast, Antrim, North Ireland; [Tincello, Douglas G.] Univ Leicester, Coll Life Sci, Dept Hlth Sci, Leicester, Leics, England	University of London; London School of Hygiene & Tropical Medicine; Medway Maritime Hospital; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; Belfast City Hospital; University of Leicester	Gurol-Urganci, I (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	ipek.gurol@lshtm.ac.uk	El-Hamamsy, Dina/ABH-3367-2021; El-Hamamsy, Dina/GXG-3131-2022; Mamza, JB/GPG-1650-2022	El-Hamamsy, Dina/0000-0002-0257-533X; van der Meulen, Jan/0000-0002-9451-2335; Gurol-Urganci, Ipek/0000-0002-6517-3485	NIHR Health Services and Delivery Research Programme [14/70/162]; National Health Service's NIHR Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust	NIHR Health Services and Delivery Research Programme; National Health Service's NIHR Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust	This study was supported by a grant from the NIHR Health Services and Delivery Research Programme (14/70/162). Independent scientific review of the proposal has been undertaken by the NIHR. Dr van der Meulen was partly supported by the National Health Service's NIHR Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust. Hospital Episode Statistics data were made available by NHS Digital and reused with the permission of NHS Digital.	Aigmueller T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.010; [Anonymous], 2018, POSITION STATEMENT M; [Anonymous], 2017, MESH OV GROUP REP; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; British Society of Urogynaecology, ACCR UN STAND SERV P; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Commission on the Future of Health and Social Care in England, 2014, UK PRIV HLTH MARK; Coyne KS, 2012, EUR UROL, V61, P88, DOI 10.1016/j.eururo.2011.07.049; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ford AA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub4; Keltie K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11821-w; Keltie K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-126; Maggiore ULR, 2017, INT UROGYNECOL J, V28, P1119, DOI 10.1007/s00192-017-3275-x; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Morling JR, 2017, LANCET, V389, P629, DOI 10.1016/S0140-6736(16)32572-7; NHS,, OPCS CLASS INT PROC; NHS Digital, HOSP EP STAT HES; NHS Digital, 2008, RETR REV SURG UR PRO; NHS digital, 2018, HES DAT DICT ADM PAT; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Scottish Government, SCOTT IND REV US SAF; Siddiqui NY, 2014, INT UROGYNECOL J, V25, P863, DOI 10.1007/s00192-013-2276-7; StataCorp, 2013, STATA STAT SOFTW REL; UK Department for Communities and Local Government, 2015, ENGL IND DEPR; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; United States Food and Drug Administration, 2008, FDA PUBL HLTH NOT SE; US Food & Drug Administration, CONS SURG MESH SUI; Ward K, 2002, BMJ-BRIT MED J, V325, P67, DOI 10.1136/bmj.325.7355.67; World Health Organization, 1992, INT STAT CLASS DIS; Wu JM, 2014, OBSTET GYNECOL, V123, P1201, DOI 10.1097/AOG.0000000000000286	32	66	68	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1659	1669		10.1001/jama.2018.14997	http://dx.doi.org/10.1001/jama.2018.14997			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357298	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000448069100015
J	Rubin, R				Rubin, Rita			Rate of Severe Childbirth Complications Has Increased	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1630	1630		10.1001/jama.2018.16199	http://dx.doi.org/10.1001/jama.2018.16199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357280				2022-12-28	WOS:000448069100029
J	Doherty, M; Jenkins, W; Richardson, H; Sarmanova, A; Abhishek, A; Ashton, D; Barclay, C; Doherty, S; Duley, L; Hatton, R; Rees, F; Stevenson, M; Zhang, WY				Doherty, Michael; Jenkins, Wendy; Richardson, Helen; Sarmanova, Aliya; Abhishek, Abhishek; Ashton, Deborah; Barclay, Christine; Doherty, Sally; Duley, Lelia; Hatton, Rachael; Rees, Frances; Stevenson, Matthew; Zhang, Weiya			Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; AMERICAN-COLLEGE; GENERAL-PRACTICE; INCIDENT GOUT; MANAGEMENT; DISEASE; UK; RECOMMENDATIONS; COMORBIDITIES; POPULATION	Background In the UK, gout management is suboptimum, with only 40% of patients receiving urate-lowering therapy, usually without titration to achieve a target serum urate concentration. Nurses successfully manage many diseases in primary care. We compared nurse-led gout care to usual care led by general practitioners (GPs) for people in the community. Methods Research nurses were trained in best practice management of gout, including providing individualised information and engaging patients in shared decision making. Adults who had experienced a gout flare in the previous 12 months were randomly assigned 1: 1 to receive nurse-led care or continue with GP-led usual care. We assessed patients at baseline and after 1 and 2 years. The primary outcome was the percentage of participants who achieved serum urate concentrations less than 360 mu mol/L (6 mg/dL) at 2 years. Secondary outcomes were flare frequency in year 2, presence of tophi, quality of life, and cost per quality-adjusted life-year (QALY) gained. Risk ratios (RRs) and 95% CIs were calculated based on intention to treat with multiple imputation. This study is registered with www. ClinicalTrials. gov, number NCT01477346. Findings 517 patients were enrolled, of whom 255 were assigned nurse-led care and 262 usual care. Nurse-led care was associated with high uptake of and adherence to urate-lowering therapy. More patients receiving nurse-led care had serum urate concentrations less than 360 mu mol/L at 2 years than those receiving usual care (95% vs 30%, RR 3.18, 95% CI 2.42-4.18, p< 0.0001). At 2 years all secondary outcomes favoured the nurse-led group. The cost per QALY gained for the nurse-led intervention was 5066 pound at 2 years. Interpretation Nurse-led gout care is efficacious and cost-effective compared with usual care. Our findings illustrate the benefits of educating and engaging patients in gout management and reaffirm the importance of a treat-to-target urate-lowering treatment strategy to improve patient-centred outcomes. Copyright (c) 2018 The Author(s). Published by Elsevier Ltd.	[Doherty, Michael; Jenkins, Wendy; Richardson, Helen; Sarmanova, Aliya; Abhishek, Abhishek; Ashton, Deborah; Barclay, Christine; Doherty, Sally; Rees, Frances; Zhang, Weiya] Univ Nottingham, Sch Med, Div Rheumatol Orthopaed & Dermatol, Nottingham, England; [Duley, Lelia] Univ Nottingham, Sch Med, Nottingham Clin Trials Unit, Nottingham, England; [Hatton, Rachael; Stevenson, Matthew] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England	University of Nottingham; University of Nottingham; University of Sheffield	Doherty, M (corresponding author), City Hosp, Acad Rheumatol, Clinical Sci Bldg, Nottingham NG5 1PB, England.	michael.doherty@nottingham.ac.uk	Duley, Lelia/E-8107-2015; Sarmanova, Aliya/AAO-8078-2020	Duley, Lelia/0000-0001-6721-5178; Sarmanova, Aliya/0000-0001-8390-6876; Doherty, Michael/0000-0002-5763-8326; , Matt/0000-0002-3099-9877	Arthritis Research UK; Arthritis Research UK [19703]; Versus Arthritis [19703] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	Arthritis Research UK.; This work was supported by Arthritis Research UK [grant number 19703]. We thank members of the Nottingham Rheumatology Patient and Public Involvement group for advice during development of the study, the participating practices (appendix); Terence O'Neill, University of Manchester; George Nuki, University of Edinburgh; Edward Roddy, University of Keele; and Malcolm Coy for participation on the independent steering committee.	Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437; Chandratre P, 2013, RHEUMATOLOGY, V52, P2031, DOI 10.1093/rheumatology/ket265; Chhana A, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0762-4; Dalbeth N, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.126; Dehlin M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1211-y; Doherty M, 2012, ANN RHEUM DIS, V71, P1765, DOI 10.1136/annrheumdis-2012-201687; Fields TR, 2017, SEMIN ARTHRITIS RHEU, V46, P601, DOI 10.1016/j.semarthrit.2016.10.006; Goldfien R., 2016, PERM J, V20, P15, DOI [10.7812/TPP/15-234, DOI 10.7812/tpp/15-234]; Goldfien RD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003627; Harrold LR, 2013, RHEUMATOLOGY, V52, P1623, DOI 10.1093/rheumatology/ket158; Harrold LR, 2010, CHRONIC ILLN, V6, P263, DOI 10.1177/1742395310378761; Hirsch JD, 2010, PATIENT-RELAT OUTCOM, V1, P1, DOI 10.2147/PROM.S8310; Holland R, 2015, INTERN MED J, V45, P189, DOI 10.1111/imj.12661; Hui M, 2017, RHEUMATOLOGY, V56, pE1, DOI 10.1093/rheumatology/kex156; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kiltz U, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209467; Kuo CF, 2016, ANN RHEUM DIS, V75, P210, DOI 10.1136/annrheumdis-2014-206410; Kuo CF, 2015, RHEUMATOLOGY, V54, P2145, DOI 10.1093/rheumatology/kev246; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Kuo CF, 2014, JAMA-J AM MED ASSOC, V312, P2684, DOI 10.1001/jama.2014.14484; Lipworth W, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7459; Martinez-Gonzalez NA, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0049-8; National Insitute for Health and Care Excellence, 2013, PEGL TREAT SEV DEB C; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Rees F, 2013, ANN RHEUM DIS, V72, P826, DOI 10.1136/annrheumdis-2012-201676; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Roddy E, 2007, RHEUMATOLOGY, V46, P1441, DOI 10.1093/rheumatology/kem150; Roddy E, 2007, ANN RHEUM DIS, V66, P1311, DOI 10.1136/ard.2007.070755; Spencer K, 2012, ANN RHEUM DIS, V71, P1490, DOI 10.1136/annrheumdis-2011-200801; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	32	145	154	4	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1403	1412		10.1016/S0140-6736(18)32158-5	http://dx.doi.org/10.1016/S0140-6736(18)32158-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX5PD	30343856	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000447800900023
J	Irving, JCE				Irving, Jessica C. E.			Earth's soft heart	SCIENCE			English	Editorial Material							INNER-CORE; SHEAR		[Irving, Jessica C. E.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Irving, JCE (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	jirving@princeton.edu		Irving, Jessica C.E./0000-0002-0866-8246	NSF [EAR1644399, EAR1736046]	NSF(National Science Foundation (NSF))	Supported by NSF grants EAR1644399 and EAR1736046	Cao A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038342; Cormier VF, 2015, GEOPHYS RES LETT, V42, P7459, DOI 10.1002/2015GL065367; Deuss A, 2008, EARTH PLANET SC LETT, V268, P364, DOI 10.1016/j.epsl.2008.01.029; DZIEWONSKI AM, 1971, NATURE, V234, P465, DOI 10.1038/234465a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Koper KD, 2005, EARTH PLANET SC LETT, V237, P680, DOI 10.1016/j.epsl.2005.07.013; Lehmann I., 1936, PUBLICATIONS BUREAU, V14, P87; Li YG, 2018, EARTH PLANET SC LETT, V493, P118, DOI 10.1016/j.epsl.2018.04.013; Olson P, 2013, SCIENCE, V342, P431, DOI 10.1126/science.1243477; Pham TS, 2018, GEOPHYS RES LETT, V45, P3035, DOI 10.1002/2018GL077244; Shearer PM, 2011, GEOPHYS J INT, V185, P1379, DOI 10.1111/j.1365-246X.2011.05011.x; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; Tkalcic H, 2018, SCIENCE, V362, P329, DOI 10.1126/science.aau7649; Vocadlo L, 2015, TREATISE GEOPHYS, V2.06, P117, DOI DOI 10.1016/B978-0-444-53802-4.00032-4	14	0	0	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412					294	294		10.1126/science.aav2296	http://dx.doi.org/10.1126/science.aav2296			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337400				2022-12-28	WOS:000447680100029
J	Singh, V; Yeoh, BS; Chassaing, B; Xiao, X; Saha, P; Olvera, RA; Lapek, JD; Zhang, LM; Wang, WB; Hao, SJ; Flythe, MD; Gonzalez, DJ; Cani, PD; Conejo-Garcia, JR; Xiong, N; Kennett, MJ; Joe, B; Patterson, AD; Gewirtz, AT; Vijay-Kumar, M				Singh, Vishal; Yeoh, Beng San; Chassaing, Benoit; Xiao, Xia; Saha, Piu; Olvera, Rodrigo Aguilera; Lapek, John D., Jr.; Zhang, Limin; Wang, Wei-Bei; Hao, Sijie; Flythe, Michael D.; Gonzalez, David J.; Cani, Patrice D.; Conejo-Garcia, Jose R.; Xiong, Na; Kennett, Mary J.; Joe, Bina; Patterson, Andrew D.; Gewirtz, Andrew T.; Vijay-Kumar, Matam			Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer	CELL			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; METABOLIC SYNDROME; HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; RECEPTOR 5; MICE; PROTECTS; BACTERIA; COLITIS	Dietary soluble fibers are fermented by gut bacteria into short-chain fatty acids (SCFA), which are considered broadly health-promoting. Accordingly, consumption of such fibers ameliorates metabolic syndrome. However, incorporating soluble fiber inulin, but not insoluble fiber, into a compositionally defined diet, induced icteric hepatocellular carcinoma (HCC). Such HCC was microbiota-dependent and observed in multiple strains of dysbiotic mice but not in germ-free nor antibiotics-treated mice. Furthermore, consumption of an inulin-enriched high-fat diet induced both dysbiosis and HCC in wild-type (WT) mice. Inulin-induced HCC progressed via early onset of cholestasis, hepatocyte death, followed by neutrophilic inflammation in liver. Pharmacologic inhibition of fermentation or depletion of fermenting bacteria markedly reduced intestinal SCFA and prevented HCC. Intervening with cholestyramine to prevent reabsorption of bile acids also conferred protection against such HCC. Thus, its benefits notwithstanding, enrichment of foods with fermentable fiber should be approached with great caution as it may increase risk of HCC.	[Singh, Vishal; Saha, Piu; Joe, Bina; Vijay-Kumar, Matam] Univ Toledo, Dept Physiol & Pharmacol, UT Microbiome Consortium, Coll Med & Life Sci, Toledo, OH 43614 USA; [Yeoh, Beng San] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; [Chassaing, Benoit] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Chassaing, Benoit; Gewirtz, Andrew T.] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Xiao, Xia; Olvera, Rodrigo Aguilera] Penn State Univ, Dept Nutr Sci, State Coll, PA 16802 USA; [Lapek, John D., Jr.; Gonzalez, David J.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Zhang, Limin; Wang, Wei-Bei; Xiong, Na; Kennett, Mary J.; Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, State Coll, PA 16802 USA; [Zhang, Limin] Chinese Acad Sci, Wuhan, Hubei, Peoples R China; [Zhang, Limin] State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Hubei, Peoples R China; [Hao, Sijie] Penn State Univ, Dept Biomed Chem, State Coll, PA 16802 USA; [Flythe, Michael D.] Univ Kentucky, USDA ARS, Lexington, KY 40546 USA; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, WELBIO Walloon Excellence Life Sci & Biotechnol, Brussels, Belgium; [Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Vijay-Kumar, Matam] Univ Toledo, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Chinese Academy of Sciences; Chinese Academy of Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; United States Department of Agriculture (USDA); University of Kentucky; Universite Catholique Louvain; WELBIO; H Lee Moffitt Cancer Center & Research Institute; University System of Ohio; University of Toledo	Vijay-Kumar, M (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, UT Microbiome Consortium, Coll Med & Life Sci, Toledo, OH 43614 USA.; Vijay-Kumar, M (corresponding author), Univ Toledo, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA.	matamvijay.kumar@utoledo.edu	D., Cani Patrice/M-8055-2016; Xiao, Xia/ABD-1457-2020; Vijay-Kumar, Matam/Q-8988-2019; Patterson, Andrew/ABF-1575-2020; Xiao, Xia/ABD-1463-2020; Conejo-Garcia, Jose R/V-1897-2019	D., Cani Patrice/0000-0003-2040-2448; Patterson, Andrew/0000-0003-2073-0070; Conejo-Garcia, Jose R/0000-0001-6431-4074; Singh, Vishal/0000-0003-3577-1713	NIH [R01CA219144, R03DK094864, R01DK097865, DK061417, DK083890]; Crohn's and Colitis Foundation of America (CCFA); CCFA Career Development Award; FRS-FNRS; Funds Baillet Latour; ERC [2013 (336452-ENIGMO)];  [WELBIO-CGR-2017-C2]; NATIONAL CANCER INSTITUTE [R01CA178687, P30CA010815, R01CA219144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083890, R01DK061417, R01DK097865, R03DK094864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); CCFA Career Development Award; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Funds Baillet Latour; ERC(European Research Council (ERC)European Commission); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The expert opinions of Dr. Jeffrey M. Peters, Department of Veterinary and Biomedical Sciences, PSU are acknowledged. We thank Dr. Dittakavi Sarma, University of Toronto, for helpful suggestions. Hops beta-acids extract was donated by S.S. Steiner, Inc. We acknowledge Dr. Xi Cheng, UT Microbiome Consortium for 16S analysis of fecal microbiota. This work was supported by the NIH (R01CA219144, R03DK094864, partial support from R01DK097865 to M.V.-K., and DK061417 and DK083890 to A.T.G.). V.S. and P.S. are supported by Research Fellowship from Crohn's and Colitis Foundation of America (CCFA). B.C. is supported by CCFA Career Development Award. P.D.C. is senior research associate of the FRS-FNRS and received grants WELBIO-CGR-2017-C2, Funds Baillet Latour, and ERC Starting Grant 2013 (336452-ENIGMO).	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arteel GE, 2013, HEPATOLOGY, V58, P1526, DOI 10.1002/hep.26596; Asimakopoulou A, 2016, HEPATOLOGY, V63, P669, DOI 10.1002/hep.27930; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051; Buege J A, 1978, Methods Enzymol, V52, P302; Cai SY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90780; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Caviglia Jorge Matias, 2015, Methods Mol Biol, V1267, P165, DOI 10.1007/978-1-4939-2297-0_8; Chassaing B, 2015, AM J PHYSIOL-GASTR L, V309, pG528, DOI 10.1152/ajpgi.00172.2015; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Dantoine TF, 1998, J AM SOC NEPHROL, V9, P2082; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Etienne-Mesmin L, 2016, CELL MOL GASTROENTER, V2, P584, DOI 10.1016/j.jcmgh.2016.04.007; Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322; Flythe MD, 2010, J APPL MICROBIOL, V109, P1169, DOI 10.1111/j.1365-2672.2010.04739.x; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grat M, 2016, TRANSPL P, V48, P1687, DOI 10.1016/j.transproceed.2016.01.077; Harlow BE, 2014, J APPL MICROBIOL, V117, P329, DOI 10.1111/jam.12532; Janssen AWF, 2017, J LIPID RES, V58, P1399, DOI 10.1194/jlr.M075713; Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018; Li M, 2017, MOL ASPECTS MED, V56, P45, DOI 10.1016/j.mam.2017.06.001; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Miles JP, 2017, INFLAMM BOWEL DIS, V23, P1133, DOI 10.1097/MIB.0000000000001155; Misikangas M, 2008, BRIT J NUTR, V99, P963, DOI 10.1017/S0007114507853414; Navarro VJ, 2017, HEPATOLOGY, V65, P363, DOI 10.1002/hep.28813; Navarro VJ, 2014, HEPATOLOGY, V60, P1399, DOI 10.1002/hep.27317; Pajari AM, 2003, INT J CANCER, V106, P653, DOI 10.1002/ijc.11270; Park J, 2016, J IMMUNOL, V196, P2388, DOI 10.4049/jimmunol.1502046; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Pool-Zobel BL, 2005, BRIT J NUTR, V93, pS73, DOI 10.1079/BJN20041349; Singh V, 2015, CELL METAB, V22, P983, DOI 10.1016/j.cmet.2015.09.028; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Tolonen AC, 2014, JOVE-J VIS EXP, DOI 10.3791/51416; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007; Zinalibdin MR, 2013, ARAB J CHEM, V6, P115, DOI 10.1016/j.arabjc.2010.09.029; Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003	51	220	234	21	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					679	+	e22	10.1016/j.cell.2018.09.004	http://dx.doi.org/10.1016/j.cell.2018.09.004			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340040	Green Accepted, Bronze			2022-12-28	WOS:000447780800012
J	Zhang, WR; Craven, TE; Malhotra, R; Cheung, AK; Chonchol, M; Drawz, P; Sarnak, MJ; Parikh, CR; Shlipak, MG; Ix, JH				Zhang, William R.; Craven, Timothy E.; Malhotra, Rakesh; Cheung, Alfred K.; Chonchol, Michel; Drawz, Paul; Sarnak, Mark J.; Parikh, Chirag R.; Shlipak, Michael G.; Ix, Joachim H.		SPRINT Res Grp	Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction A Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTION DECLINE; INJURY; ASSOCIATION; PROGRESSION; MORTALITY; ADULTS; TRIAL; RISK	Background: Whether the increased incidence of chronic kidney disease (CKD) during intensive systolic blood pressure (SBP) lowering is accompanied by intrinsic kidney injury is unknown. Objective: To compare changes in kidney damage biomarkers between incident CKD case participants and matched control participants as well as between case participants in the intensive (< 120 mm Hg) versus the standard (< 140 mm Hg) SBP management groups of SPRINT (Systolic Blood Pressure Intervention Trial). Design: Nested case-control study within SPRINT. Setting: Adults with hypertension without baseline kidney disease. Participants: Case participants (n = 162), who developed incident CKD during trial follow-up (128 in the intensive and 34 in the standard group), and control participants (n = 162) without incident CKD, who were matched on age, sex, race, baseline estimated glomerular filtration rate, and randomization group. Measurements: 9 urinary biomarkers of kidney damage were measured at baseline and at 1 year. Linear mixed-effects models were used to estimate 1-year biomarker changes. Results: Higher concentrations of urinary albumin, kidney injury molecule-1, and monocyte chemoattractant protein-1 at baseline were significantly associated with greater odds of incident CKD (adjusted odds ratio per doubling: 1.50 [95% CI, 1.14 to 1.98], 1.51 [CI, 1.05 to 2.17], and 1.70 [CI, 1.13 to 2.56], respectively). After 1 year of blood pressure intervention, incident CKD case participants in the intensive group had significantly greater decreases in albumin-creatinine ratio (ACR), interleukin-18, antichitinase-3-like protein 1 (YKL-40), and uromodulin than the matched control participants. Compared with case participants in the standard group, those in the intensive group had significantly greater decreases in ACR, beta(2)-microglobulin, alpha(1)-microglobulin, YKL-40, and uromodulin. Limitation: Biomarker measurements were available only at baseline and 1 year. Conclusion: Incident CKD in the setting of intensive SBP lowering was accompanied by decreases, rather than elevations, in levels of kidney damage biomarkers and thus may reflect benign changes in renal blood flow rather than intrinsic injury.	[Zhang, William R.; Shlipak, Michael G.] San Francisco VA Med Ctr, San Francisco, CA USA; [Zhang, William R.; Shlipak, Michael G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Craven, Timothy E.] Wake Forest Sch Med, Winston Salem, NC USA; [Malhotra, Rakesh; Ix, Joachim H.] Univ Calif San Diego, 9500 Gilman Dr,9111H, La Jolla, CA 92093 USA; [Malhotra, Rakesh] Imperial Valley Family Care Med Grp, El Centro, CA USA; [Cheung, Alfred K.] Univ Utah, Salt Lake City, UT USA; [Chonchol, Michel] Univ Colorado, Aurora, CO USA; [Drawz, Paul] Univ Minnesota, Minneapolis, MN USA; [Sarnak, Mark J.] Tufts Med Ctr, Boston, MA USA; [Parikh, Chirag R.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Zhang, William R.; Shlipak, Michael G.] Kidney Hlth Res Collaborat, 4150 Clement St,Bldg 2,Room 145, San Francisco, CA 94121 USA; [Craven, Timothy E.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Med Ctr Blvd,Room 4303, Winston Salem, NC 27157 USA; [Cheung, Alfred K.] Div Nephrol & Hypertens, 30 North 1900 East,Room 4R312, Salt Lake City, UT 84132 USA; [Chonchol, Michel] Univ Colorado Hosp, 12605 East 16th Ave, Aurora, CO 80045 USA; [Drawz, Paul] Div Renal Dis & Hypertens, 717 Delaware St Southeast,Suite 353,MMC 1932, Minneapolis, MN 55414 USA; [Sarnak, Mark J.] Tufts Med Ctr, Div Nephrol, 800 Washington St,Box 391, Boston, MA 02111 USA; [Parikh, Chirag R.] Johns Hopkins Univ, Sch Med, 1830 East Monument St,Suite 416, Baltimore, MD 21287 USA; [Ix, Joachim H.] Univ Calif San Diego, 3350 La Jolla Village Dr,Mail Code 111-H, San Diego, CA 92161 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Wake Forest University; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; Tufts Medical Center; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Wake Forest University; Wake Forest University School of Medicine; University of Colorado System; University of Colorado Hospital; Tufts Medical Center; Johns Hopkins University; University of California System; University of California San Diego	Shlipak, MG (corresponding author), Kidney Hlth Res Collaborat, 4150 Clement St,Bldg 2,Room 145, San Francisco, CA 94121 USA.	tcraven@wakehealth.edu; michael.shlipak@ucsf.edu		Parikh, Chirag/0000-0001-9051-7385	National Institute for Diabetes and Digestive and Kidney Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR000433, TL1TR001871, UL1TR001064, UL1TR001420, UL1TR000445, UL1TR002003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institute for Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute for Diabetes and Digestive and Kidney Diseases.	Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Argyropoulos CP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00073; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Blank Melanie, 2009, REV QUALIFICATION DA; Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; El-Achkar TM, 2012, AM J KIDNEY DIS, V59, P452, DOI 10.1053/j.ajkd.2011.10.054; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Huen SC, 2015, AM J PHYSIOL-RENAL, V309, pF406, DOI 10.1152/ajprenal.00682.2014; Kazancioglu R, 2013, KIDNEY INT SUPPL, V3, P368, DOI 10.1038/kisup.2013.79; Kimura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26138; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Ku E, 2015, KIDNEY INT, V87, P1055, DOI 10.1038/ki.2014.376; Landsman V, 2013, STAT MED, V32, P347, DOI 10.1002/sim.5530; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Nadkarni GN, 2016, CLIN J AM SOC NEPHRO, V11, P1343, DOI 10.2215/CJN.12051115; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Penders J, 2004, CLIN CHIM ACTA, V346, P107, DOI 10.1016/j.cccn.2004.03.037; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Peralta CA, 2012, AM J KIDNEY DIS, V60, P904, DOI 10.1053/j.ajkd.2012.05.014; Schmidt IM, 2013, J AM SOC NEPHROL, V24, P309, DOI 10.1681/ASN.2012060579; Shastri S, 2010, AM J KIDNEY DIS, V56, P434, DOI 10.1053/j.ajkd.2010.04.007; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	33	50	51	2	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 6	2018	169	9					610	+		10.7326/M18-1037	http://dx.doi.org/10.7326/M18-1037			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ4UP	30357395	Green Accepted			2022-12-28	WOS:000449399700004
J	Robert, C; Vagner, S				Robert, Caroline; Vagner, Stephan			Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases	CELL			English	Editorial Material								Diseases leading to immune activation and autoinflammatory phenotypes may provide a reservoir of potentially druggable pathways for optimizing immune adjuvants or boosting antitumor immune responses. Now, Xia et al. report that lipophilic statins or biphosphonates, targeting the mevalonate pathway, act as efficient vaccine adjuvants and synergize with anti-PD1 against cancer.	[Robert, Caroline] Gustave Roussy, Oncol Dept, Villejuif, France; [Robert, Caroline] Gustave Roussy, INSERM U981, Villejuif, France; [Robert, Caroline] Univ Paris Sud, Univ Paris Saclay, Villejuif, France; [Vagner, Stephan] PSL Res Univ, CNRS UMR 3348, Inst Curie, Orsay, France; [Vagner, Stephan] Univ Paris Sud, Univ Paris Saclay, CNRS UMR 3348, Orsay, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Robert, C (corresponding author), Gustave Roussy, Oncol Dept, Villejuif, France.; Robert, C (corresponding author), Gustave Roussy, INSERM U981, Villejuif, France.; Robert, C (corresponding author), Univ Paris Sud, Univ Paris Saclay, Villejuif, France.; Vagner, S (corresponding author), PSL Res Univ, CNRS UMR 3348, Inst Curie, Orsay, France.; Vagner, S (corresponding author), Univ Paris Sud, Univ Paris Saclay, CNRS UMR 3348, Orsay, France.	caroline.robert@gustaveroussy.fr; stephan.vagner@curie.fr	Vagner, Stephan/G-3664-2013; Robert, Caroline/G-6157-2018	Robert, Caroline/0000-0002-9493-0238; vagner, stephan/0000-0003-1452-7164				Altwairgi AK, 2015, ONCOL REP, V33, P1019, DOI 10.3892/or.2015.3741; Drenth J P, 2000, Ned Tijdschr Geneeskd, V144, P782; Ghittoni R, 2006, EUR J IMMUNOL, V36, P2885, DOI 10.1002/eji.200636567; Gnant M, 2012, CANCER TREAT REV, V38, P407, DOI 10.1016/j.ctrv.2011.09.003; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Iannelli F, 2018, RECENT PAT ANTI-CANC, V13, P184, DOI 10.2174/1574892812666171129141211; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Xia Y, 2018, CELL, V175, P1059, DOI 10.1016/j.cell.2018.08.070	10	4	4	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					901	902		10.1016/j.cell.2018.10.032	http://dx.doi.org/10.1016/j.cell.2018.10.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30388448	Bronze			2022-12-28	WOS:000449100600004
J	Tricco, AC; Zarin, W; Cardoso, R; Veroniki, AA; Khan, PA; Nincic, V; Ghassemi, M; Warren, R; Sharpe, JP; Page, AV; Straus, SE				Tricco, Andrea C.; Zarin, Wasifa; Cardoso, Roberta; Veroniki, Areti-Angeliki; Khan, Paul A.; Nincic, Vera; Ghassemi, Marco; Warren, Rachel; Sharpe, Jane P.; Page, Andrea V.; Straus, Sharon E.			Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUBUNIT CANDIDATE VACCINE; CARE DECISION-MAKING; ISPOR TASK-FORCE; GREATER-THAN-OR-EQUAL-TO-60 YEARS; SHINGLES PREVENTION; DOUBLE-BLIND; IMMUNOGENICITY; TOLERABILITY; INCONSISTENCY; INFECTION	OBJECTIVE To compare the efficacy, effectiveness, and safety of the herpes zoster live attenuated vaccine with the herpes zoster adjuvant recombinant subunit vaccine or placebo for adults aged 50 and older. DESIGN Systematic review with bayesian meta-analysis and network meta-analysis. DATA SOURCES Medline, Embase, and Cochrane Library (inception to January 2017), grey literature, and reference lists of included studies. ELIGIBILITY CRITERIA FOR STUDY SELECTION Experimental, quasi-experimental, and observational studies that compared the live attenuated vaccine with the adjuvant recombinant subunit vaccine, placebo, or no vaccine in adults aged 50 and older. Relevant outcomes were incidence of herpes zoster (primary outcome), herpes zoster ophthalmicus, postherpetic neuralgia, quality of life, adverse events, and death. RESULTS 27 studies (22 randomised controlled trials) including 2 044 504 patients, along with 18 companion reports, were included after screening 2037 titles and abstracts, followed by 175 full text articles. Network meta-analysis of five randomised controlled trials found no statistically significant differences between the live attenuated vaccine and placebo for incidence of laboratory confirmed herpes zoster. The adjuvant recombinant subunit vaccine, however, was statistically superior to both the live attenuated vaccine (vaccine efficacy 85%, 95% credible interval 31% to 98%) and placebo (94%, 79% to 98%). Network meta-analysis of 11 randomised controlled trials showed the adjuvant recombinant subunit vaccine to be associated with statistically more adverse events at injection sites than the live attenuated vaccine (relative risk 1.79, 95% credible interval 1.05 to 2.34; risk difference 30%, 95% credible interval 2% to 51%) and placebo (5.63, 3.57 to 7.29 and 53%, 30% to 73%, respectively). Network meta-analysis of nine randomised controlled trials showed the adjuvant recombinant subunit vaccine to be associated with statistically more systemic adverse events than placebo (2.28, 1.45 to 3.65 and 20%, 6% to 40%, respectively). CONCLUSION Using the adjuvant recombinant subunit vaccine might prevent more cases of herpes zoster than using the live attenuated vaccine, but the adjuvant recombinant subunit vaccine also carries a greater risk of adverse events at injection sites. PROTOCOL REGISTRATION Prospero CRD42017056389.	[Tricco, Andrea C.; Zarin, Wasifa; Cardoso, Roberta; Veroniki, Areti-Angeliki; Khan, Paul A.; Nincic, Vera; Ghassemi, Marco; Warren, Rachel; Sharpe, Jane P.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1W8, Canada; [Tricco, Andrea C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, 155 Coll St, Toronto, ON M5T 3M7, Canada; [Page, Andrea V.] Mt Sinai Hosp, Div Infect Dis, Joseph & Wolf Lebov Hlth Complex, Toronto, ON, Canada; [Page, Andrea V.; Straus, Sharon E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Straus, Sharon E.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Tricco, AC (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Knowledge Translat Program, 209 Victoria St,East Bldg, Toronto, ON M5B 1W8, Canada.; Tricco, AC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, 155 Coll St, Toronto, ON M5T 3M7, Canada.	triccoa@smh.ca	Tricco, Andrea/B-9920-2011	Tricco, Andrea/0000-0002-4114-8971; Khan, Paul/0000-0003-2863-0496; /0000-0001-6388-4825	Canadian Institutes of Health Research Drug Safety and Effectiveness Network [DNM-137713]; tier 2 Canada research chair in knowledge synthesis; tier 1 Canada research chair in knowledge translation	Canadian Institutes of Health Research Drug Safety and Effectiveness Network(Canadian Institutes of Health Research (CIHR)); tier 2 Canada research chair in knowledge synthesis; tier 1 Canada research chair in knowledge translation	This study was funded by the Canadian Institutes of Health Research Drug Safety and Effectiveness Network (DNM-137713). ACT is funded by a tier 2 Canada research chair in knowledge synthesis. SES is funded by a tier 1 Canada research chair in knowledge translation. The funder had no input into the study design; collection, analysis, and interpretation of data; writing of the manuscript; and decision to submit the paper for publication.	Ahnn S., 2005, PROTOCOL, V004, P1; An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI), 2014, UPD US HERP ZOST VAC; Beals CR, 2016, LANCET INFECT DIS, V16, P915, DOI 10.1016/S1473-3099(16)00133-X; Berger R, 1998, J INFECT DIS, V178, pS99, DOI 10.1086/514265; Bricout H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1753-y; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; CDC, 2012, LESS 3 MEAS RISK CDC; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chlibek R, 2014, VACCINE, V32, P1745, DOI 10.1016/j.vaccine.2014.01.019; Chlibek R, 2013, J INFECT DIS, V208, P1953, DOI 10.1093/infdis/jit365; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Del Giovane C, 2013, STAT MED, V32, P25, DOI 10.1002/sim.5512; Diez-Domingo J, 2015, VACCINE, V33, P789, DOI 10.1016/j.vaccine.2014.12.024; Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; Gagliardi AMZ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008858.pub3; Gershon AA, 2010, J CLIN VIROL, V48, pS2, DOI 10.1016/S1386-6532(10)70002-0; Gilderman LI, 2008, CLIN VACCINE IMMUNOL, V15, P314, DOI 10.1128/CVI.00310-07; Gross G, 2003, J CLIN VIROL, V26, P277, DOI 10.1016/S1386-6532(03)00005-2; Hales CM, 2014, MMWR-MORBID MORTAL W, V63; Hata A, 2016, DIABETIC MED, V33, P1094, DOI 10.1111/dme.13038; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Jansen JP, 2008, VALUE HEALTH, V11, P956, DOI 10.1111/j.1524-4733.2008.00347.x; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; JOHNSON R, 1995, J INFECTION, V30, P193; Kerzner B, 2007, J AM GERIATR SOC, V55, P1499, DOI 10.1111/j.1532-5415.2007.01397.x; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Langan SM, 2016, NEPHROL DIAL TRANSPL, V31, P2095, DOI 10.1093/ndt/gfv432; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Lee VK, 2000, GERIATR NURS, V21, P132, DOI 10.1067/mgn.2000.108260; Leroux-Roels I, 2012, J INFECT DIS, V206, P1280, DOI 10.1093/infdis/jis497; Levin M, 2005, SOUTH MED J, V98, pS55d; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Levin MJ, 2016, J INFECT DIS, V213, P14, DOI 10.1093/infdis/jiv480; Levin MJ, 2013, J INFECT DIS, V208, P1386, DOI 10.1093/infdis/jit342; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MacIntyre CR, 2010, HUM VACCINES, V6, P894, DOI 10.4161/hv.6.11.12852; Marin M, 2015, HUM VACC IMMUNOTHER, V11, P1157, DOI 10.1080/21645515.2015.1016681; Matters G., 2015, PRACTICAL TOOL SEARC; McDonald BM, 2017, VACCINE, V35, P6984, DOI 10.1016/j.vaccine.2017.10.067; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Murray A, 2010, SAFETY TOLERABILITY; Murray AV, 2011, HUM VACCINES, V7, P1130, DOI 10.4161/hv.7.11.17982; Oxman MN, 2008, J INFECT DIS, V197, pS228, DOI 10.1086/522159; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Petropoulou M, 2017, J CLIN EPIDEMIOL, V82, P20, DOI 10.1016/j.jclinepi.2016.11.002; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Russell AF, 2015, VACCINE, V33, P3129, DOI 10.1016/j.vaccine.2015.04.090; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Schmader KE, 2010, J AM GERIATR SOC, V58, P1634, DOI 10.1111/j.1532-5415.2010.03021.x; Sharp Merck, 2015, SPE W REG M, P1; SHINGRIX, 2017, PROD MON; Simberkoff MS, 2010, ANN INTERN MED, V152, P545, DOI 10.7326/0003-4819-152-9-201005040-00004; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Stone PW, 2002, APPL NURS RES, V15, P197, DOI 10.1053/apnr.2002.34181; Thiry N, 2002, EUR J PEDIATR, V161, P588, DOI 10.1007/s00431-002-1053-2; Tian JH, 2015, ANN INTERN MED, V163, P566, DOI [10.7326/L15-5144, 10.7326/L15-5144-2]; Tricco A, 2017, EFFECTIVENESS SAFETY; Tseng HF, 2016, J INFECT DIS, V213, P1872, DOI 10.1093/infdis/jiw047; Tseng HF, 2016, CLIN INFECT DIS, V62, P462, DOI 10.1093/cid/civ930; Tseng HF, 2014, CLIN INFECT DIS, V59, P913, DOI 10.1093/cid/ciu498; Tseng HF, 2012, J INFECT DIS, V206, P190, DOI 10.1093/infdis/jis334; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; Tyring SK, 2007, VACCINE, V25, P1877, DOI 10.1016/j.vaccine.2006.10.027; Vermeulen JN, 2012, VACCINE, V30, P904, DOI 10.1016/j.vaccine.2011.11.096; Veroniki AA, 2016, J CLIN EPIDEMIOL, V76, P193, DOI 10.1016/j.jclinepi.2016.02.016; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Vesikari T, 2013, HUM VACC IMMUNOTHER, V9, P858, DOI 10.4161/hv.23412; Vink P, 2017, HUM VACC IMMUNOTHER, V13, P574, DOI 10.1080/21645515.2016.1232787; Wells G., NEWCASTLE OTTAWA SCA; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2011, MAYO CLIN PROC, V86, P1141, DOI 10.4065/mcp.2011.0724; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304; Zhang J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3497; ZOSTAVAX&REG; II, 2017, PROD MON	87	52	57	3	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2018	363								k4029	10.1136/bmj.k4029	http://dx.doi.org/10.1136/bmj.k4029			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY8PX	30361202	Green Published, hybrid			2022-12-28	WOS:000448896000002
J	Hill, PS				Hill, Peter S.			Primary health care and universal health coverage: competing discourses?	LANCET			English	Editorial Material									[Hill, Peter S.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia	University of Queensland	Hill, PS (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia.	peter.hill@sph.uq.edu.au	Hill, Peter Stewart/AAL-8053-2020	Hill, Peter Stewart/0000-0001-7091-5108				Brolan CE, 2016, HEALTH POLICY PLANN, V31, P514, DOI 10.1093/heapol/czv101; OOMS G, 2014, BMC INT HEALTH HUM R, V14, P1, DOI DOI 10.1186/1472-698X-14-3; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Schmidt H, 2015, LANCET, V386, P928, DOI 10.1016/S0140-6736(15)60244-6; Sen K, 1998, INT J HEALTH PLAN M, V13, P199; WHO, 2008, PHARMAFORUM 0121; WHO World Bank, 2015, TRACK UN HLTH COV 1, P62; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 1978, ALM AT INT C PRIM HL; 2010, WORLD HLTH REP 2010, P1	10	3	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1374	1375		10.1016/S0140-6736(18)30699-8	http://dx.doi.org/10.1016/S0140-6736(18)30699-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343845				2022-12-28	WOS:000447800900007
J	Kremen, C; Merenlender, AM				Kremen, C.; Merenlender, A. M.			Landscapes that work for biodiversity and people	SCIENCE			English	Review							LAND-USE; RIPARIAN CORRIDORS; ECOSYSTEM SERVICES; PLANT DIVERSITY; CONSERVATION; EXTINCTION; FOOD; INTENSIFICATION; MITIGATION; MANAGEMENT		[Kremen, C.; Merenlender, A. M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kremen, C (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	ckremen@berkeley.edu		MERENLENDER, Adina/0000-0002-0681-8642				Ramirez JA, 2008, FOREST ECOL MANAG, V255, P1976, DOI 10.1016/j.foreco.2007.12.019; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Alvez Juan P., 2012, Ecological Restoration, V30, P288, DOI 10.3368/er.30.4.288; Anderson M. K., 2005, TENDING THE WILD NAT; [Anonymous], 2009, ECOSYSTEM MANAGEMENT; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Avelino J, 2012, ECOL APPL, V22, P584, DOI 10.1890/11-0869.1; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Bignal Eric M., 2000, Environmental Reviews, V8, P149, DOI 10.1139/a00-009; Bongaarts J, 2009, INT PERSPECT SEX R H, V35, P39, DOI 10.1363/ifpp.35.039.09; Bradshaw CJA, 2014, P NATL ACAD SCI USA, V111, P16610, DOI 10.1073/pnas.1410465111; Brandes E, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/1/014009; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Cameron DR, 2017, P NATL ACAD SCI USA, V114, P12833, DOI 10.1073/pnas.1707811114; Campos P., 2013, MEDITERRANEAN OAK WO; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chapin FS, 2010, TRENDS ECOL EVOL, V25, P241, DOI 10.1016/j.tree.2009.10.008; Chaplin-Kramer R, 2015, ANN NY ACAD SCI, V1355, P77, DOI 10.1111/nyas.12961; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; De Schutter, 2011, REPORT SPECIAL RAPPO; DeClerck FAJ, 2010, BIOL CONSERV, V143, P2301, DOI 10.1016/j.biocon.2010.03.026; Doak DF, 2014, TRENDS ECOL EVOL, V29, P77, DOI 10.1016/j.tree.2013.10.013; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Eastburn DJ, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0166595, 10.1371/journal.pone.019595]; Elsen PR, 2018, P NATL ACAD SCI USA, V115, P6004, DOI 10.1073/pnas.1720141115; Estrada-Carmona N, 2014, LANDSCAPE URBAN PLAN, V129, P1, DOI 10.1016/j.landurbplan.2014.05.001; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Garbach K, 2017, INT J AGR SUSTAIN, V15, P11, DOI 10.1080/14735903.2016.1174810; Gaudin ACM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113261; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Gu HY, 2014, ECOL SOC, V19, DOI 10.5751/ES-06283-190141; Gurr GM, 2016, NAT PLANTS, V2, DOI 10.1038/nplants.2016.14; Halley JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12283; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hamrick K., 2016, STATE OF PRIVATE INV; Harvey CA, 2005, AGR ECOSYST ENVIRON, V111, P200, DOI 10.1016/j.agee.2005.06.011; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Harvey CA, 2014, CONSERV LETT, V7, P77, DOI 10.1111/conl.12066; Hauer FR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600026; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hobbs RJ, 2014, FRONT ECOL ENVIRON, V12, P557, DOI 10.1890/130300; Iles A., 2012, Ecology and Society, V17, P42; International Panel of Experts on Sustainable Food Systems (IPES-Food), 2016, FROM UNIFORMITY TO D; Isbell F, 2017, J ECOL, V105, P871, DOI 10.1111/1365-2745.12789; Isbell F, 2017, NATURE, V546, P65, DOI 10.1038/nature22899; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Keeley ATH, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacb85; Keeley ATH, 2018, CONSERV BIOL, V32, P1221, DOI 10.1111/cobi.13158; Kennedy CM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501021; Kennedy CM, 2011, ECOL APPL, V21, P1837, DOI 10.1890/10-1044.1; Kremen C., 2012, Ecology and Society, V17, P44; Kremen C, 2015, ANN NY ACAD SCI, V1355, P52, DOI 10.1111/nyas.12845; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Layzer JA, 2008, AM COMP ENVIRON POLI, P1; Leach M, 2015, PATHWAY SUSTAIN, P119; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Lowder SK, 2016, WORLD DEV, V87, P16, DOI 10.1016/j.worlddev.2015.10.041; Lund, 2007, RANGELANDS, V29, P3, DOI DOI 10.2111/1551-501X(2007)29[3:AFTWR]2.0.CO;2; MacDicken KG, 2015, FOREST ECOL MANAG, V352, P47, DOI 10.1016/j.foreco.2015.02.005; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Mascia MB, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12442; Medina A, 2007, BIOTROPICA, V39, P120, DOI 10.1111/j.1744-7429.2006.00240.x; Mendenhall CD, 2016, P NATL ACAD SCI USA, V113, P14544, DOI 10.1073/pnas.1604981113; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Montenegro M., 2016, GASTRONOMICA, V16, P1, DOI [10.1525/gfc.2016.16.1.1, DOI 10.1525/GFC.2016.16.1.1]; Morse WC, 2009, ECOL SOC, V14; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Owley J., 2016, UC HASTINGS RESEARCH, P65; Pannell DJ, 2006, AUST J EXP AGR, V46, P1407, DOI 10.1071/EA05037; Payne JL, 2016, SCIENCE, V353, P1284, DOI 10.1126/science.aaf2416; Perfecto I., 2009, NATURES MATRIX LINKI; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Philpott SM, 2008, AGR ECOSYST ENVIRON, V128, P12, DOI 10.1016/j.agee.2008.04.016; Polade SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11285-y; Ponisio L. C., 2014, P ROY SOC LOND B BIO, V282, DOI DOI 10.1098/RSPB.2014.1396; Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216; Pretty J, 2014, ANN BOT-LONDON, V114, P1571, DOI 10.1093/aob/mcu205; Pringle RM, 2017, NATURE, V546, P91, DOI 10.1038/nature22902; Pywell RF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1740; RAMANKUTTY N, 2008, GLOBAL BIOGEOCHEM CY, V0022; Ramankutty N, 2018, ANNU REV PLANT BIOL, V69, P789, DOI 10.1146/annurev-arplant-042817-040256; Reynolds MD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700707; Ricciardi V, 2018, GLOB FOOD SECUR-AGR, V17, P64, DOI 10.1016/j.gfs.2018.05.002; Sanderson EW, 2018, BIOSCIENCE, V68, P412, DOI 10.1093/biosci/biy039; Schulte LA, 2017, P NATL ACAD SCI USA, V114, P11247, DOI 10.1073/pnas.1620229114; Scoones I, 2015, PATHWAY SUSTAIN, P1; Sekercioglu CH, 2015, J ORNITHOL, V156, pS343, DOI 10.1007/s10336-015-1299-x; Shafer CL, 2015, GLOB ECOL CONSERV, V3, P331, DOI 10.1016/j.gecco.2014.12.007; Sutherland W., 2017, WHAT WORKS IN CONSER, V2; Thogmartin WE, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7637; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Williams-Guillen K, 2006, ANIM CONSERV, V9, P331, DOI 10.1111/j.1469-1795.2006.00042.x; Wilson Edward O, 2016, HALF EARTH; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	105	398	405	71	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412							eaau6020	10.1126/science.aau6020	http://dx.doi.org/10.1126/science.aau6020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GX4EJ	30337381				2022-12-28	WOS:000447680100036
J	Deguine, J				Deguine, Jacques			First Encounters	CELL			English	Editorial Material							GUT MICROBIOME; GENETICS	The role of the microbiome across a range of physiological process is undebatable, but how this complex community is assembled and regulated remains only partially understood. Recent studies focused on a single sensor show that the neonatal period may represent a critical window and that immune interactions at this time could durably influence the members of the microbiome.						Deguine, Jacques/0000-0001-9218-3040				Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Fulde M, 2018, NATURE, V560, P489, DOI 10.1038/s41586-018-0395-5; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Kurilshikov A, 2017, TRENDS IMMUNOL, V38, P633, DOI 10.1016/j.it.2017.06.003; Price AE, 2018, IMMUNITY, V49, P560, DOI 10.1016/j.immuni.2018.07.016; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	7	2	2	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					601	603		10.1016/j.cell.2018.10.002	http://dx.doi.org/10.1016/j.cell.2018.10.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340031	Bronze			2022-12-28	WOS:000447780800001
J	Roostalu, J; Rickman, J; Thomas, C; Nedelec, F; Surrey, T				Roostalu, Johanna; Rickman, Jamie; Thomas, Claire; Nedelec, Francois; Surrey, Thomas			Determinants of Polar versus Nematic Organization in Networks of Dynamic Microtubules and Mitotic Motors	CELL			English	Article							CROSS-LINKS MICROTUBULES; SELF-ORGANIZATION; SPINDLE ORGANIZATION; STRUCTURAL MODEL; KINESIN; EG5; TUBULIN; TPX2; LOCALIZATION; INSTABILITY	During cell division, mitotic motors organize microtubules in the bipolar spindle into either polar arrays at the spindle poles or a "nematic'' network of aligned microtubules at the spindle center. The reasons for the distinct self-organizing capacities of dynamic microtubules and different motors are not understood. Using in vitro reconstitution experiments and computer simulations, we show that the human mitotic motors kinesin-5 KIF11 and kinesin-14 HSET, despite opposite directionalities, can both organize dynamic microtubules into either polar or nematic networks. We show that in addition to the motor properties the natural asymmetry between microtubule plus-and minus-end growth critically contributes to the organizational potential of the motors. We identify two control parameters that capture system composition and kinetic properties and predict the outcome of microtubule network organization. These results elucidate a fundamental design principle of spindle bipolarity and establish general rules for active filament network organization.	[Roostalu, Johanna; Rickman, Jamie; Thomas, Claire; Surrey, Thomas] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Nedelec, Francois] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany	Francis Crick Institute; European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England.; Nedelec, F (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	nedelec@embl.de; thomas.surrey@crick.ac.uk	Nedelec, Francois/AAC-1673-2019; Nedelec, Francois J/H-3317-2011; Surrey, Thomas/AAC-4608-2021	Nedelec, Francois/0000-0002-8141-5288; Nedelec, Francois J/0000-0002-8141-5288; Roostalu, Johanna/0000-0002-6757-0468	Francis Crick Institute, from Cancer Research UK [FC001163]; UK Medical Research Council [FC001163]; Wellcome Trust [FC001163]; Centre for Modelling in the Biosciences; Sir Henry Wellcome Postdoctoral Fellowship [100145/Z/12/Z]; European Research Council [323042]	Francis Crick Institute, from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Centre for Modelling in the Biosciences; Sir Henry Wellcome Postdoctoral Fellowship; European Research Council(European Research Council (ERC)European Commission)	We thank Marcel Knossow and Andreas Pluckthun for the gift of purified DARPin (D1)<INF>2</INF>, Michel Steinmetz for the original EB3 cDNA, Julian Gannon for cloning the SNAP-EB3 plasmid, Rupam Jha for help with purifying and labelling Alexa546-EB3, Nicholas I. Cade for microscopy support, Lewis Griffin for discussions, and Michael Way and Frank Uhlmann for critical reading of the manuscript. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001163), the UK Medical Research Council (FC001163), and the Wellcome Trust (FC001163). F.N. was supported by the Centre for Modelling in the Biosciences (https://www.bioms.de). J. Roostalu was supported by a Sir Henry Wellcome Postdoctoral Fellowship (100145/Z/12/Z) and T.S. acknowledges support from the European Research Council (Advanced Grant, project 323042). We thank EMBL for support, in particular for its high-performance computing services.	Aguirre-Portoles C, 2012, CANCER RES, V72, P1518, DOI 10.1158/0008-5472.CAN-11-1971; Alvarado J, 2017, SOFT MATTER, V13, P5624, DOI 10.1039/c7sm00834a; Atherton J, 2017, NAT STRUCT MOL BIOL, V24, P931, DOI 10.1038/nsmb.3483; Baumann H, 2014, J BIOL CHEM, V289, P22524, DOI 10.1074/jbc.M114.582015; Belmonte JM, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177796; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Braun M, 2017, NAT CHEM BIOL, V13, P1245, DOI [10.1038/nchembio.2495, 10.1038/NCHEMBIO.2495]; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Cahu J, 2009, J CELL SCI, V122, P1295, DOI 10.1242/jcs.044248; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; COLE DG, 1994, J BIOL CHEM, V269, P22913; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10837; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganguly S, 2012, P NATL ACAD SCI USA, V109, P15109, DOI 10.1073/pnas.1203575109; Goldstein RE, 2008, P NATL ACAD SCI USA, V105, P3663, DOI 10.1073/pnas.0707223105; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Head DA, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032705; Head DA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-18; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Hendershott MC, 2014, P NATL ACAD SCI USA, V111, P5860, DOI 10.1073/pnas.1404133111; Henkin G, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0142; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jha R, 2017, EMBO J, V36, P3387, DOI 10.15252/embj.201797077; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kapoor TM, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010008; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Kruse K, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031904; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Letort G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004245; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Monteith CE, 2016, BIOPHYS J, V110, P2053, DOI 10.1016/j.bpj.2016.03.036; Nedelec F, 2001, CR ACAD SCI IV-PHYS, V2, P841, DOI 10.1016/S1296-2147(01)01227-6; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nedelec F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/427; Needleman D, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.48; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Norris SR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04991-2; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Parmeggiani A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046101; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Roostalu J, 2015, NAT CELL BIOL, V17, P1422, DOI 10.1038/ncb3241; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Sanchez AD, 2017, CURR OPIN CELL BIOL, V44, P93, DOI 10.1016/j.ceb.2016.09.003; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Scholey JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02217; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Stam S, 2017, P NATL ACAD SCI USA, V114, pE10037, DOI 10.1073/pnas.1708625114; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Tanenbaum ME, 2008, EMBO J, V27, P3235, DOI 10.1038/emboj.2008.242; Tischer C, 2010, BIOPHYS J, V99, P726, DOI 10.1016/j.bpj.2010.05.026; Torisawa T, 2016, BIOPHYS J, V111, P373, DOI 10.1016/j.bpj.2016.06.010; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wollrab V., 2018, BIORXIV, DOI [10.1101/314484, DOI 10.1101/314484]; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang R, 2017, ELIFE, V6, DOI 10.7554/eLife.30959	84	51	52	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					796	+	e14	10.1016/j.cell.2018.09.029	http://dx.doi.org/10.1016/j.cell.2018.09.029			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340043	hybrid, Green Published			2022-12-28	WOS:000447780800020
J	Curley, A; Stanworth, SJ; Willoughby, K; Fustolo-Gunnink, SF; Venkatesh, V; Hudson, C; Deary, A; Hodge, R; Hopkins, V; Santamaria, BL; Mora, A; Llewelyn, C; D'Amore, A; Khan, R; Onland, W; Lopriore, E; Fijnvandraat, K; New, H; Clarke, P; Watts, T				Curley, Anna; Stanworth, Simon J.; Willoughby, Karen; Fustolo-Gunnink, Susanna F.; Venkatesh, Vidheya; Hudson, Cara; Deary, Alison; Hodge, Renate; Hopkins, Valerie; Santamaria, Beatriz Lopez; Mora, Ana; Llewelyn, Charlotte; D'Amore, Angela; Khan, Rizwan; Onland, Wes; Lopriore, Enrico; Fijnvandraat, Karin; New, Helen; Clarke, Paul; Watts, Timothy		PlaNeT2 MATISSE Collaborators	Randomized Trial of Platelet-Transfusion Thresholds in Neonates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; HEMORRHAGE; THROMBOCYTOPENIA; BIRTH	BACKGROUND Platelet transfusions are commonly used to prevent bleeding in preterm infants with thrombocytopenia. Data are lacking to provide guidance regarding thresholds for prophylactic platelet transfusions in preterm neonates with severe thrombocytopenia. METHODS In this multicenter trial, we randomly assigned infants born at less than 34 weeks of gestation in whom severe thrombocytopenia developed to receive a platelet transfusion at platelet-count thresholds of 50,000 per cubic millimeter (high-threshold group) or 25,000 per cubic millimeter (low-threshold group). Bleeding was documented prospectively with the use of a validated bleeding-assessment tool. The primary outcome was death or new major bleeding within 28 days after randomization. RESULTS A total of 660 infants (median birth weight, 740 g; and median gestational age, 26.6 weeks) underwent randomization. In the high-threshold group, 90% of the infants (296 of 328 infants) received at least one platelet transfusion, as compared with 53% (177 of 331 infants) in the low-threshold group. A new major bleeding episode or death occurred in 26% of the infants (85 of 324) in the high-threshold group and in 19% (61 of 329) in the low-threshold group (odds ratio, 1.57; 95% confidence interval [CI], 1.06 to 2.32; P = 0.02). There was no significant difference between the groups with respect to rates of serious adverse events (25% in the highthreshold group and 22% in the low-threshold group; odds ratio, 1.14; 95% CI, 0.78 to 1.67). CONCLUSIONS Among preterm infants with severe thrombocytopenia, those randomly assigned to receive platelet transfusions at a platelet-count threshold of 50,000 per cubic millimeter had a significantly higher rate of death or major bleeding within 28 days after randomization than those who received platelet transfusions at a plateletcount threshold of 25,000 per cubic millimeter.	[Curley, Anna] Natl Matern Hosp, Dept Neonatol, Holles St, Dublin 2, Ireland; [Khan, Rizwan] Univ Matern Hosp Limerick, Limerick, Ireland; [Stanworth, Simon J.] Med Natl Hlth Serv NHS Blood & Transplant, Dept Transfus Med, Oxford, England; [Stanworth, Simon J.] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Dept Haematol, Oxford, England; [Stanworth, Simon J.] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Stanworth, Simon J.] Oxford Biomed Res Ctr Haematol Theme, Oxford, England; [Willoughby, Karen] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Willoughby, Karen; Hudson, Cara; Deary, Alison; Hodge, Renate; Hopkins, Valerie; Mora, Ana; Llewelyn, Charlotte] Cambridge Univ Hosp NHS Trust, NHS Blood & Transplant Clin Trials Unit, Cambridge, England; [D'Amore, Angela] Cambridge Univ Hosp NHS Trust, Neonatal Intens Care Unit, Cambridge, England; [Santamaria, Beatriz Lopez; Watts, Timothy] Guys & St Thomas NHS Fdn Trust, Evelina London Childrens Hosp, Neonatal Intens Care Unit, London, England; [New, Helen] Imperial Coll London, NHS Blood & Transplant, London, England; [New, Helen] Imperial Coll London, Dept Hematol, London, England; [Clarke, Paul] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Neonatal Intens Care Unit, Norwich Res Pk, Norwich, Norfolk, England; [Clarke, Paul] Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich, Norfolk, England; [Fustolo-Gunnink, Susanna F.; Fijnvandraat, Karin] Sanquin Blood Supply, Ctr Clin Transfus Res, Leiden, Netherlands; [Fustolo-Gunnink, Susanna F.] Leiden Univ, Med Ctr, Dept Epidemiol, Leiden, Netherlands; [Lopriore, Enrico] Leiden Univ, Med Ctr, Dept Neonatol, Leiden, Netherlands; [Fustolo-Gunnink, Susanna F.; Fijnvandraat, Karin] Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol, Amsterdam, Netherlands; [Onland, Wes] Acad Med Ctr, Emma Childrens Hosp, Dept Neonatol, Amsterdam, Netherlands; [Venkatesh, Vidheya] Cloudnine Hosp, Neonatal Intens Care Unit, Bangalore, Karnataka, India	National Maternity Hospital, Dublin; University of Limerick; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; Imperial College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; University of East Anglia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Curley, A (corresponding author), Natl Matern Hosp, Dept Neonatol, Holles St, Dublin 2, Ireland.	acurley@nmh.ie	Lopriore, Enrico/ABE-3576-2021; Hulzebos, Christian Victor/AAY-6803-2021; Luyt, Karen/ABE-4921-2021; van der Hoeven, Markus/M-8558-2015; de Boode, Willem-Pieter/H-3569-2012	Lopriore, Enrico/0000-0002-3513-5066; Hulzebos, Christian Victor/0000-0002-8159-7501; Luyt, Karen/0000-0002-9806-1092; van der Hoeven, Markus/0000-0002-3978-256X; de Boode, Willem-Pieter/0000-0003-3194-7005; Clarke, Paul/0000-0001-6203-7632; Deary, Alison/0000-0001-8351-4186; Mahaveer, Ajit/0000-0001-9786-6860	National Health Service Blood and Transplant Research and Development Committee	National Health Service Blood and Transplant Research and Development Committee	Funded by the National Health Service Blood and Transplant Research and Development Committee and others; Current Controlled Trials number, ISRCTN87736839.	Aghai ZH, 2013, PEDIATR PULM, V48, P8, DOI 10.1002/ppul.22540; ANDREW M, 1993, J PEDIATR-US, V123, P285, DOI 10.1016/S0022-3476(05)81705-6; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bassan H, 2009, CLIN PERINATOL, V36, P737, DOI 10.1016/j.clp.2009.07.014; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Christensen RD, 2014, TRANSFUSION, V54, P104, DOI 10.1111/trf.12234; Cremer M, 2011, TRANSFUSION, V51, P2634, DOI 10.1111/j.1537-2995.2011.03208.x; Curley A, 2014, NEONATOLOGY, V106, P102, DOI 10.1159/000358481; Ferrer-Marin F, 2013, TRANSFUSION, V53, P2814, DOI 10.1111/trf.12343; Goel R, 2015, BLOOD, V125, P1470, DOI 10.1182/blood-2014-10-605493; Gunnink SF, 2014, EXPERT REV HEMATOL, V7, P387, DOI 10.1586/17474086.2014.902301; Josephson CD, 2009, PEDIATRICS, V123, P278, DOI 10.1542/peds.2007-2850; Kenton Alexander B, 2005, J Perinatol, V25, P173, DOI 10.1038/sj.jp.7211237; Lieberman L, 2014, BLOOD, V123, P1146, DOI 10.1182/blood-2013-02-435693; McFadyen JD, 2015, TRANSFUS MED REV, V29, P110, DOI 10.1016/j.tmrv.2014.11.006; Mestan KK, 2017, J PEDIATR-US, V185, P33, DOI 10.1016/j.jpeds.2017.01.015; Muthukumar P, 2012, TRANSFUSION MED, V22, P338, DOI 10.1111/j.1365-3148.2012.01171.x; New HV, 2016, BRIT J HAEMATOL, V175, P784, DOI 10.1111/bjh.14233; Poryo M, 2018, EARLY HUM DEV, V116, P1, DOI 10.1016/j.earlhumdev.2017.08.010; Resch E, 2018, EUR J PEDIATR, V177, P1045, DOI 10.1007/s00431-018-3153-7; Sola-Visner M, 2016, TRANSFUS MED REV, V30, P183, DOI 10.1016/j.tmrv.2016.05.009; Sparger KA, 2016, JAMA PEDIATR, V170, P687, DOI 10.1001/jamapediatrics.2016.0507; Stanworth SJ, 2013, NEW ENGL J MED, V368, P1771, DOI 10.1056/NEJMoa1212772; Stanworth SJ, 2009, PEDIATRICS, V124, pE826, DOI 10.1542/peds.2009-0332; Stolla M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00028; Ulusoy E, 2013, ANN HEMATOL, V92, P961, DOI 10.1007/s00277-013-1726-0; Venkatesh V, 2013, ARCH DIS CHILD-FETAL, V98, pF260, DOI 10.1136/archdischild-2012-302443	27	166	169	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2019	380	3					242	251		10.1056/NEJMoa1807320	http://dx.doi.org/10.1056/NEJMoa1807320			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HH5YY	30387697	Bronze			2022-12-28	WOS:000455806200006
J	Lowenstern, A; Al-Khatib, SM; Sharan, L; Chatterjee, R; LaPointe, NMA; Shah, B; Borre, ED; Raitz, G; Goode, A; Yapa, R; Davis, JK; Lallinger, K; Schmidt, R; Kosinski, AS; Sanders, GD				Lowenstern, Angela; Al-Khatib, Sana M.; Sharan, Lauren; Chatterjee, Ranee; LaPointe, Nancy M. Allen; Shah, Bimal; Borre, Ethan D.; Raitz, Giselle; Goode, Adam; Yapa, Roshini; Davis, J. Kelly; Lallinger, Kathryn; Schmidt, Robyn; Kosinski, Andrzej S.; Sanders, Gillian D.			Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							VITAMIN-K ANTAGONISM; MAJOR BLEEDING RISK; APIXABAN VS. WARFARIN; XA NEXT-GENERATION; CLINICAL-OUTCOMES; ANTICOAGULATION THERAPY; RANDOMIZED EVALUATION; STROKE PREVENTION; RENAL-FUNCTION; MYOCARDIAL-INFARCTION	Background: The comparative safety and effectiveness of treatments to prevent thromboembolic complications in atrial fibrillation (AF) remain uncertain. Purpose: To compare the effectiveness of medical and procedural therapies in preventing thromboembolic events and bleeding complications in adults with nonvalvular AF. Data Sources: English-language studies in several databases from 1 January 2000 to 14 February 2018. Study Selection: Two reviewers independently screened citations to identify comparative studies of treatments to prevent stroke in adults with nonvalvular AF who reported thromboembolic or bleeding complications. Data Extraction: Two reviewers independently abstracted data, assessed study quality and applicability, and rated strength of evidence. Data Synthesis: Data from 220 articles were included. Dabigatran and apixaban were superior and rivaroxaban and edoxaban were similar to warfarin in preventing stroke or systemic embolism. Apixaban and edoxaban were superior and rivaroxaban and dabigatran were similar to warfarin in reducing the risk for major bleeding. Treatment effects with dabigatran were similar in patients with renal dysfunction (interaction P > 0.05), and patients younger than 75 years had lower bleeding rates with dabigatran (interaction P < 0.001). The benefit of treatment with apixaban was consistent in many subgroups, including those with renal impairment, diabetes, and prior stroke (interaction P > 0.05 for all). The greatest bleeding risk reduction was observed in patients with a glomerular filtration rate less than 50 mL/min/1.73 m(2) (P = 0.003). Similar treatment effects were observed for rivaroxaban and edoxaban in patients with prior stroke, diabetes, or heart failure (interaction P > 0.05 for all). Limitation: Heterogeneous study populations, interventions, and outcomes. Conclusion: The available direct-acting oral anticoagulants (DOACs) are at least as effective and safe as warfarin for patients with nonvalvular AF. The DOACs had similar benefits across several patient subgroups and seemed safe and efficacious for a wide range of patients with nonvalvular AF.	[Lowenstern, Angela; Al-Khatib, Sana M.; Sharan, Lauren; Chatterjee, Ranee; LaPointe, Nancy M. Allen; Shah, Bimal; Borre, Ethan D.; Raitz, Giselle; Goode, Adam; Lallinger, Kathryn; Schmidt, Robyn; Kosinski, Andrzej S.; Sanders, Gillian D.] Duke Univ, Sch Med, Durham, NC USA; [LaPointe, Nancy M. Allen] Premier, Charlotte, NC USA; [Shah, Bimal] Livongo, Mountain View, CA USA; [Yapa, Roshini] Univ Colorado, Aurora, CO USA; [Davis, J. Kelly; Sanders, Gillian D.] Duke Univ, Durham, NC USA; [Lowenstern, Angela; Sharan, Lauren; Raitz, Giselle] 2400 Pratt St,Duke Box 3850, Durham, NC 27710 USA; [Al-Khatib, Sana M.] 7521 North Pavil Bldg, Durham, NC 27715 USA; [Chatterjee, Ranee] 411 West Chapel Hill St,Suite 500, Durham, NC 27701 USA; [LaPointe, Nancy M. Allen] 13034 Ballantyne Corp Pl, Charlotte, NC 28277 USA; [Shah, Bimal] 150 West Evelyn Ave,Suite 150, Mountain View, CA 94041 USA; [Borre, Ethan D.; Lallinger, Kathryn; Schmidt, Robyn; Sanders, Gillian D.] 2400 Pratt St, Durham, NC 27705 USA; [Goode, Adam] 2200 West Main St, Durham, NC 27703 USA; [Yapa, Roshini] 12700 East 19th Ave,Campus Box C281, Aurora, CO 80045 USA; [Davis, J. Kelly] 100 Fuqua Dr,A05G-1, Durham, NC 27708 USA; [Kosinski, Andrzej S.] DCRI, Room 7058,POB 17969, Durham, NC 27715 USA	Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University	Sanders, GD (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	gillian.sanders@duke.edu		Borre, Ethan/0000-0002-8666-5382; , Nancy/0000-0002-6390-8337; Ranard, Lauren/0000-0002-2305-156X	Patient-Centered Outcomes Research Institute [PROSPERO: CRD42017069999]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069749] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Patient-Centered Outcomes Research Institute. (PROSPERO: CRD42017069999)	Adeboyeje G, 2017, J MANAG CARE SPEC PH, V23, P968, DOI 10.18553/jmcp.2017.23.9.968; Agency for Healthcare Research and Quality, 2015, METH GUID EFF COMP E; Al-Khatib SM, 2013, EUR HEART J, V34, P2464, DOI 10.1093/eurheartj/eht135; Alexander JH, 2014, EUR HEART J, V35, P224, DOI 10.1093/eurheartj/eht445; Bahit MC, 2017, HEART, V103, P623, DOI 10.1136/heartjnl-2016-309901; Bansilal S, 2015, AM HEART J, V170, P675, DOI 10.1016/j.ahj.2015.07.006; Caro JJ, 2004, AM J MANAG CARE, V10, pS451; Connolly SJ, 2013, CIRCULATION, V128, P237, DOI 10.1161/CIRCULATIONAHA.112.001139; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cowper PA, 2017, JAMA CARDIOL, V2, P525, DOI 10.1001/jamacardio.2017.0065; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeVore AD, 2016, EUROPACE, V18, P1135, DOI 10.1093/europace/euv404; Dulli DA, 2003, NEUROEPIDEMIOLOGY, V22, P118, DOI 10.1159/000068743; Durheim MT, 2016, INT J CARDIOL, V202, P589, DOI 10.1016/j.ijcard.2015.09.062; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Ezekowitz JA, 2015, EUR HEART J-CARD PHA, V1, P86, DOI 10.1093/ehjcvp/pvu024; Fordyce CB, 2016, CIRCULATION, V134, P37, DOI 10.1161/CIRCULATIONAHA.116.021890; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Geller BJ, 2015, AM HEART J, V170, P669, DOI 10.1016/j.ahj.2015.06.020; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Graham DJ, 2016, JAMA INTERN MED, V176, P1662, DOI 10.1001/jamainternmed.2016.5954; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guimaraes PO, 2017, INT J CARDIOL, V227, P443, DOI 10.1016/j.ijcard.2016.11.014; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Halvorsen S, 2014, EUR HEART J, V35, P1864, DOI 10.1093/eurheartj/ehu046; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; Hohnloser SH, 2012, EUR HEART J, V33, P2821, DOI 10.1093/eurheartj/ehs274; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Hu PT, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004699; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Lee Won Chan, 2008, J Med Econ, V11, P281, DOI 10.3111/13696990802063425; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lin J, 2017, J MED ECON, V20, P952, DOI 10.1080/13696998.2017.1341902; Lip GYH, 2016, THROMB HAEMOSTASIS, V116, P975, DOI 10.1160/TH16-05-0403; Lopes RD, 2013, 13EHC113EF AHRQ; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Magnani G, 2016, EUR J HEART FAIL, V18, P1153, DOI 10.1002/ejhf.595; Mahaffey KW, 2014, EUR HEART J, V35, P233, DOI 10.1093/eurheartj/eht428; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Noseworthy P, 2016, J AM COLL CARDIOL, V67, P692, DOI 10.1016/S0735-1097(16)30693-3; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Rao MP, 2018, AM J MED, V131, P269, DOI 10.1016/j.amjmed.2017.10.036; Rost NS, 2016, STROKE, V47, P2075, DOI 10.1161/STROKEAHA.116.013540; Shah R, 2016, AM HEART J, V179, P77, DOI 10.1016/j.ahj.2016.05.019; Sherwood MW, 2015, J AM COLL CARDIOL, V66, P2271, DOI 10.1016/j.jacc.2015.09.024; Staerk L, 2018, J INTERN MED, V283, P45, DOI 10.1111/joim.12683; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tereshchenko LG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003206; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; U.S. Food and Drug Administration, HIGHL PRESCR INF PRA; van Diepen S, 2013, CIRC-HEART FAIL, V6, P740, DOI 10.1161/CIRCHEARTFAILURE.113.000212; Vemulapalli S, 2016, AM HEART J, V178, P74, DOI 10.1016/j.ahj.2016.05.001; Verdecchia P, 2018, EUROPACE, V20, P253, DOI 10.1093/europace/eux022; Vinereanu D, 2015, EUR HEART J, V36, P3268, DOI 10.1093/eurheartj/ehv447; Westenbrink BD, 2017, AM HEART J, V185, P140, DOI 10.1016/j.ahj.2016.12.008; Xu HY, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002587; Zelniker TA, 2019, EUR HEART J-ACUTE CA, V8, P176, DOI 10.1177/2048872618790561	64	14	14	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2018	169	11					774	+		10.7326/M18-1523	http://dx.doi.org/10.7326/M18-1523			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC4WR	30383133	Green Accepted			2022-12-28	WOS:000451806000007
J	Martinez-Gonzalez, MA				Martinez-Gonzalez, Miguel A.			Protocol Deviations, Reanalyses, and Corrections to PREDIMED Trial Derivative Study on Peripheral Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Martinez-Gonzalez, Miguel A.] Clin Univ Navarra, Fac Med, Dept Prevent Med & Publ Hlth, Irunlarrea 1, Pamplona 31008, Spain	University of Navarra	Martinez-Gonzalez, MA (corresponding author), Clin Univ Navarra, Fac Med, Dept Prevent Med & Publ Hlth, Irunlarrea 1, Pamplona 31008, Spain.	mamartinez@unav.es	Martinez-Gonzalez, Miguel A./AAE-7669-2019					[Anonymous], 2018, JAMA, V320, P2272, DOI 10.1001/jama.2018.17893; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Ruiz-Canela M, 2014, JAMA-J AM MED ASSOC, V311, P415, DOI 10.1001/jama.2013.280618	3	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2018	320	21					2272	2272		10.1001/jama.2018.16553	http://dx.doi.org/10.1001/jama.2018.16553			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4MB	30398615				2022-12-28	WOS:000452500600026
J	Blakely, T				Blakely, Tony			Major strides in forecasting future health	LANCET			English	Editorial Material									[Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand	University of Otago	Blakely, T (corresponding author), Univ Otago, Dept Publ Hlth, Wellington 6242, New Zealand.	tony.blakely@otago.ac.nz			New Zealand Health Research Council; Australian National Health and Medical Research Council	New Zealand Health Research Council(Health Research Council of New Zealand); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	I have received funding for research on simulation studies from the New Zealand Health Research Council. I am collaborating with Alan Lopez (co-author on Foreman and colleagues' Article) on a grant currently under review by the Australian National Health and Medical Research Council (the project will use data from the Institute for Health Metrics and Evaluation to undertake cost-effectiveness and intervention simulations). I thank Rebecca Bentley, Alistair Woodward, Nick Wilson, and Abie Flaxman for their comments on an earlier draft of this Comment.	Blakely T, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001856; Briggs ADM, 2017, LANCET PUBLIC HEALTH, V2, pE15, DOI 10.1016/S2468-2667(16)30037-8; Foreman KJ, 2018, LANCET; Hoogenveen RT, 2017, MED DECIS MAKING, V37, P403, DOI 10.1177/0272989X16658661; Levy DT, 2016, TOB CONTROL, V25, P413, DOI 10.1136/tobaccocontrol-2015-052334; Murray CJL, 2017, LANCET, V390, P1460, DOI 10.1016/S0140-6736(17)32367-X; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Stevenson M, 2016, LANCET, V388, P2925, DOI 10.1016/S0140-6736(16)30067-8; Veerman L., 2010, ASSESSING COST EFFEC; Woodward A., 2014, HLTH COUNTRY HIST LI; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6	11	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2018	392	10159					E14	E15		10.1016/S0140-6736(18)31861-0	http://dx.doi.org/10.1016/S0140-6736(18)31861-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ8BI	30340848	hybrid			2022-12-28	WOS:000449710900001
J	Foreman, KJ; Marquez, N; Dolgert, A; Fukutaki, K; Fullman, N; McGaughey, M; Pletcher, MA; Smith, AE; Tang, K; Yuan, CW; Brown, JC; Friedman, J; He, JW; Heuton, KP; Holmberg, M; Patel, DJ; Reidy, P; Carter, A; Cercy, K; Capin, A; Douwes-Schultz, D; Frank, T; Goettsch, F; Liu, PY; Nandakumar, V; Reitsma, MB; Reuter, V; Sadat, N; Sorensen, RJD; Srinivasan, V; Updike, RL; York, H; Lopez, AD; Lozano, R; Lim, SS; Mokdad, AH; Vollset, SE; Murray, CJL				Foreman, Kyle J.; Marquez, Neal; Dolgert, Andrew; Fukutaki, Kai; Fullman, Nancy; McGaughey, Madeline; Pletcher, Martin A.; Smith, Amanda E.; Tang, Kendrick; Yuan, Chun-Wei; Brown, Jonathan C.; Friedman, Joseph; He, Jiawei; Heuton, Kyle P.; Holmberg, Mollie; Patel, Disha J.; Reidy, Patrick; Carter, Austin; Cercy, Kelly; Capin, Abigail; Douwes-Schultz, Dirk; Frank, Tahvi; Goettsch, Falko; Liu, Patrick Y.; Nandakumar, Vishnu; Reitsma, Marissa B.; Reuter, Vince; Sadat, Nafis; Sorensen, Reed J. D.; Srinivasan, Vinay; Updike, Rachel L.; York, Hunter; Lopez, Alan D.; Lozano, Rafael; Lim, Stephen S.; Mokdad, Ali H.; Vollset, Stein Emil; Murray, Christoper J. L.			Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories	LANCET			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; UNITED-STATES; PROJECTIONS; DISEASE; HEALTH; TRENDS; SMOKING; POPULATION; DISABILITY	Background Understanding potential trajectories in health and drivers of health is crucial to guiding long -Lentil investments and policy itnpletnentation. Past work on forecasting has provided an incomplete landscape of future health scenarios, highlighting a need for a more robust modelling platform from which policy options and potential health trajectories can be assessed. This study provides a novel approach to modelling life expectancy, all -cause mortality and cause of death forecasts and alternative future scenarios for 250 causes of death from 2016 to 2040 in 195 countries and territories. Methods We modelled 250 causes and cause groups organised by the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) hierarchical cause structure, using GBD 2016 estimates from 1990-2016, to generate predictions for 2017-40. Our modelling framework used data from the GBD 2016 study to systematically account for the relationships between risk factors and health outcomes for 79 independent drivers of health. We developed a three-component model of cause-specific mortality: a component due to changes in risk factors and select interventions; the underlying mortality rate for each cause that is a function of income per capita, educational attainment, and total fertility rate under 25 years and time; and an autoregressive integrated moving average model for unexplained changes correlated with time. We assessed the performance by fitting models with data from 1990-2006 and using these to forecast for 2007-16. Our final model used for generating forecasts and alternative scenarios was fitted to data from 1990-2016. We used this model for 195 countries and territories to generate a reference scenario or forecast through 2040 for each measure by location. Additionally, we generated better health and worse health scenarios based on the 85th and 15th percentiles, respectively, of annualised rates of change across location-years for all the GBD risk factors, income per person, educational attainment, select intervention coverage, and total fertility rate under 25 years in the past. We used the model to generate all-cause age-sex specific mortality, life expectancy, and years of life lost (YLLs) for 250 causes. Scenarios for fertility were also generated and used in a cohort component model to generate population scenarios. For each reference forecast, better health, and worse health scenarios, we generated estimates of mortality and YLLs attributable to each risk factor in the future. Findings Globally, most independent drivers of health were forecast to improve by 2040, but 36 were forecast to worsen. As shown by the better health scenarios, greater progress might be possible, yet for some drivers such as high body-mass index (BMI), their toll will rise in the absence of intervention. We forecasted global life expectancy to increase by 4.4 years (95% UI 2.2 to 6.4) for men and 4.4 years (2.1 to 6.4) for women by 2040, but based on better and worse health scenarios, trajectories could range from a gain of 7.8 years (5.9 to 9.8) to a non-significant loss of 0.4 years (-2.8 to 2.2) for men, and an increase of 7.2 years (5.3 to 9.1) to essentially no change (0.1 years [-2.7 to 2. 5]) for women. In 2040, Japan, Singapore, Spain, and Switzerland had a forecasted life expectancy exceeding 85 years for both sexes, and 59 countries including China were projected to surpass a life expectancy of 80 years by 2040. At the same time, Central African Republic, Lesotho, Sotnalia, and Zimbabwe had projected life expectancies below 65 years in 2040, indicating global disparities in survival are likely to persist if current trends hold. Forecasted YLLs showed a rising toll from several non-communicable diseases (NCDs), partly driven by population growth and ageing. Differences between the reference forecast and alternative scenarios were most striking for HIV/AIDS, for which a potential increase of 120-2% (95% UI 67.2-190.3) in YLLs (nearly 118 million) was projected globally from 2016-40 under the worse health scenario. Compared with 2016, NCDs were forecast to account for a greater proportion of YLLs in all GB D regions by 2040 (67.3% of YLLs [95% UI 61.9-72.3] globally); nonetheless, in many lower-income countries, communicable, maternal, neonatal, and nutritional (CMNN) diseases still accounted for a large share of YLLs in 2040 (eg, 53.5% of YLLs [95% UI 48.3-58.5] in Sub-Saharan Africa). There were large gaps for many health risks between the reference forecast and better health scenario for attributable YLLs. In most countries, metabolic risks amenable to health care (eg, high blood pressure and high plasma fasting glucose) and risks best targeted by population -level or intersectoral interventions (eg, tobacco, high BMI, and ambient particulate matter pollution) had some of the largest differences between reference and better health scenarios. The main exception was sub-Saharan Africa, where many risks associated with poverty and lower levels of development (eg, unsafe water and sanitation, household air pollution, and child malnutrition) were projected to still account for substantive disparities between reference and better health scenarios in 2040. Interpretation With the present study, we provide a robust, flexible forecasting platform from which reference forecasts and alternative health scenarios can be explored in relation to a wide range of independent drivers of health. Our reference forecast points to overall improvements through 2040 in most countries, yet the range found across better and worse health scenarios renders a precarious vision of the future a world with accelerating progress from technical innovation but with the potential for worsening health outcomes in the absence of deliberate policy action. For some causes of YLLs, large differences between the reference forecast and alternative scenarios reflect the opportunity to accelerate gains if countries move their trajectories toward better health scenarios or alarming challenges if countries fall behind their reference forecasts. Generally, decision makers should plan for the likely continued shift toward NCDs and target resources toward the modifiable risks that drive substantial premature mortality. If such modifiable risks are prioritised today, there is opportunity to reduce avoidable mortality in the future. However, CMNN causes and related risks will remain the predominant health priority among lower -income countries. Based on our 2040 worse health scenario, there is a real risk of HIV mortality rebounding if countries lose momentum against the HIV epidemic, jeopardising decades of progress against the disease. Continued technical innovation and increased health spending, including development assistance for health targeted to the world's poorest people, are likely to remain vital components to charting a future where all populations can live full, healthy lives. Copyright 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Foreman, Kyle J.; Dolgert, Andrew; Fukutaki, Kai; Fullman, Nancy; McGaughey, Madeline; Pletcher, Martin A.; Smith, Amanda E.; Tang, Kendrick; Yuan, Chun-Wei; Brown, Jonathan C.; Patel, Disha J.; Carter, Austin; Cercy, Kelly; Douwes-Schultz, Dirk; Frank, Tahvi; Goettsch, Falko; Nandakumar, Vishnu; Reitsma, Marissa B.; Sadat, Nafis; Sorensen, Reed J. D.; Srinivasan, Vinay; Updike, Rachel L.; Lim, Stephen S.; Mokdad, Ali H.; Vollset, Stein Emil; Murray, Christoper J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Marquez, Neal] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Friedman, Joseph] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Liu, Patrick Y.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [He, Jiawei] Baidu, Beijing, Peoples R China; [Heuton, Kyle P.] OM1, Boston, MA USA; [Holmberg, Mollie] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Reidy, Patrick] Wellframe, Boston, MA USA; [Reuter, Vince] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baidu; University of British Columbia; Memorial Sloan Kettering Cancer Center; University of Melbourne; Instituto Nacional de Salud Publica	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu	Reitsma, Marissa/AAE-7719-2020; Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Mokdad, Ali H./AAD-1232-2022; Friedman, Joseph/ABA-5864-2020	Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; Mokdad, Ali H./0000-0002-4994-3339; Friedman, Joseph/0000-0002-5225-3267; Douwes-Schultz, Dirk/0000-0002-6186-2275; Carter, Austin/0000-0002-3588-6142; Frank, Tahvi/0000-0002-1972-782X; Srinivasan, Vinay/0000-0001-5779-5068; York, Hunter/0000-0001-5084-5966	NCI NIH HHS [P30 CA008748] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2018, CLIMATE CHANGE HLTH; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Banister J, 2012, CHIN EC NEW TRANSIT, P114, DOI DOI 10.1057/9781137034298_7; Cardona C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5058-9; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Cori A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084511; DE BEER J., 1997, J OFF STAT, V13, P227; de Kraker MEA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002184; Dieleman JL, 2018, LANCET, P2016; Etkind SN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0860-2; Fagnant DJ, 2015, TRANSPORT RES A-POL, V77, P167, DOI 10.1016/j.tra.2015.04.003; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fransham M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1946; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Guzman-Castillo M, 2017, LANCET PUBLIC HEALTH, V2, pE307, DOI 10.1016/S2468-2667(17)30091-9; Harper S, 2014, SCIENCE, V346, P587, DOI 10.1126/science.1254405; Hegre H, 2013, INT STUD QUART, V57, P250, DOI 10.1111/isqu.12007; Honda Y, 2014, ENVIRON HEALTH PREV, V19, P56, DOI 10.1007/s12199-013-0354-6; Hughes BB, 2011, B WORLD HEALTH ORGAN, V89, P478, DOI 10.2471/BLT.10.083766; Keilman N, 2004, EMPIRICAL ERRORS PRE; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Lager ACJ, 2012, P NATL ACAD SCI USA, V109, P8461, DOI 10.1073/pnas.1105839109; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 2018, LANCET, V392, P1995, DOI 10.1016/s0140-6736(18)32278-5; Murray CJL, 2017, LANCET, V390, P1460, DOI 10.1016/S0140-6736(17)32367-X; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; O'Neill J, 2014, ANTIMICROBIAL RESIST; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; ONeill J., 2016, TACKLING DRUG RESIST; Peltonen M, 1996, STROKE, V27, P1981, DOI 10.1161/01.STR.27.11.1981; Preston SH, 2014, DEMOGRAPHY, V51, P27, DOI 10.1007/s13524-013-0246-9; Quinn MJ, 2003, ANN ONCOL, V14, P1148, DOI 10.1093/annonc/mdg307; Raftery AE, 2013, DEMOGRAPHY, V50, P777, DOI 10.1007/s13524-012-0193-x; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Stover J., 2014, AIDS; Takayama N., 1993, GREYING JAPAN EC PER; True Fit, 2018, STAT RET FOOTW APP S; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD POP PROSP 2017; Wee D., 10 WAYS AUTONOMOUS D; Wilmoth J. R., 1996, HLTH MORTALITY ELDER, P266	52	723	754	30	200	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	2018	392	10159					2052	2090		10.1016/S0140-6736(18)31694-5	http://dx.doi.org/10.1016/S0140-6736(18)31694-5			39	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GZ8BI	30340847	Green Published, hybrid			2022-12-28	WOS:000449710900009
J	Cheng, Z; Zhou, HF; Lu, QH; Gao, HJ; Lu, L				Cheng, Zhao; Zhou, Haofei; Lu, Qiuhong; Gao, Huajian; Lu, Lei			Extra strengthening and work hardening in gradient nanotwinned metals	SCIENCE			English	Article							DEFORMATION MECHANISMS; ULTRAHIGH STRENGTH; STAINLESS-STEEL; GROWTH TWINS; PLASTICITY; ORIENTATION; MICROSTRUCTURE; BOUNDARIES; EVOLUTION; DUCTILITY	Gradient structures exist ubiquitously in nature and are increasingly being introduced in engineering. However, understanding structural gradient-related mechanical behaviors in all gradient structures, including those in engineering materials, has been challenging. We explored the mechanical performance of a gradient nanotwinned structure with highly tunable structural gradients in pure copper. A large structural gradient allows for superior work hardening and strength that can exceed those of the strongest component of the gradient structure. We found through systematic experiments and atomistic simulations that this unusual behavior is afforded by a unique patterning of ultrahigh densities of dislocations in the grain interiors. These observations not only shed light on gradient structures, but may also indicate a promising route for improving the mechanical properties of materials through gradient design.	[Cheng, Zhao; Lu, Qiuhong; Lu, Lei] Chinese Acad Sci, Inst Met Res, Shengyang Natl Lab Mat Sci, Shenyang 110016, Liaoning, Peoples R China; [Cheng, Zhao] Univ Sci & Technol China, Sch Mat Sci & Engn, Shenyang 110016, Liaoning, Peoples R China; [Zhou, Haofei; Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Chinese Academy of Sciences; Institute of Metal Research, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Brown University	Lu, L (corresponding author), Chinese Acad Sci, Inst Met Res, Shengyang Natl Lab Mat Sci, Shenyang 110016, Liaoning, Peoples R China.; Gao, HJ (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	huajian_gao@brown.edu; llu@imr.ac.cn	Lu, Lei/E-3864-2012; Gao, Huajian/F-9360-2010; Zhou, Haofei/O-7282-2018	Gao, Huajian/0000-0002-8656-846X; Zhou, Haofei/0000-0001-9226-9530; Cheng, Zhao/0000-0002-2392-5773	NSFC [51471172, U1608257]; Key Research Program of Frontier Science, CAS; National Basic Research Program of China (973 Program) [2012CB932202]; NSFC International collaboration grant [51420105001]; NSF [DMR-1709318]; XSEDE [MS090046]	NSFC(National Natural Science Foundation of China (NSFC)); Key Research Program of Frontier Science, CAS; National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC International collaboration grant; NSF(National Science Foundation (NSF)); XSEDE	Supported by NSFC grants 51471172 and U1608257, the Key Research Program of Frontier Science, CAS and the National Basic Research Program of China (973 Program, 2012CB932202) (L.L.); NSFC International collaboration grant 51420105001 (L.L. and H.G.); and NSF grant DMR-1709318 and XSEDE grant MS090046 (H.Z. and H.G.).	Asaro RJ, 2005, ACTA MATER, V53, P3369, DOI 10.1016/j.actamat.2005.03.047; ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; Beyerlein IJ, 2014, ANNU REV MATER RES, V44, P329, DOI 10.1146/annurev-matsci-070813-113304; Chakravarthy SS, 2011, P NATL ACAD SCI USA, V108, P15716, DOI 10.1073/pnas.1107035108; DICKSON JI, 1984, MATER SCI ENG, V64, pL7, DOI 10.1016/0025-5416(84)90083-1; Edalati K, 2008, MAT SCI ENG A-STRUCT, V497, P168, DOI 10.1016/j.msea.2008.06.039; Faken D., 1994, Computational Materials Science, V2, P279, DOI 10.1016/0927-0256(94)90109-0; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; Feaugas X, 1999, ACTA MATER, V47, P3617, DOI 10.1016/S1359-6454(99)00222-0; FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9; Fleck NA, 2003, SCRIPTA MATER, V48, P179, DOI 10.1016/S1359-6462(02)00338-X; Gao H, 1999, J MECH PHYS SOLIDS, V47, P1239, DOI 10.1016/S0022-5096(98)00103-3; Gurtin ME, 2005, J MECH PHYS SOLIDS, V53, P1624, DOI 10.1016/j.jmps.2004.12.008; HOOVER WG, 1986, PHYS REV A, V34, P2499, DOI 10.1103/PhysRevA.34.2499; Hughes DA, 2003, SCRIPTA MATER, V48, P147, DOI 10.1016/S1359-6462(02)00358-5; Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8; Kouzeli M, 2002, ACTA MATER, V50, P39, DOI 10.1016/S1359-6454(01)00327-5; Li JJ, 2010, MAT SCI ENG A-STRUCT, V527, P7040, DOI 10.1016/j.msea.2010.07.064; Liu ZQ, 2017, PROG MATER SCI, V88, P467, DOI 10.1016/j.pmatsci.2017.04.013; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu K, 2015, ACTA METALL SIN, V51, P1; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu QH, 2017, ACTA MATER, V127, P85, DOI 10.1016/j.actamat.2017.01.016; Ma XL, 2015, SCRIPTA MATER, V103, P57, DOI 10.1016/j.scriptamat.2015.03.006; Ma XL, 2016, ACTA MATER, V116, P43, DOI 10.1016/j.actamat.2016.06.023; Malygin GA, 2002, PHYS SOLID STATE+, V44, P1305, DOI 10.1134/1.1494626; Mishin Y, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224106; Misra A, 2005, ACTA MATER, V53, P4817, DOI 10.1016/j.actamat.2005.06.025; Mughrabi H, 2006, PHILOS MAG, V86, P4037, DOI 10.1080/14786430500509054; Nix WD, 1998, SCRIPTA MATER, V39, P545, DOI 10.1016/S1359-6462(98)00195-X; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Pan QS, 2017, NATURE, V551, P214, DOI 10.1038/nature24266; Roland T, 2006, SCRIPTA MATER, V54, P1949, DOI 10.1016/j.scriptamat.2006.01.049; Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716; Swadener JG, 2002, J MECH PHYS SOLIDS, V50, P681, DOI 10.1016/S0022-5096(01)00103-X; Thevamaran R, 2016, SCIENCE, V354, P312, DOI 10.1126/science.aag1768; Ungar T, 2007, MAT SCI ENG A-STRUCT, V462, P398, DOI 10.1016/j.msea.2006.03.156; Ungar T, 2014, ACTA MATER, V66, P251, DOI 10.1016/j.actamat.2013.11.012; Viladot D, 2013, J MICROSC-OXFORD, V252, P23, DOI 10.1111/jmi.12065; Wang HT, 2013, SCRIPTA MATER, V68, P22, DOI 10.1016/j.scriptamat.2012.05.041; Wang H, 2018, MATER RES LETT, V6, P333, DOI 10.1080/21663831.2018.1455752; Wang J, 2010, ACTA MATER, V58, P2262, DOI 10.1016/j.actamat.2009.12.013; Wei YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4580; Wu XL, 2014, MATER RES LETT, V2, P185, DOI 10.1080/21663831.2014.935821; Wu XL, 2015, P NATL ACAD SCI USA, V112, P14501, DOI 10.1073/pnas.1517193112; Wu XL, 2014, P NATL ACAD SCI USA, V111, P7197, DOI 10.1073/pnas.1324069111; Wu ZX, 2009, ACTA MATER, V57, P4508, DOI 10.1016/j.actamat.2009.06.015; Xu W, 2018, ACTA MATER, V152, P138, DOI 10.1016/j.actamat.2018.04.014; You ZS, 2011, ACTA MATER, V59, P6927, DOI 10.1016/j.actamat.2011.07.044; You ZS, 2013, ACTA MATER, V61, P217, DOI 10.1016/j.actamat.2012.09.052; Zeng Z, 2016, EXTREME MECH LETT, V8, P213, DOI 10.1016/j.eml.2015.12.005; Zhang P, 2011, MAT SCI ENG A-STRUCT, V529, P62, DOI 10.1016/j.msea.2011.08.061; Zhao ST, 2017, P NATL ACAD SCI USA, V114, P9791, DOI 10.1073/pnas.1708853114	53	341	353	72	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		559	+	eaau1925	10.1126/science.aau1925	http://dx.doi.org/10.1126/science.aau1925			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385547				2022-12-28	WOS:000450460000039
J	Oliver, D				Oliver, David			David Oliver: Incendiary healthcare hashtags David Oliver consultant in geriatrics and acute general medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2018	363								k4593	10.1136/bmj.k4593	http://dx.doi.org/10.1136/bmj.k4593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ6QK	30389697	Bronze			2022-12-28	WOS:000449566000002
J	Advani, R; Flinn, I; Popplewell, L; Forero, A; Bartlett, NL; Ghosh, N; Kline, J; Roschewski, M; LaCasce, A; Collins, GP; Tran, T; Lynn, J; Chen, JY; Volkmer, JP; Agoram, B; Huang, J; Majeti, R; Weissman, IL; Takimoto, CH; Chao, MP; Smith, SM				Advani, Ranjana; Flinn, Ian; Popplewell, Leslie; Forero, Andres; Bartlett, Nancy L.; Ghosh, Nilanjan; Kline, Justin; Roschewski, Mark; LaCasce, Ann; Collins, Graham P.; Thu Tran; Lynn, Judith; Chen, James Y.; Volkmer, Jens-Peter; Agoram, Balaji; Huang, Jie; Majeti, Ravindra; Weissman, Irving L.; Takimoto, Chris H.; Chao, Mark P.; Smith, Sonali M.			CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; FOLLICULAR LYMPHOMA; STEM-CELLS; OPEN-LABEL; PHAGOCYTOSIS; OBINUTUZUMAB; MULTICENTER; TARGET; CANCER	BACKGROUND The Hu5F9-G4 (hereafter, 5F9) antibody is a macrophage immune checkpoint inhibitor blocking CD47 that induces tumor-cell phagocytosis. 5F9 synergizes with rituximab to eliminate B-cell non-Hodgkin's lymphoma cells by enhancing macrophage-mediated antibody-dependent cellular phagocytosis. This combination was evaluated clinically. METHODS We conducted a phase 1b study involving patients with relapsed or refractory non-Hodgkin's lymphoma. Patients may have had diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma. 5F9 (at a priming dose of 1 mg per kilogram of body weight, administered intravenously, with weekly maintenance doses of 10 to 30 mg per kilogram) was given with rituximab to determine safety and efficacy and to suggest a phase 2 dose. RESULTS A total of 22 patients (15 with DLBCL and 7 with follicular lymphoma) were enrolled. Patients had received a median of 4 (range, 2 to 10) previous therapies, and 95% of the patients had disease that was refractory to rituximab. Adverse events were predominantly of grade 1 or 2. The most common adverse events were anemia and infusion-related reactions. Anemia (an expected on-target effect) was mitigated by the strategy of 5F9 prime and maintenance dosing. Dose-limiting side effects were rare. A selected phase 2 dose of 30 mg of 5F9 per kilogram led to an approximate 100% CD47-receptor occupancy on circulating white and red cells. A total of 50% of the patients had an objective (i.e., complete or partial) response, with 36% having a complete response. The rates of objective response and complete response were 40% and 33%, respectively, among patients with DLBCL and 71% and 43%, respectively, among those with follicular lymphoma. At a median follow-up of 6.2 months among patients with DLBCL and 8.1 months among those with follicular lymphoma, 91% of the responses were ongoing. CONCLUSIONS The macrophage checkpoint inhibitor 5F9 combined with rituximab showed promising activity in patients with aggressive and indolent lymphoma. No clinically significant safety events were observed in this initial study. (Funded by Forty Seven and the Leukemia and Lymphoma Society; ClinicalTrials. gov number, NCT02953509.)	[Advani, Ranjana; Thu Tran; Majeti, Ravindra; Weissman, Irving L.] Stanford Univ, Stanford, CA 94305 USA; [Popplewell, Leslie] City Hope Natl Med Ctr, Duarte, CA USA; [Lynn, Judith; Chen, James Y.; Volkmer, Jens-Peter; Agoram, Balaji; Huang, Jie; Majeti, Ravindra; Weissman, Irving L.; Takimoto, Chris H.; Chao, Mark P.] Forty Seven, Menlo Pk, CA USA; [Flinn, Ian] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA; [Forero, Andres] Univ Alabama Birmingham, Birmingham, AL USA; [Bartlett, Nancy L.] Washington Univ, St Louis, MO 63130 USA; [Ghosh, Nilanjan] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA; [Kline, Justin; Smith, Sonali M.] Univ Chicago, Chicago, IL 60637 USA; [Roschewski, Mark] NCI, Rockville, MD USA; [LaCasce, Ann] Dana Farber Canc Inst, Boston, MA 02115 USA; [Collins, Graham P.] Univ Oxford, Oxford, England	Stanford University; City of Hope; Sarah Cannon Research Institute; Tennessee Oncology; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; University of Oxford	Advani, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	radvani@stanford.edu	Smith, Sonali/AAD-9328-2020	Bartlett, Nancy/0000-0001-8470-394X; Collins, Graham/0000-0002-8803-4234; Advani, Ranjana/0000-0002-3219-2292; Majeti, Ravindra/0000-0002-5814-0984	Leukemia and Lymphoma Society; Forty Seven; NATIONAL CANCER INSTITUTE [ZIABC011916] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Forty Seven; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Forty Seven and the Leukemia and Lymphoma Society.	Casulo C, 2015, J CLIN ONCOL, V33, P2516, DOI 10.1200/JCO.2014.59.7534; Chao MP, 2011, BLOOD, V118, P4890, DOI 10.1182/blood-2011-02-338020; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Crump M, 2017, BLOOD, V130, P1800, DOI 10.1182/blood-2017-03-769620; Czuczman MS, 2017, CLIN CANCER RES, V23, P4127, DOI 10.1158/1078-0432.CCR-16-2818; Department of Health and Human Services, 2010, COMM TERM CRIT ADV E; Gholamin S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf2968; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Marcus R, 2017, NEW ENGL J MED, V377, P1331, DOI 10.1056/NEJMoa1614598; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Palanca-Wessels MCA, 2015, LANCET ONCOL, V16, P704, DOI 10.1016/S1470-2045(15)70128-2; Sehn LH, 2016, LANCET ONCOL, V17, P1081, DOI 10.1016/S1470-2045(16)30097-3; Solal-Celigny P, 2018, BRIT J HAEMATOL, V180, P217, DOI 10.1111/bjh.15023; Taylor RP, 2010, SEMIN HEMATOL, V47, P124, DOI 10.1053/j.seminhematol.2010.01.006; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Younes A, 2017, NAT REV CLIN ONCOL, V14, P335, DOI 10.1038/nrclinonc.2016.205	26	516	541	18	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2018	379	18					1711	1721		10.1056/NEJMoa1807315	http://dx.doi.org/10.1056/NEJMoa1807315			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OL	30380386	Green Accepted, Bronze			2022-12-28	WOS:000448891600006
J	Boytchev, H				Boytchev, Hristio			A EUROPEAN HEAVYWEIGHT	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					S14	S15		10.1038/d41586-018-07208-0	http://dx.doi.org/10.1038/d41586-018-07208-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382228				2022-12-28	WOS:000448900900011
J	Gubin, MM; Esaulova, E; Ward, JP; Malkova, ON; Runci, D; Wong, P; Noguchi, T; Arthur, CD; Meng, W; Alspach, E; Medrano, RFV; Fronick, C; Fehlings, M; Newell, EW; Fulton, RS; Sheehan, KCF; Oh, ST; Schreiber, RD; Artyomov, MN				Gubin, Matthew M.; Esaulova, Ekaterina; Ward, Jeffrey P.; Malkova, Olga N.; Runci, Daniele; Wong, Pamela; Noguchi, Takuro; Arthur, Cora D.; Meng, Wei; Alspach, Elise; Medrano, Ruan F. V.; Fronick, Catrina; Fehlings, Michael; Newell, Evan W.; Fulton, Robert S.; Sheehan, Kathleen C. F.; Oh, Stephen T.; Schreiber, Robert D.; Artyomov, Maxim N.			High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy	CELL			English	Article							REGULATORY T-CELLS; GENE-EXPRESSION; SINGLE CELLS; IFN-GAMMA; TUMOR; ANTI-CTLA-4; ACTIVATION; BLOCKADE; REVEALS; IMMUNOTHERAPY	Although current immune-checkpoint therapy (ICT) mainly targets lymphoid cells, it is associated with a broader remodeling of the tumor micro-environment. Here, using complementary forms of high-dimensional profiling, we define differences across all hematopoietic cells from syngeneic mouse tumors during unrestrained tumor growth or effective ICT. Unbiased assessment of gene expression of tumor-infiltrating cells by single-cell RNA sequencing (scRNAseq) and longitudinal assessment of cellular protein expression by mass cytometry (CyTOF) revealed significant remodeling of both the lymphoid and myeloid intratumoral compartments. Surprisingly, we observed multiple subpopulations of monocytes/macrophages, distinguishable by the markers CD206, CX3CR1, CD1d, and iNOS, that change over time during ICT in a manner partially dependent on IFN gamma. Our data support the hypothesis that this macrophage polarization/activation results from effects on circulatory monocytes and early macrophages entering tumors, rather than on pre-polarized mature intratumoral macrophages.	[Gubin, Matthew M.; Esaulova, Ekaterina; Ward, Jeffrey P.; Runci, Daniele; Wong, Pamela; Arthur, Cora D.; Meng, Wei; Alspach, Elise; Medrano, Ruan F. V.; Sheehan, Kathleen C. F.; Schreiber, Robert D.; Artyomov, Maxim N.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA; [Gubin, Matthew M.; Ward, Jeffrey P.; Malkova, Olga N.; Runci, Daniele; Arthur, Cora D.; Meng, Wei; Alspach, Elise; Medrano, Ruan F. V.; Sheehan, Kathleen C. F.; Oh, Stephen T.; Schreiber, Robert D.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA; [Esaulova, Ekaterina] ITMO Univ, Comp Technol Dept, St Petersburg 197110, Russia; [Ward, Jeffrey P.] Washington Univ, Sch Med, Dept Med, Div Oncol, 660 South Euclid Ave, St Louis, MO 63110 USA; [Noguchi, Takuro] Shinshu Univ, Sch Med, Dept Comprehens Canc Therapy, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Fronick, Catrina; Fulton, Robert S.] Washington Univ, Sch Med, McDonnell Genome Inst, 4444 Forest Pk Ave, St Louis, MO 63108 USA; [Fehlings, Michael; Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, 8 A Biomed Grove, Singapore 138648, Singapore; [Oh, Stephen T.] Washington Univ, Sch Med, Div Hematol, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); ITMO University; Washington University (WUSTL); Shinshu University; Washington University (WUSTL); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Washington University (WUSTL)	Schreiber, RD; Artyomov, MN (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.; Schreiber, RD (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.	rdschreiber@wustl.edu; martyomov@wustl.edu	Newell, Evan W/F-9711-2012; Noguchi, Takuro/AAW-9101-2020; Schreiber, Robert/Q-7550-2019	Newell, Evan W/0000-0002-2889-243X; Ward, Jeffrey/0000-0002-9707-895X; Gubin, Matthew/0000-0001-7443-2752; Wong, Pamela/0000-0002-6856-2603; Alspach, Elise/0000-0002-2740-9768; Schreiber, Robert/0000-0003-1590-2341	National Cancer Institute of the National Institutes of Health [RO1CA190700]; Parker Institute for Cancer Immunotherapy, the Cancer Research Institute; Janssen Pharmaceutical Company of Johnson and Johnson; Prostate Cancer Foundation; Stand Up To Cancer Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant; Cancer Research Institute; Government of Russian Federation [08-08]; National Cancer Institute of the National Institutes of Health Paul Calabresi Career Development Award in Clinical Oncology [K12CA167540]; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs; National Cancer Institute of the National Institutes of Health Cancer Center Support Grant [P30CA91842]; NATIONAL CANCER INSTITUTE [K12CA167540, R01CA190700, P30CA091842] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Parker Institute for Cancer Immunotherapy, the Cancer Research Institute; Janssen Pharmaceutical Company of Johnson and Johnson; Prostate Cancer Foundation; Stand Up To Cancer Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant; Cancer Research Institute; Government of Russian Federation; National Cancer Institute of the National Institutes of Health Paul Calabresi Career Development Award in Clinical Oncology; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs; National Cancer Institute of the National Institutes of Health Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank all members of the Schreiber and Artyomov labs for helpful discussions and technical support. We especially thank K. Zaitsev (Artyomov lab) for computational discussions. We thank the staff at ITMO University for assistance with the graphical abstract. We thank E. Unanue and G. Randolph (Washington University) for helpful comments and criticisms. We would also like to thank L. Yang and C. Wilson for assistance with MHC multimer development and staining. We thank E. Lantelme and D. Brinja at the Flow Cytometry Core for technical support with flow cytometry cell sorting. This work was supported by grants to R.D.S. and subcontract to E.W.N. from the National Cancer Institute of the National Institutes of Health under award number RO1CA190700. This work was also supported by grants to R.D.S. from the Parker Institute for Cancer Immunotherapy, the Cancer Research Institute, Janssen Pharmaceutical Company of Johnson and Johnson, and the Prostate Cancer Foundation and by a Stand Up To Cancer Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.M.G. was supported by a post-doctoral training grant (Irvington Postdoctoral Fellowship) from the Cancer Research Institute. E.E. is partially supported by a grant (08-08) from the Government of Russian Federation. J.P.W. is supported by the National Cancer Institute of the National Institutes of Health Paul Calabresi Career Development Award in Clinical Oncology (K12CA167540). Aspects of studies including mass cytometry were performed with assistance by the Immunomonitoring Laboratory (IML), which is supported by the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs and the Alvin J. Siteman Comprehensive Cancer Center that, in turn, is supported by National Cancer Institute of the National Institutes of Health Cancer Center Support Grant under award number P30CA91842. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Fehlings M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00627-z; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gubin MM, 2015, J CLIN INVEST, V125, P3413, DOI 10.1172/JCI80008; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noguchi T, 2017, CANCER IMMUNOL RES, V5, P106, DOI 10.1158/2326-6066.CIR-16-0391; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	31	171	174	6	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	2018	175	4					1014	+		10.1016/j.cell.2018.09.030	http://dx.doi.org/10.1016/j.cell.2018.09.030			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GZ1BO	30343900	Green Accepted, Bronze			2022-12-28	WOS:000449100600015
J	Landhuis, E				Landhuis, Esther			TAPPING INTO THE BRAIN'S STAR POWER	NATURE			English	Editorial Material							ASTROCYTES; IDENTIFICATION											Cabrera R, 2017, ACS CHEM NEUROSCI, V8, P1036, DOI 10.1021/acschemneuro.7b00083; Caiazzo M, 2015, STEM CELL REP, V4, P25, DOI 10.1016/j.stemcr.2014.12.002; Canals I., 2018, PROTOC EXCH, DOI [10.1038/protex.2018.088, DOI 10.1038/PROTEX.2018.088]; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Challis R. C., 2018, PREPRINT, DOI [10.1101/246405, DOI 10.1101/246405]; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Octeau JC, 2018, NEURON, V98, P49, DOI 10.1016/j.neuron.2018.03.003; Yu XZ, 2018, NEURON, V99, P1170, DOI 10.1016/j.neuron.2018.08.015	12	2	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2018	563	7729					141	143		10.1038/d41586-018-07197-0	http://dx.doi.org/10.1038/d41586-018-07197-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GY8RS	30382209				2022-12-28	WOS:000448900900061
J	Sharp, WD; Paces, JB				Sharp, Warren D.; Paces, James B.			Comment on "The earliest modern humans outside Africa"	SCIENCE			English	Editorial Material							HOMINID BURIAL SITE; ESR DATES; ISRAEL; CARMEL; SKHUL	Hershkovitz et al. (Reports, 26 January 2018, p. 456) interpreted the Misliya-1 fossil maxilla as evidence of the earliest known anatomically modern human outside Africa. However, the fossil's reported age of 177,000 to 194,000 years relies on flawed interpretations of uranium-series data. We contend that those data support a minimum age of no more than similar to 60,000 to 70,000 years.	[Sharp, Warren D.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Paces, James B.] US Geol Survey, Denver Radiogen Isotope Lab, Denver Fed Ctr, Box 25046,MS963, Denver, CO 80225 USA	Berkeley Geochronolgy Center; United States Department of the Interior; United States Geological Survey	Sharp, WD (corresponding author), Berkeley Geochronol Ctr, Berkeley, CA 94709 USA.	wsharp@bgc.org		Paces, James/0000-0002-9809-8493				Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Ludwig K.R., 2012, BERKELEY GEOCHRONOLO, V5; Ludwig KR, 2002, GEOCHIM COSMOCHIM AC, V66, P487, DOI 10.1016/S0016-7037(01)00786-4; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; Oerter EJ, 2016, P NATL ACAD SCI USA, V113, P919, DOI 10.1073/pnas.1515478113; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Valladas H, 2013, J HUM EVOL, V65, P585, DOI 10.1016/j.jhevol.2013.07.005	9	9	9	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2018	362	6413							eaat6598	10.1126/science.aat6598	http://dx.doi.org/10.1126/science.aat6598			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HA7DR	30361342				2022-12-28	WOS:000450441900001
J	Love, N; Shafer, A				Love, Nick; Shafer, Audrey			Medicine and Frankenstein-An Artistic Commemoration of the Novel's Bicentennial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HISTORY		[Love, Nick; Shafer, Audrey] Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA; [Shafer, Audrey] Stanford Univ, Sch Med, Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Shafer, Audrey] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Love, N (corresponding author), Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA.	nicklove@stanford.edu			Stanford Medicine; Muse Program Frankenstein@200 Initiative; Stanford School of Medicine Art Committee; Office of Facilities Planning and Management; Drs Ben and A. Jess Shenson Funds	Stanford Medicine; Muse Program Frankenstein@200 Initiative; Stanford School of Medicine Art Committee; Office of Facilities Planning and Management; Drs Ben and A. Jess Shenson Funds	This work was supported by the Stanford Medicine and the Muse Program Frankenstein@200 Initiative and The Drs Ben and A. Jess Shenson Funds, with faculty mentorship by Samuel Rodriguez, MD. The exhibit installation was supported by the Stanford School of Medicine Art Committee and the Office of Facilities Planning and Management.	Abyaneh MAY, 2014, JAMA DERMATOL, V150, P1062, DOI 10.1001/jamadermatol.2014.704; Greenberg SA, 2003, ARCH NEUROL-CHICAGO, V60, P126, DOI 10.1001/archneur.60.1.126; Paul SP, 2017, J DERMATOL RES, V2, P77, DOI DOI 10.17554/J.ISSN.2413-8223.2017.02.19; Shelley M.W., 1998, FRANKENSTEIN MODERN; van den Belt H, 2018, SCIENCE, V359, P137, DOI 10.1126/science.aas9167	5	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1624	1626		10.1001/jama.2018.12998	http://dx.doi.org/10.1001/jama.2018.12998			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357277				2022-12-28	WOS:000448069100001
J	[Anonymous]				[Anonymous]			Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study (vol 363, k4067, 2018)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4067	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 23	2018	363								k4445	10.1136/bmj.k4445	http://dx.doi.org/10.1136/bmj.k4445			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8PE	30352789	Green Published, Bronze			2022-12-28	WOS:000448893800003
J	[Anonymous]				[Anonymous]			The Congenial Calories of the Candy Shop (Reprinted from JAMA, vol 71, pg 1410, 1918)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Benedict CC, 1918, BOSTON MED SURG J, V179, P153, DOI 10.1056/NEJM191808011790502; 1918, JAMA, V71, P1410	2	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2018	320	16					1713	1713		10.1001/jama.2017.12633	http://dx.doi.org/10.1001/jama.2017.12633			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX8UQ	30357283				2022-12-28	WOS:000448069100036
J	Torjesen, I				Torjesen, Ingrid			Medical institute withdraws peer's invitation over "allegations of anti-Semitic sentiment"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bright M, 2010, JEWISH CHRONICLE; Secretary of State for Communities and Local Government, 2016, GOV RESP HOM AFF COM; Summerfield DA, 2007, BRIT MED J, V335, P842, DOI 10.1136/bmj.39374.493218.BE; Tonge J, 2007, BMJ	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2018	363								k4459	10.1136/bmj.k4459	http://dx.doi.org/10.1136/bmj.k4459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GY8OW	30348835				2022-12-28	WOS:000448892800009
J	Horton, R				Horton, Richard			Offline: The fetishisation of "global"	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1387	1387		10.1016/S0140-6736(18)32588-1	http://dx.doi.org/10.1016/S0140-6736(18)32588-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343851				2022-12-28	WOS:000447800900014
J	Beaulieu-Laroche, L; Toloza, EHS; van der Goes, MS; Lafourcade, M; Barnagian, D; Williams, ZM; Eskandar, EN; Frosch, MP; Cash, SS; Harnett, MT				Beaulieu-Laroche, Lou; Toloza, Enrique H. S.; van der Goes, Marie-Sophie; Lafourcade, Mathieu; Barnagian, Derrick; Williams, Ziv M.; Eskandar, Emad N.; Frosch, Matthew P.; Cash, Sydney S.; Harnett, Mark T.			Enhanced Dendritic Compartmentalization in Human Cortical Neurons	CELL			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; VOLTAGE-CLAMP; IN-VIVO; SYNAPTIC INTEGRATION; ACTION-POTENTIALS; CORTEX NEURONS; MECHANISMS; CHANNELS; SPIKES; INPUT	The biophysical features of neurons shape information processing in the brain. Cortical neurons are larger in humans than in other species, but it is unclear how their size affects synaptic integration. Here, we perform direct electrical recordings from human dendrites and report enhanced electrical compartmentalization in layer 5 pyramidal neurons. Compared to rat dendrites, distal human dendrites provide limited excitation to the soma, even in the presence of dendritic spikes. Human somas also exhibit less bursting due to reduced recruitment of dendritic electrogenesis. Finally, we find that decreased ion channel densities result in higher input resistance and underlie the lower coupling of human dendrites. We conclude that the increased length of human neurons alters their input-output properties, which will impact cortical computation.	[Beaulieu-Laroche, Lou; Toloza, Enrique H. S.; van der Goes, Marie-Sophie; Lafourcade, Mathieu; Barnagian, Derrick; Harnett, Mark T.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Williams, Ziv M.; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Cash, Sydney S.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Cash, Sydney S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Harnett, MT (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Cash, SS (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA USA.; Cash, SS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	scash@mgh.harvard.edu; harnett@mit.edu	Frosch, Matthew P/ABD-7456-2021; Lafourcade, Mathieu/GQZ-7267-2022	Frosch, Matthew P/0000-0002-3940-9861; Lafourcade, Mathieu/0000-0001-6117-1194; /0000-0001-5251-6664	Natural Sciences and Engineering Research Council of Canada (NSERC) [PGSD2-517068-2018]; Dana Foundation David Mahoney Neuroimaging Grant Program; NIH [RO1NS106031]; Klingenstein-Simons Fellowship Awards in Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS106031, R21NS103098] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dana Foundation David Mahoney Neuroimaging Grant Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein-Simons Fellowship Awards in Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Robert Desimone, Michale Fee, Sabbi Lall, and Michael Tadross for comments on the manuscript, as well as Richard Naud and Aaron Milstein for constructive criticism on the modeling. We also thank Jakob Voigts for help with statistical analyses and Yangling Chou for assistance in acquiring human tissue. We acknowledge the support of the Natural Sciences and Engineering Research Council of Canada (NSERC) (PGSD2-517068-2018 to L.B.-L.), the Dana Foundation David Mahoney Neuroimaging Grant Program, the NIH (RO1NS106031), and the Klingenstein-Simons Fellowship Awards in Neuroscience (M.T.H.).	Atkinson SE, 2009, J NEUROPHYSIOL, V102, P735, DOI 10.1152/jn.00083.2009; Beaulieu-Laroche L, 2018, NEURON, V97, P75, DOI 10.1016/j.neuron.2017.11.016; Carnevale NT, 2006, NEURON BOOK; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Dembrow NC, 2015, J NEUROSCI, V35, P4501, DOI 10.1523/JNEUROSCI.4673-14.2015; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Elston GN, 2001, J NEUROSCI, V21; Eyal G, 2016, ELIFE, V5, DOI 10.7554/eLife.16553; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Guerguiev J, 2017, ELIFE, V6, DOI 10.7554/eLife.22901; Halgren M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20662-0; Harnett MT, 2015, J NEUROSCI, V35, P1024, DOI 10.1523/JNEUROSCI.2813-14.2015; Harnett MT, 2013, NEURON, V79, P516, DOI 10.1016/j.neuron.2013.06.005; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hay E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002107; Jadi MP, 2014, PROC IEEE I ELECT EL, V102, P1; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; Mohan H, 2015, CEREB CORTEX, V25, P4839, DOI 10.1093/cercor/bhv188; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schmidt-Hieber C, 2017, NAT NEUROSCI, V20, P1114, DOI 10.1038/nn.4582; Shai AS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004090; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1998, J NEUROSCI, V18, P3501; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Takahashi N, 2016, SCIENCE, V354, P1587, DOI 10.1126/science.aah6066; Tran-Van-Minh A, 2016, NEURON, V91, P837, DOI 10.1016/j.neuron.2016.07.029; Tran-Van-Minh A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00067; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	57	96	96	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					643	+		10.1016/j.cell.2018.08.045	http://dx.doi.org/10.1016/j.cell.2018.08.045			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340039	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000447780800009
J	Shortliffe, EH; Sepulveda, MJ				Shortliffe, Edward H.; Sepulveda, Martin J.			Clinical Decision Support in the Era of Artificial Intelligence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VALIDATION; COMPUTER		[Shortliffe, Edward H.] Columbia Univ, Biomed Informat, 272 W 107th St,5B, New York, NY 10025 USA; [Shortliffe, Edward H.] Arizona State Univ, Biomed Informat, Phoenix, AZ USA; [Sepulveda, Martin J.] IBM Res, Watson Res Lab, Yorktown Hts, NY USA	Columbia University; Arizona State University; Arizona State University-Downtown Phoenix; International Business Machines (IBM)	Shortliffe, EH (corresponding author), Columbia Univ, Biomed Informat, 272 W 107th St,5B, New York, NY 10025 USA.	ted@shortliffe.net		Shortliffe, Edward/0000-0001-5201-6176				Fox John, 2000, SAFE SOUND ARTIFICIA; Hinton G, 2018, JAMA-J AM MED ASSOC, V320, P1101, DOI 10.1001/jama.2018.11100; LEDLEY RS, 1959, SCIENCE, V130, P9, DOI 10.1126/science.130.3366.9; MILLER RA, 1982, NEW ENGL J MED, V307, P468, DOI 10.1056/NEJM198208193070803; Naylor CD, 2018, JAMA-J AM MED ASSOC, V320, P1099, DOI 10.1001/jama.2018.11103; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; US FDA, 2017, SOFTW MED DEV SAMD C; YOUNG FE, 1987, ANN INTERN MED, V106, P628, DOI 10.7326/0003-4819-106-4-628; YU VL, 1979, JAMA-J AM MED ASSOC, V242, P1279, DOI 10.1001/jama.242.12.1279	9	208	213	5	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2018	320	21					2199	2200		10.1001/jama.2018.17163	http://dx.doi.org/10.1001/jama.2018.17163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD4MB	30398550				2022-12-28	WOS:000452500600006
J	Melamed, A; Margul, DJ; Chen, L; Keating, NL; del Carmen, MG; Yang, JH; Seagle, BLL; Alexander, A; Barber, EL; Rice, LW; Wright, JD; Kocherginsky, M; Shahabi, S; Rauh-Hain, JA				Melamed, Alexander; Margul, Daniell J.; Chen, Ling; Keating, Nancy L.; del Carmen, Marcela G.; Yang, Junhua; Seagle, Brandon-Luke L.; Alexander, Amy; Barber, Emma L.; Rice, Laurel W.; Wright, Jason D.; Kocherginsky, Masha; Shahabi, Shohreh; Rauh-Hain, J. Alejandro			Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC RADIATION-THERAPY; ENDOMETRIAL CANCER; PROPENSITY SCORE; RANDOMIZED-TRIAL; OPEN SURGERY; OUTCOMES; MANAGEMENT; WOMEN; LYMPHADENECTOMY; LAPAROSCOPY	BACKGROUND Minimally invasive surgery was adopted as an alternative to laparotomy (open surgery) for radical hysterectomy in patients with early-stage cervical cancer before high-quality evidence regarding its effect on survival was available. We sought to determine the effect of minimally invasive surgery on all-cause mortality among women undergoing radical hysterectomy for cervical cancer. METHODS We performed a cohort study involving women who underwent radical hysterectomy for stage IA2 or IB1 cervical cancer during the 2010-2013 period at Commission on Cancer-accredited hospitals in the United States. The study used inverse probability of treatment propensity-score weighting. We also conducted an interrupted time-series analysis involving women who underwent radical hysterectomy for cervical cancer during the 2000-2010 period, using the Surveillance, Epidemiology, and End Results program database. RESULTS In the primary analysis, 1225 of 2461 women (49.8%) underwent minimally invasive surgery. Women treated with minimally invasive surgery were more often white, privately insured, and from ZIP Codes with higher socioeconomic status, had smaller, lower-grade tumors, and were more likely to have received a diagnosis later in the study period than women who underwent open surgery. Over a median follow-up of 45 months, the 4-year mortality was 9.1% among women who underwent minimally invasive surgery and 5.3% among those who underwent open surgery (hazard ratio, 1.65; 95% confidence interval [CI], 1.22 to 2.22; P=0.002 by the log-rank test). Before the adoption of minimally invasive radical hysterectomy (i.e., in the 2000-2006 period), the 4-year relative survival rate among women who underwent radical hysterectomy for cervical cancer remained stable (annual percentage change, 0.3%; 95% CI, -0.1 to 0.6). The adoption of minimally invasive surgery coincided with a decline in the 4-year relative survival rate of 0.8% (95% CI, 0.3 to 1.4) per year after 2006 (P=0.01 for change of trend). CONCLUSIONS In an epidemiologic study, minimally invasive radical hysterectomy was associated with shorter overall survival than open surgery among women with stage IA2 or IB1 cervical carcinoma.	[Melamed, Alexander; del Carmen, Marcela G.] Harvard Med Sch, Div Gynecol Oncol, Vincent Dept Obstet & Gynecol, Massachusetts Gen Hosp, Boston, MA USA; [Keating, Nancy L.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Keating, Nancy L.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Margul, Daniell J.; Yang, Junhua; Seagle, Brandon-Luke L.; Alexander, Amy; Barber, Emma L.; Kocherginsky, Masha; Shahabi, Shohreh] Northwestern Univ, Div Gynecol Oncol, Dept Obstet & Gynecol, Prentice Womens Hosp,Feinberg Sch Med, Chicago, IL 60611 USA; [Kocherginsky, Masha] Northwestern Univ, Div Biostat, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Chen, Ling; Wright, Jason D.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Chen, Ling; Wright, Jason D.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Chen, Ling; Wright, Jason D.] New York Presbyterian Hosp, New York, NY USA; [Rice, Laurel W.] Univ Wisconsin, Div Gynecol Oncol, Dept Obstet & Gynecol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Rauh-Hain, J. Alejandro] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Rauh-Hain, J. Alejandro] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Columbia University; Columbia University; NewYork-Presbyterian Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shahabi, S (corresponding author), Northwestern Mem Hosp, Prentice Womens Hosp, 250 E Super St,Suite 05-2168, Chicago, IL 60611 USA.	sshahabi@nm.org	Melamed, Alexander/R-8299-2019	Melamed, Alexander/0000-0002-0654-0863; Margul, Daniel/0000-0002-0907-1839	National Cancer Institute [P30CA016672, 4P30CA060553-22, R25CA092203]; National Institute of Child Health and Human Development [K12HD050121-12]; American Association of Obstetricians and Gynecologists Foundation; Foundation for Women's Cancer; Jean Donovan Estate; Phebe Novakovic Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD050121] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA092203, P30CA016672, R25CA092203, P30CA060553, K08CA234333] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Association of Obstetricians and Gynecologists Foundation; Foundation for Women's Cancer; Jean Donovan Estate; Phebe Novakovic Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants (P30CA016672, 4P30CA060553-22, and R25CA092203) from the National Cancer Institute, by a grant (K12HD050121-12) from the National Institute of Child Health and Human Development, and by the American Association of Obstetricians and Gynecologists Foundation, the Foundation for Women's Cancer, the Jean Donovan Estate, and the Phebe Novakovic Fund.	Aarts JWM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003677.pub5; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; AVERETTE HE, 1993, CANCER, V71, P1422, DOI 10.1002/cncr.2820710407; Bansal N, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.015; Boffa DJ, 2017, JAMA ONCOL, V3, P1722, DOI 10.1001/jamaoncol.2016.6905; Bogani G, 2014, J MINIM INVAS GYN, V21, P857, DOI 10.1016/j.jmig.2014.03.018; Bonjer HJ, 2015, NEW ENGL J MED, V372, P1324, DOI 10.1056/NEJMoa1414882; Bregar AJ, 2017, ANN SURG ONCOL, V24, P1677, DOI 10.1245/s10434-016-5752-8; Brooks RA, 2009, GYNECOL ONCOL, V114, P75, DOI 10.1016/j.ygyno.2009.03.036; Chiantera V, 2015, GYNECOL ONCOL, V139, P47, DOI 10.1016/j.ygyno.2015.07.010; Cho H, 201101 NCI; Coker AL, 2009, GYNECOL ONCOL, V112, P365, DOI 10.1016/j.ygyno.2008.10.013; Colombo N, 2012, ANN ONCOL, V23, P27, DOI 10.1093/annonc/mds268; Commission on Cancer, CANC PROGR CAT; Conrad LB, 2015, INT J GYNECOL CANCER, V25, P1121, DOI 10.1097/IGC.0000000000000450; Ditto A, 2015, EJSO-EUR J SURG ONC, V41, P34, DOI 10.1016/j.ejso.2014.10.058; Diver E, 2017, J MINIM INVAS GYN, V24, P402, DOI 10.1016/j.jmig.2016.12.005; Dryden-Peterson S, 2016, J CLIN ONCOL, V34, P3749, DOI 10.1200/JCO.2016.67.9613; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Geetha P, 2012, J MINIM ACCESS SURG, V8, P67, DOI 10.4103/0972-9941.97584; Geisler JP, 2010, INT J GYNECOL CANCER, V20, P438, DOI 10.1111/IGC.0b013e3181cf5c2c; Gil-Moreno A, 2018, J MINIM INVASIVE GYN; Hoogendam JP, 2014, BJOG-INT J OBSTET GY, V121, P1538, DOI 10.1111/1471-0528.12822; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Janda M, 2017, JAMA-J AM MED ASSOC, V317, P1224, DOI 10.1001/jama.2017.2068; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kuo TM, 2016, CANCER CAUSE CONTROL, V27, P1117, DOI 10.1007/s10552-016-0790-x; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Lee EJ, 2011, EUR J OBSTET GYN R B, V156, P83, DOI 10.1016/j.ejogrb.2010.12.016; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Magrina JF, 2008, GYNECOL ONCOL, V109, P86, DOI 10.1016/j.ygyno.2008.01.011; Malzoni M, 2009, ANN SURG ONCOL, V16, P1316, DOI 10.1245/s10434-009-0342-7; McCann GA, 2013, GYNECOL ONCOL, V128, P44, DOI 10.1016/j.ygyno.2012.10.028; Melamed A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.08.030; Mendivil AA, 2016, SURG ONCOL, V25, P66, DOI 10.1016/j.suronc.2015.09.004; Nam JH, 2012, ANN ONCOL, V23, P903, DOI 10.1093/annonc/mdr360; National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; NEZHAT CR, 1992, AM J OBSTET GYNECOL, V166, P864, DOI 10.1016/0002-9378(92)91351-A; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Petignat P, 2007, BMJ-BRIT MED J, V335, P765, DOI 10.1136/bmj.39337.615197.80; Ramirez PT, 2018, NEW ENGL J MED, V379, P1895, DOI 10.1056/NEJMoa1806395; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roque DR, 2014, OBSTET GYNECOL SURV, V69, P426, DOI 10.1097/OGX.0000000000000089; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Sert BM, 2016, EJSO-EUR J SURG ONC, V42, P513, DOI 10.1016/j.ejso.2015.12.014; United States Department of Agriculture Economic Research Service, RUR URB CONT COD; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Walker JL, 2012, J CLIN ONCOL, V30, P695, DOI 10.1200/JCO.2011.38.8645; Wright JD, 2012, GYNECOL ONCOL, V127, P11, DOI 10.1016/j.ygyno.2012.06.031; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174	54	391	462	8	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 15	2018	379	20					1905	1914		10.1056/NEJMoa1804923	http://dx.doi.org/10.1056/NEJMoa1804923			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA2FL	30379613	Green Accepted, Bronze			2022-12-28	WOS:000450049800005
J	Wang, ZB; Yin, HL; Fu, GC				Wang, Zhaobin; Yin, Haolin; Fu, Gregory C.			Catalytic enantioconvergent coupling of secondary and tertiary electrophiles with olefins	NATURE			English	Article								Carbon-carbon bonds, including those between sp(3)-hybridized carbon atoms (alkyl-alkyl bonds), typically comprise much of the framework of organic molecules. In the case of sp(3)-hybridized carbon, the carbon can be stereogenic and the particular stereochemistry can have implications for structure and function(1-3). As a consequence, the development of methods that simultaneously construct alkyl-alkyl bonds and control stereochemistry is important, although challenging. Here we describe a strategy for enantioselective alkyl-alkyl bond formation, in which a racemic alkyl electrophile is coupled with an olefin in the presence of a hydrosilane, rather than via a traditional electrophile-nucleophile cross-coupling, through the action of a chiral nickel catalyst. We demonstrate that families of racemic alkyl halides-including secondary and tertiary electrophiles, which have not previously been shown to be suitable for enantioconvergent coupling with alkyl metal nucleophiles-cross-couple with olefins with good enantioselectivity and yield under very mild reaction conditions. Given the ready availability of olefins, our approach opens the door to developing more general methods for enantioconvergent alkyl-alkyl coupling.	[Wang, Zhaobin; Yin, Haolin; Fu, Gregory C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Fu, GC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	gcfu@caltech.edu	Yin, Haolin/E-3493-2012	Yin, Haolin/0000-0002-2063-8605	National Institutes of Health (National Institute of General Medical Sciences) [R01-GM62871]; Gordon and Betty Moore Foundation (Caltech Center for Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062871, R37GM062871] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Gordon and Betty Moore Foundation (Caltech Center for Catalysis and Chemical Synthesis); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support has been provided by the National Institutes of Health (National Institute of General Medical Sciences, R01-GM62871) and the Gordon and Betty Moore Foundation (Caltech Center for Catalysis and Chemical Synthesis). We thank L. M. Henling, D. G. VanderVelde and S. C. Virgil for assistance and discussions.	Banik B. K., 2013, LACTAMS UNIQUE STRUC; Carreira E. M., 2012, COMPREHENSIVE CHIRAL; Choi J, 2017, SCIENCE, V356, DOI 10.1126/science.aaf7230; Chrusciel R. A., 2015, WO patent, Patent No. [2015/ 120062 A2, 2015/120062A2]; Decuyper L, 2018, MED RES REV, V38, P426, DOI 10.1002/med.21443; Derosa J, 2017, J AM CHEM SOC, V139, P10657, DOI 10.1021/jacs.7b06567; Ding C.-H., 2014, COMPREHENSIVE ORGANI, V4, P648; Du XY, 2017, ACS CATAL, V7, P1227, DOI 10.1021/acscatal.6b02990; Fischer C, 2005, J AM CHEM SOC, V127, P4594, DOI 10.1021/ja0506509; Fu GC, 2017, ACS CENTRAL SCI, V3, P692, DOI 10.1021/acscentsci.7b00212; Galletti P, 2011, CURR MED CHEM, V18, P4265, DOI 10.2174/092986711797200480; Geist E, 2014, NAT PROD REP, V31, P441, DOI 10.1039/c3np70108e; Genellin CR, 2013, INTRODUCTION TO BIOLOGICAL AND SMALL MOLECULE DRUG RESEARCH AND DEVELOPMENT: THEORY AND CASE STUDIES, P399, DOI 10.1016/B978-0-12-397176-0.00015-7; Gouverneur V., 2012, FLUORINE PHARM MED C; Henry-Riyad H., 2013, HDB REAGENTS ORGANIC, P620; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Iwasaki T., 2014, COMPREHENSIVE ORGANI, V3, P337, DOI DOI 10.1016/B978-0-08-097742-3.00311-6; Julia-Hernandez F, 2017, NATURE, V545, P84, DOI 10.1038/nature22316; Lin G. Q., 2011, CHIRAL DRUGS CHEM BI; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lu X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11129; Ma S, 2009, ANGEW CHEM INT EDIT, V48, P8037, DOI 10.1002/anie.200902943; MacMillan D. W. C., 2011, SCI SYNTH, V3, P675; Murakata M, 1997, J AM CHEM SOC, V119, P11713, DOI 10.1021/ja972065g; Ojima I., 2013, LACTAMS UNIQUE STRUC, P1; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Schley ND, 2014, J AM CHEM SOC, V136, P16588, DOI 10.1021/ja508718m; Stoltz B. M., 2014, COMPREHENSIVE ORGANI, V2nd, P1; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Wang YM, 2015, J AM CHEM SOC, V137, P10524, DOI 10.1021/jacs.5b07061; Zhou F, 2018, ANGEW CHEM INT EDIT, V57, P4058, DOI 10.1002/anie.201712731	31	185	185	14	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 15	2018	563	7731					379	383		10.1038/s41586-018-0669-y	http://dx.doi.org/10.1038/s41586-018-0669-y			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA2EY	30337711	Green Accepted			2022-12-28	WOS:000450048400055
J	Simonis, FD; Neto, AS; Binnekade, JM; Braber, A; Bruin, KCM; Determann, RM; Goekoop, GJ; Heidt, J; Horn, J; Innemee, G; de Jonge, E; Juffermans, NP; Spronk, PE; Steuten, LM; Tuinman, PR; de Wilde, RBP; Vriends, M; de Abreu, MG; Pelosi, P; Schultz, MJ				Simonis, Fabienne D.; Serpa Neto, Ary; Binnekade, Jan M.; Braber, Annemarije; Bruin, Karma C. M.; Determann, Rogier M.; Goekoop, Geert-Jan; Heidt, Jeroen; Horn, Janneke; Innemee, Gerard; de Jonge, Evert; Juffermans, Nicole P.; Spronk, Peter E.; Steuten, Lotte M.; Tuinman, Pieter Roel; de Wilde, Rob B. P.; Vriends, Marijn; de Abreu, Marcelo Gama; Pelosi, Paolo; Schultz, Marcus J.		Writing Grp PReVENT Investigators	Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; LUNG-PROTECTIVE VENTILATION; MECHANICAL VENTILATION; INJURY; DELIRIUM; METAANALYSIS; MORTALITY; IMPACT; RISK	IMPORTANCE It remains uncertain whether invasive ventilation should use low tidal volumes in critically ill patients without acute respiratory distress syndrome (ARDS). OBJECTIVE To determine whether a low tidal volume ventilation strategy is more effective than an intermediate tidal volume strategy. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial, conducted from September 1, 2014, through August 20, 2017, including patients without ARDS expected to not be extubated within 24 hours after start of ventilation from 6 intensive care units in the Netherlands. INTERVENTIONS Invasive ventilation using low tidal volumes (n = 477) or intermediate tidal volumes (n = 484). MAIN OUTCOMES AND MEASURES The primary outcome was the number of ventilator-free days and alive at day 28. Secondary outcomes included length of ICU and hospital stay; ICU, hospital, and 28- and 90-day mortality; and development of ARDS, pneumonia, severe atelectasis, or pneumothorax. RESULTS In total, 961 patients (65% male), with a median age of 68 years (interquartile range [IQR], 59-76), were enrolled. At day 28, 475 patients in the low tidal volume group had a median of 21 ventilator-free days (IQR, 0-26), and 480 patients in the intermediate tidal volume group had a median of 21 ventilator-free days (IQR, 0-26) (mean difference, -0.27 [95% CI, -1.74 to 1.19]; P = .71). There was no significant difference in ICU (median, 6 vs 6 days; 0.39 [-1.09 to 1.89]; P = .58) and hospital (median, 14 vs 15 days; -0.60 [-3.52 to 2.31]; P = .68) length of stay or 28-day (34.9% vs 32.1%; hazard ratio [HR], 1.12 [0.90 to 1.40]; P = .30) and 90-day (39.1% vs 37.8%; HR, 1.07 [0.87 to 1.31]; P = .54) mortality. There was no significant difference in the percentage of patients developing the following adverse events: ARDS (3.8% vs 5.0%; risk ratio [RR], 0.86 [0.59 to 1.24]; P = .38), pneumonia (4.2% vs 3.7%; RR, 1.07 [0.78 to 1.47]; P = .67), severe atelectasis (11.4% vs 11.2%; RR, 1.00 [0.81 to 1.23]; P = .94), and pneumothorax (1.8% vs 1.3%; RR, 1.16 [0.73 to 1.84]; P = .55). CONCLUSIONS AND RELEVANCE In patients in the ICU without ARDS who were expected not to be extubated within 24 hours of randomization, a low tidal volume strategy did not result in a greater number of ventilator-free days than an intermediate tidal volume strategy.	[Simonis, Fabienne D.; Serpa Neto, Ary; Binnekade, Jan M.; Horn, Janneke; Juffermans, Nicole P.; Schultz, Marcus J.] Acad Med Ctr, Dept Intens Care, C3-423,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Simonis, Fabienne D.; Serpa Neto, Ary; Binnekade, Jan M.; Horn, Janneke; Juffermans, Nicole P.; Schultz, Marcus J.] Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands; [Serpa Neto, Ary] Hosp Israelita Albert Einstein, Dept Crit Care Med, Sao Paulo, Brazil; [Braber, Annemarije; Spronk, Peter E.] Gelre Hosp, Dept Intens Care, Apeldoorn, Netherlands; [Bruin, Karma C. M.; Goekoop, Geert-Jan] Westfriesgasthuis, Dept Intens Care, Hoorn, Netherlands; [Determann, Rogier M.] Onze Lieve Vrouw Hosp, Dept Intens Care, Amsterdam, Netherlands; [Heidt, Jeroen; Innemee, Gerard] Dept Intens Care Tergooi, Hilversum, Netherlands; [de Jonge, Evert; de Wilde, Rob B. P.] Leiden Univ, Dept Intens Care, Med Ctr, Leiden, Netherlands; [Steuten, Lotte M.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Tuinman, Pieter Roel; Vriends, Marijn] Vrije Univ Amsterdam Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Tuinman, Pieter Roel; Vriends, Marijn] Vrije Univ Amsterdam Med Ctr, REVIVE Res VUmc Intens Care, Amsterdam, Netherlands; [de Abreu, Marcelo Gama] Univ Hosp Carl Gustav Carus, Dept Anesthesiol & Intens Care, Pulm Engn Grp, Dresden, Germany; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, San Martino Policlin Hosp, IRCCS Oncol, Genoa, Italy; [Schultz, Marcus J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Hospital Israelita Albert Einstein; Gelre Hospitals; Onze Lieve Vrouwe Gasthuis Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fred Hutchinson Cancer Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Genoa; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Schultz, MJ (corresponding author), Acad Med Ctr, Dept Intens Care, C3-423,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	marcus.j.schultz@gmail.com	Tuinman, Pieter/W-8624-2019; Serpa Neto, Ary/D-1927-2012; Tuinman, Pieter/AAN-2572-2020; Rocco, Patricia/I-7460-2012; Schultz, Marcus/AAB-6379-2021; Horn, Janneke/ACB-3607-2022; De Wilde, Rob/N-7997-2013	Serpa Neto, Ary/0000-0003-1520-9387; Rocco, Patricia/0000-0003-1412-7136; Schultz, Marcus/0000-0003-3969-7792; Pelosi, Paolo/0000-0001-5055-3023; Gama de Abreu, Marcelo/0000-0002-3554-883X; De Wilde, Rob/0000-0003-2388-4243	ZonMW, Netherlands Organization for Health Research and Development; Academic Medical Center (Amsterdam, the Netherlands)	ZonMW, Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Academic Medical Center (Amsterdam, the Netherlands)(Netherlands Government)	This study was supported by a grant from ZonMW, Netherlands Organization for Health Research and Development (http://www.zonmw.nl) and the Academic Medical Center (Amsterdam, the Netherlands).	Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cuthbertson BH, 2004, INTENS CARE MED, V30, P450, DOI 10.1007/s00134-003-2004-8; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ferguson ND, 2012, JAMA-J AM MED ASSOC, V308, P1689, DOI 10.1001/jama.2012.14509; Graat ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3955; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Jubran A, 2010, INTENS CARE MED, V36, P2030, DOI 10.1007/s00134-010-1972-8; Jubran A, 2010, INTENS CARE MED, V36, P828, DOI 10.1007/s00134-010-1842-4; Kallet R H, 2001, Respir Care, V46, P1024; Kallet RH, 2006, CRIT CARE MED, V34, P8, DOI 10.1097/01.CCM.0000194538.32158.AF; LEE PC, 1990, CHEST, V97, P430, DOI 10.1378/chest.97.2.430; Needham DM, 2015, AM J RESP CRIT CARE, V191, P177, DOI 10.1164/rccm.201409-1598OC; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Neto AS, 2016, LANCET RESP MED, V4, P882, DOI 10.1016/S2213-2600(16)30305-8; Neto AS, 2014, INTENS CARE MED, V40, P950, DOI 10.1007/s00134-014-3318-4; Seymour CW, 2012, CRIT CARE MED, V40, P2788, DOI 10.1097/CCM.0b013e31825b8ade; Simonis FD, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0759-1; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; van Vught LA, 2016, JAMA-J AM MED ASSOC, V315, P1469, DOI 10.1001/jama.2016.2691	25	134	134	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2018	320	18					1872	1880		10.1001/jama.2018.14280	http://dx.doi.org/10.1001/jama.2018.14280			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HA1BH	30357256	Bronze, Green Published			2022-12-28	WOS:000449945900014
J	Whelton, PK; Williams, B				Whelton, Paul K.; Williams, Bryan			The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines More Similar Than Different	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSIS		[Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Whelton, Paul K.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Williams, Bryan] UCL, UCL Inst Cardiovasc Sci, London, England; [Williams, Bryan] UCL Hosp Biomed Res Ctr, Natl Inst Hlth Res, London, England	Tulane University; Tulane University; University of London; University College London; University of London; University College London	Whelton, PK (corresponding author), 1440 Canal St,Room 2015, New Orleans, LA 70112 USA.	pkwhelton@gmail.com		Williams, Bryan/0000-0002-8094-1841				Bundy JD, 2018, JAMA CARDIOL, V3, P572, DOI 10.1001/jamacardio.2018.1240; Gabb GM, 2016, MED J AUSTRALIA, V205, P85, DOI 10.5694/mja16.00526; Greenland P, 2018, JAMA-J AM MED ASSOC, V319, P117, DOI 10.1001/jama.2017.19675; Messerli FH, 2018, J AM COLL CARDIOL, V72, P1313, DOI 10.1016/j.jacc.2018.07.026; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Nerenberg KA, 2018, CAN J CARDIOL, V34, P506, DOI 10.1016/j.cjca.2018.02.022; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Williamson JD, RANDOMIZED TRIAL INT	10	66	66	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2018	320	17					1749	1750		10.1001/jama.2018.16755	http://dx.doi.org/10.1001/jama.2018.16755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GZ5LC	30398611				2022-12-28	WOS:000449461800008
J	Blanco-Redondo, A; Bell, B; Oren, D; Eggleton, BJ; Segev, M				Blanco-Redondo, Andrea; Bell, Bryn; Oren, Dikla; Eggleton, Benjamin J.; Segev, Mordechai			Topological protection of biphoton states	SCIENCE			English	Article							EDGE STATES; GENERATION; PHOTONICS; INTERFACE; INSULATOR; SYSTEM	The robust generation and propagation of multiphoton quantum states are crucial for applications in quantum information, computing, and communications. Although photons are intrinsically well isolated from the thermal environment, scaling to large quantum optical devices is still limited by scattering loss and other errors arising from random fabrication imperfections. The recent discoveries regarding topological phases have introduced avenues to construct quantum systems that are protected against scattering and imperfections. We experimentally demonstrate topological protection of biphoton states, the building block for quantum information systems. We provide clear evidence of the robustness of the spatial features and the propagation constant of biphoton states generated within a nanophotonics lattice with nontrivial topology and propose a concrete path to build robust entangled states for quantum gates.	[Blanco-Redondo, Andrea; Bell, Bryn; Eggleton, Benjamin J.] Univ Sydney, Sydney Nano Inst, Sch Phys, IPOS, Sydney, NSW 2006, Australia; [Oren, Dikla; Segev, Mordechai] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Oren, Dikla; Segev, Mordechai] Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel; [Bell, Bryn] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England	University of Sydney; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Oxford	Blanco-Redondo, A (corresponding author), Univ Sydney, Sydney Nano Inst, Sch Phys, IPOS, Sydney, NSW 2006, Australia.	andrea.blancoredondo@sydney.edu.au		Eggleton, Benjamin/0000-0003-4921-9727; Bell, Bryn/0000-0002-3797-412X	Technion Society of Australia (NSW); NSW Department of Industry (University of Sydney); NSW Department of Industry (Technion collaborative photonics research project); School of Physics of the University of Sydney; Australian Research Council [CE110001018, FL120100029]	Technion Society of Australia (NSW); NSW Department of Industry (University of Sydney); NSW Department of Industry (Technion collaborative photonics research project); School of Physics of the University of Sydney(University of Sydney); Australian Research Council(Australian Research Council)	We gratefully acknowledge financial support from The Technion Society of Australia (NSW) and the NSW Department of Industry (The University of Sydney and the Technion collaborative photonics research project), the School of Physics of the University of Sydney (Professor Harry Messel research fellowship), and the Australian Research Council (CE110001018, FL120100029).	Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Barik S, 2018, SCIENCE, V359, P666, DOI 10.1126/science.aaq0327; Blanco-Redondo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4160; Blanco-Redondo A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.129901; Blanco-Redondo A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.163901; Broome MA, 2013, SCIENCE, V339, P794, DOI 10.1126/science.1231440; Cardano F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11439; Cheng XJ, 2016, NAT MATER, V15, P542, DOI [10.1038/NMAT4573, 10.1038/nmat4573]; Delplace P, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195452; Gorlach MA, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.053866; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Kitagawa T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1872; Leykam D, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033815; Malkova N, 2009, OPT LETT, V34, P1633, DOI 10.1364/OL.34.001633; Mittal S., 2017, ARXIV170909984PHYSIC; Mittal S, 2016, OPT EXPRESS, V24, P15631, DOI 10.1364/OE.24.015631; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Poli C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7710; Politi A, 2009, IEEE J SEL TOP QUANT, V15, P1673, DOI 10.1109/JSTQE.2009.2026060; Rechtsman MC, 2016, OPTICA, V3, P925, DOI 10.1364/OPTICA.3.000925; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Reimer C, 2016, SCIENCE, V351, P1176, DOI 10.1126/science.aad8532; Rudner MS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.065703; Solntsev AS, 2012, OPT EXPRESS, V20, P27441, DOI 10.1364/OE.20.027441; Spring JB, 2013, SCIENCE, V339, P798, DOI 10.1126/science.1231692; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Yang ZJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.114301; Zeuner JM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.040402	31	130	131	8	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2018	362	6414			SI		568	+		10.1126/science.aau4296	http://dx.doi.org/10.1126/science.aau4296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HA7KM	30385574	Green Submitted			2022-12-28	WOS:000450460000042
J	Pasricha, SR; Drakesmith, H				Pasricha, Sant-Rayn; Drakesmith, Hal			Hemoglobinopathies in the Fetal Position	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pasricha, Sant-Rayn] Univ Melbourne, Dept Med Biol, Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Pasricha, Sant-Rayn] Royal Melbourne Hosp, Dept Diagnost Haematol, Parkville, Vic, Australia; [Pasricha, Sant-Rayn] Peter MacCallum Canc Ctr, Clin Haematol, Parkville, Vic, Australia; [Pasricha, Sant-Rayn] Royal Melbourne Hosp, Parkville, Vic, Australia; [Drakesmith, Hal] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford, England; [Drakesmith, Hal] Univ Oxford, Oxford Biomed Res Ctr, Haematol Theme, Oxford, England	University of Melbourne; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Peter Maccallum Cancer Center; Royal Melbourne Hospital; University of Oxford; University of Oxford	Pasricha, SR (corresponding author), Univ Melbourne, Dept Med Biol, Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Pasricha, SR (corresponding author), Royal Melbourne Hosp, Dept Diagnost Haematol, Parkville, Vic, Australia.; Pasricha, SR (corresponding author), Peter MacCallum Canc Ctr, Clin Haematol, Parkville, Vic, Australia.; Pasricha, SR (corresponding author), Royal Melbourne Hosp, Parkville, Vic, Australia.		Pasricha, Sant-Rayn/H-8436-2019	Pasricha, Sant-Rayn/0000-0002-5502-0434	MRC [MC_UU_12010/10, G0901149] Funding Source: UKRI; Medical Research Council [G0901149, MC_UU_00008/10, MC_UU_12010/10] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chen JJ, 2014, CURR OPIN HEMATOL, V21, P172, DOI 10.1097/MOH.0000000000000030; Grevet JD, 2018, SCIENCE, V361, P285, DOI 10.1126/science.aao0932; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409	5	4	4	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 25	2018	379	17					1675	1677		10.1056/NEJMcibr1809628	http://dx.doi.org/10.1056/NEJMcibr1809628			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GY1GI	30354961	Green Published			2022-12-28	WOS:000448273500015
J	Neogi, T; Dalbeth, N				Neogi, Tuhina; Dalbeth, Nicola			Patient education and engagement in treat-to-target gout care	LANCET			English	Editorial Material							AMERICAN-COLLEGE; RECURRENT GOUT; MANAGEMENT		[Neogi, Tuhina] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Dalbeth, Nicola] Univ Auckland, Dept Med, Auckland, New Zealand	Boston University; University of Auckland	Neogi, T (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA.	tneogi@bu.edu	Neogi, Tuhina/AAM-1110-2020		Amgen; AstraZeneca; AbbVie; Horizon; Takeda; Kowa; Janssen; Pfizer; Health Research Council of New Zealand [15/576]; Health Research Council of New Zealand; US National Institutes of Health [K24 AR070892, P60 AR47785, R01 AR062506]; US Department of Veterans Affairs [VA CSP-594]	Amgen(Amgen); AstraZeneca(AstraZeneca); AbbVie(AbbVie); Horizon; Takeda(Takeda Pharmaceutical Company Ltd); Kowa; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Health Research Council of New Zealand(Health Research Council of New Zealand); Health Research Council of New Zealand(Health Research Council of New Zealand); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs)	ND has received grants from Amgen, grants and personal fees from AstraZeneca, and personal fees from AbbVie, Horizon, Takeda, Kowa, Janssen, and Pfizer. ND is supported by the Health Research Council of New Zealand (15/576). In the past 5 years, she has been principal investigator on a clinical trial of febuxostat in early gout (funded by Takeda) and a clinical trial of lesinurad and febuxostat (funded by AstraZeneca) and co-investigator on a clinical trial of allopurinol dose escalation (funded by the Health Research Council of New Zealand). She is a member of the Eurogout genetics collaboration with Michael Doherty and Abhishek Abhishek and has published with Michael Doherty on various multiauthor consensus publications. She was a co-editor with Michael Doherty on the Oxford Textbook of Osteoarthritis and Crystal Arthropathy. TN is supported by the US National Institutes of Health (K24 AR070892, P60 AR47785, R01 AR062506) and is on the steering committee for a clinical trial of febuxostat compared with allopurinol funded by a grant from the US Department of Veterans Affairs (VA CSP-594).	Choi H, 2018, ARTHRITIS RHEUMATOL, V70, P1702, DOI 10.1002/art.40583; Dalbeth N, 2017, ARTHRITIS RHEUMATOL, V69, P2386, DOI 10.1002/art.40233; Dalbeth N, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.126; Doherty M, 2018, LANCET, V392, P1403, DOI 10.1016/S0140-6736(18)32158-5; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2017, ANN INTERN MED, V166, P71, DOI 10.7326/M16-2401; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]; White WB, 2018, NEW ENGL J MED, V378, P1200, DOI 10.1056/NEJMoa1710895	12	3	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	2018	392	10156					1379	1381		10.1016/S0140-6736(18)32415-2	http://dx.doi.org/10.1016/S0140-6736(18)32415-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GX5PD	30343848	hybrid			2022-12-28	WOS:000447800900010
J	Barbi, E; Lagona, F; Marsili, M; Vaupel, JW; Wachter, KW				Barbi, Elisabetta; Lagona, Francesco; Marsili, Marco; Vaupel, James W.; Wachter, Kenneth W.			Response to Comment on "The plateau of human mortality: Demography of longevity pioneers"	SCIENCE			English	Editorial Material									[Barbi, Elisabetta] Sapienza Univ Rome, Dept Stat, Rome, Italy; [Lagona, Francesco] Univ Roma Tre, Dept Polit Sci, Rome, Italy; [Marsili, Marco] Italian Natl Inst Stat ISTAT, Rome, Italy; [Vaupel, James W.] Univ Southern Denmark, Interdisciplinary Ctr Populat Change, Odense, Denmark; [Vaupel, James W.] Duke Univ, Populat Res Inst, Durham, NC USA; [Wachter, Kenneth W.] Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA	Sapienza University Rome; Roma Tre University; University of Southern Denmark; Duke University; University of California System; University of California Berkeley	Barbi, E (corresponding author), Sapienza Univ Rome, Dept Stat, Rome, Italy.	elisabetta.barbi@uniroma1.it	Lagona, Francesco/C-2991-2008	Lagona, Francesco/0000-0003-3364-3400; Wachter, Kenneth/0000-0003-2802-2212; marsili, marco/0000-0003-3894-9943; BARBI, Elisabetta/0000-0003-2765-8825; Vaupel, James/0000-0003-0783-3905				Barbi E, 2018, SCIENCE, V360, P1459, DOI 10.1126/science.aat3119; Beltran-Sanchez H, 2018, SCIENCE, V361, DOI 10.1126/science.aav1200; Lenart A, 2018, ARXIV180903732QBIOPE; Wachter KW, 2013, P NATL ACAD SCI USA, V110, P10141, DOI 10.1073/pnas.1306656110	4	3	4	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2018	362	6412								10.1126/science.aav3229	http://dx.doi.org/10.1126/science.aav3229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GX4EJ	30337380				2022-12-28	WOS:000447680100001
J	Do, MTH				Do, Michael Tri H.			Mixed Palettes of Melanopsin Phototransduction	CELL			English	Editorial Material								Animal photoreceptors divide into two fundamental classes, ciliary and rhabdomeric. Jiang and colleagues demonstrate that this boundary is disregarded by the intrinsically photosensitive retinal ganglion cells of mammals. These neurons draw from phototransduction mechanisms of both classes, enriching the signals that they produce to drive a diversity of visual functions.	[Do, Michael Tri H.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 3 Blackfan Circle, Boston, MA 02115 USA; [Do, Michael Tri H.] Boston Childrens Hosp, Dept Neurol, 3 Blackfan Circle, Boston, MA 02115 USA; [Do, Michael Tri H.] Harvard Med Sch, Ctr Life Sci 12061, 3 Blackfan Circle, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Do, MTH (corresponding author), Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 3 Blackfan Circle, Boston, MA 02115 USA.; Do, MTH (corresponding author), Boston Childrens Hosp, Dept Neurol, 3 Blackfan Circle, Boston, MA 02115 USA.; Do, MTH (corresponding author), Harvard Med Sch, Ctr Life Sci 12061, 3 Blackfan Circle, Boston, MA 02115 USA.	michael.do@childrens.harvard.edu	H, Michael Tri/A-5917-2009	H, Michael Tri/0000-0001-6418-0977	National Institutes of Health [R01 EY023648, R01 EY025555, R21 EY028633, P30 HD18655, P30 EY012196]; Harvard Brain Initiative; NATIONAL EYE INSTITUTE [R01EY023648, R01EY025555, P30EY012196, R21EY028633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Brain Initiative; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	G.S. Bryman, A. Liu, E.S. Milner, and C.P. Morquette provided valuable comments on the manuscript. Support was provided by the National Institutes of Health (R01 EY023648, R01 EY025555, and R21 EY028633 to M. Do; P30 HD18655 to the Boston Children's Hospital IDDRC; and P30 EY012196 to Harvard Medical School) and by the Harvard Brain Initiative (Bipolar Seed Grant to M. Do).	DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Jiang Z, 2018, CELL, V175, P652, DOI 10.1016/j.cell.2018.08.055; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sonoda T, 2018, NEURON, V99, P754, DOI 10.1016/j.neuron.2018.06.032; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	9	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					637	639		10.1016/j.cell.2018.09.046	http://dx.doi.org/10.1016/j.cell.2018.09.046			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340036	Green Accepted, Bronze			2022-12-28	WOS:000447780800006
J	Terburg, D; Scheggia, D; del Rio, RT; Klumpers, F; Ciobanu, AC; Morgan, B; Montoya, ER; Bos, PA; Giobellina, G; van den Burg, EH; de Gelder, B; Stein, DJ; Stoop, R; van Honk, J				Terburg, David; Scheggia, Diego; del Rio, Rodrigo Triana; Klumpers, Floris; Ciobanu, Alexandru Cristian; Morgan, Barak; Montoya, Estrella R.; Bos, Peter A.; Giobellina, Gion; van den Burg, Erwin H.; de Gelder, Beatrice; Stein, Dan J.; Stoop, Ron; van Honk, Jack			The Basolateral Amygdala Is Essential for Rapid Escape: A Human and Rodent Study	CELL			English	Article							CONDITIONED FEAR; THREAT; CIRCUIT; MAPS; ACTIVATIONS; AVOIDANCE; PATHWAYS; BEHAVIOR; ANXIETY; SYSTEM	Rodent research delineates how the basolateral amygdala (BLA) and central amygdala (CeA) control defensive behaviors, but translation of these findings to humans is needed. Here, we compare humans with natural-selective bilateral BLA lesions to rats with a chemogenetically silenced BLA. We find, across species, an essential role for the BLA in the selection of active escape over passive freezing during exposure to imminent yet escapable threat (T-imm). In response to T-imm, BLA-damaged humans showed increased startle potentiation and BLA-silenced rats demonstrated increased startle potentiation, freezing, and reduced escape behavior as compared to controls. Neuroimaging in humans suggested that the BLA reduces passive defensive responses by inhibiting the brainstem via the CeA. Indeed, T-imm conditioning potentiated BLA projections onto an inhibitory CeA pathway, and pharmacological activation of this pathway rescued deficient T-imm responses in BLA-silenced rats. Our data reveal how the BLA, via the CeA, adaptively regulates escape behavior from imminent threat and that this mechanism is evolutionary conserved across rodents and humans.	[Terburg, David; Montoya, Estrella R.; Bos, Peter A.; van Honk, Jack] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Terburg, David; Stein, Dan J.; van Honk, Jack] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Scheggia, Diego; del Rio, Rodrigo Triana; Ciobanu, Alexandru Cristian; Giobellina, Gion; van den Burg, Erwin H.; Stoop, Ron] Lausanne Univ, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Scheggia, Diego; del Rio, Rodrigo Triana; Ciobanu, Alexandru Cristian; Giobellina, Gion; van den Burg, Erwin H.; Stoop, Ron] Univ Hosp Ctr, Lausanne, Switzerland; [Klumpers, Floris] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Morgan, Barak] Univ Cape Town, Law Fac, Inst Safety Governance & Criminol, Global Risk Governance Program, Cape Town, South Africa; [de Gelder, Beatrice] Maastricht Univ, Dept Psychol & Neurosci, Maastricht, Netherlands; [Stein, Dan J.] Univ Cape Town, MRC, Unit Risk & Resilience Mental Disorders, Cape Town, South Africa; [van Honk, Jack] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa	Utrecht University; University of Cape Town; University of Lausanne; Radboud University Nijmegen; University of Cape Town; Maastricht University; University of Cape Town; University of Cape Town	Terburg, D (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.; Terburg, D (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa.; Stoop, R (corresponding author), Lausanne Univ, Ctr Psychiat Neurosci, Lausanne, Switzerland.; Stoop, R (corresponding author), Univ Hosp Ctr, Lausanne, Switzerland.	d.terburg@uu.nl; ron.stoop@unil.ch	Stein, Dan/A-1752-2008; Scheggia, Diego/AAS-8087-2021; Core, Vector/CAF-4832-2022; Klumpers, Floris/J-2857-2012; Ciobanu, Alexandru Cristian/B-7975-2009	Stein, Dan/0000-0001-7218-7810; Scheggia, Diego/0000-0003-2586-9717; Klumpers, Floris/0000-0002-0631-5789; Ciobanu, Alexandru Cristian/0000-0002-6352-3832; Terburg, David/0000-0003-2356-8734; Bos, Peter A/0000-0001-8944-0181	Swiss South African Joint Research Program of the Swiss National Science Foundation [IZLSZ3_148803]; Swiss South African Joint Research Program of the South African National Research Foundation [IZLSZ3_148803]; Netherlands Organization for Scientific Research (NWO) [056-24-010, VENI 451-13-004, VENI 451-14-015]; European Research Council (ERC) [FP7/2007-2013: 295673]; Biocodex; Lundbeck; Servier; Sun; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action [GA 708539]; Innosuisse; Synapsis Foundation, Switzerland	Swiss South African Joint Research Program of the Swiss National Science Foundation; Swiss South African Joint Research Program of the South African National Research Foundation; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Biocodex; Lundbeck(Lundbeck Corporation); Servier(Servier); Sun; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action; Innosuisse; Synapsis Foundation, Switzerland	We thank Drs. Fulvio Magara, Carmen E. Flores Nakandakare, and Sandra Ahrens for input on the manuscript and helpful discussions and Dr. Benjamin Boury-Jamot and Mr. Victor Amstutz for technical assistance. We are grateful to the Centre d'Etude du Comportement for their help with animal management and technical support and to Mrs. Mara Brandt for her invaluable assistance in preparing and conducting the human experiments. This work was supported by the Swiss South African Joint Research Program of the Swiss National Science Foundation and South African National Research Foundation (IZLSZ3_148803), the Netherlands Organization for Scientific Research (NWO) (Brain and Cognition 056-24-010, VENI 451-13-004, and VENI 451-14-015), and the European Research Council (ERC) (advanced grant FP7/2007-2013: 295673). In the past 3 years, D.J.S. has received research grants and/or consultancy honoraria from Biocodex, Lundbeck, Servier, and Sun. D.S. has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Action (GA 708539), E.H.v.d.B, and R.T. were funded by Innosuisse, the Synapsis Foundation, Switzerland in collaboration with Prof. Armin von Gunten. We thank the UWD subjects and control subjects for their participation in our study. This paper is in memory of Christoph Eisenegger.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1982, J NEUROSCI, V2, P791; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; de Gelder B, 2014, CORTEX, V52, P28, DOI 10.1016/j.cortex.2013.12.010; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Fadok JP, 2017, NATURE, V542, P96, DOI 10.1038/nature21047; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Glenn CR, 2012, INT J PSYCHOPHYSIOL, V86, P214, DOI 10.1016/j.ijpsycho.2012.09.006; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Heesink L, 2017, PSYCHIAT RES-NEUROIM, V266, P114, DOI 10.1016/j.pscychresns.2017.06.012; Hermans EJ, 2013, NEUROIMAGE, V66, P278, DOI 10.1016/j.neuroimage.2012.10.063; Hortensius R, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0314-16.2016; Hortensius R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0376; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Klumpers F, 2015, SOC COGN AFFECT NEUR, V10, P1161, DOI 10.1093/scan/nsu164; Klumpers F, 2010, BIOL PSYCHIAT, V68, P1031, DOI 10.1016/j.biopsych.2010.09.006; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; LeDoux JE, 2017, MOL PSYCHIATR, V22, P24, DOI 10.1038/mp.2016.166; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Low A, 2015, PSYCHOL SCI, V26, P1706, DOI 10.1177/0956797615597332; Macedo CE, 2006, BEHAV NEUROSCI, V120, P625, DOI 10.1037/0735-7044.120.3.625; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Mobbs D, 2007, SCIENCE, V317, P1079, DOI 10.1126/science.1144298; Montoya ER, 2015, HUM BRAIN MAPP, V36, P4304, DOI 10.1002/hbm.22918; Morgan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038116; Moscarello JM, 2013, J NEUROSCI, V33, P3815, DOI 10.1523/JNEUROSCI.2596-12.2013; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Solano-Castiella E, 2010, NEUROIMAGE, V49, P2958, DOI 10.1016/j.neuroimage.2009.11.027; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; van Honk J, 2002, BIOL PSYCHIAT, V52, P312, DOI 10.1016/S0006-3223(02)01346-X; van Honk J, 2013, P NATL ACAD SCI USA, V110, P2506, DOI 10.1073/pnas.1217316110; Van Hougenhouck-Tulleken W, 2004, BRIT J DERMATOL, V151, P413, DOI 10.1111/j.1365-2133.2004.06076.x; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043	50	65	65	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					723	+	e16	10.1016/j.cell.2018.09.028	http://dx.doi.org/10.1016/j.cell.2018.09.028			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340041	Green Published, hybrid			2022-12-28	WOS:000447780800015
J	Han, WF; Tellez, LA; Perkins, MH; Perez, IO; Qu, TR; Ferreira, J; Ferreira, TL; Quinn, D; Liu, ZW; Gao, XB; Kaelberer, MM; Bohorquez, DV; Shammah-Lagnado, SJ; de Lartigue, G; de Araujo, IE				Han, Wenfei; Tellez, Luis A.; Perkins, Matthew H.; Perez, Isaac O.; Qu, Taoran; Ferreira, Jozelia; Ferreira, Tatiana L.; Quinn, Daniele; Liu, Zhong-Wu; Gao, Xiao-Bing; Kaelberer, Melanie M.; Bohorquez, Diego V.; Shammah-Lagnado, Sara J.; de Lartigue, Guillaume; de Araujo, Ivan E.			A Neural Circuit for Gut-Induced Reward	CELL			English	Article							CATECHOLAMINE-CONTAINING NEURONS; ELECTRICAL SELF-STIMULATION; BRAIN COMMUNICATION; ABDOMINAL VAGUS; RAT; SYSTEM; VIRUS; TRACT; CHOLECYSTOKININ; APPETITE	The gut is now recognized as a major regulator of motivational and emotional states. However, the relevant gut-brain neuronal circuitry remains unknown. We show that optical activation of gut-innervating vagal sensory neurons recapitulates the hallmark effects of stimulating brain reward neurons. Specifically, right, but not left, vagal sensory ganglion activation sustained self-stimulation behavior, conditioned both flavor and place preferences, and induced dopamine release from Substantia nigra. Cell-specific transneuronal tracing revealed asymmetric ascending pathways of vagal origin throughout the CNS. In particular, transneuronal labeling identified the glutamatergic neurons of the dorsolateral parabrachial region as the obligatory relay linking the right vagal sensory ganglion to dopamine cells in Substantia nigra. Consistently, optical activation of parabrachio-nigral projections replicated the rewarding effects of right vagus excitation. Our findings establish the vagal gut-to-brain axis as an integral component of the neuronal reward pathway. They also suggest novel vagal stimulation approaches to affective disorders.	[Han, Wenfei; Tellez, Luis A.; Perez, Isaac O.; Qu, Taoran; Ferreira, Jozelia; Ferreira, Tatiana L.; Quinn, Daniele; de Lartigue, Guillaume; de Araujo, Ivan E.] John B Pierce Lab, New Haven, CT 06519 USA; [Han, Wenfei; Tellez, Luis A.; Ferreira, Jozelia; Ferreira, Tatiana L.; de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Han, Wenfei; Perkins, Matthew H.; de Araujo, Ivan E.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Perez, Isaac O.] Univ Nacl Autonoma Mexico, FES Iztacala, Sect Neurobiol Oral Sensat, Mexico City 04510, DF, Mexico; [Ferreira, Jozelia] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Ferreira, Tatiana L.] Fed Univ ABC, Math Comp & Cognit Ctr, Sao Paulo, Brazil; [Liu, Zhong-Wu; Gao, Xiao-Bing] Yale Univ, Dept Comparat Med, Sch Med, New Haven, CT USA; [Kaelberer, Melanie M.; Bohorquez, Diego V.] Duke Univ, Dept Med, Durham, NC USA; [Bohorquez, Diego V.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Shammah-Lagnado, Sara J.] Univ Sao Paulo, Biomed Sci Inst, Dept Physiol & Biophys, Sao Paulo, Brazil; [de Lartigue, Guillaume; de Araujo, Ivan E.] Yale Univ, Sch Med, Dept Psychol, New Haven, CT 06520 USA; [Han, Wenfei; de Araujo, Ivan E.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Han, Wenfei; de Araujo, Ivan E.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Icahn School of Medicine at Mount Sinai; Universidad Nacional Autonoma de Mexico; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Yale University; Duke University; Duke University; Universidade de Sao Paulo; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	de Araujo, IE (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; de Araujo, IE (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.; de Araujo, IE (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.; de Araujo, IE (corresponding author), Yale Univ, Sch Med, Dept Psychol, New Haven, CT 06520 USA.; de Araujo, IE (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.; de Araujo, IE (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	ivan.dearaujo@mssm.edu	Ferreira, Jozelia/C-5724-2015; de Lartigue, Guillaume/AAJ-7635-2020; Gao, Xiao-Bing/C-3121-2011; Ferreira, Tatiana L/E-3762-2013; FERREIRA, TATIANA/I-8386-2016	Ferreira, Jozelia/0000-0003-0097-3104; Gao, Xiao-Bing/0000-0002-2035-4936; Perkins, Matthew/0000-0003-4032-3771; FERREIRA, TATIANA/0000-0002-2805-513X; Perez-Martinez, Isaac/0000-0003-1063-2063; Quinn, Danielle/0000-0003-0494-9953; Tellez, Luis A/0000-0002-3101-5817; De Araujo, Ivan/0000-0003-3081-3339	NIH, United States [R01CA180030, R01DC014859, R00DK094871, R01DK116004, 1R21DA040782-01A1, K01DK103832, T32DK007568]; NATIONAL CANCER INSTITUTE [R01CA180030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK094871, T32DK007568, R01DK116004, K01DK103832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA040782] Funding Source: NIH RePORTER	NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. McDougle for assistance with behavioral assays, M. Klein and K. Buchannan for packaging the rabies constructs and vagal recordings, and members of R. Medzhitov lab (Yale) for assisting with the breathing and heart rate measurements. This work was supported by NIH, United States (R01CA180030 and R01DC014859 to I.E.d.A., R00DK094871 and R01DK116004 to G.d.L., 1R21DA040782-01A1 to X.-B.G., K01DK103832 to D.V.B., and T32DK007568 to M.M.K.).	ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; ANGYAN L, 1975, LIFE SCI, V17, P289, DOI 10.1016/0024-3205(75)90517-2; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Beutler LR, 2017, NEURON, V96, P461, DOI 10.1016/j.neuron.2017.09.043; Bohorquez DV, 2015, J CLIN INVEST, V125, P888, DOI 10.1172/JCI81121; Campos CA, 2016, CELL METAB, V23, P811, DOI 10.1016/j.cmet.2016.04.006; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Clemmensen C, 2017, CELL, V168, P758, DOI 10.1016/j.cell.2017.01.025; Coizet V, 2010, NEUROSCIENCE, V168, P263, DOI 10.1016/j.neuroscience.2010.03.049; Corbett EKA, 2005, NEUROSCIENCE, V135, P133, DOI 10.1016/j.neuroscience.2005.06.010; CROW TJ, 1973, PSYCHOL MED, V3, P66, DOI 10.1017/S0033291700046353; CROW TJ, 1971, EXPERIENTIA, V27, P662, DOI 10.1007/BF02136947; de Araujo IE, 2012, PHYSIOL BEHAV, V106, P394, DOI 10.1016/j.physbeh.2012.02.026; de Lartigue G, 2016, CURR OPIN PHARMACOL, V31, P38, DOI 10.1016/j.coph.2016.08.007; Diepenbroek C, 2017, AM J PHYSIOL-GASTR L, V313, pG342, DOI 10.1152/ajpgi.00095.2017; Farrell MS, 2013, NEUROPSYCHOPHARMACOL, V38, P854, DOI 10.1038/npp.2012.251; Franklin KBJ, 2008, THE MOUSE BRAIN IN S; Howland Robert H, 2014, Curr Behav Neurosci Rep, V1, P64; Hull C.L., 1943, PRINCIPLES BEHAV INT, DOI DOI 10.2307/1416955; INGRAM SL, 1994, NEURON, V13, P179, DOI 10.1016/0896-6273(94)90468-5; Junyent F, 2015, CURR OPIN PHARMACOL, V24, P86, DOI 10.1016/j.coph.2015.08.004; Kaur S, 2013, J NEUROSCI, V33, P7627, DOI 10.1523/JNEUROSCI.0173-13.2013; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McGovern AE, 2015, BRAIN STRUCT FUNCT, V220, P3683, DOI 10.1007/s00429-014-0883-9; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Olds J., 1976, PSYCHOPATHOLOGY HUMA; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; PEREZ C, 1991, AM J PHYSIOL, V260, pR179, DOI 10.1152/ajpregu.1991.260.1.R179; PHILLIPS AG, 1976, BRAIN RES, V104, P221, DOI 10.1016/0006-8993(76)90615-6; PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101; Puizillout J-J., 2005, CENTRAL PROJECTIONS; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Sclafani A, 2013, APPETITE, V71, P454, DOI 10.1016/j.appet.2012.05.024; SHAPIRO RE, 1985, J COMP NEUROL, V238, P473, DOI 10.1002/cne.902380411; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; SMITH GP, 1985, AM J PHYSIOL, V249, pR638, DOI 10.1152/ajpregu.1985.249.5.R638; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Su ZW, 2017, CELL REP, V21, P2724, DOI 10.1016/j.celrep.2017.11.036; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	48	279	286	15	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	2018	175	3					665	+	e23	10.1016/j.cell.2018.08.049	http://dx.doi.org/10.1016/j.cell.2018.08.049			37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX5JA	30340046	Bronze, Green Accepted			2022-12-28	WOS:000447780800011
